PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tuteja, G; Kaestner, KH				Tuteja, Geetu; Kaestner, Klaus H.			SnapShot: Forkhead transcription factors I	CELL			English	Editorial Material									Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania	Tuteja, G (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.							Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Jonsson H, 2005, CELL MOL LIFE SCI, V62, P397, DOI 10.1007/s00018-004-4365-8; Katoh M, 2004, INT J ONCOL, V25, P1495; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387	5	111	118	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6							1160.e1	10.1016/j.cell.2007.09.005	http://dx.doi.org/10.1016/j.cell.2007.09.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889656	Bronze			2022-12-01	WOS:000250507500001
J	Khanna, KM; McNamara, JT; Lefrancois, L				Khanna, Kamal M.; McNamara, Jeffery T.; Lefrancois, Leo			In situ imaging of the endogenous CD8 T cell response to infection	SCIENCE			English	Article							CLONAL EXPANSION; SPLEEN; NAIVE; DIFFERENTIATION; EXPRESSION; MIGRATION	Mounting a protective immune response is critically dependent on the orchestrated movement of cells within lymphoid organs. We report here the visualization, using major histocompatability complex class I tetramers, of the CD8-positive (CD8) T cell response in the spleens of mice to Listeria monocytogenes infection. A multistage pathway was revealed that included initial activation at the borders of the B and T cell zones followed by cluster formation with antigen-presenting cells leading to CD8 T cell exit to the red pulp via bridging channels. Strikingly, many memory CD8 T cells localized to the B cell zones and, when challenged, underwent rapid migration to the T cell zones where proliferation occurred, followed by egress via bridging channels in parallel with the primary response. Thus, the ability to track endogenous immune responses has uncovered both distinct and overlapping mechanisms and anatomical locations driving primary and secondary immune responses.	Univ Connecticut, Dept Immunol, Farmington, CT 06030 USA	University of Connecticut	Lefrancois, L (corresponding author), Univ Connecticut, Dept Immunol, Farmington, CT 06030 USA.	Llefranc@neuron.uchc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041576, P01AI056172] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI041576, R01 AI041576-06, AI56172, P01 AI056172, AI41576, P01 AI056172-05] Funding Source: Medline; PHS HHS [DRG-1886-05] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BOPUSSO P, 2003, NAT IMMUNOL, V4, P579; Garcia Z, 2007, P NATL ACAD SCI USA, V104, P4553, DOI 10.1073/pnas.0610019104; Hao Y, 2006, J EXP MED, V203, P1643, DOI 10.1084/jem.20052174; Haring JS, 2005, J IMMUNOL, V174, P6791, DOI 10.4049/jimmunol.174.11.6791; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Klonowski KD, 2006, J IMMUNOL, V177, P6738, DOI 10.4049/jimmunol.177.10.6738; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; McGavern DB, 2002, NAT IMMUNOL, V3, P918, DOI 10.1038/ni843; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; MITCHELL J, 1973, IMMUNOLOGY, V24, P93; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Potsch C, 1999, EUR J IMMUNOL, V29, P3562, DOI 10.1002/(SICI)1521-4141(199911)29:11<3562::AID-IMMU3562>3.0.CO;2-R; Skinner PJ, 2000, J IMMUNOL, V165, P613, DOI 10.4049/jimmunol.165.2.613; Unsoeld H, 2004, J IMMUNOL, V173, P3013, DOI 10.4049/jimmunol.173.5.3013; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; VANEWIJK W, 1980, CELL TISSUE RES, V212, P497, DOI 10.1007/BF00236513	20	93	93	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					116	120		10.1126/science.1146291	http://dx.doi.org/10.1126/science.1146291			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916739	Green Accepted			2022-12-01	WOS:000249915400055
J	Havas, S; Dickinson, BD; Wilson, M				Havas, Stephen; Dickinson, Barry D.; Wilson, Modena			The urgent need to reduce sodium consumption	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIETARY-SODIUM; PUBLIC-HEALTH; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; HYPERTENSION; BURDEN; PROGRAM; RISK		Amer Med Assoc, Sci Qual & Publ Hlth, Chicago, IL 60610 USA; Amer Med Assoc, Sci Policy, Chicago, IL 60610 USA; Amer Med Assoc, Profess Stand, Chicago, IL 60610 USA	American Medical Association; American Medical Association; American Medical Association	Havas, S (corresponding author), Amer Med Assoc, Sci Qual & Publ Hlth, 515 N State St, Chicago, IL 60610 USA.	stephen.havas@ama-assn.org						Appel LJ, 2006, HYPERTENSION, V47, P296, DOI 10.1161/01.HYP.0000202568.01167.B6; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; *CTR SCI PUBL INT, PET REV GRAS STAT SA; Cutler JA, 2006, HYPERTENSION, V48, P818, DOI 10.1161/01.HYP.0000245673.93844.6d; Dickinson BD, 2007, ARCH INTERN MED, V167, P1460, DOI 10.1001/archinte.167.14.1460; Food Safety Authority of Ireland, SALT HLTH REV SCI EV; Havas S, 2004, AM J PUBLIC HEALTH, V94, P19, DOI 10.2105/AJPH.94.1.19; Hoyert Donna L, 2006, Natl Vital Stat Rep, V54, P1; Institute of Medicine Food and Nutrition Board, 2004, DIET REF INT WAT POT; Joffres MR, 2007, CAN J CARDIOL, V23, P437, DOI 10.1016/S0828-282X(07)70780-8; Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mackay J, 2004, ATLAS HEART DIS STRO; MATTES RD, 1991, J AM COLL NUTR, V10, P383; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; STAMLER J, 1989, HYPERTENSION, V14, P570, DOI 10.1161/01.HYP.14.5.570; *US DHHS, HLTH PEOPL 2010, V2, pCH19; *USDA AGR RES SERV, 1997, 1994 CONT SURV FOOD, P7; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; Whelton PK, 2002, JAMA-J AM MED ASSOC, V288, P1882, DOI 10.1001/jama.288.15.1882; *WHO FOR, RED SALT INT POP REP; Young L, 2002, HEALTH PROMOT INT, V17, P13, DOI 10.1093/heapro/17.1.13	24	66	68	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2007	298	12					1439	1441		10.1001/jama.298.12.1439	http://dx.doi.org/10.1001/jama.298.12.1439			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	213WV	17895460				2022-12-01	WOS:000249698900023
J	Junt, T; Schulze, H; Chen, Z; Massberg, S; Goerge, T; Krueger, A; Wagner, DD; Graf, T; Italiano, JE; Shivdasani, RA; von Andrian, UH				Junt, Tobias; Schulze, Harald; Chen, Zhao; Massberg, Steffen; Goerge, Tobias; Krueger, Andreas; Wagner, Denisa D.; Graf, Thomas; Italiano, Joseph E., Jr.; Shivdasani, Ramesh A.; von Andrian, Ulrich H.			Dynamic visualization of thrombopoiesis within bone marrow	SCIENCE			English	Article							TRANSCRIPTION FACTOR NF-E2; IN-VIVO; PLATELET-RELEASE; PROPLATELET FORMATION; HUMAN MEGAKARYOCYTES; MICE; THROMBOCYTOPOIESIS; HEMATOPOIESIS; BIOGENESIS; CELLS	Platelets are generated from megakaryocytes (MKs) in mammalian bone marrow (BM) by mechanisms that remain poorly understood. Here we describe the use of multiphoton intravital microscopy in intact BM to visualize platelet generation in mice. MKs were observed as sessile cells that extended dynamic proplatelet-like protrusions into microvessels. These intravascular extensions appeared to be sheared from their transendothelial stems by flowing blood, resulting in the appearance of proplatelets in peripheral blood. In vitro, proplatelet production from differentiating MKs was enhanced by fluid shear. These results confirm the concept of proplatelet formation in vivo and are consistent with the possibility that blood flow-induced hydrodynamic shear stress is a biophysical determinant of thrombopoiesis.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Ctr Regulacio Genom, Barcelona 08003, Spain	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	von Andrian, UH (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	ramesh_shivdasani@dfci.harvard.edu; uva@hms.harvard.edu	Krueger, Andreas/B-9427-2009; Junt, Tobias/AAE-4389-2021; Krueger, Andreas/M-9769-2019; Graf, Thomas/B-4252-2015; von Andrian, Ulrich H/A-5775-2008; Massberg, Steffen/AAN-6054-2021	Krueger, Andreas/0000-0001-7873-7334; Krueger, Andreas/0000-0001-7873-7334; Graf, Thomas/0000-0003-2774-4117; 	NHLBI NIH HHS [HL63143, HL56949, HL068130] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056949, R56HL063143, R01HL068130, R01HL063143] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; BECKER RP, 1976, AM J ANAT, V145, P183, DOI 10.1002/aja.1001450204; Behnke O, 1998, EUR J HAEMATOL, V60, P3; Bunting S, 1997, BLOOD, V90, P3423, DOI 10.1182/blood.V90.9.3423; CHOI ES, 1995, BLOOD, V85, P402; Cramer EM, 1997, BLOOD, V89, P2336, DOI 10.1182/blood.V89.7.2336; ELDOR A, 1991, BLOOD CELLS, V17, P447; HANDAGAMA PJ, 1987, AM J VET RES, V48, P962; Howell WH, 1937, J EXP MED, V65, DOI 10.1084/jem.65.2.177; Italiano JE, 1999, J CELL BIOL, V147, P1299, DOI 10.1083/jcb.147.6.1299; Kabaya K, 1996, STEM CELLS, V14, P651, DOI 10.1002/stem.140651; KAUSHANSKY K, 1995, BLOOD, V86, P419, DOI 10.1182/blood.V86.2.419.bloodjournal862419; Kosaki G, 2005, INT J HEMATOL, V81, P208, DOI 10.1532/IJH97.04177; Larson MK, 2006, BLOOD, V108, P1509, DOI 10.1182/blood-2005-11-011957; Lecine P, 2000, BLOOD, V96, P1366, DOI 10.1182/blood.V96.4.1366.h8001366_1366_1373; Lecine P, 1998, BLOOD, V92, P1608, DOI 10.1182/blood.V92.5.1608.417k27_1608_1616; LICHTMAN MA, 1978, AM J HEMATOL, V4, P303, DOI 10.1002/ajh.2830040402; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Patel SR, 2005, BLOOD, V106, P4076, DOI 10.1182/blood-2005-06-2204; Patel SR, 2005, J CLIN INVEST, V115, P3348, DOI 10.1172/JCI26891; Poujol C, 1998, BLOOD, V92, P2012, DOI 10.1182/blood.V92.6.2012.418k28_2012_2023; RADLEY JM, 1980, BLOOD, V56, P996; Schulze H, 2006, BLOOD, V107, P3868, DOI 10.1182/blood-2005-07-2755; TAVASSOLI M, 1980, BLOOD, V55, P537; YAMADA E., 1957, ACTA ANAT, V29, P267; Zhang JH, 2007, EXP HEMATOL, V35, P490, DOI 10.1016/j.exphem.2006.11.011; ZUCKERFRANKLIN D, 1984, J CELL BIOL, V99, P390, DOI 10.1083/jcb.99.2.390	27	448	466	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2007	317	5845					1767	1770		10.1126/science.1146304	http://dx.doi.org/10.1126/science.1146304			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885137				2022-12-01	WOS:000249585900053
J	Lechene, CP; Luyten, Y; McMahon, G; Distel, DL				Lechene, Claude P.; Luyten, Yvette; McMahon, Gregory; Distel, Daniel L.			Quantitative imaging of nitrogen fixation by individual bacteria within animal cells	SCIENCE			English	Article							SYMBIOTIC MICROBIAL COMMUNITY; LYRODUS-PEDICELLATUS BIVALVIA; TEREDINIDAE; SHIPWORMS; MICROORGANISMS; PERSPECTIVES; ECOSYSTEMS; TERMITES; GILLS; GUT	Biological nitrogen fixation, the conversion of atmospheric nitrogen to ammonia for biosynthesis, is exclusively performed by a few bacteria and archaea. Despite the essential importance of biological nitrogen fixation, it has been impossible to quantify the incorporation of nitrogen by individual bacteria or to map the fate of fixed nitrogen in host cells. In this study, with multi-isotope imaging mass spectrometry we directly imaged and measured nitrogen fixation by individual bacteria within eukaryotic host cells and demonstrated that fixed nitrogen is used for host metabolism. This approach introduces a powerful way to study microbes and global nutrient cycles.	Harvard Univ, Sch Med, Natl Resource Imaging Mass Spectrometry, Cambridge, MA 02139 USA; Brigham & Womens Hosp, Cambridge, MA 02139 USA; Ctr Marine Genom Res, Ocean Genome Legacy, Ipswich, MA 01938 USA	Harvard University; Harvard University; Brigham & Women's Hospital	Lechene, CP (corresponding author), Harvard Univ, Sch Med, Natl Resource Imaging Mass Spectrometry, 65 Landsdowne St, Cambridge, MA 02139 USA.	cpl@harvard.edu; distel@oglf.org	McMahon, Greg/C-1693-2018; McMahon, Greg/C-3991-2013; Distel, Daniel/A-8047-2017	McMahon, Greg/0000-0003-3175-1512; Distel, Daniel/0000-0002-3860-194X	NIBIB NIH HHS [P41 EB001974] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001974] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; Breznak JA, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P209; CARPENTER EJ, 1975, SCIENCE, V187, P551, DOI 10.1126/science.187.4176.551; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; Daniel G, 2003, ACS SYM SER, V845, P34; DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157; Distel DL, 2003, ACS SYM SER, V845, P253; DISTEL DL, 1991, APPL ENVIRON MICROB, V57, P2376, DOI 10.1128/AEM.57.8.2376-2382.1991; Distel DL, 2002, INT J SYST EVOL MICR, V52, P2261, DOI [10.1099/ijs.0.02184-0, 10.1099/00207713-52-6-2261]; Distel DL, 2002, APPL ENVIRON MICROB, V68, P6292, DOI 10.1128/AEM.68.12.6292-6299.2002; FISHER CR, 1990, REV AQUAT SCI, V2, P399; GALLAGER SM, 1981, J EXP MAR BIOL ECOL, V52, P63, DOI 10.1016/0022-0981(81)90171-4; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; Luyten YA, 2006, APPL ENVIRON MICROB, V72, P412, DOI 10.1128/AEM.72.1.412-417.2006; McMahon G, 2006, APPL SURF SCI, V252, P6895, DOI 10.1016/j.apsusc.2006.02.170; Nardi JB, 2002, J INSECT PHYSIOL, V48, P751, DOI 10.1016/S0022-1910(02)00105-1; Noda S, 1999, APPL ENVIRON MICROB, V65, P4935; Ohkuma M, 1999, APPL ENVIRON MICROB, V65, P4926; POPHAM JD, 1973, MAR BIOL, V19, P338, DOI 10.1007/BF00348904; Rai AN, 2000, NEW PHYTOL, V147, P449, DOI 10.1046/j.1469-8137.2000.00720.x; Rynk R., 1992, ON FARM COMPOSTING H; VILLAREAL TA, 1992, NATO ADV SCI I C-MAT, V362, P163; WATERBURY JB, 1983, SCIENCE, V221, P1401, DOI 10.1126/science.221.4618.1401; Zehr JP, 2000, TRENDS MICROBIOL, V8, P68, DOI 10.1016/S0966-842X(99)01670-4; 2004, GENETICS REGULATION	26	202	208	5	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2007	317	5844					1563	1566		10.1126/science.1145557	http://dx.doi.org/10.1126/science.1145557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872448				2022-12-01	WOS:000249467900046
J	Parton, LE; Ye, CP; Coppari, R; Enriori, PJ; Choi, B; Zhang, CY; Xu, C; Vianna, CR; Balthasar, N; Lee, CE; Elmquist, JK; Cowley, MA; Lowell, BB				Parton, Laura E.; Ye, Chian Ping; Coppari, Roberto; Enriori, Pablo J.; Choi, Brian; Zhang, Chen-Yu; Xu, Chun; Vianna, Claudia R.; Balthasar, Nina; Lee, Charlotte E.; Elmquist, Joel K.; Cowley, Michael A.; Lowell, Bradford B.			Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity	NATURE			English	Article							SENSITIVE K+ CHANNELS; BETA-CELL DYSFUNCTION; UNCOUPLING PROTEIN-2; ATP CHANNELS; HYPOTHALAMIC NEURONS; WEIGHT HOMEOSTASIS; PROTON LEAK; LEPTIN; BRAIN; NUCLEUS	A subset of neurons in the brain, known as 'glucose-excited' neurons, depolarize and increase their firing rate in response to increases in extracellular glucose. Similar to insulin secretion by pancreatic beta-cells(1), glucose excitation of neurons is driven by ATP-mediated closure of ATP-sensitive potassium (K-ATP) channels(2-5). Although beta-cell-like glucose sensing in neurons is well established, its physiological relevance and contribution to disease states such as type 2 diabetes remain unknown. To address these issues, we disrupted glucose sensing in glucose-excited pro-opiomelanocortin (POMC) neurons(5) via transgenic expression of a mutant Kir6.2 subunit (encoded by the Kcnj11 gene) that prevents ATP-mediated closure of K-ATP channels(6,7). Here we show that this genetic manipulation impaired the whole-body response to a systemic glucose load, demonstrating a role for glucose sensing by POMC neurons in the overall physiological control of blood glucose. We also found that glucose sensing by POMC neurons became defective in obese mice on a high-fat diet, suggesting that loss of glucose sensing by neurons has a role in the development of type 2 diabetes. The mechanism for obesity-induced loss of glucose sensing in POMC neurons involves uncoupling protein 2 (UCP2), a mitochondrial protein that impairs glucose-stimulated ATP production(8). UCP2 negatively regulates glucose sensing in POMC neurons. We found that genetic deletion of Ucp2 prevents obesity-induced loss of glucose sensing, and that acute pharmacological inhibition of UCP2 reverses loss of glucose sensing. We conclude that obesity-induced, UCP2-mediated loss of glucose sensing in glucose-excited neurons might have a pathogenic role in the development of type 2 diabetes.	Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China; Harvard Univ, Sch Med, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, Boston, MA 02215 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Ctr Hypothalam Res, Dallas, TX 75390 USA	Oregon Health & Science University; Oregon National Primate Research Center; Nanjing University; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Cowley, MA (corresponding author), Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA.	cowleym@ohsu.edu; blowell@bidmc.harvard.edu	vianna, claudia/I-4991-2012; Cowley, Michael A/B-9428-2008; Coppari, Roberto/B-4799-2014	Cowley, Michael A/0000-0001-7811-134X; Enriori, Pablo/0000-0003-1309-2875; COPPARI, Roberto/0000-0003-1288-6948	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK053477] Funding Source: NIH RePORTER; NIDDK NIH HHS [R37 DK053477] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; ASHFORD MLJ, 1990, PFLUG ARCH EUR J PHY, V415, P479, DOI 10.1007/BF00373626; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Burdakov D, 2005, J NEUROSCI, V25, P2429, DOI 10.1523/JNEUROSCI.4925-04.2005; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Dallaporta M, 2000, NEUROSCI LETT, V278, P77, DOI 10.1016/S0304-3940(99)00898-8; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Horvath TL, 1999, J NEUROSCI, V19, P10417; Ibrahim N, 2003, ENDOCRINOLOGY, V144, P1331, DOI 10.1210/en.2002-221033; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Joseph JW, 2002, DIABETES, V51, P3211, DOI 10.2337/diabetes.51.11.3211; Kang L, 2004, DIABETES, V53, P549, DOI 10.2337/diabetes.53.3.549; Koster JC, 2000, CELL, V100, P645, DOI 10.1016/S0092-8674(00)80701-1; Koster JC, 1999, J PHYSIOL-LONDON, V515, P19, DOI 10.1111/j.1469-7793.1999.019ad.x; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Laybutt DR, 2002, J BIOL CHEM, V277, P10912, DOI 10.1074/jbc.M111751200; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Mountjoy PD, 2007, DIABETOLOGIA, V50, P168, DOI 10.1007/s00125-006-0473-3; Perkins KL, 2006, J NEUROSCI METH, V154, P1, DOI 10.1016/j.jneumeth.2006.02.010; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Richard D, 2001, BIOCHEM SOC T, V29, P812, DOI 10.1042/0300-5127:0290812; Richard D, 1998, J COMP NEUROL, V397, P549; Routh VH, 2003, DIABETES-METAB RES, V19, P348, DOI 10.1002/dmrr.404; SILVER IA, 1994, J NEUROSCI, V14, P5068; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	30	507	516	4	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					228	U7		10.1038/nature06098	http://dx.doi.org/10.1038/nature06098			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17728716				2022-12-01	WOS:000249394500052
J	Cuomo, CA; Gueldener, U; Xu, JR; Trail, F; Turgeon, BG; Di Pietro, A; Walton, JD; Ma, LJ; Baker, SE; Rep, M; Adam, G; Antoniw, J; Baldwin, T; Calvo, S; Chang, YL; DeCaprio, D; Gale, LR; Gnerre, S; Goswami, RS; Hammond-Kosack, K; Harris, LJ; Hilburn, K; Kennell, JC; Kroken, S; Magnuson, JK; Mannhaupt, G; Mauceli, E; Mewes, HW; Mitterbauer, R; Muehlbauer, G; Munsterkotter, M; Nelson, D; O'Donnell, K; Ouellet, T; Qi, WH; Quesneville, H; Roncero, MIG; Seong, KY; Tetko, IV; Urban, M; Waalwijk, C; Ward, TJ; Yao, JQ; Birren, BW; Kistler, HC				Cuomo, Christina A.; Gueldener, Ulrich; Xu, Jin-Rong; Trail, Frances; Turgeon, B. Gillian; Di Pietro, Antonio; Walton, Jonathan D.; Ma, Li-Jun; Baker, Scott E.; Rep, Martijn; Adam, Gerhard; Antoniw, John; Baldwin, Thomas; Calvo, Sarah; Chang, Yueh-Long; DeCaprio, David; Gale, Liane R.; Gnerre, Sante; Goswami, Rubella S.; Hammond-Kosack, Kim; Harris, Linda J.; Hilburn, Karen; Kennell, John C.; Kroken, Scott; Magnuson, Jon K.; Mannhaupt, Gertrud; Mauceli, Evan; Mewes, Hans-Werner; Mitterbauer, Rudolf; Muehlbauer, Gary; Muensterkoetter, Martin; Nelson, David; O'Donnell, Kerry; Ouellet, Therese; Qi, Weihong; Quesneville, Hadi; Roncero, M. Isabel G.; Seong, Kye-Yong; Tetko, Igor V.; Urban, Martin; Waalwijk, Cees; Ward, Todd J.; Yao, Jiqiang; Birren, Bruce W.; Kistler, H. Corby			The Fusarium graminearum genome reveals a link between localized polymorphism and pathogen specialization	SCIENCE			English	Article							NEUROSPORA; DNA	We sequenced and annotated the genome of the filamentous fungus Fusarium graminearum, a major pathogen of cultivated cereals. Very few repetitive sequences were detected, and the process of repeat-induced point mutation, in which duplicated sequences are subject to extensive mutation, may partially account for the reduced repeat content and apparent low number of paralogous (ancestrally duplicated) genes. A second strain of F. graminearum contained more than 10,000 single-nucleotide polymorphisms, which were frequently located near telomeres and within other discrete chromosomal segments. Many highly polymorphic regions contained sets of genes implicated in plant-fungus interactions and were unusually divergent, with higher rates of recombination. These regions of genome innovation may result from selection due to interactions of F. graminearum with its plant hosts.	Univ Minnesota, St Paul, MN 55108 USA; MIT, Broad Inst, Cambridge, MA 02142 USA; Tech Univ Munich, D-8050 Freising Weihenstephan, Germany; GSF, Natl Res Ctr Environm & Hlth, Inst Bioinformat, Neuherberg, Germany; Purdue Univ, W Lafayette, IN 47907 USA; Michigan State Univ, E Lansing, MI 48824 USA; Cornell Univ, Ithaca, NY 14853 USA; Univ Cordoba, Cordoba, Spain; Pacific NW Natl Lab, Richland, WA 99352 USA; Univ Amsterdam, NL-1012 WX Amsterdam, Netherlands; Univ Nat Resources & Appl Life Sci, BOKU, Vienna, Austria; Rothamsted Res, Harpenden, Herts, England; Agr & Agri Food Canada, Ottawa, ON, Canada; Univ Ottawa, Ottawa, ON, Canada; USDA ARS, Cereal Dis Lab, St Paul, MN 55108 USA; St Louis Univ, St Louis, MO 63103 USA; Univ Arizona, Tucson, AZ 85721 USA; Univ Tennessee, Memphis, TN 38163 USA; USDA ARS, Natl Ctr Agr Utilizat Res, Peoria, IL 61604 USA; Inst Jacques Monod, F-75251 Paris, France; Plant Res Int, Wageningen, Netherlands; Natl Acad Sci Ukraine, Inst Bioorgan Chem & Photochem, Kiev, Ukraine	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Michigan State University; Cornell University; Universidad de Cordoba; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Amsterdam; University of Natural Resources & Life Sciences, Vienna; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Agriculture & Agri Food Canada; University of Ottawa; United States Department of Agriculture (USDA); Saint Louis University; University of Arizona; University of Tennessee System; University of Tennessee Health Science Center; United States Department of Agriculture (USDA); UDICE-French Research Universities; Universite Paris Cite; National Academy of Sciences Ukraine	Kistler, HC (corresponding author), Univ Minnesota, St Paul, MN 55108 USA.	hckist@umn.edu	Baker, Scott E/X-2065-2018; Waalwijk, Cees/X-9439-2019; Kistler, Harold/AAC-1645-2019; Münsterkötter, Martin/C-5288-2017; Ma, Li-Jun/AAG-2359-2020; Cuomo, Christina/L-2222-2019; Güldener, Ulrich/G-5227-2012; Münsterkötter, Martin/L-3436-2019; Tetko, Igor V./B-1540-2010; Di Pietro, Antonio/K-9220-2014; Baker, Scott E./ABB-1635-2020; Qi, Weihong/ABC-7380-2021; Quesneville, Hadi/AAG-1048-2020; Roncero, M. Isabel G./M-2496-2014; Mewes, Hans-Werner/A-8204-2019; Urban, Martin/G-6004-2010	Baker, Scott E/0000-0001-5085-3106; Waalwijk, Cees/0000-0001-5367-2108; Kistler, Harold/0000-0001-5312-6297; Münsterkötter, Martin/0000-0002-0044-2381; Cuomo, Christina/0000-0002-5778-960X; Güldener, Ulrich/0000-0001-5052-8610; Münsterkötter, Martin/0000-0002-0044-2381; Tetko, Igor V./0000-0002-6855-0012; Di Pietro, Antonio/0000-0001-5930-5763; Baker, Scott E./0000-0001-5085-3106; Quesneville, Hadi/0000-0003-3001-4908; DeCaprio, Dave/0000-0001-8931-9461; Harris, Linda/0000-0002-9098-305X; Roncero, M. Isabel G./0000-0002-5283-7836; Ma, Li-Jun/0000-0002-2733-3708; Qi, Weihong/0000-0001-8581-908X; Broz, Karen/0000-0001-7928-7216; Adam, Gerhard/0000-0002-3008-3797; Mewes, Hans-Werner/0000-0002-9713-6398; Magnuson, Jon/0000-0001-7712-7024; Turgeon, Barbara/0000-0001-7979-7662; Hammond-Kosack, kim/0000-0002-9699-485X; Rep, Martijn/0000-0003-3608-6283; Urban, Martin/0000-0003-2440-4352; Nelson, David/0000-0003-0583-5421	BBSRC [BBS/E/C/00004880] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004880, BBS/E/C/00004187, BBS/E/C/00004494] Funding Source: Medline; NHGRI NIH HHS [U54 HG003067] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Chang DC, 2006, JAMA-J AM MED ASSOC, V296, P953, DOI 10.1001/jama.296.8.953; Dignani MC, 2004, CLIN MICROBIOL INFEC, V10, P67, DOI 10.1111/j.1470-9465.2004.00845.x; Gale LR, 2005, GENETICS, V171, P985, DOI 10.1534/genetics.105.044842; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI [10.1111/j.1364-3703.2004.00252.x, 10.1111/J.1364-3703.2004.00252.X]; Guldener U, 2006, FUNGAL GENET BIOL, V43, P316, DOI 10.1016/j.fgb.2006.01.005; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Leslie BAS., 2006, FUSARIUM LAB MANUAL, DOI [10.1002/9780470278376, DOI 10.1002/9780470278376]; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; SELKER EU, 1987, CELL, V51, P741, DOI 10.1016/0092-8674(87)90097-3; Solomon PS, 2003, MOL PLANT PATHOL, V4, P203, DOI 10.1046/j.1364-3703.2003.00161.x; WALTON JD, 1994, PLANT PHYSIOL, V104, P1113, DOI 10.1104/pp.104.4.1113; Watters MK, 1999, GENETICS, V153, P705; Winzeler EA, 2003, GENETICS, V163, P79	16	650	1051	6	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2007	317	5843					1400	1402		10.1126/science.1143708	http://dx.doi.org/10.1126/science.1143708			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209GR	17823352				2022-12-01	WOS:000249377500049
J	Thorleifsson, G; Magnusson, KP; Sulem, P; Walters, GB; Gudbjartsson, DF; Stefansson, H; Jonsson, T; Jonasdottir, A; Jonasdottir, A; Stefansdottir, G; Masson, G; Hardarson, GA; Petursson, H; Arnarsson, A; Motallebipour, M; Wallerman, O; Wadelius, C; Gulcher, JR; Thorsteinsdottir, U; Kong, A; Jonasson, F; Stefansson, K				Thorleifsson, Gudmar; Magnusson, Kristinn P.; Sulem, Patrick; Walters, G. Bragi; Gudbjartsson, Daniel F.; Stefansson, Hreinn; Jonsson, Thorlakur; Jonasdottir, Adalbjorg; Jonasdottir, Aslaug; Stefansdottir, Gerdur; Masson, Gisli; Hardarson, Gudmundur A.; Petursson, Hjorvar; Arnarsson, Arsaell; Motallebipour, Mehdi; Wallerman, Ola; Wadelius, Claes; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Jonasson, Fridbert; Stefansson, Kari			Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma	SCIENCE			English	Article							OPEN-ANGLE GLAUCOMA; PSEUDOEXFOLIATION SYNDROME; LAMINA-CRIBROSA; LYSYL-OXIDASE; IDENTIFICATION; ASSOCIATION; PREVALENCE; MUTATIONS; STABILITY; ELASTOSIS	Glaucoma is a leading cause of irreversible blindness. A genome-wide search yielded multiple single-nucleotide polymorphisms (SNPs) in the 15q24.1 region associated with glaucoma. Further investigation revealed that the association is confined to exfoliation glaucoma (XFG). Two nonsynonymous SNPs in exon 1 of the gene LOXL1 explain the association, and the data suggest that they confer risk of XFG mainly through exfoliation syndrome (XFS). About 25% of the general population is homozygous for the highest-risk haplotype, and their risk of suffering from XFG is more than 100 times that of individuals carrying only low-risk haplotypes. The population-attributable risk is more than 99%. The product of LOXL1 catalyzes the formation of elastin fibers found to be a major component of the lesions in XFG.	Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; deCODE Genet Inc, IS-101 Reykjavik, Iceland; Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden; Natl Univ Hosp Reykjavik, Dept Ophthalmol, IS-101 Reykjavik, Iceland	University of Iceland; Uppsala University; Landspitali National University Hospital	Jonasson, F (corresponding author), Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland.	fridbert@landspitali.is; kstefans@decode.is	Magnusson, Kristinn/A-6479-2011; Magnusson, Kristinn P Pétur/X-4907-2019; Stefansson, Kari/AAE-7187-2019; Jonasson, Fridbert/ABA-9889-2021; Walters, G. Bragi/L-4215-2013	Magnusson, Kristinn/0000-0003-4528-6826; Magnusson, Kristinn P Pétur/0000-0003-4528-6826; Walters, G. Bragi/0000-0002-5415-6487; Stefansson, Hreinn/0000-0002-9331-6666; Wallerman, Ola/0000-0003-1037-7904; Kong, Augustine/0000-0001-8193-5438; Gudbjartsson, Daniel/0000-0002-5222-9857				Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Hewitt AW, 2006, CLIN EXP OPHTHALMOL, V34, P472, DOI 10.1111/j.1442-9071.2006.01268.x; Jeng SM, 2007, J GLAUCOMA, V16, P117, DOI 10.1097/01.ijg.0000243470.13343.8b; Jonasson F, 2003, EYE, V17, P747, DOI 10.1038/sj.eye.6700374; Kirwan RP, 2005, MOL VIS, V11, P798; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; MANTEL N, 1959, J NATL CANCER I, V22, P719; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; NETLAND PA, 1995, OPHTHALMOLOGY, V102, P878, DOI 10.1016/S0161-6420(95)30939-6; Pena JDO, 1998, EXP EYE RES, V67, P517, DOI 10.1006/exer.1998.0539; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Ringvold A, 1999, ACTA OPHTHALMOL SCAN, V77, P371, DOI 10.1034/j.1600-0420.1999.770401.x; Ritch R, 2003, PROG RETIN EYE RES, V22, P253, DOI 10.1016/S1350-9462(02)00014-9; Schlotzer-Schrehardt U, 2006, AM J OPHTHALMOL, V141, P921, DOI 10.1016/j.ajo.2006.01.047; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Thomassin L, 2005, J BIOL CHEM, V280, P42848, DOI 10.1074/jbc.M506832200; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83; Zhang HP, 2006, HUM MOL GENET, V15, P807, DOI 10.1093/hmg/ddl024	22	504	534	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2007	317	5843					1397	1400		10.1126/science.1146554	http://dx.doi.org/10.1126/science.1146554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209GR	17690259				2022-12-01	WOS:000249377500048
J	Aricescu, AR; Siebold, C; Choudhuri, K; Chang, VT; Lu, WX; Davis, SJ; van der Merwe, PA; Jones, EY				Aricescu, A. Radu; Siebold, Christian; Choudhuri, Kaushik; Chang, Veronica T.; Lu, Weixian; Davis, Simon J.; van der Merwe, P. Anton; Jones, E. Yvonne			Structure of a tyrosine phosphatase adhesive interaction reveals a spacer-clamp mechanism	SCIENCE			English	Article							CELL-CELL ADHESION; HOMOPHILIC BINDING; PTP-MU; RPTP-MU; KAPPA; DOMAIN; EXPRESSION; JUNCTIONS; FAMILY; RHO	Cell-cell contacts are fundamental to multicellular organisms and are subject to exquisite levels of control. Human RPTP mu is a type IIB receptor protein tyrosine phosphatase that both forms an adhesive contact itself and is involved in regulating adhesion by dephosphorylating components of cadherin-catenin complexes. Here we describe a 3.1 angstrom crystal structure of the RPTPm ectodomain that forms a homophilic trans ( antiparallel) dimer with an extended and rigid architecture, matching the dimensions of adherens junctions. Cell surface expression of deletion constructs induces intercellular spacings that correlate with the ectodomain length. These data suggest that the RPTPm ectodomain acts as a distance gauge and plays a key regulatory function, locking the phosphatase to its appropriate functional location.	Univ Oxford, Canc Res UK, Receptor Struct Res Grp, Div Struct Biol, Oxford OX3 7BN, England; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	Cancer Research UK; University of Oxford; University of Oxford; University of Oxford	Jones, EY (corresponding author), Univ Oxford, Canc Res UK, Receptor Struct Res Grp, Div Struct Biol, Henry Wellcome Bldg Genom Med,Roosevelt Dr, Oxford OX3 7BN, England.	yvonne@strubi.ox.ac.uk	Jones, Yvonne/N-8111-2019; Jones, Yvonne/J-2293-2016; van der Merwe, P. Anton/F-8539-2011; Aricescu, Alexandru/L-3891-2013	Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; Aricescu, Alexandru ARadu/0000-0003-3783-1388; Choudhuri, Kaushik/0000-0002-3911-027X	MRC [G9722488, G9900061] Funding Source: UKRI; Medical Research Council [G9722488, G19/31, G9900061] Funding Source: Medline; Wellcome Trust [081894] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Anders L, 2006, MOL CELL BIOL, V26, P3917, DOI 10.1128/MCB.26.10.3917-3934.2006; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Aricescu AR, 2006, EMBO J, V25, P701, DOI 10.1038/sj.emboj.7600974; Besco J, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-14; Besco JA, 2006, BRAIN RES, V1116, P50, DOI 10.1016/j.brainres.2006.07.122; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Brady-Kalnay SM, 1998, J CELL BIOL, V141, P287, DOI 10.1083/jcb.141.1.287; BRADYKALNAY SM, 1993, J CELL BIOL, V122, P961, DOI 10.1083/jcb.122.4.961; Campan M, 1996, BIOCHEMISTRY-US, V35, P3797, DOI 10.1021/bi952552d; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Cheng J, 1997, J BIOL CHEM, V272, P7264, DOI 10.1074/jbc.272.11.7264; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Cismasiu VB, 2004, J BIOL CHEM, V279, P26922, DOI 10.1074/jbc.M313115200; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Del Vecchio RL, 2005, J BIOL CHEM, V280, P1603, DOI 10.1074/jbc.M410181200; Fuchs M, 1998, MECH DEVELOP, V70, P91, DOI 10.1016/S0925-4773(97)00179-2; Fuchs M, 1996, J BIOL CHEM, V271, P16712, DOI 10.1074/jbc.271.28.16712; GEBBINK MFBG, 1995, J CELL BIOL, V131, P251, DOI 10.1083/jcb.131.1.251; GEBBINK MFBG, 1993, J BIOL CHEM, V268, P16101; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Miyaguchi K, 2000, J STRUCT BIOL, V132, P169, DOI 10.1006/jsbi.2000.4244; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Sallee JL, 2006, J BIOL CHEM, V281, P16189, DOI 10.1074/jbc.R600003200; SAP J, 1994, MOL CELL BIOL, V14, P1; Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006; STAEHELIN LA, 1974, INT REV CYTOL, V39, P191, DOI 10.1016/S0074-7696(08)60940-7; Sui XF, 2005, AM J PATHOL, V166, P1247, DOI 10.1016/S0002-9440(10)62343-7; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Yudushkin IA, 2007, SCIENCE, V315, P115, DOI 10.1126/science.1134966; Zondag GCM, 2000, J BIOL CHEM, V275, P11264, DOI 10.1074/jbc.275.15.11264; ZONDAG GCM, 1995, J BIOL CHEM, V270, P14247, DOI 10.1074/jbc.270.24.14247	34	85	87	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2007	317	5842					1217	1220		10.1126/science.1144646	http://dx.doi.org/10.1126/science.1144646			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205PJ	17761881				2022-12-01	WOS:000249126800039
J	Betts, RA; Boucher, O; Collins, M; Cox, PM; Falloon, PD; Gedney, N; Hemming, DL; Huntingford, C; Jones, CD; Sexton, DMH; Webb, MJ				Betts, Richard A.; Boucher, Olivier; Collins, Matthew; Cox, Peter M.; Falloon, Peter D.; Gedney, Nicola; Hemming, Deborah L.; Huntingford, Chris; Jones, Chris D.; Sexton, David M. H.; Webb, Mark J.			Projected increase in continental runoff due to plant responses to increasing carbon dioxide	NATURE			English	Article							DOUBLED ATMOSPHERIC CO2; CLIMATE-CHANGE; VEGETATION FEEDBACKS; STOMATAL CONDUCTANCE; PHOTOSYNTHESIS; EVAPOTRANSPIRATION; TRANSPIRATION; MODEL	In addition to influencing climatic conditions directly through radiative forcing, increasing carbon dioxide concentration influences the climate system through its effects on plant physiology(1). Plant stomata generally open less widely under increased carbon dioxide concentration(2), which reduces transpiration(1,3-6) and thus leaves more water at the land surface(7). This driver of change in the climate system, which we term 'physiological forcing', has been detected in observational records of increasing average continental runoff over the twentieth century(8). Here we use an ensemble of experiments with a global climate model that includes a vegetation component to assess the contribution of physiological forcing to future changes in continental runoff, in the context of uncertainties in future precipitation. We find that the physiological effect of doubled carbon dioxide concentrations on plant transpiration increases simulated global mean runoff by 6 per cent relative to pre-industrial levels; an increase that is comparable to that simulated in response to radiatively forced climate change (11 +/- 6 per cent). Assessments of the effect of increasing carbon dioxide concentrations on the hydrological cycle that only consider radiative forcing(9-11) will therefore tend to underestimate future increases in runoff and overestimate decreases. This suggests that freshwater resources may be less limited than previously assumed under scenarios of future global warming, although there is still an increased risk of drought. Moreover, our results highlight that the practice of assessing the climate-forcing potential of all greenhouse gases in terms of their radiative forcing potential relative to carbon dioxide does not accurately reflect the relative effects of different greenhouse gases on freshwater resources.	Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England; Univ Exeter, Sch Engn Comp & Math, Exeter EX4 4QF, Devon, England; Met Off, Joint Ctr Hydrometeorol Res, Wallingford OX10 8BB, Oxon, England; Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England	Met Office - UK; Hadley Centre; University of Exeter; Met Office - UK; UK Centre for Ecology & Hydrology (UKCEH)	Betts, RA (corresponding author), Met Off Hadley Ctr, Fitzroy Rd, Exeter EX1 3PB, Devon, England.	richard.betts@metoffice.gov.uk	Huntingford, Christopher/A-4307-2008; Betts, Richard A/P-8976-2015; Jones, Chris/I-2983-2014; Collins, Matthew/F-8473-2011; Boucher, Olivier/K-7483-2012; Boucher, Olivier/J-5810-2012; Cox, Peter Michae;/B-3299-2012	Huntingford, Christopher/0000-0002-5941-7770; Betts, Richard A/0000-0002-4929-0307; Jones, Chris/0000-0002-7141-9285; Collins, Matthew/0000-0003-3785-6008; Boucher, Olivier/0000-0003-2328-5769; Boucher, Olivier/0000-0003-2328-5769; Cox, Peter Michae;/0000-0002-0679-2219; Falloon, Peter/0000-0001-7567-8885	Natural Environment Research Council [ceh010024, ceh010022, ceh010023] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], CLIM CHANG 1994 RAD; Betts RA, 2004, THEOR APPL CLIMATOL, V78, P157, DOI 10.1007/s00704-004-0050-y; Betts RA, 1999, GEOPHYS RES LETT, V26, P1457, DOI 10.1029/1999GL900283; Betts RA, 1997, NATURE, V387, P796, DOI 10.1038/42924; Betts RA, 2000, GLOBAL ECOL BIOGEOGR, V9, P171, DOI 10.1046/j.1365-2699.2000.00160.x; COLLATZ GJ, 1992, AUST J PLANT PHYSIOL, V19, P519, DOI 10.1071/PP9920519; COLLATZ GJ, 1991, AGR FOREST METEOROL, V54, P107, DOI 10.1016/0168-1923(91)90002-8; Compagnucci R, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, P191; Cox P.M., 2001, DESCRIPTION TRIFFID; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Cox PM, 1999, CLIM DYNAM, V15, P183, DOI 10.1007/s003820050276; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; de Wit M, 2006, SCIENCE, V311, P1917, DOI 10.1126/science.1119929; Douville H, 2000, J GEOPHYS RES-ATMOS, V105, P14841, DOI 10.1029/1999JD901086; FIELD CB, 1995, PLANT CELL ENVIRON, V18, P1214, DOI 10.1111/j.1365-3040.1995.tb00630.x; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Gedney N, 2006, NATURE, V439, P835, DOI 10.1038/nature04504; Hungate BA, 2002, GLOBAL CHANGE BIOL, V8, P289, DOI 10.1046/j.1365-2486.2002.00468.x; Jacobs C. M. J., 1994, THESIS WAGENINGEN AG; Leipprand A, 2006, HYDROLOG SCI J, V51, P171, DOI 10.1623/hysj.51.1.171; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; Roderick ML, 2002, SCIENCE, V298, P1410; Sellers PJ, 1996, SCIENCE, V271, P1402, DOI 10.1126/science.271.5254.1402; SELLERS PJ, 1992, REMOTE SENS ENVIRON, V42, P187, DOI 10.1016/0034-4257(92)90102-P; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; *UN FCCC, 1999, UNEPIUC992 UNFCCC; Warren R, 2006, AVOIDING DANGEROUS C, P93; Webb MJ, 2006, CLIM DYNAM, V27, P17, DOI 10.1007/s00382-006-0111-2; WIGLEY TML, 1985, NATURE, V314, P149, DOI 10.1038/314149a0	30	486	499	10	256	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 30	2007	448	7157					1037	U5		10.1038/nature06045	http://dx.doi.org/10.1038/nature06045			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205EU	17728755				2022-12-01	WOS:000249097600035
J	Denic, V; Weissman, JS				Denic, Vladimir; Weissman, Jonathan S.			A molecular caliper mechanism for determining very long-chain fatty acid length	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; ELONGATION; YEAST; GENE; SYNTHASE; IDENTIFICATION; DIFFERENTIATION; BIOSYNTHESIS; ORGANIZATION; PASTICCINO2	Very long-chain fatty acids ( VLCFAs) are essential lipids whose functional diversity is enabled by variation in their chain length. The full VLCFA biosynthetic machinery and how this machinery generates structural diversity remain elusive. Proteoliposomes reconstituted here from purified membrane components-an elongase protein ( Elop), a novel dehydratase, and two reductases-catalyzed repeated rounds of two-carbon addition that elongated shorter FAs into VLCFAs whose length was dictated by the specific Elop homolog present. Mutational analysis revealed that the Elop active site faces the cytosol, whereas VLCFA length is determined by a lysine near the luminal end of an Elop transmembrane helix. By stepping the lysine residue along one face of the helix toward the cytosol, we engineered novel synthases with correspondingly shorter VLCFA outputs. Thus the distance between the active site and the lysine residue determines chain length. Our results uncover a mutationally adjustable, caliper-like mechanism that generates the repertoire of cellular VLCFAs.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94158 USA; California Inst Quantitat Biomed Res, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X				Alberts B., 2002, MOL BIOL CELL; Beaudoin F, 2000, P NATL ACAD SCI USA, V97, P6421, DOI 10.1073/pnas.110140197; Beaudoin F, 2002, J BIOL CHEM, V277, P11481, DOI 10.1074/jbc.M111441200; Bellec Y, 2002, PLANT J, V32, P713, DOI 10.1046/j.1365-313X.2002.01456.x; BROWSE J, 1986, ANAL BIOCHEM, V152, P141, DOI 10.1016/0003-2697(86)90132-6; Cane DE, 1998, SCIENCE, V282, P63, DOI 10.1126/science.282.5386.63; CINTI DL, 1992, PROG LIPID RES, V31, P1, DOI 10.1016/0163-7827(92)90014-A; Da Costa M, 2006, PLANT CELL, V18, P1426, DOI 10.1105/tpc.105.040485; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Graham IA, 2007, CURR OPIN BIOTECH, V18, P142, DOI 10.1016/j.copbio.2007.01.014; Han GS, 2002, J BIOL CHEM, V277, P35440, DOI 10.1074/jbc.M205620200; Ivessa AS, 1997, EUR J CELL BIOL, V74, P399; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Kemp S, 2005, MOL GENET METAB, V84, P144, DOI 10.1016/j.ymgme.2004.09.015; Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Leonard AE, 2004, PROG LIPID RES, V43, P36, DOI 10.1016/S0163-7827(03)00040-7; Leonard AE, 2002, LIPIDS, V37, P733, DOI 10.1007/s11745-002-0955-6; Lester RL, 2001, ANAL BIOCHEM, V298, P283, DOI 10.1006/abio.2001.5368; Livore VI, 2007, FEBS J, V274, P264, DOI 10.1111/j.1742-4658.2006.05581.x; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; Matsuoka K, 2000, METHODS, V20, P417, DOI 10.1006/meth.2000.0955; McMahon A, 2007, MOL VIS, V13, P258; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; NUGTEREN DH, 1965, BIOCHIM BIOPHYS ACTA, V106, P280, DOI 10.1016/0005-2760(65)90036-6; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Paul S, 2006, J BIOL CHEM, V281, P9018, DOI 10.1074/jbc.M507723200; Pecoul B, 2004, PLOS MED, V1, P19, DOI 10.1371/journal.pmed.0010006; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; POULOS A, 1992, ADV EXP MED BIOL, V318, P331; Puyaubert J, 2005, EUR J LIPID SCI TECH, V107, P263, DOI 10.1002/ejlt.200590024; Rossler H, 2003, MOL GENET GENOMICS, V269, P290, DOI 10.1007/s00438-003-0836-0; Schneiter R, 2004, BIOCHEM J, V381, P941, DOI 10.1042/BJ20040320; Schneiter R, 1996, MOL CELL BIOL, V16, P7161; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Toulmay A, 2007, BIOCHIMIE, V89, P249, DOI 10.1016/j.biochi.2006.07.020; TSUJI S, 1984, J BIOCHEM-TOKYO, V96, P1241, DOI 10.1093/oxfordjournals.jbchem.a134942; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Vasireddy V, 2007, HUM MOL GENET, V16, P471, DOI 10.1093/hmg/ddl480; WELCH JW, 1973, J BACTERIOL, V115, P464, DOI 10.1128/JB.115.1.464-466.1973; Westerberg R, 2006, J BIOL CHEM, V281, P4958, DOI 10.1074/jbc.M511588200; Wu GH, 2005, NAT BIOTECHNOL, V23, P1013, DOI 10.1038/nbt1107	50	192	230	7	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2007	130	4					663	677		10.1016/j.cell.2007.06.031	http://dx.doi.org/10.1016/j.cell.2007.06.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	208KY	17719544	Bronze			2022-12-01	WOS:000249319400017
J	Linder, JF; Meyers, FJ				Linder, John F.; Meyers, Frederick J.			Palliative care for prison inmates - "Don't let me die in prison"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE CARE; HEALTH-CARE; ACADEMIC MEDICINE; COMMUNITY-HEALTH; SYSTEM; POPULATION; RELEASE; IMPACT; JAILS; WOMEN	The number of older inmates in US correctional facilities is increasing and with it the need for quality palliative health care services. Morbidity and mortality are high in this population. Palliative care in the correctional setting includes most of the challenges faced in the free-living community and several unique barriers to inmate care. Successful models of hospice care in prisons have been established and should be disseminated and evaluated. This article highlights why the changing demo-graphics of prison populations necessitates hospice in this setting and highlights many of the barriers that correctional and consulting physicians face while providing palliative care. Issues specific to palliative care and hospice in prison include palliative care standards, inmate-physician and inmate-family relationships, confidentiality, interdisciplinary care, do-not-resuscitate orders and advance medical directives, medical parole, and the use of inmate volunteers in prison hospice programs. We also include practical recommendations to community-based physicians working with incarcerated or recently released prisoners and describe solutions that can be implemented on an individual and systems basis.	Univ Calif Davis, Dept Internal Med, Div Hematol & Oncol, Ctr Canc, Sacramento, CA 95864 USA; Univ Calif Davis, Smith Coll, Sch Social Work, Ctr Canc, Sacramento, CA 95864 USA	University of California System; University of California Davis; Smith College; University of California System; University of California Davis	Meyers, FJ (corresponding author), Univ Calif Davis, Dept Internal Med, Div Hematol & Oncol, Ctr Canc, 4150 V St,3100, Sacramento, CA 95864 USA.	fred.meyers@ucdmc.ucdavis.edu						*AM BOARD HOSP PAL, 2007, PHYS BOARD CERT HOSP; *AM MED ASS, 2007, COD ETH POL FIND; *AMA COUNC ETH JUD, 2005, COLL ACT PAT ADV; Anno BJ., 2004, J CORRECT HEALTH CAR, V10, P287; ANNO BJ, 2004, ADDRESSING NEEDS ELD, P162; BARENS E, 1998, ANGOLA PRISON HOSPIC; BARNARD J, 1999, CONVICTED MURDERERS; Bauersmith Joan, 2002, J Palliat Med, V5, P667, DOI 10.1089/109662102320880471; BECK A, 1995, PRISONERS 1994, P15; BECK A, 2001, PRISONERS 2000, P16; Beck JA, 1999, J LAW MED ETHICS, V27, P216, DOI 10.1111/j.1748-720X.1999.tb01455.x; Bennett Ian M, 2003, Cancer Control, V10, P81; Bick J., 2002, J CORRECT HEALTH CAR, V9, P131; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Bond GD, 2005, INT J AGING HUM DEV, V61, P161, DOI 10.2190/7H5P-2AHJ-L34Q-GW9U; Boyle Barbara A, 2002, J Palliat Med, V5, P671, DOI 10.1089/109662102320880480; Brunicardi BO, 1998, TELEMED J, V4, P49, DOI 10.1089/tmj.1.1998.4.49; Byock Ira, 2002, Correctcare, V16, P18; Byock I, 2006, J PALLIAT MED, V9, P137, DOI 10.1089/jpm.2006.9.137; *CDC, 2003, DEATHS PERC TOT DEAT; *CDC, 2004, DEATHS PERC TOT DEAT; *CDC, 2002, DEATHS PERC TOT DEAT; *CDC, 2001, DEATHS PERC TOT DEAT; *CDCP, 2007, HLTH ISS CORR; Chandler Cynthia, 2003, Berkeley Womens Law J, V18, P40; Cohn F, 1999, J LAW MED ETHICS, V27, P252, DOI 10.1111/j.1748-720X.1999.tb01459.x; Craig E., 2002, J CORRECT HEALTH CAR, V9, P149; CUMMINGS C, 1999, OLDER INMATES IMPACT, P87; Dubler NN, 1998, J LAW MED ETHICS, V26, P149, DOI 10.1111/j.1748-720X.1998.tb01670.x; Enders Sheila R, 2005, J Palliat Med, V8, P432, DOI 10.1089/jpm.2005.8.432; ENDERS SR, 2004, SIMPLE ANSWERS DIFFI, P100; Evans Carol, 2002, J Palliat Med, V5, P553, DOI 10.1089/109662102760269797; Falter Robert G., 1999, J CORRECT HEALTH CAR, V6, P149, DOI [DOI 10.1177/107834589900600202, 10.1177/107834589900600202]; Fazel S, 2001, AGE AGEING, V30, P403, DOI 10.1093/ageing/30.5.403; Freudenberg N, 2001, J URBAN HEALTH, V78, P214, DOI 10.1093/jurban/78.2.214; Gelband H, 2001, IMPROVING PALLIATIVE, P344; Haigler KO, 1994, LITERACY PRISON WALL, P187; Harris F, 2007, HEALTH SOC CARE COMM, V15, P56, DOI 10.1111/j.1365-2524.2006.00662.x; HARRISON P, 2006, PRISONERS 2005, P13; Head Barbara., 2005, J HOSPICE PALLIATIVE, V7, P354, DOI [10.1097/00129191-200511000-00016, DOI 10.1097/00129191-200511000-00016]; Hornblum AM, 1997, BRIT MED J, V315, P1437, DOI 10.1136/bmj.315.7120.1437; Kendig NE, 2004, JAMA-J AM MED ASSOC, V292, P501, DOI 10.1001/jama.292.4.501; KING AEO, 1993, FAM SOC-J CONTEMP H, V74, P145, DOI 10.1177/104438949307400302; KINSELLA C, 2004, CORRECTIONS HLTH CAR, P38; La Vigne N. G., 2005, J CONTEMP CRIM JUST, V21, P314, DOI [10.1177/1043986205281727, DOI 10.1177/1043986205281727]; Linder John F, 2002, J Palliat Med, V5, P903, DOI 10.1089/10966210260499096; Linder John F, 2002, J Palliat Med, V5, P549, DOI 10.1089/109662102760269788; Maeve MK, 1999, CRIME LAW SOCIAL CH, V31, P49, DOI 10.1023/A:1008376229520; Magee CG, 2005, AM J PUBLIC HEALTH, V95, P1712, DOI 10.2105/AJPH.2005.063677; Mathew P, 2005, CANCER-AM CANCER SOC, V104, P2197, DOI 10.1002/cncr.21468; McCue M J, 1997, Telemed J, V3, P11, DOI 10.1089/tmj.1.1997.3.11; Meyers FJ, 2003, J CLIN ONCOL, V21, P1412, DOI 10.1200/JCO.2003.01.104; MEYERS FJ, 2002, 38 ANN AM SOC CLIN O; Mitka M, 2004, JAMA-J AM MED ASSOC, V292, P423, DOI 10.1001/jama.292.4.423; MUMOLA C, 1997, PRISONERS 1996, P15; MUMOLA CJ, 2007, MED CAUSES DEATH STA, P12; NACCI P, 2002, IMPLEMENTING TELEMED, P73; National Commission on Correctional Health Care, 2003, STAND HLTH SERV PRIS; Parker FR, 1999, J LAW MED ETHICS, V27, P240, DOI 10.1111/j.1748-720X.1999.tb01458.x; *PARTN CLEAR HLTH, 2003, ER LOW HLTH LIT 1 PU; PUISIS M, 2006, CLIN PRACTICE CORREC, P608; Raimer BG, 2004, JAMA-J AM MED ASSOC, V292, P485, DOI 10.1001/jama.292.4.485; Ratcliff M, 2000, J Palliat Med, V3, P509, DOI 10.1089/jpm.2000.3.4.509; Ratcliff Margaret, 2004, J Palliat Med, V7, P373; Reviere R, 2004, J WOMEN AGING, V16, P55, DOI 10.1300/J074v16n01_05; Smith B. V., 1994, AIDS and Public Policy Journal, V9, P78; STEPHAN J, 2004, STATE PRISONER EXPEN, P9; Taylor Mark, 2007, Mod Healthc, V37, P25; Udesky L, 2005, LANCET, V366, P796, DOI 10.1016/S0140-6736(05)67197-8; *US DEP JUST, 1998, HOSP PALL CAR PRIS S; Voelker R, 2004, JAMA-J AM MED ASSOC, V291, P1549, DOI 10.1001/jama.291.13.1549; Watson R, 2004, INT J NURS STUD, V41, P119, DOI 10.1016/S0020-7489(03)00128-7; Weatherhead Kendra, 2003, Health Matrix Clevel, V13, P429; *WHO, 1990, CANC PAIN REL PALL C, P75; Yorston GA, 2006, J AM ACAD PSYCHIATRY, V34, P333; Zigmond Jessica, 2007, Mod Healthc, V37, P54; 2000, INNOVATIONS END OF L	77	45	45	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2007	298	8					894	901		10.1001/jama.298.8.894	http://dx.doi.org/10.1001/jama.298.8.894			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202CS	17712073				2022-12-01	WOS:000248880200023
J	Clantin, B; Delattre, AS; Rucktooa, P; Saint, N; Meli, AC; Locht, C; Jacob-Dubuisson, F; Villeret, V				Clantin, Bernard; Delattre, Anne-Sophie; Rucktooa, Prakash; Saint, Nathalie; Meli, Albano C.; Locht, Camille; Jacob-Dubuisson, Francoise; Villeret, Vincent			Structure of the membrane protein FhaC: A member of the Omp85-TpsB transporter superfamily	SCIENCE			English	Article							CONSERVED BACTERIAL PROTEIN; LARGER PORE-SIZE; OUTER-MEMBRANE; FILAMENTOUS HEMAGGLUTININ; 2-PARTNER SECRETION; FUNCTIONAL-CHARACTERIZATION; BORDETELLA-PERTUSSIS; ESCHERICHIA-COLI; BIOGENESIS; DOMAIN	In Gram-negative bacteria and eukaryotic organelles, beta-barrel proteins of the outer membrane protein 85-two-partner secretion B (Omp85-TpsB) superfamily are essential components of protein transport machineries. The TpsB transporter FhaC mediates the secretion of Bordetella pertussis filamentous hemagglutinin (FHA). We report the 3.15 angstrom crystal structure of FhaC. The transporter comprises a 16-stranded beta barrel that is occluded by an N-terminal alpha helix and an extracellular loop and a periplasmic module composed of two aligned polypeptide-transport-associated (POTRA) domains. Functional data reveal that FHA binds to the POTRA 1 domain via its N-terminal domain and likely translocates the adhesin-repeated motifs in an extended hairpin conformation, with folding occurring at the cell surface. General features of the mechanism obtained here are likely to apply throughout the superfamily.	Univ Lille 2, UMR8161, CNRS, Inst Biol Lille, F-59021 Lille, France; Inst Pasteur, F-59019 Lille, France; IFR142, F-59019 Lille, France; INSERM, U629, F-59019 Lille, France; INSERM, U629, F-34090 Montpellier, France; INSERM, U554, F-34090 Montpellier, France; Univ Montpellier 1, CNRS, UMR5048, Montpellier, France; Univ Montpellier 2, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier	Jacob-Dubuisson, F (corresponding author), Univ Lille 2, UMR8161, CNRS, Inst Biol Lille, 1 Rue Prof Calmette, F-59021 Lille, France.	francoise.jacob@ibl.fr; vincent.villeret@ibl.fr	Locht, Camille/L-3516-2018; Meli, Albano C./O-7647-2018; Jacob-Dubuisson, Françoise/F-1610-2018; Saint, Nathalie/S-5286-2016	Meli, Albano C./0000-0002-1727-3027; Jacob-Dubuisson, Françoise/0000-0002-5102-1704; Saint, Nathalie/0000-0001-5219-9486; Rucktooa, Prakash/0000-0003-2050-7389; Villeret, Vincent/0000-0003-4504-056X; Locht, Camille/0000-0001-7295-7336				Bolter B, 1998, P NATL ACAD SCI USA, V95, P15831, DOI 10.1073/pnas.95.26.15831; Clantin B, 2004, P NATL ACAD SCI USA, V101, P6194, DOI 10.1073/pnas.0400291101; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Guedin S, 2000, J BIOL CHEM, V275, P30202, DOI 10.1074/jbc.M005515200; Hinnah SC, 1997, EMBO J, V16, P7351, DOI 10.1093/emboj/16.24.7351; Hodak H, 2006, MOL MICROBIOL, V61, P368, DOI 10.1111/j.1365-2958.2006.05242.x; Jacob-Dubuisson F, 2004, BBA-MOL CELL RES, V1694, P235, DOI 10.1016/j.bbamcr.2004.03.008; Kajava AV, 2001, MOL MICROBIOL, V42, P279, DOI 10.1046/j.1365-2958.2001.02598.x; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Lou KL, 1996, J BIOL CHEM, V271, P20669, DOI 10.1074/jbc.271.34.20669; Mazar J, 2006, MOL MICROBIOL, V62, P641, DOI 10.1111/j.1365-2958.2006.05392.x; Meli AC, 2006, J BIOL CHEM, V281, P158, DOI 10.1074/jbc.M508524200; Moslavac S, 2005, FEBS J, V272, P1367, DOI 10.1111/j.1742-4658.2005.04569.x; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Phale PS, 1997, P NATL ACAD SCI USA, V94, P6741, DOI 10.1073/pnas.94.13.6741; Saint N, 1996, J BIOL CHEM, V271, P20676, DOI 10.1074/jbc.271.34.20676; Sanchez-Pulido L, 2003, TRENDS BIOCHEM SCI, V28, P523, DOI 10.1016/j.tibs.2003.08.003; Van Gelder P, 2000, BIOPHYS CHEM, V85, P153, DOI 10.1016/S0301-4622(99)00153-2; Voulhoux R, 2004, RES MICROBIOL, V155, P129, DOI 10.1016/j.resmic.2003.11.007; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Yen MR, 2002, BBA-BIOMEMBRANES, V1562, P6, DOI 10.1016/S0005-2736(02)00359-0	25	208	212	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					957	961		10.1126/science.1143860	http://dx.doi.org/10.1126/science.1143860			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702945				2022-12-01	WOS:000248780200043
J	Airan, RD; Meltzer, LA; Roy, M; Gong, YQ; Chen, H; Deisseroth, K				Airan, Raag D.; Meltzer, Leslie A.; Roy, Madhuri; Gong, Yuqing; Chen, Han; Deisseroth, Karl			High-speed Imaging reveals neurophysiological links to behavior in an animal model of depression	SCIENCE			English	Article							HIPPOCAMPAL NEUROGENESIS; MAJOR DEPRESSION; STRESS; CELLS	The hippocampus is one of several brain areas thought to play a central role in affective behaviors, but the underlying local network dynamics are not understood. We used quantitative voltage-sensitive dye imaging to probe hippocampal dynamics with millisecond resolution in brain slices after bidirectional modulation of affective state in rat models of depression. We found that a simple measure of real-time activity-stimulus-evoked percolation of activity through the dentate gyrus relative to the hippocampal output subfield-accounted for induced changes in animal behavior independent of the underlying mechanism of action of the treatments. Our results define a circuit-level neurophysiological endophenotype for affective behavior and suggest an approach to understanding circuit-level substrates underlying psychiatric disease symptoms.	Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; Stanford Univ, Program Neurosci, Stanford, CA 94305 USA; Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; Stanford Univ, Dept Stat, Stanford, CA 94305 USA; Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	Yan, Shuo/B-8381-2009	Airan, Raag/0000-0001-5259-5606				Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; BIRNSTIEL S, 1995, SYNAPSE, V20, P117, DOI 10.1002/syn.890200204; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Cowan WM, 2000, ANNU REV NEUROSCI, V23, P343, DOI 10.1146/annurev.neuro.23.1.343; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Hasselmo ME, 2005, NEURAL NETWORKS, V18, P1172, DOI 10.1016/j.neunet.2005.08.007; Henn FA, 2004, BIOL PSYCHIAT, V56, P146, DOI 10.1016/j.biopsych.2004.04.011; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lopez-Rubalcava C, 2000, NEUROPSYCHOPHARMACOL, V22, P191, DOI 10.1016/S0893-133X(99)00100-1; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Tecott LH, 2004, NAT NEUROSCI, V7, P462, DOI 10.1038/nn1225; Walling SG, 2004, J NEUROSCI, V24, P598, DOI 10.1523/JNEUROSCI.4426-03.2004; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097	26	306	312	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2007	317	5839					819	823		10.1126/science.1144400	http://dx.doi.org/10.1126/science.1144400			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17615305				2022-12-01	WOS:000248624500045
J	Fountain, SJ; Parkinson, K; Young, MT; Cao, LS; Thompson, CRL; North, RA				Fountain, Samuel J.; Parkinson, Katie; Young, Mark T.; Cao, Lishuang; Thompson, Christopher R. L.; North, R. Alan			An intracellular P2X receptor required for osmoregulation in Dictyostelium discoideum	NATURE			English	Article							CONTRACTILE VACUOLE; ION CHANNELS; MOLECULAR-PROPERTIES; MEMBRANE; TRIMERS; PROTEIN; MOTIF; LVSA	P2X receptors are membrane ion channels gated by extracellular ATP(1,2) that are found widely in vertebrates, but not previously in microbes. Here we identify a weakly related gene in the genome of the social amoeba Dictyostelium discoideum, and show, with the use of heterologous expression in human embryonic kidney cells, that it encodes a membrane ion channel activated by ATP (30-100 mu M). Site-directed mutagenesis revealed essential conservation of structure-function relations with P2X receptors of higher organisms. The receptor was insensitive to the usual P2X antagonists(3) but was blocked by nanomolar concentrations of Cu2+ ions. In D. discoideum, the receptor was found on intracellular membranes, with prominent localization to an osmoregulatory organelle, the contractile vacuole. Targeted disruption of the gene in D. discoideum resulted in cells that were unable to regulate cell volume in hypotonic conditions. Cell swelling in these mutant cells was accompanied by a marked inhibition of contractile vacuole emptying. These findings demonstrate a new functional role for P2X receptors on intracellular organelles, in this case in osmoregulation.	Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Thompson, CRL (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	christopher.thompson@manchester.ac.uk; r.a.north@manchester.ac.uk	Fountain, Samuel J/C-2142-2011; Young, Mark T/E-8928-2010; North, Richard/GQA-6156-2022	Young, Mark T/0000-0002-9615-9002; 	Medical Research Council [G0400103, G0400103(70396)] Funding Source: Medline; Wellcome Trust [074950] Funding Source: Medline; MRC [G0400103] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allen RD, 2000, BIOESSAYS, V22, P1035; Allen RD, 2002, INT REV CYTOL, V215, P351; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Chaumont S, 2004, J BIOL CHEM, V279, P29628, DOI 10.1074/jbc.M403940200; Coddou C, 2003, J BIOL CHEM, V278, P36777, DOI 10.1074/jbc.M305177200; Gerald NJ, 2002, TRAFFIC, V3, P50, DOI 10.1034/j.1600-0854.2002.30107.x; Gever JR, 2006, PFLUG ARCH EUR J PHY, V452, P513, DOI 10.1007/s00424-006-0070-9; Heuser J, 2006, EUR J CELL BIOL, V85, P859, DOI 10.1016/j.ejcb.2006.05.011; Jentsch TJ, 2004, NAT CELL BIOL, V6, P1039, DOI 10.1038/ncb1104-1039; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Masse K, 2006, GENOMICS, V87, P366, DOI 10.1016/j.ygeno.2005.11.003; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Roberts JA, 2006, PFLUG ARCH EUR J PHY, V452, P486, DOI 10.1007/s00424-006-0073-6; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Wu WI, 2004, TRAFFIC, V5, P346, DOI 10.1111/j.1600-0854.2004.00177.x; ZHU QL, 1992, J CELL BIOL, V118, P347, DOI 10.1083/jcb.118.2.347	19	115	118	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2007	448	7150					200	203		10.1038/nature05926	http://dx.doi.org/10.1038/nature05926			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17625565	Green Accepted			2022-12-01	WOS:000247934500044
J	Colon-Ramos, DA; Margeta, MA; Shen, K				Colon-Ramos, Daniel A.; Margeta, Milica A.; Shen, Kang			Glia promote local synaptogenesis through UNC-6 (netrin) signaling in C-elegans	SCIENCE			English	Article							NERVOUS-SYSTEM; C-ELEGANS; CAENORHABDITIS-ELEGANS; COLORECTAL-CANCER; SYNAPSE FORMATION; RECEPTORS; NEURONS; AXONS; CUES; MORPHOGENESIS	Neural circuits are assembled through the coordinated innervation of pre- and postsynaptic partners. We show that connectivity between two interneurons, AIY and RIA, in Caenorhabditis elegans is orchestrated by a pair of glial cells that express UNC-6 (netrin). In the postsynaptic neuron RIA, the netrin receptor UNC-40 (DCC, deleted in colorectal cancer) plays a conventional guidance role, directing outgrowth of the RIA process ventrally toward the glia. In the presynaptic neuron AIY, UNC-40 (DCC) plays an unexpected and previously uncharacterized role: It cell-autonomously promotes assembly of presynaptic terminals in the immediate vicinity of the glial cell endfeet. These results indicate that netrin can be used both for guidance and local synaptogenesis and suggest that glial cells can function as guideposts during the assembly of neural circuits in vivo.	Stanford Univ, Dept Biol Sci, Herrin Labs 144, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Shen, K (corresponding author), Stanford Univ, Dept Biol Sci, Herrin Labs 144, Stanford, CA 94305 USA.	kangshen@stanford.edu		Margeta, Milica/0000-0002-5902-4168	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS057931] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM007365] Funding Source: Medline; NINDS NIH HHS [K99 NS057931-01, K99 NS057931] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Allen NJ, 2005, CURR OPIN NEUROBIOL, V15, P542, DOI 10.1016/j.conb.2005.08.006; Baker KA, 2006, CURR OPIN NEUROBIOL, V16, P529, DOI 10.1016/j.conb.2006.08.002; Bloch-Gallego E, 1999, J NEUROSCI, V19, P4407; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Freeman MR, 2006, CURR OPIN NEUROBIOL, V16, P119, DOI 10.1016/j.conb.2005.12.004; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Juttner R, 2005, CELL MOL LIFE SCI, V62, P2811, DOI 10.1007/s00018-005-5299-5; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Komiyama T, 2006, CURR OPIN NEUROBIOL, V16, P67, DOI 10.1016/j.conb.2005.12.002; Leonardo ED, 1997, COLD SPRING HARB SYM, V62, P467; Murai KK, 2004, NEUROSCIENTIST, V10, P304, DOI 10.1177/1073858403262221; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; Salie R, 2005, NEURON, V45, P189, DOI 10.1016/j.neuron.2005.01.002; Shaham S, 2006, CURR OPIN NEUROBIOL, V16, P522, DOI 10.1016/j.conb.2006.08.001; Strickland P, 2006, DEVELOPMENT, V133, P823, DOI 10.1242/dev.02261; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1983, COLD SPRING HARB SYM, V48, P633, DOI 10.1101/SQB.1983.048.01.067; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Yochem J, 2003, DEVELOPMENT, V130, P4761, DOI 10.1242/dev.00701	27	200	201	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847					103	106		10.1126/science.1143762	http://dx.doi.org/10.1126/science.1143762			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916735	Green Accepted			2022-12-01	WOS:000249915400051
J	Jensen, K; Call, J; Tomasello, M				Jensen, Keith; Call, Josep; Tomasello, Michael			Chimpanzees are rational maximizers in an ultimatum game	SCIENCE			English	Article							ALTRUISTIC PUNISHMENT; GROUP MEMBERS; RECIPROCITY; EVOLUTION; COOPERATION; TOLERANCE; ECONOMICS; INEQUITY; FAIRNESS; CHILDREN	Traditional models of economic decision-making assume that people are self-interested rational maximizers. Empirical research has demonstrated, however, that people will take into account the interests of others and are sensitive to norms of cooperation and fairness. In one of the most robust tests of this finding, the ultimatum game, individuals will reject a proposed division of a monetary windfall, at a cost to themselves, if they perceive it as unfair. Here we show that in an ultimatum game, humans' closest living relatives, chimpanzees (Pan troglodytes), are rational maximizers and are not sensitive to fairness. These results support the hypothesis that other-regarding preferences and aversion to inequitable outcomes, which play key roles in human social organization, distinguish us from our closest living relatives.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	Max Planck Society	Jensen, K (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.	jensen@eva.mpg.de	Galantucci, Bruno/E-5770-2010	Call Balaguer, Josep/0000-0002-8597-8336				BOLTON GE, 1995, GAME ECON BEHAV, V10, P95, DOI 10.1006/game.1995.1026; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; BOYSEN ST, 1989, J COMP PSYCHOL, V103, P23, DOI 10.1037/0735-7036.103.1.23; Brauer J, 2006, P ROY SOC B-BIOL SCI, V273, P3123, DOI 10.1098/rspb.2006.3693; Brosnan SF, 2005, P ROY SOC B-BIOL SCI, V272, P253, DOI 10.1098/rspb.2004.2947; Camerer ColinF., 2003, BEHAV GAME THEORY EX; Falk A, 2006, GAME ECON BEHAV, V54, P293, DOI 10.1016/j.geb.2005.03.001; Falk A, 2003, ECON INQ, V41, P20, DOI 10.1093/ei/41.1.20; Fehr E, 1998, EUR ECON REV, V42, P845, DOI 10.1016/S0014-2921(97)00131-1; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; FRANK RH, 1987, AM ECON REV, V77, P593; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hanus D, 2007, J COMP PSYCHOL, V121, P241, DOI 10.1037/0735-7036.121.3.241; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Jensen K, 2006, P ROY SOC B-BIOL SCI, V273, P1013, DOI 10.1098/rspb.2005.3417; Jensen K, 2007, P NATL ACAD SCI USA, V104, P13046, DOI 10.1073/pnas.0705555104; Melis AP, 2006, ANIM BEHAV, V72, P275, DOI 10.1016/j.anbehav.2005.09.018; Murnighan JK, 1998, J ECON PSYCHOL, V19, P415, DOI 10.1016/S0167-4870(98)00017-8; Nishida T, 1999, ANTHROPOL SCI, V107, P141, DOI 10.1537/ase.107.141; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; RABIN M, 1993, AM ECON REV, V83, P1281; Shinada M, 2004, EVOL HUM BEHAV, V25, P379, DOI 10.1016/j.evolhumbehav.2004.08.001; Silk JB, 2005, NATURE, V437, P1357, DOI 10.1038/nature04243; Stevens JR, 2002, BEHAV ECOL, V13, P393, DOI 10.1093/beheco/13.3.393; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; WARNEKEN F, 2007, PLOS BIOL, V5, P1414, DOI ARTN e184	33	229	234	6	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847					107	109		10.1126/science.1145850	http://dx.doi.org/10.1126/science.1145850			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916736				2022-12-01	WOS:000249915400052
J	Tabuchi, K; Blundell, J; Etherton, MR; Hammer, RE; Liu, XR; Powell, CM; Sudhof, TC				Tabuchi, Katsuhiko; Blundell, Jacqueline; Etherton, Mark R.; Hammer, Robert E.; Liu, Xinran; Powell, Craig M.; Suedhof, Thomas C.			Neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice	SCIENCE			English	Article							NEUREXINS; SYNAPSES; BALANCE; BINDING; PSD-95; GENES; MODEL; NLGN4	Autism spectrum disorders (ASDs) are characterized by impairments in social behaviors that are sometimes coupled to specialized cognitive abilities. A small percentage of ASD patients carry mutations in genes encoding neuroligins, which are postsynaptic cell-adhesion molecules. We introduced one of these mutations into mice: the Arg(451)-> Cys(451) (R451C) substitution in neuroligin-3. R451C mutant mice showed impaired social interactions but enhanced spatial learning abilities. Unexpectedly, these behavioral changes were accompanied by an increase in inhibitory synaptic transmission with no apparent effect on excitatory synapses. Deletion of neuroligin-3, in contrast, did not cause such changes, indicating that the R451C substitution represents a gain-of-function mutation. These data suggest that increased inhibitory synaptic transmission may contribute to human ASDs and that the R451C knockin mice may be a useful model for studying autism-related behaviors.	Univ Texas, SW Med Ctr, Dept Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Dept Neurosci, Dallas, TX 75390 USA.	thomas.sudhof@utsouthwestern.edu		Powell, Craig/0000-0001-5451-2165	NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH065975, R37MH052804, R01MH081164] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [K08 MH065975, K08 MH065975-05, K08 MH065975-04, R37 MH052804, R01 MH081164, R37 MH52804-08] Funding Source: Medline; Autism Speaks [AS1264] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Autism Speaks		American Psychiatric Association, 2002, DIAGN STAT MAN MENT, Vfifth; Belmonte MK, 2006, NAT NEUROSCI, V9, P1221, DOI 10.1038/nn1765; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Garber K, 2007, SCIENCE, V317, P190, DOI 10.1126/science.317.5835.190; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hussman JP, 2001, J AUTISM DEV DISORD, V31, P247, DOI 10.1023/A:1010715619091; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Moldin SO, 2006, J NEUROSCI, V26, P6893, DOI 10.1523/JNEUROSCI.1944-06.2006; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; OCONNOR N, 1989, BRIT J PSYCHOL, V80, P97, DOI 10.1111/j.2044-8295.1989.tb02305.x; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Silberberg G, 2005, TRENDS NEUROSCI, V28, P541, DOI 10.1016/j.tins.2005.08.004; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Yan J, 2005, MOL PSYCHIATR, V10, P329, DOI 10.1038/sj.mp.4001629	36	674	716	2	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					71	76		10.1126/science.1146221	http://dx.doi.org/10.1126/science.1146221			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17823315	Green Accepted			2022-12-01	WOS:000249915400041
J	Terry, I; Walter, GH; Moore, C; Roemer, R; Hull, C				Terry, Irene; Walter, Gimme H.; Moore, Chris; Roemer, Robert; Hull, Craig			Odor-mediated push-pull pollination in cycads	SCIENCE			English	Article							EVOLUTION		Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia; Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; University of Queensland; Utah System of Higher Education; University of Utah	Terry, I (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	terry@biology.utah.edu	Walter, Gimme/AAC-3635-2019	Walter, Gimme/0000-0003-1025-7101				Grimaldi D, 2004, J PALEONTOL, V78, P941, DOI 10.1666/0022-3360(2004)078<0941:MTAEEO>2.0.CO;2; PELLMYR O, 1986, TAXON, V35, P76, DOI 10.2307/1221036; Schiestl FP, 2001, OECOLOGIA, V126, P531, DOI 10.1007/s004420000552; Tang W., 2004, VISTAS PALAEOBOTANY, P383; Terry I, 2004, PLANT SYST EVOL, V243, P233, DOI 10.1007/s00606-003-0087-x; Terry LI, 2005, AM J BOT, V92, P931, DOI 10.3732/ajb.92.6.931	6	114	120	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					70	70		10.1126/science.1145147	http://dx.doi.org/10.1126/science.1145147			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916726				2022-12-01	WOS:000249915400040
J	Herkenhoff, KE; Byrne, S; Russell, PS; Fishbaugh, KE; McEwen, AS				Herkenhoff, K. E.; Byrne, S.; Russell, P. S.; Fishbaugh, K. E.; McEwen, A. S.			Meter-scale morphology of the north polar region of Mars	SCIENCE			English	Article							LAYERED DEPOSITS; GEOLOGIC HISTORY; STRATIGRAPHY	Mars' north pole is covered by a dome of layered ice deposits. Detailed (similar to 30 centimeters per pixel) images of this region were obtained with the High-Resolution Imaging Science Experiment on board the Mars Reconnaissance Orbiter (MRO). Planum Boreum basal unit scarps reveal cross-bedding and show evidence for recent mass wasting, flow, and debris accumulation. The north polar layers themselves are as thin as 10 centimeters but appear to be covered by a dusty veneer in places, which may obscure thinner layers. Repetition of particular layer types implies that quasi-periodic climate changes influenced the stratigraphic sequence in the polar layered deposits, informing models for recent climate variations on Mars.	US Geol Survey, Astrogeol Team, Flagstaff, AZ 86001 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; Int Space Sci Inst, CH-3012 Bern, Switzerland	United States Department of the Interior; United States Geological Survey; University of Arizona; University of Bern	Herkenhoff, KE (corresponding author), US Geol Survey, Astrogeol Team, Flagstaff, AZ 86001 USA.	kherkenhoff@usgs.gov	Byrne, Shane/B-8104-2012					BYRNE S, 2002, J GEOPHYS RES, V107; Clifford SM, 2005, ICARUS, V174, P291, DOI 10.1016/j.icarus.2004.12.012; CUTTS JA, 1982, ICARUS, V50, P216, DOI 10.1016/0019-1035(82)90124-5; Edgett KS, 2003, GEOMORPHOLOGY, V52, P289, DOI 10.1016/S0169-555X(02)00262-3; Fenton LK, 2000, ICARUS, V147, P433, DOI 10.1006/icar.2000.6459; FISHBAUGH K, 2006, J GEOPHYS RES, V111; Fishbaugh KE, 2005, ICARUS, V174, P444, DOI 10.1016/j.icarus.2004.06.021; HOWARD AD, 1982, ICARUS, V50, P161, DOI 10.1016/0019-1035(82)90123-3; JOHNSON A. M., 1970, PHYS PROCESSES GEOLO; Kolb EJ, 2001, ICARUS, V154, P22, DOI 10.1006/icar.2001.6676; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; Laskar J, 2002, NATURE, V419, P375, DOI 10.1038/nature01066; MALIN M, 2001, J GEOPHYS RES, V106, P23439; McEwen A., 2007, J GEOPHYS RES, V112, DOI 10.1029/2005JE002605; MILKOVICH S, 2006, MARS, V2, P21, DOI DOI 10.1555/MARS.2006.0003; MILKOVICH SM, 2005, J GEOPHYS RES, V110; MURCHIE S, 2007, LUN PLAN SCI C, V38; PHILLIPS RJ, 2007, LUN PLAN SCI C, V38; Seu R, 2007, SCIENCE, V317, P1715, DOI 10.1126/science.1144120; Tanaka KL, 2005, NATURE, V437, P991, DOI 10.1038/nature04065; THOMAS P, 1992, MARS	21	78	79	3	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1711	1715		10.1126/science.1143544	http://dx.doi.org/10.1126/science.1143544			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885127				2022-12-01	WOS:000249585900036
J	Lankau, RA; Strauss, SY				Lankau, Richard A.; Strauss, Sharon Y.			Mutual feedbacks maintain both genetic and species diversity in a plant community	SCIENCE			English	Article							COMPETITIVE RELATIONSHIPS; GENOTYPIC DIVERSITY; EVOLUTION; CONSEQUENCES; MAINTENANCE; GAME	The forces that maintain genetic diversity among individuals and diversity among species are usually studied separately. Nevertheless, diversity at one of these levels may depend on the diversity at the other. We have combined observations of natural populations, quantitative genetics, and field experiments to show that genetic variation in the concentration of an allelopathic secondary compound in Brassica nigra is necessary for the coexistence of B. nigra and its competitor species. In addition, the diversity of competing species was required for the maintenance of genetic variation in the trait within B. nigra. Thus, conservation of species diversity may also necessitate maintenance of the processes that sustain the genetic diversity of each individual species.	Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA	University of California System; University of California Davis	Lankau, RA (corresponding author), Univ Missouri, Dept Biol, 1 Univ Blvd, St Louis, MO 63121 USA.	ralankau@gmail.com	Ion, Rodica-Mariana/B-2839-2008; Lankau, Richard A/B-9760-2008; Somoghi, Raluca/E-8969-2016; Ionita, Ionica/P-9456-2017; Dumitrescu, Ovidiu/C-4738-2011; Strauss, Sharon/J-1827-2012	Ion, Rodica-Mariana/0000-0002-9842-3321; Lankau, Richard A/0000-0001-9995-328X; Somoghi, Raluca/0000-0002-7648-3147; Ionita, Ionica/0000-0002-6958-234X; Strauss, Sharon/0000-0002-6117-4085				Abrams PA, 2006, EVOLUTION, V60, P427; BULMER MG, 1989, GENOME, V31, P761, DOI 10.1139/g89-135; BUSS LW, 1979, AM NAT, V113, P223, DOI 10.1086/283381; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CHESSON PL, 1989, J MATH BIOL, V27, P117, DOI 10.1007/BF00276099; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Falconer DS, 1996, INTRO QUANTITATIVE G; FEENY P, 1982, BIOCHEM SYST ECOL, V10, P23, DOI 10.1016/0305-1978(82)90047-3; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kimura M., 1983, NEUTRAL THEORY MOL E; Kliebenstein DJ, 2004, PLANT CELL ENVIRON, V27, P675, DOI 10.1111/j.1365-3040.2004.01180.x; Laird RA, 2006, AM NAT, V168, P182, DOI 10.1086/506259; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; Raybould AF, 2001, HEREDITY, V87, P383, DOI 10.1046/j.1365-2540.2001.00954.x; SCHREINER RP, 1993, NEW PHYTOL, V123, P107, DOI 10.1111/j.1469-8137.1993.tb04536.x; Siemens DH, 2002, ECOLOGY, V83, P505, DOI 10.1890/0012-9658(2002)083[0505:CODITC]2.0.CO;2; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Stinson KA, 2006, PLOS BIOL, V4, P727, DOI 10.1371/journal.pbio.0040140; Strauss SY, 2004, ANNU REV ECOL EVOL S, V35, P435, DOI 10.1146/annurev.ecolsys.35.112202.130215; TAYLOR DR, 1990, AM NAT, V136, P305, DOI 10.1086/285100; Tilman D., 1982, Monographs in Population Biology, pi; Traw MB, 2002, EVOLUTION, V56, P2196, DOI 10.1111/j.0014-3820.2002.tb00144.x; Vellend M, 2006, ECOLOGY, V87, P304, DOI 10.1890/05-0173; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2	27	270	274	5	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2007	317	5844					1561	1563		10.1126/science.1147455	http://dx.doi.org/10.1126/science.1147455			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872447				2022-12-01	WOS:000249467900045
J	Oppenheimer, M; O'Neill, BC; Webster, M; Agrawala, S				Oppenheimer, Michael; O'Neill, Brian C.; Webster, Mort; Agrawala, Shardul			Climate change - The limits of consensus	SCIENCE			English	Editorial Material							TECHNOLOGICAL-CHANGE; UNCERTAINTY; MODEL		Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; Brown Univ, Watson Inst Int Studies, Providence, RI 02912 USA; MIT, MIT Joint Program Sci & Policy Global Change, Cambridge, MA 02139 USA; OECD, Paris, France	Princeton University; Princeton University; International Institute for Applied Systems Analysis (IIASA); Brown University; Massachusetts Institute of Technology (MIT); Organisation for Economic Co-operation & Development (OECD)	Oppenheimer, M (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.	omichael@princeton.edu	O'Neill, Brian C./E-6531-2013	O'Neill, Brian C./0000-0001-7505-8897; Oppenheimer, Michael/0000-0002-9708-5914				Agrawala S, 1998, CLIMATIC CHANGE, V39, P621, DOI 10.1023/A:1005312331477; Baker E, 2005, RESOUR ENERGY ECON, V27, P19, DOI 10.1016/j.reseneeco.2004.05.002; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gerlagh R, 2003, RESOUR ENERGY ECON, V25, P35, DOI 10.1016/S0928-7655(02)00020-9; Goulder LH, 1999, RESOUR ENERGY ECON, V21, P211, DOI 10.1016/S0928-7655(99)00004-4; Houghton J. T, 1990, SCI ASS CLIM CHANG R, P365; Houghton J. T., 2001, CLIMATE CHANGE 2001; IPCC, 2007, CLIM CHANG 2007 PHYS; IPCC, 1996, FULL TEXT CLIM CHANG; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; MORGAN G, 1990, UNCERTAINTY GUIDE DE; OPPENHEIMER M, 2006, C LEARN CLIM CHANG I; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Parson E.A., 2003, PROTECTING OZONE LAY; PATT A, 1999, RISK DECISION POLICY, V4, P1; Patt A, 2007, GLOBAL ENVIRON CHANG, V17, P37, DOI 10.1016/j.gloenvcha.2006.10.002; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; ROWLAND FS, 1989, AM SCI, V77, P36; Scambos T., 2001, IMAGES ANTARCTIC ICE; Vaughan DG, 2002, CLIMATIC CHANGE, V52, P65, DOI 10.1023/A:1013038920600; Webster MD, 2002, ATMOS ENVIRON, V36, P3659, DOI 10.1016/S1352-2310(02)00245-5; *WORLD MET ORG, 1991, 25 WORLD MET ORG; *WORLD MET ORG, 1988, 18 WORLD MET ORG; *WORLD MET ORG, 1986, 16 WORLD MET ORG; Zickfeld K, 2007, CLIMATIC CHANGE, V82, P235, DOI 10.1007/s10584-007-9246-3	25	111	112	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2007	317	5844					1505	1506		10.1126/science.1144831	http://dx.doi.org/10.1126/science.1144831			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872430				2022-12-01	WOS:000249467900025
J	Affolder, R; Rizzo, I; Burgess, C; Bchir, A; Lob-Levyt, J				Affolder, Rebecca; Rizzo, Ivone; Burgess, Craig; Bchir, Abdallah; Lob-Levyt, Julian			A prescription for drug delivery	NATURE			English	Editorial Material									GAVI Alliance, Geneva, Switzerland		Affolder, R (corresponding author), GAVI Alliance, Geneva, Switzerland.								0	1	1	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					170	172		10.1038/449170a	http://dx.doi.org/10.1038/449170a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851513	Bronze			2022-12-01	WOS:000249394500037
J	Xing, W; Zou, Y; Liu, Q; Liu, JN; Luo, X; Huang, QQ; Chen, S; Zhu, LH; Bi, RC; Hao, Q; Wu, JW; Zhou, JM; Chai, JJ				Xing, Weiman; Zou, Yan; Liu, Qun; Liu, Jianing; Luo, Xi; Huang, Qingqiu; Chen, She; Zhu, Lihuang; Bi, Ruchang; Hao, Quan; Wu, Jia-Wei; Zhou, Jian-Min; Chai, Jijie			The structural basis for activation of plant immunity by bacterial effector protein AvrPto	NATURE			English	Article							TOMATO PTO KINASE; DISEASE RESISTANCE; RECOGNITION SPECIFICITY; HYPERSENSITIVE RESPONSE; MOLECULAR-BASIS; SPECK DISEASE; SECRETION; MECHANISM; PATHOGENS; PRF	Pathogenic microbes use effectors to enhance susceptibility in host plants. However, plants have evolved a sophisticated immune system to detect these effectors using cognate disease resistance proteins(1), a recognition that is highly specific, often elicits rapid and localized cell death, known as a hypersensitive response, and thus potentially limits pathogen growth(2-5). Despite numerous genetic and biochemical studies on the interactions between pathogen effector proteins and plant resistance proteins, the structural bases for such interactions remain elusive. The direct interaction between the tomato protein kinase Pto and the Pseudomonas syringae effector protein AvrPto is known to trigger disease resistance and programmed cell death(6,7) through the nucleotide-binding site/leucine-rich repeat (NBS-LRR) class of disease resistance protein Prf(8). Here we present the crystal structure of an AvrPto-Pto complex. Contrary to the widely held hypothesis that AvrPto activates Pto kinase activity, our structural and biochemical analyses demonstrated that AvrPto is an inhibitor of Pto kinase in vitro. The AvrPto-Pto interaction is mediated by the phosphorylation-stabilized P+1 loop and a second loop in Pto, both of which negatively regulate the Prf-mediated defences in the absence of AvrPto in tomato plants. Together, our results show that AvrPto derepresses host defences by interacting with the two defence-inhibition loops of Pto.	Natl Inst Biol Sci, Beijing 102206, Peoples R China; Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; Cornell Univ, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA; Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	National Institute of Biological Sciences, Beijing; Tsinghua University; Cornell University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Chai, JJ (corresponding author), Natl Inst Biol Sci, No 7 Sci Pk Rd, Beijing 102206, Peoples R China.	chaijijie@nibs.ac.cn	Hao, Quan/C-4304-2009; Liu, Qun/A-8757-2011; Zhou, Jian-Min/A-3140-2013; Zou, Yan/AAR-2564-2020; Luo, Xi/AAC-9973-2021; Xing, Weiman/G-5697-2010	Liu, Qun/0000-0002-1179-290X; Zhou, Jian-Min/0000-0002-9943-2975; Zou, Yan/0000-0002-4743-4995; Chai, Jijie/0000-0001-7591-3873; Hao, Quan/0000-0002-9642-0514; Xing, Weiman/0000-0002-6238-0075				Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; BOSSEMEYER D, 1993, EMBO J, V12, P849, DOI 10.1002/j.1460-2075.1993.tb05725.x; Chang JH, 2002, MOL PLANT MICROBE IN, V15, P281, DOI 10.1094/MPMI.2002.15.3.281; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Frederick RD, 1998, MOL CELL, V2, P241, DOI 10.1016/S1097-2765(00)80134-3; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Innes RW, 2004, PLANT PHYSIOL, V135, P695, DOI 10.1104/pp.104.040410; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Rathjen JP, 1999, EMBO J, V18, P3232, DOI 10.1093/emboj/18.12.3232; Riely BK, 2001, P NATL ACAD SCI USA, V98, P2059, DOI 10.1073/pnas.98.4.2059; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; Scofield SR, 1996, SCIENCE, V274, P2063, DOI 10.1126/science.274.5295.2063; Sessa G, 2000, EMBO J, V19, P2257, DOI 10.1093/emboj/19.10.2257; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Wu AJ, 2004, PLANT CELL, V16, P2809, DOI 10.1105/tpc.104.024141; Wulf' J, 2004, STRUCTURE, V12, P1257, DOI 10.1016/j.str.2004.04.017	29	140	155	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					243	U11		10.1038/nature06109	http://dx.doi.org/10.1038/nature06109			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17694048				2022-12-01	WOS:000249394500055
J	Moussavi, S; Chatterji, S; Verdes, E; Tandon, A; Patel, V; Ustun, B				Moussavi, Saba; Chatterji, Somnath; Verdes, Emese; Tandon, Ajay; Patel, Vikram; Ustun, Bedirhan			Depression, chronic diseases, and decrements in health: results from the World Health Surveys	LANCET			English	Article							QUALITY-OF-LIFE; PRIMARY-CARE PATIENTS; MAJOR DEPRESSION; MEDICAL COMORBIDITY; OLDER-ADULTS; SYMPTOMS; COSTS; DISABILITY; ILLNESS; IMPACT	Background Depression is an important public-health problem, and one of the leading causes of disease burden worldwide. Depression is often comorbid with other chronic diseases and can worsen their associated health outcomes. Few studies have explored the effect of depression, alone or as a comorbidity, on overall health status. Methods The WHO World Health Survey (WHS) studied adults aged 18 years and older to obtain data for health, health-related outcomes, and their determinants. Prevalence of depression in respondents based on ICD-10 criteria was estimated. Prevalence values for four chronic physical diseases-angina, arthritis, asthma, and diabetes-were also estimated using algorithms derived via a Diagnostic Item Probability Study. Mean health scores were constructed using factor analysis and compared across different disease states and demographic variables. The relation of these disease states to mean health scores was determined through regression modelling. Findings Observations were available for 245 404 participants from 60 countries in all regions of the world. Overall, 1-year prevalence for ICD-10 depressive episode alone was 3.2% (95% CI 3.0-3.5); for angina 4.5% (4.3-4.8); for arthritis 4.1% (3.8-4.3); for asthma 3.3% (2.9-3.6); and for diabetes 2.0% (1.8-2.2). An average of between 9.3% and 23.0% of participants with one or more chronic physical disease had comorbid depression. This result was significantly higher than the likelihood of having depression in the absence of a chronic physical disease (p<0.0001). After adjustment for socioeconomic factors and health conditions, depression had the largest effect on worsening mean health scores compared with the other chronic conditions. Consistently across countries and different demographic characteristics, respondents with depression comorbid with one or more chronic diseases had the worst health scores of all the disease states. Interpretation Depression produces the greatest decrement in health compared with the chronic diseases angina, arthritis, asthma, and diabetes. The comorbid state of depression incrementally worsens health compared with depression alone, with any of the chronic diseases alone, and with any combination of chronic diseases without depression. These results indicate the urgency of addressing depression as a public-health priority to reduce disease burden and disability, and to improve the overall health of populations.	WHO, Dept Measurement & Hlth Informat Syst, Geneva 27, Switzerland; Asian Dev Bank, Econ & Res Dept, Manila, Philippines; London Sch Hyg & Trop Med, London WC1, England	World Health Organization; Asian Development Bank; University of London; London School of Hygiene & Tropical Medicine	Chatterji, S (corresponding author), WHO, Dept Measurement & Hlth Informat Syst, Geneva 27, Switzerland.	chatterjis@who.int	Yan, Shuo/B-8381-2009; Schmitz, Norbert/A-5177-2010; CHATTERJI, Somnath/ABE-6832-2020	Schmitz, Norbert/0000-0001-7777-6323; Patel, Vikram/0000-0003-1066-8584				Ahmad OB, 2014, AGE STANDARDIZATION; Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; Andress G, 2001, BRIT MED J, V322, P419, DOI 10.1136/bmj.322.7283.419; [Anonymous], 1996, SUMM GLOB BURD DIS; Arnow BA, 2006, PSYCHOSOM MED, V68, P262, DOI 10.1097/01.psy.0000204851.15499.fc; Bayliss Elizabeth A, 2005, Health Qual Life Outcomes, V3, P51; Bogner HR, 2005, AM J GERIAT PSYCHIAT, V13, P861, DOI 10.1176/appi.ajgp.13.10.861; Cassano P, 2002, J PSYCHOSOM RES, V53, P849, DOI 10.1016/S0022-3999(02)00304-5; CASSILETH BR, 1984, NEW ENGL J MED, V311, P506, DOI 10.1056/NEJM198408233110805; Chapman D. P., 2005, Preventing Chronic Disease, V2, pA14; Chisholm D, 2003, BRIT J PSYCHIAT, V183, P121, DOI 10.1192/bjp.183.2.121; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; Egede LE, 2004, DIABETES CARE, V27, P421, DOI 10.2337/diacare.27.2.421; Fortin M, 2006, QUAL LIFE RES, V15, P83, DOI 10.1007/s11136-005-8661-z; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Furlong WJ, 2001, ANN MED, V33, P375, DOI 10.3109/07853890109002092; Goodwin RD, 2003, GEN HOSP PSYCHIAT, V25, P479, DOI 10.1016/S0163-8343(03)00071-9; Harpole LH, 2005, GEN HOSP PSYCHIAT, V27, P4, DOI 10.1016/j.genhosppsych.2004.09.004; Herrman H, 2002, PSYCHOL MED, V32, P889, DOI 10.1017/S003329170200586X; Hyman S, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P605; Isacson D, 2005, EUR PSYCHIAT, V20, P205, DOI 10.1016/j.eurpsy.2004.12.011; KATON W, 1992, GEN HOSP PSYCHIAT, V14, P237, DOI 10.1016/0163-8343(92)90094-Q; KATON W, 1993, J AFFECT DISORDERS, V27, P245, DOI 10.1016/0165-0327(93)90048-O; Katon W, 2003, GEN HOSP PSYCHIAT, V25, P158, DOI 10.1016/S0163-8343(03)00013-6; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kosloski K, 2005, J GERONTOL B-PSYCHOL, V60, pP296, DOI 10.1093/geronb/60.6.P296; Lin EHB, 2006, ANN FAM MED, V4, P46, DOI 10.1370/afm.423; Luber MP, 2000, INT J PSYCHIAT MED, V30, P1, DOI 10.2190/YTRY-E86M-G1VC-LC79; Mathers C. D., 2006, GLOBAL BURDEN DIS RI, P45; Noel PH, 2004, ANN FAM MED, V2, P555, DOI 10.1370/afm.143; Ormel J, 1998, J AM GERIATR SOC, V46, P39, DOI 10.1111/j.1532-5415.1998.tb01011.x; Owsley C, 2004, OPHTHALMOLOGY, V111, P2259, DOI 10.1016/j.ophtha.2004.06.026; Patel V, 2004, TROP MED INT HEALTH, V9, P539, DOI 10.1111/j.1365-3156.2004.01243.x; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Salomon J, 2003, HLTH SYSTEMS PERFORM; Simon GE, 2000, GEN HOSP PSYCHIAT, V22, P153, DOI 10.1016/S0163-8343(00)00072-4; Simon GE, 2002, GEN HOSP PSYCHIAT, V24, P328, DOI 10.1016/S0163-8343(02)00201-3; Solomon DA, 2000, AM J PSYCHIAT, V157, P229, DOI 10.1176/appi.ajp.157.2.229; Strine TW, 2004, PSYCHIAT SERV, V55, P1408, DOI 10.1176/appi.ps.55.12.1408; Theme-Filha Mariza Miranda, 2005, Cad Saude Publica, V21 Suppl, P43; UNITED NATIONS POPULATION DIVISION, 2000, WORLD POP PROSP 2000; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; Ustun TB., 2003, HLTH SYSTEMS PERFORM; Ustun TB., 2003, WORLD HLTH SURVEYS H; USTUN TB, 2001, DEPRESSION SOCIAL EC; Wang J, 2001, POSITIONS-E ASIA CUL, V9, P1, DOI 10.1215/10679847-9-1-1; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; World Health Organization, 2012, WHO APPL ICD 10 DEAT	49	2448	2510	13	426	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2007	370	9590					851	858		10.1016/S0140-6736(07)61415-9	http://dx.doi.org/10.1016/S0140-6736(07)61415-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	214JH	17826170				2022-12-01	WOS:000249733300030
J	Butts, DA; Weng, C; Jin, J; Yeh, CI; Lesica, NA; Alonso, JM; Stanley, GB				Butts, Daniel A.; Weng, Chong; Jin, Jianzhong; Yeh, Chun-I; Lesica, Nicholas A.; Alonso, Jose-Manuel; Stanley, Garrett B.			Temporal precision in the neural code and the timescales of natural vision	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; SPIKE TRAINS; SOMATOSENSORY CORTEX; VISUAL INFORMATION; NEURONS; DISCRIMINATION; REPRESENTATION; VARIABILITY; INTEGRATION; RESPONSES	The timing of action potentials relative to sensory stimuli can be precise down to milliseconds in the visual system(1-7), even though the relevant timescales of natural vision are much slower. The existence of such precision contributes to a fundamental debate over the basis of the neural code and, specifically, what timescales are important for neural computation(8-10). Using recordings in the lateral geniculate nucleus, here we demonstrate that the relevant timescale of neuronal spike trains depends on the frequency content of the visual stimulus, and that 'relative', not absolute, precision is maintained both during spatially uniform white-noise visual stimuli and naturalistic movies. Using information-theoretic techniques, we demonstrate a clear role of relative precision, and show that the experimentally observed temporal structure in the neuronal response is necessary to represent accurately the more slowly changing visual world. By establishing a functional role of precision, we link visual neuron function on slow timescales to temporal structure in the response at faster timescales, and uncover a straightforward purpose of fine-timescale features of neuronal spike trains.	Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; Cornell Univ, Weill Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; SUNY Coll Optometry, Dept Biol Sci, New York, NY 10036 USA; Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA	Harvard University; Cornell University; State University of New York (SUNY) System; SUNY Optometry; University of Connecticut	Butts, DA (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	dab2024@med.cornell.edu	Butts, Daniel A/B-8346-2008	Butts, Daniel A/0000-0002-0158-5317; Stanley, Garrett/0000-0003-2039-7706; Lesica, Nicholas/0000-0001-5238-4462; YEH, CHUN-I/0000-0002-2375-0723				Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Berry MJ, 1998, J NEUROSCI, V18, P2200; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Boloori AR, 2006, J NEUROSCI, V26, P3767, DOI 10.1523/JNEUROSCI.4056-05.2006; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Brenner N, 2000, NEURAL COMPUT, V12, P1531, DOI 10.1162/089976600300015259; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; Chichilnisky EJ, 2003, J NEUROSCI, V23, P6681; Dan Y, 1998, NAT NEUROSCI, V1, P501, DOI 10.1038/2217; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Gabbiani F, 1996, NATURE, V384, P564, DOI 10.1038/384564a0; Kayser C, 2003, J NEUROPHYSIOL, V90, P1910, DOI 10.1152/jn.00195.2003; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; Lazar AA, 2004, IEEE T CIRCUITS-I, V51, P2060, DOI 10.1109/TCSI.2004.835026; Lesica NA, 2006, PLOS BIOL, V4, P1201, DOI 10.1371/journal.pbio.0040209; Lewen GD, 2001, NETWORK-COMP NEURAL, V12, P317, DOI 10.1088/0954-898X/12/3/305; Liu RC, 2001, J NEUROPHYSIOL, V86, P2789, DOI 10.1152/jn.2001.86.6.2789; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Narayan R, 2006, J NEUROPHYSIOL, V96, P252, DOI 10.1152/jn.01257.2005; PHILLIPS JR, 1988, P NATL ACAD SCI USA, V85, P1317, DOI 10.1073/pnas.85.4.1317; Pola G, 2003, NETWORK-COMP NEURAL, V14, P35, DOI 10.1088/0954-898X/14/1/303; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; THEUNISSEN F, 1995, J COMPUT NEUROSCI, V2, P149, DOI 10.1007/BF00961885; Uzzell VJ, 2004, J NEUROPHYSIOL, V92, P780, DOI 10.1152/jn.01171.2003; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weng C, 2005, J NEUROPHYSIOL, V93, P3537, DOI 10.1152/jn.00847.2004; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	32	274	287	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2007	449	7158					92	U64		10.1038/nature06105	http://dx.doi.org/10.1038/nature06105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207ED	17805296				2022-12-01	WOS:000249233500042
J	D'Angelo, G; Polishchuk, E; Di Tullio, G; Santoro, M; Di Campli, A; Godi, A; West, G; Bielawski, J; Chuang, CC; van der Spoel, AC; Platt, FM; Hannun, YA; Polishchuk, R; Mattjus, P; De Matteis, MA				D'Angelo, Giovanni; Polishchuk, Elena; Di Tullio, Giuseppe; Santoro, Michele; Di Campli, Antonella; Godi, Anna; West, Gun; Bielawski, Jacek; Chuang, Chia-Chen; van der Spoel, Aarnoud C.; Platt, Frances M.; Hannun, Yusuf A.; Polishchuk, Roman; Mattjus, Peter; De Matteis, Maria Antonietta			Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide	NATURE			English	Article							GLYCOLIPID TRANSFER PROTEIN; GOLGI-COMPLEX; MEMBRANE TRAFFICKING; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; ADP-RIBOSYLATION; CELL-SURFACE; BREFELDIN-A; MDCK CELLS; TRANSPORT	The molecular machinery responsible for the generation of transport carriers moving from the Golgi complex to the plasma membrane relies on a tight interplay between proteins and lipids. Among the lipid-binding proteins of this machinery, we previously identified the four-phosphate adaptor protein FAPP2, the pleckstrin homology domain of which binds phosphatidylinositol 4-phosphate and the small GTPase ARF1. FAPP2 also possesses a glycolipid-transfer-protein homology domain. Here we show that human FAPP2 is a glucosylceramide-transfer protein that has a pivotal role in the synthesis of complex glycosphingolipids, key structural and signalling components of the plasma membrane. The requirement for FAPP2 makes the whole glycosphingolipid synthetic pathway sensitive to regulation by phosphatidylinositol 4-phosphate and ARF1. Thus, by coupling the synthesis of glycosphingolipids with their export to the cell surface, FAPP2 emerges as crucial in determining the lipid identity and composition of the plasma membrane.	Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Chieti, Italy; Abo Akad Univ, Dept Biochem & Pharm, FI-20520 Turku, Finland; Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Abo Akademi University; Medical University of South Carolina; University of Oxford	De Matteis, MA (corresponding author), Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, Via Nazl 8-A, I-66030 Chieti, Italy.	dematteis@negrisud.it	Mattjus, Peter/AAQ-7531-2021; Platt, Frances/G-1004-2010; De Matteis, Maria Antonietta/AHE-5161-2022; Mattjus, Peter/ABE-3596-2021	De Matteis, Maria Antonietta/0000-0003-0053-3061; Mattjus, Peter/0000-0001-8991-5933; Platt, Frances/0000-0001-7614-0403; DI CAMPLI, ANTONELLA/0000-0003-4504-5942; DANGELO, GIOVANNI/0000-0001-5466-8709; van der Spoel, Aarnoud/0000-0002-2338-5316; D'Angelo, Giovanni/0000-0002-0734-4127; Polishchuk, Roman/0000-0002-7698-1955	Telethon [GGP06166] Funding Source: Medline	Telethon(Fondazione Telethon)		Bard F, 2006, ANNU REV CELL DEV BI, V22, P439, DOI 10.1146/annurev.cellbio.21.012704.133126; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Boldin SA, 2000, J BIOL CHEM, V275, P9905, DOI 10.1074/jbc.275.14.9905; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Brade L, 2000, GLYCOBIOLOGY, V10, P629, DOI 10.1093/glycob/10.6.629; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; Chang MC, 2006, MOL CELL NEUROSCI, V31, P525, DOI 10.1016/j.mcn.2005.11.006; De Matteis MA, 2004, BBA-BIOMEMBRANES, V1666, P264, DOI 10.1016/j.bbamem.2004.07.002; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; De Matteis MA, 2007, BBA-MOL CELL BIOL L, V1771, P761, DOI 10.1016/j.bbalip.2007.04.004; Drecktrah D, 1999, MOL BIOL CELL, V10, P4021, DOI 10.1091/mbc.10.12.4021; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Godi A, 1998, P NATL ACAD SCI USA, V95, P8607, DOI 10.1073/pnas.95.15.8607; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Lannert H, 1998, J BIOL CHEM, V273, P2939, DOI 10.1074/jbc.273.5.2939; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; LODISH HF, 1984, J CELL BIOL, V98, P1720, DOI 10.1083/jcb.98.5.1720; Luini A, 2005, CURR OPIN CELL BIOL, V17, P353, DOI 10.1016/j.ceb.2005.06.012; Malakhova ML, 2005, J BIOL CHEM, V280, P26312, DOI 10.1074/jbc.M500481200; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Millar CA, 2000, TRAFFIC, V1, P141, DOI 10.1034/j.1600-0854.2000.010206.x; Mironov AA, 2004, EUR J CELL BIOL, V83, P263, DOI 10.1078/0171-9335-00377; Nylund M, 2006, BBA-BIOMEMBRANES, V1758, P807, DOI 10.1016/j.bbamem.2006.04.023; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; ROSENWALD AG, 1992, BIOCHEMISTRY-US, V31, P3581, DOI 10.1021/bi00129a005; Sala G, 2002, PEDIATR RES, V52, P645, DOI 10.1203/01.PDR.0000032383.67029.F7; Schwarz A, 1997, J NEUROSCI, V17, P2929; Sprong H, 2001, J CELL BIOL, V155, P369, DOI 10.1083/jcb.200106104; Tamboli IY, 2005, J BIOL CHEM, V280, P28110, DOI 10.1074/jbc.M414525200; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Vieira OV, 2006, P NATL ACAD SCI USA, V103, P18556, DOI 10.1073/pnas.0608291103; Vieira OV, 2005, J CELL BIOL, V170, P521, DOI 10.1083/jcb.200503078; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; Wing DR, 2001, ANAL BIOCHEM, V298, P207, DOI 10.1006/abio.2001.5393; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; YOUNG WW, 1990, P NATL ACAD SCI USA, V87, P6838, DOI 10.1073/pnas.87.17.6838; Yu S, 2006, J CELL BIOL, V174, P359, DOI 10.1083/jcb.200603044	46	307	314	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2007	449	7158					62	U43		10.1038/nature06097	http://dx.doi.org/10.1038/nature06097			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207ED	17687330				2022-12-01	WOS:000249233500035
J	Conen, D; Ridker, PM; Buring, JE; Glynn, RJ				Conen, David; Ridker, Paul M.; Buring, Julie E.; Glynn, Robert J.			Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LIFE-STYLE MODIFICATION; C-REACTIVE PROTEIN; PRIMARY PREVENTION; HYPERTENSION; DISEASE; MODELS; PARTICIPANTS; METAANALYSIS; PREDICTION; CANCER	Objective To compare cardiovascular risk among women with high normal blood pressure (130-9/85-9 mm Hg) against those with normal blood pressure (120-9/75-84 mm Hg) and those with baseline hypertension. Design Prospective cohort study. Setting Women's health study, United States. Participants 39 322 initially healthy women classified into four categories according to self reported baseline blood pressure and followed for a median of 10.2 years. Main outcome measures Time to cardiovascular death, myocardial infarction, or stroke (major cardiovascular event-primary end point); progression to hypertension. Results 982 (2.5%) women developed a major cardiovascular event, and 8686 (30.1%) women without baseline hypertension progressed to hypertension. The age adjusted event rate for the primary end point was 1.6/1000 person years among women with normal blood pressure, 2.9/1000 person years among those with high normal blood pressure, and 4.3/1000 person years among those with baseline hypertension. Compared with women with high normal blood pressure (reference group), those with normal blood pressure had a lower risk of a major cardiovascular event (adjusted hazard ratio 0.61, 95% confidence interval 0.48 to 0.76) and of incident hypertension (0.42, 0.40 to 0.44). The hazard ratio for a major cardiovascular event in women with baseline hypertension was 1.30 (1.08 to 1.57). Women who progressed to hypertension (reference group) during the first 48 months of the study had a higher cardiovascular risk than those who remained normotensive (adjusted hazard ratio 0.64, 0.50 to 0.81). Women with high normal blood pressure at baseline who progressed to hypertension (reference group) had similar outcome rates to women with baseline hypertension (adjusted hazard ratio 1.17, 0.88 to 1.55). Conclusion The cardiovascular risk of women with high normal blood pressure is higher than that of women with normal blood pressure. The cardiovascular risk of women who progress to hypertension is increased shortly after a diagnosis of hypertension has been made. Trial registration Clinical trials NCT00000479.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Cardiovasc Med, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Conen, D (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med, 900 Commonwealth Ave, Boston, MA 02215 USA.	conend@uhbs.ch			NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; APPEL LJ, 2003, JAMA-J AM MED ASSOC, V289, P2803; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; COX DR, 1972, J R STAT SOC B, V34, P187; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Elmer PJ, 2006, ANN INTERN MED, V144, P485, DOI 10.7326/0003-4819-144-7-200604040-00007; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Glynn RJ, 2002, HYPERTENSION, V39, P105, DOI 10.1161/hy1201.097199; Huang PYA, 2007, J GEN INTERN MED, V22, P606, DOI 10.1007/s11606-007-0144-1; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kshirsagar AV, 2006, AM J MED, V119, P133, DOI 10.1016/j.amjmed.2005.08.023; Kurth T, 2005, CIRCULATION, V111, P1992, DOI 10.1161/01.CIR.0000161822.83163.B6; Lee IM, 1999, J NATL CANCER I, V91, P2102, DOI 10.1093/jnci/91.24.2102; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; MANSOOR GA, 1994, J HYPERTENS, V12, P703; Pickering TG, 2006, NEW ENGL J MED, V354, P2368, DOI 10.1056/NEJMra060433; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; ROSNER B, 1977, AM J EPIDEMIOL, V106, P306, DOI 10.1093/oxfordjournals.aje.a112466; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; Verberk WJ, 2005, J AM COLL CARDIOL, V46, P743, DOI 10.1016/j.jacc.2005.05.058; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657; Whelton SP, 2002, ANN INTERN MED, V136, P493, DOI 10.7326/0003-4819-136-7-200204020-00006	34	78	87	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2007	335	7617					432	436B		10.1136/bmj.39269.672188.AE	http://dx.doi.org/10.1136/bmj.39269.672188.AE			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	208VF	17704543	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000249346600032
J	Perkins, S; de Wit, M				Perkins, Sarah; de Wit, Melanie			The African private sector steps in to fill the drug gap	LANCET			English	Editorial Material									Univ Toronto, Fac Law, Toronto, ON M5S 2C5, Canada	University of Toronto	Perkins, S (corresponding author), Univ Toronto, Fac Law, Toronto, ON M5S 2C5, Canada.	s.perkins@utoronto.ca						*GLOB FUND FIGHT A, LIST COUNTR BEL ICH; *GOV CAN, REV CAN ACC MED REG; HEMS J, 2007, CAMR CONSULTATION PA; Trouiller P, 2002, LANCET, V359, P2188, DOI 10.1016/S0140-6736(02)09096-7; *W AFR HLTH ORG, REP EXTR ASS WAHO HL	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2007	370	9589					722	723		10.1016/S0140-6736(07)61094-0	http://dx.doi.org/10.1016/S0140-6736(07)61094-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206UV	17658595				2022-12-01	WOS:000249209300009
J	Lydeard, JR; Jain, S; Yamaguchi, M; Haber, JE				Lydeard, John R.; Jain, Suvi; Yamaguchi, Miyuki; Haber, James E.			Break-induced replication and telomerase-independent telomere maintenance require Pol32	NATURE			English	Article							DNA-POLYMERASE-DELTA; DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; IN-VIVO; GENE CONVERSION; BYPASS PATHWAY; RECOMBINATION; YEAST; REPAIR; CHECKPOINT	Break- induced replication ( BIR) is an efficient homologous recombination process to initiate DNA replication when only one end of a chromosome double- strand break shares homology with a template(1-5). BIR is thought to re- establish replication at stalled and broken replication forks and to act at eroding telomeres in cells that lack telomerase in pathways known as ' alternative lengthening of telomeres' ( reviewed in refs 2, 6). Here we show that, in haploid budding yeast, Rad51- dependent BIR induced by HO endonuclease requires the lagging strand DNA Pol alpha- primase complex as well as Pol delta to initiate new DNA synthesis. Pol epsilon is not required for the initial primer extension step of BIR but is required to complete 30 kb of new DNA synthesis. Initiation of BIR also requires the nonessential DNA Pol delta subunit Pol32 primarily through its interaction with another Pol delta subunit, Pol31. HO-induced gene conversion, in which both ends of a double- strand break engage in homologous recombination, does not require Pol32. Pol32 is also required for the recovery of both Rad51-dependent and Rad51- independent survivors in yeast strains lacking telomerase. These results strongly suggest that both types of telomere maintenance pathways occur by recombination-dependent DNA replication. Thus Pol32, dispensable for replication and for gene conversion, is uniquely required for BIR; this finding provides an opening into understanding how DNA replication re- start mechanisms operate in eukaryotes. We also note that Pol32 homologues have been identified both in fission yeast and in metazoans where telomerase- independent survivors with alternative telomere maintenance have also been identified(2,6,7).	Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02454 USA	Brandeis University	Haber, JE (corresponding author), Brandeis Univ, Rosenstiel Ctr, MS029, Waltham, MA 02454 USA.	haber@brandeis.edu		Haber, James/0000-0002-1878-0610	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122, R01GM020056, R01GM076020] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007122, R01 GM076020-03, R01 GM020056-32, R01 GM076020-02, R01 GM020056-33, R01 GM076020-01A1, R01 GM076020, R01 GM020056] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BUDD ME, 1993, MOL CELL BIOL, V13, P496, DOI 10.1128/MCB.13.1.496; Chen QJ, 2001, MOL CELL BIOL, V21, P1819, DOI 10.1128/MCB.21.5.1819-1827.2001; Corrette-Bennett SE, 2004, NUCLEIC ACIDS RES, V32, P6268, DOI 10.1093/nar/gkh965; Davis AP, 2004, MOL CELL BIOL, V24, P2344, DOI 10.1128/MCB.24.6.2344-2351.2004; Giot L, 1997, GENETICS, V146, P1239; Haber JE, 2006, DNA REPAIR, V5, P998, DOI 10.1016/j.dnarep.2006.05.025; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Holmes AM, 1999, CELL, V96, P415, DOI 10.1016/S0092-8674(00)80554-1; Huang ME, 2002, GENETICS, V160, P1409; Huang ME, 2000, CURR GENET, V38, P178, DOI 10.1007/s002940000149; Ira G, 2006, MOL CELL BIOL, V26, P9424, DOI 10.1128/MCB.01654-06; Johansson E, 2004, J BIOL CHEM, V279, P1907, DOI 10.1074/jbc.M310362200; Johansson E, 2001, J BIOL CHEM, V276, P43824, DOI 10.1074/jbc.M108842200; Le S, 1999, GENETICS, V152, P143; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Malkova A, 2005, MOL CELL BIOL, V25, P933, DOI 10.1128/MCB.25.3.933-944.2005; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; Morrow DM, 1997, GENETICS, V147, P371; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugawara N, 2006, METHOD ENZYMOL, V408, P416, DOI 10.1016/S0076-6879(06)08026-8; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Teng SC, 2000, MOL CELL, V6, P947, DOI 10.1016/S1097-2765(05)00094-8; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Torres JZ, 2004, MOL CELL BIOL, V24, P3198, DOI 10.1128/MCB.24.8.3198-3212.2004; Torres JZ, 2004, GENE DEV, V18, P498, DOI 10.1101/gad.1154704; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Wang X, 2004, MOL CELL BIOL, V24, P6891, DOI 10.1128/MCB.24.16.6891-6899.2004	32	353	361	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2007	448	7155					820	U10		10.1038/nature06047	http://dx.doi.org/10.1038/nature06047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17671506				2022-12-01	WOS:000248754200043
J	Sitch, S; Cox, PM; Collins, WJ; Huntingford, C				Sitch, S.; Cox, P. M.; Collins, W. J.; Huntingford, C.			Indirect radiative forcing of climate change through ozone effects on the land-carbon sink	NATURE			English	Article							SURFACE OZONE; RESPONSES; TROPOSPHERE; EMISSIONS; EXPOSURE; IMPACT; TREES; CO2	The evolution of the Earth's climate over the twenty- first century depends on the rate at which anthropogenic carbon dioxide emissions are removed from the atmosphere by the ocean and land carbon cycles(1). Coupled climate - carbon cycle models suggest that global warming will act to limit the land- carbon sink(2), but these first generation models neglected the impacts of changing atmospheric chemistry. Emissions associated with fossil fuel and biomass burning have acted to approximately double the global mean tropospheric ozone concentration(3), and further increases are expected over the twenty- first century(4). Tropospheric ozone is known to damage plants, reducing plant primary productivity and crop yields(5), yet increasing atmospheric carbon dioxide concentrations are thought to stimulate plant primary productivity(6). Increased carbon dioxide and ozone levels can both lead to stomatal closure, which reduces the uptake of either gas, and in turn limits the damaging effect of ozone and the carbon dioxide fertilization of photosynthesis(6). Here we estimate the impact of projected changes in ozone levels on the land- carbon sink, using a global land carbon cycle model modified to include the effect of ozone deposition on photosynthesis and to account for interactions between ozone and carbon dioxide through stomatal closure(7). For a range of sensitivity parameters based on manipulative field experiments, we find a significant suppression of the global land- carbon sink as increases in ozone concentrations affect plant productivity. In consequence, more carbon dioxide accumulates in the atmosphere. We suggest that the resulting indirect radiative forcing by ozone effects on plants could contribute more to global warming than the direct radiative forcing due to tropospheric ozone increases.	Hadley Ctr Climate Predict & Res JCHMR, Met Off, Wallingford OX10 8BB, Oxon, England; Ctr Ecol & Hydrol Wallingford, Wallingford OX10 8BB, Oxon, England; Univ Exeter, Sch Engn Comp Sci & Math, Exeter ES4 4QF, Devon, England; Hadley Ctr Climate Predict & Res, Met Off, Exeter EX1 3PB, Devon, England	Met Office - UK; Hadley Centre; UK Centre for Ecology & Hydrology (UKCEH); University of Exeter; Met Office - UK; Hadley Centre	Sitch, S (corresponding author), Hadley Ctr Climate Predict & Res JCHMR, Met Off, Maclean Bldg, Wallingford OX10 8BB, Oxon, England.	stephen.sitch@metoffice.gov.uk	Cox, Peter Michae;/B-3299-2012; Collins, William/A-5895-2010; Huntingford, Christopher/A-4307-2008; Sitch, Stephen A/F-8034-2015	Cox, Peter Michae;/0000-0002-0679-2219; Collins, William/0000-0002-7419-0850; Huntingford, Christopher/0000-0002-5941-7770; Sitch, Stephen A/0000-0003-1821-8561	Natural Environment Research Council [ceh010010] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Ashmore MR, 2005, PLANT CELL ENVIRON, V28, P949, DOI 10.1111/j.1365-3040.2005.01341.x; Berntsen TK, 2000, J GEOPHYS RES-ATMOS, V105, P8915, DOI 10.1029/1999JD901139; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Cox PM, 1999, CLIM DYNAM, V15, P183, DOI 10.1007/s003820050276; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Dentener F, 2006, ENVIRON SCI TECHNOL, V40, P3586, DOI 10.1021/es0523845; Ehhalt D, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P239; Essery RLH, 2003, J HYDROMETEOROL, V4, P530, DOI 10.1175/1525-7541(2003)004<0530:EROSHI>2.0.CO;2; Felzer B, 2005, CLIMATIC CHANGE, V73, P345, DOI 10.1007/s10584-005-6776-4; FIELD CB, 1995, PLANT CELL ENVIRON, V18, P1214, DOI 10.1111/j.1365-3040.1995.tb00630.x; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gauss M, 2006, ATMOS CHEM PHYS, V6, P575, DOI 10.5194/acp-6-575-2006; Gauss M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002624; Gedney N, 2006, NATURE, V439, P835, DOI 10.1038/nature04504; Imhoff ML, 2004, NATURE, V429, P870, DOI 10.1038/nature02619; Karlsson PE, 2004, ATMOS ENVIRON, V38, P2283, DOI 10.1016/j.atmosenv.2004.01.027; Karnosky DF, 2005, PLANT CELL ENVIRON, V28, P965, DOI 10.1111/j.1365-3040.2005.01362.x; Karnosky DF, 2003, FUNCT ECOL, V17, P289, DOI 10.1046/j.1365-2435.2003.00733.x; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Nussbaum S, 2000, ENVIRON POLLUT, V109, P463, DOI 10.1016/S0269-7491(00)00049-X; Percy KE, 2007, ENVIRON POLLUT, V147, P554, DOI 10.1016/j.envpol.2006.10.009; Pleijel H, 2004, ATMOS ENVIRON, V38, P2259, DOI 10.1016/j.atmosenv.2003.09.076; Ramaswamy V, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P349; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sanderson MG, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017642; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; van der Werf GR, 2003, GLOBAL CHANGE BIOL, V9, P547, DOI 10.1046/j.1365-2486.2003.00604.x; Volk M, 2006, GLOBAL CHANGE BIOL, V12, P74, DOI 10.1111/j.1365-2486.2005.01083.x; Wang XP, 2004, ATMOS ENVIRON, V38, P4383, DOI 10.1016/j.atmosenv.2004.03.067	30	653	705	18	342	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					791	U4		10.1038/nature06059	http://dx.doi.org/10.1038/nature06059			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17653194				2022-12-01	WOS:000248754200036
J	Pey, AL; Martinez, A				Pey, Angel L.; Martinez, Aurora			Tetrahydrobiopterin for patients with phenylketonuria	LANCET			English	Editorial Material							PHENYLALANINE-HYDROXYLASE DEFICIENCY; WILD-TYPE; IN-VIVO; BINDING; CELLS		Univ Bergen, Dept Biomed, N-5009 Bergen, Norway	University of Bergen	Martinez, A (corresponding author), Univ Bergen, Dept Biomed, N-5009 Bergen, Norway.	aurora.martinez@biomed.uib.no	Martinez, Aurora/M-3088-2019	Martinez, Aurora/0000-0003-1643-6506; Pey, Angel Luis/0000-0001-7706-3243				Aguado C, 2006, FEBS LETT, V580, P1697, DOI 10.1016/j.febslet.2006.02.005; Ames BN, 2002, AM J CLIN NUTR, V75, P616, DOI 10.1093/ajcn/75.4.616; Blau N, 2004, MOL GENET METAB, V82, P101, DOI 10.1016/j.ymgme.2004.03.006; Erlandsen H, 2004, P NATL ACAD SCI USA, V101, P16903, DOI 10.1073/pnas.0407256101; Kure S, 2004, MOL GENET METAB, V83, P150, DOI 10.1016/j.ymgme.2004.06.016; Kure S, 1999, J PEDIATR-US, V135, P375, DOI 10.1016/S0022-3476(99)70138-1; Levy HL, 2007, LANCET, V370, P504, DOI 10.1016/S0140-6736(07)61234-3; MITNAUL LJ, 1995, P NATL ACAD SCI USA, V92, P885, DOI 10.1073/pnas.92.3.885; Pey AL, 2005, MOL GENET METAB, V86, pS43, DOI 10.1016/j.ymgme.2005.04.008; Pey AL, 2004, J AM CHEM SOC, V126, P13670, DOI 10.1021/ja047713s; SCRIVER CR, 2001, METABOLIC MOL BASES, P1667; Teigen K, 2003, J BIOMOL STRUCT DYN, V20, P733, DOI 10.1080/07391102.2003.10506889; Thony B, 2004, FEBS LETT, V577, P507, DOI 10.1016/j.febslet.2004.10.056	13	10	10	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2007	370	9586					462	463		10.1016/S0140-6736(07)61209-4	http://dx.doi.org/10.1016/S0140-6736(07)61209-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	199TJ	17693159				2022-12-01	WOS:000248717800006
J	Novotny, V; Miller, SE; Hulcr, J; Drew, RAI; Basset, Y; Janda, M; Setliff, GP; Darrow, K; Stewart, AJA; Auga, J; Isua, B; Molem, K; Manumbor, M; Tamtiai, E; Mogia, M; Weiblen, GD				Novotny, Vojtech; Miller, Scott E.; Hulcr, Jiri; Drew, Richard A. I.; Basset, Yves; Janda, Milan; Setliff, Gregory P.; Darrow, Karolyn; Stewart, Alan J. A.; Auga, John; Isua, Brus; Molem, Kenneth; Manumbor, Markus; Tamtiai, Elvis; Mogia, Martin; Weiblen, George D.			Low beta diversity of herbivorous insects in tropical forests	NATURE			English	Article							HOST-SPECIFICITY; NEW-GUINEA; SPECIES RICHNESS; RAIN-FOREST; LEPIDOPTERA; ASSEMBLAGES; DIPTERA; PLANTS; AGRICULTURE; TEPHRITIDAE	Recent advances in understanding insect communities in tropical forests(1,2) have contributed little to our knowledge of large-scale patterns of insect diversity, because incomplete taxonomic knowledge of many tropical species hinders the mapping of their distribution records(3). This impedes an understanding of global biodiversity patterns and explains why tropical insects are under-represented in conservation biology. Our study of approximately 500 species from three herbivorous guilds feeding on foliage (caterpillars, Lepidoptera), wood (ambrosia beetles, Coleoptera) and fruit (fruitflies, Diptera) found a low rate of change in species composition (beta diversity) across 75,000 square kilometres of contiguous lowland rainforest in Papua New Guinea, as most species were widely distributed. For caterpillars feeding on large plant genera, most species fed on multiple host species, so that even locally restricted plant species did not support endemic herbivores. Large plant genera represented a continuously distributed resource easily colonized by moths and butterflies over hundreds of kilometres. Low beta diversity was also documented in groups with differing host specificity (fruitflies and ambrosia beetles), suggesting that dispersal limitation does not have a substantial role in shaping the distribution of insect species in New Guinea lowland rainforests. Similar patterns of low beta diversity can be expected in other tropical lowland rainforests, as they are typically situated in the extensive low basins of major tropical rivers similar to the Sepik-Ramu region of New Guinea studied here.	Acad Sci Czech Republ, Ctr Biol, Ceske Budejovice 37005, Czech Republic; Acad Sci Czech Republ, Sch Biol Sci, Ceske Budejovice 37005, Czech Republic; Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20013 USA; Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; Griffith Univ, Australian Sch Environm Studies, Brisbane, Qld 4111, Australia; Smithsonian Trop Res Inst, Balboa, Ancon, Panama; Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; New Guinea Binatang Res Ctr, Madang, Papua N Guinea; Univ Minnesota, Bell Museum Nat Hist, Biol Sci Ctr 250, St Paul, MN 55108 USA; Univ Minnesota, Dept Plant Biol, Biol Sci Ctr 250, St Paul, MN 55108 USA	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Academy of Sciences; Smithsonian Institution; Smithsonian National Museum of Natural History; Michigan State University; Griffith University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Sussex; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Novotny, V (corresponding author), Acad Sci Czech Republ, Ctr Biol, Branisovska 31, Ceske Budejovice 37005, Czech Republic.	novotny@entu.cas.cz	Basset, Yves F/B-6642-2014; Novotny, Vojtech/G-9434-2014; Janda, Milan/H-7216-2014; Hulcr, Jiri/AAE-4210-2019	Basset, Yves F/0000-0002-1942-5717; Novotny, Vojtech/0000-0001-7918-8023; Janda, Milan/0000-0003-3038-0107; Hulcr, Jiri/0000-0002-8706-4618; Setliff, Gregory/0000-0002-1853-0232; Miller, Scott/0000-0002-4138-1378; Stewart, Alan/0000-0001-7878-8879				ABBOTT LD, 1995, J SOUTHE ASIAN EARTH, V11, P33, DOI 10.1016/0743-9547(94)00032-A; Barthlott W., 1996, ERDKUNDE, V50, P317, DOI [10.3112/erdkunde.1996.04.03, DOI 10.3112/ERDKUNDE.1996.04.03, 10.1007/s004250050096, DOI 10.1007/S004250050096]; Basset Y, 2004, J APPL ECOL, V41, P163, DOI 10.1111/j.1365-2664.2004.00878.x; Beaver R.A., 1989, P121; BEAVER RA, 1979, NATURE, V281, P139, DOI 10.1038/281139a0; Beck J, 2007, J ANIM ECOL, V76, P230, DOI 10.1111/j.1365-2656.2006.01189.x; Brown Keith S. Jr, 2005, P166; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Clarke AR, 2004, AUST J ENTOMOL, V43, P148, DOI 10.1111/j.1440-6055.2004.00395.x; Colwell RK, 2005, ESTIMATES STAT ESTIM; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Davies HL, 1997, GEM 97: PNG GEOLOGY EXPLORATION AND MINING CONFERENCE, PROCEEDINGS, P61; DREW R A I, 1989, Memoirs of the Queensland Museum, V26, P1; Erwin T. L., 2004, FOREST CANOPIES, P259; Farrell BD, 2001, EVOLUTION, V55, P2011, DOI 10.1111/j.0014-3820.2001.tb01318.x; Fletcher BS, 1998, AUST J ENTOMOL, V37, P315, DOI 10.1111/j.1440-6055.1998.tb01589.x; Gascon C, 2000, P NATL ACAD SCI USA, V97, P13672, DOI 10.1073/pnas.230136397; GASTON KJ, 1993, J TROP ECOL, V9, P491, DOI 10.1017/S0266467400007550; Hall JPW, 2002, EVOLUTION, V56, P1489; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; HOFT R, 1992, DICT GENERA FAMILIES, V13; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; Hubell SP, 2001, UNIFIED NEUTRAL THEO; Hulcr J, 2007, MOL ECOL NOTES, V7, P549, DOI 10.1111/j.1471-8286.2007.01786.x; Koleff P, 2003, GLOBAL ECOL BIOGEOGR, V12, P483, DOI 10.1046/j.1466-822X.2003.00056.x; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Leps J, 2001, J ECOL, V89, P186, DOI 10.1046/j.1365-2745.2001.00540.x; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Miller SE, 2003, P ENTOMOL SOC WASH, V105, P1034; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; NIX HA, 1972, BRIDGE BARRIER NATUR, P61; Novotny V, 2005, ANN ZOOL FENN, V42, P463; Novotny V, 2005, J BIOGEOGR, V32, P1303, DOI 10.1111/j.1365-2699.2005.01225.x; Novotny V, 2005, J TROP ECOL, V21, P67, DOI 10.1017/S0266467404002044; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Novotny V, 2000, P ROY SOC B-BIOL SCI, V267, P947, DOI 10.1098/rspb.2000.1095; Novotny V, 2004, CONSERV BIOL, V18, P227, DOI 10.1111/j.1523-1739.2004.00293.x; Novotny V, 2002, P ROY SOC B-BIOL SCI, V269, P2337, DOI 10.1098/rspb.2002.2166; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Novotny V, 2007, SCIENCE, V315, DOI 10.1126/science.1139702; Odegaard F, 2006, BIODIVERS CONSERV, V15, P83, DOI 10.1007/s10531-004-3106-5; Odegaard F, 2000, BIOL J LINN SOC, V71, P583, DOI 10.1006/bijl.2000.0468; Orr AG, 1996, MONOG BIOL, V74, P125; Paijmans K., 1976, NEW GUINEA VEGETATIO; Pigram C. J., 1987, BMR Journal of Australian Geology & Geophysics, V10, P193; Pitman NCA, 1999, ECOLOGY, V80, P2651, DOI 10.1890/0012-9658(1999)080[2651:TSDIAU]2.0.CO;2; REINER EJ, 1964, GEOGR REV, V54, P20, DOI 10.2307/213028; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Ruokolainen K, 2002, J TROP ECOL, V18, P935, DOI 10.1017/S0266467402002614; STORK NE, 1993, BIODIVERS CONSERV, V2, P215, DOI 10.1007/BF00056669; Swadling P, 1997, WORLD ARCHAEOL, V29, P1; Wood A.W., 1982, BIOGEOGRAPHY ECOLOGY, VVol. 42, P73, DOI 10.1007/978-94-009-8632-9_5; Wurm S. A., 1981, LANGUAGE ATLAS PACIF	54	198	211	0	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2007	448	7154					692	U8		10.1038/nature06021	http://dx.doi.org/10.1038/nature06021			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687324				2022-12-01	WOS:000248598000044
J	Johnson, CP; Tang, HY; Carag, C; Speicher, DW; Discher, DE				Johnson, Colin P.; Tang, Hsin-Yao; Carag, Christine; Speicher, David W.; Discher, Dennis E.			Forced unfolding of proteins within cells	SCIENCE			English	Article							SPECTRIN REPEATS; IMMUNOGLOBULIN DOMAINS; MECHANICAL-PROPERTIES; MOLECULAR-STRUCTURE; ERYTHROID SPECTRIN; ELASTICITY; ADHESION; TITIN; SPECTROSCOPY; FIBRONECTIN	To identify cytoskeletal proteins that change conformation or assembly within stressed cells, in situ labeling of sterically shielded cysteines with fluorophores was analyzed by fluorescence imaging, quantitative mass spectrometry, and sequential two-dye labeling. Within red blood cells, shotgun labeling showed that shielded cysteines in the two isoforms of the cytoskeletal protein spectrin were increasingly labeled as a function of shear stress and time, indicative of forced unfolding of specific domains. Within mesenchymal stem cells-as a prototypical adherent cell-nonmuscle myosin IIA and vimentin are just two of the cytoskeletal proteins identified that show differential labeling in tensed versus drug-relaxed cells. Cysteine labeling of proteins within live cells can thus be used to fluorescently map out sites of molecular-scale deformation, and the results also suggest means to colocalize signaling events such as phosphorylation with forced unfolding.	Univ Penn, Biophys Engn Lab, Philadelphia, PA 19104 USA; Wistar Inst Anat & Biol, Syst Biol Div, Philadelphia, PA 19104 USA	University of Pennsylvania; The Wistar Institute	Discher, DE (corresponding author), Univ Penn, Biophys Engn Lab, Philadelphia, PA 19104 USA.	discher@seas.upenn.edu	Krieger, Christine/AAX-6822-2021	Krieger, Christine/0000-0002-1856-415X; Tang, Hsin-Yao/0000-0003-1838-018X; Johnson, Colin/0000-0002-6783-2835; discher, dennis/0000-0001-6163-2229	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022575] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007049] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR022575, S10 RR022575-01A1] Funding Source: Medline; NHLBI NIH HHS [R01 HL062352-09A1, R01 HL062352] Funding Source: Medline; NIAMS NIH HHS [R21 AR056128-02, R21 AR056128-01A1, R21 AR056128] Funding Source: Medline; NIBIB NIH HHS [R01 EB007049-03, R01 EB007049-01, R01 EB007049-02, R01 EB007049] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Abu-Lail NI, 2006, MATRIX BIOL, V25, P175, DOI 10.1016/j.matbio.2005.10.007; Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6; An XL, 2006, J BIOL CHEM, V281, P10527, DOI 10.1074/jbc.M513725200; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Carl P, 2001, P NATL ACAD SCI USA, V98, P1565, DOI 10.1073/pnas.031409698; CHIANCONE E, 1970, J BIOL CHEM, V245, P4105; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; ERICKSON HP, 1994, P NATL ACAD SCI USA, V91, P10114, DOI 10.1073/pnas.91.21.10114; EVANS EA, 1980, MECH THERMODYNAMICS, P190; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Ha JH, 1998, NAT STRUCT BIOL, V5, P730, DOI 10.1038/1436; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Johnson CP, 2007, BLOOD, V109, P3538, DOI 10.1182/blood-2006-07-038588; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Kusunoki H, 2004, STRUCTURE, V12, P645, DOI 10.1016/j.str.2004.02.022; Law R, 2003, BIOPHYS J, V85, P3286, DOI 10.1016/S0006-3495(03)74747-X; Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437; Lee JCM, 2001, BIOPHYS J, V81, P3178, DOI 10.1016/S0006-3495(01)75954-1; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; MOHANDAS N, 1994, ANNU REV BIOPH BIOM, V23, P787, DOI 10.1146/annurev.bb.23.060194.004035; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Ortiz V, 2005, J MOL BIOL, V349, P638, DOI 10.1016/j.jmb.2005.03.086; Ramamurthy B, 2004, BIOCHEMISTRY-US, V43, P14832, DOI 10.1021/bi0490284; Randles LG, 2007, BIOPHYS J, V92, P571, DOI 10.1529/biophysj.106.093690; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776; Silverman JA, 2002, J BIOL CHEM, V277, P30968, DOI 10.1074/jbc.M203172200; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sun SJ, 1997, MOL BIOL CELL, V8, P421, DOI 10.1091/mbc.8.3.421; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Williams PM, 2003, NATURE, V422, P446, DOI 10.1038/nature01517	38	276	286	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					663	666		10.1126/science.1139857	http://dx.doi.org/10.1126/science.1139857			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17673662	Green Accepted			2022-12-01	WOS:000248494400046
J	Patra, S; Kumar, A; Trivedi, SS; Puri, M; Sarin, SK				Patra, Sharda; Kumar, Ashish; Trivedi, Shubha Sagar; Puri, Manju; Sarin, Shiv Kumar			Maternal and fetal outcomes in pregnant women with acute hepatitis e virus infection	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE VIRAL-HEPATITIS; ACUTE LIVER-FAILURE; CLINICAL-COURSE; ETIOLOGY; TRANSMISSION; INDIA	Background: Hepatitis E virus (HEV) infection is known to cause severe liver disease in pregnant women. It is unclear whether obstetric and fetal outcomes are worse in pregnant women with HEV infection than in women with other forms of viral hepatitis. Objective: To compare maternal, obstetric, and fetal outcomes in pregnant women with acute viral hepatitis caused by HEV and other hepatitis viruses. Design: Observational cohort. Setting: Tertiary care hospital, New Delhi, India. Patients: 220 consecutive pregnant women presenting with jaundice caused by acute viral hepatitis. Measurements: Maternal mortality and medical complications, obstetric complications, deliveries, and fetal outcomes. Results: Infection with HEV caused acute viral hepatitis in 60% of included women. Fulminant hepatic failure was more common (relative risk, 2.7 [95% Cl, 1.7 to 4.2]; P = 0.001) and maternal mortality was greater (relative risk, 6.0 [Cl, 2.7 to 13.3]; P < 0.001) in HEV-infected women than in non-HEV-infected women. Women with HEV infection were more likely than those with other forms of viral hepatitis to have obstetric complications (relative risk, 4.1 [Cl, 1.7 to 10.2] for antepartum hemorrhage and 1.9 [Cl, 1.3 to 2.7] for intrauterine fetal death; P < 0.001 for both) and poor fetal outcomes (relative risk, 1.2 [Cl, 1.0 to 1.4] for preterm delivery [P = 0.0051 and 1.8 [Cl, 1.2 to 2.51 for stillbirth [P = 0.026]). Limitations: The findings may not apply to community settings, to women who are asymptomatic or have only minor symptoms, or in the setting of an HEV epidemic. Conclusions: Pregnant women with jaundice and acute viral hepatitis caused by HEV infection had a higher maternal mortality rate and worse obstetric and fetal outcomes than did pregnant women with jaundice and acute viral hepatitis caused by other types of viral hepatitis.	GB Pant Hosp, Dept Gastroenterol, New Delhi 110002, India; Lady Hardinge Med Coll & Hosp, New Delhi, India	Govind Ballabh Pant Institute of Postgraduate Medical Education & Research; Lady Hardinge Medical College & Hospital	Sarin, SK (corresponding author), GB Pant Hosp, Dept Gastroenterol, Room 201,Acad Block, New Delhi 110002, India.	sksarin@nda.vsnl.net.in	Kumar, Ashish/F-6737-2010; Kumar, Ashish/GRR-3470-2022	Kumar, Ashish/0000-0001-6680-7227; Kumar, Ashish/0000-0002-4476-3494				Acharya SK, 1996, HEPATOLOGY, V23, P1448, DOI 10.1053/jhep.1996.v23.pm0008675163; Arankalle V A, 2000, Indian J Gastroenterol, V19, P24; Aziz Aliya B., 1997, JPMA (Journal of the Pakistan Medical Association), V47, P198; Gelpi A P, 1978, Int J Gynaecol Obstet, V17, P73; Jaiswal SPB, 2001, INT J GYNECOL OBSTET, V72, P103, DOI 10.1016/S0020-7292(00)00264-2; KHUROO MS, 1981, AM J MED, V70, P252, DOI 10.1016/0002-9343(81)90758-0; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P224, DOI 10.1046/j.1365-2893.2003.00415.x; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P61, DOI 10.1046/j.1365-2893.2003.00398.x; KHUROO MS, 1980, AM J MED, V68, P818, DOI 10.1016/0002-9343(80)90200-4; Khuroo MS, 1997, HEPATOLOGY, V26, P244; KHUROO MS, 1995, LANCET, V345, P1025, DOI 10.1016/S0140-6736(95)90761-0; Krawczynski K, 2000, INFECT DIS CLIN N AM, V14, P669, DOI 10.1016/S0891-5520(05)70126-4; Kumar A, 2004, INT J GYNECOL OBSTET, V85, P240, DOI 10.1016/j.ijgo.2003.11.018; Kumar RM, 2001, EUR J OBSTET GYN R B, V100, P9, DOI 10.1016/S0301-2115(01)00448-1; MEDHAT A, 1993, INT J GYNECOL OBSTET, V40, P25, DOI 10.1016/0020-7292(93)90768-R; Mishra D, 2003, Indian J Pediatr, V70, P273, DOI 10.1007/BF02725598; NAYAK NC, 1989, J GASTROEN HEPATOL, V4, P345, DOI 10.1111/j.1440-1746.1989.tb00846.x; Pal R, 2005, J GASTROEN HEPATOL, V20, P1094, DOI 10.1111/j.1440-1746.2005.03875.x; SARIN SK, 2006, TXB LIVER DIS, P693; Schwartz E, 1999, CLIN INFECT DIS, V29, P1312, DOI 10.1086/313430; Singh Sarman, 2003, Indian Journal of Pediatrics, V70, P37, DOI 10.1007/BF02722743; Strand RT, 2003, SCAND J INFECT DIS, V35, P401, DOI 10.1080/00365540310010930; Trey C, 1970, Prog Liver Dis, V3, P282; TSEGA E, 1993, ETHIOPIAN MED J, V31, P173	24	268	274	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 3	2007	147	1					28	33		10.7326/0003-4819-147-1-200707030-00005	http://dx.doi.org/10.7326/0003-4819-147-1-200707030-00005			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	186MN	17606958				2022-12-01	WOS:000247782900004
J	Lande, R; Gregorio, J; Facchinetti, V; Chatterjee, B; Wang, YH; Homey, B; Cao, W; Wang, YH; Su, B; Nestle, FO; Zal, T; Mellman, I; Schroder, JM; Liu, YJ; Gilliet, M				Lande, Roberto; Gregorio, Josh; Facchinetti, Valeria; Chatterjee, Bithi; Wang, Yi-Hong; Homey, Bernhard; Cao, Wei; Wang, Yui-Hsi; Su, Bing; Nestle, Frank O.; Zal, Tomasz; Mellman, Ira; Schroeder, Jens-Michael; Liu, Yong-Jun; Gilliet, Michel			Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide	NATURE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTORS; HUMAN SKIN; INNATE IMMUNITY; VERTEBRATE DNA; BACTERIAL-DNA; PSORIASIS; ALPHA; AUTOIMMUNITY; LL-37	Plasmacytoid dendritic cells (pDCs) sense viral and microbial DNA through endosomal Toll-like receptors to produce type 1 interferons. pDCs do not normally respond to self-DNA, but this restriction seems to break down in human autoimmune disease by an as yet poorly understood mechanism. Here we identify the antimicrobial peptide LL37 (also known as CAMP) as the key factor that mediates pDC activation in psoriasis, a common autoimmune disease of the skin. LL37 converts inert self-DNA into a potent trigger of interferon production by binding the DNA to form aggregated and condensed structures that are delivered to and retained within early endocytic compartments in pDCs to trigger Toll-like receptor 9. Thus, our data uncover a fundamental role of an endogenous antimicrobial peptide in breaking innate tolerance to self-DNA and suggest that this pathway may drive autoimmunity in psoriasis.	Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Genentech Inc, San Francisco, CA 94080 USA; Univ Dusseldorf, Dept Dermatol, D-40225 Dusseldorf, Germany; Kings Coll London Sch Med, St Johns Inst Dermatol, London SE1 9RT, England; Univ Kiel, Univ Hosp Schleswig Holstein, Dept Dermatol, D-24105 Kiel, Germany	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Yale University; Roche Holding; Genentech; Heinrich Heine University Dusseldorf; University of London; King's College London; University of Kiel; Schleswig Holstein University Hospital	Gilliet, M (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA.	mgilliet@mdanderson.org	Lande, Roberto/L-5803-2019; Lande, Roberto/B-9987-2016; Schroeder, Jens M/B-3994-2009; Mellman, Ira/ABG-5896-2020	Lande, Roberto/0000-0001-8398-4567; Lande, Roberto/0000-0001-8398-4567; Cao, Wei/0000-0002-8952-9159; Zal, Tomasz/0000-0002-3469-4261				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Braff MH, 2005, J INVEST DERMATOL, V125, P9, DOI 10.1111/j.0022-202X.2004.23587.x; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Dufourcq J, 1998, FEBS LETT, V421, P7, DOI 10.1016/S0014-5793(97)01522-6; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Griffiths CEM, 1996, J ROY SOC MED, V89, P315, DOI 10.1177/014107689608900604; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Harder J, 2005, J LEUKOCYTE BIOL, V77, P476, DOI 10.1189/jlb.0704409; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Heilborn JD, 2003, J INVEST DERMATOL, V120, P379, DOI 10.1046/j.1523-1747.2003.12069.x; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Kubo T, 2001, NUCLEOS NUCLEOT NUCL, V20, P1313, DOI 10.1081/NCN-100002544; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Li XQ, 2005, BIOCHEMISTRY-US, V44, P14688, DOI 10.1021/bi051519g; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Means TK, 2005, J CLIN INVEST, V115, P407, DOI 10.1172/JCI200523025; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nickoloff BJ, 2004, J CLIN INVEST, V113, P1664, DOI 10.1172/JCI200422147; Niidome T, 2000, J PEPT SCI, V6, P271, DOI 10.1002/1099-1387(200006)6:6<271::AID-PSC249>3.3.CO;2-6; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Paulsen F, 2002, J PATHOL, V198, P369, DOI 10.1002/path.1224; Ronnblom L, 2003, AUTOIMMUNITY, V36, P463, DOI 10.1080/08916930310001602128; Sandgren S, 2004, J BIOL CHEM, V279, P17951, DOI 10.1074/jbc.M311440200; Schauber J, 2006, EUR J GASTROEN HEPAT, V18, P615, DOI 10.1097/00042737-200606000-00007; Stacey KJ, 2003, J IMMUNOL, V170, P3614, DOI 10.4049/jimmunol.170.7.3614; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129; Zal T, 2006, TRAFFIC, V7, P1607, DOI 10.1111/j.1600-0854.2006.00498.x; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	42	1267	1337	3	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					564	U6		10.1038/nature06116	http://dx.doi.org/10.1038/nature06116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17873860				2022-12-01	WOS:000249893500037
J	Arboleda-Florez, J				Arboleda-Florez, Julio			Severe mental and neurological disorders in Mozambique	LANCET			English	Editorial Material												Jearflo@aol.com						Andrade L, 2000, B WORLD HEALTH ORGAN, V78, P413; Bijl RV, 2003, HEALTH AFFAIR, V22, P122, DOI 10.1377/hlthaff.22.3.122; Patel V, 2007, LANCET, V370, P1055, DOI 10.1016/S0140-6736(07)61479-2; World Health Organization (WHO), 2005, MENT HLTH ATL	4	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2007	370	9592					1012	1013		10.1016/S0140-6736(07)61456-1	http://dx.doi.org/10.1016/S0140-6736(07)61456-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	214HJ	17889227				2022-12-01	WOS:000249727900006
J	Turner, AH; Makovicky, PJ; Norell, MA				Turner, Alan H.; Makovicky, Peter J.; Norell, Mark A.			Feather quill knobs in the dinosaur Velociraptor	SCIENCE			English	Article									Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA	American Museum of Natural History (AMNH); Field Museum of Natural History (Chicago)	Turner, AH (corresponding author), Amer Museum Nat Hist, Div Paleontol, Cent Pk W & 79th St, New York, NY 10024 USA.	turner@amnh.org						Clarke J, 2004, B AM MUS NAT HIST, P1; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; Elzanowski Andrzej, 2002, P129; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Hopp TP, 2004, LIFE O PAST, P234; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855	8	48	50	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2007	317	5845					1721	1721		10.1126/science.1145076	http://dx.doi.org/10.1126/science.1145076			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885130				2022-12-01	WOS:000249585900039
J	Morel, CM				Morel, Carlos M.			The road to recovery	NATURE			English	Editorial Material							DEVELOPING-COUNTRIES; EXPERIENCE; BRAZIL		Fiocruz MS, Ctr Technol Dev Hlth, BR-21045900 Rio De Janeiro, Brazil; Fiocruz MS, Med & Drugs Technol Inst, BR-21045900 Rio De Janeiro, Brazil	Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Morel, CM (corresponding author), Fiocruz MS, Ctr Technol Dev Hlth, BR-21045900 Rio De Janeiro, Brazil.		Morel, Carlos/AHD-9349-2022; Casas, Carmen Phang Romero/J-3465-2017; Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019	Casas, Carmen Phang Romero/0000-0002-2759-0544; Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009				Almeida Celia, 2002, Cad. Saúde Pública, V18, P905, DOI 10.1590/S0102-311X2002000400002; Basu P, 2005, NAT BIOTECHNOL, V23, P13, DOI 10.1038/nbt0105-13; Bernardes AT, 2003, RES POLICY, V32, P865, DOI 10.1016/S0048-7333(02)00089-6; Borgatti S.P., 1999, UCINET 6 0 VERSION 1; BUSS PM, 2005, VACINAS SOROS IMUNIZ; Ferrer M, 2004, NAT BIOTECHNOL, V22, pDC8, DOI 10.1038/nbt1204supp-DC8; GADELHA C, 2003, SAUDE MANGUINHOS, V10, P697; Gama A. A. S., 2003, QUIM NOVA, V26, P618; Gadelha CAG, 2006, REV SAUDE PUBL, V40, P11, DOI 10.1590/S0034-89102006000400003; Levi GC, 2002, AIDS, V16, P2373, DOI 10.1097/00002030-200212060-00001; Mahoney RT, 2007, VACCINE, V25, P4003, DOI 10.1016/j.vaccine.2007.02.047; Morel C., 2005, INNOVATION STRATEGY, V1, P1; Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538; Olive JM, 1997, J INFECT DIS, V175, pS189, DOI 10.1093/infdis/175.Supplement_1.S189; Temporão José Gomes, 2003, Hist. cienc. saude-Manguinhos, V10, P601, DOI 10.1590/S0104-59702003000500008; Viotti EB, 2002, TECHNOL FORECAST SOC, V69, P653, DOI 10.1016/S0040-1625(01)00167-6	16	15	15	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					180	182		10.1038/449180a	http://dx.doi.org/10.1038/449180a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851516	Bronze, Green Published			2022-12-01	WOS:000249394500040
J	Greten, FR; Arkan, MC; Bollrath, J; Hsu, LC; Goode, J; Miething, C; Goktuna, SI; Neuenhahn, M; Fierer, J; Paxian, S; Van Rooijen, N; Xu, YJ; O'Cain, T; Jaffee, BB; Busch, DH; Duyster, J; Schmid, RM; Eckmann, L; Karin, M				Greten, Florian R.; Arkan, Melek C.; Bollrath, Julia; Hsu, Li-Chung; Goode, Jason; Miething, Cornelius; Goktuna, Serkan I.; Neuenhahn, Michael; Fierer, Joshua; Paxian, Stephan; Van Rooijen, Nico; Xu, Yajun; O'Cain, Timothy; Jaffee, Bruce B.; Busch, Dirk H.; Duyster, Justus; Schmid, Roland M.; Eckmann, Lars; Karin, Michael			NF-kappa B is a negative regulator of IL-1 beta secretion as revealed by genetic and pharmacological inhibition of IKK beta	CELL			English	Article							PRECURSOR INTERLEUKIN-1-BETA; INFLAMMATORY CASPASES; LINKS INFLAMMATION; MICE DEFICIENT; INNATE; ACTIVATION; ENZYME; ALPHA; DEATH; MACROPHAGES	IKK beta-dependent NF-kappa B activation plays a key role in innate immunity and inflammation, and inhibition of IKK beta has been considered as a likely anti-inflammatory therapy. Surprisingly, however, mice with a targeted IKK beta deletion in myeloid cells are more susceptible to endotoxin-induced shock than control mice. Increased endotoxin susceptibility is associated with elevated plasma IL-1 beta as a result of increased pro-IL-1 beta processing, which was also seen upon bacterial infection. In macrophages enhanced pro-IL-1 beta processing depends on caspase-1, whose activation is inhibited by NF-kappa B-dependent gene products. In neutrophils, however, IL-1 beta secretion is caspase-1 independent and depends on serine proteases, whose activity is also inhibited by NF-kappa B gene products. Prolonged pharmacologic inhibition of IKK beta also augments IL-1 beta secretion upon endotoxin challenge. These results unravel an unanticipated role for IKK beta-dependent NF-kappa B signaling in the negative control of IL-1 beta production and highlight potential complications of long-term IKK beta inhibition.	Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-81675 Munich, Germany; Tech Univ Munich, Klinikum Rechts Isar, Dept Med 3, D-81675 Munich, Germany; Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Vrije Univ Amsterdam, Med Ctr, NL-1007 MB Amsterdam, Netherlands; Millenoum Pharmaceut, Cambridge, MA 02139 USA	Technical University of Munich; Technical University of Munich; Technical University of Munich; University of California System; University of California San Diego; University of California System; University of California San Diego; Vrije Universiteit Amsterdam; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals	Greten, FR (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-81675 Munich, Germany.	florian.greten@lrz.tum.de; karinoffice@ucsd.edu	Greten, Florian R/AAF-5196-2020; Miething, Cornelius/F-9498-2014; Van Rooijen, Nico/Z-1578-2019; , jfierer/W-2823-2019	Greten, Florian R/0000-0002-3928-6080; Miething, Cornelius/0000-0003-4699-3805; Goktuna, Serkan/0000-0001-6169-768X; Hsu, Li-Chung/0000-0001-7206-5231	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061712, R01AI043477, R01AI056075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070867, P01DK035108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006376] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI061712, AI56075, R01 AI043477-10, AI43477, AI061712, R01 AI056075, R01 AI043477, R01 AI056075-05, R01 AI061712-04] Funding Source: Medline; NIDDK NIH HHS [P01 DK035108-190002, P01 DK035108-190014, DK35108, R01 DK070867, DK70867, P01 DK035108, R01 DK070867-02] Funding Source: Medline; NIEHS NIH HHS [R01 ES006376] Funding Source: Medline; PHS HHS [E06486] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Algul H, 2007, J CLIN INVEST, V117, P1490, DOI 10.1172/JCI29882; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; BLACK RA, 1988, J BIOL CHEM, V263, P9437; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dinarello CA, 2005, CRIT CARE MED, V33, pS460, DOI 10.1097/01.CCM.0000185500.11080.91; DINARELLO CA, 1986, J CLIN INVEST, V77, P1734, DOI 10.1172/JCI112495; Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S; Fantuzzi G, 1997, J IMMUNOL, V158, P1818; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; HAZUDA DJ, 1990, J BIOL CHEM, V265, P6318; HOGQUIST KA, 1991, P NATL ACAD SCI USA, V88, P8485, DOI 10.1073/pnas.88.19.8485; Horwitz BH, 1997, IMMUNITY, V6, P765, DOI 10.1016/S1074-7613(00)80451-3; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; IRMLER M, 1995, J EXP MED, V181, P1917, DOI 10.1084/jem.181.5.1917; Kannan-Thulasiraman P, 2002, J BIOL CHEM, V277, P41230, DOI 10.1074/jbc.M200379200; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kisseleva T, 2006, J CLIN INVEST, V116, P2955, DOI 10.1172/JCI27392; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu Z, 2000, CELL, V102, P647, DOI 10.1016/S0092-8674(00)00087-8; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; MCLNTYRE KW, 2003, ARTHRITIS RHEUM, V48, P2652; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Miething C, 2007, P NATL ACAD SCI USA, V104, P4594, DOI 10.1073/pnas.0604716104; MIZUTANI H, 1991, J EXP MED, V174, P821, DOI 10.1084/jem.174.4.821; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Ogura Y, 2006, CELL, V126, P659, DOI 10.1016/j.cell.2006.08.002; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Ruocco MG, 2005, J EXP MED, V201, P1677, DOI 10.1084/jem.20042081; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; SUFFREDINI AF, 1995, J IMMUNOL, V155, P5038; Taylor PR, 2003, IMMUNITY, V19, P2, DOI 10.1016/S1074-7613(03)00178-X; vanRooijen N, 1997, TRENDS BIOTECHNOL, V15, P178, DOI 10.1016/S0167-7799(97)01019-6; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Vassiloyanakopoulos AP, 1998, P NATL ACAD SCI USA, V95, P7676, DOI 10.1073/pnas.95.13.7676; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Wiesner O, 2005, FEBS LETT, V579, P5305, DOI 10.1016/j.febslet.2005.08.056; Zeng WL, 2000, J CELL BIOCHEM, V78, P519, DOI 10.1002/1097-4644(20000915)78:4<519::AID-JCB1>3.0.CO;2-V; Zingarelli B, 2005, CRIT CARE MED, V33, pS414, DOI 10.1097/01.CCM.0000186079.88909.94	55	494	512	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2007	130	5					918	931		10.1016/j.cell.2007.07.009	http://dx.doi.org/10.1016/j.cell.2007.07.009			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	212GI	17803913	Bronze, Green Accepted			2022-12-01	WOS:000249581500022
J	Mathieu, O; Reinders, J; Caikovski, M; Smathajitt, C; Paszkowski, J				Mathieu, Olivier; Reinders, Jon; Caikovski, Marian; Smathajitt, Chotika; Paszkowski, Jerzy			Transgenerational stability of the Arabidopsis epigenome is coordinated by CG methylation	CELL			English	Article							DNA GLYCOSYLASE/LYASE ROS1; HISTONE H3 METHYLATION; CPG METHYLATION; DE-NOVO; EPIGENETIC INHERITANCE; ENDOGENOUS TARGETS; METHYLTRANSFERASE; HETEROCHROMATIN; MAINTENANCE; LYSINE-9	Maintenance of CG methylation (m CG) patterns is essential for chromatin-mediated epigenetic regulation of transcription in plants and mammals. However, functional links between m CG and other epigenetic mechanisms in vivo remain obscure. Using successive generations of an Arabidopsis thaliana mutant deficient in maintaining m CG, we find that m CG loss triggers genome-wide activation of alternative epigenetic mechanisms. However, these mechanisms, which involve RNA-directed DNA methylation, inhibiting expression of DNA demethylases, and retargeting of histone H3K9 methylation, act in a stochastic and uncoordinated fashion. As a result, new and aberrant epigenetic patterns are progressively formed over several plant generations in the absence of m CG. Interestingly, the unconventional redistribution of epigenetic marks is necessary to "rescue'' the loss of m CG, since mutant plants impaired in rescue activities are severely dwarfed and sterile. Our results provide evidence that m CG is a central coordinator of epigenetic memory that secures stable transgenerational inheritance in plants.	Univ Geneva, Lab Plant Genet, CH-1211 Geneva 4, Switzerland; Univ Blaise Pascal, CNRS, UMR 6547, F-63177 Aubiere, France	University of Geneva; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Mathieu, O (corresponding author), Univ Geneva, Lab Plant Genet, Sci 3,30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	olivier.mathieu@univ-bpclermont.fr; jerzy.paszkowski@bioveg.unige.ch	Yokthongwattana, Chotika/T-4820-2019; Mathieu, Olivier/AAV-6593-2021	Mathieu, Olivier/0000-0001-5302-1102; Yokthongwattana, Chotika/0000-0001-7016-8384				Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Aufsatz W, 2004, PLANT MOL BIOL, V54, P793, DOI 10.1007/s11103-004-0179-1; Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; Birke M, 2002, NUCLEIC ACIDS RES, V30, P958, DOI 10.1093/nar/30.4.958; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Brzeski J, 2003, J BIOL CHEM, V278, P823, DOI 10.1074/jbc.M209260200; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jorgensen HF, 2004, MOL CELL BIOL, V24, P3387, DOI 10.1128/MCB.24.8.3387-3395.2004; Kakutani T, 1999, GENETICS, V151, P831; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Kankel MW, 2003, GENETICS, V163, P1109; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; Mathieu O, 2004, J CELL SCI, V117, P4881, DOI 10.1242/jcs.01479; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Perez-Burgos L, 2004, METHOD ENZYMOL, V376, P234; Probst AV, 2003, PLANT J, V33, P743, DOI 10.1046/j.1365-313X.2003.01667.x; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Steimer A, 2000, PLANT CELL, V12, P1165, DOI 10.1105/tpc.12.7.1165; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Vaillant I, 2006, EMBO REP, V7, P1273, DOI 10.1038/sj.embor.7400791; VANBLOKLAND R, 1994, PLANT J, V6, P861, DOI 10.1046/j.1365-313X.1994.6060861.x; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Wada Y, 2003, J BIOL CHEM, V278, P42386, DOI 10.1074/jbc.M303892200; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059; Zilberman D, 2005, CURR OPIN GENET DEV, V15, P557, DOI 10.1016/j.gde.2005.07.002	50	301	316	3	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2007	130	5					851	862		10.1016/j.cell.2007.07.007	http://dx.doi.org/10.1016/j.cell.2007.07.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	212GI	17803908	Bronze			2022-12-01	WOS:000249581500017
J	Tanaka, T; Ohkubo, S; Tatsuno, I; Prives, C				Tanaka, Tomoaki; Ohkubo, Shuichi; Tatsuno, Ichiro; Prives, Carol			hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes	CELL			English	Article							HISTONE LYSINE METHYLATION; CHROMOSOME SEGREGATION; DNA-DAMAGE; HUMAN HOMOLOG; APOPTOTIC FUNCTION; PROSTATE-CANCER; BUDDING YEAST; TUMOR-CELLS; CSE1; INDUCTION	The p53 tumor suppressor protein regulates many genes that can determine different cellular outcomes such as growth arrest or cell death. Promoter-selective transactivation by p53, although critical for the different cellular outcomes, is not well understood. We report here that the human cellular apoptosis susceptibility protein ( hCAS/CSE1L) associates with a subset of p53 target promoters, including PIG3, in a p53-autonomous manner. Downregulation of hCAS/CSE1L decreases transcription from those p53 target promoters to which it preferentially binds and reduces apoptosis. In addition, hCAS/CSE1L silencing leads to increased methylation of histone H3 lysine 27 within the PIG3 gene. hCAS/CSE1L was previously shown to function as a nucleo-cytoplasmic transport factor, as does its closely related yeast homologue Cse1, which can also associate with chromatin and serve as a barrier protein that prevents spreading of heterochromatin. Thus, human CAS/CSE1L can bind select genes with significant functional consequences for p53-mediated transcription and determine cellular outcome.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Chiba Univ, Grad Sch Med, Dept Clin Cell Biol & Med, Chiba 2608670, Japan; Taiho Pharmaceut Co Ltd, Adv Res Lab, Hanno, Saitama 3578527, Japan	Columbia University; Chiba University; Taiho Pharmaceutical	Prives, C (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	clp3@columbia.edu			NCI NIH HHS [CA77742] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077742] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Baptiste N, 2002, ONCOGENE, V21, P9, DOI 10.1038/sj/onc/1205015; Bates S, 1999, CELL MOL LIFE SCI, V55, P28, DOI 10.1007/s000180050267; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brinkmann U, 1996, BIOCHEMISTRY-US, V35, P6891, DOI 10.1021/bi952829+; BRINKMANN U, 1995, P NATL ACAD SCI USA, V92, P10427, DOI 10.1073/pnas.92.22.10427; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Contente A, 2002, NAT GENET, V30, P315, DOI 10.1038/ng836; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Cook A, 2005, MOL CELL, V18, P355, DOI 10.1016/j.molcel.2005.03.021; Ehrenhofer-Murray AE, 2004, EUR J BIOCHEM, V271, P2335, DOI 10.1111/j.1432-1033.2004.04162.x; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Kosova B, 2000, J BIOL CHEM, V275, P343, DOI 10.1074/jbc.275.1.343; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; LACHNER M, 2003, CELL DEATH DIFFER, V13, P951; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Ludwig RL, 1996, MOL CELL BIOL, V16, P4952; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Menendez D, 2006, MOL CELL BIOL, V26, P2297, DOI 10.1128/MCB.26.6.2297-2308.2006; Minsky N, 2004, MOL CELL, V16, P631, DOI 10.1016/j.molcel.2004.10.016; Ogryzko VV, 1997, BIOCHEMISTRY-US, V36, P9493, DOI 10.1021/bi970236o; Ohkubo S, 2006, J BIOL CHEM, V281, P16943, DOI 10.1074/jbc.M601388200; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Prives C, 1999, J PATHOL, V187, P112; Rhodes DR, 2003, J NATL CANCER I, V95, P661, DOI 10.1093/jnci/95.9.661; Ronen D, 1996, CELL GROWTH DIFFER, V7, P21; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Shikama N, 1999, MOL CELL, V4, P365, DOI 10.1016/S1097-2765(00)80338-X; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; XIAO ZX, 1993, MOL CELL BIOL, V13, P4691, DOI 10.1128/MCB.13.8.4691	46	149	154	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2007	130	4					638	650		10.1016/j.cell.2007.08.001	http://dx.doi.org/10.1016/j.cell.2007.08.001			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	208KY	17719542	Bronze			2022-12-01	WOS:000249319400015
J	Elias, LAB; Wang, DD; Kriegstein, AR				Elias, Laura A. B.; Wang, Doris D.; Kriegstein, Arnold R.			Gap junction adhesion is necessary for radial migration in the neocortex	NATURE			English	Article							FETAL MONKEY NEOCORTEX; NEURAL CREST CELLS; C6 GLIOMA-CELLS; NEURONAL MIGRATION; GLIAL-CELLS; DIFFERENTIAL EXPRESSION; CEREBRAL-CORTEX; CONNEXIN; COMMUNICATION; MODULATION	Radial glia, the neuronal stem cells of the embryonic cerebral cortex, reside deep within the developing brain and extend radial fibres to the pial surface, along which embryonic neurons migrate to reach the cortical plate. Here we show that the gap junction subunits connexin 26 (Cx26) and connexin 43 (Cx43) are expressed at the contact points between radial fibres and migrating neurons, and acute downregulation of Cx26 or Cx43 impairs the migration of neurons to the cortical plate. Unexpectedly, gap junctions do not mediate neuronal migration by acting in the classical manner to provide an aqueous channel for cell-cell communication. Instead, gap junctions provide dynamic adhesive contacts that interact with the internal cytoskeleton to enable leading process stabilization along radial fibres as well as the subsequent translocation of the nucleus. These results indicate that gap junction adhesions are necessary for glial-guided neuronal migration, raising the possibility that the adhesive properties of gap junctions may have an important role in other physiological processes and diseases associated with gap junction function.	Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Elias, LAB (corresponding author), Univ Calif San Francisco, Grad Program Neurosci, 513 Parnassus Ave, San Francisco, CA 94143 USA.	EliasL@stemcell.ucsf.edu; KriegsteinA@stemcell.ucsf.edu		Wang, Doris/0000-0001-6112-3002				Adams NC, 2002, DEVELOPMENT, V129, P965; Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Anton ES, 1997, DEVELOPMENT, V124, P3501; Beahm DL, 2006, J BIOL CHEM, V281, P7994, DOI 10.1074/jbc.M506533200; Bittman K, 1997, J NEUROSCI, V17, P7037; CAMERON RS, 1994, J NEUROSCI, V14, P3139; DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; ELSABBAN ME, 1994, INVAS METAST, V14, P164; Falk MM, 2000, J CELL SCI, V113, P4109; FISHELL G, 1991, DEVELOPMENT, V113, P755; Fushiki S, 2003, J NEUROPATH EXP NEUR, V62, P304, DOI 10.1093/jnen/62.3.304; GADISSEUX JF, 1990, DEV BRAIN RES, V52, P39, DOI 10.1016/0165-3806(90)90220-S; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; GREGORY WA, 1988, J NEUROSCI, V8, P1728; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Huang GY, 1998, J CELL BIOL, V143, P1725, DOI 10.1083/jcb.143.6.1725; Ito A, 2000, J CLIN INVEST, V105, P1189, DOI 10.1172/JCI8257; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Lai A, 2006, J CELL SCI, V119, P532, DOI 10.1242/jcs.02770; Lin JHC, 2002, J NEUROSCI, V22, P4302, DOI 10.1523/JNEUROSCI.22-11-04302.2002; Lin R, 2001, J CELL BIOL, V154, P815, DOI 10.1083/jcb.200102027; Lo CW, 1999, TRENDS CARDIOVAS MED, V9, P63, DOI 10.1016/S1050-1738(99)00015-8; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; Malatesta P, 2000, DEVELOPMENT, V127, P5253; MEYER RA, 1992, J CELL BIOL, V119, P179, DOI 10.1083/jcb.119.1.179; Nadarajah B, 1997, J NEUROSCI, V17, P3096; NAUS CCG, 1991, NEUROSCI LETT, V126, P33, DOI 10.1016/0304-3940(91)90364-Y; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Oliveira R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-7; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schmid RS, 2005, CEREB CORTEX, V15, P1632, DOI 10.1093/cercor/bhi041; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Wiencken-Barger AE, 2007, GLIA, V55, P675, DOI 10.1002/glia.20484; Xu X, 2001, J CELL BIOL, V154, P217, DOI 10.1083/jcb.200105047; Xu X, 2006, DEVELOPMENT, V133, P3629, DOI 10.1242/dev.02543	43	434	442	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2007	448	7156					901	U3		10.1038/nature06063	http://dx.doi.org/10.1038/nature06063			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202OM	17713529				2022-12-01	WOS:000248912900041
J	Ding, M; Chao, D; Wang, G; Shen, K				Ding, Mei; Chao, Dan; Wang, George; Shen, Kang			Spatial regulation of an E3 ubiquitin ligase directs selective synapse elimination	SCIENCE			English	Article							VENTRAL NERVE CORD; C-ELEGANS; PROTEASOME SYSTEM; CAENORHABDITIS-ELEGANS; GLUTAMATE RECEPTORS; DIFFERENTIATION; DEGRADATION; SCF; NEUROTRANSMITTER; SYNAPTOGENESIS	Stereotyped synaptic connectivity can arise both by precise recognition between appropriate partners during synaptogenesis and by selective synapse elimination. The molecular mechanisms that underlie selective synapse removal are largely unknown. We found that stereotyped developmental elimination of synapses in the Caenorhabditis elegans hermaphrodite-specific motor neuron (HSNL) was mediated by an E3 ubiquitin ligase, a Skp1-cullin-F-box (SCF) complex composed of SKR-1 and the F-box protein SEL-10. SYG-1, a synaptic adhesion molecule, bound to SKR-1 and inhibited assembly of the SCF complex, thereby protecting nearby synapses. Thus, subcellular regulation of ubiquitin-mediated protein degradation contributes to precise synaptic connectivity through selective synapse elimination.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Program Neurosci, Stanford, CA 94305 USA	Stanford University; Stanford University	Shen, K (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	kangshen@stanford.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER; NINDS NIH HHS [1R01NS048392] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Jager S, 2004, P NATL ACAD SCI USA, V101, P12549, DOI 10.1073/pnas.0405087101; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	27	84	98	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					947	951		10.1126/science.1145727	http://dx.doi.org/10.1126/science.1145727			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17626846				2022-12-01	WOS:000248780200040
J	Liu, HJ; Fergusson, MM; Castilho, RM; Liu, J; Cao, L; Chen, JH; Malide, D; Rovira, II; Schimel, D; Kuo, CJ; Gutkind, JS; Hwang, PM; Finkel, T				Liu, Hongjun; Fergusson, Maria M.; Castilho, Rogerio M.; Liu, Jie; Cao, Liu; Chen, Jichun; Malide, Daniela; Rovira, Ilsa I.; Schimel, Daniel; Kuo, Calvin J.; Gutkind, J. Silvio; Hwang, Paul M.; Finkel, Toren			Augmented Wnt signaling in a mammalian model of accelerated aging	SCIENCE			English	Article							HEMATOPOIETIC STEM-CELL; KLOTHO; SKIN; MICE; DIFFERENTIATION; ACTIVATION; REPAIR; LEADS	The contribution of stem and progenitor cell dysfunction and depletion in normal aging remains incompletely understood. We explored this concept in the Klotho mouse model of accelerated aging. Analysis of various tissues and organs from young Klotho mice revealed a decrease in stem cell number and an increase in progenitor cell senescence. Because klotho is a secreted protein, we postulated that klotho might interact with other soluble mediators of stem cells. We found that klotho bound to various Wnt family members. In a cell culture model, the Wnt-klotho interaction resulted in the suppression of Wnt biological activity. Tissues and organs from klotho-deficient animals showed evidence of increased Wnt signaling, and ectopic expression of klotho antagonized the activity of endogenous and exogenous Wnt. Both in vitro and in vivo, continuous Wnt exposure triggered accelerated cellular senescence. Thus, klotho appears to be a secreted Wnt antagonist and Wnt proteins have an unexpected role in mammalian aging.	NHLBI, Cardiol Branch, NIH, Bethesda, MD 20892 USA; Natl Inst Dent & Craniofacial Res, Oral Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; NHLBI, Light Microscopy Core Facil, NIH, Bethesda, MD 20892 USA; NIH, Mouse Imaging Facil, Bethesda, MD 20892 USA; Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; Stanford University	Finkel, T (corresponding author), NHLBI, Cardiol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	finkelt@nih.gov	Castilho, Rogerio M/E-4987-2010; Gutkind, J. Silvio/J-1201-2016; Gutkind, J. Silvio/A-1053-2009	Castilho, Rogerio M/0000-0001-5358-612X; Gutkind, J. Silvio/0000-0002-5150-4482; Kuo, Calvin/0000-0002-7427-5985	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005101, Z01HL005012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000551, Z01DE000558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069989] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIDDK NIH HHS [1 R01 DK069989-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Braun KM, 2004, J INVEST DERM SYMP P, V9, P196, DOI 10.1111/j.1087-0024.2004.09313.x; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Vitale-Cross L, 2004, CANCER RES, V64, P8804, DOI 10.1158/0008-5472.CAN-04-2623; Xiao NM, 2004, CHINESE MED J-PEKING, V117, P742; Yamashita T, 2000, J ENDOCRINOL, V164, P239, DOI 10.1677/joe.0.1640239	22	558	594	3	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2007	317	5839					803	806		10.1126/science.1143578	http://dx.doi.org/10.1126/science.1143578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690294				2022-12-01	WOS:000248624500040
J	Dong, MQ; Venable, JD; Au, N; Xu, T; Park, SK; Cociorva, D; Johnson, JR; Dillin, A; Yates, JR				Dong, Meng-Qiu; Venable, John D.; Au, Nora; Xu, Tao; Park, Sung Kyu; Cociorva, Daniel; Johnson, Jeffrey R.; Dillin, Andrew; Yates, John R., III			Quantitative mass spectrometry identifies insulin signaling targets in C-elegans	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; LONGEVITY; DAF-16; CALCINEURIN; METABOLISM; DIAPAUSE; GENES; PROTEOMICS; BEHAVIOR	DAF-2, an insulin receptor-like protein, regulates metabolism, development, and aging in Caenorhabditis elegans. In a quantitative proteomic study, we identified 86 proteins that were more or less abundant in long-lived daf-2 mutant worms than in wild-type worms. Genetic studies on a subset of these proteins indicated that they act in one or more processes regulated by DAF-2, including entry into the dauer developmental stage and aging. In particular, we discovered a compensatory mechanism activated in response to reduced DAF-2 signaling, which involves the protein phosphatase calcineurin.	Scripps Res Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA; Univ Calif San Diego, La Jolla, CA 92093 USA	Scripps Research Institute; Salk Institute; University of California System; University of California San Diego	Yates, JR (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	jyates@scripps.edu	Xu, Tao/A-9353-2009		NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070696, R01DK074798, R21DK067598] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR11823-10] Funding Source: Medline; NIDDK NIH HHS [DK074798, DK070696, DK067598] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bandyopadhyay J, 2002, MOL BIOL CELL, V13, P3281, DOI 10.1091/mbc.E02-01-0005; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; Gems D, 1998, GENETICS, V150, P129; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Krijgsveld J, 2003, NAT BIOTECHNOL, V21, P927, DOI 10.1038/nbt848; Kuhara A, 2002, NEURON, V33, P751, DOI 10.1016/S0896-6273(02)00607-4; Lee J, 2004, J MOL BIOL, V344, P585, DOI 10.1016/j.jmb.2004.09.050; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; McElwee JJ, 2006, MECH AGEING DEV, V127, P458, DOI 10.1016/j.mad.2006.01.006; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Venable JD, 2004, NAT METHODS, V1, P39, DOI 10.1038/NMETH705; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	21	241	263	0	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					660	663		10.1126/science.1139952	http://dx.doi.org/10.1126/science.1139952			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17673661				2022-12-01	WOS:000248494400045
J	Molina, DM; Wetterholm, A; Kohl, A; McCarthy, AA; Niegowski, D; Ohlson, E; Hammarberg, T; Eshaghi, S; Haeggstrom, J; Nordlund, PR				Molina, Daniel Martinez; Wetterholm, Anders; Kohl, Andreas; McCarthy, Andrew A.; Niegowski, Damian; Ohlson, Eva; Hammarberg, Tove; Eshaghi, Said; Haeggstroem, Jesper Z.; Nordlund, Paer			Structural basis for synthesis of inflammatory mediators by human leukotriene C-4 synthase	NATURE			English	Article							GLUTATHIONE; REFINEMENT; ASTHMA	Cysteinyl leukotrienes are key mediators in inflammation and have an important role in acute and chronic inflammatory diseases of the cardiovascular and respiratory systems, in particular bronchial asthma. In the biosynthesis of cysteinyl leukotrienes, conversion of arachidonic acid forms the unstable epoxide leukotriene A(4) (LTA(4)). This intermediate is conjugated with glutathione (GSH) to produce leukotriene C-4 (LTC4) in a reaction catalysed by LTC4 synthase(1): this reaction is the key step in cysteinyl leukotriene formation. Here we present the crystal structure of the human LTC4 synthase in its apo and GSH- complexed forms to 2.00 and 2.15 angstrom resolution, respectively. The structure reveals a homotrimer, where each monomer is composed of four transmembrane segments. The structure of the enzyme in complex with substrate reveals that the active site enforces a horseshoe- shaped conformation on GSH, and effectively positions the thiol group for activation by a nearby arginine at the membrane - enzyme interface. In addition, the structure provides a model for how the omega- end of the lipophilic co- substrate is pinned at one end of a hydrophobic cleft, providing a molecular 'ruler' to align the reactive epoxide at the thiol of glutathione. This provides newstructural insights into themechanismof LTC4 formation, and also suggests that the observed binding and activation of GSHmight be common for a family of homologous proteins important for inflammatory and detoxification responses.	Karolinska Inst, Div Biophys, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Karolinska Inst, Div Chem, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Karolinska Inst, Struct Genom Consortium, S-17177 Stockholm, Sweden; Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Stockholm University; European Molecular Biology Laboratory (EMBL)	Haeggstrom, J (corresponding author), Karolinska Inst, Div Biophys, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	said.eshaghi@ki.se; jesper.haeggstrom@ki.se; par.nordlund@ki.se	McCarthy, Andrew A/A-5926-2013	McCarthy, Andrew A/0000-0003-4478-0136				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bisgaard H, 2001, PEDIATRICS, V107, P381, DOI 10.1542/peds.107.2.381; COREY EJ, 1980, J AM CHEM SOC, V102, P1436, DOI 10.1021/ja00524a045; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; DAHLEN SE, 1981, P NATL ACAD SCI-BIOL, V78, P3887, DOI 10.1073/pnas.78.6.3887; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Drazen JM, 1999, NEW ENGL J MED, V340, P197, DOI 10.1056/NEJM199901213400306; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; HANNA CJ, 1981, NATURE, V290, P343, DOI 10.1038/290343a0; Holm PJ, 2006, J MOL BIOL, V360, P934, DOI 10.1016/j.jmb.2006.05.056; IZUMI T, 1988, BIOCHIM BIOPHYS ACTA, V959, P305; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lam BK, 2002, PROSTAG OTH LIPID M, V68-9, P511, DOI 10.1016/S0090-6980(02)00052-7; Leslie AGW, 1992, PROTEIN CRYSTALLOGR, V26, P27; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Morgenstern R, 2001, BIOCHEMISTRY-US, V40, P3378, DOI 10.1021/bi0023394; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WEISS JW, 1982, SCIENCE, V216, P196, DOI 10.1126/science.7063880; YOSHIMOTO T, 1988, J CLIN INVEST, V81, P866, DOI 10.1172/JCI113396	28	155	159	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2007	448	7153					613	U13		10.1038/nature06009	http://dx.doi.org/10.1038/nature06009			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17632546				2022-12-01	WOS:000248446700048
J	Bryant, DA; Costas, AMG; Maresca, JA; Chew, AGM; Klatt, CG; Bateson, MM; Tallon, LJ; Hostetler, J; Nelson, WC; Heidelberg, JF; Ward, DM				Bryant, Donald A.; Costas, Amaya M. Garcia; Maresca, Julia A.; Chew, Aline Gomez Maqueo; Klatt, Christian G.; Bateson, Mary M.; Tallon, Luke J.; Hostetler, Jessica; Nelson, William C.; Heidelberg, John F.; Ward, David M.			Candidatus Chloracidobacterium thermophilum: An aerobic phototrophic acidobacterium	SCIENCE			English	Article							YELLOWSTONE-NATIONAL-PARK; MICROBIAL MAT COMMUNITY; PHOTOSYNTHESIS; ENVIRONMENT; DIVERSITY; BACTERIA; GENOMICS	Only five bacterial phyla with members capable of chlorophyll (Chl)-based phototrophy are presently known. Metagenomic data from the phototrophic microbial mats of alkaline siliceous hot springs in Yellowstone National Park revealed the existence of a distinctive bacteriochlorophyll ( BChl)-synthesizing, phototrophic bacterium. A highly enriched culture of this bacterium grew photoheterotrophically, synthesized BChls a and c under oxic conditions, and had chlorosomes and type 1 reaction centers. "Candidatus Chloracidobacterium thermophilum" is a BChl-producing member of the poorly characterized phylum Acidobacteria.	Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; Inst Genom Res, Rockville, MD 20850 USA; Univ So Calif, Dept Biol, Wrigley Marine Sci Ctr, Avalon, CA 90704 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman; J. Craig Venter Institute; University of Southern California	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	dab14@psu.edu	Gomez Maqueo Chew, Aline/D-8631-2016; Costas, Amaya Garcia/AAE-6827-2020; Nelson, William C/E-9263-2016	Gomez Maqueo Chew, Aline/0000-0001-6075-2907; Nelson, William C/0000-0002-1873-3929; Heidelberg, John/0000-0003-0673-3224; Maresca, Julia/0000-0002-3955-1585				Allewalt JP, 2006, APPL ENVIRON MICROB, V72, P544, DOI 10.1128/AEM.72.1.544-550.2006; Barns SM, 1999, APPL ENVIRON MICROB, V65, P1731; Bryant DA, 2006, TRENDS MICROBIOL, V14, P488, DOI 10.1016/j.tim.2006.09.001; Camara-Artigas A, 2003, PHOTOSYNTH RES, V75, P49, DOI 10.1023/A:1022406703110; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; FRIGAARD NU, 2006, COMPLEX INTRACELLULA, V2, P79, DOI DOI 10.1007/7171_021; GOLBECK JH, 1993, P NATL ACAD SCI USA, V90, P1642, DOI 10.1073/pnas.90.5.1642; Hauska G, 2001, BBA-BIOENERGETICS, V1507, P260, DOI 10.1016/S0005-2728(01)00200-6; Kanokratana P, 2004, J BASIC MICROB, V44, P430, DOI 10.1002/jobm.200410388; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Quaiser A, 2003, MOL MICROBIOL, V50, P563, DOI 10.1046/j.1365-2958.2003.03707.x; Schubert WD, 1998, J MOL BIOL, V280, P297, DOI 10.1006/jmbi.1998.1824; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Ward DM, 2006, PHILOS T R SOC B, V361, P1997, DOI 10.1098/rstb.2006.1919; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; WARD DM, 2007, HEREDITY        0606, DOI DOI 10.1038/SJ.HDY.6801011; Yim LC, 2006, FEMS MICROBIOL ECOL, V57, P80, DOI 10.1111/j.1574-6941.2006.00104.x	20	264	274	2	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					523	526		10.1126/science.1143236	http://dx.doi.org/10.1126/science.1143236			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656724				2022-12-01	WOS:000248339800048
J	Takaoka, A; Wang, Z; Choi, MK; Yanai, H; Negishi, H; Ban, T; Lu, Y; Miyagishi, M; Kodama, T; Honda, K; Ohba, Y; Taniguchi, T				Takaoka, Akinori; Wang, ZhiChao; Choi, Myoung Kwon; Yanai, Hideyuki; Negishi, Hideo; Ban, Tatsuma; Lu, Yan; Miyagishi, Makoto; Kodama, Tatsuhiko; Honda, Kenya; Ohba, Yusuke; Taniguchi, Tadatsugu			DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response	NATURE			English	Article							TOLL-LIKE RECEPTORS; PATTERN-RECOGNITION RECEPTORS; DOUBLE-STRANDED-RNA; RIG-I; ANTIVIRAL RESPONSES; GENE INDUCTION; HUMAN ZBP1; LOCALIZATION; VIRUSES; DOMAINS	Central to innate immunity is the sensing of pathogen-associated molecular patterns by cytosolic and membrane-associated receptors(1-4). In particular, DNA is a potent activator of immune responses during infection or tissue damage(5-7), and evidence indicates that, in addition to the membrane-associated Toll-like receptor 9, an unidentified cytosolic DNA sensor(s) can activate type I interferon (IFN) and other immune responses(8-10). Here we report on a candidate DNA sensor, previously named DLM-1 ( also called Z-DNA binding protein 1 (ZBP1))(11), for which biological function had remained unknown; we now propose the alternative name DAI (DNA-dependent activator of IFN-regulatory factors(12)). The artificial expression of otherwise IFN-inducible DAI (DLM-1/ ZBP1) in mouse fibroblasts selectively enhances the DNA-mediated induction of type I IFN and other genes involved in innate immunity. On the other hand, RNA interference of messenger RNA for DAI (DLM-1/ ZBP1) in cells inhibits this gene induction programme upon stimulation by DNA from various sources. Moreover, DAI (DLM-1/ZBP1) binds to double-stranded DNA and, by doing so, enhances its association with the IRF3 transcription factor and the TBK1 serine/threonine kinase. These observations underscore an integral role of DAI (DLM-1/ZBP1) in the DNA-mediated activation of innate immune responses, and may offer new insight into the signalling mechanisms underlying DNA- associated antimicrobial immunity and autoimmune disorders.	Univ Tokyo, Dept Immunol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Dept 21st Century,Ctr Excellence Program, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; Hokkaido Univ, Div Signaling Canc & Immunol, Inst Med Genet, Sapporo, Hokkaido 0600815, Japan; Hokkaido Univ, Dept Lab Med, Grad Sch Med, Kita Ku, Sapporo, Hokkaido 0600815, Japan; Univ Tokyo, Dept Mol Biol & Med, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Hokkaido University; Hokkaido University; University of Tokyo	Taniguchi, T (corresponding author), Univ Tokyo, Dept Immunol, Grad Sch Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	tada@m.u-tokyo.ac.jp	Miyagishi, Makoto/L-8174-2016; Yanai, Hideyuki/AGK-5933-2022; Honda, Kenya/N-5297-2015; Ohba, Yusuke/E-7944-2011	Miyagishi, Makoto/0000-0001-7654-3616; Yanai, Hideyuki/0000-0002-0115-9000; 				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Braun CS, 2003, BIOPHYS J, V84, P1114, DOI 10.1016/S0006-3495(03)74927-3; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Deigendesch N, 2006, NUCLEIC ACIDS RES, V34, P5007, DOI 10.1093/nar/gkl575; Fu YN, 1999, GENE, V240, P157, DOI 10.1016/S0378-1119(99)00419-9; Ha SC, 2006, BBA-PROTEINS PROTEOM, V1764, P320, DOI 10.1016/j.bbapap.2005.12.012; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ishii KJ, 2006, TRENDS IMMUNOL, V27, P525, DOI 10.1016/j.it.2006.09.002; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Pham HT, 2006, BIOCHEM BIOPH RES CO, V348, P145, DOI 10.1016/j.bbrc.2006.07.061; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rich A, 2003, NAT REV GENET, V4, P566, DOI 10.1038/nrg1115; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schwartz T, 2001, NAT STRUCT BIOL, V8, P761, DOI 10.1038/nsb0901-761; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; SUGGS JW, 1986, NUCLEIC ACIDS RES, V14, P3703; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tokunaga T, 1999, JPN J INFECT DIS, V52, P1; Verthelyi D, 2003, TRENDS IMMUNOL, V24, P519, DOI 10.1016/S1471-4906(03)00243-6; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	30	1210	1285	7	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					501	U14		10.1038/nature06013	http://dx.doi.org/10.1038/nature06013			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17618271				2022-12-01	WOS:000248302700053
J	Goldacre, B				Goldacre, Ben			Medicine and the media - MMR: the scare stories are back	BRITISH MEDICAL JOURNAL			English	Editorial Material												ben@badscience.net		Goldacre, Ben/0000-0002-5127-4728					0	13	13	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2007	335	7611					126	127		10.1136/bmj.39280.447419.59	http://dx.doi.org/10.1136/bmj.39280.447419.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195RA	17634177	Green Published			2022-12-01	WOS:000248428100030
J	Tinetti, G; Vidal-Madjar, A; Liang, MC; Beaulieu, JP; Yung, Y; Carey, S; Barber, RJ; Tennyson, J; Ribas, I; Allard, N; Ballester, GE; Sing, DK; Selsis, F				Tinetti, Giovanna; Vidal-Madjar, Alfred; Liang, Mao-Chang; Beaulieu, Jean-Philippe; Yung, Yuk; Carey, Sean; Barber, Robert J.; Tennyson, Jonathan; Ribas, Ignasi; Allard, Nicole; Ballester, Gilda E.; Sing, David K.; Selsis, Franck			Water vapour in the atmosphere of a transiting extrasolar planet	NATURE			English	Article							TRANSMISSION SPECTRA; THERMAL EMISSION; LIGHT CURVES; LINE; ABSORPTION; HYDROGEN	Water is predicted to be among the most abundant (if not the most abundant) molecular species after hydrogen in the atmospheres of close-in extrasolar giant planets ('hot Jupiters')(1,2). Several attempts have been made to detect water on such planets, but have either failed to find compelling evidence for it(3,4) or led to claims that should be taken with caution(5). Here we report an analysis of recent observations of the hot Jupiter HD 189733b (ref. 6) taken during the transit, when the planet passed in front of its parent star. We find that absorption by water vapour is the most likely cause of the wavelength-dependent variations in the effective radius of the planet at the infrared wavelengths 3.6 mu m, 5.8 mu m (both ref. 7) and 8 mu m (ref. 8). The larger effective radius observed at visible wavelengths(9) may arise from either stellar variability or the presence of clouds/hazes. We explain the report of a non-detection of water on HD 189733b (ref. 4) as being a consequence of the nearly isothermal vertical profile of the planet's atmosphere.	European Space Agcy, I-00044 Frascati, Italy; UCL, Dept Phys & Astron, London WC1E 6BT, England; Univ Paris 06, CNRS, Inst Astrophys Paris, F-75014 Paris, France; Acad Sinica, Res Ctr Environm Changes, Taipei 115, Taiwan; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; CALTECH, IPAC Spitzer Sci Ctr, Pasadena, CA 91125 USA; CSIC, IEEC, Inst Ciencias Espai, Bellaterra 08193, Spain; Univ Arizona, Dept Planetary Sci, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Ctr Natl Etud Spatiales, F-75001 Paris, France; CNRS, Ecole Normale Super, F-69364 Lyon, France	European Space Agency; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Academia Sinica - Taiwan; California Institute of Technology; California Institute of Technology; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); University of Arizona; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Tinetti, G (corresponding author), European Space Agcy, I-00044 Frascati, Italy.	gio@gps.caltech.edu	Liang, Mao-Chang/P-9796-2018; Liang, Mao-Chang/AAG-4305-2021; Ribas, Ignasi/M-2134-2014; Tinetti, Giovanna/Q-4697-2019; Tinetti, Giovanna/G-7956-2017; Tennyson, Jonathan/I-2222-2012	Liang, Mao-Chang/0000-0002-5294-9344; Ribas, Ignasi/0000-0002-6689-0312; Tinetti, Giovanna/0000-0001-6058-6654; Tinetti, Giovanna/0000-0001-6058-6654; Tennyson, Jonathan/0000-0002-4994-5238; Carey, Sean/0000-0002-0221-6871; Sing, David/0000-0001-6050-7645; Selsis, Franck/0000-0001-9619-5356; Beaulieu, Jean-Philippe/0000-0003-0014-3354	EPSRC [EP/E043674/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E043674/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Allard NF, 2007, ASTRON ASTROPHYS, V465, P1085, DOI 10.1051/0004-6361:20066616; Allard NF, 2003, ASTRON ASTROPHYS, V411, pL473, DOI 10.1051/0004-6361:20031299; Ballester GE, 2007, NATURE, V445, P511, DOI 10.1038/nature05525; Barber RJ, 2006, MON NOT R ASTRON SOC, V368, P1087, DOI 10.1111/j.1365-2966.2006.10184.x; Barman T, 2007, ASTROPHYS J, V661, pL191, DOI 10.1086/518736; BEAULIEU JP, UNPUB ASTROPHYS J; Borysow A, 2001, J QUANT SPECTROSC RA, V68, P235, DOI 10.1016/S0022-4073(00)00023-6; Bouchy F, 2005, ASTRON ASTROPHYS, V444, pL15, DOI 10.1051/0004-6361:200500201; Brown TM, 2001, ASTROPHYS J, V553, P1006, DOI 10.1086/320950; Burrows A, 2006, ASTROPHYS J, V650, P1140, DOI 10.1086/507269; Charbonneau D, 2005, ASTROPHYS J, V626, P523, DOI 10.1086/429991; Charbonneau D, 2002, ASTROPHYS J, V568, P377, DOI 10.1086/338770; Deming D, 2005, NATURE, V434, P740, DOI 10.1038/nature03507; Fortney JJ, 2006, ASTROPHYS J, V652, P746, DOI 10.1086/508442; FORTNEY JJ, UNPUB ASTROPHYS J; Grillmair CJ, 2007, ASTROPHYS J, V658, pL115, DOI 10.1086/513741; HANEL RA, 1972, J GEOPHYS RES, V77, P2629, DOI 10.1029/JC077i015p02629; Knutson HA, 2007, NATURE, V447, P183, DOI 10.1038/nature05782; Knutson HA, 2007, ASTROPHYS J, V655, P564, DOI 10.1086/510111; Liang MC, 2007, ASTROPHYS J, V661, pL199, DOI 10.1086/518785; Liang MC, 2003, ASTROPHYS J, V596, pL247, DOI 10.1086/379314; Richardson LJ, 2007, NATURE, V445, P892, DOI 10.1038/nature05636; Richardson LJ, 2006, ASTROPHYS J, V649, P1043, DOI 10.1086/506503; Rothman LS, 2005, J QUANT SPECTROSC RA, V96, P139, DOI 10.1016/j.jqsrt.2004.10.008; Seager S, 2000, ASTROPHYS J, V537, P916, DOI 10.1086/309088; Tinetti G, 2007, ASTROPHYS J, V654, pL99, DOI 10.1086/510716; Vidal-Madjar A, 2004, ASTROPHYS J, V604, pL69, DOI 10.1086/383347; Vidal-Madjar A, 2003, NATURE, V422, P143, DOI 10.1038/nature01448; Winn JN, 2007, ASTRON J, V133, P1828, DOI 10.1086/512159; Yung Y.L., 1989, ATMOSPHERIC RAD	30	391	393	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2007	448	7150					169	171		10.1038/nature06002	http://dx.doi.org/10.1038/nature06002			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17625559	Green Submitted, Green Accepted			2022-12-01	WOS:000247934500036
J	Conway, PH; Cnaan, A; Zaoutis, T; Henry, BV; Grundmeier, RW; Keren, R				Conway, Patrick H.; Cnaan, Avital; Zaoutis, Theoklis; Henry, Brandon V.; Grundmeier, Robert W.; Keren, Ron			Recurrent urinary tract infections in children - Risk factors and association with prophylactic antimicrobials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY VESICOURETERAL REFLUX; CONTROLLED-TRIAL; BACTERIURIA; MANAGEMENT; THERAPY	Context The evidence regarding risk factors for recurrent urinary tract infection ( UTI) and the risks and benefits of antimicrobial prophylaxis in children is scant. Objectives To identify risk factors for recurrent UTI in a pediatric primary care cohort, to determine the association between antimicrobial prophylaxis and recurrent UTI, and to identify the risk factors for resistance among recurrent UTIs. Design, Patients, and Setting From a network of 27 primary care pediatric practices in urban, suburban, and semirural areas spanning 3 states, a cohort of children aged 6 years or younger who were diagnosed with first UTI between July 1, 2001, and May 31, 2006, was assembled. Time-to-event analysis was used to determine risk factors for recurrent UTI and the association between antimicrobial prophylaxis and recurrent UTI, and a nested case-control study was performed among children with recurrent UTI to identify risk factors for resistant infections. Main Outcome Measures Time to recurrent UTI and antimicrobial resistance of recurrent UTI pathogens. Results Among 74 974 children in the network, 611 (0.007 per person-year) had a first UTI and 83 (0.12 per person-year after first UTI) had a recurrent UTI. In multivariable Cox time-to-event models, factors associated with increased risk of recurrent UTI included white race (0.17 per person-year; hazard ratio [HR], 1.97; 95% confidence interval [CI], 1.22-3.16), age 3 to 4 years (0.22 per person-year; HR, 2.75; 95% CI, 1.37-5.51), age 4 to 5 years (0.19 per person-year; HR, 2.47; 95% CI, 1.19-5.12), and grade 4 to 5 vesicoureteral reflux (0.60 per person-year; HR, 4.38; 95% CI, 1.26-15.29). Sex and grade 1 to 3 vesicoureteral reflux were not associated with risk of recurrence. Antimicrobial prophylaxis was not associated with decreased risk of recurrent UTI ( HR, 1.01; 95% CI, 0.50-2.02), even after adjusting for propensity to receive prophylaxis, but was a risk factor for antibimicrobial resistance among children with recurrent UTI ( HR, 7.50; 95% CI, 1.60-35.17). Conclusion Among the children in this study, antimicrobial prophylaxis was not associated with decreased risk of recurrent UTI, but was associated with increased risk of resistant infections.	Univ Penn, Robert Wood Johnson Clin Scholars Program, Philadelphia, PA 19104 USA; Univ Penn, Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Gen Pediat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Biostat & Epidemiol, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA; Cincinnati Childrens Hosp Med Ctr, Ctr Hlth Care Qual, Cincinnati, OH USA; Cincinnati Childrens Hosp Med Ctr, Div Gen Pediat, Cincinnati, OH USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Conway, PH (corresponding author), Univ Penn, Robert Wood Johnson Clin Scholars Program, 423 Guardian Dr,Bloddey Hall 1303A, Philadelphia, PA 19104 USA.	pconway2@mail.med.upenn.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K23HD043179] Funding Source: NIH RePORTER; NCRR NIH HHS [U54 RR023567-01] Funding Source: Medline; NICHD NIH HHS [K23 HD043179] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Bergman DA, 1999, PEDIATRICS, V103, P843; BISSET GS, 1987, AM J ROENTGENOL, V148, P479, DOI 10.2214/ajr.148.3.479; Downs SH, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.4.e54; Elder JS, 1997, J UROLOGY, V157, P1846, DOI 10.1016/S0022-5347(01)64882-1; Garin EH, 2006, PEDIATRICS, V117, P626, DOI 10.1542/peds.2005-1362; GLEESON FV, 1991, ARCH DIS CHILD, V66, P1282, DOI 10.1136/adc.66.11.1282; Gorelick MH, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.5.e54; Hellerstein S, 2002, PEDIATR NEPHROL, V17, P506, DOI 10.1007/s00467-002-0899-x; HELLSTROM A, 1991, ARCH DIS CHILD, V66, P232, DOI 10.1136/adc.66.2.232; HOBERMAN A, 1994, J PEDIATR-US, V124, P513, DOI 10.1016/S0022-3476(05)83127-0; Kwok Wing-Yee, 2006, BMC Pediatr, V6, P10, DOI 10.1186/1471-2431-6-10; LEBOWITZ RL, 1985, PEDIATR RADIOL, V15, P105, DOI 10.1007/BF02388714; LOHR JA, 1977, PEDIATRICS, V59, P562; Lutter SA, 2005, ARCH PEDIAT ADOL MED, V159, P924, DOI 10.1001/archpedi.159.10.924; Mahant S, 2002, ARCH DIS CHILD, V86, P419, DOI 10.1136/adc.86.6.419; Mazzola BL, 2003, J NEPHROL, V16, P133; MCKERROW W, 1984, BRIT MED J, V289, P299, DOI 10.1136/bmj.289.6440.299; Panaretto KS, 1999, J PAEDIATR CHILD H, V35, P454, DOI 10.1046/j.1440-1754.1999.355417.x; Reddy PP, 1997, PEDIATRICS, V100, P555; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; SAVAGE DCL, 1975, LANCET, V1, P358; Shaikh N, 2003, PEDIATRICS, V112, P1134, DOI 10.1542/peds.112.5.1134; SMELLIE JM, 1988, PEDIATR NEPHROL, V2, P12, DOI 10.1007/BF00870372; SMELLIE JM, 1978, LANCET, V2, P175; SNODGRASS W, 1991, UROLOGY, V38, P341, DOI 10.1016/0090-4295(91)80148-Z; UHARI M, 1988, BRIT MED J, V297, P450, DOI 10.1136/bmj.297.6646.450; WAN JL, 1995, J UROLOGY, V154, P797, DOI 10.1016/S0022-5347(01)67167-2; WILLIAMS GJ, 2006, COCHRANE DB SYST REV, V3; WINBERG J, 1974, Acta Paediatrica Scandinavica Supplement, P1; WINBERG J, 1975, KIDNEY INT, V8, pS101	31	243	256	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2007	298	2					179	186		10.1001/jama.298.2.179	http://dx.doi.org/10.1001/jama.298.2.179			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188HI	17622599	Bronze			2022-12-01	WOS:000247910600023
J	Kniemeyer, O; Musat, F; Sievert, SM; Knittel, K; Wilkes, H; Blumenberg, M; Michaelis, W; Classen, A; Bolm, C; Joye, SB; Widdel, F				Kniemeyer, Olaf; Musat, Florin; Sievert, Stefan M.; Knittel, Katrin; Wilkes, Heinz; Blumenberg, Martin; Michaelis, Walter; Classen, Arno; Bolm, Carsten; Joye, Samantha B.; Widdel, Friedrich			Anaerobic oxidation of short-chain hydrocarbons by marine sulphate-reducing bacteria	NATURE			English	Article							GULF-OF-MEXICO; GUAYMAS BASIN; HYDROTHERMAL SEDIMENTS; GAS HYDRATE; METHANE; CARBON; CALIFORNIA; REDUCTION; PROPANE; COMMUNITIES	The short-chain hydrocarbons ethane, propane and butane are constituents of natural gas. They are usually assumed to be of thermochemical origin(1), but biological formation of ethane and propane has been also observed(2). Microbial utilization of short-chain hydrocarbons has been shown in some aerobic species(3,4) but not in anaerobic species of bacteria. On the other hand, anaerobic utilization of short-chain hydrocarbons would in principle be expected because various anaerobic bacteria grow with higher homologues (>= C-6)(5). Indeed, chemical analyses of hydrocarbon-rich habitats with limited or no access of oxygen indicated in situ biodegradation of short-chain hydrocarbons(6-10). Here we report the enrichment of sulphate-reducing bacteria (SRB) with such capacity from marine hydrocarbon seep areas. Propane or n-butane as the sole growth substrate led to sediment-free sulphate-reducing enrichment cultures growing at 12, 28 or 60 degrees C. With ethane, a slower enrichment with residual sediment was obtained at 12 degrees C. Isolation experiments resulted in a mesophilic pure culture (strain BuS5) that used only propane and n-butane (methane, isobutane, alcohols or carboxylic acids did not support growth). Complete hydrocarbon oxidation to CO2 and the preferential oxidation of C-12-enriched alkanes were observed with strain BuS5 and other cultures. Metabolites of propane included iso- and n-propylsuccinate, indicating a subterminal as well as an unprecedented terminal alkane activation with involvement of fumarate. According to 16S ribosomal RNA analyses, strain BuS5 affiliates with Desulfosarcina/Desulfococcus, a cluster of widespread marine SRB. An enrichment culture with propane growing at 60 degrees C was dominated by Desulfotomaculum-like SRB. Our results suggest that diverse SRB are able to thrive in seep areas and gas reservoirs on propane and butane, thus altering the gas composition and contributing to sulphide production.	Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02536 USA; Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany; Univ Hamburg, Inst Biogeochem & Marine Chem, D-20146 Hamburg, Germany; Rhein Westfal TH Aachen Univ, Inst Organ Chem, D-52056 Aachen, Germany; Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA	Max Planck Society; Woods Hole Oceanographic Institution; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Hamburg; RWTH Aachen University; University System of Georgia; University of Georgia	Widdel, F (corresponding author), Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.	fwiddel@mpi-bremen.de	Bolm, Carsten/G-2247-2014; Kniemeyer, Olaf/K-1253-2013; Musat, Florin/CAF-4018-2022; Musat, Florin/AAI-9615-2020	Bolm, Carsten/0000-0001-9415-9917; Kniemeyer, Olaf/0000-0002-9493-6402; Musat, Florin/0000-0002-4240-3495; Joye, Samantha/0000-0003-1610-451X; Blumenberg, Martin/0000-0002-9791-8568; Sievert, Stefan/0000-0002-9541-2707				AECKERSBERG F, 1991, ARCH MICROBIOL, V156, P5, DOI 10.1007/BF00418180; Alperin MI, 1988, GLOBAL BIOGEOCHEM CY, V2, P279, DOI 10.1029/GB002i003p00279; Arp DJ, 1999, MICROBIOL-SGM, V145, P1173, DOI 10.1099/13500872-145-5-1173; ASHRAF W, 1994, FEMS MICROBIOL LETT, V122, P1, DOI 10.1111/j.1574-6968.1994.tb07134.x; Balows A., 1992, PROKARYOTES, P3352, DOI [10.1007/978-1-4757-2191-1_21, DOI 10.1007/978-1-4757-2191-1_]; CLAYPOOL GE, 1983, ANNU REV EARTH PL SC, V11, P299, DOI 10.1146/annurev.ea.11.050183.001503; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Formolo MJ, 2004, CHEM GEOL, V205, P253, DOI 10.1016/j.chemgeo.2003.12.021; Gieg LM, 2002, ENVIRON SCI TECHNOL, V36, P3755, DOI 10.1021/es0205333; GIESE B, 1977, CHEM BER-RECL, V110, P2588, DOI 10.1002/cber.19771100717; GIESE B, 1984, CHEM BER-RECL, V117, P3175, DOI 10.1002/cber.19841171103; GIESE B, 1982, CHEM BER-RECL, V115, P2012, DOI 10.1002/cber.19821150533; Head IM, 2003, NATURE, V426, P344, DOI 10.1038/nature02134; Hinrichs KU, 2006, P NATL ACAD SCI USA, V103, P14684, DOI 10.1073/pnas.0606535103; Joye SB, 2004, CHEM GEOL, V205, P219, DOI 10.1016/j.chemgeo.2003.12.019; Kallmeyer J, 2004, APPL ENVIRON MICROB, V70, P1231, DOI 10.1128/AEM.70.2.1231-1233.2004; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Kinnaman FS, 2007, GEOCHIM COSMOCHIM AC, V71, P271, DOI 10.1016/j.gca.2006.09.007; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Martens CS, 1999, AM J SCI, V299, P589, DOI 10.2475/ajs.299.7-9.589; Martini AM, 2003, AAPG BULL, V87, P1355, DOI 10.1306/031903200184; Moser DP, 2005, APPL ENVIRON MICROB, V71, P8773, DOI 10.1128/AEM.71.12.8773-8783.2005; Niemann H, 2006, GEOCHIM COSMOCHIM AC, V70, P5336, DOI 10.1016/j.gca.2006.08.010; Orcutt BN, 2004, CHEM GEOL, V205, P239, DOI 10.1016/j.chemgeo.2003.12.020; PLASSDULMER C, 1995, GLOBAL BIOGEOCHEM CY, V9, P79, DOI 10.1029/94GB02416; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rabus R, 2001, J BACTERIOL, V183, P1707, DOI 10.1128/JB.183.5.1707-1715.2001; Sassen R, 2004, CHEM GEOL, V205, P195, DOI 10.1016/j.chemgeo.2003.12.032; Seifert R, 2006, ORG GEOCHEM, V37, P1411, DOI 10.1016/j.orggeochem.2006.03.007; SIMONEIT BRT, 1988, CHEM GEOL, V71, P169, DOI 10.1016/0009-2541(88)90113-1; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; Swofford D. L., 1999, PAUP 4 0 PHYLOGENETI; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; Weber A, 2002, DEEP-SEA RES PT I, V49, P827, DOI 10.1016/S0967-0637(01)00079-6; Wenger LM, 2002, SPE RESERV EVAL ENG, V5, P375, DOI 10.2118/80168-PA; WHELAN JK, 1988, ORG GEOCHEM, V12, P171, DOI 10.1016/0146-6380(88)90253-7; WIDDEL F, 2006, PROKARYOTES, V2, P1028, DOI DOI 10.1007/1020-1387-30742-30747_	37	247	256	4	175	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2007	449	7164					898	U10		10.1038/nature06200	http://dx.doi.org/10.1038/nature06200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17882164				2022-12-01	WOS:000250230600045
J	Lecuyer, E; Yoshida, H; Parthasarathy, N; Alm, C; Babak, T; Cerovina, T; Hughes, TR; Tomancak, P; Krause, HM				Lecuyer, Eric; Yoshida, Hideki; Parthasarathy, Neela; Alm, Christina; Babak, Tomas; Cerovina, Tanja; Hughes, Timothy R.; Tomancak, Pavel; Krause, Henry M.			Global analysis of mRNA localization reveals a prominent role in organizing cellular architecture and function	CELL			English	Article							GENE-EXPRESSION; ASYMMETRIC LOCALIZATION; DEPENDENT LOCALIZATION; TRANSPOSABLE ELEMENTS; DEVELOPMENTAL CONTROL; APICAL LOCALIZATION; DROSOPHILA; PROTEIN; ORGANIZATION; COMPLEX	Although subcellular mRNA trafficking has been demonstrated as a mechanism to control protein distribution, it is generally believed that most protein localization occurs subsequent to translation. To address this point, we developed and employed a high-resolution fluorescent in situ hybridization procedure to comprehensively evaluate mRNA localization dynamics during early Drosophila embryogenesis. Surprisingly, of the 3370 genes analyzed, 71% of those expressed encode subcellularly localized mRNAs. Dozens of new and striking localization patterns were observed, implying an equivalent variety of localization mechanisms. Tight correlations between mRNA distribution and subsequent protein localization and function, indicate major roles for mRNA localization in nucleating localized cellular machineries. A searchable web resource documenting mRNA expression and localization dynamics has been established and will serve as an invaluable tool for dissecting localization mechanisms and for predicting gene functions and interactions.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M4X 1K9, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M4X 1K9, Canada; Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M4X 1K9, Canada; Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	University of Toronto; University of Toronto; University of Toronto; Max Planck Society	Krause, HM (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 100 Coll St, Toronto, ON M4X 1K9, Canada.	h.krause@utoronto.ca	Tomancak, Pavel/C-2109-2009	Tomancak, Pavel/0000-0002-2222-9370; Krause, Henry/0000-0002-6182-7074; Babak, Tomas/0000-0003-0879-0134				Adereth Y, 2005, NAT CELL BIOL, V7, P1240, DOI 10.1038/ncb1335; Alliegro MC, 2006, P NATL ACAD SCI USA, V103, P9034, DOI 10.1073/pnas.0602859103; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016; Brandt A, 2006, CURR BIOL, V16, P543, DOI 10.1016/j.cub.2006.01.051; Broadus J, 1998, NATURE, V391, P792, DOI 10.1038/35861; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007; DAVIS I, 1991, CELL, V67, P927, DOI 10.1016/0092-8674(91)90366-7; De Renzis S, 2007, PLOS BIOL, V5, P1036, DOI 10.1371/journal.pbio.0050117; DOSSANTOS G, 2007, IN PRESS DEV; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Drusco A, 2005, P NATL ACAD SCI USA, V102, P10947, DOI 10.1073/pnas.0504934102; Dubowy J, 1998, MECH DEVELOP, V70, P193, DOI 10.1016/S0925-4773(97)00185-8; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Erdmann VA, 2001, CELL MOL LIFE SCI, V58, P960, DOI 10.1007/PL00000913; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; GAVIS ER, 1992, CELL, V71, P301, DOI 10.1016/0092-8674(92)90358-J; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Gore AV, 2005, NATURE, V438, P1030, DOI 10.1038/nature04184; Grosskortenhaus R, 2006, GENE DEV, V20, P2618, DOI 10.1101/gad.1445306; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hughes JR, 2004, CURR BIOL, V14, P1950, DOI 10.1016/j.cub.2004.10.022; Jansen RP, 2001, NAT REV MOL CELL BIO, V2, P247, DOI 10.1038/35067016; Jenny A, 2006, DEVELOPMENT, V133, P2827, DOI 10.1242/dev.02456; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; KARR TL, 1986, J CELL BIOL, V102, P1494, DOI 10.1083/jcb.102.4.1494; Kloc M, 2005, DEVELOPMENT, V132, P3445, DOI 10.1242/dev.01919; Kloc M, 2002, CELL, V108, P533, DOI 10.1016/S0092-8674(02)00651-7; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lambert JD, 2002, NATURE, V420, P682, DOI 10.1038/nature01241; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; MELTON DA, 1987, NATURE, V328, P80, DOI 10.1038/328080a0; Mingle LA, 2005, J CELL SCI, V118, P2425, DOI 10.1242/jcs.02371; Mueller W, 2007, ONCOGENE, V26, P583, DOI 10.1038/sj.onc.1209805; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Park Y, 2002, SCIENCE, V298, P1620, DOI 10.1126/science.1076686; Parthasarathy N., 2007, METHOD MOL BIOL, P289; Pilot F, 2006, DEVELOPMENT, V133, P711, DOI 10.1242/dev.02251; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Rothwell WF, 1998, DEVELOPMENT, V125, P1295; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; Seydoux G, 1997, DEVELOPMENT, V124, P2191; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Simmonds AJ, 2001, CELL, V105, P197, DOI 10.1016/S0092-8674(01)00311-7; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Tadros W, 2007, DEV CELL, V12, P847, DOI 10.1016/j.devcel.2007.05.009; Tadros W, 2007, DEV CELL, V12, P143, DOI 10.1016/j.devcel.2006.10.005; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Van Doren M, 1998, CURR BIOL, V8, P243; Willingham AT, 2006, CELL, V125, P1215, DOI 10.1016/j.cell.2006.06.009; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang J, 1998, CELL, V94, P515, DOI 10.1016/S0092-8674(00)81592-5	70	657	671	2	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2007	131	1					174	187		10.1016/j.cell.2007.08.003	http://dx.doi.org/10.1016/j.cell.2007.08.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923096	Bronze			2022-12-01	WOS:000249934700020
J	Anbar, AD; Duan, Y; Lyons, TW; Arnold, GL; Kendall, B; Creaser, RA; Kaufman, AJ; Gordon, GW; Scott, C; Garvin, J; Buick, R				Anbar, Ariel D.; Duan, Yun; Lyons, Timothy W.; Arnold, Gail L.; Kendall, Brian; Creaser, Robert A.; Kaufman, Alan J.; Gordon, Gwyneth W.; Scott, Clinton; Garvin, Jessica; Buick, Roger			A whiff of oxygen before the Great Oxidation Event?	SCIENCE			English	Article							ATMOSPHERIC OXYGEN; SULFUR ISOTOPES; BLACK SHALES; RISE; MOLYBDENUM; EVOLUTION; GEOCHEMISTRY; SEDIMENTS; PGE; OS	High-resolution chemostratigraphy reveals an episode of enrichment of the redox-sensitive transition metals molybdenum and rhenium in the late Archean Mount McRae Shale in Western Australia. Correlations with organic carbon indicate that these metals were derived from contemporaneous seawater. Rhenium/osmium geochronology demonstrates that the enrichment is a primary sedimentary feature dating to 2501 +/- 8 million years ago (Ma). Molybdenum and rhenium were probably supplied to Archean oceans by oxidative weathering of crustal sulfide minerals. These findings point to the presence of small amounts of O-2 in the environment more than 50 million years before the start of the Great Oxidation Event.	Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; Univ Maryland, Dept Geol, College Pk, MD 20742 USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of California System; University of California Riverside; University of Alberta; University System of Maryland; University of Maryland College Park; University of Washington; University of Washington Seattle	Anbar, AD (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	anbar@asu.edu	Arnold, Gail L/A-5572-2010; Kendall, Brian S/I-6820-2012	Arnold, Gail L/0000-0001-9631-9830; Kendall, Brian/0000-0002-8914-2309; Buick, Roger/0000-0003-0139-1659; Creaser, Robert/0000-0002-7672-035X				Algeo TJ, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2004PA001112; Arnold GL, 2004, SCIENCE, V304, P87, DOI 10.1126/science.1091785; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; BERTINE KK, 1973, GEOCHIM COSMOCHIM AC, V37, P1415, DOI 10.1016/0016-7037(73)90080-X; Blum AE, 1995, REV MINERAL, V31, P291; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Claire M., 2006, GEOBIOLOGY, V4, P239, DOI [10.1111/j.1472-4669.2006.00084.x, DOI 10.1111/J.1472-4669.2006.00084.X]; COLLIER RW, 1985, LIMNOL OCEANOGR, V30, P1351, DOI 10.4319/lo.1985.30.6.1351; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Goldblatt C, 2006, NATURE, V443, P683, DOI 10.1038/nature05169; Hannah JL, 2004, EARTH PLANET SC LETT, V225, P43, DOI 10.1016/j.epsl.2004.06.013; Helz GR, 1996, GEOCHIM COSMOCHIM AC, V60, P3631, DOI 10.1016/0016-7037(96)00195-0; Holland H. D., 1984, CHEM EVOLUTION ATMOS; Holland HD, 2002, GEOCHIM COSMOCHIM AC, V66, P3811, DOI 10.1016/S0016-7037(02)00950-X; Kaufman AJ, 2007, SCIENCE, V317, P1900, DOI 10.1126/science.1138700; Kopp RE, 2005, P NATL ACAD SCI USA, V102, P11131, DOI 10.1073/pnas.0504878102; Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058; McManus J, 2006, GEOCHIM COSMOCHIM AC, V70, P4643, DOI 10.1016/j.gca.2006.06.1564; MORACHEVSKII DE, 1960, GEOCHEMISTRY, V6, P649; Morford JL, 1999, GEOCHIM COSMOCHIM AC, V63, P1735, DOI 10.1016/S0016-7037(99)00126-X; Nelson DR, 1999, PRECAMBRIAN RES, V97, P165, DOI 10.1016/S0301-9268(99)00031-5; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Scott CT, 2004, GEOCHIM COSMOCHIM AC, V68, pA787; Siebert C, 2005, GEOCHIM COSMOCHIM AC, V69, P1787, DOI 10.1016/j.gca.2004.10.006; TAYLOR SR, 1995, REV GEOPHYS, V33, P241, DOI 10.1029/95RG00262; Trendall AF, 1998, AUST J EARTH SCI, V45, P137, DOI 10.1080/08120099808728374; Wille M, 2007, GEOCHIM COSMOCHIM AC, V71, P2417, DOI 10.1016/j.gca.2007.02.019; WILLIAMSON MA, 1994, GEOCHIM COSMOCHIM AC, V58, P5443, DOI 10.1016/0016-7037(94)90241-0	29	655	674	12	290	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846					1903	1906		10.1126/science.1140325	http://dx.doi.org/10.1126/science.1140325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901330				2022-12-01	WOS:000249764300035
J	Huang, CC; Lam, SN; Acharya, P; Tang, M; Xiang, SH; Hussan, SSU; Stanfield, RL; Robinson, J; Sodroski, J; Wilson, IA; Wyatt, R; Bewley, CA; Kwong, PD				Huang, Chih-chin; Lam, Son N.; Acharya, Priyamvada; Tang, Min; Xiang, Shi-Hua; Hussan, Syed Shahzad-ul; Stanfield, Robyn L.; Robinson, James; Sodroski, Joseph; Wilson, Ian A.; Wyatt, Richard; Bewley, Carole A.; Kwong, Peter D.			Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN; CORECEPTOR; BINDING; RECEPTORS; ENTRY; V3; DETERMINANTS; DOMAINS; REGION	The CCR5 co-receptor binds to the HIV-1 gp120 envelope glycoprotein and facilitates HIV-1 entry into cells. Its N terminus is tyrosine-sulfated, as are many antibodies that react with the co-receptor binding site on gp120. We applied nuclear magnetic resonance and crystallographic techniques to analyze the structure of the CCR5 N terminus and that of the tyrosine-sulfated antibody 412d in complex with gp120 and CD4. The conformations of tyrosine-sulfated regions of CCR5 (alpha-helix) and 412d (extended-loop) are surprisingly different. Nonetheless, a critical sulfotyrosine on CCR5 and on 412d induces similar structural rearrangements in gp120. These results now provide a framework for understanding HIV-1 interactions with the CCR5 N terminus during viral entry and define a conserved site on gp120, whose recognition of sulfotyrosine engenders posttranslational mimicry by the immune system.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; NIDDKD, Bioorgan Chem Lab, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Tulane Univ, Med Ctr, Dept Pediat, New Orleans, LA 70112 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Scripps Research Institute; Scripps Research Institute; Tulane University	Bewley, CA (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.	caroleb@mail.nih.gov; pdkwong@nih.gov	Stanfield, Robyn/AAH-3190-2019	Bewley, Carole/0000-0003-2203-0852; Acharya, Priyamvada/0000-0002-0089-277X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, U19AI067854, Z01AI005022, Z01AI005025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK032103] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 AI999999] Funding Source: Medline; NIAID NIH HHS [U19 AI067854, U19 AI067854-03, P30 AI060354] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Brelot A, 1997, J VIROL, V71, P4744, DOI 10.1128/JVI.71.6.4744-4751.1997; Choe H, 2003, CELL, V114, P161, DOI 10.1016/S0092-8674(03)00508-7; CLEMENTS GJ, 1991, AIDS RES HUM RETROV, V7, P3, DOI 10.1089/aid.1991.7.3; Cormier EG, 2000, P NATL ACAD SCI USA, V97, P5762, DOI 10.1073/pnas.97.11.5762; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; Cormier EG, 2001, J VIROL, V75, P5541, DOI 10.1128/JVI.75.12.5541-5549.2001; Doranz BJ, 1997, J VIROL, V71, P6305, DOI 10.1128/JVI.71.9.6305-6314.1997; Dragic T, 2001, J GEN VIROL, V82, P1807, DOI 10.1099/0022-1317-82-8-1807; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; FEENEY J, 1983, BIOCHEMISTRY-US, V22, P628, DOI 10.1021/bi00272a016; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Kabat EA, 1991, SEQUENCES PROTEINS I, V5th; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Quiocho FA, 1996, KIDNEY INT, V49, P943, DOI 10.1038/ki.1996.132; Rabut GEE, 1998, J VIROL, V72, P3464, DOI 10.1128/JVI.72.4.3464-3468.1998; Rizzuto C, 2000, AIDS RES HUM RETROV, V16, P741, DOI 10.1089/088922200308747; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; Wuthrich K., 1986, NMR PROTEINS NUCL AC; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiang SH, 2005, J VIROL, V79, P6068, DOI 10.1128/JVI.79.10.6068-6077.2005	28	331	348	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2007	317	5846					1930	1934		10.1126/science.1145373	http://dx.doi.org/10.1126/science.1145373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901336	Green Submitted, Green Accepted			2022-12-01	WOS:000249764300042
J	Yang, HY; Yang, T; Baur, JA; Perez, E; Matsui, T; Carmona, JJ; Lamming, DW; Souza-Pinto, NC; Bohr, VA; Rosenzweig, A; de Cabo, R; Sauve, AA; Sinclair, DA				Yang, Hongying; Yang, Tianle; Baur, Joseph A.; Perez, Evelyn; Matsui, Takashi; Carmona, Juan J.; Lamming, Dudley W.; Souza-Pinto, Nadja C.; Bohr, Vilhelm A.; Rosenzweig, Anthony; de Cabo, Rafael; Sauve, Anthony A.; Sinclair, David A.			Nutrient-sensitive mitochondrial NAD(+) levels dictate cell survival	CELL			English	Article							COLONY-ENHANCING FACTOR; LIFE-SPAN EXTENSION; NICOTINAMIDE ADENINE-DINUCLEOTIDE; CALORIE RESTRICTION; SACCHAROMYCES-CEREVISIAE; DEACETYLASE ACTIVITY; OXIDATIVE STRESS; SIR2 PROTEIN; ACETYL-COA; APOPTOSIS	A major cause of cell death caused by genotoxic stress is thought to be due to the depletion of NAD+ from the nucleus and the cytoplasm. Here we show that NAD+ levels in mitochondria remain at physiological levels following genotoxic stress and can maintain cell viability even when nuclear and cytoplasmic pools of NAD+ are depleted. Rodents fasted for 48 hr show increased levels of the NAD+ biosynthetic enzyme Nampt and a concomitant increase in mitochondrial NAD+. Increased Nampt provides protection against cell death and requires an intact mitochondrial NAD+ salvage pathway as well as the mitochondrial NAD(+)- dependent deacetylases SIRT3 and SIRT4. We discuss the relevance of these findings to understanding how nutrition modulates physiology and to the evolution of apoptosis.	Cornell Univ, Weill Med Col, Dept Pharmacol, New York, NY 10021 USA; NIA, Lab Expt Gerontol, Inst Hlth, Baltimore, MD 21224 USA; NIA, Lab Mol Gerontol, Inst Hlth, Baltimore, MD 21224 USA; Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA	Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Beth Israel Deaconess Medical Center	Sinclair, DA (corresponding author), Harvard Univ, Sch Med, Paul F Glenn Labs, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	david_sinclair@hms.harvard.edu	de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/E-7996-2010; Bohr, Vilhelm/AAP-5931-2020; Rosenzweig, Anthony/AAD-7893-2019; Souza-Pinto, Nadja/T-3050-2019; Baur, Joseph A/D-8163-2011; Souza-Pinto, Nadja C./C-3462-2013; Lamming, Dudley/O-7191-2015; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0003-2830-5693; Souza-Pinto, Nadja/0000-0003-4206-964X; Souza-Pinto, Nadja C./0000-0003-4206-964X; Lamming, Dudley/0000-0002-0079-4467; Carmona, Juan/0000-0002-3029-4658; de Cabo, Rafael/0000-0002-3354-2442; Baur, Joseph/0000-0001-8262-6549; Sinclair, David/0000-0002-9936-436X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027916, Z01AG000362, R01AG028730, R01AG019719] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIA NIH HHS [R01AG028730, P01 AG027916-04S20003, P01 AG027916-010003, P01 AG027916-020003, P01 AG027916-030003, R01 AG019719-07, R01 AG028730-02, R01 AG028730, R01 AG028730-01A1, R01 AG019719-06A1, P01 AG027916-04S10003, P01 AG027916, P01 AG027916-040003, R01 AG019719] Funding Source: Medline; NIDDK NIH HHS [R01 DK 073466, R01 DK073466] Funding Source: Medline; NIGMS NIH HHS [R01 GM068072, R01GM068072] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Andersson SGE, 2003, PHILOS T R SOC B, V358, P165, DOI 10.1098/rstb.2002.1193; Ando K, 2002, MICROSC RES TECHNIQ, V59, P293, DOI 10.1002/jemt.10207; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Barile M, 1996, CONTACT DERMATITIS, V35, P113, DOI 10.1111/j.1600-0536.1996.tb02309.x; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bitterman KJ, 2003, MICROBIOL MOL BIOL R, V67, P376, DOI 10.1128/MMBR.67.3.376-399.2003; Brenner C, 2005, STRUCTURE, V13, P1239, DOI 10.1016/j.str.2005.08.004; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Campisi J, 2003, EXP GERONTOL, V38, P5, DOI 10.1016/S0531-5565(02)00152-3; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Di Lisa F, 2006, CARDIOVASC RES, V70, P191, DOI 10.1016/j.cardiores.2006.01.016; Drevs J, 2003, ANTICANCER RES, V23, P4853; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; FOSTER JW, 1990, J BACTERIOL, V172, P4187, DOI 10.1128/jb.172.8.4187-4196.1990; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Guarente L, 2005, MECH AGEING DEV, V126, P923, DOI 10.1016/j.mad.2005.03.013; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Higami Y, 2000, CELL TISSUE RES, V301, P125, DOI 10.1007/s004419900156; Horton JK, 2005, DNA REPAIR, V4, P1111, DOI 10.1016/j.dnarep.2005.05.011; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; James SJ, 1998, ENVIRON HEALTH PERSP, V106, P307, DOI 10.2307/3433932; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kitani T, 2003, FEBS LETT, V544, P74, DOI 10.1016/S0014-5793(03)00476-9; KUN E, 1975, P NATL ACAD SCI USA, V72, P1436, DOI 10.1073/pnas.72.4.1436; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; NOACK H, 1992, ANAL BIOCHEM, V202, P162, DOI 10.1016/0003-2697(92)90222-S; North BJ, 2007, TRENDS BIOCHEM SCI, V32, P1, DOI 10.1016/j.tibs.2006.11.002; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Porcu M, 2005, TRENDS PHARMACOL SCI, V26, P94, DOI 10.1016/j.tips.2004.12.009; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Sauve AA, 2005, MOL CELL, V17, P595, DOI 10.1016/j.molcel.2004.12.032; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; TOBIN A, 1980, PLANT PHYSIOL, V66, P225, DOI 10.1104/pp.66.2.225; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; van Wijk SJL, 2005, FREE RADICAL BIO MED, V39, P81, DOI 10.1016/j.freeadbiomed.2005.03.021; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; Yang HY, 2006, EXP GERONTOL, V41, P718, DOI 10.1016/j.exger.2006.06.003; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang YP, 2002, MECH AGEING DEV, V123, P245, DOI 10.1016/S0047-6374(01)00349-9	63	729	765	4	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6					1095	1107		10.1016/j.cell.2007.07.035	http://dx.doi.org/10.1016/j.cell.2007.07.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889652	Green Accepted, Bronze			2022-12-01	WOS:000250507500018
J	Callan, B; Gillespie, I				Callan, Benedicte; Gillespie, Iain			The path to new medicines	NATURE			English	Editorial Material									OECD, Div Biotechnol, Paris, France	Organisation for Economic Co-operation & Development (OECD)	Callan, B (corresponding author), OECD, Div Biotechnol, Paris, France.								0	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					164	165		10.1038/449164a	http://dx.doi.org/10.1038/449164a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851511				2022-12-01	WOS:000249394500035
J	Paulson, JC				Paulson, James C.			Innate immune response triggers lupus-like autoimmune disease	CELL			English	Editorial Material							C-TYPE LECTINS; DENDRITIC CELLS; MACROPHAGES	Autoimmune disease is typically defined as an aberrant response of lymphocytes to self antigens that ultimately leads to tissue damage. Reporting in Immunity, Green et al. ( 2007) now show that mice lacking alpha-mannosidase II develop an autoimmune disease similar to lupus. Remarkably, this illness is precipitated by an innate immune response to altered self glycans that mimic molecular patterns found on pathogens.	Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92014 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92014 USA	Scripps Research Institute; Scripps Research Institute	Paulson, JC (corresponding author), Scripps Res Inst, Dept Physiol Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92014 USA.	jpaulson@scripps.edu	Paulson, James/AAG-3565-2019					Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; GREEN RS, 2007, IMMUNITY; Linehan SA, 1999, J EXP MED, V189, P1961, DOI 10.1084/jem.189.12.1961; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Mensah-Brown EPK, 2006, ANN NY ACAD SCI, V1084, P49, DOI 10.1196/annals.1372.014; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Yu CCK, 1996, J EXP MED, V183, P371, DOI 10.1084/jem.183.2.371	10	21	24	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 24	2007	130	4					589	591		10.1016/j.cell.2007.08.009	http://dx.doi.org/10.1016/j.cell.2007.08.009			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	208KY	17719535	Bronze			2022-12-01	WOS:000249319400008
J	Baena-Gonzalez, E; Rolland, F; Thevelein, JM; Sheen, J				Baena-Gonzalez, Elena; Rolland, Filip; Thevelein, Johan M.; Sheen, Jen			A central integrator of transcription networks in plant stress and energy signalling	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; NITRATE REDUCTASE; SUCROSE; TRANSDUCTION; IDENTIFICATION; PATHWAYS; LEAVES; METABOLISM	Photosynthetic plants are the principal solar energy converter sustaining life on Earth. Despite its fundamental importance, little is known about how plants sense and adapt to darkness in the daily light-dark cycle, or how they adapt to unpredictable environmental stresses that compromise photosynthesis and respiration and deplete energy supplies. Current models emphasize diverse stress perception and signalling mechanisms(1,2). Using a combination of cellular and systems screens, we show here that the evolutionarily conserved Arabidopsis thaliana protein kinases, KIN10 and KIN11 (also known as AKIN10/At3g01090 and AKIN11/At3g29160, respectively), control convergent reprogramming of transcription in response to seemingly unrelated darkness, sugar and stress conditions. Sensing and signalling deprivation of sugar and energy, KIN10 targets a remarkably broad array of genes that orchestrate transcription networks, promote catabolism and suppress anabolism. Specific bZIP transcription factors partially mediate primary KIN10 signalling. Transgenic KIN10 overexpression confers enhanced starvation tolerance and lifespan extension, and alters architecture and developmental transitions. Significantly, double kin10 kin11 deficiency abrogates the transcriptional switch in darkness and stress signalling, and impairs starch mobilization at night and growth. These studies uncover surprisingly pivotal roles of KIN10/11 in linking stress, sugar and developmental signals to globally regulate plant metabolism, energy balance, growth and survival. In contrast to the prevailing view that sucrose activates plant SnRK1s (Snf1-related protein kinases)(3-6), our functional analyses of Arabidopsis KIN10/11 provide compelling evidence that SnRK1s are inactivated by sugars and share central roles with the orthologous yeast Snf1 and mammalian AMPK in energy signalling.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; VIB, Dept Mol Microbiol, B-3001 Louvain, Belgium; Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, B-3001 Louvain, Belgium	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Flanders Institute for Biotechnology (VIB); KU Leuven	Rolland, F (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.	baena@molbio.mgh.harvard.edu; filip.rolland@bio.kuleuven.be	Thevelein, Johan M./A-7897-2013; Baena-González, Elena/G-5811-2013; Baena-González, Elena/AAI-4051-2020; Thevelein, Johan M./AAK-4203-2021	Thevelein, Johan M./0000-0002-2626-0180; Baena-González, Elena/0000-0001-6598-3579; Baena-González, Elena/0000-0001-6598-3579; Rolland, Filip/0000-0003-2601-0752				Bhalerao RP, 1999, P NATL ACAD SCI USA, V96, P5322, DOI 10.1073/pnas.96.9.5322; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Boudsocq M, 2004, J BIOL CHEM, V279, P41758, DOI 10.1074/jbc.M405259200; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Burch-Smith TM, 2006, PLANT PHYSIOL, V142, P21, DOI 10.1104/pp.106.084624; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Cheng SH, 2001, FEBS LETT, V503, P185, DOI 10.1016/S0014-5793(01)02732-6; Contento AL, 2004, PLANT PHYSIOL, V135, P2330, DOI 10.1104/pp.104.044362; Fujiki Y, 2001, PHYSIOL PLANTARUM, V111, P345, DOI 10.1034/j.1399-3054.2001.1110312.x; Gomez LD, 2006, PLANT J, V46, P69, DOI 10.1111/j.1365-313X.2006.02662.x; Gonzali S, 2005, ANN BOT-LONDON, V96, P661, DOI 10.1093/aob/mci218; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; Halford NG, 2003, J EXP BOT, V54, P467, DOI 10.1093/jxb/erg038; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Huang JZ, 2001, PLANT CELL PHYSIOL, V42, P1079, DOI 10.1093/pcp/pce137; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kaiser WM, 2001, J EXP BOT, V52, P1981, DOI 10.1093/jexbot/52.363.1981; Kotting O, 2005, PLANT PHYSIOL, V137, P242, DOI 10.1104/pp.104.055954; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; LAM HM, 1994, PLANT PHYSIOL, V106, P1347, DOI 10.1104/pp.106.4.1347; Li YH, 2006, GENOME RES, V16, P414, DOI 10.1101/gr.4237406; Lin JF, 2004, PLANT J, V39, P612, DOI 10.1111/j.1365-313X.2004.02160.x; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Loreti E, 2005, PLANT PHYSIOL, V137, P1130, DOI 10.1104/pp.104.057299; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Palenchar PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r91; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Purcell PC, 1998, PLANT J, V14, P195, DOI 10.1046/j.1365-313X.1998.00108.x; Radchuk R, 2006, PLANT PHYSIOL, V140, P263, DOI 10.1104/pp.105.071167; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Ryu CM, 2004, PLANT J, V40, P322, DOI 10.1111/j.1365-313X.2004.02211.x; Schluepmann H, 2003, P NATL ACAD SCI USA, V100, P6849, DOI 10.1073/pnas.1132018100; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Sugden C, 1999, PLANT PHYSIOL, V120, P257, DOI 10.1104/pp.120.1.257; Thelander M, 2004, EMBO J, V23, P1900, DOI 10.1038/sj.emboj.7600182; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tiessen A, 2003, PLANT J, V35, P490, DOI 10.1046/j.1365-313X.2003.01823.x; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhang YH, 2001, PLANT J, V28, P431, DOI 10.1046/j.1365-313X.2001.01167.x; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	45	979	1022	23	364	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2007	448	7156					938	U10		10.1038/nature06069	http://dx.doi.org/10.1038/nature06069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202OM	17671505				2022-12-01	WOS:000248912900049
J	Lindau, ST; Schumm, LP; Laumann, EO; Levinson, W; O'Muircheartaigh, CA; Waite, LJ				Lindau, Stacy Tessler; Schumm, L. Philip; Laumann, Edward O.; Levinson, Wendy; O'Muircheartaigh, Colm A.; Waite, Linda J.			A study of sexuality and health among older adults in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ERECTILE DYSFUNCTION; DEPRESSIVE SYMPTOMS; ATTITUDES; MEN; WOMEN; PREVALENCE; BEHAVIORS; RECOMMENDATIONS; AGE	Background: Despite the aging of the population, little is known about the sexual behaviors and sexual function of older people. Methods: We report the prevalence of sexual activity, behaviors, and problems in a national probability sample of 3005 U.S. adults (1550 women and 1455 men) 57 to 85 years of age, and we describe the association of these variables with age and health status. Results: The unweighted survey response rate for this probability sample was 74.8%, and the weighted response rate was 75.5%. The prevalence of sexual activity declined with age (73% among respondents who were 57 to 64 years of age, 53% among respondents who were 65 to 74 years of age, and 26% among respondents who were 75 to 85 years of age); women were significantly less likely than men at all ages to report sexual activity. Among respondents who were sexually active, about half of both men and women reported at least one bothersome sexual problem. The most prevalent sexual problems among women were low desire (43%), difficulty with vaginal lubrication (39%), and inability to climax (34%). Among men, the most prevalent sexual problems were erectile difficulties (37%). Fourteen percent of all men reported using medication or supplements to improve sexual function. Men and women who rated their health as being poor were less likely to be sexually active and, among respondents who were sexually active, were more likely to report sexual problems. A total of 38% of men and 22% of women reported having discussed sex with a physician since the age of 50 years. Conclusions: Many older adults are sexually active. Women are less likely than men to have a spousal or other intimate relationship and to be sexually active. Sexual problems are frequent among older adults, but these problems are infrequently discussed with physicians.	Univ Chicago, Dept Obstet & Gynecol, Pritzker Sch Med, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Pritzker Sch Med, Chicago, IL 60637 USA; Univ Chicago, MacLean Ctr Clin Med Eth, Pritzker Sch Med, Chicago, IL 60637 USA; Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; Univ Chicago, Dept Sociol, Chicago, IL 60637 USA; Univ Chicago, Harris Sch Publ Policy Studies, Chicago, IL 60637 USA; Univ Chicago, NORC, Chicago, IL 60637 USA; Univ Toronto, Dept Med, Toronto, ON, Canada	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Toronto	Lindau, ST (corresponding author), Univ Chicago, Dept Obstet & Gynecol, Pritzker Sch Med, 5841 S Maryland Ave,MC2050, Chicago, IL 60637 USA.	slindau@uchicago.edu		Schumm, Phil/0000-0002-3050-2429	NIA NIH HHS [R01 AG021487-05, 5R01 AG021487, R01 AG021487] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG021487] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Addis IB, 2006, OBSTET GYNECOL, V107, P755, DOI 10.1097/01.AOG.0000202398.27428.e2; Agresti A., 1990, CATEGORICAL DATA ANA, pXV; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890423349; Araujo AB, 2004, J AM GERIATR SOC, V52, P1502, DOI 10.1111/j.0002-8614.2004.52413.x; Araujo AB, 1998, PSYCHOSOM MED, V60, P458, DOI 10.1097/00006842-199807000-00011; Bachmann GA, 2004, MENOPAUSE, V11, P120, DOI 10.1097/01.GME.0000075502.60230.28; Bacon CG, 2003, ANN INTERN MED, V139, P161, DOI 10.7326/0003-4819-139-3-200308050-00005; Basson R, 2004, J SEX MED, V1, P24, DOI 10.1111/j.1743-6109.2004.10105.x; BINDER DA, 1983, INT STAT REV, V51, P279, DOI 10.2307/1402588; BRAMLET MD, 2001, ADV DATA VITAL HLTH, V323; Camacho ME, 2005, INT J IMPOT RES, V17, pS52, DOI 10.1038/sj.ijir.3901429; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Fenton KA, 2001, SEX TRANSM INFECT, V77, P84, DOI 10.1136/sti.77.2.84; Finger WW, 1997, J FAM PRACTICE, V44, P33; Fisher GD, 2005, DR009 HRS U MICH; Fleiss J.L., 2013, STAT METHODS RATES P; Gott M, 2004, SOC SCI MED, V58, P2093, DOI 10.1016/j.socscimed.2003.08.025; He W, 2005, 65 US; ISSELBACHER KJ, 1994, HARRISONS PRINCIPLES, P262; Laumann EO, 2006, ARCH SEX BEHAV, V35, P145, DOI 10.1007/s10508-005-9005-3; Laumann Edward O., 1994, SOCIAL ORG SEXUALITY, P88; Laumann EO, 2005, INT J IMPOT RES, V17, P39, DOI 10.1038/sj.ijir.3901250; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P1174; Lindau ST, 2003, PERSPECT BIOL MED, V46, pS74, DOI 10.1353/pbm.2003.0069; Lindau ST, 2006, J WOMENS HEALTH, V15, P747, DOI 10.1089/jwh.2006.15.747; Lue TF, 2004, J SEX MED, V1, P6, DOI 10.1111/j.1743-6109.2004.10104.x; Mercer CH, 2005, SEX TRANSM INFECT, V81, P394, DOI 10.1136/sti.2005.015149; Minino A. M., 2006, NATL VITAL STAT REPO, V54; MORLEY JE, 2003, PRINCIPLES GERIATRIC, P1311; *NFO, 1999, AARP MOD MAT SEX SUR; Nicolosi A, 2004, J AFFECT DISORDERS, V82, P235, DOI 10.1016/j.jad.2003.12.008; Nicolosi A, 2004, UROLOGY, V64, P991, DOI 10.1016/j.urology.2004.06.055; Nusbaum MRH, 2004, J AM GERIATR SOC, V52, P117, DOI 10.1111/j.1532-5415.2004.52020.x; NUSBAUM MRH, 2002, J FAMILY PRACTICE, V51, P706; OMUIRCHEARTAIGH C, 2007, NSHAP NATL SOCIAL LI; Rosen RC, 2005, UROL CLIN N AM, V32, P403, DOI 10.1016/j.ucl.2005.08.004; Schover LR, 2000, PRINCIPLES AND PRACTICE OF SEX THERAPY, THIRD EDITION, P398; Selvin E, 2007, AM J MED, V120, P151, DOI 10.1016/j.amjmed.2006.06.010; StataCorp, 2015, STAT STAT SOFTW REL; U.S. Census Bureau, 2003, OLD POP US MARCH 200	41	1260	1305	0	128	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2007	357	8					762	774		10.1056/NEJMoa067423	http://dx.doi.org/10.1056/NEJMoa067423			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	202MU	17715410	Green Accepted			2022-12-01	WOS:000248906700005
J	Kuhl, CK; Schrading, S; Bieling, HB; Wardelmann, E; Leutner, CC; Koenig, R; Kuhn, W; Schild, HH				Kuhl, Christiane K.; Schrading, Simone; Bieling, Heribert B.; Wardelmann, Eva; Leutner, Claudia C.; Koenig, Roy; Kuhn, Walther; Schild, Hans H.			MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study	LANCET			English	Article							DIFFERENT GENETIC PATHWAYS; HIGH FAMILIAL RISK; BREAST-CANCER; MAMMOGRAPHY; WOMEN; LESIONS; CLASSIFICATION; EVOLUTION; STANDARDIZATION; SURVEILLANCE	Background Diagnosing breast cancer in its intraductal stage might be helpful to prevent the development of invasive cancer. Our aim was to investigate the sensitivity with which ductal carcinoma in situ (DCIS) is diagnosed by mammography and by breast MRI. Methods During a 5-year period, 7319 women who were referred to an academic national breast Centre received MRI in addition to mammography for diagnostic assessment and screening. Mammograms and breast MRI studies were assessed independently by different radiologists. We investigated the sensitivity of each method of detection and compared the biological profiles of mammography-diagnosed DCIS versus DCIS detected by MRI alone. We also compared the risk profiles of women with mammography-detected DCIS with those of MRI-detected DCIS. Findings 193 women received a final surgical pathology diagnosis of pure DCIS. Of those, 167 had undergone both imaging tests preoperatively. 93 (56%) of these cases were diagnosed by mammography and 153 (92%) by MRI (p<0.0001). Of the 89 high-grade DCIS, 43 (48%) were missed by mammography, but diagnosed by MRI alone; all 43 cases missed by mammography were detected by MRI. By contrast, MRI detected 87 (98%) of these lesions; the two cases missed by MRI were detected by mammography. Age, menopausal status, personal or family history of breast cancer or of benign breast disease, and breast density of women with MRI-only diagnosed DCIS did not differ significantly from those of women with mammography-diagnosed DCIS. Interpretation MRI could help improve the ability to diagnose DCIS, especially DICIS with high nuclear grade.	Univ Bonn, Dept Radiol, D-53105 Bonn, Germany; Univ Bonn, Dept Pathol, D-53105 Bonn, Germany; Univ Bonn, Dept Gynaecol Oncol, D-53105 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn	Kuhl, CK (corresponding author), Univ Bonn, Dept Radiol, Sigmund Freud Str 25, D-53105 Bonn, Germany.	kuhl@uni-bonn.de	Schrading, Simone/ABI-3051-2020; Kuhl, Christiane K/H-3301-2013	Kuhl, Christiane K/0000-0001-8696-2363				ACR, 2003, ACR BREAST IM REP DA, V5; Alexander F E, 1997, J Med Screen, V4, P152; ALLRED DC, 1994, BREAST CANCER RES TR, V32, P13, DOI 10.1007/BF00666202; American College of Radiology, ACR APPR CRIT BREAST; Baxter NN, 2004, JNCI-J NATL CANCER I, V96, P443, DOI 10.1093/jnci/djh069; Bazzocchi M, 2006, AM J ROENTGENOL, V186, P1723, DOI 10.2214/AJR.04.1898; Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; Boetes C, 1997, EUR RADIOL, V7, P1231, DOI 10.1007/s003300050281; Brown LF, 1999, CLIN CANCER RES, V5, P1041; Buerger H, 1999, J PATHOL, V189, P521, DOI 10.1002/(SICI)1096-9896(199912)189:4<521::AID-PATH472>3.0.CO;2-B; Douglas-Jones A, 2005, HISTOPATHOLOGY, V47, P202, DOI 10.1111/j.1365-2559.2005.02208.x; Ernster VL, 2002, J NATL CANCER I, V94, P1546; Esserman LJ, 2006, J CLIN ONCOL, V24, P4603, DOI 10.1200/JCO.2005.04.5518; Evans A, 2003, BREAST CANCER RES, V5, P250, DOI 10.1186/bcr621; Farabegoli F, 2002, J PATHOL, V196, P280, DOI 10.1002/path.1048; Fischer U, 1996, ROFO FORTSCHR RONTG, V164, P290, DOI 10.1055/s-2007-1015657; Fisher ER, 1999, CANCER-AM CANCER SOC, V86, P429, DOI 10.1002/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO;2-Y; Furman-Haran E, 2005, CANCER-AM CANCER SOC, V104, P708, DOI 10.1002/cncr.21225; Guidi AJ, 1997, CANCER, V80, P1945, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1945::AID-CNCR11>3.0.CO;2-Y; HOLLAND R, 1994, SEMIN DIAGN PATHOL, V11, P167; Ikeda DM, 2001, J MAGN RESON IMAGING, V13, P889, DOI 10.1002/jmri.1127; Joensuu H, 2004, JAMA-J AM MED ASSOC, V292, P1064, DOI 10.1001/jama.292.9.1064; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Kuhl CK, 2005, J CLIN ONCOL, V23, P8469, DOI 10.1200/JCO.2004.00.4960; Kuhl CK, 2000, EUR RADIOL, V10, P46, DOI 10.1007/s003300050006; LAGIOS MD, 1995, CANCER LETT, V90, P97, DOI 10.1016/0304-3835(94)03683-A; Leach MO, 2005, LANCET, V365, P1769, DOI 10.1016/S0140-6736(05)66481-1; Lehman CD, 2007, NEW ENGL J MED, V356, P1295, DOI 10.1056/NEJMoa065447; Leonard GD, 2004, JNCI-J NATL CANCER I, V96, P906, DOI 10.1093/jnci/djh164; May DS, 1998, AM J ROENTGENOL, V170, P97, DOI 10.2214/ajr.170.1.9423608; Menell JH, 2005, BREAST J, V11, P382, DOI 10.1111/j.1075-122X.2005.00121.x; Morakkabati-Spitz N, 2005, EUR RADIOL, V15, P2010, DOI 10.1007/s00330-005-2755-4; Morrow M, 2004, J NATL CANCER I, V96, P424, DOI 10.1093/jnci/djh088; O'Connell P, 1998, JNCI-J NATL CANCER I, V90, P697, DOI 10.1093/jnci/90.9.697; Orel SG, 1997, RADIOLOGY, V202, P413, DOI 10.1148/radiology.202.2.9015067; OTTINETTI A, 1988, BREAST CANCER RES TR, V11, P241, DOI 10.1007/BF01807282; REMMELE W, 1987, PATHOLOGE, V8, P138; ROSNER D, 1980, ANN SURG, V192, P139, DOI 10.1097/00000658-198008000-00001; Roylance R, 2002, J PATHOL, V196, P32, DOI 10.1002/path.1006; Sardanelli F, 2007, RADIOLOGY, V242, P698, DOI 10.1148/radiol.2423051965; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Schnitt SJ, 1997, HUM PATHOL, V28, P877, DOI 10.1016/S0046-8177(97)90000-9; Shen Y, 2005, JNCI-J NATL CANCER I, V97, P1195, DOI 10.1093/jnci/dji239; SILVERSTEIN MJ, 1995, LANCET, V345, P1154	44	487	518	0	29	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 11	2007	370	9586					485	492		10.1016/S0140-6736(07)61232-X	http://dx.doi.org/10.1016/S0140-6736(07)61232-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	199TJ	17693177				2022-12-01	WOS:000248717800027
J	Lan, F; Collins, RE; De Cegli, R; Alpatov, R; Horton, JR; Shi, XB; Gozani, O; Cheng, XD; Shi, Y				Lan, Fei; Collins, Robert E.; De Cegli, Rossella; Alpatov, Roman; Horton, John R.; Shi, Xiaobing; Gozani, Or; Cheng, Xiaodong; Shi, Yang			Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression	NATURE			English	Article							PHD FINGER; MOLECULAR-BASIS; METHYLATION; CHROMODOMAINS; BINDING; DNMT3L; DOMAIN; DEMETHYLATION; IMPRINTS; H3K4ME3	Histone methylation is crucial for regulating chromatin structure, gene transcription and the epigenetic state of the cell. LSD1 is a lysine-specific histone demethylase that represses transcription by demethylating histone H3 on lysine 4 (ref. 1). The LSD1 complex contains a number of proteins, all of which have been assigned roles in events upstream of LSD1-mediated demethylation(2-4) apart from BHC80 (also known as PHF21A), a plant homeodomain (PHD) finger-containing protein. Here we report that, in contrast to the PHD fingers of the bromodomain PHD finger transcription factor (BPTF) and inhibitor of growth family 2 (ING2), which bind methylated H3K4 (H3K4me3)(5,6), the PHD finger of BHC80 binds unmethylated H3K4 (H3K4me0), and this interaction is specifically abrogated by methylation of H3K4. The crystal structure of the PHD finger of BHC80 bound to an unmodified H3 peptide has revealed the structural basis of the recognition of H3K4me0. Knockdown of BHC80 by RNA inhibition results in the de-repression of LSD1 target genes, and this repression is restored by the reintroduction of wild-type BHC80 but not by a PHD-finger mutant that cannot bind H3. Chromatin immunoprecipitation showed that BHC80 and LSD1 depend reciprocally on one another to associate with chromatin. These findings couple the function of BHC80 to that of LSD1, and indicate that unmodified H3K4 is part of the 'histone code'(7). They further raise the possibility that the generation and recognition of the unmodified state on histone tails in general might be just as crucial as post-translational modifications of histone for chromatin and transcriptional regulation.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy	Harvard University; Harvard Medical School; Emory University; Stanford University; University of Naples Federico II	Cheng, XD (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	xcheng@emory.edu; yshi@hms.harvard.edu	De Cegli, Rossella/ABA-4372-2020; Gozani, Or P/I-6157-2013; Horton, John R/ABB-4770-2020; Horton, John/F-2375-2010	Gozani, Or/0000-0002-1365-4463; De Cegli, Rossella/0000-0002-8526-8692; Collins, Robert/0000-0002-4580-5991; Horton, John/0000-0001-9749-8068; Shi, Xiaobing/0000-0001-5242-8189	NIGMS NIH HHS [R01 GM068680-02, R01 GM068680] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068680] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hata K, 2002, DEVELOPMENT, V129, P1983; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Iwase S, 2004, BIOCHEM BIOPH RES CO, V322, P601, DOI 10.1016/j.bbrc.2004.07.163; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kwan AHY, 2003, STRUCTURE, V11, P803, DOI 10.1016/S0969-2126(03)00122-9; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sui G, 2005, METH MOL B, V309, P205; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	34	321	355	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2007	448	7154					718	U14		10.1038/nature06034	http://dx.doi.org/10.1038/nature06034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687328	Green Accepted			2022-12-01	WOS:000248598000050
J	Moran, SL; Bishop, AT				Moran, Steven L.; Bishop, Allen T.			Clinical update: surgical management of rheumatoid hand	LANCET			English	Article							TERM-FOLLOW-UP; ARTHRITIS; SYNOVECTOMY; JOINT; WRIST; ARTHROPLASTY; TENOSYNOVECTOMY; DEFORMITIES; IMPLANTS; RUPTURES		Mayo Clin, Coll Med, Dept Orthoped Surg, Div Plast Surg, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Orthoped Surg, Div Hand Surg, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Moran, SL (corresponding author), Mayo Clin, Coll Med, Dept Orthoped Surg, Div Plast Surg, Rochester, MN 55905 USA.	moran.steven@mayo.edu						Alderman AK, 2003, J RHEUMATOL, V30, P1464; Chung KC, 2006, J HAND SURG-AM, V31A, P289, DOI 10.1016/j.jhsa.2005.10.005; Cook SD, 1999, J BONE JOINT SURG AM, V81A, P635, DOI 10.2106/00004623-199905000-00005; HINDLEY CJ, 1991, J HAND SURG-BRIT EUR, V16B, P275, DOI 10.1016/0266-7681(91)90053-Q; ISHIKAWA H, 1992, J HAND SURG-AM, V17A, P1109, DOI 10.1016/S0363-5023(09)91076-0; Ishikawa H, 2005, J HAND SURG-AM, V30A, P658, DOI 10.1016/j.jhsa.2005.02.005; Jain A, 2001, ARTHRITIS RHEUM, V44, P1754, DOI 10.1002/1529-0131(200108)44:8<1754::AID-ART310>3.0.CO;2-8; Jain A, 2002, J HAND SURG-AM, V27A, P449, DOI 10.1053/jhsu.2002.32958; Mandl LA, 2002, J RHEUMATOL, V29, P2488; MCEWEN C, 1988, J RHEUMATOL, V15, P765; Nakamura H, 2000, INT ORTHOP, V24, P242, DOI 10.1007/s002640000168; NICOLLE FV, 1971, ANN RHEUM DIS, V30, P476, DOI 10.1136/ard.30.5.476; Parker W, 2006, HAND CLIN, V22, P183, DOI 10.1016/j.hcl.2006.02.012; Pereira JA, 2001, J HAND SURG-BRIT EUR, V26, P229, DOI 10.1054/jhsb.2001.0574; Ryu J, 1998, J HAND SURG-BRIT EUR, V23B, P658, DOI 10.1016/S0266-7681(98)80022-3; SWANSON AB, 1972, J BONE JOINT SURG AM, VA 54, P435, DOI 10.2106/00004623-197254030-00001; Tolat AR, 1996, J HAND SURG-BRIT EUR, V21B, P538, DOI 10.1016/S0266-7681(96)80061-1; Trail IA, 2004, J BONE JOINT SURG BR, V86B, P1002, DOI 10.1302/0301-620X.86B7.15061; VAUGHANJACKSON OJ, 1959, P ROY SOC MED, V52, P132; WILDE AH, 1974, J BONE JOINT SURG AM, VA 56, P71, DOI 10.2106/00004623-197456010-00008	20	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 4	2007	370	9585					372	374		10.1016/S0140-6736(07)61175-1	http://dx.doi.org/10.1016/S0140-6736(07)61175-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197XL	17679002				2022-12-01	WOS:000248590200010
J	Tarantola, D; Gruskin, S				Tarantola, Daniel; Gruskin, Sofia			New guidance on recommended HIV testing and counselling	LANCET			English	Editorial Material									Univ New S Wales, Fac Med, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia; Harvard Univ, Sch Publ Hlth, Program Int Hlth & Human Rights, Boston, MA 02115 USA	University of New South Wales Sydney; Harvard University; Harvard T.H. Chan School of Public Health	Tarantola, D (corresponding author), Univ New S Wales, Fac Med, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia.	d.tarantola@unsw.edu.au						[Anonymous], 2007, MANUAL ESTIMATING NA; [Anonymous], REV REC HIV TEST AD; Ehiri John E, 2005, AIDS Public Policy J, V20, P25; *HUM RIGHTS WATCH, 2007, COMM WHO UNAIDS DRAF; JURGENS R, 2007, ROUTINIZING HIV TEST; KIPPAX S, 2006, COMMENTS GUIDANCE PR; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Oxman AD, 2007, LANCET, V369, P1883, DOI 10.1016/S0140-6736(07)60675-8; *UNAIDS REF GROUP, 2007, CRIM HIV TRANSM	9	12	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2007	370	9583					202	203		10.1016/S0140-6736(07)61102-7	http://dx.doi.org/10.1016/S0140-6736(07)61102-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194MG	17658377				2022-12-01	WOS:000248347900008
J	Strom, L; Karlsson, C; Lindroos, HB; Wedahl, S; Katou, Y; Shirahige, K; Sjogren, C				Stroem, Lena; Karlsson, Charlotte; Betts Lindroos, Hanna; Wedahl, Sara; Katou, Yuki; Shirahige, Katsuhiko; Sjoegren, Camilla			Postreplicative formation of cohesion is required for repair and induced by a single DNA break	SCIENCE			English	Article							SISTER-CHROMATID COHESION; DOUBLE-STRAND BREAKS; DAMAGE-RESPONSE; BUDDING YEAST; COMPLEX; PROTEIN; CHECKPOINT; ANAPHASE; RECOMBINATION; ESTABLISHMENT	Sister-chromatid cohesion, established during replication by the protein complex cohesin, is essential for both chromosome segregation and double-strand break (DSB) repair. Normally, cohesion formation is strictly limited to the S phase of the cell cycle, but DSBs can trigger cohesion also after DNA replication has been completed. The function of this damage-induced cohesion remains unknown. In this investigation, we show that damage-induced cohesion is essential for repair in postreplicative cells in yeast. Furthermore, it is established genome-wide after induction of a single DSB, and it is controlled by the DNA damage response and cohesin-regulating factors. We thus define a cohesion establishment pathway that is independent of DNA duplication and acts together with cohesion formed during replication in sister chromatid-based DSB repair.	Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Tokyo Inst Technol, Ctr Gene Res, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Karolinska Institutet; Tokyo Institute of Technology	Sjogren, C (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	camilla.sjogren@ki.se	Ström, Lena/AAJ-9025-2020	Lindroos, Hanna/0000-0002-8455-8452; Strom, Lena/0000-0002-8898-3675; Shirahige, Katsuhiko/0000-0002-7862-1144; Bjorkegren, Camilla/0000-0001-7354-9270				Blankley RT, 2004, J CELL SCI, V117, P601, DOI 10.1242/jcs.00907; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Cohen-Fix O, 1999, GENE DEV, V13, P1950, DOI 10.1101/gad.13.15.1950; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; Kenna MA, 2003, MOL CELL BIOL, V23, P2999, DOI 10.1128/MCB.23.8.2999-3007.2003; Kim JS, 2002, J BIOL CHEM, V277, P45149, DOI 10.1074/jbc.M209123200; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Strom L, 2005, CELL CYCLE, V4, P536, DOI 10.4161/cc.4.4.1613; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679	28	233	237	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2007	317	5835					242	245		10.1126/science.1140649	http://dx.doi.org/10.1126/science.1140649			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17626884				2022-12-01	WOS:000247968600042
J	Petraglia, M; Korisettar, R; Boivin, N; Clarkson, C; Ditchfield, P; Jones, S; Koshy, J; Lahr, MM; Oppenheimer, C; Pyle, D; Roberts, R; Schwenninger, JL; Arnold, L; White, K				Petraglia, Michael; Korisettar, Ravi; Boivin, Nicole; Clarkson, Christopher; Ditchfield, Peter; Jones, Sacha; Koshy, Jinu; Lahr, Marta Mirazon; Oppenheimer, Clive; Pyle, David; Roberts, Richard; Schwenninger, Jean-Luc; Arnold, Lee; White, Kevin			Middle paleolithic assemblages from the Indian subcontinent before and after the Toba super-eruption	SCIENCE			English	Article							MODERN HUMAN ORIGINS; VOLCANIC WINTER; ASH; DISPERSAL; EVOLUTION; BEHAVIOR; SOUTH	The Youngest Toba Tuff (YTT) eruption, which occurred in Indonesia 74,000 years ago, is one of Earth's largest known volcanic events. The effect of the YTT eruption on existing populations of humans, and accordingly on the course of human evolution, is debated. Here we associate the YTT with archaeological assemblages at Jwalapuram, in the Jurreru River valley of southern India. Broad continuity of Middle Paleolithic technology across the YTT event suggests that hominins persisted regionally across this major eruptive event.	Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England; Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA; Karnatak Univ, Dept Hist & Archaeol, Dharwad 580003, Karnataka, India; Univ Queensland, Sch Social Sci, St Lucia, Qld, Australia; Univ Oxford, Archaeol & Hist Art Res Lab, Oxford OX1 3QY, England; Univ Cambridge, Dept Geog, Cambridge CB2 3EN, England; Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; Univ Wollongong, GeoQUEST Res Ctr, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia; Univ Reading, Dept Geog, Reading RG6 6AB, Berks, England	University of Cambridge; Smithsonian Institution; Smithsonian National Museum of Natural History; Karnatak University; University of Queensland; University of Oxford; University of Cambridge; University of Oxford; University of Wollongong; University of Reading	Petraglia, M (corresponding author), Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England.	m.petraglia@human-evol.cam.ac.uk	Pyle, David M/C-5707-2009; Arnold, Lee J/J-4356-2018; Petraglia, Michael/ABA-9748-2021; Oppenheimer, Clive/G-9881-2013; Roberts, Richard Graham/B-8245-2013	Pyle, David M/0000-0002-2663-9940; Arnold, Lee J/0000-0001-9603-3824; Oppenheimer, Clive/0000-0003-4506-7260; Roberts, Richard Graham/0000-0002-0128-4119; Jones, Sacha/0000-0003-0492-2662; Mirazon Lahr, Marta/0000-0001-5752-5770; Petraglia, Michael/0000-0003-2522-5727; BOIVIN, NICOLE/0000-0002-7783-4199; Koshy, Jinu/0000-0003-3246-0485; Clarkson, Chris/0000-0002-8938-8974	Natural Environment Research Council [NER/T/S/2002/00468] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ACHARYYA SK, 1993, QUATERNARY RES, V40, P10, DOI 10.1006/qres.1993.1051; Ambrose SH, 2003, J HUM EVOL, V45, P231, DOI 10.1016/j.jhevol.2003.08.001; Ambrose SH, 1998, J HUM EVOL, V34, P623, DOI 10.1006/jhev.1998.0219; CHESNER CA, 1991, GEOLOGY, V19, P200, DOI 10.1130/0091-7613(1991)019<0200:EHOESL>2.3.CO;2; Gathorne-Hardy FJ, 2003, J HUM EVOL, V45, P227, DOI 10.1016/S0047-2484(03)00105-2; James HVA, 2005, CURR ANTHROPOL, V46, pS3, DOI 10.1086/444365; Jones GS, 2005, CLIM DYNAM, V25, P725, DOI 10.1007/s00382-005-0066-8; Jones SC, 2007, VERTEBR PALEOBIOL PA, P173, DOI 10.1007/1-4020-5562-5_8; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Mason BG, 2004, B VOLCANOL, V66, P735, DOI 10.1007/s00445-004-0355-9; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; MISRA VN, 1989, MAN ENV, V14, P1764; MURTY MLK, 1974, P AM PHILOS SOC, V118, P196; Oppenheimer C, 2002, QUATERNARY SCI REV, V21, P1593, DOI 10.1016/S0277-3791(01)00154-8; Petraglia MD, 2003, ANTIQUITY, V77, P671, DOI 10.1017/S0003598X00061639; RAMPINO MR, 1993, QUATERNARY RES, V40, P269, DOI 10.1006/qres.1993.1081; RAMPINO MR, 1992, NATURE, V359, P50, DOI 10.1038/359050a0; RAMPINO MR, 1993, SCIENCE, V262, P1955, DOI 10.1126/science.8266085; Reddy K. T., 1977, ASIAN PERSPECT, V20, P206; ROSE WI, 1990, GLOBAL PLANET CHANGE, V89, P269, DOI 10.1016/0921-8181(90)90023-6; ROSE WI, 1987, GEOLOGY, V15, P913, DOI 10.1130/0091-7613(1987)15<913:DOAITG>2.0.CO;2; SHANE P, 1995, QUATERNARY RES, V44, P200, DOI 10.1006/qres.1995.1064; Westgate JA, 1998, QUATERNARY RES, V50, P107, DOI 10.1006/qres.1998.1974	25	205	213	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2007	317	5834					114	116		10.1126/science.1141564	http://dx.doi.org/10.1126/science.1141564			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17615356				2022-12-01	WOS:000247776700063
J	Check, E				Check, Erika			Abbott's AIDS fight-back	NATURE			English	News Item								In March 2007, Abbott Laboratories withdrew its application to register the AIDS drug Aluvia in Thailand because since November 2006, the Thai government has issued a series of compulsory licences to enable it to manufacture or purchase generic copies of patented medicines from third parties without the consent of the patent holder. In May, the company sued the French activist group Act Up-Paris in a Paris court after it had launched an attack on the company's website. Abbott's hardball tactics reflect the high stakes of the latest round of disputes to break out between the industry and governments over drug pricing and access.											0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					14	14		10.1038/448014a	http://dx.doi.org/10.1038/448014a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17611514	Bronze			2022-12-01	WOS:000247720900012
J	Lindholm, P; Voutilainen, MH; Lauren, J; Peranen, J; Leppanen, VM; Andressoo, JO; Lindahl, M; Janhunen, S; Kalkkinen, N; Timmusk, T; Tuominen, RK; Saarma, M				Lindholm, Pivi; Voutilainen, Merja H.; Lauren, Juha; Peranen, Johan; Leppanen, Veli-Matti; Andressoo, Jaan-Olle; Lindahl, Maria; Janhunen, Sanna; Kalkkinen, Nisse; Timmusk, Tonis; Tuominen, Raimo K.; Saarma, Mart			Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo	NATURE			English	Article							MICE LACKING GDNF; PARTIAL LESION MODEL; PARKINSONS-DISEASE; INFUSION; RAT; 6-HYDROXYDOPAMINE; EXPRESSION; DEGENERATION; RECOVERY; 6-OHDA	In Parkinson's disease, brain dopamine neurons degenerate most prominently in the substantia nigra(1). Neurotrophic factors promote survival, differentiation and maintenance of neurons in developing and adult vertebrate nervous system(2,3). The most potent neurotrophic factor for dopamine neurons described so far is the glial-cell-line-derived neurotrophic factor (GDNF)(4). Here we have identified a conserved dopamine neurotrophic factor (CDNF) as a trophic factor for dopamine neurons. CDNF, together with its previously described vertebrate and invertebrate homologue the mesencephalic-astrocyte-derived neurotrophic factor(5), is a secreted protein with eight conserved cysteine residues, predicting a unique protein fold and defining a new, evolutionarily conserved protein family. CDNF (Armetl1) is expressed in several tissues of mouse and human, including the mouse embryonic and postnatal brain. In vivo, CDNF prevented the 6-hydroxydopamine (6-OHDA)-induced degeneration of dopaminergic neurons in a rat experimental model of Parkinson's disease. A single injection of CDNF before 6-OHDA delivery into the striatum significantly reduced amphetamine-induced ipsilateral turning behaviour and almost completely rescued dopaminergic tyrosine-hydroxylase-positive cells in the substantia nigra. When administered four weeks after 6-OHDA, intrastriatal injection of CDNF was able to restore the dopaminergic function and prevent the degeneration of dopaminergic neurons in substantia nigra. Thus, CDNF was at least as efficient as GDNF in both experimental settings. Our results suggest that CDNF might be beneficial for the treatment of Parkinson's disease.	Univ Helsinki, Inst Biotechnol, Viikki Bioctr, FIN-00014 Helsinki, Finland; Univ Helsinki, Div Pharmacol & Toxicol, Viikki Bioctr, Fac Pharm, FIN-00014 Helsinki, Finland; Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia	University of Helsinki; University of Helsinki; Tallinn University of Technology	Saarma, M (corresponding author), Univ Helsinki, Inst Biotechnol, Viikki Bioctr, POB 56, FIN-00014 Helsinki, Finland.	mart.saarma@helsinki.fi	Andressoo, Jaan-Olle/AFU-7846-2022; Kalkkinen, Nisse EJ/B-3923-2010; Voutilainen, Merja/D-9601-2014; Lindahl, Maria/AHE-1252-2022; Andressoo, Jaan-Olle/AAA-1216-2021; Timmusk, Tonis/H-4889-2015	Andressoo, Jaan-Olle/0000-0002-0271-3157; Leppanen, Veli-Matti/0000-0001-7100-965X; Timmusk, Tonis/0000-0002-1015-3348; Pulkkila, Paivi/0000-0003-3022-5035; Voutilainen, Merja/0000-0002-9832-7655; Lindahl, Maria/0000-0002-5674-8830				Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Akerud P, 2001, J NEUROSCI, V21, P8108, DOI 10.1523/JNEUROSCI.21-20-08108.2001; Aoi M, 2000, NEUROSCI RES, V36, P319, DOI 10.1016/S0168-0102(00)00097-3; BOWENKAMP KE, 1995, J COMP NEUROL, V355, P479, DOI 10.1002/cne.903550402; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Granholm ACE, 1997, J NEUROSCI, V17, P1168; Hidalgo A, 2006, BRAIN BEHAV EVOLUT, V68, P173, DOI 10.1159/000094086; HOFFER BJ, 1994, NEUROSCI LETT, V182, P107, DOI 10.1016/0304-3940(94)90218-6; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jaaro H, 2001, TRENDS NEUROSCI, V24, P79, DOI 10.1016/S0166-2236(00)01690-8; Janhunen S, 2005, NEUROSCI LETT, V381, P314, DOI 10.1016/j.neulet.2005.02.038; Kearns CM, 1997, J NEUROSCI, V17, P7111; KEARNS CM, 1995, BRAIN RES, V672, P104, DOI 10.1016/0006-8993(94)01366-P; Keinanen K, 1998, BIOCHEM J, V330, P1461, DOI 10.1042/bj3301461; Kirik D, 2000, EUR J NEUROSCI, V12, P3871, DOI 10.1046/j.1460-9568.2000.00274.x; Kirik D, 2001, EUR J NEUROSCI, V13, P1589, DOI 10.1046/j.0953-816x.2001.01534.x; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Patel NK, 2005, ANN NEUROL, V57, P298, DOI 10.1002/ana.20374; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Peranen J, 2001, METHOD ENZYMOL, V329, P188; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Rosenblad C, 1999, EUR J NEUROSCI, V11, P1554, DOI 10.1046/j.1460-9568.1999.00566.x; Rosenblad C, 1998, NEUROSCIENCE, V82, P129; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; SAUER H, 1995, P NATL ACAD SCI USA, V92, P8935, DOI 10.1073/pnas.92.19.8935; TIMMUSK T, 1993, EUR J NEUROSCI, V5, P605, DOI 10.1111/j.1460-9568.1993.tb00526.x; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411	35	320	349	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					73	77		10.1038/nature05957	http://dx.doi.org/10.1038/nature05957			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17611540				2022-12-01	WOS:000247720900040
J	Sawa, M; Nusinow, DA; Kay, SA; Imaizumi, T				Sawa, Mariko; Nusinow, Dmitri A.; Kay, Steve A.; Imaizumi, Takato			FKF1 and GIGANTEA complex formation is required for day-length measurement in Arabidopsis	SCIENCE			English	Article							CIRCADIAN CLOCK; PROTEIN; LIGHT; CONSTANS; DOMAINS; FLORIGEN	Precise timing of CONSTANS (CO) gene expression is necessary for day-length discrimination for photoperiodic flowering. The FLAVIN-BINDING, KELCH REPEAT, F-BOX 1 (FKF1), and GIGANTEA (GI) proteins regulate CO transcription in Arabidopsis. We demonstrate that FKF1 and GI proteins form a complex in a blue-light-dependentmanner. The timing of this interaction regulates the timing of daytime CO expression. FKF1 function is dependent on GI, which interacts with a CO repressor, CYCLING DOF FACTOR 1 (CDF1), and controls CDF1 stability. GI, FKF1, and CDF1 proteins associate with CO chromatin. Thus, the FKF1-GI complex forms on the CO promoter in late afternoon to regulate CO expression, providing a mechanistic view of how the coincidence of light with circadian timing regulates photoperiodic flowering.	Scripps Res Inst, Dept Biochem, La Jolla, CA 92037 USA	Scripps Research Institute	Imaizumi, T (corresponding author), Scripps Res Inst, Dept Biochem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	timaizumi@ucsd.edu	Sawa, Mariko/B-9944-2016; Nusinow, Dmitri/K-9129-2013	Sawa, Mariko/0000-0002-8056-3043; Nusinow, Dmitri/0000-0002-0497-1723	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056006, R01GM067837, R01GM079712] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM067837, GM067837, R01 GM056006, R01 GM079712-03, GM056006, GM079712, R01 GM079712] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Corbesier L, 2006, J EXP BOT, V57, P3395, DOI 10.1093/jxb/erl095; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; David KM, 2006, FEBS LETT, V580, P1193, DOI 10.1016/j.febslet.2006.01.016; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; Nozaki D, 2004, BIOCHEMISTRY-US, V43, P8373, DOI 10.1021/bi0494727; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Yamaguchi A, 2005, PLANT CELL PHYSIOL, V46, P1175, DOI 10.1093/pcp/pci151; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Zeevaart JAD, 2006, PLANT CELL, V18, P1783, DOI 10.1105/tpc.106.043513; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128	16	588	666	7	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848					261	265		10.1126/science.1146994	http://dx.doi.org/10.1126/science.1146994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17872410	Green Accepted			2022-12-01	WOS:000250086100044
J	Vermeulen, M; Mulder, KW; Denissov, S; Pijnappel, WWMP; van Schaik, FMA; Varier, RA; Baltissen, MPA; Stunnenberg, HG; Mann, M; Timmers, HTM				Vermeulen, Michiel; Mulder, Klaas W.; Denissov, Sergei; Pijnappel, W. W. M. Pim; van Schaik, Frederik M. A.; Varier, Radhika A.; Baltissen, Marijke P. A.; Stunnenberg, Henk G.; Mann, Matthias; Timmers, H. Th. Marc			Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4	CELL			English	Article							RNA-POLYMERASE-II; SPECTROMETRY-BASED PROTEOMICS; PHD FINGER; PROTEIN INTERACTIONS; MOLECULAR REGULATION; H3K4 TRIMETHYLATION; DIVERSE FUNCTIONS; NUCLEAR-PROTEIN; BINDING PROTEIN; GENE-EXPRESSION	Trimethylation of histone H3 at lysine 4 (H3K4me3) is regarded as a hallmark of active human promoters, but it remains unclear how this posttranslational modification links to transcriptional activation. Using a stable isotope labeling by amino acids in cell culture (SILAC)based proteomic screening we show that the basal transcription factor TFIID directly binds to the H3K4me3 mark via the plant homeodomain (PHD) finger of TAF3. Selective loss of H3K4me3 reduces transcription from and TFIID binding to a subset of promoters in vivo. Equilibrium binding assays and competition experiments show that the TAF3 PHD finger is highly selective for H3K4me3. In transient assays, TAF3 can act as a transcriptional coactivator in a PHD finger-dependent manner. Interestingly, asymmetric dimethylation of H3R2 selectively inhibits TFIID binding to H3K4me3, whereas acetylation of H3K9 and H3K14 potentiates TFIID interaction. Our experiments reveal crosstalk between histone modifications and the transcription factor TFIID. This has important implications for regulation of RNA polymerase II-mediated transcription in higher eukaryotes.	Max Planck Inst Biochem, Dept Proteom & Signal Transduct, D-82152 Martinsried, Germany; Univ Utrecht, Med Ctr, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Biol Mol, NL-6500 HB Nijmegen, Netherlands	Max Planck Society; Utrecht University; Radboud University Nijmegen	Mann, M (corresponding author), Max Planck Inst Biochem, Dept Proteom & Signal Transduct, D-82152 Martinsried, Germany.	mmann@biochem.mpg.de; h.t.m.timmers@umcutrecht.nl	Stunnenberg, Hendrik G./D-6875-2012; Mann, Matthias/A-3454-2013; Mulder, Klaas/A-1882-2013; Vermeulen, Michiel/C-8883-2013	Stunnenberg, Hendrik G./0000-0002-0066-1576; Mann, Matthias/0000-0003-1292-4799; Mulder, Klaas/0000-0001-8516-4458; Vermeulen, Michiel/0000-0003-0836-6894; Pijnappel, Pim/0000-0002-7042-2482; Varier, Radhika/0000-0003-1302-3159				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Denissov S, 2007, EMBO J, V26, P944, DOI 10.1038/sj.emboj.7601550; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dominguez C, 2004, STRUCTURE, V12, P633, DOI 10.1016/j.str.2004.03.004; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dreijerink KMA, 2006, CANCER RES, V66, P4929, DOI 10.1158/0008-5472.CAN-05-4461; Ernst P, 2001, MOL CELL BIOL, V21, P2249, DOI 10.1128/MCB.21.7.2249-2258.2001; Gangloff YG, 2001, MOL CELL BIOL, V21, P5109, DOI 10.1128/MCB.21.15.5109-5121.2001; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lee DH, 2005, MOL CELL BIOL, V25, P9674, DOI 10.1128/MCB.25.21.9674-9686.2005; Lee S, 2006, P NATL ACAD SCI USA, V103, P15392, DOI 10.1073/pnas.0607313103; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Martinez-Campa C, 2004, MOL CELL, V15, P69, DOI 10.1016/j.molcel.2004.05.022; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Nicolas RH, 1996, GENE, V175, P233, DOI 10.1016/0378-1119(96)82845-9; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pointud JC, 2001, DEV BIOL, V237, P368, DOI 10.1006/dbio.2001.0358; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; RUTHENBURG AJ, 2007, NATURE, V25, P15; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, P NATL ACAD SCI USA, V104, P2086, DOI 10.1073/pnas.0610993104; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	50	629	647	0	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 5	2007	131	1					58	69		10.1016/j.cell.2007.08.016	http://dx.doi.org/10.1016/j.cell.2007.08.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17884155	Bronze			2022-12-01	WOS:000249934700011
J	Fujisawa, K; Wrana, JL; Culotti, JG				Fujisawa, Kazuko; Wrana, Jeffrey L.; Culotti, Joseph G.			The slit receptor EVA-1 coactivates a SAX-3/robo-mediated guidance signal in C-elegans	SCIENCE			English	Article							AXON GUIDANCE; CAENORHABDITIS-ELEGANS; HEPARAN-SULFATE; DROSOPHILA; PROTEIN; MIDLINE; ROUNDABOUT; REPELLENT	The SAX-3/roundabout (Robo) receptor has Shiga-like toxin 1 (SLT-1)/Slit-dependent and -independent functions in guiding cell and axon migrations. We identified enhancer of ventral-axon guidance defects of unc-40 mutants (EVA-1) as a Caenorhabditis elegans transmembrane receptor for SLT-1. EVA-1 has two predicted galactose-binding ectodomains, acts cell-autonomously for SLT-1/Slit-dependent axon migration functions of SAX-3/Robo, binds to SLT-1 and SAX-3, colocalizes with SAX-3 on cells, and provides cell specificity to the activation of SAX-3 signaling by SLT-1. Double mutants of eva-1 or slt-1 with sax-3 mutations suggest that SAX-3 can (when slt-1 or eva-1 function is reduced) inhibit a parallel-acting guidance mechanism, which involves UNC-40/deleted in colorectal cancer.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Culotti, JG (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	culotti@mshri.on.ca	Culotti, Joseph/G-6467-2013; Wrana, Jeffrey/F-8857-2013	Culotti, Joseph/0000-0001-6325-4612	NINDS NIH HHS [NS41397] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041397] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Culotti JG, 1996, CURR OPIN NEUROBIOL, V6, P81, DOI 10.1016/S0959-4388(96)80012-2; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Liang Y, 1999, J BIOL CHEM, V274, P17885, DOI 10.1074/jbc.274.25.17885; Reymond A, 2001, GENOMICS, V78, P46, DOI 10.1006/geno.2001.6640; Selleck SB, 2001, SEMIN CELL DEV BIOL, V12, P127, DOI 10.1006/scdb.2000.0242; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	16	49	57	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2007	317	5846					1934	1938		10.1126/science.1144874	http://dx.doi.org/10.1126/science.1144874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901337				2022-12-01	WOS:000249764300043
J	Jasti, J; Furukawa, H; Gonzales, EB; Gouaux, E				Jasti, Jayasankar; Furukawa, Hiroyasu; Gonzales, Eric B.; Gouaux, Eric			Structure of acid-sensing ion channel 1 at 1.9A resolution and low pH	NATURE			English	Article							GATED NA+ CHANNEL; ION CHANNELS; SODIUM-CHANNEL; ACETYLCHOLINE-RECEPTOR; EXTRACELLULAR DOMAIN; ACTIVATED CURRENTS; SUBUNIT; H+; DESENSITIZATION; ASIC1	Acid-sensing ion channels (ASICs) are voltage-independent, proton-activated receptors that belong to the epithelial sodium channel/degenerin family of ion channels and are implicated in perception of pain, ischaemic stroke, mechanosensation, learning and memory. Here we report the low-pH crystal structure of a chicken ASIC1 deletion mutant at 1.9 angstrom resolution. Each subunit of the chalice-shaped homotrimer is composed of short amino and carboxy termini, two transmembrane helices, a bound chloride ion and a disulphide-rich, multidomain extracellular region enriched in acidic residues and carboxyl-carboxylate pairs within 3 angstrom, suggesting that at least one carboxyl group bears a proton. Electrophysiological studies on aspartate-to-asparagine mutants confirm that these carboxyl-carboxylate pairs participate in proton sensing. Between the acidic residues and the transmembrane pore lies a disulphide-rich 'thumb' domain poised to couple the binding of protons to the opening of the ion channel, thus demonstrating that proton activation involves long-range conformational changes.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360; Gonzales, Eric B./0000-0001-8596-9053				Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Bellizzi JJ, 1999, STRUCTURE, V7, pR263, DOI 10.1016/S0969-2126(00)80020-9; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eskandari S, 1999, J BIOL CHEM, V274, P27281, DOI 10.1074/jbc.274.38.27281; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Grunder S, 2000, NEUROREPORT, V11, P1607; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2001, J GEN PHYSIOL, V118, P679, DOI 10.1085/jgp.118.6.679; KORKUSHKO AO, 1983, NEUROPHYSIOLOGY+, V15, P469; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Lingueglia E, 2006, PEPTIDES, V27, P1138, DOI 10.1016/j.peptides.2005.06.037; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; O'Hagan R, 2005, INT REV NEUROBIOL, V69, P169, DOI 10.1016/S0074-7742(05)69006-X; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; REYNOLDS JA, 1978, BIOCHEMISTRY-US, V17, P2035, DOI 10.1021/bi00604a001; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; SAWYER L, 1982, NATURE, V295, P79, DOI 10.1038/295079a0; Snyder PM, 1998, J BIOL CHEM, V273, P681, DOI 10.1074/jbc.273.2.681; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Todorovic NA, 2005, ANN NY ACAD SCI, V1048, P331, DOI 10.1196/annals.1342.030; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396	53	798	823	0	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2007	449	7160					316	+		10.1038/nature06163	http://dx.doi.org/10.1038/nature06163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17882215				2022-12-01	WOS:000249557300040
J	Wang, HY; Ouyang, YS; Somers, WG; Chia, W; Lu, BW				Wang, Hongyan; Ouyang, Yingshi; Somers, W. Gregory; Chia, William; Lu, Bingwei			Polo inhibits progenitor self-renewal and regulates Numb asymmetry by phosphorylating Pon	NATURE			English	Article							DROSOPHILA AURORA-A; NEURAL STEM-CELLS; TUMOR-SUPPRESSOR; SPINDLE ORIENTATION; DIVISION; PROTEIN; LOCALIZATION; NEUROBLAST; DIFFERENTIATION; MITOSIS	Self-renewal and differentiation are cardinal features of stem cells. Asymmetric cell division provides one fundamental mechanism by which stem cell self-renewal and differentiation are balanced(1,2). A failure of this balance could lead to diseases such as cancer(3-6). During asymmetric division of stem cells, factors controlling their self-renewal and differentiation are unequally segregated between daughter cells. Numb is one such factor that is segregated to the differentiating daughter cell during the stem-cell-like neuroblast divisions in Drosophila melanogaster 7, where it inhibits self-renewal(8,9). The localization and function of Numb is cell-cycle-dependent(7,10-12). Here we show that Polo (ref. 13), a key cell cycle regulator, the mammalian counterparts of which have been implicated as oncogenes as well as tumour suppressors(14,15), acts as a tumour suppressor in the larval brain. Supernumerary neuroblasts are produced at the expense of neurons in polo mutants. Polo directly phosphorylates Partner of Numb (Pon, ref. 16), an adaptor protein for Numb, and this phosphorylation event is important for Pon to localize Numb. In polo mutants, the asymmetric localization of Pon, Numb and atypical protein kinase C are disrupted, whereas other polarity markers are largely unaffected. Overexpression of Numb suppresses neuroblast over-proliferation caused by polo mutations, suggesting that Numb has a major role in mediating this effect of Polo. Our results reveal a biochemical link between the cell cycle and the asymmetric protein localization machinery, and indicate that Polo can inhibit progenitor self-renewal by regulating the localization and function of Numb.	Stanford Univ, Sch Med, Ctr Geriatr Res Educ & Clin, VA Palo Alto Hlth Care Syst,Dept Pathol, Palo Alto, CA 94304 USA; Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 117604, Singapore	Geriatric Research Education & Clinical Center; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; National University of Singapore; National University of Singapore	Lu, BW (corresponding author), Stanford Univ, Sch Med, Ctr Geriatr Res Educ & Clin, VA Palo Alto Hlth Care Syst,Dept Pathol, Palo Alto, CA 94304 USA.	wchia@tll.org.sg; bingwei@stanford.edu	Somers, Wayne/C-2638-2011; Wang, Hongyan/AAB-3030-2019	Wang, Hongyan/0000-0003-4623-1878; Yu, Fengwei/0000-0003-0268-199X; Lu, Bingwei/0000-0002-5807-7014	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043167] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH080378] Funding Source: Medline; NINDS NIH HHS [R01 NS043167-08, R01 NS043167-02, R01 NS043167-04, R01 NS043167-03, R01 NS043167-06A1, R01 NS043167, R01 NS043167-05, R01 NS043167-10, R01 NS043167-09, R01 NS043167-07, R01 NS043167-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bhalerao S, 2005, CURR BIOL, V15, P1583, DOI 10.1016/j.cub.2005.07.061; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Clarke AS, 2005, DEV CELL, V8, P53, DOI 10.1016/j.devcel.2004.12.003; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Moutinho-Santos T, 1999, BIOL CELL, V91, P585, DOI 10.1016/S0248-4900(00)88523-8; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; SUNKEL CE, 1988, J CELL SCI, V89, P25; Tio M, 2001, NATURE, V409, P1063, DOI 10.1038/35059124; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Zhou Y, 2007, CELL, V129, P163, DOI 10.1016/j.cell.2007.02.037	30	134	139	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2007	449	7158					96	U70		10.1038/nature06056	http://dx.doi.org/10.1038/nature06056			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207ED	17805297	Green Accepted			2022-12-01	WOS:000249233500043
J	Yin, P; Jiang, CQ; Cheng, KK; Lam, TH; Lam, KH; Miller, MR; Zhang, WS; Thomas, GN; Adab, P				Yin, P.; Jiang, C. Q.; Cheng, K. K.; Lam, T. H.; Lam, K. H.; Miller, M. R.; Zhang, W. S.; Thomas, G. N.; Adab, P.			Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study	LANCET			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; RESPIRATORY SYMPTOMS; LUNG-FUNCTION; PULMONARY-FUNCTION; CIGARETTE-SMOKING; HONG-KONG; MORTALITY; HEALTH; DISEASE; HAZARDS	Background Chronic obstructive pulmonary disease (COPD) is a leading cause of mortality in China, where the population is also exposed to high levels of passive smoking, yet little information exists on the effects of such exposure on COPD. We examined the relation between passive smoking and COPD and respiratory symptoms in an adult Chinese population. Methods We used baseline data from the Guangzhou Biobank Cohort Study. Of 20430 men and women over the age of 50 recruited in 200346, 15 379 never smokers (6497 with valid spirometry) were included in this cross-sectional analysis. We measured passive smoking exposure at home and work by two self-reported measures (density and duration of exposure). Diagnosis of COPD was based on spirometry and defined according to the GOLD guidelines. Findings There was an association between risk of COPD and self-reported exposure to passive smoking at home and work (adjusted odds ratio 1.48, 95% CI 1.18-1.85 for high level exposure; equivalent to 40 h a week for more than 5 years). There were significant associations between reported respiratory symptoms and increasing passive smoking exposure (1 . 16, 1.07-1.25 for any symptom). Interpretation Exposure to passive smoking is associated with an increased prevalence of COPD and respiratory symptoms. If this association is causal, we estimate that 1. 9 million excess deaths from COPD among never smokers could be attributable to passive smoking in the current population in China. Our findings provide strong evidence for urgent measures against passive smoking in China.	Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England; Guangzhou Number 12 Peoples Hosp, Guangzhou, Peoples R China; Guangzhou Med Univ, Guangzhou, Peoples R China; Univ Hong Kong, Dept Community Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England	University of Birmingham; Guangzhou Medical University; University of Hong Kong; University of Birmingham	Cheng, KK (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England.	k.k.cheng@bham.ac.uk	Thomas, G. Neil/A-1879-2013; Adab, Peymane/ABC-9651-2021; Cheng, Kar/AAL-8899-2021; Lam, Tai Hing/C-4317-2009	Thomas, G. Neil/0000-0002-2777-1847; Adab, Peymane/0000-0001-9087-3945; Cheng, Kar/0000-0002-1516-1857; Lam, Kin Bong Hubert/0000-0003-1228-3362; Lam, Tai Hing/0000-0002-2033-9971				Berglund DJ, 1999, CHEST, V115, P49, DOI 10.1378/chest.115.1.49; BROWN CA, 1994, J EPIDEMIOL COMMUN H, V48, P134, DOI 10.1136/jech.48.2.134; Brownson RC, 1998, EPIDEMIOL REV, V20, P218, DOI 10.1093/oxfordjournals.epirev.a017982; Chen R, 2001, OCCUP ENVIRON MED, V58, P563, DOI 10.1136/oem.58.9.563; de Marco R, 2004, THORAX, V59, P120, DOI 10.1136/thorax.2003.011163; Eisner Mark D, 2005, Environ Health, V4, P7, DOI 10.1186/1476-069X-4-7; Eisner MD, 2002, ENVIRON HEALTH PERSP, V110, P765, DOI 10.1289/ehp.02110765; Fidan F, 2004, TOB CONTROL, V13, P161, DOI 10.1136/tc.2003.003731; Gerbase MW, 2006, AM J RESP CRIT CARE, V174, P1125, DOI 10.1164/rccm.200512-1890OC; Ho SY, 2007, ANN EPIDEMIOL, V17, P126, DOI 10.1016/j.annepidem.2006.06.010; Ip MSM, 2006, CHEST, V129, P384, DOI 10.1378/chest.129.2.384; Jaakkola MS, 2002, SCAND J WORK ENV HEA, V28, P52; Janson C, 2001, LANCET, V358, P2103, DOI 10.1016/S0140-6736(01)07214-2; Jiang CQ, 2006, INT J EPIDEMIOL, V35, P844, DOI 10.1093/ije/dyl131; KAUFFMANN F, 1983, AM J EPIDEMIOL, V117, P269, DOI 10.1093/oxfordjournals.aje.a113539; Kunzli N, 2000, SOZ PRAVENTIV MED, V45, P208, DOI 10.1007/BF01306015; Lam TH, 2000, JAMA-J AM MED ASSOC, V284, P756, DOI 10.1001/jama.284.6.756; Larsson ML, 2003, EUR RESPIR J, V21, P672, DOI 10.1183/09031936.03.00033702; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; McGhee SM, 2005, BMJ-BRIT MED J, V330, P287, DOI 10.1136/bmj.38342.706748.47; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Niu SR, 1998, BRIT MED J, V317, P1423, DOI 10.1136/bmj.317.7170.1423; Pauwels R A, 2001, Respir Care, V46, P798; Pellegrino R, 2005, EUR RESPIR J, V26, P1104, DOI 10.1183/09031936.05.00026705; Svanes C, 2004, THORAX, V59, P295, DOI 10.1136/thx.2003.009746; Tang Taiqin, 2000, Zhonghua Jiehe He Huxi Zazhi, V23, P730; Upton MN, 2004, AM J RESP CRIT CARE, V169, P479, DOI 10.1164/rccm.200211-1357OC; XU XP, 1995, AM J RESP CRIT CARE, V151, P41, DOI 10.1164/ajrccm.151.1.7812570; Yang GH, 2001, TOB CONTROL, V10, P170, DOI 10.1136/tc.10.2.170; [杨功焕 Yang Gonghuan], 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P77; Zhang H, 2003, RESPIROLOGY, V8, P17, DOI 10.1046/j.1440-1843.2003.00433.x	31	188	205	1	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2007	370	9589					751	757		10.1016/S0140-6736(07)61378-6	http://dx.doi.org/10.1016/S0140-6736(07)61378-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206UV	17765524				2022-12-01	WOS:000249209300029
J	Kimchi, T; Xu, J; Dulac, C				Kimchi, Tali; Xu, Jennings; Dulac, Catherine			A functional circuit underlying male sexual behaviour in the female mouse brain	NATURE			English	Article							MICE MUS-MUSCULUS; MUTANT MICE; COURTSHIP BEHAVIOR; VOMERONASAL ORGAN; PHEROMONE; DISCRIMINATION; REPRODUCTION; TRP2; VOCALIZATIONS; TRANSDUCTION	In mice, pheromone detection is mediated by the vomeronasal organ and the main olfactory epithelium. Male mice that are deficient for Trpc2, an ion channel specifically expressed in VNO neurons and essential for VNO sensory transduction, are impaired in sex discrimination and male-male aggression. We report here that Trpc2(-/-) female mice show a reduction in female-specific behaviour, including maternal aggression and lactating behaviour. Strikingly, mutant females display unique characteristics of male sexual and courtship behaviours such as mounting, pelvic thrust, solicitation, anogenital olfactory investigation, and emission of complex ultrasonic vocalizations towards male and female conspecific mice. The same behavioural phenotype is observed after VNO surgical removal in adult animals, and is not accompanied by disruption of the oestrous cycle and sex hormone levels. These findings suggest that VNO-mediated pheromone inputs act in wild-type females to repress male behaviour and activate female behaviours. Moreover, they imply that functional neuronal circuits underlying male-specific behaviours exist in the normal female mouse brain.	Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Dulac, C (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kimhi@fas.harvard.edu; dulac@fas.harvard.edu		Xu, Jennings/0000-0002-3068-0559; Dulac, Catherine/0000-0001-5024-5418				Afonso VM, 2006, HORM BEHAV, V49, P30, DOI 10.1016/j.yhbeh.2005.04.013; BEACH FA, 1968, PERSPECTIVES REPROD, P88; Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; EDWARDS DA, 1971, HORM BEHAV, V2, P49, DOI 10.1016/0018-506X(71)90037-7; Fang JM, 1999, ANIM BEHAV, V57, P545, DOI 10.1006/anbe.1998.1025; Gourbal BEF, 2004, NATURWISSENSCHAFTEN, V91, P381, DOI 10.1007/s00114-004-0543-7; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Keller M, 2006, EUR J NEUROSCI, V23, P521, DOI 10.1111/j.1460-9568.2005.04589.x; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; MAGGIO JC, 1985, J COMP PSYCHOL, V99, P420, DOI 10.1037/0735-7036.99.4.420; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; MANNING A, 1974, HORM BEHAV, V5, P19, DOI 10.1016/0018-506X(74)90004-X; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Moles A, 2000, ANIM BEHAV, V60, P689, DOI 10.1006/anbe.2000.1504; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Pankevich DE, 2004, J NEUROSCI, V24, P9451, DOI 10.1523/JNEUROSCI.2376-04.2004; SAGOVIA S, 1993, BRAIN RES BRAIN RES, V18, P51; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; White NR, 1998, PHYSIOL BEHAV, V63, P467, DOI 10.1016/S0031-9384(97)00484-8; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039	30	293	298	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2007	448	7157					1009	U1		10.1038/nature06089	http://dx.doi.org/10.1038/nature06089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205EU	17676034				2022-12-01	WOS:000249097600029
J	Eiler, JM				Eiler, John M.			Geochemistry - The oldest fossil or just another rock?	SCIENCE			English	Editorial Material							EARLY ARCHEAN ROCKS; SUPRACRUSTAL ROCKS; SILICON ISOTOPES; WEST GREENLAND; ION-MICROPROBE; AKILIA; LIFE; ORIGIN; APATITE; CLUES		CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Eiler, JM (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	eiler@gps.caltech.edu						Andre L, 2006, EARTH PLANET SC LETT, V245, P162, DOI 10.1016/j.epsl.2006.02.046; Dauphas N, 2004, SCIENCE, V306, P2077, DOI 10.1126/science.1104639; Fedo CM, 2002, SCIENCE, V296, P1448, DOI 10.1126/science.1070336; Lepland A, 2005, GEOLOGY, V33, P77, DOI 10.1130/G20890.1; Manning CE, 2006, AM J SCI, V306, P303, DOI 10.2475/05.2006.02; McKeegan KD, 2007, GEOLOGY, V35, P591, DOI 10.1130/G23465A.1; Mojzsis SJ, 2002, SCIENCE, V298; Mojzsis SJ, 2003, GEOCHIM COSMOCHIM AC, V67, P1635, DOI 10.1016/S0016-7037(03)00059-0; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Nutman AP, 2006, PRECAMBRIAN RES, V147, P100, DOI 10.1016/j.precamres.2006.02.005; Robert F, 2006, NATURE, V443, P969, DOI 10.1038/nature05239; Sano Y, 1999, NATURE, V400, P127, DOI 10.1038/22032; SCHIDLOWSKI M, 1988, NATURE, V333, P313, DOI 10.1038/333313a0; Whitehouse MJ, 2005, CHEM GEOL, V222, P112, DOI 10.1016/j.chemgeo.2005.06.004; Whitehouse MJ, 2003, PRECAMBRIAN RES, V126, P259, DOI 10.1016/S0301-9268(03)00098-6; Whitehouse MJ, 1999, CHEM GEOL, V160, P201, DOI 10.1016/S0009-2541(99)00066-2	16	12	13	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2007	317	5841					1046	1047		10.1126/science.1146923	http://dx.doi.org/10.1126/science.1146923			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	203AE	17717176				2022-12-01	WOS:000248946700033
J	Swartz, TE; Tseng, TS; Frederickson, MA; Paris, G; Comerci, DJ; Rajashekara, G; Kim, JG; Mudgett, MB; Splitter, GA; Ugalde, RA; Goldbaum, FA; Briggs, WR; Bogomolni, RA				Swartz, Trevor E.; Tseng, Tong-Seung; Frederickson, Marcus A.; Paris, Gaston; Comerci, Diego J.; Rajashekara, Gireesh; Kim, Jung-Gun; Mudgett, Mary Beth; Splitter, Gary A.; Ugalde, Rodolfo A.; Goldbaum, Fernando A.; Briggs, Winslow R.; Bogomolni, Roberto A.			Blue-light-activated histidine kinases: Two-component sensors in bacteria	SCIENCE			English	Article							GENOME SEQUENCE; DOMAIN; BRUCELLA; PHOTOCYCLE; RECEPTOR; PHOTOTROPIN-1; PROTEINS; MODEL	Histidine kinases, used for environmental sensing by bacterial two-component systems, are involved in regulation of bacterial gene expression, chemotaxis, phototaxis, and virulence. Flavin-containing domains function as light-sensory modules in plant and algal phototropins and in fungal blue-light receptors. We have discovered that the prokaryotes Brucella melitensis, Brucella abortus, Erythrobacter litoralis, and Pseudomonas syringae contain light-activated histidine kinases that bind a flavin chromophore and undergo photochemistry indicative of cysteinyl-flavin adduct formation. Infection of macrophages by B. abortus was stimulated by light in the wild type but was limited in photochemically inactive and null mutants, indicating that the flavin-containing histidine kinase functions as a photoreceptor regulating B. abortus virulence.	Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, Buenos Aires, DF, Argentina; Univ Wisconsin, Dept Anim Hlth & Biomed Sci, Madison, WI USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Univ Nacl San Martin, CONICET, Inst Invest Biotecnol, San Martin, Argentina; Ohio State Univ, FAHRP OARDC, Wooster, OH USA	University of California System; University of California Santa Cruz; Carnegie Institution for Science; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Wisconsin System; University of Wisconsin Madison; Stanford University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University System of Ohio; Ohio State University	Bogomolni, RA (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	bogo@chemistry.ucsc.edu	Rajashekara, Gireesh/E-3913-2011; Paris, Gaston/J-6100-2014	Paris, Gaston/0000-0001-5984-7394; Comerci, Diego J./0000-0003-1949-4226; Goldbaum, Fernando/0000-0001-6235-3002	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068886] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandre MTA, 2007, BIOCHEMISTRY-US, V46, P3129, DOI 10.1021/bi062074e; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Corchnoy SB, 2003, J BIOL CHEM, V278, P724, DOI 10.1074/jbc.M209119200; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2003, BIOCHEMISTRY-US, V42, P2, DOI 10.1021/bi026978l; Crosson S, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P323, DOI 10.1002/352760510X.ch15; DelVecchio VG, 2002, P NATL ACAD SCI USA, V99, P443, DOI 10.1073/pnas.221575398; Elzer PH, 2002, VET MICROBIOL, V90, P425, DOI 10.1016/S0378-1135(02)00226-2; Gaidenko TA, 2006, J BACTERIOL, V188, P6387, DOI 10.1128/JB.00691-06; Halling SM, 2005, J BACTERIOL, V187, P2715, DOI 10.1128/JB.187.8.2715-2726.2005; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Klumpp S, 2002, EUR J BIOCHEM, V269, P1067, DOI 10.1046/j.1432-1033.2002.02755.x; Kottke T, 2003, BIOPHYS J, V84, P1192, DOI 10.1016/S0006-3495(03)74933-9; Krauss U, 2005, PHYS CHEM CHEM PHYS, V7, P2804, DOI 10.1039/b504554a; Losi A, 2004, PHOTOCH PHOTOBIO SCI, V3, P566, DOI 10.1039/b400728j; Losi A, 2002, BIOPHYS J, V82, P2627, DOI 10.1016/S0006-3495(02)75604-X; LOSI A, 2006, FLAVINS PHOTOCHEMIST, P217; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Ugalde RA, 1999, MICROBES INFECT, V1, P1211, DOI 10.1016/S1286-4579(99)00240-3; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7	28	187	198	3	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2007	317	5841					1090	1093		10.1126/science.1144306	http://dx.doi.org/10.1126/science.1144306			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203AE	17717187				2022-12-01	WOS:000248946700047
J	Adams, TD; Gress, RE; Smith, SC; Halverson, RC; Simper, SC; Rosamond, WD; LaMonte, MJ; Stroup, AM; Hunt, SC				Adams, Ted D.; Gress, Richard E.; Smith, Sherman C.; Halverson, R. Chad; Simper, Steven C.; Rosamond, Wayne D.; LaMonte, Michael J.; Stroup, Antoinette M.; Hunt, Steven C.			Long-term mortality after gastric bypass surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SELF-REPORTED WEIGHT; QUALITY-OF-LIFE; BARIATRIC SURGERY; OBESITY; SURVIVAL; OVERWEIGHT; MORBIDITY; OUTCOMES; TRENDS	Background: Although gastric bypass surgery accounts for 80% of bariatric surgery in the United States, only limited long-term data are available on mortality among patients who have undergone this procedure as compared with severely obese persons from a general population. Methods: In this retrospective cohort study, we determined the long-term mortality (from 1984 to 2002) among 9949 patients who had undergone gastric bypass surgery and 9628 severely obese persons who applied for driver's licenses. From these subjects, 7925 surgical patients and 7925 severely obese control subjects were matched for age, sex, and body-mass index. We determined the rates of death from any cause and from specific causes with the use of the National Death Index. Results: During a mean follow-up of 7.1 years, adjusted long-term mortality from any cause in the surgery group decreased by 40%, as compared with that in the control group (37.6 vs. 57.1 deaths per 10,000 person-years, P<0.001); cause-specific mortality in the surgery group decreased by 56% for coronary artery disease (2.6 vs. 5.9 per 10,000 person-years, P=0.006), by 92% for diabetes (0.4 vs. 3.4 per 10,000 person-years, P=0.005), and by 60% for cancer (5.5 vs. 13.3 per 10,000 person-years, P<0.001). However, rates of death not caused by disease, such as accidents and suicide, were 58% higher in the surgery group than in the control group (11.1 vs. 6.4 per 10,000 person-years, P=0.04). Conclusions: Long-term total mortality after gastric bypass surgery was significantly reduced, particularly deaths from diabetes, heart disease, and cancer. However, the rate of death from causes other than disease was higher in the surgery group than in the control group.	Univ Utah, Sch Med, Cardiovasc Genet Div, Salt Lake City, UT 84108 USA; LDS Hosp, Intermt Hlth & Fitness Inst, Salt Lake City, UT USA; Rocky Mt Associated Phys, Salt Lake City, UT USA; Univ Utah, Utah Canc Registry, Salt Lake City, UT USA; Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA; SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY USA	Utah System of Higher Education; University of Utah; Intermountain Healthcare; Utah System of Higher Education; University of Utah; University of North Carolina; University of North Carolina Chapel Hill; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Adams, TD (corresponding author), Univ Utah, Sch Med, Cardiovasc Genet Div, 420 Chipeta Way,Rm 1160, Salt Lake City, UT 84108 USA.	ted.adams@utah.edu	LaMonte, Mike/AAC-9953-2021; Kohn, Geoffrey P/A-9056-2009		NCI NIH HHS [N01-PC-35141] Funding Source: Medline; NCRR NIH HHS [M01 RR000064, M01-RR00064] Funding Source: Medline; NIDDK NIH HHS [R01 DK055006, DK-55006] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055006] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abrahamson PE, 2006, CANCER EPIDEM BIOMAR, V15, P1871, DOI 10.1158/1055-9965.EPI-06-0356; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Adams TD, 2005, CONTEMP CLIN TRIALS, V26, P534, DOI 10.1016/j.cct.2005.05.003; Arcila D, 2002, OBES SURG, V12, P661, DOI 10.1381/096089202321019648; Bender R, 2006, J CLIN EPIDEMIOL, V59, P1064, DOI 10.1016/j.jclinepi.2006.01.006; Buchwald H, 2005, JAMA-J AM MED ASSOC, V293, P1728; Ceschi M, 2007, SWISS MED WKLY, V137, P50; Christou NV, 2004, ANN SURG, V240, P416, DOI 10.1097/01.sla.0000137343.63376.19; Clark MM, 2003, OBES SURG, V13, P739, DOI 10.1381/096089203322509318; Collazo-Clavell ML, 2006, MAYO CLIN PROC, V81, pS11; Courcoulas AP, 2005, JAMA-J AM MED ASSOC, V294, P2848; COURCOULAS AP, 2005, JAMA-J AM MED ASSOC, V295, P1957; Elkins G, 2005, OBES SURG, V15, P546, DOI 10.1381/0960892053723385; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flum DR, 2004, J AM COLL SURGEONS, V199, P543, DOI 10.1016/j.jamcollsurg.2004.06.014; Herpertz S, 2003, INT J OBESITY, V27, P1300, DOI 10.1038/sj.ijo.0802410; Horm J., 1996, NATL DEATH INDEX PLU, pA5; King TK, 1996, ADDICT BEHAV, V21, P283, DOI 10.1016/0306-4603(95)00058-5; Kolotkin RL, 2003, OBES SURG, V13, P371, DOI 10.1381/096089203765887688; Kushner RF, 2006, MAYO CLIN PROC, V81, pS46; MacDonald K G Jr, 1997, J Gastrointest Surg, V1, P213, DOI 10.1016/S1091-255X(97)80112-6; McAdams MA, 2007, OBESITY, V15, P188, DOI 10.1038/oby.2007.504; McMahon MM, 2006, MAYO CLIN PROC, V81, pS34; McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79; *NIH, 1998, OBES RES, V6, P464; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pope GD, 2002, J GASTROINTEST SURG, V6, P855, DOI 10.1016/S1091-255X(02)00085-9; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; Santry HP, 2005, JAMA-J AM MED ASSOC, V294, P1909, DOI 10.1001/jama.294.15.1909; Sarwer DB, 2005, OBES RES, V13, P639, DOI 10.1038/oby.2005.71; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; SJOSTROM L, 1992, INT J OBESITY, V16, P465; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Solomon CG, 2004, NEW ENGL J MED, V351, P2751, DOI 10.1056/NEJMe048308; Sorensen T I A, 2003, Obes Rev, V4, P3, DOI 10.1046/j.1467-789X.2003.00090.x; Sowemimo OA, 2007, SURG OBES RELAT DIS, V3, P73, DOI 10.1016/j.soard.2006.10.017; Steinbrook R, 2004, NEW ENGL J MED, V350, P1075, DOI 10.1056/NEJMp048029; Villanueva EV, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-11; Wolfe BM, 2005, JAMA-J AM MED ASSOC, V294, P1960, DOI 10.1001/jama.294.15.1960; Yang D, 2003, Obes Rev, V4, P9, DOI 10.1046/j.1467-789X.2003.00092.x; Zhang W, 2005, OBES SURG, V15, P43, DOI 10.1381/0960892052993422	41	1730	1787	1	99	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2007	357	8					753	761		10.1056/NEJMoa066603	http://dx.doi.org/10.1056/NEJMoa066603			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202MU	17715409				2022-12-01	WOS:000248906700004
J	Kim, S; Malinverni, JC; Sliz, P; Silhavy, TJ; Harrison, SC; Kahne, D				Kim, Seokhee; Malinverni, Juliana C.; Sliz, Piotr; Silhavy, Thomas J.; Harrison, Stephen C.; Kahne, Daniel			Structure and function of an essential component of the outer membrane protein assembly machine	SCIENCE			English	Article							ESCHERICHIA-COLI; CHEMICAL CONDITIONALITY; BIOGENESIS; IDENTIFICATION; DOMAIN; MITOCHONDRIA; SURFACE; CHANNEL; COMPLEX; FAMILY	Integral beta-barrel proteins are found in the outer membranes of mitochondria, chloroplasts, and Gram-negative bacteria. The machine that assembles these proteins contains an integral membrane protein, called YaeT in Escherichia coli, which has one or more polypeptide transport-associated (POTRA) domains. The crystal structure of a periplasmic fragment of YaeT reveals the POTRA domain fold and suggests a model for how POTRA domains can bind different peptide sequences, as required for a machine that handles numerous beta-barrel protein precursors. Analysis of POTRA domain deletions shows which are essential and provides a view of the spatial organization of this assembly machine.	Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA	Harvard University; Princeton University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital	Kahne, D (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	kahne@chemistry.harvard.edu	Kim, Seokhee/C-2303-2018	Kim, Seokhee/0000-0003-0806-583X; Sliz, Piotr/0000-0002-6522-0835; Silhavy, Thomas/0000-0001-7672-5153	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034821, R01GM034821, R01GM066174] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM66174, GM34821] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Doerrler WT, 2005, J BIOL CHEM, V280, P27679, DOI 10.1074/jbc.M504796200; Ertel F, 2005, J BIOL CHEM, V280, P28281, DOI 10.1074/jbc.M503035200; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Habib SJ, 2007, J CELL BIOL, V176, P77, DOI 10.1083/jcb.200602050; Harrison SC, 1996, CELL, V86, P341, DOI 10.1016/S0092-8674(00)80105-1; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; Moslavac S, 2005, FEBS J, V272, P1367, DOI 10.1111/j.1742-4658.2005.04569.x; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Paschen SA, 2005, TRENDS BIOCHEM SCI, V30, P575, DOI 10.1016/j.tibs.2005.08.009; Pfanner N, 2004, NAT STRUCT MOL BIOL, V11, P1044, DOI 10.1038/nsmb852; Reumann S, 1999, P NATL ACAD SCI USA, V96, P784, DOI 10.1073/pnas.96.2.784; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Ruiz N, 2006, ACS CHEM BIOL, V1, P385, DOI 10.1021/cb600128v; Sanchez-Pulido L, 2003, TRENDS BIOCHEM SCI, V28, P523, DOI 10.1016/j.tibs.2003.08.003; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Werner J, 2005, MOL MICROBIOL, V57, P1450, DOI 10.1111/j.1365-2958.2005.04775.x; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	26	285	291	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					961	964		10.1126/science.1143993	http://dx.doi.org/10.1126/science.1143993			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702946				2022-12-01	WOS:000248780200044
J	Spoor, F; Leakey, MG; Gathogo, PN; Brown, FH; Anton, SC; McDougall, I; Kiarie, C; Manthi, FK; Leakey, LN				Spoor, F.; Leakey, M. G.; Gathogo, P. N.; Brown, F. H.; Anton, S. C.; McDougall, I.; Kiarie, C.; Manthi, F. K.; Leakey, L. N.			Implications of new early Homo fossils from Ileret, east of Lake Turkana, Kenya	NATURE			English	Article							KOOBI-FORA-FORMATION; OLDUVAI-GORGE; PLIOCENE; BASIN; PALEOANTHROPOLOGY; PLEISTOCENE; REMAINS; ERECTUS; DMANISI; SKULLS	Sites in eastern Africa have shed light on the emergence and early evolution of the genus Homo(1-6). The best known early hominin species, H. habilis and H. erectus, have often been interpreted as time-successive segments of a single anagenetic evolutionary lineage(3,7-10). The case for this was strengthened by the discovery of small early Pleistocene hominin crania from Dmanisi in Georgia that apparently provide evidence of morphological continuity between the two taxa(11,12). Here we describe two new cranial fossils from the Koobi Fora Formation, east of Lake Turkana in Kenya, that have bearing on the relationship between species of early Homo. A partial maxilla assigned to H. habilis reliably demonstrates that this species survived until later than previously recognized, making an anagenetic relationship with H. erectus unlikely. The discovery of a particularly small calvaria of H. erectus indicates that this taxon overlapped in size with H. habilis, and may have shown marked sexual dimorphism. The new fossils confirm the distinctiveness of H. habilis and H. erectus, independently of overall cranial size, and suggest that these two early taxa were living broadly sympatrically in the same lake basin for almost half a million years.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Koobi Fora Res Project, Nairobi 00502, Kenya; SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; NYU, Dept Anthropol, New York, NY 10003 USA; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Natl Museums Kenya, Div Palaeontol, Nairobi 00100, Kenya	University of London; University College London; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Utah System of Higher Education; University of Utah; New York University; Australian National University	Spoor, F (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	f.spoor@ucl.ac.uk; meaveleakey@uuplus.com	Spoor, Fred/C-1718-2008	Leakey, Louise/0000-0003-3420-6341				Aiello LC, 2002, AM J HUM BIOL, V14, P551, DOI 10.1002/ajhb.10069; Andrews P., 1984, Courier Forschungsinstitut Senckenberg, V69, P167; Anton SC, 2004, J HUM EVOL, V46, P337, DOI 10.1016/j.jhevol.2003.12.005; Anton Susan C., 2007, P1655, DOI 10.1007/978-3-540-33761-4_54; Asfaw B, 2002, NATURE, V416, P317, DOI 10.1038/416317a; Blumenschine RJ, 2003, SCIENCE, V299, P1217, DOI 10.1126/science.1075374; BROMAGE TG, 1995, J HUM EVOL, V28, P71, DOI 10.1006/jhev.1995.1007; Brown FH, 2006, J GEOL SOC LONDON, V163, P185, DOI 10.1144/0016-764904-165; de Lumley MA, 2006, ANTHROPOLOGIE, V110, P1, DOI 10.1016/j.anthro.2006.02.001; FEIBEL CS, 1989, AM J PHYS ANTHROPOL, V78, P595, DOI 10.1002/ajpa.1330780412; Gathogo PN, 2006, J AFR EARTH SCI, V45, P369, DOI 10.1016/j.jafrearsci.2006.03.006; Hay R.L., 1976, GEOLOGY OLDUVAI GORG; HOWELL FC, 1982, CAMBRIDGE HIST AFRIC, V1, P70; KIMBEL WH, 1991, J HUM EVOL, V20, P355, DOI 10.1016/0047-2484(91)90016-O; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; Leakey M.D., 1971, OLDUVAI GORGE; LEAKEY MG, 1978, KOOBI FORA RES PROJE, V1; MANEGA PC, 1993, THHESIS U COLORADO; Marquez S, 2001, ANAT REC, V262, P344, DOI 10.1002/ar.1046; McDougall I, 2006, J GEOL SOC LONDON, V163, P205, DOI 10.1144/0016-764904-166; Potts R, 2004, SCIENCE, V305, P75, DOI 10.1126/science.1097661; Rightmire GP, 2006, J HUM EVOL, V50, P115, DOI 10.1016/j.jhevol.2005.07.009; Tattersall I, 2000, EVOL ANTHROPOL, V9, P2, DOI 10.1002/(SICI)1520-6505(2000)9:1<2::AID-EVAN2>3.0.CO;2-2; Tobias P.V., 1989, P141; Tobias PV, 1991, OLDUVAI GORGE, V4; Vekua A, 2002, SCIENCE, V297, P85, DOI 10.1126/science.1072953; WALTER RC, 1991, NATURE, V354, P145, DOI 10.1038/354145a0; WOOD B, 1991, KOOBI FLORA RES PROJ, V4	28	218	226	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2007	448	7154					688	691		10.1038/nature05986	http://dx.doi.org/10.1038/nature05986			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687323				2022-12-01	WOS:000248598000043
J	Jayachandran, R; Sundaramurthy, V; Combaluzier, B; Mueller, P; Korf, H; Huygen, K; Miyazaki, T; Albrecht, I; Massner, J; Pieters, J				Jayachandran, Rajesh; Sundaramurthy, Varadharajan; Combaluzier, Benoit; Mueller, Philipp; Korf, Hannelie; Huygen, Kris; Miyazaki, Toru; Albrecht, Imke; Massner, Jan; Pieters, Jean			Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin	CELL			English	Article							GREEN FLUORESCENT PROTEIN; ACTIN-BINDING PROTEIN; ENDOPLASMIC-RETICULUM; INTRACELLULAR SURVIVAL; TUBERCULOSIS; PHAGOCYTOSIS; CHOLESTEROL; INHIBITION; MEMBRANE; DYNAMICS	Pathogenic mycobacteria survive within macrophages by avoiding lysosomal delivery, instead residing in mycobacterial phagosomes. Upon infection, the leukocyte- specific protein coronin 1 is actively recruited to mycobacterial phagosomes, where it blocks lysosomal delivery by an unknown mechanism. Analysis of macrophages from coronin 1- deficient mice showed that coronin 1 is dispensable for Factindependent processes such as phagocytosis, motility, and membrane ruffling. However, upon mycobacterial infection, coronin 1 was required for activation of the Ca2+- dependent phosphatase calcineurin, thereby blocking lysosomal delivery of mycobacteria. In the absence of coronin 1, calcineurin activity did not occur, resulting in lysosomal delivery and killing of mycobacteria. Furthermore, blocking calcineurin activation with cyclosporin A or FK506 led to lysosomal delivery and intracellular mycobacterial killing. These results demonstrate a role for coronin 1 in activating Ca2+ dependent signaling processes in macrophages and reveal a function for calcineurin in the regulation of phagosome- lysosome fusion upon mycobacterial infection.	Univ Basel, Bioctr, CH-4056 Basel, Switzerland; WIV Pasteur Inst Brussels, Brussels, Belgium; Univ Tokyo, Tokyo 106, Japan	University of Basel; University of Tokyo	Pieters, J (corresponding author), Univ Basel, Bioctr, Klingelbergstr 50, CH-4056 Basel, Switzerland.	jean.pieters@unibas.ch	Sundaramurthy, Varadharajan/AGK-2349-2022	Sundaramurthy, Varadharajan/0000-0003-2562-8518; Huygen, Kris/0000-0001-7808-0512; Miyazaki, Toru/0000-0003-3842-4362; Korf, Hannelie/0000-0003-3540-0138; Pieters, Jean/0000-0002-5284-9757				Albrecht I, 2006, INT IMMUNOL, V18, P755, DOI 10.1093/intimm/dxl013; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BOSLOVER S, 2001, BIOCHEM J, V356, P345; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Butcher SP, 1997, J NEUROSCI, V17, P6939; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; DHANDAYUTHAPANI S, 1995, MOL MICROBIOL, V17, P901, DOI 10.1111/j.1365-2958.1995.mmi_17050901.x; Ferrari G, 1997, J CELL BIOL, V139, P1433, DOI 10.1083/jcb.139.6.1433; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Fukui Y, 1999, CELL MOTIL CYTOSKEL, V42, P204, DOI 10.1002/(SICI)1097-0169(1999)42:3<204::AID-CM4>3.0.CO;2-L; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042; Hasan Z, 1997, MOL MICROBIOL, V24, P545, DOI 10.1046/j.1365-2958.1997.3591731.x; Heil-Chapdelaine RA, 1998, CURR BIOL, V8, P1281, DOI 10.1016/S0960-9822(07)00539-8; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Itoh S, 2002, BIOL PHARM BULL, V25, P837, DOI 10.1248/bpb.25.837; Le Cabec V, 2002, J IMMUNOL, V169, P2003, DOI 10.4049/jimmunol.169.4.2003; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MacMicking JD, 2005, CURR OPIN MICROBIOL, V8, P74, DOI 10.1016/j.mib.2004.12.012; Malik ZA, 2000, J EXP MED, V191, P287, DOI 10.1084/jem.191.2.287; Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811; MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4; Muller-Taubenberger A, 2001, EMBO J, V20, P6772, DOI 10.1093/emboj/20.23.6772; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Rubart M, 2004, J CLIN INVEST, V114, P775, DOI 10.1172/JCI200421589; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Rybakin V, 2005, BIOESSAYS, V27, P625, DOI 10.1002/bies.20235; Schuller S, 2001, CELL MICROBIOL, V3, P785, DOI 10.1046/j.1462-5822.2001.00155.x; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; STEINMAN RM, 1995, J EXP MED, V182, P283, DOI 10.1084/jem.182.2.283; Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939; Tanghe A, 2001, INFECT IMMUN, V69, P3041, DOI 10.1128/IAI.69.5.3041-3047.2001; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; Velasco-Velazquez MA, 2003, MICROB PATHOGENESIS, V35, P125, DOI 10.1016/S0882-4010(03)00099-8; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5; Yan M, 2005, MOL BIOL CELL, V16, P3077, DOI 10.1091/mbc.E04-11-0989; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	49	209	223	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2007	130	1					37	50		10.1016/j.cell.2007.04.043	http://dx.doi.org/10.1016/j.cell.2007.04.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632055	Bronze			2022-12-01	WOS:000248587000009
J	Rennert, G; Bisland-Naggan, S; Barnett-Griness, O; Bar-Joseph, N; Zhang, SY; Rennert, HS; Narod, SA				Rennert, Gad; Bisland-Naggan, Shantih; Barnett-Griness, Ofra; Bar-Joseph, Naomi; Zhang, Shiyu; Rennert, Hedy S.; Narod, Steven A.			Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SURVIVAL; CARCINOMA; FREQUENCY	BACKGROUND: Some features of breast cancer in women with a BRCA1 mutation suggest that hereditary breast cancer has a poor outcome. We conducted a national population-based study of Israeli women to determine the influence, if any, of a BRCA1 or a BRCA2 mutation on the prognosis in breast cancer. METHODS: We obtained data on all incident cases of invasive breast cancer that were diagnosed from January 1, 1987, to December 31, 1988, and recorded in the Israel National Cancer Registry. We requested a paraffin-embedded tumor block or an unstained slide and the corresponding pathological and clinical records for all such cases. DNA extracted from the tumor specimens was analyzed for the three founder mutations in BRCA1 and BRCA2. For each subject, available pathological and oncologic records were reviewed. RESULTS: We were able to retrieve a pathological sample from 1794 of 2514 subjects (71%). Among those women, we obtained medical records for 1545 (86%). A BRCA1 or BRCA2 mutation was identified in 10% of the women who were of Ashkenazi Jewish ancestry. The adjusted hazard ratios for death from breast cancer were not significantly different among mutation carriers and noncarriers (hazard ratio among BRCA1 carriers, 0.76; 95% confidence interval [CI], 0.45 to 1.30; P=0.31; hazard ratio among BRCA2 carriers, 1.31; 95% CI, 0.80 to 2.15; P=0.28). Among women who were treated with chemotherapy, the hazard ratio for death among BRCA1 carriers was 0.48 (95% CI, 0.19 to 1.21; P=0.12). CONCLUSIONS: Breast cancer-specific rates of death among Israeli women are similar for carriers of a BRCA founder mutation and noncarriers.	Carmel Hosp, Natl Canc Control Ctr, Clalit Hlth Serv, IL-34362 Haifa, Israel; Carmel Hosp, Dept Community Med & Epidemiol, IL-34362 Haifa, Israel; Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada	Clalit Health Services; Carmel Medical Center; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Toronto; University Toronto Affiliates; Womens College Hospital	Rennert, G (corresponding author), Carmel Hosp, Natl Canc Control Ctr, Clalit Hlth Serv, IL-34362 Haifa, Israel.	rennert@tx.technion.ac.il	Narod, Steven A/AAA-6112-2022	Rennert, Gad/0000-0002-8512-068X	NCI NIH HHS [CA8097] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brekelmans CTM, 2006, ANN ONCOL, V17, P391, DOI 10.1093/annonc/mdj095; Eerola H, 2001, INT J CANCER, V93, P368, DOI 10.1002/ijc.1341; El-Tamer M, 2004, ANN SURG ONCOL, V11, P157, DOI 10.1245/ASO.2004.05.018; Goffin JR, 2003, CANCER-AM CANCER SOC, V97, P527, DOI 10.1002/cncr.11080; Goode EL, 2002, CANCER RES, V62, P3052; Johannsson OT, 1997, EUR J CANCER, V33, P362, DOI 10.1016/S0959-8049(97)89007-7; Karp SE, 1997, CANCER-AM CANCER SOC, V80, P435, DOI 10.1002/(SICI)1097-0142(19970801)80:3<435::AID-CNCR11>3.0.CO;2-Y; Kauff ND, 2002, J MED GENET, V39, P611, DOI 10.1136/jmg.39.8.611; Kuperstein G, 2000, CLIN GENET, V57, P213, DOI 10.1034/j.1399-0004.2000.570307.x; *MIN HLTH, 1997, ISR CANC REG 1997; Moller P, 2002, INT J CANCER, V101, P555, DOI 10.1002/ijc.10641; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; PARKIN DM, 2000, IARC SCI PUBLICATION, V155; Phelan CM, 2002, HUM MUTAT, V20, P352, DOI 10.1002/humu.10123; RENNERT G, 1999, BREAST CANC SCREENIN; RENNERT G, 1999, INT EP ASS M FLOR IT; Robson ME, 2004, BREAST CANCER RES, V6, pR8, DOI 10.1186/bcr658; Stoppa-Lyonnet D, 2000, J CLIN ONCOL, V18, P4053, DOI 10.1200/JCO.2000.18.24.4053; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Warner E, 1999, J NATL CANCER I, V91, P1241, DOI 10.1093/jnci/91.14.1241	20	233	238	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2007	357	2					115	123		10.1056/NEJMoa070608	http://dx.doi.org/10.1056/NEJMoa070608			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188NX	17625123				2022-12-01	WOS:000247927700005
J	Chevrier, V; Poulet, F; Bibring, JP				Chevrier, Vincent; Poulet, Francois; Bibring, Jean-Pierre			Early geochemical environment of Mars as determined from thermodynamics of phyllosilicates	NATURE			English	Article							MERIDIANI; CLIMATE	Images of geomorphological features that seem to have been produced by the action of liquid water have been considered evidence for wet surface conditions on early Mars(1). Moreover, the recent identification of large deposits of phyllosilicates, associated with the ancient Noachian terrains(2,3) suggests long-timescale weathering(4) of the primary basaltic crust by liquid water(2,5). It has been proposed that a greenhouse effect resulting from a carbon-dioxide-rich atmosphere sustained the temperate climate required to maintain liquid water on the martian surface during the Noachian(6,7). The apparent absence of carbonates and the low escape rates of carbon dioxide(8), however, are indicative of an early martian atmosphere with low levels of carbon dioxide. Here we investigate the geochemical conditions prevailing on the surface of Mars during the Noachian period using calculations of the aqueous equilibria of phyllosilicates. Our results show that Fe3+-rich phyllosilicates probably precipitated under weakly acidic to alkaline pH, an environment different from that of the following period, which was dominated by strongly acid weathering(9) that led to the sulphate deposits identified on Mars(10-12). Thermodynamic calculations demonstrate that the oxidation state of the martian surface was already high, supporting early escape of hydrogen. Finally, equilibrium with carbonates implies that phyllosilicate precipitation occurs preferentially at a very low partial pressure of carbon dioxide. We suggest that the possible absence of Noachian carbonates more probably resulted from low levels of atmospheric carbon dioxide, rather than primary acidic conditions(13). Other greenhouse gases may therefore have played a part in sustaining a warm and wet climate on the early Mars.	Univ Arkansas, WM Keck Lab Space Simulat, Arkansas Ctr Space & Planetary Sci, Fayetteville, AR 72701 USA; Univ Paris Sud, Inst Astrophys Spatiale, F-91405 Orsay, France; CNRS, UMR 8617, F-91405 Orsay, France	University of Arkansas System; University of Arkansas Fayetteville; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay	Chevrier, V (corresponding author), Univ Arkansas, WM Keck Lab Space Simulat, Arkansas Ctr Space & Planetary Sci, MUSE 202, Fayetteville, AR 72701 USA.	vchevrie@uark.edu						Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; Barabash S, 2007, SCIENCE, V315, P501, DOI 10.1126/science.1134358; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Catling DC, 2003, ICARUS, V165, P277, DOI 10.1016/S0019-1035(03)00173-8; Chevrier V, 2004, GEOLOGY, V32, P1033, DOI 10.1130/G21078.1; EGGLETON RA, 1987, CLAY CLAY MINER, V35, P161, DOI 10.1346/CCMN.1987.0350301; Encrenaz T, 2004, ICARUS, V170, P424, DOI 10.1016/j.icarus.2004.05.008; Fairen AG, 2004, NATURE, V431, P423, DOI 10.1038/nature02911; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Glotch TD, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002672; GOODING JL, 1978, ICARUS, V33, P483, DOI 10.1016/0019-1035(78)90186-0; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; Lammer H, 2003, ICARUS, V165, P9, DOI 10.1016/S0019-1035(03)00170-2; Madden MEE, 2004, NATURE, V431, P821, DOI 10.1038/nature02971; Malin MC, 2003, SCIENCE, V302, P1931, DOI 10.1126/science.1090544; Meunier A, 2007, TERRA NOVA, V19, P95, DOI 10.1111/j.1365-3121.2006.00719.x; Naumov MV, 2005, GEOFLUIDS, V5, P165, DOI 10.1111/j.1468-8123.2005.00092.x; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; Sagan C, 1997, SCIENCE, V276, P1217, DOI 10.1126/science.276.5316.1217; Sheldon ND, 2006, PRECAMBRIAN RES, V147, P148, DOI 10.1016/j.precamres.2006.02.004; Sheldon ND, 2002, GEOLOGY, V30, P919, DOI 10.1130/0091-7613(2002)030<0919:LOLIET>2.0.CO;2; Solomon SC, 2005, SCIENCE, V307, P1214, DOI 10.1126/science.1101812; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; Tosca NJ, 2005, EARTH PLANET SC LETT, V240, P122, DOI 10.1016/j.epsl.2005.09.042; Wang A, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002516	29	151	151	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					60	63		10.1038/nature05961	http://dx.doi.org/10.1038/nature05961			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17611538				2022-12-01	WOS:000247720900037
J	Arnesen, H; Lunde, K; Aakhus, S; Forfang, K				Arnesen, Harald; Lunde, Ketil; Aakhus, Svend; Forfang, Kolbjorn			Cell therapy in myocardial infarction	LANCET			English	Editorial Material							LEFT-VENTRICULAR VOLUME; PROGENITOR CELLS; MARROW; REPAIR; TRIAL		Ullevaal Univ Hosp, Dept Cardiol, N-0407 Oslo, Norway; Rikshosp Radiumhosp Univ Hosp, Dept Cardiol, Oslo, Norway	University of Oslo; University of Oslo	Arnesen, H (corresponding author), Ullevaal Univ Hosp, Dept Cardiol, N-0407 Oslo, Norway.	harald.arnesen@ulleval.no						DODGE HT, 1960, AM HEART J, V60, P762, DOI 10.1016/0002-8703(60)90359-8; Grebe O, 2004, Z KARDIOL, V93, P686; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Korbling M, 2003, NEW ENGL J MED, V349, P570, DOI 10.1056/NEJMra022361; LUNDE K, 2006, NO LONG TERM EFFECTS; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; SHEEHAN FH, 1989, AM J CARDIOL, V64, P661, DOI 10.1016/0002-9149(89)90498-0; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C	11	39	46	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 30	2007	369	9580					2142	2143		10.1016/S0140-6736(07)60992-1	http://dx.doi.org/10.1016/S0140-6736(07)60992-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	184LX	17604783				2022-12-01	WOS:000247644200008
J	Ganser-Pornillos, BK; Cheng, A; Yeager, M				Ganser-Pornillos, Barbie K.; Cheng, Anchi; Yeager, Mark			Structure of full-length HIV-1CA: a model for the mature capsid lattice	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ROUS-SARCOMA-VIRUS; AMINO-TERMINAL DOMAIN; ELECTRON-MICROSCOPY; IN-VITRO; DIMERIZATION DOMAIN; CRYSTAL-STRUCTURES; SELF-ASSOCIATION; PROTEIN; RESOLUTION	The capsids of mature retroviruses perform the essential function of organizing the viral genome for efficient replication. These capsids are modeled as fullerene structures composed of closed hexameric arrays of the viral CA protein, but a high-resolution structure of the lattice has remained elusive. A three-dimensional map of two-dimensional crystals of the R18L mutant of HIV-1 CA was derived by electron cryocrystallography. The docking of high-resolution domain structures into the map yielded the first unambiguous model for full-length HIV-1 CA. Three important protein-protein assembly interfaces are required for capsid formation. Each CA hexamer is composed of an inner ring of six N-terminal domains and an outer ring of C-terminal domains that form dimeric linkers connecting neighboring hexamers. Interactions between the two domains of CA further stabilize the hexamer and provide a structural explanation for the mechanism of action of known HIV-1 assembly inhibitors.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Clin, Div Cardiovasc Dis, La Jolla, CA 92037 USA; Univ Virginia Hlth Syst, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	Scripps Research Institute; Scripps Research Institute; University of Virginia	Yeager, M (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yeager@scripps.edu			NCRR NIH HHS [P41 RR17573, P41 RR017573] Funding Source: Medline; NIAID NIH HHS [T32-AI07244] Funding Source: Medline; NIGMS NIH HHS [R01 GM066087] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066087] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Accola MA, 2000, J VIROL, V74, P6198, DOI 10.1128/JVI.74.13.6198-6202.2000; AMOS LA, 1983, PROG BIOPHYS MOL BIO, V39, P183, DOI 10.1016/0079-6107(83)90017-2; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; Bowzard JB, 2001, J VIROL, V75, P6850, DOI 10.1128/JVI.75.15.6850-6856.2001; Briggs JAG, 2006, J MOL BIOL, V355, P157, DOI 10.1016/j.jmb.2005.10.025; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Cheng AC, 2004, ACTA CRYSTALLOGR A, V60, P351, DOI 10.1107/S0108767304010396; COMILESCU CC, 2000, J MOL BIOL, V306, P783; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Gottlinger HG, 2001, AIDS, V15, pS13; Gross I, 1998, J VIROL, V72, P4798, DOI 10.1128/JVI.72.6.4798-4810.1998; Gross I, 2000, EMBO J, V19, P103, DOI 10.1093/emboj/19.1.103; HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; Ivanov D, 2007, P NATL ACAD SCI USA, V104, P4353, DOI 10.1073/pnas.0609477104; Jin ZM, 1999, J MOL BIOL, V286, P83, DOI 10.1006/jmbi.1998.2443; Kelly BN, 2006, BIOCHEMISTRY-US, V45, P11257, DOI 10.1021/bi060927x; Khorasanizadeh S, 1999, J MOL BIOL, V291, P491, DOI 10.1006/jmbi.1999.2986; Kingston RL, 2000, STRUCTURE, V8, P617, DOI 10.1016/S0969-2126(00)00148-9; Kotov A, 1999, J VIROL, V73, P8824, DOI 10.1128/JVI.73.10.8824-8830.1999; Krausslich H.G., 1996, MORPHOGENESIS MATURA; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Lanman J, 2003, J MOL BIOL, V325, P759, DOI 10.1016/S0022-2836(02)01245-7; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Mayo K, 2003, J MOL BIOL, V325, P225, DOI 10.1016/S0022-2836(02)01176-2; Mayo K, 2002, J MOL BIOL, V316, P667, DOI 10.1006/jmbi.2001.5354; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Parker SD, 2001, J VIROL, V75, P9543, DOI 10.1128/JVI.75.19.9543-9548.2001; ROSE S, 1992, PROTEINS, V13, P112, DOI 10.1002/prot.340130204; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang C, 2003, J MOL BIOL, V327, P1013, DOI 10.1016/S0022-2836(03)00289-4; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Tang JH, 2006, J STRUCT BIOL, V154, P59, DOI 10.1016/j.jsb.2005.10.013; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; VALPUESTA JM, 1994, J MOL BIOL, V240, P281, DOI 10.1006/jmbi.1994.1445; Vogt V. M., 1997, P27; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Welker R, 2000, J VIROL, V74, P1168, DOI 10.1128/JVI.74.3.1168-1177.2000; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Yeager M, 1998, P NATL ACAD SCI USA, V95, P7299, DOI 10.1073/pnas.95.13.7299	53	262	273	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 5	2007	131	1					70	79		10.1016/j.cell.2007.08.018	http://dx.doi.org/10.1016/j.cell.2007.08.018			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923088	Bronze			2022-12-01	WOS:000249934700012
J	Liu, QL; Hendrickson, WA				Liu, Qinglian; Hendrickson, Wayne A.			Insights into Hsp70 chaperone activity from a crystal structure of the yeast Hsp110 Sse1	CELL			English	Article							SHOCK COGNATE PROTEIN; NUCLEOTIDE EXCHANGE FACTORS; MOLECULAR CHAPERONE; SUBSTRATE-BINDING; ALLOSTERIC REGULATION; PEPTIDE-BINDING; INTERDOMAIN COMMUNICATION; CONFORMATIONAL-CHANGES; CYTOSOLIC HSP70; ATPASE FRAGMENT	Classic Hsp70 chaperones assist in diverse processes of protein folding and translocation, and Hsp110s had seemed by sequence to be distant relatives within an Hsp70 superfamily. The 2.4 angstrom resolution structure of Sse1 with ATP shows that Hsp110s are indeed Hsp70 relatives, and it provides insight into allosteric coupling between sites for ATP and polypeptidesubstrate binding in Hsp70s. Subdomain structures are similar in intact Sse1( ATP) and in the separate Hsp70 domains, but conformational dispositions are radically different. Interfaces between Sse1 domains are extensive, intimate, and conservative in sequence with Hsp70s. We propose that Sse1( ATP) may be an evolutionary vestige of the Hsp70( ATP) state, and an analysis of 64 mutant variants in Sse1 and three Hsp70 homologs supports this hypothesis. An atomic-level understanding of Hsp70 communication between ATP and substratebinding domains follows. Requirements on Sse1 for yeast viability are in keeping with the distinct function of Hsp110s as nucleotide exchange factors.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Hendrickson, WA (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	wayne@convex.hhmi.columbia.edu			NIGMS NIH HHS [R37 GM034102, R01 GM034102, R01 GM034102-22, R01 GM034102-21, GM34102, R01 GM034102-23] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034102, R37GM034102] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Becker J, 1996, MOL CELL BIOL, V16, P4378; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Burkholder WF, 1996, P NATL ACAD SCI USA, V93, P10632, DOI 10.1073/pnas.93.20.10632; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLAHERTY KM, 1994, J BIOL CHEM, V269, P12899; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hesterkamp T, 1998, EMBO J, V17, P4818, DOI 10.1093/emboj/17.16.4818; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Johnson ER, 1999, BIOCHEMISTRY-US, V38, P10823, DOI 10.1021/bi990816g; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Li JZ, 2006, BIOCHEM J, V398, P353, DOI 10.1042/BJ20060618; Liu QL, 2001, J BIOL CHEM, V276, P6112, DOI 10.1074/jbc.M009519200; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Moro F, 2006, PROTEIN SCI, V15, P223, DOI 10.1110/ps.051732706; Moro F, 2003, FEBS LETT, V533, P119, DOI 10.1016/S0014-5793(02)03752-3; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Revington M, 2005, J MOL BIOL, V349, P163, DOI 10.1016/j.jmb.2005.03.033; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; Shaner L, 2006, BIOCHEMISTRY-US, V45, P15075, DOI 10.1021/bi061279k; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; WILBANKS SM, 1995, BIOCHEMISTRY-US, V34, P12095, DOI 10.1021/bi00038a002; Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200; Yamagishi N, 2004, J BIOL CHEM, V279, P41727, DOI 10.1074/jbc.M407947200; Zhang YB, 2004, P NATL ACAD SCI USA, V101, P10272, DOI 10.1073/pnas.0401313101; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	43	183	187	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 5	2007	131	1					106	120		10.1016/j.cell.2007.08.039	http://dx.doi.org/10.1016/j.cell.2007.08.039			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923091	Bronze, Green Accepted			2022-12-01	WOS:000249934700015
J	Cobaleda, C; Jochum, W; Busslinger, M				Cobaleda, Cesar; Jochum, Wolfram; Busslinger, Meinrad			Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors	NATURE			English	Article							IN-VIVO; GENE REARRANGEMENT; STEM-CELLS; PAX5; MICE; TRANSCRIPTION; RECONSTITUTION; INACTIVATION; MUTAGENESIS; COMMITMENT	Lineage commitment and differentiation to a mature cell type are considered to be unidirectional and irreversible processes under physiological conditions(1). The commitment of haematopoietic progenitors to the B-cell lineage(2,3) and their development to mature B lymphocytes(4,5) critically depend on the transcription factor encoded by the paired box gene 5 (Pax5). Here we show that conditional Pax5 deletion in mice allowed mature B cells from peripheral lymphoid organs to dedifferentiate in vivo back to early uncommitted progenitors in the bone marrow, which rescued T lymphopoiesis in the thymus of T-cell-deficient mice. These B-cell-derived T lymphocytes carried not only immunoglobulin heavy- and light-chain gene rearrangements but also participated as functional T cells in immune reactions. Mice lacking Pax5 in mature B cells also developed aggressive lymphomas, which were identified by their gene expression profile as progenitor cell tumours. Hence, the complete loss of Pax5 in late B cells could initiate lymphoma development and uncovered an extraordinary plasticity of mature peripheral B cells despite their advanced differentiation stage.	Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Hosp, Dept Pathol, CH-8091 Zurich, Switzerland	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Zurich; University Zurich Hospital	Busslinger, M (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	busslinger@imp.ac.at	Cobaleda, Cesar/D-4668-2011; Busslinger, Meinrad J./J-1249-2016	Cobaleda, Cesar/0000-0003-3807-9204; Busslinger, Meinrad J./0000-0002-9111-9351				Batch MJ, 1997, AGT CYTOGENETIC LAB; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Fleischmann A, 2003, CANCER CELL, V4, P477, DOI 10.1016/S1535-6108(03)00280-0; FORSTER I, 1990, P NATL ACAD SCI USA, V87, P4781, DOI 10.1073/pnas.87.12.4781; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Holmes ML, 2006, GENE DEV, V20, P933, DOI 10.1101/gad.1396206; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Sato H, 2004, J IMMUNOL, V172, P4858, DOI 10.4049/jimmunol.172.8.4858; Schaniel C, 2002, BLOOD, V99, P472, DOI 10.1182/blood.V99.2.472; Schaniel C, 2002, BLOOD, V99, P2760, DOI 10.1182/blood.V99.8.2760; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; Schwenk F, 1998, NUCLEIC ACIDS RES, V26, P1427, DOI 10.1093/nar/26.6.1427; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shaw AC, 1999, P NATL ACAD SCI USA, V96, P2239, DOI 10.1073/pnas.96.5.2239; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; SUDO T, 1993, P NATL ACAD SCI USA, V90, P9125, DOI 10.1073/pnas.90.19.9125; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2	40	361	381	0	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 27	2007	449	7161					473	U8		10.1038/nature06159	http://dx.doi.org/10.1038/nature06159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17851532				2022-12-01	WOS:000249724800043
J	Seandel, M; James, D; Shmelkov, SV; Falciatori, I; Kim, J; Chavala, S; Scherr, DS; Zhang, F; Torres, R; Gale, NW; Yancopoulos, GD; Murphy, A; Valenzuela, DM; Hobbs, RM; Pandolfi, PP; Rafii, S				Seandel, Marco; James, Daylon; Shmelkov, Sergey V.; Falciatori, Ilaria; Kim, Jiyeon; Chavala, Sai; Scherr, Douglas S.; Zhang, Fan; Torres, Richard; Gale, Nicholas W.; Yancopoulos, George D.; Murphy, Andrew; Valenzuela, David M.; Hobbs, Robin M.; Pandolfi, Pier Paolo; Rafii, Shahin			Generation of functional multipotent adult stem cells from GPR125(+) germline progenitors	NATURE			English	Article							NEONATAL MOUSE TESTIS; IN-VIVO; PLURIPOTENCY; EXPRESSION; MICE; SPERMATOGENESIS; TRANSPLANTATION; RENEWAL; CULTURE; GENES	Adult mammalian testis is a source of pluripotent stem cells(1). However, the lack of specific surface markers has hampered identification and tracking of the unrecognized subset of germ cells that gives rise to multipotent cells(2). Although embryonic-like cells can be derived from adult testis cultures after only several weeks in vitro(1), it is not known whether adult self-renewing spermatogonia in long-term culture can generate such stem cells as well. Here, we show that highly proliferative adult spermatogonial progenitor cells (SPCs) can be efficiently obtained by cultivation on mitotically inactivated testicular feeders containing CD34(+) stromal cells. SPCs exhibit testicular repopulating activity in vivo and maintain the ability in long-term culture to give rise to multipotent adult spermatogonial-derived stem cells (MASCs). Furthermore, both SPCs and MASCs express GPR125, an orphan adhesion-type G-protein-coupled receptor. In knock-in mice bearing a GPR125-beta-galactosidase (LacZ) fusion protein under control of the native Gpr125 promoter (GPR125-LacZ), expression in the testis was detected exclusively in spermatogonia and not in differentiated germ cells. Primary GPR125-LacZ SPC lines retained GPR125 expression, underwent clonal expansion, maintained the phenotype of germline stem cells, and reconstituted spermatogenesis in busulphan-treated mice. Long-term cultures of GPR125(+) SPCs (GSPCs) also converted into GPR125(+) MASC colonies. GPR125(+) MASCs generated derivatives of the three germ layers and contributed to chimaeric embryos, with concomitant downregulation of GPR125 during differentiation into GPR125(+) cells. MASCs also differentiated into contractile cardiac tissue in vitro and formed functional blood vessels in vivo. Molecular bookmarking by GPR125 in the adult mouse and, ultimately, in the human testis could enrich for a population of SPCs for derivation of GPR125(+) MASCs, which may be employed for genetic manipulation, tissue regeneration and revascularization of ischaemic organs.	Weill Cornell Med Coll, Howard Hughes Med Inst, Dept Med Genet, New York, NY 10065 USA; Weill Cornell Med Coll, Dept Urol, New York, NY 10065 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Canc Ctr, Canc Genet Program, Boston, MA 02115 USA; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, Canc Biol & Genet Program, New York, NY 10065 USA; Mem Sloan Kettering Canc Ctr, Div Med Oncol, Dept Med, New York, NY 10065 USA	Cornell University; Howard Hughes Medical Institute; Cornell University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Regeneron; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Rafii, S (corresponding author), Weill Cornell Med Coll, Howard Hughes Med Inst, Dept Med Genet, New York, NY 10065 USA.	srafii@med.cornell.edu	Mordwinkin, Nicholas M/A-4347-2010; Hobbs, Robin/I-2577-2014; Scherr, Daniel/D-4098-2019	Hobbs, Robin/0000-0002-3853-2614; Scherr, Daniel/0000-0001-5868-5493; Murphy, Andrew/0000-0003-4152-4081	Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [K08 EY021171] Funding Source: Medline; NHLBI NIH HHS [U01 HL066952-020002, R01 HL058707-03, P01 HL059312-060006, R01 HL097797-02, R01 HL097797, P50 HL084936-020003, R21 HL083222, P01 HL059312, R01 HL061849-03, P01 HL067839-040004, U01 HL066952-010002, U01 HL066952-050002, R01 HL061849-02, R01 HL075234-01, R01 HL061849-03S1, U01 HL066952-040002, P50 HL084936-030003, P01 HL059312-080006, R01 HL075234, P01 HL059312-070006, R21 HL083222-01, R21 HL083222-02, P50 HL084936-040003, P50 HL084936-010003, U01 HL066952-030002, P01 HL067839-010004, R01 HL058707-04, P01 HL059312-090006, R01 HL061849-04, P01 HL067839-030004, P50 HL084936, P01 HL067839-020004, P01 HL067839-050004, R01 HL097797-03, P01 HL059312-100006, R01 HL061849-05, R01 HL075234-02, U01 HL066952, R01 HL061849, R01 HL075234-04, R01 HL097797-01, R01 HL075234-03, P01 HL067839] Funding Source: Medline; NATIONAL EYE INSTITUTE [K08EY021171] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075234, P01HL059312, U01HL066952, R01HL058707, R01HL061849, R01HL097797, P01HL067839, R21HL083222, P50HL084936] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baba S, 2007, STEM CELLS, V25, P1375, DOI 10.1634/stemcells.2006-0574; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Ehmcke J, 2006, REPROD FERT DEVELOP, V18, P7, DOI 10.1071/RD05119; ENDERS GC, 1994, DEV BIOL, V163, P331, DOI 10.1006/dbio.1994.1152; FIERING SN, 1991, CYTOMETRY, V12, P291, DOI 10.1002/cyto.990120402; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2006, NAT BIOTECHNOL, V24, P663, DOI 10.1038/nbt0606-663; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kuroda N, 2004, HISTOL HISTOPATHOL, V19, P743, DOI 10.14670/HH-19.743; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Reijo RA, 2000, BIOL REPROD, V63, P1490, DOI 10.1095/biolreprod63.5.1490; Ryu BY, 2004, DEV BIOL, V274, P158, DOI 10.1016/j.ydbio.2004.07.004; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schatten G, 2005, NAT METHODS, V2, P455, DOI 10.1038/nmeth0605-455; Schrans-Stassen BHGJ, 2001, BIOL REPROD, V65, P771, DOI 10.1095/biolreprod65.3.771; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Simon A, 2007, CELL, V128, P825, DOI 10.1016/j.cell.2007.02.026; Sun JF, 2005, P NATL ACAD SCI USA, V102, P128, DOI 10.1073/pnas.0403198102; Tanaka SS, 2000, GENE DEV, V14, P841; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Wang PJ, 2005, HUM MOL GENET, V14, P2911, DOI 10.1093/hmg/ddi322	32	322	350	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2007	449	7160					346	+		10.1038/nature06129	http://dx.doi.org/10.1038/nature06129			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17882221	Green Accepted			2022-12-01	WOS:000249557300046
J	Rosado, CJ; Buckle, AM; Law, RHP; Butcher, RE; Kan, WT; Bird, CH; Ung, K; Browne, KA; Baran, K; Bashtannyk-Puhalovich, TA; Faux, NG; Wong, W; Porter, CJ; Pike, RN; Ellisdon, AM; Pearce, MC; Bottomley, SP; Emsley, J; Smith, AI; Rossjohn, J; Hartland, EL; Voskoboinik, I; Trapani, JA; Bird, PI; Dunstone, MA; Whisstock, JC				Rosado, Carlos J.; Buckle, Ashley M.; Law, Ruby H. P.; Butcher, Rebecca E.; Kan, Wan-Ting; Bird, Catherina H.; Ung, Kheng; Browne, Kylie A.; Baran, Katherine; Bashtannyk-Puhalovich, Tanya A.; Faux, Noel G.; Wong, Wilson; Porter, Corrine J.; Pike, Robert N.; Ellisdon, Andrew M.; Pearce, Mary C.; Bottomley, Stephen P.; Emsley, Jonas; Smith, A. Ian; Rossjohn, Jamie; Hartland, Elizabeth L.; Voskoboinik, Ilia; Trapani, Joseph A.; Bird, Phillip I.; Dunstone, Michelle A.; Whisstock, James C.			A common fold mediates vertebrate defense and bacterial attack	SCIENCE			English	Article							HUMAN-COMPLEMENT; PORE FORMATION; 9TH COMPONENT; CELL-DEATH; PERFORIN; PROTEIN; APOPTOSIS; PNEUMOLYSIN; INDUCTION; MECHANISM	Proteins containing membrane attack complex/perforin (MACPF) domains play important roles in vertebrate immunity, embryonic development, and neural-cell migration. In vertebrates, the ninth component of complement and perforin form oligomeric pores that lyse bacteria and kill virus-infected cells, respectively. However, the mechanism of MACPF function is unknown. We determined the crystal structure of a bacterial MACPF protein, Plu-MACPF from Photorhabdus luminescens, to 2.0 angstrom resolution. The MACPF domain reveals structural similarity with pore-forming cholesterol-dependent cytolysins (CDCs) from Gram-positive bacteria. This suggests that lytic MACPF proteins may use a CDC-like mechanism to form pores and disrupt cell membranes. Sequence similarity between bacterial and vertebrate MACPF domains suggests that the fold of the CDCs, a family of proteins important for bacterial pathogenesis, is probably used by vertebrates for defense against infection.	Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; Natl Inst Med Res, Div Virol, Ridgeway, London NW7 1AA, England; Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3002, Australia; Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England; Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; Univ Melbourne, Dept Genet, Parkville, Vic 3010, Australia; Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia	Monash University; Monash University; Peter Maccallum Cancer Center; University of Nottingham; Monash University; University of Melbourne; University of Melbourne	Dunstone, MA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	michelle.dunstone@med.monash.edu.au; whisstock@med.monash.edu.au	Faux, Noel/C-4423-2011; Buckle, Ashley/P-8366-2016; Rossjohn, Jamie/F-9032-2013; emsley, jonas/A-8509-2016; Dunstone, Michelle/I-2895-2014; Hartland, Elizabeth/O-2569-2014	Faux, Noel/0000-0003-4594-8818; Buckle, Ashley/0000-0003-2943-9044; Rossjohn, Jamie/0000-0002-2020-7522; emsley, jonas/0000-0002-8949-8030; Voskoboinik, Ilia/0000-0002-6410-009X; Ellisdon, Andrew/0000-0002-2248-9914; Smith, Ian/0000-0002-4143-2892; Wong, Wilson/0000-0003-1335-8047; Dunstone, Michelle/0000-0002-6026-648X; law, ruby/0000-0001-5432-5781; Hartland, Elizabeth/0000-0003-4254-2863; Whisstock, James/0000-0003-4200-5611; Pike, Robert/0000-0002-2083-0269; Bird, Phillip/0000-0002-6695-606X; Trapani, Joseph/0000-0003-0983-1532				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; CHEN G, 1995, J EXP MED, V181, P2295, DOI 10.1084/jem.181.6.2295; DiScipio RG, 1999, MOL IMMUNOL, V36, P575, DOI 10.1016/S0161-5890(99)00073-5; Gilbert RJC, 1999, CELL, V97, P647, DOI 10.1016/S0092-8674(00)80775-8; Haag ES, 1999, DEV BIOL, V211, P77, DOI 10.1006/dbio.1999.9283; Huang Y, 2006, J BIOL CHEM, V281, P27398, DOI 10.1074/jbc.M603690200; Kadota K, 2004, P NATL ACAD SCI USA, V101, P16310, DOI 10.1073/pnas.0406187101; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; LI JD, 1991, NATURE, V353, P815, DOI 10.1038/353815a0; LICHTENHELD MG, 1988, NATURE, V335, P448, DOI 10.1038/335448a0; LOCKERT DH, 1995, J BIOL CHEM, V270, P19723, DOI 10.1074/jbc.270.34.19723; MARTIN JR, 1994, NATURE, V367, P741, DOI 10.1038/367741a0; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Murzin AG, 1998, CURR OPIN STRUC BIOL, V8, P380, DOI 10.1016/S0959-440X(98)80073-0; PEITSCH MC, 1990, MOL IMMUNOL, V27, P589, DOI 10.1016/0161-5890(90)90001-G; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; Ponting CP, 1999, CURR BIOL, V9, pR911, DOI 10.1016/S0960-9822(00)80102-5; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; SHINKAI Y, 1988, NATURE, V334, P525, DOI 10.1038/334525a0; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Trambas C, 2005, BLOOD, V106, P932, DOI 10.1182/blood-2004-09-3713; Trapani JA, 1998, INT REV CYTOL, V182, P111, DOI 10.1016/S0074-7696(08)62169-5; TSCHOPP J, 1986, NATURE, V322, P831, DOI 10.1038/322831a0; Voskoboinik I, 2005, BLOOD, V105, P4700, DOI 10.1182/blood-2004-12-4935; Voskoboinik I, 2007, BLOOD, V110, P1184, DOI 10.1182/blood-2007-02-072850; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Zheng C, 1996, SCIENCE, V272, P417, DOI 10.1126/science.272.5260.417	29	213	225	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2007	317	5844					1548	1551		10.1126/science.1144706	http://dx.doi.org/10.1126/science.1144706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17717151				2022-12-01	WOS:000249467900041
J	Oliveira, PJC; Asner, GP; Knapp, DE; Almeyda, A; Galvan-Gildemeister, R; Keene, S; Raybin, RF; Smith, RC				Oliveira, Paulo J. C.; Asner, Gregory P.; Knapp, David E.; Almeyda, Angelica; Galvan-Gildemeister, Ricardo; Keene, Sam; Raybin, Rebecca F.; Smith, Richard C.			Land-use allocation protects the Peruvian Amazon	SCIENCE			English	Article							BRAZILIAN AMAZON; RAIN-FOREST; DEFORESTATION; BIODIVERSITY; CONSERVATION; DYNAMICS; BASIN; FIRE	Disturbance and deforestation have profound ecological and socioeconomic effects on tropical forests, but their diffuse patterns are difficult to detect and quantify at regional scales. We expanded the Carnegie forest damage detection system to show that, between 1999 and 2005, disturbance and deforestation rates throughout the Peruvian Amazon averaged 632 square kilometers per year and 645 square kilometers per year, respectively. However, only 1 to 2% occurred within natural protected areas, indigenous territories contained only 11% of the forest disturbances and 9% of the deforestation, and recent forest concessions effectively protected against clear-cutting. Although the region shows recent increases in disturbance and deforestation rates and leakage into forests surrounding concession areas, land-use policy and remoteness are serving to protect the Peruvian Amazon.	Carnegie Inst Washington, Dept Global Ecol, Stanford, CA 94305 USA; Stanford Univ, Dept Anthropol Sci, Stanford, CA 94305 USA; Inst Bien Comun, Lima 18, Peru; Boston Univ, Dept Elect & Comp Engn, Boston, MA 02215 USA	Carnegie Institution for Science; Stanford University; Boston University	Asner, GP (corresponding author), Carnegie Inst Washington, Dept Global Ecol, Stanford, CA 94305 USA.	gpa@stanford.edu	Zambrano, Angelica Almeyda/Q-4758-2017; Asner, Gregory/G-9268-2013	Zambrano, Angelica Almeyda/0000-0001-5081-9936; Asner, Gregory/0000-0001-7893-6421; Oliveira, Paulo/0000-0002-4071-3924				Alvarez NL, 2003, AMBIO, V32, P269, DOI 10.1639/0044-7447(2003)032[0269:LNAPTD]2.0.CO;2; Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Asner GP, 2004, GLOBAL CHANGE BIOL, V10, P765, DOI 10.1111/j.1529-8817.2003.00756.x; Asner GP, 2005, EARTH INTERACT, V9, DOI 10.1175/EI134.1; Asner GP, 2006, P NATL ACAD SCI USA, V103, P12947, DOI 10.1073/pnas.0604093103; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; *CONAM INRENA, 2005, IM0302 CONAM INRENA, V1; Curran LM, 2006, P NATL ACAD SCI USA, V103, P12663, DOI 10.1073/pnas.0605449103; DINERSTEIN E, 1995, CONSERVATION ASSESSM; FAO, 2006, 147 FAO; *FAO, 2006, 201 FAO PER INF NAC; Foley JA, 2007, FRONT ECOL ENVIRON, V5, P25, DOI 10.1890/1540-9295(2007)5[25:ARFDAL]2.0.CO;2; GENTRY AH, 1992, OIKOS, V63, P19, DOI 10.2307/3545512; GRACE J, 1995, SCIENCE, V270, P778, DOI 10.1126/science.270.5237.778; Holdsworth AR, 1997, ECOL APPL, V7, P713, DOI 10.1890/1051-0761(1997)007[0713:FIASLR]2.0.CO;2; Imbernon J, 1999, AMBIO, V28, P509; *INRENA, 2003, PER FOR NUM 2002; Maki S, 2001, ENVIRON CONSERV, V28, P199, DOI 10.1017/S0376892901000212; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad D, 2002, SCIENCE, V295, P629, DOI 10.1126/science.1067053; SHUKLA J, 1990, SCIENCE, V247, P1322, DOI 10.1126/science.247.4948.1322; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; *SZF CDC UNALM, 2006, HAC SIST MON AMB REM, V5; Werth D, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000717	24	236	248	5	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2007	317	5842					1233	1236		10.1126/science.1146324	http://dx.doi.org/10.1126/science.1146324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205PJ	17690260				2022-12-01	WOS:000249126800044
J	Frazer, KA; Eskin, E; Kang, HM; Bogue, MA; Hinds, DA; Beilharz, EJ; Gupta, RV; Montgomery, J; Morenzoni, MM; Nilsen, GB; Pethiyagoda, CL; Stuve, LL; Johnson, FM; Daly, MJ; Wade, CM; Cox, DR				Frazer, Kelly A.; Eskin, Eleazar; Kang, Hyun Min; Bogue, Molly A.; Hinds, David A.; Beilharz, Erica J.; Gupta, Robert V.; Montgomery, Julie; Morenzoni, Matt M.; Nilsen, Geoffrey B.; Pethiyagoda, Charit L.; Stuve, Laura L.; Johnson, Frank M.; Daly, Mark J.; Wade, Claire M.; Cox, David R.			A sequence-based variation map of 8.27 million SNPs in inbred mouse strains	NATURE			English	Article							HAPLOTYPE DIVERSITY; GENETIC-VARIATION; PHENOME PROJECT; LABORATORY MICE; GENOME; PATTERNS; DATABASE; REVEALS; SYSTEM	A dense map of genetic variation in the laboratory mouse genome will provide insights into the evolutionary history of the species(1) and lead to an improved understanding of the relationship between inter-strain genotypic and phenotypic differences. Here we resequence the genomes of four wild-derived and eleven classical strains. We identify 8.27 million high-quality single nucleotide polymorphisms (SNPs) densely distributed across the genome, and determine the locations of the high (divergent subspecies ancestry) and low (common subspecies ancestry) SNP-rate intervals(2-6) for every pairwise combination of classical strains. Using these data, we generate a genome-wide haplotype map containing 40,898 segments, each with an average of three distinct ancestral haplotypes. For the haplotypes in the classical strains that are unequivocally assigned ancestry, the genetic contributions of the Mus musculus subspecies-M. m. domesticus, M. m. musculus, M. m. castaneus and the hybrid M. m. molossinus-are 68%, 6%, 3% and 10%, respectively; the remaining 13% of haplotypes are of unknown ancestral origin. The considerable regional redundancy of the SNP data will facilitate imputation of the majority of these genotypes in less-densely typed classical inbred strains to provide a complete view of variation in additional strains.	Perlegen Sci, Mountain View, CA 94043 USA; Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; Jackson Lab, Bar Harbor, ME 04609 USA; NIEHS, Toxicol Operat Branch, Res Triangle Pk, NC 27709 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego; Jackson Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Frazer, KA (corresponding author), Perlegen Sci, 2021 Stierlin Court, Mountain View, CA 94043 USA.	frazer.kelly@scrippshealth.org	Eskin, Eleazar/J-9187-2012; Daly, Mark J/B-2453-2017	Eskin, Eleazar/0000-0003-1149-4758; Daly, Mark J/0000-0002-0949-8752; Hinds, David/0000-0002-4911-803X; Frazer, Kelly/0000-0002-6060-8902; Wade, Claire/0000-0003-3413-4771	NHLBI NIH HHS [K25 HL080079] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL080079] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bogue M, 2003, J APPL PHYSIOL, V95, P1335, DOI 10.1152/japplphysiol.00562.2003; Bogue MA, 2004, GENETICA, V122, P71, DOI 10.1007/s10709-004-1438-4; BONHOMME F, 1987, BIOL J LINN SOC, V30, P51, DOI 10.1111/j.1095-8312.1987.tb00288.x; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Frazer KA, 2004, GENOME RES, V14, P1493, DOI 10.1101/gr.2627804; Grubb SC, 2004, BIOINFORMATICS, V20, P2857, DOI 10.1093/bioinformatics/bth299; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Ideraabdullah FY, 2004, GENOME RES, V14, P1880, DOI 10.1101/gr.2519704; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; NAKAMURA M, 1962, P JPN ACAD, V38, P348, DOI 10.2183/pjab1945.38.348; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Silver L.M., 1995, MOUSE GENETICS CONCE; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Wade CM, 2005, NAT GENET, V37, P1175, DOI 10.1038/ng1666; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wahlsten D, 2003, BRAIN RES, V971, P47, DOI 10.1016/S0006-8993(03)02354-0; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100; Yalcin B, 2004, P NATL ACAD SCI USA, V101, P9734, DOI 10.1073/pnas.0401189101; Zhang JH, 2005, GENOME RES, V15, P241, DOI 10.1101/gr.2901705	26	346	359	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2007	448	7157					1050	U8		10.1038/nature06067	http://dx.doi.org/10.1038/nature06067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205EU	17660834				2022-12-01	WOS:000249097600038
J	Hattori, M; Tanaka, Y; Fukai, S; Ishitani, R; Nureki, O				Hattori, Motoyuki; Tanaka, Yoshiki; Fukai, Shuya; Ishitani, Ryuichiro; Nureki, Osamu			Crystal structure of the MgtE Mg2+ transporter	NATURE			English	Article							RAY DIFFRACTION ANALYSIS; HUMAN SOLUTE CARRIER; MAGNESIUM TRANSPORT; FUNCTIONAL-CHARACTERIZATION; PROTEIN; CORA; CHANNEL; CLONING; CRYSTALLIZATION; SLC41A1	The magnesium ion Mg2+ is a vital element involved in numerous physiological processes. Mg2+ has the largest hydrated radius among all cations, whereas its ionic radius is the smallest. It remains obscure how Mg2+ transporters selectively recognize and dehydrate the large, fully hydrated Mg2+ cation for transport(1). Recently the crystal structures of the CorA Mg2+ transporter(2-5) were reported(6-8). The MgtE family of Mg2+ transporters is ubiquitously distributed in all phylogenetic domains(9-11), and human homologues have been functionally characterized and suggested to be involved in magnesium homeostasis(12-14). However, the MgtE transporters have not been thoroughly characterized. Here we determine the crystal structures of the full-length Thermus thermophilus MgtE at 3.5 angstrom resolution, and of the cytosolic domain in the presence and absence of Mg2+ at 2.3 angstrom and 3.9 angstrom resolutions, respectively. The transporter adopts a homodimeric architecture, consisting of the carboxy-terminal five transmembrane domains and the amino-terminal cytosolic domains, which are composed of the superhelical N domain and tandemly repeated cystathionine-beta-synthase domains. A solvent-accessible pore nearly traverses the transmembrane domains, with one potential Mg2+ bound to the conserved Asp 432 within the pore. The transmembrane (TM)5 helices from both subunits close the pore through interactions with the 'connecting helices', which connect the cystathionine-beta-synthase and transmembrane domains. Four putative Mg2+ ions are bound at the interface between the connecting helices and the other domains, and this may lock the closed conformation of the pore. A structural comparison of the two states of the cytosolic domains showed the Mg2+-dependent movement of the connecting helices, which might reorganize the transmembrane helices to open the pore. These findings suggest a homeostasis mechanism, in which Mg2+ bound between cytosolic domains regulates Mg2+ flux by sensing the intracellular Mg2+ concentration. Whether this presumed regulation controls gating of an ion channel or opening of a secondary active transporter remains to be determined.	Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Kanagawa 2268501, Japan; Tokyo Inst Technol, Ctr Biol Resources & Informat, Midori Ku, Kanagawa 2268501, Japan; SORST, JST, Kawaguchi, Saitama 3320012, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Nureki, O (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, 4259 Nagatsuta Cho, Kanagawa 2268501, Japan.	nureki@bio.titech.ac.jp	Fukai, Shuya/X-4838-2018; NUREKI, OSAMU/G-4960-2014; Hattori, Motoyuki/B-6069-2014	Fukai, Shuya/0000-0002-1241-1443; Hattori, Motoyuki/0000-0002-5327-5337; Tanaka, Yoshiki/0000-0001-6960-5276				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bennetts B, 2005, J BIOL CHEM, V280, P32452, DOI 10.1074/jbc.M502890200; Biemans-Oldehinkel E, 2006, P NATL ACAD SCI USA, V103, P10624, DOI 10.1073/pnas.0603871103; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; Goytain A, 2005, PHYSIOL GENOMICS, V21, P337, DOI 10.1152/physiolgenomics.00261.2004; Goytain A, 2005, BIOCHEM BIOPH RES CO, V330, P701, DOI 10.1016/j.bbrc.2005.03.037; Hattori M, 2007, ACTA CRYSTALLOGR F, V63, P682, DOI 10.1107/S1744309107032332; HMIEL SP, 1986, J BACTERIOL, V168, P1444, DOI 10.1128/jb.168.3.1444-1450.1986; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; ISHITANI R, 2006, CUEMOL MOL VISUALIZA; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kehres DG, 2002, BIOMETALS, V15, P261, DOI 10.1023/A:1016078832697; Kowal P, 2007, J BIOL CHEM, V282, P2047, DOI 10.1074/jbc.M608356200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Maguire ME, 2006, FRONT BIOSCI-LANDMRK, V11, P3149, DOI 10.2741/2039; NELSON DL, 1971, J BIOL CHEM, V246, P3042; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Payandeh J, 2006, EMBO J, V25, P3762, DOI 10.1038/sj.emboj.7601269; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Sahni J, 2007, BIOCHEM J, V401, P505, DOI 10.1042/BJ20060673; SMITH RL, 1995, J BACTERIOL, V177, P1233, DOI 10.1128/jb.177.5.1233-1238.1995; Tanaka Y, 2007, ACTA CRYSTALLOGR F, V63, P678, DOI 10.1107/S1744309107032344; Tieleman DP, 2001, PROTEINS, V44, P63, DOI 10.1002/prot.1073; TOWNSEND DE, 1995, J BACTERIOL, V177, P5350, DOI 10.1128/jb.177.18.5350-5354.1995; Wabakken T, 2003, BIOCHEM BIOPH RES CO, V306, P718, DOI 10.1016/S0006-291X(03)01030-1; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504	34	143	147	5	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2007	448	7157					1072	U13		10.1038/nature06093	http://dx.doi.org/10.1038/nature06093			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205EU	17700703				2022-12-01	WOS:000249097600043
J	Wiesner, S; Ogunjimi, AA; Wang, HR; Rotin, D; Sicheri, F; Wrana, JL; Forman-Kay, JD				Wiesner, Silke; Ogunjimi, Abiodun A.; Wang, Hong-Rui; Rotin, Daniela; Sicheri, Frank; Wrana, Jeffrey L.; Forman-Kay, Julie D.			Autoinhibition of the HECT-Type ubiquitin ligase smurf2 through its c2 domain	CELL			English	Article							EPITHELIAL NA+ CHANNEL; TGF-BETA RECEPTOR; PROTEIN LIGASE; HUMAN NEDD4; DEGRADATION; POLARITY; PATHWAY; TARGETS; SMAD7; FAMILY	Ubiquitination of proteins is an abundant modification that controls numerous cellular processes. Many Ubiquitin ( Ub) protein ligases ( E3s) target both their substrates and themselves for degradation. However, the mechanisms regulating their catalytic activity are largely unknown. The C2-WW-HECT-domain E3 Smurf2 downregulates transforming growth factor-beta ( TGF-beta) signaling by targeting itself, the adaptor protein Smad7, and TGF-beta receptor kinases for degradation. Here, we demonstrate that an intramolecular interaction between the C2 and HECT domains inhibits Smurf2 activity, stabilizes Smurf2 levels in cells, and similarly inhibits certain other C2-WW-HECT-domain E3s. Using NMR analysis the C2 domain was shown to bind in the vicinity of the catalytic cysteine, where it interferes with Ub thioester formation. The HECT-binding domain of Smad7, which activates Smurf2, antagonizes this inhibitory interaction. Thus, interactions between C2 and HECT domains autoinhibit a subset of HECT-type E3s to protect them and their substrates from futile degradation in cells.	Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Wiesner, S (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	silke@pound.med.utoronto.ca; wrana@mshri.on.ca; forman@sickkids.ca	Sicheri, Frank/F-8856-2013; Wrana, Jeffrey/F-8857-2013	Wiesner, Silke/0000-0003-0015-0167; Forman-Kay, Julie/0000-0001-8265-972X; Wang, Hong-Rui/0000-0002-2916-8849				Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Chong PA, 2006, J BIOL CHEM, V281, P17069, DOI 10.1074/jbc.M601493200; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Kamynina E, 2001, AM J PHYSIOL-RENAL, V281, pF469, DOI 10.1152/ajprenal.2001.281.3.F469; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Snyder PM, 2001, J BIOL CHEM, V276, P28321, DOI 10.1074/jbc.M011487200; Springael JY, 1999, BIOCHEM BIOPH RES CO, V257, P561, DOI 10.1006/bbrc.1999.0505; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Ubach J, 1999, NAT CELL BIOL, V1, P106, DOI 10.1038/10076; Wang GL, 2001, MOL CELL BIOL, V21, P3564, DOI 10.1128/MCB.21.10.3564-3575.2001; Wang HR, 2006, METHOD ENZYMOL, V406, P437, DOI 10.1016/S0076-6879(06)06032-0; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	30	205	215	1	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 24	2007	130	4					651	662		10.1016/j.cell.2007.06.050	http://dx.doi.org/10.1016/j.cell.2007.06.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	208KY	17719543	Bronze			2022-12-01	WOS:000249319400016
J	Soda, M; Choi, YL; Enomoto, M; Takada, S; Yamashita, Y; Ishikawa, S; Fujiwara, SI; Watanabe, H; Kurashina, K; Hatanaka, H; Bando, M; Ohno, S; Ishikawa, Y; Aburatani, H; Niki, T; Sohara, Y; Sugiyama, Y; Mano, H				Soda, Manabu; Choi, Young Lim; Enomoto, Munehiro; Takada, Shuji; Yamashita, Yoshihiro; Ishikawa, Shunpei; Fujiwara, Shin-ichiro; Watanabe, Hideki; Kurashina, Kentaro; Hatanaka, Hisashi; Bando, Masashi; Ohno, Shoji; Ishikawa, Yuichi; Aburatani, Hiroyuki; Niki, Toshiro; Sohara, Yasunori; Sugiyama, Yukihiko; Mano, Hiroyuki			Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer	NATURE			English	Article							ANAPLASTIC LYMPHOMA KINASE; TYROSINE KINASE; FACTOR-RECEPTOR; ALK; MUTATIONS; GEFITINIB; TRANSLOCATIONS; PROLIFERATION; INHIBITOR; COMMON	Improvement in the clinical outcome of lung cancer is likely to be achieved by identification of the molecular events that underlie its pathogenesis. Here we show that a small inversion within chromosome 2p results in the formation of a fusion gene comprising portions of the echinoderm microtubule-associated protein-like 4 (EML4) gene and the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer (NSCLC) cells. Mouse 3T3 fibroblasts forced to express this human fusion tyrosine kinase generated transformed foci in culture and subcutaneous tumours in nude mice. The EML4-ALK fusion transcript was detected in 6.7% (5 out of 75) of NSCLC patients examined; these individuals were distinct from those harbouring mutations in the epidermal growth factor receptor gene. Our data demonstrate that a subset of NSCLC patients may express a transforming fusion kinase that is a promising candidate for a therapeutic target as well as for a diagnostic molecular marker in NSCLC.	Jichi Med Univ, Div Funct Genom, Tochigi 3290498, Japan; Jichi Med Univ, Div Pulm Med, Tochigi 3290498, Japan; Jichi Med Univ, Dept Pathol, Tochigi 3290498, Japan; Jichi Med Univ, Div Gen Thorac Surg, Tochigi 3290498, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan; Japanese Fdn Canc Res, Inst Canc, Tokyo 1358550, Japan; Japan Sci & Technol Agcy, CREST, Saitama 3320012, Japan	Jichi Medical University; Jichi Medical University; Jichi Medical University; Jichi Medical University; University of Tokyo; Japanese Foundation for Cancer Research; Japan Science & Technology Agency (JST)	Mano, H (corresponding author), Jichi Med Univ, Div Funct Genom, Tochigi 3290498, Japan.	hmano@jichi.ac.jp	niki, toshiro/K-8917-2012; Fujiwara, Shin-ichiro/ABH-2030-2020	Fujiwara, Shin-ichiro/0000-0002-4523-2994; Takada, Shuji/0000-0002-9406-4683				Choi YL, 2007, LEUKEMIA RES, V31, P203, DOI 10.1016/j.leukres.2006.05.006; Donella-Deana A, 2005, BIOCHEMISTRY-US, V44, P8533, DOI 10.1021/bi0472954; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Duyster J, 2001, ONCOGENE, V20, P5623, DOI 10.1038/sj.onc.1204594; Eichenmuller B, 2002, J BIOL CHEM, V277, P1301, DOI 10.1074/jbc.M106628200; Fujiwara S, 2005, BIOCHEM BIOPH RES CO, V338, P1256, DOI 10.1016/j.bbrc.2005.10.080; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Hatanaka H, 2007, BIOCHEM BIOPH RES CO, V356, P723, DOI 10.1016/j.bbrc.2007.03.048; Hernandez L, 2002, AM J PATHOL, V160, P1487, DOI 10.1016/S0002-9440(10)62574-6; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kaul KL, 2001, CLIN CHEM, V47, P1553; Li RS, 2006, J MED CHEM, V49, P1006, DOI 10.1021/jm050824x; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marzec M, 2005, LAB INVEST, V85, P1544, DOI 10.1038/labinvest.3700348; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Onishi M, 1996, EXP HEMATOL, V24, P324; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pollmann M, 2006, EXP CELL RES, V312, P3241, DOI 10.1016/j.yexcr.2006.06.035; Pulford K, 2004, J CELL PHYSIOL, V199, P330, DOI 10.1002/jcp.10472; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; SHIOTA M, 1994, ONCOGENE, V9, P1567; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Watanabe S, 1996, J BIOL CHEM, V271, P12681, DOI 10.1074/jbc.271.21.12681; Yamashita Y, 2001, J BIOL CHEM, V276, P39012, DOI 10.1074/jbc.M106249200; Yoshizuka N, 2004, J BIOL CHEM, V279, P43998, DOI 10.1074/jbc.M406082200	27	3809	4144	13	351	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2007	448	7153					561	U3		10.1038/nature05945	http://dx.doi.org/10.1038/nature05945			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17625570				2022-12-01	WOS:000248446700036
J	Hamilton, GL; Kang, EJ; Mba, M; Toste, FD				Hamilton, Gregory L.; Kang, Eun Joo; Mba, Miriam; Toste, F. Dean			A powerful chiral counterion strategy for asymmetric transition metal catalysis	SCIENCE			English	Article							GOLD; HYDROGENATION; CYCLIZATION; COMPLEXES	Traditionally, transition metal-catalyzed enantioselective transformations rely on chiral ligands tightly bound to the metal to induce asymmetric product distributions. Here we report high enantioselectivities conferred by a chiral counterion in a metal-catalyzed reaction. Two different transformations catalyzed by cationic gold( I) complexes generated products in 90 to 99% enantiomeric excess with the use of chiral binaphthol-derived phosphate anions. Furthermore, we show that the chiral counterion can be combined additively with chiral ligands to enable an asymmetric transformation that cannot be achieved by either method alone. This concept of relaying chiral information via an ion pair should be applicable to a vast number of metal-mediated processes.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Toste, FD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	fdtoste@berkeley.edu	Toste, F. Dean/Y-2556-2019; Kang, Eun/AAK-7225-2020	Toste, F. Dean/0000-0001-8018-2198; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073932] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM073932] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akiyama T, 2006, ADV SYNTH CATAL, V348, P999, DOI 10.1002/adsc.200606074; Bates RW, 2002, CHEM SOC REV, V31, P12, DOI 10.1039/b103904k; Connon SJ, 2006, ANGEW CHEM INT EDIT, V45, P3909, DOI 10.1002/anie.200600529; Dorta R, 2004, J ORGANOMET CHEM, V689, P751, DOI 10.1016/j.jorganchem.2003.12.012; Gonzalez-Arellano C, 2005, CHEM COMMUN, P3451, DOI 10.1039/b505271h; Gorin DJ, 2007, NATURE, V446, P395, DOI 10.1038/nature05592; Hashmi ASK, 2006, ANGEW CHEM INT EDIT, V45, P7896, DOI 10.1002/anie.200602454; ITO Y, 1986, J AM CHEM SOC, V108, P6405, DOI 10.1021/ja00280a056; Jimenez-Nunez E, 2007, CHEM COMMUN, P333, DOI 10.1039/b612008c; Johansson MJ, 2005, J AM CHEM SOC, V127, P18002, DOI 10.1021/ja0552500; Lacour J, 2003, CHEM SOC REV, V32, P373, DOI 10.1039/b205251m; LaLonde RL, 2007, J AM CHEM SOC, V129, P2452, DOI 10.1021/ja068819l; Lelais G, 2006, ALDRICHIM ACTA, V39, P79; Liu C, 2007, ORG LETT, V9, P1935, DOI 10.1021/ol070483c; Llewellyn DB, 2005, TETRAHEDRON-ASYMMETR, V16, P1789, DOI 10.1016/j.tetasy.2005.04.004; Llewellyn DB, 2000, ORG LETT, V2, P4165, DOI 10.1021/ol000303y; Martin NJA, 2006, J AM CHEM SOC, V128, P13368, DOI 10.1021/ja065708d; Mayer S, 2006, ANGEW CHEM INT EDIT, V45, P4193, DOI 10.1002/anie.200600512; Mulzer J., 1999, COMPREHENSIVE ASYMME, V1; Munoz MP, 2005, ORGANOMETALLICS, V24, P1293, DOI 10.1021/om0491645; O'Donnell M.J., 2000, CATALYTIC ASYMMETRIC, P727; Taylor MS, 2006, ANGEW CHEM INT EDIT, V45, P1520, DOI 10.1002/anie.200503132; Zhang LM, 2006, ADV SYNTH CATAL, V348, P2271, DOI 10.1002/adsc.200600368; Zhang ZB, 2007, ANGEW CHEM INT EDIT, V46, P283, DOI 10.1002/anie.200603260	24	697	699	9	253	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					496	499		10.1126/science.1145229	http://dx.doi.org/10.1126/science.1145229			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	194JD	17656720				2022-12-01	WOS:000248339800040
J	Weart, RB; Lee, AH; Chien, AC; Haeusser, DP; Hill, NS; Levin, PA				Weart, Richard B.; Lee, Amy H.; Chien, An-Chun; Haeusser, Daniel P.; Hill, Norbert S.; Levin, Petra Anne			A metabolic sensor governing cell size in bacteria	CELL			English	Article							CHROMOSOME SEGREGATION; DIVISION PROTEIN; FTSZ; GROWTH; REPLICATION; INITIATION; LENGTH; PHOSPHOGLUCOMUTASE; IDENTIFICATION; LOCALIZATION	Nutrient availability is one of the strongest determinants of cell size. When grown in rich media, single-celled organisms such as yeast and bacteria can be up to twice the size of their slow-growing counterparts. The ability to modulate size in a nutrient-dependent manner requires cells to: (1) detect when they have reached the appropriate mass for a given growth rate and (2) transmit this information to the division apparatus. We report the identification of a metabolic sensor that couples nutritional availability to division in Bacillus subtilis. A key component of this sensor is an effector, UgtP, which localizes to the division site in a nutrient-dependent manner and inhibits assembly of the tubulin-like cell division protein FtsZ. This sensor serves to maintain a constant ratio of FtsZ rings to cell length regardless of growth rate and ensures that cells reach the appropriate mass and complete chromosome segregation prior to cytokinesis.	Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Levin, PA (corresponding author), Washington Univ, Dept Biol, St Louis, MO 63130 USA.	plevin@biology.wustl.edu	Lee, Amy Huei-Yi/K-3896-2019	Lee, Amy Huei-Yi/0000-0003-3250-3246; Hill, Norbert/0000-0002-4719-2893; Levin, Petra/0000-0003-2071-0547	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064671] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM64671, R01 GM064671-01A1, R01 GM064671-02, R01 GM064671, R01 GM064671-05, R01 GM064671-03, R01 GM064671-04] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Britton RA, 1999, J BACTERIOL, V181, P5860, DOI 10.1128/JB.181.18.5860-5864.1999; Cao M, 2004, J BACTERIOL, V186, P1136, DOI 10.1128/JB.186.4.1136-1146.2004; Chivers PT, 1999, PROTEIN SCI, V8, P2494, DOI 10.1110/ps.8.11.2494; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Den Blaauwen T, 1999, J BACTERIOL, V181, P5167, DOI 10.1128/JB.181.17.5167-5175.1999; DONACHIE WD, 1989, J BACTERIOL, V171, P4633, DOI 10.1128/jb.171.9.4633-4639.1989; FANTES P, 1977, EXP CELL RES, V107, P377, DOI 10.1016/0014-4827(77)90359-7; Feucht A, 2001, MOL MICROBIOL, V40, P115, DOI 10.1046/j.1365-2958.2001.02356.x; Haeusser DP, 2004, MOL MICROBIOL, V52, P801, DOI 10.1111/j.1365-2958.2004.04016.x; Hardy CD, 2005, MOL MICROBIOL, V57, P1636, DOI 10.1111/j.1365-2958.2005.04799.x; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; JAACKS KJ, 1989, J BACTERIOL, V171, P4121, DOI 10.1128/JB.171.8.4121-4129.1989; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Lazarevic V, 2005, APPL ENVIRON MICROB, V71, P39, DOI 10.1128/AEM.71.1.39-45.2005; Lee PS, 2006, MOL MICROBIOL, V60, P853, DOI 10.1111/j.1365-2958.2006.05140.x; Levin PA, 1999, P NATL ACAD SCI USA, V96, P9642, DOI 10.1073/pnas.96.17.9642; Levin PA, 2001, J BACTERIOL, V183, P5449, DOI 10.1128/JB.183.18.5449-5452.2001; Levin PA, 1998, J BACTERIOL, V180, P6048, DOI 10.1128/JB.180.22.6048-6051.1998; Levin PA, 2002, METHOD MICROBIOL, V31, P115, DOI 10.1016/S0580-9517(02)31007-9; Lin DCH, 1997, P NATL ACAD SCI USA, V94, P4721, DOI 10.1073/pnas.94.9.4721; LU M, 1994, J BACTERIOL, V176, P5847, DOI 10.1128/JB.176.18.5847-5851.1994; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Nishibori A, 2005, J BACTERIOL, V187, P2163, DOI 10.1128/JB.187.6.2163-2174.2005; Price KD, 1997, J BACTERIOL, V179, P4959, DOI 10.1128/jb.179.15.4959-4961.1997; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; SARGENT MG, 1975, J BACTERIOL, V123, P7, DOI 10.1128/JB.123.1.7-19.1975; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Shackelford GS, 2004, PROTEIN SCI, V13, P2130, DOI 10.1110/ps.04801104; Sharpe ME, 1998, J BACTERIOL, V180, P547, DOI 10.1128/JB.180.3.547-555.1998; Weart RB, 2005, MOL MICROBIOL, V57, P238, DOI 10.1111/j.1365-2958.2005.04673.x; Weart RB, 2003, J BACTERIOL, V185, P2826, DOI 10.1128/JB.185.9.2826-2834.2003; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002	36	251	254	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					335	347		10.1016/j.cell.2007.05.043	http://dx.doi.org/10.1016/j.cell.2007.05.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662947	Bronze, Green Accepted			2022-12-01	WOS:000248588000022
J	Gregor, T; Wieschaus, EF; McGregor, AP; Bialek, W; Tank, DW				Gregor, Thomas; Wieschaus, Eric F.; McGregor, Alistair P.; Bialek, William; Tank, David W.			Stability and nuclear dynamics of the bicoid morphogen gradient	CELL			English	Article							DROSOPHILA; DIFFUSION; PROTEIN; CALCIUM; PATTERN; GFP	Patterning in multicellular organisms results from spatial gradients in morphogen concentration, but the dynamics of these gradients remain largely unexplored. We characterize, through in vivo optical imaging, the development and stability of the Bicoid morphogen gradient in Drosophila embryos that express a Bicoid- eGFP fusion protein. The gradient is established rapidly ( similar to 1 hr after fertilization), with nuclear Bicoid concentration rising and falling during mitosis. Interphase levels result from a rapid equilibrium between Bicoid uptake and removal. Initial interphase concentration in nuclei in successive cycles is constant ( +/- 10%), demonstrating a form of gradient stability, but it subsequently decays by approximately 30%. Both direct photobleaching measurements and indirect estimates of Bicoid- eGFP diffusion constants ( D <= 1 mu m(2)/s) provide a consistent picture of Bicoid transport on short ( similar to min) time scales but challenge traditional models of long- range gradient formation. A new model is presented emphasizing the possible role of nuclear dynamics in shaping and scaling the gradient.	Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; Princeton Univ, Dept Biol Mol, Princeton, NJ 08544 USA; Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University; Princeton University	Gregor, T (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	tg2@princeton.edu		Gregor, Thomas/0000-0001-9460-139X; McGregor, Alistair/0000-0002-2908-2420	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508, R01GM077599] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50 GM071508, R01 GM077599-02, R01 GM077599, R01 GM077599-01, P50 GM071508-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARIIZUMI T, 1995, ZOOL SCI, V12, P509, DOI 10.2108/zsj.12.509; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Brown EB, 1999, BIOPHYS J, V77, P2837, DOI 10.1016/S0006-3495(99)77115-8; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dhananjayan SC, 2005, ESSAYS BIOCHEM, V41, P69, DOI 10.1042/EB0410069; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Fersht A., 1985, ENZYME STRUCTURE MEC; Foe Victoria E., 1993, P149; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Hazelrigg T, 1998, DEV BIOL, V199, P245, DOI 10.1006/dbio.1998.8922; HODGKIN AL, 1957, J PHYSIOL-LONDON, V138, P253, DOI 10.1113/jphysiol.1957.sp005850; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Kiseleva E, 2001, J CELL SCI, V114, P3607; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Lacalli T.C., 1991, Seminars in Developmental Biology, V2, P107; LAWRENCE P, 1992, GENETICS ANIMAL DESI; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Thummel CS, 1992, DROS INF SERV, V71, P150; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wieschaus E., 1986, P199; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; ZECCA M, 1995, DEVELOPMENT, V121, P2265	31	348	352	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2007	130	1					141	152		10.1016/j.cell.2007.05.026	http://dx.doi.org/10.1016/j.cell.2007.05.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632061	Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000248587000017
J	Fulweiler, RW; Nixon, SW; Buckley, BA; Granger, SL				Fulweiler, R. W.; Nixon, S. W.; Buckley, B. A.; Granger, S. L.			Reversal of the net dinitrogen gas flux in coastal marine sediments	NATURE			English	Article							SPRING PHYTOPLANKTON BLOOM; NARRAGANSETT-BAY; NITROGEN-FIXATION; CLIMATE-CHANGE; WATER; EUTROPHICATION; TEMPERATURE; ECOSYSTEMS; PHOSPHORUS; REDUCTION	The flux of nitrogen from land and atmosphere to estuaries and the coastal ocean has increased substantially in recent decades. The observed increase in nitrogen loading is caused by population growth, urbanization, expanding water and sewer infrastructure, fossil fuel combustion and synthetic fertilizer consumption(1,2). Most of the nitrogen is removed by denitrification in the sediments of estuaries and the continental shelf, leading to a reduction in both cultural eutrophication and nitrogen pollution of the open ocean(3,4). Nitrogen fixation, however, is thought to be a negligible process in sub-tidal heterotrophic marine systems(5). Here we report sediment core data from Narragansett Bay, USA, which demonstrate that heterotrophic marine sediments can switch from being a net sink to being a net source of nitrogen. Mesocosm and core incubation experiments, together with a historic data set of mean annual chlorophyll production(6,7), support the idea that a climate-induced decrease in primary production has led to a decrease in organic matter deposition to the benthos and the observed reversal of the net sediment nitrogen flux. Our results suggest that some estuaries may no longer remove nitrogen from the water column. Instead, nitrogen could be exported to the continental shelf and the open ocean and could shift the effect of anthropogenic nitrogen loading beyond the immediate coastal zone.	Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	University of Rhode Island	Fulweiler, RW (corresponding author), Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA.	wally@gso.uri.edu	Fulweiler, Robinson W./A-3806-2010	Fulweiler, Robinson W./0000-0003-0871-4246				Borkman DG, 1998, ICES J MAR SCI, V55, P668, DOI 10.1006/jmsc.1998.0380; BORKMAN GD, 2002, THESIS U RHODE ISLAN; Brush MJ, 2002, MAR ECOL PROG SER, V238, P31, DOI 10.3354/meps238031; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Farnsworth EJ, 1995, J ECOL, V83, P967, DOI 10.2307/2261178; FULWEILER RW, IN PRESS HYDROBIOLOG; Furnas M.J., 1976, ESTUARINE PROCESSES, V1, P118; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Gardner WS, 2006, LIMNOL OCEANOGR, V51, P558, DOI 10.4319/lo.2006.51.1_part_2.0558; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; HOWARTH RW, 1988, LIMNOL OCEANOGR, V33, P669, DOI 10.4319/lo.1988.33.4_part_2.0669; KANA TM, 1994, ANAL CHEM, V66, P4166, DOI 10.1021/ac00095a009; Keller AA, 1999, LIMNOL OCEANOGR, V44, P344, DOI 10.4319/lo.1999.44.2.0344; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Li YQ, 1998, ICES J MAR SCI, V55, P661, DOI 10.1006/jmsc.1998.0383; Nixon SW, 1996, BIOGEOCHEMISTRY, V35, P141, DOI 10.1007/BF02179826; Nixon SW, 1995, BIOGEOCHEMISTRY, V31, P15; NIXON SW, ECOSYSTEM BASED ESTU; Nixon SW, 1980, MARINE BENTHIC DYNAM, P219; Nixon SX, 2004, ESTUARIES, V27, P397, DOI 10.1007/BF02803532; Nowicld B.L., 1991, THESIS U RHODE ISLAN; Oviatt C, 2002, ESTUAR COAST SHELF S, V54, P1013, DOI 10.1006/ecss.2001.0872; OVIATT C, 1995, MAR ECOL PROG SER, V116, P171, DOI 10.3354/meps116171; Pinckney JL, 2001, ORG GEOCHEM, V32, P585, DOI 10.1016/S0146-6380(00)00196-0; SEITZINGER S, 1982, THESIS U RHODE ISLAN; Seitzinger SP, 1996, BIOGEOCHEMISTRY, V35, P235, DOI 10.1007/BF02179829; SEITZINGER SP, 1987, MAR ECOL PROG SER, V37, P65, DOI 10.3354/meps037065; SISLER FD, 1951, SCIENCE, V113, P511, DOI 10.1126/science.113.2940.511; Townsend D.W., 1988, BIOL OCEANOGR, V5, P215, DOI DOI 10.1080/01965581.1987.10749514; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	31	151	154	2	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2007	448	7150					180	182		10.1038/nature05963	http://dx.doi.org/10.1038/nature05963			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17625562				2022-12-01	WOS:000247934500039
J	Landgraf, P; Rusu, M; Sheridan, R; Sewer, A; Iovino, N; Aravin, A; Pfeffer, S; Rice, A; Kamphorst, AO; Landthaler, M; Lin, C; Socci, ND; Hermida, L; Fulci, V; Chiaretti, S; Foa, R; Schliwka, J; Fuchs, U; Novosel, A; Muller, RU; Schermer, B; Bissels, U; Inman, J; Phan, Q; Chien, MC; Weir, DB; Choksi, R; De Vita, G; Frezzetti, D; Trompeter, HI; Hornung, V; Teng, G; Hartmann, G; Palkovits, M; Di Lauro, R; Wernet, P; Macino, G; Rogler, CE; Nagle, JW; Ju, JY; Papavasiliou, FN; Benzing, T; Lichter, P; Tam, W; Brownstein, MJ; Bosio, A; Borkhardt, A; Russo, JJ; Sander, C; Zavolan, M; Tuschl, T				Landgraf, Pablo; Rusu, Mirabela; Sheridan, Robert; Sewer, Alain; Iovino, Nicola; Aravin, Alexei; Pfeffer, Sebastien; Rice, Amanda; Kamphorst, Alice O.; Landthaler, Markus; Lin, Carolina; Socci, Nicholas D.; Hermida, Leandro; Fulci, Valerio; Chiaretti, Sabina; Foa, Robin; Schliwka, Julia; Fuchs, Uta; Novosel, Astrid; Mueller, Roman-Ulrich; Schermer, Bernhard; Bissels, Ute; Inman, Jason; Phan, Quang; Chien, Minchen; Weir, David B.; Choksi, Ruchi; De Vita, Gabriella; Frezzetti, Daniela; Trompeter, Hans-Ingo; Hornung, Veit; Teng, Grace; Hartmann, Gunther; Palkovits, Miklos; Di Lauro, Robert; Wernet, Peter; Macino, Giuseppe; Rogler, Charles E.; Nagle, James W.; Ju, Jingyue; Papavasiliou, F. Nina; Benzing, Thomas; Lichter, Peter; Tam, Wayne; Brownstein, Michael J.; Bosio, Andreas; Borkhardt, Arndt; Russo, James J.; Sander, Chris; Zavolan, Mihaela; Tuschl, Thomas			A mammalian microRNA expression atlas based on small RNA library sequencing	CELL			English	Article							MENTAL-RETARDATION PROTEIN; POSTTRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; C-ELEGANS; IDENTIFICATION; CLONING; MODULATION; ZEBRAFISH; VIRUSES; TARGETS	MicroRNAs (miRNAs) are small noncoding regulatory RNAs that reduce stability and/or translation of fully or partially sequence-complementary target mRNAs. In order to identify miRNAs and to assess their expression patterns, we sequenced over 250 small RNA libraries from 26 different organ systems and cell types of human and rodents that were enriched in neuronal as well as normal and malignant hematopoietic cells and tissues. We present expression profiles derived from clone count data and provide computational tools for their analysis. Unexpectedly, a relatively small set of miRNAs, many of which are ubiquitously expressed, account for most of the differences in miRNA profiles between cell lineages and tissues. This broad survey also provides detailed and accurate information about mature sequences, precursors, genome locations, maturation processes, inferred transcriptional units, and conservation patterns. We also propose a subclassification scheme for miRNAs for assisting future experimental and computational functional analyses.	Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10021 USA; Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, New York, NY 10021 USA; Deutsch Krebsforschungszentrum, Div Mol Genet, D-69120 Heidelberg, Germany; Univ Munich, Dr Von Haunerschen Kinderspital, Dept Hematol & Oncol, D-80337 Munich, Germany; Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany; Miltenyi Biotec GmbH, D-50829 Cologne, Germany; Inst Genom Res, Rockville, MD 20850 USA; J Craig Venter Inst, Funct Genom, Rockville, MD 20850 USA; Columbia Genome Ctr, Russ Berrie Pavilion, New York, NY 10032 USA; Univ Dusseldorf, Med Ctr, Inst Transplantat Diagnost & Cell Therapeut, D-40225 Dusseldorf, Germany; Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10021 USA; Hungarian Acad Sci Semmelweis Univ, Lab Neuromorphol, Budapest, Hungary; Albert Einstein Coll Med, Bronx, NY 10461 USA; Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; Univ Bonn, Univ Hosp, Div Clin Pharmacol, D-53105 Bonn, Germany; Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; IRGS, Biogem Scarl, I-83031 Ariano Irpino, Italy; Columbia Univ, Dept Chem Engn, New York, NY 10027 USA; NIH, NINDS, DNA Sequencing Facil, Bethesda, MD 20892 USA; Univ Munich, Dept Internal Med, Div Clin Pharmacol, D-80366 Munich, Germany; Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; IBM Corp, CNRS, F-678084 Strasbourg, France; Cold Spring Harbor Lab, Howard Hughes Med Inst, Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Rockefeller Univ, Lab Dev Neurogenet, New York, NY 10021 USA; Univ Dusseldorf, Med Ctr, Dept Pediat Oncol Hematol & Immunol, D-40225 Dusseldorf, Germany; Univ Lausanne, Dept Med Genet, Computat Biol Grp, CH-1005 Lausanne, Switzerland	University of Basel; Howard Hughes Medical Institute; Rockefeller University; Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich; University of Freiburg; Miltenyi Biotec; J. Craig Venter Institute; J. Craig Venter Institute; Columbia University; Heinrich Heine University Dusseldorf; Rockefeller University; Semmelweis University; Yeshiva University; Albert Einstein College of Medicine; Cornell University; University of Bonn; Swiss Institute of Bioinformatics; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Munich; University of Massachusetts System; University of Massachusetts Worcester; Centre National de la Recherche Scientifique (CNRS); International Business Machines (IBM); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Rockefeller University; Heinrich Heine University Dusseldorf; University of Lausanne	Zavolan, M (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	mihaela.zavolan@unibas.ch; ttuschl@rockefeller.edu	Sander, Chris/H-1452-2011; Zavolan, Mihaela/S-3888-2016; Benzing, Thomas/X-5476-2019; Hornung, Veit/C-3565-2012; Hartmann, Gunther/P-7492-2017; Schermer, Bernhard/E-9972-2014; Di Lauro, Roberto/A-2746-2012; Pfeffer, Sebastien/A-6512-2010; Frezzetti, Daniela/AAI-2410-2019; Müller, Roman-Ulrich/AAK-3493-2021; Pfeffer, Sébastien/H-3212-2019; Fulci, Valerio/J-1963-2015; Landthaler, Markus/A-1427-2010; De Vita, Gabriella/H-4422-2011; Palkovits, Miklos/F-2707-2013	Sander, Chris/0000-0001-6059-6270; Hornung, Veit/0000-0002-4150-194X; Hartmann, Gunther/0000-0003-1021-2018; Schermer, Bernhard/0000-0002-5194-9000; Di Lauro, Roberto/0000-0001-9493-3036; Pfeffer, Sebastien/0000-0002-8458-348X; Frezzetti, Daniela/0000-0002-7500-5506; Müller, Roman-Ulrich/0000-0001-6910-0745; Pfeffer, Sébastien/0000-0002-8458-348X; Fulci, Valerio/0000-0002-1173-585X; Landthaler, Markus/0000-0002-1075-8734; De Vita, Gabriella/0000-0002-7302-1174; Palkovits, Miklos/0000-0003-0578-0387; Rusu, Mirabela/0000-0002-0372-0367; CHIARETTI, Sabina/0000-0001-8499-4492; Hermida, Leandro Cruz/0000-0003-3887-518X; Bosio, Andreas/0000-0001-9776-2535; Kamphorst, Alice/0000-0002-9230-9501; Zavolan, Mihaela/0000-0002-8832-2041	NIGMS NIH HHS [P01 GM073047-03, P01 GM073047, P01 GM073047-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM073047] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2005, HUM MOL GENET, V14, pR183, DOI 10.1093/hmg/ddi271; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; De Vita G, 2005, MOL ENDOCRINOL, V19, P76, DOI 10.1210/me.2004-0172; Diederichs S, 2006, CANCER RES, V66, P6097, DOI 10.1158/0008-5472.CAN-06-0537; Eisenberg E, 2005, TRENDS GENET, V21, P77, DOI 10.1016/j.tig.2004.12.005; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Iwai N, 2005, BIOCHEM BIOPH RES CO, V331, P1439, DOI 10.1016/j.bbrc.2005.04.051; Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kluiver J, 2006, LEUKEMIA, V20, P1931, DOI 10.1038/sj.leu.2404387; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; Nelson JM, 2006, J CORP FINANC, V12, P187, DOI 10.1016/j.jcorpfin.2005.07.002; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; PFEFFER S, 2003, CURRENT PROTOCOLS MO; Plante I, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/64347; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rigoutsos I, 2006, P NATL ACAD SCI USA, V103, P6605, DOI 10.1073/pnas.0601688103; Shivdasani Ramesh A, 2006, Blood, V108, P3646; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takada S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl653; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041	69	2887	4166	9	342	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2007	129	7					1401	1414		10.1016/j.cell.2007.04.040	http://dx.doi.org/10.1016/j.cell.2007.04.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604727	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000247911400024
J	Zomot, E; Bendahan, A; Quick, M; Zhao, YF; Javitch, JA; Kanner, BI				Zomot, Elia; Bendahan, Annie; Quick, Matthias; Zhao, Yongfang; Javitch, Jonathan A.; Kanner, Baruch I.			Mechanism of chloride interaction with neurotransmitter: sodium symporters	NATURE			English	Article							AMINOBUTYRIC-ACID TRANSPORTER; CL-COTRANSPORT FUNCTION; RAT-BRAIN; GABA TRANSPORTER; GLYCINE TRANSPORTERS; BACTERIAL HOMOLOG; MOLECULAR-BASIS; ION-BINDING; IDENTIFICATION; GAT1	Neurotransmitter: sodium symporters (NSS) have a critical role in regulating neurotransmission and are targets for psycho-stimulants, anti-depressants and other drugs(1,2). Whereas the non-homologous glutamate transporters mediate chloride conductance(3), in the eukaryotic NSS chloride is transported together with the neurotransmitter(4-7). In contrast, transport by the bacterial NSS family members LeuT, Tyt1 and TnaT is chloride independent(8-10). The crystal structure of LeuT reveals an occluded binding pocket containing leucine and two sodium ions(9), and is highly relevant for the neurotransmitter transporters(11-13). However, the precise role of chloride in neurotransmitter transport and the location of its binding site remain elusive. Here we show that introduction of a negatively charged amino acid at or near one of the two putative sodium-binding sites of the GABA (gamma-aminobutyric acid) transporter GAT-1 from rat brain (also called SLC6A1)(14,15) renders both net flux and exchange of GABA largely chloride independent. In contrast to wild-type GAT-1, a marked stimulation of the rate of net flux, but not of exchange, was observed when the internal pH was lowered. Equivalent mutations introduced in the mouse GABA transporter GAT4 (SLC6A11) and the human dopamine transporter DAT (SLC6A3) also result in chloride-independent transport, whereas the reciprocal mutations in LeuT and Tyt1 render substrate binding and/or uptake by these bacterial NSS chloride dependent. Our data indicate that the negative charge, provided either by chloride or by the transporter itself, is required during binding and translocation of the neurotransmitter, probably to counterbalance the charge of the co-transported sodium ions.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, IL-91120 Jerusalem, Israel; Columbia Univ, Ctr Mol Recognit, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA	Hebrew University of Jerusalem; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, POB 12272, IL-91120 Jerusalem, Israel.	kannerb@cc.huji.ac.il	Zhao, Yongfang/B-5437-2010	Javitch, Jonathan/0000-0001-7395-2967	NIDA NIH HHS [K05 DA022413] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Hilgemann DW, 1999, J GEN PHYSIOL, V114, P459, DOI 10.1085/jgp.114.3.459; KANNER BI, 1994, J EXP BIOL, V196, P237; KEYNAN S, 1988, BIOCHEMISTRY-US, V27, P12, DOI 10.1021/bi00401a003; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; Krause S, 2005, MOL PHARMACOL, V68, P1728, DOI 10.1124/mol.105.013870; Loo DDF, 2000, J BIOL CHEM, V275, P37414, DOI 10.1074/jbc.M007241200; Lu CC, 1999, J GEN PHYSIOL, V114, P429, DOI 10.1085/jgp.114.3.429; Mager S, 1996, J NEUROSCI, V16, P5405; Mari SA, 2006, CELL MOL LIFE SCI, V63, P100, DOI 10.1007/s00018-005-5512-6; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; RADIAN R, 1986, J BIOL CHEM, V261, P5437; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200	27	175	177	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2007	449	7163					726	U9		10.1038/nature06133	http://dx.doi.org/10.1038/nature06133			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218VV	17704762	Bronze			2022-12-01	WOS:000250045000045
J	Huber, JA; Mark Welch, D; Morrison, HG; Huse, SM; Neal, PR; Butterfield, DA; Sogin, ML				Huber, Julie A.; Mark Welch, David; Morrison, Hilary G.; Huse, Susan M.; Neal, Phillip R.; Butterfield, David A.; Sogin, Mitchell L.			Microbial population structures in the deep marine biosphere	SCIENCE			English	Article							DIVERSITY; SEA; PROCHLOROCOCCUS; RIDGE	The analytical power of environmental DNA sequences for modeling microbial ecosystems depends on accurate assessments of population structure, including diversity (richness) and relative abundance (evenness). We investigated both aspects of population structure for microbial communities at two neighboring hydrothermal vents by examining the sequences of more than 900,000 microbial small-subunit ribosomal RNA amplicons. The two vent communities have different population structures that reflect local geochemical regimes. Descriptions of archaeal diversity were nearly exhaustive, but despite collecting an unparalleled number of sequences, statistical analyses indicated additional bacterial diversity at every taxonomic level. We predict that hundreds of thousands of sequences will be necessary to capture the vast diversity of microbial communities, and that different patterns of evenness for both high- and low-abundance taxa may be important in defining microbial ecosystem dynamics.	Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA 02543 USA; Univ Washington, Joint Inst Study Atmosphere & Ocean, Seattle, WA 98105 USA	Marine Biological Laboratory - Woods Hole; University of Washington; University of Washington Seattle	Huber, JA (corresponding author), Marine Biol Lab, Josephine Bay Paul Ctr, 7 MBL St, Woods Hole, MA 02543 USA.	jhuber@mbl.edu	Butterfield, David/H-3815-2016; Sogin, Mitchell/AAE-7186-2019	Butterfield, David/0000-0002-1595-9279; Morrison, Hilary/0000-0003-0281-326X; Mark Welch, David/0000-0001-9774-4580; Huber, Julie/0000-0002-4790-7633				Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Butterfield DA, 2004, GEOPH MONOG SERIES, V144, P269, DOI 10.1029/144GM17; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; CHAO A, 1984, SCAND J STAT, V11, P265; DeLong E, 2007, NAT REV MICROBIOL, V5, P326, DOI 10.1038/nrmicro1674; EMBLEY R, 1999, EOS T AM GEOPHYS UN, V80, P213; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Huber JA, 2003, FEMS MICROBIOL ECOL, V43, P393, DOI 10.1111/j.1574-6941.2003.tb01080.x; Huber JA, 2002, APPL ENVIRON MICROB, V68, P1585, DOI 10.1128/AEM.68.4.1585-1594.2002; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; JOHNSON HP, 1990, J GEOPHYS RES-SOLID, V95, P12689, DOI 10.1029/JB095iB08p12689; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; Maruyama A, 1998, CAH BIOL MAR, V39, P249; Massana R, 2000, APPL ENVIRON MICROB, V66, P1777, DOI 10.1128/AEM.66.5.1777-1787.2000; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; RAUP D M, 1975, Paleobiology, V1, P333; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	23	681	717	1	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					97	100		10.1126/science.1146689	http://dx.doi.org/10.1126/science.1146689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916733				2022-12-01	WOS:000249915400049
J	McClellan, AJ; Xia, Y; Deutschbauer, AM; Davis, RW; Gerstein, M; Frydman, J				McClellan, Amie J.; Xia, Yu; Deutschbauer, Adam M.; Davis, Ron W.; Gerstein, Mark; Frydman, Judith			Diverse cellular functions of the Hsp90 molecular chaperone uncovered using systems approaches	CELL			English	Article							SUPEROXIDE-DISMUTASE; IN-VIVO; PROTEIN; COMPLEX; GENOME; HEAT-SHOCK-PROTEIN-90; GELDANAMYCIN; REQUIREMENT; DELETION; DATABASE	A comprehensive understanding of the cellular functions of the Hsp90 molecular chaperone has remained elusive. Although Hsp90 is essential, highly abundant under normal conditions, and further induced by environmental stress, only a limited number of Hsp90 "clients'' have been identified. To define Hsp90 function, a panelofgenome-wide chemical-genetic screens in Saccharomyces cerevisiae were combined with bioinformatic analyses. This approach identified several unanticipated functions of Hsp90 under normal conditions and in response to stress. Under normal growth conditions, Hsp90 plays a major role in various aspects of the secretory pathway and cellular transport; during environmental stress, Hsp90 is required for the cell cycle, meiosis, and cytokinesis. Importantly, biochemical and cell biological analyses validated several of these Hsp90-dependent functions, highlighting the potential of our integrated global approach to uncover chaperone functions in the cell.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Stanford University; Stanford University; Yale University	Frydman, J (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	jfrydman@stanford.edu	McClellan, Amie/V-8950-2019; Xia, Yu/W-6150-2019	Xia, Yu/0000-0002-5596-5518; McClellan, Amie/0000-0002-8033-6748; , judith/0000-0003-2302-6943	NIGMS NIH HHS [5P50GM062413-03, GM64992, GM56433] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM064992, R01GM056433, P50GM062413] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bansal PK, 2004, MOL CELL BIOL, V24, P8069, DOI 10.1128/MCB.24.18.8069-8079.2004; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Bohen SP, 1998, MOL CELL BIOL, V18, P3330, DOI 10.1128/MCB.18.6.3330; Brachmann CB, 1998, YEAST, V14, P115; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Catlett MG, 2006, J BIOL CHEM, V281, P33739, DOI 10.1074/jbc.M603847200; Chen CY, 2006, MOL BIOL CELL, V17, P3494, DOI 10.1091/mbc.E05-12-1096; Chiosis G, 2006, ACS CHEM BIOL, V1, P279, DOI 10.1021/cb600224w; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Dwight SS, 2004, BRIEF BIOINFORM, V5, P9, DOI 10.1093/bib/5.1.9; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Giaever G, 2003, TRENDS PHARMACOL SCI, V24, P444, DOI 10.1016/S0165-6147(03)00225-6; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Lange BMH, 2002, EMBO J, V21, P5364, DOI 10.1093/emboj/cdf531; Lingelbach LB, 2004, MOL CELL BIOL, V24, P8938, DOI 10.1128/MCB.24.20.8938-8950.2004; LIU XF, 1994, MOL CELL BIOL, V14, P7037, DOI 10.1128/MCB.14.11.7037; Luk EEC, 2001, J BIOL CHEM, V276, P47556, DOI 10.1074/jbc.M108923200; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Millson SH, 2005, EUKARYOT CELL, V4, P849, DOI 10.1128/EC.4.5.849-860.2005; Mimnaugh EG, 2006, MOL CANCER RES, V4, P667, DOI 10.1158/1541-7786.MCR-06-0019; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; Nomura M, 2004, J CELL PHYSIOL, V201, P374, DOI 10.1002/jcp.20090; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Picard D, 2006, TRENDS ENDOCRIN MET, V17, P229, DOI 10.1016/j.tem.2006.06.003; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Ryan PE, 2006, TRENDS BIOCHEM SCI, V31, P79, DOI 10.1016/j.tibs.2005.12.004; Sakisaka T, 2002, EMBO J, V21, P6125, DOI 10.1093/emboj/cdf603; Sangster TA, 2004, BIOESSAYS, V26, P348, DOI 10.1002/bies.20020; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stemmann O, 2002, P NATL ACAD SCI USA, V99, P8585, DOI 10.1073/pnas.082223899; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Ungar D, 2002, J CELL BIOL, V157, P405, DOI 10.1083/jcb.200202016; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	54	370	384	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2007	131	1					121	135		10.1016/j.cell.2007.07.036	http://dx.doi.org/10.1016/j.cell.2007.07.036			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923092	Bronze			2022-12-01	WOS:000249934700016
J	Kamerow, D				Kamerow, Douglas			Wham, bam, thank you CAM	BRITISH MEDICAL JOURNAL			English	Editorial Material							ALTERNATIVE MEDICINE; COMPLEMENTARY					dkamerow@bmj.com		Kamerow, Douglas/0000-0001-7000-9957				Franck L, 2007, BRIT MED J, V334, P506, DOI 10.1136/bmj.39122.512211.BE; Franck L, 2007, BRIT MED J, V334, P507; Shekelle PG, 2005, ANN INTERN MED, V142, P1042, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00003	3	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 29	2007	335	7621					647	647		10.1136/bmj.39349.437442.43	http://dx.doi.org/10.1136/bmj.39349.437442.43			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218AY	17901515	Green Published			2022-12-01	WOS:000249989600038
J	Allen, EA; Pasley, BN; Duong, T; Freeman, RD				Allen, Elena A.; Pasley, Brian N.; Duong, Thang; Freeman, Ralph D.			Transcranial magnetic stimulation elicits coupled neural and hemodynamic consequences	SCIENCE			English	Article							HUMAN MOTOR CORTEX; BLOOD-FLOW; REGIONAL EXCITABILITY; CORTICAL EXCITABILITY; VISUAL-CORTEX; BRAIN; MODULATION; RAT; OSCILLATIONS; OXYGENATION	Transcranial magnetic stimulation (TMS) is an increasingly common technique used to selectively modify neural processing. However, application of TMS is limited by uncertainty concerning its physiological effects. We applied TMS to the cat visual cortex and evaluated the neural and hemodynamic consequences. Short TMS pulse trains elicited initial activation (similar to 1 minute) and prolonged suppression (5 to 10 minutes) of neural responses. Furthermore, TMS disrupted the temporal structure of activity by altering phase relationships between neural signals. Despite the complexity of this response, neural changes were faithfully reflected in hemodynamic signals; quantitative coupling was present over a range of stimulation parameters. These results demonstrate long-lasting neural responses to TMS and support the use of hemodynamic-based neuroimaging to effectively monitor these changes over time.	Univ Calif Berkeley, Sch Optometry, Helen Wills Neurosci Inst, Grp Vis Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Freeman, RD (corresponding author), Univ Calif Berkeley, Sch Optometry, Helen Wills Neurosci Inst, Grp Vis Sci, Berkeley, CA 94720 USA.	freeman@neurovision.berkeley.edu			NEI NIH HHS [EY03176, EY01175] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY003176, R01EY001175] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARKER AT, 1985, LANCET, V1, P1106; Berwick J, 2002, J CEREBR BLOOD F MET, V22, P670, DOI 10.1097/00004647-200206000-00005; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; GEORE MS, 2007, TRANSCRANIAL MAGNETI; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; Holscher C, 1997, J NEUROSCI, V17, P6470; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jacobs J, 2007, J NEUROSCI, V27, P3839, DOI 10.1523/JNEUROSCI.4636-06.2007; Maeda F, 2000, CLIN NEUROPHYSIOL, V111, P800, DOI 10.1016/S1388-2457(99)00323-5; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Pascual-Leone A, 1998, J CLIN NEUROPHYSIOL, V15, P333, DOI 10.1097/00004691-199807000-00005; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Pasley BN, 2007, NEUROIMAGE, V36, P269, DOI 10.1016/j.neuroimage.2006.09.015; Paus T, 1998, J NEUROPHYSIOL, V79, P1102, DOI 10.1152/jn.1998.79.2.1102; Sack AT, 2003, BRAIN RES REV, V43, P41, DOI 10.1016/S0165-0173(03)00191-7; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Siebner HR, 2001, NEUROIMAGE, V14, P883, DOI 10.1006/nimg.2001.0889; Singh N, 2007, PROG NEUROBIOL, V81, P29, DOI 10.1016/j.pneurobio.2006.11.009; Suh M, 2005, J NEUROSCI, V25, P68, DOI 10.1523/JNEUROSCI.2823-04.2005; Takano B, 2004, NEUROIMAGE, V23, P849, DOI 10.1016/j.neuroimage.2004.06.032; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Wang H, 1996, NEUROREPORT, V7, P521, DOI 10.1097/00001756-199601310-00035; Wespatat V, 2004, J NEUROSCI, V24, P9067, DOI 10.1523/JNEUROSCI.2221-04.2004; Zheng Y, 2002, NEUROIMAGE, V16, P617, DOI 10.1006/nimg.2002.1078	30	225	238	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2007	317	5846					1918	1921		10.1126/science.1146426	http://dx.doi.org/10.1126/science.1146426			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901333				2022-12-01	WOS:000249764300039
J	Philippot, P; Van Zuilen, M; Lepot, K; Thomazo, C; Farquhar, J; Van Kranendonk, MJ				Philippot, Pascal; Van Zuilen, Mark; Lepot, Kevin; Thomazo, Christophe; Farquhar, James; Van Kranendonk, Martin J.			Early Archaean microorganisms preferred elemental sulfur, not sulfate	SCIENCE			English	Article							ISOTOPE FRACTIONATION; BACTERIAL REDUCTION; WESTERN-AUSTRALIA; CYCLE; OCEAN; DISPROPORTIONATION; ATMOSPHERE; MECHANISM; EVOLUTION; SULPHATE	Microscopic sulfides with low S-34/S-32 ratios in marine sulfate deposits from the 3490-million-year-old Dresser Formation, Australia, have been interpreted as evidence for the presence of early sulfate-reducing organisms on Earth. We show that these microscopic sulfides have a massin-dependently fractionated sulfur isotopic anomaly (Delta S-33) that differs from that of their host sulfate (barite). These microscopic sulfides could not have been produced by sulfate-reducing microbes, nor by abiologic processes that involve reduction of sulfate. Instead, we interpret the combined negative delta S-34 and positive Delta S-33 signature of these microscopic sulfides as evidence for the early existence of organisms that disproportionate elemental sulfur.	CNRS, Inst Phys Globe, Equipe Geobiosphere Actuelle & Primit, F-75005 Paris, France; Univ Maryland, Dept Geol, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; Geol Survey Western Australia, Perth, WA 6004, Australia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University System of Maryland; University of Maryland College Park; Geological Survey of Western Australia	Philippot, P (corresponding author), CNRS, Inst Phys Globe, Equipe Geobiosphere Actuelle & Primit, 4 Pl Jussieu, F-75005 Paris, France.	philippot@ipgp.jussieu.fr	Van Kranendonk, Martin J/J-8755-2012; Philippot, Pascal/AAD-4313-2020; Lepot, Kevin/C-7072-2014	Van Kranendonk, Martin J/0000-0002-0611-2703; Thomazo, Christophe/0000-0002-2475-0514; van Zuilen, Mark/0000-0001-6723-6366; Lepot, Kevin/0000-0003-0556-0405				AHMEND JP, 2004, SULFUR BIOGEOCHEMIST, V379, P17; CAMERON EM, 1982, NATURE, V296, P145, DOI 10.1038/296145a0; Canfield DE, 1999, AM J SCI, V299, P697, DOI 10.2475/ajs.299.7-9.697; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; CANFIELD DE, 1994, SCIENCE, V266, P1973, DOI 10.1126/science.11540246; Canfield DE, 2001, REV MINERAL GEOCHEM, V43, P607, DOI 10.2138/gsrmg.43.1.607; Canfield DE, 2001, GEOCHIM COSMOCHIM AC, V65, P1117, DOI 10.1016/S0016-7037(00)00584-6; Canfield DE, 1998, LIMNOL OCEANOGR, V43, P253, DOI 10.4319/lo.1998.43.2.0253; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; FRY B, 1984, FEMS MICROBIOL LETT, V22, P283; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Habicht KS, 1998, GEOCHIM COSMOCHIM AC, V62, P2585, DOI 10.1016/S0016-7037(98)00167-7; HARRISON AG, 1958, T FARADAY SOC, V54, P84, DOI 10.1039/tf9585400084; Kamber BS, 2007, GEOBIOLOGY, V5, P5, DOI 10.1111/j.1472-4669.2006.00091.x; KEMP ALW, 1968, GEOCHIM COSMOCHIM AC, V32, P71, DOI 10.1016/0016-7037(68)90088-4; LAMBERT IB, 1978, NATURE, V276, P808, DOI 10.1038/276808a0; Nijman W, 1998, PRECAMBRIAN RES, V88, P25, DOI 10.1016/S0301-9268(97)00062-4; OHMOTO H, 1993, SCIENCE, V262, P555, DOI 10.1126/science.11539502; Ohmoto H., 1997, GEOCHEMISTRY HYDROTH, P517; Ono S, 2003, EARTH PLANET SC LETT, V213, P15, DOI 10.1016/S0012-821X(03)00295-4; RUNNEGAR B, 2001, GEOL SOC AM, pA4104; Rye RO, 2005, CHEM GEOL, V215, P5, DOI 10.1016/j.chemgeo.2004.06.034; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; Shen YN, 2004, EARTH-SCI REV, V64, P243, DOI 10.1016/S0012-8252(03)00054-0; Smith JW, 2000, GEOCHEM J, V34, P95, DOI 10.2343/geochemj.34.95; STETTER KO, 1990, FEMS MICROBIOL LETT, V75, P117, DOI 10.1016/0378-1097(90)90526-V; STETTER KO, 1983, NATURE, V305, P309, DOI 10.1038/305309a0; THORPE RI, 1992, ARCHAEAN TERRAINS PR, V22, P395; Ueno Y, 2004, GEOCHIM COSMOCHIM AC, V68, P573, DOI 10.1016/S0016-7037(03)00462-9; VANKRANENDONK MJ, 2006, 200614 W AUST GEOL S, P25	33	228	234	2	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2007	317	5844					1534	1537		10.1126/science.1145861	http://dx.doi.org/10.1126/science.1145861			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872441				2022-12-01	WOS:000249467900037
J	Kim, HM; Park, BS; Kim, JI; Kim, SE; Lee, J; Oh, SC; Enkhbayar, P; Matsushima, N; Lee, H; Yoo, OJ; Lee, JO				Kim, Ho Min; Park, Beom Seok; Kim, Jung-In; Kim, Sung Eun; Lee, Judong; Oh, Se Cheol; Enkhbayar, Purevjav; Matsushima, Norio; Lee, Hayyoung; Yoo, Ook Joon; Lee, Jie-Oh			Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist eritoran	CELL			English	Article							LEUCINE-RICH REPEAT; LIPOPOLYSACCHARIDE-BINDING; MONOMERIC ENDOTOXIN; PROTEIN COMPLEXES; MD-2 BINDS; TOLL; TLR4; RECOGNITION; REGION; MICE	TLR4 and MD-2 form a heterodimer that recognizes LPS (lipopolysaccharide) from Gram-negative bacteria. Eritoran is an analog of LPS that antagonizes its activity by binding to the TLR4-MD- 2 complex. We determined the structure of the full-length ectodomain of the mouse TLR4 and MD-2 complex. We also produced a series of hybrids of human TLR4 and hagfish VLR and determined their structures with and without bound MD-2 and Eritoran. TLR4 is an atypical member of the LRR family and is composed of N-terminal, central, and C-terminal domains. The beta sheet of the central domain shows unusually small radii and large twist angles. MD-2 binds to the concave surface of the N-terminal and central domains. The interaction with Eritoran is mediated by a hydrophobic internal pocket in MD-2. Based on structural analysis and mutagenesis experiments on MD-2 and TLR4, we propose a model of TLR4-MD-2 dimerization induced by LPS.	Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Ctr Biomed Res, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Inst Biocentury, Taejon 305701, South Korea; Natl Univ Mongolia, Fac Biol, Ulaanbaatar, Mongolia; Sapporo Med Univ, Sch Hlth Sci, Sapporo, Hokkaido 0608556, Japan; Chungnam Natl Univ, Sch Biosci & Biotechnol, Dept Biol, Taejon 305764, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); National University of Mongolia; Sapporo Medical University; Chungnam National University	Lee, JO (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea.	jieoh.lee@kaist.ac.kr	Lee, Jie-Oh/C-1581-2011; Yoo, Ook Joon/C-1860-2011; Lee, Jie-Oh/AAG-4302-2020; Kim, Ho Min/G-2712-2011; KIM, SUNG EUN/E-4918-2011	Lee, Jie-Oh/0000-0001-6519-6049				Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; Brandenburg K, 2004, BIOCHEMISTRY-US, V43, P4039, DOI 10.1021/bi0361158; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Derewenda U, 2002, J MOL BIOL, V318, P189, DOI 10.1016/S0022-2836(02)00027-X; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gioannini TL, 2005, J ENDOTOXIN RES, V11, P117, DOI 10.1179/096805105X35198; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Haziot A, 1995, Prog Clin Biol Res, V392, P349; He XLL, 2003, NEURON, V38, P177, DOI 10.1016/S0896-6273(03)00232-0; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hyakushima N, 2004, J IMMUNOL, V173, P6949, DOI 10.4049/jimmunol.173.11.6949; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kim H, 2005, J MICROELECTROMECH S, V14, P1347, DOI 10.1109/JMEMS.2005.859102; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Matsushima N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-124; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Mullarkey M, 2003, J PHARMACOL EXP THER, V304, P1093, DOI 10.1124/jpet.102.044487; Muroi M, 2006, J BIOL CHEM, V281, P5484, DOI 10.1074/jbc.M509193200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nishitani C, 2006, J BIOL CHEM, V281, P38322, DOI 10.1074/jbc.M606904200; Nishitania C, 2005, BIOCHEM BIOPH RES CO, V328, P586, DOI 10.1016/j.bbrc.2005.01.021; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; Re F, 2002, J BIOL CHEM, V277, P23427, DOI 10.1074/jbc.M202554200; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Rossignol Daniel P, 2005, Curr Opin Investig Drugs, V6, P496; Schromm AB, 2001, J EXP MED, V194, P79, DOI 10.1084/jem.194.1.79; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2005, J IMMUNOL, V175, P6465, DOI 10.4049/jimmunol.175.10.6465; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235; Wright CS, 2003, J MOL BIOL, V331, P951, DOI 10.1016/S0022-2836(03)00794-0	56	803	856	4	129	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2007	130	5					906	917		10.1016/j.cell.2007.08.002	http://dx.doi.org/10.1016/j.cell.2007.08.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	212GI	17803912	Bronze			2022-12-01	WOS:000249581500021
J	Zhou, Z; Zhen, J; Karpowich, NK; Goetz, RM; Law, CJ; Reith, MEA; Wang, DN				Zhou, Zheng; Zhen, Juan; Karpowich, Nathan K.; Goetz, Regina M.; Law, Christopher J.; Reith, Maarten E. A.; Wang, Da-Neng			LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake	SCIENCE			English	Article							SENSITIVE DOPAMINE TRANSPORTER; NOREPINEPHRINE TRANSPORTERS; MONOAMINE TRANSPORTERS; ION-BINDING; INHIBITORS; SEROTONIN	Tricyclic antidepressants exert their pharmacological effect-inhibiting the reuptake of serotonin, norepinephrine, and dopamine-by directly blocking neurotransmitter transporters (SERT, NET, and DAT, respectively) in the presynaptic membrane. The drug-binding site and the mechanism of this inhibition are poorly understood. We determined the crystal structure at 2.9 angstroms of the bacterial leucine transporter (LeuT), a homolog of SERT, NET, and DAT, in complex with leucine and the antidepressant desipramine. Desipramine binds at the inner end of the extracellular cavity of the transporter and is held in place by a hairpin loop and by a salt bridge. This binding site is separated from the leucine-binding site by the extracellular gate of the transporter. By directly locking the gate, desipramine prevents conformational changes and blocks substrate transport. Mutagenesis experiments on human SERT and DAT indicate that both the desipramine-binding site and its inhibition mechanism are probably conserved in the human neurotransmitter transporters.	NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Reith, MEA (corresponding author), NYU, Sch Med, Dept Psychiat, 540 1st Ave, New York, NY 10016 USA.	maarten.reith@med.nyu.edu; wang@saturn.med.nyu.edu	Reith, Maarten E/A-4601-2008; Reith, Maarten E./AAD-2303-2019; Zhen, Juan/E-8593-2016; Law, Christopher/E-7174-2011; Goetz, Regina/M-2411-2019	Reith, Maarten E./0000-0002-1900-842X; Zhen, Juan/0000-0002-6111-9692; Goetz, Regina/0000-0003-3681-4703; Wang, Da-Neng/0000-0002-6496-4699	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK060841, R01DK053973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM095315, R21GM075936, U54GM075026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013261, R01DA019676] Funding Source: NIH RePORTER; NIDA NIH HHS [DA013261, R01 DA019676, R01 DA013261, DA019676] Funding Source: Medline; NIDDK NIH HHS [R21 DK060841, R01 DK053973] Funding Source: Medline; NIGMS NIH HHS [U54 GM095315, R21 GM075936, GM075936, U54 GM075026, GM075026] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Blakely RD, 2005, PHYSIOLOGY, V20, P225, DOI 10.1152/physiol.00013.2005; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Brunton L.B., 2005, GOODMAN GILMANS PHAR, V11th ed; Cantu MD, 2005, J CHROMATOGR A, V1068, P99, DOI 10.1016/j.chroma.2004.12.009; Chen Nian-Hang, 2002, P53; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Eshleman AJ, 1999, J PHARMACOL EXP THER, V289, P877; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gumnick JF, 2000, J CLIN PSYCHIAT, V61, P5; HERTTING G, 1961, NATURE, V192, P172, DOI 10.1038/192172a0; Iversen L, 2006, BRIT J PHARMACOL, V147, pS82, DOI 10.1038/sj.bjp.0706428; Jayanthi LD, 1998, MOL PHARMACOL, V54, P601; Klimek V, 1997, J NEUROSCI, V17, P8451; Mortensen OV, 2006, J NEUROCHEM, V98, P1531, DOI 10.1111/j.1471-4159.2006.04060.x; Nelson N, 1998, J NEUROCHEM, V71, P1785; Olivier B, 2000, Prog Drug Res, V54, P59; Porzgen P, 2001, MOL PHARMACOL, V59, P83; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Roubert C, 2001, J BIOL CHEM, V276, P8254, DOI 10.1074/jbc.M009798200; Saier MH, 2000, MICROBIOL-SGM, V146, P1775, DOI 10.1099/00221287-146-8-1775; Schafer WR, 1999, CELL, V98, P551, DOI 10.1016/S0092-8674(00)80042-2; Schloss P, 1998, J PSYCHOPHARMACOL, V12, P115, DOI 10.1177/026988119801200201; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	26	273	277	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2007	317	5843					1390	1393		10.1126/science.1147614	http://dx.doi.org/10.1126/science.1147614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209GR	17690258	Green Accepted			2022-12-01	WOS:000249377500046
J	Buist, AS; McBurnie, MA; Vollmer, WM; Gillespie, S; Burney, P; Mannino, DM; Menezes, AMB; Sullivan, SD; Lee, TA; Weiss, KB; Jensen, RL; Marks, GB; Gulsvik, A; Nizankowska-Mogilnicka, E				Buist, A. Sonia; McBurnie, Mary Ann; Vollmer, William M.; Gillespie, Suzanne; Burney, Peter; Mannino, David M.; Menezes, Ana M. B.; Sullivan, Sean D.; Lee, Todd A.; Weiss, Kevin B.; Jensen, Robert L.; Marks, Guy B.; Gulsvik, Amund; Nizankowska-Mogilnicka, Ewa		BOLD Collaborative Res Grp	International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study	LANCET			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CHILDHOOD RESPIRATORY-INFECTION; ADULT LUNG-FUNCTION; US POPULATION; BURDEN; HEALTH; IMPACT; STANDARDIZATION; SMOKERS; GENDER	Background Chronic obstructive pulmonary disease (COPD) is a growing cause of morbidity and mortality worldwide, and accurate estimates of the prevalence of this disease are needed to anticipate the future burden of COPD, target key risk factors, and plan for providing COPD-related health services. We aimed to measure the prevalence of COPD and its risk factors and investigate variation across countries by age, sex, and smoking status. Methods Participants from 12 sites (n=9425) completed postbronchodilator spirometry testing plus questionnaires about respiratory symptoms, health status, and exposure to COPD risk factors. COPD prevalence estimates based on the Global Initiative for Chronic Obstructive Lung Disease staging criteria were adjusted for the target population. Logistic regression was used to estimate adjusted odds ratios (ORs) for COPD associated with 10-year age increments and 10-pack-year (defined as the number of cigarettes smoked per day divided by 20 and multiplied by the number of years that the participant smoked) increments. Meta-analyses provided pooled estimates for these risk factors. Findings The prevalence of stage II or higher COPD was 10 . 1% (SE 4 . 8) overall, 11 . 8% (7.9) for men, and 8.5% (5.8) for women. The ORs for 10-year age increments were much the same across sites and for women and men. The overall pooled estimate was 1.94 (95% CI 1.80-2.10) per 10-year increment. Site-specific pack-year ORs varied significantly in women (pooled OR=1.28,95% CI 1.15-1.42, p=0.012),but not in men (1.16,1.12-1.21,p=0.743). Interpretation This worldwide study showed higher levels and more advanced staging of spirometrically confirmed COPD than have typically been reported. However, although age and smoking are strong contributors to COPD, they do not fully explain variations in disease prevalence-other factors also seem to be important. Although smoking cessation is becoming an increasingly urgent objective for an ageing worldwide population, a better understanding of other factors that contribute to COPD is crucial to assist local public-health officials in developing the best possible primary and secondary prevention policies for their regions.	Oregon Hlth & Sci Univ, Portland, OR 97239 USA; Kaiser Permanente Ctr Hlth Res, Portland, OR USA; Imperial Coll, Natl Heart & Lung Inst, London, England; Univ Kentucky, Lexington, KY USA; Univ Fed Pelotas, Pelotas, Brazil; Univ Washington, Seattle, WA 98195 USA; Hines VA Hosp, Hines, IL USA; Northwestern Univ, Chicago, IL 60611 USA; Latter Day St Hosp, Salt Lake City, UT 84143 USA; Woolcock Inst Med Res, Sydney, NSW, Australia; Univ Bergen, Bergen, Norway; Jagiellonian Univ, Sch Med, Dept Med, Div Pulm Dis, Krakow, Poland	Oregon Health & Science University; Kaiser Permanente; Imperial College London; University of Kentucky; Universidade Federal de Pelotas; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Northwestern University; University of Sydney; Woolcock Institute of Medical Research; University of Bergen; Jagiellonian University	Buist, AS (corresponding author), Oregon Hlth & Sci Univ, MC UHN 67,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	BOLD@kpchr.org	Marks, Guy B./F-5058-2013; Menezes, Ana MB/G-7266-2012	Marks, Guy B./0000-0002-8976-8053; Menezes, Ana MB/0000-0002-2996-9427; Lee, Todd/0000-0003-3619-5367; Burney, Peter/0000-0001-8635-5678; Mannino, David/0000-0003-3646-7828				Antonelli-Incalzi R, 2003, EUR RESPIR J, V22, P444, DOI 10.1183/09031936.03.00101203; BAKKE PS, 1991, THORAX, V46, P863, DOI 10.1136/thx.46.12.863; BARKER DJP, 1991, BRIT MED J, V303, P671, DOI 10.1136/bmj.303.6804.671; BARKER DJP, 1986, BRIT MED J, V293, P1271, DOI 10.1136/bmj.293.6557.1271; Buist A Sonia, 2005, COPD, V2, P277, DOI 10.1081/COPD-200057610; Garrido PC, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-31; Celli BR, 2006, EUR RESPIR J, V27, P242, DOI 10.1183/09031936.06.00129305; de Torres JP, 2005, CHEST, V128, P2012, DOI 10.1378/chest.128.4.2012; Enright P, 2006, CHEST, V129, P833, DOI 10.1378/chest.129.4.833; Feenstra TL, 2001, AM J RESP CRIT CARE, V164, P590, DOI 10.1164/ajrccm.164.4.2003167; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Global Initiative for Chronic Obstructive Lung Disease, 2006, GLOB STRAT DIAGN MAN; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Halbert RJ, 2003, CHEST, V123, P1684, DOI 10.1378/chest.123.5.1684; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hardie JA, 2002, EUR RESPIR J, V20, P1117, DOI 10.1183/09031936.02.00023202; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hnizdo E, 2002, AM J EPIDEMIOL, V156, P738, DOI 10.1093/aje/kwf105; Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32; Hnizdo Eva, 2006, COPD, V3, P95, DOI 10.1080/15412550600651552; Hoogendoorn M, 2005, EUR RESPIR J, V26, P223, DOI 10.1183/09031936.05.00122004; LOHR S, 1999, DESIGN ANAL; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Lundback B, 2003, RESP MED, V97, P115, DOI 10.1053/rmed.2003.1446; Mannino DM, 2007, THORAX, V62, P237, DOI 10.1136/thx.2006.068379; Mannino DM, 2006, RESP MED, V100, P115, DOI 10.1016/j.rmed.2005.03.035; *MAP RES I, LING VAL METH; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Perez-Padilla R, 2006, RESP CARE, V51, P1167; Ran Pi-xin, 2006, Zhonghua Nei Ke Za Zhi, V45, P974; Schirnhofer L, 2007, CHEST, V131, P29, DOI 10.1378/chest.06-0365; Silverman EK, 2000, AM J RESP CRIT CARE, V162, P2152, DOI 10.1164/ajrccm.162.6.2003112; Stein CE, 1997, THORAX, V52, P895, DOI 10.1136/thx.52.10.895; Tinkelman D, 2003, AM J MANAG CARE, V9, P767; Venables WN., 2002, MODERN APPL STAT S 4, V4th Ed., DOI [10.1007/978-0-387-21706-2, 10.1007/978-1-4757-2719-7_7]	37	1434	1529	2	112	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2007	370	9589					741	750		10.1016/S0140-6736(07)61377-4	http://dx.doi.org/10.1016/S0140-6736(07)61377-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206UV	17765523				2022-12-01	WOS:000249209300028
J	Di Talia, S; Skotheim, JM; Bean, JM; Siggia, ED; Cross, FR				Di Talia, Stefano; Skotheim, Jan M.; Bean, James M.; Siggia, Eric D.; Cross, Frederick R.			The effects of molecular noise and size control on variability in the budding yeast cell cycle	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION; CLN3; DIVISION; START; PROMOTERS; KINASES; GROWTH; GENE	Molecular noise in gene expression can generate substantial variability in protein concentration(1). However, its effect on the precision of a natural eukaryotic circuit such as the control of cell cycle remains unclear. We use single-cell imaging of fluorescently labelled budding yeast to measure times from division to budding (G1) and from budding to the next division. The variability in G1 decreases with the square root of the ploidy through a 1N/2N/4N ploidy series, consistent with simple stochastic models for molecular noise. Also, increasing the gene dosage of G1 cyclins decreases the variability in G1. A new single-cell reporter for cell protein content allows us to determine the contribution to temporal G1 variability of deterministic size control (that is, smaller cells extending G1). Cell size control contributes significantly to G1 variability in daughter cells but not in mother cells. However, even in daughters, size-independent noise is the largest quantitative contributor to G1 variability. Exit of the transcriptional repressor Whi5 from the nucleus partitions G1 into two temporally uncorrelated and functionally distinct steps. The first step, which depends on the G1 cyclin gene CLN3, corresponds to noisy size control that extends G1 in small daughters, but is of negligible duration in mothers. The second step, whose variability decreases with increasing CLN2 gene dosage, is similar in mothers and daughters. This analysis decomposes the regulatory dynamics of the Start transition into two independent modules, a size sensing module and a timing module, each of which is predominantly controlled by a different G1 cyclin.	Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA	Rockefeller University	Cross, FR (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10021 USA.	fcross@mail.rockefeller.edu	Skotheim, Jan/C-3238-2015	Skotheim, Jan/0000-0001-8420-6820; Bean, James/0000-0001-6733-5794; Di Talia, Stefano/0000-0001-9758-7925				Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; Bi E, 1998, J CELL BIOL, V142, P1301, DOI 10.1083/jcb.142.5.1301; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; CROSS FR, 1995, CURR OPIN CELL BIOL, V7, P790, DOI 10.1016/0955-0674(95)80062-X; CROSS FR, 1988, MOL CELL BIOL, V8, P4675, DOI 10.1128/MCB.8.11.4675; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; DONNAN L, 1983, NATURE, V304, P630, DOI 10.1038/304630a0; ELLIOTT SG, 1978, P NATL ACAD SCI USA, V75, P4384, DOI 10.1073/pnas.75.9.4384; HARTWELL LH, 1977, J CELL BIOL, V75, P422, DOI 10.1083/jcb.75.2.422; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Koch C, 1996, GENE DEV, V10, P129, DOI 10.1101/gad.10.2.129; LORD PG, 1983, J CELL SCI, V59, P183; LORD PG, 1981, J CELL SCI, V50, P361; McInerny CJ, 1997, GENE DEV, V11, P1277, DOI 10.1101/gad.11.10.1277; MOORE SA, 1988, J BIOL CHEM, V263, P9674; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; NURSE P, 1980, NATURE, V286, P9, DOI 10.1038/286009a0; Samoilov MS., 2006, NAT REV GENET, V2006, pr, DOI [10.1126/stke.3662006re17, DOI 10.1126/STKE.3662006RE17]; Schroedinger E., 1944, WHAT IS LIFE; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; STUART D, 1995, GENE DEV, V9, P2780, DOI 10.1101/gad.9.22.2780; Sveiczer A, 1996, J CELL SCI, V109, P2947; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; WHEALS AE, 1982, MOL CELL BIOL, V2, P361, DOI 10.1128/MCB.2.4.361; Wijnen H, 2002, MOL CELL BIOL, V22, P4402, DOI 10.1128/MCB.22.12.4402-4418.2002; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606	30	329	333	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2007	448	7156					947	U12		10.1038/nature06072	http://dx.doi.org/10.1038/nature06072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202OM	17713537				2022-12-01	WOS:000248912900051
J	Ji, HB; Ramsey, MR; Hayes, DN; Fan, C; McNamara, K; Kozlowski, P; Torrice, C; Wu, MC; Shimamura, T; Perera, SA; Liang, MC; Cai, DP; Naumov, GN; Bao, L; Contreras, CM; Li, DN; Chen, L; Krishnamurthy, J; Koivunen, J; Chirieac, LR; Padera, RF; Bronson, RT; Lindeman, NI; Christiani, DC; Lin, XH; Shapiro, GI; Janne, PA; Johnson, BE; Meyerson, M; Kwiatkowski, DJ; Castrillon, DH; Bardeesy, N; Sharpless, NE; Wong, KK				Ji, Hongbin; Ramsey, Matthew R.; Hayes, D. Neil; Fan, Cheng; McNamara, Kate; Kozlowski, Piotr; Torrice, Chad; Wu, Michael C.; Shimamura, Takeshi; Perera, Samanthi A.; Liang, Mei-Chih; Cai, Dongpo; Naumov, George N.; Bao, Lei; Contreras, Cristina M.; Li, Danan; Chen, Liang; Krishnamurthy, Janakiraman; Koivunen, Jussi; Chirieac, Lucian R.; Padera, Robert F.; Bronson, Roderick T.; Lindeman, Neal I.; Christiani, David C.; Lin, Xihong; Shapiro, Geoffrey I.; Jaenne, Pasi A.; Johnson, Bruce E.; Meyerson, Matthew; Kwiatkowski, David J.; Castrillon, Diego H.; Bardeesy, Nabeel; Sharpless, Norman E.; Wong, Kwok-Kin			LKB1 modulates lung cancer differentiation and metastasis	NATURE			English	Article							MOUSE MODEL; CELL; EXPRESSION; ADENOCARCINOMAS; IDENTIFICATION; ACTIVATION; NORMALIZATION; INACTIVATION; P16(INK4A); LKB1/STK11	Germline mutation in serine/ threonine kinase 11 ( STK11, also called LKB1) results in Peutz - Jeghers syndrome, characterized by intestinal hamartomas and increased incidence of epithelial cancers(1). Although uncommon in most sporadic cancers(2), inactivating somatic mutations of LKB1 have been reported in primary human lung adenocarcinomas and derivative cell lines(3-5). Here we used a somatically activatable mutant Kras- driven model of mouse lung cancer to compare the role of Lkb1 to other tumour suppressors in lung cancer. Although Kras mutation cooperated with loss of p53 or Ink4a/ Arf ( also known as Cdkn2a) in this system, the strongest cooperation was seen with homozygous inactivation of Lkb1. Lkb1- deficient tumours demonstrated shorter latency, an expanded histological spectrum ( adeno-, squamous and large- cell carcinoma) and more frequent metastasis compared to tumours lacking p53 or Ink4a/ Arf. Pulmonary tumorigenesis was also accelerated by hemizygous inactivation of Lkb1. Consistent with these findings, inactivation of LKB1 was found in 34% and 19% of 144 analysed human lung adenocarcinomas and squamous cell carcinomas, respectively. Expression profiling in human lung cancer cell lines and mouse lung tumours identified a variety of metastasis-promoting genes, such as NEDD9, VEGFC and CD24, as targets of LKB1 repression in lung cancer. These studies establish LKB1 as a critical barrier to pulmonary tumorigenesis, controlling initiation, differentiation and metastasis.	Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Environm Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biostat, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ludwig Ctr Dana Farber, Harvard Canc Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Translat Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Surg, Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Tennessee System; University of Tennessee Health Science Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Wong, KK (corresponding author), Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA.	nelbardeesy@partners.org; nes@med.unc.edu; kwong1@partners.org	Meyerson, Matthew L/E-7123-2012; Wu, Michael/X-5084-2019; Chirieac, Lucian R./AAD-2030-2019; Kozlowski, Piotr/I-1860-2019; ji, Hongbin/I-5625-2017	Wu, Michael/0000-0002-3357-6570; Kozlowski, Piotr/0000-0003-3770-7715; ji, Hongbin/0000-0003-0891-6390; Ramsey, Matthew/0000-0003-2402-8502; Koivunen, Jussi/0000-0001-6425-1640; wong, kwok kin/0000-0001-6323-235X; Liang, Mei-Chih/0000-0002-7389-2455; Hayes, D. Neil/0000-0001-6203-7771; Chen, Liang/0000-0001-7300-6604; Sharpless, Norman/0000-0001-7078-9455				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Avizienyte E, 1999, AM J PATHOL, V154, P677, DOI 10.1016/S0002-9440(10)65314-X; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carretero J, 2004, ONCOGENE, V23, P4037, DOI 10.1038/sj.onc.1207502; Entius MM, 1997, GUT, V41, P320, DOI 10.1136/gut.41.3.320; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hayes DN, 2006, J CLIN ONCOL, V24, P5079, DOI 10.1200/JCO.2005.05.1748; Hearle N, 2006, CLIN CANCER RES, V12, P3209, DOI 10.1158/1078-0432.CCR-06-0083; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kozlowski P, 2007, HUM GENET, V121, P389, DOI 10.1007/s00439-006-0308-9; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Tuveson DA, 1999, ONCOGENE, V18, P5318, DOI 10.1038/sj.onc.1203107; Volikos E, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039875; Zhuang ZG, 2006, MOL CANCER RES, V4, P843, DOI 10.1158/1541-7786.MCR-06-0118	36	752	816	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					807	U7		10.1038/nature06030	http://dx.doi.org/10.1038/nature06030			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17676035				2022-12-01	WOS:000248754200040
J	Dodoo, A; Adjei, S; Couper, M; Hugman, B; Edwards, R				Dodoo, Alexander; Adjei, Sam; Couper, Mary; Hugman, Bruce; Edwards, Ralph			When rumours derail a mass deworming exercise	LANCET			English	Editorial Material							COMMUNITY PERCEPTION		Univ Ghana, Sch Med, Korle Bu Teaching Hosp, Ctr Trop Clin Pharmacol & Therapeut, Accra, Ghana; Ghana Hlth Serv, Accra, Ghana; WHO, PSM QSM, CH-1211 Geneva, Switzerland; Uppsala Monitoring Ctr, Uppsala, Sweden	University of Ghana; Ghana Health Service; World Health Organization	Dodoo, A (corresponding author), Univ Ghana, Sch Med, Korle Bu Teaching Hosp, Ctr Trop Clin Pharmacol & Therapeut, Accra, Ghana.	alexooo@yahoo.com						Brooker S, 2001, TROP MED INT HEALTH, V6, P1075, DOI 10.1046/j.1365-3156.2001.00806.x; *GHANAWEB, 2007, DEW DRUG IS SAF GHS; *GHANAWEB, 2007, DEW SCAR HITS VOLT; *GHANAWEB, 2007, NO PUP HAS DIED DEW; *UGMS CTR PHARM, 2007, MIN HLTH RESP CONC N; Ulukanligil M, 2006, AM J TROP MED HYG, V75, P1063, DOI 10.4269/ajtmh.2006.75.1063; 2007, DAILY GUIDE     0213; 1997, LANCET, V350, P1041; 1998, EFFECTIVE COMMUNICAT	9	24	24	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	2007	370	9586					465	466		10.1016/S0140-6736(07)61211-2	http://dx.doi.org/10.1016/S0140-6736(07)61211-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	199TJ	17693161				2022-12-01	WOS:000248717800008
J	Brack, AS; Conboy, MJ; Roy, S; Lee, M; Kuo, CJ; Keller, C; Rando, TA				Brack, Andrew S.; Conboy, Michael J.; Roy, Sudeep; Lee, Mark; Kuo, Calvin J.; Keller, Charles; Rando, Thomas A.			Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis	SCIENCE			English	Article							GENE-EXPRESSION; BETA-CATENIN; PATHWAY; AGE; TRANSCRIPTION; REGENERATION; ACTIVATION; MICE	The regenerative potential of skeletal muscle declines with age, and this impairment is associated with an increase in tissue fibrosis. We show that muscle stem cells (satellite cells) from aged mice tend to convert from a myogenic to a fibrogenic lineage as they begin to proliferate and that this conversion is mediated by factors in the systemic environment of the old animals. We also show that this lineage conversion is associated with an activation of the canonical Wnt signaling pathway in aged myogenic progenitors and can be suppressed by Wnt inhibitors. Furthermore, components of serum from aged mice that bind to the Frizzled family of proteins, which are Wnt receptors, may account for the elevated Wnt signaling in aged cells. These results indicate that the Wnt signaling pathway may play a critical role in tissue-specific stem cell aging and an increase in tissue fibrosis with age.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; VA Palo Alto Hlth Care Syst, CRECC, Stanford, CA 94305 USA; VA Palo Alto Hlth Care Syst, Neurol Serv, Stanford, CA 94305 USA	Stanford University; Stanford University; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	rando@stanford.edu		Rando, Thomas/0000-0001-5843-8564; Keller, Charles/0000-0003-2505-7487; Kuo, Calvin/0000-0002-7427-5985	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023806, R01AG023806] Funding Source: NIH RePORTER; NIA NIH HHS [AG23806] Funding Source: Medline; NIDDK NIH HHS [DK069989] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Conboy IM, 2005, CELL CYCLE, V4, P407, DOI 10.4161/cc.4.3.1518; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; DasGupta R, 1999, DEVELOPMENT, V126, P4557; GOLDSPINK G, 1994, NEUROMUSCULAR DISORD, V4, P183, DOI 10.1016/0960-8966(94)90019-1; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Hagen T, 2002, J BIOL CHEM, V277, P23330, DOI 10.1074/jbc.M201364200; Holowacz T, 2006, DEV DYNAM, V235, P633, DOI 10.1002/dvdy.20672; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jiang F, 2006, J HEPATOL, V45, P401, DOI 10.1016/j.jhep.2006.03.016; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3	17	1034	1109	4	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2007	317	5839					807	810		10.1126/science.1144090	http://dx.doi.org/10.1126/science.1144090			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690295				2022-12-01	WOS:000248624500041
J	Feliciangeli, S; Bendahhou, S; Sandoz, G; Gounon, P; Reichold, M; Warth, R; Lazdunski, M; Barhanin, J; Lesage, F				Feliciangeli, Sylvain; Bendahhou, Said; Sandoz, Guillaume; Gounon, Pierre; Reichold, Markus; Warth, Richard; Lazdunski, Michel; Barhanin, Jacques; Lesage, Florian			Does sumoylation control K2P1/TWIK1 background K+ channels?	CELL			English	Article							POTASSIUM CHANNELS; TWIK-1; PHARMACOLOGY; EXPRESSION; SUMO-1; KIDNEY	A novel model for the regulation of cell excitability has recently been proposed. It originates from the observation that the background K+ channel K2P1 (TWIK1) may be silenced by sumoylation in Xenopus oocytes and that inactivation of the putative sumoylation site ( mutation K274E) gives rise to robust current expression in transfected COS-7 cells. Here, we show that only the mutation K274E, and not K274R, is associated with an increase of K2P1 current density, suggesting a charge effect of K274E. Furthermore, we failed to observe any band shift by western blot analysis that would confirm an eventual sumoylation of K2P1 in COS-7 cells and oocytes.	CNRS, Inst Paul Hamel, Inst Pharmacol Mol & Cellulaire, UMR6097, 660 Route Lucioles, F-06560 Valbonne, France; Univ Nice, Ctr Commun Microscopie Appl, F-06108 Nice, France; Inst Physiol, D-93053 Regensburg, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Lesage, F (corresponding author), CNRS, Inst Paul Hamel, Inst Pharmacol Mol & Cellulaire, UMR6097, 660 Route Lucioles, F-06560 Valbonne, France.	lesage@ipmc.cnrs.fr	Warth, Richard/N-7119-2014; sandoz, guillaume/AAI-9236-2020; Feliciangeli, Sylvain/Q-1292-2016; Lesage, Florian/D-5097-2011; Reichold, Markus/J-9933-2015; Lesage, Florian/P-9780-2019	Warth, Richard/0000-0001-6084-0659; sandoz, guillaume/0000-0003-1251-0852; Feliciangeli, Sylvain/0000-0003-3358-3719; Lesage, Florian/0000-0002-4406-7106; Lesage, Florian/0000-0002-4406-7106				Altschuler Y, 1999, J CELL BIOL, V147, P7, DOI 10.1083/jcb.147.1.7; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Decressac S, 2004, EMBO REP, V5, P1171, DOI 10.1038/sj.embor.7400292; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; Kim D, 2005, CURR PHARM DESIGN, V11, P2717, DOI 10.2174/1381612054546824; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Knuesel M, 2005, MOL CELL PROTEOMICS, V4, P1626, DOI 10.1074/mcp.T500011-MCP200; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Lesage F, 1996, EMBO J, V15, P6400, DOI 10.1002/j.1460-2075.1996.tb01031.x; Lesage F, 1997, FEBS LETT, V402, P28, DOI 10.1016/S0014-5793(96)01491-3; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Nie X, 2005, PFLUG ARCH EUR J PHY, V451, P479, DOI 10.1007/s00424-005-1480-9; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Patel AJ, 2000, J BIOL CHEM, V275, P28722, DOI 10.1074/jbc.M003755200; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Talley EM, 2003, NEUROSCIENTIST, V9, P46, DOI 10.1177/1073858402239590; Tang ZS, 2005, J BIOL CHEM, V280, P38153, DOI 10.1074/jbc.M508168200; WILSON VG, 2005, STKE 2005	23	66	70	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2007	130	3					563	569		10.1016/j.cell.2007.06.012	http://dx.doi.org/10.1016/j.cell.2007.06.012			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693262	Bronze			2022-12-01	WOS:000249038100022
J	Lee, NK; Sowa, H; Hinoi, E; Ferron, M; Ahn, JD; Confavreux, C; Dacquin, R; Mee, PJ; Mckee, MD; Jung, DY; Zhang, Z; Kim, JK; Mauvais-Jarvis, F; Ducy, P; Karsenty, G				Lee, Na Kyung; Sowa, Hideaki; Hinoi, Eiichi; Ferron, Mathieu; Ahn, Jong Deok; Confavreux, Cyrille; Dacquin, Romain; Mee, Patrick J.; Mckee, Marc D.; Jung, Dae Young; Zhang, Zhiyou; Kim, Jason K.; Mauvais-Jarvis, Franck; Ducy, Patricia; Karsenty, Gerard			Endocrine regulation of energy metabolism by the skeleton	CELL			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; INSULIN-RESISTANCE; BONE MASS; DIABETES-MELLITUS; OSTEOBLAST; MICE; ADIPONECTIN; OBESITY; LEPTIN; OSTEOCALCIN	The regulation of bone remodeling by an adipocyte-derived hormone implies that bone may exert a feedback control of energy homeostasis. To test this hypothesis we looked for genes expressed in osteoblasts, encoding signaling molecules and affecting energy metabolism. We show here that mice lacking the protein tyrosine phosphatase OST-PTP are hypoglycemic and are protected from obesity and glucose intolerance because of an increase in beta-cell proliferation, insulin secretion, and insulin sensitivity. In contrast, mice lacking the osteoblast-secreted molecule osteocalcin display decreased beta-cell proliferation, glucose intolerance, and insulin resistance. Removing one Osteocalcin allele from OST-PTP-deficient mice corrects their metabolic phenotype. Ex vivo, osteocalcin can stimulate CyclinD1 and Insulin expression in beta-cells and Adiponectin, an insulin-sensitizing adipokine, in adipocytes; in vivo osteocalcin can improve glucose tolerance. By revealing that the skeleton exerts an endocrine regulation of sugar homeostasis this study expands the biological importance of this organ and our understanding of energy metabolism.	Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; CHO A Pharm, CHO A Biotechnol Res Inst, Seoul 143701, South Korea; Ecole Normale Super Lyon, Lab Endocrinol Mol & Differenciat Hematopoiet & O, UMR5161, F-69364 Lyon, France; Univ Cambridge, Ctr Stem Cell Res, Cambridge CB2 1TN, England; McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; Penn State Univ, Milton S Hershey Med Ctr, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA	Columbia University; Columbia University; Ecole Normale Superieure de Lyon (ENS de LYON); University of Cambridge; McGill University; McGill University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Northwestern University	Karsenty, G (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA.	gk2172@columbia.edu	McKee, Marc D/E-2187-2011; Ferron, Mathieu/M-7794-2013	McKee, Marc D/0000-0001-8349-965X; Kim, Jason/0000-0002-7185-042X	NIAMS NIH HHS [R01 AR045548-08, R01 AR045548] Funding Source: Medline; NICHD NIH HHS [R01 HD065439] Funding Source: Medline; NIDDK NIH HHS [R01 DK080756] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080756] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berkner KL, 2005, ANNU REV NUTR, V25, P127, DOI 10.1146/annurev.nutr.25.050304.092713; BRECHER G, 1965, J EXP MED, V121, P395, DOI 10.1084/jem.121.3.395; Cousin W, 2004, BIOCHEM BIOPH RES CO, V321, P259, DOI 10.1016/j.bbrc.2004.06.137; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Dacquin R, 2004, DEV DYNAM, V229, P826, DOI 10.1002/dvdy.20003; DeGroot LJ., 2001, ENDOCRINOLOGY, V4th ed.; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Elefteriou F, 2006, CELL METAB, V4, P441, DOI 10.1016/j.cmet.2006.10.010; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; MARUYAMA H, 1984, J CLIN INVEST, V74, P2296, DOI 10.1172/JCI111658; MAURO LJ, 1994, J BIOL CHEM, V269, P30659; Mauvais-Jarvis F, 2002, J CLIN INVEST, V109, P141, DOI 10.1172/JCI200213305; Mauvais-Jarvis F, 2000, DIABETES, V49, P2126, DOI 10.2337/diabetes.49.12.2126; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Otabe S, 2007, AM J PHYSIOL-ENDOC M, V293, pE210, DOI 10.1152/ajpendo.00645.2006; Price P A, 1989, Connect Tissue Res, V21, P51, DOI 10.3109/03008208909049995; Raju B, 2005, DIABETES, V54, P757, DOI 10.2337/diabetes.54.3.757; Rosato MT, 1998, CALCIFIED TISSUE INT, V63, P107, DOI 10.1007/s002239900498; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035	35	1779	1919	5	155	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2007	130	3					456	469		10.1016/j.cell.2007.05.047	http://dx.doi.org/10.1016/j.cell.2007.05.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693256	Green Submitted, Green Accepted, Bronze			2022-12-01	WOS:000249038100014
J	Butman, JA; Kim, HJ; Baggenstos, M; Ammerman, JM; Dambrosia, J; Patsalides, A; Patronas, NJ; Oldfield, EH; Lonser, RR				Butman, John A.; Kim, H. Jeffrey; Baggenstos, Martin; Ammerman, Joshua M.; Dambrosia, James; Patsalides, Athos; Patronas, Nicholas J.; Oldfield, Edward H.; Lonser, Russell R.			Mechanisms of morbid hearing loss associated with tumors of the endolymphatic sac in von Hippel-Lindau disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CENTRAL-NERVOUS-SYSTEM; NATURAL-HISTORY; VHL GENE; HEMANGIOBLASTOMAS; IDENTIFICATION; ADENOCARCINOMA; MANAGEMENT	Context Endolymphatic sac tumors (ELSTs) are associated with von Hippel-Lindau disease and cause irreversible sensorineural hearing loss (SNHL) and vestibulopathy. The underlying mechanisms of audiovestibular morbidity remain unclear and optimal timing of treatment is not known. Objective To define the mechanisms underlying audiovestibular pathophysiology associated with ELSTs. Design, Setting, and Patients Prospective and serial evaluation of patients with von Hippel-Lindau disease and ELSTs at the National Institutes of Health between May 1990 and December 2006. Main Outcome Measures Clinical findings and audiologic data were correlated with serial magnetic resonance imaging and computed tomography imaging studies to determine mechanisms underlying audiovestibular dysfunction. Results Thirty-five patients with von Hippel-Lindau disease and ELSTs in 38 ears (3 bilateral ELSTs) were identified. Tumor invasion of the otic capsule was associated with larger tumors (P = .01) and occurred in 7 ears (18%) causing SNHL (100%). No evidence of otic capsule invasion was present in the remaining 31 ears (82%). SNHL developed in 27 of these 31 ears (87%) either suddenly (14 ears; 52%) or gradually (13 ears; 48%) and 4 ears had normal hearing. Intralabyrinthine hemorrhage was found in 11 of 14 ears with sudden SNHL (79%; P < .001) but occurred in none of the 17 ears with gradual SNHL or normal hearing. Tumor size was not related to SNHL (P = .23) or vestibulopathy (P = .83). Conclusions ELST-associated SNHL and vestibulopathy may occur suddenly due to tumor-associated intralabyrinthine hemorrhage, or insidiously, consistent with endolymphatic hydrops. Both of these pathophysiologic mechanisms occur with small tumors that are not associated with otic capsule invasion.	NIH, Dept Diagnost Radiol, Ctr Clin, Bethesda, MD 20892 USA; Natl Inst Hlth & Other Commun Disorders, Neurootol Branch, NIH, Bethesda, MD USA; NINDS, Biostat Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Butman, JA (corresponding author), NIH, Dept Diagnost Radiol, Ctr Clin, Bldg 10,Room 1C365, Bethesda, MD 20892 USA.	jbutman@nih.gov	Butman, John/J-2780-2013; Butman, John A/A-2694-2008	Butman, John/0000-0002-1547-9195; 	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002855, ZIANS003053, Z01NS003053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000064, ZIADC000064] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Choo D, 2004, J NEUROSURG, V100, P480, DOI 10.3171/jns.2004.100.3.0480; Gaeta M, 1999, NEURORADIOLOGY, V41, P799, DOI 10.1007/s002340050845; Hansen MR, 2004, LARYNGOSCOPE, V114, P1470, DOI 10.1097/00005537-200408000-00028; HEFFNER DK, 1989, CANCER, V64, P2292, DOI 10.1002/1097-0142(19891201)64:11<2292::AID-CNCR2820641119>3.0.CO;2-#; Kim HJ, 2005, J NEUROSURG, V102, P503, DOI 10.3171/jns.2005.102.3.0503; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Libutti SK, 1998, SURGERY, V124, P1153, DOI 10.1067/msy.1998.91823; Libutti SK, 2000, SURGERY, V128, P1022, DOI 10.1067/msy.2000.110239; LINEHAN WM, 1995, JAMA-J AM MED ASSOC, V273, P564; Lonser RR, 2005, ANN NEUROL, V58, P392, DOI 10.1002/ana.20584; Lonser RR, 2004, NEW ENGL J MED, V350, P2481, DOI 10.1056/NEJMoa040666; Lonser RR, 2003, J NEUROSURG, V98, P106, DOI 10.3171/jns.2003.98.1.0106; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; Manski TJ, 1997, JAMA-J AM MED ASSOC, V277, P1461, DOI 10.1001/jama.277.18.1461; Megerian CA, 2002, OTOL NEUROTOL, V23, P378, DOI 10.1097/00129492-200205000-00026; MEGERIAN CA, 1995, LARYNGOSCOPE, V105, P801, DOI 10.1288/00005537-199508000-00006; NEUMANN HPH, 1991, LANCET, V337, P1052, DOI 10.1016/0140-6736(91)91705-Y; Richard S, 1998, J INTERN MED, V243, P547; Rodrigues S, 2004, OTOL NEUROTOL, V25, P599, DOI 10.1097/00129492-200407000-00030; SCHUKNECHT HF, 1975, J LARYNGOL OTOL, V89, P985, DOI 10.1017/S0022215100081305; Thomassin J M, 2000, Ann Otolaryngol Chir Cervicofac, V117, P274; Vortmeyer AO, 1997, JNCI-J NATL CANCER I, V89, P970, DOI 10.1093/jnci/89.13.970-a; Vortmeyer AO, 2000, NEUROLOGY, V55, P460, DOI 10.1212/WNL.55.3.460; Wait SD, 2004, ANN NEUROL, V55, P236, DOI 10.1002/ana.10807; WALTHER MM, 1995, J UROLOGY, V154, P2010, DOI 10.1016/S0022-5347(01)66674-6; Wanebo JE, 2003, J NEUROSURG, V98, P82, DOI 10.3171/jns.2003.98.1.0082	26	54	56	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2007	298	1					41	48		10.1001/jama.298.1.41	http://dx.doi.org/10.1001/jama.298.1.41			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185OU	17609489				2022-12-01	WOS:000247721100020
J	Korbel, JO; Urban, AE; Affourtit, JP; Godwin, B; Grubert, F; Simons, JF; Kim, PM; Palejev, D; Carriero, NJ; Du, L; Taillon, BE; Chen, ZT; Tanzer, A; Saunders, ACE; Chi, JX; Yang, FT; Carter, NP; Hurles, ME; Weissman, SM; Harkins, TT; Gerstein, MB; Egholm, M; Snyder, M				Korbel, Jan O.; Urban, Alexander Eckehart; Affourtit, Jason P.; Godwin, Brian; Grubert, Fabian; Simons, Jan Fredrik; Kim, Philip M.; Palejev, Dean; Carriero, Nicholas J.; Du, Lei; Taillon, Bruce E.; Chen, Zhoutao; Tanzer, Andrea; Saunders, A. C. Eugenia; Chi, Jianxiang; Yang, Fengtang; Carter, Nigel P.; Hurles, Matthew E.; Weissman, Sherman M.; Harkins, Timothy T.; Gerstein, Mark B.; Egholm, Michael; Snyder, Michael			Paired-end mapping reveals extensive structural variation in the human genome	SCIENCE			English	Article							COPY NUMBER VARIATION; SEGMENTAL DUPLICATIONS; ARRAY CGH; RESOLUTION; SUSCEPTIBILITY; POLYMORPHISM; BREAKPOINTS; VARIANTS	Structural variation of the genome involves kilobase- to megabase-sized deletions, duplications, insertions, inversions, and complex combinations of rearrangements. We introduce high-throughput and massive paired- end mapping (PEM), a large-scale genome-sequencing method to identify structural variants (SVs) similar to 3 kilobases (kb) or larger that combines the rescue and capture of paired ends of 3-kb fragments, massive 454 sequencing, and a computational approach to map DNA reads onto a reference genome. PEM was used to map SVs in an African and in a putatively European individual and identified shared and divergent SVs relative to the reference genome. Overall, we fine-mapped more than 1000 SVs and documented that the number of SVs among humans is much larger than initially hypothesized; many of the SVs potentially affect gene function. The breakpoint junction sequences of more than 200 SVs were determined with a novel pooling strategy and computational analysis. Our analysis provided insights into the mechanisms of SV formation in humans.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; 454 Life Sci, Branford, CT 06405 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; Univ Leipzig, Dept Comp Sci, D-04107 Leipzig, Germany; Univ Vienna, Inst Theoret Chem, A-1090 Vienna, Austria; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Roche Appl Sci, Indianapolis, IN 46250 USA; Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA	Yale University; European Molecular Biology Laboratory (EMBL); Yale University; Yale University; Yale University; Yale University; Leipzig University; University of Vienna; Wellcome Trust Sanger Institute; Roche Holding; Yale University	Egholm, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	megholm@454.com; michael.snyder@yale.edu	Korbel, Jan O/G-6470-2012; Tanzer, Andrea/L-3147-2015; Tanzer, Andrea/AAY-5431-2021	Korbel, Jan O/0000-0002-2798-3794; Tanzer, Andrea/0000-0003-2873-4236; Tanzer, Andrea/0000-0003-2873-4236; Snyder, Michael/0000-0003-0784-7987; Palejev, Dean/0000-0002-0563-6636	NCRR NIH HHS [RR19895, S10 RR019895] Funding Source: Medline; Wellcome Trust [077008, 077014] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Belshaw R, 2005, J VIROL, V79, P12507, DOI 10.1128/JVI.79.19.12507-12514.2005; Coe BP, 2007, GENOMICS, V89, P647, DOI 10.1016/j.ygeno.2006.12.012; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Kim Philip, UNPUB; Korbel JO, 2007, P NATL ACAD SCI USA, V104, P10110, DOI 10.1073/pnas.0703834104; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Urban AE, 2006, P NATL ACAD SCI USA, V103, P4534, DOI 10.1073/pnas.0511340103	23	823	920	0	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2007	318	5849					420	426		10.1126/science.1149504	http://dx.doi.org/10.1126/science.1149504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17901297	Green Accepted			2022-12-01	WOS:000250230400038
J	Burke, W; Psaty, BM				Burke, Wylie; Psaty, Bruce M.			Personalized medicine in the era of genomics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WIDE ASSOCIATION; RISK; BREAST; SUSCEPTIBILITY; VARIANT; PHARMACOGENETICS; ALLELES; DISEASE; GENES		Univ Washington, Dept Med Hist & Eth, Seattle, WA 98195 USA; Univ Washington, Ctr Genom & Healthcare Equal, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; Univ Washington, Grp Hlth, Hlth Serv Ctr Hlth Studies, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Burke, W (corresponding author), Univ Washington, Dept Med Hist & Eth, Box 257120, Seattle, WA 98195 USA.	wbuk@u.washington.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL074745, R01HL068639, R01HL085251, R01HL087652, R01HL080295, R01HL043201, R01HL060739] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003374] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50HG003374] Funding Source: Medline; NHLBI NIH HHS [HL085251, HL087652, HL68639, HL080295, HL60739, HL43201, HL74745] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altshuler D, 2007, NAT GENET, V39, P813, DOI 10.1038/ng0707-813; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Berg AO, 2005, ANN INTERN MED, V143, P355, DOI 10.7326/0003-4819-143-5-200509060-00011; Bowersox J, 2001, PEDIATRICS, V108, P972; Christensen K, 2007, NEW ENGL J MED, V356, P1094, DOI 10.1056/NEJMp068126; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Goldstein DB, 2003, NAT REV GENET, V4, P937, DOI 10.1038/nrg1229; Guttmacher AE, 2003, NEW ENGL J MED, V349, P996, DOI 10.1056/NEJMe038132; Guttmacher AE, 2007, NAT REV GENET, V8, P151, DOI 10.1038/nrg2007; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Marteau TM, 2006, SOC SCI MED, V62, P1360, DOI 10.1016/j.socscimed.2005.08.005; Pharoah PDP, 2007, PLOS GENET, V3, P401, DOI 10.1371/journal.pgen.0030042; Rockhill B, 2000, EPIDEMIOL REV, V22, P176, DOI 10.1093/oxfordjournals.epirev.a018017; Roses AD, 2004, NAT REV GENET, V5, P645, DOI 10.1038/nrg1432; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Schaumberg DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P55, DOI 10.1001/archopht.125.1.55; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; Wilkinson JM, 2003, AM J HEALTH PROMOT, V18, P157, DOI 10.4278/0890-1171-18.2.157; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618	25	151	157	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2007	298	14					1682	1684		10.1001/jama.298.14.1682	http://dx.doi.org/10.1001/jama.298.14.1682			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218IO	17925520				2022-12-01	WOS:000250009400024
J	Garrett, WS; Lord, GM; Punit, S; Lugo-Villarino, G; Mazmanian, SK; Ito, S; Glickman, JN; Glimcher, LH				Garrett, Wendy S.; Lord, Graham M.; Punit, Shivesh; Lugo-Villarino, Geanncarlo; Mazmanian, Sarkis K.; Ito, Susumu; Glickman, Jonathan N.; Glimcher, Laurie H.			Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system	CELL			English	Article							COLONIC DENDRITIC CELLS; ACTIVATION; RESPONSES; CURE	Inflammatory bowel disease (IBD) has been attributed to overexuberant host immunity or the emergence of harmful intestinal flora. The transcription factor T-bet orchestrates inflammatory genetic programs in both adaptive and innate immunity. We describe a profound and unexpected function for T-bet in influencing the behavior of host inflammatory activity and commensal bacteria. T-bet deficiency in the innate immune system results in spontaneous and communicable ulcerative colitis in the absence of adaptive immunity and increased susceptibility to colitis in immunologically intact hosts. T-bet controls the response of the mucosal immune system to commensal bacteria by regulating TNF-alpha production in colonic dendritic cells, critical for colonic epithelial barrier maintenance. Loss of T-bet influences bacterial populations to become colitogenic, and this colitis is communicable to genetically intact hosts. These findings reveal a novel function for T-bet as a peacekeeper of host-commensal relationships and provide new perspectives on the pathophysiology of IBD.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Guys & St Thomas NHS Fdn Trust, NIHR Biomed Res Ctr, London SE1 9RT, England; Kings Coll London, London WC2R 2LS, England	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; California Institute of Technology; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Lord, GM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.	graham.lord@kcl.ac.uk; lglimche@hsph.harvard.edu	Mazmanian, Sarkis/ABD-7729-2021; Abraham, Sabu/E-1144-2019; Lord, Graham M/B-3797-2011; Eckhardt, Erik/G-1567-2010; Lugo, Geanncarlo/H-4674-2019	Mazmanian, Sarkis/0000-0003-2713-1513; Abraham, Sabu/0000-0002-0916-5827; Lugo, Geanncarlo/0000-0003-4620-8491; Garrett, Wendy/0000-0002-5092-0150; Lord, Graham/0000-0003-2069-4743	NATIONAL CANCER INSTITUTE [R01CA112663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056296] Funding Source: NIH RePORTER; Medical Research Council [G108/380] Funding Source: Medline; NCI NIH HHS [R01 CA112663, CA112663, R01 CA112663-06, R01 CA112663-07] Funding Source: Medline; NIAID NIH HHS [P01 AI056296-04, P01 AI056296-05, P01 AI056296, P01 AI056296-02, P01 AI056296-01, P01 AI056296-010001, AI56296, P01 AI056296-03] Funding Source: Medline; MRC [G108/380] Funding Source: UKRI	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baumgart DC, 1998, CELL IMMUNOL, V187, P52, DOI 10.1006/cimm.1998.1307; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Bruewer M, 2006, ANN NY ACAD SCI, V1072, P242, DOI 10.1196/annals.1326.017; CAMERINI V, 1993, J IMMUNOL, V151, P1765; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Dorfman DM, 2003, AM J CLIN PATHOL, V120, P866, DOI 10.1309/J3CTLTTJEVUY4YL0; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Glimcher LH, 2007, NAT IMMUNOL, V8, P448, DOI 10.1038/ni0507-448; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Lan JG, 2005, WORLD J GASTROENTERO, V11, P3375, DOI 10.3748/wjg.v11.i22.3375; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Magalhaes JG, 2007, SEMIN IMMUNOL, V19, P106, DOI 10.1016/j.smim.2006.12.006; Maloy KJ, 2005, IMMUNOL LETT, V97, P189, DOI 10.1016/j.imlet.2005.01.004; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Niess JH, 2006, CURR OPIN GASTROEN, V22, P354, DOI 10.1097/01.mog.0000231807.03149.54; Rakoff-Nahoum S, 2006, CURR TOP MICROBIOL, V308, P1; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rigby RJ, 2005, CLIN EXP IMMUNOL, V139, P245, DOI 10.1111/j.1365-2249.2004.02674.x; Rogler G, 2001, SCAND J GASTROENTERO, V36, P389, DOI 10.1080/003655201300051216; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Shen C, 2006, INFLAMM BOWEL DIS, V12, P22, DOI 10.1097/01.MIB.0000194185.69800.07; Silva MA, 2004, INFLAMM BOWEL DIS, V10, P504, DOI 10.1097/00054725-200409000-00003; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tannock GW, 2007, SEMIN IMMUNOL, V19, P94, DOI 10.1016/j.smim.2006.09.001; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Weigmann B, 2002, GUT, V51, P301, DOI 10.1136/gut.51.3.301; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590	36	688	731	2	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2007	131	1					33	45		10.1016/j.cell.2007.08.017	http://dx.doi.org/10.1016/j.cell.2007.08.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923086	Green Accepted, Bronze			2022-12-01	WOS:000249934700009
J	Asser-Kaiser, S; Fritsch, E; Undorf-Spahn, K; Kienzle, J; Eberle, KE; Gund, NA; Reineke, A; Zebitz, CPW; Heckel, DG; Huber, J; Jehle, JA				Asser-Kaiser, S.; Fritsch, E.; Undorf-Spahn, K.; Kienzle, J.; Eberle, K. E.; Gund, N. A.; Reineke, A.; Zebitz, C. P. W.; Heckel, D. G.; Huber, J.; Jehle, J. A.			Rapid emergence of baculovirus resistance in codling moth due to dominant, sex-linked inheritance	SCIENCE			English	Article								Insect-specific baculoviruses are increasingly used as biological control agents of lepidopteran pests in agriculture and forestry, and they have been previously regarded as robust to resistance development by the insects. However, in more than a dozen cases of field resistance of the codling moth Cydia pomonella to commercially applied C. pomonella granulovirus (CpGV) in German orchards, resistance ratios exceed 1000. The rapid emergence of resistance is facilitated by sex-linkage and concentration-dependent dominance of the major resistance gene and genetic uniformity of the virus. When the gene is fixed, resistance levels approach 100,000-fold. Our findings highlight the need for development of resistance management strategies for baculoviruses.	Agr Serv Ctr Palatinate, DLR Rheinpfalz, Dept Phytopathol, Lab Biotechnol Crop Protect, D-67435 Neustadt, Germany; Fed Biol Res Ctr, Inst Biol Control, D-64287 Darmstadt, Germany; Univ Hohenheim, Inst Phytomed, D-70593 Stuttgart, Germany; Max Planck Inst Chem Ecol, Dept Entomol, D-07745 Jena, Germany	Helmholtz Association; German Aerospace Centre (DLR); University Hohenheim; Max Planck Society	Jehle, JA (corresponding author), Agr Serv Ctr Palatinate, DLR Rheinpfalz, Dept Phytopathol, Lab Biotechnol Crop Protect, Breitenweg 71, D-67435 Neustadt, Germany.	heckel@ice.mpg.de; johannes.jehle@dlr.rlp.de	Zebitz, Claus/ABW-3991-2022; Heckel, David G/K-2138-2013	Heckel, David G/0000-0001-8991-2150; Jehle, Johannes A./0000-0002-8143-7743				Briese D., 1986, BIOL BACULOVIRUSES, P89; Crook NE, 1997, J GEN VIROL, V78, P965, DOI 10.1099/0022-1317-78-4-965; Eberle KE, 2006, J INVERTEBR PATHOL, V93, P201, DOI 10.1016/j.jip.2006.07.001; Fritsch E., 2005, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V57, P29; Fukova I, 2005, GENOME, V48, P1083, DOI 10.1139/G05-063; FUXA JR, 1993, PARASITES PATHOGENS, V2, P197; Huber J., 1981, Mitteilungen der Deutschen Gesellschaft fur Allgemeine und Angewandte Entomologie, V2, P141; Hunter-Fujita FR, 1998, INSECT VIRUSES PEST; MALLET J, 1989, TRENDS ECOL EVOL, V4, P336, DOI 10.1016/0169-5347(89)90088-8; Moscardi F, 1999, ANNU REV ENTOMOL, V44, P257, DOI 10.1146/annurev.ento.44.1.257; Mota-Sanchez D, 2002, BOOK SOIL P, P241; Sauphanor B., 2006, PHYTOMA DEFENSE VEGE, V590, P24; TANADA Y, 1964, J INSECT PATHOL, V6, P378; THEILMANN DA, 2005, VIRUS TAXONOMY, P177	14	111	128	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846					1916	1918		10.1126/science.1146542	http://dx.doi.org/10.1126/science.1146542			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901332				2022-12-01	WOS:000249764300038
J	Purnell, MA; Bell, MA; Baines, DC; Hart, PJB; Travis, MP				Purnell, Mark A.; Bell, Michael A.; Baines, David C.; Hart, Paul J. B.; Travis, Matthew P.			Correlated evolution and dietary change in fossil stickleback	SCIENCE			English	Article							THREESPINE STICKLEBACK		Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England	University of Leicester; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Leicester	Purnell, MA (corresponding author), Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England.	mark.purnell@leicester.ac.uk	Purnell, Mark/A-2336-2010; Self, Casey J/B-6871-2011; Hart, Paul JB/A-1814-2008	Purnell, Mark/0000-0002-1777-9220; Hart, Paul JB/0000-0002-9188-2437	Natural Environment Research Council [NE/B000125/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bell MA, 2006, PALEOBIOLOGY, V32, P562, DOI 10.1666/05026.1; Purnell MA, 2006, J ANIM ECOL, V75, P967, DOI 10.1111/j.1365-2656.2006.01116.x; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; Schluter D., 2000, ECOLOGY ADAPTIVE RAD	4	33	35	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2007	317	5846					1887	1887		10.1126/science.1147337	http://dx.doi.org/10.1126/science.1147337			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901325				2022-12-01	WOS:000249764300029
J	Jin, MS; Kim, SE; Heo, JY; Lee, ME; Kim, HM; Paik, SG; Lee, HY; Lee, JO				Jin, Mi Sun; Kim, Sung Eun; Heo, Jin Young; Lee, Mi Eun; Kim, Ho Min; Paik, Sang-Gi; Lee, Hayyoung; Lee, Jie-Oh			Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide	CELL			English	Article							TOLL-LIKE RECEPTORS; LEUCINE-RICH REPEAT; PEPTIDOGLYCAN-ASSOCIATED LIPOPROTEIN; BORRELIA-BURGDORFERI LIPOPROTEINS; ESCHERICHIA-COLI; CUTTING EDGE; BACTERIAL LIPOPEPTIDES; LEPROMATOUS LEPROSY; TREPONEMA-PALLIDUM; OUTER MEMBRANE	TLR2 in association with TLR1 or TLR6 plays an important role in the innate immune response by recognizing microbial lipoproteins and lipopeptides. Here we present the crystal structures of the human TLR1- TLR2- lipopeptide complex and of the mouse TLR2- lipopeptide complex. Binding of the tri- acylated lipopeptide, Pam(3)CSK(4), induced the formation of an `` m'' shaped heterodimer of the TLR1 and TLR2 ectodomains whereas binding of the diacylated lipopeptide, Pam(2)CSK(4), did not. The three lipid chains of Pam3CSK4 mediate the heterodimerization of the receptor; the two esterbound lipid chains are inserted into a pocket in TLR2, while the amide- bound lipid chain is inserted into a hydrophobic channel in TLR1. An extensive hydrogen- bonding network, as well as hydrophobic interactions, between TLR1 and TLR2 further stabilize the heterodimer. We propose that formation of the TLR1- TLR2 heterodimer brings the intracellular TIR domains close to each other to promote dimerization and initiate signaling.	Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Inst Biocentury, Taejon 305701, South Korea; Chungnam Natl Univ, Sch Biosci & Biotechnol, Dept Biol, Taejon 305764, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Chungnam National University	Lee, JO (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea.	jieoh.lee@kaist.ac.kr	Kang, Jin Young/E-4384-2019; Kim, Ho Min/G-2712-2011; KIM, SUNG EUN/E-4918-2011; Lee, Jie-Oh/C-1581-2011; Lee, Jie-Oh/AAG-4302-2020	Lee, Jie-Oh/0000-0001-6519-6049				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Babu MM, 2002, BIOINFORMATICS, V18, P641, DOI 10.1093/bioinformatics/18.4.641; BELISLE JT, 1994, J BACTERIOL, V176, P2151, DOI 10.1128/JB.176.8.2151-2157.1994; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; BERG M, 1994, AM J PHYSIOL, V266, pC1684, DOI 10.1152/ajpcell.1994.266.6.C1684; BESSLER WG, 1985, J IMMUNOL, V135, P1900; Bochud PY, 2003, J IMMUNOL, V170, P3451, DOI 10.4049/jimmunol.170.7.3451; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; BRAUN V, 1975, BIOCHIM BIOPHYS ACTA, V415, P335, DOI 10.1016/0304-4157(75)90013-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Chambaud I, 1999, TRENDS MICROBIOL, V7, P493, DOI 10.1016/S0966-842X(99)01641-8; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Deininger S, 2003, J IMMUNOL, V170, P4134, DOI 10.4049/jimmunol.170.8.4134; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; Gautam JK, 2006, J BIOL CHEM, V281, P30132, DOI 10.1074/jbc.M602057200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Grabiec A, 2004, J BIOL CHEM, V279, P48004, DOI 10.1074/jbc.M405311200; HANTKE K, 1973, EUR J BIOCHEM, V34, P284, DOI 10.1111/j.1432-1033.1973.tb02757.x; Hashimoto M, 2007, INFECT IMMUN, V75, P1926, DOI 10.1128/IAI.02083-05; Henderson B, 1996, MICROBIOL REV, V60, P316, DOI 10.1128/MMBR.60.2.316-341.1996; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Iwaki D, 2005, BIOCHEM BIOPH RES CO, V328, P173, DOI 10.1016/j.bbrc.2004.12.162; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kang TJ, 2001, FEMS IMMUNOL MED MIC, V31, P53, DOI 10.1111/j.1574-695X.2001.tb01586.x; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kirk P, 2005, IMMUNITY, V23, P347, DOI 10.1016/j.immuni.2005.09.008; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Manukyan M, 2005, EUR J IMMUNOL, V35, P911, DOI 10.1002/eji.200425336; Matsushima N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-124; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meng GX, 2003, J BIOL CHEM, V278, P39822, DOI 10.1074/jbc.M304766200; MIZUNO T, 1979, J BIOCHEM-TOKYO, V86, P991, DOI 10.1093/oxfordjournals.jbchem.a132631; Morath S, 2005, J ENDOTOXIN RES, V11, P348, DOI 10.1179/096805105X67328; Morr M, 2002, EUR J IMMUNOL, V32, P3337, DOI 10.1002/1521-4141(200212)32:12<3337::AID-IMMU3337>3.0.CO;2-#; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; Nakata T, 2006, CELL MICROBIOL, V8, P1899, DOI 10.1111/j.1462-5822.2006.00756.x; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Omueti KO, 2007, J IMMUNOL, V178, P6387, DOI 10.4049/jimmunol.178.10.6387; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; SEIFERT R, 1990, BIOCHEM J, V267, P795, DOI 10.1042/bj2670795; Sellati TJ, 1998, J IMMUNOL, V160, P5455; Shibata K, 2000, J IMMUNOL, V165, P6538, DOI 10.4049/jimmunol.165.11.6538; Sugawara I, 2003, MICROBIOL IMMUNOL, V47, P327, DOI 10.1111/j.1348-0421.2003.tb03404.x; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tosatto SCE, 2005, J COMPUT BIOL, V12, P1316, DOI 10.1089/cmb.2005.12.1316; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; WIESMULLER KH, 1992, INT J PEPT PROT RES, V40, P255; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; ZLOTNICK GW, 1988, J BIOL CHEM, V263, P9790	65	949	990	3	109	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6					1071	1082		10.1016/j.cell.2007.09.008	http://dx.doi.org/10.1016/j.cell.2007.09.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889651	Bronze			2022-12-01	WOS:000250507500016
J	Tocheri, MW; Orr, CM; Larson, SG; Sutikna, T; Jatmiko; Saptomo, EW; Due, RA; Djubiantono, T; Morwood, MJ; Jungers, WL				Tocheri, Matthew W.; Orr, Caley M.; Larson, Susan G.; Sutikna, Thomas; Jatmiko; Saptomo, E. Wahyu; Due, Rokus Awe; Djubiantono, Tony; Morwood, Michael J.; Jungers, William L.			The primitive wrist of Homo floresiensis and its implications for hominin evolution	SCIENCE			English	Article							AUSTRALOPITHECUS-AFARENSIS; EASTERN INDONESIA; LATE PLEISTOCENE; OLDUVAI GORGE; GRAN DOLINA; HAND; AFFINITIES; ATAPUERCA; CAPITATE; REMAINS	Whether the Late Pleistocene hominin fossils from Flores, Indonesia, represent a new species, Homo floresiensis, or pathological modern humans has been debated. Analysis of three wrist bones from the holotype specimen (LB1) shows that it retains wrist morphology that is primitive for the African ape-human clade. In contrast, Neandertals and modern humans share derived wrist morphology that forms during embryogenesis, which diminishes the probability that pathology could result in the normal primitive state. This evidence indicates that LB1 is not a modern human with an undiagnosed pathology or growth defect; rather, it represents a species descended from a hominin ancestor that branched off before the origin of the clade that includes modern humans, Neandertals, and their last common ancestor.	Natl Museum Nat Hist, Dept Anthropol, Human Origins Program, Smithsonian Inst, Washington, DC 20013 USA; Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW 2522, Australia; Natl Res & Dev Ctr Archaeol, Jakarta, Indonesia; SUNY Stony Brook, Sch Med, Dept Anat Sci, Stony Brook, NY 11794 USA; Arizona State Univ, Inst Human Origins, Tempe, AZ 85287 USA; Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of Wollongong; National Research & Development Centre for Archaeology - Indonesia; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Tocheri, MW (corresponding author), Natl Museum Nat Hist, Dept Anthropol, Human Origins Program, Smithsonian Inst, Washington, DC 20013 USA.	tocherim@si.edu	Larson, Susan/AAL-1935-2021; Tocheri, Matthew/H-8851-2019; Tocheri, Matthew/C-5288-2013; Sutikna, Thomas/C-4709-2018	Tocheri, Matthew/0000-0001-7600-8998; Sutikna, Thomas/0000-0002-9742-4226				Argue D, 2006, J HUM EVOL, V51, P360, DOI 10.1016/j.jhevol.2006.04.013; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; CIHAK R, 1972, ERG ANAT ENTWICKLU, V46, P1; Falgueres C, 1999, J HUM EVOL, V37, P343, DOI 10.1006/jhev.1999.0326; Falk D, 2005, SCIENCE, V308, P242, DOI 10.1126/science.1109727; Jacob T, 2006, P NATL ACAD SCI USA, V103, P13421, DOI 10.1073/pnas.0605563103; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Kivell TL, 2007, J HUM EVOL, V52, P321, DOI 10.1016/j.jhevol.2006.10.002; Lewis O.J., 1989, FUNCTIONAL MORPHOLOG; Lorenzo C, 1999, J HUM EVOL, V37, P501, DOI 10.1006/jhev.1999.0341; Martin RD, 2006, ANAT REC PART A, V288A, P1123, DOI 10.1002/ar.a.20389; MARZKE MW, 1983, J HUM EVOL, V12, P197, DOI 10.1016/S0047-2484(83)80025-6; MCHENRY HM, 1983, AM J PHYS ANTHROPOL, V62, P187, DOI 10.1002/ajpa.1330620208; Moore MW, 2007, J HUM EVOL, V52, P85, DOI 10.1016/j.jhevol.2006.08.002; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; NAPIER J, 1962, NATURE, V196, P409, DOI 10.1038/196409a0; Panger MA, 2002, EVOL ANTHROPOL, V11, P235, DOI 10.1002/evan.10094; SARMIENTO EE, 2002, NEW ANATOMIST, V269, P50; Sarmiento Esteban E., 1994, American Museum Novitates, V3091, P1; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Spranger J, 2002, BONE DYSPLASIAS ATLA, V2nd; Stafford BJ, 1998, J MORPHOL, V235, P135, DOI 10.1002/(SICI)1097-4687(199802)235:2<135::AID-JMOR4>3.0.CO;2-8; SUSMAN RL, 1979, AM J PHYS ANTHROPOL, V51, P311, DOI 10.1002/ajpa.1330510303; Thorington RW, 2000, J MORPHOL, V246, P85, DOI 10.1002/1097-4687(200011)246:2<85::AID-JMOR4>3.0.CO;2-5; Tocheri M.W., 2007, THESIS ARIZONA STATE; Tocheri MW, 2005, J HUM EVOL, V49, P570, DOI 10.1016/j.jhevol.2005.06.005; Tocheri MW, 2003, AM J PHYS ANTHROPOL, V122, P101, DOI 10.1002/ajpa.10235; Ward C, 1999, EVOL ANTHROPOL, V7, P197, DOI 10.1002/(SICI)1520-6505(1999)7:6<197::AID-EVAN4>3.0.CO;2-T; Weidenreich F., 1941, Palaeontologia Sinica New Ser D, Vno. 5, P1; Zelzer E, 2003, NATURE, V423, P343, DOI 10.1038/nature01659	31	136	140	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1743	1745		10.1126/science.1147143	http://dx.doi.org/10.1126/science.1147143			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885135	Green Published			2022-12-01	WOS:000249585900046
J	Wojtowicz, WM; Wu, W; Andre, I; Qian, B; Baker, D; Zipursky, SL				Wojtowicz, Woj M.; Wu, Wei; Andre, Ingemar; Qian, Bin; Baker, David; Zipursky, S. Lawrence			A vast repertoire of Dscam binding Specificities arises from modular interactions of variable ig domains	CELL			English	Article							LEECH HAEMENTERIA-GHILIANII; SENSORY NEURONS; DROSOPHILA DSCAM; CELL-ADHESION; AXON GUIDANCE; DEVELOPMENTAL ARBORIZATION; BRANCHING PATTERN; SELF-AVOIDANCE; DIVERSITY; MORPHOGENESIS	Dscam encodes a family of cell surface proteins required for establishing neural circuits in Drosophila. Alternative splicing of Drosophila Dscam can generate 19,008 distinct extracellular domains containing different combinations of three variable immunoglobulin domains. To test the binding properties of many Dscam isoforms, we developed a high- throughput ELISA- based binding assay. We provide evidence that 95% (> 18,000) of Dscam isoforms exhibit striking isoform- specific homophilic binding. We demonstrate that each of the three variable domains binds to the same variable domain in an opposing isoform and identify the structural elements that mediate this self- binding of each domain. These studies demonstrate that self- binding domains can assemble in different combinations to generate an enormous family of homophilic binding proteins. We propose that this vast repertoire of Dscam recognition molecules is sufficient to provide each neuron with a unique identity and homotypic binding specificity, thereby allowing neuronal processes to distinguish between self and nonself.	Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Washington, Howard Hughes Med Inst, Dept Biochem, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zipursky, SL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	lzipursky@mednet.ucla.edu	Baker, David/K-8941-2012; André, Ingemar/O-4777-2014	Baker, David/0000-0001-7896-6217; André, Ingemar/0000-0002-4753-8233; Zipursky, Stephen/0000-0001-5630-7181	Howard Hughes Medical Institute Funding Source: Medline; NIDCD NIH HHS [R01 DC006485, R01 DC006485-05] Funding Source: Medline; NIGMS NIH HHS [T32 GM007185, GM07185] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006485] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bayer MW, 2007, J COMP NEUROL, V500, P850, DOI 10.1002/cne.21228; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Graveley BR, 2004, RNA, V10, P1499, DOI 10.1261/rna.7105504; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Kidd T, 2007, NEURON, V54, P350, DOI 10.1016/j.neuron.2007.04.018; KRAMER AP, 1985, J NEUROSCI, V5, P759; KRAMER AP, 1985, J NEUROSCI, V5, P768; KRAMER AP, 1983, J NEUROSCI, V3, P2474; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shapiro L, 1996, NEURON, V17, P435, DOI 10.1016/S0896-6273(00)80176-2; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Uemura T, 1998, CELL, V93, P1095, DOI 10.1016/S0092-8674(00)81452-X; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zinn K, 2007, CELL, V129, P455, DOI 10.1016/j.cell.2007.04.024; Zipursky SL, 2006, TRENDS BIOCHEM SCI, V31, P581, DOI 10.1016/j.tibs.2006.08.003	30	160	163	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2007	130	6					1134	1145		10.1016/j.cell.2007.08.026	http://dx.doi.org/10.1016/j.cell.2007.08.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889655	Green Accepted, Bronze			2022-12-01	WOS:000250507500021
J	Zhang, SY; Jouanguy, E; Ugolini, S; Smahi, A; Elain, G; Romero, P; Segal, D; Sancho-Shimizu, V; Lorenzo, L; Puel, A; Picard, C; Chapgier, A; Plancoulaine, S; Titeux, M; Cognet, C; von Bernuth, H; Ku, CL; Casrouge, A; Zhang, XX; Barreiro, L; Leonard, J; Hamilton, C; Lebon, P; Heron, B; Vallee, L; Quintana-Murci, L; Hovnanian, A; Rozenberg, F; Vivier, E; Geissmann, F; Tardieu, M; Abel, L; Casanova, JL				Zhang, Shen-Ying; Jouanguy, Emmanuelle; Ugolini, Sophie; Smahi, Asma; Elain, Gaelle; Romero, Pedro; Segal, David; Sancho-Shimizu, Vanessa; Lorenzo, Lazaro; Puel, Anne; Picard, Capucine; Chapgier, Ariane; Plancoulaine, Sabine; Titeux, Matthias; Cognet, Celine; von Bernuth, Horst; Ku, Cheng-Lung; Casrouge, Armanda; Zhang, Xin-Xin; Barreiro, Luis; Leonard, Joshua; Hamilton, Claire; Lebon, Pierre; Heron, Benedicte; Vallee, Louis; Quintana-Murci, Lluis; Hovnanian, Alain; Rozenberg, Flore; Vivier, Eric; Geissmann, Frederic; Tardieu, Marc; Abel, Laurent; Casanova, Jean-Laurent			TLR3 deficiency in patients with herpes simplex encephalitis	SCIENCE			English	Article							TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; T-LYMPHOCYTES; NK CELLS; VIRUS; RECOGNITION; EXPRESSION; GENE; ALPHA/BETA; ACTIVATION	Some Toll and Toll-like receptors (TLRs) provide immunity to experimental infections in animal models, but their contribution to host defense in natural ecosystems is unknown. We report a dominant-negative TLR3 allele in otherwise healthy children with herpes simplex virus 1 (HSV-1) encephalitis. TLR3 is expressed in the central nervous system (CNS), where it is required to control HSV-1, which spreads from the epithelium to the CNS via cranial nerves. TLR3 is also expressed in epithelial and dendritic cells, which apparently use TLR3-independent pathways to prevent further dissemination of HSV-1 and to provide resistance to other pathogens in TLR3-deficient patients. Human TLR3 appears to be redundant in host defense to most microbes but is vital for natural immunity to HSV-1 in the CNS, which suggests that neurotropic viruses have contributed to the evolutionary maintenance of TLR3.	Fac Med Necker Enfants Malad, INSERM, U550, F-75015 Paris, France; Univ Paris 05, F-75015 Paris, France; Shanghai Jiao Tong Univ, Rui Jin Hosp, French Chinese Lab Genet & Life Sci, Shanghai 200025, Peoples R China; Marseille Luminy Immunol Inst, F-13288 Marseille, France; Hop Necker Enfants Malad, INSERM, U781, Dept Genet, F-75015 Paris, France; Hop Necker Enfants Malad, INSERM, U838, Lab Mononucl Cell Biol, F-75015 Paris, France; Univ Lausanne Hosp, Lausanne Branch, Ludwig Inst Canc Res, CH-1005 Lausanne, Switzerland; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; Hop Necker Enfants Malad, Ctr Study Immunodeficiencies, F-75015 Paris, France; Univ Toulouse 3, INSERM, U563, F-31000 Toulouse, France; Inst Pasteur, CNRS, URA3012, F-75015 Paris, France; Univ Paris 05, Cochin St Vincent de Paul Hosp, F-75014 Paris, France; Trousseau Hosp, F-75012 Paris, France; Ctr Hosp Reg & Univ Lille, F-59037 Lille, France; Univ Paris Sud, Hop Bicetre, F-94720 Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Shanghai Jiao Tong University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Ludwig Institute for Cancer Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Casanova, JL (corresponding author), Fac Med Necker Enfants Malad, INSERM, U550, F-75015 Paris, France.	casanova@necker.fr	Abel, Laurent/H-8888-2017; Hovnanian, Alain/I-4711-2017; Smahi, Asma/J-4184-2017; Quintana-Murci, Lluis/AAB-7468-2022; Zhang, Shen-Ying/I-2685-2017; PLANCOULAINE, Sabine/E-2824-2017; Titeux, Matthias/K-8411-2017; von Bernuth, Horst/AAQ-9797-2021; Leonard, Joshua/B-7649-2009; Lorenzo, Lazaro/H-7902-2017; Jouanguy, Emmanuelle/H-7901-2017; KU, Cheng-Lung/L-6073-2015; Vivier, Eric/F-8939-2010; Barreiro, Luis/I-7772-2015; Casanova, Jean-Laurent/I-3418-2017; Rozenberg, Flore/O-8854-2017; Li, Chia Cheng/D-9906-2015; Picard, Capucine/H-3914-2017; KU, Cheng-Lung/AAT-1033-2020; Puel, Anne/H-7305-2017	Abel, Laurent/0000-0001-7016-6493; Hovnanian, Alain/0000-0003-3412-7512; Smahi, Asma/0000-0002-6002-0981; Zhang, Shen-Ying/0000-0002-9449-3672; PLANCOULAINE, Sabine/0000-0003-0725-8306; Titeux, Matthias/0000-0001-7386-2769; von Bernuth, Horst/0000-0002-5812-7675; Lorenzo, Lazaro/0000-0001-6648-8684; Jouanguy, Emmanuelle/0000-0002-7358-9157; KU, Cheng-Lung/0000-0002-0643-2256; Vivier, Eric/0000-0001-7022-8287; Picard, Capucine/0000-0001-8788-5056; KU, Cheng-Lung/0000-0002-0643-2256; Puel, Anne/0000-0003-2603-0323; geissmann, frederic/0000-0001-5029-2468; Chapgier, Ariane/0000-0002-1734-0744; Quintana-Murci, Lluis/0000-0003-2429-6320; Ugolini, Sophie/0000-0003-4041-0103; Barreiro, Luis/0000-0001-9456-367X; Leonard, Joshua/0000-0003-4359-6126; Casanova, Jean-Laurent/0000-0002-7782-4169	Medical Research Council [G0900867] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Casanova JL, 2007, SCIENCE, V317, P617, DOI 10.1126/science.1142963; Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Cerundolo V, 2006, SEMIN IMMUNOL, V18, P330, DOI 10.1016/j.smim.2006.07.006; Chapgier A, 2006, J IMMUNOL, V176, P5078, DOI 10.4049/jimmunol.176.8.5078; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Eidenschenk C, 2006, J IMMUNOL, V177, P8835, DOI 10.4049/jimmunol.177.12.8835; Gowen BB, 2006, J IMMUNOL, V177, P6301, DOI 10.4049/jimmunol.177.9.6301; Hardarson HS, 2007, AM J PHYSIOL-HEART C, V292, pH251, DOI 10.1152/ajpheart.00398.2006; Hidaka F, 2006, CLIN IMMUNOL, V119, P188, DOI 10.1016/j.clim.2006.01.005; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; JACQUEMONT B, 1975, J VIROL, V15, P707, DOI 10.1128/JVI.15.4.707-713.1975; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Lee H, 2007, GLIA, V55, P712, DOI 10.1002/glia.20493; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P17696, DOI 10.1074/jbc.M700209200; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P7668, DOI 10.1074/jbc.M610946200; Rudd BD, 2006, J IMMUNOL, V176, P1937, DOI 10.4049/jimmunol.176.3.1937; Schmidt KN, 2004, J IMMUNOL, V172, P138, DOI 10.4049/jimmunol.172.1.138; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Tabiasco J, 2006, J IMMUNOL, V177, P8708, DOI 10.4049/jimmunol.177.12.8708; Turvey SE, 2006, CLIN IMMUNOL, V120, P1, DOI 10.1016/j.clim.2006.02.003; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Yang K, 2005, IMMUNITY, V23, P465, DOI 10.1016/j.immuni.2005.09.016	39	800	828	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2007	317	5844					1522	1527		10.1126/science.1139522	http://dx.doi.org/10.1126/science.1139522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872438				2022-12-01	WOS:000249467900034
J	Dolin, R				Dolin, Raphael			Perspective: Noroviruses - Challenges to control	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFECTIOUS NONBACTERIAL GASTROENTERITIS		Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Dolin, R (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; DOLIN R, 1972, P SOC EXP BIOL MED, V140, P578, DOI 10.3181/00379727-140-36508; Green K, 2007, FIELDS VIROLOGY, P949; KAPIKIAN AZ, 1972, J VIROL, V10, P1075, DOI 10.1128/JVI.10.5.1075-1081.1972; XI JA, 1990, SCIENCE, V250, P1580, DOI 10.1126/science.2177224	5	36	45	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2007	357	11					1072	1073		10.1056/NEJMp078050	http://dx.doi.org/10.1056/NEJMp078050			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209KK	17855667				2022-12-01	WOS:000249387200002
J	Corson, TW; Crews, CM				Corson, Timothy W.; Crews, Craig M.			Molecular understanding and modern application of traditional medicines: Triumphs and trials	CELL			English	Article							TRIPTERYGIUM-WILFORDII; ANTIMALARIAL; TRIPTOLIDE; RECEPTOR; CURCUMIN	Traditional medicines provide fertile ground for modern drug development, but first they must pass along a pathway of discovery, isolation, and mechanistic studies before eventual deployment in the clinic. Here, we highlight the challenges along this route, focusing on the compounds artemisinin, triptolide, celastrol, capsaicin, and curcumin.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; Yale Univ, Dept Chem & Pharmacol, New Haven, CT 06511 USA	Yale University; Yale University	Crews, CM (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.	craig.crews@yale.edu	Corson, Timothy W./B-6851-2009; Crews, Craig M./ABH-9346-2020	Corson, Timothy W./0000-0002-1402-7875; Crews, Craig M./0000-0002-8456-2005	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062120] Funding Source: NIH RePORTER; NIAID NIH HHS [AI055194] Funding Source: Medline; NIGMS NIH HHS [GM062120, R01 GM062120-11, R01 GM062120] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; ASAWAMAHASAKDA W, 1994, ANTIMICROB AGENTS CH, V38, P1854, DOI 10.1128/AAC.38.8.1854; Brinker AM, 2005, J CHROMATOGR A, V1070, P65, DOI 10.1016/j.chroma.2005.02.083; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cortright DN, 2007, BBA-MOL BASIS DIS, V1772, P978, DOI 10.1016/j.bbadis.2007.03.003; Dasgupta P, 1997, BRIT J UROL, V80, P845, DOI 10.1046/j.1464-410X.1997.00424.x; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Efferth T, 2007, PLANTA MED, V73, P299, DOI 10.1055/s-2007-967138; GREENWOOD D, 1992, J ANTIMICROB CHEMOTH, V30, P417, DOI 10.1093/jac/30.4.417; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hsu CH, 2007, ADV EXP MED BIOL, V595, P471; Immke DC, 2006, SEMIN CELL DEV BIOL, V17, P582, DOI 10.1016/j.semcdb.2006.09.004; Leuenroth SJ, 2005, CHEM BIOL, V12, P1259, DOI 10.1016/j.chembiol.2005.09.009; Leuenroth SJ, 2007, P NATL ACAD SCI USA, V104, P4389, DOI 10.1073/pnas.0700499104; Liu CZ, 2006, APPL MICROBIOL BIOT, V72, P11, DOI 10.1007/s00253-006-0452-0; Mahdi JG, 2006, CELL PROLIFERAT, V39, P147, DOI 10.1111/j.1365-2184.2006.00377.x; Qiu Daoming, 2003, Drugs R D, V4, P1, DOI 10.2165/00126839-200304010-00001; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Schmidt BM, 2007, NAT CHEM BIOL, V3, P360, DOI 10.1038/nchembio0707-360; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Tao XL, 2000, RHEUM DIS CLIN N AM, V26, P29, DOI 10.1016/S0889-857X(05)70118-6; Vennerstrom JL, 2004, NATURE, V430, P900, DOI 10.1038/nature02779; Yang D, 1998, J ORG CHEM, V63, P6446, DOI 10.1021/jo981362g	24	414	437	6	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2007	130	5					769	774		10.1016/j.cell.2007.08.021	http://dx.doi.org/10.1016/j.cell.2007.08.021			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	212GI	17803898	Bronze, Green Accepted, Green Submitted			2022-12-01	WOS:000249581500007
J	Stern, DA; Morgan, WJ; Wright, AL; Guerra, S; Martinez, FD				Stern, Debra A.; Morgan, Wayne J.; Wright, Anne L.; Guerra, Stefano; Martinez, Fernando D.			Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study	LANCET			English	Article							1ST 6 YEARS; RESPIRATORY ILLNESS; MATERNAL SMOKING; NATURAL-HISTORY; PULMONARY-FUNCTION; CIGARETTE-SMOKING; PARENTAL SMOKING; EXPIRATORY FLOW; GLOBAL BURDEN; EARLY-LIFE	Background Together with smoking, the lung function attained in early adulthood is one of the strongest predictors of chronic obstructive pulmonary disease. We aimed to investigate whether lung function in early adulthood is, in turn, affected by airway function measured shortly after birth. Methods Non-selected infants were enrolled at birth in the Tucson Children's Respiratory Study between 1980 and 1984. We measured maximal expiratory flows at functional residual capacity (Vmax(FRC) in 169 of these infants by the chest compression technique at a mean of 2.3 months (SD 1 . 9). We also obtained measurements of lung function for 123 of these participants at least once at ages 11, 16, and 22 years. Indices were forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), and forced expiratory flow between 25% and 75% of FVC (FEF25-75), both before and after treatment with a bronchodilator (180 mu g of albuterol). Findings Participants who had infant VmaxFRC in the lowest quartile also had lower values for the FEV1/FVC ratio (-5.2%, p<0 . 0001), FEF25-75 (-663 mL/s, p<0 . 0001), and FEV1 (-233 mL, p=0 . 001) up to age 22, after adjustment for height, weight, age, and sex, than those in the upper three quartiles combined. The magnitude and significance of this effect did not change after additional adjustment for wheeze, smoking, atopy, or parental asthma. Interpretation Poor airway function shortly after birth should be recognised as a risk factor for airflow obstruction in young adults. Prevention of chronic obstructive pulmonary disease might need to start in fetal life.	Univ Arizona, Hlth Sci Ctr, Arizona Resp Ctr, Tucson, AZ 85724 USA; Univ Arizona, Dept Pediat, Tucson, AZ 85724 USA; Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ 85724 USA	University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Arizona	Martinez, FD (corresponding author), Univ Arizona, Hlth Sci Ctr, Arizona Resp Ctr, Tucson, AZ 85724 USA.	fernando@arc.arizona.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL014136, R01HL056177] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL056177-13, R01 HL056177, HL-56177, HL-14136] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beech DJ, 2000, EARLY HUM DEV, V59, P193, DOI 10.1016/S0378-3782(00)00095-5; BOSSE R, 1980, ARCH ENVIRON HEALTH, V35, P247; Brown H., 1999, APPL MIXED MODELS ME; BUCHER U., 1961, THORAX, V16, P207, DOI 10.1136/thx.16.3.207; BURROWS B, 1977, AM REV RESPIR DIS, V115, P751; BURROWS B, 1987, AM REV RESPIR DIS, V135, P788, DOI 10.1164/arrd.1987.135.4.788; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Cook DG, 1998, THORAX, V53, P884, DOI 10.1136/thx.53.10.884; DAWSON SV, 1977, J APPL PHYSIOL, V43, P498, DOI 10.1152/jappl.1977.43.3.498; Dezateux C, 1999, AM J RESP CRIT CARE, V159, P403, DOI 10.1164/ajrccm.159.2.9712029; Filippone M, 2003, LANCET, V361, P753, DOI 10.1016/S0140-6736(03)12633-5; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Gilliland FD, 2000, THORAX, V55, P271, DOI 10.1136/thorax.55.4.271; HANRAHAN JP, 1992, AM REV RESPIR DIS, V145, P1129, DOI 10.1164/ajrccm/145.5.1129; HIBBERT ME, 1989, PEDIATR PULM, V7, P101, DOI 10.1002/ppul.1950070209; Hole DJ, 1996, BRIT MED J, V313, P711; Hoo AF, 2004, AM J RESP CRIT CARE, V170, P527, DOI 10.1164/rccm.200311-1552OC; ISLAM T, 2007, THORAX, V111, P1512; James AL, 2005, AM J RESP CRIT CARE, V171, P109, DOI 10.1164/rccm.200402-230OC; Johnston IDA, 1998, NEW ENGL J MED, V338, P581, DOI 10.1056/NEJM199802263380904; Kajekar R, 2007, PHARMACOL THERAPEUT, V114, P129, DOI 10.1016/j.pharmthera.2007.01.011; Mannino David M, 2002, Respir Care, V47, P1184; Mannino DM, 2006, EUR RESPIR J, V27, P627, DOI 10.1183/09031936.06.00024605; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; MARTINEZ FD, 1988, NEW ENGL J MED, V319, P1112, DOI 10.1056/NEJM198810273191702; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; NORTHWAY WH, 1990, NEW ENGL J MED, V323, P1793, DOI 10.1056/NEJM199012273232603; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; PRIDE NB, 1967, J APPL PHYSIOL, V23, P646, DOI 10.1152/jappl.1967.23.5.646; SAMET JM, 1983, AM REV RESPIR DIS, V127, P508, DOI 10.1164/arrd.1983.127.4.508; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Stein RT, 1997, THORAX, V52, P946, DOI 10.1136/thx.52.11.946; Stern DA, 2004, CLIN EXP ALLERGY, V34, P1563, DOI 10.1111/j.1365-2222.2004.02088.x; Stocks J, 2003, RESPIROLOGY, V8, P266, DOI 10.1046/j.1440-1843.2003.00478.x; TAGER IB, 1988, AM REV RESPIR DIS, V138, P837, DOI 10.1164/ajrccm/138.4.837; TAGER IB, 1993, AM REV RESPIR DIS, V147, P811, DOI 10.1164/ajrccm/147.4.811; TAUSSIG LM, 1989, AM J EPIDEMIOL, V129, P1219, DOI 10.1093/oxfordjournals.aje.a115242; TEPPER RS, 1986, AM REV RESPIR DIS, V134, P513; Turner SW, 2004, AM J RESP CRIT CARE, V169, P921, DOI 10.1164/rccm.200307-891OC; Vrijlandt EJLE, 2006, AM J RESP CRIT CARE, V173, P890, DOI 10.1164/rccm.200507-1140OC; WANG XB, 1993, PEDIATR PULM, V15, P75, DOI 10.1002/ppul.1950150204; Weiss ST, 1996, AM J RESP CRIT CARE, V154, pS208, DOI 10.1164/ajrccm/154.6_Pt_2.S208; Whitsett JA, 2006, PAEDIATR RESPIR REV, V7, pS248, DOI 10.1016/j.prrv.2006.04.188; WRIGHT AL, 1989, AM J EPIDEMIOL, V129, P1232, DOI 10.1093/oxfordjournals.aje.a115243	45	386	401	0	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2007	370	9589					758	764		10.1016/S0140-6736(07)61379-8	http://dx.doi.org/10.1016/S0140-6736(07)61379-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206UV	17765525	Green Accepted			2022-12-01	WOS:000249209300030
J	Bendall, SC; Stewart, MH; Menendez, P; George, D; Vijayaragavan, K; Werbowetski-Ogilvie, T; Ramos-Mejia, V; Rouleau, A; Yang, JB; Bosse, M; Lajoie, G; Bhatia, M				Bendall, Sean C.; Stewart, Morag H.; Menendez, Pablo; George, Dustin; Vijayaragavan, Kausalia; Werbowetski-Ogilvie, Tamra; Ramos-Mejia, Veronica; Rouleau, Anne; Yang, Jiabi; Bosse, Marc; Lajoie, Gilles; Bhatia, Mickie			IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro	NATURE			English	Article							MOUSE EMBRYONIC FIBROBLASTS; SELF-RENEWAL; GROWTH; RECEPTOR; EXPRESSION; DIFFERENTIATION; SB-431542; INHIBITOR; SUPPORT; CULTURE	Distinctive properties of stem cells are not autonomously achieved, and recent evidence points to a level of external control from the microenvironment. Here, we demonstrate that self-renewal and pluripotent properties of human embryonic stem (ES) cells depend on a dynamic interplay between human ES cells and autologously derived human ES cell fibroblast-like cells (hdFs). Human ES cells and hdFs are uniquely defined by insulin-like growth factor (IGF)- and fibroblast growth factor (FGF)-dependence. IGF 1 receptor (IGF1R) expression was exclusive to the human ES cells, whereas FGF receptor 1 (FGFR1) expression was restricted to surrounding hdFs. Blocking the IGF-II/IGF1R pathway reduced survival and clonogenicity of human ES cells, whereas inhibition of the FGF pathway indirectly caused differentiation. IGF-II is expressed by hdFs in response to FGF, and alone was sufficient in maintaining human ES cell cultures. Our study demonstrates a direct role of the IGF-II/IGF1R axis on human ES cell physiology and establishes that hdFs produced by human ES cells themselves define the stem cell niche of pluripotent human stem cells.	McMaster Univ, Michael G DeGroote Sch Med, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada; Univ Western Ontario, Don Rix Prot Identificat Facil, Dept Biochem, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada	McMaster University; Western University (University of Western Ontario)	Bhatia, M (corresponding author), McMaster Univ, Michael G DeGroote Sch Med, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada.	mbhatia@mcmaster.ca	Bujan, Pablo Menendez/W-3736-2017; Vijayaragavan, Kausalia/AAM-8590-2021; Bendall, Sean/AGG-0126-2022; Ramos-Mejia, Veronica/C-4338-2017; Bosse, Marc/AAM-8593-2021	Bujan, Pablo Menendez/0000-0001-9372-1007; Ramos-Mejia, Veronica/0000-0002-8013-4273; Bendall, Sean/0000-0003-1341-2453; Werbowetski-Ogilvie, Tamra/0000-0002-5469-0559				Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; Chi MMY, 2000, ENDOCRINOLOGY, V141, P4784, DOI 10.1210/en.141.12.4784; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Heyner S, 1997, Early Pregnancy, V3, P153; Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102; Hofmann F, 2005, DRUG DISCOV TODAY, V10, P1041, DOI 10.1016/S1359-6446(05)03512-9; HUANG S, 1992, NATURE, V360, P745, DOI 10.1038/360745a0; HUANG S, 1994, NATURE, V368, P664, DOI 10.1038/368664a0; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kauma SW, 2000, J REPROD FERTIL, P31; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Lighten AD, 1997, MOL REPROD DEV, V47, P134, DOI 10.1002/(SICI)1098-2795(199706)47:2<134::AID-MRD2>3.0.CO;2-N; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; ORFAO A, 1995, SCAND J CLIN LAB INV, V55, P145, DOI 10.3109/00365519509090577; ORFAO A, 1995, HAEMATOLOGICA, V80, P69; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Wang LS, 2005, BLOOD, V105, P4598, DOI 10.1182/blood-2004-10-4065; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	31	474	536	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 30	2007	448	7157					1015	U3		10.1038/nature06027	http://dx.doi.org/10.1038/nature06027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205EU	17625568				2022-12-01	WOS:000249097600030
J	Cassar, N; Bender, ML; Barnett, BA; Fan, S; Moxim, WJ; Levy, H; Tilbrook, B				Cassar, Nicolas; Bender, Michael L.; Barnett, Bruce A.; Fan, Songmiao; Moxim, Walter J.; Levy, Hiram, II; Tilbrook, Bronte			The Southern Ocean biological response to Aeolian iron deposition	SCIENCE			English	Article							NATURAL ORGANIC-LIGANDS; PACIFIC SECTOR; MARINE-PHYTOPLANKTON; DISSOLVED FE; WATERS; LIMITATION; BLOOMS; COMPLEXATION; PRODUCTIVITY; ENRICHMENT	Biogeochemical rate processes in the Southern Ocean have an important impact on the global environment. Here, we summarize an extensive set of published and new data that establishes the pattern of gross primary production and net community production over large areas of the Southern Ocean. We compare these rates with model estimates of dissolved iron that is added to surface waters by aerosols. This comparison shows that net community production, which is comparable to export production, is proportional to modeled input of soluble iron in aerosols. Our results strengthen the evidence that the addition of aerosol iron fertilizes export production in the Southern Ocean. The data also show that aerosol iron input particularly enhances gross primary production over the large area of the Southern Ocean downwind of dry continental areas.	Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA; CSIRO, Marine & Atmospher Res & Antarctic Climate, Hobart, Tas 7001, Australia; CSIRO, Ecosyst Cooperat Res Ctr, Hobart, Tas 7001, Australia	Princeton University; National Oceanic Atmospheric Admin (NOAA) - USA; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Cassar, N (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	ncassar@princeton.edu	Tilbrook, Bronte/W-4007-2019; Tilbrook, Bronte/A-1522-2012; Cassar, Nicolas/B-4260-2011; Fan, Song-Miao/A-8004-2008	Tilbrook, Bronte/0000-0001-9385-3827; Tilbrook, Bronte/0000-0001-9385-3827; Cassar, Nicolas/0000-0003-0100-3783; Fan, Song-Miao/0000-0001-8352-8035				Blain S, 2007, NATURE, V446, P1070, DOI 10.1038/nature05700; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Bucciarelli E, 2001, MAR CHEM, V73, P21, DOI 10.1016/S0304-4203(00)00070-0; de Baar HJW, 1999, MAR CHEM, V66, P1, DOI 10.1016/S0304-4203(99)00022-5; DEBAAR HJW, 1995, NATURE, V373, P412, DOI 10.1038/373412a0; Dickson ML, 2001, DEEP-SEA RES PT II, V48, P4101, DOI 10.1016/S0967-0645(01)00082-0; Fan SM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024852; Hand JL, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004574; Hendricks MB, 2004, DEEP-SEA RES PT I, V51, P1541, DOI 10.1016/j.dsr.2004.06.006; Hiscock MR, 2003, DEEP-SEA RES PT II, V50, P533, DOI 10.1016/S0967-0645(02)00583-0; Hutchins DA, 1999, NATURE, V400, P858, DOI 10.1038/23680; LAWS EA, 1991, DEEP-SEA RES, V38, P143, DOI 10.1016/0198-0149(91)90059-O; Mahowald NM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006653; Maldonado MT, 2001, LIMNOL OCEANOGR, V46, P1802, DOI 10.4319/lo.2001.46.7.1802; Measures CI, 2001, DEEP-SEA RES PT II, V48, P3913, DOI 10.1016/S0967-0645(01)00074-1; Nelson DM, 2001, DEEP-SEA RES PT II, V48, P3973, DOI 10.1016/S0967-0645(01)00076-5; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Prezelin BB, 2000, J MAR RES, V58, P165, DOI 10.1357/002224000321511133; Reuer MK, 2007, DEEP-SEA RES PT I, V54, P951, DOI 10.1016/j.dsr.2007.02.007; Robinson RS, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001114; RUE EL, 1995, MAR CHEM, V50, P117, DOI 10.1016/0304-4203(95)00031-L; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; Sedwick PN, 1997, DEEP-SEA RES PT I, V44, P1239, DOI 10.1016/S0967-0637(97)00021-6; Sedwick PN, 1997, GEOPHYS RES LETT, V24, P2515, DOI 10.1029/97GL02596; Sosik HM, 2002, DEEP-SEA RES PT I, V49, P1195, DOI 10.1016/S0967-0637(02)00015-8; SPRENT P, 1980, BIOMETRICS, V36, P547, DOI 10.2307/2530224; Strzepek R. F., 2005, GLOBAL BIOGEOCHEM CY, V19; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; Sunda WG, 1997, MAR CHEM, V57, P169, DOI 10.1016/S0304-4203(97)00045-5; Twining BS, 2004, LIMNOL OCEANOGR, V49, P2115, DOI 10.4319/lo.2004.49.6.2115; Wang XJ, 2001, J GEOPHYS RES-OCEANS, V106, P31525, DOI 10.1029/2000JC000645; WU JF, 1995, MAR CHEM, V50, P159, DOI 10.1016/0304-4203(95)00033-N	33	171	175	5	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2007	317	5841					1067	1070		10.1126/science.1144602	http://dx.doi.org/10.1126/science.1144602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203AE	17717181				2022-12-01	WOS:000248946700040
J	Mobbs, D; Petrovic, P; Marchant, JL; Hassabis, D; Weiskopf, N; Seymour, B; Dolan, RJ; Frith, CD				Mobbs, Dean; Petrovic, Predrag; Marchant, Jennifer L.; Hassabis, Demis; Weiskopf, Nikolaus; Seymour, Ben; Dolan, Raymond J.; Frith, Christopher D.			When fear is near: Threat imminence elicits prefrontal-periaqueductal gray shifts in humans	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; PANIC DISORDER; BEHAVIOR; BRAIN	Humans, like other animals, alter their behavior depending on whether a threat is close or distant. We investigated spatial imminence of threat by developing an active avoidance paradigm in which volunteers were pursued through a maze by a virtual predator endowed with an ability to chase, capture, and inflict pain. Using functional magnetic resonance imaging, we found that as the virtual predator grew closer, brain activity shifted from the ventromedial prefrontal cortex to the periaqueductal gray. This shift showed maximal expression when a high degree of pain was anticipated. Moreover, imminence-driven periaqueductal gray activity correlated with increased subjective degree of dread and decreased confidence of escape. Our findings cast light on the neural dynamics of threat anticipation and have implications for the neurobiology of human anxiety-related disorders.	UCL, Funct Imaging Lab, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England	University of London; University College London	Mobbs, D (corresponding author), UCL, Funct Imaging Lab, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England.	d.mobbs@fil.ion.ucl.ac.uk	Weiskopf, Nikolaus/B-9357-2008; Frith, Chris D/A-2171-2009; Petrovic, Predrag/AAS-6736-2020	Weiskopf, Nikolaus/0000-0001-5239-1881; Frith, Chris D/0000-0002-8665-0690; Petrovic, Predrag/0000-0002-5536-945X; Seymour, Ben/0000-0003-1724-5832; Dolan, Ray/0000-0001-9356-761X	Wellcome Trust [078865] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Bandler R, 2000, BRAIN RES BULL, V53, P95, DOI 10.1016/S0361-9230(00)00313-0; Berns GS, 2006, SCIENCE, V312, P754, DOI 10.1126/science.1123721; BLANCHARD RJ, 1990, E M I LIF S, V8, P89; Craske MG., 1999, ANXIETY DISORDERS PS; DEAKIN J F W, 1991, Journal of Psychopharmacology, V5, P305, DOI 10.1177/026988119100500414; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Duvernoy HM, 1995, HUMAN BRAIN STEM CER; FANSELOW MS, 1994, PSYCHON B REV, V1, P429, DOI 10.3758/BF03210947; FENSELOW MS, 1988, EVOLUTION LEARNING, P185; Floyd NS, 2000, J COMP NEUROL, V422, P556, DOI 10.1002/1096-9861(20000710)422:4<556::AID-CNE6>3.0.CO;2-U; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; Graeff FG, 2004, NEUROSCI BIOBEHAV R, V28, P239, DOI 10.1016/j.neubiorev.2003.12.004; Hadjipavlou G, 2006, PAIN, V123, P169, DOI 10.1016/j.pain.2006.02.027; Hsieh JC, 1999, NEUROSCI LETT, V262, P61, DOI 10.1016/S0304-3940(99)00060-9; Johansen JP, 2004, NAT NEUROSCI, V7, P398, DOI 10.1038/nn1207; Lang PJ, 2006, PROG BRAIN RES, V156, P3, DOI 10.1016/S0079-6123(06)56001-7; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; NASHOLD BS, 1969, J NEUROSURG, V30, P14, DOI 10.3171/jns.1969.30.1.0014; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Price JL, 2005, J COMP NEUROL, V493, P132, DOI 10.1002/cne.20750; Protopopescu X, 2006, NEUROREPORT, V17, P361, DOI 10.1097/01.wnr.0000203354.80438.1; Rau V, 2007, UNDERSTANDING TRAUMA: INTEGRATING BIOLOGICAL, CLINICAL, AND CULTURAL PERSPECTIVES, P27, DOI 10.1017/CBO9780511500008.005; REIMAN EM, 1989, ARCH GEN PSYCHIAT, V46, P493; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Vianna MRM, 2001, BRAZ J MED BIOL RES, V34, P233, DOI 10.1590/S0100-879X2001000200011	27	581	592	3	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2007	317	5841					1079	1083		10.1126/science.1144298	http://dx.doi.org/10.1126/science.1144298			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203AE	17717184	Green Published, Green Accepted			2022-12-01	WOS:000248946700044
J	Ooi, SKT; Qiu, C; Bernstein, E; Li, KQ; Jia, D; Yang, Z; Erdjument-Bromage, H; Tempst, P; Lin, SP; Allis, CD; Cheng, XD; Bestor, TH				Ooi, Steen K. T.; Qiu, Chen; Bernstein, Emily; Li, Keqin; Jia, Da; Yang, Zhe; Erdjument-Bromage, Hediye; Tempst, Paul; Lin, Shau-Ping; Allis, C. David; Cheng, Xiaodong; Bestor, Timothy H.			DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA	NATURE			English	Article							METHYLTRANSFERASE; CELLS	Mammals use DNA methylation for the heritable silencing of retrotransposons and imprinted genes and for the inactivation of the X chromosome in females. The establishment of patterns of DNA methylation during gametogenesis depends in part on DNMT3L, an enzymatically inactive regulatory factor that is related in sequence to the DNA methyltransferases DNMT3A and DNMT3B(1,2). The main proteins that interact in vivo with the product of an epitope-tagged allele of the endogenous Dnmt3L gene were identified by mass spectrometry as DNMT3A2, DNMT3B and the four core histones. Peptide interaction assays showed that DNMT3L specifically interacts with the extreme amino terminus of histone H3; this interaction was strongly inhibited by methylation at lysine 4 of histone H3 but was insensitive to modifications at other positions. Crystallographic studies of human DNMT3L showed that the protein has a carboxy-terminal methyltransferase-like domain and an N-terminal cysteine-rich domain. Cocrystallization of DNMT3L with the tail of histone H3 revealed that the tail bound to the cysteine-rich domain of DNMT3L, and substitution of key residues in the binding site eliminated the H3 tail-DNMT3L interaction. These data indicate that DNMT3L recognizes histone H3 tails that are unmethylated at lysine 4 and induces de novo DNA methylation by recruitment or activation of DNMT3A2.	Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Emory Univ, Dept Biochem, Atlanta, GA 30322 USA; Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Natl Taiwan Univ, Inst Biotechnol, Taipei 106, Taiwan	Columbia University; Emory University; Rockefeller University; Memorial Sloan Kettering Cancer Center; National Taiwan University	Cheng, XD (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA.	XCheng@emory.edu; THB12@columbia.edu	Hu, Ruogu/B-2203-2008	Erdjument-Bromage, Hediye/0000-0003-0224-3594; Ooi, Steen/0000-0003-4198-9014; Lin, Shau-Ping/0000-0003-3423-991X; Jia, Da/0000-0002-2205-1998; Tempst, Paul/0000-0002-6680-3987	NIGMS NIH HHS [R01 GM049245-14, R01 GM049245] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049245] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Appanah R, 2007, PLOS GENET, V3, P241, DOI 10.1371/journal.pgen.0030027; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Chen ZX, 2005, J CELL BIOCHEM, V95, P902, DOI 10.1002/jcb.20447; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Lei H, 1996, DEVELOPMENT, V122, P3195; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036	21	1043	1074	4	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2007	448	7154					714	U13		10.1038/nature05987	http://dx.doi.org/10.1038/nature05987			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687327	Green Accepted, Green Published			2022-12-01	WOS:000248598000049
J	Bayer, CP; Klasen, F; Adam, H				Bayer, Christophe Pierre; Klasen, Fionna; Adam, Hubertus			Association of trauma and PTSD symptoms with openness to reconciliation and feelings of revenge among former Ugandan and Congolese child soldiers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Tens of thousands of the estimated 250 000 child soldiers worldwide are abused or have been abused during the last decade in Africa's Great Lakes Region. In the process of rebuilding the war-torn societies, it is important to understand how psychological trauma may shape the former child soldiers' ability to reconcile. Objective To investigate the association of posttraumatic stress disorder ( PTSD) symptoms and openness to reconciliation and feelings of revenge in former Ugandan and Congolese child soldiers. Design, Setting, and Participants Cross-sectional field study of 169 former child soldiers ( aged 11-18 years) in rehabilitation centers in Uganda and the Democratic Republic of the Congo, conducted in 2005. Main Outcome Measures Potentially traumatic war-related experiences assessed via a sample-specific events scale; PTSD symptoms assessed using the Child Posttraumatic Stress Disorder Reaction Index (CPTSD-RI), with a score of 35 or higher indicating clinically important PTSD symptoms; and openness to reconciliation and feelings of revenge assessed via structured questionnaires. Results Children participating in this study were a mean of 15.3 years old. These former child soldiers reported that they had been ( violently) recruited by armed forces at a young age ( mean [ SD], 12.1 [ 2] years), had served a mean of 38 months ( SD, 24 months), and had been demobilized a mean of 2.3 months before data collection ( SD, 2.4 months). The children were exposed to a high level of potentially traumatic events ( mean [ SD], 11.1 [2.99]). The most commonly reported traumatic experiences were having witnessed shooting (92.9%), having witnessed someone wounded (89.9%), and having been seriously beaten (84%). A total of 54.4% reported having killed someone, and 27.8% reported that they were forced to engage in sexual contact. Of the 169 interviewed, 59 (34.9%; 95% confidence interval, 34.4%-35.4%) had a PTSD symptom score higher than 35. Children who showed more PTSD symptoms had significantly less openness to reconciliation (rho=- 0.34, P <. 001) and more feelings of revenge (rho= 0.29, P <. 001). Conclusions PTSD symptoms are associated with less openness to reconciliation and more feelings of revenge among former Ugandan and Congolese child soldiers. The effect of psychological trauma should be considered when these children are rehabilitated and reintegrated into civilian society.	Univ Clin Hamburg Eppendorf, Children Tomorrow Fdn, Outpatient Clin Refugee Children & Families, Dept Child & Adolescent Psychiat, D-20246 Hamburg, Germany; Hosp PSychiat Neurol & Child & Adolescent Psychia, Eberswalde, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Klasen, F (corresponding author), Univ Clin Hamburg Eppendorf, Children Tomorrow Fdn, Outpatient Clin Refugee Children & Families, Dept Child & Adolescent Psychiat, Martinistr 52, D-20246 Hamburg, Germany.	klasen@children-for-tomorrow.de						ADAM H, 2006, MENTAL HLTH REFUGEE; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boothby NG, 2000, SCI AM, V282, P60, DOI 10.1038/scientificamerican0600-60; *DEM REP CONG, 2006, DRC CHILDR WAR CREAT; Derluyn I, 2004, LANCET, V363, P861, DOI 10.1016/S0140-6736(04)15734-6; Hawkins SS, 2006, J PEDIATR PSYCHOL, V31, P420, DOI 10.1093/jpepsy/jsj039; *INT LAB ORG, 2003, WOUND CHILDH US CHIL; McCullough ME, 1998, J PERS SOC PSYCHOL, V75, P1586, DOI 10.1037/0022-3514.75.6.1586; NADER K, 1990, AM J PSYCHIAT, V147, P1526; NADER KO, 1993, BRIT J CLIN PSYCHOL, V32, P407, DOI 10.1111/j.2044-8260.1993.tb01075.x; *OFF SPEC REPR SEC, 2005, REP GEN ASS A 60 335; Pham PN, 2004, JAMA-J AM MED ASSOC, V292, P602, DOI 10.1001/jama.292.5.602; SAVJAK N, 2003, PSIHOLOGIJA ONLINE, V36, P59; Smith P, 2002, J TRAUMA STRESS, V15, P147, DOI 10.1023/A:1014812209051; Steinberg Alan M, 2004, Curr Psychiatry Rep, V6, P96, DOI 10.1007/s11920-004-0048-2; Weiss D. S., 1997, ASSESSING; 1989, ARES4425 UN GEN ASS; 2006, AFRICA RES B, V43, DOI UNSP 17043A-17044A	18	186	186	0	39	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2007	298	5					555	559		10.1001/jama.298.5.555	http://dx.doi.org/10.1001/jama.298.5.555			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195US	17666676	Bronze			2022-12-01	WOS:000248438100023
J	Adachi, K; Oiwa, K; Nishizaka, T; Furuike, S; Noji, H; Itoh, H; Yoshida, M; Kinosita, K				Adachi, Kengo; Oiwa, Kazuhiro; Nishizaka, Takayuki; Furuike, Shou; Noji, Hiroyuki; Itoh, Hiroyasu; Yoshida, Masasuke; Kinosita, Kazuhiko, Jr.			Coupling of rotation and catalysis in F-1-ATPase revealed by single-molecule imaging and manipulation	CELL			English	Article							ATP SYNTHASE; ACTIVITY-COEFFICIENTS; MECHANISM; F1-ATPASE; MOTOR; HYDROLYSIS; RESOLUTION; SUBSTEPS; DISTINCT; PATHWAY	F1-ATPase is a rotary molecular motor that proceeds in 120 degrees steps, each driven by ATP hydrolysis. How the chemical reactions that occur in three catalytic sites are coupled to mechanical rotation is the central question. Here, we show by high-speed imaging of rotation in single molecules of F1 that phosphate release drives the last 40 degrees of the 120 degrees step, and that the 40 degrees rotation accompanies reduction of the affinity for phosphate. We also show, by single-molecule imaging of a fluorescent ATP analog Cy3-ATP while F1 is forced to rotate slowly, that release of Cy3-ADP occurs at similar to 240 degrees after it is bound as Cy3-ATP at 0 degrees. This and other results suggest that the affinity for ADP also decreases with rotation, and thus ADP release contributes part of energy for rotation. Together with previous results, the coupling scheme is now basically complete.	Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, Tokyo 1698555, Japan; Natl Inst Informat & Commun Technol, Kobe Adv Res Ctr, Kobe, Hyogo 6512492, Japan; Gakushuin Univ, Dept Phys, Tokyo 1718588, Japan; Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; Hamamatsu Photon KK, Tsukuba Res Lab, Tsukuba, Ibaraki 3002635, Japan; CREST, Tsukuba, Ibaraki 3002635, Japan; ERATO, ATP Syst Project, Midori Ku, Yokohama, Kanagawa 2260026, Japan; Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Waseda University; National Institute of Information & Communications Technology (NICT) - Japan; Gakushuin University; Osaka University; Hamamatsu Photonics; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Tokyo Institute of Technology	Kinosita, K (corresponding author), Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, Tokyo 1698555, Japan.	kazuhiko@waseda.jp	Oiwa, Kazuhiro/D-7721-2011	Oiwa, Kazuhiro/0000-0002-1281-113X				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12961, DOI 10.1021/bi971478r; Boyer P.D., 1981, PRESENT STATUS BINDI, P231; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Cohn EJ, 1927, J AM CHEM SOC, V49, P173, DOI 10.1021/ja01400a021; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; ESTESO MA, 1987, J ELECTROANAL CHEM, V230, P69, DOI 10.1016/0022-0728(87)80132-8; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; Kinosita K, 2000, PHILOS T R SOC B, V355, P473, DOI 10.1098/rstb.2000.0589; Kinosita K, 2004, ANNU REV BIOPH BIOM, V33, P245, DOI 10.1146/annurev.biophys.33.110502.132716; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Masaike T, 2002, J BIOL CHEM, V277, P21643, DOI 10.1074/jbc.M110297200; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Oiwa K, 2003, BIOPHYS J, V84, P634, DOI 10.1016/S0006-3495(03)74883-8; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Shimabukuro K, 2006, BIOPHYS J, V90, P1028, DOI 10.1529/biophysj.105.067298; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Sillen L.G., 1964, SPEC PUBL, V17; Weber J, 2000, BBA-BIOENERGETICS, V1458, P300, DOI 10.1016/S0005-2728(00)00082-7; WEBER J, 1994, J BIOL CHEM, V269, P20462; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yasuda R, 2003, P NATL ACAD SCI USA, V100, P9314, DOI 10.1073/pnas.1637860100; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	31	297	299	0	52	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2007	130	2					309	321		10.1016/j.cell.2007.05.020	http://dx.doi.org/10.1016/j.cell.2007.05.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662945	Bronze			2022-12-01	WOS:000248588000020
J	Melnick, JG; Parkin, G				Melnick, Jonathan G.; Parkin, Gerard			Cleaving mercury-alkyl bonds: A functional model for mercury detoxification by MerB	SCIENCE			English	Article							ORGANOMERCURIAL LYASE MERB; HG-C BOND; CRYSTAL-STRUCTURE; COMPLEXES; COORDINATION; PROTEINS; PROTONOLYSIS; RESISTANCE; MECHANISM; CATALYSIS	The extreme toxicity of organomercury compounds that are found in the environment has focused attention on the mechanisms of action of bacterial remediating enzymes. We describe facile room-temperature protolytic cleavage by a thiol of the Hg-C bond in mercury-alkyl compounds that emulate the structure and function of the organomercurial lyase MerB. Specifically, the tris( 2-mercapto-1-t-butylimidazolyl) hydroborato ligand [Tm-But], which features three sulfur donors, has been used to synthesize [Tm-But] HgR alkyl compounds (R = methyl or ethyl) that react with phenylthiol (PhSH) to yield [Tm-But] HgSPh and RH. Although [Tm-But] HgR compounds exist as linear two-coordinate complexes in the solid state, H-1 nuclear magnetic resonance spectroscopy indicates that the complexes exist in rapid equilibrium with their higher-coordinate [kappa(2)-Tm-But] HgR and [kappa(3)-Tm-But] HgR isomers in solution. Facile access to a higher-coordinate species is proposed to account for the exceptional reactivity of [ TmBut] HgR relative to that of other two-coordinate mercury-alkyl compounds.	Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University	Parkin, G (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.	parkin@columbia.edu			NIGMS NIH HHS [GM046502] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046502] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARBARO P, 1994, INORG CHEM, V33, P6163, DOI 10.1021/ic00104a029; Barkay T, 2003, FEMS MICROBIOL REV, V27, P355, DOI 10.1016/S0168-6445(03)00046-9; Benison GC, 2004, BIOCHEMISTRY-US, V43, P8333, DOI 10.1021/bi049662h; CANTY AJ, 1987, AUST J CHEM, V40, P1609, DOI 10.1071/CH9871609; Cassidy I, 2002, EUR J INORG CHEM, P1235; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Di Lello P, 2004, BIOCHEMISTRY-US, V43, P8322, DOI 10.1021/bi049669z; Fitzgerald WF, 2007, CHEM REV, V107, P641, DOI 10.1021/cr050353m; GOPINATH E, 1987, J AM CHEM SOC, V109, P7903, DOI 10.1021/ja00259a061; Hartwig A, 2002, FOOD CHEM TOXICOL, V40, P1179, DOI 10.1016/S0278-6915(02)00043-1; HOLLOWAY CE, 1995, J ORGANOMET CHEM, V495, P1, DOI 10.1016/0022-328X(95)05395-6; KREEVOY MM, 1957, J AM CHEM SOC, V79, P5927, DOI 10.1021/ja01579a025; Lobbia GG, 1998, J ORGANOMET CHEM, V552, P31; MOORE MJ, 1990, ACCOUNTS CHEM RES, V23, P301, DOI 10.1021/ar00177a006; Ni B, 2006, J PHYS CHEM A, V110, P9451, DOI 10.1021/jp061852+; NORRIS AR, 1983, CAN J CHEM, V61, P1536, DOI 10.1139/v83-267; Parkin G, 2004, CHEM REV, V104, P699, DOI 10.1021/cr0206263; Pitts KE, 2002, BIOCHEMISTRY-US, V41, P10287, DOI 10.1021/bi0259148; Rabinovich D, 2006, STRUCT BOND, V120, P143, DOI 10.1007/430_031; Razmiafshari M, 2001, TOXICOL APPL PHARM, V172, P1, DOI 10.1006/taap.2001.9132; Strasdeit H, 2000, ANGEW CHEM INT EDIT, V39, P784, DOI 10.1002/(SICI)1521-3773(20000218)39:4<784::AID-ANIE784>3.3.CO;2-Q; Tai HC, 2006, J PHYS CHEM A, V110, P452, DOI 10.1021/jp0529826; White JL, 2002, J CHEM SOC DALTON, P2987, DOI 10.1039/b111558h; Wilhelm M, 2004, EUR J INORG CHEM, P2301, DOI 10.1002/ejic.200300907; Witkiewicz-Kucharczyk A, 2006, TOXICOL LETT, V162, P29, DOI 10.1016/j.toxlet.2005.10.018; WRIGHT JG, 1990, PROG INORG CHEM, V38, P323	26	82	84	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2007	317	5835					225	227		10.1126/science.1144314	http://dx.doi.org/10.1126/science.1144314			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	189DC	17626880				2022-12-01	WOS:000247968600036
J	Nash, R				Nash, Robert			Health-care workers in influenza pandemics	LANCET			English	Editorial Material							DUTY		Univ Oxford, John Radcliffe Hosp, Sch Med, Oxford OX3 9DU, England	University of Oxford	Nash, R (corresponding author), Univ Oxford, John Radcliffe Hosp, Sch Med, Oxford OX3 9DU, England.	robertnash@doctors.org.uk	Nash, Robert/AAO-9847-2020	Nash, Robert/0000-0002-7861-3734				*ECDC INFL TEAM, 2005, EURO SURVEILL, V10; Ehrenstein BP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-311; Harrod ME, 2006, MED J AUSTRALIA, V185, pS58; Irvin C., 2007, ACAD EMERG MED S1, V14, P13; Qureshi K, 2005, J URBAN HEALTH, V82, P378, DOI 10.1093/jurban/jti086; Ruderman Carly, 2006, BMC Med Ethics, V7, pE5, DOI 10.1186/1472-6939-7-5; WHO, 2003, WHO M REPORT; Yen MY, 2006, J HOSP INFECT, V62, P195, DOI 10.1016/j.jhin.2005.02.011	8	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2007	370	9584					300	301		10.1016/S0140-6736(07)61140-4	http://dx.doi.org/10.1016/S0140-6736(07)61140-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195QG	17662865	Green Published, Bronze			2022-12-01	WOS:000248426100009
J	Min, JH; Pavletich, NP				Min, Jung-Hyun; Pavletich, Nikola P.			Recognition of DNA damage by the Rad4 nucleotide excision repair protein	NATURE			English	Article							GROUP-C PROTEIN; ADDUCT OPPOSITE DT; XERODERMA-PIGMENTOSUM; SOLUTION CONFORMATION; BINDING DOMAIN; BASE-PAIRS; CIS-SYN; GROUP-A; COMPLEX; DUPLEX	Mutations in the nucleotide excision repair (NER) pathway can cause the xeroderma pigmentosum skin cancer predisposition syndrome. NER lesions are limited to one DNA strand, but otherwise they are chemically and structurally diverse, being caused by a wide variety of genotoxic chemicals and ultraviolet radiation. The xeroderma pigmentosum C (XPC) protein has a central role in initiating global-genome NER by recognizing the lesion and recruiting downstream factors. Here we present the crystal structure of the yeast XPC orthologue Rad4 bound to DNA containing a cyclobutane pyrimidine dimer (CPD) lesion. The structure shows that Rad4 inserts a beta-hairpin through the DNA duplex, causing the two damaged base pairs to flip out of the double helix. The expelled nucleotides of the undamaged strand are recognized by Rad4, whereas the two CPD-linked nucleotides become disordered. These findings indicate that the lesions recognized by Rad4/XPC thermodynamically destabilize the Watson-Crick double helix in a manner that facilitates the flipping-out of two base pairs.	Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.	pavletin@mkscc.org		Min, Jung-Hyun/0000-0002-4221-9321				Anantharaman V, 2001, HUM MOL GENET, V10, P1627, DOI 10.1093/hmg/10.16.1627; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Batty D, 2000, J MOL BIOL, V300, P275, DOI 10.1006/jmbi.2000.3857; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchko GW, 2001, NUCLEIC ACIDS RES, V29, P2635, DOI 10.1093/nar/29.12.2635; Buschta-Hedayat N, 1999, P NATL ACAD SCI USA, V96, P6090, DOI 10.1073/pnas.96.11.6090; Buterin T, 2005, CHEM BIOL, V12, P913, DOI 10.1016/j.chembiol.2005.06.011; Buterin T, 2000, CANCER RES, V60, P1849; Camenisch U, 2006, NAT STRUCT MOL BIOL, V13, P278, DOI 10.1038/nsmb1061; Cheng CC, 1996, CONTROL ENG PRACT, V4, P645, DOI 10.1016/0967-0661(96)00046-9; Chou SH, 2001, J MOL BIOL, V312, P769, DOI 10.1006/jmbi.2001.4964; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Cosman M, 1996, BIOCHEMISTRY-US, V35, P9850, DOI 10.1021/bi9605346; COSMAN M, 1993, BIOCHEMISTRY-US, V32, P12488, DOI 10.1021/bi00097a029; COSMAN M, 1995, BIOCHEMISTRY-US, V34, P1295, DOI 10.1021/bi00004a024; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; DELOSSANTOS C, 1992, BIOCHEMISTRY-US, V31, P5245, DOI 10.1021/bi00138a002; Dip R, 2004, DNA REPAIR, V3, P1409, DOI 10.1016/j.dnarep.2004.05.005; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Gao YG, 1999, BIOCHEMISTRY-US, V38, P16452, DOI 10.1021/bi9914614; Geacintov NE, 2002, BIOPOLYMERS, V65, P202, DOI 10.1002/bip.10239; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Gunz D, 1996, J BIOL CHEM, V271, P25089, DOI 10.1074/jbc.271.41.25089; Hey T, 2002, BIOCHEMISTRY-US, V41, P6583, DOI 10.1021/bi012202t; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Ikegami T, 1998, NAT STRUCT BIOL, V5, P701, DOI 10.1038/1400; Jing YQ, 1998, NUCLEIC ACIDS RES, V26, P3845, DOI 10.1093/nar/26.16.3845; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIM JK, 1995, EUR J BIOCHEM, V228, P849, DOI 10.1111/j.1432-1033.1995.0849m.x; Kusumoto R, 2001, MUTAT RES-DNA REPAIR, V485, P219, DOI 10.1016/S0921-8777(00)00082-3; LEGERSKI R, 1992, NATURE, V359, P70, DOI 10.1038/359070a0; Madura K, 2004, TRENDS BIOCHEM SCI, V29, P637, DOI 10.1016/j.tibs.2004.10.008; Mao B, 1999, BIOCHEMISTRY-US, V38, P10831, DOI 10.1021/bi991212f; Masutani C, 1997, MOL CELL BIOL, V17, P6915, DOI 10.1128/MCB.17.12.6915; MASUTANI C, 1994, EMBO J, V13, P1831, DOI 10.1002/j.1460-2075.1994.tb06452.x; McAteer K, 1998, J MOL BIOL, V282, P1013, DOI 10.1006/jmbi.1998.2062; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; OHANDLEY SF, 1993, BIOCHEMISTRY-US, V32, P2481, DOI 10.1021/bi00061a005; Ortolan TG, 2004, NUCLEIC ACIDS RES, V32, P6490, DOI 10.1093/nar/gkh987; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2002, DNA REPAIR, V1, P95, DOI 10.1016/S1568-7864(01)00008-8; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Thompson JR, 2006, J BIOL CHEM, V281, P18746, DOI 10.1074/jbc.M513667200; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wang M, 2000, BIOCHEMISTRY-US, V39, P6433, DOI 10.1021/bi000472q; Yang A, 2006, BIOCHEMISTRY-US, V45, P3653, DOI 10.1021/bi0524868; Yang ZG, 2006, BIOCHEMISTRY-US, V45, P15921, DOI 10.1021/bi061626q	50	316	332	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2007	449	7162					570	U7		10.1038/nature06155	http://dx.doi.org/10.1038/nature06155			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17882165				2022-12-01	WOS:000249893500038
J	Alvaro, D; Macarri, G; Mancino, MG; Marzioni, M; Bragazzi, M; Onori, P; Corradini, SG; Invernizzi, P; Franchitto, A; Attill, AF; Gaudio, E; Benedetti, A				Alvaro, Domenico; Macarri, Gianpiero; Mancino, Maria Grazia; Marzioni, Marco; Bragazzi, MariaConsiglia; Onori, Paolo; Corradini, Stefano Ginanni; Invernizzi, Pietro; Franchitto, Antonio; Attill, Adolfo F.; Gaudio, Eugenio; Benedetti, Antonio			Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; DIGITAL IMAGE-ANALYSIS; BREAST-CANCER CELLS; BINDING-PROTEINS; ESTROGEN-RECEPTOR; STEROID-HORMONES; ROUTINE CYTOLOGY; CARCINOMA-CELLS; BRUSH CYTOLOGY; FACTOR (IGF)-I	Background: Cholangiocarcinoma cells express and secrete insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF). Objective: To measure IGF-I and VEGF in bile and serum of patients with extrahepatic cholangiocarcinoma and to evaluate their performance as diagnostic markers. Design: Cross-sectional study. Setting: Inpatients at the Division of Gastroenterology, University Hospital, Ancona, Italy. Patients: 73 patients who consecutively had endoscopic retrograde cholangiopancreatography (ERCP), including patients with extrahepatic cholangiocarcinoma (n = 29), pancreatic cancer (n = 19), and benign biliary abnormalities (n = 25; bile duct stones, primary sclerosing cholangitis, and cholangitis). Measurements: Diagnosis was based on conventional radiology, ERCP, and follow-up. Insulin-like growth factor I and VEGF were measured by using enzyme-linked immunosorbent assay. Results: The biliary IGF-I concentration was 15- to 20-fold higher (P < 0.001) in extrahepatic cholangiocarcinoma (mean, 84.6 nmol/L [95% Cl, 74.0 to 95.2 nmol/L]) than in pancreatic cancer (5.8 nmol/L [Cl, 4.0 to 7.5 nmol/L]) or benign biliary abnormalities (4.1 nmol/L [Cl, 3.1 to 5.2 nmol/L]). The area under the receiver-operating characteristic curve was 1 when biliary IGF-I values in the extrahepatic cholangiocarcinoma were compared with benign biliary abnormalities or pancreatic cancer. In contrast, biliary VEGF concentration was similar in the 3 groups. Serum IGF-I levels were similar among the groups, whereas serum VEGF levels were higher in the cholangiocarcinoma (0.97 ng/mL [Cl, 0.59 to 1.35 ng/mL]; P = 0.0016) and pancreatic cancer groups (0.66 ng/mL [Cl, 0.43 to 0.88 ng/mL); P < 0.001) compared with patients with benign biliary abnormalities (0.28 ng/mL [Cl, 0.17 to 0.37 ng/mL]). Limitations: Data were obtained in a small sample, the study was performed in a single center, and few patients had a tissue diagnosis. Conclusions: Biliary IGF-I levels in patients undergoing ERCP for biliary obstruction may differentiate extrahepatic cholangiocarcinoma from either pancreatic cancer or benign biliary abnormalities.	Univ Roma La Sapienza, Dept Clin Med, Div Gastroenterol, I-00137 Rome, Italy; Polytechn Univ Marche, Ancona, Italy; State Univ Laquila, Laquila, Italy; Univ Milan, Sch Med, San Paolo Hosp, Milan, Italy	Sapienza University Rome; Marche Polytechnic University; San Paolo-Polo Universitaria Hospital; University of Milan	Alvaro, D (corresponding author), Univ Roma La Sapienza, Dept Clin Med, Div Gastroenterol, Via Roberto Rossellini 51, I-00137 Rome, Italy.	domenico.alvaro@uniromal.it	Mancino, Maria Grazia/AAC-4125-2022; Marzioni, Marco/A-8153-2011; Franchitto, Antonio/C-8095-2009; Onori, Paolo/J-9394-2013; ALVARO, Domenico/J-8600-2018; Invernizzi, Pietro/AAB-8367-2022; Benedetti, Antonio/A-8189-2011	Marzioni, Marco/0000-0001-6014-6165; Onori, Paolo/0000-0002-7195-3760; ALVARO, Domenico/0000-0003-3771-9644; Invernizzi, Pietro/0000-0003-3262-1998; Benedetti, Antonio/0000-0003-0280-4574; Ginanni Corradini, Stefano/0000-0002-0839-1961; FRANCHITTO, Antonio/0000-0003-0822-3690; mancino, maria grazia/0000-0003-1771-5056; Attili, Adolfo Francesco/0000-0001-7240-7246				Adesanya OO, 1999, P NATL ACAD SCI USA, V96, P3287, DOI 10.1073/pnas.96.6.3287; Ahmad S, 1999, BIOCHEM PHARMACOL, V58, P425, DOI 10.1016/S0006-2952(99)00125-2; Alvaro D, 2005, J HEPATOL, V43, P875, DOI 10.1016/j.jhep.2005.04.011; Alvaro D, 2006, AM J PATHOL, V169, P877, DOI 10.2353/ajpath.2006.050464; Baron TH, 2004, CLIN GASTROENTEROL H, V2, P214, DOI 10.1016/S1542-3565(04)00006-0; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blendis Laurie, 2002, Gastroenterology, V122, P237, DOI 10.1016/S0016-5085(02)80088-9; Boberg KM, 2006, J HEPATOL, V45, P568, DOI 10.1016/j.jhep.2006.05.010; Bremnes RM, 2006, LUNG CANCER, V51, P143, DOI 10.1016/j.lungcan.2005.09.005; Capri M, 2006, ANN NY ACAD SCI, V1067, P252, DOI 10.1196/annals.1354.033; CHAURASIA OP, 1994, REGUL PEPTIDES, V50, P113, DOI 10.1016/0167-0115(94)90026-4; Dunger DB, 2003, HORM RES, V60, P131, DOI 10.1159/000074514; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fulcher AS, 2000, RADIOLOGY, V215, P71, DOI 10.1148/radiology.215.1.r00ap2671; Gores GJ, 2003, HEPATOLOGY, V37, P961, DOI 10.1053/jhep.2003.50200; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hata H, 1998, ONCOLOGY-BASEL, V55, P35, DOI 10.1159/000055257; Helle SI, 2004, BEST PRACT RES CL EN, V18, P67, DOI 10.1016/S1521-690X(03)00045-9; Hyder SM, 2002, AM J PATHOL, V161, P345, DOI 10.1016/S0002-9440(10)64186-7; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Juul A, 2003, GROWTH HORM IGF RES, V13, P113, DOI 10.1016/S1096-6374(03)00038-8; Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592; Kahlert S, 2000, J BIOL CHEM, V275, P18447, DOI 10.1074/jbc.M910345199; Kassem M, 1998, CALCIFIED TISSUE INT, V62, P60, DOI 10.1007/s002239900395; Khan SA, 2002, J HEPATOL, V37, P806, DOI 10.1016/S0168-8278(02)00297-0; Kim JH, 2002, RADIOGRAPHICS, V22, P1335, DOI 10.1148/rg.226025060; Kipp BR, 2004, AM J GASTROENTEROL, V99, P1675, DOI 10.1111/j.1572-0241.2004.30281.x; Lazaridis KN, 2005, GASTROENTEROLOGY, V128, P1655, DOI 10.1053/j.gastro.2005.03.040; Levy C, 2005, DIGEST DIS SCI, V50, P1734, DOI 10.1007/s10620-005-2927-8; Lin YS, 2004, INT J CANCER, V110, P584, DOI 10.1002/ijc.20147; Malhi H, 2006, ALIMENT PHARM THER, V23, P1287, DOI 10.1111/j.1365-2036.2006.02900.x; Mancino A, 2006, HEPATOLOGY, V44, p389A; Neufeld G, 2006, CANCER METAST REV, V25, P373, DOI 10.1007/s10555-006-9011-5; Park BK, 2006, AM J CLIN ONCOL-CANC, V29, P138, DOI 10.1097/01.coc.0000204402.29830.08; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Rumalla A, 2001, MAYO CLIN PROC, V76, P29, DOI 10.4065/76.1.29; Ruohola JK, 1999, MOL CELL ENDOCRINOL, V149, P29, DOI 10.1016/S0303-7207(99)00003-9; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Singh P, 2006, CURR OPIN GASTROEN, V22, P294, DOI 10.1097/01.mog.0000218967.60633.64; Stephen RL, 2001, J BIOL CHEM, V276, P40080, DOI 10.1074/jbc.M105892200; Taylor PC, 2005, RHEUMATOLOGY, V44, P721, DOI 10.1093/rheumatology/keh524; TURLEY SD, 1978, J LIPID RES, V19, P924; Vitellas KM, 2000, RADIOGRAPHICS, V20, P939, DOI 10.1148/radiographics.20.4.g00jl23939; West J, 2006, BRIT J CANCER, V94, P1751, DOI 10.1038/sj.bjc.6603127; WIMALASENA J, 1993, ONCOL RES, V5, P325; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151; Zech CJ, 2004, EUR RADIOL, V14, P1174, DOI 10.1007/s00330-004-2327-z; Zhou J, 2001, J INVEST MED, V49, P47, DOI 10.2310/6650.2001.34090	49	46	50	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2007	147	7					451	459		10.7326/0003-4819-147-7-200710020-00003	http://dx.doi.org/10.7326/0003-4819-147-7-200710020-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221GF	17909206				2022-12-01	WOS:000250214700002
J	Page, L; Drife, J				Page, Lesley; Drife, Jim			Do we have enough evidence to judge midwife led maternity units safe?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Coll London, Florence Nightingale Sch Nursing & Midwifery, London SE1 9NH, England	University of London; King's College London	Page, L (corresponding author), Kings Coll London, Florence Nightingale Sch Nursing & Midwifery, London SE1 9NH, England.	Lesley.page@kcl.ac.uk							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 29	2007	335	7621					642	643		10.1136/bmj.39343.471227.AD	http://dx.doi.org/10.1136/bmj.39343.471227.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218AY	17901510	Green Published			2022-12-01	WOS:000249989600034
J	McEwen, AS; Hansen, CJ; Delamere, WA; Eliason, EM; Herkenhoff, KE; Keszthelyi, L; Gulick, VC; Kirk, RL; Mellon, MT; Grant, JA; Thomas, N; Weitz, CM; Squyres, SW; Bridges, NT; Murchie, SL; Seelos, F; Seelos, K; Okubo, CH; Milazzo, MP; Tornabene, LL; Jaeger, WL; Byrne, S; Russell, PS; Griffes, JL; Martinez-Alonso, S; Davatzes, A; Chuang, FC; Thomson, BJ; Fishbaugh, KE; Dundas, CM; Kolb, KJ; Banks, ME; Wray, JJ				McEwen, A. S.; Hansen, C. J.; Delamere, W. A.; Eliason, E. M.; Herkenhoff, K. E.; Keszthelyi, L.; Gulick, V. C.; Kirk, R. L.; Mellon, M. T.; Grant, J. A.; Thomas, N.; Weitz, C. M.; Squyres, S. W.; Bridges, N. T.; Murchie, S. L.; Seelos, F.; Seelos, K.; Okubo, C. H.; Milazzo, M. P.; Tornabene, L. L.; Jaeger, W. L.; Byrne, S.; Russell, P. S.; Griffes, J. L.; Martinez-Alonso, S.; Davatzes, A.; Chuang, F. C.; Thomson, B. J.; Fishbaugh, K. E.; Dundas, C. M.; Kolb, K. J.; Banks, M. E.; Wray, J. J.			A closer look at water-related geologic activity on Mars	SCIENCE			English	Article							CRATERING RATE; DEPOSITS; MISSION; FATE	Water has supposedly marked the surface of Mars and produced characteristic landforms. To understand the history of water on Mars, we take a close look at key locations with the High-Resolution Imaging Science Experiment on board the Mars Reconnaissance Orbiter, reaching fine spatial scales of 25 to 32 centimeters per pixel. Boulders ranging up to similar to 2 meters in diameter are ubiquitous in the middle to high latitudes, which include deposits previously interpreted as fine-grained ocean sediments or dusty snow. Bright gully deposits identify six locations with very recent activity, but these lie on steep (20 degrees to 35 degrees) slopes where dry mass wasting could occur. Thus, we cannot confirm the reality of ancient oceans or water in active gullies but do see evidence of fluvial modification of geologically recent mid-latitude gullies and equatorial impact craters.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Delamere Support Syst, Boulder, CO 80304 USA; US Geol Survey, Flagstaff, AZ 86001 USA; NASA, Ames Res Ctr, SETI Inst, Moffett Field, CA 94035 USA; Univ Colorado, Boulder, CO 80309 USA; Smithsonian Ctr Earth & Planetary Studies, Washington, DC USA; Planetary Sci Inst, Tucson, AZ 85719 USA; Cornell Univ, Ithaca, NY 14853 USA; Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Int Space Sci Inst, Bern, Switzerland	University of Arizona; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Colorado System; University of Colorado Boulder; Cornell University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	McEwen, AS (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	mcewen@lpl.arizona.edu	Byrne, Shane/B-8104-2012; Davatzes, Alexandra/B-1479-2012; Bridges, Nathan T/D-6341-2016; Seelos, Kimberly D/F-4647-2015; Thomson, Bradley/AAA-3496-2022; Wray, James J/B-8457-2008; Murchie, Scott L/E-8030-2015; Martinez-Alonso, Sara/D-8594-2011; Seelos, Frank/C-7875-2016; Mellon, Michael/C-3456-2016; Thomas, Nicolas/G-4693-2015	Seelos, Kimberly D/0000-0001-7236-0580; Thomson, Bradley/0000-0001-8635-8932; Wray, James J/0000-0001-5559-2179; Murchie, Scott L/0000-0002-1616-8751; Martinez-Alonso, Sara/0000-0001-5185-8670; Seelos, Frank/0000-0001-9721-941X; Okubo, Chris/0000-0001-9776-8128; Kestay, Laszlo/0000-0003-1879-4331; Tornabene, Livio Leonardo/0000-0002-1479-6711; Grant, John/0000-0001-8276-1281; Dundas, Colin/0000-0003-2343-7224; Thomas, Nicolas/0000-0002-0146-0071				BarnouinJha OS, 1996, J GEOPHYS RES-PLANET, V101, P21099, DOI 10.1029/96JE01949; Carr M. H., 1977, Journal of Geophysical Research, V82, P4039, DOI 10.1029/JS082i028p04039; Carr MH, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001963; Christensen PR, 2003, NATURE, V422, P45, DOI 10.1038/nature01436; Heather DJ, 2003, ICARUS, V163, P307, DOI 10.1016/S0019-1035(02)00063-5; Ivanov BA, 2001, SPACE SCI REV, V96, P87, DOI 10.1023/A:1011941121102; Kreslavsky MA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001831; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Malin MC, 2006, SCIENCE, V314, P1573, DOI 10.1126/science.1135156; McEwen A. S., 2007, J GEOPHYS RES-PLANET, V112, DOI DOI 10.1029/2005JE002605; Mellon MT, 1997, J GEOPHYS RES-PLANET, V102, P25617, DOI 10.1029/97JE02582; Murchie S, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002682; Mustard JF, 2001, NATURE, V412, P411, DOI 10.1038/35086515; Okubo CH, 2007, SCIENCE, V315, P983, DOI 10.1126/science.1136855; Osinski GR, 2006, METEORIT PLANET SCI, V41, P1571, DOI 10.1111/j.1945-5100.2006.tb00436.x; Segura TL, 2002, SCIENCE, V298, P1977, DOI 10.1126/science.1073586; Squyres S. W., 1992, MARS, P523; TORNABENE LL, 2004, LUNAR PLANET SCI, V38; Williams KE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029507; Williams RME, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025618; WILLIAMS RME, 2004, LUNAR PLANCET SCI, V35; WILLIAMS RME, 2004, AM GEOPH UN FALL M; Zurek RW, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002701	23	122	124	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2007	317	5845					1706	1709		10.1126/science.1143987	http://dx.doi.org/10.1126/science.1143987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885125				2022-12-01	WOS:000249585900034
J	Puthenveedu, MA; Yudowski, GA; von Zastrow, M				Puthenveedu, Manojkumar A.; Yudowski, Guillermo A.; von Zastrow, Mark			Endocytosis of neurotransmitter receptors: location matters	CELL			English	Editorial Material							MEMBRANE; PROTEINS	Endocytosis of excitatory glutamate receptors from the postsynaptic plasma membrane plays a fundamental role in synaptic function and plasticity. In a recent study published in Neuron, Lu et al. ( 2007) describe protein interactions that link zones of receptor endocytosis directly to the postsynaptic scaffold and propose that local trafficking of receptors facilitated by these endocytic zones is required to maintain synaptic responsiveness.	Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA.	mark.vonzastrow@ucsf.edu	; Puthenveedu, Manojkumar/A-3795-2016	Yudowski, Guillermo/0000-0001-5989-4131; Puthenveedu, Manojkumar/0000-0002-3177-4231	NIDA NIH HHS [K99 DA023444-02, K99 DA023444] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA023444] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; LU J, 2007, NEURON; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Yudowski GA, 2006, NAT NEUROSCI, V9, P622, DOI 10.1038/nn1679	11	6	9	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6					988	989		10.1016/j.cell.2007.09.006	http://dx.doi.org/10.1016/j.cell.2007.09.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889644	Bronze			2022-12-01	WOS:000250507500009
J	Okutsu, T; Shikina, S; Kanno, M; Takeuchi, Y; Yoshizaki, G				Okutsu, Tomoyuki; Shikina, Shinya; Kanno, Megumi; Takeuchi, Yutaka; Yoshizaki, Goro			Production of trout offspring from triploid salmon parents	SCIENCE			English	Article							GERM-CELLS; FISH		Tokyo Univ Marine Sci & Technol, Dept Marine Biosci, Minato Ku, Tokyo 1088477, Japan; Japan Sci & Technol Agcy, SORST, Chiyoda Ku, Tokyo 1020075, Japan	Tokyo University of Marine Science & Technology; Japan Science & Technology Agency (JST)	Yoshizaki, G (corresponding author), Tokyo Univ Marine Sci & Technol, Dept Marine Biosci, Minato Ku, 4-5-7 Konan, Tokyo 1088477, Japan.	goro@kaiyodai.ac.jp	Wei, Qiwei/B-6928-2014; YOSHIZAKI, Goro/O-1937-2014	Wei, Qiwei/0000-0002-6366-1020; Takeuchi, Yutaka/0000-0001-5450-4632				Okutsu T, 2006, P NATL ACAD SCI USA, V103, P2725, DOI 10.1073/pnas.0509218103; Okutsu T, 2006, J REPROD DEVELOP, V52, P685, DOI 10.1262/jrd.18096; Takeuchi Y, 2004, NATURE, V430, P629, DOI 10.1038/430629a; Takeuchi Y, 2003, BIOL REPROD, V69, P1142, DOI 10.1095/biolreprod.103.017624	4	187	207	4	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2007	317	5844					1517	1517		10.1126/science.1145626	http://dx.doi.org/10.1126/science.1145626			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872437				2022-12-01	WOS:000249467900032
J	Hattori, D; Demir, E; Kim, HW; Viragh, E; Zipursky, SL; Dickson, BJ				Hattori, Daisuke; Demir, Ebru; Kim, Ho Won; Viragh, Erika; Zipursky, S. Lawrence; Dickson, Barry J.			Dscam diversity is essential for neuronal wiring and self-recognition	NATURE			English	Article							AXON GUIDANCE; DROSOPHILA DSCAM; MOLECULAR DIVERSITY; MORPHOGENESIS; MELANOGASTER; ORGANIZATION; SPECIFICITY; AVOIDANCE; CADHERINS; PATTERNS	Neurons are thought to use diverse families of cell-surface molecules for cell recognition during circuit assembly. In Drosophila, alternative splicing of the Down syndrome cell adhesion molecule (Dscam) gene potentially generates 38,016 closely related transmembrane proteins of the immunoglobulin superfamily, each comprising one of 19,008 alternative ectodomains linked to one of two alternative transmembrane segments(1). These ectodomains show isoform-specific homophilic binding, leading to speculation that Dscam proteins mediate cell recognition(2). Genetic studies have established that Dscam is required for neural circuit assembly(1,3-10), but the extent to which isoform diversity contributes to this process is not known. Here we provide conclusive evidence that Dscam diversity is essential for circuit assembly. Using homologous recombination, we reduced the entire repertoire of Dscam ectodomains to just a single isoform. Neural circuits in these mutants are severely disorganized. Furthermore, we show that it is crucial for neighbouring neurons to express distinct isoforms, but that the specific identity of the isoforms expressed in an individual neuron is unimportant. We conclude that Dscam diversity provides each neuron with a unique identity by which it can distinguish its own processes from those of other neurons, and that this self-recognition is essential for wiring the Drosophila brain.	Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90049 USA; Inst Mol Pathol, A-1030 Vienna, Austria	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90049 USA.	lzipursky@mednet.ucla.edu; dickson@imp.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Zipursky, Stephen/0000-0001-5630-7181	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Graveley BR, 2004, RNA, V10, P1499, DOI 10.1261/rna.7105504; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jefferis GSXE, 2006, SEMIN CELL DEV BIOL, V17, P50, DOI 10.1016/j.semcdb.2005.12.002; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; KRAMER AP, 1983, J NEUROSCI, V3, P2474; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Nern A, 2005, P NATL ACAD SCI USA, V102, P12944, DOI 10.1073/pnas.0502888102; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Newsome TP, 2000, DEVELOPMENT, V127, P851; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STORTKUHL KF, 1994, CELL TISSUE RES, V275, P27, DOI 10.1007/BF00305373; Takeichi M, 1997, COLD SPRING HARB SYM, V62, P505; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; WOJTOWICZ WM, IN PRESS CELL; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zipursky SL, 2006, TRENDS BIOCHEM SCI, V31, P581, DOI 10.1016/j.tibs.2006.08.003	28	158	160	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					223	U6		10.1038/nature06099	http://dx.doi.org/10.1038/nature06099			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851526	Green Accepted			2022-12-01	WOS:000249394500051
J	Raivio, T; Falardeau, J; Dwyer, A; Quinton, R; Hayes, FJ; Hughes, VA; Cole, LW; Pearce, SH; Lee, H; Boepple, P; Crowley, WF; Pitteloud, N				Raivio, Taneli; Falardeau, John; Dwyer, Andrew; Quinton, Richard; Hayes, Frances J.; Hughes, Virginia A.; Cole, Lindsay W.; Pearce, Simon H.; Lee, Hang; Boepple, Paul; Crowley, William F. Hr; Pitteloud, Nelly			Reversal of idiopathic hypogonadotropic hypogonadism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GONADOTROPIN-RELEASING-HORMONE; KALLMANN-SYNDROME; DELAYED PUBERTY; OLFACTORY-BULB; MUTATIONS; RECEPTOR; GENE; DEFICIENCY; VARIANT; CELLS	Background: Idiopathic hypogonadotropic hypogonadism, which may be associated with anosmia (the Kallmann syndrome) or with a normal sense of smell, is a treatable form of male infertility caused by a congenital defect in the secretion or action of gonadotropin-releasing hormone (GnRH). Patients have absent or incomplete sexual maturation by the age of 18. Idiopathic hypogonadotropic hypogonadism was previously thought to require lifelong therapy. We describe 15 men in whom reversal of idiopathic hypogonadotropic hypogonadism was sustained after discontinuation of hormonal therapy. Methods: We defined the sustained reversal of idiopathic hypogonadotropic hypogonadism as the presence of normal adult testosterone levels after hormonal therapy was discontinued. Results: Ten sustained reversals were identified retrospectively. Five sustained reversals were identified prospectively among 50 men with idiopathic hypogonadotropic hypogonadism after a mean (+/-SD) duration of treatment interruption of 6+/-3 weeks. Of the 15 men who had a sustained reversal, 4 had anosmia. At initial evaluation, 6 men had absent puberty, 9 had partial puberty, and all had abnormal secretion of GnRH-induced luteinizing hormone. All 15 men had received previous hormonal therapy to induce virilization, fertility, or both. Among those whose hypogonadism was reversed, the mean serum level of endogenous testosterone increased from 55+/-29 ng per deciliter (1.9+/-1.0 nmol per liter) to 386+/-91 ng per deciliter (13.4+/-3.2 nmol per liter, P<0.001), the luteinizing hormone level increased from 2.7+/-2.0 to 8.5+/-4.6 IU per liter (P<0.001), the level of follicle-stimulating hormone increased from 2.5+/-1.7 to 9.5+/-12.2 IU per liter (P<0.01), and testicular volume increased from 8+/-5 to 16+/-7 ml (P<0.001). Pulsatile luteinizing hormone secretion and spermatogenesis were documented. Conclusions: Sustained reversal of normosmic idiopathic hypogonadotropic hypogonadism and the Kallmann syndrome was noted after discontinuation of treatment in about 10% of patients with either absent or partial puberty. Therefore, brief discontinuation of hormonal therapy to assess reversibility of hypogonadotropic hypogonadism is reasonable. (ClinicalTrials.gov number, NCT00392756.) N Engl J Med 2007;357:863-73.	Massachusetts Gen Hosp, Harvard Ctr Reprod Endocrine Sci, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Reprod Endocrine Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Gen Clin Res Ctr, Boston, MA 02114 USA; Univ Newcastle Upon Tyne, Sch Clin Med Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Newcastle University - UK	Pitteloud, N (corresponding author), Massachusetts Gen Hosp, Harvard Ctr Reprod Endocrine Sci, Bartlett Hall Extens 5, Boston, MA 02114 USA.	npitteloud@partners.org	Pearce, Simon/AAB-3692-2019; Dwyer, Andrew A./D-8099-2012; PITTELOUD, Nelly/K-2709-2014	Pearce, Simon/0000-0001-8384-8063; Dwyer, Andrew A./0000-0002-7023-6794; 	NCRR NIH HHS [M01-RR-01066] Funding Source: Medline; NICHD NIH HHS [U54 HD029164, U54HD028138-16, R01 HD015788, U54 HD028138, R01HD015788-21] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD015788, U54HD028138] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD029164] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; BAUMAN A, 1986, J ANDROL, V7, P224; BURRIS AS, 1988, J CLIN ENDOCR METAB, V66, P1144, DOI 10.1210/jcem-66-6-1144; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; DOTY RL, 1985, NEUROPSYCHOLOGIA, V23, P667, DOI 10.1016/0028-3932(85)90067-3; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Grumbach MM, 2005, J CLIN ENDOCR METAB, V90, P3122, DOI 10.1210/jc.2004-2465; Hayes FJ, 1999, J CLIN ENDOCR METAB, V84, P1028, DOI 10.1210/jc.84.3.1028; Hebert JM, 2003, DEVELOPMENT, V130, P1101, DOI 10.1242/dev.00334; HOFFMAN AR, 1982, NEW ENGL J MED, V307, P1237, DOI 10.1056/NEJM198211113072003; Kadva A, 1996, CLIN ENDOCRINOL, V44, P103, DOI 10.1046/j.1365-2265.1996.00650.x; Layman LC, 1998, NAT GENET, V18, P14, DOI 10.1038/ng0198-14; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; MacLusky NJ, 2006, NEUROSCIENCE, V138, P957, DOI 10.1016/j.neuroscience.2005.12.054; MCCULLAGH EP, 1953, J CLIN ENDOCR METAB, V13, P489, DOI 10.1210/jcem-13-5-489; Miura K, 2004, J HUM GENET, V49, P265, DOI 10.1007/s10038-004-0137-4; Moore IT, 2004, J NEUROSCI, V24, P10182, DOI 10.1523/JNEUROSCI.3475-04.2004; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Oliveira LMB, 2001, J CLIN ENDOCR METAB, V86, P1532, DOI 10.1210/jc.86.4.1532; Pitteloud N, 2006, P NATL ACAD SCI USA, V103, P6281, DOI 10.1073/pnas.0600962103; Pitteloud N, 2005, DIABETES CARE, V28, P1636, DOI 10.2337/diacare.28.7.1636; Pitteloud N, 2005, J CLIN ENDOCR METAB, V90, P1317, DOI 10.1210/jc.2004-1361; Pitteloud N, 2002, J CLIN ENDOCR METAB, V87, P152, DOI 10.1210/jc.87.1.152; Pitteloud N, 2001, J CLIN ENDOCR METAB, V86, P2470, DOI 10.1210/jc.86.6.2470; Pitteloud N, 2007, J CLIN INVEST, V117, P457, DOI 10.1172/JCI29884; Pitteloud N, 2006, MOL CELL ENDOCRINOL, V254, P60, DOI 10.1016/j.mce.2006.04.021; Quinton R, 1997, J CLIN ENDOCR METAB, V82, P309, DOI 10.1210/jc.82.1.309; Quinton R, 1999, CLIN ENDOCRINOL, V50, P481; Quinton R, 2001, CLIN ENDOCRINOL, V55, P163, DOI 10.1046/j.1365-2265.2001.01277.x; Ribeiro RS, 2007, EUR J ENDOCRINOL, V156, P285, DOI 10.1530/eje.1.02342; SANTEN RJ, 1971, J CLIN ENDOCR METAB, V33, P970, DOI 10.1210/jcem-33-6-970; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Seminara SB, 1998, ENDOCR REV, V19, P521, DOI 10.1210/er.19.5.521; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Tsai PS, 2005, MOL ENDOCRINOL, V19, P225, DOI 10.1210/me.2004-0330; Waldstreicher J, 1996, J CLIN ENDOCR METAB, V81, P4388, DOI 10.1210/jc.81.12.4388; *WHO, 1999, WHO LA MAN EX HUM SE; Wray S, 2002, FRONT NEUROENDOCRIN, V23, P292, DOI 10.1016/S0091-3022(02)00001-8	41	238	260	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2007	357	9					863	873		10.1056/NEJMoa066494	http://dx.doi.org/10.1056/NEJMoa066494			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204TA	17761590	Bronze			2022-12-01	WOS:000249065700005
J	Storch, KF; Paz, C; Signorovitch, J; Raviola, E; Pawlyk, B; Li, T; Weitz, CJ				Storch, Kai-Florian; Paz, Carlos; Signorovitch, James; Raviola, Elio; Pawlyk, Basil; Li, Tiansen; Weitz, Charles J.			Intrinsic circadian clock of the mammalian retina: Importance for retinal processing of visual information	CELL			English	Article							MESSENGER-RNA EXPRESSION; GENE-EXPRESSION; MOUSE; RHYTHMS; PROTEIN; LIGHT; TRANSCRIPTION; DROSOPHILA; PACEMAKER; DOPAMINE	Circadian clocks are widely distributed in mammalian tissues, but little is known about the physiological functions of clocks outside the suprachiasmatic nucleus of the brain. The retina has an intrinsic circadian clock, but its importance for vision is unknown. Here we show that mice lacking Bmal1, a gene required for clock function, had abnormal retinal transcriptional responses to light and defective inner retinal electrical responses to light, but normal photoreceptor responses to light and retinas that appeared structurally normal by light and electron microscopy. We generated mice with a retina-specific genetic deletion of Bmal1, and they had defects of retinal visual physiology essentially identical to those of mice lacking Bmal1 in all tissues and lacked a circadian rhythm of inner retinal electrical responses to light. Our findings indicate that the intrinsic circadian clock of the retina regulates retinal visual processing in vivo.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ophthalmol,Berman Gund Lab, Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Weitz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	cweitz@hms.harvard.edu			NEI NIH HHS [R01 EY001344, R01 EY010309, EY001344, EY10309] Funding Source: Medline; NINDS NIH HHS [R01 NS055831-01, R01 NS055831, NS055831] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010309, R01EY001344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055831] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Bailey MJ, 2004, J BIOL CHEM, V279, P52247, DOI 10.1074/jbc.M405679200; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; BESHARSE JC, 1983, NATURE, V305, P133, DOI 10.1038/305133a0; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; CAHILL GM, 1993, NEURON, V10, P573, DOI 10.1016/0896-6273(93)90160-S; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Doyle SE, 2002, VISUAL NEUROSCI, V19, P593, DOI 10.1017/S0952523802195058; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Durgan DJ, 2006, J BIOL CHEM, V281, P24254, DOI 10.1074/jbc.M601704200; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GOTO M, 1989, J PINEAL RES, V7, P195, DOI 10.1111/j.1600-079X.1989.tb00667.x; Gustincich S, 2004, P NATL ACAD SCI USA, V101, P5069, DOI 10.1073/pnas.0400913101; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hayasaka N, 2002, J NEUROSCI, V22, P1600, DOI 10.1523/JNEUROSCI.22-05-01600.2002; Humphries A, 2004, BIOCHEM BIOPH RES CO, V320, P551, DOI 10.1016/j.bbrc.2004.06.006; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kondratov RV, 2006, FASEB J, V20, P530, DOI 10.1096/fj.05-5321fje; Kraves S, 2006, NAT NEUROSCI, V9, P212, DOI 10.1038/nn1633; LAVAIL MM, 1978, INVEST OPHTH VIS SCI, V17, P1189; Li C., 2003, ANAL GENE EXPRESSION, P120; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lu C, 2001, NEUROSCIENCE, V107, P35, DOI 10.1016/S0306-4522(01)00337-2; Manglapus MK, 1998, J NEUROSCI, V18, P4775; Masana MI, 1996, MOL BRAIN RES, V42, P193, DOI 10.1016/S0169-328X(96)00031-9; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; McGoogan JM, 1999, AM J PHYSIOL-REG I, V277, pR1418, DOI 10.1152/ajpregu.1999.277.5.R1418; Miranda-Anaya M, 2002, J BIOL RHYTHM, V17, P526, DOI 10.1177/0748730402238235; Nir I, 2002, J NEUROSCI, V22, P2063, DOI 10.1523/JNEUROSCI.22-06-02063.2002; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panda S, 2004, J BIOL RHYTHM, V19, P374, DOI 10.1177/0748730404269008; PIERCE ME, 1993, NEURON, V10, P579, DOI 10.1016/0896-6273(93)90161-J; Ripperger JA, 2000, GENE DEV, V14, P679; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Tanoue S, 2004, CURR BIOL, V14, P638, DOI 10.1016/j.cub.2004.04.009; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Wijnen H, 2006, PLOS GENET, V2, P326, DOI 10.1371/journal.pgen.0020039; Witkovsky P, 2003, J NEUROSCI, V23, P7670; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660	54	309	315	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2007	130	4					730	741		10.1016/j.cell.2007.06.045	http://dx.doi.org/10.1016/j.cell.2007.06.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	208KY	17719549	Green Accepted, Bronze			2022-12-01	WOS:000249319400022
J	Welch, JM; Lu, J; Rodriguiz, RM; Trotta, NC; Peca, J; Ding, JD; Feliciano, C; Chen, M; Adams, JP; Luo, JH; Dudek, SM; Weinberg, RJ; Calakos, N; Wetsel, WC; Feng, GP				Welch, Jeffrey M.; Lu, Jing; Rodriguiz, Ramona M.; Trotta, Nicholas C.; Peca, Joao; Ding, Jin-Dong; Feliciano, Catia; Chen, Meng; Adams, J. Paige; Luo, Jianhong; Dudek, Serena M.; Weinberg, Richard J.; Calakos, Nicole; Wetsel, William C.; Feng, Guoping			Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice	NATURE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; NMDA-RECEPTORS; HIPPOCAMPAL SYNAPSES; POSTSYNAPTIC DENSITY; SUBUNIT COMPOSITION; NERVOUS-SYSTEM; DISEASE MODELS; MESSENGER-RNA; PROTEINS; TRAFFICKING	Obsessive-compulsive disorder (OCD) is an anxiety-spectrum disorder characterized by persistent intrusive thoughts (obsessions) and repetitive actions (compulsions). Dysfunction of cortico-striato-thalamo-cortical circuitry is implicated in OCD, although the underlying pathogenic mechanisms are unknown. SAP90/PSD95-associated protein 3 (SAPAP3; also known as DLGAP3) is a postsynaptic scaffolding protein at excitatory synapses that is highly expressed in the striatum. Here we show that mice with genetic deletion of Sapap3 exhibit increased anxiety and compulsive grooming behaviour leading to facial hair loss and skin lesions; both behaviours are alleviated by a selective serotonin reuptake inhibitor. Electrophysiological, structural and biochemical studies of Sapap3-mutant mice reveal defects in cortico-striatal synapses. Furthermore, lentiviral-mediated selective expression of Sapap3 in the striatum rescues the synaptic and behavioural defects of Sapap3-mutant mice. These findings demonstrate a critical role for SAPAP3 at cortico-striatal synapses and emphasize the importance of cortico-striatal circuitry in OCD-like behaviours.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ctr Translat Neurosci, Div Neurol, Durham, NC 27710 USA; Zhejiang Univ, Sch Med, Dept Neurobiol, Hangzhou 310058, Zhejiang, Peoples R China; Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; Univ N Carolina, Ctr Neurosci, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Gulbenkian Inst Sci, P-2781901 Oeiras, Portugal; NIEHS, NIH, Res Triangle Pk, NC 27709 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Zhejiang University; Universidade de Coimbra; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Feng, GP (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	feng@neuro.duke.edu	Ding, Jindong/B-3324-2008; Weinberg, Richard/AAC-1898-2020; Feng, Guoping/Y-2827-2019; Peça, João/K-7900-2013; Dudek, Serena/C-6561-2009	Ding, Jindong/0000-0003-0427-0369; Peça, João/0000-0003-4989-2129; Dudek, Serena/0000-0003-4094-8368; Feliciano, Catia/0000-0001-7545-6924; Weinberg, Richard/0000-0001-9689-7278	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES100221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS054840, R01NS039444] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 ES100221-06] Funding Source: Medline; NIMH NIH HHS [R01 MH081201, R01 MH081201-01] Funding Source: Medline; NINDS NIH HHS [K02 NS054840-02, R01 NS039444, K02 NS054840, R01 NS039444-06] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aouizerate B, 2004, PROG NEUROBIOL, V72, P195, DOI 10.1016/j.pneurobio.2004.02.004; Arnold PD, 2006, ARCH GEN PSYCHIAT, V63, P769, DOI 10.1001/archpsyc.63.7.769; Arnold PD, 2004, PSYCHOPHARMACOLOGY, V174, P530, DOI 10.1007/s00213-004-1847-1; Bakeman R., 1997, OBSERVING INTERACTIO, P56; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Carey G, 1981, ANXIETY NEW RES CHAN, P117; Chakrabarty K, 2005, NEUROPSYCHOPHARMACOL, V30, P1735, DOI 10.1038/sj.npp.1300733; Chapman DE, 2003, J NEUROPHYSIOL, V89, P69, DOI 10.1152/jn.00342.2002; CRAWLEY JN, 1980, PHARM BIOCH BEHAV, V12, P167; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Dickel DE, 2006, ARCH GEN PSYCHIAT, V63, P778, DOI 10.1001/archpsyc.63.7.778; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Greer JM, 2002, NEURON, V33, P23, DOI 10.1016/S0896-6273(01)00564-5; Hanna GL, 2002, AM J MED GENET, V114, P541, DOI 10.1002/ajmg.10519; INOUYE E, 1965, AM J PSYCHIAT, V121, P1171, DOI 10.1176/ajp.121.12.1171; KARNO M, 1988, ARCH GEN PSYCHIAT, V45, P1094, DOI 10.1001/archpsyc.1988.01800360042006; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kindler S, 2004, MOL BRAIN RES, V126, P14, DOI 10.1016/j.molbrainres.2004.03.014; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; Li LJ, 2004, J NEUROPHYSIOL, V92, P2738, DOI 10.1152/jn.00308.2004; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Nestadt G, 2000, ARCH GEN PSYCHIAT, V57, P358, DOI 10.1001/archpsyc.57.4.358; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Parker MJ, 2004, J NEUROSCI, V24, P378, DOI 10.1523/JNEUROSCI.3865-03.2004; Pogorelov VM, 2005, NEUROPSYCHOPHARMACOL, V30, P1818, DOI 10.1038/sj.npp.1300724; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Prybylowski K, 2004, J BIOL CHEM, V279, P9673, DOI 10.1074/jbc.R300029200; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shi J, 1997, J NEUROSCI, V17, P6264; Shugart YY, 2006, MOL PSYCHIATR, V11, P763, DOI 10.1038/sj.mp.4001847; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Swedo S., 2004, NEUROBIOLOGY MENTAL, P628; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Torres AR, 2006, AM J PSYCHIAT, V163, P1978, DOI 10.1176/appi.ajp.163.11.1978; Tovar KR, 1999, J NEUROSCI, V19, P4180; TREIT D, 1988, PHARMACOL BIOCHEM BE, V31, P959, DOI 10.1016/0091-3057(88)90413-3; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; van Zundert B, 2004, TRENDS NEUROSCI, V27, P428, DOI 10.1016/j.tins.2004.05.010; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432; Welch JM, 2004, J COMP NEUROL, V472, P24, DOI 10.1002/cne.20060	50	487	504	4	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2007	448	7156					894	U2		10.1038/nature06104	http://dx.doi.org/10.1038/nature06104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202OM	17713528	Green Accepted, Green Submitted			2022-12-01	WOS:000248912900040
J	Daneman, N; Green, KA; Low, DE; Simor, AE; Willey, B; Schwartz, B; Toye, B; Jessamine, P; Tyrrell, GJ; Krajden, S; Ramage, L; Rose, D; Schertzberg, R; Bragg, D; McGeer, A				Daneman, Nick; Green, Karen A.; Low, Donald E.; Simor, Andrew E.; Willey, Barbara; Schwartz, Benjamin; Toye, Baldwin; Jessamine, Peter; Tyrrell, Gregory J.; Krajden, Sigmund; Ramage, Lee; Rose, David; Schertzberg, Ruth; Bragg, Delena; McGeer, Allison		Ontario Grp A Streptococcal St Grp	Surveillance for hospital outbreaks of invasive group A streptococcal infections in Ontario, Canada, 1992 to 2000	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-CARE WORKERS; BETA-HEMOLYTIC STREPTOCOCCUS; WOUND INFECTIONS; ANAL CARRIER; BURNS UNIT; PERTUSSIS VACCINATION; NOSOCOMIAL INFECTIONS; VAGINAL CARRIER; NEWBORN NURSERY; MATERNITY UNIT	Background: Streptococcus pyogenes can cause severe disease in the individual patient and dramatic hospital outbreaks. Objective: To describe the epidemiology of hospital outbreaks of invasive group A streptococcal infection in order to understand the potential benefit of proposed outbreak investigation and management strategies. Design: Prospective, population-based surveillance. Setting: Short-term care hospitals in Ontario, Canada. Patients: Persons with a positive culture for group A streptococcus from a normally sterile site between 1 January 1992 and 31 December 2000. Measurements: Laboratory-based surveillance identified patients with nosocomial invasive group A streptococcal infection. Epidemiologic and microbiological investigations were used to detect transmission. Results: Of 2351 cases of invasive group A streptococcal disease, 291 (12%) were hospital acquired. Twenty-nine (10%) nosocomial cases occurred as part of 20 outbreaks. Seventy percent (14 of 20) of outbreaks involved nonsurgical, nonobstetric patients. Community-acquired cases initiated 25% of outbreaks; most were cases of necrotizing fasciitis in patients admitted to the intensive care unit. outbreaks were small (median, 2 cases [range, 2 to 10 cases]) and short (median duration, 6 days [range, 0 to 30 days]). The median time between the first 2 cases was 4.5 days. The most common mode of propagation was patient-to-patient transmission. A staff carrier was the primary mode of transmission in 2 (10%) outbreaks, but 1 or more health care workers were colonized with the outbreak strain in 6 of 18 (33%) other outbreaks. Limitations: Some outbreaks with 1 case of invasive disease may have been missed; advice provided to participating hospitals may have reduced the number and size of outbreaks. Conclusions: Practices to prevent hospital transmission of group A streptococci should include isolation of patients admitted to the intensive care unit with necrotizing fasciitis, investigation after a single nosocomial case, and emphasis on identifying and treating health care worker carriers on surgical and obstetric services and patient reservoirs on other wards.	Univ Toronto, Mt Sinai Hosp, Sunnybrook Hlth Sci Ctr, St Josephs Hlth Ctr,Scarborough Hosp, Toronto, ON M5G 1X5, Canada; Humber River Reg Hosp, Toronto, ON, Canada; Ctr Dis Control & Prevent, Atlanta, GA USA; Ottawa Hosp, Ottawa, ON, Canada; Natl Ctr Streptococus, Edmonton, AB, Canada; Hamilton Hlth Sci, Hamilton, ON, Canada; Grand River Hosp, Waterloo, ON, Canada	Scarborough Hospital; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Saint Joseph's Health Centre, Toronto; Sinai Health System Toronto; Sunnybrook Health Science Center; Western University (University of Western Ontario); Centers for Disease Control & Prevention - USA; University of Ottawa; Ottawa Hospital Research Institute; McMaster University	McGeer, A (corresponding author), Univ Toronto, Mt Sinai Hosp, Sunnybrook Hlth Sci Ctr, St Josephs Hlth Ctr,Scarborough Hosp, Room 210,600 Univ Ave, Toronto, ON M5G 1X5, Canada.	amcgeer@mtsinai.on.ca	Tyrrell, Gregory/ABA-7203-2021; Low, Donald/B-1726-2012; mcgeer, allison/H-7747-2014; McGeer, Allison/AAB-6885-2020	mcgeer, allison/0000-0001-5647-6137; McGeer, Allison/0000-0001-5647-6137; Kaul, Rupert/0000-0002-1586-4093; Walmsley, Sharon/0000-0002-3959-5692	PHS HHS [200-91-0929, 200-94-0877] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALLEN KD, 1990, J HOSP INFECT, V16, P178, DOI 10.1016/0195-6701(90)90065-V; Aragon T, 1999, JAMA-J AM MED ASSOC, V281, P1077; Beall B, 2002, CLIN INFECT DIS, V35, P950, DOI 10.1086/342692; Berg U, 1982, J Hosp Infect, V3, P333, DOI 10.1016/0195-6701(82)90064-0; BERKELMAN RL, 1982, JAMA-J AM MED ASSOC, V247, P2680, DOI 10.1001/jama.247.19.2680; Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; BURNETT IA, 1990, J HOSP INFECT, V15, P173, DOI 10.1016/0195-6701(90)90127-A; BYGDEMAN S, 1978, SCAND J INFECT DIS, V10, P45, DOI 10.3109/inf.1978.10.issue-1.10; Campbell JR, 1996, J PEDIATR-US, V129, P396, DOI 10.1016/S0022-3476(96)70072-0; CLAESSON BEB, 1985, J HOSP INFECT, V6, P304, DOI 10.1016/0195-6701(85)90035-0; Davies BI, 1999, J INFECTION, V38, P185, DOI 10.1016/S0163-4453(99)90249-9; Davies HD, 1996, NEW ENGL J MED, V335, P547, DOI 10.1056/NEJM199608223350803; DECKER J, 1976, MMWR MORB MORTAL WKL, V25; DECKER MD, 1985, JAMA-J AM MED ASSOC, V253, P679, DOI 10.1001/jama.253.5.679; DiPersio JR, 1996, CLIN INFECT DIS, V22, P490, DOI 10.1093/clinids/22.3.490; DOWSETT EG, 1975, BMJ-BRIT MED J, V1, P500, DOI 10.1136/bmj.1.5956.500; Ejlertsen T, 2001, SCAND J INFECT DIS, V33, P734, DOI 10.1080/003655401317074518; Fica A, 2003, REV MED CHILE, V131, P145; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; GEHLBACH SH, 1975, PEDIATRICS, V55, P422; GEIL C C, 1970, Pediatrics, V46, P849; GEZON HM, 1973, PEDIATRICS, V51, P383; Gonzalez-Rey C, 2003, COMP IMMUNOL MICROB, V26, P25, DOI 10.1016/S0147-9571(02)00019-X; GORDON G, 1994, BRIT J OBSTET GYNAEC, V101, P447, DOI 10.1111/j.1471-0528.1994.tb11922.x; GRIFFITH F, 1934, HYGIENE, V34, P442; Gruteke P, 1996, J CLIN MICROBIOL, V34, P114, DOI 10.1128/JCM.34.1.114-118.1996; GRYSKA PF, 1970, J AMER MED ASSOC, V213, P1189, DOI 10.1001/jama.213.7.1189; HOLLOWAY WJ, 1967, DEL MED J, V39, P263; ISENBERG HD, 1984, J CLIN MICROBIOL, V19, P366, DOI 10.1128/JCM.19.3.366-370.1984; Kakis A, 2002, CLIN INFECT DIS, V35, P1353, DOI 10.1086/344279; Kolmos HJ, 1997, J HOSP INFECT, V35, P207, DOI 10.1016/S0195-6701(97)90208-5; LANNIGAN R, 1985, DIAGN MICR INFEC DIS, V3, P337, DOI 10.1016/0732-8893(85)90008-2; LEHTONEN OPJ, 1987, J INFECTION, V14, P263, DOI 10.1016/S0163-4453(87)93585-7; MAGEE JT, 1991, J MED MICROBIOL, V35, P304, DOI 10.1099/00222615-35-5-304; MASTRO TD, 1990, NEW ENGL J MED, V323, P968, DOI 10.1056/NEJM199010043231406; MAXTED WR, 1973, J MED MICROBIOL, V6, P83, DOI 10.1099/00222615-6-1-83; MCGREGOR J, 1984, AM J OBSTET GYNECOL, V150, P385, DOI 10.1016/S0002-9378(84)80144-1; MCINTYRE DM, 1968, AM J OBSTET GYNECOL, V101, P308, DOI 10.1016/0002-9378(68)90056-2; MCKEE WM, 1966, LANCET, V2, P1007; MEAD PB, 1968, OBSTET GYNECOL, V32, P460; Memish Z A, 1994, Can J Infect Dis, V5, P276; NASH FW, 1965, POSTGRAD MED J, V41, P182, DOI 10.1136/pgmj.41.474.182; NELSON JD, 1976, J PEDIATR-US, V89, P792, DOI 10.1016/S0022-3476(76)80809-8; NICOLLE LE, 1986, INFECT CONT HOSP EP, V7, P177, DOI 10.1017/S0195941700064031; *ONT GROUP STREPT, 2005, CLIN INFECT DIS, V41, P334; *ONT HOSP ASS, 2007, COMM DIS SURV PROT G; PAUL SM, 1990, INFECT CONT HOSP EP, V11, P643; PORTNOY J, 1974, CAN ANAESTH SOC J, V21, P498, DOI 10.1007/BF03005845; Pritchard V G, 1988, J Gerontol Nurs, V14, P19; QUINN RW, 1965, ARCH ENVIRON HEALTH, V11, P28, DOI 10.1080/00039896.1965.10664166; Rahman M, 1981, J Hosp Infect, V2, P63, DOI 10.1016/0195-6701(81)90007-4; Ramage L, 1996, INFECT CONT HOSP EP, V17, P429; REID RI, 1983, J INFECTION, V6, P219, DOI 10.1016/S0163-4453(83)93549-1; RICHMAN DD, 1977, J PEDIATR-US, V90, P387, DOI 10.1016/S0022-3476(77)80698-7; RIDGWAY EJ, 1993, J HOSP INFECT, V25, P173, DOI 10.1016/0195-6701(93)90035-X; ROTTA J, 1971, J EXP MED, V134, P1298, DOI 10.1084/jem.134.5.1298; Rutishauser J, 1999, INFECTION, V27, P259, DOI 10.1007/s150100050024; SCHAFFNER W, 1969, NEW ENGL J MED, V280, P1224, DOI 10.1056/NEJM196905292802209; SCHRACK WD, 1979, PENN MED, V82, P35; SCHWARTZ B, 1992, CLIN INFECT DIS, V15, P277, DOI 10.1093/clinids/15.2.277; SIMON PA, 1993, PEDIATR INFECT DIS J, V12, P368, DOI 10.1097/00006454-199305000-00003; STAMM WE, 1978, J INFECT DIS, V138, P287, DOI 10.1093/infdis/138.3.287; STETLER HC, 1985, PEDIATRICS, V75, P299; TANCER ML, 1969, AM J OBSTET GYNECOL, V103, P1028, DOI 10.1016/S0002-9378(16)34455-6; Tyrrell GJ, 2002, J CLIN MICROBIOL, V40, P4466, DOI 10.1128/JCM.40.12.4466-4471.2002; VIGLIONESE A, 1991, AM J MED, V91, pS329, DOI 10.1016/0002-9343(91)90391-A; WALTER CW, 1974, ANESTH ANALG, V53, P631; Weber DJ, 1996, INFECT CONT HOSP EP, V17, P753; WEBSTER A, 1987, SCAND J INFECT DIS, V19, P205, DOI 10.3109/00365548709032399; WHITBY M, 1984, J HOSP INFECT, V5, P63, DOI 10.1016/0195-6701(84)90102-6; WIESENTHAL AM, 1984, INFECT CONT HOSP EP, V5, P271, DOI 10.1017/S0195941700060318	71	32	32	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2007	147	4					234	241		10.7326/0003-4819-147-4-200708210-00004	http://dx.doi.org/10.7326/0003-4819-147-4-200708210-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201AP	17709757				2022-12-01	WOS:000248804200003
J	Righelato, R; Spracklen, DV				Righelato, Renton; Spracklen, Dominick V.			Environment - Carbon mitigation by biofuels or by saving and restoring forests?	SCIENCE			English	Editorial Material									World Land Trust, Halesworth IP19 8AB, Suffolk, England; Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England	University of Leeds	Righelato, R (corresponding author), World Land Trust, Halesworth IP19 8AB, Suffolk, England.	renton@worldlandtrust.org	Spracklen, Dominick V/B-4890-2014; Spracklen, Dominick/AAA-6257-2019					Elsayed MA, 2003, CARBON ENERGY BALANC; *EUCAR JRC CONCAWE, 2006, WELL TO WHEELS AN FU; *INT EN AUTH, 2004, BIOF TRANSP INT PERS, pCH6; Kirschbaum MUF, 2003, BIOMASS BIOENERG, V24, P297, DOI 10.1016/S0961-9534(02)00171-X; Larson E, 2005, SCI TECHN ADV PAN GL; Raghu S, 2006, SCIENCE, V313, P1742, DOI 10.1126/science.1129313; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; WATSON RT, 2001, LAND USE LAND USE CH, P184	8	242	252	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					902	902		10.1126/science.1141361	http://dx.doi.org/10.1126/science.1141361			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702929				2022-12-01	WOS:000248780200023
J	Meyerhardt, JA; Niedzwiecki, D; Hollis, D; Saltz, LB; Hu, FB; Mayer, RJ; Nelson, H; Whittom, R; Hantel, A; Thomas, J; Fuchs, CS				Meyerhardt, Jeffrey A.; Niedzwiecki, Donna; Hollis, Donna; Saltz, Leonard B.; Hu, Frank B.; Mayer, Robert J.; Nelson, Heidi; Whittom, Renaud; Hantel, Alexander; Thomas, James; Fuchs, Charles S.			Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOOD-FREQUENCY QUESTIONNAIRE; CORONARY-HEART-DISEASE; TOTAL-ENERGY-INTAKE; IOWA WOMENS HEALTH; COLORECTAL-CANCER; MEAT CONSUMPTION; LIFE-STYLE; VITAMIN-D; PROSPECTIVE COHORT; PHYSICAL-ACTIVITY	Context Dietary factors have been associated with the risk of developing colon cancer but the influence of diet on patients with established disease is unknown. Objective To determine the association of dietary patterns with cancer recurrences and mortality of colon cancer survivors. Design, Setting, and Patients Prospective observational study of 1009 patients with stage III colon cancer who were enrolled in a randomized adjuvant chemotherapy trial (CALGB 89803) between April 1999 and May 2001. Patients reported on dietary intake using a semiquantitative food frequency questionnaire during and 6 months after adjuvant chemotherapy. We identified 2 major dietary patterns, prudent and Western, by factor analysis. The prudent pattern was characterized by high intakes of fruits and vegetables, poultry, and fish; the Western pattern was characterized by high intakes of meat, fat, refined grains, and dessert. Patients were followed up for cancer recurrence or death. Main Outcome Measures Disease-free survival, recurrence-free survival, and overall survival by dietary pattern. Results During a median follow-up of 5.3 years for the overall cohort, 324 patients had cancer recurrence, 223 patients died with cancer recurrence, and 28 died without documented cancer recurrence. A higher intake of a Western dietary pattern after cancer diagnosis was associated with a significantly worse disease-free survival (colon cancer recurrences or death). Compared with patients in the lowest quintile of Western dietary pattern, those in the highest quintile experienced an adjusted hazard ratio (AHR) for disease-free survival of 3.25 (95% confidence interval [CI], 2.04-5.19; P for trend < .001). The Western dietary pattern was associated with a similar detriment in recurrence-free survival (AHR, 2.85; 95% CI, 1.75-4.63) and overall survival (AHR, 2.32; 95% CI, 1.36-3.96]), comparing highest to lowest quintiles (both with P for trend < .001). The reduction in disease-free survival with a Western dietary pattern was not significantly modified by sex, age, nodal stage, body mass index, physical activity level, baseline performance status, or treatment group. In contrast, the prudent dietary pattern was not significantly associated with cancer recurrence or mortality. Conclusions Higher intake of a Western dietary pattern may be associated with a higher risk of recurrence and mortality among patients with stage III colon cancer treated with surgery and adjuvant chemotherapy. Further studies are needed to delineate which components of such a diet show the strongest association.	Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Duke Univ, Med Ctr, CALGB Stat Ctr, Durham, NC USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Brigham & Womens Hosp, Harvard Sch Publ Hlth, Boston, MA 02115 USA; Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Mayo Clin Fdn, Rochester, MN USA; Hop Sacre Coeur, Dept Med, Montreal, PQ H4J 1C5, Canada; Loyola Univ, Stritch Sch Med, Div Hematol & Oncol, Maywood, IL 60153 USA; Ohio State Univ, Div Hematol & Oncol, Columbus, OH 43210 USA	Harvard University; Dana-Farber Cancer Institute; Duke University; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Mayo Clinic; Universite de Montreal; Loyola University Chicago; University System of Ohio; Ohio State University	Meyerhardt, JA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	jmeyerhardt@partners.org		Niedzwiecki, Donna/0000-0002-3566-0450; Saltz, Leonard/0000-0001-8353-4670	NCI NIH HHS [CA31946, CA33601, K07CA097992] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U10CA031946, K07CA097992, U10CA033601] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adeyemo D, 2001, CANCER LETT, V164, P77, DOI 10.1016/S0304-3835(00)00720-5; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; BOSTICK RM, 1993, CANCER RES, V53, P4230; BOSTICK RM, 1993, AM J EPIDEMIOL, V137, P1302, DOI 10.1093/oxfordjournals.aje.a116640; Chao A, 2005, JAMA-J AM MED ASSOC, V293, P172, DOI 10.1001/jama.293.2.172; CHLEBOWSKI RT, 2005, P AN M AM SOC CLIN, V23, P10; COX DR, 1972, J R STAT SOC B, V34, P187; Demark-Wahnefried W, 2000, CANCER-AM CANCER SOC, V88, P674, DOI 10.1002/(SICI)1097-0142(20000201)88:3&lt;674::AID-CNCR26&gt;3.0.CO;2-R; Dray X, 2003, GUT, V52, P868, DOI 10.1136/gut.52.6.868; Feskanich D, 2004, CANCER EPIDEM BIOMAR, V13, P1502; Fung T, 2003, ARCH INTERN MED, V163, P309, DOI 10.1001/archinte.163.3.309; Fung TT, 2004, ARCH INTERN MED, V164, P2235, DOI 10.1001/archinte.164.20.2235; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; Fung TT, 2001, AM J CLIN NUTR, V73, P61; GARLAND C, 1985, LANCET, V1, P307, DOI 10.1016/S0140-6736(85)91082-7; GIOVANNUCCI E, 1995, JNCI-J NATL CANCER I, V87, P265, DOI 10.1093/jnci/87.4.265; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P875, DOI 10.1093/jnci/85.11.875; Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002; Giovannucci E, 2002, GASTROENTEROL CLIN N, V31, P925, DOI 10.1016/S0889-8553(02)00057-2; GIOVANNUCCI E, 1994, CANCER RES, V54, P2390; GLYNN SA, 1994, NUTR CANCER, V22, P101, DOI 10.1080/01635589409514336; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Kesse E, 2006, AM J EPIDEMIOL, V164, P1085, DOI 10.1093/aje/kwj324; Kim MK, 2005, INT J CANCER, V115, P790, DOI 10.1002/ijc.20943; Larsson SC, 2005, INT J CANCER, V113, P829, DOI 10.1002/ijc.20658; Lee MM, 2000, J NATL CANCER I, V92, P42, DOI 10.1093/jnci/92.1.42; Martinez ME, 2005, RECENT RESULTS CANC, V166, P177; Martinez ME, 1998, CANCER EPIDEM BIOMAR, V7, P163; Meyerhardt JA, 2005, J CLIN ONCOL, V23, P8453, DOI 10.1200/JCO.2005.02.5460; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3527, DOI 10.1200/JCO.2006.06.0855; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3535, DOI 10.1200/JCO.2006.06.0863; Michaud DS, 2005, J NATL CANCER I, V97, P518, DOI 10.1093/jnci/dji094; Patterson RE, 2002, J ALTERN COMPLEM MED, V8, P477, DOI 10.1089/107555302760253676; Pierce JP, 2007, JAMA-J AM MED ASSOC, V298, P289, DOI 10.1001/jama.298.3.289; RANDALL E, 1992, NUTR CANCER, V18, P265, DOI 10.1080/01635589209514227; SALTZ LB, IN PRESS J CLIN ONCO; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Sandhu MS, 2001, CANCER EPIDEM BIOMAR, V10, P439; Satia JA, 2004, CANCER EPIDEM BIOMAR, V13, P1022; Schulze MB, 2001, BRIT J NUTR, V85, P363, DOI 10.1079/BJN2000254; Slattery ML, 1997, NUTR CANCER, V28, P52, DOI 10.1080/01635589709514553; SLATTERY ML, 1989, INT J EPIDEMIOL, V18, P792, DOI 10.1093/ije/18.4.792; Slattery ML, 1998, AM J EPIDEMIOL, V148, P4, DOI 10.1093/aje/148.1.4-a; Terry P, 2001, AM J EPIDEMIOL, V154, P1143, DOI 10.1093/aje/154.12.1143; US Department of Agriculture (USDA) Agricultural Research Service, 2007, USDA NUTR DAT STAND; van Dam RM, 2002, ANN INTERN MED, V136, P201, DOI 10.7326/0003-4819-136-3-200202050-00008; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT WC, 1990, NEW ENGL J MED, V323, P1664, DOI 10.1056/NEJM199012133232404; WILLETT WC, 1987, J AM DIET ASSOC, V87, P43; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wu K, 2004, CANCER CAUSE CONTROL, V15, P853, DOI 10.1007/s10552-004-1809-2; Wu K, 2002, CANCER EPIDEM BIOMAR, V11, P1298; Wu K, 2002, JNCI-J NATL CANCER I, V94, P437, DOI 10.1093/jnci/94.6.437; Zubrod CG, 1960, J CHRON DIS, V11, P7	56	293	299	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2007	298	7					754	764		10.1001/jama.298.7.754	http://dx.doi.org/10.1001/jama.298.7.754			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	199XP	17699009	Bronze			2022-12-01	WOS:000248728800020
J	Rajasekaran, NS; Connell, P; Christians, ES; Yan, LJ; Taylor, RP; Orosz, A; Zhang, XQ; Stevenson, TJ; Peshock, RM; Leopold, JA; Barry, WH; Loscalzo, J; Odelberg, SJ; Benjamin, IJ				Rajasekaran, Namakkal S.; Connell, Patrice; Christians, Elisabeth S.; Yan, Liang-Jun; Taylor, Ryan P.; Orosz, Andras; Zhang, Xiu Q.; Stevenson, Tamara J.; Peshock, Ronald M.; Leopold, Jane A.; Barry, William H.; Loscalzo, Joseph; Odelberg, Shannon J.; Benjamin, Ivor J.			Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice	CELL			English	Article							HEAT-SHOCK-PROTEIN; DESMIN-RELATED CARDIOMYOPATHY; OXIDATIVE STRESS; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE ACTIVITY; MOLECULAR CHAPERONES; SKELETAL MYOPATHY; OXIDANT STRESS; GLUTATHIONE; APOPTOSIS; REGULATORS	The autosomal dominant mutation in the human alpha B-crystallin gene inducing a R120G amino acid exchange causes a multisystem, protein aggregation disease including cardiomyopathy. The pathogenesis of cardiomyopathy in this mutant (hR120GCryAB) is poorly understood. Here, we show that transgenic mice overexpressing cardiac-specific hR120GCryAB recapitulate the cardiomyopathy in humans and find that the mice are under reductive stress. The myopathic hearts show an increased recycling of oxidized glutathione ( GSSG) to reduced glutathione (GSH), which is due to the augmented expression and enzymatic activities of glucose-6-phosphate dehydrogenase (G6PD), glutathione reductase, and glutathione peroxidase. The intercross of hR120GCryAB cardiomyopathic animals with mice with reduced G6PD levels rescues the progeny from cardiac hypertrophy and protein aggregation. These findings demonstrate that dysregulation of G6PD activity is necessary and sufficient for maladaptive reductive stress and suggest a novel therapeutic target for abrogating R120GCryAB cardiomyopathy and heart failure in humans.	Univ Utah, Sch Med, Dept Internal Med, Div Cardiol,Ctr Cardiovasc Translat Biomed, Salt Lake City, UT 84132 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Ctr Dev Biol, UMR5547, F-31062 Toulouse, France; Univ Texas, SW Med Ctr, Dept Radiol, Dallas, TX 75390 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Cardiovasc Med Div, Boston, MA 02115 USA	Utah System of Higher Education; University of Utah; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Benjamin, IJ (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Div Cardiol,Ctr Cardiovasc Translat Biomed, 30 N 1900 E,Room 4A100, Salt Lake City, UT 84132 USA.	ivor.benjamin@hsc.utah.edu	Loscalzo, Joseph/ABD-8980-2021; peshock, ron/Q-6381-2019	peshock, ron/0000-0003-3217-1966; Yan, Liang-Jun/0000-0002-5815-5430	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063834] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006438] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL063834-01A1, 5R01 HL63874, R01 HL063834] Funding Source: Medline; NIH HHS [DP1 OD006438] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Baek SH, 2000, J CELL PHYSIOL, V183, P100, DOI 10.1002/(SICI)1097-4652(200004)183:1<100::AID-JCP12>3.0.CO;2-F; Benjamin IJ, 2005, J CLIN INVEST, V115, P495, DOI 10.1172/JCI200524477; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Christians ES, 2002, CRIT CARE MED, V30, pS43, DOI 10.1097/00003246-200201001-00006; Clemen CS, 2005, FEBS LETT, V579, P3777, DOI 10.1016/j.febslet.2005.05.051; Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; FARDEAU M, 1978, J AM STAT ASSOC, V88, P920; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Goldfarb LG, 2004, BRAIN, V127, P723, DOI 10.1093/brain/awh033; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Gupte SA, 2006, J MOL CELL CARDIOL, V41, P340, DOI 10.1016/j.yjmcc.2006.05.003; Handy DE, 2006, J BIOL CHEM, V281, P3382, DOI 10.1074/jbc.M511295200; Hansen JM, 2006, ANNU REV PHARMACOL, V46, P215, DOI 10.1146/annurev.pharmtox.46.120604.141122; HOCHMAN JH, 1982, P NATL ACAD SCI-BIOL, V79, P6866, DOI 10.1073/pnas.79.22.6866; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652; KLETZIEN RF, 1994, FASEB J, V8, P174, DOI 10.1096/fasebj.8.2.8119488; Knowlton AA, 1998, J MOL CELL CARDIOL, V30, P811, DOI 10.1006/jmcc.1998.0646; Kumar LVS, 1999, J BIOL CHEM, V274, P24137, DOI 10.1074/jbc.274.34.24137; Kumar MS, 2005, BIOCHEM J, V391, P335, DOI 10.1042/BJ20050506; Leopold JA, 2003, J BIOL CHEM, V278, P32100, DOI 10.1074/jbc.M301293200; Leopold JA, 2001, FASEB J, V15, P1771, DOI 10.1096/fj.00-0893fje; Leopold JA, 2007, NAT MED, V13, P189, DOI 10.1038/nm1545; Liu MG, 2006, INVEST OPHTH VIS SCI, V47, P3461, DOI 10.1167/iovs.05-1438; Maloyan A, 2005, CIRCULATION, V112, P3451, DOI 10.1161/CIRCULATIONAHA.105.572552; Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Pilotto A, 2006, BIOCHEM BIOPH RES CO, V346, P1115, DOI 10.1016/j.bbrc.2006.05.203; Preville X, 1999, EXP CELL RES, V247, P61, DOI 10.1006/excr.1998.4347; Russell RL, 1999, ARCH BIOCHEM BIOPHYS, V370, P236, DOI 10.1006/abbi.1999.1404; Sam F, 2005, J CARD FAIL, V11, P473, DOI 10.1016/j.cardfail.2005.01.007; Sanbe A, 2004, P NATL ACAD SCI USA, V101, P10132, DOI 10.1073/pnas.0401900101; Selcen D, 2004, BRAIN, V127, P439, DOI 10.1093/brain/awh052; SIMONS JF, 1995, J CELL BIOL, V130, P41, DOI 10.1083/jcb.130.1.41; Tome ME, 2006, ANTIOXID REDOX SIGN, V8, P1315, DOI 10.1089/ars.2006.8.1315; Trotter EW, 2002, MOL MICROBIOL, V46, P869, DOI 10.1046/j.1365-2958.2002.03216.x; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Xiao XZ, 1999, AM J HUM GENET, V64, P685, DOI 10.1086/302305; Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528	45	343	358	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2007	130	3					427	439		10.1016/j.cell.2007.06.044	http://dx.doi.org/10.1016/j.cell.2007.06.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693254	Bronze, Green Accepted			2022-12-01	WOS:000249038100012
J	Calmy, A; Hirschel, B; Cooper, DA; Carr, A				Calmy, Alexandra; Hirschel, Bernard; Cooper, David A.; Carr, Andrew			Clinical update: adverse effects of antiretroviral therapy	LANCET			English	Article							HIV-INFECTED PATIENTS; TENOFOVIR DF; ADULTS; ZIDOVUDINE; EFAVIRENZ; ABACAVIR; DISEASE; COHORT; TRIAL		St Vincents Hosp, Sydney, NSW 2010, Australia; Univ Geneva, Hop Cantonal, Serv Malad Infect, CH-1211 Geneva, Switzerland; Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia	St Vincents Hospital Sydney; University of Geneva; University of New South Wales Sydney; Kirby Institute	Calmy, A (corresponding author), St Vincents Hosp, Sydney, NSW 2010, Australia.	acalmy@gmail.com						Brar I, 2007, JAIDS-J ACQ IMM DEF, V45, P66, DOI 10.1097/QAI.0b013e318031d7e3; *DHSS, 2006, GUID US ANT AG HIV 1; Fitch KV, 2006, AIDS, V20, P1843, DOI 10.1097/01.aids.0000244203.95758.db; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2005, CLIN INFECT DIS, V40, P1194, DOI 10.1086/428840; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Kappelhoff BS, 2005, ANTIVIR THER, V10, P489; Law M, 2006, ANTIVIR THER, V11, P179; Mallet V, 2007, AIDS, V21, P187, DOI 10.1097/QAD.0b013e3280119e47; Mallon PWG, 2006, AIDS, V20, P1003, DOI 10.1097/01.aids.0000222072.37749.5a; MOCROFT A, 2006, 16 INT AIDS C; Moyle GJ, 2006, AIDS, V20, P2043, DOI 10.1097/01.aids.0000247574.33998.03; Rauch A, 2006, CLIN INFECT DIS, V43, P99, DOI 10.1086/504874; Ssali F, 2006, ANTIVIR THER, V11, P741; Stein JH, 2007, NEW ENGL J MED, V356, P1773, DOI 10.1056/NEJMe078037; SUTINEN J, 2005, 7 INT WORKSH ADV EV, P7	16	57	58	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 7	2007	370	9581					12	14		10.1016/S0140-6736(07)61027-7	http://dx.doi.org/10.1016/S0140-6736(07)61027-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187QE	17617255				2022-12-01	WOS:000247862300009
J	Guccione, E; Bassi, C; Casadio, F; Martinato, F; Cesaroni, M; Schuchlautz, H; Luscher, B; Amati, B				Guccione, Ernesto; Bassi, Christian; Casadio, Fabio; Martinato, Francesca; Cesaroni, Matteo; Schuchlautz, Henning; Luescher, Bernhard; Amati, Bruno			Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive	NATURE			English	Article							RNA-POLYMERASE-II; ARGININE METHYLATION; MOLECULAR RECOGNITION; STRUCTURAL BASIS; PROTEIN WDR5; IN-VIVO; C-MYC; METHYLTRANSFERASE; CHROMATIN; H4	Eukaryotic genomes are organized into active (euchromatic) and inactive (heterochromatic) chromatin domains. Post-translational modifications of histones (or 'marks') are key in defining these functional states, particularly in promoter regions(1,2). Mutual regulatory interactions between these marks-and the enzymes that catalyse them-contribute to the shaping of this epigenetic landscape, in a manner that remains to be fully elucidated(1,2). We previously observed that asymmetric di-methylation of histone H3 arginine 2 (H3R2me2a) counter-correlates with di- and tri-methylation of H3 lysine 4 (H3K4me2, H3K4me3) on human promoters(3). Here we show that the arginine methyltransferase PRMT6 catalyses H3R2 di- methylation in vitro and controls global levels of H3R2me2a in vivo. H3R2 methylation by PRMT6 was prevented by the presence of H3K4me3 on the H3 tail. Conversely, the H3R2me2a mark prevented methylation of H3K4 as well as binding to the H3 tail by an ASH2/WDR5/MLL-family methyltransferase complex(4-7). Chromatin immunoprecipitation showed that H3R2me2a was distributed within the body and at the 39 end of human genes, regardless of their transcriptional state, whereas it was selectively and locally depleted from active promoters, coincident with the presence of H3K4me3. Hence, the mutual antagonism between H3R2 and H3K4 methylation, together with the association of MLL-family complexes with the basal transcription machinery(8), may contribute to the localized patterns of H3K4 tri-methylation characteristic of transcriptionally poised or active promoters in mammalian genomes(1-3,9,10).	European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; RWTH Aachen Univ Hosp, Inst Biochem, Div Biochem & Mol Biol, D-52074 Aachen, Germany	IRCCS European Institute of Oncology (IEO); RWTH Aachen University; RWTH Aachen University Hospital	Amati, B (corresponding author), European Inst Oncol, Dept Expt Oncol, IFOM IEO Campus, I-20139 Milan, Italy.	bruno.amati@ifom-ieo-campus.it	guccione, ernesto/G-9874-2011; Amati, Bruno/AAM-3418-2020; Luscher, Bernhard/A-7330-2011	Kleine, Henning/0000-0003-2559-6608; Luscher, Bernhard/0000-0002-9622-8709; Amati, Bruno/0000-0002-2958-1799				Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; KIRMIZIS A, NATURE; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Tenney K, 2005, J CELL BIOCHEM, V95, P429, DOI 10.1002/jcb.20421; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06	33	338	348	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2007	449	7164					933	U18		10.1038/nature06166	http://dx.doi.org/10.1038/nature06166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17898714				2022-12-01	WOS:000250230600053
J	Choi, WY; Giraldez, AJ; Schier, AF				Choi, Wen-Yee; Giraldez, Antonio J.; Schier, Alexander F.			Target protectors reveal dampening and balancing of nodal agonist and antagonist by miR-430	SCIENCE			English	Article							GENE-EXPRESSION; MICRORNAS; BRAIN; NOISE	MicroRNAs (miRNAs) repress hundreds of target messenger RNAs (mRNAs), but the physiological roles of specific miRNA-mRNA interactions remain largely elusive. We report that zebrafish microRNA-430 (miR-430) dampens and balances the expression of the transforming growth factor-beta (TGF-beta) Nodal agonist squint and the TGF-beta Nodal antagonist lefty. To disrupt the interaction of specific miRNA-mRNA pairs, we developed target protector morpholinos complementary to miRNA binding sites in target mRNAs. Protection of squint or lefty mRNAs from miR-430 resulted in enhanced or reduced Nodal signaling, respectively. Simultaneous protection of squint and lefty or absence of miR-430 caused an imbalance and reduction in Nodal signaling. These findings establish an approach to analyze the in vivo roles of specific miRNA-mRNA pairs and reveal a requirement for miRNAs in dampening and balancing agonist/antagonist pairs.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; NYU, Sch Med, Dev Genet Program, New York, NY 10016 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Harvard University; New York University; Yale University	Schier, AF (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	antonio.giraldez@yale.edu; schier@fas.harvard.edu		Schier, Alexander Franz/0000-0001-7645-5325; Giraldez, Antonio/0000-0002-6823-137X				Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5	21	399	422	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2007	318	5848					271	274		10.1126/science.1147535	http://dx.doi.org/10.1126/science.1147535			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17761850				2022-12-01	WOS:000250086100047
J	Agger, K; Cloos, PAC; Christensen, J; Pasini, D; Rose, S; Rappsilber, J; Issaeva, I; Canaani, E; Salcini, AE; Helin, K				Agger, Karl; Cloos, Paul A. C.; Christensen, Jesper; Pasini, Diego; Rose, Simon; Rappsilber, Juri; Issaeva, Irina; Canaani, Eli; Salcini, Anna Elisabetta; Helin, Kristian			UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development	NATURE			English	Article							EMBRYONIC STEM-CELLS; CAENORHABDITIS-ELEGANS; INK4A-ARF LOCUS; TARGET GENES; POLYCOMB; PROTEINS; METHYLATION	The trithorax and the polycomb group proteins are chromatin modifiers, which play a key role in the epigenetic regulation of development, differentiation and maintenance of cell fates(1-3). The polycomb repressive complex 2 (PRC2) mediates transcriptional repression by catalysing the di- and tri-methylation of Lys 27 on histone H3 (H3K27me2/me3)(3). Owing to the essential role of the PRC2 complex in repressing a large number of genes involved in somatic processes, the H3K27me3 mark is associated with the unique epigenetic state of stem cells(4-7). The rapid decrease of the H3K27me3 mark during specific stages of embryogenesis and stem-cell differentiation indicates that histone demethylases specific for H3K27me3 may exist. Here we show that the human JmjC-domain-containing proteins UTX and JMJD3 demethylate tri-methylated Lys 27 on histone H3. Furthermore, we demonstrate that ectopic expression of JMJD3 leads to a strong decrease of H3K27me3 levels and causes delocalization of polycomb proteins in vivo. Consistent with the strong decrease in H3K27me3 levels associated with HOX genes during differentiation, we show that UTX directly binds to the HOXB1 locus and is required for its activation. Finally mutation of F18E9.5, a Caenorhabditis elegans JMJD3 orthologue, or inhibition of its expression, results in abnormal gonad development. Taken together, these results suggest that H3K27me3 demethylation regulated by UTX/JMJD3 proteins is essential for proper development. Moreover, the recent demonstration that UTX associates with the H3K4me3 histone methyltransferase MLL2 (ref. 8) supports a model in which the coordinated removal of repressive marks, polycomb group displacement, and deposition of activating marks are important for the stringent regulation of transcription during cellular differentiation.	Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark; Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark; Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	University of Copenhagen; University of Copenhagen; University of Edinburgh; Weizmann Institute of Science	Helin, K (corresponding author), Univ Copenhagen, Biotech Res & Innovat Ctr, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	kristian.helin@bric.dk	Rappsilber, Juri/ABF-3328-2020; Salcini, Anna Elisabetta/G-4472-2017; Helin, Kristian/K-2526-2019; Pasini, Diego/J-9674-2012; Helin, Kristian/HDM-8306-2022; Rappsilber, Juri/B-7265-2015	Pasini, Diego/0000-0002-9879-6486; Rappsilber, Juri/0000-0001-5999-1310; Helin, Kristian/0000-0003-1975-6097; Salcini, Anna Elisabetta/0000-0001-5828-2512; Cloos, Paul/0000-0001-5863-0054				Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; BRENNER S, 1974, GENETICS, V77, P71; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LEE VMY, 1986, J NEUROSCI, V6, P514; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5	20	946	998	4	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2007	449	7163					731	U10		10.1038/nature06145	http://dx.doi.org/10.1038/nature06145			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218VV	17713478				2022-12-01	WOS:000250045000046
J	Beck, M; Lucic, V; Forster, F; Baumeister, W; Medalia, O				Beck, Martin; Lucic, Vladan; Foerster, Friedrich; Baumeister, Wolfgang; Medalia, Ohad			Snapshots of nuclear pore complexes in action captured by cryo-electron tomography	NATURE			English	Article							PROTEIN IMPORT; NUCLEOCYTOPLASMIC TRANSPORT; SYSTEMS-ANALYSIS; VISUALIZATION; NUCLEOPORINS; ARCHITECTURE; REPEATS; BINDING; BETA	Nuclear pore complexes reside in the nuclear envelope of eukaryotic cells and mediate the nucleocytoplasmic exchange of macromolecules(1). Traffic is regulated by mobile transport receptors that target their cargo to the central translocation channel, where phenylalanine-glycine-rich repeats serve as binding sites(2). The structural analysis of the nuclear pore is a formidable challenge given its size, its location in a membranous environment and its dynamic nature. Here we have used cryo-electron tomography(3) to study the structure of nuclear pore complexes in their functional environment, that is, in intact nuclei of Dictyostelium discoideum. A new image-processing strategy compensating for deviations of the asymmetric units (protomers) from a perfect eight-fold symmetry enabled us to refine the structure and to identify new features. Furthermore, the superposition of a large number of tomograms taken in the presence of cargo, which was rendered visible by gold nanoparticles, has yielded a map outlining the trajectories of import cargo. Finally, we have performed single-molecule Monte Carlo simulations of nuclear import to interpret the experimentally observed cargo distribution in the light of existing models for nuclear import.	Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society	Baumeister, W (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.	baumeist@biochem.mpg.de; omedalia@bgu.ac.il	Beck, Martin/B-5589-2011; Lucic, Vladan/AAA-8128-2020; Foerster, Friedrich/D-3710-2009	Beck, Martin/0000-0002-7397-1321; Lucic, Vladan/0000-0003-3698-7436; Foerster, Friedrich/0000-0002-6044-2746; Medalia, Ohad/0000-0003-0994-2937				AKEY CW, 1995, J MOL BIOL, V248, P273, DOI 10.1006/jmbi.1995.0221; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Becskei A, 2005, CURR OPIN CELL BIOL, V17, P27, DOI 10.1016/j.ceb.2004.12.010; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Coggan JS, 2005, SCIENCE, V309, P446, DOI 10.1126/science.1108239; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Fahrenkrog B, 2004, TRENDS BIOCHEM SCI, V29, P175, DOI 10.1016/j.tibs.2004.02.006; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; Hinshaw JE, 2003, J STRUCT BIOL, V141, P259, DOI 10.1016/S1047-8477(02)00626-3; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Kiseleva E, 1998, J CELL SCI, V111, P223; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730; Pante N, 1996, SCIENCE, V273, P1729, DOI 10.1126/science.273.5282.1729; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Rutherford SA, 1997, EXP CELL RES, V232, P146, DOI 10.1006/excr.1997.3487; SAXTON WO, 1992, ULTRAMICROSCOPY, V46, P287, DOI 10.1016/0304-3991(92)90020-K; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Smith AE, 2002, SCIENCE, V295, P488, DOI 10.1126/science.1064732; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101	30	270	275	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					611	615		10.1038/nature06170	http://dx.doi.org/10.1038/nature06170			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17851530				2022-12-01	WOS:000249893500048
J	Neutel, AM; Heesterbeek, JAP; van de Koppel, J; Hoenderboom, G; Vos, A; Kaldeway, C; Berendse, F; de Ruiter, PC				Neutel, Anje-Margriet; Heesterbeek, Johan A. P.; van de Koppel, Johan; Hoenderboom, Guido; Vos, An; Kaldeway, Coen; Berendse, Frank; de Ruiter, Peter C.			Reconciling complexity with stability in naturally assembling food webs	NATURE			English	Article							TROPHIC CASCADES; SOIL; PRODUCTIVITY; ECOSYSTEMS; DYNAMICS; REAL; COMMUNITIES; SYSTEM	Understanding how complex food webs assemble through time is fundamental both for ecological theory and for the development of sustainable strategies of ecosystem conservation and restoration. The build-up of complexity in communities is theoretically difficult, because in random-pattern models complexity leads to instability(1). There is growing evidence, however, that nonrandom patterns in the strengths of the interactions between predators and prey strongly enhance system stability(2-4). Here we show how such patterns explain stability in naturally assembling communities. We present two series of below-ground food webs along natural productivity gradients in vegetation successions(5,6). The complexity of the food webs increased along the gradients. The stability of the food webs was captured by measuring the weight of feedback loops(7) of three interacting 'species' locked in omnivory. Low predator-prey biomass ratios in these omnivorous loops were shown to have a crucial role in preserving stability as productivity and complexity increased during succession. Our results show the build-up of food-web complexity in natural productivity gradients and pin down the feedback loops that govern the stability of whole webs. They show that it is the heaviest three-link feedback loop in a network of predator-prey effects that limits its stability. Because the weight of these feedback loops is kept relatively low by the biomass build-up in the successional process, complexity does not lead to instability.	Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; Univ Utrecht, Fac Vet Med, NL-3508 TD Utrecht, Netherlands; Netherlands Inst Ecol, NIOO KNAW, Ctr Estuarine & Marine Ecol, Spatial Ecol Dept, NL-4400 AC Yerseke, Netherlands; Univ Wageningen & Res Ctr, Dept ICT, NL-6700 AB Wageningen, Netherlands; Univ Wageningen & Res Ctr, Soil Sci Ctr, NL-6700 AA Wageningen, Netherlands; Wageningen Univ, Nat Conservat & Plant Ecol Grp, NL-6708 PB Wageningen, Netherlands; Univ Utrecht, Copernicus Inst Sustainable Dev & Innovat, Dept Environm Sci, NL-3508 TC Utrecht, Netherlands	University of York - UK; Utrecht University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Utrecht University	Neutel, AM (corresponding author), British Antarctic Survey, High Cross,Madingley Rd, Cambridge CB3 0ET, England.	anjute@bas.ac.uk	Van de Koppel, Johan/E-7266-2010	Heesterbeek, Hans/0000-0001-8537-6418	NERC [bas010021] Funding Source: UKRI; Natural Environment Research Council [bas010021] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], 1979, PLANT STRATEGIES VEG; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; BERENDSE F, 1990, PERSPECTIVES PLANT C, P94; BLOEM J, 1995, APPL ENVIRON MICROB, V61, P926, DOI 10.1128/AEM.61.3.926-936.1995; BRUSSAARD L, 1990, NETH J AGR SCI, V38, P283; Cohen J., 1990, COMMUNITY FOOD WEBS; DERUITER PC, 1993, PLANT SOIL, V157, P263, DOI 10.1007/BF00011055; DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; GARDNER MR, 1970, NATURE, V228, P784, DOI 10.1038/228784a0; HAIRSTON NG, 1993, AM NAT, V142, P379, DOI 10.1086/285546; Halaj J, 2001, AM NAT, V157, P262, DOI 10.1086/319190; HASSINK J, 1991, SOIL BIOL BIOCHEM, V23, P515, DOI 10.1016/0038-0717(91)90108-V; HOFBAUER J, 1988, THEORY EVOLUTION DYN, P204; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; HUNT HW, 1987, BIOL FERT SOILS, V3, P57, DOI 10.1007/BF00260580; Kaunzinger CMK, 1998, NATURE, V395, P495, DOI 10.1038/26741; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; MOORE JC, 1993, SCIENCE, V261, P906, DOI 10.1126/science.261.5123.906; MOORE JC, 1988, ANNU REV ENTOMOL, V33, P419, DOI 10.1146/annurev.en.33.010188.002223; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; OLFF H, 1993, J ECOL, V81, P693, DOI 10.2307/2261667; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103	29	260	272	8	197	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2007	449	7162					599	U11		10.1038/nature06154	http://dx.doi.org/10.1038/nature06154			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17914396	Green Submitted, Green Published			2022-12-01	WOS:000249893500045
J	Hotopp, JCD; Clark, ME; Oliveira, DCSG; Foster, JM; Fischer, P; Torres, MC; Giebel, JD; Kumar, N; Ishmael, N; Wang, SL; Ingram, J; Nene, RV; Shepard, J; Tomkins, J; Richards, S; Spiro, DJ; Ghedin, E; Slatko, BE; Tettelin, H; Werren, JH				Hotopp, Julie C. Dunning; Clark, Michael E.; Oliveira, Deodoro C. S. G.; Foster, Jeremy M.; Fischer, Peter; Munoz Torres, Monica C.; Giebel, Jonathan D.; Kumar, Nikhil; Ishmael, Nadeeza; Wang, Shiliang; Ingram, Jessica; Nene, Rahul V.; Shepard, Jessica; Tomkins, Jeffrey; Richards, Stephen; Spiro, David J.; Ghedin, Elodie; Slatko, Barton E.; Tettelin, Herve; Werren, John H.			Widespread lateral gene transfer from intracellular bacteria to multicellular eukaryotes	SCIENCE			English	Article							IMMUNODOMINANT ANTIGEN; DIROFILARIA-IMMITIS; WOLBACHIA; GENOMES	Although common among bacteria, lateral gene transfer-the movement of genes between distantly related organisms-is thought to occur only rarely between bacteria and multicellular eukaryotes. However, the presence of endosymbionts, such as Wolbachia pipientis, within some eukaryotic germlines may facilitate bacterial gene transfers to eukaryotic host genomes. We therefore examined host genomes for evidence of gene transfer events from Wolbachia bacteria to their hosts. We found and confirmed transfers into the genomes of four insect and four nematode species that range from nearly the entire Wolbachia genome (>1 megabase) to short (<500 base pairs) insertions. Potential Wolbachia-to-host transfers were also detected computationally in three additional sequenced insect genomes. We also show that some of these inserted Wolbachia genes are transcribed within eukaryotic cells lacking endosymbionts. Therefore, heritable lateral gene transfer occurs into eukaryotic hosts from their prokaryote symbionts, potentially providing a mechanism for acquisition of new genes and functions.	Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15261 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Clemson Univ, Genom Inst, Clemson, SC 29634 USA; Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA; New England Biolabs Inc, Mol Parasitol Div, Ipswich, MA 01938 USA; Univ Rochester, Dept Biol, Rochester, NY 14627 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Baylor College of Medicine; Clemson University; Washington University (WUSTL); New England Biolabs; University of Rochester	Hotopp, JCD (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Hlth Sci Facil 2,Room S-445,20 Penn St, Baltimore, MD 21201 USA.	jhotopp@som.umaryland.edu	Ghedin, Elodie/Y-5654-2019; Dunning Hotopp, Julie/E-7762-2010; Fischer, Peter/A-2746-2008	Ghedin, Elodie/0000-0002-1515-725X; Dunning Hotopp, Julie/0000-0003-3862-986X; Werren, John/0000-0001-9353-2070; Fischer, Peter/0000-0003-4558-3417				Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; Campbell B.C., 1993, Insect Molecular Biology, V2, P225; DANIELS SB, 1990, GENETICS, V124, P339; Doolittle WE, 1998, TRENDS GENET, V14, P307; Fenn K, 2006, PLOS PATHOG, V2, P887, DOI 10.1371/journal.ppat.0020094; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Salzberg SL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r23; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Sugane K, 1999, J HELMINTHOL, V73, P265, DOI 10.1017/S0022149X99000426; SUN S, 1994, J HELMINTHOL, V68, P259, DOI 10.1017/S0022149X00014449; SUN SH, 1991, J HELMINTHOL, V65, P149, DOI 10.1017/S0022149X00010622; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069	17	554	587	2	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1753	1756		10.1126/science.1142490	http://dx.doi.org/10.1126/science.1142490			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17761848	Green Submitted			2022-12-01	WOS:000249585900049
J	Ortlund, EA; Bridgham, JT; Redinbo, MR; Thornton, JW				Ortlund, Eric A.; Bridgham, Jamie T.; Redinbo, Matthew R.; Thornton, Joseph W.			Crystal structure of an ancient protein: Evolution by conformational epistasis	SCIENCE			English	Article							MINERALOCORTICOID RECEPTOR; COMPENSATORY EVOLUTION; HORMONE-RECEPTOR; ADAPTATION; ARCHITECTURE; LANDSCAPE; STABILITY	The structural mechanisms by which proteins have evolved new functions are known only indirectly. We report x-ray crystal structures of a resurrected ancestral protein-the similar to 450 million-year-old precursor of vertebrate glucocorticoid (GR) and mineralocorticoid (MR) receptors. Using structural, phylogenetic, and functional analysis, we identify the specific set of historical mutations that recapitulate the evolution of GR's hormone specificity from an MR-like ancestor. These substitutions repositioned crucial residues to create new receptor-ligand and intraprotein contacts. Strong epistatic interactions occur because one substitution changes the conformational position of another site. "Permissive" mutations-substitutions of no immediate consequence, which stabilize specific elements of the protein and allow it to tolerate subsequent function-switching changes-played a major role in determining GR's evolutionary trajectory.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Oregon	Thornton, JW (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	joet@uoregon.edu	Thornton, Joseph/GSN-4190-2022; Ortlund, Eric Anthony/P-3121-2019; Ortlund, Eric Anthony/F-4672-2014	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029	NIDDK NIH HHS [R01-DK622229] Funding Source: Medline; NIGMS NIH HHS [R01 GM081592-01, R01 GM081592, F32 GM074398, R01 GM081592-02, R01-GM081592, F32-GM074398] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081592, F32GM074398] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bentley P., 1998, COMP VERTEBRATE ENDO; Benton M.J., 2005, VERTEBRATE PALAEONTO; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Campbell-Valois FX, 2006, J MOL BIOL, V362, P151, DOI 10.1016/j.jmb.2006.06.061; CHARLESWORTH B, 1990, EVOLUTIONARY INNOVATIONS, P47; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; Golding GB, 1998, MOL BIOL EVOL, V15, P355, DOI 10.1093/oxfordjournals.molbev.a025932; Gould S.J., 1989, WONDERFUL LIFE BURGE; Haag ES, 2005, EVOLUTION, V59, P1620, DOI 10.1111/j.0014-3820.2005.tb01813.x; Hedstrom L, 1996, BIOL CHEM, V377, P465; JANVIER P., 1996, EARLY VERTEBRATES; Kern AD, 2004, NAT GENET, V36, P1207, DOI 10.1038/ng1451; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Kinch LN, 2002, CURR OPIN STRUC BIOL, V12, P400, DOI 10.1016/S0959-440X(02)00338-X; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Orr HA, 2002, EVOLUTION, V56, P1317, DOI 10.1111/j.0014-3820.2002.tb01446.x; PERUTZ MF, 1983, MOL BIOL EVOL, V1, P1; Provine W.B., 1971, ORIGINS THEORETICAL; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Sturm A, 2005, ENDOCRINOLOGY, V146, P47, DOI 10.1210/en.2004-0128; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Turner JM, 2006, P NATL ACAD SCI USA, V103, P6483, DOI 10.1073/pnas.0601756103; Vatzaki EH, 1999, EUR J BIOCHEM, V260, P176, DOI 10.1046/j.1432-1327.1999.00142.x; WAGNER RL, 1995, NATURE, V378, P690, DOI 10.1038/378690a0; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125	32	302	306	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2007	317	5844					1544	1548		10.1126/science.1142819	http://dx.doi.org/10.1126/science.1142819			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17702911	Green Submitted, Green Accepted			2022-12-01	WOS:000249467900040
J	Goldberg, AL				Goldberg, Alfred L.			On prions, proteasomes, and mad cows	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROTEIN-DEGRADATION		Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051923-12, R01 GM051923] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Prusiner SB, 2004, PRION BIOL DIS; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019	5	15	16	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2007	357	11					1150	1152		10.1056/NEJMcibr073962	http://dx.doi.org/10.1056/NEJMcibr073962			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209KK	17855677				2022-12-01	WOS:000249387200013
J	Dann, CE; Wakeman, CA; Sieling, CL; Baker, SC; Irnov, I; Winkler, WC				Dann, Charles E., III; Wakeman, Catherine A.; Sieling, Cecelia L.; Baker, Stephanie C.; Irnov, Irnov; Winkler, Wade C.			Structure and mechanism of a metal-sensing regulatory RNA	CELL			English	Article							MAGNESIUM TRANSPORT; GENE-EXPRESSION; MESSENGER-RNA; ION BINDING; RIBOSWITCHES; TRANSCRIPTION; STABILITY; MOTIFS; SYSTEM	Organisms maintain the correct balance of intracellular metals primarily through metal-sensing proteins that control transport and storage of the target ion(s). Here, we reveal the basis of metal sensing and genetic control by a metal-loregulatory RNA. Our data demonstrate that a previously uncharacterized orphan riboswitch, renamed the "M-box," is a divalent metal-sensing RNA involved in Mg2+ homeostasis. A combination of genetic, biochemical, and biophysical techniques demonstrate that Mg2+ induces a compacted tertiary architecture for M-box RNAs that regulates the accessibility of nucleotides involved in genetic control. Molecular details are provided by crystallographic structure determination of a Mg2+-bound M-box RNA. Given the distribution of this RNA element, it may constitute a common mode for bacterial metal ion regulation, and its discovery suggests the possibility of additional RNA-based metal sensors in modern and primordial organisms.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Winkler, WC (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA.	wade.winkler@utsouthwestern.edu	Dann, Charles E/C-2747-2018	Irnov, Irnov/0000-0001-8631-4075; Wakeman, Catherine/0000-0003-0311-6669				Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; Batey RT, 2006, CURR OPIN STRUC BIOL, V16, P299, DOI 10.1016/j.sbi.2006.05.001; BIACHOO N, 2002, MOL MICROBIOL, V6, P1613; Cate JH, 1997, NAT STRUCT BIOL, V4, P553, DOI 10.1038/nsb0797-553; Corbino KA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r70; COWAN JA, 1993, J INORG BIOCHEM, V49, P171, DOI 10.1016/0162-0134(93)80002-Q; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Das R, 2005, J AM CHEM SOC, V127, P8272, DOI 10.1021/ja051422h; de Hoon MJL, 2005, PLOS COMPUT BIOL, V1, P212, DOI 10.1371/journal.pcbi.0010025; DeRose VJ, 2003, CURR OPIN STRUC BIOL, V13, P317, DOI 10.1016/S0959-440X(03)00077-0; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; Gardner RC, 2003, CURR OPIN PLANT BIOL, V6, P263, DOI 10.1016/S1369-5266(03)00032-3; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; HMIEL SP, 1986, J BACTERIOL, V168, P1444, DOI 10.1128/jb.168.3.1444-1450.1986; Hougland JL, 2005, PLOS BIOL, V3, P1536, DOI 10.1371/journal.pbio.0030277; Jarmer H, 2002, FEMS MICROBIOL LETT, V206, P197, DOI 10.1111/j.1574-6968.2002.tb11009.x; Kehres DG, 2002, BIOMETALS, V15, P261, DOI 10.1023/A:1016078832697; Klein DJ, 2004, RNA, V10, P1366, DOI 10.1261/rna.7390804; LANDICK R, 1987, TRANSCRIPTION ATTENU, P1276; LATHAM JA, 1989, SCIENCE, V245, P276, DOI 10.1126/science.2501870; Lee JC, 2006, J MOL BIOL, V360, P978, DOI 10.1016/j.jmb.2006.05.066; Li YF, 1999, J AM CHEM SOC, V121, P5364, DOI 10.1021/ja990592p; MacDiarmid CW, 1998, J BIOL CHEM, V273, P1727, DOI 10.1074/jbc.273.3.1727; Maguire ME, 2006, FRONT BIOSCI-LANDMRK, V11, P3149, DOI 10.2741/2039; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Moore CM, 2005, CURR OPIN MICROBIOL, V8, P188, DOI 10.1016/j.mib.2005.02.007; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Pennella MA, 2005, BIOMETALS, V18, P413, DOI 10.1007/s10534-005-3716-8; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Sigel RKO, 2007, CHEM REV, V107, P97, DOI 10.1021/cr0502605; Smith RL, 1998, MOL MICROBIOL, V28, P217, DOI 10.1046/j.1365-2958.1998.00810.x; SMITH RL, 1995, J BACTERIOL, V177, P1638, DOI 10.1128/jb.177.6.1638-1640.1995; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Takamoto K, 2004, J MOL BIOL, V343, P1195, DOI 10.1016/j.jmb.2004.08.080; Vicens Q, 2006, TRENDS BIOCHEM SCI, V31, P41, DOI 10.1016/j.tibs.2005.11.008; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Winkler WC, 2005, CURR OPIN CHEM BIOL, V9, P594, DOI 10.1016/j.cbpa.2005.09.016; Winkler WC, 2005, ARCH MICROBIOL, V183, P151, DOI 10.1007/s00203-005-0758-9; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967; Woodson SA, 2005, CURR OPIN CHEM BIOL, V9, P104, DOI 10.1016/j.cbpa.2005.02.004	46	285	303	2	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2007	130	5					878	892		10.1016/j.cell.2007.06.051	http://dx.doi.org/10.1016/j.cell.2007.06.051			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	212GI	17803910	Bronze			2022-12-01	WOS:000249581500019
J	Kremer, BE; Adang, LA; Macara, IG				Kremer, Brandon E.; Adang, Laura A.; Macara, Ian G.			Septins regulate actin organization and cell-cycle arrest through nuclear accumulation of NCK mediated by SOCS7	CELL			English	Article							MAMMALIAN SEPTIN; BINDING-PROTEIN; MORPHOGENESIS CHECKPOINT; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; GROWTH-HORMONE; CYTOSKELETON; COMPLEX; YEAST; CYTOKINESIS	Mammalian septins are GTP-binding proteins the functions of which are not well understood. Knockdown of SEPT2, 6, and 7 causes stress fibers to disintegrate and cells to lose polarity. We now show that this phenotype is induced by nuclear accumulation of the adaptor protein NCK, as the effects can be reversed or induced by cytoplasmic or nuclear NCK, respectively. NCK is carried into the nucleus by SOCS7 (suppressor of cytokine signaling 7), which possesses nuclear import/export signals. SOCS7 interacts with septins and NCK through distinct domains. DNA damage induces actin and septin rearrangement and rapid nuclear accumulation of NCK and SOCS7. Moreover, NCK expression is essential for cell-cycle arrest. The septin-SOCS7-NCK axis intersects with the canonical DNA damage cascade downstream of ATM/ATR and is essential for p53 Ser15 phosphorylation. These data illuminate an unanticipated connection between septins, SOCS7, NCK signaling, and the DNA damage response.	Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia	Macara, IG (corresponding author), Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA.	igm9c@virginia.edu			NCI NIH HHS [P01 CA040042, P01 CA040042-219004] Funding Source: Medline; NCRR NIH HHS [S10 RR015783-01A1] Funding Source: Medline; NIAID NIH HHS [T32 AI007046] Funding Source: Medline; NIGMS NIH HHS [GM66306, T32 GM07267-27, R01 GM066306, R01 GM070902-04, GM50526, R01 GM050526-14, R01 GM050526, T32 GM007267, R01 GM070902] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA040042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066306, R01GM070902, T32GM007267, R01GM050526] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Bolderson E, 2004, HUM MOL GENET, V13, P2937, DOI 10.1093/hmg/ddh316; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; Castillon GA, 2003, CURR BIOL, V13, P654, DOI 10.1016/S0960-9822(03)00247-1; Enserink JM, 2006, J CELL BIOL, V175, P729, DOI 10.1083/jcb.200605080; Field CM, 1999, TRENDS CELL BIOL, V9, P387, DOI 10.1016/S0962-8924(99)01632-3; FOX MH, 1980, CYTOMETRY, V1, P71, DOI 10.1002/cyto.990010114; Hall PA, 2005, J PATHOL, V206, P269, DOI 10.1002/path.1789; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; Ito H, 2005, ONCOGENE, V24, P7064, DOI 10.1038/sj.onc.1208862; Joberty G, 1999, MOL CELL BIOL, V19, P6585; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Joberty G, 2001, NAT CELL BIOL, V3, P861, DOI 10.1038/ncb1001-861; Kadota J, 2004, MOL BIOL CELL, V15, P5329, DOI 10.1091/mbc.E04-03-0254; Keaton MA, 2006, CURR OPIN MICROBIOL, V9, P540, DOI 10.1016/j.mib.2006.10.004; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; Kissel H, 2005, DEV CELL, V8, P353, DOI 10.1016/j.devcel.2005.01.021; Krebs DL, 2000, J CELL SCI, V113, P2813; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kusch J, 2002, GENE DEV, V16, P1627, DOI 10.1101/gad.222602; Latreille M, 2006, J BIOL CHEM, V281, P26633, DOI 10.1074/jbc.M513556200; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Low C, 2006, J BIOL CHEM, V281, P30697, DOI 10.1074/jbc.M605179200; Martens N, 2005, J BIOL CHEM, V280, P13817, DOI 10.1074/jbc.M411596200; Martens N, 2004, EXP CELL RES, V298, P239, DOI 10.1016/j.yexcr.2004.04.002; Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652; Matuoka K, 1997, BIOCHEM BIOPH RES CO, V239, P488, DOI 10.1006/bbrc.1997.7492; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Nagata KI, 2005, ONCOGENE, V24, P65, DOI 10.1038/sj.onc.1208101; Oegema K, 2000, J CELL BIOL, V150, P539, DOI 10.1083/jcb.150.3.539; Ono R, 2005, MOL CELL BIOL, V25, P10965, DOI 10.1128/MCB.25.24.10965-10978.2005; Richards SA, 1996, J CELL BIOL, V134, P1157, DOI 10.1083/jcb.134.5.1157; Sheffield PJ, 2003, J BIOL CHEM, V278, P3483, DOI 10.1074/jbc.M209701200; Sibani S, 2005, J CELL SCI, V118, P3247, DOI 10.1242/jcs.02427; Smith JA, 2005, CANCER RES, V65, P1027; Smolka MB, 2006, J CELL BIOL, V175, P743, DOI 10.1083/jcb.200605081; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Vega IE, 2003, NEUROREPORT, V14, P31, DOI 10.1097/00001756-200301200-00006; Xue J, 2004, J NEUROCHEM, V91, P579, DOI 10.1111/j.1471-4159.2004.02755.x; Zhu T, 1998, J BIOL CHEM, V273, P33864, DOI 10.1074/jbc.273.50.33864	47	159	170	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2007	130	5					837	850		10.1016/j.cell.2007.06.053	http://dx.doi.org/10.1016/j.cell.2007.06.053			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	212GI	17803907	Green Accepted, Bronze			2022-12-01	WOS:000249581500016
J	Schaetzlein, S; Kodandaramireddy, NR; Ju, ZY; Lechel, A; Stepczynska, A; Lilli, DR; Clark, AB; Rudolph, C; Kuhnel, F; Wei, KC; Schlegelberger, B; Schirmacher, P; Kunkel, TA; Greenberg, RA; Edelmann, W; Rudolph, KL				Schaetzlein, Sonja; Kodandaramireddy, N. R.; Ju, Zhenyu; Lechel, Andre; Stepczynska, Anna; Lilli, Dana R.; Clark, Alan B.; Rudolph, Cornelia; Kuhnel, Florian; Wei, Kaichun; Schlegelberger, Brigitte; Schirmacher, Peter; Kunkel, Thomas A.; Greenberg, Roger A.; Edelmann, Winfried; Rudolph, K. Lenhard			Exonuclease-1 deletion impairs DNA damage signaling and prolongs lifespan of telomere-dysfunctional mice	CELL			English	Article							DOUBLE-STRAND BREAKS; CELL-CYCLE; PULMONARY-FIBROSIS; HUMAN FIBROBLASTS; BUDDING YEAST; IN-VIVO; CANCER; CHECKPOINT; SENESCENCE; REPAIR	Exonuclease-1 (EXO1) mediates checkpoint induction in response to telomere dysfunction in yeast, but it is unknown whether EXO1 has similar functions in mammalian cells. Here we show that deletion of the nuclease domain of Exo1 reduces accumulation of DNA damage and DNA damage signal induction in telomeredysfunctional mice. Exo1 deletion improved organ maintenance and lifespan of telomeredysfunctional mice but did not increase chromosomal instability or cancer formation. Deletion of Exo1 also ameliorated the induction of DNA damage checkpoints in response to g-irradiation and conferred cellular resistance to 6-thioguanine-induced DNA damage. Exo1 deletion impaired upstream induction of DNA damage responses by reducing ssDNA formation and the recruitment of Replication Protein A (RPA) and ATR at DNA breaks. Together, these studies provide evidence that EXO1 contributes to DNA damage signal induction in mammalian cells, and deletion of Exo1 can prolong survival in the context of telomere dysfunction.	Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; Hannover Med Sch, Inst Cell & Mol Pathol, D-30625 Hannover, Germany; Univ Penn, Sch Med, Abramson Famuly Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; NIEHS, Struct Biol Lab, Res Triangle Pk, NC 27709 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Univ Hosp, Inst Pathol, D-69120 Heidelberg, Germany	Hannover Medical School; Hannover Medical School; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Yeshiva University; Albert Einstein College of Medicine; Ruprecht Karls University Heidelberg	Rudolph, KL (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany.	lenhard.rudolph@uni-ulm.de	Lechel, André/AAQ-2041-2021; Kunkel, Thomas A./D-5088-2019	Lechel, André/0000-0003-0221-6959; Kunkel, Thomas A./0000-0002-9900-1788; Nalapareddy, Kodandaramireddy/0000-0003-3290-5114; Rudolph, Karl Lenhard/0000-0002-4839-2862	Intramural NIH HHS [Z99 ES999999] Funding Source: Medline; NCI NIH HHS [R01CA093484] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093484] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Ball SE, 1998, BLOOD, V91, P3582; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; BUTLER WB, 1984, ANAL BIOCHEM, V141, P70, DOI 10.1016/0003-2697(84)90426-3; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; CHEN CY, 1994, P NATL ACAD SCI USA, V91, P2684, DOI 10.1073/pnas.91.7.2684; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [DOI 10.1038/NATURE02118, 10.1038/nature02118]; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Djojosubroto MW, 2003, MOL CELLS, V15, P164; Frank O, 2004, BLOOD, V104, P3543, DOI 10.1182/blood-2004-03-0852; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; GREENBERG RA, 2006, CELL, V20, P34; Hackett JA, 2003, MOL CELL BIOL, V23, P8450, DOI 10.1128/MCB.23.23.8450-8461.2003; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Horton JK, 2000, J BIOL CHEM, V275, P2211, DOI 10.1074/jbc.275.3.2211; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; Lechel A, 2005, EMBO REP, V6, P275, DOI 10.1038/sj.embor.7400352; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Maringele L, 2004, GENETICS, V166, P1641, DOI 10.1534/genetics.166.4.1641; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Maser RS, 2007, MOL CELL BIOL, V27, P2253, DOI 10.1128/MCB.01354-06; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Namiki Y, 2006, P NATL ACAD SCI USA, V103, P580, DOI 10.1073/pnas.0510223103; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Qi L, 2003, CANCER RES, V63, P8188; Rizki A, 2001, NATURE, V411, P713, DOI 10.1038/35079641; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Satyanarayana A, 2004, MOL CELL BIOL, V24, P5459, DOI 10.1128/MCB.24.12.5459-5474.2004; Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tomita K, 2003, MOL CELL BIOL, V23, P5186, DOI 10.1128/MCB.23.15.5186-5197.2003; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Vaziri H, 1996, EXP GERONTOL, V31, P295, DOI 10.1016/0531-5565(95)02025-X; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100	60	121	124	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 7	2007	130	5					863	877		10.1016/j.cell.2007.08.029	http://dx.doi.org/10.1016/j.cell.2007.08.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	212GI	17803909	Bronze, Green Accepted			2022-12-01	WOS:000249581500018
J	Turner, AH; Pol, D; Clarke, JA; Erickson, GM; Norell, MA				Turner, Alan H.; Pol, Diego; Clarke, Julia A.; Erickson, Gregory M.; Norell, Mark A.			A basal Dromaeosaurid and size evolution preceding avian flight	SCIENCE			English	Article							THEROPOD; DINOSAUR; FOSSIL; BIRDS	Fossil evidence for changes in dinosaurs near the lineage leading to birds and the origin of flight has been sparse. A dinosaur from Mongolia represents the basal divergence within Dromaeosauridae. The taxon's small body size and phylogenetic position imply that extreme miniaturization was ancestral for Paraves (the clade including Avialae, Troodontidae, and Dromaeosauridae), phylogenetically earlier than where flight evolution is strongly inferred. In contrast to the sustained small body sizes among avialans throughout the Cretaceous Period, the two dinosaurian lineages most closely related to birds, dromaeosaurids and troodontids, underwent four independent events of gigantism, and in some lineages size increased by nearly three orders of magnitude. Thus, change in theropod body size leading to flight's origin was not unidirectional.	Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, RA-9100 Trelew, Argentina; N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; N Carolina Museum Nat Sci, Div Paleontol, Raleigh, NC 27601 USA; Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	American Museum of Natural History (AMNH); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of North Carolina; North Carolina State University; State University System of Florida; Florida State University	Turner, AH (corresponding author), Amer Museum Nat Hist, Div Paleontol, Cent Pk W & 79th St, New York, NY 10024 USA.	turner@amnh.org	/B-4978-2011; Pol, Diego/A-8007-2008	/0000-0003-2218-2637; Pol, Diego/0000-0002-9690-7517				Buffetaut E, 2005, NATURWISSENSCHAFTEN, V92, P477, DOI 10.1007/s00114-005-0022-9; Clarke JA, 2006, J ANAT, V208, P287, DOI 10.1111/j.1469-7580.2006.00534.x; Dashzeveg D, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)498[0001:NSSDEA]2.0.CO;2; ELZANOWSKI A, 1993, AM J SCI, V293A, P235, DOI 10.2475/ajs.293.A.235; Forster CA, 1998, SCIENCE, V279, P1915, DOI 10.1126/science.279.5358.1915; Gaudin Timothy J., 2006, P1; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; [Ji Qiang 季强], 2005, [地质通报, Geological Bulletin of China], V24, P197; Kielan-Jaworowska Z., 1972, Palaeontologia Polonica, VNo. 27, P5; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P184; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Makovicky PJ, 2003, AM MUS NOVIT, P1; Norell MA, 2001, NATURE, V409, P181, DOI 10.1038/35051563; Norell Mark A., 1999, American Museum Novitates, V3282, P1; Norell MA, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3545[1:ANDTFU]2.0.CO;2; Novas FE, 2005, NATURE, V433, P858, DOI 10.1038/nature03285; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Turner AH, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)3557[1:ASDTFS]2.0.CO;2; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2004, NATURE, V431, P838, DOI 10.1038/nature02898; Xu X, 2002, NATURE, V415, P780, DOI 10.1038/415780a; Xu X, 2007, NATURE, V447, P844, DOI 10.1038/nature05849; Zhou ZH, 2004, NATURWISSENSCHAFTEN, V91, P455, DOI 10.1007/s00114-004-0570-4	24	236	250	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2007	317	5843					1378	1381		10.1126/science.1144066	http://dx.doi.org/10.1126/science.1144066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209GR	17823350				2022-12-01	WOS:000249377500042
J	Lindell, D; Jaffe, JD; Coleman, ML; Futschik, ME; Axmann, IM; Rector, T; Kettler, G; Sullivan, MB; Steen, R; Hess, WR; Church, GM; Chisholm, SW				Lindell, Debbie; Jaffe, Jacob D.; Coleman, Maureen L.; Futschik, Matthias E.; Axmann, Ilka M.; Rector, Trent; Kettler, Gregory; Sullivan, Matthew B.; Steen, Robert; Hess, Wolfgang R.; Church, George M.; Chisholm, Sallie W.			Genome-wide expression dynamics of a marine virus and host reveal features of co-evolution	NATURE			English	Article							PHOTOSYNTHESIS GENES; PROCHLOROCOCCUS; EVOLUTION; SYNECHOCOCCUS; PHAGE; BACTERIOPHAGE; PROTEIN	Interactions between bacterial hosts and their viruses ( phages) lead to reciprocal genome evolution through a dynamic co-evolutionary process(1-5). Phage-mediated transfer of host genes often located in genome islands-has had a major impact on microbial evolution(1,4,6). Furthermore, phage genomes have clearly been shaped by the acquisition of genes from their hosts(2,3,5). Here we investigate whole-genome expression of a host and phage, the marine cyanobacterium Prochlorococcus MED4 and the T7-like cyanophage P-SSP7, during lytic infection, to gain insight into these co-evolutionary processes. Although most of the phage genome was linearly transcribed over the course of infection, four phage-encoded bacterial metabolism genes formed part of the same expression cluster, even though they are physically separated on the genome. These genes-encoding photosystem II D1 ( psbA), high-light inducible protein (hli), transaldolase (talC) and ribonucleotide reductase (nrd)-are transcribed together with phage DNA replication genes and seem to make up a functional unit involved in energy and deoxynucleotide production for phage replication in resource-poor oceans. Also unique to this system was the upregulation of numerous genes in the host during infection. These may be host stress response genes and/or genes induced by the phage. Many of these host genes are located in genome islands and have homologues in cyanophage genomes. We hypothesize that phage have evolved to use upregulated host genes, leading to their stable incorporation into phage genomes and their subsequent transfer back to hosts in genome islands. Thus activation of host genes during infection may be directing the co-evolution of gene content in both host and phage genomes.	MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Genet, BioPolymers Facil, Boston, MA 02115 USA; Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany; Univ Freiburg, Inst Biol, D-79104 Freiburg, Germany	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Humboldt University of Berlin; University of Freiburg	Chisholm, SW (corresponding author), MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA.	chisholm@mit.edu	Futschik, Matthias/AAK-8837-2020; Sullivan, Matthew B/H-3256-2011	Futschik, Matthias/0000-0002-6245-8071; Sullivan, Matthew B/0000-0003-4040-9831; Coleman, Maureen/0000-0001-5065-0106; Axmann, Ilka Maria/0000-0002-0856-8667; Chisholm, Sallie/0000-0003-1480-2445; church, george/0000-0001-6232-9969; Lindell, Debbie/0000-0003-0612-4517				Breitbart M, 2004, FEMS MICROBIOL LETT, V236, P249, DOI 10.1016/j.femsle.2004.05.042; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Chen ZH, 2005, NUCLEIC ACIDS RES, V33, P6172, DOI 10.1093/nar/gki915; Clokie MRJ, 2006, ENVIRON MICROBIOL, V8, P827, DOI 10.1111/j.1462-2920.2005.00969.x; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Filee J, 2003, RES MICROBIOL, V154, P237, DOI 10.1016/S0923-2508(03)00066-4; Hendrix RW, 2000, TRENDS MICROBIOL, V8, P504, DOI 10.1016/S0966-842X(00)01863-1; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; LENSKI RE, 1985, ANN NAT, V124, P585; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Millard A, 2004, P NATL ACAD SCI USA, V101, P11007, DOI 10.1073/pnas.0401478101; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Molineux I.J., 2005, BACTERIOPHAGES, V2, P277; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; TABOR S, 1987, J BIOL CHEM, V262, P16212; TILLY K, 1981, P NATL ACAD SCI-BIOL, V78, P1629, DOI 10.1073/pnas.78.3.1629; Tolonen AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100087; Ueno H, 2004, VIROLOGY, V329, P134, DOI 10.1016/j.virol.2004.08.001; Zeidner G, 2005, ENVIRON MICROBIOL, V7, P1505, DOI 10.1111/j.1462-2920.2005.00833.x	25	231	247	5	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2007	449	7158					83	86		10.1038/nature06130	http://dx.doi.org/10.1038/nature06130			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207ED	17805294				2022-12-01	WOS:000249233500040
J	Vilotijevic, I; Jamison, TF				Vilotijevic, Ivan; Jamison, Timothy F.			Epoxide-opening cascades promoted by water	SCIENCE			English	Article							BREVETOXIN-B; DIRECTING-GROUP; LIQUID WATER; CYCLIZATION; CATALYSIS; REARRANGEMENTS; BIOSYNTHESIS; CONSTRUCTION; CHEMISTRY; SYSTEMS	Selectivity rules in organic chemistry have been inferred largely from nonaqueous environments. In contrast, enzymes operate in water, and the chemical effect of the medium change remains only partially understood. Structural characterization of the " ladder" polyether marine natural products raised a puzzle that persisted for 20 years: Although the stereochemistry of adjacent tetrahydropyran ( THP) cycles would seem to arise from a biosynthetic cascade of epoxide-opening reactions, experience in organic solvents argued consistently that such a pathway would be kinetically disfavored. We report that neutral water acts as an optimal promoter for the requisite ring-opening selectivity, once a single templating THP is appended to a chain of epoxides. This strategy offers a high- yielding route to the naturally occurring ladder core and highlights the likely importance of aqueous-medium effects in underpinning certain noteworthy enzymatic selectivities.	MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Jamison, TF (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	tfj@mit.edu	Vilotijevic, Ivan/Y-8063-2019	Vilotijevic, Ivan/0000-0001-6199-0632	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072566] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM-72566, R01 GM072566, R01 GM072566-05] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALDWIN JE, 1976, J CHEM SOC CHEM COMM, P734, DOI 10.1039/c39760000734; Bravo F, 2003, ORG LETT, V5, P2123, DOI 10.1021/ol034539o; CANE DE, 1983, J AM CHEM SOC, V105, P3594, DOI 10.1021/ja00349a040; CHOU HN, 1987, J AM CHEM SOC, V109, P2184, DOI 10.1021/ja00241a048; COXON JM, 1973, AUST J CHEM, V26, P2521, DOI 10.1071/CH9732521; DANISHEFSKY S, 1974, J AM CHEM SOC, V96, P1256, DOI 10.1021/ja00811a068; Gallimore AR, 2006, CHEM BIOL, V13, P453, DOI 10.1016/j.chembiol.2006.01.013; Heffron TP, 2006, SYNLETT, P2329, DOI 10.1055/s-2006-949637; Hirama M, 2001, SCIENCE, V294, P1904, DOI 10.1126/science.1065757; JANDA KD, 1993, SCIENCE, V259, P490, DOI 10.1126/science.8424171; Kleiner CM, 2006, CHEM COMMUN, P4315, DOI 10.1039/b605850g; LEE MS, 1986, J AM CHEM SOC, V108, P7855, DOI 10.1021/ja00284a072; Li CJ, 2006, CHEM SOC REV, V35, P68, DOI 10.1039/b507207g; LIN YY, 1981, J AM CHEM SOC, V103, P6773, DOI 10.1021/ja00412a053; Lindstrom UM, 2002, CHEM REV, V102, P2751, DOI 10.1021/cr010122p; NAKANISHI K, 1985, TOXICON, V23, P473, DOI 10.1016/0041-0101(85)90031-5; Narayan S, 2005, ANGEW CHEM INT EDIT, V44, P3275, DOI 10.1002/anie.200462883; NICOLAOU KC, 1995, J AM CHEM SOC, V117, P1173, DOI 10.1021/ja00108a052; Nicolaou KC, 1998, NATURE, V392, P264, DOI 10.1038/32623; NICOLAOU KC, 1989, J AM CHEM SOC, V111, P5330, DOI 10.1021/ja00196a043; RIDEOUT DC, 1980, J AM CHEM SOC, V102, P7816, DOI 10.1021/ja00546a048; SCHREIBER SL, 1986, J AM CHEM SOC, V108, P2106, DOI 10.1021/ja00268a070; Simpson GL, 2006, J AM CHEM SOC, V128, P1056, DOI 10.1021/ja057973p; Smith JD, 2004, SCIENCE, V306, P851, DOI 10.1126/science.1102560; Snyder RV, 2005, PHYTOCHEMISTRY, V66, P1767, DOI 10.1016/j.phytochem.2005.06.010; STILL WC, 1986, J AM CHEM SOC, V108, P2105, DOI 10.1021/ja00268a069; Su Z, 2007, ANGEW CHEM INT EDIT, V46, P6163, DOI 10.1002/anie.200701966; Tokiwano T, 2000, SYNLETT, P335; Tokunaga M, 1997, SCIENCE, V277, P936, DOI 10.1126/science.277.5328.936; TRAINER VL, 1994, J BIOL CHEM, V269, P19904; Tu Y, 1996, J AM CHEM SOC, V118, P9806, DOI 10.1021/ja962345g; Vohringer-Martinez E, 2007, SCIENCE, V315, P497, DOI 10.1126/science.1134494; Wan S, 2007, J AM CHEM SOC, V129, P7915, DOI 10.1021/ja0709674; Wernet P, 2004, SCIENCE, V304, P995, DOI 10.1126/science.1096205; Wu MH, 1999, ANGEW CHEM INT EDIT, V38, P2012, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<2012::AID-ANIE2012>3.0.CO;2-H	35	206	210	2	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2007	317	5842					1189	1192		10.1126/science.1146421	http://dx.doi.org/10.1126/science.1146421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	205PJ	17761875	Green Accepted			2022-12-01	WOS:000249126800031
J	Hafler, DA; Compston, A; Sawcer, S; Lander, ES; Daly, MJ; De Jager, PL; de Bakker, PIW; Gabriel, SB; Mirel, DB; Ivinson, AJ; Pericak-Vance, MA; Gregory, SG; Rioux, JD; McCauley, JL; Haines, JL; Barcellos, LF; Cree, B; Oksenberg, JR; Hauser, SL				Hafler, David A.; Compston, Alastair; Sawcer, Stephen; Lander, Eric S.; Daly, Mark J.; De Jager, Philip L.; de Bakker, Paul I. W.; Gabriel, Stacey B.; Mirel, Daniel B.; Ivinson, Adrian J.; Pericak-Vance, Margaret A.; Gregory, Simon G.; Rioux, John D.; McCauley, Jacob L.; Haines, Jonathan L.; Barcellos, Lisa F.; Cree, Bruce; Oksenberg, Jorge R.; Hauser, Stephen L.		Int Multiple Sclerosis Genetics Co	Risk alleles for multiple sclerosis identified by a genomewide study	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REGULATORY T-CELLS; LYMPHOID TYROSINE PHOSPHATASE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; SINGLE-NUCLEOTIDE POLYMORPHISMS; INTERLEUKIN-7 RECEPTOR-ALPHA; TYPE-1 DIABETES LOCUS; WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; DIAGNOSTIC-CRITERIA; SUSCEPTIBILITY LOCI	Background: Multiple sclerosis has a clinically significant heritable component. We conducted a genomewide association study to identify alleles associated with the risk of multiple sclerosis. Methods: We used DNA microarray technology to identify common DNA sequence variants in 931 family trios (consisting of an affected child and both parents) and tested them for association. For replication, we genotyped another 609 family trios, 2322 case subjects, and 789 control subjects and used genotyping data from two external control data sets. A joint analysis of data from 12,360 subjects was performed to estimate the overall significance and effect size of associations between alleles and the risk of multiple sclerosis. Results: A transmission disequilibrium test of 334,923 single-nucleotide polymorphisms (SNPs) in 931 family trios revealed 49 SNPs having an association with multiple sclerosis (P<1 x 10(sup -4)); of these SNPs, 38 were selected for the second-stage analysis. A comparison between the 931 case subjects from the family trios and 2431 control subjects identified an additional nonoverlapping 32 SNPs (P<0.001). An additional 40 SNPs with less stringent P values (<0.01) were also selected, for a total of 110 SNPs for the second-stage analysis. Of these SNPs, two within the interleukin-2 receptor (alpha) gene (IL2RA) were strongly associated with multiple sclerosis (P=2.96 x 10(sup -8)), as were a nonsynonymous SNP in the interleukin-7 receptor (alpha) gene (IL7RA) (P=2.94 x 10(sup -7)) and multiple SNPs in the HLA-DRA locus (P=8.94 x 10(sup -81)). Conclusions: Alleles of IL2RA and IL7RA and those in the HLA locus are identified as heritable risk factors for multiple sclerosis.	Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Div Mol Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Broad Inst, Boston, MA USA; MIT, Cambridge, MA 02139 USA; Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Clin Neurosci, Cambridge CB2 2QQ, England; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; Harvard Partners Ctr Genet & Genom, Boston, MA USA; Harvard Univ, Sch Med, Harvard Ctr Neurodgenerat & Repair, Boston, MA USA; Duke Univ, Med Ctr, Durham, NC USA; Univ Miami, Sch Med, Miami, FL USA; Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Duke University; University of Miami; Universite de Montreal; Vanderbilt University; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Ivinson, AJ (corresponding author), Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Div Mol Immunol, 75 Francis St, Boston, MA 02115 USA.		Daly, Mark J/B-2453-2017; Haines, Jonathan/C-3374-2012; Cree, Bruce C/AAV-6109-2020; Rioux, John D/A-9599-2015; Hauser, Stephen L/J-2978-2016; de Bakker, Paul IW/B-8730-2009	Daly, Mark J/0000-0002-0949-8752; Haines, Jonathan/0000-0002-4351-4728; Cree, Bruce C/0000-0001-7689-2533; Rioux, John D/0000-0001-7560-8326; de Bakker, Paul IW/0000-0001-7735-7858; Gregory, Simon/0000-0002-7805-1743	NCRR NIH HHS [U54-RR020278-1] Funding Source: Medline; NIAID NIH HHS [U19 AI067152, AI067152, P01-AI039671] Funding Source: Medline; NINDS NIH HHS [NS032830, NS049477, NS26799, NS2427] Funding Source: Medline; Wellcome Trust [076113] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067152, P01AI039671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026799, R01NS049477, R01NS032830] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Baecher-Allan C, 2006, IMMUNOL REV, V212, P203, DOI 10.1111/j.0105-2896.2006.00417.x; Bayer AL, 2007, J IMMUNOL, V178, P4062, DOI 10.4049/jimmunol.178.7.4062; Begovich AB, 2005, AM J HUM GENET, V76, P184, DOI 10.1086/427244; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bielekova B, 2004, P NATL ACAD SCI USA, V101, P17565, DOI 10.1073/pnas.0404694101; Bielekova B, 2004, P NATL ACAD SCI USA, V101, P8705, DOI 10.1073/pnas.0402653101; Bielekova B, 1999, J NEUROIMMUNOL, V100, P115, DOI 10.1016/S0165-5728(99)00200-3; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; COMPSTON A, 2005, MCALPINES MULTIPLE S, P113; Criswell LA, 2005, RHEUMATOLOGY, V44, P9, DOI 10.1093/rheumatology/kei054; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; De Jager PL, 2006, EUR J HUM GENET, V14, P317, DOI 10.1038/sj.ejhg.5201548; de Kleer IM, 2004, J IMMUNOL, V172, P6435, DOI 10.4049/jimmunol.172.10.6435; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Gregersen PK, 2005, NAT GENET, V37, P1300, DOI 10.1038/ng1205-1300; GREGORY SG, IN PRESS NAT GENET; Haas J, 2005, EUR J IMMUNOL, V35, P3343, DOI 10.1002/eji.200526065; Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; He YW, 1996, J EXP MED, V184, P289, DOI 10.1084/jem.184.1.289; Kyogoku C, 2004, ARTHRITIS RHEUM, V50, P671, DOI 10.1002/art.20029; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Lucchinetti CF, 1996, BRAIN PATHOL, V6, P259, DOI 10.1111/j.1750-3639.1996.tb00854.x; Matesanz F, 2007, J NEUROL, V254, P682, DOI 10.1007/s00415-006-0416-4; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; O'Connor KC, 2005, J IMMUNOL, V175, P1974, DOI 10.4049/jimmunol.175.3.1974; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; PRINEAS JW, 1978, LAB INVEST, V38, P409; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rose JW, 2004, ANN NEUROL, V56, P864, DOI 10.1002/ana.20287; Sawcer S, 2005, AM J HUM GENET, V77, P454; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Teutsch SM, 2003, EUR J HUM GENET, V11, P509, DOI 10.1038/sj.ejhg.5200994; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Velaga MR, 2004, J CLIN ENDOCR METAB, V89, P5862, DOI 10.1210/jc.2004-1108; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; WUCHERPFENNIG KW, 1992, P NATL ACAD SCI USA, V89, P4588, DOI 10.1073/pnas.89.10.4588; Yeo TW, 2007, ANN NEUROL, V61, P228, DOI 10.1002/ana.21063; Yu AX, 2006, J IMMUNOL, V177, P5115, DOI 10.4049/jimmunol.177.8.5115; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang Z, 2005, GENES IMMUN, V6, P145, DOI 10.1038/sj.gene.6364171	64	1278	1308	1	110	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2007	357	9					851	862		10.1056/NEJMoa073493	http://dx.doi.org/10.1056/NEJMoa073493			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204TA	17660530				2022-12-01	WOS:000249065700004
J	Singh, SK; Yamashita, A; Gouaux, E				Singh, Satinder K.; Yamashita, Atsuko; Gouaux, Eric			Antidepressant binding site in a bacterial homologue of neurotransmitter transporters	NATURE			English	Article							CYSTEINE-SCANNING MUTAGENESIS; HUMAN SEROTONIN TRANSPORTERS; NOREPINEPHRINE TRANSPORTER; INHIBITION; COTRANSPORTER; MUTATIONS; RECEPTORS; MECHANISM; DRUGS; MODEL	Sodium-coupled transporters are ubiquitous pumps that harness pre-existing sodium gradients to catalyse the thermodynamically unfavourable uptake of essential nutrients, neurotransmitters and inorganic ions across the lipid bilayer(1). Dysfunction of these integral membrane proteins has been implicated in glucose/galactose malabsorption(2), congenital hypothyroidism(3), Bartter's syndrome(4), epilepsy(5), depression(6), autism(7) and obsessive-compulsive disorder(8). Sodium-coupled transporters are blocked by a number of therapeutically important compounds, including diuretics(9), anticonvulsants(10) and antidepressants(11), many of which have also become indispensable tools in biochemical experiments designed to probe antagonist binding sites and to elucidate transport mechanisms. Steady-state kinetic data have revealed that both competitive(12,13) and noncompetitive(14,15) modes of inhibition exist. Antagonist dissociation experiments on the serotonin transporter (SERT) have also unveiled the existence of a low-affinity allosteric site that slows the dissociation of inhibitors from a separate high-affinity site(16). Despite these strides, atomic-level insights into inhibitor action have remained elusive. Here we screen a panel of molecules for their ability to inhibit LeuT, a prokaryotic homologue of mammalian neurotransmitter sodium symporters, and show that the tricyclic antidepressant (TCA) clomipramine noncompetitively inhibits substrate uptake. Cocrystal structures show that clomipramine, along with two other TCAs, binds in an extracellular-facing vestibule about 11 angstrom above the substrate and two sodium ions, apparently stabilizing the extracellular gate in a closed conformation. Off-rate assays establish that clomipramine reduces the rate at which leucine dissociates from LeuT and reinforce our contention that this TCA inhibits LeuT by slowing substrate release. Our results represent a molecular view into noncompetitive inhibition of a sodium-coupled transporter and define principles for the rational design of new inhibitors.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA; Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University; Columbia University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Yamashita, Atsuko/H-5566-2017; Gouaux, Eric/Y-4370-2019	Yamashita, Atsuko/0000-0002-8001-4642; Gouaux, Eric/0000-0002-8549-2360				Barker Eric L., 1995, P321; BEAUMONT K, 1988, P NATL ACAD SCI USA, V85, P2311, DOI 10.1073/pnas.85.7.2311; Cantu MD, 2005, J CHROMATOGR A, V1068, P99, DOI 10.1016/j.chroma.2004.12.009; Hahn M. K., 2002, Pharmacogenomics Journal, V2, P217, DOI 10.1038/sj.tpj.6500106; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Ju PC, 2004, J BIOL CHEM, V279, P22983, DOI 10.1074/jbc.M312484200; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; Keller PC, 2004, BIOCHEMISTRY-US, V43, P8510, DOI 10.1021/bi035971g; Krogsgaard-Larsen P, 2000, CURR PHARM DESIGN, V6, P1193, DOI 10.2174/1381612003399608; Mitchell SM, 2004, J BIOL CHEM, V279, P24089, DOI 10.1074/jbc.M311173200; Neubauer HA, 2006, MOL PHARMACOL, V69, P1242, DOI 10.1124/mol.105.018507; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; Ozaki N, 2003, MOL PSYCHIATR, V8, P933, DOI 10.1038/sj.mp.4001365; Paczkowski FA, 2007, J BIOL CHEM, V282, P17837, DOI 10.1074/jbc.M610813200; Pohlenz J, 1999, BIOCHIMIE, V81, P469, DOI 10.1016/S0300-9084(99)80097-2; Richerson GB, 2004, ADV EXP MED BIOL, V548, P76; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; SMART L, 1981, EUR J PHARMACOL, V75, P265, DOI 10.1016/0014-2999(81)90553-7; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; TALVENHEIMO J, 1979, J BIOL CHEM, V254, P4631; Uryu K, 2000, ANESTH ANALG, V91, P546, DOI 10.1213/00000539-200009000-00008; Vroye L, 1998, PFLUG ARCH EUR J PHY, V435, P259; Wright EM, 2002, CELL BIOCHEM BIOPHYS, V36, P115, DOI 10.1385/CBB:36:2-3:115; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zomot E, 2003, J BIOL CHEM, V278, P42950, DOI 10.1074/jbc.M209307200	30	331	339	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2007	448	7156					952	956		10.1038/nature06038	http://dx.doi.org/10.1038/nature06038			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202OM	17687333				2022-12-01	WOS:000248912900052
J	Chen, GK; Zhuchenko, O; Kuspa, A				Chen, Guokai; Zhuchenko, Olga; Kuspa, Adam			Immune-like phagocyte activity in the social amoeba	SCIENCE			English	Article							DICTYOSTELIUM-DISCOIDEUM; LEGIONELLA-PNEUMOPHILA; INNATE IMMUNITY; SIGNALING PATHWAYS; PATTERN-FORMATION; PATHOGEN; RECOGNITION; RECEPTORS; EVOLUTION; ANIMALS	Social amoebae feed on bacteria in the soil but aggregate when starved to form a migrating slug. We describe a previously unknown cell type in the social amoeba, which appears to provide detoxification and immune-like functions and which we term sentinel ( S) cells. S cells were observed to engulf bacteria and sequester toxins while circulating within the slug, eventually being sloughed off. A Toll/ interleukin-1 receptor (TIR) domain protein, TirA, was also required for some S cell functions and for vegetative amoebae to feed on live bacteria. This apparent innate immune function in social amoebae, and the use of TirA for bacterial feeding, suggest an ancient cellular foraging mechanism that may have been adapted to defense functions well before the diversification of the animals.	Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Kuspa, A (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	akuspa@bcm.tmc.edu		Kuspa, Adam/0000-0002-9156-149X	NICHD NIH HHS [P01 HD039691, P01 HD039691-04, P01 HD039691-08, HD39691, P01 HD039691-06, P01 HD039691-03, P01 HD039691-05, P01 HD039691-07] Funding Source: Medline; NIGMS NIH HHS [R01 GM052359-10, R01 GM052359, GM52359, R01 GM052359-11, R01 GM052359-13, R01 GM052359-12] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD039691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052359] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anjard C, 2002, EUKARYOT CELL, V1, P643, DOI 10.1128/EC.1.4.643-652.2002; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Baldauf SL, 1997, P NATL ACAD SCI USA, V94, P12007, DOI 10.1073/pnas.94.22.12007; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Brown V, 2006, EUR J IMMUNOL, V36, P742, DOI 10.1002/eji.200535158; Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Casademunt E, 2002, DIFFERENTIATION, V70, P23, DOI 10.1046/j.1432-0436.2002.700103.x; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Germain RN, 2004, NAT MED, V10, P1307, DOI 10.1038/nm1159; Good JR, 2000, DEV BIOL, V220, P53, DOI 10.1006/dbio.2000.9611; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kessin RH., 2001, DICTYOSTELIUM EVOLUT; Lee SW, 2006, P NATL ACAD SCI USA, V103, P18395, DOI 10.1073/pnas.0605508103; Maeda M, 2003, EUKARYOT CELL, V2, P627, DOI 10.1128/EC.2.3.627-637.2003; Medzhitov R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI 10.1016/S0952-7915(98)80024-1; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Parker JE, 1997, PLANT CELL, V9, P879, DOI 10.1105/tpc.9.6.879; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Shuman HA, 1998, CURR TOP MICROBIOL, V225, P99; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Solomon JM, 2000, INFECT IMMUN, V68, P2939, DOI 10.1128/IAI.68.5.2939-2947.2000; Song J, 2005, PLOS COMPUT BIOL, V1, P579, DOI 10.1371/journal.pcbi.0010071; STERNFELD J, 1981, DIFFERENTIATION, V20, P10, DOI 10.1111/j.1432-0436.1981.tb01150.x; Strassmann JE, 2004, ASM NEWS, V70, P526; Tauber AI, 2003, NAT REV MOL CELL BIO, V4, P897, DOI 10.1038/nrm1244; WILLIAMS J, 1997, DICTYOSTELIUM MODEL, P293; Williams JG, 2006, EMBO REP, V7, P694, DOI 10.1038/sj.embor.7400714; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600	33	131	138	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					678	681		10.1126/science.1143991	http://dx.doi.org/10.1126/science.1143991			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17673666	Green Accepted			2022-12-01	WOS:000248494400050
J	Chinchilla, D; Zipfel, C; Robatzek, S; Kemmerling, B; Nurnberger, T; Jones, JDG; Felix, G; Boller, T				Chinchilla, Delphine; Zipfel, Cyril; Robatzek, Silke; Kemmerling, Birgit; Nuernberger, Thorsten; Jones, Jonathan D. G.; Felix, Georg; Boller, Thomas			A flagellin-induced complex of the receptor FLS2 and BAK1 initiates plant defence	NATURE			English	Article							INNATE IMMUNITY; ARABIDOPSIS-THALIANA; KINASE; PERCEPTION; BRASSINOSTEROIDS; PHOSPHORYLATION; ENDOCYTOSIS; DOMAIN; SIGNAL; GENE	Plants sense potential microbial invaders by using pattern-recognition receptors to recognize pathogen-associated molecular patterns (PAMPs)(1). In Arabidopsis thaliana, the leucine-rich repeat receptor kinases flagellin-sensitive 2 (FLS2) (ref. 2) and elongation factor Tu receptor (EFR) ( ref. 3) act as pattern-recognition receptors for the bacterial PAMPs flagellin(4) and elongation factor Tu (EF-Tu) ( ref. 5) and contribute to resistance against bacterial pathogens. Little is known about the molecular mechanisms that link receptor activation to intracellular signal transduction. Here we show that BAK1 (BRI1-associated receptor kinase 1), a leucine-rich repeat receptor-like kinase that has been reported to regulate the brassinosteroid receptor BRI1 (refs 6,7), is involved in signalling by FLS2 and EFR. Plants carrying bak1 mutations show normal flagellin binding but abnormal early and late flagellin-triggered responses, indicating that BAK1 acts as a positive regulator in signalling. The bak1-mutant plants also show a reduction in early, but not late, EF-Tu-triggered responses. The decrease in responses to PAMPs is not due to reduced sensitivity to brassino-steroids. We provide evidence that FLS2 and BAK1 form a complex in vivo, in a specific ligand-dependent manner, within the first minutes of stimulation with flagellin. Thus, BAK1 is not only associated with developmental regulation through the plant hormone receptor BRI1 ( refs 6,7), but also has a functional role in PRR-dependent signalling, which initiates innate immunity.	Univ Basel, Zurich Basel Plant Sci Ctr, Inst Bot, CH-4056 Basel, Switzerland; Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; Univ Tubingen, Inst Plant Biochem, ZMBP, D-72076 Tubingen, Germany	University of Basel; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Max Planck Society; Eberhard Karls University of Tubingen	Chinchilla, D (corresponding author), Univ Basel, Zurich Basel Plant Sci Ctr, Inst Bot, Hebelstr 1, CH-4056 Basel, Switzerland.	delphine.chinchilla@unibas.ch; thomas.boller@unibas.ch	ZIPFEL, CYRIL/ABD-5076-2021; Jones, Jonathan DG/J-5129-2012; Boller, Thomas/G-3500-2012; ZIPFEL, CYRIL B/D-7103-2011; Robatzek, Silke/B-6844-2013	ZIPFEL, CYRIL/0000-0003-4935-8583; Jones, Jonathan DG/0000-0002-4953-261X; Boller, Thomas/0000-0001-6768-7503; ZIPFEL, CYRIL B/0000-0003-4935-8583; Kemmerling, Birgit/0000-0003-1174-0189				Albrecht C, 2005, PLANT CELL, V17, P3337, DOI 10.1105/tpc.105.036814; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Colcombet J, 2005, PLANT CELL, V17, P3350, DOI 10.1105/tpc.105.036731; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; FELIX G, 1991, P NATL ACAD SCI USA, V88, P8831, DOI 10.1073/pnas.88.19.8831; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Kauschmann A, 1996, PLANT J, V9, P701, DOI 10.1046/j.1365-313X.1996.9050701.x; Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 2007, TRENDS PLANT SCI, V12, P37, DOI 10.1016/j.tplants.2006.11.002; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	31	1194	1267	15	367	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					497	U12		10.1038/nature05999	http://dx.doi.org/10.1038/nature05999			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17625569	Green Published			2022-12-01	WOS:000248302700052
J	Unal, E; Heidinger-Pauli, JM; Koshland, D				Uenal, Elcin; Heidinger-Pauli, Jill M.; Koshland, Douglas			DNA double-strand breaks trigger genome-wide sister-chromatid cohesion through Eco1 (Ctf7)	SCIENCE			English	Article							ESTABLISHMENT; REPLICATION; PROTEINS; DAMAGE; RECRUITMENT; PATHWAY; COMPLEX; REPAIR	Faithful chromosome segregation and repair of DNA double-strand breaks (DSBs) require cohesin, the protein complex that mediates sister-chromatid cohesion. Cohesion between sister chromatids is thought to be generated only during ongoing DNA replication by an obligate coupling between cohesion establishment factors such as Eco1 (Ctf7) and the replisome. Using budding yeast, we challenge this model by showing that cohesion is generated by an Eco1-dependent but replication-independent mechanism in response to DSBs in G(2)/M. Furthermore, our studies reveal that Eco1 has two functions: a cohesive activity and a conserved acetyltransferase activity, which triggers the generation of cohesion in response to the DSB and the DNA damage checkpoint. Finally, the DSB-induced cohesion is not limited to broken chromosomes but occurs also on unbroken chromosomes, suggesting that the DNA damage checkpoint through Eco1 provides genome-wide protection of chromosome integrity.	Howard Hughes Med Inst, Carnegie Inst, Dept Embryol, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Carnegie Institution for Science; Howard Hughes Medical Institute; Johns Hopkins University	Koshland, D (corresponding author), Howard Hughes Med Inst, Carnegie Inst, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.	koshland@ciwemb.edu		Unal, Elcin/0000-0002-6768-609X				Brands A, 2005, CURR BIOL, V15, pR50, DOI 10.1016/j.cub.2004.12.052; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Kim JS, 2002, J BIOL CHEM, V277, P45149, DOI 10.1074/jbc.M209123200; Koshland DE, 2000, CURR OPIN CELL BIOL, V12, P297, DOI 10.1016/S0955-0674(00)00092-2; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Meluh PB, 2002, EUR J BIOCHEM, V269, P2300, DOI 10.1046/j.1432-1033.2002.02886.x; Milutinovich M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030012; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; STROM L, 2007, CURR OPIN CELL BIOL; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Watrin E, 2006, EXP CELL RES, V312, P2687, DOI 10.1016/j.yexcr.2006.06.024	19	243	246	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2007	317	5835					245	248		10.1126/science.1140637	http://dx.doi.org/10.1126/science.1140637			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17626885				2022-12-01	WOS:000247968600043
J	Toth, AL; Varala, K; Newman, TC; Miguez, FE; Hutchison, SK; Willoughby, DA; Simons, JF; Egholm, M; Hunt, JH; Hudson, ME; Robinson, GE				Toth, Amy L.; Varala, Kranthi; Newman, Thomas C.; Miguez, Fernando E.; Hutchison, Stephen K.; Willoughby, David A.; Simons, Jan Fredrik; Egholm, Michael; Hunt, James H.; Hudson, Matthew E.; Robinson, Gene E.			Wasp gene expression supports an evolutionary link between maternal behavior and eusociality	SCIENCE			English	Article							HONEY-BEE; SEQUENCE; ORIGIN; PERIOD; BRAIN; AGE	The presence of workers that forgo reproduction and care for their siblings is a defining feature of eusociality and a major challenge for evolutionary theory. It has been proposed that worker behavior evolved from maternal care behavior. We explored this idea by studying gene expression in the primitively eusocial wasp Polistes metricus. Because little genomic information existed for this species, we used 454 sequencing to generate 391,157 brain complementary DNA reads, resulting in robust hits to 3017 genes from the honey bee genome, from which we identified and assayed orthologs of 32 honey bee behaviorally related genes. Wasp brain gene expression in workers was more similar to that in foundresses, which show maternal care, than to that in queens and gynes, which do not. Insulin-related genes were among the differentially regulated genes, suggesting that the evolution of eusociality involved major nutritional and reproductive pathways.	Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; 454 Life Sci, Branford, CT 06405 USA; Univ Missouri, Dept Biol, St Louis, MO 63121 USA; Univ Illinois, Neurosci Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Missouri System; University of Missouri Saint Louis; University of Illinois System; University of Illinois Urbana-Champaign	Toth, AL (corresponding author), Univ Illinois, Dept Entomol, 320 Morrill Hall, Urbana, IL 61801 USA.	amytoth@uiuc.edu	Miguez, Fernando E/B-7988-2012; Toth, Amy L/A-9196-2011; Hudson, Matthew E/A-4438-2008; Hunt, James/D-1740-2009; Varala, Kranthi/A-2954-2013	Hudson, Matthew E/0000-0002-4737-0936; Varala, Kranthi/0000-0003-1051-6636				Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; AMENT SA, 2006, SOC NEUROSCIENCE ITI; [Anonymous], 1991, SOCIAL BIOL WASPS; Barchuk AR, 2004, INSECT MOL BIOL, V13, P459, DOI 10.1111/j.0962-1075.2004.00506.x; Ben-Shahar Y, 2004, J EXP BIOL, V207, P3281, DOI 10.1242/jeb.01151; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Bloch G, 2001, J BIOL RHYTHM, V16, P444, DOI 10.1177/074873001129002123; Bloch Guy, 2002, P195; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Danforth BN, 2004, SYST BIOL, V53, P309, DOI 10.1080/10635150490423737; Evans H. E., 1970, THE WASPS; HUDSON ME, 2007, MOL ECOL NOTES, DOI DOI 10.1111/J.1471-8286.2007.020189.X; Hunt GJ, 2007, NATURWISSENSCHAFTEN, V94, P247, DOI 10.1007/s00114-006-0183-1; Hunt JH, 1999, EVOLUTION, V53, P225, DOI 10.1111/j.1558-5646.1999.tb05348.x; Hunt JH, 2007, EVOLUTION SOCIAL WAS; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Linksvayer TA, 2005, Q REV BIOL, V80, P317, DOI 10.1086/432266; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Nunes FMF, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-84; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sumner S, 2006, P ROY SOC B-BIOL SCI, V273, P19, DOI 10.1098/rspb.2005.3291; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; Turillazzi S., 1996, NATURAL HIST EVOLUTI; Venables WN., 2002, MODERN APPL STAT S 4, V4th Ed., DOI [10.1007/978-0-387-21706-2, 10.1007/978-1-4757-2719-7_7]; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; West Eberhard M. J., 1969, Miscellaneous Publications Museum of Zoology University of Michigan, VNo. 140, P1; West-Eberhard Mary Jane, 1996, P290; West-Eberhard Mary Jane, 2003, pi; Wheeler DE, 2006, INSECT MOL BIOL, V15, P597, DOI 10.1111/j.1365-2583.2006.00681.x; Wheeler WM, 1928, SOCIAL INSECTS THEIR; Whitfield CW, 2006, P NATL ACAD SCI USA, V103, P16068, DOI 10.1073/pnas.0606909103; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Whitfield CW, 2002, GENOME RES, V12, P555, DOI 10.1101/gr.5302; Wilson E.O., 1971, INSECT SOC; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102	36	207	215	1	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2007	318	5849					441	444		10.1126/science.1146647	http://dx.doi.org/10.1126/science.1146647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17901299				2022-12-01	WOS:000250230400044
J	Amodeo, GA; Rudolph, MJ; Tong, L				Amodeo, Gabriele A.; Rudolph, Michael J.; Tong, Liang			Crystal structure of the heterotrimer core of Saccharomyces cerevisiae AMPK homologue SNF1	NATURE			English	Article							ACTIVATED PROTEIN-KINASE; ALPHA-SUBUNITS; YEAST SNF1; DOMAIN; GLYCOGEN; BINDING; DISEASE; COMPLEX; STRESS; MODELS	AMP-activated protein kinase ( AMPK) is a central regulator of energy homeostasis in mammals and is an attractive target for drug discovery against diabetes, obesity and other diseases(1-5). The AMPK homologue in Saccharomyces cerevisiae, known as SNF1, is essential for responses to glucose starvation as well as for other cellular processes, although SNF1 seems to be activated by a ligand other than AMP(1,6-8). Here we report the crystal structure at 2.6 angstrom resolution of the heterotrimer core of SNF1. The ligand-binding site in the gamma-subunit (Snf4) has clear structural differences from that of the Schizosaccharomyces pombe enzyme(9), although our crystallographic data indicate that AMP can also bind to Snf4. The glycogen-binding domain in the beta-subunit (Sip2) interacts with Snf4 in the heterotrimer but should still be able to bind carbohydrates(10-13). Our structure is supported by a large body of biochemical and genetic data on this complex(1,6-8,14-18). Most significantly, the structure reveals that part of the regulatory sequence in the alpha-subunit (Snf1)(15,16,18,19) is sequestered by Snf4, demonstrating a direct interaction between the alpha- and gamma-subunits and indicating that our structure may represent the heterotrimer core of SNF1 in its activated state.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu		Tong, Liang/0000-0002-0563-6468				Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carling D, 2005, BIOCHIMIE, V87, P87, DOI 10.1016/j.biochi.2004.10.017; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Day P, 2007, ACTA CRYSTALLOGR D, V63, P587, DOI 10.1107/S0907444907009110; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hamilton SR, 2001, FEBS LETT, V500, P163, DOI 10.1016/S0014-5793(01)02602-3; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Jiang R, 1996, GENE DEV, V10, P3105, DOI 10.1101/gad.10.24.3105; Jiang R, 1997, MOL CELL BIOL, V17, P2099, DOI 10.1128/MCB.17.4.2099; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; LEECH J, 1973, LANCET, V2, P265; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nayak V, 2006, STRUCTURE, V14, P477, DOI 10.1016/j.str.2005.12.008; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pang T, 2007, J BIOL CHEM, V282, P495, DOI 10.1074/jbc.M605790200; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Rudolph MJ, 2007, STRUCTURE, V15, P65, DOI 10.1016/j.str.2006.11.014; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Sanz P, 2003, BIOCHEM SOC T, V31, P178; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; Wiatrowski HA, 2004, MOL CELL BIOL, V24, P352, DOI 10.1128/MCB.24.1.352-361.2004	37	130	135	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2007	449	7161					492	U13		10.1038/nature06127	http://dx.doi.org/10.1038/nature06127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17851534				2022-12-01	WOS:000249724800047
J	DeSmet, PAGM; Kramers, C; Britten, N				DeSmet, Peter A. G. M.; Kramers, Cees; Britten, Nicky			Can drug regimens be adapted to patients, or vice versa?	LANCET			English	Editorial Material							MUCOCUTANEOUS REACTIONS; LOW DOSAGE; SIMVASTATIN; HYPERCHOLESTEROLEMIA; CHOLESTEROL; ADHERENCE; GOLD		Radboud Univ Nijmegen Med Ctr, Dept Clin Pharm, NL-6525 GA Nijmegen, Netherlands; Radboud Univ Nijmegen, Dept Pharmacol & Toxicol, Nijmegen, Netherlands; Univ Plymouth, Peninsula Med Sch, Exeter, Devon, England; Univ Exeter, Exeter, Devon, England	Radboud University Nijmegen; Radboud University Nijmegen; University of Exeter; University of Plymouth; University of Exeter	DeSmet, PAGM (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Clin Pharm, NL-6525 GA Nijmegen, Netherlands.	pdesmet@winap.nl	Smet, P.A.G.M./L-4654-2015; Kramers, C./L-4458-2015					Cheatum DE, 1996, J RHEUMATOL, V23, P944; Hughes DA, 2003, CLIN PHARMACOL THER, V74, P1, DOI 10.1016/S0009-9236(03)00091-2; Jenkins DJA, 2005, AM J CLIN NUTR, V81, P380; KLINKHOFF AV, 1995, J RHEUMATOL, V22, P1657; Kripalani S, 2007, ARCH INTERN MED, V167, P540, DOI 10.1001/archinte.167.6.540; Mangin EFM, 2004, ANN PHARMACOTHER, V38, P1789, DOI 10.1345/aph.1E134; Moreyra AE, 2005, ARCH INTERN MED, V165, P1161, DOI 10.1001/archinte.165.10.1161; Pound P, 2005, SOC SCI MED, V61, P133, DOI 10.1016/j.socscimed.2004.11.063; Rindone JP, 1999, PHARMACOTHERAPY, V19, P399, DOI 10.1592/phco.19.6.399.31045; TUOMILEHTO J, 1994, J CARDIOVASC PHARM, V24, P941, DOI 10.1097/00005344-199424060-00012	10	2	2	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 8	2007	370	9590					813	814		10.1016/S0140-6736(07)61395-6	http://dx.doi.org/10.1016/S0140-6736(07)61395-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	214JH	17826156				2022-12-01	WOS:000249733300011
J	Hadithi, M; von Blomberg, ME; Crusius, BA; Bloemena, E; Kostense, PJ; Meijer, JWR; Mulder, CJJ; Stehouwer, CDA; Pena, AS				Hadithi, Muhammed; von Blomberg, Mary E.; Crusius, Bart A.; Bloemena, Elisabeth; Kostense, Pieter J.; Meijer, Jos W. R.; Mulder, Chris J. J.; Stehouwer, Coen D. A.; Pena, Amado S.			Accuracy of serologic tests and HLA-DQ typing for diagnosing Celiac disease	ANNALS OF INTERNAL MEDICINE			English	Article							TISSUE TRANSGLUTAMINASE ANTIBODIES; ENDOMYSIAL ANTIBODY; GLUTEN; SENSITIVITY; PREVALENCE; CRITERIA; ELISA	Background: Estimates of the diagnostic performance of serologic testing and HLA-DQ typing for detecting celiac disease have mainly come from case-control studies. Objective: To define the performance of serologic testing and HLA-DQ typing prospectively. Design: Prospective cohort study. Setting: University hospital. Patients: Patients referred for small-bowel biopsy for the diagnosis of celiac disease. Interventions: Celiac serologic testing (antigliadin antibodies (AGA], antitransglutaminase antibodies [TGA], and antiendomysium antibodies [EMA]) and HLA-DQ typing. Measurements: Diagnostic performance of serologic testing and HLA-DQ typing compared with a reference standard of abnormal histologic findings and clinical resolution after a gluten-free diet. Results: Sixteen of 463 participants had celiac disease (prevalence, 3.46% [95% Cl, 1.99% to 5.55%]). A positive result on both TGA and EMA testing had a sensitivity of 81% (Cl, 54% to 95.9%), specificity of 99.3% (Cl, 98.0% to 99.9%), and negative predictive value of 99.3% (Cl, 98.0% to 99.9%). Testing positive for either HLA-DQ type maximized sensitivity (100% [Cl, 79% to 100%]) and negative predictive value (100% [Cl, 98.6% to 100%]), whereas testing negative for both minimized the negative likelihood ratio (0.00 [Cl, 0.00 to 0.40]) and posttest probability (0% [Cl, 0% to 1.4%]). The addition of HLA-DQ typing to TGA and EMA testing, and the addition of serologic testing to HLA-DQ typing, did not change test performance compared with either testing strategy alone. Limitation: Few cases of celiac disease precluded meaningful comparisons of testing strategies. Conclusions: In a patient population referred for symptoms and signs of celiac disease with a prevalence of celiac disease of 3.46%, TGA and EMA testing were the most sensitive serum antibody tests and a negative HLA-DQ type excluded the diagnosis. However, the addition of HLA-DQ typing to TGA and EMA testing, and the addition of serologic testing to HLA-DQ typing, provided the same measures of test performance as either testing strategy alone.	Het Groene Hart Ziekenhuis, Dept Gastroenterol, NL-2800 BB Gouda, Netherlands; Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; Rijnstate Hosp, Arnhem, Netherlands; Univ Hosp Maastricht, Maastricht, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Rijnstate Hospital; Maastricht University; Maastricht University Medical Centre (MUMC)	Hadithi, M (corresponding author), Het Groene Hart Ziekenhuis, Dept Gastroenterol, POB 1098, NL-2800 BB Gouda, Netherlands.	muhammed.hadithi@ghz.nl	Bloemena, Elisabeth/AAZ-1247-2021; Stehouwer, Coen/AAB-3435-2021; Bloemena, Elisabeth/V-1095-2018	Bloemena, Elisabeth/0000-0002-0221-9538; Stehouwer, Coen/0000-0001-8752-3223				Abrams JA, 2004, DIGEST DIS SCI, V49, P546, DOI 10.1023/B:DDAS.0000026296.02308.00; Altman DG., 2000, STAT CONFIDENCE, P105; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; Baldas V, 2000, GUT, V47, P628, DOI 10.1136/gut.47.5.628; Catassi C, 2001, EUR J GASTROEN HEPAT, V13, P1123; Collin P, 1999, ANN MED, V31, P399, DOI 10.3109/07853899908998797; Collin P, 2005, EUR J GASTROEN HEPAT, V17, P85, DOI 10.1097/00042737-200501000-00017; CORRAO G, 1994, GUT, V35, P771, DOI 10.1136/gut.35.6.771; Cranney A, 2005, GASTROENTEROLOGY, V128, pS109, DOI 10.1053/j.gastro.2005.02.019; CRUSIUS JB, 2002, THESIS VRIJE U AMSTE; Csizmadia CGDS, 2000, J PEDIATR-US, V137, P756, DOI 10.1067/mpd.2000.110421; Cummins A, 2002, GASTROENTEROLOGY, V122, P246, DOI 10.1053/gast.2002.30908; Dahele AVM, 2001, QJM-INT J MED, V94, P195, DOI 10.1093/qjmed/94.4.195; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Dickey W, 2000, SCAND J GASTROENTERO, V35, P181; Dickey W, 2001, SCAND J GASTROENTERO, V36, P511, DOI 10.1080/003655201750153359; Dieterich W, 1998, GASTROENTEROLOGY, V115, P1317, DOI 10.1016/S0016-5085(98)70007-1; Dieterich W, 2003, INT ARCH ALLERGY IMM, V132, P98, DOI 10.1159/000073710; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5; Hill ID, 2005, GASTROENTEROLOGY, V128, pS25, DOI 10.1053/j.gastro.2005.02.012; Kagnoff MF, 2005, GASTROENTEROLOGY, V128, pS10, DOI 10.1053/j.gastro.2005.02.008; Kaukinen K, 2002, AM J GASTROENTEROL, V97, P695, DOI 10.1111/j.1572-0241.2002.05471.x; Korponay-Szabo IR, 2003, GUT, V52, P1567, DOI 10.1136/gut.52.11.1567; LERNER A, 1994, CLIN EXP IMMUNOL, V95, P78; LUNDIN KEA, 1994, HUM IMMUNOL, V41, P24, DOI 10.1016/0198-8859(94)90079-5; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Mazzarella G, 2003, GUT, V52, P57, DOI 10.1136/gut.52.1.57; Murdock AM, 2005, EUR J GASTROEN HEPAT, V17, P41, DOI 10.1097/00042737-200501000-00009; Picarelli A, 1996, GASTROENTEROLOGY, V111, P608, DOI 10.1053/gast.1996.v111.pm8780564; Reeves GEM, 2006, EUR J GASTROEN HEPAT, V18, P493, DOI 10.1097/00042737-200605000-00006; Rostom A, 2005, GASTROENTEROLOGY, V128, pS38, DOI 10.1053/j.gastro.2005.02.028; Sanders DS, 2001, LANCET, V358, P1504, DOI 10.1016/S0140-6736(01)06581-3; Sblattero D, 2000, AM J GASTROENTEROL, V95, P1253; Schuppan D, 2000, GASTROENTEROLOGY, V119, P234, DOI 10.1053/gast.2000.8521; Schweizer JJ, 2004, SCAND J GASTROENTERO, V39, P359, DOI 10.1080/00365520310008503; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; Wahab PJ, 2002, AM J CLIN PATHOL, V118, P459; Wahab PJ, 2001, AM J GASTROENTEROL, V96, P1464, DOI 10.1111/j.1572-0241.2001.03812.x; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909; Wong RCW, 2002, J CLIN PATHOL, V55, P488, DOI 10.1136/jcp.55.7.488	42	155	161	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 4	2007	147	5					294	302		10.7326/0003-4819-147-5-200709040-00003	http://dx.doi.org/10.7326/0003-4819-147-5-200709040-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	207ZO	17785484				2022-12-01	WOS:000249289800002
J	Seelig, B; Szostak, JW				Seelig, Burckhard; Szostak, Jack W.			Selection and evolution of enzymes from a partially randomized non-catalytic scaffold	NATURE			English	Article							IN-VITRO SELECTION; MESSENGER-RNA; DIRECTED EVOLUTION; INDUSTRIAL BIOCATALYSIS; ACTIVE-SITE; DESIGN; PROTEINS; IDENTIFICATION; STRATEGIES; ANTIBODIES	Enzymes are exceptional catalysts that facilitate a wide variety of reactions under mild conditions, achieving high rate-enhancements with excellent chemo-, regio- and stereoselectivities. There is considerable interest in developing new enzymes for the synthesis of chemicals and pharmaceuticals(1-3) and as tools for molecular biology. Methods have been developed for modifying and improving existing enzymes through screening, selection and directed evolution(4,5). However, the design and evolution of truly novel enzymes has relied on extensive knowledge of the mechanism of the reaction(6-10). Here we show that genuinely new enzymatic activities can be created de novo without the need for prior mechanistic information by selection from a naive protein library of very high diversity, with product formation as the sole selection criterion. We used messenger RNA display, in which proteins are covalently linked to their encoding mRNA(11), to select for functional proteins from an in vitro translated protein library of > 10(12) independent sequences without the constraints imposed by any in vivo step. This technique has been used to evolve new peptides and proteins that can bind a specific ligand(12-18), from both random- sequence libraries(12,14-16) and libraries based on a known protein fold(17,18). We now describe the isolation of novel RNA ligases from a library that is based on a zinc finger scaffold(18,19), followed by in vitro directed evolution to further optimize these enzymes. The resulting ligases exhibit multiple turnover with rate enhancements of more than two- million- fold.	Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol, Simches Res Ctr 7215, Boston, MA 02114 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, CCIB, Simches Res Ctr 7215, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol, Simches Res Ctr 7215, 185 Cambridge St, Boston, MA 02114 USA.	szostak@molbio.mgh.harvard.edu	Seelig, Burckhard/D-1042-2013	Seelig, Burckhard/0000-0001-8598-0586	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aharoni A, 2005, CURR OPIN CHEM BIOL, V9, P210, DOI 10.1016/j.cbpa.2005.02.002; Baggio R, 2002, J MOL RECOGNIT, V15, P126, DOI 10.1002/jmr.567; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; Bloom JD, 2005, CURR OPIN STRUC BIOL, V15, P447, DOI 10.1016/j.sbi.2005.06.004; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; BONNER G, 1994, J BIOL CHEM, V269, P25120; BRYANT FR, 1981, J AM CHEM SOC, V103, P696, DOI 10.1021/ja00393a047; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Cesaro-Tadic S, 2003, NAT BIOTECHNOL, V21, P679, DOI 10.1038/nbt828; Cherry JR, 2003, CURR OPIN BIOTECH, V14, P438, DOI 10.1016/S0958-1669(03)00099-5; Cho G, 2000, J MOL BIOL, V297, P309, DOI 10.1006/jmbi.2000.3571; Cho GS, 2006, CHEM BIOL, V13, P139, DOI 10.1016/j.chembiol.2005.10.015; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cujec TP, 2002, CHEM BIOL, V9, P253, DOI 10.1016/S1074-5521(02)00098-4; Dwyer MA, 2004, SCIENCE, V304, P1967, DOI 10.1126/science.1098432; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Griffiths AD, 2000, CURR OPIN BIOTECH, V11, P338, DOI 10.1016/S0958-1669(00)00109-9; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Holmbeck SMA, 1998, J MOL BIOL, V281, P271, DOI 10.1006/jmbi.1998.1908; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; Kurz M, 2000, Nucleic Acids Res, V28, pE83, DOI 10.1093/nar/28.18.e83; Liu RH, 2000, METHOD ENZYMOL, V318, P268; McCafferty DG, 1997, BIOCHEMISTRY-US, V36, P10498, DOI 10.1021/bi970543u; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; Panke S, 2004, CURR OPIN BIOTECH, V15, P272, DOI 10.1016/j.copbio.2004.06.011; Park HS, 2006, SCIENCE, V311, P535, DOI 10.1126/science.1118953; Purtha WE, 2005, J AM CHEM SOC, V127, P13124, DOI 10.1021/ja0533702; Raffler NA, 2003, CHEM BIOL, V10, P69, DOI 10.1016/S1074-5521(02)00309-5; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rohatgi R, 1996, J AM CHEM SOC, V118, P3332, DOI 10.1021/ja953712b; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Slootstra JW, 1997, MOL DIVERS, V2, P156, DOI 10.1007/BF01682203; VOLCKAERT G, 1977, ANAL BIOCHEM, V83, P228, DOI 10.1016/0003-2697(77)90531-0; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; WILSON DS, 2000, CURRENT PROTOCOLS S, V51; Xu LH, 2002, CHEM BIOL, V9, P933, DOI 10.1016/S1074-5521(02)00187-4; Xu Y, 2004, BIOORGAN MED CHEM, V12, P5247, DOI 10.1016/j.bmc.2004.03.077	37	156	166	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					828	U13		10.1038/nature06032	http://dx.doi.org/10.1038/nature06032			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17700701	Green Accepted			2022-12-01	WOS:000248754200045
J	Chuang, JZ; Zhao, Y; Sung, CH				Chuang, Jen-Zen; Zhao, Yu; Sung, Ching-Hwa			SARA-regulated vesicular targeting underlies formation of the Light-Sensing organelle in mammalian rods	CELL			English	Article							FYVE DOMAIN PROTEIN; PHOTORECEPTOR OUTER SEGMENT; RAB5 EFFECTOR EEA1; RETINITIS-PIGMENTOSA; RETINAL DEGENERATION; RHODOPSIN GENE; SYNTAXIN 7; LOCALIZATION; MEMBRANE; CELLS	The light-sensing organelle of the vertebrate rod photoreceptor, the outer segment (OS), is a modified cilium containing similar to 1,000 stacked disc membranes that are densely packed with visual pigment rhodopsin. The mammalian OS is renewed every ten days; new discs are assembled at the base of the OS by a poorly understood mechanism. Our results suggest that discs are formed and matured in a process that involves specific phospholipid-directed vesicular membrane targeting. Rhodopsin-laden vesicles in the OS axonemal cytoplasm fuse with nascent discs that are highly specialized with abundant phosphatidylinositol 3-phosphate (PI3P). This membrane coupling is regulated by the FYVE domain-containing protein, SARA, through its direct interaction with PI3P, rhodopsin, and SNARE protein syntaxin 3. Our model, in contrast to the previously proposed evagination model, suggests that the vesicular delivery of rhodopsin in the OS concentrates rhodopsin into discs, and this process directly participates in disc biogenesis.	Cornell Univ, Weill Med Coll, Dept Ophthalmol, Margaret M Dyson Res Inst, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, New York, NY 10021 USA	Cornell University; Cornell University	Chuang, JZ (corresponding author), Cornell Univ, Weill Med Coll, Dept Ophthalmol, Margaret M Dyson Res Inst, 1300 York Ave, New York, NY 10021 USA.	jzchuang@med.cornell.edu; chsung@med.cornell.edu			NATIONAL EYE INSTITUTE [R01EY011307, R01EY016805] Funding Source: NIH RePORTER; NEI NIH HHS [EY11307, R01 EY011307, R01 EY016805] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BLANKS JC, 1982, J COMP NEUROL, V212, P231, DOI 10.1002/cne.902120303; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Chuang JZ, 2004, J CLIN INVEST, V114, P131, DOI 10.1172/JCI200421136; COOK NJ, 1989, J BIOL CHEM, V264, P6996; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; Foster FM, 2003, J CELL SCI, V116, P3037, DOI 10.1242/jcs.00609; Gaisano HY, 1996, MOL BIOL CELL, V7, P2019, DOI 10.1091/mbc.7.12.2019; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hagstrom SA, 1999, INVEST OPHTH VIS SCI, V40, P2795; Hong DH, 2000, P NATL ACAD SCI USA, V97, P3649, DOI 10.1073/pnas.060037497; Hu Y, 2002, J CELL SCI, V115, P4755, DOI 10.1242/jcs.00177; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; Jayaraman L, 2000, J BIOL CHEM, V275, P40710, DOI 10.1074/jbc.M005799200; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; LI TS, 1995, P NATL ACAD SCI USA, V92, P3551, DOI 10.1073/pnas.92.8.3551; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; Li ZY, 1998, INVEST OPHTH VIS SCI, V39, P808; Low SH, 1996, MOL BIOL CELL, V7, P2007, DOI 10.1091/mbc.7.12.2007; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; MATSUMOTO B, 1985, INVEST OPHTH VIS SCI, V26, P628; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Mendez A, 2003, J NEUROSCI, V23, P3124; MIYAGUCHI K, 1992, J NEUROCYTOL, V21, P449, DOI 10.1007/BF01191508; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; OBATA S, 1992, CELL TISSUE RES, V269, P39, DOI 10.1007/BF00384724; Peng XR, 1997, MOL BIOL CELL, V8, P399, DOI 10.1091/mbc.8.3.399; Peterson JJ, 2003, EXP EYE RES, V76, P553, DOI 10.1016/S0014-4835(03)00032-0; Prekeris R, 1999, MOL BIOL CELL, V10, P3891, DOI 10.1091/mbc.10.11.3891; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Seet LF, 2001, J BIOL CHEM, V276, P42445, DOI 10.1074/jbc.M105917200; Sharma N, 2006, J CELL BIOL, V173, P937, DOI 10.1083/jcb.200603132; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; Stenmark H, 1999, J CELL SCI, V112, P4175; SUNG CH, 1994, J NEUROSCI, V14, P5818; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216; WILLIAMS DS, 1988, J COMP NEUROL, V272, P161, DOI 10.1002/cne.902720202; Wong SH, 1998, J BIOL CHEM, V273, P375, DOI 10.1074/jbc.273.1.375; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61	46	113	113	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2007	130	3					535	547		10.1016/j.cell.2007.06.030	http://dx.doi.org/10.1016/j.cell.2007.06.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693260	Green Accepted, Bronze			2022-12-01	WOS:000249038100020
J	Dyer, LA; Singer, MS; Lill, JT; Stireman, JO; Gentry, GL; Marquis, RJ; Ricklefs, RE; Greeney, HF; Wagner, DL; Morais, HC; Diniz, IR; Kursar, TA; Coley, PD				Dyer, L. A.; Singer, M. S.; Lill, J. T.; Stireman, J. O.; Gentry, G. L.; Marquis, R. J.; Ricklefs, R. E.; Greeney, H. F.; Wagner, D. L.; Morais, H. C.; Diniz, I. R.; Kursar, T. A.; Coley, P. D.			Host specificity of Lepidoptera in tropical and temperate forests	NATURE			English	Article							DIVERSITY; PLANT; DEFENSES; INSECTS	For numerous taxa, species richness is much higher in tropical than in temperate zone habitats(1). A major challenge in community ecology and evolutionary biogeography is to reveal the mechanisms underlying these differences. For herbivorous insects, one such mechanism leading to an increased number of species in a given locale could be increased ecological specialization, resulting in a greater proportion of insect species occupying narrow niches within a community. We tested this hypothesis by comparing host specialization in larval Lepidoptera (moths and butterflies) at eight different New World forest sites ranging in latitude from 15 degrees S to 55 degrees N. Here we show that larval diets of tropical Lepidoptera are more specialized than those of their temperate forest counterparts: tropical species on average feed on fewer plant species, genera and families than do temperate caterpillars. This result holds true whether calculated per lepidopteran family or for a caterpillar assemblage as a whole. As a result, there is greater turnover in caterpillar species composition (greater beta diversity) between tree species in tropical faunas than in temperate faunas. We suggest that greater specialization in tropical faunas is the result of differences in trophic interactions; for example, there are more distinct plant secondary chemical profiles from one tree species to the next in tropical forests than in temperate forests as well as more diverse and chronic pressures from natural enemy communities.	Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA; George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA; Univ Missouri, Dept Biol, St Louis, MO 63121 USA; Yanayacu Biol Stn, Quito, Ecuador; Ctr Creat Studies, Quito, Ecuador	Tulane University; Wesleyan University; George Washington University; University System of Ohio; Wright State University Dayton; University of Missouri System; University of Missouri Saint Louis; Yanayacu Biological Station	Dyer, LA (corresponding author), Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA.	ldyer@tulane.edu	Lill, John/A-7935-2009; Diniz, Ivone/J-1804-2012; TATSUTA, HARUKI/F-2997-2010	Diniz, Ivone/0000-0002-4252-8810; Stireman, John/0000-0001-8792-3980				Armbruster WS, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P260; Chase J.M., 2003, ECOLOGICAL NICHES LI; Coley PD, 2006, OIKOS, V115, P219, DOI 10.1111/j.2006.0030-1299.14928.x; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Darwin C., 1859, ORIGIN SPECIES MEANS; Diniz IR, 1997, BIODIVERS CONSERV, V6, P817, DOI 10.1023/B:BIOC.0000010404.17467.6c; Dyer Lee A., 2002, P67, DOI 10.1017/CBO9780511542190.004; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Gentry GL, 2002, ECOLOGY, V83, P3108, DOI 10.1890/0012-9658(2002)083[3108:OTCNON]2.0.CO;2; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hawkins BA, 2003, AM NAT, V161, P40, DOI 10.1086/345479; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Irschick D, 2005, OIKOS, V110, P404, DOI 10.1111/j.0030-1299.2005.13927.x; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; Kiflawi M, 2004, ECOLOGY, V85, P2895, DOI 10.1890/03-3058; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Marquis Robert J., 1994, P261; MCGUGAN BM, 1958, FOREST LEPIDOPTERA C, V1; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Odegaard F, 2005, ECOL LETT, V8, P612, DOI 10.1111/j.1461-0248.2005.00758.x; Price Peter W., 2002, P3; SCHULTER D, 2000, ECOLOGY ADAPTIVE RAD; Stireman JO, 2005, P NATL ACAD SCI USA, V102, P17384, DOI 10.1073/pnas.0508839102; Stireman JO, 2003, ECOLOGY, V84, P296, DOI 10.1890/0012-9658(2003)084[0296:DOPHAI]2.0.CO;2; THOMAS CD, 1990, NATURE, V347, P237, DOI 10.1038/347237a0; Thompson J.N., 2005, INTERSPEC INTERACT; Tilman D., 1982, Monographs in Population Biology, pi; Wallace AR, 1878, TROPICAL NATURE OTHE; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563; Wilf P, 2006, SCIENCE, V313, P1112, DOI 10.1126/science.1129569	35	353	365	2	210	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 9	2007	448	7154					696	U9		10.1038/nature05884	http://dx.doi.org/10.1038/nature05884			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687325				2022-12-01	WOS:000248598000045
J	Brown, RL				Brown, Rachel L.			Epilepsy onscreen: getting it wrong	LANCET			English	Editorial Material									Univ Oxford Somerville Coll, Oxford OX2 6HD, England	University of Oxford	Brown, RL (corresponding author), Univ Oxford Somerville Coll, Oxford OX2 6HD, England.	r.l.brown@some.oxon.org						BAXENDALE S, 2007, EPILEPSY BEHAV  0628; *JOHN AMB, 2007, IFIRSTAID 1 AID ADV	2	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 4	2007	370	9585					371	371		10.1016/S0140-6736(07)61174-X	http://dx.doi.org/10.1016/S0140-6736(07)61174-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197XL	17679001				2022-12-01	WOS:000248590200009
J	Escobar-Restrepo, JM; Huck, N; Kessler, S; Gagliardini, V; Gheyselinck, J; Yang, WC; Grossniklaus, U				Escobar-Restrepo, Juan-Miguel; Huck, Norbert; Kessler, Sharon; Gagliardini, Valeria; Gheyselinck, Jacqueline; Yang, Wei-Cai; Grossniklaus, Ueli			The FERONIA receptor-like kinase mediates male-female interactions during pollen tube reception	SCIENCE			English	Article							SELF-INCOMPATIBILITY; INTERSPECIFIC POLLINATIONS; ARABIDOPSIS-THALIANA; MALE DETERMINANT; GENE FAMILY; GUIDANCE; FERTILIZATION; BRASSICACEAE; PROTEINS; STIGMA	In flowering plants, signaling between the male pollen tube and the synergid cells of the female gametophyte is required for fertilization. In the Arabidopsis thaliana mutant feronia ( fer), fertilization is impaired; the pollen tube fails to arrest and thus continues to grow inside the female gametophyte. FER encodes a synergid-expressed, plasma membrane-localized receptor-like kinase. We found that the FER protein accumulates asymmetrically in the synergid membrane at the filiform apparatus. Interspecific crosses using pollen from Arabidopsis lyrata and Cardamine flexuosa on A. thaliana stigmas resulted in a fer-like phenotype that correlates with sequence divergence in the extracellular domain of FER. Our findings show that the female control of pollen tube reception is based on a FER-dependent signaling pathway, which may play a role in reproductive isolation barriers.	Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; Chinese Acad Sci, Key Lab Mol & Dev Biol, Inst Genet & Dev Biol, Beijing 100101, Peoples R China	University of Zurich; University of Zurich; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Grossniklaus, U (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	grossnik@botinst.uzh.ch	Kessler, Sharon A/T-4784-2017; Yang, Wei-Cai/AAX-7879-2021; Grossniklaus, Ueli/E-9995-2016; Grossniklaus, Ueli/A-2736-2012	Kessler, Sharon A/0000-0002-7964-0451; Yang, Wei-Cai/0000-0003-0252-7079; Grossniklaus, Ueli/0000-0002-0522-8974; Gagliardini, Valeria/0000-0001-9471-0764				Grossniklaus U, 1998, SEMIN CELL DEV BIOL, V9, P227, DOI 10.1006/scdb.1997.0214; Higashiyama T, 2001, SCIENCE, V293, P1480, DOI 10.1126/science.1062429; HISCOCK SJ, 1993, THEOR APPL GENET, V86, P744, DOI 10.1007/BF00222665; HUANG BQ, 1992, INT REV CYTOL, V140, P233, DOI 10.1016/S0074-7696(08)61099-2; Huck N, 2003, DEVELOPMENT, V130, P2149, DOI 10.1242/dev.00458; HULSKAMP M, 1995, PLANT CELL, V7, P57, DOI 10.1105/tpc.7.1.57; HULSKAMP M, 1995, PLANT J, V8, P703, DOI 10.1046/j.1365-313X.1995.08050703.x; Kachroo A, 2002, PLANT CELL, V14, pS227, DOI 10.1105/tpc.010440; KANDASAMY MK, 1994, DEVELOPMENT, V120, P3405; KAPIL RN, 1975, PHYTOMORPHOLOGY, V25, P334; KAUL V, 1986, CAN J BOT, V64, P282, DOI 10.1139/b86-042; Kim S, 2003, P NATL ACAD SCI USA, V100, P16125, DOI 10.1073/pnas.2533800100; Marton ML, 2005, SCIENCE, V307, P573, DOI 10.1126/science.1104954; Mishima M, 2003, J BIOL CHEM, V278, P36389, DOI 10.1074/jbc.M305305200; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Primakoff P, 2002, SCIENCE, V296, P2183, DOI 10.1126/science.1072029; Ray S, 1997, DEVELOPMENT, V124, P2489; Rotman N, 2003, CURR BIOL, V13, P432, DOI 10.1016/S0960-9822(03)00093-9; RUSSELL SD, 1992, INT REV CYTOL, V140, P357, DOI 10.1016/S0074-7696(08)61102-X; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Shimizu KK, 2000, DEVELOPMENT, V127, P4511; Shimizu KK, 2002, POPUL ECOL, V44, P221, DOI 10.1007/s101440200025; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tang WH, 2004, PLANT J, V39, P343, DOI 10.1111/j.1365-313X.2004.02139.x; von Besser K, 2006, DEVELOPMENT, V133, P4761, DOI 10.1242/dev.02683; WILLIAMS EG, 1986, AUST J BOT, V34, P413, DOI 10.1071/BT9860413	30	460	479	1	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					656	660		10.1126/science.1143562	http://dx.doi.org/10.1126/science.1143562			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17673660				2022-12-01	WOS:000248494400044
J	Mellman, I				Mellman, Ira			Perspectives - Private lives: Reflections and challenges in understanding the cell biology of the immune system	SCIENCE			English	Editorial Material							MHC CLASS-I; DENDRITIC CELLS; LYSOSOMAL COMPARTMENTS; ENDOCYTIC COMPARTMENTS; ANTIGEN PRESENTATION; T-CELLS; MOLECULES; COMPLEX; TRANSPORT; VIVO	The immune system comprises a variety of cell types whose activities must be carefully regulated to act as a coherent unit for the purpose of host defense. To perform their autonomous functions, immune cells must rely on the same basic organizational features that apply to all cells, although immune cells often exhibit remarkable degrees of specialization and adaptation. The study of these specializations has lagged behind advances in understanding the immune response and cell biology individually. As a result, there are great opportunities, but also great challenges, for new conceptual discoveries by taking a more cell-biological approach to probing the function of the immune system.	Genentech Inc, Dept Res Oncol, San Francisco, CA 94080 USA; Yale Univ, Sch Med, Dept Cell Biol, Ludwig Inst Canc Res, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Immunobiol, Ludwig Inst Canc Res, New Haven, CT 06520 USA	Roche Holding; Genentech; Ludwig Institute for Cancer Research; Yale University; Ludwig Institute for Cancer Research; Yale University	Mellman, I (corresponding author), Genentech Inc, Dept Res Oncol, 1 DNA Way,Mail Stop 212, San Francisco, CA 94080 USA.	mellman.ira@gene.com	Mellman, Ira/ABG-5896-2020					Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; Huang AYC, 1996, IMMUNITY, V4, P349, DOI 10.1016/S1074-7613(00)80248-4; Kleijmeer MJ, 1997, J CELL BIOL, V139, P639, DOI 10.1083/jcb.139.3.639; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lord JM, 1998, J CELL BIOL, V140, P733; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; Pierre P, 1996, IMMUNITY, V4, P229, DOI 10.1016/S1074-7613(00)80431-8; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Stinchcombe J, 2004, SCIENCE, V305, P55, DOI 10.1126/science.1095291; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; TOWNSEND ARM, 1984, J EXP MED, V160, P552, DOI 10.1084/jem.160.2.552; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411	27	7	7	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					625	627		10.1126/science.1142955	http://dx.doi.org/10.1126/science.1142955			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	196PL	17673653				2022-12-01	WOS:000248494400034
J	Marijon, E; Ou, P; Celermajer, DS; Ferreira, B; Mocumbi, AO; Jani, D; Paquet, C; Jacob, S; Sidi, D; Jouven, X				Marijon, Eloi; Ou, Phalla; Celermajer, David S.; Ferreira, Beatriz; Mocumbi, Ana Olga; Jani, Dinesh; Paquet, Christophe; Jacob, Sophie; Sidi, Daniel; Jouven, Xavier			Prevalence of rheumatic heart disease detected by echocardiographic screening	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERM-FOLLOW-UP; FEVER; DIAGNOSIS; CARDITIS; CHILDREN	Background: Epidemiologic studies of the prevalence of rheumatic heart disease have used clinical screening with echocardiographic confirmation of suspected cases. We hypothesized that echocardiographic screening of all surveyed children would show a significantly higher prevalence of rheumatic heart disease. Methods: Randomly selected schoolchildren from 6 through 17 years of age in Cambodia and Mozambique were screened for rheumatic heart disease according to standard clinical and echocardiographic criteria. Results: Clinical examination detected rheumatic heart disease that was confirmed by echocardiography in 8 of 3677 children in Cambodia and 5 of 2170 children in Mozambique; the corresponding prevalence rates and 95% confidence intervals (CIs) were 2.2 cases per 1000 (95% CI, 0.7 to 3.7) for Cambodia and 2.3 cases per 1000 (95% CI, 0.3 to 4.3) for Mozambique. In contrast, echocardiographic screening detected 79 cases of rheumatic heart disease in Cambodia and 66 cases in Mozambique, corresponding to prevalence rates of 21.5 cases per 1000 (95% CI, 16.8 to 26.2) and 30.4 cases per 1000 (95% CI, 23.2 to 37.6), respectively. The mitral valve was involved in the great majority of cases (87.3% in Cambodia and 98.4% in Mozambique). Conclusions: Systematic screening with echocardiography, as compared with clinical screening, reveals a much higher prevalence of rheumatic heart disease (approximately 10 times as great). Since rheumatic heart disease frequently has devastating clinical consequences and secondary prevention may be effective after accurate identification of early cases, these results have important public health implications. N Engl J Med 2007;357:470-6.	Hop Necker Enfants Malad, Dept Pediat Cardiol, Paris, France; Hop Necker Enfants Malad, Dept Pediat Radiol, Paris, France; Maputo Heart Inst, Maputo, Mozambique; Phnom Penh Heart Ctr, Phnom Penh, Cambodia; Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; Natl Inst Publ Hlth Surveillance, St Maurice, France; INSERM, Unite Avenir 780, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Sydney; Institute of Public Health Surveillance; Institut National de la Sante et de la Recherche Medicale (Inserm)	Marijon, E (corresponding author), Univ Paris 05, Georges Pompidou Europeen Hosp, Serv Cardiol 2, 20 Rue Leblanc, F-75908 Paris 15, France.	eloi_marijon@yahoo.fr		Mocumbi, Ana/0000-0002-9564-2860; Jacob, Sophie/0000-0003-1729-305X				Anabwani GM, 1996, E AFR MED J, V73, P215; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Carapetis JR, 2000, EPIDEMIOL INFECT, V124, P239, DOI 10.1017/S0950268800003514; DAJANI AS, 1992, JAMA-J AM MED ASSOC, V268, P2069, DOI 10.1001/jama.1992.03490150121036; Figueroa FE, 2001, HEART, V85, P407, DOI 10.1136/heart.85.4.407; McDonald M, 2005, HEART, V91, P1131, DOI 10.1136/hrt.2004.057570; Meira ZMA, 2005, HEART, V91, P1019, DOI 10.1136/hrt.2004.042762; Minich LD, 1997, CLIN CARDIOL, V20, P924, DOI 10.1002/clc.4960201105; Narula J, 2001, LANCET, V358, P2000, DOI 10.1016/S0140-6736(01)06993-8; *SPEC WRIT GROUP C, 1993, JAMA-J AM MED ASSOC, V269, P476; Vasan RS, 1996, CIRCULATION, V94, P73, DOI 10.1161/01.CIR.94.1.73; Veasy LG, 2001, LANCET, V357, P1994, DOI 10.1016/S0140-6736(00)05134-5; WHO Expert Consultation Report, 2001, RHEUM FEV RHEUM HEAR; WILSON NJ, 1995, INT J CARDIOL, V50, P1, DOI 10.1016/0167-5273(95)02325-Q	15	478	491	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2007	357	5					470	476		10.1056/NEJMoa065085	http://dx.doi.org/10.1056/NEJMoa065085			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195UB	17671255				2022-12-01	WOS:000248436300008
J	Tomari, Y; Du, T; Zamore, PD				Tomari, Yukihide; Du, Tingting; Zamore, Phillip D.			Sorting of Drosophila small silencing RNAs	CELL			English	Article							ENZYME COMPLEX; MICRORNA TARGETS; PASSENGER-STRAND; DISTINCT ROLES; INTERFERENCE; SIRNA; MELANOGASTER; CLEAVAGE; DICER-2; GENES	In Drosophila, small interfering RNAs (siRNAs), which direct RNA interference through the Argonaute protein Ago2, are produced by a biogenesis pathway distinct from microRNAs (miRNAs), which regulate endogenous mRNA expression as guides for Ago1. Here, we report that siRNAs and miRNAs are sorted into Ago1 and Ago2 by pathways independent from the processes that produce these two classes of small RNAs. Such small-RNA sorting reflects the structure of the double-stranded assembly intermediates-the miRNA/miRNA* and siRNA duplexes-from which Argonaute proteins are loaded. We find that the Dcr-2/R2D2 heterodimer acts as a gatekeeper for the assembly of Ago2 complexes, promoting the incorporation of siRNAs and disfavoring miRNAs as loading substrates for Drosophila Ago2. A separate mechanism acts in parallel to favor miRNA/miRNA* duplexes and exclude siRNAs from assembly into Ago1 complexes. Thus, in flies small-RNA duplexes are actively sorted into Argonaute-containing complexes according to their intrinsic structures.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; PRESTO, Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	University of Massachusetts System; University of Massachusetts Worcester; University of Tokyo; Japan Science & Technology Agency (JST)	Tomari, Y (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	tomari@iam.u-tokyo.ac.jp; phillip.zamore@umassmed.edu	Zamore, Phillip D/A-8941-2013; Tomari, Yukihide/A-8009-2009	Tomari, Yukihide/0000-0001-8442-0851; Zamore, Phillip/0000-0002-4505-9618	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM062862, R01 GM065236-08, GM65236, R01 GM062862, R01 GM062862-09, R01 GM065236, GM62862] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062862, R37GM062862, R01GM065236] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Haley B, 2003, METHODS, V30, P330, DOI 10.1016/S1046-2023(03)00052-5; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim JH, 2006, MOL CELL TOXICOL, V2, P29; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Pham JW, 2005, J BIOL CHEM, V280, P39278, DOI 10.1074/jbc.M509202200; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x	47	288	298	4	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2007	130	2					299	308		10.1016/j.cell.2007.05.057	http://dx.doi.org/10.1016/j.cell.2007.05.057			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662944	Green Accepted, Bronze			2022-12-01	WOS:000248588000019
J	Ploegh, HL				Ploegh, Hidde L.			A lipid-based model for the creation of an escape hatch from the endoplasmic reticulum	NATURE			English	Article							I MEMBRANE-PROTEIN; CROSS-PRESENTATION; RETRO-TRANSLOCATION; DROPLETS; DEGRADATION; DISLOCATION; MECHANISMS; PROTEASOME; TRANSPORT; INITIATE	Lipids are not encoded by a DNA template and therefore cannot be mutated, knocked out or knocked down. This by no means renders them impotent from a cell biological perspective. Here I propose a model for the involvement of lipid rearrangements in the execution of crucial steps in ( glyco) protein quality control.	MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Ploegh, HL (corresponding author), MIT, Whitehead Inst Biomed Res, Dept Biol, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu						Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Daniels R, 2004, CELL BIOCHEM BIOPHYS, V41, P113, DOI 10.1385/CBB:41:1:113; De Jong AS, 2006, J BIOL CHEM, V281, P14144, DOI 10.1074/jbc.M511766200; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fiebiger E, 2002, EMBO J, V21, P1041, DOI 10.1093/emboj/21.5.1041; Fujimoto T, 2006, AUTOPHAGY, V2, P299, DOI 10.4161/auto.2904; Furman MH, 2003, J BIOL CHEM, V278, P34804, DOI 10.1074/jbc.M300913200; Gilbert J, 2006, J VIROL, V80, P10868, DOI 10.1128/JVI.01117-06; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; Imai J, 2005, INT IMMUNOL, V17, P45, DOI 10.1093/intimm/dxh184; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; McManaman JL, 2003, J LIPID RES, V44, P668, DOI 10.1194/jlr.C200021-JLR200; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Ostermeyer AG, 2001, J CELL BIOL, V152, P1071, DOI 10.1083/jcb.152.5.1071; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; RUDD PM, 1995, BBA-PROTEIN STRUCT M, V1248, P1, DOI 10.1016/0167-4838(94)00230-E; Schekman R, 2004, NATURE, V429, P817, DOI 10.1038/429817a; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Tirosh B, 2003, J BIOL CHEM, V278, P6664, DOI 10.1074/jbc.M210158200; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; van Meer G, 2004, CURR OPIN CELL BIOL, V16, P373, DOI 10.1016/j.ceb.2004.06.004; vanKuppeveld FJM, 1997, EMBO J, V16, P3519, DOI 10.1093/emboj/16.12.3519; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	45	217	221	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					435	438		10.1038/nature06004	http://dx.doi.org/10.1038/nature06004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653186				2022-12-01	WOS:000248302700039
J	[Anonymous]				[Anonymous]			Nuclear test	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					387	387		10.1038/448387a	http://dx.doi.org/10.1038/448387a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653146	Bronze			2022-12-01	WOS:000248302700001
J	Binshtok, AM; Bean, BP; Woolf, CJ				Binshtok, Alexander M.; Bean, Bruce P.; Woolf, Clifford J.			Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers	NATURE			English	Article							LOCAL-ANESTHETICS; RECEPTOR; TETRODOTOXIN; CAPSAICIN; LIDOCAINE; CURRENTS; NEURONS; ACCESS; SITE; RATS	Most local anaesthetics used clinically are relatively hydrophobic molecules that gain access to their blocking site on the sodium channel by diffusing into or through the cell membrane(1). These anaesthetics block sodium channels and thereby the excitability of all neurons, not just sensory neurons. We tested the possibility of selectively blocking the excitability of primary sensory nociceptor (pain-sensing) neurons by introducing the charged, membrane-impermeant lidocaine derivative QX-314 through the pore of the noxious-heat-sensitive TRPV1 channel. Here we show that charged sodium-channel blockers can be targeted into nociceptors by the application of TRPV1 agonists to produce a pain-specific local anaesthesia. QX-314 applied externally had no effect on the activity of sodium channels in small sensory neurons when applied alone, but when applied in the presence of the TRPV1 agonist capsaicin, QX-314 blocked sodium channels and inhibited excitability. Inhibition by co-applied QX-314 and capsaicin was restricted to neurons expressing TRPV1. Injection of QX-314 together with capsaicin into rat hindpaws produced a long-lasting (more than 2 h) increase in mechanical and thermal nociceptive thresholds. Long-lasting decreases in pain sensitivity were also seen with regional injection of QX-314 and capsaicin near the sciatic nerve; however, in contrast to the effect of lidocaine, the application of QX-314 and capsaicin together was not accompanied by motor or tactile deficits.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University	Bean, BP (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	bruce_bean@hms.harvard.edu	Woolf, Clifford/A-9784-2010	Binshtok, Alexander/0000-0002-3620-8116				Amaya F, 2006, J NEUROSCI, V26, P12852, DOI 10.1523/JNEUROSCI.4015-06.2006; CAHALAN MD, 1979, BIOPHYS J, V27, P39, DOI 10.1016/S0006-3495(79)85201-7; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; FRAZIER DT, 1970, J PHARMACOL EXP THER, V171, P45; Hara K, 2004, ANESTH ANALG, V98, P1380, DOI 10.1213/01.AE.00001079935.84035.48; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hellwig N, 2004, J BIOL CHEM, V279, P34553, DOI 10.1074/jbc.M402966200; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; Liu L, 2001, J NEUROPHYSIOL, V85, P745, DOI 10.1152/jn.2001.85.2.745; Meyers JR, 2003, J NEUROSCI, V23, P4054; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; QU YS, 1995, P NATL ACAD SCI USA, V92, P11839, DOI 10.1073/pnas.92.25.11839; Sluka KA, 1997, PAIN, V71, P165, DOI 10.1016/S0304-3959(97)03371-X; STRICHARTZ GR, 1973, J GEN PHYSIOL, V62, P37, DOI 10.1085/jgp.62.1.37; Sunami A, 2000, P NATL ACAD SCI USA, V97, P2326, DOI 10.1073/pnas.030438797; YEH JZ, 1978, BIOPHYS J, V24, P569, DOI 10.1016/S0006-3495(78)85403-4	16	315	339	5	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2007	449	7162					607	U13		10.1038/nature06191	http://dx.doi.org/10.1038/nature06191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17914397				2022-12-01	WOS:000249893500047
J	Rosen, CJ				Rosen, Clifford J.			The rosiglitazone story - Lessons from an FDA advisory committee meeting	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Joseph Hosp, Maine Ctr Osteoporosis, Bangor, ME 04401 USA; Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Rosen, CJ (corresponding author), St Joseph Hosp, Maine Ctr Osteoporosis, Bangor, ME 04401 USA.							Gerrits CM, 2007, PHARMACOEPIDEM DR S, V16, P1065, DOI 10.1002/pds.1470; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Kahn SE, 2007, NEW ENGL J MED, V356, P1387; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Richter B, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006063	7	157	158	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2007	357	9					844	846		10.1056/NEJMp078167	http://dx.doi.org/10.1056/NEJMp078167			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204TA	17687124				2022-12-01	WOS:000249065700002
J	Cyna, AM; Dodd, J				Cyna, Allan M.; Dodd, Jodie			Clinical update: obstetric anaesthesila	LANCET			English	Article							CONSENT; ANESTHESIA		Womens & Childrens Hosp, Dept Womens Anaesthesia, Adelaide, SA 5006, Australia; Univ Adelaide, Discipline Obstet & Gynaecol, Adelaide, SA, Australia	Womens & Childrens Hospital Australia; University of Adelaide	Cyna, AM (corresponding author), Womens & Childrens Hosp, Dept Womens Anaesthesia, Adelaide, SA 5006, Australia.	allan.cyna@cywhs.sa.gov.au	Cyna, Allan/AAN-5201-2021; Dodd, Jodie/Y-6849-2019	Dodd, Jodie/0000-0002-6363-4874; Cyna, Allan/0000-0002-3138-1091				[Anonymous], 2007, ANESTHESIOLOGY, V106, P843; *AUSTR NZ COLL AN, 2005, AC PAIN MAN SCI EV; Bolton TJ, 2003, ANAESTHESIA, V58, P277, DOI 10.1046/j.1365-2044.2003.30435.x; Chan A.S.J., 2006, PREGNANCY OUTCOME S; Clergue F, 1999, ANESTHESIOLOGY, V91, P1509, DOI 10.1097/00000542-199911000-00045; Clyburn PA, 2004, ANAESTHESIA, V59, P1157, DOI 10.1111/j.1365-2044.2004.04060.x; *COCHR COLL, 2007, COCHRANE LIB; Cyna AM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002251.pub2; Douglas MJ, 2005, EVIDENCE-BASED OBSTETRIC ANESTHESIA, P165; Hepner DL, 2006, ANESTHESIOLOGY, V105, P241, DOI 10.1097/00000542-200608000-00005; Jackson A, 2000, CAN J ANAESTH, V47, P1068, DOI 10.1007/BF03027957; Kelly GD, 2004, INT J OBSTET ANESTH, V13, P71, DOI 10.1016/j.ijoa.2003.08.002; Lewis G., 2004, WHY MOTHERS DIE 2000; Murray D, 2007, ANESTHESIOLOGY, V106, P895, DOI 10.1097/01.anes.0000265145.40825.ac; Ng KW, 2004, COCHRANE DB SYST REV, V2; Paech M, 2006, ANAESTH INTENS CARE, V34, P147, DOI 10.1177/0310057X0603400224; Saravanakumar K, 2006, ANAESTHESIA, V61, P36, DOI 10.1111/j.1365-2044.2005.04433.x; Simmons SW, 2007, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003401.PUB2; Turnbull DK, 2003, BRIT J ANAESTH, V91, P718, DOI 10.1093/bja/aeg231; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089	20	18	19	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 25	2007	370	9588					640	642		10.1016/S0140-6736(07)61320-8	http://dx.doi.org/10.1016/S0140-6736(07)61320-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205RD	17720001				2022-12-01	WOS:000249131400010
J	Shema, R; Sacktor, TC; Dudai, Y				Shema, Reut; Sacktor, Todd Charlton; Dudai, Yadin			Rapid erasure of long-term memory associations in the cortex by an inhibitor of PKM zeta	SCIENCE			English	Article							CONDITIONED TASTE-AVERSION; RAT INSULAR CORTEX; KINASE M-ZETA; GUSTATORY CORTEX; BEHAVING RAT; RECONSOLIDATION; CONSOLIDATION; NEUROBIOLOGY; MAINTENANCE; ACTIVATION	Little is known about the neuronal mechanisms that subserve long-term memory persistence in the brain. The components of the remodeled synaptic machinery, and how they sustain the new synaptic or cellwide configuration over time, are yet to be elucidated. In the rat cortex, long-term associative memories vanished rapidly after local application of an inhibitor of the protein kinase C isoform, protein kinase M zeta (PKM zeta). The effect was observed for at least several weeks after encoding and may be irreversible. In the neocortex, which is assumed to be the repository of multiple types of long-term memory, persistence of memory is thus dependent on ongoing activity of a protein kinase long after that memory is considered to have consolidated into a long-term stable form.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Physiol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Pharmacol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Neurol, Brooklyn, NY 11203 USA	Weizmann Institute of Science; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Dudai, Y (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	yadin.dudai@weizmann.ac.il			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH053576, R01MH057068] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH53576, MH57068] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bahar A, 2004, J NEUROPHYSIOL, V92, P3298, DOI 10.1152/jn.00198.2004; Balleine BW, 2000, J NEUROSCI, V20, P8954; BARTLETT EC, 1932, REMEMBERING STUDY EX; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Berman DE, 1998, J NEUROSCI, V18, P10037; Bermudez-Rattoni F, 2004, NAT REV NEUROSCI, V5, P209, DOI 10.1038/nrn1344; BURESOVA O, 1980, BEHAV BRAIN RES, V1, P299; BUXBAUM JD, 1989, J BIOL CHEM, V264, P9344; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; DUDAI Y, 2002, MEMORY A Z KEYWORDS; DUVILLARD XD, 1981, CHEM SENSES, V6, P143, DOI 10.1093/chemse/6.2.143; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Koh MT, 2003, BEHAV NEUROSCI, V117, P1416, DOI 10.1037/0735-7044.117.6.1416; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Miller P, 2005, PLOS BIOL, V3, P705, DOI 10.1371/journal.pbio.0030107; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2006, LEARN MEMORY, V13, P530, DOI 10.1101/lm.350906; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Roman C, 2006, BEHAV NEUROSCI, V120, P1257, DOI 10.1037/0735-7044.120.6.1257; Rosenblum K, 1997, J NEUROSCI, V17, P5129; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; Stone ME, 2005, LEARN MEMORY, V12, P579, DOI 10.1101/lm.32305; Tronson NC, 2006, NAT NEUROSCI, V9, P167, DOI 10.1038/nn1628; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; YAMAMOTO T, 1994, BEHAV BRAIN RES, V65, P123, DOI 10.1016/0166-4328(94)90097-3; Yefet K, 2006, EUR J NEUROSCI, V24, P1434, DOI 10.1111/j.1460-9568.2006.05009.x	30	282	296	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					951	953		10.1126/science.1144334	http://dx.doi.org/10.1126/science.1144334			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702943				2022-12-01	WOS:000248780200041
J	Ingelsson, E; Schaefer, EJ; Contois, JH; McNamara, JR; Sullivan, L; Keyes, MJ; Pencina, MJ; Schoonmaker, C; Wilson, PWF; D'Agostino, RB; Vasan, RS				Ingelsson, Erik; Schaefer, Ernst J.; Contois, John H.; McNamara, Judith R.; Sullivan, Lisa; Keyes, Michelle J.; Pencina, Michael J.; Schoonmaker, Christopher; Wilson, Peter W. F.; D'Agostino, Ralph B.; Vasan, Ramachandran S.			Clinical utility of different lipid measures for prediction of coronary heart disease in men and women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							APOLIPOPROTEIN-A-I; DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; REFERENCE INTERVALS; BETA-BLOCKERS; RISK-FACTORS; PLASMA; PREVENTION; PARAMETERS	Context Evidence is conflicting regarding the performance of apolipoproteins vs traditional lipids for predicting coronary heart disease (CHD) risk. Objectives To compare performance of different lipid measures for CHD prediction using discrimination and calibration characteristics and reclassification of risk categories; to assess incremental utility of apolipoproteins over traditional lipids for CHD prediction. Design, Setting, and Participants Population-based, prospective cohort from, Framingham, Massachusetts. We evaluated serum total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), non HDL-C, apolipoprotein (apo) A-I and apo B, and 3 lipid ratios ( total cholesterol: HDL-C, LDL-C: HDL-C, and apo B: apo A-I) in 3322 middle-aged white participants who attended the fourth offspring examination cycle (1987-1991) and were without cardiovascular disease. Fifty-three percent of the participants were women. Main Outcome Measure Incidence of first CHD event (recognized or unrecognized myocardial infarction, angina pectoris, coronary insufficiency, or coronary heart disease death). Results After a median follow-up of 15.0 years, 291 participants, 198 of whom were men, developed CHD. In multivariate models adjusting for nonlipid risk factors, the apo B: apo A-I ratio predicted CHD (hazard ratio [HR] per SD increment, 1.39; 95% confidence interval [CI], 1.23-1.58 in men and HR, 1.40; 95% CI, 1.16-1.67 in women), but risk ratios were similar for total cholesterol: HDL-C (HR, 1.39; 95% CI, 1.22-1.58 in men and HR, 1.39; 95% CI, 1.17-1.66 in women) and for LDL-C: HDL-C (HR, 1.35; 95% CI, 1.18-1.54 in men and HR, 1.36; 95% CI 1.14-1.63 in women). In both sexes, models using the apo B: apo A-I ratio demonstrated performance characteristics comparable with but not better than that for other lipid ratios. The apo B: apo A-I ratio did not predict CHD risk in a model containing all components of the Framingham risk score including total cholesterol: HDL-C (P = .12 in men; P = .58 in women). Conclusions In this large, population-based cohort, the overall performance of apo B: apo A-I ratio for prediction of CHD was comparable with that of traditional lipid ratios but did not offer incremental utility over total cholesterol: HDL-C. These data do not support measurement of apo B or apo A-I in clinical practice when total cholesterol and HDL-C measurements are available.	Boston Univ, Sch Med, Framingham Study, Framingham, MA USA; Tufts Univ, Lipid Metab Lab, Jean Mayer US Dept Agr, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; Boston Univ, Dept Biostat, Sch Publ Hlth, Cardiol Sect,Sch Med, Boston, MA 02215 USA; Boston Univ, Dept Math & Stat, Sch Publ Hlth, Cardiol Sect,Sch Med, Boston, MA 02215 USA; Boston Univ, Dept Prevent Med, Sch Publ Hlth, Cardiol Sect,Sch Med, Boston, MA 02215 USA; Emory Univ, Sch Med, Div Cardiol, Dept Med, Atlanta, GA 30322 USA	Boston University; Tufts University; United States Department of Agriculture (USDA); Boston University; Boston University; Boston University; Emory University	Vasan, RS (corresponding author), Framingham Heart Dis Epidemiol Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.	vasan@bu.edu	应, 宁宁/G-9472-2011; Wilson, Peter W.F./J-2455-2016; Ramachandran, Vasan/Y-2527-2019	Ramachandran, Vasan/0000-0001-7357-5970; Sullivan, Lisa/0000-0003-0726-7149; Pencina, Michael/0000-0001-5798-8855	NHLBI NIH HHS [N01-HC-25195, 2K24HL04334] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALBERS JJ, 1978, CLIN CHEM, V24, P853; Barter PJ, 2006, J INTERN MED, V259, P247, DOI 10.1111/j.1365-2796.2006.01616.x; Benn M, 2007, ARTERIOSCL THROM VAS, V27, P661, DOI 10.1161/01.ATV.0000255580.73689.8e; BIELMANN P, 1982, INT J CLIN PHARM TH, V20, P259; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Contois JH, 1996, CLIN CHEM, V42, P515; Contois JH, 1996, CLIN CHEM, V42, P507; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; D'Agostino RB, 2004, HDB STAT, V23; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Denke MA, 2005, CIRCULATION, V112, P3368, DOI 10.1161/CIRCULATIONAHA.105.588178; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARVENGT C, 1987, J CLIN PHARMACOL, V27, P475, DOI 10.1002/j.1552-4604.1987.tb03052.x; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KANNEL WB, 1987, NIH PUBLICATION; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Liu J, 2006, AM J CARDIOL, V98, P1363, DOI 10.1016/j.amjcard.2006.06.032; MARCOVINA SM, 1994, CLIN CHEM, V40, P586; MCNAMARA JR, 1987, CLIN CHIM ACTA, V166, P1, DOI 10.1016/0009-8981(87)90188-4; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pischon T, 2005, CIRCULATION, V112, P3375, DOI 10.1161/CIRCULATIONAHA.104.532499; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Schweitzer M, 2002, ATHEROSCLEROSIS, V162, P201, DOI 10.1016/S0021-9150(01)00700-6; Shai I, 2004, CIRCULATION, V110, P2824, DOI 10.1161/01.CIR.0000146339.57154.9B; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Sniderman AD, 2005, CIRCULATION, V112, P3366, DOI 10.1161/CIRCULATIONAHA.105.583336; Sniderman AD, 2003, LANCET, V361, P777, DOI 10.1016/S0140-6736(03)12663-3; Talmud PJ, 2002, ARTERIOSCL THROM VAS, V22, P1918, DOI 10.1161/01.ATV.0000035521.22199.C7; van der Steeg WA, 2007, ANN INTERN MED, V146, P640, DOI 10.7326/0003-4819-146-9-200705010-00007; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	441	447	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2007	298	7					776	785		10.1001/jama.298.7.776	http://dx.doi.org/10.1001/jama.298.7.776			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	199XP	17699011	Bronze			2022-12-01	WOS:000248728800022
J	Potter, S; Govindarajulu, S; Shere, M; Braddon, F; Curran, G; Greenwood, R; Sahu, AK; Cawthorn, SJ				Potter, Shelley; Govindarajulu, Sasi; Shere, Mike; Braddon, Fiona; Curran, Geoffrey; Greenwood, Rosemary; Sahu, Ajay K.; Cawthorn, Simon J.			Referral patterns, cancer diagnoses, and waiting times after introduction of two week wait rule for breast cancer: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SUSPECTED CANCER; 2-WEEK WAIT; IMPACT	Objective To investigate the long term impact of the two week wait rule for breast cancer on referral patterns, cancer diagnoses, and waiting times. Design Prospective cohort study. Setting A specialist breast clinic in a teaching hospital in Bristol. Participants All patients referred to breast clinic from primary care between 1999 and 2005. Main outcome measures Number, route, and outcome of referrals from primary care and waiting times for urgent and routine appointments. Results The annual number of referrals increased by 9% over the seven years from 3499 in 1999 to 3821 in 2005. Routine referrals decreased by 24% (from 1748 to 1331), but two week wait referrals increased by 42% (from 1751 to 2490) during this time. The percentage of patients diagnosed with cancer in the two week wait group decreased from 12.8% (224/1751) in 1999 to 7.7% (191/2490) in 2005 (P<0.001), while the number of cancers detected in the "routine" group increased from 2.5% (43/1748) to 5.3% (70/1331) (P<0.001) over the same period. About 27% (70/261) of people with cancer are currently referred in the non-urgent group. Waiting times for routine referrals have increased with time. Conclusion The two week wait rule for breast cancer is failing patients. The number of cancers detected in the two week wait population is decreasing, and an unacceptable proportion is now being referred via the routine route. If breast cancer services are to be improved, the two week wait rule should be reviewed urgently.	Frenchay Hosp, Breast Care Ctr, Bristol BS16 1JE, Avon, England; Southmead Hosp, Bristol, Avon, England; United Bristol Healthcare Trust, Res & Dev Unit, Bristol, Avon, England	Southmead Hospital	Cawthorn, SJ (corresponding author), Frenchay Hosp, Breast Care Ctr, Bristol BS16 1JE, Avon, England.	Simon.Cawthorn@nbt.nhs.uk	Potter, Shelley/C-5924-2012	Potter, Shelley/0000-0002-6977-312X				Bray F, 2002, EUR J CANCER, V38, P99, DOI 10.1016/S0959-8049(01)00350-1; Cant PJ, 2000, BRIT J SURG, V87, P1082, DOI 10.1046/j.1365-2168.2000.01551.x; Coates AS, 1999, LANCET, V353, P1112, DOI 10.1016/S0140-6736(99)00082-3; Dodds W, 2004, EUR J CANCER CARE, V13, P82, DOI 10.1111/j.1365-2354.2004.00447.x; Fentiman IS, 2005, INT J CLIN PRACT, V59, P1251, DOI 10.1111/j.1368-5031.2005.00728d.x; Ganz Patricia A., 2000, Breast J, V6, P324, DOI 10.1046/j.1524-4741.2000.20042.x; GRIFFITHS C, 2006, EUR J SURG ONCOL, V32, P1042; Hanna SJ, 2005, INT J CLIN PRACT, V59, P1334, DOI 10.1111/j.1368-5031.2005.00687.x; *HCS, 1998, 1998242 HCS; Jones R, 2001, BRIT MED J, V322, P1555, DOI 10.1136/bmj.322.7302.1555; Khawaja AR, 2000, EUR J SURG ONCOL, V26, P536, DOI 10.1053/ejso.2000.0942; *NAT I CLIN EXC, 2005, NICE GUID REF SUSP C; PAICE A, 2006, EUR J SURG ONCOL, V32, pA1036; PAICE A, 2006, EUR J SURG ONC, V32, P1036; Patel RS, 2000, EUR J SURG ONCOL, V26, P452, DOI 10.1053/ejso.1999.0920; Sauven P, 2001, BRIT MED J, V323, P864; Sauven P, 2002, BREAST, V11, P262, DOI 10.1054/brst.2001.0390	17	74	75	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2007	335	7614					288	290A		10.1136/bmj.39258.688553.55	http://dx.doi.org/10.1136/bmj.39258.688553.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	203PV	17631514	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000248987400024
J	Donald, PF; Sanderson, FJ; Burfield, IJ; Bierman, SM; Gregory, RD; Waliczky, Z				Donald, Paul F.; Sanderson, Fiona J.; Burfield, Ian J.; Bierman, Stijn M.; Gregory, Richard D.; Waliczky, Zoltan			International conservation policy delivers benefits for birds in Europe	SCIENCE			English	Article							AGRICULTURAL INTENSIFICATION; BIODIVERSITY; POPULATION; STATE	Conservation of the planet's biodiversity will depend on international policy intervention, yet evidence-based assessment of the success of such intervention is lacking. Poor understanding of the effectiveness of international policy instruments exposes them to criticism or abandonment and reduces opportunities to improve them. Comparative analyses of population trends provide strong evidence for a positive impact of one such instrument, the European Union's Birds Directive, and we identify positive associations between the rate of provision of certain conservation measures through the directive and the response of bird populations. The results suggest that supranational conservation policy can bring measurable conservation benefits, although future assessments will require the setting of quantitative objectives and an increase in the availability of data from monitoring schemes.	Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; Birdlife Int, Cambridge CB3 0NA, England; Univ Edinburgh, Edinburgh EH9 3JZ, Midlothian, Scotland	Royal Society for Protection of Birds; BirdLife International; University of Edinburgh	Donald, PF (corresponding author), Royal Soc Protect Birds, Lodge, Sandy SG19 2DL, Beds, England.	paul.donald@rspb.org.uk	Bierman, Stijn M/F-8281-2010	Sanderson, Fiona/0000-0003-4726-4145; Gregory, Richard/0000-0002-7419-5053; Donald, Paul F./0000-0003-0023-6200				Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; Balmford A, 2003, TRENDS ECOL EVOL, V18, P326, DOI 10.1016/S0169-5347(03)00067-3; Balmford A, 2005, PHILOS T ROY SOC B, V360, P221, DOI 10.1098/rstb.2004.1599; Balmford A, 2005, ECOL LETT, V8, P1218, DOI 10.1111/j.1461-0248.2005.00814.x; *BIRDL INT EUR BIR, 2000, BIRDL CONS SER, V10; BirdLife International, 2004, BIRDS EUR POP EST TR, V12; Boere GC, 2002, CONSERV BIOL SER, V7, P246; Cahill AJ, 2006, ORYX, V40, P161, DOI 10.1017/S0030605306000366; Donald PF, 2006, AGR ECOSYST ENVIRON, V116, P189, DOI 10.1016/j.agee.2006.02.007; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Green RE, 2005, CONSERV BIOL, V19, P56, DOI 10.1111/j.1523-1739.2005.00289.x; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Male TD, 2005, ECOL LETT, V8, P986, DOI 10.1111/j.1461-0248.2005.00806.x; Pain DJ, 2006, ANIM CONSERV, V9, P322, DOI 10.1111/j.1469-1795.2006.00040.x; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; ROHLF DJ, 1991, CONSERV BIOL, V5, P273, DOI 10.1111/j.1523-1739.1991.tb00139.x; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; STEWARTOATEN A, 1986, COTROL IMPACT PAIR; Stokstad E, 2005, SCIENCE, V309, P2150, DOI 10.1126/science.309.5744.2150; Tucker G. M., 1994, BIRDLIFE CONSERVATIO, V3; Watzold F, 2005, BIOL CONSERV, V123, P327, DOI 10.1016/j.biocon.2004.12.001	22	236	249	3	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2007	317	5839					810	813		10.1126/science.1146002	http://dx.doi.org/10.1126/science.1146002			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690296				2022-12-01	WOS:000248624500042
J	Sakaguchi, S; Powrie, F				Sakaguchi, Shimon; Powrie, Fiona			Perspective - Emerging challenges in regulatory T cell function and biology	SCIENCE			English	Editorial Material							TARGET GENES; TGF-BETA; FOXP3; SELF; INTERLEUKIN-2; DIFFERENTIATION; SUPPRESSION; INDUCTION; T(H)17	Much progress has been made in understanding how the immune system is regulated, with a great deal of recent interest in naturally occurring CD4(+) regulatory T cells that actively engage in the maintenance of immunological self-tolerance and immune homeostasis. The challenge ahead for immunologists is the further elucidation of the molecular and cellular processes that govern the development and function of these cells. From this, exciting possibilities are emerging for the manipulation of regulatory T cell pathways in treating immunological diseases and suppressing or augmenting physiological immune responses.	Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto 6068507, Japan; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Kyoto University; University of Oxford	Sakaguchi, S (corresponding author), Kyoto Univ, Dept Expt Pathol, Inst Frontier Med Sci, Kyoto 6068507, Japan.		Sakaguchi, Shimon/C-9535-2009		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; COOMBES JL, IN PRESS J EXP MED; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; SUN CM, IN PRESS J EXP MED; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; YAMAGUCHI T, IN PRESS IMMUNITY; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	37	185	206	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2007	317	5838					627	629		10.1126/science.1142331	http://dx.doi.org/10.1126/science.1142331			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	196PL	17673654				2022-12-01	WOS:000248494400035
J	Park, CB; Asin-Cayuela, J; Camara, Y; Shi, YH; Pellegrini, M; Gaspari, M; Wibom, R; Hultenby, K; Erdjument-Bromage, H; Tempst, P; Falkenberg, M; Gustafsson, CM; Larsson, NG				Park, Chan Bae; Asin-Cayuela, Jorge; Camara, Yolanda; Shi, Yonghong; Pellegrini, Mina; Gaspari, Martina; Wibom, Rolf; Hultenby, Kjell; Erdjument-Bromage, Hediye; Tempst, Paul; Falkenberg, Maria; Gustafsson, Claes M.; Larsson, Nils-Goran			MTERF3 is a negative regulator of mammalian mtDNA transcription	CELL			English	Article							MITOCHONDRIAL-DNA POLYMERASE; TERMINATION FACTOR MTERF; GENE-EXPRESSION; ATP PRODUCTION; RIBOSOMAL-RNA; IN-VITRO; MICE; PROTEIN; FAMILY; CELLS	Regulation of mammalian mtDNA gene expression is critical for altering oxidative phosphorylation capacity in response to physiological demands and disease processes. The basal machinery for initiation of mtDNA transcription has been molecularly defined, but the mechanisms regulating its activity are poorly understood. In this study, we show that MTERF3 is a negative regulator of mtDNA transcription initiation. The MTERF3 gene is essential because homozygous knockout mouse embryos die in midgestation. Tissue-specific inactivation of MTERF3 in the heart causes aberrant mtDNA transcription and severe respiratory chain deficiency. MTERF3 binds the mtDNA promoter region and depletion of MTERF3 increases transcription initiation on both mtDNA strands. This increased transcription initiation leads to decreased expression of critical promoter-distal tRNA genes, which is possibly explained by transcriptional collision on the circular mtDNA molecule. To our knowledge, MTERF3 is the first example of a mitochondrial protein that acts as a specific repressor of mammalian mtDNA transcription initiation in vivo.	Karolinska Inst, Dept Lab Med, S-14186 Stockholm, Sweden; Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10021 USA	Karolinska Institutet; Memorial Sloan Kettering Cancer Center	Gustafsson, CM (corresponding author), Karolinska Inst, Dept Lab Med, S-14186 Stockholm, Sweden.	claes.gustafsson@ki.se; nils-goran.larsson@ki.se	Larsson, Nils-Göran/GVS-5578-2022; Cámara, Yolanda/K-4597-2014; Cámara, Yolanda/P-2540-2019; shi, yonghong/E-8254-2017	Larsson, Nils-Göran/0000-0001-5100-996X; Cámara, Yolanda/0000-0003-2458-6942; shi, yonghong/0000-0002-5265-7982; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Gustafsson, Claes/0000-0003-3531-8468				Asin-Cayuela J, 2005, J BIOL CHEM, V280, P25499, DOI 10.1074/jbc.M501145200; BINDOFF LA, 1993, J BIOL CHEM, V268, P19559; CAREY J, 1991, METHOD ENZYMOL, V208, P103; DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Enriquez J A, 1996, Methods Enzymol, V264, P50, DOI 10.1016/S0076-6879(96)64008-7; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184; Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; HEDDI A, 1993, J BIOL CHEM, V268, P12156; Koga A, 2003, NEUROMUSCULAR DISORD, V13, P259, DOI 10.1016/S0960-8966(02)00267-5; KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Micol V, 1996, Methods Enzymol, V264, P158, DOI 10.1016/S0076-6879(96)64017-8; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Roberti M, 2006, BBA-BIOENERGETICS, V1757, P1199, DOI 10.1016/j.bbabio.2006.04.026; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; SHANG J, 1994, J BIOL CHEM, V269, P29112; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Tempst Paul, 1994, Methods (Orlando), V6, P248, DOI 10.1006/meth.1994.1027; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Trifunovic A, 2006, BBA-BIOENERGETICS, V1757, P611, DOI 10.1016/j.bbabio.2006.03.003; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	40	176	191	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2007	130	2					273	285		10.1016/j.cell.2007.05.046	http://dx.doi.org/10.1016/j.cell.2007.05.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662942	Bronze			2022-12-01	WOS:000248588000017
J	Wadman, M				Wadman, Meredith			The pain game	NATURE			English	News Item																		Cannon CP, 2006, LANCET, V368, P1771, DOI 10.1016/S0140-6736(06)69666-9; Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692	4	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2007	448	7152					400	401		10.1038/448400a	http://dx.doi.org/10.1038/448400a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653159				2022-12-01	WOS:000248302700014
J	Merkle, FT; Mirzadeh, Z; Alvarez-Buylla, A				Merkle, Florian T.; Mirzadeh, Zaman; Alvarez-Buylla, Arturo			Mosaic organization of neural stem cells in the adult brain	SCIENCE			English	Article							OLFACTORY-BULB INTERNEURONS; RADIAL GLIA; NEURONS; GENERATION; FOREBRAIN; ZONE; SUBPOPULATIONS; NEUROGENESIS; PROGENITORS; ASTROCYTES	The in vivo potential of neural stem cells in the postnatal mouse brain is not known, but because they produce many different types of neurons, they must be either very versatile or very diverse. By specifically targeting stem cells and following their progeny in vivo, we showed that postnatal stem cells in different regions produce different types of neurons, even when heterotopically grafted or grown in culture. This suggests that rather than being plastic and homogeneous, neural stem cells are a restricted and diverse population of progenitors.	Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu	Merkle, Florian/A-2639-2011	Merkle, Florian/0000-0002-8513-2998; Alvarez-Buylla, Arturo/0000-0003-4426-8925				Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Campbell K, 2003, CURR OPIN NEUROBIOL, V13, P50, DOI 10.1016/S0959-4388(03)00009-6; De Marchis S, 2007, J NEUROSCI, V27, P657, DOI 10.1523/JNEUROSCI.2870-06.2007; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Fukushima N, 2002, NEUROSCI RES, V44, P467, DOI 10.1016/S0168-0102(02)00173-6; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; HACK MA, 2005, NAT NEUROSCI; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Imura T, 2003, J NEUROSCI, V23, P2824; JACOBOWITZ DM, 1991, J COMP NEUROL, V304, P198, DOI 10.1002/cne.903040205; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; KOSAKA K, 1995, NEUROSCI RES, V23, P73, DOI 10.1016/0168-0102(95)00930-R; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; PRICE JL, 1970, J CELL SCI, V7, P125; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rubenstein JLR, 1998, CURR OPIN NEUROBIOL, V8, P18, DOI 10.1016/S0959-4388(98)80004-4; Scheffler B, 2005, P NATL ACAD SCI USA, V102, P9353, DOI 10.1073/pnas.0503965102; Seri B, 2006, CEREB CORTEX, V16, pI103, DOI 10.1093/cercor/bhk027; SHEPHERD GM, 1998, SYNOPATIC ORG BRAIN; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Ventura RE, 2007, J NEUROSCI, V27, P4297, DOI 10.1523/JNEUROSCI.0399-07.2007; Waclaw RR, 2006, NEURON, V49, P503, DOI 10.1016/j.neuron.2006.01.018	29	611	629	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2007	317	5836					381	384		10.1126/science.1144914	http://dx.doi.org/10.1126/science.1144914			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	191RR	17615304				2022-12-01	WOS:000248150200049
J	Light, DW				Light, Donald W.			Is G8 putting pro-fits before the world's poorest children?	LANCET			English	Editorial Material									Ctr Bioeth, Princeton, NJ 08540 USA		Light, DW (corresponding author), Ctr Bioeth, Princeton, NJ 08540 USA.	dlight@princeton.edu						BARDER O, 2006, 80 CTR GLOB DEV; *CTR GLOB DEV, 2005, MAK MARK VACC ID ACT; FARLOW A, 2005, INNOVATION STRATEGY, V1, P66; *GAVI ALL WORLD BA, 2007, Q A ADV MARK COMM AM; Hardon A, 2005, SOC SCI MED, V60, P345, DOI 10.1016/j.socscimed.2004.05.008; Kremer M, 2004, STRONG MED CREATING; LEVINE O, 2006, GAVI ALLIANCE INVEST; Light DW, 2005, PLOS MED, V2, P934, DOI 10.1371/journal.pmed.0020271; ROSENTHAL E, 2007, NY TIMES        0210; Tremonti G., 2005, ADV MARKET COMMITMEN; 2006, AMC PILOT PROPOSAL	11	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2007	370	9584					297	298		10.1016/S0140-6736(07)61138-6	http://dx.doi.org/10.1016/S0140-6736(07)61138-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	195QG	17662863				2022-12-01	WOS:000248426100007
J	Kirmizis, A; Santos-Rosa, H; Penkett, CJ; Singer, MA; Vermeulen, M; Mann, M; Bahler, J; Green, RD; Kouzarides, T				Kirmizis, Antonis; Santos-Rosa, Helena; Penkett, Christopher J.; Singer, Michael A.; Vermeulen, Michiel; Mann, Matthias; Baehler, Juerg; Green, Roland D.; Kouzarides, Tony			Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR REGULATION; LYSINE METHYLATION; GENE-EXPRESSION; PHD FINGER; YEAST; CHROMATIN; GENOME; TRANSCRIPTION; GENERATION	Modifications on histones control important biological processes through their effects on chromatin structure(1-3). Methylation at lysine 4 on histone H3 (H3K4) is found at the 5' end of active genes and contributes to transcriptional activation by recruiting chromatin-remodelling enzymes(4,5). An adjacent arginine residue (H3R2) is also known to be asymmetrically dimethylated (H3R2me2a) in mammalian cells(6), but its location within genes and its function in transcription are unknown. Here we show that H3R2 is also methylated in budding yeast (Saccharomyces cerevisiae), and by using an antibody specific for H3R2me2a in a chromatin immunoprecipitation-on-chip analysis we determine the distribution of this modification on the entire yeast genome. We find that H3R2me2a is enriched throughout all heterochromatic loci and inactive euchromatic genes and is present at the 3' end of moderately transcribed genes. In all cases the pattern of H3R2 methylation is mutually exclusive with the trimethyl form of H3K4 (H3K4me3). We show that methylation at H3R2 abrogates the trimethylation of H3K4 by the Set1 methyltransferase. The specific effect on H3K4me3 results from the occlusion of Spp1, a Set1 methyltransferase subunit necessary for trimethylation. Thus, the inability of Spp1 to recognize H3 methylated at R2 prevents Set1 from trimethylating H3K4. These results provide the first mechanistic insight into the function of arginine methylation on chromatin.	Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QN, England; Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; NimbleGen Syst Inc, Madison, WI 53711 USA; Max Planck Inst Biochem, Dept Proteom & Signal Transduct, D-82152 Martinsried, Germany	University of Cambridge; Wellcome Trust Sanger Institute; Roche Holding; Roche NimbleGen; Max Planck Society	Kouzarides, T (corresponding author), Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	t.kouzarides@gurdon.cam.ac.uk	Vermeulen, Michiel/C-8883-2013; Bahler, Jurg/B-4572-2009; Mann, Matthias/A-3454-2013	Vermeulen, Michiel/0000-0003-0836-6894; Bahler, Jurg/0000-0003-4036-1532; Mann, Matthias/0000-0003-1292-4799; Kouzarides, Tony/0000-0002-8918-4162	Cancer Research UK [A6517] Funding Source: Medline; Wellcome Trust [092096, 077118] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; GUCCIONE E, NATURE; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Morillon A, 2003, SCIENCE, V300, P492, DOI 10.1126/science.1081379; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Perez-Burgos L, 2004, METHOD ENZYMOL, V376, P234; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Wood A, 2007, MOL CELL BIOL, V27, P709, DOI 10.1128/MCB.01627-06; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	29	262	263	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2007	449	7164					928	U17		10.1038/nature06160	http://dx.doi.org/10.1038/nature06160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17898715	Green Accepted			2022-12-01	WOS:000250230600052
J	Lan, F; Bayliss, PE; Rinn, JL; Whetstine, JR; Wang, JK; Chen, SZ; Iwase, S; Alpatov, R; Issaeva, I; Canaani, E; Roberts, TM; Chang, HY; Shi, Y				Lan, Fei; Bayliss, Peter E.; Rinn, John L.; Whetstine, Johnathan R.; Wang, Jordon K.; Chen, Shuzhen; Iwase, Shigeki; Alpatov, Roman; Issaeva, Irina; Canaani, Eli; Roberts, Thomas M.; Chang, Howard Y.; Shi, Yang			A histone H3 lysine 27 demethylase regulates animal posterior development	NATURE			English	Article							EMBRYONIC STEM-CELLS; METHYLTRANSFERASE ACTIVITY; X-INACTIVATION; BREAST-CANCER; TARGET GENES; Y-CHROMOSOME; POLYCOMB; METHYLATION; PROTEIN; REPRESSION	The recent discovery of a large number of histone demethylases suggests a central role for these enzymes in regulating histone methylation dynamics. Histone H3K27 trimethylation (H3K27me3) has been linked to polycomb-group-protein-mediated suppression of Hox genes and animal body patterning, X-chromosome inactivation and possibly maintenance of embryonic stem cell (ESC) identity. An imbalance of H3K27 methylation owing to overexpression of the methylase EZH2 has been implicated in metastatic prostate and aggressive breast cancers. Here we show that the JmjC-domain-containing related proteins UTX and JMJD3 catalyse demethylation of H3K27me3/2. UTX is enriched around the transcription start sites of many HOX genes in primary human fibroblasts, in which HOX genes are differentially expressed, but is selectively excluded from the HOX loci in ESCs, in which HOX genes are largely silent. Consistently, RNA interference inhibition of UTX led to increased H3K27me3 levels at some HOX gene promoters. Importantly, morpholino oligonucleotide inhibition of a zebrafish UTX homologue resulted in mis-regulation of hox genes and a striking posterior developmental defect, which was partially rescued by wild-type, but not by catalytically inactive, human UTX. Taken together, these findings identify a small family of H3K27 demethylases with important, evolutionarily conserved roles in H3K27 methylation regulation and in animal anterior-posterior development.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Stanford Univ, Sch Med, Dept Dermatol, Program Epithelial Biol, Stanford, CA 94305 USA; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Stanford University; Weizmann Institute of Science	Shi, Y (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	yshi@hms.harvard.edu	Iwase, Shigeki/J-8294-2019	Iwase, Shigeki/0000-0003-2280-7422; Wang, Jordon/0000-0003-1108-2534; Bayliss, Peter/0000-0003-4807-6365; Rinn, John/0000-0002-7231-7539				Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Eissenberg JC, 2007, NAT STRUCT MOL BIOL, V14, P344, DOI 10.1038/nsmb1217; Ginalski K, 2004, P NATL ACAD SCI USA, V101, P2305, DOI 10.1073/pnas.0306306101; Greenfield A, 1996, NAT GENET, V14, P474, DOI 10.1038/ng1296-474; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wang JB, 2002, MAMM GENOME, V13, P493, DOI 10.1007/s00335-002-2182-7; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001	40	587	618	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2007	449	7163					689	U3		10.1038/nature06192	http://dx.doi.org/10.1038/nature06192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218VV	17851529				2022-12-01	WOS:000250045000036
J	Blow, N				Blow, Nathan			Genomics: The personal side of genomics	NATURE			English	Editorial Material																		Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068	6	24	35	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2007	449	7162					627	632		10.1038/449627a	http://dx.doi.org/10.1038/449627a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17914399				2022-12-01	WOS:000249893500051
J	Jaillon, O; Aury, JM; Noel, B; Policriti, A; Clepet, C; Casagrande, A; Choisne, N; Aubourg, S; Vitulo, N; Jubin, C; Vezzi, A; Legeai, F; Hugueney, P; Dasilva, C; Horner, D; Mica, E; Jublot, D; Poulain, J; Bruyere, C; Billault, A; Segurens, B; Gouyvenoux, M; Ugarte, E; Cattonaro, F; Anthouard, V; Vico, V; Del Fabbro, C; Alaux, M; Di Gaspero, G; Dumas, V; Felice, N; Paillard, S; Juman, I; Moroldo, M; Scalabrin, S; Canaguier, A; Le Clainche, I; Malacrida, G; Durand, E; Pesole, G; Laucou, V; Chatelet, P; Merdinoglu, D; Delledonne, M; Pezzotti, M; Lecharny, A; Scarpelli, C; Artiguenave, F; Pe, ME; Valle, G; Morgante, M; Caboche, M; Adam-Blondon, AF; Weissenbach, J; Quetier, F; Wincker, P				Jaillon, Olivier; Aury, Jean-Marc; Noel, Benjamin; Policriti, Alberto; Clepet, Christian; Casagrande, Alberto; Choisne, Nathalie; Aubourg, Sebastien; Vitulo, Nicola; Jubin, Claire; Vezzi, Alessandro; Legeai, Fabrice; Hugueney, Philippe; Dasilva, Corinne; Horner, David; Mica, Erica; Jublot, Delphine; Poulain, Julie; Bruyere, Clemence; Billault, Alain; Segurens, Beatrice; Gouyvenoux, Michel; Ugarte, Edgardo; Cattonaro, Federica; Anthouard, Veronique; Vico, Virginie; Del Fabbro, Cristian; Alaux, Michael; Di Gaspero, Gabriele; Dumas, Vincent; Felice, Nicoletta; Paillard, Sophie; Juman, Irena; Moroldo, Marco; Scalabrin, Simone; Canaguier, Aurelie; Le Clainche, Isabelle; Malacrida, Giorgio; Durand, Eleonore; Pesole, Graziano; Laucou, Valerie; Chatelet, Philippe; Merdinoglu, Didier; Delledonne, Massimo; Pezzotti, Mario; Lecharny, Alain; Scarpelli, Claude; Artiguenave, Francois; Pe, M. Enrico; Valle, Giorgio; Morgante, Michele; Caboche, Michel; Adam-Blondon, Anne-Francoise; Weissenbach, Jean; Quetier, Francis; Wincker, Patrick		French-Italian Public	The grapevine genome sequence suggests ancestral hexaploidization in major angiosperm phyla	NATURE			English	Article							GENE; DUPLICATION; IDENTIFICATION; POLYPLOIDY; MAP; MONOTERPENES; RESVERATROL; DIVERGENCE; EVOLUTION; MARKERS	The analysis of the first plant genomes provided unexpected evidence for genome duplication events in species that had previously been considered as true diploids on the basis of their genetics(1-3). These polyploidization events may have had important consequences in plant evolution, in particular for species radiation and adaptation and for the modulation of functional capacities(4-10). Here we report a high-quality draft of the genome sequence of grapevine (Vitis vinifera) obtained from a highly homozygous genotype. The draft sequence of the grapevine genome is the fourth one produced so far for flowering plants, the second for a woody species and the first for a fruit crop ( cultivated for both fruit and beverage). Grapevine was selected because of its important place in the cultural heritage of humanity beginning during the Neolithic period(11). Several large expansions of gene families with roles in aromatic features are observed. The grapevine genome has not undergone recent genome duplication, thus enabling the discovery of ancestral traits and features of the genetic organization of flowering plants. This analysis reveals the contribution of three ancestral genomes to the grapevine haploid content. This ancestral arrangement is common to many dicotyledonous plants but is absent from the genome of rice, which is a monocotyledon. Furthermore, we explain the chronology of previously described whole-genome duplication events in the evolution of flowering plants.	Univ Evry, CEA, F-91057 Evry, France; Univ Evry, CNRS, UMR 8030, F-91057 Evry, France; Ist Genom Applicata, I-33100 Udine, Italy; Univ Udine, Dipartimento Matemat & Informat, I-33100 Udine, Italy; Univ Evry Genom Vegetale, INRA, UMR 1165, URGV,CNRS, F-91057 Evry, France; Univ Udine, Dipartimento Sci Agr & Ambientali, I-33100 Udine, Italy; Univ Padua, CRIBI, I-35121 Padua, Italy; URGI, F-91034 Evry, France; Univ Strasbourg, INRA, UMR 1131, F-68021 Colmar, France; Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy; Univ Bari, Dipartmento Biochim & Biol Mol, I-70125 Bari, Italy; CNR, Ist Tecnol Biomed, I-70125 Bari, Italy; Univ Montpellier 2, IRD Montpellier SupAgro, INRA, UMR 1097, F-34060 Montpellier 1, France; CIRAD, IRD Montpellier SupAgro, INRA, UMR 1098, F-34060 Montpellier 1, France; Univ Verona, Dipartimento Sci & Tecnol, I-37134 Verona, Italy; Univ Verona, Dipartimento Sci Tecnol & Mercati Vite & Vino, I-37029 S Floriano, VR, Italy; Univ Siena, VIGNA, CRA Initiat, I-53100 Siena, Italy; Univ Siena, Consorzio Interuniv Nazl Biol Mol Piante, I-53100 Siena, Italy	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; University of Udine; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Udine; University of Padua; INRAE; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Milan; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); University of Verona; University of Verona; University of Siena; University of Siena	Wincker, P (corresponding author), Univ Evry, CEA, 2 Rue Gaston Cremieux,BP5706, F-91057 Evry, France.	pwincker@genoscope.cns.fr	Pesole, Graziano/E-9051-2014; Pesole, Graziano/K-5283-2019; Jublot, Delphine/M-7102-2014; Aury, Jean-Marc/N-1621-2019; Pesole, Graziano/C-1408-2009; Del Fabbro, Cristian/C-5523-2014; Casagrande, Alberto/N-1197-2015; mica, erica/AAA-3931-2020; Delledonne, Massimo/O-8685-2017; Di Gaspero, Gabriele/AAF-2982-2020; Horner, David/AAC-2274-2022; Hugueney, Philippe/AAU-5903-2020; VEZZI, ALESSANDRO/AAB-7686-2022; Jaillon, Olivier/GRY-6287-2022; Quetier, Francis/J-7923-2017	Pesole, Graziano/0000-0003-3663-0859; Aury, Jean-Marc/0000-0003-1718-3010; Pesole, Graziano/0000-0003-3663-0859; Del Fabbro, Cristian/0000-0001-8189-6192; Casagrande, Alberto/0000-0002-8681-1482; Hugueney, Philippe/0000-0002-1641-9274; VEZZI, ALESSANDRO/0000-0002-8629-6644; Poulain, Julie/0000-0002-8744-3116; di gaspero, gabriele/0000-0001-5810-2163; Durand, Eleonore/0000-0002-0912-9252; Quetier, Francis/0000-0003-4388-9287; Delledonne, Massimo/0000-0002-7100-4581; Alaux, Michael/0000-0001-9356-4072; CHOISNE, Nathalie/0000-0001-6024-1664; Noel, Benjamin/0000-0002-5830-3253; Vitulo, Nicola/0000-0002-9571-0747; ADAM-BLONDON, Anne-Francoise/0000-0002-3412-9086; MORGANTE, Michele/0000-0003-2591-2156; Legeai, Fabrice/0000-0002-6472-4839; Jaillon, Olivier/0000-0002-7237-9596; VALLE, GIORGIO/0000-0003-4377-5685				Adam-Blondon AF, 2005, THEOR APPL GENET, V110, P1363, DOI 10.1007/s00122-005-1924-9; Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Aubourg S, 2002, MOL GENET GENOMICS, V267, P730, DOI 10.1007/s00438-002-0709-y; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; CRANE PR, 1995, NATURE, V374, P27, DOI 10.1038/374027a0; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Doligez A, 2006, THEOR APPL GENET, V113, P369, DOI 10.1007/s00122-006-0295-1; ESHED Y, 1995, GENETICS, V141, P1147; Howe KL, 2002, GENOME RES, V12, P1418, DOI 10.1101/gr.149502; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jaillon O, 2003, COLD SPRING HARB SYM, V68, P275, DOI 10.1101/sqb.2003.68.275; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Lamoureux D, 2006, THEOR APPL GENET, V113, P344, DOI 10.1007/s00122-006-0301-7; LODHI MA, 1995, GENOME, V38, P786, DOI 10.1139/g95-100; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Mateo JJ, 2000, J CHROMATOGR A, V881, P557, DOI 10.1016/S0021-9673(99)01342-4; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McGovern PE, 1997, EXPEDITION, V39, P3; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Seoighe C, 2004, TRENDS GENET, V20, P461, DOI 10.1016/j.tig.2004.07.008; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Soderlund C, 2000, GENOME RES, V10, P1772, DOI 10.1101/gr.GR-1375R; Tholl D, 2004, PLANT CELL, V16, P977, DOI 10.1105/tpc.020156; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201	40	2560	2921	36	481	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 27	2007	449	7161					463	U5		10.1038/nature06148	http://dx.doi.org/10.1038/nature06148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17721507	Green Published, hybrid			2022-12-01	WOS:000249724800041
J	Patel, V; Simbine, APF; Soares, IC; Weiss, HA; Wheeler, E				Patel, Vikram; Simbine, Ana Paula Ferrao; Soares, Isabel Cristina; Weiss, Helen A.; Wheeler, Erica			Prevalence of severe mental and neurological disorders in Mozambique: a population-based survey	LANCET			English	Article							DEVELOPING-COUNTRIES; SCHIZOPHRENIA; ETHIOPIA; EPILEPSY	Background The scarcity of information about the mental and neurological health of people in Mozambique has hindered policymaking and investment. We aimed to assess the prevalence of seizure disorders, psychoses, and mental retardation in urban and rural Mozambique. Methods 2739 households were randomly selected, 1796 of which were in Maputo city and 943 in the rural town of Culamba. A key informant from each household was asked to identify household members with disorders that matched the descriptions given in case vignettes. Key informants were also asked about causes of disorders, and their treatment, and current state. Findings Lifetime prevalence rates for all three disorders were higher in rural than in urban settings. Prevalence of psychoses (in adults) was 4.4% in the rural town versus 1.6% in the city (standardised prevalence ratio 2.79); mental retardation 1.9% versus 1.3% (1.48); and seizure disorders 4.0% versus 1.6% (2.00). Of the three disorders, key informants most frequently attributed psychoses to supernatural causes, followed by seizure disorder. In about three-quarters of all cases, households had consulted a traditional medical practitioner. Nearly half the people with these disorders in rural areas were rated as being in poor health. Interpretation Advocacy to improve understanding of mental disorders; investment in mental-health resources in rural areas; and collaboration with traditional medical practitioners are urgently needed, especially in the poor rural areas of Mozambique.	Univ London London Sch Hyg & Trop Med, NPHIRU, London WC1E 7HT, England; Minist Hlth, Govt Mozambique, Maputo, Mozambique; WHO, Dept Mental Hlth & Subst Dependence, CH-1211 Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Patel, V (corresponding author), Univ London London Sch Hyg & Trop Med, NPHIRU, Keppel St, London WC1E 7HT, England.	vikram.patel@lshtm.ac.uk	weiss, helen/ABC-7823-2021	weiss, helen/0000-0003-3547-7936; Patel, Vikram/0000-0003-1066-8584	Medical Research Council [G0700837] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		BENTOVIM DI, 1986, BRIT J PSYCHIAT, V148, P576, DOI 10.1192/bjp.148.5.576; Birbeck GL, 2004, TROP MED INT HEALTH, V9, P92, DOI 10.1046/j.1365-3156.2003.01149.x; *INE, 1999, PROJ AN POP PROV AR; ISAAC MK, 1980, BRIT J PSYCHIAT, V137, P540, DOI 10.1192/bjp.137.6.540; Kebede D, 1999, ACTA PSYCHIAT SCAND, V100, P11, DOI 10.1111/j.1600-0447.1999.tb10688.x; Kleinman A., 1981, PATIENTS HEALERS CON; OSUNTOKUN BO, 1987, EPILEPSIA, V28, P272, DOI 10.1111/j.1528-1157.1987.tb04218.x; PATEL V, 1995, SOC SCI MED, V40, P1291, DOI 10.1016/0277-9536(94)00231-H; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; RWIZA HT, 1992, EPILEPSIA, V33, P1051, DOI 10.1111/j.1528-1157.1992.tb01758.x; Shaji KS, 2002, INT J GERIATR PSYCH, V17, P222, DOI 10.1002/gps.553; Shibre T, 2002, INT J SOC PSYCHIATR, V48, P200, DOI 10.1177/002076402128783244; STEVENS J, 1987, BRIT J PSYCHIAT, V151, P393, DOI 10.1192/bjp.151.3.393; *WHO, 1999, REG STRAT MENT HLTH; WIG NN, 1980, ACTA PSYCHIAT SCAND, V61, P111, DOI 10.1111/j.1600-0447.1980.tb00571.x; World Health Organization (WHO), 2005, MENT HLTH ATL	16	37	38	2	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 22	2007	370	9592					1055	1060		10.1016/S0140-6736(07)61479-2	http://dx.doi.org/10.1016/S0140-6736(07)61479-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	214HJ	17889244				2022-12-01	WOS:000249727900029
J	Bates, M; Huang, B; Dempsey, GT; Zhuang, XW				Bates, Mark; Huang, Bo; Dempsey, Graham T.; Zhuang, Xiaowei			Multicolor super-resolution imaging with photo-switchable fluorescent probes	SCIENCE			English	Article							SINGLE MOLECULES; ENERGY-TRANSFER; QUANTUM DOTS; MICROSCOPY; LOCALIZATION; CELLS; RESOLUTION; NANOSCOPY	Recent advances in far-field optical nanoscopy have enabled fluorescence imaging with a spatial resolution of 20 to 50 nanometers. Multicolor super-resolution imaging, however, remains a challenging task. Here, we introduce a family of photo-switchable fluorescent probes and demonstrate multicolor stochastic optical reconstruction microscopy (STORM). Each probe consists of a photo-switchable "reporter" fluorophore that can be cycled between fluorescent and dark states, and an "activator" that facilitates photo-activation of the reporter. Combinatorial pairing of reporters and activators allows the creation of probes with many distinct colors. Iterative, color-specific activation of sparse subsets of these probes allows their localization with nanometer accuracy, enabling the construction of a super-resolution STORM image. Using this approach, we demonstrate multicolor imaging of DNA model samples and mammalian cells with 20- to 30-nanometer resolution. This technique will facilitate direct visualization of molecular interactions at the nanometer scale.	Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu	Huang, Bo/D-4854-2009	Dempsey, Graham/0000-0002-9273-7506; Bates, Mark/0000-0003-0668-5277	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068518] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 068518, R01 GM068518, R01 GM068518-05] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Bates M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108101; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Chen I, 2005, CURR OPIN BIOTECH, V16, P35, DOI 10.1016/j.copbio.2004.12.003; Donnert G, 2007, BIOPHYS J, V92, pL67, DOI 10.1529/biophysj.107.104497; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gordon MP, 2004, P NATL ACAD SCI USA, V101, P6462, DOI 10.1073/pnas.0401638101; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Ha T, 1999, P NATL ACAD SCI USA, V96, P9077, DOI 10.1073/pnas.96.16.9077; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Heilemann M, 2005, J AM CHEM SOC, V127, P3801, DOI 10.1021/ja044686x; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hohng S, 2004, BIOPHYS J, V87, P1328, DOI 10.1529/biophysj.104.043935; Kim SY, 2006, P NATL ACAD SCI USA, V103, P10929, DOI 10.1073/pnas.0604503103; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Lidke KA, 2005, OPT EXPRESS, V13, P7052, DOI 10.1364/OPEX.13.007052; Moerner WE, 1999, SCIENCE, V283, P1670, DOI 10.1126/science.283.5408.1670; Nan XL, 2005, J PHYS CHEM B, V109, P24220, DOI 10.1021/jp056360w; Novotny B. H., 2006, PRINCIPLES NANO OPTI; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Qu XH, 2004, P NATL ACAD SCI USA, V101, P11298, DOI 10.1073/pnas.0402155101; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; WEBER K, 1978, P NATL ACAD SCI USA, V75, P1820, DOI 10.1073/pnas.75.4.1820; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	31	1031	1114	21	864	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1749	1753		10.1126/science.1146598	http://dx.doi.org/10.1126/science.1146598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17702910	Green Accepted			2022-12-01	WOS:000249585900048
J	Lu, M; Fu, D				Lu, Min; Fu, Dax			Structure of the zinc transporter YiiP	SCIENCE			English	Article							ESCHERICHIA-COLI; FUNCTIONAL-CHARACTERIZATION; METAL-BINDING; PROTEINS; CHEMISTRY; FAMILY; MICE; FIEF	YiiP is a membrane transporter that catalyzes Zn2+/H+ exchange across the inner membrane of Escherichia coli. Mammalian homologs of YiiP play critical roles in zinc homeostasis and cell signaling. Here, we report the x-ray structure of YiiP in complex with zinc at 3.8 angstrom resolution. YiiP is a homodimer held together in a parallel orientation through four Zn2+ ions at the interface of the cytoplasmic domains, whereas the two transmembrane domains swing out to yield a Y-shaped structure. In each protomer, the cytoplasmic domain adopts a metallochaperone-like protein fold; the transmembrane domain features a bundle of six transmembrane helices and a tetrahedral Zn2+ binding site located in a cavity that is open to both the membrane outer leaflet and the periplasm.	Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Fu, D (corresponding author), Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA.	dax@bnl.gov		Fu, Dax/0000-0002-2663-1316	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065137] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anton A, 2004, J BACTERIOL, V186, P7499, DOI 10.1128/JB.186.22.7499-7507.2004; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Chao Y, 2004, J BIOL CHEM, V279, P17173, DOI 10.1074/jbc.M400208200; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Frederickson CJ, 2001, BIOMETALS, V14, P353, DOI 10.1023/A:1012934207456; Furia T, 1980, HDB FOOD ADDITIVES, V2; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Grass G, 2001, J BACTERIOL, V183, P4664, DOI 10.1128/JB.183.15.4664-4667.2001; Hirzel K, 2006, NEURON, V52, P679, DOI 10.1016/j.neuron.2006.09.035; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; NIES DH, 1995, J IND MICROBIOL, V14, P186, DOI 10.1007/BF01569902; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Rosenzweig AC, 2000, CURR OPIN CHEM BIOL, V4, P140, DOI 10.1016/S1367-5931(99)00066-6; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wei YN, 2006, J BIOL CHEM, V281, P23492, DOI 10.1074/jbc.M602254200; Wei YN, 2005, J BIOL CHEM, V280, P33716, DOI 10.1074/jbc.M506107200; Wei YN, 2004, J BIOL CHEM, V279, P39251, DOI 10.1074/jbc.M407044200; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766	26	283	291	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1746	1748		10.1126/science.1143748	http://dx.doi.org/10.1126/science.1143748			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17717154	Green Submitted			2022-12-01	WOS:000249585900047
J	Franco, EL				Franco, Eduardo L.			Commentary: Health inequity could increase in poor countries if universal HPV vaccination is not adopted	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER		McGill Univ, Dept Oncol, Montreal, PQ H2W 1S6, Canada; McGill Univ, Dept Epidemiol, Montreal, PQ H2W 1S6, Canada	McGill University; McGill University	Franco, EL (corresponding author), McGill Univ, Dept Oncol, Montreal, PQ H2W 1S6, Canada.	eduardo.franco@mcgill.ca	Franco, Eduardo/C-6445-2014	Franco, Eduardo/0000-0002-4409-8084				Batson A, 2006, VACCINE, V24, P219, DOI 10.1016/j.vaccine.2006.05.042; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Franco EL, 2006, VACCINE, V24, P171, DOI 10.1016/j.vaccine.2006.05.061; *GAVI ALL, 2005, PROGR REP 2005; Kane MA, 2006, VACCINE, V24, P132, DOI 10.1016/j.vaccine.2006.05.128; Kotaniemi-Talonen L, 2005, BRIT J CANCER, V93, P862, DOI 10.1038/sj.bjc.6602799; Quinn M, 1999, BRIT MED J, V318, P904, DOI 10.1136/bmj.318.7188.904; Raffle AE, 2007, BMJ-BRIT MED J, V335, P375, DOI 10.1136/bmj.39273.458322.BE; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741	10	10	11	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2007	335	7616					378	379		10.1136/bmj.39280.457350.BE	http://dx.doi.org/10.1136/bmj.39280.457350.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	206VC	17717367	Green Published			2022-12-01	WOS:000249210000025
J	Giraud, M; Taubert, R; Vandiedonck, C; Ke, XY; Levi-Strauss, M; Pagani, F; Baralle, FE; Eymard, B; Tranchant, C; Gajdos, P; Vincent, A; Willcox, N; Beeson, D; Kyewski, B; Garchon, HJ				Giraud, Matthieu; Taubert, Richard; Vandiedonck, Claire; Ke, Xiayi; Levi-Strauss, Matthieu; Pagani, Franco; Baralle, Francisco E.; Eymard, Bruno; Tranchant, Christine; Gajdos, Philippe; Vincent, Angela; Willcox, Nick; Beeson, David; Kyewski, Bruno; Garchon, Henri-Jean			An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus	NATURE			English	Article							AUTOIMMUNE REGULATOR AIRE; T-CELL TOLERANCE; INSULIN EXPRESSION; MYASTHENIA-GRAVIS; EPITHELIAL-CELLS; GENE-EXPRESSION; IDDM2 LOCUS; TRANSCRIPTION; MUTATION; ALLELES	Promiscuous expression of tissue-restricted auto-antigens in the thymus imposes T-cell tolerance and provides protection from autoimmune diseases(1-3). Promiscuous expression of a set of self-antigens occurs in medullary thymic epithelial cells(4,5) and is partly controlled by the autoimmune regulator (AIRE), a nuclear protein for which loss-of-function mutations cause the type 1 autoimmune polyendocrine syndrome(6,7). However, additional factors must be involved in the regulation of this promiscuous expression. Here we describe a mechanism controlling thymic transcription of a prototypic tissue-restricted human auto-antigen gene, CHRNA1. This gene encodes the alpha-subunit of the muscle acetylcholine receptor, which is the main target of pathogenic auto-antibodies in autoimmune myasthenia gravis(8,9). On re-sequencing theCHRNA1 gene, we identified a functional bi-allelic variant in the promoter that is associated with early onset of disease in two independent human populations (France and United Kingdom). We show that this variant prevents binding of interferon regulatory factor 8 (IRF8) and abrogates CHRNA1 promoter activity in thymic epithelial cells in vitro. Notably, both the CHRNA1 promoter variant and AIRE modulate CHRNA1 messenger RNA levels in human medullary thymic epithelial cells ex vivo and also in a transactivation assay. These findings reveal a critical function of AIRE and the interferon signalling pathway in regulating quantitative expression of this auto-antigen in the thymus, suggesting that together they set the threshold for self-tolerance versus autoimmunity.	INSERM, U580, F-75015 Paris, France; Univ Paris 05, F-75015 Paris, France; Univ Oxford, Weatherhall Inst Mol Med, Neurosci Grp, Oxford OX3 9DS, England; German Canc Res Ctr, Tumor Immunol Program, Div Dev Immunol, D-69120 Heidelberg, Germany; Univ Manchester, CIGMR, Manchester M13 9PT, Lancs, England; Univ Manchester, ARC, Epidemiol Unit, Manchester M13 9PT, Lancs, England; Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; Hop La Pitie Salpetriere, Inst Myol, F-75013 Paris, France; CHRU, Hop Civil, Serv Neurol, F-67091 Strasbourg, France; Hop Raymond Poincare, Serv Reanimat, F-92380 Garches, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Oxford; Helmholtz Association; German Cancer Research Center (DKFZ); University of Manchester; University of Manchester; International Center for Genetic Engineering & Biotechnology (ICGEB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP	Garchon, HJ (corresponding author), INSERM, U580, F-75015 Paris, France.	garchon@necker.fr	Giraud, Matthieu/E-4972-2017; Ke, Xiayi/C-7674-2009; Vincent, Angela/AAE-7310-2019	Giraud, Matthieu/0000-0002-1208-9677; Pagani, Franco/0000-0002-2678-3459; vandiedonck, claire/0000-0002-6669-6923; tranchant, christine/0000-0002-2895-1292	MRC [G117/490] Funding Source: UKRI; Medical Research Council [G117/490] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Barnes B, 2002, J INTERF CYTOK RES, V22, P59, DOI 10.1089/107999002753452665; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chentoufi AA, 2002, DIABETES, V51, P1383, DOI 10.2337/diabetes.51.5.1383; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FERNANDEZ E, 1994, BLOOD, V83, P3245; Gotter J, 2004, J EXP MED, V199, P155, DOI 10.1084/jem.20031677; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Liston A, 2005, IMMUNOL REV, V204, P87, DOI 10.1111/j.0105-2896.2005.00253.x; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; Lohoff M, 2005, NAT REV IMMUNOL, V5, P125, DOI 10.1038/nri1552; Mathis D, 2004, IMMUNITY, V20, P509, DOI 10.1016/S1074-7613(04)00111-6; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Pagani F, 2002, NAT GENET, V30, P426, DOI 10.1038/ng858; Pitkanen J, 2005, BIOCHEM BIOPH RES CO, V333, P944, DOI 10.1016/j.bbrc.2005.05.187; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Sabater L, 2005, J AUTOIMMUN, V25, P312, DOI 10.1016/j.jaut.2005.08.006; Sillanpaa N, 2004, MOL IMMUNOL, V41, P1185, DOI 10.1016/j.molimm.2004.06.004; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Taubert R, 2007, EUR J IMMUNOL, V37, P838, DOI 10.1002/eji.200636962; Thebault-Baumont K, 2003, J CLIN INVEST, V111, P851, DOI 10.1172/JCI200316584; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Vincent A, 2002, NAT REV IMMUNOL, V2, P797, DOI 10.1038/nri916	28	145	155	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2007	448	7156					934	U9		10.1038/nature06066	http://dx.doi.org/10.1038/nature06066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202OM	17687331				2022-12-01	WOS:000248912900048
J	Hansen, ML; Gunn, PW; Kaelber, DC				Hansen, Matthew L.; Gunn, Paul W.; Kaelber, David C.			Underdiagnosis of hypertension in children and adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR RISK-FACTORS; BLOOD-PRESSURE; OVERWEIGHT; DISEASE; CHILDHOOD; ATHEROSCLEROSIS; POPULATION; PREVALENCE; TRENDS	Context Pediatric hypertension is increasing in prevalence with the pediatric obesity epidemic. Diagnosis of hypertension in children is complicated because normal and abnormal blood pressure values vary with age, sex, and height and are therefore difficult to remember. Objectives To determine the frequency of undiagnosed hypertension and prehypertension and to identify patient factors associated with this underdiagnosis. Design, Setting, and Participants A cohort study of 14 187 children and adolescents aged 3 to 18 years who were observed at least 3 times for well-child care between June 1999 and September 2006 in the outpatient clinics in a large academic urban medical system in northeast Ohio. For children and adolescents who met criteria for hypertension or prehypertension at 3 or more well-child care visits, the proportion with a hypertension-related International Classification of Diseases, Ninth Revision code in the diagnoses list, problem list, or past medical history list of any visit was determined. Main Outcome Measures Proportion of children and adolescents with 3 or more elevated age-adjusted and height-adjusted blood pressure measurements at well-child care visits and with a diagnosis of hypertension or prehypertension documented in the electronic medical record. Multivariate logistic regression identified patient factors associated with a correct diagnosis. Results Of 507 children and adolescents (3.6%) who had hypertension, 131 (26%) had a diagnosis of hypertension or elevated blood pressure documented in the electronic medical record. Patient factors that increased the adjusted odds of a correct diagnosis were a 1-year increase in age over age 3 (odds ratio [OR], 1.09; 95% confidence interval [CI], 1.03-1.16), number of elevated blood pressure readings beyond 3 (OR, 1.77; 95% CI, 1.21-2.57), increase of 1% in height-for-age percentile (OR, 1.02; 95% CI, 1.01-1.03), having an obesity-related diagnosis (OR, 2.61; 95% CI, 1.49-4.55), and number of blood pressure readings in the stage 2 hypertension range (OR, 1.68; 95% CI, 1.29-2.19). Of 485 children and adolescents (3.4%) who had prehypertension, 55 (11%) had an appropriate diagnosis documented in the electronic medical record. Patient factors that increased the adjusted odds of being diagnosed with prehypertension included a 1-year increase in age over age 3 (OR, 1.21; 95% CI, 1.09-1.34) and number of elevated blood pressure readings beyond 3 (OR, 3.07; 95% CI, 2.20-4.28). Conclusions Hypertension and prehypertension were frequently undiagnosed in this pediatric population. Patient age, height, obesity-related diagnoses, and magnitude and frequency of abnormal blood pressure readings all increased the odds of diagnosis.	Case Western Reserve Univ, Sch Med, Cleveland, OH USA; Oregon Hlth & Sci Univ, Sch Med, Dept Emergency Med, Portland, OR USA; Metrohlth Med Ctr, Dept Internal Med, Cleveland, OH USA; Metrohlth Med Ctr, Dept Pediat, Cleveland, OH USA; Partners Healthcare, Ctr Informat Technol Leadership, Boston, MA USA; Harvard Univ, Boston Childrens Hosp, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Case Western Reserve University; Oregon Health & Science University; MetroHealth System; MetroHealth System; Partners Healthcare System; Harvard University; Boston Children's Hospital; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	Kaelber, DC (corresponding author), 18 Upton St, Cambridge, MA 02139 USA.	dkaelber@partners.org	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; Kaelber, David/0000-0001-7855-9515				Arnett DK, 2001, AM J HYPERTENS, V14, P200, DOI 10.1016/S0895-7061(00)01262-0; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; BURKE GL, 1987, CIRCULATION, V75, P106, DOI 10.1161/01.CIR.75.1.106; Ford ES, 2004, PEDIATRICS, V114, P1534, DOI 10.1542/peds.2004-0674; Franco MCP, 2006, HYPERTENSION, V48, P45, DOI 10.1161/01.HYP.0000223446.49596.3a; Johnson DG, 1999, CHINA ECON REV, V10, P1, DOI 10.1016/S1043-951X(99)00002-4; Johnson MC, 1999, AM J HYPERTENS, V12, P1009, DOI 10.1016/S0895-7061(99)00087-4; Knoflach M, 2003, CIRCULATION, V108, P1064, DOI 10.1161/01.CIR.0000085996.95532.FF; LAUER RM, 1989, PEDIATRICS, V84, P633; Luepker RV, 1999, J PEDIATR-US, V134, P668, DOI 10.1016/S0022-3476(99)70279-9; MALCOLM DD, 1993, PEDIATRICS, V92, P703; Moore William E, 2006, Prev Chronic Dis, V3, pA114; Morrison JA, 1999, AM J PUBLIC HEALTH, V89, P1708, DOI 10.2105/AJPH.89.11.1708; MUNGER RG, 1988, J HYPERTENS, V6, P647, DOI 10.1097/00004872-198808000-00008; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; National Center for Health Statistics, CDC GROWTH CHARTS US; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Sanchez A, 2000, ATHEROSCLEROSIS, V152, P265, DOI 10.1016/S0021-9150(00)00532-3; *SAS I INC, 2006, SAS SYST WIND COMP P; Sinaiko AR, 1996, NEW ENGL J MED, V335, P1968, DOI 10.1056/NEJM199612263352607; Sorof JM, 2004, PEDIATRICS, V113, P475, DOI 10.1542/peds.113.3.475; Strauss RS, 2001, JAMA-J AM MED ASSOC, V286, P2845, DOI 10.1001/jama.286.22.2845; 2006, LIPPINCOTT MANUAL NU	24	542	559	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2007	298	8					874	879		10.1001/jama.298.8.874	http://dx.doi.org/10.1001/jama.298.8.874			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202CS	17712071	Bronze			2022-12-01	WOS:000248880200021
J	Donohue, JM; Cevasco, M; Rosenthal, MB				Donohue, Julie M.; Cevasco, Marisa; Rosenthal, Meredith B.			A decade of direct-to-consumer advertising of prescription drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROMOTION; CHOICE	Background: Evidence suggests that direct-to-consumer advertising of prescription drugs increases pharmaceutical sales and both helps to avert underuse of medicines and leads to potential overuse. Concern about such advertising has increased recently owing to the withdrawal from the market of heavily advertised drugs found to carry serious risks. Moreover, the Food and Drug Administration (FDA) has been criticized for its weak enforcement of laws regulating such advertising. Methods: We examined industry-wide trends in spending by pharmaceutical companies on direct-to-consumer advertising and promotion to physicians during the past decade. We characterized the drugs for which such advertising is used and assessed the timing of advertising after a drug is introduced. Finally, we examined trends in the FDA's regulation of drug advertising. Results: Total spending on pharmaceutical promotion grew from $11.4 billion in 1996 to $29.9 billion in 2005. Although during that time spending on direct-to-consumer advertising increased by 330%, it made up only 14% of total promotional expenditures in 2005. Direct-to-consumer campaigns generally begin within a year after the approval of a product by the FDA. In the context of regulatory changes requiring legal review before issuing letters, the number of letters sent by the FDA to pharmaceutical manufacturers regarding violations of drug-advertising regulations fell from 142 in 1997 to only 21 in 2006. Conclusions: Spending on direct-to-consumer advertising has continued to increase in recent years in spite of the criticisms leveled against it. Our findings suggest that calls for a moratorium on such advertising for new drugs would represent a dramatic departure from current practices.	Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15261 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard T.H. Chan School of Public Health; Vanderbilt University	Donohue, JM (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Crabtree Hall A613,130 DeSoto St, Pittsburgh, PA 15261 USA.	jdonohue@pitt.edu		Rosenthal, Meredith/0000-0003-3410-0184; Donohue, Julie/0000-0003-2418-6017	NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024154] Funding Source: NIH RePORTER; NCRR NIH HHS [KL2-RR024154-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Angell M., 2004, TRUTH DRUG CO; ARNOLD M, 2006, MED MARKETING ME APR, P38; BACIU A, 2006, FUTURE DRUG SAFETY P; Berndt ER, 2002, J ECON PERSPECT, V16, P45, DOI 10.1257/089533002320950975; Bradford WD, 2006, HEALTH AFFAIR, V25, P1371, DOI 10.1377/hlthaff.25.5.1371; Cassels A, 2006, BRIT MED J, V332, P1469, DOI 10.1136/bmj.332.7556.1469-a; Donohue JM, 2004, J PUBLIC POLICY MARK, V23, P115, DOI 10.1509/jppm.23.2.115.51395; Donohue JM, 2004, MED CARE, V42, P1176, DOI 10.1097/00005650-200412000-00004; DONOHUE JM, 2006, INT J PHARM MED, V20, P17; *GEN ACC OFF, 2002, FDA OV DIR TO CONS A; Gonul FF, 2001, J MARKETING, V65, P79, DOI 10.1509/jmkg.65.3.79.18329; *GOV ACC OFF, 2006, PRESCR DRUGS IMPR NE; Hollon MF, 2005, JAMA-J AM MED ASSOC, V293, P2030, DOI 10.1001/jama.293.16.2030; Iizuka T, 2005, J ECON MANAGE STRAT, V14, P701, DOI 10.1111/j.1530-9134.2005.00079.x; Iizuka T, 2004, J IND ECON, V52, P349, DOI 10.1111/j.0022-1821.2004.00230.x; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V294, P2436; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; *PHARM RES MAN AM, 2005, PHRMA GUID PRINC DIR; Pines WL, 1999, FOOD DRUG LAW J, V54, P489; Risso JA, 1999, J LAW ECON, V42, P89; Rosenthal M., 2003, FRONTIERS HLTH POLIC, V6, P1, DOI DOI 10.2202/1558-9544.1044; Rosenthal MB, 2002, NEW ENGL J MED, V346, P498, DOI 10.1056/NEJMsa012075; SAUL S, 2005, NY TIMES        0702, pC13; Watson Rory, 2003, BMJ, V326, P1284, DOI 10.1136/bmj.326.7402.1284-b; Wolfe SM, 2002, NEW ENGL J MED, V346, P1424; ELECT ORANGE BOOK AP	26	340	344	4	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2007	357	7					673	681		10.1056/NEJMsa070502	http://dx.doi.org/10.1056/NEJMsa070502			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	200EF	17699817				2022-12-01	WOS:000248746000007
J	Malathi, K; Dong, BH; Gale, M; Silverman, RH				Malathi, Krishnamurthy; Dong, Beihua; Gale, Michael, Jr.; Silverman, Robert H.			Small self-RNA generated by RNase L amplifies antiviral innate immunity	NATURE			English	Article							HEPATITIS-C VIRUS; RIG-I; INTERFERON ACTION; 2-5A-DEPENDENT RNASE; ADAPTER PROTEIN; RESPONSES; INFECTION; IDENTIFICATION; RIBONUCLEASE; EXPRESSION	Antiviral innate immunity is initiated in response to RNA molecules that are produced in virus- infected cells(1). These RNAs activate signalling cascades that activate the genes that encode alpha- and beta- interferon ( IFN). Signalling occurs through the interaction of the RNAs with either of two pathogen recognition receptors, retinoic acid- inducible gene- I ( RIG- I, also known as DDX58) and melanoma differentiation associated gene- 5 ( MDA5, also known as IFIH1), which contain amino- terminal caspase activation and recruitment domains ( CARD) and carboxy- terminal DExD/ H Box RNA helicase motifs(2-5). RIG- I and MDA5 interact with another CARD protein, interferon-beta promotor stimulator protein- 1 ( IPS- 1, also known as MAVS, VISA and Cardif), in the mitochondrial membrane, which relays the signal through the transcription factors interferon regulatory factor 3 ( IRF- 3) and nuclear factor ( NF)- kappa B to the IFN-beta gene(6-10). Although the signalling pathway is well understood, the origin of the RNA molecules that initiate these processes is not. Here we show that activation of the antiviral endoribonuclease, RNase L-11, by 2',5'- linked oligoadenylate ( 2-5A)(12) produces small RNA cleavage products from self- RNA that initiate IFN production. Accordingly, mouse embryonic fibroblasts lacking RNase L were resistant to the induction of IFN-beta expression in response to 2- 5A, dsRNA or viral infection. Single-stranded regions of RNA are cleaved 39 of UpUp and UpAp sequences by RNase L during viral infections, resulting in small, often duplex, RNAs13,14. We show that small self- RNAs produced by the action of RNase L on cellular RNA induce IFN-beta expression and that the signalling involves RIG- I, MDA5 and IPS- 1. Mice lacking RNase L produce significantly less IFN-beta during viral infections than infected wild- type mice. Furthermore, activation of RNase L with 2- 5A in vivo induced the expression of IFN-beta in wild- type but not RNase L- deficient mice. Our results indicate that RNase L has an essential role in the innate antiviral immune response that relieves the requirement for direct sensing of non- self RNA.	Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA; Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	Cleveland Clinic Foundation; University of Washington; University of Washington Seattle	Silverman, RH (corresponding author), Cleveland Clin, Dept Canc Biol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	silverr@ccf.org		Gale, Michael/0000-0002-6332-7436	NCI NIH HHS [R01 CA044059-24, R01 CA044059] Funding Source: Medline; NIAID NIH HHS [R15 AI089518, R15 AI089518-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA044059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI089518] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; BEATTIE E, 1995, J VIROL, V69, P499, DOI 10.1128/JVI.69.1.499-505.1995; DONG BH, 1994, J BIOL CHEM, V269, P14153; Flodstrom-Tullberg M, 2005, J IMMUNOL, V174, P1171, DOI 10.4049/jimmunol.174.3.1171; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Han JQ, 2004, J INTERF CYTOK RES, V24, P664, DOI 10.1089/jir.2004.24.664; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; KERR IM, 1978, P NATL ACAD SCI USA, V75, P256, DOI 10.1073/pnas.75.1.256; Kubota K, 2004, J BIOL CHEM, V279, P37832, DOI 10.1074/jbc.M400089200; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Malathi K, 2005, P NATL ACAD SCI USA, V102, P14533, DOI 10.1073/pnas.0507551102; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Saito T, 2007, CURR OPIN IMMUNOL, V19, P17, DOI 10.1016/j.coi.2006.11.003; Samuel MA, 2006, J VIROL, V80, P7009, DOI 10.1128/JVI.00489-06; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Thakur CS, 2005, METH MOLEC MED, V116, P103; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; WRESCHNER DH, 1981, NATURE, V289, P414, DOI 10.1038/289414a0; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355	30	460	481	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					816	U9		10.1038/nature06042	http://dx.doi.org/10.1038/nature06042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17653195	Green Accepted			2022-12-01	WOS:000248754200042
J	Burns, T				Burns, Tom			Is it acceptable for people to be paid to adhere to medication?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; NHS Direct, London EC1V 9PS, England		Burns, T (corresponding author), Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	tom.burns@psych.ox.ac.uk							0	22	24	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 4	2007	335	7613					232	233		10.1136/bmj.39286.399514.BE	http://dx.doi.org/10.1136/bmj.39286.399514.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201QC	17673764	Green Published			2022-12-01	WOS:000248846700024
J	Mocroft, A; Phillips, A; Gatell, J; Ledergerber, B; Fisher, M; Clumeck, N; Losso, M; Lazzarin, A; Fatkenheuer, G; Lundgren, JD				Mocroft, A.; Phillips, A.; Gatell, J.; Ledergerber, B.; Fisher, M.; Clumeck, N.; Losso, M.; Lazzarin, A.; Fatkenheuer, G.; Lundgren, J. D.		EuroSIDA Study Grp	Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study	LANCET			English	Article							CELL COUNT; POSITIVE INDIVIDUALS; CLINICAL-PRACTICE; VIRUS-INFECTION; T-LYMPHOCYTES; RECOVERY; INCREASES; EUROSIDA; INTERRUPTION; PROGRESSION	Background Combination antiretroviral therapy (cART) has been shown to reduce mortality and morbidity in patients with HIV. As viral replication falls, the CD4 count increases, but whether the CD4 count returns to the level seen in HIV-negative people is unknown. We aimed to assess whether the CD4 count for patients with maximum virological suppression (viral load <50 copies per mL) continues to increase with long-term CART to reach levels seen in HIV-negative populations. Methods We compared increases in CD4 counts in 1835 antiretroviral-naive patients who started CART from EuroSIDA, a pan-European observational cohort study. Rate of increase in CD4 count (per year) occurring between pairs of consecutive viral loads below 50 copies per mL was estimated using generalised linear models, accounting for multiple measurements for individual patients. Findings The median CD4 count at starting CART was 204 cells per mu L (IQR 85-330). The greatest mean yearly increase in CD4 count of 100 cells per mu L was seen in the year after starting CART. Significant, but lower, yearly increases in CD4 count, around 50 cells per mu L, were seen even at 5 years after starting CART in patients whose current CD4 count was less than 500 cells per mu L. The only groups without significant increases in CD4 count were those where CART had been taken for more than 5 years with a current CD4 count of more than 500 cells per mu L, (current mean CD4 count 774 cells per mu L; 95% CI 764-783). Patients starting CART with low CD4 counts (<200 cells per mu L) had significant rises in CD4 counts even after 5 years of CART. Interpretation Normalisation. of CD4 counts in HIV-infected patients for all infected individuals might be achievable if viral suppression with cART can be maintained for a sufficiently long period of time.	UCL Royal Free & UCL Med Sch, Royal Free Ctr HIV Med, London NW3 2PF, England; UCL Royal Free & UCL Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; Hosp Clin Barcelona, Barcelona, Spain; Univ Zurich Hosp, CH-8091 Zurich, Switzerland; Royal Sussex Cty Hosp, Brighton BN2 5BE, E Sussex, England; St Pierre Hosp, Brussels, Belgium; Hosp JM Ramos Mejia, Buenos Aires, DF, Argentina; Univ Milan, Osped San Raffaele, I-20127 Milan, Italy; Univ Cologne, Cologne, Germany; Univ Copenhagen, Panum Inst, Copenhagen HIV Program, DK-1168 Copenhagen, Denmark	University of London; University College London; University of London; University College London; University of Barcelona; Hospital Clinic de Barcelona; University of Zurich; University Zurich Hospital; University of Brighton; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Hospital Ramos Mejia; University of Buenos Aires; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Cologne; University of Copenhagen	Mocroft, A (corresponding author), UCL Royal Free & UCL Med Sch, Royal Free Ctr HIV Med, Royal Free Campus, London NW3 2PF, England.	a.mocroft@pcps.uci.ac.uk	Ledergerber, Bruno/B-5656-2009; Mocroft, Amanda/G-8748-2011; VALLET, Yannick/F-9979-2011; Phillips, Andrew N/B-4427-2008; Mocroft, Amanda/C-1527-2008; Lundgren, Jens/AAE-6876-2019; LAZZARIN, Adriano/K-3607-2018	Ledergerber, Bruno/0000-0002-6881-4401; Mocroft, Amanda/0000-0001-8316-1122; Phillips, Andrew N/0000-0003-2384-4807; LAZZARIN, Adriano/0000-0003-2551-7754				[Anonymous], GUID US ANT AG HIV 1; Bannister WP, 2006, JAIDS-J ACQ IMM DEF, V42, P229, DOI 10.1097/01.qai.0000214815.95786.31; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; BOFILL M, 1992, CLIN EXP IMMUNOL, V88, P243, DOI 10.1111/j.1365-2249.1992.tb03068.x; Carpenter CCJ, 1996, JAMA-J AM MED ASSOC, V276, P146, DOI 10.1001/jama.276.2.146; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; Chene G, 2003, LANCET, V362, P679, DOI 10.1016/S0140-6736(03)14229-8; Coakley EPG, 2000, AIDS, V14, P1147, DOI 10.1097/00002030-200006160-00011; Deeks SG, 2003, AIDS, V17, P361, DOI 10.1097/00002030-200302140-00010; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hakim FT, 1997, BLOOD, V90, P3789, DOI 10.1182/blood.V90.9.3789; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; HANSON DL, 1995, ARCH INTERN MED, V155, P1537, DOI 10.1001/archinte.155.14.1537; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Lampe FC, 2006, ARCH INTERN MED, V166, P521, DOI 10.1001/archinte.166.5.521; Lange CG, 2003, AIDS, V17, P2015, DOI 10.1097/00002030-200309260-00002; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Lundgren JD, 2002, J INFECT DIS, V185, P178, DOI 10.1086/338267; Maini MK, 1996, GENITOURIN MED, V72, P27; Mocroft A, 1998, ARCH INTERN MED, V158, P491, DOI 10.1001/archinte.158.5.491; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Mocroft A, 2006, AIDS, V20, P1141, DOI 10.1097/01.aids.0000226954.95094.39; Monforte AD, 2005, JAIDS-J ACQ IMM DEF, V38, P407, DOI 10.1097/01.qai.0000147529.57240.b0; Moore RD, 2005, JAIDS-J ACQ IMM DEF, V39, P195; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; Podlekareva D, 2006, J INFECT DIS, V194, P633, DOI 10.1086/506366; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Smith CJ, 2003, AIDS, V17, P963, DOI 10.1097/00002030-200305020-00004; Staszewski S, 1999, AIDS, V13, P951, DOI 10.1097/00002030-199905280-00011; Sterling TR, 2001, AIDS, V15, P2251, DOI 10.1097/00002030-200111230-00006; Taffe P, 2002, AIDS, V16, P747, DOI 10.1097/00002030-200203290-00010; Tarwater PM, 2001, J ACQ IMMUN DEF SYND, V27, P168, DOI 10.1097/00126334-200106010-00012; Valdez H, 2002, AIDS, V16, P1859, DOI 10.1097/00002030-200209270-00002; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678	40	194	197	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	2007	370	9585					407	413		10.1016/S0140-6736(07)60948-9	http://dx.doi.org/10.1016/S0140-6736(07)60948-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197XL	17659333				2022-12-01	WOS:000248590200030
J	Mueller, SN; Hosiawa-Meagher, KA; Konieczny, BT; Sullivan, BM; Bachmann, MF; Locksley, RM; Ahmed, R; Matloubian, M				Mueller, Scott N.; Hosiawa-Meagher, Karoline A.; Konieczny, Bogumila T.; Sullivan, Brandon M.; Bachmann, Martin F.; Locksley, Richard M.; Ahmed, Rafi; Matloubian, Mehrdad			Regulation of homeostatic chemokine expression and cell trafficking during immune responses	SCIENCE			English	Article							LYMPHOID-ORGAN CHEMOKINE; MICE LACKING EXPRESSION; DENDRITIC CELLS; MIGRATION; MOTILITY; LIGANDS; NODES; SLC	The chemokines CCL21 and CXCL13 are immune factors that dictate homing and motility of lymphocytes and dendritic cells in lymphoid tissues. However, the means by which these chemokines are regulated and how they influence cell trafficking during immune responses remain unclear. We show that CCL21 and CXCL13 are transiently down-regulated within lymphoid tissues during immune responses by a mechanism controlled by the cytokine interferon-gamma. This modulation was found to alter the localization of lymphocytes and dendritic cells within responding lymphoid tissues. As a consequence, priming of T cell responses to a second distinct pathogen after chemokine modulation became impaired. We propose that this transient chemokine modulation may help orchestrate local cellularity, thus minimizing competition for space and resources in activated lymphoid tissues.	Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Cytos Biotechnol AG, CH-8952 Schlieren, Switzerland	Emory University; Emory University; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mueller, SN (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	mueller@microbio.emory.edu	Mueller, Scott N/B-1918-2012	Mueller, Scott N/0000-0002-3838-3989	NIAID NIH HHS [AI30048] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030048, R37AI030048] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Benedict CA, 2006, PLOS PATHOG, V2, P164, DOI 10.1371/journal.ppat.0020016; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Friedman RS, 2006, NAT IMMUNOL, V7, P1101, DOI 10.1038/ni1384; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Mori S, 2001, J EXP MED, V193, P207, DOI 10.1084/jem.193.2.207; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Saeki H, 1999, J IMMUNOL, V162, P2472; Serra HM, 2004, ALLERGY, V59, P1219, DOI 10.1111/j.1398-9995.2004.00531.x; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706	18	198	203	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					670	674		10.1126/science.1144830	http://dx.doi.org/10.1126/science.1144830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17673664				2022-12-01	WOS:000248494400048
J	Silverman, JG; Decker, MR; Gupta, J; Maheshwari, A; Willis, BM; Raj, A				Silverman, Jay G.; Decker, Michele R.; Gupta, Jhumka; Maheshwari, Ayonija; Willis, Brian M.; Raj, Anita			HIV prevalence and predictors of infection in sex-trafficked Nepalese girls and women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTOR; INDIA; WORKERS; MUMBAI; PROSTITUTION; EXPERIENCE; EPIDEMIC; ASIA	Context Sex trafficking of girls and women is widespread across South Asia and is recognized as both a violent gender-based crime and major human rights violation. Inadequate empirical data exist to characterize this phenomenon and its related health consequences, such as human immunodeficiency virus (HIV) infection. Objective To determine the prevalence of HIV infection among repatriated sex-trafficked Nepalese girls and women and to identify trafficking-related predictors of such infection. Design Medical and case records of 287 repatriated girls and women reporting being trafficked from Nepal for sexual exploitation and receiving rehabilitative services between January 1997 and December 2005 at a major nongovernmental organization were systematically reviewed in January 2006. Setting Major Nepalese nongovernmental organization providing shelter and care to repatriated survivors of sex trafficking. Main Outcome Measures Prevalence of and risk for HIV based on demographic characteristics and on trafficking- and prostitution-related experiences. Results Among 287 repatriated Nepalese sex-trafficked girls and women, 109 (38.0%) tested positive for HIV. Among those with complete documentation of trafficking experiences (n=225), median age at time of trafficking was 17.0 years, with 33 (14.7%) trafficked prior to age 15 years. Compared with those trafficked at 18 years or older, girls trafficked prior to age 15 years were at increased risk for HIV ( adjusted odds ratio [AOR], 3.70; 95% confidence interval [CI], 1.32-10.34), with 20 of 33 (60.6%) infected among this youngest age group. Additional factors associated with HIV positivity included being trafficked to Mumbai ( AOR, 4.85; 95% CI, 2.16-10.89) and longer duration of forced prostitution ( AOR, 1.02; 95% CI, 1.01-1.03; indicating increased risk per additional month of brothel servitude). In post hoc analyses, girls trafficked prior to age 15 years had increased odds of having been detained in multiple brothels ( odds ratio [ OR], 5.03; 95% CI, 1.96-12.93) and in brothels for a duration of 1 year or more ( OR, 2.67; 95% CI, 1.12-6.33) vs those trafficked at 18 years or older. Conclusions In this study, repatriated Nepalese sex-trafficked girls and women were found to have a high prevalence of HIV infection, with increased risk among those trafficked prior to age 15 years. Present findings demonstrate the need for greater attention to reducing and intervening in sex trafficking in South Asia, particularly among the very young.	Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; ECPAT Int, Washington, DC USA; Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; Boston University	Silverman, JG (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 667 Huntington Ave, Boston, MA 02115 USA.	jsilverm@hsph.harvard.edu		Decker, Michele/0000-0002-7085-7080	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI060354] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bansal R K, 1992, Indian J Matern Child Health, V3, P108; Beyrer C, 2001, SOC SCI MED, V53, P543, DOI 10.1016/S0277-9536(00)00358-0; BEYRER C, 2003, BROWN J WORLD AFFAIR, V10, P105; *C RES SERV, 2001, TRAFF WOM CHILDR US; Chakraborty A. K., 1994, Journal of Communicable Diseases, V26, P161; Chander Anil, 2004, Nepal Med Coll J, V6, P60; Hennick M., 2004, ASIAN PAC MIGR J, V13, P305, DOI [10.1177/011719680401300302, DOI 10.1177/011719680401300302]; Hosain GMM, 2005, PUBLIC HEALTH, V119, P371, DOI 10.1016/j.puhe.2004.08.015; Huda S, 2006, INT J GYNECOL OBSTET, V94, P374, DOI 10.1016/j.ijgo.2006.04.027; Human Rights Watch, 1995, RAP PROF TRAFF NEP G; *JOINT UN PROGR HI, 2 5 MILL PEOPL LIV H; *JOINT UN PROGR HI, DEC 06 AIDS EP UPD; *JOINT UN PROGR HI, 2006, NEP COUNTR PROF; Kannangai R, 2003, JAIDS-J ACQ IMM DEF, V32, P573, DOI 10.1097/00126334-200304150-00018; Madhivanan P, 2005, SEX TRANSM DIS, V32, P685, DOI 10.1097/01.olq.0000175405.36124.3b; Nair P, 2004, REPORT TRAFFICKING W, VI; *NAT AIDS CONTROL, 2006, HIV AIDS EP SURV EST; Poudel P, 2000, Gend Dev, V8, P74, DOI 10.1080/741923626; Raymond JG, 2004, VIOLENCE AGAINST WOM, V10, P1156, DOI 10.1177/1077801204268609; Sarkar K, 2006, J INFECTION, V53, P255, DOI 10.1016/j.jinf.2005.11.009; Sharma V, 1996, Sex Marital Ther, V11, P147, DOI 10.1080/02674659608404426; Silverman JG, 2007, INT J GYNECOL OBSTET, V97, P221, DOI 10.1016/j.ijgo.2006.12.003; Silverman JG, 2006, JAIDS-J ACQ IMM DEF, V43, P588; Singh S, 2005, PLOS MED, V2, P705, DOI 10.1371/journal.pmed.0020216; United Nations, 2000, PROT PREV SUPPR PUN; *US DEP STAT, 2005, VICT TRAFF VIOL PROT; Willis BM, 2002, LANCET, V359, P1417, DOI 10.1016/S0140-6736(02)08355-1; *WORLD BANK, 2006, HIV AIDS NEP; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	29	127	129	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2007	298	5					536	542		10.1001/jama.298.5.536	http://dx.doi.org/10.1001/jama.298.5.536			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195US	17666674	Bronze			2022-12-01	WOS:000248438100021
J	Deans, TL; Cantor, CR; Collins, JJ				Deans, Tara L.; Cantor, Charles R.; Collins, James J.			A tunable genetic switch based on RNAi and repressor proteins for regulating gene expression in mammalian cells	CELL			English	Article							DIPHTHERIA-TOXIN; TRANSGENE EXPRESSION; NOISE-PROPAGATION; TOGGLE SWITCH; APOPTOSIS; SYSTEM; MOUSE; BAX; OVEREXPRESSION; INTERFERENCE	Here, we introduce an engineered, tunable genetic switch that couples repressor proteins and an RNAi target design to effectively turn any gene off. We used the switch to regulate the expression of EGFP in mouse and human cells and found that it offers > 99% repression as well as the ability to tune gene expression. To demonstrate the system's modularity and level of gene silencing, we used the switch to tightly regulate the expression of diphtheria toxin and Cre recombinase, respectively. We also used the switch to tune the expression of a proapoptotic gene and show that a threshold expression level is required to induce apoptosis. This work establishes a system for tight, tunable control of mammalian gene expression that can be used to explore the functional role of various genes as well as to determine whether a phenotype is the result of a threshold response to changes in gene expression.	Boston Univ, Ctr Biodynam, Dept Biomed Engn, Boston, MA 02215 USA; Boston Univ, Ctr Adv Biotechnol, Boston, MA 02215 USA	Boston University; Boston University	Collins, JJ (corresponding author), Boston Univ, Ctr Biodynam, Dept Biomed Engn, Boston, MA 02215 USA.	jcollins@bu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070583] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM070583] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson DG, 2004, P NATL ACAD SCI USA, V101, P16028, DOI 10.1073/pnas.0407218101; Aneja R, 2006, MOL CANCER THER, V5, P2366, DOI 10.1158/1535-7163.MCT-06-0205; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; BROWN M, 1987, CELL, V49, P603, DOI 10.1016/0092-8674(87)90536-8; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GREENFIELD L, 1983, P NATL ACAD SCI-BIOL, V80, P6853, DOI 10.1073/pnas.80.22.6853; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; HU MCT, 1987, CELL, V48, P555, DOI 10.1016/0092-8674(87)90234-0; Imai T, 2001, P NATL ACAD SCI USA, V98, P224, DOI 10.1073/pnas.011528898; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Isalan M, 2005, PLOS BIOL, V3, P488, DOI 10.1371/journal.pbio.0030064; Katiyar SK, 2005, MOL CANCER THER, V4, P207; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kramer BP, 2005, METAB ENG, V7, P241, DOI 10.1016/j.ymben.2005.02.005; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Malphettes L, 2006, J BIOTECHNOL, V124, P732, DOI 10.1016/j.jbiotec.2006.01.003; ORNITZ DM, 1991, P NATL ACAD SCI USA, V88, P698, DOI 10.1073/pnas.88.3.698; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pastorino JG, 1998, J BIOL CHEM, V273, P7770, DOI 10.1074/jbc.273.13.7770; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Peng WD, 2002, MOL THER, V6, P537, DOI 10.1006/mthe.2002.0694; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Scrable H, 2002, SEMIN CELL DEV BIOL, V13, P109, DOI 10.1016/S1084-9521(02)00017-4; Shinoura N, 1999, ONCOGENE, V18, P5703, DOI 10.1038/sj.onc.1202966; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	48	198	225	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					363	372		10.1016/j.cell.2007.05.045	http://dx.doi.org/10.1016/j.cell.2007.05.045			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662949	Bronze			2022-12-01	WOS:000248588000024
J	Myong, S; Bruno, MM; Pyle, AM; Ha, T				Myong, Sua; Bruno, Michael M.; Pyle, Anna M.; Ha, Taekjip			Spring-loaded mechanism of DNA unwinding by hepatitis C virus NS3 helicase	SCIENCE			English	Article							SINGLE-STRANDED-DNA; UVRD HELICASE; STEP-SIZE; RNA; PROTEIN; TRANSLOCATION; DOMAIN; RESOLUTION; DYNAMICS; TIME	NS3, an essential helicase for replication of hepatitis C virus, is a model enzyme for investigating helicase function. Using single-molecule fluorescence analysis, we showed that NS3 unwinds DNA in discrete steps of about three base pairs ( bp). Dwell time analysis indicated that about three hidden steps are required before a 3-bp step is taken. Taking into account the available structural data, we propose a spring-loaded mechanism in which several steps of one nucleotide per adenosine triphosphate molecule accumulate tension on the protein-DNA complex, which is relieved periodically via a burst of 3-bp unwinding. NS3 appears to shelter the displaced strand during unwinding, and, upon encountering a barrier or after unwinding > 18 bp, it snaps or slips backward rapidly and repeats unwinding many times in succession. Such repetitive unwinding behavior over a short stretch of duplex may help to keep secondary structures resolved during viral genome replication.	Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; Yale Univ, New Haven, CT 06511 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Yale University; Howard Hughes Medical Institute	Myong, S (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	myong@uiuc.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060620, R01GM065367] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01-GM060620, R01 GM060620, R01-GM065367, R01 GM065367] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Chao L, 1999, J VIROL, V73, P8798, DOI 10.1128/JVI.73.10.8798-8807.1999; DIBISCEGLIE AM, 1997, HEPATOLOGY S, V26, P345; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; HOUGHTON M, 1991, HEPATOLOGY, V14, P381, DOI 10.1016/0270-9139(91)91430-9; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kang LW, 1998, ACTA CRYSTALLOGR D, V54, P121, DOI 10.1107/S0907444997008883; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; KIM DW, 1995, BIOCHEM BIOPH RES CO, V215, P160, DOI 10.1006/bbrc.1995.2447; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Korolev S, 1998, PROTEIN SCI, V7, P605, DOI 10.1002/pro.5560070309; Lavanchy D, 1999, J HEPATOL, V31, P146, DOI 10.1016/S0168-8278(99)80392-4; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Marians KJ, 1997, STRUCTURE, V5, P1129, DOI 10.1016/S0969-2126(97)00263-3; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Seeff LB, 1998, HEPATOLOGY, V28, P1710, DOI 10.1002/hep.510280636; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Tai CL, 1996, J VIROL, V70, P8477, DOI 10.1128/JVI.70.12.8477-8484.1996; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Yao Hang-Ping, 2002, Zhejiang Da Xue Xue Bao Yi Xue Ban, V31, P2	24	237	241	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					513	516		10.1126/science.1144130	http://dx.doi.org/10.1126/science.1144130			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656723	Green Accepted			2022-12-01	WOS:000248339800045
J	Carpten, JD; Faber, AL; Horn, C; Donoho, GP; Briggs, SL; Robbins, CM; Hostetter, G; Boguslawski, S; Moses, TY; Savage, S; Uhlik, M; Lin, AM; Du, J; Qian, YW; Zeckner, DJ; Tucker-Kellogg, G; Touchman, J; Patel, K; Mousses, S; Bittner, M; Schevitz, R; Lai, MHT; Blanchard, KL; Thomas, JE				Carpten, John D.; Faber, Andrew L.; Horn, Candice; Donoho, Gregory P.; Briggs, Stephen L.; Robbins, Christiane M.; Hostetter, Galen; Boguslawski, Sophie; Moses, Tracy Y.; Savage, Stephanie; Uhlik, Mark; Lin, Aimin; Du, Jian; Qian, Yue-Wei; Zeckner, Douglas J.; Tucker-Kellogg, Greg; Touchman, Jeffrey; Patel, Ketan; Mousses, Spyro; Bittner, Michael; Schevitz, Richard; Lai, Mei-Huei T.; Blanchard, Kerry L.; Thomas, James E.			A transforming mutation in the pleckstrin homology domain of AKT1 in cancer	NATURE			English	Article							PROTEIN-KINASE-B; PIK3CA GENE; BREAST CANCERS; PHOSPHATIDYLINOSITOL 3-KINASE; ONCOGENIC TRANSFORMATION; SIGNALING PATHWAY; HIGH-FREQUENCY; ACTIVATION; AKT/PKB; PROTOONCOGENE	Although AKT1 (v-akt murine thymoma viral oncogene homologue 1) kinase is a central member of possibly the most frequently activated proliferation and survival pathway in cancer, mutation of AKT1 has not been widely reported. Here we report the identification of a somatic mutation in human breast, colorectal and ovarian cancers that results in a glutamic acid to lysine substitution at amino acid 17 (E17K) in the lipid-binding pocket of AKT1. Lys 17 alters the electrostatic interactions of the pocket and forms new hydrogen bonds with a phosphoinositide ligand. This mutation activates AKT1 by means of pathological localization to the plasma membrane, stimulates downstream signalling, transforms cells and induces leukaemia in mice. This mechanism indicates a direct role of AKT1 in human cancer, and adds to the known genetic alterations that promote oncogenesis through the phosphatidylinositol-3-OH kinase/AKT pathway. Furthermore, the E17K substitution decreases the sensitivity to an allosteric kinase inhibitor, so this mutation may have important clinical utility for AKT drug development.	Lilly Corp Ctr, Lilly Res Labs, Canc Discovery Res, Indianapolis, IN 46285 USA; Translat Genom Res Inst, Div Integrated Canc Genom, Phoenix, AZ 85004 USA; Lilly Corp Ctr, Lilly Res Labs, Global Struct Biol, Indianapolis, IN 46285 USA; Lilly Corp Ctr, Lilly Res Labs, Integrat Biol, Indianapolis, IN 46285 USA; Lilly Singapore, Ctr Drug Discovery, Singapore 117528, Singapore; Translat Genom Res Inst, Scottsdale, AZ 85259 USA	Eli Lilly; Translational Genomics Research Institute; Eli Lilly; Eli Lilly; Translational Genomics Research Institute	Blanchard, KL (corresponding author), Lilly Corp Ctr, Lilly Res Labs, Canc Discovery Res, Indianapolis, IN 46285 USA.	kblanc@lilly.com; thomas_james_e@lilly.com	Tucker-Kellogg, Greg/G-3344-2012	Tucker-Kellogg, Greg/0000-0001-8407-9251				ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ADAMS JM, 1991, BIOCHIM BIOPHYS ACTA, V1072, P9, DOI 10.1016/0304-419X(91)90004-5; AHMED NN, 1993, ONCOGENE, V8, P1957; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Fukuda M, 1996, J BIOL CHEM, V271, P30303, DOI 10.1074/jbc.271.48.30303; HAWLEY RG, 1994, GENE THER, V1, P136; Khan S, 2004, INT J CANCER, V112, P407, DOI 10.1002/ijc.20447; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Knobbe CB, 2003, BRAIN PATHOL, V13, P507; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Li WQ, 2004, J BIOL CHEM, V279, P37398, DOI 10.1074/jbc.M405730200; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Mirza AM, 2000, CELL GROWTH DIFFER, V11, P279; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Soung YH, 2006, ONCOLOGY-BASEL, V70, P285, DOI 10.1159/000096289; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stocker H, 2002, SCIENCE, V295, P2088, DOI 10.1126/science.1068094; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Watton SJ, 1999, CURR BIOL, V9, P433, DOI 10.1016/S0960-9822(99)80192-4; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369	37	942	979	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					439	U1		10.1038/nature05933	http://dx.doi.org/10.1038/nature05933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17611497				2022-12-01	WOS:000248302700040
J	Moffatt, MF; Kabesch, M; Liang, LM; Dixon, AL; Strachan, D; Heath, S; Depner, M; von Berg, A; Bufe, A; Rietschel, E; Heinzmann, A; Simma, B; Frischer, T; Willis-Owen, SAG; Wong, KCC; Illig, T; Vogelberg, C; Weiland, SK; von Mutius, E; Abecasis, GR; Farrall, M; Gut, IG; Lathrop, GM; Cookson, WOC				Moffatt, Miriam F.; Kabesch, Michael; Liang, Liming; Dixon, Anna L.; Strachan, David; Heath, Simon; Depner, Martin; von Berg, Andrea; Bufe, Albrecht; Rietschel, Ernst; Heinzmann, Andrea; Simma, Burkard; Frischer, Thomas; Willis-Owen, Saffron A. G.; Wong, Kenny C. C.; Illig, Thomas; Vogelberg, Christian; Weiland, Stephan K.; von Mutius, Erika; Abecasis, Goncalo R.; Farrall, Martin; Gut, Ivo G.; Lathrop, G. Mark; Cookson, William O. C.			Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma	NATURE			English	Article							NORMALIZATION	Asthma is caused by a combination of poorly understood genetic and environmental factors(1,2). We have systematically mapped the effects of single nucleotide polymorphisms ( SNPs) on the presence of childhood onset asthma by genome-wide association. We characterized more than 317,000 SNPs in DNA from 994 patients with childhood onset asthma and 1,243 non-asthmatics, using family and case-referent panels. Here we show multiple markers on chromosome 17q21 to be strongly and reproducibly associated with childhood onset asthma in family and case-referent panels with a combined P value of P < 10(-12). In independent replication studies the 17q21 locus showed strong association with diagnosis of childhood asthma in 2,320 subjects from a cohort of German children (P=0.0003) and in 3,301 subjects from the British 1958 Birth Cohort (P=0.0005). We systematically evaluated the relationships between markers of the 17q21 locus and transcript levels of genes in Epstein - Barr virus (EBV)-transformed lymphoblastoid cell lines from children in the asthma family panel used in our association study. The SNPs associated with childhood asthma were consistently and strongly associated (P < 10(-22)) in cis with transcript levels of ORMDL3, a member of a gene family that encodes transmembrane proteins anchored in the endoplasmic reticulum(3). The results indicate that genetic variants regulating ORMDL3 expression are determinants of susceptibility to childhood asthma.	Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; Univ Munich, Childrens Hosp, D-80337 Munich, Germany; Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; Univ Oxford, Wellcome Trust, Ctr Human Genet, Oxford OX3 7BN, England; Univ London, Div Community Hlth Sci, London SW17 0RE, England; CEA, Ctr Natl Genotypage, Inst Genom, F-91057 Evry, France; Marien Hosp, Res Inst Prevent Allerg Dis, Childrens Dept, D-46483 Wesel, Germany; Ruhr Univ Bochum, Dept Expt Pneumol, D-44789 Bochum, Germany; Univ Cologne, Childrens Hosp, D-50924 Cologne, Germany; Univ Freiburg, Childrens Hosp, D-79106 Freiburg, Germany; Feldkirch Hosp, Childrens Dept, A-6800 Feldkirch, Austria; Univ Vienna, Childrens Hosp, A-1090 Vienna, Austria; GSF, Res Ctr Environm & Hlth, Inst Epidemiol, D-85764 Neuherberg, Germany; Tech Univ Dresden, Childrens Hosp, S-01307 Dresden, Germany; Univ Ulm, Inst Epidemiol, D-89081 Ulm, Germany	Imperial College London; University of Munich; University of Michigan System; University of Michigan; University of Oxford; Wellcome Centre for Human Genetics; University of London; CEA; UDICE-French Research Universities; Universite Paris Saclay; St. Marien Hospital; Ruhr University Bochum; University of Cologne; University of Freiburg; University of Vienna; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Ulm University	Cookson, WOC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England.	w.cookson@imperial.ac.uk	Abecasis, Goncalo R/B-7840-2010; Gut, Ivo/ABF-3188-2020; Kabesch, Michael/AAB-5701-2020; Heath, Simon C/J-4138-2012; Kabesch, Michael/GZM-1583-2022	Heath, Simon C/0000-0002-9550-0897; Abecasis, Goncalo/0000-0003-1509-1825; Bufe, Albrecht/0000-0001-7335-9362; Willis-Owen, Saffron/0000-0003-2633-1150; von Mutius, Erika/0000-0002-8893-4515	MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buetow KH, 2001, P NATL ACAD SCI USA, V98, P581, DOI 10.1073/pnas.021506298; Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; Cardon LR, 1999, AM J HUM GENET, V65, pA245; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Setakis E, 2006, GENOME RES, V16, P290, DOI 10.1101/gr.4346306; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Wedzicha JA, 2003, THORAX, V58, P1, DOI 10.1136/thorax.58.1.1; Weiland SK, 2004, EUR RESPIR J, V24, P406, DOI 10.1183/09031936.04.00090303; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; 1987, AM REV RESP DIS, V136, P225, DOI 10.1164/ajrccm/136.1.225	22	1148	1212	2	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					470	U5		10.1038/nature06014	http://dx.doi.org/10.1038/nature06014			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17611496	Green Published			2022-12-01	WOS:000248302700046
J	Richter, S; Geldner, N; Schrader, J; Wolters, H; Stierhof, YD; Rios, G; Koncz, C; Robinson, DG; Jurgens, G				Richter, Sandra; Geldner, Niko; Schrader, Jarmo; Wolters, Hanno; Stierhof, York-Dieter; Rios, Gabino; Koncz, Csaba; Robinson, David G.; Juergens, Gerd			Functional diversification of closely related ARF-GEFs in protein secretion and recycling	NATURE			English	Article							NUCLEOTIDE-EXCHANGE FACTORS; BREFELDIN-A; AUXIN TRANSPORT; FACTORS GEA1P; PLANT-CELLS; ARABIDOPSIS; GOLGI; GNOM; LOCALIZATION; TRAFFICKING	Guanine-nucleotide exchange factors on ADP-ribosylation factor GTPases (ARF-GEFs) regulate vesicle formation in time and space by activating ARF substrates on distinct donor membranes(1). Mammalian GBF1 (ref. 2) and yeast Gea1/2 ( ref. 3) ARF-GEFs act at Golgi membranes, regulating COPI-coated vesicle formation. In contrast, their Arabidopsis thaliana homologue GNOM (GN) is required for endosomal recycling, playing an important part in development(4). This difference indicates an evolutionary divergence of trafficking pathways between animals and plants, and raised the question of how endoplasmic reticulum - Golgi transport is regulated in plants. Here we demonstrate that the closest homologue of GNOM in Arabidopsis, GNOM-LIKE1 (GNL1; NM_ 123312; At5g39500), performs this ancestral function. GNL1 localizes to and acts primarily at Golgi stacks, regulating COPI-coated vesicle formation. Surprisingly, GNOM can functionally substitute for GNL1, but not vice versa. Our results suggest that large ARF-GEFs of the GBF1 class perform a conserved role in endoplasmic reticulum - Golgi trafficking and secretion, which is done by GNL1 and GNOM in Arabidopsis, whereas GNOM has evolved to perform an additional plant-specific function of recycling from endosomes to the plasma membrane. Duplication and diversification of ARF-GEFs in plants contrasts with the evolution of entirely new classes of ARF-GEFs(5) for endosomal trafficking in animals, which illustrates the independent evolution of complex endosomal pathways in the two kingdoms.	Univ Tubingen, ZMBP, D-72076 Tubingen, Germany; Max Planck Inst Pflanzenzuchtung, D-50829 Cologne, Germany; Heidelberg Univ, Dept Cell Biol, Heidelberg Inst Plant Sci, D-69120 Heidelberg, Germany	Eberhard Karls University of Tubingen; Max Planck Society; Ruprecht Karls University Heidelberg	Jurgens, G (corresponding author), Univ Tubingen, ZMBP, Auf Morgenstelle 3, D-72076 Tubingen, Germany.	gerd.juergens@zmbp.uni-tuebingen.de	Rios, Gabino/F-4046-2011; Geldner, Niko/Y-2481-2019	Rios, Gabino/0000-0002-1398-282X; Geldner, Niko/0000-0002-2300-9644				Barzilay E, 2005, TRAFFIC, V6, P794, DOI 10.1111/j.1600-0854.2005.00317.x; Cherfils J, 2005, BIOCHEM SOC T, V33, P635, DOI 10.1042/BST0330635; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Lee GJ, 2004, PLANT CELL PHYSIOL, V45, P1211, DOI 10.1093/pcp/pch142; MAYER U, 1993, DEVELOPMENT, V117, P149; Mouratou B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-20; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Peyroche A, 2001, J CELL SCI, V114, P2241; Pimpl P, 2000, PLANT CELL, V12, P2219, DOI 10.1105/tpc.12.11.2219; Rios G, 2002, PLANT J, V32, P243, DOI 10.1046/j.1365-313X.2002.01416.x; Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shin HW, 2004, J BIOCHEM, V136, P761, DOI 10.1093/jb/mvh185; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Song J, 2006, PLANT CELL, V18, P2258, DOI 10.1105/tpc.105.039123; Spang A, 2001, MOL BIOL CELL, V12, P1035, DOI 10.1091/mbc.12.4.1035; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Ueda T, 2004, PLANT J, V40, P783, DOI 10.1111/j.1365-313X.2004.02249.x; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Volker A, 2001, J CELL SCI, V114, P3001; Weijers D, 2003, PLANT PHYSIOL, V133, P1882, DOI 10.1104/pp.103.030692; Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173	30	181	194	0	39	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 26	2007	448	7152					488	U10		10.1038/nature05967	http://dx.doi.org/10.1038/nature05967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653190	Green Published			2022-12-01	WOS:000248302700050
J	Ameres, SL; Martinez, J; Schroeder, R				Ameres, Stefan Ludwig; Martinez, Javier; Schroeder, Renee			Molecular basis for target RNA recognition and cleavage by human RISC	CELL			English	Article							INFLUENCES SIRNA EFFICACY; DOUBLE-STRANDED-RNA; MESSENGER-RNA; CRYSTAL-STRUCTURE; PASSENGER-STRAND; INTERFERENCE; ARGONAUTE2; MICRORNA; PROTEIN; GENE	The RNA- Induced Silencing Complex ( RISC) is a ribonucleoprotein particle composed of a single- stranded short interfering RNA ( siRNA) and an endonucleolytically active Argonaute protein, capable of cleaving mRNAs complementary to the siRNA. The mechanism by which RISC cleaves a target RNA is well understood, however it remains enigmatic how RISC finds its target RNA. Here, we show, both in vitro and in vivo, that the accessibility of the target site correlates directly with the efficiency of cleavage, demonstrating that RISC is unable to unfold structured RNA. In the course of target recognition, RISC transiently contacts single-stranded RNA nonspecifically and promotes siRNA- target RNA annealing. Furthermore, the 50 part of the siRNA within RISC creates a thermodynamic threshold that determines the stable association of RISC and the target RNA. We therefore provide mechanistic insights by revealing features of RISC and target RNAs that are crucial to achieve efficiency and specificity in RNA interference.	Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Martinez, J (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, IMBA, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	javier.martinez@imba.oeaw.ac.at; renee.schroeder@univie.ac.at	Ameres, Stefan L./B-4046-2012; Ameres, Stefan/G-3775-2010	Ameres, Stefan L./0000-0002-8248-3098; Martinez, Javier/0000-0001-9152-7323				Ameres SL, 2005, EMBO J, V24, P358, DOI 10.1038/sj.emboj.7600531; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boese Q, 2005, METHOD ENZYMOL, V392, P73, DOI 10.1016/S0076-6879(04)92005-8; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brown KM, 2005, NAT STRUCT MOL BIOL, V12, P469, DOI 10.1038/nsmb931; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gu S, 2005, RNA, V11, P38, DOI 10.1261/rna.7158605; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Heale BSE, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni026; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Luo KQ, 2004, BIOCHEM BIOPH RES CO, V318, P303, DOI 10.1016/j.bbrc.2004.04.027; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Overhoff M, 2005, J MOL BIOL, V348, P871, DOI 10.1016/j.jmb.2005.03.012; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Schubert S, 2005, J MOL BIOL, V348, P883, DOI 10.1016/j.jmb.2005.03.011; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sen GL, 2005, DIFFERENTIATION, V73, P287, DOI 10.1111/j.1432-0436.2005.00029.x; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Wassarman KM, 2002, CELL, V109, P141, DOI 10.1016/S0092-8674(02)00717-1; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	62	379	416	3	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2007	130	1					101	112		10.1016/j.cell.2007.04.037	http://dx.doi.org/10.1016/j.cell.2007.04.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632058	Bronze			2022-12-01	WOS:000248587000014
J	Rust, MJ; Markson, JS; Lane, WS; Fisher, DS; O'Shea, EK				Rust, Michael J.; Markson, Joseph S.; Lane, William S.; Fisher, Daniel S.; O'Shea, Erin K.			Ordered phosphorylation governs oscillation of a three-protein circadian clock	SCIENCE			English	Article							KAIC PHOSPHORYLATION; SYNECHOCOCCUS-ELONGATUS; CRYSTAL-STRUCTURE; PROTEIN KAIA; RHYTHM; MODEL; CYCLE	The simple circadian oscillator found in cyanobacteria can be reconstituted in vitro using three proteins-KaiA, KaiB, and KaiC. The total phosphorylation level of KaiC oscillates with a circadian period, but the mechanism underlying its sustained oscillation remains unclear. We have shown that four forms of KaiC differing in their phosphorylation state appear in an ordered pattern arising from the intrinsic autokinase and autophosphatase rates of KaiC and their modulation by KaiA. Kinetic and biochemical data indicate that one of these phosphoforms inhibits the activity of KaiA through interaction with KaiB, providing the crucial feedback that sustains oscillation. A mathematical model constrained by experimental data quantitatively reproduces the circadian period and the distinctive dynamics of the four phosphoforms.	Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol,Dept Mol & Cellular & Biol, Cambridge, MA 02138 USA; Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol,Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Microchem & Prote Anal Facil, Cambridge, MA 02138 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Stanford University	O'Shea, EK (corresponding author), Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol,Dept Mol & Cellular & Biol, Cambridge, MA 02138 USA.	erin_oshea@harvard.edu	Fisher, Daniel S/A-4134-2011	Markson, Joseph/0000-0002-3167-3887; Fisher, Daniel/0000-0002-5559-2491				Clodong S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100128; Emberly E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.038303; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Iwasaki H, 1999, EMBO J, V18, P1137, DOI 10.1093/emboj/18.5.1137; Kageyama H, 2003, J BIOL CHEM, V278, P2388, DOI 10.1074/jbc.M208899200; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; Kurosawa G, 2006, BIOPHYS J, V91, P2015, DOI 10.1529/biophysj.105.076554; Mehra A, 2006, PLOS COMPUT BIOL, V2, P816, DOI 10.1371/journal.pcbi.0020096; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Miyoshi F, 2007, J BIOL RHYTHM, V22, P69, DOI 10.1177/0748730406295749; Mori T, 2002, P NATL ACAD SCI USA, V99, P17203, DOI 10.1073/pnas.262578499; Mori T, 2007, PLOS BIOL, V5, P841, DOI 10.1371/journal.pbio.0050093; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; Takigawa-Imamura H, 2006, J BIOL RHYTHM, V21, P405, DOI 10.1177/0748730406291329; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; van Zon JS, 2007, P NATL ACAD SCI USA, V104, P7420, DOI 10.1073/pnas.0608665104; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Ye S, 2004, J BIOL CHEM, V279, P20511, DOI 10.1074/jbc.M400077200; Yoda M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000408	27	257	270	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 2	2007	318	5851					809	812		10.1126/science.1148596	http://dx.doi.org/10.1126/science.1148596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17916691	Green Accepted			2022-12-01	WOS:000250583900044
J	Stommel, JM; Kimmelman, AC; Ying, HQ; Nabioullin, R; Ponugoti, AH; Wiedemeyer, R; Stegh, AH; Bradner, JE; Ligon, KL; Brennan, C; Chin, L; DePinho, RA				Stommel, Jayne M.; Kimmelman, Alec C.; Ying, Haoqiang; Nabioullin, Roustem; Ponugoti, Aditya H.; Wiedemeyer, Ruprecht; Stegh, Alexander H.; Bradner, James E.; Ligon, Keith L.; Brennan, Cameron; Chin, Lynda; DePinho, Ronald A.			Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies	SCIENCE			English	Article							CONFERS ENHANCED TUMORIGENICITY; DIFFUSE GLIOMAS; INHIBITORS; CANCER; GLIOBLASTOMA; MARKER; COMMON; BRAIN; GENE; MET	Targeted therapies that inhibit receptor tyrosine kinases (RTKs) and the downstream phosphatidylinositol 3-kinase (PI3K) signaling pathway have shown promising anticancer activity, but their efficacy in the brain tumor glioblastoma multiforme (GBM) and other solid tumors has been modest. We hypothesized that multiple RTKs are coactivated in these tumors and that redundant inputs drive and maintain downstream signaling, thereby limiting the efficacy of therapies targeting single RTKs. Tumor cell lines, xenotransplants, and primary tumors indeed show multiple concomitantly activated RTKs. Combinations of RTK inhibitors and/or RNA interference, but not single agents, decreased signaling, cell survival, and anchorage-independent growth even in glioma cells deficient in PTEN, a frequently inactivated inhibitor of PI3K. Thus, effective GBM therapy may require combined regimens targeting multiple RTKs.	Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Harvard Radiat Oncol Program, Boston, MA 02115 USA; Dana Farber Canc Inst, Belfer Inst Innovat Canc Sci, Ctr Appl Canc Sci, Boston, MA 02115 USA; Dana Farber Canc Inst, Div Hematol Neoplasia, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Div Neuropathol, Boston, MA 02115 USA; Cornell Univ, Dept Neurosurg, Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Neurol Surg, New York, NY 10021 USA; Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	DePinho, RA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu	Stommel, Jayne M/M-3439-2017; Ying, Haoqiang/AAK-4325-2020; Brennan, Cameron/R-7082-2019	Brennan, Cameron/0000-0003-4064-8891; DePinho, Ronald/0000-0002-5625-577X	NATIONAL CANCER INSTITUTE [P01CA095616, R01CA099041] Funding Source: NIH RePORTER; NCI NIH HHS [5P01CA95616, R01CA99041] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; El-Obeid A, 1997, CANCER RES, V57, P5598; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Nagane M, 1996, CANCER RES, V56, P5079; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Rich JN, 2004, J CLIN ONCOL, V22, P133, DOI 10.1200/JCO.2004.08.110; Sonoda Y, 2001, CANCER RES, V61, P4956; Sugawara K, 2002, LAB INVEST, V82, P345, DOI 10.1038/labinvest.3780428; Varmus H, 2006, SCIENCE, V312, P1162, DOI 10.1126/science.1126758; Wang HM, 2004, LAB INVEST, V84, P941, DOI 10.1038/labinvest.3700123; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Wen PY, 2006, CLIN CANCER RES, V12, P4899, DOI 10.1158/1078-0432.CCR-06-0773; WULLICH B, 1994, ANTICANCER RES, V14, P577	20	714	769	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2007	318	5848					287	290		10.1126/science.1142946	http://dx.doi.org/10.1126/science.1142946			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17872411				2022-12-01	WOS:000250086100051
J	Stolarski, J; Meibom, A; Przenioslo, R; Mazur, M				Stolarski, Jaroslaw; Meibom, Anders; Przenioslo, Radoslaw; Mazur, Maciej			A Cretaceous scleractinian coral with a calcitic skeleton	SCIENCE			English	Article							ANISOTROPIC LATTICE-DISTORTIONS; EVOLUTION; GEOCHEMISTRY; ARAGONITE; SEAWATER; REEF; PH	It has been generally thought that scleractinian corals form purely aragonitic skeletons. We show that a well-preserved fossil coral, Coelosmilia sp. from the Upper Cretaceous (about 70 million years ago), has preserved skeletal structural features identical to those observed in present-day scleractinians. However, the skeleton of Coelosmilia sp. is entirely calcitic. Its fine-scale structure and chemistry indicate that the calcite is primary and did not form from the diagenetic alteration of aragonite. This result implies that corals, like other groups of marine, calcium carbonate-producing organisms, can form skeletons of different carbonate polymorphs.	Polish Acad Sci, Inst Paleobiol, PL-00818 Warsaw, Poland; Museum Natl Hist Nat, LEME, F-75005 Paris, France; Univ Warsaw, Inst Expt Phys, PL-00681 Warsaw, Poland; Univ Warsaw, Dept Chem, Lab Electrochem, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences; Museum National d'Histoire Naturelle (MNHN); University of Warsaw; University of Warsaw	Stolarski, J (corresponding author), Polish Acad Sci, Inst Paleobiol, Twarda 51-55, PL-00818 Warsaw, Poland.	stolacy@twarda.pan.pl	Stolarski, Jaroslaw/AAF-7331-2019; Stolarski, Jaroslaw/V-9586-2017	Stolarski, Jaroslaw/0000-0003-0994-6823; Stolarski, Jaroslaw/0000-0003-0994-6823; Przenioslo, Radoslaw/0000-0002-7550-6976; Mazur, Maciej/0000-0002-9197-5553; Meibom, Anders/0000-0002-4542-2819				Allison N, 2005, GEOCHIM COSMOCHIM AC, V69, P3801, DOI 10.1016/j.gca.2005.01.026; BARNES DJ, 1984, J EXP MAR BIOL ECOL, V79, P213, DOI 10.1016/0022-0981(84)90196-5; BOGGILD OB, 1930, D KGL DANSKE VIDENSK, V2, P232; Cairns Stephen D., 1995, New Zealand Oceanographic Institute Memoir, V103, P1; Constanz B., 1990, P201; CORNISH V, 1888, GEOL MAG, V5, P66; Cuif Jean-Pierre, 1998, Palaeontologische Zeitschrift, V72, P257; Cuif JP, 2005, J STRUCT BIOL, V150, P319, DOI 10.1016/j.jsb.2005.03.004; Enders M., 1932, Archiv fuer Naturgeschichte Berlin (NF), V1, P646; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Gautret P, 2000, ACTA PALAEONTOL POL, V45, P107; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Meibom A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028657; Meibom A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025968; OLIVER WA, 1980, PALEOBIOLOGY, V6, P146, DOI 10.1017/S0094837300006709; Pokroy B, 2004, NAT MATER, V3, P900, DOI 10.1038/nmat1263; Pokroy B, 2006, J STRUCT BIOL, V155, P96, DOI 10.1016/j.jsb.2006.03.008; Ries JB, 2006, GEOLOGY, V34, P525, DOI 10.1130/G22600.1; Rollion-Bard C, 2003, EARTH PLANET SC LETT, V215, P275, DOI 10.1016/S0012-821X(03)00391-1; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Roniewicz Ewa, 1993, Courier Forschungsinstitut Senckenberg, V164, P233; Sinclair DJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027183; Sorauf JE, 1999, J PALEONTOL, V73, P1029, DOI 10.1017/S0022336000030961; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; Stolarski J, 2005, ACTA PALAEONTOL POL, V50, P847; Stolarski J, 2003, ACTA PALAEONTOL POL, V48, P497; Stolarski J, 2007, FACIES, V53, P67, DOI 10.1007/s10347-006-0089-6; Wendt J., 1990, P45; [No title captured]	31	65	69	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					92	94		10.1126/science.1149237	http://dx.doi.org/10.1126/science.1149237			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916731				2022-12-01	WOS:000249915400047
J	Kefi, S; Rietkerk, M; Alados, CL; Pueyo, Y; Papanastasis, VP; ElAich, A; de Ruiter, PC				Kefi, Sonia; Rietkerk, Max; Alados, Concepcion L.; Pueyo, Yolanda; Papanastasis, Vasilios P.; ElAich, Ahmed; de Ruiter, Peter C.			Spatial vegetation patterns and imminent desertification in Mediterranean arid ecosystems	NATURE			English	Article							SELF-ORGANIZED PATCHINESS; CATASTROPHIC SHIFTS; GLOBAL DESERTIFICATION; FACILITATION; CRITICALITY; DISTURBANCE; COMPETITION; SIGNATURES; DYNAMICS; SYSTEMS	Humans and climate affect ecosystems and their services(1), which may involve continuous and discontinuous transitions from one stable state to another(2). Discontinuous transitions are abrupt, irreversible and among the most catastrophic changes of ecosystems identified(1). For terrestrial ecosystems, it has been hypothesized that vegetation patchiness could be used as a signature of imminent transitions(3,4). Here, we analyse how vegetation patchiness changes in arid ecosystems with different grazing pressures, using both field data and a modelling approach. In the modelling approach, we extrapolated our analysis to even higher grazing pressures to investigate the vegetation patchiness when desertification is imminent. In three arid Mediterranean ecosystems in Spain, Greece and Morocco, we found that the patch-size distribution of the vegetation follows a power law. Using a stochastic cellular automaton model, we show that local positive interactions among plants can explain such power-law distributions. Furthermore, with increasing grazing pressure, the field data revealed consistent deviations from power laws. Increased grazing pressure leads to similar deviations in the model. When grazing was further increased in the model, we found that these deviations always and only occurred close to transition to desert, independent of the type of transition, and regardless of the vegetation cover. Therefore, we propose that patch-size distributions may be a warning signal for the onset of desertification.	Univ Utrecht, Copernicus Inst, Dept Environm Sci, NL-3508 TC Utrecht, Netherlands; Pyrenean Inst Ecol, Zaragoza 50192, Spain; Aristotle Univ Thessaloniki, Lab Rangeland Ecol, Thessaloniki 54006, Greece; Inst Agron & Vet Hassan II, Dept Anim Prod, Rabat, Morocco; Univ Wageningen & Res Ctr, Soil Ctr, NL-6708 PB Wageningen, Netherlands	Utrecht University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); Aristotle University of Thessaloniki; Wageningen University & Research	Kefi, S (corresponding author), Univ Utrecht, Copernicus Inst, Dept Environm Sci, POB 80115, NL-3508 TC Utrecht, Netherlands.	kefi@geo.uu.nl	Pueyo, Yolanda/I-4248-2015; Alados, Concepción L/K-8085-2014; Rietkerk, Max/H-6235-2011	Pueyo, Yolanda/0000-0001-6970-7790; Alados, Concepción L/0000-0002-6227-861X; Kefi, Sonia/0000-0002-9678-7770; Rietkerk, Max/0000-0002-2698-3848				Aguiar MR, 1999, TRENDS ECOL EVOL, V14, P273, DOI 10.1016/S0169-5347(99)01612-2; Alados CL, 2006, BIOL J LINN SOC, V87, P103, DOI 10.1111/j.1095-8312.2006.00559.x; Alados CL, 2004, ECOL MODEL, V180, P523, DOI 10.1016/j.ecolmodel.2003.10.034; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; Brown JH, 2002, PHILOS T R SOC B, V357, P619, DOI 10.1098/rstb.2001.0993; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Guichard F, 2003, AM NAT, V161, P889, DOI 10.1086/375300; INGERSON TE, 1984, PHYSICA D, V10, P59, DOI 10.1016/0167-2789(84)90249-5; IWASA Y, 2000, GEOMETRY ECOLOGICAL, P227; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kefi S, 2007, THEOR POPUL BIOL, V71, P367, DOI 10.1016/j.tpb.2006.09.003; KUTZNETSOV YA, 1997, CONTENT MULTIPLATFOR; Malamud BD, 1998, SCIENCE, V281, P1840, DOI 10.1126/science.281.5384.1840; MATSUDA H, 1992, PROG THEOR PHYS, V88, P1035, DOI 10.1143/PTP.88.1035; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING; NOYMEIR I, 1975, J ECOL, V63, P459, DOI 10.2307/2258730; Pascual M, 2005, TRENDS ECOL EVOL, V20, P88, DOI 10.1016/j.tree.2004.11.012; Pascual M, 2002, PHILOS T ROY SOC B, V357, P657, DOI 10.1098/rstb.2001.0983; Pueyo Y, 2007, BASIC APPL ECOL, V8, P158, DOI 10.1016/j.baae.2006.03.009; Pugnaire FI, 1996, ECOLOGY, V77, P1420, DOI 10.2307/2265539; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; SCHABENBERGER O, 2002, CONT STAT MODELS PLA, P1; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; SOLE RV, 2006, SELF ORG COMPLEX ECO, P215; Vandermeer J, 2006, SCIENCE, V311, P1000, DOI 10.1126/science.1121432; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; [No title captured]	30	680	711	20	503	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					213	U5		10.1038/nature06111	http://dx.doi.org/10.1038/nature06111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851524	Green Published			2022-12-01	WOS:000249394500049
J	Gilbert, WV; Zhou, KH; Butler, TK; Doudna, JA				Gilbert, Wendy V.; Zhou, Kaihong; Butler, Tamira K.; Doudna, Jennifer A.			Cap-independent translation is required for starvation-induced differentiation in yeast	SCIENCE			English	Article							INITIATION-FACTOR; MESSENGER-RNAS; SACCHAROMYCES-CEREVISIAE; PROTEIN; COMPLEX; EIF4G	Cellular internal ribosome entry sites ( IRESs) are untranslated segments of mRNA transcripts thought to initiate protein synthesis in response to environmental stresses that prevent canonical 5' cap-dependent translation. Although numerous cellular mRNAs are proposed to have IRESs, none has a demonstrated physiological function or molecular mechanism. Here we show that seven yeast genes required for invasive growth, a developmental pathway induced by nutrient limitation, contain potent IRESs that require the initiation factor eIF4G for cap-independent translation. In contrast to the RNA structure-based activity of viral IRESs, we show that an unstructured A-rich element mediates internal initiation via recruitment of the poly( A) binding protein ( Pab1) to the 5' untranslated region ( UTR) of invasive growth messages. A 5' UTR mutation that impairs IRES activity compromises invasive growth, which indicates that cap-independent translation is required for physiological adaptation to stress.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	doudna@berkeley.edu		/0000-0003-2807-9657				Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; BABLANIAN R, 1991, J VIROL, V65, P4449, DOI 10.1128/JVI.65.8.4449-4460.1991; Berset C, 1998, P NATL ACAD SCI USA, V95, P4264, DOI 10.1073/pnas.95.8.4264; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Holmes LEA, 2004, MOL CELL BIOL, V24, P2998, DOI 10.1128/MCB.24.7.2998-3010.2004; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; Kahvejian A, 2005, GENE DEV, V19, P104, DOI 10.1101/gad.1262905; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Liu HP, 1996, GENETICS, V144, P967; Marr MT, 2007, GENE DEV, V21, P175, DOI 10.1101/gad.1506407; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Mulder J, 1998, J VIROL, V72, P8813, DOI 10.1128/JVI.72.11.8813-8819.1998; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Sachs A, 2000, COLD SPRING HARBOR M, V39, P447; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Suzuki C, 2003, YEAST, V20, P407, DOI 10.1002/yea.970; von der Haar T, 2002, MOL MICROBIOL, V46, P531, DOI 10.1046/j.1365-2958.2002.03172.x; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584	19	145	148	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2007	317	5842					1224	1227		10.1126/science.1144467	http://dx.doi.org/10.1126/science.1144467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205PJ	17761883				2022-12-01	WOS:000249126800041
J	Fischler, W; Kong, P; Marella, S; Scott, K				Fischler, Walter; Kong, Priscilla; Marella, Sunanda; Scott, Kristin			The detection of carbonation by the Drosophila gustatory system	NATURE			English	Article							CANDIDATE TASTE RECEPTORS; RESPONSES; NEURONS; MELANOGASTER; BEHAVIOR; OXYGEN; BRAIN	There are five known taste modalities in humans: sweet, bitter, sour, salty and umami (the taste of monosodium glutamate). Although the fruitfly Drosophila melanogaster tastes sugars, salts and noxious chemicals, the nature and number of taste modalities in this organism is not clear. Previous studies have identified one taste cell population marked by the gustatory receptor gene Gr5a that detects sugars, and a second population marked by Gr66a that detects bitter compounds(1-4). Here we identify a novel taste modality in this insect: the taste of carbonated water. We use a combination of anatomical, calcium imaging and behavioural approaches to identify a population of taste neurons that detects CO2 and mediates taste acceptance behaviour. The taste of carbonation may allow Drosophila to detect and obtain nutrients from growing microorganisms. Whereas CO2 detection by the olfactory system mediates avoidance(5), CO2 detection by the gustatory system mediates acceptance behaviour, demonstrating that the context of CO2 determines appropriate behaviour. This work opens up the possibility that the taste of carbonation may also exist in other organisms.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Scott, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 291 Life Sci Addit, Berkeley, CA 94720 USA.	kscott@berkeley.edu		Fischler-Ruiz, Walter/0000-0003-3998-3588	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006252] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC006252] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Coates EL, 2001, RESP PHYSIOL, V129, P219, DOI 10.1016/S0034-5687(01)00292-4; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Inoshita T, 2006, P NATL ACAD SCI USA, V103, P1094, DOI 10.1073/pnas.0502376103; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; MCGUIRE SE, 2004, SCI STKE 2004; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8	22	94	102	3	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2007	448	7157					1054	U9		10.1038/nature06101	http://dx.doi.org/10.1038/nature06101			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205EU	17728758				2022-12-01	WOS:000249097600039
J	St Maurice, M; Reinhardt, L; Surinya, KH; Attwood, PV; Wallace, JC; Cleland, WW; Rayment, I				St Maurice, Martin; Reinhardt, Laurie; Surinya, Kathy H.; Attwood, Paul V.; Wallace, John C.; Cleland, W. Wallace; Rayment, Ivan			Domain architecture of pyruvate carboxylase, a biotin-dependent multifunctional enzyme	SCIENCE			English	Article							ACETYL-COENZYME; CRYSTAL-STRUCTURE; ATP-BINDING; B-DOMAIN; SUBUNIT; PROTEIN; TRANSCARBOXYLASE; IDENTIFICATION; SYNTHASE; RESIDUE	Biotin-dependent multifunctional enzymes carry out metabolically important carboxyl group transfer reactions and are potential targets for the treatment of obesity and type 2 diabetes. These enzymes use a tethered biotin cofactor to carry an activated carboxyl group between distantly spaced active sites. The mechanism of this transfer has remained poorly understood. Here we report the complete structure of pyruvate carboxylase at 2.0 angstroms resolution, which shows its domain arrangement. The structure, when combined with mutagenic analysis, shows that intermediate transfer occurs between active sites on separate polypeptide chains. In addition, domain rearrangements associated with activator binding decrease the distance between active-site pairs, providing a mechanism for allosteric activation. This description provides insight into the function of biotin-dependent enzymes and presents a new paradigm for multifunctional enzyme catalysis.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; Univ Western Australia, Sch Biomed Biomol & Chem Sci, Crawley, WA 6009, Australia	University of Wisconsin System; University of Wisconsin Madison; University of Adelaide; University of Western Australia	Rayment, I (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	Ivan_Rayment@biochem.wisc.edu	Attwood, Paul V/I-8207-2012; St.Maurice, Martin/AAL-5054-2021; , John/AAP-5150-2020; St. Maurice, Martin/AGJ-6319-2022; rayment, ivan/A-2720-2008	St. Maurice, Martin/0000-0002-6507-9528; rayment, ivan/0000-0001-9279-7835; Reinhardt, Laurie/0000-0002-5488-0440; Surinya, Kathy/0000-0003-0507-2962	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR035186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070455] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR35186] Funding Source: Medline; NIGMS NIH HHS [GM070455] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATTWOOD PV, 1993, BIOCHEM J, V290, P583, DOI 10.1042/bj2900583; Attwood PV, 2002, ACCOUNTS CHEM RES, V35, P113, DOI 10.1021/ar000049+; CAZZULO JJ, 1968, ARCH BIOCHEM BIOPHYS, V127, P563, DOI 10.1016/0003-9861(68)90263-4; CHAPMANSMITH A, 1991, BIOCHEM J, V276, P759, DOI 10.1042/bj2760759; de Queiroz MS, 2007, J THEOR BIOL, V246, P167, DOI 10.1016/j.jtbi.2006.12.025; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; FAHIEN LA, 1993, J BIOL CHEM, V268, P17935; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Hall PR, 2004, EMBO J, V23, P3621, DOI 10.1038/sj.emboj.7600373; Jitrapakdee S, 2006, CELL MOL LIFE SCI, V63, P843, DOI 10.1007/s00018-005-5410-y; Jitrapakdee S, 2003, CURR PROTEIN PEPT SC, V4, P217, DOI 10.2174/1389203033487199; Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001; Kazuta Y, 1998, FEBS LETT, V427, P377, DOI 10.1016/S0014-5793(98)00472-4; Kondo S, 2004, ACTA CRYSTALLOGR D, V60, P486, DOI 10.1107/S0907444904000423; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; PetersWendisch PG, 1997, MICROBIOL-SGM, V143, P1095, DOI 10.1099/00221287-143-4-1095; Rangan VS, 1998, J BIOL CHEM, V273, P34949, DOI 10.1074/jbc.273.52.34949; Raushel FM, 2003, ACCOUNTS CHEM RES, V36, P539, DOI 10.1021/ar020047k; Reddy DV, 1998, PROTEIN SCI, V7, P2156, DOI 10.1002/pro.5560071013; Roberts EL, 1999, BIOCHEMISTRY-US, V38, P5045, DOI 10.1021/bi982466o; Studer R, 2007, J MOL BIOL, V367, P547, DOI 10.1016/j.jmb.2006.12.035; Tang YY, 2006, P NATL ACAD SCI USA, V103, P11124, DOI 10.1073/pnas.0601924103; Thoden JB, 2000, J BIOL CHEM, V275, P16183, DOI 10.1074/jbc.275.21.16183; Thoden JB, 2000, BIOCHEMISTRY-US, V39, P8791, DOI 10.1021/bi000926j; Thoden JB, 1999, BIOCHEMISTRY-US, V38, P2347, DOI 10.1021/bi982517h; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Yongbiao J, 2004, BIOCHEMISTRY-US, V43, P5912, DOI 10.1021/bi035783q	29	95	98	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2007	317	5841					1076	1079		10.1126/science.1144504	http://dx.doi.org/10.1126/science.1144504			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203AE	17717183				2022-12-01	WOS:000248946700043
J	Rezende, EL; Lavabre, JE; Guimaraes, PR; Jordano, P; Bascompte, J				Rezende, Enrico L.; Lavabre, Jessica E.; Guimaraes, Paulo R., Jr.; Jordano, Pedro; Bascompte, Jordi			Non-random coextinctions in phylogenetically structured mutualistic networks	NATURE			English	Article							PLANT-ANIMAL INTERACTIONS; COEVOLUTIONARY NETWORKS; EVOLUTIONARY HISTORY; SPECIALIZATION; EXTINCTIONS; CONSTRAINTS; ADAPTATION; TOLERANCE	The interactions between plants and their animal pollinators and seed dispersers have moulded much of Earth's biodiversity(1-3). Recently, it has been shown that these mutually beneficial interactions form complex networks with a well-defined architecture that may contribute to biodiversity persistence(4-8). Little is known, however, about which ecological and evolutionary processes generate these network patterns(3,9). Here we use phylogenetic methods(10,11) to show that the phylogenetic relationships of species predict the number of interactions they exhibit in more than one-third of the networks, and the identity of the species with which they interact in about half of the networks. As a consequence of the phylogenetic effects on interaction patterns, simulated extinction events tend to trigger coextinction cascades of related species. This results in a non-random pruning of the evolutionary tree(12,13) and a more pronounced loss of taxonomic diversity than expected in the absence of a phylogenetic signal. Our results emphasize how the simultaneous consideration of phylogenetic information and network architecture can contribute to our understanding of the structure and fate of species-rich communities.	CSIC, Estac Biol Donana, Integrat Ecol Grp, E-41080 Seville, Spain; Univ Estadual Campinas, Inst Fis Gleb Wataghin, BR-13083970 Campinas, SP, Brazil	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidade Estadual de Campinas	Bascompte, J (corresponding author), CSIC, Estac Biol Donana, Integrat Ecol Grp, Apdo 1056, E-41080 Seville, Spain.	bascompte@ebd.csic.es	Rezende, Enrico L./S-3219-2019; Rezende, Enrico L/B-8029-2012; Guimaraes, Paulo/B-1099-2008; Jordano, Pedro/A-5162-2008; Guimaraes, Paulo R./E-1915-2016; Guimarães-Junior, Paulo R/M-1298-2016; Bascompte, Jordi/B-7596-2008	Rezende, Enrico L./0000-0002-6245-9605; Rezende, Enrico L/0000-0002-6245-9605; Jordano, Pedro/0000-0003-2142-9116; Guimaraes, Paulo R./0000-0001-9161-8305; Bascompte, Jordi/0000-0002-0108-6411				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; [Anonymous], [No title captured]; ARMBRUSTER WS, 1992, BIOSCIENCE, V42, P12, DOI 10.2307/1311623; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bronstein JL, 2006, NEW PHYTOL, V172, P412, DOI 10.1111/j.1469-8137.2006.01864.x; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.1111/j.1558-5646.1964.tb01674.x; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; HERRERA CM, 1992, AM NAT, V140, P421, DOI 10.1086/285420; Ives AR, 2006, AM NAT, V168, pE1, DOI 10.1086/505157; JORDANO P, 1995, AM NAT, V145, P163, DOI 10.1086/285735; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; LEGENDRE P, 1998, NUMERICAL ECOLOGY, P254; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Thompson JN, 2006, SCIENCE, V312, P372, DOI 10.1126/science.1126904; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Waser NM, 2006, PLANT POLLINATOR INT; WHEELWRIGHT NT, 1993, VEGETATIO, V108, P163	27	376	382	5	194	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2007	448	7156					925	U6		10.1038/nature05956	http://dx.doi.org/10.1038/nature05956			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202OM	17713534	Green Submitted			2022-12-01	WOS:000248912900046
J	Hu, J; Zhong, C; Ding, C; Chi, QY; Walz, A; Mombaerts, P; Matsunami, H; Luo, MM				Hu, Ji; Zhong, Chun; Ding, Cheng; Chi, Qiuyi; Walz, Andreas; Mombaerts, Peter; Matsunami, Hiroaki; Luo, Minmin			Detection of near-atmospheric concentrations of CO2 by an olfactory subsystem in the mouse	SCIENCE			English	Article							CARBON-DIOXIDE DETECTION; GATED CATION CHANNEL; SENSORY NEURONS; DETECTION THRESHOLD; ANHYDRASE; MICE; STIMULATION; DROSOPHILA; DEFICIENT; ANOSMIA	Carbon dioxide (CO2) is an important environmental cue for many organisms but is odorless to humans. It remains unclear whether the mammalian olfactory system can detect CO2 at concentrations around the average atmospheric level (0.038%). We demonstrated the expression of carbonic anhydrase type II (CAII), an enzyme that catabolizes CO2, in a subset of mouse olfactory neurons that express guanylyl cyclase D (GC-D+ neurons) and project axons to necklace glomeruli in the olfactory bulb. Exposure to CO2 activated these GC-D+ neurons, and exposure of a mouse to CO2 activated bulbar neurons associated with necklace glomeruli. Behavioral tests revealed CO2 detection thresholds of similar to 0.066%, and this sensitive CO2 detection required CAII activity. We conclude that mice detect CO2 at near-atmospheric concentrations through the olfactory subsystem of GC-D+ neurons.	Natl Inst Biol Sci, Beijing 102206, Peoples R China; Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Rockefeller Univ, New York, NY 10021 USA	National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Biophysics, CAS; Duke University; Rockefeller University	Luo, MM (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	luominmin@nibs.ac.cn	Ding, Cheng/N-6735-2016; Hu, Ji/H-2293-2011	Luo, Minmin/0000-0003-3535-6624				Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; Clevenger AC, 2006, CHEM SENSES, V31, P9, DOI 10.1093/chemse/bjj001; Coates EL, 2001, RESP PHYSIOL, V129, P219, DOI 10.1016/S0034-5687(01)00292-4; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Ferris KE, 2007, CHEM SENSES, V32, P263, DOI 10.1093/chemse/bjl054; FULLE HJ, 1995, P NATL ACAD SCI USA, V92, P3571, DOI 10.1073/pnas.92.8.3571; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Harned HS, 1943, J AM CHEM SOC, V65, P2030, DOI 10.1021/ja01250a059; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Juilfs DM, 1997, P NATL ACAD SCI USA, V94, P3388, DOI 10.1073/pnas.94.7.3388; KHALIFAH RG, 1971, J BIOL CHEM, V246, P2561; Kimoto M, 2004, J HISTOCHEM CYTOCHEM, V52, P1057, DOI 10.1369/jhc.3a6243.2004; Lahiri S, 2003, INT J BIOCHEM CELL B, V35, P1413, DOI 10.1016/S1357-2725(03)00050-5; LEWIS SE, 1988, P NATL ACAD SCI USA, V85, P1962, DOI 10.1073/pnas.85.6.1962; Lin WH, 2004, J NEUROSCI, V24, P3703, DOI 10.1523/JNEUROSCI.0188-04.2004; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; McBride K, 2003, CHEM SENSES, V28, P659, DOI 10.1093/chemse/bjg053; Meyer MR, 2000, P NATL ACAD SCI USA, V97, P10595, DOI 10.1073/pnas.97.19.10595; Pan PW, 2006, J PHYSIOL-LONDON, V571, P319, DOI 10.1113/jphysiol.2005.102590; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; SHINODA K, 1993, BRAIN RES, V618, P160, DOI 10.1016/0006-8993(93)90440-X; Shusterman D, 2003, CHEM SENSES, V28, P595, DOI 10.1093/chemse/bjg050; Stange G, 1999, MICROSC RES TECHNIQ, V47, P416, DOI 10.1002/(SICI)1097-0029(19991215)47:6<416::AID-JEMT5>3.0.CO;2-X; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; TEICHER MH, 1980, BRAIN RES, V194, P530, DOI 10.1016/0006-8993(80)91237-8; Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d; YOUNGENTOB SL, 1991, PHYSIOL BEHAV, V49, P21, DOI 10.1016/0031-9384(91)90224-C	28	174	179	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					953	957		10.1126/science.1144233	http://dx.doi.org/10.1126/science.1144233			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702944				2022-12-01	WOS:000248780200042
J	Laurance, W; Luizao, R				Laurance, William; Luizao, Regina			Driving a wedge into the Amazon	NATURE			English	Editorial Material							FOREST FRAGMENTS; DEFORESTATION; DECAY		Smithsonian Trop Res Inst, Balboa, Ancon, Panama; Natl Inst Amazonian Res, Dept Ecol, BR-69011970 Manaus, Amazonas, Brazil	Smithsonian Institution; Smithsonian Tropical Research Institute; Institute Nacional de Pesquisas da Amazonia	Laurance, W (corresponding author), Smithsonian Trop Res Inst, Apartado 0843-03092, Balboa, Ancon, Panama.		Laurance, William F/B-2709-2012	Laurance, William F/0000-0003-4430-9408				AYRES JM, 1997, ABORDAGENS INOVADORA; Fearnside PM, 2006, ENVIRON MANAGE, V38, P705, DOI 10.1007/s00267-005-0295-y; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Laurance WF, 2004, SCIENCE, V304, P1109, DOI 10.1126/science.304.5674.1109b; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Lovejoy T.E., 1986, P257; Pimm SL, 1998, NATURE, V393, P23, DOI 10.1038/29892; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397	9	26	26	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2007	448	7152					409	410		10.1038/448409a	http://dx.doi.org/10.1038/448409a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653170				2022-12-01	WOS:000248302700024
J	Joo, HY; Zhai, L; Yang, CY; Nie, SY; Erdjument-Bromage, H; Tempst, P; Chang, CB; Wang, HB				Joo, Heui-Yun; Zhai, Ling; Yang, Chunying; Nie, Shuyi; Erdjument-Bromage, Hediye; Tempst, Paul; Chang, Chenbei; Wang, Hengbin			Regulation of cell cycle progression and gene expression by H2A deubiquitination	NATURE			English	Article							HISTONE H2A; RECOMBINANT HISTONES; X-INACTIVATION; UBIQUITYLATION; UBIQUITINATION; TRANSCRIPTION; PHOSPHORYLATION; PURIFICATION; CHROMOSOMES; METHYLATION	Post-translational histone modifications have important regulatory roles in chromatin structure and function(1-3). One example of such modifications is histone ubiquitination, which occurs predominately on histone H2A and H2B. Although the recent identification of the ubiquitin ligase for histone H2A has revealed important roles for H2A ubiquitination in Hox gene silencing(4-6) as well as in X-chromosome inactivation(7,8), the enzyme(s) involved in H2A deubiquitination and the function of H2A deubiquitination are not known. Here we report the identification and functional characterization of the major deubiquitinase for histone H2A, Ubp-M (also called USP16). Ubp-M prefers nucleosomal substrates in vitro, and specifically deubiquitinates histone H2A but not H2B in vitro and in vivo. Notably, knockdown of Ubp-M in HeLa cells results in slow cell growth rates owing to defects in the mitotic phase of the cell cycle. Further studies reveal that H2A deubiquitination by Ubp-M is a prerequisite for subsequent phosphorylation of Ser 10 of H3 and chromosome segregation when cells enter mitosis. Furthermore, we demonstrate that Ubp-M regulates Hox gene expression through H2A deubiquitination and that blocking the function of Ubp-M results in defective posterior development in Xenopus laevis. This study identifies the major deubiquitinase for histone H2A and demonstrates that H2A deubiquitination is critically involved in cell cycle progression and gene expression.	Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Memorial Sloan Kettering Cancer Center	Wang, HB (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Kaul Human Genet Bldg 402A,720 S 20th St, Birmingham, AL 35294 USA.	hbwang@uab.edu	Yang, Chunying/C-2888-2011	Tempst, Paul/0000-0002-6680-3987; Wang, Hengbin/0000-0003-2414-0609; Erdjument-Bromage, Hediye/0000-0003-0224-3594				Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Cai SY, 1999, P NATL ACAD SCI USA, V96, P2828, DOI 10.1073/pnas.96.6.2828; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; ERDJUMENTBROMAG.H, 1988, J CHROMATOGR A, V826, P167; Fang J, 2004, J BIOL CHEM, V279, P52812, DOI 10.1074/jbc.C400493200; Fang J, 2004, METHOD ENZYMOL, V377, P213; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Luger K, 1999, METHOD ENZYMOL, V304, P3; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mimnaugh EG, 2001, CELL DEATH DIFFER, V8, P1182, DOI 10.1038/sj.cdd.4400924; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wei JH, 2006, J BIOL CHEM, V281, P22537, DOI 10.1074/jbc.M600826200; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0	26	239	255	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2007	449	7165					1068	U9		10.1038/nature06256	http://dx.doi.org/10.1038/nature06256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17914355				2022-12-01	WOS:000250395000056
J	Holland, SM; DeLeo, FR; Elloumi, HZ; Hsu, AP; Uzel, G; Brodsky, N; Freeman, AF; Demidowich, A; Davis, J; Turner, ML; Anderson, VL; Darnell, DN; Welch, PA; Kuhns, DB; Frucht, DM; Malech, HL; Gallin, JI; Kobayashi, SD; Whitney, AR; Voyich, JM; Musser, JM; Woellner, C; Schaffer, AA; Puck, JM; Grimbacher, B				Holland, Steven M.; Deleo, Frank R.; Elloumi, Houda Z.; Hsu, Amy P.; Uzel, Gulbu; Brodsky, Nina; Freeman, Alexandra F.; Demidowich, Andrew; Davis, Joie; Turner, Maria L.; Anderson, Victoria L.; Darnell, Dirk N.; Welch, Pamela A.; Kuhns, Douglas B.; Frucht, David M.; Malech, Harry L.; Gallin, John I.; Kobayashi, Scott D.; Whitney, Adeline R.; Voyich, Jovanka M.; Musser, James M.; Woellner, Cristina; Schaeffer, Alejandro A.; Puck, Jennifer M.; Grimbacher, Bodo			STAT3 mutations in the hyper-IgE syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPERIMMUNOGLOBULIN-E SYNDROME; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; CYTOKINE SIGNALS; INNATE IMMUNITY; T-CELLS; DISEASE; INTERFERON; DEFICIENCY; ACTIVATION	Background The hyper-IgE syndrome (or Job's syndrome) is a rare disorder of immunity and connective tissue characterized by dermatitis, boils, cyst-forming pneumonias, elevated serum IgE levels, retained primary dentition, and bone abnormalities. Inheritance is autosomal dominant; sporadic cases are also found. Methods We collected longitudinal clinical data on patients with the hyper-IgE syndrome and their families and assayed the levels of cytokines secreted by stimulated leukocytes and the gene expression in resting and stimulated cells. These data implicated the signal transducer and activator of transcription 3 gene (STAT3) as a candidate gene, which we then sequenced. Results We found increased levels of proinflammatory gene transcripts in unstimulated peripheral-blood neutrophils and mononuclear cells from patients with the hyper-IgE syndrome, as compared with levels in control cells. In vitro cultures of mononuclear cells from patients that were stimulated with lipopolysaccharide, with or without interferon-(gamma), had higher tumor necrosis factor (alpha) levels than did identically treated cells from unaffected persons (P=0.003). In contrast, the cells from patients with the hyper-IgE syndrome generated lower levels of monocyte chemoattractant protein 1 in response to the presence of interleukin-6 (P=0.03), suggesting a defect in interleukin-6 signaling through its downstream mediators, one of which is STAT3. We identified missense mutations and single-codon in-frame deletions in STAT3 in 50 familial and sporadic cases of the hyper-IgE syndrome. Eighteen discrete mutations, five of which were hot spots, were predicted to directly affect the DNA-binding and SRC homology 2 (SH2) domains. Conclusions Mutations in STAT3 underlie sporadic and dominant forms of the hyper-IgE syndrome, an immunodeficiency syndrome involving increased innate immune response, recurrent infections, and complex somatic features.	NIAID, NIH, Bethesda, MD 20892 USA; NIAID, Hamilton, MT USA; NHGRI, Bethesda, MD 20892 USA; Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; Sci Applicat Int Corp, NCI, Frederick, MD USA; US FDA, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA; Royal Free Hosp & UCL, London, England; Univ Calif San Francisco, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); US Food & Drug Administration (FDA); University of London; University College London; University of California System; University of California San Francisco	Holland, SM (corresponding author), NIAID, NIH, CRC B3-4141 MSC 1684, Bethesda, MD 20892 USA.	smh@nih.gov	Schaffer, Alejandro A/F-2902-2012; Schaffer, Alejandro/N-1222-2019	Brodsky, Nina/0000-0003-2472-7397; DeLeo, Frank/0000-0003-3150-2516; Hsu, Amy/0000-0001-6841-2122; Kobayashi, Scott/0000-0002-5705-1381; Malech, Harry/0000-0001-5874-5775	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N01-CO-12400] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000645, Z01AI000900, Z01AI000646, Z01AI000155] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [Z01LM000097] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BUCKLEY RH, 1972, PEDIATRICS, V49, P59; Buckley RH, 2001, CLIN REV ALLERG IMMU, V20, P139, DOI 10.1385/CRIAI:20:1:139; Chehimi J, 2001, CLIN IMMUNOL, V100, P49, DOI 10.1006/clim.2001.5039; COLOTTA F, 1992, BLOOD, V80, P2012; DAVIS SD, 1966, LANCET, V1, P1013; DELPRETE G, 1989, J CLIN INVEST, V84, P1830, DOI 10.1172/JCI114368; Fleisher TA, 1999, CLIN IMMUNOL, V90, P425, DOI 10.1006/clim.1998.4654; FREEMAN AF, 2007, PED AC SOC ANN M TOR; Freeman AF, 2007, J ALLERGY CLIN IMMUN, V119, P1234, DOI 10.1016/j.jaci.2006.12.666; Freeman AF, 2007, PEDIATRICS, V119, pE1121, DOI 10.1542/peds.2006-2649; Grimbacher B, 1999, AM J HUM GENET, V65, P735, DOI 10.1086/302547; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Hokuto I, 2004, J CLIN INVEST, V113, P28, DOI 10.1172/JCI200419491; Holland SM, 1998, J INFECT DIS, V178, P1095, DOI 10.1086/515670; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Kobayashi SD, 2004, J IMMUNOL, V172, P636, DOI 10.4049/jimmunol.172.1.636; Kobayashi SD, 2002, P NATL ACAD SCI USA, V99, P6901, DOI 10.1073/pnas.092148299; Ling JC, 2007, CLIN IMMUNOL, V122, P255, DOI 10.1016/j.clim.2006.10.005; Maritano D, 2004, NAT IMMUNOL, V5, P401, DOI 10.1038/ni1052; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Panopoulos AD, 2002, J BIOL CHEM, V277, P19001, DOI 10.1074/jbc.M112271200; Panopoulos AD, 2006, BLOOD, V108, P3682, DOI 10.1182/blood-2006-02-003012; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Renner ED, 2004, J PEDIATR-US, V144, P93, DOI 10.1016/S0022-3476(03)00449-9; Sakamoto E, 2005, J LEUKOCYTE BIOL, V78, P301, DOI 10.1189/jlb.1104690; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tanaka T, 2005, CLIN EXP IMMUNOL, V140, P524, DOI 10.1111/j.1365-2249.2005.02805.x; Wang L, 2005, EXP HEMATOL, V33, P308, DOI 10.1016/j.exphem.2004.11.014; Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Wooten DK, 2000, J BIOL CHEM, V275, P26566, DOI 10.1074/jbc.M003495200; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhang ZY, 2005, BIOCHEM BIOPH RES CO, V328, P800, DOI 10.1016/j.bbrc.2005.01.019	39	827	871	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2007	357	16					1608	1619		10.1056/NEJMoa073687	http://dx.doi.org/10.1056/NEJMoa073687			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221AY	17881745				2022-12-01	WOS:000250200500006
J	Biertumpfel, C; Yang, W; Suck, D				Biertuempfel, Christian; Yang, Wei; Suck, Dietrich			Crystal structure of T4 endonuclease VII resolving a Holliday junction	NATURE			English	Article							FAST SEDIMENTING DNA; NUCLEIC-ACIDS; ESCHERICHIA-COLI; DIFFRACTION DATA; ACTIVE-SITE; CLEAVAGE; BINDING; RESOLUTION; BACTERIOPHAGE-T4; CRYSTALLOGRAPHY	Holliday proposed a four-way DNA junction as an intermediate in homologous recombination(1), and such Holliday junctions have since been identified as a central component in DNA recombination and repair(2). Phage T4 endonuclease VII (endo VII) was the first enzyme shown to resolve Holliday junctions into duplex DNAs by introducing symmetrical nicks in equivalent strands(3). Several Holliday junction resolvases have since been characterized(4), but an atomic structure of a resolvase complex with a Holliday junction remained elusive. Here we report the crystal structure of an inactive T4 endo VII(N62D) complexed with an immobile four-way junction with alternating arm lengths of 10 and 14 base pairs. The junction is a hybrid of the conventional square-planar and stacked-X conformation. Endo VII protrudes into the junction point from the minor groove side, opening it to a 14 angstrom x 32 angstrom parallelogram. This interaction interrupts the coaxial stacking, yet every base pair surrounding the junction remains intact. Additional interactions involve the positively charged protein and DNA phosphate backbones. Each scissile phosphate that is two base pairs from the crossover interacts with a Mg2+ ion in the active site. The similar overall shape and surface charge potential of the Holliday junction resolvases endo VII, RuvC, Ydc2, Hjc and RecU, despite having different folds, active site composition and DNA sequence preference, suggest a conserved binding mode for Holliday junctions.	NIDDKD, Mol Biol Lab, Bethesda, MD 20892 USA; European Mol Biol Lab, Struct & Computat Biol Programme, D-69117 Heidelberg, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); European Molecular Biology Laboratory (EMBL)	Yang, W (corresponding author), NIDDKD, Mol Biol Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA.	wei.yang@nih.gov; suck@embl.de	Yang, Wei/D-4926-2011; Yang, Wei/ABB-4785-2020	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195; Biertumpfel, Christian/0000-0002-7528-6547	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036145] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ariyoshi M, 2000, P NATL ACAD SCI USA, V97, P8257, DOI 10.1073/pnas.140212997; ARIYOSHI M, 1994, CELL, V78, P1063, DOI 10.1016/0092-8674(94)90280-1; Biswas T, 2005, NATURE, V435, P1059, DOI 10.1038/nature03657; Bond CS, 2001, P NATL ACAD SCI USA, V98, P5509, DOI 10.1073/pnas.091613398; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Ceschini S, 2001, EMBO J, V20, P6601, DOI 10.1093/emboj/20.23.6601; Conway AB, 2003, J MOL BIOL, V326, P425, DOI 10.1016/S0022-2836(02)01370-0; Declais AC, 2001, J MOL BIOL, V307, P1145, DOI 10.1006/jmbi.2001.4541; DUCKETT DR, 1988, CELL, V55, P79, DOI 10.1016/0092-8674(88)90011-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GiraudPanis MJE, 1997, EMBO J, V16, P2528, DOI 10.1093/emboj/16.9.2528; GiraudPanis MJE, 1996, J BIOL CHEM, V271, P33148, DOI 10.1074/jbc.271.51.33148; Golz S, 1997, EUR J BIOCHEM, V245, P573, DOI 10.1111/j.1432-1033.1997.00573.x; Gopaul DN, 1998, EMBO J, V17, P4175, DOI 10.1093/emboj/17.14.4175; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KEMPER B, 1976, J VIROL, V18, P1000, DOI 10.1128/JVI.18.3.1000-1015.1976; KEMPER B, 1976, J VIROL, V18, P992, DOI 10.1128/JVI.18.3.992-999.1976; Khuu PA, 2006, J MOL RECOGNIT, V19, P234, DOI 10.1002/jmr.765; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; LAVERY R, 1989, J BIOMOL STRUCT DYN, V6, P655, DOI 10.1080/07391102.1989.10507728; Lilley DMJ, 2000, Q REV BIOPHYS, V33, P109, DOI 10.1017/S0033583500003590; Lilley DMJ, 2001, NAT REV MOL CELL BIO, V2, P433, DOI 10.1038/35073057; Liu YL, 2004, NAT REV MOL CELL BIO, V5, P937, DOI 10.1038/nrm1502; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McGregor N, 2005, STRUCTURE, V13, P1341, DOI 10.1016/j.str.2005.05.011; MIZUUCHI K, 1982, CELL, V29, P357, DOI 10.1016/0092-8674(82)90152-0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pohler JRG, 1996, J MOL BIOL, V260, P678; Raaijmakers H, 1999, EMBO J, V18, P1447, DOI 10.1093/emboj/18.6.1447; Raaijmakers H, 2001, J MOL BIOL, V308, P311, DOI 10.1006/jmbi.2001.4592; Scholz SR, 2003, BIOCHEMISTRY-US, V42, P9288, DOI 10.1021/bi0348765; SOLARO PC, 1993, J MOL BIOL, V230, P868, DOI 10.1006/jmbi.1993.1207; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013	39	92	94	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					616	U14		10.1038/nature06152	http://dx.doi.org/10.1038/nature06152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17873859				2022-12-01	WOS:000249893500049
J	Treadway, K				Treadway, Katharine			The code	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02215 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Treadway, K (corresponding author), Harvard Univ, Sch Med, Boston, MA 02215 USA.								0	16	16	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2007	357	13					1273	1275		10.1056/NEJMp078115	http://dx.doi.org/10.1056/NEJMp078115			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214BR	17898094				2022-12-01	WOS:000249711500001
J	De Santa, F; Totaro, MG; Prosperini, E; Notarbartolo, S; Testa, G; Natoli, G				De Santa, Francesca; Totaro, Maria Grazia; Prosperini, Elena; Notarbartolo, Samuele; Testa, Giuseppe; Natoli, Gioacchino			The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing	CELL			English	Article							NF-KAPPA-B; EMBRYONIC STEM-CELLS; TARGET GENES; METHYLTRANSFERASE COMPLEX; DEVELOPMENTAL REGULATORS; BONE-FORMATION; METHYLATION; CHROMATIN; PROTEINS; TRANSDETERMINATION	Epigenetic chromatin marks restrict the ability of differentiated cells to change gene expression programs in response to environmental cues and to transdifferentiate. Polycomb group ( PcG) proteins mediate gene silencing and repress transdifferentiation in a manner dependent on histone H3 lysine 27 trimethylation ( H3K27me3). However, macrophages migrated into inflamed tissues can transdifferentiate, but it is unknown whether inflammation alters PcG- dependent silencing. Here we show that the JmjC- domain protein Jmjd3 is a H3K27me demethylase expressed in macrophages in response to bacterial products and inflammatory cytokines. Jmjd3 binds PcG target genes and regulates their H3K27me3 levels and transcriptional activity. The discovery of an inducible enzyme that erases a histone mark controlling differentiation and cell identity provides a link between inflammation and reprogramming of the epigenome, which could be the basis for macrophage plasticity and might explain the differentiation abnormalities in chronic inflammation.	IEO, Dept Expt Oncol, Campus IFOM, IEO, I-20139 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO)	Natoli, G (corresponding author), IEO, Dept Expt Oncol, Campus IFOM, IEO, Via Adamello 16, I-20139 Milan, Italy.	gioacchino.natoli@ifom-ieo-campus.it	Natoli, gioacchino/J-2100-2018; Notarbartolo, Samuele/X-9697-2019; Natoli, gioacchino/ABB-8679-2020; Testa, Giuseppe/J-4572-2012; De Santa, Francesca/A-2954-2014; PROSPERINI, ELENA/AAB-1952-2021; DE SANTA, FRANCESCA/AAX-5810-2020	Notarbartolo, Samuele/0000-0001-5910-4910; De Santa, Francesca/0000-0002-0034-5450; DE SANTA, FRANCESCA/0000-0002-0034-5450; Testa, Giuseppe/0000-0002-9104-0918; Natoli, Gioacchino/0000-0003-0711-2411				Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Echeverri K, 2002, SCIENCE, V298, P1993, DOI 10.1126/science.1077804; FUJIMORI Y, 1992, BIOCHEM BIOPH RES CO, V186, P1362, DOI 10.1016/S0006-291X(05)81556-6; Gazzerro E, 2006, REV ENDOCR METAB DIS, V7, P51, DOI 10.1007/s11154-006-9000-6; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; HADORN E, 1968, SCI AM, V219, P110, DOI 10.1038/scientificamerican1168-110; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jobin C, 1998, J IMMUNOL, V160, P410; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; KLOSE RJ, 2007, CELL, V7, P715; Koehntop KD, 2005, J BIOL INORG CHEM, V10, P87, DOI 10.1007/s00775-005-0624-x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Zhang X, 2003, CURR OPIN RHEUMATOL, V15, P387, DOI 10.1097/00002281-200307000-00004	48	696	717	2	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6					1083	1094		10.1016/j.cell.2007.08.019	http://dx.doi.org/10.1016/j.cell.2007.08.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17825402	Bronze			2022-12-01	WOS:000250507500017
J	Haw, SJ; Gruer, L				Haw, Sally J.; Gruer, Laurence			Changes in exposure of adult non-smokers to secondhand smoke after implementation of smoke-free legislation in Scotland: national cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article									NHS Hlth Scotland, Edinburgh EH12 5EZ, Midlothian, Scotland; NHS Hlth Scotland, Glasgow G3 7LS, Lanark, Scotland		Haw, SJ (corresponding author), NHS Hlth Scotland, Edinburgh EH12 5EZ, Midlothian, Scotland.	Sally.Haw@health.scot.nhs.uk		Gruer, Laurence/0000-0002-1089-2896				Akhtar PC, 2007, BMJ-BRIT MED J, V335, P545, DOI 10.1136/bmj.39311.550197.AE; Blake M., 2004, HLTH SURVEY ENGLAND, V3; Borland R, 2006, TOB CONTROL, V15, P42, DOI 10.1136/tc.2005.012492; Bromley C, 2005, SCOTTISH HLTH SURVEY; Fong GT, 2006, TOB CONTROL, V15, P51, DOI 10.1136/tc.2005.013649; Haw SJ, 2006, J PUBLIC HEALTH-UK, V28, P24, DOI 10.1093/pubmed/fdi080; Heloma A, 2003, ADDICTION, V98, P1111, DOI 10.1046/j.1360-0443.2003.00429.x; Jarvis MJ, 2000, BRIT MED J, V321, P343, DOI 10.1136/bmj.321.7257.343; MALAM S, 2005, HLTH ED POPULATION S; MULCAHY M, 2005, J INDOOR AIR S2, V15, P86; PACHACEK T, 2004, BRIT MED J, V328, P980; Pickett MS, 2006, TOB CONTROL, V15, DOI 10.1136/tc.2005.015073; Semple S, 2007, TOB CONTROL, V16, P127, DOI 10.1136/tc.2006.018119; THOMSON G, 2005, J NZ MED ASS, V118, P1213; *US DEP HHS, 2003, 2 US DEP HHS	15	172	177	1	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 15	2007	335	7619					549	+		10.1136/bmj.39315.670208.47	http://dx.doi.org/10.1136/bmj.39315.670208.47			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215ED	17827485	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000249790200035
J	Martello, G; Zacchigna, L; Inui, M; Montagner, M; Adorno, M; Mamidi, A; Morsut, L; Soligo, S; Tran, U; Dupont, S; Cordenonsi, M; Wessely, O; Stefano, P				Martello, Graziano; Zacchigna, Luca; Inui, Masafumi; Montagner, Marco; Adorno, Maddalena; Mamidi, Anant; Morsut, Leonardo; Soligo, Sandra; Tran, Uyen; Dupont, Sirio; Cordenonsi, Michelangelo; Wessely, Oliver; Piccolo, Stefano			MicroRNA control of nodal signalling	NATURE			English	Article							EARLY XENOPUS DEVELOPMENT; MESODERM INDUCTION; BETA-CATENIN; ZEBRAFISH; EXPRESSION; GASTRULATION; ORGANIZER; RECEPTORS; PATTERNS; EMBRYOS	MicroRNAs are crucial modulators of gene expression, yet their involvement as effectors of growth factor signalling is largely unknown. Ligands of the transforming growth factor-beta superfamily are essential for development and adult tissue homeostasis. In early Xenopus embryos, signalling by the transforming growth factor-beta ligand Nodal is crucial for the dorsal induction of the Spemann's organizer. Here we report that Xenopus laevis microRNAs miR-15 and miR-16 restrict the size of the organizer by targeting the Nodal type II receptor Acvr2a. Endogenous miR-15 and miR-16 are ventrally enriched as they are negatively regulated by the dorsal Wnt/beta-catenin pathway. These findings exemplify the relevance of microRNAs as regulators of early embryonic patterning acting at the crossroads of fundamental signalling cascades.	Univ Padua, Dept Histol Microbiol & Med Biotechnol, Sect Histol & Embryol, I-35126 Padua, Italy; Louisiana State Univ, Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA 70112 USA	University of Padua; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Stefano, P (corresponding author), Univ Padua, Dept Histol Microbiol & Med Biotechnol, Sect Histol & Embryol, Viale Colombo 3, I-35126 Padua, Italy.	piccolo@bio.unipd.it	Dupont, Sirio/AAP-8133-2021; Cordenonsi, Michelangelo/K-7692-2016; Montagner, Marco/AAY-3236-2020; Inui, Masafumi/GWZ-2521-2022	Cordenonsi, Michelangelo/0000-0002-8253-5724; Montagner, Marco/0000-0003-3080-2138; Inui, Masafumi/0000-0003-4720-007X; Martello, Graziano/0000-0001-5520-085X; Dupont, Sirio/0000-0002-6869-1966; PICCOLO, STEFANO/0000-0002-2037-0004; Mamidi, Anant/0000-0001-7953-7991	Telethon [GGP04030] Funding Source: Medline	Telethon(Fondazione Telethon)		Agius E, 2000, DEVELOPMENT, V127, P1173; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Cha YR, 2006, DEV BIOL, V290, P246, DOI 10.1016/j.ydbio.2005.10.043; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Faure S, 2000, DEVELOPMENT, V127, P2917; Feldman B, 2002, CURR BIOL, V12, P2129, DOI 10.1016/S0960-9822(02)01361-1; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Norris DP, 1999, GENE DEV, V13, P1575, DOI 10.1101/gad.13.12.1575; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Pogoda HM, 2000, CURR BIOL, V10, P1041, DOI 10.1016/S0960-9822(00)00669-2; Schohl A, 2002, DEVELOPMENT, V129, P37; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Song JW, 1999, DEV BIOL, V213, P157, DOI 10.1006/dbio.1999.9370; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Vize PD, 1996, DEV BIOL, V177, P226, DOI 10.1006/dbio.1996.0158; Watanabe T, 2005, FEBS LETT, V579, P318, DOI 10.1016/j.febslet.2004.11.067; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569	32	159	178	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2007	449	7159					183	U1		10.1038/nature06100	http://dx.doi.org/10.1038/nature06100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17728715				2022-12-01	WOS:000249394500041
J	Schorghofer, N				Schorghofer, Norbert			Dynamics of ice ages on Mars	NATURE			English	Article							GROUND ICE; ASTRONOMICAL THEORY; HIGH OBLIQUITY; NEAR-SURFACE; DEPOSITS; PRECIPITATION; INSOLATION; LATITUDES; STABILITY; HYDROGEN	Unlike Earth, where astronomical climate forcing is comparatively small, Mars experiences dramatic changes in incident sunlight that are capable of redistributing ice on a global scale(1-6). The geographic extent of the subsurface ice found poleward of approximately +/-60 degrees latitude on both hemispheres of Mars(7-9) coincides with the areas where ice is stable(7,10,11). However, the tilt of Mars' rotation axis (obliquity) changed considerably in the past several million years. Earlier work(3,12) has shown that regions of ice stability, which are defined by temperature and atmospheric humidity, differed in the recent past from today's, and subsurface ice is expected to retreat quickly when unstable(11-13). Here I explain how the subsurface ice sheets could have evolved to the state in which we see them today. Simulations of the retreat and growth of ground ice as a result of sublimation loss and recharge reveal forty major ice ages over the past five million years. Today, this gives rise to pore ice at mid-latitudes and a three-layered depth distribution in the high latitudes of, from top to bottom, a dry layer, pore ice, and a massive ice sheet. Combined, these layers provide enough ice to be compatible with existing neutron and gamma-ray measurements(7-9).	Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; Univ Hawaii, NASA, Astrobiol Inst, Honolulu, HI 96822 USA	University of Hawaii System; National Aeronautics & Space Administration (NASA); University of Hawaii System	Schorghofer, N (corresponding author), Univ Hawaii, Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA.	norbert@hawaii.edu	Schorghofer, Norbert/A-1194-2007	Schorghofer, Norbert/0000-0002-5821-4066				Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Feldman WC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028936; Feldman WC, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002160; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; Forget F, 2006, SCIENCE, V311, P368, DOI 10.1126/science.1120335; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Hudson TL, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002815; JAKOSKY BM, 1985, NATURE, V315, P559, DOI 10.1038/315559a0; Laskar J, 2004, ICARUS, V170, P343, DOI 10.1016/j.icarus.2004.04.005; Laskar J, 2002, NATURE, V419, P375, DOI 10.1038/nature01066; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Levrard B, 2004, NATURE, V431, P1072, DOI 10.1038/nature03055; Litvak ML, 2006, ICARUS, V180, P23, DOI 10.1016/j.icarus.2005.08.009; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Mellon MT, 2004, ICARUS, V169, P324, DOI 10.1016/j.icarus.2003.10.022; MELLON MT, 1993, J GEOPHYS RES-PLANET, V98, P3345, DOI 10.1029/92JE02355; Mellon MT, 1997, J GEOPHYS RES-PLANET, V102, P19357, DOI 10.1029/97JE01346; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; Mustard JF, 2001, NATURE, V412, P411, DOI 10.1038/35086515; Prettyman TH, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002139; Schorghofer N, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002350; Schorghofer N, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041201; TOON OB, 1980, ICARUS, V44, P552, DOI 10.1016/0019-1035(80)90130-X; WARD WR, 1974, J GEOPHYS RES, V79, P3375, DOI 10.1029/JC079i024p03375	25	77	79	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2007	449	7159					192	U2		10.1038/nature06082	http://dx.doi.org/10.1038/nature06082			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851518				2022-12-01	WOS:000249394500043
J	Remmers, EF; Plenge, RM; Lee, AT; Graham, RR; Hom, G; Behrens, TW; de Bakker, PIW; Le, JM; Lee, HS; Batliwalla, F; Li, W; Masters, SL; Booty, MG; Carulli, JP; Padyukov, L; Alfredsson, L; Klareskog, L; Chen, WV; Amos, CI; Criswell, LA; Seldin, MF; Kastner, DL; Gregersen, PK				Remmers, Elaine F.; Plenge, Robert M.; Lee, Annette T.; Graham, Robert R.; Hom, Geoffrey; Behrens, Timothy W.; de Bakker, Paul I. W.; Le, Julie M.; Lee, Hye-Soon; Batliwalla, Franak; Li, Wentian; Masters, Seth L.; Booty, Matthew G.; Carulli, John P.; Padyukov, Leonid; Alfredsson, Lars; Klareskog, Lars; Chen, Wei V.; Amos, Christopher I.; Criswell, Lindsey A.; Seldin, Michael F.; Kastner, Daniel L.; Gregersen, Peter K.			STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC ASSOCIATION; TYROSINE-PHOSPHATASE; SUSCEPTIBILITY; LINKAGE; DISEASE; PTPN22; SCAN; POLYMORPHISM; METAANALYSIS	Background Rheumatoid arthritis is a chronic inflammatory disease with a substantial genetic component. Susceptibility to disease has been linked with a region on chromosome 2q. Methods We tested single-nucleotide polymorphisms (SNPs) in and around 13 candidate genes within the previously linked chromosome 2q region for association with rheumatoid arthritis. We then performed fine mapping of the STAT1-STAT4 region in a total of 1620 case patients with established rheumatoid arthritis and 2635 controls, all from North America. Implicated SNPs were further tested in an independent case-control series of 1529 patients with early rheumatoid arthritis and 881 controls, all from Sweden, and in a total of 1039 case patients and 1248 controls from three series of patients with systemic lupus erythematosus. Results A SNP haplotype in the third intron of STAT4 was associated with susceptibility to both rheumatoid arthritis and systemic lupus erythematosus. The minor alleles of the haplotype-defining SNPs were present in 27% of chromosomes of patients with established rheumatoid arthritis, as compared with 22% of those of controls (for the SNP rs7574865, P=2.81 x 10(-7); odds ratio for having the risk allele in chromosomes of patients vs. those of controls, 1.32). The association was replicated in Swedish patients with recent-onset rheumatoid arthritis (P=0.02) and matched controls. The haplotype marked by rs7574865 was strongly associated with lupus, being present on 31% of chromosomes of case patients and 22% of those of controls (P=1.87 x 10(-9); odds ratio for having the risk allele in chromosomes of patients vs. those of controls, 1.55). Homozygosity of the risk allele, as compared with absence of the allele, was associated with a more than doubled risk for lupus and a 60% increased risk for rheumatoid arthritis. Conclusions A haplotype of STAT4 is associated with increased risk for both rheumatoid arthritis and systemic lupus erythematosus, suggesting a shared pathway for these illnesses.	Feinstein Inst Med Res, Manhasset, NY 11030 USA; NIAMSD, Bethesda, MD 20892 USA; Broad Inst, Cambridge, MA USA; Brigham & Womens Hosp, Manhasset, NY USA; Genentech Inc, San Francisco, CA 94080 USA; Hanyang Univ, Coll Med, Seoul 133791, South Korea; Biogen Idec, Cambridge, MA USA; Karolinska Inst, Stockholm, Sweden; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Univ Calif Davis, San Francisco, CA USA	Northwell Health; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Roche Holding; Genentech; Hanyang University; Biogen; Karolinska Institutet; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Davis	Gregersen, PK (corresponding author), Feinstein Inst Med Res, 350 Community Dr, Manhasset, NY 11030 USA.	peterg@nshs.edu	Alfredsson, Lars/AAC-9007-2019; Masters, Seth L/N-2886-2013; Padyukov, Leonid/A-4890-2009; de Bakker, Paul IW/B-8730-2009; Booty, Matthew G/G-9536-2012	Alfredsson, Lars/0000-0003-1688-6697; Masters, Seth L/0000-0003-4763-576X; Padyukov, Leonid/0000-0003-2950-5670; de Bakker, Paul IW/0000-0001-7735-7858; Remmers, Elaine F/0000-0002-9522-1249; Klareskog, Lars/0000-0001-9601-6186; Li, Wentian/0000-0003-1155-110X; Booty, Matthew/0000-0002-0835-3439	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041139, Z01AR041180] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR000079, 5-M01-RR-00079, M01 RR018535] Funding Source: Medline; NIAID NIH HHS [K08 AI055314-05, N01-AI95386, K08 AI055314, K08 AI055314-04, N01AI95386, K08 AI055314-03, K08 AI055314-02, K08 AI055314-01A1] Funding Source: Medline; NIAMS NIH HHS [R01 AR052300, R01 AR050267, R01 AR-44804, N01-AR-2-2263, N01-AR-1-2256, R01 AR044422, R01 AR44422] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Amos CI, 2006, GENES IMMUN, V7, P277, DOI 10.1038/sj.gene.6364295; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bauer JW, 2006, PLOS MED, V3, P2274, DOI 10.1371/journal.pmed.0030491; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cantor RM, 2004, ARTHRITIS RHEUM, V50, P3203, DOI 10.1002/art.20511; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Choi SJ, 2006, RHEUMATOLOGY, V45, P166, DOI 10.1093/rheumatology/kei128; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Etzel CJ, 2006, HUM GENET, V119, P634, DOI 10.1007/s00439-006-0171-8; Finnegan A, 2002, J IMMUNOL, V169, P3345, DOI 10.4049/jimmunol.169.6.3345; Fries JF, 2002, ARTHRITIS RHEUM, V46, P2320, DOI 10.1002/art.10485; Fukao T, 2001, J IMMUNOL, V166, P4446, DOI 10.4049/jimmunol.166.7.4446; Goronzy JJ, 2001, PRIMER RHEUMATIC DIS, P209; Gray-McGuire C, 2000, AM J HUM GENET, V67, P1460, DOI 10.1086/316891; Gregersen PK, 2006, NAT REV GENET, V7, P917, DOI 10.1038/nrg1944; Gregersen PK, 2006, SEMIN IMMUNOL, V18, P214, DOI 10.1016/j.smim.2006.03.009; Hildner KM, 2007, J IMMUNOL, V178, P3427, DOI 10.4049/jimmunol.178.6.3427; Irigoyen P, 2005, ARTHRITIS RHEUM-US, V52, P3813, DOI 10.1002/art.21419; Jacob CO, 2003, J IMMUNOL, V171, P1564, DOI 10.4049/jimmunol.171.3.1564; Jawaheer D, 2003, ARTHRITIS RHEUM-US, V48, P906, DOI 10.1002/art.10989; Klinman DM, 2005, ANN NY ACAD SCI, V1058, P87, DOI 10.1196/annals.1359.015; LEE HS, IN PRESS MOL MED; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Morinobu A, 2002, P NATL ACAD SCI USA, V99, P12281, DOI 10.1073/pnas.182618999; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Nishikomori R, 2002, J IMMUNOL, V169, P4388, DOI 10.4049/jimmunol.169.8.4388; Padyukov L, 2004, ARTHRITIS RHEUM, V50, P3085, DOI 10.1002/art.20553; Petri M, 2000, RHEUM DIS CLIN N AM, V26, P199, DOI 10.1016/S0889-857X(05)70135-6; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Remoli ME, 2007, J LEUKOCYTE BIOL, V81, P355, DOI 10.1189/jlb.0506319; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Thorburn CM, 2007, GENES IMMUN, V8, P279, DOI 10.1038/sj.gene.6364383; Tsunemi Y, 2002, J DERMATOL SCI, V30, P161, DOI 10.1016/S0923-1811(02)00072-5; Vandiedonck C, 2006, ANN NEUROL, V59, P404, DOI 10.1002/ana.20751; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Wolfe F, 2003, ARTHRITIS RHEUM, V48, P1530, DOI 10.1002/art.11024; WORDSWORTH BP, 1992, SPRINGER SEMIN IMMUN, V14, P59	51	743	779	0	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2007	357	10					977	986		10.1056/NEJMoa073003	http://dx.doi.org/10.1056/NEJMoa073003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206VK	17804842	Green Accepted			2022-12-01	WOS:000249210800004
J	Smith, SW				Smith, Sheila Weiss			Sidelining safety - The FDA's inadequate response to the IOM	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Maryland, Sch Pharm, Ctr Drugs & Publ Policy, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Smith, SW (corresponding author), Univ Maryland, Sch Pharm, Ctr Drugs & Publ Policy, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA.							BACIU A, 2006, FUTURE DRUG SAFETY P; Breckenridge Institute, 2006, IND VER VAL AERS 2 R; *CTR DRUG EV RES, 1998, CDER 1997 REP NAT IM; *FOOD DRUG ADM, 2007, FUT DRUG SAF PROM PR; Kohn L., 1999, ERR IS HUMAN BUILDIN	5	12	13	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2007	357	10					960	963		10.1056/NEJMp078157	http://dx.doi.org/10.1056/NEJMp078157			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206VK	17804840				2022-12-01	WOS:000249210800002
J	Ashe, KH				Ashe, Karen H.			A tale about tau	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Ashe, KH (corresponding author), Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA.							Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736	6	15	20	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2007	357	9					933	935		10.1056/NEJMcibr073552	http://dx.doi.org/10.1056/NEJMcibr073552			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204TA	17761598				2022-12-01	WOS:000249065700015
J	Konev, AY; Tribus, M; Park, SY; Podhraski, V; Lim, CY; Emelyanov, AV; Vershilova, E; Pirrotta, V; Kadonaga, JT; Lusser, A; Fyodorov, DV				Konev, Alexander Y.; Tribus, Martin; Park, Sung Yeon; Podhraski, Valerie; Lim, Chin Yan; Emelyanov, Alexander V.; Vershilova, Elena; Pirrotta, Vincenzo; Kadonaga, James T.; Lusser, Alexandra; Fyodorov, Dmitry V.			CHD1 motor protein is required for deposition of histone variant h3.3 into chromatin in vivo	SCIENCE			English	Article							MALE PRONUCLEUS; ISWI; REPLACEMENT; SUBUNITS; ACF	The organization of chromatin affects all aspects of nuclear DNA metabolism in eukaryotes. H3.3 is an evolutionarily conserved histone variant and a key substrate for replication-independent chromatin assembly. Elimination of chromatin remodeling factor CHD1 in Drosophila embryos abolishes incorporation of H3.3 into the male pronucleus, renders the paternal genome unable to participate in zygotic mitoses, and leads to the development of haploid embryos. Furthermore, CHD1, but not ISWI, interacts with HIRA in cytoplasmic extracts. Our findings establish CHD1 as a major factor in replacement histone metabolism in the nucleus and reveal a critical role for CHD1 in the earliest developmental instances of genome-scale, replication-independent nucleosome assembly. Furthermore, our results point to the general requirement of adenosine triphosphate (ATP)-utilizing motor proteins for histone deposition in vivo.	Innsbruck Med Univ, Bioctr, Div Mol Biol, A-6020 Innsbruck, Austria; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA	Medical University of Innsbruck; Yeshiva University; Albert Einstein College of Medicine; Rutgers State University New Brunswick; University of California System; University of California San Diego	Fyodorov, DV (corresponding author), Innsbruck Med Univ, Bioctr, Div Mol Biol, Fritz Pregl Str 3, A-6020 Innsbruck, Austria.	alexandra.lusser@i-med.ac.at; dfyodoro@aecom.yu.edu	Konev, Alexander/J-4401-2015	Konev, Alexander/0000-0002-4497-6377; Lim, Chin Yan/0000-0002-1585-002X; Lusser, Alexandra/0000-0002-2226-9081	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074233, R01GM058272] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [Y 275] Funding Source: researchfish; Austrian Science Fund FWF [Y 275] Funding Source: Medline; NIGMS NIH HHS [GM74233, GM58272, R01 GM058272, R01 GM074233] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund FWF(Austrian Science Fund (FWF)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Callaini G, 1996, DEV BIOL, V176, P199, DOI 10.1006/dbio.1996.0127; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Jin JJ, 2005, TRENDS BIOCHEM SCI, V30, P680, DOI 10.1016/j.tibs.2005.10.003; Loppin B, 2005, NATURE, V437, P1386, DOI 10.1038/nature04059; Loyola A, 2003, MOL CELL BIOL, V23, P6759, DOI 10.1128/MCB.23.19.6759-6768.2003; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Raja SJ, 2005, MOL CELL BIOL, V25, P6165, DOI 10.1128/MCB.25.14.6165-6177.2005; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Torres-Padilla ME, 2006, INT J DEV BIOL, V50, P455, DOI 10.1387/ijdb.052073mt; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Walfridsson J, 2005, NUCLEIC ACIDS RES, V33, P2868, DOI 10.1093/nar/gki579; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472	17	191	199	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2007	317	5841					1087	1090		10.1126/science.1145339	http://dx.doi.org/10.1126/science.1145339			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203AE	17717186	Green Accepted			2022-12-01	WOS:000248946700046
J	Armani, AM; Kulkarni, RP; Fraser, SE; Flagan, RC; Vahala, KJ				Armani, Andrea M.; Kulkarni, Rajan P.; Fraser, Scott E.; Flagan, Richard C.; Vahala, Kerry J.			Label-free, single-molecule detection with optical microcavities	SCIENCE			English	Article							FLUORESCENCE SPECTROSCOPY; PROTEIN; SURFACE; DNA; CELL; NANOPARTICLES; RESONANCE; DYNAMICS; ARRAYS	Current single-molecule detection techniques require labeling the target molecule. We report a highly specific and sensitive optical sensor based on an ultrahigh quality (Q) factor (Q > 10(8)) whispering-gallery microcavity. The silica surface is functionalized to bind the target molecule; binding is detected by a resonant wavelength shift. Single-molecule detection is confirmed by observation of single-molecule binding events that shift the resonant frequency, as well as by the statistics for these shifts over many binding events. These shifts result from a thermo-optic mechanism. Additionally, label-free, single-molecule detection of interleukin-2 was demonstrated in serum. These experiments demonstrate a dynamic range of 10(12) in concentration, establishing the microcavity as a sensitive and versatile detector.	CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Fraser, SE (corresponding author), CALTECH, Dept Appl Phys, MC 128-95, Pasadena, CA 91125 USA.	sefraser@caltech.edu; flagan@caltech.edu	Armani, Andrea/X-7611-2019; Armani, Andrea/A-8132-2010; Armani, Andrea/A-1216-2007; Fraser, Scott/Y-3406-2019	Armani, Andrea/0000-0001-9890-5104; Armani, Andrea/0000-0001-9890-5104; Fraser, Scott/0000-0002-5377-0223				Ambrose WP, 1999, CHEM REV, V99, P2929, DOI 10.1021/cr980132z; Armani AM, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2099529; Armani DK, 2003, NATURE, V421, P925, DOI 10.1038/nature01371; Arnold S, 2003, OPT LETT, V28, P272, DOI 10.1364/OL.28.000272; Boyd RW, 2001, APPL OPTICS, V40, P5742, DOI 10.1364/AO.40.005742; Burg TP, 2007, NATURE, V446, P1066, DOI 10.1038/nature05741; Cao YWC, 2002, SCIENCE, V297, P1536, DOI 10.1126/science.297.5586.1536; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Fureder-Kitzmuller E, 2005, CHEM PHYS LETT, V404, P13, DOI 10.1016/j.cplett.2005.01.053; Huang B, 2007, SCIENCE, V315, P81, DOI 10.1126/science.1133992; HUGHES RC, 1991, SCIENCE, V254, P74, DOI 10.1126/science.254.5028.74; Jaiswal JK, 2007, NAT CHEM BIOL, V3, P92, DOI 10.1038/nchembio855; Krioukov E, 2002, OPT LETT, V27, P512, DOI 10.1364/OL.27.000512; Ksendzov A, 2005, OPT LETT, V30, P3344, DOI 10.1364/OL.30.003344; Kulkarni RP, 2006, BIOPHYS J, V90, pL42, DOI 10.1529/biophysj.105.077941; Lang MJ, 2004, NAT METHODS, V1, P133, DOI 10.1038/NMETH714; Mazur B, 2004, HEMATOL ONCOL, V22, P27, DOI 10.1002/hon.725; Moore BD, 2004, NAT BIOTECHNOL, V22, P1133, DOI 10.1038/nbt1003; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Nakatani K, 2001, NAT BIOTECHNOL, V19, P51, DOI 10.1038/83505; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Vijayendran RA, 2001, ANAL CHEM, V73, P471, DOI 10.1021/ac000523p; Wu GH, 2001, NAT BIOTECHNOL, V19, P856, DOI 10.1038/nbt0901-856; Yeo WS, 2005, ANGEW CHEM INT EDIT, V44, P5480, DOI 10.1002/anie.200501363; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138; Zhong ZH, 2003, SCIENCE, V302, P1377, DOI 10.1126/science.1090899	29	936	982	15	433	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2007	317	5839					783	787		10.1126/science.1145002	http://dx.doi.org/10.1126/science.1145002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17615303				2022-12-01	WOS:000248624500034
J	Frey, S; Gorlich, D				Frey, Steffen; Goerlich, Dirk			A saturated FG-repeat hydrogel can reproduce the permeability properties of nuclear pore complexes	CELL			English	Article							IMPORTIN-BETA; STRUCTURAL BASIS; PROTEIN IMPORT; BINDING-SITES; TRANSPORT; NUCLEOPORINS; NTF2; IDENTIFICATION; TRANSLOCATION; ARCHITECTURE	The permeability barrier of nuclear pore complexes (NPCs) controls the exchange between nucleus and cytoplasm. It suppresses the flux of inert macromolecules >= 30 kDa but allows rapid passage of even very large cargoes, provided these are bound to appropriate nuclear transport receptors. We show here that a saturated hydrogel formed by a single nucleoporin FG-repeat domain is sufficient to reproduce the permeability properties of NPCs. Importin beta and related nuclear transport receptors entered such hydrogel > 10003 faster than a similarly sized inert macromolecule. The FG-hydrogel even reproduced import signal-dependent and importin-mediated cargo influx, allowing importin b to accelerate the gel entry of a large cognate cargo more than 20,000-fold. Intragel diffusion of the importin beta-cargo complex occurred rapidly enough to traverse an NPC within approximate to 12 ms. We extend the "selective phase model'' to explain these effects.	Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany	Max Planck Society; Ruprecht Karls University Heidelberg	Gorlich, D (corresponding author), Max Planck Inst Biophys Chem, Fassberg 11, D-37077 Gottingen, Germany.	goerlich@mpibpc.mpg.de	Görlich, Dirk/B-8296-2017	Görlich, Dirk/0000-0002-4343-5210; Steffen, Frey/0000-0002-5134-9961				Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Bayliss R, 2002, EMBO J, V21, P2843, DOI 10.1093/emboj/cdf305; Bednenko J, 2003, J CELL BIOL, V162, P391, DOI 10.1083/jcb.200303085; Burke B, 2006, SCIENCE, V314, P766, DOI 10.1126/science.1135739; CHI NC, 1995, J CELL BIOL, V130, P265, DOI 10.1083/jcb.130.2.265; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Cushman I, 2006, METHODS, V39, P329, DOI 10.1016/j.ymeth.2006.06.011; Denning DP, 2007, MOL CELL PROTEOMICS, V6, P272, DOI 10.1074/mcp.M600309-MCP200; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Elbaum M, 2006, SCIENCE, V314, P766, DOI 10.1126/science.1135924; ENENKEL C, 1995, J BIOL CHEM, V270, P16499, DOI 10.1074/jbc.270.28.16499; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Harel A, 2003, MOL BIOL CELL, V14, P4387, DOI 10.1091/mbc.E03-05-0275; HURT EC, 1988, EMBO J, V7, P4323, DOI 10.1002/j.1460-2075.1988.tb03331.x; Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Kustanovich T, 2004, BIOPHYS J, V86, P2008, DOI 10.1016/S0006-3495(04)74262-9; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Morris K, 2003, LANCET NEUROL, V2, P587, DOI 10.1016/S1474-4422(03)00545-3; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Ryan KJ, 2007, MOL BIOL CELL, V18, P886, DOI 10.1091/mbc.E06-06-0525; Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Walther TC, 2003, NATURE, V424, P689, DOI 10.1038/nature01898; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Weis K, 1996, EMBO J, V15, P1818, DOI 10.1002/j.1460-2075.1996.tb00531.x; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101	41	362	361	2	62	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2007	130	3					512	523		10.1016/j.cell.2007.06.024	http://dx.doi.org/10.1016/j.cell.2007.06.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693259	Green Submitted, Bronze			2022-12-01	WOS:000249038100018
J	Perfeito, L; Fernandes, L; Mota, C; Gordo, I				Perfeito, Lilia; Fernandes, Lisete; Mota, Catarina; Gordo, Isabel			Adaptive mutations in bacteria: High rate and small effects	SCIENCE			English	Article							BENEFICIAL MUTATIONS; SACCHAROMYCES-CEREVISIAE; LANDSCAPE MODEL; POPULATIONS; ADAPTATION; EVOLUTION; SELECTION; VIRUS; SEX	Evolution by natural selection is driven by the continuous generation of adaptive mutations. We measured the genomic mutation rate that generates beneficial mutations and their effects on fitness in Escherichia coli under conditions in which the effect of competition between lineages carrying different beneficial mutations is minimized. We found a rate on the order of 10(-5) per genome per generation, which is 1000 times as high as previous estimates, and a mean selective advantage of 1%. Such a high rate of adaptive evolution has implications for the evolution of antibiotic resistance and pathogenicity.	Gulbenkian Inst Sci, P-2780156 Oeiras, Portugal; Escola Super Tecnol Saude Lisboa, Lisbon, Portugal	Universidade de Lisboa	Gordo, I (corresponding author), Gulbenkian Inst Sci, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal.	igordo@igc.gulbenkian.pt	Perfeito, Lilia/I-1618-2013; Gordo, Isabel/D-6770-2013; Perfeito, Lilia/AAE-1245-2020; fernandes, lisete/E-6522-2016; Mota, Catarina/M-4281-2013	Perfeito, Lilia/0000-0003-4844-8763; Gordo, Isabel/0000-0003-1622-5143; Perfeito, Lilia/0000-0003-4844-8763; fernandes, lisete/0000-0002-3384-2031; Mota, Catarina/0000-0002-5440-9157				Barrett RDH, 2006, GENETICS, V174, P2071, DOI 10.1534/genetics.106.062406; Barrett RDH, 2006, BIOL LETTERS, V2, P236, DOI 10.1098/rsbl.2006.0439; Bataillon T, 2000, HEREDITY, V84, P497, DOI 10.1046/j.1365-2540.2000.00727.x; Betancourt AJ, 2006, CURR OPIN GENET DEV, V16, P618, DOI 10.1016/j.gde.2006.10.006; Burch CL, 1999, GENETICS, V151, P921; Charlesworth J, 2006, MOL BIOL EVOL, V23, P1348, DOI 10.1093/molbev/msk025; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Estes S, 2003, EVOLUTION, V57, P1022, DOI 10.1111/j.0014-3820.2003.tb00313.x; Fisher R.A., 1930, GENETICAL THEORY NAT; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Grimberg B, 2005, EVOLUTION, V59, P431; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Imhof M, 2001, P NATL ACAD SCI USA, V98, P1113, DOI 10.1073/pnas.98.3.1113; Joseph SB, 2004, GENETICS, V168, P1817, DOI 10.1534/genetics.104.033761; Kassen R, 2006, NAT GENET, V38, P484, DOI 10.1038/ng1751; Kimura M., 1983, NEUTRAL THEORY MOL E; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Orr HA, 2003, GENETICS, V163, P1519; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; Rozen DE, 2002, CURR BIOL, V12, P1040, DOI 10.1016/S0960-9822(02)00896-5; Schlotterer C, 2006, J EVOLUTION BIOL, V19, P1671, DOI 10.1111/j.1420-9101.2006.01108.x; Shaw RG, 2000, GENETICS, V155, P369; Zeyl C, 2005, GENETICS, V169, P1825, DOI 10.1534/genetics.104.027102	27	216	217	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2007	317	5839					813	815		10.1126/science.1142284	http://dx.doi.org/10.1126/science.1142284			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690297	Green Submitted			2022-12-01	WOS:000248624500043
J	Schuh, M; Ellenberg, J				Schuh, Melina; Ellenberg, Jan			Self-organization of MTOCs replaces Centrosome Function during Acentrosomal Spindle Assembly in Live Mouse Oocytes	CELL			English	Article							NUCLEAR-ENVELOPE BREAKDOWN; XENOPUS EXTRACT SPINDLES; CYCLE-DEPENDENT CHANGES; NEWT LUNG-CELLS; MICROTUBULE DYNAMICS; MITOTIC SPINDLE; FLUORESCENT PROTEIN; MEIOTIC MATURATION; GAMMA-TUBULIN; CHROMOSOME CONGRESSION	Chromosome segregation in mammalian oocytes is driven by a microtubule spindle lacking centrosomes. Here, we analyze centrosome-independent spindle assembly by quantitative high-resolution confocal imaging in live maturing mouse oocytes. We show that spindle assembly proceeds by the self-organization of over 80 microtubule organizing centers (MTOCs) that form de novo from a cytoplasmic microtubule network in prophase and that functionally replace centrosomes. Initially distributed throughout the ooplasm, MTOCs congress at the center of the oocyte, where they contribute to a massive, Ran-dependent increase of the number of microtubules after nuclear envelope breakdown and to the individualization of clustered chromosomes. Through progressive MTOC clustering and activation of kinesin-5, the multipolar MTOC aggregate self- organizes into a bipolar intermediate, which then elongates and thereby establishes chromosome biorientation. Finally, a stable barrel-shaped acentrosomal metaphase spindle with oscillating chromosomes and astral-like microtubules forms that surprisingly exhibits key properties of a centrosomal spindle.	European Mol Biol Lab, Gene Express Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Ellenberg, J (corresponding author), European Mol Biol Lab, Gene Express Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	jan.ellenberg@embl.de	Ellenberg, Jan/I-4688-2014	Ellenberg, Jan/0000-0001-5909-701X				Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Bastiaens P, 2006, TRENDS CELL BIOL, V16, P125, DOI 10.1016/j.tcb.2006.01.005; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; Brunet S, 2005, REPRODUCTION, V130, P801, DOI 10.1530/rep.1.00364; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; CALARCO PG, 1972, J CELL SCI, V10, P369; Calaro PG, 2000, MICROSC RES TECHNIQ, V49, P428, DOI 10.1002/(SICI)1097-0029(20000601)49:5<428::AID-JEMT4>3.0.CO;2-K; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Can A, 2003, MOL HUM REPROD, V9, P749, DOI 10.1093/molehr/gag093; Carabatsos MJ, 2000, MICROSC RES TECHNIQ, V49, P435, DOI 10.1002/(SICI)1097-0029(20000601)49:5<435::AID-JEMT5>3.0.CO;2-H; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Clarke PR, 2001, TRENDS CELL BIOL, V11, P366, DOI 10.1016/S0962-8924(01)02071-2; Combelles CMH, 2001, DEV BIOL, V239, P281, DOI 10.1006/dbio.2001.0444; Desai A, 1998, J CELL BIOL, V141, P703, DOI 10.1083/jcb.141.3.703; Dumont J, 2007, J CELL BIOL, V176, P295, DOI 10.1083/jcb.200605199; Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889; GARD DL, 1992, DEV BIOL, V151, P516, DOI 10.1016/0012-1606(92)90190-R; Goodman B, 2006, BIOCHEM SOC T, V34, P716, DOI 10.1042/BST0340716; GUETHHALLONET C, 1993, J CELL SCI, V105, P157; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Jaffe LA, 2004, METHOD CELL BIOL, V74, P219; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Karsenti E, 2004, BIOL CELL, V96, P237, DOI 10.1016/j.biolcel.2003.12.008; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Kudo NR, 2006, CELL, V126, P135, DOI 10.1016/j.cell.2006.05.033; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Litman Pninit, 2000, BMC Cell Biology, V1, P1, DOI 10.1186/1471-2121-1-1; LONGO FJ, 1985, DEV BIOL, V107, P382, DOI 10.1016/0012-1606(85)90320-3; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; Manandhar G, 2005, BIOL REPROD, V72, P2, DOI 10.1095/biolreprod.104.031245; MARO B, 1985, J CELL BIOL, V101, P1665, DOI 10.1083/jcb.101.5.1665; MATTSON BA, 1990, MOL REPROD DEV, V25, P374, DOI 10.1002/mrd.1080250411; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; MESSINGER SM, 1991, J CELL SCI, V100, P289; Olson KR, 1999, METHOD ENZYMOL, V302, P103, DOI 10.1016/S0076-6879(99)02013-3; Palacios I, 1996, J CELL BIOL, V133, P485, DOI 10.1083/jcb.133.3.485; PALACIOS MJ, 1993, J CELL SCI, V104, P383; Piehl M, 2004, P NATL ACAD SCI USA, V101, P1584, DOI 10.1073/pnas.0308205100; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Rusan NM, 2002, J CELL BIOL, V158, P997, DOI 10.1083/jcb.200204109; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4152, DOI 10.1073/pnas.82.12.4152; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Skold HN, 2005, J CELL SCI, V118, P1745, DOI 10.1242/jcs.02304; SORENSEN RA, 1973, AM J ANAT, V136, P265, DOI 10.1002/aja.1001360302; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Stepanova T, 2003, J NEUROSCI, V23, P2655; Strickland L, 2004, METHOD CELL BIOL, V74, P371; VANBLERKOM J, 1991, P NATL ACAD SCI USA, V88, P5031, DOI 10.1073/pnas.88.11.5031; VANBLERKOM J, 1986, J EMBRYOL EXP MORPH, V93, P213; WASSARMAN PM, 1978, J CELL SCI, V29, P171; Yajima J, 2003, EMBO J, V22, P1067, DOI 10.1093/emboj/cdg102	60	366	374	3	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2007	130	3					484	498		10.1016/j.cell.2007.06.025	http://dx.doi.org/10.1016/j.cell.2007.06.025			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693257	Bronze, Green Submitted			2022-12-01	WOS:000249038100016
J	Fuss, SH; Omura, M; Mombaerts, P				Fuss, Stefan H.; Omura, Masayo; Mombaerts, Peter			Local and cis effects of the H element on expression of odorant receptor genes in mouse	CELL			English	Article							OLFACTORY SENSORY NEURONS; AXON GUIDANCE; EPITHELIUM; GLOMERULI; CHOICE; SYSTEM; LHX2; BULB; PROJECTION; IDENTITY	From the similar to 1,200 odorant receptor (OR) genes in the mouse genome, an olfactory sensory neuron is thought to express only one gene. The mechanisms of OR gene choice are not understood. A 2.1 kilobase region (the H element) adjacent to a cluster of seven OR genes has been proposed as a trans- and pan-enhancer for OR gene expression. Here, we deleted the H element by gene targeting in mice. The deletion abolishes expression of a family of three OR genes proximal to H, and H operates in cis on these genes. Deletion of H has a graded effect on expression of a distal group of four OR genes, commensurate with genomic distance. There is no demonstrable effect on expression of OR genes located outside the cluster. Our findings are not consistent with the hypothesis of H as an essential trans-acting enhancer for genome-wide regulation of OR gene expression.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Mombaerts, P (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	peter@rockefeller.edu	Fuss, Stefan H/G-2065-2011	Fuss, Stefan H/0000-0002-3076-1121				Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; Hirota J, 2007, MOL CELL NEUROSCI, V34, P679, DOI 10.1016/j.mcn.2007.01.014; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Ishii T, 2001, GENES CELLS, V6, P71, DOI 10.1046/j.1365-2443.2001.00398.x; Iwema CL, 2004, J NEUROSCI, V24, P356, DOI 10.1523/JNEUROSCI.1219-03.2004; Kolterud A, 2004, DEVELOPMENT, V131, P5319, DOI 10.1242/dev.01416; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Nakatani H, 2003, EUR J NEUROSCI, V18, P2425, DOI 10.1046/j.1460-9568.2003.02998.x; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Qasba P, 1998, J NEUROSCI, V18, P227; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rothman A, 2005, MOL CELL NEUROSCI, V28, P535, DOI 10.1016/j.mcn.2004.11.006; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Strotmann J, 2004, J NEUROSCI, V24, P7754, DOI 10.1523/JNEUROSCI.2588-04.2004; Tsuboi A, 1999, J NEUROSCI, V19, P8409; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Young JM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r71; Zhang XH, 2007, GENOMICS, V89, P441, DOI 10.1016/j.ygeno.2007.01.002; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	40	144	146	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					373	384		10.1016/j.cell.2007.06.023	http://dx.doi.org/10.1016/j.cell.2007.06.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662950	Bronze			2022-12-01	WOS:000248588000025
J	Mameli, M; Balland, B; Lujan, R; Luscher, C				Mameli, Manuel; Balland, Benedicte; Lujan, Rafael; Luescher, Christian			Rapid synthesis and synaptic insertion of GluR2 for mGluR-LTD in the ventral tegmental area	SCIENCE			English	Article							LONG-TERM DEPRESSION; CA2+-PERMEABLE AMPA RECEPTORS; PROTEIN-SYNTHESIS; DOPAMINE NEURONS; IN-VIVO; DEPENDENT REGULATION; PLASTICITY; POLYRIBOSOMES; REQUIREMENT; ACTIVATION	The activation of metabotropic glutamate receptors (mGluRs) leads to long-term depression (mGluR-LTD) at many synapses of the brain. The induction of mGluR-LTD is well characterized, whereas the mechanisms underlying its expression remain largely elusive. mGluR-LTD in the ventral tegmental area (VTA) efficiently reverses cocaine-induced strengthening of excitatory inputs onto dopamine neurons. We show that mGluR-LTD is expressed by an exchange of GluR2-lacking AMPA receptors for GluR2-containing receptors with a lower single-channel conductance. The synaptic insertion of GluR2 depends on de novo protein synthesis via rapid messenger RNA translation of GluR2. Regulated synthesis of GluR2 in the VTA is therefore required to reverse cocaine-induced synaptic plasticity.	Univ Geneva, Dept Basic Neurosci, Fac Med, CH-1211 Geneva, Switzerland; Univ Castilla La Mancha, Dept Ciencias Med, Fac Med, Ctr Reg Invest Biomed, Albacete 02006, Spain; Univ Hosp Geneva, Neurol Clin, Dept Clin Neurosci, CH-1211 Geneva, Switzerland	University of Geneva; Universidad de Castilla-La Mancha; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Dept Basic Neurosci, Fac Med, CH-1211 Geneva, Switzerland.	Christian.Luscher@medecine.unige.ch	Lujan, Rafael/G-2555-2015; Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Lujan Miras, Rafael/0000-0003-2001-9545; Mameli, Manuel/0000-0002-0570-6964				Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bellone C, 2005, EUR J NEUROSCI, V21, P1280, DOI 10.1111/j.1460-9568.2005.03979.x; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Eberwine J, 2002, NEUROCHEM RES, V27, P1065, DOI 10.1023/A:1020956805307; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Hartmann J, 2004, J NEUROSCI, V24, P5119, DOI 10.1523/JNEUROSCI.4193-03.2004; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kacharmina JE, 2000, P NATL ACAD SCI USA, V97, P11545, DOI 10.1073/pnas.97.21.11545; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2002, J NEUROSCI, V22, P3881, DOI 10.1523/JNEUROSCI.22-10-03881.2002; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Oguro K, 1999, J NEUROSCI, V19, P9218; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; STEWARD O, 1988, J NEUROSCI, V8, P176; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077	26	216	221	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					530	533		10.1126/science.1142365	http://dx.doi.org/10.1126/science.1142365			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656725				2022-12-01	WOS:000248339800050
J	Annas, GJ				Annas, George J.			Cancer and the constitution - Choice at life's end	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				ANAND G, 2007, WALL STREET J   0315, pA1; Annas G J, 1992, Health Matrix Clevel, V2, P119; Annas George J, 2005, Stetson Law Rev, V35, P49; Annas George J, 1989, Villanova Law Rev, V34, P771; Annas GJ, 1997, NEW ENGL J MED, V337, P1098, DOI 10.1056/NEJM199710093371523; Appelbaum PS, 2006, KENNEDY INST ETHIC J, V16, P367, DOI 10.1353/ken.2006.0021; Berezikov E, 2000, GENOME BIOL, V1; Brugarolas J, 2007, NEW ENGL J MED, V356, P185, DOI 10.1056/NEJMe068263; Callahan Daniel., 1998, FALSE HOPES WHY AM Q; Coetzee J., 1990, AGE IRON; CULBERT M, 1974, VITAMIN B17 FORBIDDE; *FDA, 2006, PROP RUL CHARG INV D; *FDA, 2006, FDA PROP RUL OV EXP; Groopman Jerome, 2006, New Yorker, P40; Jacobson PD, 2007, JAMA-J AM MED ASSOC, V297, P205, DOI 10.1001/jama.297.2.205; KATZ J, 1984, SILENT WORLD DOCTOR, P151; MILLER HI, 2006, WALL STREET J   0302, pA15; NATHAN D, 2007, CANC TREATMENT REVOL; Patterson James T., 1987, DREAD DIS CANC MODER; PRUDHOMME A, 2004, CELL GAME S WAKSALS; Robertson JA, 2006, HASTINGS CENT REP, V36, P15, DOI 10.1353/hcr.2006.0101; 2005, WALL STREET J   0329, pA14; 2005, WALL STREET J   0324, pA14	23	12	13	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					408	413		10.1056/NEJMhle070625	http://dx.doi.org/10.1056/NEJMhle070625			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193OL	17652658	Green Published			2022-12-01	WOS:000248283500016
J	Dietzl, G; Chen, D; Schnorrer, F; Su, KC; Barinova, Y; Fellner, M; Gasser, B; Kinsey, K; Oppel, S; Scheiblauer, S; Couto, A; Marra, V; Keleman, K; Dickson, BJ				Dietzl, Georg; Chen, Doris; Schnorrer, Frank; Su, Kuan-Chung; Barinova, Yulia; Fellner, Michaela; Gasser, Beate; Kinsey, Kaolin; Oppel, Silvia; Scheiblauer, Susanne; Couto, Africa; Marra, Vincent; Keleman, Krystyna; Dickson, Barry J.			A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila	NATURE			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; INTERFERENCE; EXPRESSION; MELANOGASTER; IDENTIFICATION; INITIATION; PATHWAYS; SCREENS; VECTOR	Forward genetic screens in model organisms have provided important insights into numerous aspects of development, physiology and pathology. With the availability of complete genome sequences and the introduction of RNA-mediated gene interference (RNAi), systematic reverse genetic screens are now also possible. Until now, such genome-wide RNAi screens have mostly been restricted to cultured cells and ubiquitous gene inactivation in Caenorhabditis elegans. This powerful approach has not yet been applied in a tissue-specific manner. Here we report the generation and validation of a genome-wide library of Drosophila melanogaster RNAi transgenes, enabling the conditional inactivation of gene function in specific tissues of the intact organism. Our RNAi transgenes consist of short gene fragments cloned as inverted repeats and expressed using the binary GAL4/UAS system. We generated 22,270 transgenic lines, covering 88% of the predicted protein-coding genes in the Drosophila genome. Molecular and phenotypic assays indicate that the majority of these transgenes are functional. Our transgenic RNAi library thus opens up the prospect of systematically analysing gene functions in any tissue and at any stage of the Drosophila lifespan.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; Res Inst Mol Pathol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	dickson@imp.ac.at	Schnorrer, Frank/AIE-3578-2022; Dickson, Barry/AAE-7632-2019	Schnorrer, Frank/0000-0002-9518-7263; Dickson, Barry/0000-0003-0715-892X; Couto, Africa/0000-0002-3868-5637; Chen, Doris/0000-0001-8835-0280				Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Beall EL, 2002, GENETICS, V162, P217; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; BRAND AH, 1993, DEVELOPMENT, V118, P401; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fortier E, 2000, GENESIS, V26, P240, DOI 10.1002/(SICI)1526-968X(200004)26:4<240::AID-GENE40>3.0.CO;2-P; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Kalidas S, 2002, NEURON, V33, P177, DOI 10.1016/S0896-6273(02)00560-3; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Lam G, 2000, CURR BIOL, V10, P957, DOI 10.1016/S0960-9822(00)00631-X; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Martinek S, 2000, GENETICS, V156, P1717; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reichhart JM, 2002, GENESIS, V34, P160, DOI 10.1002/gene.10122; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Rozen S, 2000, Methods Mol Biol, V132, P365; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Stebbins MJ, 2001, P NATL ACAD SCI USA, V98, P10775, DOI 10.1073/pnas.121186498; TOMANCAK P, 2002, GENOME BIOL, V3; Van Roessel P, 2002, GENESIS, V34, P170, DOI 10.1002/gene.10146; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01	43	1900	1947	5	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2007	448	7150					151	U1		10.1038/nature05954	http://dx.doi.org/10.1038/nature05954			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17625558				2022-12-01	WOS:000247934500033
J	Cooper, D; Cahn, P; Lewin, S; Kaldor, J; McClure, C; Kort, R; Boyd, M				Cooper, David; Cahn, Pedro; Lewin, Sharon; Kaldor, John; McClure, Craig; Kort, Rodney; Boyd, Mark			The Sydney Declaration: a call to scale up research	LANCET			English	Editorial Material									Int AIDS Soc, CH-1216 Geneva, Switzerland; Univ New S Wales, Sydney, NSW, Australia; Fdn Huesped, Buenos Aires, DF, Argentina; Monash Univ, Clayton, Vic 3168, Australia; Alfred Hosp, Prahran, Vic 3181, Australia	University of New South Wales Sydney; Monash University; Florey Institute of Neuroscience & Mental Health	Kort, R (corresponding author), Int AIDS Soc, CH-1216 Geneva, Switzerland.	Rodney.Kort@iasociety.org	Kaldor, John M/D-4545-2011; Lewin, Sharon/Z-3297-2019	Lewin, Sharon Ruth/0000-0002-0330-8241					0	12	12	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2007	370	9581					7	8		10.1016/S0140-6736(07)61024-1	http://dx.doi.org/10.1016/S0140-6736(07)61024-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187QE	17617252				2022-12-01	WOS:000247862300006
J	Azzalin, CM; Reichenbach, P; Khoriauli, L; Giulotto, E; Lingner, J				Azzalin, Claus M.; Reichenbach, Patrick; Khoriauli, Lela; Giulotto, Elena; Lingner, Joachim			Telomeric repeat-containing RNA and RNA surveillance factors at mammalian chromosome ends	SCIENCE			English	Article							HUMAN-CELLS; PROTEIN; YEAST; DECAY; SENESCENCE; EXPRESSION; PATHWAYS; UPF1	Telomeres, the DNA-protein complexes located at the end of linear eukaryotic chromosomes, are essential for chromosome stability. Until now, telomeres have been considered to be transcriptionally silent. We demonstrate that mammalian telomeres are transcribed into telomeric repeat-containing RNA (TERRA). TERRA molecules are heterogeneous in length, are transcribed from several subtelomeric loci toward chromosome ends, and localize to telomeres. We also show that suppressors with morphogenetic defects in genitalia (SMG) proteins, which are effectors of nonsense-mediated messenger RNA decay, are enriched at telomeres in vivo, negatively regulate TERRA association with chromatin, and protect chromosome ends from telomere loss. Thus, telomeres are actively transcribed into TERRA, and SMG factors represent a molecular link between TERRA regulation and the maintenance of telomere integrity.	Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; Natl Ctr Competence Res, CH-1211 Geneva, Switzerland; Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy	Swiss Institute Experimental Cancer Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; University of Pavia	Lingner, J (corresponding author), Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland.	joachim.lingner@isrec.ch	azzalin, claus M/K-3898-2015	azzalin, claus M/0000-0002-9396-1980; GIULOTTO, ELENA/0000-0002-4705-2049; Lingner, Joachim/0000-0002-2853-5803				Azzalin CM, 2006, CURR BIOL, V16, P433, DOI 10.1016/j.cub.2006.01.018; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Behm-Ansmant I, 2006, GENE DEV, V20, P391, DOI 10.1101/gad.1407606; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Chiu SY, 2003, RNA, V9, P77, DOI 10.1261/rna.2137903; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Ng K, 2007, EMBO REP, V8, P34, DOI 10.1038/sj.embor.7400871; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; REDON S, 2007, IN PRESS NUCL R 1016; Reichenbach P, 2003, CURR BIOL, V13, P568, DOI 10.1016/S0960-9822(03)00173-8; SANDELL LL, 1994, P NATL ACAD SCI US, V91; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Snow BE, 2003, CURR BIOL, V13, P698, DOI 10.1016/S0960-9822(03)00210-0; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006	27	885	920	0	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2007	318	5851					798	801		10.1126/science.1147182	http://dx.doi.org/10.1126/science.1147182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17916692				2022-12-01	WOS:000250583900041
J	Whisson, SC; Boevink, PC; Moleleki, L; Avrova, AO; Morales, JG; Gilroy, EM; Armstrong, MR; Grouffaud, S; van West, P; Chapman, S; Hein, I; Toth, IK; Pritchard, L; Birch, PRJ				Whisson, Stephen C.; Boevink, Petra C.; Moleleki, Lucy; Avrova, Anna O.; Morales, Juan G.; Gilroy, Eleanor M.; Armstrong, Miles R.; Grouffaud, Severine; van West, Pieter; Chapman, Sean; Hein, Ingo; Toth, Ian K.; Pritchard, Leighton; Birch, Paul R. J.			A translocation signal for delivery of oomycete effector proteins into host plant cells	NATURE			English	Article							PHYTOPHTHORA-INFESTANS; PSEUDOMONAS-SYRINGAE; POTATO INFECTION; DOWNY MILDEW; AVIRULENCE; GENE; RESISTANCE; SECRETION; PATHOGEN; TRANSCRIPTION	Bacterial(1), oomycete(2) and fungal(3) plant pathogens establish disease by translocation of effector proteins into host cells, where they may directly manipulate host innate immunity. In bacteria, translocation is through the type III secretion system(1), but analogous processes for effector delivery are uncharacterized in fungi and oomycetes. Here we report functional analyses of two motifs, RXLR and EER, present in translocated oomycete effectors(2). We use the Phytophthora infestans RXLR-EER-containing protein Avr3a as a reporter for translocation because it triggers RXLR-EER-independent hypersensitive cell death following recognition within plant cells that contain the R3a resistance protein(4,5). We show that Avr3a, with or without RXLR-EER motifs, is secreted from P. infestans biotrophic structures called haustoria, demonstrating that these motifs are not required for targeting to haustoria or for secretion. However, following replacement of Avr3a RXLR-EER motifs with alanine residues, singly or in combination, or with residues KMIK-DDK-representing a change that conserves physicochemical properties of the protein-P. infestans fails to deliver Avr3a or an Avr3a-GUS fusion protein into plant cells, demonstrating that these motifs are required for translocation. We show that RXLR-EER-encoding genes are transcriptionally upregulated during infection. Bioinformatic analysis identifies 425 potential genes encoding secreted RXLR-EER class proteins in the P. infestans genome. Identification of this class of proteins provides unparalleled opportunities to determine how oomycetes manipulate hosts to establish infection.	Scottish Crop Res Inst, Plant Pathol Programme, Dundee DD2 5DA, Scotland; Univ Aberdeen, Inst Med Sci, Aberdeen Oomycete Grp, Aberdeen AB25 2ZD, Scotland	James Hutton Institute; University of Aberdeen	Birch, PRJ (corresponding author), Scottish Crop Res Inst, Plant Pathol Programme, Dundee DD2 5DA, Scotland.	Paul.Birch@scri.ac.uk	Pritchard, Leighton/A-7331-2008; Chapman, Sean N/H-5193-2013; Boevink, Petra/AAO-6498-2021; Moleleki, Lucy/E-8951-2010; Birch, Paul/F-7681-2012	Pritchard, Leighton/0000-0002-8392-2822; Boevink, Petra/0000-0002-7021-9097; Birch, Paul/0000-0002-6559-3746; Hein, Ingo/0000-0002-0128-2084; van West, Pieter/0000-0002-0767-6017; Gilroy, Eleanor/0000-0002-5301-4268; Moleleki, Lucy/0000-0002-1003-4621	BBSRC [BB/E007120/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E007120/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Allen RL, 2004, SCIENCE, V306, P1957, DOI 10.1126/science.1104022; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Avrova AO, 2003, FUNGAL GENET BIOL, V40, P4, DOI 10.1016/S1087-1845(03)00063-X; Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Blanco FA, 2005, MOL MICROBIOL, V56, P638, DOI 10.1111/j.1365-2958.2005.04575.x; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; DENECKE J, 1990, PLANT CELL, V2, P51, DOI 10.1105/tpc.2.1.51; Dodds PN, 2004, PLANT CELL, V16, P755, DOI 10.1105/tpc.020040; Ellis J, 2006, TRENDS PLANT SCI, V11, P61, DOI 10.1016/j.tplants.2005.12.008; Grenville-Briggs LJ, 2005, FUNGAL GENET BIOL, V42, P244, DOI 10.1016/j.fgb.2004.11.009; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Haldar K, 2006, NAT REV MICROBIOL, V4, P922, DOI 10.1038/nrmicro1549; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Holeva MC, 2004, MOL PLANT MICROBE IN, V17, P943, DOI 10.1094/MPMI.2004.17.9.943; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; JUDELSON HS, 1991, MOL PLANT MICROBE IN, V4, P602, DOI 10.1094/MPMI-4-602; Lindeberg M, 2006, MOL PLANT MICROBE IN, V19, P1151, DOI 10.1094/MPMI-19-1151; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Ridout CJ, 2006, PLANT CELL, V18, P2402, DOI 10.1105/tpc.106.043307; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Toth IK, 2005, CURR OPIN PLANT BIOL, V8, P424, DOI 10.1016/j.pbi.2005.04.001; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van West P, 1999, FEMS MICROBIOL LETT, V178, P71, DOI 10.1111/j.1574-6968.1999.tb13761.x	27	524	567	6	202	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 1	2007	450	7166					115	+		10.1038/nature06203	http://dx.doi.org/10.1038/nature06203			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226JR	17914356				2022-12-01	WOS:000250585800048
J	Watanabe, K; Toh, Y; Suto, K; Shimizu, Y; Oka, N; Wada, T; Tomita, K				Watanabe, Kazunori; Toh, Yukimatsu; Suto, Kyoko; Shimizu, Yoshihiro; Oka, Natsuhisa; Wada, Takeshi; Tomita, Kozo			Protein-based peptide-bond formation by aminoacyl-tRNA protein transferase	NATURE			English	Article							N-END RULE; SUBSTRATE RECOGNITION; CRYSTAL-STRUCTURES; PATHWAY; SYSTEM; FAMILY; NUCLEOTIDES; MECHANISM; INSIGHTS; SUBUNIT	Eubacterial leucyl/phenylalanyl-tRNA protein transferase (LF-transferase) catalyses peptide-bond formation by using Leu-tRNA(Leu) (or Phe-tRNA(Phe)) and an amino-terminal Arg (or Lys) of a protein, as donor and acceptor substrates, respectively. However, the catalytic mechanism of peptide-bond formation by LF-transferase remained obscure. Here we determine the structures of complexes of LF-transferase and phenylalanyl adenosine, with and without a short peptide bearing an N-terminal Arg. Combining the two separate structures into one structure as well as mutation studies reveal the mechanism for peptide-bond formation by LF-transferase. The electron relay from Asp 186 to Gln 188 helps Gln 188 to attract a proton from the alpha-amino group of the N-terminal Arg of the acceptor peptide. This generates the attacking nucleophile for the carbonyl carbon of the aminoacyl bond of the aminoacyl-tRNA, thus facilitating peptide-bond formation. The protein-based mechanism for peptide-bond formation by LF-transferase is similar to the reverse reaction of the acylation step observed in the peptide hydrolysis reaction by serine proteases.	Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, Tsukuba, Ibaraki 3058566, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Tomita, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, 1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	kozo-tomita@aist.go.jp	Tomita, Kozo/J-5746-2013; Toh, Yukimatsu/B-6549-2013; Shimizu, Yoshihiro/A-6472-2016; Tomita, Kozo/E-9390-2017; Oka, Natsuhisa/ABC-1654-2021; Watanabe, Kazunori/G-6671-2012	Shimizu, Yoshihiro/0000-0003-3499-1394; Tomita, Kozo/0000-0002-7374-3898; Oka, Natsuhisa/0000-0002-3114-9233; Watanabe, Kazunori/0000-0003-3678-636X				Abramochkin G, 1996, J BIOL CHEM, V271, P22901, DOI 10.1074/jbc.271.37.22901; Benson TE, 2002, STRUCTURE, V10, P1107, DOI 10.1016/S0969-2126(02)00807-9; Beringer M, 2007, MOL CELL, V26, P311, DOI 10.1016/j.molcel.2007.03.015; Biarrotte-Sorin S, 2004, STRUCTURE, V12, P257, DOI 10.1016/j.str.2004.01.006; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHLADEK S, 1973, BIOCHEMISTRY-US, V12, P5135, DOI 10.1021/bi00749a017; COWTAN K, 1994, NEWSLETTER PROTEIN C, V31, P34; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; GOTTIKH BP, 1970, TETRAHEDRON, V26, P4419, DOI 10.1016/S0040-4020(01)93090-X; Hegde SS, 2001, J BIOL CHEM, V276, P6998, DOI 10.1074/jbc.M008591200; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Ichetovkin IE, 1997, J BIOL CHEM, V272, P33009, DOI 10.1074/jbc.272.52.33009; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAJI H, 1963, Biochim Biophys Acta, V76, P474; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Nandi D, 2006, J BIOSCIENCES, V31, P137, DOI 10.1007/BF02705243; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Rodnina MV, 2007, TRENDS BIOCHEM SCI, V32, P20, DOI 10.1016/j.tibs.2006.11.007; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; SOFFER RL, 1973, J BIOL CHEM, V248, P8424; STEITZ TA, 1982, ANNU REV BIOPHYS BIO, V11, P419, DOI 10.1146/annurev.bb.11.060182.002223; Suto K, 2006, EMBO J, V25, P5942, DOI 10.1038/sj.emboj.7601433; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Trobro S, 2006, BIOCHEMISTRY-US, V45, P7049, DOI 10.1021/bi0605383; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; Varshavsky A, 2003, NAT CELL BIOL, V5, P373, DOI 10.1038/ncb0503-373; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003	35	66	66	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2007	449	7164					867	U5		10.1038/nature06167	http://dx.doi.org/10.1038/nature06167			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LY	17891155				2022-12-01	WOS:000250230600038
J	Aboa-Eboule, C; Brisson, C; Maunsell, E; Masse, B; Bourbonnais, R; Vezina, M; Milot, A; Theroux, P; Dagenais, GR				Aboa-Eboule, Corine; Brisson, Chantal; Maunsell, Elizabeth; Masse, Benoit; Bourbonnais, Renee; Vezina, Michel; Milot, Alain; Theroux, Pierre; Dagenais, Gilles R.			Job strain and risk of acute recurrent coronary heart disease events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPUTERIZED RECORD LINKAGE; ACUTE MYOCARDIAL-INFARCTION; MORTALITY DATA-BASE; CARDIOVASCULAR-DISEASE; SOCIAL SUPPORT; WHITEHALL-II; CONTENT QUESTIONNAIRE; SECONDARY PREVENTION; PROSPECTIVE COHORT; DECISION LATITUDE	Context There is evidence that job strain increases the risk of a first coronary heart disease (CHD) event. However, little is known about its association with the risk of recurrent CHD events after a first myocardial infarction (MI). Objective To determine whether job strain increases the risk of recurrent CHD events. Design, Setting, and Patients Prospective cohort study of 972 men and women aged 35 to 59 years who returned to work after a first MI and were then followed up between February 10, 1996, and June 22, 2005. Patients were interviewed at baseline (on average, 6 weeks after their return to work), then after 2 and 6 years subsequently. Job strain, a combination of high psychological demands and low decision latitude, was evaluated in 4 quadrants: high strain (high demands and low latitude), active (high demands and high latitude), passive (low demands and low latitude), and low strain. A chronic job strain variable was constructed based on the first 2 interviews, and patients were divided into those exposed to high strain at both interviews and those unexposed to high strain at 1 or both interviews. The survival analyses were presented separately for 2 periods: before 2.2 years and at 2.2 years and beyond. Main Outcome Measure The outcome was a composite of fatal CHD, nonfatal MI, and unstable angina. Results The outcome was documented in 206 patients. In the unadjusted analysis, chronic job strain was associated with recurrent CHD in the second period after 2.2 years of follow-up (hazard ratio [HR], 2.20; 95% CI, 1.32-3.66; respective event rates for patients exposed and unexposed to chronic job strain, 6.18 and 2.81 per 100 person-years). Chronic job strain remained an independent predictor of recurrent CHD in a multivariate model adjusted for 26 potentially confounding factors (HR, 2.00; 95% CI, 1.08-3.72). Conclusion Chronic job strain after a first MI was associated with an increased risk of recurrent CHD.	Univ Quebec, Ctr Hosp, Unite Rech Sante Populat, Quebec City, PQ G1S 4L8, Canada; Univ Laval, Unite Rech Sante Populat, Quebec City, PQ G1K 7P4, Canada; Inst Cardiol Quebec, Quebec City, PQ, Canada; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; Inst Cardiol, Montreal, PQ, Canada	Laval University; University of Quebec; Laval University; Laval University; Fred Hutchinson Cancer Center; Universite de Montreal; Institut de Cardiologie de Montreal	Brisson, C (corresponding author), Univ Quebec, Ctr Hosp, Unite Rech Sante Populat, 1050 Chemin Ste Foy, Quebec City, PQ G1S 4L8, Canada.	cbrisson@uresp.ulaval.ca		Masse, Benoit/0000-0002-4944-8098				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; ALFREDSSON L, 1985, INT J EPIDEMIOL, V14, P378, DOI 10.1093/ije/14.3.378; Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; AUDET N, 1998, CAHIER TECHNIQUE MET, V2, P215; BAREFOOT JC, 1989, PSYCHOSOM MED, V51, P46, DOI 10.1097/00006842-198901000-00005; Belkic KL, 2004, SCAND J WORK ENV HEA, V30, P85, DOI 10.5271/sjweh.769; BIRKETT NJ, 1992, AM J EPIDEMIOL, V136, P356, DOI 10.1093/oxfordjournals.aje.a116500; Bosma H, 1997, BRIT MED J, V314, P558, DOI 10.1136/bmj.314.7080.558; Brisson C, 1998, WORK STRESS, V12, P322, DOI 10.1080/02678379808256870; Cohn JN, 2006, AM J CARDIOL, V97, p4F, DOI 10.1016/j.amjcard.2006.03.004; Collins SM, 2005, AM J IND MED, V48, P182, DOI 10.1002/ajim.20204; De Bacquer D, 2005, AM J EPIDEMIOL, V161, P434, DOI 10.1093/aje/kwi040; De Lange AH, 2004, WORK STRESS, V18, P149, DOI 10.1080/02678370412331270860; de Lange Annet H, 2003, J Occup Health Psychol, V8, P282, DOI 10.1037/1076-8998.8.4.282; Deelstra JT, 2003, J APPL PSYCHOL, V88, P324, DOI 10.1037/0021-9010.88.2.324; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Eaker ED, 2004, AM J EPIDEMIOL, V159, P950, DOI 10.1093/aje/kwh127; FAUCETT JA, 1991, PAIN, V44, P35, DOI 10.1016/0304-3959(91)90144-M; GOLDBERG MS, 1993, CAN J PUBLIC HEALTH, V84, P201; HAAN MN, 1988, ANN CLIN RES, V20, P143; Hammar N, 1998, OCCUP ENVIRON MED, V55, P548, DOI 10.1136/oem.55.8.548; HAYNES SG, 1978, AM J EPIDEMIOL, V107, P382; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; ILFELD FW, 1976, PSYCHOL REP, V39, P1215, DOI 10.2466/pr0.1976.39.3f.1215; JOHNSON DR, 1983, AM SOCIOL REV, V48, P398, DOI 10.2307/2095231; JOHNSON JV, 1988, AM J PUBLIC HEALTH, V78, P1336, DOI 10.2105/AJPH.78.10.1336; Johnson JV, 1996, AM J PUBLIC HEALTH, V86, P324, DOI 10.2105/AJPH.86.3.324; Kaplan RC, 2002, J CLIN EPIDEMIOL, V55, P654, DOI 10.1016/S0895-4356(02)00405-5; Karasek R., 1985, JOB CONTENT QUESTION; Karasek R.A., 1990, HLTH WORK STRESS PRO; KARASEK RA, 1983, VALIDATION SURVEY IN; Kivimaki M, 2006, PSYCHOSOM MED, V68, P398, DOI 10.1097/01.psy.0000221252.84351.e2; KOMITZER M, 2006, EUR J CARDIVOASC PRE, V13, P695; KORNOWSKI R, 1993, AM J CARDIOL, V72, P883, DOI 10.1016/0002-9149(93)91100-V; Kuper H, 2003, J EPIDEMIOL COMMUN H, V57, P147, DOI 10.1136/jech.57.2.147; LANDSBERGIS PA, 1994, SCAND J WORK ENV HEA, V20, P349, DOI 10.5271/sjweh.1386; Larocque B, 1998, REV EPIDEMIOL SANTE, V46, P371; Levy AR, 1999, CAN J CARDIOL, V15, P1277; Libby P, 2002, NATURE, V420, P868, DOI [10.1038/nature01323, 10.1161/ATVBAHA.108.179705]; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Monfared AAT, 2006, PHARMACOEPIDEM DR S, V15, P19, DOI 10.1002/pds.1131; Netterstrom B, 2006, EUR J CARDIOV PREV R, V13, P414, DOI 10.1097/00149831-200606000-00018; Newby LK, 2006, CIRCULATION, V113, P203, DOI 10.1161/CIRCULATIONAHA.105.505636; Orth-Gomer K, 2000, JAMA-J AM MED ASSOC, V284, P3008, DOI 10.1001/jama.284.23.3008; Paquet M, 2005, J ADV NURS, V51, P567, DOI 10.1111/j.1365-2648.2005.03544.x; Pilote L, 2004, CAN J CARDIOL, V20, P61; REED DM, 1989, AM J EPIDEMIOL, V129, P495, DOI 10.1093/oxfordjournals.aje.a115160; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; Rouleau JL, 1996, J AM COLL CARDIOL, V27, P1119, DOI 10.1016/0735-1097(95)00599-4; Rozanski A, 2005, J AM COLL CARDIOL, V45, P637, DOI 10.1016/j.jacc.2004.12.005; Sajadieh A, 2004, EUR HEART J, V25, P363, DOI 10.1016/j.ehj.2003.12.003; SCHNALL PL, 1994, ANNU REV PUBL HEALTH, V15, P381, DOI 10.1146/annurev.pu.15.050194.002121; SHANNON HS, 1989, CAN J PUBLIC HEALTH, V80, P54; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; TAYLOR GJ, 1990, CAN J PSYCHIAT, V35, P290, DOI 10.1177/070674379003500402; THEORELL T, 1991, INT J CARDIOL, V30, P61, DOI 10.1016/0167-5273(91)90125-9	56	132	134	0	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2007	298	14					1652	1660		10.1001/jama.298.14.1652	http://dx.doi.org/10.1001/jama.298.14.1652			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218IO	17925517	Bronze			2022-12-01	WOS:000250009400021
J	Semenza, GL				Semenza, Gregg L.			Life with oxygen	SCIENCE			English	Editorial Material							GENE-EXPRESSION; HYPOXIA; HIF-1-ALPHA; HIF; FAMILY	The survival of all metazoan organisms is dependent on the regulation of O-2 delivery and utilization to maintain a balance between the generation of energy and production of potentially toxic oxidants. Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that functions as a master regulator of oxygen homeostasis and has essential roles in metazoan development, physiology, and disease pathogenesis. Remarkable progress has been made in delineating the molecular mechanisms whereby changes in cellular oxygenation are transduced to the nucleus as changes in gene transcription through the activity of HIF-1. Pharmacologic agents that activate or inhibit the hypoxia signal transduction pathway may be useful therapies for ischemic and neoplastic disorders, respectively, which are the major causes of mortality in industrialized societies.	Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Program, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Program, Broadway Res Bldg,Suite 671,733 N Broadway, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu						Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Makino Y, 2007, J BIOL CHEM, V282, P14073, DOI 10.1074/jbc.M700732200; Peet Daniel, 2006, Novartis Found Symp, V272, P37; REED MJ, 2004, SCI AGING KNOWLEDGE, pPE7; Semenza G. L., 2007, SCI STKE, pcm8; Severinghaus JW, 2003, ADV EXP MED BIOL, V543, P7; Tomita M, 2007, BIOCHEM J, V406, P317, DOI 10.1042/BJ20070286; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	17	505	529	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					62	64		10.1126/science.1147949	http://dx.doi.org/10.1126/science.1147949			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916722				2022-12-01	WOS:000249915400036
J	Patel, AA; Chen, MH; Renshaw, AA; D'Amico, AV				Patel, Abhijit A.; Chen, Ming-Hui; Renshaw, Andrew A.; D'Amico, Anthony V.			PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; CONFORMAL RADIATION-THERAPY; PROGNOSTIC-SIGNIFICANCE; RADICAL PROSTATECTOMY; BIOCHEMICAL RECURRENCE; ANDROGEN SUPPRESSION; CONSENSUS CONFERENCE; RADIOTHERAPY; ADENOCARCINOMA; CARCINOMA	Context In 2005, the International Society of Urologic Pathology consensus conference recommended that men with biopsy Gleason score 3 + 4 or 4 + 3 prostate cancer and tertiary pattern 5 should have their cancer classified as Gleason score 8 or 9, respectively. Yet, the management of men with Gleason score 7 vs 8 or 9 prostate cancer differs. Objective To compare the prognostic significance of Gleason score 7 with tertiary grade 5 vs other Gleason scores with respect to time to prostate-specific antigen (PSA) failure in men with prostate cancer. Design, Setting, and Patients From 1989 to 2005, 2370 men with clinical tumor category 1c to 3b, node-negative, and nonmetastatic prostate cancer underwent definitive therapy with surgery or radiation therapy with or without hormonal therapy. A pathologist with expertise in genitourinary cancers assigned Gleason scores to the prostate needle biopsy specimens. Cox regression was used to assess whether a significant association existed between the presence of tertiary grade 5 in men with Gleason score 7 disease and time to recurrence compared with men with Gleason score 7 without tertiary grade 5, Gleason score 5 to 6, or 8 to 10 disease, adjusting for known prognostic factors and treatment. Main Outcome Measure Time to PSA failure. Results Men with Gleason score 7 and tertiary grade 5 disease had a significantly shorter time to PSA failure than men with 7 without tertiary grade 5 (median time, 5.0 vs 6.7 years, respectively; adjusted hazard ratio (HR), 0.56; 95% confidence interval [CI], 0.32-0.97; P = .04) or score of 6 or less (median time, 15.4 years; adjusted HR, 0.24; 95% CI, 0.13-0.43; P < .001). However, a significant difference was not observed when these men were compared with men with Gleason score 8 to 10 disease (median time, 5.1 years; adjusted HR, 0.96; 95% CI, 0.54-1.71; P = .90). Conclusion In this study population, men with prostate cancer having biopsy Gleason score 7 and tertiary grade 5 had a higher risk of PSA-failure when compared with men with Gleason score 7 without tertiary grade 5 and had a comparable risk with men with Gleason score 8 to 10.	Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Baptist Hosp Miami, Dept Pathol, Miami, FL USA; Univ Connecticut, Dept Stat, Storrs, CT 06269 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Baptist Hospital Miami; University of Connecticut	Patel, AA (corresponding author), Brigham & Womens Hosp, Dept Radiat Oncol, 75 Francis St,L-2 Level, Boston, MA 02115 USA.	aapatel@partners.org			NATIONAL CANCER INSTITUTE [R01CA074015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070335] Funding Source: NIH RePORTER; NCI NIH HHS [CA 74015] Funding Source: Medline; NIGMS NIH HHS [GM 70335] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALHARA M, 1994, UROLOGY, V43, P60; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; Cookson MS, 2007, J UROLOGY, V177, P540, DOI 10.1016/j.juro.2006.10.097; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; Denham JW, 2005, LANCET ONCOL, V6, P841, DOI 10.1016/S1470-2045(05)70348-X; Egevad L, 2005, HUM PATHOL, V36, P5, DOI 10.1016/j.humpath.2004.10.001; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; GLEASON DF, 1992, HUM PATHOL, V23, P273, DOI 10.1016/0046-8177(92)90108-F; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Grimm PD, 2001, INT J RADIAT ONCOL, V51, P31, DOI 10.1016/S0360-3016(01)01601-7; Hanks GE, 2003, J CLIN ONCOL, V21, P3972, DOI 10.1200/JCO.2003.11.023; Hattab EM, 2006, J UROLOGY, V175, P1695, DOI 10.1016/S0022-5347(05)00998-5; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kattan MW, 2003, J CLIN ONCOL, V21, P4568, DOI 10.1200/JCO.2003.05.046; Klein JP, 1997, SURVIVAL ANAL TECHNI, P96; MELLINGER GT, 1967, J UROLOGY, V97, P331, DOI 10.1016/S0022-5347(17)63039-8; Mosse CA, 2004, AM J SURG PATHOL, V28, P394, DOI 10.1097/00000478-200403000-00014; Newgard CD, 2004, ACAD EMERG MED, V11, P953, DOI 10.1197/j.aem.2004.02.530; Pan CC, 2000, AM J SURG PATHOL, V24, P563, DOI 10.1097/00000478-200004000-00011; Partin AW, 2001, UROLOGY, V58, P843, DOI 10.1016/S0090-4295(01)01441-8; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Pollack A, 2000, J CLIN ONCOL, V18, P3904, DOI 10.1200/JCO.2000.18.23.3904; Rasiah KK, 2003, CANCER, V98, P2560, DOI 10.1002/cncr.11850; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; Sim HG, 2007, J UROLOGY, V177, P157, DOI 10.1016/S0022-5347(18)30723-7; Trpkov K, 2007, MODERN PATHOL, V20, p180A; Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233	28	56	57	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2007	298	13					1533	1538		10.1001/jama.298.13.1533	http://dx.doi.org/10.1001/jama.298.13.1533			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216EE	17911498	Bronze			2022-12-01	WOS:000249860500025
J	Jaillais, Y; Santambrogio, M; Rozier, F; Fobis-Loisy, I; Miege, C; Gaude, T				Jaillais, Yvon; Santambrogio, Martina; Rozier, Frederique; Fobis-Loisy, Isabelle; Miege, Christine; Gaude, Thierry			The retromer protein VPS29 links cell polarity and organ initiation in plants	CELL			English	Article							DEPENDENT AUXIN GRADIENTS; GNOM ARF-GEF; ARABIDOPSIS-THALIANA; REQUIRES RETROMER; EFFLUX; TRANSPORT; TRAFFICKING; RECEPTOR; WNT; PHOSPHOESTERASE	A key feature of plants ( as opposed to animals) is their ability to establish new organs not only during embryogenesis, but also throughout their development. A master regulator of organ initiation in plants is the phytohormone auxin. Auxin acts locally as a morphogen and is directionally transported from cell to cell by polarized auxin efflux carriers, termed PIN- FORMED ( PIN) proteins. Here we report that the Arabidopsis ortholog of the yeast and mammalian vacuolar protein sorting 29 ( VPS29), a member of the retromer complex, mediates the formation of new axes of development. Furthermore, we show that VPS29 is required for endosome homeostasis, PIN protein cycling, and dynamic PIN1 repolarization during development. We propose a model that links VPS29 function, PIN1 polarity, and organ initiation in plants.	Univ Lyon 1, Ecole Normale Super Lyon, CNRS,Inst Natl Rech Agronom, Inst Federatif Rech 128,Reprod & Dev Plantes, 48 Allee Italie, F-69364 Lyon 07, France	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Gaude, T (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, CNRS,Inst Natl Rech Agronom, Inst Federatif Rech 128,Reprod & Dev Plantes, 48 Allee Italie, F-69364 Lyon 07, France.	thierry.gaude@ens-lyon.fr	JAILLAIS, Yvon/U-3223-2018	JAILLAIS, Yvon/0000-0003-4923-883X; GAUDE, Thierry/0000-0002-0804-9445				Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Christensen SK, 2000, CELL, V100, P469, DOI 10.1016/S0092-8674(00)80682-0; Collins BM, 2005, NAT STRUCT MOL BIOL, V12, P594, DOI 10.1038/nsmb954; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Damen E, 2006, BIOCHEM J, V398, P399, DOI 10.1042/BJ20060033; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Furutani M, 2004, DEVELOPMENT, V131, P5021, DOI 10.1242/dev.01388; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926; Griffin CT, 2005, P NATL ACAD SCI USA, V102, P15173, DOI 10.1073/pnas.0409558102; Jaillais Y, 2006, NATURE, V443, P106, DOI 10.1038/nature05046; Lavy M, 2007, CURR BIOL, V17, P947, DOI 10.1016/j.cub.2007.04.038; Leyser O, 2006, CURR BIOL, V16, pR424, DOI 10.1016/j.cub.2006.05.014; Li H, 2001, PLANT PHYSIOL, V126, P670, DOI 10.1104/pp.126.2.670; Oliviusson P, 2006, PLANT CELL, V18, P1239, DOI 10.1105/tpc.105.035907; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Shimada T, 2006, PLANT CELL PHYSIOL, V47, P1187, DOI 10.1093/pcp/pcj103; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102; Tao LZ, 2002, PLANT CELL, V14, P2745, DOI 10.1105/tpc.006320; Vanoosthuyse V, 2003, PLANT PHYSIOL, V133, P919, DOI 10.1104/pp.103.023846; Verges M, 2004, NAT CELL BIOL, V6, P763, DOI 10.1038/ncb1153; Vernoux T, 2000, DEVELOPMENT, V127, P5157; Wang DQ, 2005, J BIOL CHEM, V280, P22962, DOI 10.1074/jbc.M500464200; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Xu J, 2005, CURR OPIN PLANT BIOL, V8, P613, DOI 10.1016/j.pbi.2005.09.003; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449	40	179	186	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2007	130	6					1057	1070		10.1016/j.cell.2007.08.040	http://dx.doi.org/10.1016/j.cell.2007.08.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889650	Bronze			2022-12-01	WOS:000250507500015
J	Zuber, MT; Phillips, RJ; Andrews-Hanna, JC; Asmar, SW; Konopliv, AS; Lemoine, FG; Plaut, JJ; Smith, DE; Smrekar, SE				Zuber, Maria T.; Phillips, Roger J.; Andrews-Hanna, Jeffrey C.; Asmar, Sami W.; Konopliv, Alexander S.; Lemoine, Frank G.; Plaut, Jeffrey J.; Smith, David E.; Smrekar, Suzanne E.			Density of Mars' south polar layered deposits	SCIENCE			English	Article							CAP	Both poles of Mars are hidden beneath caps of layered ice. We calculated the density of the south polar layered deposits by combining the gravity field obtained from initial results of radio tracking of the Mars Reconnaissance Orbiter with existing surface topography from the Mars Orbiter Laser Altimeter on the Mars Global Surveyor spacecraft and basal topography from the Mars Advanced Radar for Subsurface and Ionospheric Sounding on the Mars Express spacecraft. The results indicate a best-fit density of 1220 kilograms per cubic meter, which is consistent with water ice that has similar to 15% admixed dust. The results demonstrate that the deposits are probably composed of relatively clean water ice and also refine the martian surface-water inventory.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91009 USA; NASA, Goddard Space Flight Ctr, Solar syst Explorat div, Greenbelt, MD 20771 USA	Massachusetts Institute of Technology (MIT); Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Zuber, MT (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	zuber@mit.edu	Lemoine, Frank/D-1215-2013; Smrekar, Suzanne/AAH-8074-2020	Smrekar, Suzanne/0000-0001-8775-075X; Lemoine, Frank G./0000-0002-3051-1456				Bibring JP, 2004, NATURE, V428, P627, DOI 10.1038/nature02461; Byrne S, 2003, SCIENCE, V299, P1051, DOI 10.1126/science.1080148; Durham WB, 1999, GEOPHYS RES LETT, V26, P3493, DOI 10.1029/1999GL008373; Johnson CL, 2000, ICARUS, V144, P313, DOI 10.1006/icar.1999.6310; Malin MC, 2001, SCIENCE, V294, P2146, DOI 10.1126/science.1066416; Neumann GA, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002262; PARKER RL, 1973, GEOPHYS J ROY ASTR S, V31, P447, DOI 10.1111/j.1365-246X.1973.tb06513.x; PHILLIPS RJ, 2007, 7 INT C MARS 9 13 JU; Plaut JJ, 2007, SCIENCE, V316, P92, DOI 10.1126/science.1139672; Seu R, 2007, SCIENCE, V317, P1715, DOI 10.1126/science.1144120; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Titus TN, 2003, SCIENCE, V299, P1048, DOI 10.1126/science.1080497; Zuber MT, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002833; Zurek RW, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002701	15	62	64	3	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2007	317	5845					1718	1719		10.1126/science.1146995	http://dx.doi.org/10.1126/science.1146995			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885129				2022-12-01	WOS:000249585900038
J	Feinberg, AW; Feigel, A; Shevkoplyas, SS; Sheehy, S; Whitesides, GM; Parker, KK				Feinberg, Adam W.; Feigel, Alex; Shevkoplyas, Sergey S.; Sheehy, Sean; Whitesides, George M.; Parker, Kevin Kit			Muscular thin films for building actuators and powering devices	SCIENCE			English	Article							ENGINEERED HEART-TISSUE; CARDIAC-MUSCLE; SHEETS; MECHANICS	We demonstrate the assembly of biohybrid materials from engineered tissues and synthetic polymer thin films. The constructs were built by culturing neonatal rat ventricular cardiomyocytes on polydimethylsiloxane thin films micropatterned with extracellular matrix proteins to promote spatially ordered, two-dimensional myogenesis. The constructs, termed muscular thin films, adopted functional, three-dimensional conformations when released from a thermally sensitive polymer substrate and were designed to perform biomimetic tasks by varying tissue architecture, thin-film shape, and electrical-pacing protocol. These centimeter-scale constructs perform functions as diverse as gripping, pumping, walking, and swimming with fine spatial and temporal control and generating specific forces as high as 4 millinewtons per square millimeter.	Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Engn & Appl Sci, Dis Biophys Grp, Cambridge, MA 02138 USA	Harvard University; Harvard University	Whitesides, GM (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	gwhitesides@gmwgroup.harvard.edu; kkparker@seas.harvard.edu	Feinberg, Adam W/AAM-8547-2020; Shevkoplyas, Sergey/G-2466-2010; Feinberg, Adam W/A-7103-2009; Feigel, Alexander/AAN-3680-2021	Feinberg, Adam W/0000-0003-3338-5456; Feinberg, Adam W/0000-0003-3338-5456; Shevkoplyas, Sergey/0000-0002-8203-8365				Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM., 2001, EXCITATION CONTRACTI, V2, DOI [10.1007/978-94-010-0658-3, DOI 10.1007/978-94-010-0658-3]; Boncheva M, 2005, P NATL ACAD SCI USA, V102, P3924, DOI 10.1073/pnas.0500807102; BRADY AJ, 1979, NATURE, V282, P728, DOI 10.1038/282728a0; Budick SA, 2000, J EXP BIOL, V203, P2565; Bursac N, 2002, CIRC RES, V91, pE45, DOI 10.1161/01.RES.0000047530.88338.EB; Costa KD, 1999, AM J PHYSIOL-HEART C, V276, pH595, DOI 10.1152/ajpheart.1999.276.2.H595; Ebron VH, 2006, SCIENCE, V311, P1580, DOI 10.1126/science.1120182; Fishman MC, 1997, DEVELOPMENT, V124, P2099; Forouhar AS, 2006, SCIENCE, V312, P751, DOI 10.1126/science.1123775; Huffard CL, 2005, SCIENCE, V307, P1927, DOI 10.1126/science.1109616; Klein Y, 2007, SCIENCE, V315, P1116, DOI 10.1126/science.1135994; Lieber SC, 2004, AM J PHYSIOL-HEART C, V287, pH645, DOI 10.1152/ajpheart.00564.2003; LOAH A, 2005, APPL SURF SCI, V239, P410; Madden JDW, 2004, IEEE J OCEANIC ENG, V29, P706, DOI 10.1109/JOE.2004.833135; Mendias CL, 2005, FASEB J, V19, pA1118, DOI 10.1096/fj.04-2034fje; Muller UK, 2000, J EXP BIOL, V203, P193; Nishimura S, 2004, AM J PHYSIOL-HEART C, V287, pH196, DOI 10.1152/ajpheart.00948.2003; Shimizu T, 2001, TISSUE ENG, V7, P141, DOI 10.1089/107632701300062732; Tan JL, 2004, TISSUE ENG, V10, P865, DOI 10.1089/1076327041348365; Tanaka Y, 2007, LAB CHIP, V7, P207, DOI 10.1039/b612082b; Torrent-Guasp F, 2004, EUR J CARDIO-THORAC, V25, P376, DOI 10.1016/j.ejcts.2003.12.020; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Winges SA, 2005, INTEGR COMP BIOL, V45, P679, DOI 10.1093/icb/45.4.679; Xi JZ, 2005, NAT MATER, V4, P180, DOI 10.1038/nmat1308; Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394; Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023	28	544	558	13	278	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2007	317	5843					1366	1370		10.1126/science.1146885	http://dx.doi.org/10.1126/science.1146885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209GR	17823347				2022-12-01	WOS:000249377500039
J	Sieber, JJ; Willig, KI; Kutzner, C; Gerding-Reimers, C; Harke, B; Donnert, G; Rammner, B; Eggeling, C; Hell, SW; Grubmuller, H; Lang, T				Sieber, Jochen J.; Willig, Katrin I.; Kutzner, Carsten; Gerding-Reimers, Claas; Harke, Benjamin; Donnert, Gerald; Rammner, Burkhard; Eggeling, Christian; Hell, Stefan W.; Grubmueller, Helmut; Lang, Thorsten			Anatomy and dynamics of a supramolecular membrane protein cluster	SCIENCE			English	Article							PLASMA-MEMBRANE; FLUORESCENCE MICROSCOPY; CELL-MEMBRANES; SNARE; EXOCYTOSIS; RESOLUTION; FUSION; SYNTAXIN-4; DOCKING; DOMAINS	Most plasmalemmal proteins organize in submicrometer-sized clusters whose architecture and dynamics are still enigmatic. With syntaxin 1 as an example, we applied a combination of far-field optical nanoscopy, biochemistry, fluorescence recovery after photobleaching (FRAP) analysis, and simulations to show that clustering can be explained by self-organization based on simple physical principles. On average, the syntaxin clusters exhibit a diameter of 50 to 60 nanometers and contain 75 densely crowded syntaxins that dynamically exchange with freely diffusing molecules. Self-association depends on weak homophilic protein-protein interactions. Simulations suggest that clustering immobilizes and conformationally constrains the molecules. Moreover, a balance between self-association and crowding-induced steric repulsions is sufficient to explain both the size and dynamics of syntaxin clusters and likely of many oligomerizing membrane proteins that form supramolecular structures.	Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Lang, T (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany.	tlang@gwdg.de	Willig, Katrin/AAH-5418-2020	Willig, Katrin/0000-0002-1860-334X				Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Donnert G, 2006, P NATL ACAD SCI USA, V103, P11440, DOI 10.1073/pnas.0604965103; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fukuda M, 2001, J BIOL CHEM, V276, P40319, DOI 10.1074/jbc.M105356200; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Kai M, 2006, J BIOCHEM, V140, P677, DOI 10.1093/jb/mvj195; Kanazawa K, 2005, J BONE MINER RES, V20, P2053, DOI 10.1359/JBMR.050706; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Laage R, 2000, J BIOL CHEM, V275, P17481, DOI 10.1074/jbc.M910092199; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Lerman JC, 2000, BIOCHEMISTRY-US, V39, P8470, DOI 10.1021/bi0003994; Low SH, 2006, MOL BIOL CELL, V17, P977, DOI 10.1091/mbc.E05-05-0462; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Ohara-Imaizumi M, 2004, J BIOL CHEM, V279, P8403, DOI 10.1074/jbc.M308954200; Predescu SA, 2005, J BIOL CHEM, V280, P37130, DOI 10.1074/jbc.M505659200; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Uhles S, 2003, J CELL BIOL, V163, P1327, DOI 10.1083/jcb.200306093; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592	23	341	345	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2007	317	5841					1072	1076		10.1126/science.1141727	http://dx.doi.org/10.1126/science.1141727			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203AE	17717182	Green Published			2022-12-01	WOS:000248946700042
J	Gahl, WA; Balog, JZ; Kleta, R				Gahl, William A.; Balog, Joan Z.; Kleta, Robert			Nephropathic cystinosis in adults: Natural history and effects of oral cysteamine therapy	ANNALS OF INTERNAL MEDICINE			English	Article							LEUKOCYTE GRANULAR FRACTIONS; SWALLOWING DYSFUNCTION; CORNEAL CRYSTALS; PUBERTAL CHANGES; CTNS MUTATIONS; TRANSPORT; GENE; MANIFESTATIONS; INSUFFICIENCY; HYPERTENSION	Background: The full burden of nephropathic cystinosis in adulthood and the effects of long-term oral cysteamine therapy on its nonrenal complications have not been elucidated. Objective: To assess the severity of cystinosis in adults receiving and not receiving oral cysteamine therapy. Design: Case series. Setting: National Institutes of Health Clinical Center. Patients: 100 persons (58 men and 42 women) age 18 to 45 years with nephropathic cystinosis examined between January 1985 and May 2006. Measurements: Historical data were collected on renal transplantation, administration of oral cysteamine, and time and cause of death. Patients were evaluated for height and weight; thyroid, pulmonary, and swallowing function; muscle atrophy; hypogonadism (in men); retinopathy; vascular and cerebral calcifications; diabetes mellitus; and homozygosity for the common 57-kb deletion in CTNS. Laboratory studies were also performed. Results: Of 100 adults with nephropathic cystinosis, 92 had received a renal allograft and 33 had died. At least half of the patients had hypothyroidism, hypergonadotropic hypogonadism (in men), pulmonary insufficiency, swallowing abnormalities, or myopathy. One third of the patients had retinopathy or vascular calcifications, and 24% had diabetes. Homozygosity for the 57-kb CTNS deletion was associated with an increased risk for death and morbidity. The 39 patients who received long-term ( >= 8 years) oral cysteamine therapy were taller and heavier, had a renal allograft later in life, had lower cholesterol levels, and experienced fewer complications and deaths than patients who received cysteamine for fewer than 8 years. The frequency of diabetes mellitus, myopathy, pulmonary dysfunction, hypothyroidism, and death increased as time off cysteamine treatment increased, and it decreased as time on cysteamine therapy increased. Limitations: The study was retrospective and not randomized. The criteria used to measure adequacy of treatment were arbitrary. Conclusions: Untreated nephropathic cystinosis causes extensive morbidity and death in adulthood. Long-term oral cysteamine therapy mitigates these effects.	NHGRI, NIH, Intramural Off Rare Dis, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Gahl, WA (corresponding author), NHGRI, NIH, Intramural Off Rare Dis, 10 Ctr Dr,Bldg 10,Room 10C-103, Bethesda, MD 20892 USA.	bgahl@helix.nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIDHG200352, ZIAHG000215, Z01HG000215, Z01HG200352] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Anikster Y, 1999, MOL GENET METAB, V66, P111, DOI 10.1006/mgme.1998.2790; Anikster Y, 2001, CHEST, V119, P394, DOI 10.1378/chest.119.2.394; Anikster Y, 2000, PEDIATR RES, V47, P17, DOI 10.1203/00006450-200001000-00007; CHARNAS LR, 1994, ANN NEUROL, V35, P181, DOI 10.1002/ana.410350209; CHIK CL, 1993, ANN INTERN MED, V119, P568, DOI 10.7326/0003-4819-119-7_Part_1-199310010-00004; Dogulu CF, 2004, J PEDIATR-US, V145, P673, DOI 10.1016/j.jpeds.2004.06.080; EHRICH JHH, 1979, NEUROPADIATRIE, V10, P128, DOI 10.1055/s-0028-1085319; Fidler MC, 2007, BRIT J CLIN PHARMACO, V63, P36, DOI 10.1111/j.1365-2125.2006.02734.x; FINK JK, 1989, ARCH NEUROL-CHICAGO, V46, P543, DOI 10.1001/archneur.1989.00520410077027; FIVUSH B, 1988, J PEDIATR-US, V112, P49, DOI 10.1016/S0022-3476(88)80119-7; FIVUSH B, 1987, AM J DIS CHILD, V141, P1087, DOI 10.1001/archpedi.1987.04460100065027; Gahl W A, 1986, Adv Pediatr, V33, P95; Gahl W.A., 2001, METAB MOL BASES INHE, V4, P5085; GAHL WA, 1986, J PEDIATR-US, V109, P605, DOI 10.1016/S0022-3476(86)80221-9; GAHL WA, 1983, BIOCHEM J, V216, P393, DOI 10.1042/bj2160393; GAHL WA, 1985, BIOCHEM J, V228, P545, DOI 10.1042/bj2280545; GAHL WA, 1987, NEW ENGL J MED, V316, P971, DOI 10.1056/NEJM198704163161602; Gahl WA, 2002, NEW ENGL J MED, V347, P111, DOI 10.1056/NEJMra020552; GAHL WA, 1988, NEW ENGL J MED, V319, P1461, DOI 10.1056/NEJM198812013192206; GAHL WA, 1992, BIOCHEM MED METAB B, V48, P275, DOI 10.1016/0885-4505(92)90074-9; GAHL WA, 1982, SCIENCE, V217, P1263, DOI 10.1126/science.7112129; GAHL WA, 1987, PEDIATR RES, V21, P193, DOI 10.1203/00006450-198702000-00016; Gahl WA, 2000, MOL GENET METAB, V71, P100, DOI 10.1006/mgme.2000.3062; JONAS AJ, 1982, J BIOL CHEM, V257, P13185; KAISERKUPFER MI, 1987, NEW ENGL J MED, V316, P775, DOI 10.1056/NEJM198703263161304; KAISERKUPFER MI, 1990, ARCH OPHTHALMOL-CHIC, V108, P689, DOI 10.1001/archopht.1990.01070070075038; KAISERKUPFER MI, 1986, ARCH OPHTHALMOL-CHIC, V104, P706, DOI 10.1001/archopht.1986.01050170096030; KIMONIS VE, 1995, J CLIN ENDOCR METAB, V80, P3257, DOI 10.1210/jc.80.11.3257; Kleta R, 2004, EXPERT OPIN PHARMACO, V5, P2255, DOI 10.1517/14656566.5.11.2255; Kleta R, 2001, MOL GENET METAB, V74, P332, DOI 10.1006/mgme.2001.3218; MARKELLO TC, 1993, NEW ENGL J MED, V328, P1157, DOI 10.1056/NEJM199304223281604; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; MCDOWELL GA, 1995, NAT GENET, V10, P246, DOI 10.1038/ng0695-246; O'Brien K, 2006, CLIN GASTROENTEROL H, V4, P387, DOI 10.1016/j.cgh.2005.12.013; OSHIMA RG, 1974, J BIOL CHEM, V249, P6033; PISONI RL, 1985, J BIOL CHEM, V260, P4791; Shotelersuk V, 1998, AM J HUM GENET, V63, P1352, DOI 10.1086/302118; Sonies BC, 2005, MEDICINE, V84, P137, DOI 10.1097/01.md.0000164204.00159.d4; SONIES BC, 1990, NEW ENGL J MED, V323, P565, DOI 10.1056/NEJM199008303230903; THEODOROPOULOS DS, 1993, JAMA-J AM MED ASSOC, V270, P2200, DOI 10.1001/jama.270.18.2200; Thoene J, 1999, MOL GENET METAB, V67, P283, DOI 10.1006/mgme.1999.2876; THOENE JG, 1976, J CLIN INVEST, V58, P180, DOI 10.1172/JCI108448; Town M, 1998, NAT GENET, V18, P319, DOI 10.1038/ng0498-319; Tsilou ET, 2006, OPHTHALMOLOGY, V113, P1002, DOI 10.1016/j.ophtha.2005.12.026; Ueda M, 2006, CLIN J AM SOC NEPHRO, V1, P555, DOI 10.2215/CJN.01431005; VOGEL DG, 1990, J NEUROPATH EXP NEUR, V49, P591, DOI 10.1097/00005072-199011000-00005	47	156	159	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 21	2007	147	4					242	250		10.7326/0003-4819-147-4-200708210-00006	http://dx.doi.org/10.7326/0003-4819-147-4-200708210-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201AP	17709758				2022-12-01	WOS:000248804200004
J	de la Rocha, J; Doiron, B; Shea-Brown, E; Josic, K; Reyes, A				de la Rocha, Jaime; Doiron, Brent; Shea-Brown, Eric; Josic, Kresimir; Reyes, Alex			Correlation between neural spike trains increases with firing rate	NATURE			English	Article							PYRAMIDAL NEURONS; VISUAL-CORTEX; DISCHARGE; CELLS; SYNCHRONIZATION; COMPUTATION; POPULATION; MACAQUE; INPUT; WEAK	Populations of neurons in the retina(1-3), olfactory system(4), visual(5) and somatosensory(6) thalamus, and several cortical regions(7-10) show temporal correlation between the discharge times of their action potentials ( spike trains). Correlated firing has been linked to stimulus encoding(9), attention(11), stimulus discrimination(4), and motor behaviour(12). Nevertheless, the mechanisms underlying correlated spiking are poorly understood(2,3,13-20), and its coding implications are still debated(13,16,21,22). It is not clear, for instance, whether correlations between the discharges of two neurons are determined solely by the correlation between their afferent currents, or whether they also depend on the mean and variance of the input. We addressed this question by computing the spike train correlation coefficient of unconnected pairs of in vitro cortical neurons receiving correlated inputs. Notably, even when the input correlation remained fixed, the spike train output correlation increased with the firing rate, but was largely independent of spike train variability. With a combination of analytical techniques and numerical simulations using 'integrate- and- fire' neuron models we show that this relationship between output correlation and firing rate is robust to input heterogeneities. Finally, this overlooked relationship is replicated by a standard threshold- linear model, demonstrating the universality of the result. This connection between the rate and correlation of spiking activity links two fundamental features of the neural code.	NYU, Ctr Neural Sci, New York, NY 10003 USA; NYU, Courant Inst Math Sci, New York, NY 10012 USA; Univ Houston, Dept Math, Houston, TX 77204 USA	New York University; New York University; University of Houston System; University of Houston	Doiron, B (corresponding author), Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA.	jrocha@cns.nyu.edu; bdoiron@cns.nyu.edu	de la Rocha, Jaime/I-2119-2015	de la Rocha, Jaime/0000-0002-3314-9384				Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Binder MD, 2001, J NEUROPHYSIOL, V86, P2266, DOI 10.1152/jn.2001.86.5.2266; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Doiron B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.030903; Dorn JD, 2003, J NEUROPHYSIOL, V89, P2271, DOI 10.1152/jn.000889.2002; Galan RF, 2006, J NEUROSCI, V26, P3646, DOI 10.1523/JNEUROSCI.4605-05.2006; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Lau D, 2000, J NEUROSCI, V20, P9071; Lindner B, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061919; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Reyes AD, 2003, NAT NEUROSCI, V6, P593, DOI 10.1038/nn1056; Ricciardi LM, 1977, DIFFUSION PROCESSES; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Svirskis G, 2003, NETWORK-COMP NEURAL, V14, P747, DOI 10.1088/0954-898X/14/4/307; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	30	456	459	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					802	U6		10.1038/nature06028	http://dx.doi.org/10.1038/nature06028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17700699				2022-12-01	WOS:000248754200039
J	Lee, DF; Kuo, HP; Chen, CT; Hsu, JM; Chou, CK; Wei, Y; Sun, HL; Li, LY; Ping, B; Huang, WC; He, X; Hung, JY; Lai, CC; Ding, Q; Su, JL; Yang, JY; Sahin, AA; Hortobagyi, GN; Tsai, FJ; Tsai, CH; Hung, MC				Lee, Dung-Fang; Kuo, Hsu-Ping; Chen, Chun-Te; Hsu, Jung-Mao; Chou, Chao-Kai; Wei, Yongkun; Sun, Hui-Lung; Li, Long-Yuan; Ping, Bo; Huang, Wei-Chien; He, Xianghuo; Hung, Jen-Yu; Lai, Chien-Chen; Ding, Qingqing; Su, Jen-Liang; Yang, Jer-Yen; Sahin, Aysegul A.; Hortobagyi, Gabriel N.; Tsai, Fuu-Jen; Tsai, Chang-Hai; Hung, Mien-Chie			IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway	CELL			English	Article							KAPPA-B KINASE; CELL-GROWTH; TUBEROUS SCLEROSIS; BREAST-CANCER; MAMMALIAN TARGET; GENE-EXPRESSION; MOUSE MODEL; PHOSPHORYLATION; ACTIVATION; ALPHA	TNF alpha has recently emerged as a regulator linking inflammation to cancer pathogenesis, but the detailed cellular and molecular mechanisms underlying this link remain to be elucidated. The tuberous sclerosis 1 (TSC1)/TSC2 tumor suppressor complex serves as a repressor of the mTOR pathway, and disruption of TSC1/TSC2 complex function may contribute to tumorigenesis. Here we show that IKK beta, a major downstream kinase in the TNFa signaling pathway, physically interacts with and phosphorylates TSC1 at Ser487 and Ser511, resulting in suppression of TSC1. The IKK beta mediated TSC1 suppression activates them TOR pathway, enhances angiogenesis, and results in tumor development. We further find that expression of activated IKKb is associated with TSC1 Ser511 phosphorylation and VEGF production in multiple tumor types and correlates with poor clinical outcome of breast cancer patients. Our findings identify a pathway that is critical for inflammation-mediated tumor angiogenesis and may provide a target for clinical intervention in human cancer.	Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; Univ Texas, Grad Sch Biomed Sci, Houston, TX 77030 USA; China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan; Asia Univ, Taichung 413, Taiwan; Univ Texas, MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; University of Texas System; UTMD Anderson Cancer Center	Hung, MC (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mhung@mdanderson.org	Hsu, Jung-Mao/AAC-9527-2019; /AGZ-4617-2022; Huang, Wei-Chien/H-3126-2019; He, Xianghuo/I-1497-2014; Huang, Wei-Chien/D-1740-2012; Tsai, Fuu-Jen/J-4140-2015; Hung, Mien-Chie/ABD-5911-2021; Hsu, Jung-Mao/AAP-8045-2020	/0000-0002-7133-8266; Huang, Wei-Chien/0000-0001-6467-8716; He, Xianghuo/0000-0001-8872-668X; Huang, Wei-Chien/0000-0001-6467-8716; Hung, Mien-Chie/0000-0003-4317-4740; CHOU, CHAO-KAI/0000-0001-5231-5264; Lee, Dung-Fang/0000-0003-2387-597X; Li, Long-Yuan/0000-0001-7472-8318	NCI NIH HHS [CA16672, CA116199, R01 CA109311, P01 CA099031, R01 CA058880] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA109311, P30CA016672, P50CA116199, P01CA099031, R01CA058880] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Benvenuto G, 2000, ONCOGENE, V19, P6306, DOI 10.1038/sj.onc.1204009; BINGLE L, 1995, J PATHOL, V377, P441; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Camp RL, 1999, CANCER, V86, P2259, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2259::AID-CNCR13>3.0.CO;2-2; Chang JY, 1997, ONCOGENE, V14, P561, DOI 10.1038/sj.onc.1200861; Chong-Kopera H, 2006, J BIOL CHEM, V281, P8313, DOI 10.1074/jbc.C500451200; Chung J, 2002, J CELL BIOL, V158, P165, DOI 10.1083/jcb.200112015; Delhase M, 2000, NATURE, V406, P367, DOI 10.1038/35019154; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; El-Hashemite N, 2003, CANCER RES, V63, P5173; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Klos KS, 2006, CANCER RES, V66, P2028, DOI 10.1158/0008-5472.CAN-04-4559; Korherr C, 2006, P NATL ACAD SCI USA, V103, P4240, DOI 10.1073/pnas.0511319103; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lamberti C, 2001, J BIOL CHEM, V276, P42276, DOI 10.1074/jbc.M104227200; Lee SH, 2004, P NATL ACAD SCI USA, V101, P17416, DOI 10.1073/pnas.0408061101; Li Y, 2003, J BIOL CHEM, V278, P13663, DOI 10.1074/jbc.M300862200; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Young J, 1998, MOL MED TODAY, V4, P313, DOI 10.1016/S1357-4310(98)01245-3; Zou YY, 2002, CANCER RES, V62, P8	42	505	533	1	43	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 10	2007	130	3					440	455		10.1016/j.cell.2007.05.058	http://dx.doi.org/10.1016/j.cell.2007.05.058			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693255	Bronze			2022-12-01	WOS:000249038100013
J	Carmody, RJ; Ruan, QG; Palmer, S; Hilliard, B; Chen, YHH				Carmody, Ruaidhri J.; Ruan, Qingguo; Palmer, Scott; Hilliard, Brendan; Chen, Youhai H.			Negative regulation of Toll-like receptor signaling by NF-kappa B p50 ubiquitination blockade	SCIENCE			English	Article							IMMUNE-RESPONSES; DNA-BINDING; BCL-3; HOMODIMERS; TOLERANCE; SPECIFICITY; ONCOPROTEIN; PROTEINS; SUBUNIT; ENCODES	Toll-like receptors (TLRs) trigger the production of inflammatory cytokines and shape adaptive and innate immunity to pathogens. We report the identification of B cell leukemia (Bcl)-3 as an essential negative regulator of TLR signaling. By blocking ubiquitination of p50, a member of the nuclear factor (NF)-kB family, Bcl-3 stabilizes a p50 complex that inhibits gene transcription. As a consequence, Bcl-3-deficient mice and cells were found to be hypersensitive to TLR activation and unable to control responses to lipopolysaccharides. Thus, p50 ubiquitination blockade by Bcl-3 limits the strength of TLR responses and maintains innate immune homeostasis. These findings indicate that the p50 ubiquitination pathway can be selectively targeted to control deleterious inflammatory diseases.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Chen, YHH (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	yhc@mail.med.upenn.edu	Chen, Youhai/AAJ-4031-2021; Carmody, Ruaidhri/H-5396-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050059, R01AI069289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070691] Funding Source: NIH RePORTER; NIAID NIH HHS [AI50059, AI069289] Funding Source: Medline; NIDDK NIH HHS [DK070691] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Caamano JH, 1996, MOL CELL BIOL, V16, P1342; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Franzoso G, 1997, IMMUNITY, V6, P479, DOI 10.1016/S1074-7613(00)80291-5; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; INOUE J, 1993, ONCOGENE, V8, P2067; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; KERR LD, 1992, GENE DEV, V6, P2352, DOI 10.1101/gad.6.12a.2352; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Medvedev AE, 2006, J ENDOTOXIN RES, V12, P133, DOI 10.1179/096805106X102255; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Schwarz EM, 1997, GENE DEV, V11, P187, DOI 10.1101/gad.11.2.187; URBAN MB, 1990, GENE DEV, V4, P1975, DOI 10.1101/gad.4.11.1975; Watanabe N, 1997, EMBO J, V16, P3609, DOI 10.1093/emboj/16.12.3609; ZIEGLERHEITBROCK HWL, 1994, J BIOL CHEM, V269, P17001	24	181	188	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2007	317	5838					675	678		10.1126/science.1142953	http://dx.doi.org/10.1126/science.1142953			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17673665				2022-12-01	WOS:000248494400049
J	Ago, H; Kanaoka, Y; Irikura, D; Lam, BK; Shimamura, T; Austen, KF; Miyano, M				Ago, Hideo; Kanaoka, Yoshihide; Irikura, Daisuke; Lam, Bing K.; Shimamura, Tatsuro; Austen, K. Frank; Miyano, Masashi			Crystal structure of a human membrane protein involved in cysteinyl leukotriene biosynthesis	NATURE			English	Article							C-4 SYNTHASE; GLUTATHIONE; IDENTIFICATION; TRANSFERASE; EXPRESSION; SUBSTANCE; CLONING; ENZYME	The cysteinyl leukotrienes, namely leukotriene (LT)C-4 and its metabolites LTD4 and LTE4, the components of slow-reacting substance of anaphylaxis(1,2), are lipid mediators of smooth muscle constriction(3-5) and inflammation(6,7), particularly implicated in bronchial asthma(8,9). LTC4 synthase (LTC4S), the pivotal enzyme for the biosynthesis of LTC4 (ref. 10), is an 18-kDa integral nuclear membrane protein(11,12) that belongs to a superfamily of membrane-associated proteins in eicosanoid and glutathione metabolism that includes 5-lipoxygenase- activating protein, microsomal glutathione S-transferases (MGSTs), and microsomal prostaglandin E synthase 1 (ref. 13). LTC4S conjugates glutathione to LTA(4), the endogenous substrate derived from arachidonic acid through the 5-lipoxygenase pathway(14). In contrast with MGST2 and MGST3 (refs 15, 16), LTC4S does not conjugate glutathione to xenobiotics(17). Here we show the atomic structure of human LTC4S in a complex with glutathione at 3.3 angstrom resolution by X-ray crystallography and provide insights into the high substrate specificity for glutathione and LTA(4) that distinguishes LTC4S from other MGSTs. The LTC4S monomer has four transmembrane alpha-helices and forms a threefold symmetric trimer as a unit with functional domains across each interface. Glutathione resides in a U-shaped conformation within an interface between adjacent monomers, and this binding is stabilized by a loop structure at the top of the interface. LTA(4) would fit into the interface so that Arg 104 of one monomer activates glutathione to provide the thiolate anion that attacks C6 of LTA(4) to form a thioether bond, and Arg 31 in the neighbouring monomer donates a proton to form a hydroxyl group at C5, resulting in 5(S)-hydroxy-6(R)-S-glutathionyl-7,9-trans-11,14-cis-eicosatetraenoic acid (LTC4). These findings provide a structural basis for the development of LTC4S inhibitors for a proinflammatory pathway mediated by three cysteinyl leukotriene ligands whose stability and potency are different and by multiple cysteinyl leukotriene receptors whose functions may be non-redundant.	Harima Inst, Struct Biophys Lab, RIKEN SPring Ctr 8, Sayo, Hyogo 6795148, Japan; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	RIKEN; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Miyano, M (corresponding author), Harima Inst, Struct Biophys Lab, RIKEN SPring Ctr 8, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	fausten@rics.bwh.harvard.edu; miyano@spring8.or.jp	Miyano, Masashi/R-2785-2016	Miyano, Masashi/0000-0003-2253-6175; Ago, Hideo/0000-0002-9040-488X				Adachi S, 2001, NUCL INSTRUM METH A, V467, P711, DOI 10.1016/S0168-9002(01)00472-7; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beller TC, 2004, P NATL ACAD SCI USA, V101, P3047, DOI 10.1073/pnas.0400235101; Bresell A, 2005, FEBS J, V272, P1688, DOI 10.1111/j.1742-4658.2005.04596.x; BROCKLEHURST WE, 1960, J PHYSIOL-LONDON, V151, P416, DOI 10.1113/jphysiol.1960.sp006449; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Christmas P, 2002, J BIOL CHEM, V277, P28902, DOI 10.1074/jbc.M203074200; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; DAHLEN SE, 1981, P NATL ACAD SCI-BIOL, V78, P3887, DOI 10.1073/pnas.78.6.3887; Holm PJ, 2006, J MOL BIOL, V360, P934, DOI 10.1016/j.jmb.2006.05.056; Jakobsson PJ, 1997, J BIOL CHEM, V272, P22934, DOI 10.1074/jbc.272.36.22934; Jakobsson PJ, 1996, J BIOL CHEM, V271, P22203, DOI 10.1074/jbc.271.36.22203; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanaoka Y, 2001, J BIOL CHEM, V276, P22608, DOI 10.1074/jbc.M103562200; Kellaway CH, 1940, Q J EXP PHYSIOL CMS, V30, P121; Kim DC, 2006, J IMMUNOL, V176, P4440, DOI 10.4049/jimmunol.176.7.4440; LAM BK, 1994, P NATL ACAD SCI USA, V91, P7663, DOI 10.1073/pnas.91.16.7663; Lam BK, 1997, J BIOL CHEM, V272, P13923, DOI 10.1074/jbc.272.21.13923; MANNING PJ, 1990, NEW ENGL J MED, V323, P1736, DOI 10.1056/NEJM199012203232504; MARFAT A, 1985, ADV PROSTAG THROMB L, V14, P155; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Schmidt- Krey I, 2004, STRUCTURE, V12, P2009, DOI 10.1016/j.str.2004.08.008; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; SOTER NA, 1983, J INVEST DERMATOL, V80, P115, DOI 10.1111/1523-1747.ep12531738; Thoren S, 2003, J BIOL CHEM, V278, P22199, DOI 10.1074/jbc.M303227200; WEISS JW, 1982, SCIENCE, V216, P196, DOI 10.1126/science.7063880; WELSCH DJ, 1994, P NATL ACAD SCI USA, V91, P9745, DOI 10.1073/pnas.91.21.9745; YOSHIMOTO T, 1988, J CLIN INVEST, V81, P866, DOI 10.1172/JCI113396; Zimmer JSD, 2004, J LIPID RES, V45, P2138, DOI 10.1194/jlr.M400240-JLR200	31	122	127	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2007	448	7153					609	U12		10.1038/nature05936	http://dx.doi.org/10.1038/nature05936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17632548				2022-12-01	WOS:000248446700047
J	Niemann, HH; Jager, V; Butler, PJG; van den Heuvel, J; Schmidt, S; Ferraris, D; Gherardi, E; Heinz, DW				Niemann, Hartmut H.; Jaeger, Volker; Butler, P. Jonathan G.; van den Heuvel, Joop; Schmidt, Sabine; Ferraris, Davide; Gherardi, Ermanno; Heinz, Dirk W.			Structure of the human receptor tyrosine kinase met in complex with the Listeria invasion protein InIB	CELL			English	Article							GROWTH FACTOR/SCATTER FACTOR; HOST-CELL INVASION; SURFACE PROTEIN; L-MONOCYTOGENES; SEMA DOMAIN; GW DOMAINS; INTERNALIN; INLB; ENTRY; SUFFICIENT	The tyrosine kinase Met, the product of the c-met proto-oncogene and the receptor for hepatocyte growth factor/scatter factor (HGF/SF), mediates signals critical for cell survival and migration. The human pathogen Listeria monocytogenes exploits Met signaling for invasion of host cells via its surface protein InlB. We present the crystal structure of the complex between a large fragment of the human Met ectodomain and the Met-binding domain of InlB. The concave face of the InlB leucine-rich repeat region interacts tightly with the first immunoglobulin-like domain of the Met stalk, a domain which does not bind HGF/SF. A second contact between InlB and the Met Sema domain locks the otherwise flexible receptor in a rigid, signaling competent conformation. Full Met activation requires the additional C-terminal domains of InlB which induce heparin-mediated receptor clustering and potent signaling. Thus, although it elicits a similar cellular response, InlB is not a structural mimic of HGF/SF.	Helmholtz Ctr Infect Res, Div Struct Biol, Braunschweig, Germany; MRC Ctr & Lab Mol Biol, Cambridge CB2 2QH, England	Helmholtz Association; Helmholtz-Center for Infection Research	Gherardi, E (corresponding author), Helmholtz Ctr Infect Res, Div Struct Biol, Inhoffenstr 7, Braunschweig, Germany.	egherard@mrc-lmb.cam.ac.uk; dirk.heinz@helmholtz-hzi.de	Ferraris, Davide Maria/AAP-7110-2020; Gherardi, Ermanno/AAB-9608-2022; Niemann, Hartmut/F-7947-2011; Ferraris, Davide Maria/AAO-9743-2020	Niemann, Hartmut/0000-0002-8582-0360; Ferraris, Davide Maria/0000-0001-5112-9910; GHERARDI, ERMANNO/0000-0002-0016-2945	MRC [G9704528] Funding Source: UKRI; Medical Research Council [G9704528] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banerjee M, 2004, MOL MICROBIOL, V52, P257, DOI 10.1111/j.1365-2958.2003.03968.x; Bierne H, 2002, J CELL SCI, V115, P3357; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BRAUN J, 2000, P SOC PHOTO-OPT INS, V1, P32; Braun L, 1999, MOL MICROBIOL, V34, P10, DOI 10.1046/j.1365-2958.1999.01560.x; Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Braun L, 1997, MOL MICROBIOL, V25, P285, DOI 10.1046/j.1365-2958.1997.4621825.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Galan JE, 2000, CELL, V103, P363, DOI 10.1016/S0092-8674(00)00127-6; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Gherardi E, 2003, P NATL ACAD SCI USA, V100, P12039, DOI 10.1073/pnas.2034936100; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; HAYES DB, 2006, RASMB SOFTWARE ARCH; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.3.CO;2-I; Holmes O, 2007, J MOL BIOL, V367, P395, DOI 10.1016/j.jmb.2006.12.061; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Ireton K, 1999, J BIOL CHEM, V274, P17025, DOI 10.1074/jbc.274.24.17025; Jonquieres R, 2001, MOL MICROBIOL, V42, P955, DOI 10.1046/j.1365-2958.2001.02704.x; Jonquieres R, 1999, MOL MICROBIOL, V34, P902, DOI 10.1046/j.1365-2958.1999.01652.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kong-Beltran M, 2004, CANCER CELL, V6, P75, DOI 10.1016/j.ccr.2004.06.013; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90, DOI DOI 10.1007/S00249-009-0425-1; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Machner MP, 2003, MOL MICROBIOL, V48, P1525, DOI 10.1046/j.1365-2958.2003.03532.x; Majeed S, 2003, STRUCTURE, V11, P1061, DOI 10.1016/S0969-2126(03)00185-0; Marino M, 2002, EMBO J, V21, P5623, DOI 10.1093/emboj/cdf558; Marino M, 1999, MOL CELL, V4, P1063, DOI 10.1016/S1097-2765(00)80234-8; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Parida SK, 1998, MOL MICROBIOL, V28, P81, DOI 10.1046/j.1365-2958.1998.00776.x; Pentecost M, 2006, PLOS PATHOG, V2, P29, DOI 10.1371/journal.ppat.0020003; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Prat M, 1998, J CELL SCI, V111, P237; Rubin JS, 2001, J BIOL CHEM, V276, P32977, DOI 10.1074/jbc.M105486200; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schubert WD, 2003, CHEMBIOCHEM, V4, P1285, DOI 10.1002/cbic.200300624; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Schubert WD, 2001, J MOL BIOL, V312, P783, DOI 10.1006/jmbi.2001.4989; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0	51	123	135	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					235	246		10.1016/j.cell.2007.05.037	http://dx.doi.org/10.1016/j.cell.2007.05.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662939	Bronze, Green Submitted			2022-12-01	WOS:000248588000014
J	Yan, L; Vatner, DE; O'Connor, JP; Ivessa, A; Ge, H; Chen, W; Hirotani, S; Ishikawa, Y; Sadoshima, J; Vatner, SF				Yan, Lin; Vatner, Dorothy E.; O'Connor, J. Patrick; Ivessa, Andreas; Ge, Hui; Chen, Wei; Hirotani, Shinichi; Ishikawa, Yoshihiro; Sadoshima, Junichi; Vatner, Stephen F.			Type 5 adenylyl cyclase disruption increases longevity and protects against stress	CELL			English	Article							ADRENERGIC-RECEPTOR BLOCKADE; PRESERVES CARDIAC-FUNCTION; LIFE-SPAN; OXIDATIVE STRESS; CALORIC RESTRICTION; CAENORHABDITIS-ELEGANS; HEART-FAILURE; DWARF MOUSE; SACCHAROMYCES-CEREVISIAE; SKELETAL-MUSCLE	Mammalian models of longevity are related primarily to caloric restriction and alterations in metabolism. We examined mice in which type 5 adenylyl cyclase (AC5) is knocked out (AC5 KO) and which are resistant to cardiac stress and have increased median lifespan of similar to 30%. AC5 KO mice are protected from reduced bone density and susceptibility to fractures of aging. Old AC5 KO mice are also protected from aging-induced cardiomyopathy, e.g., hypertrophy, apoptosis, fibrosis, and reduced cardiac function. Using a proteomic-based approach, we demonstrate a significant activation of the Raf/MEK/ERK signaling pathway and upregulation of cell protective molecules, including superoxide dismutase. Fibroblasts isolated from AC5 KO mice exhibited ERK-dependent resistance to oxidative stress. These results suggest that AC is a fundamentally important mechanism regulating lifespan and stress resistance.	UMDNJ, Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; UMDNJ, Med Sch, Cardiovasc Res Inst, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Sadoshima, J (corresponding author), UMDNJ, Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA.	sadoshju@umdnj.edu; vatnersf@umdnj.edu		Ivessa, Andreas/0000-0002-7578-1337; Sadoshima, Junichi/0000-0003-3724-4132	NHLBI NIH HHS [HL65183, HL033107, HL069020, HL059139, HL069752] Funding Source: Medline; NIA NIH HHS [AG014121, AG023137, AG028854] Funding Source: Medline; NICHD NIH HHS [HD01457] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001457] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059139, P01HL069020, R01HL065183, R37HL033107, T32HL069752, R01HL033107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028854, R01AG014121, R01AG023137] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120; Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Asai K, 1999, J CLIN INVEST, V104, P551, DOI 10.1172/JCI7418; Atienza JM, 2000, J BIOL CHEM, V275, P20638, DOI 10.1074/jbc.M910024199; Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Chrisp CE, 1996, VET PATHOL, V33, P735, DOI 10.1177/030098589603300620; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Du XJ, 2000, CARDIOVASC RES, V48, P448, DOI 10.1016/S0008-6363(00)00187-5; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Geng YJ, 1999, CIRC RES, V84, P34; GLOBOCNIK E, 1978, Folia Morphologica (Prague), V26, P1; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Houslay MD, 2000, MOL PHARMACOL, V58, P659, DOI 10.1124/mol.58.4.659; Hutter D, 2000, J GERONTOL A-BIOL, V55, pB125, DOI 10.1093/gerona/55.3.B125; Ikeyama S, 2002, FASEB J, V16, pA1163, DOI 10.1096/fj.01-0409fje; Ishii N, 2000, FREE RADICAL RES, V33, P857, DOI 10.1080/10715760000301371; Iwase M, 1996, CIRC RES, V78, P517, DOI 10.1161/01.RES.78.4.517; Kapur S, 2004, BONE, V35, P525, DOI 10.1016/j.bone.2004.04.007; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; LAKATTA EG, 1993, PHYSIOL REV, V73, P413, DOI 10.1152/physrev.1993.73.2.413; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Liggett SB, 2000, CIRCULATION, V101, P1707; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lithgow GJ, 1996, BIOESSAYS, V18, P809, DOI 10.1002/bies.950181007; Lorenzini A, 2002, EXP GERONTOL, V37, P1149, DOI 10.1016/S0531-5565(02)00133-X; LOUTIT JF, 1976, J ANAT, V122, P357; Madsen MA, 2004, BIOCHEM BIOPH RES CO, V318, P998, DOI 10.1016/j.bbrc.2004.04.126; Manigrasso MB, 2004, J ORTHOP TRAUMA, V18, P687, DOI 10.1097/00005131-200411000-00006; Meloche S, 2000, CYTOGENET CELL GENET, V88, P249, DOI 10.1159/000015530; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Miller RA, 1999, J GERONTOL A-BIOL, V54, pB297, DOI 10.1093/gerona/54.7.B297; Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142; Miller RA, 1997, IMMUNOL REV, V160, P79, DOI 10.1111/j.1600-065X.1997.tb01029.x; Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje; Murakami S, 2003, FASEB J, V17, P1565, DOI 10.1096/fj.02-1092fje; Naf D, 2002, CANCER RES, V62, P1235; Okumura S, 2003, P NATL ACAD SCI USA, V100, P9986, DOI 10.1073/pnas.1733772100; Okumura S, 2003, CIRCULATION, V108, P48; Okumura S, 2003, CIRC RES, V93, P364, DOI 10.1161/01.RES.0000086986.35568.63; Romanick MA, 2004, MECH AGEING DEV, V125, P269, DOI 10.1016/j.mad.2004.02.001; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; STORER JB, 1966, J GERONTOL, V21, P404, DOI 10.1093/geronj/21.3.404; Sun JT, 2002, GENETICS, V161, P661; SWYNGHEDAUW B, 1995, AM J CARDIOL, V76, pD2, DOI 10.1016/S0002-9149(99)80484-6; Taylor RP, 2003, ACTA PHYSIOL SCAND, V178, P107, DOI 10.1046/j.1365-201X.2003.01132.x; Torres C, 2003, EXP CELL RES, V290, P195, DOI 10.1016/S0014-4827(03)00309-4; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Wolff JE, 2001, DEV MED CHILD NEUROL, V43, P71, DOI 10.1017/S0012162201230114; Yang J, 2005, EXP GERONTOL, V40, P867, DOI 10.1016/j.exger.2005.08.001; Yoon SO, 2002, MECH AGEING DEV, V123, P1597, DOI 10.1016/S0047-6374(02)00095-7; Zhen XC, 1999, J GERONTOL A-BIOL, V54, pB539, DOI 10.1093/gerona/54.12.B539; Zhu ZJ, 2005, MOL CARCINOGEN, V42, P170, DOI 10.1002/mc.20071	65	264	271	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					247	258		10.1016/j.cell.2007.05.038	http://dx.doi.org/10.1016/j.cell.2007.05.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662940	Bronze			2022-12-01	WOS:000248588000015
J	Wong, TY; Liew, G; Mitchell, P				Wong, Tien Y.; Liew, Gerald; Mitchell, Paul			Clinical update: new treatments for age-related macular degeneration	LANCET			English	Article							RANIBIZUMAB; RISK		Univ Melbourne, Ctr Eye Res, Melbourne, Vic 3002, Australia; Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore Eye Res Inst, Singapore 117548, Singapore; Univ Sydney, Ctr Vis Res, Sydney, NSW 2006, Australia	University of Melbourne; National University of Singapore; Singapore National Eye Center; University of Sydney	Wong, TY (corresponding author), Univ Melbourne, Ctr Eye Res, Melbourne, Vic 3002, Australia.	twong@unimelb.edu.au	Wong, Tien Yin/AAC-9724-2020; Mitchell, Paul/P-1498-2014; Liew, Gerald/AAB-6870-2022	Wong, Tien Yin/0000-0002-8448-1264; 				Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Chakravarthy U, 2006, BRIT J OPHTHALMOL, V90, P1188, DOI 10.1136/bjo.2005.082255; Cugati S, 2007, ARCH OPHTHALMOL-CHIC, V125, P917, DOI 10.1001/archopht.125.7.917; Duan YK, 2007, OPHTHALMOLOGY, V114, P732, DOI 10.1016/j.ophtha.2006.07.045; Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358, DOI 10.1152/ajpcell.2001.280.6.C1358; Fung AE, 2006, BRIT J OPHTHALMOL, V90, P1344, DOI 10.1136/bjo.2006.099598; *GEN, 2007, SAF UPD LUC; Gillies MC, 2007, NEW ENGL J MED, V356, P748; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Larsson A., 2002, Angiogenesis, V5, P107, DOI 10.1023/A:1021588227705; *MAC AMD STUD GROU, 2007, PEG 1 YEAR SYST SAF, DOI DOI 10.1016/J.OPHTHA.2007.02.021; *NAT EYE I, 2006, NIH STIM DEV TEST NE; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rosenfeld PJ, 2006, AM J OPHTHALMOL, V142, P141, DOI 10.1016/j.ajo.2006.03.036; *ROYAL COLL OPHTH, 2006, AMD INT GUID ROYAL C; Wong TY, 2007, OPHTHALMOLOGY, V114, P86, DOI 10.1016/j.ophtha.2006.06.039; Wong TY, 2006, ANN INTERN MED, V145, P98, DOI 10.7326/0003-4819-145-2-200607180-00007	18	113	117	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 21	2007	370	9583					204	206		10.1016/S0140-6736(07)61104-0	http://dx.doi.org/10.1016/S0140-6736(07)61104-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194MG	17658379				2022-12-01	WOS:000248347900010
J	Hardy, WR; Li, LY; Wang, Z; Sedy, J; Fawcett, J; Frank, E; Kucera, J; Pawson, T				Hardy, W. Rod; Li, Lingying; Wang, Zhi; Sedy, Jiri; Fawcett, James; Frank, Eric; Kucera, Jan; Pawson, Tony			Combinatorial ShcA docking interactions support diversity in tissue morphogenesis	SCIENCE			English	Article							MUSCLE-SPINDLE; SIGNAL TRANSDUCTION; ADAPTER PROTEIN; SENSORY NEURONS; CRE RECOMBINASE; IN-VIVO; RECEPTOR; EXPRESSION; PHOSPHOTYROSINE; PATHWAY	Changes in protein-protein interactions may allow polypeptides to perform unexpected regulatory functions. Mammalian ShcA docking proteins have amino-terminal phosphotyrosine (pTyr) binding (PTB) and carboxyl-terminal Src homology 2 (SH2) domains, which recognize specific pTyr sites on activated receptors, and a central region with two phosphorylated tyrosine-X-asparagine (pYXN) motifs ( where X represents any amino acid) that each bind the growth factor receptor-bound protein 2 (Grb2) adaptor. Phylogenetic analysis indicates that ShcA may signal through both pYXN-dependent and - independent pathways. We show that, in mice, cardiomyocyte-expressed ShcA directs mid-gestational heart development by a PTB-dependent mechanism that does not require the pYXN motifs. In contrast, the pYXN motifs are required with PTB and SH2 domains in the same ShcA molecule for the formation of muscle spindles, skeletal muscle sensory organs that regulate motor behavior. Thus, combinatorial differences in ShcA docking interactions may yield multiple signaling mechanisms to support diversity in tissue morphogenesis.	Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Vet Adm Med Ctr, Boston, MA 02130 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA; Charles Univ Prague, Inst Anat, Fac Med 1, Prague 12000, Czech Republic; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Vet Adm Med Ctr, Boston, MA 02130 USA	Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Tufts University; Charles University Prague; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Kucera, J (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.	jfkucera@bu.edu; pawson@mshri.on.ca	Pawson, Tony J/E-4578-2013	Fawcett, Jim/0000-0003-0043-2164	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024373] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS024373-18, R01 NS024373, R01 NS024373-20, R01 NS024373-19] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Altiok N, 1997, EMBO J, V16, P717, DOI 10.1093/emboj/16.4.717; Andrechek ER, 2002, MOL CELL BIOL, V22, P4714, DOI 10.1128/MCB.22.13.4714-4722.2002; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Chen HH, 2003, CURR OPIN NEUROBIOL, V13, P96, DOI 10.1016/S0959-4388(03)00006-0; Chen HH, 2002, J NEUROSCI, V22, P3512; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Ganju P, 1998, EUR J NEUROSCI, V10, P1995, DOI 10.1046/j.1460-9568.1998.00209.x; Gu HH, 2000, MOL CELL BIOL, V20, P7109, DOI 10.1128/MCB.20.19.7109-7120.2000; Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7; KAVANAUGH WM, 1995, SCIENCE, V268, P1177, DOI 10.1126/science.7539155; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; Lai KMV, 2000, GENE DEV, V14, P1132; Leu M, 2003, DEVELOPMENT, V130, P2291, DOI 10.1242/dev.00447; Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0; Luzi L, 2000, CURR OPIN GENET DEV, V10, P668, DOI 10.1016/S0959-437X(00)00146-5; MAEDA N, 1983, NATURE, V302, P61, DOI 10.1038/302061a0; Maina F, 1996, CELL, V87, P531, DOI 10.1016/S0092-8674(00)81372-0; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nakamura T, 2002, ONCOGENE, V21, P22, DOI 10.1038/sj.onc.1205019; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Postigo A, 2002, GENE DEV, V16, P633, DOI 10.1101/gad.217902; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Tourtellotte WG, 2001, DEV BIOL, V232, P388, DOI 10.1006/dbio.2001.0202; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322	31	47	47	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2007	317	5835					251	256		10.1126/science.1140114	http://dx.doi.org/10.1126/science.1140114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17626887	Green Accepted			2022-12-01	WOS:000247968600045
J	Kelly, BC; Ikonomou, MG; Blair, JD; Morin, AE; Gobas, FAPC				Kelly, Barry C.; Ikonomou, Michael G.; Blair, Joel D.; Morin, Anne E.; Gobas, Frank A. P. C.			Food web-specific biomagnification of persistent organic pollutants	SCIENCE			English	Article							TROUT ONCORHYNCHUS-MYKISS; DECABROMODIPHENYL ETHER; PERFLUOROOCTANE SULFONATE; DIETARY ACCUMULATION; AQUATIC ORGANISMS; TROPHIC TRANSFER; BIOACCUMULATION; MAGNIFICATION; MECHANISM; CHEMICALS	Substances that accumulate to hazardous levels in living organisms pose environmental and human-health risks, which governments seek to reduce or eliminate. Regulatory authorities identify bioaccumulative substances as hydrophobic, fat-soluble chemicals having high octanol-water partition coefficients (K-OW) (>= 100,000). Here we show that poorly metabolizable, moderately hydrophobic substances with a K-OW between 100 and 100,000, which do not biomagnify ( that is, increase in chemical concentration in organisms with increasing trophic level) in aquatic food webs, can biomagnify to a high degree in food webs containing air-breathing animals ( including humans) because of their high octanol-air partition coefficient (K-OA) and corresponding low rate of respiratory elimination to air. These low K-OW-high K-OA chemicals, representing a third of organic chemicals in commercial use, constitute an unidentified class of potentially bioaccumulative substances that require regulatory assessment to prevent possible ecosystem and human-health consequences.	Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada; Fisheries & Oceans Canada, Inst Ocean Sci, Ocean Sci Div, Sidney, BC V8L 4B2, Canada	Simon Fraser University; Fisheries & Oceans Canada	Gobas, FAPC (corresponding author), Simon Fraser Univ, Sch Resource & Environm Management, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	gobas@sfu.ca		Kelly, Barry/0000-0002-3449-6310				Arnot JA, 2006, ENVIRON REV, V14, P257, DOI [10.1139/A06-005, 10.1139/a06-005]; CHEN YCJ, 1992, JAMA-J AM MED ASSOC, V268, P3213, DOI 10.1001/jama.268.22.3213; CONNOLLY JP, 1988, ENVIRON SCI TECHNOL, V22, P99, DOI 10.1021/es00166a011; Cook PM, 2003, ENVIRON SCI TECHNOL, V37, P3864, DOI 10.1021/es034045m; Fisk AT, 1998, ENVIRON TOXICOL CHEM, V17, P951, DOI [10.1002/etc.5620170526, 10.1897/1551-5028(1998)017&lt;0951:DAADOH&gt;2.3.CO;2]; Fisk AT, 2001, ENVIRON SCI TECHNOL, V35, P732, DOI 10.1021/es001459w; Giesy JP, 2001, ENVIRON SCI TECHNOL, V35, P1339, DOI 10.1021/es001834k; GLADEN BC, 1988, J PEDIATR-US, V113, P991, DOI 10.1016/S0022-3476(88)80569-9; Gobas FAPC, 1999, ENVIRON SCI TECHNOL, V33, P133, DOI 10.1021/es980681m; Gobas FAPC, 2003, QSAR COMB SCI, V22, P329, DOI 10.1002/qsar.200390022; GOBAS FAPC, 1993, ENVIRON SCI TECHNOL, V27, P2855, DOI 10.1021/es00049a028; Hoekstra PF, 2003, ENVIRON POLLUT, V124, P509, DOI 10.1016/S0269-7491(02)00482-7; Hop H, 2002, ENVIRON SCI TECHNOL, V36, P2589, DOI 10.1021/es010231l; Ikonomou MG, 2002, ENVIRON SCI TECHNOL, V36, P1886, DOI 10.1021/es011401x; Kannan K, 2001, ENVIRON SCI TECHNOL, V35, P1593, DOI 10.1021/es001873w; Kelly BC, 2001, ENVIRON SCI TECHNOL, V35, P325, DOI 10.1021/es0011966; Kelly BC, 2003, ENVIRON SCI TECHNOL, V37, P2966, DOI 10.1021/es021035x; Kierkegaard A, 1999, ENVIRON SCI TECHNOL, V33, P1612, DOI 10.1021/es9807082; MACKAY D, 1982, ENVIRON SCI TECHNOL, V16, P274, DOI 10.1021/es00099a008; Martin JW, 2003, ENVIRON TOXICOL CHEM, V22, P189, DOI [10.1897/1551-5028(2003)022&lt;0189:DAOPAI&gt;2.0.CO;2, 10.1002/etc.5620220125]; Morck A, 2003, DRUG METAB DISPOS, V31, P900, DOI 10.1124/dmd.31.7.900; RATCLIFF.DA, 1967, NATURE, V215, P208, DOI 10.1038/215208a0; Stapleton HM, 2004, ENVIRON SCI TECHNOL, V38, P112, DOI 10.1021/es034746j; Tomy GT, 2004, ENVIRON SCI TECHNOL, V38, P6475, DOI 10.1021/es049620g; UNEP, 2001, C PLEN STOCKH CONV P; WOODWELL GM, 1967, SCI AM, V216, P24, DOI 10.1038/scientificamerican0367-24	26	640	689	24	617	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2007	317	5835					236	239		10.1126/science.1138275	http://dx.doi.org/10.1126/science.1138275			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17626882				2022-12-01	WOS:000247968600040
J	Pursell, ZF; Isoz, I; Lundstrom, EB; Johansson, E; Kunkel, TA				Pursell, Zachary F.; Isoz, Isabelle; Lundstroem, Else-Britt; Johansson, Erik; Kunkel, Thomas A.			Yeast DNA polymerase epsilon participates in leading-strand DNA replication	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; S-PHASE; POL EPSILON; CHECKPOINT; REPAIR; ERRORS; FORK	Multiple DNA polymerases participate in replicating the leading and lagging strands of the eukaryotic nuclear genome. Although 50 years have passed since the first DNA polymerase was discovered, the identity of the major polymerase used for leading-strand replication is uncertain. We constructed a derivative of yeast DNA polymerase e that retains high replication activity but has strongly reduced replication fidelity, particularly for thymine-deoxythymidine 5'-monophosphate (T-dTMP) but not adenine-deoxyadenosine 5'-monophosphate (A-dAMP) mismatches. Yeast strains with this DNA polymerase e allele have elevated rates of T to A substitution mutations. The position and rate of these substitutions depend on the orientation of the mutational reporter and its location relative to origins of DNA replication and reveal a pattern indicating that DNA polymerase e participates in leading-strand DNA replication.	NIEHS, Mol Genet Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; NIEHS, Struct Biol Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; Umea Univ, Dept Med Biochem & Biophys, SE-90187 Umea, Sweden	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Umea University	Kunkel, TA (corresponding author), NIEHS, Mol Genet Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA.	kunkel@niehs.nih.gov	Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788; Johansson, Erik/0000-0002-8526-6224	Intramural NIH HHS [Z01 ES065070-17] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065070] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Dua R, 2000, J BIOL CHEM, V275, P28816, DOI 10.1074/jbc.M002376200; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; FERGUSON BM, 1991, CELL, V65, P507, DOI 10.1016/0092-8674(91)90468-E; Fuss J, 2002, J BIOL CHEM, V277, P8658, DOI 10.1074/jbc.M110615200; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; NAVAS TA, 1995, CELL, V80, P29, DOI 10.1016/0092-8674(95)90448-4; Pavlov YI, 2003, CURR BIOL, V13, P744, DOI 10.1016/S0960-9822(03)00284-7; Pavlov YI, 2002, MOL CELL, V10, P207, DOI 10.1016/S1097-2765(02)00567-1; Poloumienko A, 2001, MOL BIOL CELL, V12, P3317, DOI 10.1091/mbc.12.11.3317; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shcherbakova PV, 1996, GENETICS, V142, P717; Shcherbakova PV, 1999, MOL CELL BIOL, V19, P3177	14	397	408	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2007	317	5834					127	130		10.1126/science.1144067	http://dx.doi.org/10.1126/science.1144067			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17615360	Green Accepted			2022-12-01	WOS:000247776700068
J	Saleska, SR; Didan, K; Huete, AR; da Rocha, HR				Saleska, Scott R.; Didan, Kamel; Huete, Alfredo R.; da Rocha, Humberto R.			Amazon forests green-up during 2005 drought	SCIENCE			English	Article									Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA; Univ Sao Paulo, Dept Atmospher Sci, BR-05508090 Sao Paulo, Brazil	University of Arizona; University of Arizona; Universidade de Sao Paulo	Saleska, SR (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	saleska@email.arizona.edu	Huete, Alfredo R/C-1294-2008; Mitchard, Edward T A/C-6346-2009; Saleska, Scott R/K-1733-2016	Huete, Alfredo R/0000-0003-2809-2376; Mitchard, Edward T A/0000-0002-5690-4055; Saleska, Scott R/0000-0002-4974-3628				Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946, 10.1029/2006GL028946.]; Betts RA, 2004, THEOR APPL CLIMATOL, V78, P157, DOI 10.1007/s00704-004-0050-y; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Makarieva AM, 2007, HYDROL EARTH SYST SC, V11, P1013, DOI 10.5194/hess-11-1013-2007; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0	7	419	430	6	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2007	318	5850					612	612		10.1126/science.1146663	http://dx.doi.org/10.1126/science.1146663			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17885095	Green Submitted			2022-12-01	WOS:000250409200036
J	Lee, MG; Villa, R; Trojer, P; Norman, J; Yan, KP; Reinberg, D; Di Croce, L; Shiekhattar, R				Lee, Min Gyu; Villa, Raffaella; Trojer, Patrick; Norman, Jessica; Yan, Kai-Ping; Reinberg, Danny; Di Croce, Luciano; Shiekhattar, Ramin			Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination	SCIENCE			English	Article							HISTONE LYSINE METHYLATION; TARGET GENES; METHYLTRANSFERASE ACTIVITY; CELL FATE; H3; TRIMETHYLATION; ENHANCER; COMPLEX; PROTEIN; GENOME	Methylation of histone H3 lysine 27 (H3K27) is a posttranslational modification that is highly correlated with genomic silencing. Here we show that human UTX, a member of the Jumonji C family of proteins, is a di- and trimethyl H3K27 demethylase. UTX occupies the promoters of HOX gene clusters and regulates their transcriptional output by modulating the recruitment of polycomb repressive complex 1 and the monoubiquitination of histone H2A. Moreover, UTX associates with mixed-lineage leukemia (MLL) 2/3 complexes, and during retinoic acid signaling events, the recruitment of the UTX complex to HOX genes results in H3K27 demethylation and a concomitant methylation of H3K4. Our results suggest a concerted mechanism for transcriptional activation in which cycles of H3K4 methylation by MLL2/3 are linked with the demethylation of H3K27 through UTX.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; Ctr Regulacio Genom, Barcelona, Spain; NYU, Sch Med, Dept Biochem, Howard Hughes Med Inst, New York, NY 10016 USA	The Wistar Institute; ICREA; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Howard Hughes Medical Institute; New York University	Shiekhattar, R (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	ramin.shiekhattar@crg.es	Di Croce, Luciano/E-7759-2015; Villa, Raffaella/D-5223-2018	Di Croce, Luciano/0000-0003-3488-6228; Reinberg, Danny/0000-0003-4288-2016	NCI NIH HHS [R01CA090758] Funding Source: Medline; ICREA Funding Source: Custom; NATIONAL CANCER INSTITUTE [R01CA090758] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICREA(ICREA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Eissenberg JC, 2007, NAT STRUCT MOL BIOL, V14, P344, DOI 10.1038/nsmb1217; Etchegaray JP, 2006, J BIOL CHEM, V281, P21209, DOI 10.1074/jbc.M603722200; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	27	566	592	3	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 19	2007	318	5849					447	450		10.1126/science.1149042	http://dx.doi.org/10.1126/science.1149042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221LW	17761849				2022-12-01	WOS:000250230400046
J	Mishra, P; Socolich, M; Wall, MA; Graves, J; Wang, Z; Ranganathan, R				Mishra, Prashant; Socolich, Michael; Wall, Mark A.; Graves, Jennifer; Wang, ZiFen; Ranganathan, Rama			Dynamic scaffolding in a G protein-coupled signaling system	CELL			English	Article							PDZ-DOMAIN PROTEIN; DROSOPHILA PHOTORECEPTOR CELLS; IN-VIVO; RETINAL DEGENERATION; CA2+ CHANNEL; KINASE-C; COMPLEXES; TRP; PHOTOTRANSDUCTION; DEACTIVATION	The INAD scaffold organizes a multiprotein complex that is essential for proper visual signaling in Drosophila photoreceptor cells. Here we show that one of the INAD PDZ domains (PDZ5) exists in a redox-dependent equilibrium between two conformations-a reduced form that is similar to the structure of other PDZ domains, and an oxidized form in which the ligand-binding site is distorted through formation of a strong intramolecular disulfide bond. We demonstrate transient light-dependent formation of this disulfide bond in vivo and find that transgenic flies expressing a mutant INAD in which PDZ5 is locked in the reduced state display severe defects in termination of visual responses and visually mediated reflex behavior. These studies demonstrate a conformational switch mechanism for PDZ domain function and suggest that INAD behaves more like a dynamic machine rather than a passive scaffold, regulating signal transduction at the millisecond timescale through cycles of conformational change.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75216 USA; Univ Texas, SW Med Ctr, Green Ctr, Div Syst Biol, Dallas, TX 75216 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75216 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Ranganathan, R (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75216 USA.	rama.ranganathan@utsouthwestern.edu		Socolich, Michael/0000-0002-0702-1061				Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; CELNIKER SE, 2002, GENOME BIOL, V3; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; FRANCESCHINI N, 1981, NATURE, V291, P241, DOI 10.1038/291241a0; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hardie RC, 2001, J EXP BIOL, V204, P3403; HOLMQVIST MH, 1991, J COMP PHYSIOL A, V169, P451, DOI 10.1007/BF00197657; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; Huber A, 2001, EUR J NEUROSCI, V14, P769, DOI 10.1046/j.0953-816x.2001.01704.x; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; HWANG C, 1995, METHOD ENZYMOL, V251, P212, DOI 10.1016/0076-6879(95)51123-7; Iakhine R, 2004, J NEUROSCI, V24, P2516, DOI 10.1523/JNEUROSCI.5426-03.2004; JOHNSON EC, 1986, J GEN PHYSIOL, V88, P651, DOI 10.1085/jgp.88.5.651; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; Keese MA, 1999, FEBS LETT, V447, P135, DOI 10.1016/S0014-5793(99)00296-3; Kimple ME, 2001, EMBO J, V20, P4414, DOI 10.1093/emboj/20.16.4414; LAUGHLIN SB, 1993, J COMP PHYSIOL A, V172, P593, DOI 10.1007/BF00213682; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; Matsumoto H, 1999, Novartis Found Symp, V224, P225; Montell C, 2005, J PHYSIOL-LONDON, V567, P45, DOI 10.1113/jphysiol.2005.092551; Montell C, 1998, CURR OPIN NEUROBIOL, V8, P389, DOI 10.1016/S0959-4388(98)80066-4; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; OCarroll DC, 1996, NATURE, V382, P63, DOI 10.1038/382063a0; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Popescu DC, 2006, J NEUROSCI, V26, P8570, DOI 10.1523/JNEUROSCI.1478-06.2006; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; SAJEWSKI RP, 1980, J AM CHEM SOC, V102, P2011; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; SEIFERT P, 1990, J EVOLUTION BIOL, V3, P225, DOI 10.1046/j.1420-9101.1990.3030225.x; Shieh BH, 1997, P NATL ACAD SCI USA, V94, P12682, DOI 10.1073/pnas.94.23.12682; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; Tsunoda S, 1999, CELL CALCIUM, V26, P165, DOI 10.1054/ceca.1999.0070; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; WU CF, 1978, J GEN PHYSIOL, V71, P249, DOI 10.1085/jgp.71.3.249; Wyman R.J., 1984, P133	50	77	78	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 5	2007	131	1					80	92		10.1016/j.cell.2007.07.037	http://dx.doi.org/10.1016/j.cell.2007.07.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923089	Bronze			2022-12-01	WOS:000249934700013
J	Wadman, M				Wadman, Meredith			Copycat consolidation	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2007	449	7161					393	393		10.1038/449393a	http://dx.doi.org/10.1038/449393a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17898741	Bronze			2022-12-01	WOS:000249724800014
J	Zou, YZ; Stastny, P; Susal, C; Dohler, B; Opelz, G				Zou, Yizhou; Stastny, Peter; Suesal, Caner; Doehler, Bernd; Opelz, Gerhard			Antibodies against MICA antigens and kidney-transplant rejection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RENAL-ALLOGRAFT REJECTION; ENDOTHELIAL-CELLS; SURFACE EXPRESSION; HLA ANTIBODY; IDENTIFICATION; CYTOTOXICITY; MOLECULES; FAILURE; RISK	Background Good HLA-A, HLA-B, and HLA-DR matches do not guarantee rejection-free renal transplantation. Some kidney transplants fail despite such matches, suggesting that other antigens might be targets for rejection. Major-histocompatibility-complex (MHC) class I-related chain A (MICA) antigens are polymorphic and can elicit antibody production. We sought to determine whether an immune response to MICA antigens might play a role in the failure of kidney allografts. Methods Pretransplantation serum samples from 1910 recipients of kidney transplants from deceased donors were tested for anti-MICA antibodies with an assay in which single MICA antigens were attached to polystyrene microspheres. Results Antibodies against MICA alleles were detected in 217 of the 1910 patients (11.4%). The presence of MICA antibodies was associated with renal-allograft rejection. The mean (+/-SE) 1-year graft-survival rate was 88.3+/-2.2% among recipients with anti-MICA antibodies as compared with 93.0+/-0.6% among recipients without anti-MICA antibodies (P=0.01). Among recipients of first kidney transplants, the survival rate was even lower among MICA antibody-positive patients (87.8+/-2.4%) than among MICA antibody-negative recipients (93.5+/-0.6%, P=0.005). In addition, the association of MICA sensitization with reduced graft survival was more evident in kidney-transplant recipients with good HLA matching: among 326 recipients who received well-matched kidneys (0 or 1 HLA-A plus HLA-B plus HLA-DR mismatch), sensitization against MICA was associated with poorer allograft survival (83.2+/-5.8% among those with anti-MICA antibodies vs. 95.1+/-1.3% among those without such antibodies, P=0.002). Conclusions Presensitization of kidney-transplant recipients against MICA antigens is associated with an increased frequency of graft loss and might contribute to allograft loss among recipients who are well matched for HLA. N Engl J Med 2007;357:1293-300.	Univ Texas, SW Med Ctr, Dept Internal Med, Transplantat Immunol Div, Dallas, TX 75390 USA; Univ Heidelberg, Dept Transplantat Immunol, Heidelberg, Germany	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Ruprecht Karls University Heidelberg	Stastny, P (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Transplantat Immunol Div, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	peter.stastny@utsouthwestern.edu						Abdi R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133754; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Cardarelli F, 2005, TRANSPLANT INT, V18, P532, DOI 10.1111/j.1432-2277.2005.00085.x; Carter V, 2005, TRANSPLANT P, V37, P654, DOI 10.1016/j.transproceed.2004.12.043; COX DR, 1972, J R STAT SOC B, V34, P187; Dragun D, 2005, NEW ENGL J MED, V352, P558, DOI 10.1056/NEJMoa035717; Hankey KG, 2002, TRANSPLANTATION, V73, P304, DOI 10.1097/00007890-200201270-00029; JEANNET M, 1970, NEW ENGL J MED, V282, P111, DOI 10.1056/NEJM197001152820301; Jinushi M, 2003, J IMMUNOL, V170, P1249, DOI 10.4049/jimmunol.170.3.1249; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kekomaki S, 2001, TISSUE ANTIGENS, V57, P154, DOI 10.1034/j.1399-0039.2001.057002154.x; KRISTENSEN T, 1976, ACTA PATH MICRO IM C, V84, P304; Lee PC, 2002, TRANSPLANTATION, V74, P1192, DOI 10.1097/00007890-200210270-00025; Menier C, 2002, INT J CANCER, V100, P63, DOI 10.1002/ijc.10460; Mizutani K, 2005, AM J TRANSPLANT, V5, P2265, DOI 10.1111/j.1600-6143.2005.01016.x; Mizutani K, 2006, HUM IMMUNOL, V67, P683, DOI 10.1016/j.humimm.2006.06.002; Mizutani K, 2006, HUM IMMUNOL, V67, P223, DOI 10.1016/j.humimm.2006.02.007; MORAES JR, 1977, J CLIN INVEST, V60, P449, DOI 10.1172/JCI108795; MORAES JR, 1975, 6 INT HIST WORKSH C, P391; Opelz G, 2005, LANCET, V365, P1570, DOI 10.1016/S0140-6736(05)66458-6; PATEL R, 1969, NEW ENGL J MED, V280, P735, DOI 10.1056/NEJM196904032801401; Quiroga I, 2006, TRANSPLANTATION, V81, P1196, DOI 10.1097/01.tp.0000205788.05322.42; Sumitran-Holgersson S, 2002, TRANSPLANTATION, V74, P268, DOI 10.1097/00007890-200207270-00019; Tieng V, 2002, P NATL ACAD SCI USA, V99, P2977, DOI 10.1073/pnas.032668099; Tinckam K, 2005, TRANSPLANTATION, V79, P836, DOI 10.1097/01.TP.0000155187.81806.DF; Trpkov K, 1996, TRANSPLANTATION, V61, P1586, DOI 10.1097/00007890-199606150-00007; Vermehren D, 2002, TRANSPLANTATION, V74, P1479, DOI 10.1097/00007890-200212150-00001; Zhang YZ, 2006, HUM IMMUNOL, V67, P215, DOI 10.1016/j.humimm.2006.02.014; Zou YZ, 2006, HUM IMMUNOL, V67, P230, DOI 10.1016/j.humimm.2006.02.017; Zou YZ, 2002, HUM IMMUNOL, V63, P30, DOI 10.1016/S0198-8859(01)00349-4; Zwirner NW, 1999, HUM IMMUNOL, V60, P323, DOI 10.1016/S0198-8859(98)00128-1; Zwirner NW, 2000, HUM IMMUNOL, V61, P917, DOI 10.1016/S0198-8859(00)00162-2	32	315	365	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2007	357	13					1293	1300		10.1056/NEJMoa067160	http://dx.doi.org/10.1056/NEJMoa067160			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214BR	17898098				2022-12-01	WOS:000249711500005
J	Balskus, EP; Jacobsen, EN				Balskus, Emily P.; Jacobsen, Eric N.			Asymmetric catalysis of the transannular Diels-Alder reaction	SCIENCE			English	Article							CHIRAL OXAZABOROLIDINE; ALPHA-DEPROTONATION; STRATEGY; DESYMMETRIZATION	Transannular chemical reactions are unparalleled in their ability to generate high degrees of stereochemical and architectural complexity in a single transformation. However, the successful application of this approach in synthesis depends on the ability to predict and control the outcome of the transannular reaction. Use of a chiral catalyst in this context represents an attractive, yet unused, strategy. This report describes a catalytic, asymmetric transannnular Diels-Alder (TADA) reaction that affords polycyclic products in high enantiomeric excess. This catalyst system can also alter the inherent diastereoselectivity of cyclizations with substrates containing chiral centers. Additionally, the catalytic enantioselective TADA has been used as the key step in a total synthesis of the sesquiterpene 11,12-diacetoxydrimane; this route may provide a general approach to the polycyclic carbon framework shared by many terpene natural products.	Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University	Jacobsen, EN (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	jacobsen@chemistry.harvard.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059316] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-59316, R01 GM059316] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burke MD, 2004, ANGEW CHEM INT EDIT, V43, P46, DOI 10.1002/anie.200300626; Corey EJ, 2002, J AM CHEM SOC, V124, P3808, DOI 10.1021/ja025848x; DESLONGCHAMPS P, 1992, PURE APPL CHEM, V64, P1831, DOI 10.1351/pac199264121831; Deslongchamps P., 1991, ALDRICHIM ACTA, V24, P43; Evans D.A., 1999, COMPREHENSIVE ASYMME, V3; Fraga BM, 2006, NAT PROD REP, V23, P943, DOI 10.1039/b507870a; Hodgson DM, 1999, CHEM COMMUN, P309, DOI 10.1039/a809105f; Hodgson DM, 1998, J CHEM SOC PERK T 1, P2151, DOI 10.1039/a802434k; Hodgson DM, 2001, ORG LETT, V3, P441, DOI 10.1021/ol006947n; Inoue M, 2007, J ORG CHEM, V72, P3065, DOI 10.1021/jo0700474; Knopff O, 2007, ANGEW CHEM INT EDIT, V46, P1307, DOI 10.1002/anie.200604518; Lu K, 2006, ORG LETT, V8, P1193, DOI 10.1021/ol060221v; Marsault E, 2001, TETRAHEDRON, V57, P4243, DOI 10.1016/S0040-4020(01)00121-1; MASAMUNE S, 1985, ANGEW CHEM INT EDIT, V24, P1, DOI 10.1002/anie.198500013; Montagnac A, 1996, J NAT PROD, V59, P866, DOI 10.1021/np9603737; Myers AG, 1997, J AM CHEM SOC, V119, P6496, DOI 10.1021/ja970402f; NEGI M, 1993, ENZYME MICROB TECH, V15, P483, DOI 10.1016/0141-0229(93)90080-L; Ryu DH, 2003, J AM CHEM SOC, V125, P6388, DOI 10.1021/ja035393r; STORK G, 1992, J AM CHEM SOC, V114, P7578, DOI 10.1021/ja00045a049; TAMAO K, 1983, J ORG CHEM, V48, P2120, DOI 10.1021/jo00160a046; Witter DJ, 1996, J ORG CHEM, V61, P2613, DOI 10.1021/jo952117p; Zhou G, 2003, ORG LETT, V5, P3979, DOI 10.1021/ol035542a	22	83	83	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1736	1740		10.1126/science.1146939	http://dx.doi.org/10.1126/science.1146939			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	212HD	17885133				2022-12-01	WOS:000249585900044
J	Zuckerman, S; Lahad, A; Shmueli, A; Zimran, A; Peleg, L; Orr-Urtreger, A; Levy-Lahad, E; Sagi, M				Zuckerman, Shachar; Lahad, Amnon; Shmueli, Amir; Zimran, Ari; Peleg, Leah; Orr-Urtreger, Avi; Levy-Lahad, Ephrat; Sagi, Michal			Carrier screening for Gaucher disease - Lessons for low-penetrance, treatable diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASHKENAZI-JEWISH POPULATION; ENZYME REPLACEMENT THERAPY; TAY-SACHS-DISEASE; ETHNIC-GROUPS; MUTATIONS; ISRAEL; GENE; PREVALENCE; DISORDERS; FREQUENCY	Context The aim of carrier screening is to prevent severe, untreatable genetic disease by identifying couples at risk before the birth of an affected child, and providing such couples with options for reproductive outcomes for affected pregnancies. Gaucher disease (GD) is an autosomal recessive storage disorder, relatively frequent in Ashkenazi Jews. Carrier screening for GD is controversial because common type 1 GD is often asymptomatic and effective treatment exists. However, screening is offered to Ashkenazi Jews worldwide and has been offered in Israel since 1995. Objective To examine the scope and outcomes of nationwide GD screening. Design, Setting, and Participants All Israeli genetic centers provided data on the number of individuals screened for GD, the number of carriers identified, the number of carrier couples identified, and the mutations identified in these couples between January 1, 1995, and March 31, 2003. Carrier couples were interviewed via telephone between January 21, 2003, and August 31, 2004, using a structured questionnaire for relevant outcome measures. Main Outcome Measures Screening scope (number of testing centers, tested individuals, and carrier couples), screening process (type of pretest and posttest consultations), and screening outcomes (utilization of prenatal diagnosis and pregnancy terminations). Results Between January 1, 1995, and March 31, 2003, 10 of 12 Israeli genetic centers (83.3%) offered carrier screening. Carrier frequency was 5.7%, and 83 carrier couples were identified among an estimated 28 893 individuals screened. There were 82 couples at risk for offspring with type 1 GD. Seventy of 82 couples (85%) were at risk for asymptomatic or mildly affected offspring and 12 of 82 couples (15%) were at risk for moderately affected offspring. At postscreening, 65 interviewed couples had 90 pregnancies, and prenatal diagnosis was performed in 68 pregnancies (76%), detecting 16 fetuses with GD (24%). Pregnancies were terminated in 2 of 13 fetuses (15%) predicted to be asymptomatic or mildly affected and 2 of 3 fetuses (67%) with predicted moderate disease. There were significantly fewer pregnancy terminations in couples who in addition to genetic counseling had medical counseling with a GD expert (1 of 13 [8%] vs 3 of 3 with no medical counseling [100%], P = .007). Conclusions In this study of GD screening among Ashkenazi Jewish couples in Israel, most couples did not terminate affected pregnancies, although screening was associated with a few pregnancy terminations. The main possible benefit was providing couples with knowledge and control. The divergence of these outcomes from stated goals of screening programs is likely to confront carrier screening programs for low-penetrance diseases.	Shaare Zedek Med Ctr, Med Genet Unit, IL-91031 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Family Med, IL-91010 Jerusalem, Israel; Shaare Zedek Med Ctr, Gaucher Clin, IL-91031 Jerusalem, Israel; Chaim Sheba Med Ctr, Danek Gertner Inst Human Genet, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Tel Aviv sourasky Med Ctr, Inst Genet, IL-69978 Tel Aviv, Israel; Hadassah Hebrew Univ Hosp, Dept Human Genet, Jerusalem, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Lahad, A (corresponding author), Shaare Zedek Med Ctr, Med Genet Unit, POB 3235, IL-91031 Jerusalem, Israel.	lahad@szmc.org.il	Levy-Lahad, Ephrat/F-2186-2018	Levy-Lahad, Ephrat/0000-0002-2637-1921; Orr-Urtreger, Avi/0000-0001-9305-6203				Allitto BA, 1997, AM J HUM GENET, V61, pA325; Azuri J, 1998, GENET TEST, V2, P297, DOI 10.1089/gte.1998.2.297; Ben-Chetrit E, 2003, ISR MED ASSOC J, V5, P592; BEUTLER E, 1992, BLOOD, V79, P1662; Beutler E, 1997, BAILLIERE CLIN HAEM, V10, P751, DOI 10.1016/S0950-3536(97)80038-8; BEUTLER E, 1993, AM J HUM GENET, V52, P85; BEUTLER E, 2001, METABOLIC MOL BASES, P3635; Brautbar A, 2003, BLOOD CELL MOL DIS, V31, P187, DOI 10.1016/S1079-9796(03)00126-8; Burke W, 2001, GENET TEST, V5, P201, DOI 10.1089/10906570152742245; Cao A, 1991, CURR OPIN GENET DEV, V1, P48, DOI 10.1016/0959-437X(91)80040-S; Connock M, 2006, HEALTH TECHNOL ASSES, V10, pIII; Ekstein J, 2001, ADV GENET, V44, P297; Elstein D, 2005, GENET TEST, V9, P26, DOI 10.1089/gte.2005.9.26; Elstein D, 1998, QJM-MON J ASSOC PHYS, V91, P483, DOI 10.1093/qjmed/91.7.483; Eng CM, 1997, JAMA-J AM MED ASSOC, V278, P1268, DOI 10.1001/jama.278.15.1268; GERSHONIBARUCH R, 1994, AM J HUM GENET, V54, P586; Heitner R, 2002, BLOOD CELL MOL DIS, V28, P127, DOI 10.1006/bcmd.2002.0497; Horowitz M, 1998, HUM MUTAT, V12, P240, DOI 10.1002/(SICI)1098-1004(1998)12:4<240::AID-HUMU4>3.0.CO;2-J; *ISR MED ASS, 2004, POS PAP CARR SCREEN; Kaback MM, 2000, EUR J PEDIATR, V159, pS192, DOI 10.1007/PL00014401; Kannai R, 2006, ISR MED ASSOC J, V8, P347; Kesselman I, 2006, BLOOD CELL MOL DIS, V37, P46, DOI 10.1016/j.bcmd.2006.05.002; Kogan A, 2001, AM J MED GENET, V102, P272, DOI 10.1002/ajmg.1438; Kronn D, 1998, ARCH INTERN MED, V158, P777, DOI 10.1001/archinte.158.7.777; Langlois S, 2006, J OBSTET GYNAECOL CA, V28, P324, DOI 10.1016/S1701-2163(16)32131-4; Lerer I, 2000, AM J MED GENET, V95, P53, DOI 10.1002/1096-8628(20001106)95:1<53::AID-AJMG11>3.0.CO;2-2; Lilani Anjali, 2005, Hum Reprod Genet Ethics, V11, P28; McCabe ERB, 1996, JAMA-J AM MED ASSOC, V275, P548, DOI 10.1001/jama.1996.03530310054033; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; Sagi M, 1998, SCI CONTEXT, V11, P419, DOI 10.1017/S0269889700003112; Strom CM, 2004, GENET MED, V6, P145, DOI 10.1097/01.GIM.0000127267.57526.D1; Vallance H, 2003, CRIT REV CL LAB SCI, V40, P473, DOI 10.1080/10408360390247832; Wallerstein R, 2001, GENET TEST, V5, P61, DOI 10.1089/109065701750168789; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Wertz DC, 2002, AM J MED GENET, V108, P29, DOI 10.1002/ajmg.10212; WILLIAMS FIB, 1993, J PHYS IV, V3, P3, DOI 10.1051/jp4:1993201; WILSON JMG, 1968, PRINCIPLES PRACTICE, P473; Zimran A, 1997, Harefuah, V133, P107; Zimran A, 2000, ISRAEL MED ASSOC J, V2, P80; ZIMRAN A, 1992, MEDICINE, V71, P337, DOI 10.1097/00005792-199211000-00002; ZIMRAN A, 1994, AM J MED GENET, V50, P74, DOI 10.1002/ajmg.1320500116	43	60	62	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2007	298	11					1281	1290		10.1001/jama.298.11.1281	http://dx.doi.org/10.1001/jama.298.11.1281			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211LA	17878420	Bronze			2022-12-01	WOS:000249524100018
J	Schwarz, EB; Postlethwaite, DA; Hung, YY; Armstrong, MA				Schwarz, Eleanor Bimla; Postlethwaite, Debbie A.; Hung, Yun-Yi; Armstrong, Mary Anne			Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; UNINTENDED PREGNANCY; RISK CLASSIFICATION; DRUG-USE; PRESCRIPTION; INFORMATION	Background: Certain medications are identified by the U.S. Food and Drug Administration (FDA) as class D or X because they increase the risk for birth defects if used during pregnancy. Objective: To assess pregnancy rates and the frequency of contraceptive counseling documented with prescriptions for class D or X drugs filled by women of reproductive age. Design: Description of prescriptions filled in 2001. Setting: A large health maintenance organization in northern California in 2001. Patients: 488 175 women age 15 to 44 years who filled a total of 1 011 658 class A, B, D, or X prescriptions. Measurements: Medications dispensed, contraceptive counseling, and pregnancy testing. Results: A class D or X prescription was filled by 1 of every 6 women studied. Women who filled a prescription for class D or X medications were no more likely than women who filled prescriptions for safer, class A or B medications to have received contraceptive counseling, filled a contraceptive prescription, or been sterilized (48% vs. 51% of prescriptions). There was little variation by clinical indication in rates of contraceptive counseling with class D or X prescriptions, except for isotretinoin. Women who filled a class D or X prescription were only slightly less likely to have a pregnancy documented within 3 months than women filling a class A or B prescription (1.0% vs. 1.4% of prescriptions). Limitations: International Classification of Diseases, Ninth Revision, codes underestimate contraceptive counseling. Documentation of a positive pregnancy test after filling a prescription may overestimate medication use in early pregnancy. Women who filled several prescriptions are overrepresented in prescription analyses. Conclusion: Prescriptions for potentially teratogenic medications are frequently filled by women of childbearing age without documentation of contraceptive counseling.	Univ Pittsburgh, Ctr Res Hlth Care, Pittsburgh, PA 15213 USA; Kaiser Permanente No California, Womens Hlth Res Inst, Oakland, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kaiser Permanente	Schwarz, EB (corresponding author), Univ Pittsburgh, Ctr Res Hlth Care, 230 McKee Place,Suite 600, Pittsburgh, PA 15213 USA.	schwarzeb@upmc.edu		Schwarz, Eleanor Bimla/0000-0002-9912-8236	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K23HD051585] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R43CA094612, R44CA094612] Funding Source: NIH RePORTER; NCI NIH HHS [R43 CA094612, R44 CA094612] Funding Source: Medline; NICHD NIH HHS [K23 HD051585, K23 HD051585-01, K23 HD051585-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Addis A, 2000, DRUG SAFETY, V23, P245, DOI 10.2165/00002018-200023030-00006; Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; Bankole A, 1998, INT FAM PLAN PERSPEC, V24, P117, DOI 10.2307/3038208; Briggs G.C., 2002, DRUGS PREGNANCY LACT; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V54, P1301; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Lee E, 2006, PHARMACOEPIDEM DR S, V15, P537, DOI 10.1002/pds.1241; *METC HUM RES CONS, 2005, WOM HLTH CAR UND COS; PERMANENTE K, 2006, KAISER HLTH PLAN BEN; Pole M, 2000, J CLIN PHARMACOL, V40, P573; Sannerstedt R, 1996, DRUG SAFETY, V14, P69, DOI 10.2165/00002018-199614020-00001; Sanz E, 2001, EUR J OBSTET GYN R B, V95, P127, DOI 10.1016/S0301-2115(00)00375-4; Schwarz EB, 2005, AM J MED, V118, P1240, DOI 10.1016/j.amjmed.2005.02.029; TRUSSEL J, 1999, FAM PLANN PERSPECT, V64, P72; Trussell J, 2004, CONTRACEPTION, V70, P89, DOI 10.1016/j.contraception.2004.03.009; Weisman CS, 2002, WOMEN HEALTH ISS, V12, P79, DOI 10.1016/S1049-3867(01)00147-5; WILSON JG, 1981, AM J OBSTET GYNECOL, V141, P567, DOI 10.1016/S0002-9378(15)33279-8; 2006, PHYS DESK REFERENCE	19	62	65	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2007	147	6					370	376		10.7326/0003-4819-147-6-200709180-00006	http://dx.doi.org/10.7326/0003-4819-147-6-200709180-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214GY	17876020	Green Accepted			2022-12-01	WOS:000249726200002
J	Kiel, MJ; He, SH; Ashkenazi, R; Gentry, SN; Teta, M; Kushner, JA; Jackson, TL; Morrison, SJ				Kiel, Mark J.; He, Shenghui; Ashkenazi, Rina; Gentry, Sara N.; Teta, Monica; Kushner, Jake A.; Jackson, Trachette L.; Morrison, Sean J.			Haematopoietic stem cells do not asymmetrically segregate chromosomes or retain BrdU	NATURE			English	Article							TEMPLATE DNA STRANDS; SELECTIVE SEGREGATION; NICHE; DIFFERENTIATION; KINETICS; DIVISION; CYCLE; SKIN	Stem cells are proposed to segregate chromosomes asymmetrically during self-renewing divisions so that older ('immortal') DNA strands are retained in daughter stem cells whereas newly synthesized strands segregate to differentiating cells(1-6). Stem cells are also proposed to retain DNA labels, such as 5-bromo-2-deoxyuridine (BrdU), either because they segregate chromosomes asymmetrically or because they divide slowly(5,7-9). However, the purity of stem cells among BrdU-label-retaining cells has not been documented in any tissue, and the 'immortal strand hypothesis' has not been tested in a system with definitive stem cell markers. Here we tested these hypotheses in haematopoietic stem cells (HSCs), which can be highly purified using well characterized markers. We administered BrdU to newborn mice, mice treated with cyclophosphamide and granulocyte colony-stimulating factor, and normal adult mice for 4 to 10 days, followed by 70 days without BrdU. In each case, less than 6% of HSCs retained BrdU and less than 0.5% of all BrdU-retaining haematopoietic cells were HSCs, revealing that BrdU has poor specificity and poor sensitivity as an HSC marker. Sequential administration of 5-chloro-2-deoxyuridine and 5-iodo-2-deoxyuridine indicated that all HSCs segregate their chromosomes randomly. Division of individual HSCs in culture revealed no asymmetric segregation of the label. Thus, HSCs cannot be identified on the basis of BrdU-label retention and do not retain older DNA strands during division, indicating that these are not general properties of stem cells.	Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Endocrinol, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	He, Shenghui/L-4833-2018; Morrison, Sean/ABD-5326-2021; Kushner, Jake A/AAF-5049-2022; Kushner, Jake A/AFJ-8198-2022	He, Shenghui/0000-0001-8842-7137; Kushner, Jake A/0000-0002-3646-1744; Kushner, Jake A/0000-0002-3646-1744; Morrison, Sean/0000-0003-1587-8329	NIA NIH HHS [R01 AG024945-03, R01 AG024945-02, R01 AG024945-05, R01 AG024945-03S1, R01 AG024945-01, R01 AG024945-04, R01 AG024945] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG024945] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Armakolas A, 2006, SCIENCE, V311, P1146, DOI 10.1126/science.1120519; Bonhoeffer S, 2000, J IMMUNOL, V164, P5049, DOI 10.4049/jimmunol.164.10.5049; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Karpowicz P, 2005, J CELL BIOL, V170, P721, DOI 10.1083/jcb.200502073; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Potten CS, 2002, J CELL SCI, V115, P2381; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	22	307	318	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					238	U10		10.1038/nature06115	http://dx.doi.org/10.1038/nature06115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17728714	Green Accepted, Green Published			2022-12-01	WOS:000249394500054
J	Freireich, EJ; Gesme, D				Freireich, Emil J.; Gesme, Dean			Should terminally ill patients have the right to take drugs that pass phase I testing?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Freireich, EJ (corresponding author), Univ Texas, MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA.	efreirei@mdanderson.org; dean.gesme@usoncology.com							0	10	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2007	335	7618					478	478		10.1136/bmj.39244.451192.AD	http://dx.doi.org/10.1136/bmj.39244.451192.AD			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	210LO	17823187	Green Published			2022-12-01	WOS:000249457900027
J	Wei, B; O'Leary, S; Dowell, R				Wei, Benjamin; O'Leary, Stephen; Dowell, Richard			Cochlear implantation: one or two?	LANCET			English	Editorial Material									Bion Ear Inst, Melbourne, Vic 3002, Australia; Univ Melbourne, Dept Otolaryngol, Melbourne, Vic, Australia	University of Melbourne	Wei, B (corresponding author), Bion Ear Inst, Melbourne, Vic 3002, Australia.	bwei@bioniocear.org	Dowell, Richard/AAX-7046-2020	O'Leary, Stephen/0000-0001-6926-2103				Gantz Bruce J, 2006, Audiol Neurootol, V11 Suppl 1, P63, DOI 10.1159/000095616; Gfeller Kate E, 2006, Audiol Neurootol, V11 Suppl 1, P12, DOI 10.1159/000095608; Gstoettner Wolfgang K, 2006, Audiol Neurootol, V11 Suppl 1, P49, DOI 10.1159/000095614; James Chris J, 2006, Audiol Neurootol, V11 Suppl 1, P57, DOI 10.1159/000095615; Litovsky RY, 2006, INT J AUDIOL, V45, pS78, DOI 10.1080/14992020600782956; Long CJ, 2006, JARO-J ASSOC RES OTO, V7, P352, DOI 10.1007/s10162-006-0049-4; Neuman AC, 2007, EAR HEARING, V28, P73, DOI 10.1097/01.aud.0000249910.80803.b9; *NIDCD, 2006, COCHL IMPL; Ricketts TA, 2006, EAR HEARING, V27, P763, DOI 10.1097/01.aud.0000240814.27151.b9; van Hoesel RJM, 2003, J ACOUST SOC AM, V113, P1617, DOI 10.1121/1.1539520	10	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 1	2007	370	9589					719	720		10.1016/S0140-6736(07)61355-5	http://dx.doi.org/10.1016/S0140-6736(07)61355-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206UV	17765506				2022-12-01	WOS:000249209300007
J	Perea, G; Araque, A				Perea, Gertrudis; Araque, Alfonso			Astrocytes potentiate transmitter release at single hippocampal synapses	SCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC-TRANSMISSION; D-SERINE; GLUTAMATE RELEASE; ACTIVATION; CALCIUM; FACILITATION; EXOCYTOSIS; PLASTICITY; RECEPTORS	Astrocytes play active roles in brain physiology. They respond to neurotransmitters and modulate neuronal excitability and synaptic function. However, the influence of astrocytes on synaptic transmission and plasticity at the single synapse level is unknown. Ca2+ elevation in astrocytes transiently increased the probability of transmitter release at hippocampal area CA3-CA1 synapses, without affecting the amplitude of synaptic events. This form of short-term plasticity was due to the release of glutamate from astrocytes, a process that depended on Ca2+ and soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) protein and that activated metabotropic glutamate receptors (mGluRs). The transient potentiation of transmitter release became persistent when the astrocytic signal was temporally coincident with postsynaptic depolarization. This persistent plasticity was mGluR-mediated but N-methyl-D-aspartate receptorin-dependent. These results indicate that astrocytes are actively involved in the transfer and storage of synaptic information.	CSIC, Inst Cajal, E-28002 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Araque, A (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	araque@cajal.csic.es	Perea, Gertrudis/V-3308-2017; RIVADULLA, CASTO/K-8425-2012	Perea, Gertrudis/0000-0001-5924-9175; RIVADULLA, CASTO/0000-0001-5580-3917				Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Isaac JTR, 1996, P NATL ACAD SCI USA, V93, P8710, DOI 10.1073/pnas.93.16.8710; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Liu QS, 2004, P NATL ACAD SCI USA, V101, P3172, DOI 10.1073/pnas.0306731101; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin ED, 2007, GLIA, V55, P36, DOI 10.1002/glia.20431; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Rodriguez-Moreno A, 1998, NEURON, V21, P1477, DOI 10.1016/S0896-6273(00)80665-0; Schwartz NE, 2000, J NEUROPHYSIOL, V84, P415, DOI 10.1152/jn.2000.84.1.415; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; VOLTERRA A, 2005, NEUROGLIA, P190; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7	25	494	513	0	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 24	2007	317	5841					1083	1086		10.1126/science.1144640	http://dx.doi.org/10.1126/science.1144640			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203AE	17717185				2022-12-01	WOS:000248946700045
J	Hall, WD; Mattick, RP				Hall, Wayne D.; Mattick, Richard P.			Clinical update: codeine maintenance in opioid dependence	LANCET			English	Article							METHADONE; BUPRENORPHINE; EFFICACY; ADDICTS		Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia	University of Queensland; University of New South Wales Sydney	Hall, WD (corresponding author), Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia.	w.hall@sph.uq.edu.au	Hall, Wayne D/A-3283-2008	Hall, Wayne D/0000-0003-1984-0096				Amato L, 2005, J SUBST ABUSE TREAT, V28, P321, DOI 10.1016/j.jsat.2005.02.007; Auriacombe M, 2001, JAMA-J AM MED ASSOC, V285, P45, DOI 10.1001/jama.285.1.45; Comer SD, 2006, ARCH GEN PSYCHIAT, V63, P210, DOI 10.1001/archpsyc.63.2.210; DEGENHARDT L, 2004, COMP QUANTIFICATION, P1109; DOLE VP, 1965, J AMER MED ASSOC, V193, P646, DOI 10.1001/jama.1965.03090080008002; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fischer B, 2006, CAN MED ASSOC J, V175, P1385, DOI 10.1503/cmaj.060729; GERSTEIN DR, 1990, TREATING DRUG PROBLE, V1; Gibson AE, 2003, MED J AUSTRALIA, V179, P38, DOI 10.5694/j.1326-5377.2003.tb05417.x; Hall W, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P907; Krausz M, 1998, ADDICTION, V93, P1161, DOI 10.1046/j.1360-0443.1998.93811614.x; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Mattick RP, 1996, LANCET, V347, P97, DOI 10.1016/S0140-6736(96)90215-9; Mattick RP, 2003, COCHRANE DB SYST REV, V2; Minozzi S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001333.pub2; Rehm J, 2001, LANCET, V358, P1417, DOI 10.1016/S0140-6736(01)06529-1; Reisine T., 1996, GOODMAN GILMANS PHAR, P521; Robertson JR, 2006, ADDICTION, V101, P1752, DOI 10.1111/j.1360-0443.2006.01603.x; van den Brink W, 2006, CAN J PSYCHIAT, V51, P635, DOI 10.1177/070674370605101003; Ward J, 1999, LANCET, V353, P221, DOI 10.1016/S0140-6736(98)05356-2	20	8	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	2007	370	9587					550	552		10.1016/S0140-6736(07)61273-2	http://dx.doi.org/10.1016/S0140-6736(07)61273-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201HA	17707737				2022-12-01	WOS:000248820900010
J	Chen, HC; McCaffery, JM; Chan, DC				Chen, Hsiuchen; McCaffery, J. Michael; Chan, David C.			Mitochondrial fusion protects against neurodegeneration in the cerebellum	CELL			English	Article							DOMINANT OPTIC ATROPHY; CRE RECOMBINASE EXPRESSION; MARIE-TOOTH-DISEASE; AXONAL-TRANSPORT; PURKINJE-CELLS; CYTOCHROME-C; OPA1; MOUSE; GTPASE; MUTATIONS	Mutations in the mitochondrial fusion gene Mfn2 cause the human neurodegenerative disease Charcot-Marie-Tooth type 2A. However, the cellular basis underlying this relationship is poorly understood. By removing Mfn2 from the cerebellum, we established a model for neurodegeneration caused by loss of mitochondrial fusion. During development and after maturity, Purkinje cells require Mfn2 but not Mfn1 for dendritic outgrowth, spine formation, and cell survival. In vivo, cell culture, and electron microscopy studies indicate that mutant Purkinje cells have aberrant mitochondrial distribution, ultrastructure, and electron transport chain activity. In fibroblasts lacking mitochondrial fusion, the majority of mitochondria lack mitochondrial DNA nucleoids. This deficiency provides a molecular mechanism for the dependence of respiratory activity on mitochondrial fusion. Our results show that exchange of mitochondrial contents is important for mitochondrial function as well as organelle distribution in neurons and have important implications for understanding the mechanisms of neurodegeneration due to perturbations in mitochondrial fusion.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Johns Hopkins Univ, Dept Biol, Integrated Imaging Ctr, Baltimore, MD 21218 USA	California Institute of Technology; Johns Hopkins University	Chan, DC (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	dchan@caltech.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023454, S10RR021023, S10RR022588, S10RR019409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062967] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR019409-01, S10 RR023454, S10 RR021023-01, S10 RR022588, S10 RR022588-01, S10 RR023454-01] Funding Source: Medline; NIGMS NIH HHS [GM062967] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Aller MI, 2003, GENESIS, V36, P97, DOI 10.1002/gene.10204; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Barski JJ, 2000, GENESIS, V28, P93, DOI 10.1002/1526-968X(200011/12)28:3/4<93::AID-GENE10>3.3.CO;2-N; BAURLE J, 1994, ACTA NEUROPATHOL, V88, P237; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004; Chizhikov V, 2003, MOL GENET METAB, V80, P54, DOI 10.1016/j.ymgme.2003.08.019; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Kimmel RA, 2000, GENE DEV, V14, P1377; LAINE J, 1994, J COMP NEUROL, V339, P159, DOI 10.1002/cne.903390202; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MCCAFFERY JM, 1995, METHOD ENZYMOL, V257, P259; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	43	647	662	4	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 10	2007	130	3					548	562		10.1016/j.cell.2007.06.026	http://dx.doi.org/10.1016/j.cell.2007.06.026			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693261	Bronze			2022-12-01	WOS:000249038100021
J	Rodriguez, JP; Taber, AB; Daszak, P; Sukumar, R; Valladares-Padua, C; Padua, S; Aguirre, LF; Medellin, RA; Acosta, M; Aguirre, AA; Bonacic, C; Bordino, P; Bruschini, J; Buchori, D; Gonzalez, S; Mathew, T; Mendez, M; Mugica, L; Pacheco, LF; Dobson, AP; Pearl, M				Rodriguez, J. P.; Taber, A. B.; Daszak, P.; Sukumar, R.; Valladares-Padua, C.; Padua, S.; Aguirre, L. F.; Medellin, R. A.; Acosta, M.; Aguirre, A. A.; Bonacic, C.; Bordino, P.; Bruschini, J.; Buchori, D.; Gonzalez, S.; Mathew, T.; Mendez, M.; Mugica, L.; Pacheco, L. F.; Dobson, A. P.; Pearl, M.			Environment - Globalization of conservation: a view from the south	SCIENCE			English	Editorial Material							BIODIVERSITY; HOTSPOTS		Wildlife Trust, New York, NY USA; Inst Venezolano Invest Cient, Caracas, Venezuela; PROVITA, Caracas, Venezuela; Consortium Conservat Med, New York, NY USA; Indian Inst Sci, Bangalore 560012, Karnataka, India; Asian Nat Conservat Fdn, Bangalore, Karnataka, India; IPE, Sao Paulo, Brazil; Univ Mayor San Simon, Ctr Biodivers & Genet, Cochabamba, Bolivia; BIOTA, Ctr Estudios Biol Teor & Aplicada, La Paz, Bolivia; Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; Univ La Habana, Havana, Cuba; Fauna Australis, Santiago, Chile; Pontificia Univ Catolica Chile, Santiago, Chile; AquaMarina, Ctr Estudios Ciencias Marinas, Pinamar, Argentina; Bogor Agr Univ, Bogor, Indonesia; PEKA Indonesia Fdn, Bogor, Indonesia; Univ Republica, Fac Ciencias, IIBCE, Montevideo, Uruguay; Columbia Univ, New York, NY USA; Univ Mayor San Andres, La Paz, Bolivia; Princeton Univ, Princeton, NJ 08544 USA	Venezuelan Institute Science Research; Indian Institute of Science (IISC) - Bangalore; Universidad Nacional Autonoma de Mexico; Universidad de la Habana; Pontificia Universidad Catolica de Chile; Bogor Agricultural University; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Universidad de la Republica, Uruguay; Columbia University; Universidad Mayor de San Andres; Princeton University	Taber, AB (corresponding author), Wildlife Trust, New York, NY USA.	taber@wildlifetrust.org	daszak, peter/U-4588-2017; Pacheco, F.A.L./H-6400-2013; Buchori, Damayanti/L-5878-2017; Rodriguez, Jon P/G-7224-2012; Gonzalez, Susana A/F-1300-2017; Raman, Sukumar/C-9809-2013; González, Susana/AAC-7053-2021; Bonacic, Cristian/O-2558-2014; Rodriguez, Jon P/A-1491-2009; Aguirre, Luis F./AAE-9255-2019	daszak, peter/0000-0002-2046-5695; Pacheco, F.A.L./0000-0002-2399-5261; Buchori, Damayanti/0000-0002-2843-0737; González, Susana/0000-0001-6470-6182; Bonacic, Cristian/0000-0003-2175-076X; Rodriguez, Jon P/0000-0001-5019-2870; Aguirre, Luis F./0000-0002-4194-1523				Aswani S, 2006, HUM ORGAN, V65, P81, DOI 10.17730/humo.65.1.4y2q0vhe4l30n0uj; Barrett CB, 2001, BIOSCIENCE, V51, P497, DOI 10.1641/0006-3568(2001)051[0497:CTBAWI]2.0.CO;2; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Castro G., 2000, MAPPING CONSERVATION; Chapman B, 2004, PHYS WORLD, V17, P17; Easterly W., 2006, WHITE MANS BURDEN WH; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Halpern BS, 2006, CONSERV BIOL, V20, P56, DOI 10.1111/j.1523-1739.2005.00258.x; Herrera Amilcar O., 1976, CATASTROPHE NEW SOC; Hulme D., 2001, African wildlife and livelihoods: the promise and performance of community conservation; MEADOWS D H, 1972, P205; Mendelson JR, 2006, SCIENCE, V313, P48, DOI 10.1126/science.1128396; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Norse Elliott A., 2005, MARINE CONSERVATION; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; PEREDO B, 2007, MOTION MAGAZINE 0610; RANSOM D, 2005, NEW INT, V383, P2; Rodriguez JP, 2005, CONSERV BIOL, V19, P969, DOI 10.1111/j.1523-1739.2005.00555.x; Ruiz R. M., 2003, Journal of Sustainable Forestry, V17, P7, DOI 10.1300/J091v17n01_02; Saberwal V., 2003, BATTLES NATURE SCI P; Schwartzman S, 2005, CONSERV BIOL, V19, P721, DOI 10.1111/j.1523-1739.2005.00695.x; SILVIUS KM, 2004, PEOPLE NATURE; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; 2007, ECONOMIST, V383, P67	25	91	97	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2007	317	5839					755	756		10.1126/science.1145560	http://dx.doi.org/10.1126/science.1145560			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690278				2022-12-01	WOS:000248624500022
J	Tomlins, SA; Laxman, B; Dhanasekaran, SM; Helgeson, BE; Cao, XH; Morris, DS; Menon, A; Jing, XJ; Cao, Q; Han, B; Yu, JD; Wang, L; Montie, JE; Rubin, MA; Pienta, KJ; Roulston, D; Shah, RB; Varambally, S; Mehra, R; Chinnaiyan, AM				Tomlins, Scott A.; Laxman, Bharathi; Dhanasekaran, Saravana M.; Helgeson, Beth E.; Cao, Xuhong; Morris, David S.; Menon, Anjana; Jing, Xiaojun; Cao, Qi; Han, Bo; Yu, Jindan; Wang, Lei; Montie, James E.; Rubin, Mark A.; Pienta, Kenneth J.; Roulston, Diane; Shah, Rajal B.; Varambally, Sooryanarayana; Mehra, Rohit; Chinnaiyan, Arul M.			Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer	NATURE			English	Article							HIGH-FREQUENCY; EXPRESSION; TMPRSS2-ERG; TRANSLOCATIONS; IDENTIFICATION; MECHANISMS; RELEVANT; PATHWAYS; 3Q21	Recently, we identified recurrent gene fusions involving the 59 untranslated region of the androgen-regulated gene TMPRSS2 and the ETS (E26 transformation-specific) family genes ERG, ETV1 or ETV4 in most prostate cancers(1,2). Whereas TMPRSS2 ERG fusions are predominant, fewer TMPRSS2-ETV1 cases have been identified than expected on the basis of the frequency of high (outlier) expression of ETV1 (refs 3-13). Here we explore the mechanism of ETV1 outlier expression in human prostate tumours and prostate cancer cell lines. We identified previously unknown 59 fusion partners in prostate tumours with ETV1 outlier expression, including untranslated regions from a prostate-specific androgen-induced gene (SLC45A3) and an endogenous retroviral element (HERV-K_22q11.23), a prostate-specific androgen-repressed gene (C15orf21), and a strongly expressed housekeeping gene (HNRPA2B1). To study aberrant activation of ETV1, we identified two prostate cancer cell lines, LNCaP and MDA-PCa 2B, that had ETV1 outlier expression. Through distinct mechanisms, the entire ETV1 locus (7p21) is rearranged to a 1.5-megabase prostate-specific region at 14q13.3-14q21.1 in both LNCaP cells (cryptic insertion) and MDA- PCa 2B cells (balanced translocation). Because the common factor of these rearrangements is aberrant ETV1 overexpression, we recapitulated this event in vitro and in vivo, demonstrating that ETV1 overexpression in benign prostate cells and in the mouse prostate confers neoplastic phenotypes. Identification of distinct classes of ETS gene rearrangements demonstrates that dormant oncogenes can be activated in prostate cancer by juxtaposition to tissue-specific or ubiquitously active genomic loci. Subversion of active genomic regulatory elements may serve as a more generalized mechanism for carcinoma development. Furthermore, the identification of androgen-repressed and insensitive 59 fusion partners may have implications for the anti-androgen treatment of advanced prostate cancer.	Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Michigan Ctr Translat Pathol, Dept Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Cao, Qi/A-5517-2010; Pienta, Kenneth/E-7679-2015	Cao, Qi/0000-0002-5140-3681; Rubin, Mark/0000-0002-8321-9950; Pienta, Kenneth/0000-0002-4138-2186; Tomlins, Scott/0000-0001-8661-9821; Varambally, Sooryanarayana/0000-0002-2277-1127; Dhanasekaran, saravana mohan/0000-0002-0489-2224				Beheshti B, 2000, MOL DIAGN, V5, P23, DOI 10.2165/00066982-200005010-00008; Cai CM, 2007, MOL ENDOCRINOL, V21, P1835, DOI 10.1210/me.2006-0480; Cerveira N, 2006, NEOPLASIA, V8, P826, DOI 10.1593/neo.06427; DEMICHELIS F, 2007, ONCOGENE        0122, DOI DOI 10.1038/SJ.ONC.1210237; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Hermans KG, 2006, CANCER RES, V66, P10658, DOI 10.1158/0008-5472.CAN-06-1871; Korenchuk S, 2001, IN VIVO, V15, P163; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lin BY, 1999, CANCER RES, V59, P4180; MEHRA R, 2007, MODERN PATHOL, V6, P1177; Mertz KD, 2007, NEOPLASIA, V9, P200, DOI 10.1593/neo.07103; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Rhodes DR, 2007, NEOPLASIA, V9, P443, DOI 10.1593/neo.07292; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Soller MJ, 2006, GENE CHROMOSOME CANC, V45, P717, DOI 10.1002/gcc.20329; Specht K, 2001, AM J PATHOL, V158, P419, DOI 10.1016/S0002-9440(10)63985-5; Stauffer Yves, 2004, Cancer Immun, V4, P2; SUZUKAWA K, 1994, BLOOD, V84, P2681; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; van Bokhoven A, 2003, PROSTATE, V57, P226, DOI 10.1002/pros.10291; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wiemels JL, 1999, CANCER RES, V59, P4075; Wieser R, 2002, LEUKEMIA LYMPHOMA, V43, P59, DOI 10.1080/10428190210196; Winnes M, 2007, ONCOL REP, V17, P1033; Yoshimoto M, 2006, NEOPLASIA, V8, P465, DOI 10.1593/neo.06283; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	34	600	642	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	2007	448	7153					595	U9		10.1038/nature06024	http://dx.doi.org/10.1038/nature06024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17671502	Green Published			2022-12-01	WOS:000248446700044
J	Moglia, A; Menciassi, A; Dario, P; Cuschieri, A				Moglia, Andrea; Menciassi, Arianna; Dario, Paolo; Cuschieri, Alfted			Clinical update: endoscopy for small-bowel turnours	LANCET			English	Article							DOUBLE-BALLOON ENTEROSCOPY; WIRELESS CAPSULE ENDOSCOPY; INTRAOPERATIVE ENTEROSCOPY; TUMORS; LIMITATIONS; EXPERIENCE; DIAGNOSIS; YIELD		Scuola Super Sant Anna, I-56127 Pisa, Italy; Italian Inst Technol Network, Genoa, Italy	Scuola Superiore Sant'Anna; Istituto Italiano di Tecnologia - IIT	Moglia, A (corresponding author), Scuola Super Sant Anna, I-56127 Pisa, Italy.	andrea.moglia@crim.sssup.it	Moglia, Andrea/Y-5433-2018; Cuschieri, Alfred/A-7634-2013; Cuschieri, Alfred/O-4092-2019; Menciassi, Arianna/A-2664-2010	Moglia, Andrea/0000-0002-3365-580X; Cuschieri, Alfred/0000-0003-0764-5947; 				Bailey AA, 2006, AM J GASTROENTEROL, V101, P2237, DOI 10.1111/j.1572-0241.2006.00749.x; Chong AKH, 2006, GASTROINTEST ENDOSC, V64, P445, DOI 10.1016/j.gie.2006.04.007; Cobrin GM, 2006, CANCER-AM CANCER SOC, V107, P22, DOI 10.1002/cncr.21975; De Leusse A, 2007, GASTROENTEROLOGY, V132, P855, DOI 10.1053/j.gastro.2006.12.002; Flieger D, 2005, ENDOSCOPY, V37, P1174, DOI 10.1055/s-2005-921045; Hadithi M, 2006, AM J GASTROENTEROL, V101, P52, DOI 10.1111/j.1572-0241.2005.00346.x; Hartmann D, 2005, GASTROINTEST ENDOSC, V61, P826, DOI 10.1016/S0016-5107(05)00372-X; Hatzaras I, 2007, ARCH SURG-CHICAGO, V142, P229, DOI 10.1001/archsurg.142.3.229; HERBERT J, 2005, CANC PRINCIPLES PRAC, P1035; Hsu CM, 2007, DIGEST DIS SCI, V52, P162, DOI 10.1007/s10620-006-9554-x; Jakobs R, 2006, WORLD J GASTROENTERO, V12, P313, DOI 10.3748/wjg.v12.i2.313; Lepage C, 2006, AM J GASTROENTEROL, V101, P2826, DOI 10.1111/j.1572-0241.2006.00854.x; Matsumoto T, 2005, ENDOSCOPY, V37, P827, DOI 10.1055/s-2005-870207; May A, 2007, AM J GASTROENTEROL, V102, P527, DOI 10.1111/j.1572-0241.2007.01063.x; Mehdizadeh S, 2006, GASTROINTEST ENDOSC, V64, P740, DOI 10.1016/j.gie.2006.05.022; Moglia A, 2007, BIOMED MICRODEVICES, V9, P235, DOI 10.1007/s10544-006-9025-3; Rondonotti E, 2005, GASTROINTEST ENDOSC, V62, P712, DOI 10.1016/j.gie.2005.05.002; Suzuki T, 2007, DIGEST DIS SCI, V52, P1914, DOI 10.1007/s10620-007-9749-9; Triester SL, 2005, AM J GASTROENTEROL, V100, P2407, DOI 10.1111/j.1572-0241.2005.00274.x; Yamamoto H, 2004, CLIN GASTROENTEROL H, V2, P1010, DOI 10.1016/S1542-3565(04)00453-7	20	21	22	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 14	2007	370	9582					114	116		10.1016/S0140-6736(07)61066-6	http://dx.doi.org/10.1016/S0140-6736(07)61066-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	190WP	17630023				2022-12-01	WOS:000248091600009
J	Imrie, J; Elford, J; Kippax, S; Hart, GJ				Imrie, John; Elford, Jonathan; Kippax, Susan; Hart, Graham J.			Biomedical HIV prevention - and social science	LANCET			English	Editorial Material							SEXUAL RISK BEHAVIOR; MEN		Univ New S Wales, Natl Ctr HIV Social Res, Sydney, NSW, Australia; City Univ London, Inst Hlth Sci, London EC1V 0HB, England; UCL, Ctr Sexual Hlth & HIV Res, London, England	University of New South Wales Sydney; City University London; University of London; University College London	Imrie, J (corresponding author), Univ New S Wales, Natl Ctr HIV Social Res, Sydney, NSW, Australia.	j.imrie@unsw.edu.au		Hart, Graham/0000-0001-9676-6577				Aral SO, 1998, LANCET, V351, P33; AYODO H, 2007, E AFRICAN STAND 0331; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BANSA E, 2007, E AFRICAN STAND 0228; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Foss AM, 2003, AIDS, V17, P1227, DOI 10.1097/00002030-200305230-00015; *GLOB CAMP MICR, CELL SULF TRIALS CLO; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; PETERSON L, 2007, PLOS CLIN TRIALS MAY; Truong HHM, 2006, SEX TRANSM INFECT, V82, P461, DOI 10.1136/sti.2006.019950; UNAIDS & WHO, 2007, WHO UNAIDS ANN REC E	12	31	31	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 7	2007	370	9581					10	11		10.1016/S0140-6736(07)61026-5	http://dx.doi.org/10.1016/S0140-6736(07)61026-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	187QE	17617254				2022-12-01	WOS:000247862300008
J	Kowalski, MP; Dubouix-Bourandy, A; Bajmoczi, M; Golan, DE; Zaidi, T; Coutinho-Sledge, YS; Gygi, MP; Gygi, SP; Wiemer, EAC; Pier, GB				Kowalski, Michael P.; Dubouix-Bourandy, Anne; Bajmoczi, Milan; Golan, David E.; Zaidi, Tanweer; Coutinho-Sledge, Yamara S.; Gygi, Melanie P.; Gygi, Steven P.; Wiemer, Erik A. C.; Pier, Gerald B.			Host resistance to lung infection mediated by major vault protein in epithelial cells	SCIENCE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PSEUDOMONAS-AERUGINOSA INFECTION; CYSTIC-FIBROSIS PATIENTS; DRUG-RESISTANCE; MUTANT CFTR; DEFENSE; DISEASE; LOCALIZATION; PHOSPHATASE; CLEARANCE	The airway epithelium plays an essential role in innate immunity to lung pathogens. Ribonucleoprotein particles primarily composed of major vault protein (MVP) are highly expressed in cells that encounter xenobiotics. However, a clear biologic function for MVP is not established. We report here that MVP is rapidly recruited to lipid rafts when human lung epithelial cells are infected with Pseudomonas aeruginosa, and maximal recruitment is dependent on bacterial binding to the cystic fibrosis transmembrane conductance regulator. MVP was also essential for optimal epithelial cell internalization and clearance of P. aeruginosa. These results suggest that MVP makes a substantial contribution to epithelial cell-mediated resistance to infection.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; Novartis Inst Biomed Res, Cambridge, MA 02139 USA; Inst Federatif Biol Purpan, Lab Bacteriol Hyg, Toulouse, France; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; Erasmus MC, Josephine Nefkens Inst, Dept Med Oncol, NL-3015 GE Rotterdam, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Novartis; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Erasmus University Rotterdam; Erasmus MC	Pier, GB (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA.	gpier@channing.harvard.edu	Pier, Gerald/AAO-2692-2021	Pier, Gerald/0000-0002-9112-2331; Wiemer, Erik/0000-0002-0673-7236	NHLBI NIH HHS [R01 HL058398, R37 HL032854, R01 HL 58398-08, R37 HL 32854-22] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058398, R37HL032854] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Cannon CL, 2003, AM J RESP CELL MOL, V29, P188, DOI 10.1165/rcmb.4898; Chung JH, 2005, CANCER RES, V65, P4108, DOI 10.1158/0008-5472.CAN-05-0124; Cortes G, 2002, INFECT IMMUN, V70, P1075, DOI 10.1128/IAI.70.3.1075-1080.2002; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Grassme H, 2000, SCIENCE, V290, P527, DOI 10.1126/science.290.5491.527; Herrmann C, 1999, J CELL BIOL, V144, P1163, DOI 10.1083/jcb.144.6.1163; Kerem B, 1996, EUR J HUM GENET, V4, P65; Kickhoefer VA, 1998, J BIOL CHEM, V273, P8971, DOI 10.1074/jbc.273.15.8971; Kolli S, 2004, J BIOL CHEM, V279, P29374, DOI 10.1074/jbc.M313955200; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; Mossink MH, 2003, ONCOGENE, V22, P7458, DOI 10.1038/sj.onc.1206947; Mossink MH, 2003, IMMUNOLOGY, V110, P58, DOI 10.1046/j.1365-2567.2003.01708.x; Mossink MH, 2002, CANCER RES, V62, P7298; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Pier GB, 1996, AM J RESP CRIT CARE, V154, pS175, DOI 10.1164/ajrccm/154.4_Pt_2.S175; Pier GB, 1997, P NATL ACAD SCI USA, V94, P12088, DOI 10.1073/pnas.94.22.12088; Pier GB, 1996, SCIENCE, V271, P64, DOI 10.1126/science.271.5245.64; Reiniger N, 2005, INFECT IMMUN, V73, P6822, DOI 10.1128/IAI.73.10.6822-6830.2005; SCHEFFER GL, 1995, NAT MED, V1, P578, DOI 10.1038/nm0695-578; Schrager HM, 1998, J CLIN INVEST, V101, P1708, DOI 10.1172/JCI2121; Schroeder TH, 2002, P NATL ACAD SCI USA, V99, P6907, DOI 10.1073/pnas.092160899; Schroeder TH, 2001, J IMMUNOL, V166, P7410, DOI 10.4049/jimmunol.166.12.7410; Steiner E, 2006, J CELL SCI, V119, P459, DOI 10.1242/jcs.02773; STGEME JW, 1992, J INFECT DIS, V165, pS117, DOI 10.1093/infdis/165-Supplement_1-S117; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Xiang ZM, 2006, BIOCHEM BIOPH RES CO, V347, P288, DOI 10.1016/j.bbrc.2006.06.076; Yi CL, 2005, CANCER RES, V65, P5835, DOI 10.1158/0008-5472.CAN-05-0423; Yu ZB, 2002, J BIOL CHEM, V277, P40247, DOI 10.1074/jbc.M207608200	30	93	96	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2007	317	5834					130	132		10.1126/science.1142311	http://dx.doi.org/10.1126/science.1142311			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17615361	Green Accepted			2022-12-01	WOS:000247776700069
J	Perkins, HS				Perkins, Henry S.			Controlling death: The false promise of advance directives	ANNALS OF INTERNAL MEDICINE			English	Article							OF-LIFE CARE; SELF-DETERMINATION ACT; DECISION-MAKING; HEALTH-CARE; PHYSICIAN ORDERS; END; COMPLETION; DISCUSSIONS; FACILITIES; ETHNICITY	Advance directives promise patients a say in their future care but actually have had little effect. Many experts blame problems with completion and implementation, but the advance directive concept itself may be fundamentally flawed. Advance directives simply presuppose more control over future care than is realistic. Medical crises cannot be predicted in detail, making most prior instructions difficult to adapt, irrelevant, or even misleading. Furthermore, many proxies either do not know patients' wishes or do not pursue those wishes effectively. Thus, unexpected problems arise often to defeat advance directives, as the case in this paper illustrates. Because advance directives offer only limited benefit, advance care planning should emphasize not the completion of directives but the emotional preparation of patients and families for future crises. The existentialist Albert Camus might suggest that physicians should warn patients and families that momentous, unforeseeable decisions lie ahead. Then, when the crisis hits, physicians should provide guidance; should help make decisions despite the inevitable uncertainties; should share responsibility for those decisions; and, above all, should courageously see patients and families through the fearsome experience of dying.	Univ Texas, Hlth Sci Ctr, Dept Med, Div Gen Med, San Antonio, TX 78229 USA; Ecumenical Ctr Relig & Hlth, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio	Perkins, HS (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med, Div Gen Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.							Annas GJ, 2005, NEW ENGL J MED, V352, P1710, DOI 10.1056/NEJMlim050643; Balaban RB, 2000, J GEN INTERN MED, V15, P195, DOI 10.1046/j.1525-1497.2000.07228.x; BECK RN, 1969, PERSPECTIVES PHILOS, P437; Bloche MG, 2005, NEW ENGL J MED, V352, P2371, DOI 10.1056/NEJMp058104; Bradley EH, 2001, AM J MED, V111, P218, DOI 10.1016/S0002-9343(01)00798-7; BRETT AS, 1991, JAMA-J AM MED ASSOC, V266, P825, DOI 10.1001/jama.266.6.825; BURT RA, 2005, HASTINGS CENT REP; CALLAHAN D, 2005, HASTINGS CENT REP; CAMUS A, 1972, PLAGUE, P286; CUGLIARI AM, 1995, ARCH INTERN MED, V155, P1893, DOI 10.1001/archinte.155.17.1893; Dresser R, 2005, HASTINGS CENT REP, V35, P20, DOI 10.1353/hcr.2005.0061; DUBLER NN, 2005, HASTINGS CENT REP; Eleazer GP, 1996, J AM GERIATR SOC, V44, P938, DOI 10.1111/j.1532-5415.1996.tb01864.x; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; EMANUEL LL, 1989, JAMA-J AM MED ASSOC, V261, P3288, DOI 10.1001/jama.261.22.3288; EMANUEL LL, 1991, NEW ENGL J MED, V324, P889, DOI 10.1056/NEJM199103283241305; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Fischer GS, 1998, J GEN INTERN MED, V13, P447, DOI 10.1046/j.1525-1497.1998.00133.x; FOLEY KM, 2005, HASTING CENT REP; Galambos CM, 1998, HEALTH SOC WORK, V23, P275, DOI 10.1093/hsw/23.4.275; Gordon NP, 1999, ARCH INTERN MED, V159, P701, DOI 10.1001/archinte.159.7.701; Gostin LO, 2005, JAMA-J AM MED ASSOC, V293, P2403, DOI 10.1001/jama.293.19.2403; Hammes BJ, 1998, ARCH INTERN MED, V158, P383, DOI 10.1001/archinte.158.4.383; Hanson LC, 1996, ARCH INTERN MED, V156, P1018, DOI 10.1001/archinte.156.9.1018; Hickman SE, 2004, J AM GERIATR SOC, V52, P1424, DOI 10.1111/j.1532-5415.2004.52402.x; HICKMAN SE, 2005, HASTING CENT REP; Hoffmann DE, 1996, J LAW MED ETHICS, V24, P5, DOI 10.1111/j.1748-720X.1996.tb01829.x; JENNINGS B, 2005, HASTINGS CENT REP; Kahana B, 2004, J AM GERIATR SOC, V52, P1163, DOI 10.1111/j.1532-5415.2004.52316.x; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; KOENIG B, 2006, BIOETHICS EXAMINER, V9, P4; KOENIG B, 2006, BIOETHICS EXAMINER, V9, P1; Lee MA, 2000, J AM GERIATR SOC, V48, P1219, DOI 10.1111/j.1532-5415.2000.tb02594.x; LEVINE C, 2005, NY TIMES        1206, pD5; Lo B, 2004, ARCH INTERN MED, V164, P1501, DOI 10.1001/archinte.164.14.1501; LYNN J, 1993, HASTINGS CENT REP, V23, P20, DOI 10.2307/3562275; MacIntyre A., 1967, ENCYCL PHILOS, V3, P147; Molloy DW, 2000, JAMA-J AM MED ASSOC, V283, P1437, DOI 10.1001/jama.283.11.1437; Morrison RS, 2004, ARCH INTERN MED, V164, P2421, DOI 10.1001/archinte.164.22.2421; Morrison RS, 1998, J CLIN ETHIC, V9, P118; Murphy ST, 1996, J LAW MED ETHICS, V24, P108, DOI 10.1111/j.1748-720X.1996.tb01843.x; MURRAY TH, 2005, HASTINGS CENT REP; Palker N B, 1995, Nurse Pract, V20, P7; PALKER NB, 1995, NURSE PRACTITIONER, V20, P17; PALKER NB, 1995, NURSE PRACTITIONER, V20, P13; Patel RV, 2004, J CRIT CARE, V19, P1, DOI 10.1016/j.jcrc.2004.02.002; Pearlman RA, 2005, ARCH INTERN MED, V165, P667, DOI 10.1001/archinte.165.6.667; PEARLMAN RA, 2002, YOUR LIFE YOUR CHOIC; Perkins HS, 2002, J GEN INTERN MED, V17, P48, DOI 10.1046/j.1525-1497.2002.01032.x; Perkins HS, 2004, AM J MED SCI, V327, P25, DOI 10.1097/00000441-200401000-00006; PERKINS HS, 2008, IN PRESS; REILLY BM, 1995, ARCH INTERN MED, V155, P2317, DOI 10.1001/archinte.155.21.2317; Rosenfeld KE, 2000, J GEN INTERN MED, V15, P620, DOI 10.1046/j.1525-1497.2000.06289.x; RUBIN SM, 1994, JAMA-J AM MED ASSOC, V271, P209, DOI 10.1001/jama.271.3.209; Schwartz CE, 2002, ARCH INTERN MED, V162, P1611, DOI 10.1001/archinte.162.14.1611; Singer PA, 1997, J GEN INTERN MED, V12, P729, DOI 10.1046/j.1525-1497.1997.07157.x; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; SINGER PA, 1992, ARCH INTERN MED, V152, P22, DOI 10.1001/archinte.152.1.22; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; SUGARMAN J, 1992, ARCH INTERN MED, V152, P343, DOI 10.1001/archinte.152.2.343; Sulmasy DP, 1996, J GEN INTERN MED, V11, P657, DOI 10.1007/BF02600156; Teno JM, 1998, J GEN INTERN MED, V13, P439, DOI 10.1046/j.1525-1497.1998.00132.x; Thorevska N, 2005, J CRIT CARE, V20, P26, DOI 10.1016/j.jcrc.2004.11.002; Tierney WM, 2001, J GEN INTERN MED, V16, P32, DOI 10.1046/j.1525-1497.2001.00215.x; Tulsky JA, 2005, JAMA-J AM MED ASSOC, V294, P359, DOI 10.1001/jama.294.3.359; Volicer L, 2002, J AM GERIATR SOC, V50, P761, DOI 10.1046/j.1532-5415.2002.50175.x; Wolfson J, 2005, HASTINGS CENT REP, V35, P16, DOI 10.2307/3528798; 1978, LIVING WILL; MED ORDERS LIFE SUST	69	252	254	2	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 3	2007	147	1					51	57		10.7326/0003-4819-147-1-200707030-00008	http://dx.doi.org/10.7326/0003-4819-147-1-200707030-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	186MN	17606961				2022-12-01	WOS:000247782900007
J	Meijers, R; Puettmann-Holgado, R; Skiniotis, G; Liu, JH; Walz, T; Wang, JH; Schmucker, D				Meijers, Rob; Puettmann-Holgado, Roland; Skiniotis, Georgios; Liu, Jin-Huan; Walz, Thomas; Wang, Jia-Huai; Schmucker, Dietmar			Structural basis of Dscam isoform specificity	NATURE			English	Article							DROSOPHILA DSCAM; AXON GUIDANCE; PROTEIN RECOGNITION; SURFACE-RECEPTORS; CRYSTAL-STRUCTURE; SELF-AVOIDANCE; DIVERSITY; HORSESHOE; NEURONS	The Dscam gene gives rise to thousands of diverse cell surface receptors(1) thought to provide homophilic and heterophilic recognition specificity for neuronal wiring(2-4) and immune responses(5). Mutually exclusive splicing allows for the generation of sequence variability in three immunoglobulin ecto-domains, D2, D3 and D7. We report X-ray structures of the amino-terminal four immunoglobulin domains (D1-D4) of two distinct Dscam isoforms. The structures reveal a horseshoe configuration, with variable residues of D2 and D3 constituting two independent surface epitopes on either side of the receptor. Both isoforms engage in homo-dimerization coupling variable domain D2 with D2, and D3 with D3. These interactions involve symmetric, antiparallel pairing of identical peptide segments from epitope I that are unique to each isoform. Structure-guided mutagenesis and swapping of peptide segments confirm that epitope I, but not epitope II, confers homophilic binding specificity of full-length Dscam receptors. Phylogenetic analysis shows strong selection of matching peptide sequences only for epitope I. We propose that peptide complementarity of variable residues in epitope I of Dscam is essential for homophilic binding specificity.	Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Univ Freiburg, Inst Biol 3, D-79104 Freiburg, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Freiburg	Wang, JH (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	jwang@red.dfci.harvard.edu; dietmar_schmucker@dfci.harvard.edu	Meijers, Rob/D-5521-2011	Walz, Thomas/0000-0003-2606-2835; Meijers, Rob/0000-0003-2872-6279; Skiniotis, Georgios/0000-0003-0238-7846				Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; COWTAN KD, 2001, INT TABLES CRYSTALLO; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; LAFORTELLE E, 1997, METHOD ENZYMOL, V276, P472; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schmucker D, 2004, NEURON, V44, P219, DOI 10.1016/j.neuron.2004.10.004; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schurmann G, 2001, MOL BIOL CELL, V12, P1765, DOI 10.1091/mbc.12.6.1765; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Wang JH, 2002, TRENDS BIOCHEM SCI, V27, P122, DOI 10.1016/S0968-0004(01)02038-2; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652	33	118	120	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2007	449	7161					487	U12		10.1038/nature06147	http://dx.doi.org/10.1038/nature06147			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17721508				2022-12-01	WOS:000249724800046
J	Norris, JM; Yin, X; Lamb, MM; Barriga, K; Seifert, J; Hoffman, M; Orton, HD; Baron, AE; Clare-Salzler, M; Chase, HP; Szabo, NJ; Erlich, H; Eisenbarth, GS; Rewers, M				Norris, Jill M.; Yin, Xiang; Lamb, Molly M.; Barriga, Katherine; Seifert, Jennifer; Hoffman, Michelle; Orton, Heather D.; Baron, Anna E.; Clare-Salzler, Michael; Chase, H. Peter; Szabo, Nancy J.; Erlich, Henry; Eisenbarth, George S.; Rewers, Marian			Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOOD-FREQUENCY QUESTIONNAIRE; TUMOR-NECROSIS-FACTOR; PRESCHOOL-CHILDREN; LIPID EXTRACTION; DENDRITIC CELLS; YOUNG DAISY; VITAMIN-D; NOD MICE; INSULIN; AUTOANTIBODIES	Context Cod liver oil supplements in infancy have been associated with a decreased risk of type 1 diabetes mellitus in a retrospective study. Objective To examine whether intakes of omega-3 and omega-6 fatty acids are associated with the development of islet autoimmunity (IA) in children. Design, Setting, and Participants A longitudinal, observational study, the Diabetes Autoimmunity Study in the Young (DAISY), conducted in Denver, Colorado, between January 1994 and November 2006, of 1770 children at increased risk for type 1 diabetes, defined as either possession of a high diabetes risk HLA genotype or having a sibling or parent with type 1 diabetes. The mean age at follow-up was 6.2 years. Islet autoimmunity was assessed in association with reported dietary intake of polyunsaturated fatty acids starting at age 1 year. A case-cohort study (N = 244) was also conducted in which risk of IA by polyunsaturated fatty acid content of erythrocyte membranes (as a percentage of total lipids) was examined. Main Outcome Measure Risk of IA, defined as being positive for insulin, glutamic acid decarboxylase, or insulinoma-associated antigen-2 autoantibodies on 2 consecutive visits and still autoantibody positive or having diabetes at last follow-up visit. Results Fifty-eight children developed IA. Adjusting for HLA genotype, family history of type 1 diabetes, caloric intake, and omega-6 fatty acid intake, omega-3 fatty acid intake was inversely associated with risk of IA (hazard ratio [HR], 0.45; 95% confidence interval [CI], 0.21-0.96; P = .04). The association was strengthened when the definition of the outcome was limited to those positive for 2 or more autoantibodies (HR, 0.23; 95% CI, 0.09-0.58; P = .002). In the case-cohort study, omega-3 fatty acid content of erythrocyte membranes was also inversely associated with IA risk (HR, 0.63; 95% CI, 0.41-0.96; P = .03). Conclusion Dietary intake of omega-3 fatty acids is associated with reduced risk of IA in children at increased genetic risk for type 1 diabetes.	Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Roche Mol Syst, Dept Human Genet, Alameda, CA USA; Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; Univ Florida, Analyt Toxicol Core Lab, Gainesville, FL USA; Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; Hlth Sci Ctr, Aurora, CO USA; Univ Colorado, Dept Prevent Med & Biometr, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Roche Holding; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Denver	Norris, JM (corresponding author), Univ Colorado, Dept Prevent Med & Biostat, 4200 E 9th Ave,Box B-119, Denver, CO 80262 USA.	jill.norris@uchsc.edu		Lamb, Molly/0000-0002-2331-2555	NIDDK NIH HHS [R01-DK49654, P30 DK 57516, R01 DK049654, DK32493] Funding Source: Medline; PHS HHS [P01-142288] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057516, R37DK032493, R01DK032493, R01DK049654] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison P.D., 1982, SOCIOL METHODOL, V13, P61, DOI [10.2307/270718, DOI 10.2307/270718]; Arab L, 2003, J NUTR, V133, p925S, DOI 10.1093/jn/133.3.925S; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Baur LA, 2000, LIPIDS, V35, P77, DOI 10.1007/s11745-000-0497-y; BENHAMOU PY, 1995, PANCREAS, V11, P26, DOI 10.1097/00006676-199507000-00003; Bingham SA, 1997, AM J CLIN NUTR, V65, P1130; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Calder PC, 1998, NUTR REV, V56, pS70; Calder PC, 2001, LIPIDS, V36, P1007, DOI 10.1007/s11745-001-0812-7; Chase HP, 2004, DIABETES, V53, P2569, DOI 10.2337/diabetes.53.10.2569; Dahlen E, 1998, J IMMUNOL, V160, P3585; Dahlquist G, 1999, DIABETOLOGIA, V42, P51, DOI 10.1007/s001250051112; De Caterina Raffaele, 2004, Curr Atheroscler Rep, V6, P485, DOI 10.1007/s11883-004-0090-x; ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501; FEUNEKES GIJ, 1993, AM J CLIN NUTR, V58, P489, DOI 10.1093/ajcn/58.4.489; GLATZ JFC, 1989, AM J CLIN NUTR, V49, P269, DOI 10.1093/ajcn/49.2.269; Green EA, 1999, IMMUNOL REV, V169, P11, DOI 10.1111/j.1600-065X.1999.tb01302.x; HAYTOWITZ DB, 1995, J NUTR, V125, P1952, DOI 10.1093/jn/125.7.1952; HEMPEL SL, 1994, J CLIN INVEST, V93, P391, DOI 10.1172/JCI116971; Hughes DA, 2000, AM J CLIN NUTR, V71, p357S, DOI 10.1093/ajcn/71.1.357s; HUNTER DJ, 1992, AM J EPIDEMIOL, V135, P418, DOI 10.1093/oxfordjournals.aje.a116302; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Iso H, 2001, JAMA-J AM MED ASSOC, V285, P304, DOI 10.1001/jama.285.3.304; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; Kleemann R, 1998, J AUTOIMMUN, V11, P97, DOI 10.1006/jaut.1997.0179; KOSTRABA JN, 1992, EPIDEMIOLOGY, V3, P232, DOI 10.1097/00001648-199205000-00008; LaGasse JM, 2002, DIABETES CARE, V25, P505, DOI 10.2337/diacare.25.3.505; LEFKOWITH J, 1990, J EXP MED, V171, P729, DOI 10.1084/jem.171.3.729; LETY MA, 1992, CLIN IMMUNOL IMMUNOP, V64, P188, DOI 10.1016/0090-1229(92)90199-X; Litherland SA, 1999, J CLIN INVEST, V104, P515, DOI 10.1172/JCI4852; MAXWELL RJ, 1983, LIPIDS, V18, P453, DOI 10.1007/BF02535785; Mohan IK, 2001, NUTRITION, V17, P126, DOI 10.1016/S0899-9007(00)00468-8; Mori TA, 1999, METABOLISM, V48, P1402, DOI 10.1016/S0026-0495(99)90150-6; Norris JM, 2007, DIABETES, V56, pA262; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; ORTON HD, EUR J CLIN NUTR; Parrish LA, 2003, EPIDEMIOLOGY, V14, P213, DOI 10.1097/00001648-200303000-00016; Poppitt Sally D, 2005, Lipids Health Dis, V4, P30, DOI 10.1186/1476-511X-4-30; Rewers M, 1996, DIABETOLOGIA, V39, P807, DOI 10.1007/s001250050514; ROMON M, 1995, METABOLISM, V44, P1139, DOI 10.1016/0026-0495(95)90006-3; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; SINGER JD, 1991, PSYCHOL BULL, V110, P268, DOI 10.1037/0033-2909.110.2.268; STEIN AD, 1992, AM J EPIDEMIOL, V135, P667, DOI 10.1093/oxfordjournals.aje.a116346; Stene LC, 2003, AM J CLIN NUTR, V78, P1128, DOI 10.1093/ajcn/78.6.1128; Verge CF, 1996, DIABETES, V45, P926, DOI 10.2337/diabetes.45.7.926; WANDER RC, 1991, AM J CLIN NUTR, V54, P326, DOI 10.1093/ajcn/54.2.326; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697; Yu LP, 1996, J CLIN ENDOCR METAB, V81, P4264, DOI 10.1210/jc.81.12.4264	50	193	196	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2007	298	12					1420	1428		10.1001/jama.298.12.1420	http://dx.doi.org/10.1001/jama.298.12.1420			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	213WV	17895458	Bronze			2022-12-01	WOS:000249698900021
J	Phillips, R; Amos, A; Ritchie, D; Cunningham-Burley, S; Martin, C				Phillips, Richard; Amos, Amanda; Ritchie, Deborah; Cunningham-Burley, Sarah; Martin, Claudia			Smoking in the home after the smoke-free legislation in Scotland: qualitative study	BRITISH MEDICAL JOURNAL			English	Article							REDUCING CHILDRENS EXPOSURE; ENVIRONMENTAL TOBACCO-SMOKE	Objective To explore the accounts of smokers and nonsmokers (who live with smokers) of smoking in their homes and cars after the Scottish smoke-free legislation; to examine the reported impact of the legislation on smoking in the home; and to consider the implications for future initiatives aimed at reducing children's exposure to secondhand smoke in the home. Design and setting A qualitative cross sectional study involving semistructured interviews conducted across Scotland shortly after the implementation of the legislation on 26 March 2006. Participants A purposively selected sample of 50 adults (aged 18-75) drawn from all socioeconomic groups, included smokers living with smokers, smokers living with non-smokers, and non-smokers living with smokers. Results Passive smoking was a well recognised term. Respondents had varied understandings of the risks of secondhand smoke, with a few rejecting evidence of such risks. Children, however, were perceived as vulnerable. Most reported that they restricted smoking in their homes, with a range of restrictions across social classes and home smoking profiles. Spatial, relational, health, and aesthetic factors influenced the development of restrictions. Children and grandchildren were important considerations in the development and modification of restrictions. Other strategies were also used to militate against secondhand smoke, such as opening windows. The meaning of the home as somewhere private and social identity were important underlying factors. Respondents reported greater restrictions on smoking in their cars. There were diverse views on the smoke-free legislation. Few thought it had influenced their smoking in the home, and none thought it had affected how they restricted smoking in their homes. Conclusions These data suggest two normative discourses around smoking in the home. The first relates to acceptable social identity as a hospitable person who is not anti-smoker. The second relates to moral identity as a caring parent or grandparent. Awareness of the risks of secondhand smoke, despite ambivalence about health messages and the fluidity of smoking restrictions, provides clear opportunities for public health initiatives to support people attain smoke-free homes.	Univ Edinburgh, Sch Med, Div Community Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; Univ Edinburgh, Sch Med, Sch Hlth Social Sci, Edinburgh EH8 9AG, Midlothian, Scotland; Scottish Ctr Social Res, Edinburgh EH3 9W, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Amos, A (corresponding author), Univ Edinburgh, Sch Med, Div Community Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland.	amanda.amos@ed.ac.uk						Ashley MJ, 1998, TOB CONTROL, V7, P61, DOI 10.1136/tc.7.1.61; Bancroft A, 2003, SOC SCI MED, V56, P1261, DOI 10.1016/S0277-9536(02)00124-7; Bromley C, 2005, SCOTTISH HLTH SURVEY; Glaser B. G., 1978, THEORETICAL SENSITIV; Haw SJ, 2006, J PUBLIC HEALTH-UK, V28, P24, DOI 10.1093/pubmed/fdi080; Hill L, 2003, HEALTH PROMOT J AUST, V14, P196; Hole D., 2004, PASSIVE SMOKING ASS; Hovell MF, 2000, TOB CONTROL, V9, P40; Jamrozik K, 2005, BMJ; Jones S, 2004, SMOKING REPROD LIFE; Muller T., 2007, BREAKING CYCLE CHILD; Poland B, 2006, TOB CONTROL, V15, P59, DOI 10.1136/tc.2004.009886; Poland BD, 2000, HEALTH PLACE, V6, P1, DOI 10.1016/S1353-8292(99)00025-8; ROBINSON J, 2007, SOC SCI MED; ROBINSON J, 2007, HLTH PLACE; Roseby R, 2002, COCHRANE DB SYST REV; Royal College of Physicians, 2005, GOING SMOK FREE MED; *SCOTT EX, 2006, SMOK PUBL PLAC NOV 2; Wiltshire S, 2003, HEALTH EDUC RES, V18, P292, DOI 10.1093/her/cyf031	19	74	75	1	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 15	2007	335	7619					553	+		10.1136/bmj.39301.497593.55	http://dx.doi.org/10.1136/bmj.39301.497593.55			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215ED	17827488	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000249790200036
J	Toyama, BH; Kelly, MJS; Gross, JD; Weissman, JS				Toyama, Brandon H.; Kelly, Mark J. S.; Gross, John D.; Weissman, Jonathan S.			The structural basis of yeast prion strain variants	NATURE			English	Article							OLIGOPEPTIDE REPEATS; PROTEIN; SUP35; TRANSMISSION; CONFORMATIONS; PROPAGATION; NUCLEATION; ASSIGNMENT; INDUCTION; ELEMENTS	Among the many surprises to arise from studies of prion biology, perhaps the most unexpected is the strain phenomenon whereby a single protein can misfold into structurally distinct, infectious states that cause distinguishable phenotypes(1-3). Similarly, proteins can adopt a spectrum of conformations in non-infectious diseases of protein folding; some are toxic and others are well tolerated(4). However, our understanding of the structural differences underlying prion strains and how these differences alter their physiological impact remains limited. Here we use a combination of solution NMR, amide hydrogen/deuterium (H/D) exchange and mutagenesis to study the structural differences between two strain conformations, termed Sc4 and Sc37 (ref. 5), of the yeast Sup35 prion. We find that these two strains have an overlapping amyloid core spanning most of the Gln/Asn-rich first 40 amino acids that is highly protected from H/D exchange and very sensitive to mutation. These features indicate that the cores are composed of tightly packed beta-sheets possibly resembling 'steric zipper' structures revealed by X-ray crystallography of Sup35-derived peptides(6,7). The stable structure is greatly expanded in the Sc37 conformation to encompass the first 70 amino acids, revealing why this strain shows increased fibre stability and decreased ability to undergo chaperone-mediated replication(8). Our findings establish that prion strains involve large-scale conformational differences and provide a structural basis for understanding a broad range of functional studies, including how conformational changes alter the physiological impact of prion strains.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; Calif Inst Quantitat biomed Res, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X; Toyama, Brandon/0000-0002-8355-9138				Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793; Crist CG, 2003, GENES CELLS, V8, P603, DOI 10.1046/j.1365-2443.2003.00661.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 1996, GENETICS, V144, P1375; Fiaux J, 2002, NATURE, V418, P207, DOI 10.1038/nature00860; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; King CY, 2001, J MOL BIOL, V307, P1247, DOI 10.1006/jmbi.2001.4542; KRAULIS PJ, 1989, J MAGN RESON, V84, P627, DOI 10.1016/0022-2364(89)90130-3; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Liu JJ, 2002, P NATL ACAD SCI USA, V99, P16446, DOI 10.1073/pnas.252652099; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Parham SN, 2001, EMBO J, V20, P2111, DOI 10.1093/emboj/20.9.2111; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Shkundina IS, 2006, GENETICS, V172, P827, DOI 10.1534/genetics.105.048660; Sparrer HE, 2000, SCIENCE, V289, P595, DOI 10.1126/science.289.5479.595; Sun ZYJ, 2005, J BIOMOL NMR, V33, P43, DOI 10.1007/s10858-005-1284-4; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Tuite MF, 2006, METHODS, V39, P9, DOI 10.1016/j.ymeth.2006.04.001; Yamaguchi KI, 2004, J MOL BIOL, V338, P559, DOI 10.1016/j.jmb.2004.02.067	36	276	277	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2007	449	7159					233	U8		10.1038/nature06108	http://dx.doi.org/10.1038/nature06108			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17767153	Green Published			2022-12-01	WOS:000249394500053
J	Weiner, L; Han, R; Scicchitano, BM; Li, J; Hasegawa, K; Grossi, M; Lee, D; Brissette, JL				Weiner, Lorin; Han, Rong; Scicchitano, Bianca M.; Li, Jian; Hasegawa, Kiyotaka; Grossi, Maddalena; Lee, David; Brissette, Janice L.			Dedicated epithelial recipient cells determine pigmentation patterns	CELL			English	Article							FIBROBLAST-GROWTH-FACTOR; NORMAL HUMAN MELANOCYTES; SERUM-FREE MEDIUM; TERMINAL DIFFERENTIATION; NUDE GENE; HAIR FOLLICLE; KERATIN GENE; EPIDERMAL MELANOBLASTS; HUMAN SKIN; EXPRESSION	Mammals generate external coloration via dedicated pigment-producing cells but arrange pigment into patterns through mechanisms largely unknown. Here, using mice as models, we show that patterns ultimately emanate from dedicated pigment-receiving cells. These pigment recipients are epithelial cells that recruit melanocytes to their position in the skin and induce the transfer of melanin. We identify Foxn1 (a transcription factor) as an activator of this "pigment recipient phenotype" and Fgf2 (a growth factor and Foxn1 target) as a signal released by recipients. When Foxn1-and thus dedicated recipients-are redistributed in the skin, new patterns of pigmentation develop, suggesting a mechanism for the evolution of coloration. We conclude that recipients provide a cutaneous template or blueprint that instructs melanocytes where to place pigment. As Foxn1 and Fgf2 also modulate epithelial growth and differentiation, the Foxn1 pathway should serve as a nexus coordinating cell division, differentiation, and pigmentation.	Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Harvard University; Massachusetts General Hospital; Harvard University; University of Lausanne	Brissette, JL (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.	jbrissette@partners.org	Scicchitano, Bianca Maria/B-7800-2017	Scicchitano, Bianca Maria/0000-0002-9599-6642; Han, Rong/0000-0002-5766-8277	NIAMS NIH HHS [R01 AR045284, R01 AR045284-10, AR045284] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045284] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alanko T, 1999, J INVEST DERMATOL, V113, P111, DOI 10.1046/j.1523-1747.1999.00636.x; Baxter RM, 2002, J INVEST DERMATOL, V118, P303, DOI 10.1046/j.0022-202x.2001.01662.x; BHORA FY, 1995, J SURG RES, V59, P236, DOI 10.1006/jsre.1995.1160; Brissette JL, 1996, GENE DEV, V10, P2212, DOI 10.1101/gad.10.17.2212; Cunliffe VT, 2002, MAMM GENOME, V13, P245, DOI 10.1007/s00335-001-3079-6; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; GONZALEZ AM, 1990, J CELL BIOL, V110, P753, DOI 10.1083/jcb.110.3.753; HALABAN R, 1988, J CELL BIOL, V107, P1611, DOI 10.1083/jcb.107.4.1611; HALABAN R, 1987, IN VITRO CELL DEV B, V23, P47; Han R, 2002, PIGM CELL RES, V15, P290, DOI 10.1034/j.1600-0749.2002.02027.x; HERLYN M, 1988, EXP CELL RES, V179, P322, DOI 10.1016/0014-4827(88)90271-6; HIROBE T, 1992, DEVELOPMENT, V114, P435; HOLBROOK KA, 1991, PATHOPHYSIOLOGY DERM, P3; HORIKAWA T, 1995, J INVEST DERMATOL, V104, P256, DOI 10.1111/1523-1747.ep12612795; IMOKAWA G, 1993, J INVEST DERMATOL, V100, P47, DOI 10.1111/1523-1747.ep12354117; Janes SM, 2004, J CELL SCI, V117, P4157, DOI 10.1242/jcs.01302; Johns SA, 2005, DEV DYNAM, V232, P1062, DOI 10.1002/dvdy.20278; KOPFMAIER P, 1990, ACTA ANAT, V139, P178; Kunisada T, 1998, DEVELOPMENT, V125, P2915; Langbein L, 1999, J BIOL CHEM, V274, P19874, DOI 10.1074/jbc.274.28.19874; Lee D, 1999, DEV BIOL, V208, P362, DOI 10.1006/dbio.1999.9221; LEVINE N, 1991, JAMA-J AM MED ASSOC, V266, P2730, DOI 10.1001/jama.266.19.2730; LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593; Mecklenburg L, 2005, EXP DERMATOL, V14, P797, DOI 10.1111/j.1600-0625.2005.00362.x; Mecklenburg L, 2004, J INVEST DERMATOL, V123, P1001, DOI 10.1111/j.0022-202X.2004.23442.x; Meier N, 1999, MECH DEVELOP, V89, P215, DOI 10.1016/S0925-4773(99)00218-X; Militzer K, 1996, J EXP ANIM SCI, V38, P1; Montagna W., 1974, STRUCTURE FUNCTION S, V3rd, P28; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; OHTSUKI M, 1992, J INVEST DERMATOL, V99, P206, DOI 10.1111/1523-1747.ep12650436; Oka M, 2004, J INVEST DERMATOL, V123, P930, DOI 10.1111/j.0022-202X.2004.23454.x; OKEEFE EJ, 1988, J INVEST DERMATOL, V90, P767, DOI 10.1111/1523-1747.ep12560956; PANTELOURIS EM, 1968, NATURE, V217, P370, DOI 10.1038/217370a0; Pla P, 2004, PIGM CELL RES, V17, P142, DOI 10.1046/j.1600-0749.2003.00121.x; Plikus M, 2004, AM J PATHOL, V164, P1099, DOI 10.1016/S0002-9440(10)63197-5; Prowse DM, 1999, DEV BIOL, V212, P54, DOI 10.1006/dbio.1999.9328; Puri N, 1996, ARCH DERMATOL RES, V288, P633, DOI 10.1007/s004030050116; SAITOU M, 1995, NATURE, V374, P159, DOI 10.1038/374159a0; Schlake T, 1997, P NATL ACAD SCI USA, V94, P3842, DOI 10.1073/pnas.94.8.3842; Schlake T, 2000, DEV DYNAM, V217, P368, DOI 10.1002/(SICI)1097-0177(200004)217:4<368::AID-DVDY4>3.0.CO;2-Z; Schlake T, 2001, MECH DEVELOP, V109, P419, DOI 10.1016/S0925-4773(01)00538-X; Schofer C, 2001, ANAT EMBRYOL, V203, P137, DOI 10.1007/s004290000148; Schorpp M, 1997, IMMUNOGENETICS, V46, P509, DOI 10.1007/s002510050312; Schuddekopf K, 1996, P NATL ACAD SCI USA, V93, P9661, DOI 10.1073/pnas.93.18.9661; Seiberg M, 2000, EXP CELL RES, V254, P25, DOI 10.1006/excr.1999.4692; SHIPLEY GD, 1989, J CELL PHYSIOL, V138, P511, DOI 10.1002/jcp.1041380310; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Stevens Alan, 1996, P243; STOCKER KM, 1991, DEVELOPMENT, V111, P635; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563; Virador V, 2001, PIGM CELL RES, V14, P289, DOI 10.1034/j.1600-0749.2001.140410.x; Weiner L, 1998, DIFFERENTIATION, V63, P263, DOI 10.1007/s002580050251; Yamane T, 1999, DEV DYNAM, V216, P450, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<450::AID-DVDY13>3.0.CO;2-0; ZHANG A, 1997, INT J DIGITAL LIB, V1, P386	58	77	81	1	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 7	2007	130	5					932	942		10.1016/j.cell.2007.07.024	http://dx.doi.org/10.1016/j.cell.2007.07.024			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	212GI	17803914	Bronze			2022-12-01	WOS:000249581500023
J	Unniraman, S; Schatz, DG				Unniraman, Shyam; Schatz, David G.			Strand-biased spreading of mutations during somatic hypermutation	SCIENCE			English	Article							CLASS-SWITCH RECOMBINATION; DNA-POLYMERASE-ETA; IMMUNOGLOBULIN VARIABLE GENES; MICE; REPAIR; DEFICIENT; PATTERN; ERROR; MSH6; AID	Somatic hypermutation ( SHM) is a major means by which diversity is achieved in antibody genes, and it is initiated by the deamination of cytosines to uracils in DNA by activation-induced deaminase ( AID). However, the process that leads from these initiating deamination events to mutations at other residues remains poorly understood. We demonstrate that a single cytosine on the top ( nontemplate) strand is sufficient to recruit AID and lead to mutations of upstream and downstream A/T residues. In contrast, the targeting of cytosines on the bottom strand by AID does not lead to substantial mutation of neighboring residues. This strand asymmetry is eliminated in mice deficient in mismatch repair, indicating that the error-prone mismatch repair machinery preferentially targets top-strand uracils in a way that promotes SHM during the antibody response.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06511 USA; Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06511 USA	Howard Hughes Medical Institute; Yale University; Yale University	Schatz, DG (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06511 USA.	david.schatz@yale.edu	Schatz, David/A-6748-2013	Schatz, David/0000-0002-5669-1176				Bardwell PD, 2004, NAT IMMUNOL, V5, P224, DOI 10.1038/ni1031; Delbos F, 2005, J EXP MED, V201, P1191, DOI 10.1084/jem.20050292; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Kelsoe G, 1996, Semin Immunol, V8, P179, DOI 10.1006/smim.1996.0022; Kim N, 1999, J EXP MED, V190, P21, DOI 10.1084/jem.190.1.21; Klotz EL, 1998, J IMMUNOL, V161, P782; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; Martin A, 2003, J EXP MED, V198, P1171, DOI 10.1084/jem.20030880; Martomo SA, 2004, J EXP MED, V200, P61, DOI 10.1084/jem.20040691; Martomo SA, 2006, CURR OPIN IMMUNOL, V18, P243, DOI 10.1016/j.coi.2006.03.007; Mayorov VI, 2005, J IMMUNOL, V174, P7781, DOI 10.4049/jimmunol.174.12.7781; Michael N, 2003, IMMUNITY, V19, P235, DOI 10.1016/S1074-7613(03)00204-8; Neuberger MS, 2005, NAT REV IMMUNOL, V5, P171, DOI 10.1038/nri1553; Phung QH, 1998, J EXP MED, V187, P1745, DOI 10.1084/jem.187.11.1745; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Shapiro GS, 2002, J IMMUNOL, V168, P2302, DOI 10.4049/jimmunol.168.5.2302; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	22	44	47	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2007	317	5842					1227	1230		10.1126/science.1145065	http://dx.doi.org/10.1126/science.1145065			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205PJ	17761884				2022-12-01	WOS:000249126800042
J	Reichenbach, T; Mobilia, M; Frey, E				Reichenbach, Tobias; Mobilia, Mauro; Frey, Erwin			Mobility promotes and jeopardizes biodiversity in rock-paper-scissors games	NATURE			English	Article							SPATIAL COMPETITION; ALLELOPATHY; EVOLUTION; WAVES	Biodiversity is essential to the viability of ecological systems. Species diversity in ecosystems is promoted by cyclic, non-hierarchical interactions among competing populations. Central features of such non-transitive relations are represented by the 'rock-paper-scissors' game, in which rock crushes scissors, scissors cut paper, and paper wraps rock. In combination with spatial dispersal of static populations, this type of competition results in the stable coexistence of all species and the long-term maintenance of biodiversity(1-5). However, population mobility is a central feature of real ecosystems: animals migrate, bacteria run and tumble. Here, we observe a critical influence of mobility on species diversity. When mobility exceeds a certain value, biodiversity is jeopardized and lost. In contrast, below this critical threshold all subpopulations coexist and an entanglement of travelling spiral waves forms in the course of time. We establish that this phenomenon is robust; it does not depend on the details of cyclic competition or spatial environment. These findings have important implications for maintenance and temporal development of ecological systems and are relevant for the formation and propagation of patterns in microbial populations or excitable media.	Univ Munich, Arnold Sommerfeld Ctr Theoret Phys, D-80333 Munich, Germany; Univ Munich, Dept Phys, Ctr NanoSci, D-80333 Munich, Germany	University of Munich; University of Munich	Frey, E (corresponding author), Univ Munich, Arnold Sommerfeld Ctr Theoret Phys, Theresienstr 37, D-80333 Munich, Germany.	frey@lmu.de	Frey, Erwin/M-2613-2017; Mobilia, Mauro/A-7045-2010; Reichenbach, Tobias/G-7475-2011	Frey, Erwin/0000-0001-8792-3358; Mobilia, Mauro/0000-0002-1424-567X; Reichenbach, Tobias/0000-0003-3367-3511				Aranson IS, 2002, REV MOD PHYS, V74, P99, DOI 10.1103/RevModPhys.74.99; BERG HCE, 2003, MOTION; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Czaran TL, 2002, P NATL ACAD SCI USA, V99, P786, DOI 10.1073/pnas.012399899; Durrett R, 1998, THEOR POPUL BIOL, V53, P30, DOI 10.1006/tpbi.1997.1338; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Durrett R, 1997, J THEOR BIOL, V185, P165, DOI 10.1006/jtbi.1996.0292; Dykhuizen DE, 1998, ANTON LEEUW INT J G, V73, P25, DOI 10.1023/A:1000665216662; Gardiner C. W., 1983, HDB STOCHASTIC METHO; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; Hastings A, 2004, TRENDS ECOL EVOL, V19, P39, DOI 10.1016/j.tree.2003.09.007; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hofbauer J., 1998, EVOLUTIONARY GAMES P, DOI 10.1017/CBO9781139173179; Igoshin OA, 2004, P NATL ACAD SCI USA, V101, P4256, DOI 10.1073/pnas.0400704101; JACKSON JBC, 1975, P NATL ACAD SCI USA, V72, P5160, DOI 10.1073/pnas.72.12.5160; Johnson CR, 2002, P ROY SOC B-BIOL SCI, V269, P655, DOI 10.1098/rspb.2001.1948; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; King AA, 2003, THEOR POPUL BIOL, V64, P431, DOI 10.1016/S0040-5809(03)00100-X; Kirkup BC, 2004, NATURE, V428, P412, DOI 10.1038/nature02429; LEVIN SA, 1974, AM NAT, V108, P207, DOI 10.1086/282900; MAY RM, 1975, SIAM J APPL MATH, V29, P243, DOI 10.1137/0129022; Maynard Smith J., 1982, pi; Nowak M., 2007, Q REV BIOL, V82; Redner S., 2001, GUIDE 1 PASSAGE PROC; Reichenbach T, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051907; SIEGERT F, 1995, CURR BIOL, V5, P937, DOI 10.1016/S0960-9822(95)00184-9; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Thul R, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.188103; WIGGINS S, 1990, INTRO APPLIED NONLIN, pCH2	31	502	505	4	130	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 30	2007	448	7157					1046	1049		10.1038/nature06095	http://dx.doi.org/10.1038/nature06095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205EU	17728757	Green Submitted, Green Accepted			2022-12-01	WOS:000249097600037
J	Bennett, EJ; Shaler, TA; Woodman, B; Ryu, KY; Zaitseva, TS; Becker, CH; Bates, GP; Schulman, H; Kopito, RR				Bennett, Eric J.; Shaler, Thomas A.; Woodman, Ben; Ryu, Kwon-Yul; Zaitseva, Tatiana S.; Becker, Christopher H.; Bates, Gillian P.; Schulman, Howard; Kopito, Ron R.			Global changes to the ubiquitin system in Huntington's disease	NATURE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; IN MOUSE MODEL; PROTEASOME SYSTEM; PARKINSONS-DISEASE; DYSFUNCTION; IMPAIRMENT; NUCLEAR; QUANTIFICATION; AGGREGATION; DEGRADATION	Huntington's disease (HD) is a dominantly inherited neuro-degenerative disorder caused by expansion of CAG triplet repeats in the huntingtin (HTT) gene (also called HD) and characterized by accumulation of aggregated fragments of polyglutamine-expanded HTT protein in affected neurons(1,2). Abnormal enrichment of HD inclusion bodies with ubiquitin, a diagnostic characteristic of HD and many other neurodegenerative disorders including Alzheimer's and Parkinson's diseases(3,4), has suggested that dysfunction in ubiquitin metabolism may contribute to the pathogenesis of these diseases(5,6). Because modification of proteins with polyubiquitin chains regulates many essential cellular processes including protein degradation, cell cycle, transcription, DNA repair and membrane trafficking(7), disrupted ubiquitin signalling is likely to have broad consequences for neuronal function and survival. Although ubiquitin-dependent protein degradation is impaired in cell-culture models of HD8-11 and of other neurodegenerative diseases(12,13), it has not been possible to evaluate the function of the ubiquitin-proteasome system (UPS) in HD patients or in animal models of the disease, and a functional role for UPS impairment in neurodegenerative disease pathogenesis remains controversial(14-16). Here we exploit a mass-spectrometry-based method to quantify polyubiquitin chains(17) and demonstrate that the abundance of these chains is a faithful endogenous biomarker of UPS function. Lys 48-linked polyubiquitin chains accumulate early in pathogenesis in brains from the R6/2 transgenic mouse model of HD, from a knock-in model of HD and from human HD patients, establishing that UPS dysfunction is a consistent feature of HD pathology. Lys 63- and Lys 11-linked polyubiquitin chains, which are not typically associated with proteasomal targeting, also accumulate in the R6/2 mouse brain. Thus, HD is linked to global changes in the ubiquitin system to a much greater extent than previously recognized.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; PPD Biomarker Discovery Inc, Menlo Pk, CA 94025 USA; Kings Coll London, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England	Stanford University; University of London; King's College London	Kopito, RR (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	kopito@stanford.edu	Bates, Gillian P/E-1146-2012; Longo, Kenneth A/A-5631-2010	Bates, Gillian P/0000-0002-4041-6305; Ryu, Kwon-Yul/0000-0001-6104-8575	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Barr JR, 1996, CLIN CHEM, V42, P1676; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; DASS C, 1989, INT J PEPT PROT RES, V34, P81; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Kabashi E, 2004, J NEUROCHEM, V89, P1325, DOI 10.1111/j.1471-4159.2004.02453.x; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; LOWE J, 1988, J PATHOL, V155, P9, DOI 10.1002/path.1711550105; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mayer R J, 1989, Prog Clin Biol Res, V317, P809; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Tobin AJ, 2000, TRENDS CELL BIOL, V10, P531, DOI 10.1016/S0962-8924(00)01853-5; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Verhoef LGGC, 2002, HUM MOL GENET, V11, P2689, DOI 10.1093/hmg/11.22.2689; Wang HL, 2007, CELL SIGNAL, V19, P573, DOI 10.1016/j.cellsig.2006.08.006; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004	28	408	412	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2007	448	7154					704	U11		10.1038/nature06022	http://dx.doi.org/10.1038/nature06022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687326				2022-12-01	WOS:000248598000047
J	Peltecu, G				Peltecu, Gheorghe			Cellulitis after treatment for breast cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Carol Davila Univ Med, Bucharest 010455, Romania	Carol Davila University of Medicine & Pharmacy	Peltecu, G (corresponding author), Carol Davila Univ Med, Bucharest 010455, Romania.	peltecu@dnt.ro							0	2	2	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2007	357	5					488	488		10.1056/NEJMicm065836	http://dx.doi.org/10.1056/NEJMicm065836			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195UB	17671257				2022-12-01	WOS:000248436300010
J	Forstemann, K; Horwich, MD; Wee, L; Tomari, Y; Zamore, PD				Foerstemann, Klaus; Horwich, Michael D.; Wee, LiangMeng; Tomari, Yukihide; Zamore, Phillip D.			Drosophila microRNAs are sorted into functionally distinct argonaute complexes after production by Dicer-1	CELL			English	Article							RNA-INTERFERENCE; CRYSTAL-STRUCTURE; PASSENGER-STRAND; STRUCTURAL BASIS; MESSENGER-RNAS; ENZYME DICER; SIRNA; RECOGNITION; CLEAVAGE; SLICER	Small interfering RNAs (siRNAs) and microRNAs (miRNAs) guide distinct classes of RNA-induced silencing complexes (RISCs) to repress mRNA expression in biological processes ranging from development to antiviral defense. In Drosophila, separate but conceptually similar endonucleolytic pathways produce siRNAs and miRNAs. Here, we show that despite their distinct biogenesis, double-stranded miRNAs and siRNAs participate in a common sorting step that partitions them into Ago1- or Ago2-containing effector complexes. These distinct complexes silence their target RNAs by different mechanisms. miRNA-loaded Ago2-RISC mediates RNAi, but only Ago1 is able to repress an mRNA with central mismatches in its miRNA-binding sites. Conversely, Ago1 cannot mediate RNAi, because it is an inefficient nuclease whose catalytic rate is limited by the dissociation of its reaction products. Thus, the two members of the Drosophila Ago subclade of Argonaute proteins are functionally specialized, but specific small RNA classes are not restricted to associate with Ago1 or Ago2.	Univ Munich, Gene Ctr, D-81377 Munich, Germany; Univ Munich, CiPS, D-81377 Munich, Germany; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; PRESTO, Japan Sci & Technol Agcy, Kawagoe, Saitama 3320012, Japan	University of Munich; University of Munich; University of Tokyo; Japan Science & Technology Agency (JST)	Zamore, PD (corresponding author), Univ Munich, Gene Ctr, Foedor Lynen Str 25, D-81377 Munich, Germany.	phillip.zamore@umassmed.edu	Tomari, Yukihide/A-8009-2009; Zamore, Phillip D/A-8941-2013; Wee, Liang Meng/U-2188-2017	Tomari, Yukihide/0000-0001-8442-0851; Wee, Liang Meng/0000-0003-3870-8568; Zamore, Phillip/0000-0002-4505-9618	Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [5 P30 DK032520, P30 DK032520, P30 DK032520-259007] Funding Source: Medline; NIGMS NIH HHS [R37 GM062862, R01 GM062862-08, R01 GM065236-07, GM62862, R01 GM065236, R01 GM062862, GM65236] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062862, R01GM065236, R01GM062862] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Davis AC, 2001, J HIGH ENERGY PHYS; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Haley B, 2003, METHODS, V30, P330, DOI 10.1016/S1046-2023(03)00052-5; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Preall JB, 2006, CURR BIOL, V16, P530, DOI 10.1016/j.cub.2006.01.061; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; STELLER H, 1985, EMBO J, V4, P167, DOI 10.1002/j.1460-2075.1985.tb02332.x; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	83	296	314	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					287	297		10.1016/j.cell.2007.05.056	http://dx.doi.org/10.1016/j.cell.2007.05.056			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662943	Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000248588000018
J	Rodrigo-Brenni, MC; Morgan, DO				Rodrigo-Brenni, Monica C.; Morgan, David O.			Sequential E2s drive polyubiquitin chain assembly on APC targets	CELL			English	Article							UBIQUITIN-CONJUGATING ENZYME; ANAPHASE-PROMOTING COMPLEX; MITOTIC CYCLIN; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; DEPENDENT PROTEOLYSIS; DEGRADATION; DESTRUCTION; SYSTEM; TRANSLOCATION	The anaphase- promoting complex ( APC), or cyclosome, is an E3 ubiquitin- protein ligase that collaborates with E2 ubiquitin- conjugating enzymes to assemble polyubiquitin chains on proteins important for cell- cycle progression. It remains unclear how the APC - or many other E3s - promotes the multiple distinct reactions necessary for chain assembly. We addressed this problem by analyzing APC interactions with different E2s. We screened all budding yeast E2s as APC coenzymes in vitro and found that two, Ubc4 and Ubc1, are the key E2 partners for the APC. These proteins display strikingly different but complementary enzymatic behaviors: Ubc4 supports the rapid monoubiquitination of multiple lysines on APC targets, while Ubc1 catalyzes K48- linked polyubiquitin chain assembly on preattached ubiquitins. Mitotic APC function is lost in yeast strains lacking both Ubc1 and Ubc4. E2- 25K, a human homolog of Ubc1, also promotes APC- dependent chain extension on preattached ubiquitins. We propose that sequential E2 proteins catalyze K48- linked polyubiquitination and thus proteasomal destruction of APC targets.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	david.morgan@ucsf.edu		Morgan, David/0000-0001-8753-4416	NIGMS NIH HHS [R01 GM053270, GM53270] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053270, R37GM053270] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aristarkhov A, 1996, P NATL ACAD SCI USA, V93, P4294, DOI 10.1073/pnas.93.9.4294; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Carroll CW, 2005, METHOD ENZYMOL, V398, P219, DOI 10.1016/S0076-6879(05)98018-X; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; CHEN ZJ, 1991, J BIOL CHEM, V266, P15698; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Flierman D, 2006, P NATL ACAD SCI USA, V103, P11589, DOI 10.1073/pnas.0605215103; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; HERSHKO A, 1994, J BIOL CHEM, V269, P4940; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hodgins R, 1996, J BIOL CHEM, V271, P28766, DOI 10.1074/jbc.271.46.28766; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoppe T, 2005, TRENDS BIOCHEM SCI, V30, P183, DOI 10.1016/j.tibs.2005.02.004; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kraft C, 2006, METHODS, V38, P39, DOI 10.1016/j.ymeth.2005.07.005; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Mathe E, 2004, CURR BIOL, V14, P1723, DOI 10.1016/j.cub.2004.09.023; Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Morgan DO., 2007, CELL CYCLE PRINCIPLE; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Passmore LA, 2005, METHOD ENZYMOL, V398, P195, DOI 10.1016/S0076-6879(05)98017-8; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Seino H, 2003, MOL CELL BIOL, V23, P3497, DOI 10.1128/MCB.23.10.3497-3505.2003; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; SOMMER T, 1993, NATURE, V365, P176, DOI 10.1038/365176a0; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Townsley FM, 1998, YEAST, V14, P747, DOI 10.1002/(SICI)1097-0061(19980615)14:8<747::AID-YEA271>3.0.CO;2-T; Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yu HT, 1996, CURR BIOL, V6, P455, DOI 10.1016/S0960-9822(02)00513-4	50	197	203	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2007	130	1					127	139		10.1016/j.cell.2007.05.027	http://dx.doi.org/10.1016/j.cell.2007.05.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632060	Bronze			2022-12-01	WOS:000248587000016
J	Diamond, GA; Bax, L; Kaul, S				Diamond, George A.; Bax, Leon; Kaul, Sanjay			Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death	ANNALS OF INTERNAL MEDICINE			English	Article							SPARSE DATA; METAANALYSIS; OUTCOMES; TRIALS	A recent, widely publicized meta-analysis of 42 clinical trials concluded that rosiglitazone was associated with an approximately 43% increased risk for myocardial infarction and an approximately 64% increased risk for cardiovascular death. The sensitivity of these conclusions to several methodological choices was not assessed. The meta-analysis was not based on a comprehensive search for all studies that might yield evidence about rosiglitazone's cardiovascular effects. Studies were combined on the basis of a lack of statistical heterogeneity, despite substantial variability in study design and outcome assessment. The meta-analytic approach that was used required the exclusion of studies with zero events in the treatment and control groups. Alternative meta-analytic approaches that use continuity corrections show lower odds ratios that are not statistically significant. We conclude that the risk for myocardial infarction and death from cardiovascular disease for diabetic patients taking rosiglitazone is uncertain: Neither increased nor decreased risk is established.	Univ Calif Los Angeles, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kaul, S (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	kaul@cshs.org						*ADV COMM BRIEF DO, 2007, CARD SAFT ROS; Bax Leon, 2006, BMC Med Res Methodol, V6, P50, DOI 10.1186/1471-2288-6-50; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; COOK DJ, 1991, AM J MED, V91, P519, DOI 10.1016/0002-9343(91)90189-5; Friedrich JO, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-5; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; McAfee AT, 2007, PHARMACOEPIDEM DR S, V16, P711, DOI 10.1002/pds.1443; Nathan DM, 2007, NEW ENGL J MED, V357, P64, DOI 10.1056/NEJMe078117; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Psaty BM, 2007, NEW ENGL J MED, V357, P67, DOI 10.1056/NEJMe078116; Richter B, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006063; Sankey SS, 1996, COMMUN STAT SIMULAT, V25, P1031, DOI 10.1080/03610919608813357; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; WHITEHEAD A, 1991, STAT MED, V10, P1665, DOI 10.1002/sim.4780101105	14	225	230	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2007	147	8					578	581		10.7326/0003-4819-147-8-200710160-00182	http://dx.doi.org/10.7326/0003-4819-147-8-200710160-00182			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224HC	17679700				2022-12-01	WOS:000250437100008
J	Parker, JB; Bianchet, MA; Krosky, DJ; Friedman, JI; Amzel, LM; Stivers, JT				Parker, Jared B.; Bianchet, Mario A.; Krosky, Daniel J.; Friedman, Joshua I.; Amzel, L. Mario; Stivers, James T.			Enzymatic capture of an extrahelical thymine in the search for uracil in DNA	NATURE			English	Article							FLIPPING MECHANISM; GLYCOSYLASE; KINETICS; REPAIR; CATALYSIS; EXCISION; NMR	The enzyme uracil DNA glycosylase (UNG) excises unwanted uracil bases in the genome using an extrahelical base recognition mechanism. Efficient removal of uracil is essential for prevention of C-to-T transition mutations arising from cytosine deamination, cytotoxic U center dot A pairs arising from incorporation of dUTP in DNA, and for increasing immunoglobulin gene diversity during the acquired immune response. A central event in all of these UNG-mediated processes is the singling out of rare U center dot A or U center dot G base pairs in a background of approximately 10(9) T center dot A or C center dot G base pairs in the human genome. Here we establish for the human and Escherichia coli enzymes that discrimination of thymine and uracil is initiated by thermally induced opening of T center dot A and U center dot A base pairs and not by active participation of the enzyme. Thus, base-pair dynamics has a critical role in the genome-wide search for uracil, and may be involved in initial damage recognition by other DNA repair glycosylases.	Johns Hopkins Med Sch, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Med Sch, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Stivers, JT (corresponding author), Johns Hopkins Med Sch, Dept Pharmacol & Mol Sci, 725 N Wolfe St, Baltimore, MD 21205 USA.	jstivers@jhmi.edu	Bianchet, Mario a/K-2131-2015	Bianchet, Mario a/0000-0001-9032-7549; Amzel, L. Mario/0000-0002-0129-9572	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056834, R01GM066895] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056834-11A2, R01 GM056834, R01 GM066895] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Cao CY, 2006, J AM CHEM SOC, V128, P13034, DOI 10.1021/ja062978n; Cao CY, 2004, NAT STRUCT MOL BIOL, V11, P1230, DOI 10.1038/nsmb864; Chen LW, 2002, CHEM BIOL, V9, P345, DOI 10.1016/S1074-5521(02)00120-5; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11876, DOI 10.1021/bi9910880; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11866, DOI 10.1021/bi9910878; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Gueron M, 1995, METHOD ENZYMOL, V261, P383; GUERON M, 1990, STRUCTURE METHODS, V3, P113; Jiang YL, 2002, BIOCHEMISTRY-US, V41, P11236, DOI 10.1021/bi026226r; Kavli B, 1996, EMBO J, V15, P3442, DOI 10.1002/j.1460-2075.1996.tb00710.x; Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014; Krosky DJ, 2005, BIOCHEMISTRY-US, V44, P5949, DOI 10.1021/bi050084u; Krosky DJ, 2004, BIOCHEMISTRY-US, V43, P4188, DOI 10.1021/bi036303y; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MOE JG, 1992, BIOCHEMISTRY-US, V31, P8421, DOI 10.1021/bi00151a005; Moran S, 1996, NUCLEIC ACIDS RES, V24, P2044, DOI 10.1093/nar/24.11.2044; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Ren RXF, 1996, J AM CHEM SOC, V118, P7671, DOI 10.1021/ja9612763; Seiple L, 2006, NUCLEIC ACIDS RES, V34, P140, DOI 10.1093/nar/gkj430; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Snoussi K, 2002, BIOCHEMISTRY-US, V41, P12467, DOI 10.1021/bi020184p; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; Xiao GY, 1999, PROTEINS, V35, P13	30	164	164	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2007	449	7161					433	U2		10.1038/nature06131	http://dx.doi.org/10.1038/nature06131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17704764	Green Accepted			2022-12-01	WOS:000249724800034
J	Yoshida, S; Sukeno, M; Nabeshima, YI				Yoshida, Shosei; Sukeno, Mamiko; Nabeshima, Yo-ichi			A vasculature-associated niche for undifferentiated spermatogonia in the mouse testis	SCIENCE			English	Article							STEM-CELL NICHE; SPERMATOGENESIS; DIFFERENTIATION; IDENTIFICATION	Mammalian spermatogenesis produces numerous sperm for a long period based on a highly potent stem cell system, which relies on a special microenvironment, or niche, that has not yet been identified. In this study, using time-lapse imaging of green fluorescent protein-labeled undifferentiated spermatogonia (A(undiff)) and three-dimensional reconstitution, we revealed a biased localization of Aundiff to the vascular network and accompanying Leydig and other interstitial cells, in intact testes. Differentiating spermatogonia left these niche regions and dispersed throughout the basal compartment of the seminiferous epithelium. Moreover, rearrangement of A(undiff) accompanied the vasculature alteration. We propose that the mammalian germline niche is established as a consequence of vasculature pattern formation. This is different from what is observed in Drosophila or Caenorhabditis elegans, which display developmentally specified niche structures within polarized gonads.	Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan	Kyoto University	Yoshida, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan.	shosei@lmls.med.kyoto-u.ac.jp		Yoshida, Shosei/0000-0001-8861-1866				Brennan J, 2002, DEV BIOL, V244, P418, DOI 10.1006/dbio.2002.0578; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1170, DOI 10.1095/biolreprod65.4.1170; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1179, DOI 10.1095/biolreprod65.4.1179; CLERMONT Y, 1961, AM J ANAT, V108, P79, DOI 10.1002/aja.1001080106; Davidoff MS, 2004, J CELL BIOL, V167, P935, DOI 10.1083/jcb.200409107; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; De Rooij DG, 2000, J ANDROL, V21, P776; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Hess RA, 2006, CELL CYCLE, V5, P1164, DOI 10.4161/cc.5.11.2775; Hilton B. T., 1993, CELL MOL BIOL TESTIS, P238; LEBLOND CP, 1952, ANN NY ACAD SCI, V55, P548, DOI 10.1111/j.1749-6632.1952.tb26576.x; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Nikolova G, 2007, TRENDS CELL BIOL, V17, P19, DOI 10.1016/j.tcb.2006.11.005; NISHIMUNE Y, 1978, FERTIL STERIL, V29, P95; Ogawa T, 2005, INT J HEMATOL, V82, P381, DOI 10.1532/IJH97.05088; Ohbo K, 2003, DEV BIOL, V258, P209, DOI 10.1016/S0012-1606(03)00111-8; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Russell L, 1990, HISTOLOGICAL HISTOPA; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; Yamashita YM, 2005, INT J HEMATOL, V82, P377, DOI 10.1532/IJH97.05097; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316	29	350	367	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1722	1726		10.1126/science.1144885	http://dx.doi.org/10.1126/science.1144885			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17823316				2022-12-01	WOS:000249585900040
J	Mizutani, K; Yoon, K; Dang, L; Tokunaga, A; Gaiano, N				Mizutani, Ken-ichi; Yoon, Keejung; Dang, Louis; Tokunaga, Akinori; Gaiano, Nicholas			Differential Notch signalling distinguishes neural stem cells from intermediate progenitors	NATURE			English	Article							TRANSGENIC MICE; CEREBRAL-CORTEX; MOUSE-BRAIN; NEUROGENESIS; ACTIVATION; EXPRESSION; FOREBRAIN; PROMOTERS; NEURONS; EBNA2	During brain development, neurons and glia are generated from a germinal zone containing both neural stem cells (NSCs) and more limited intermediate neural progenitors (INPs)(1-3). The signalling events that distinguish between these two proliferative neural cell types remain poorly understood. The Notch signalling pathway is known to maintain NSC character and to inhibit neurogenesis, although little is known about the role of Notch signalling in INPs. Here we show that both NSCs and INPs respond to Notch receptor activation, but that NSCs signal through the canonical Notch effector C-promoter binding factor 1 (CBF1), whereas INPs have attenuated CBF1 signalling. Furthermore, whereas knock-down of CBF1 promotes the conversion of NSCs to INPs, activation of CBF1 is insufficient to convert INPs back to NSCs. Using both transgenic and transient in vivo reporter assays we show that NSCs and INPs coexist in the telencephalic ventricular zone and that they can be prospectively separated on the basis of CBF1 activity. Furthermore, using in vivo transplantation we show that whereas NSCs generate neurons, astrocytes and oligodendrocytes at similar frequencies, INPs are predominantly neurogenic. Together with previous work on haematopoietic stem cells(4), this study suggests that the use or blockade of the CBF1 cascade downstream of Notch is a general feature distinguishing stem cells from more limited progenitors in a variety of tissues.	Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Gaiano, N (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	gaiano@jhmi.edu		Dang, Louis/0000-0003-4853-4952; Yoon, Keejung/0000-0002-2361-9039; Tokunaga, Akinori/0000-0001-9560-0516				Battiste J, 2007, DEVELOPMENT, V134, P285, DOI 10.1242/dev.02727; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Deprimo SE, 1996, TRANSGENIC RES, V5, P459, DOI 10.1007/BF01980211; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gal JS, 2006, J NEUROSCI, V26, P1045, DOI 10.1523/JNEUROSCI.4499-05.2006; He WL, 2001, J NEUROSCI, V21, P8854, DOI 10.1523/JNEUROSCI.21-22-08854.2001; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Mason HA, 2005, DEVELOPMENT, V132, P4247, DOI 10.1242/dev.02008; Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008; Mizutani K, 2005, DEVELOPMENT, V132, P1295, DOI 10.1242/dev.01693; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohtsuka T, 2006, MOL CELL NEUROSCI, V31, P109, DOI 10.1016/j.mcn.2005.09.006; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sawamoto K, 2001, J NEUROSCI RES, V65, P220, DOI 10.1002/jnr.1145; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tokunaga A, 2004, J NEUROCHEM, V90, P142, DOI 10.1111/j.1471-4159.2004.02470.x; Waltzer L, 1995, NUCLEIC ACIDS RES, V23, P4939, DOI 10.1093/nar/23.24.4939; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Yun K, 2002, DEVELOPMENT, V129, P5029	29	391	405	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2007	449	7160					351	+		10.1038/nature06090	http://dx.doi.org/10.1038/nature06090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17721509				2022-12-01	WOS:000249557300047
J	Akhtar, PC; Currie, DB; Currie, CE; Haw, SJ				Akhtar, Patricia C.; Currie, Dorothy B.; Currie, Candace E.; Haw, Sally J.			Changes in child exposure to environmental tobacco smoke (CHETS) study after implementation of smoke-free legislation in Scotland: national cross sectional survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PASSIVE SMOKING; SALIVA COTININE; HEALTH	Objective To detect any change in exposure to secondhand smoke among primary schoolchildren after implementation of smoke-free legislation in Scotland in March 2006. Design Comparison of nationally representative, cross sectional, class based surveys carried out in the same schools before and after legislation. Setting Scotland. Participants 2559 primary schoolchildren (primary 7; mean age 11.4 years) surveyed in January 2006 (before smoke-free legislation) and 2424 in January 2007 (after legislation). Outcome measures Salivary cotinine concentrations, reports of parental smoking, and exposure to tobacco smoke in public and private places before and after legislation. Results The geometric mean salivary cotinine concentration in non-smoking children fell from 0.36 (95% confidence interval 0.32 to 0.40) ng/ml to 0.22 (0.19 to 0.25) ng/ml after the introduction of smoke-free legislation in Scotland-a 39% reduction. The extent of the fall in cotinine concentration varied according to the number of parent figures in the home who smoked but was statistically significant only among pupils living in households in which neither parent figure smoked (51% fall, from 0.14 (0.13 to 0.16) ng/ml to 0.07 (0.06 to 0.08) ng/ml) and among pupils living in households in which only the father figure smoked (44% fall, from 0.57 (0.47 to 0.70) ng/ml to 0.32 (0.25 to 0.42) ng/ml). Little change occurred in reported exposure to secondhand smoke in pupils' own homes or in cars, but a small decrease in exposure in other people's homes was reported. Pupils reported lower exposure in cafes and restaurants and in public transport after legislation. Conclusions The Scottish smoke-free legislation has reduced exposure to secondhand smoke among young people in Scotland, particularly among groups with lower exposure in the home. We found no evidence of increased secondhand smoke exposure in young people associated with displacement of parental smoking into the home. The Scottish smoke-free legislation has thus had a positive short term impact on young people's health, but further efforts are needed to promote both smoke-free homes and smoking cessation.	Univ Edinburgh, Child & Adolescent Hlth Res Unit, Edinburgh EH8 8AQ, Midlothian, Scotland; NHS Hlth Scotland, Edinburgh EH12 5EZ, Midlothian, Scotland	University of Edinburgh	Akhtar, PC (corresponding author), Univ Edinburgh, Child & Adolescent Hlth Res Unit, Edinburgh EH8 8AQ, Midlothian, Scotland.	patricia.akhtar@ed.ac.uk	Currie, Dorothy/AAM-3210-2020	Currie, Dorothy/0000-0001-7321-9394				Allwright S, 2005, BMJ-BRIT MED J, V331, P1117, DOI 10.1136/bmj.38636.499225.55; *ASH SCOTL, SMOK FREE LEG WORLD; Batista-Foguet JM, 2004, SOC INDIC RES, V67, P315, DOI 10.1023/B:SOCI.0000032341.14612.b8; Borland R, 2006, TOB CONTROL, V15, P42, DOI 10.1136/tc.2005.012492; Boyce W., 2004, YOUNG PEOPLES HLTH C, P13; BROMLEY C, 2005, SCOTTISH HLTH SURVEY, V3; COOK DG, 1994, BRIT MED J, V308, P384, DOI 10.1136/bmj.308.6925.384; Currie CE, 1997, HEALTH EDUC RES, V12, P385, DOI 10.1093/her/12.3.385; Department of Health, HLTH SURV ENGL; Fong GT, 2006, TOB CONTROL, V15, P51, DOI 10.1136/tc.2005.013649; *GTTS COLL GROUP, 2006, TOB CONTROL, V15, P4; HETLAND J, 2005, 4 HEMILSIRUS; HINCHLIFFE D, 2005, CMND6374; Jarvis MJ, 2003, NICOTINE TOB RES, V5, P349, DOI 10.1080/1462220031000094213; JARVIS MJ, 1985, BRIT MED J, V291, P927, DOI 10.1136/bmj.291.6500.927; Jarvis MJ, 2000, BRIT MED J, V321, P343, DOI 10.1136/bmj.321.7257.343; JARVIS MJ, 1989, MUTAT RES, V222, P101, DOI 10.1016/0165-1218(89)90023-2; Kallio K, 2007, CIRCULATION, V115, P3205, DOI 10.1161/CIRCULATIONAHA.106.674804; O'Dowd Adrian, 2005, BMJ, V331, P129, DOI 10.1136/bmj.331.7509.129-b; Pickett MS, 2006, TOB CONTROL, V15, DOI 10.1136/tc.2005.015073; Royal College of Physicians, 2005, GOING SMOK FREE MED; Semple S, 2007, TOB CONTROL, V16, P127, DOI 10.1136/tc.2006.018119; Thaqi A, 2005, INDOOR AIR, V15, P302, DOI 10.1111/j.1600-0668.2005.00361.x	23	165	170	2	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2007	335	7619					545	+		10.1136/bmj.39311.550197.AE	http://dx.doi.org/10.1136/bmj.39311.550197.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215ED	17827487	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000249790200034
J	DeRoeck, D; Jodar, L; Clemens, J				DeRoeck, Denise; Jodar, Luis; Clemens, John			Perspective: Putting typhoid vaccination on the global health agenda	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FEVER		Int Vaccine Inst, Seoul, South Korea	International Vaccine Institute	DeRoeck, D (corresponding author), Int Vaccine Inst, Seoul, South Korea.							Acosta CJ, 2004, EXPERT OPIN BIOL TH, V4, P1939, DOI 10.1517/14712598.4.12.1939; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; *IN VACC RES, TYPH FEV; Ochiai RL, 2005, EMERG INFECT DIS, V11, P1764, DOI 10.3201/eid1111.050168	4	46	46	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2007	357	11					1069	1071		10.1056/NEJMp078144	http://dx.doi.org/10.1056/NEJMp078144			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	209KK	17855666				2022-12-01	WOS:000249387200001
J	Hopkins, AL; Witty, MJ; Nwaka, S				Hopkins, Andrew L.; Witty, Michael J.; Nwaka, Solomon			Mission possible	NATURE			English	Editorial Material							DRUG DISCOVERY; CHALLENGES; DISEASES		Pfizer Global Res & Dev, Sandwich, Kent, England; Pfizer Anim Hlth, Sandwich, Kent, England; WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland	Pfizer; Pfizer; World Health Organization	Hopkins, AL (corresponding author), Pfizer Global Res & Dev, Sandwich, Kent, England.		Hopkins, Andrew/H-5138-2011	Hopkins, Andrew/0000-0003-1977-018X				Bredel M, 2004, NAT REV GENET, V5, P262, DOI 10.1038/nrg1317; Chesbrough H., 2006, OPEN BUSINESS MODELS; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Munos B, 2006, NAT REV DRUG DISCOV, V5, P723, DOI 10.1038/nrd2131; Nwaka S, 2003, NAT REV DRUG DISCOV, V2, P919, DOI 10.1038/nrd1230; Nwaka S, 2006, NAT REV DRUG DISCOV, V5, P941, DOI 10.1038/nrd2144; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pink R, 2005, NAT REV DRUG DISCOV, V4, P727, DOI 10.1038/nrd1824; Ropars AL, 2005, NEW LANDSCAPE NEGLEC	10	42	47	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					166	169		10.1038/449166a	http://dx.doi.org/10.1038/449166a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851512				2022-12-01	WOS:000249394500036
J	Scanlon, TM; Caylor, KK; Levin, SA; Rodriguez-Iturbe, I				Scanlon, Todd M.; Caylor, Kelly K.; Levin, Simon A.; Rodriguez-Iturbe, Ignacio			Positive feedbacks promote power-law clustering of Kalahari vegetation	NATURE			English	Article							LOCAL INTERACTIONS; SPATIAL-PATTERNS; DYNAMICS; DISTURBANCE; SIGNATURES; SAVANNAS; ECOLOGY; FORESTS; AFRICA; MODEL	The concept of local-scale interactions driving large-scale pattern formation has been supported by numerical simulations, which have demonstrated that simple rules of interaction are capable of reproducing patterns observed in nature(1,2). These models of self-organization suggest that characteristic patterns should exist across a broad range of environmental conditions provided that local interactions do indeed dominate the development of community structure. Readily available observations that could be used to support these theoretical expectations, however, have lacked sufficient spatial extent or the necessary diversity of environmental conditions to confirm the model predictions. We use high-resolution satellite imagery to document the prevalence of self-organized vegetation patterns across a regional rainfall gradient in southern Africa, where percent tree cover ranges from 65% to 4%. Through the application of a cellular automata model, we find that the observed power-law distributions of tree canopy cluster sizes can arise from the interacting effects of global-scale resource constraints (that is, water availability) and local-scale facilitation. Positive local feedbacks result in power-law distributions without entailing threshold behaviour commonly associated with criticality. Our observations provide a framework for integrating a diverse suite of previous studies that have addressed either mean wet season rainfall or landscape-scale soil moisture variability as controls on the structural dynamics of arid and semi-arid ecosystems.	Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; Indiana Univ, Dept Geog, Bloomington, IN 47401 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA	University of Virginia; Indiana University System; Indiana University Bloomington; Princeton University; Princeton University	Scanlon, TM (corresponding author), Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA.	tms2v@virginia.edu	Scanlon, Todd M/B-8743-2008; Caylor, Kelly/ABF-2818-2020; Caylor, Kelly/B-7734-2008; Levin, Simon A/J-1218-2014	Caylor, Kelly/0000-0002-6466-6448; Caylor, Kelly/0000-0002-6466-6448; Levin, Simon A/0000-0002-8216-5639; Scanlon, Todd/0000-0001-8869-1675				AGUIAR MR, 1994, OIKOS, V70, P26, DOI 10.2307/3545695; ARCHER S, 1995, ECOSCIENCE, V2, P83, DOI 10.1080/11956860.1995.11682272; Asner GP, 2003, REMOTE SENS ENVIRON, V87, P521, DOI 10.1016/j.rse.2003.08.006; CALE WG, 1989, BIOSCIENCE, V39, P600, DOI 10.2307/1311089; Caylor KK, 2003, J ARID ENVIRON, V54, P281, DOI 10.1006/jare.2002.1090; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; GRASSBERGER P, 1993, J PHYS A-MATH GEN, V26, P2081, DOI 10.1088/0305-4470/26/9/007; Guichard F, 2003, AM NAT, V161, P889, DOI 10.1086/375300; Halley JM, 2004, ECOL LETT, V7, P254, DOI 10.1111/j.1461-0248.2004.00568.x; Holdo RM, 2005, PLANT ECOL, V180, P77, DOI 10.1007/s11258-005-2796-4; Katori M, 1998, FRACTALS, V6, P81, DOI 10.1142/S0218348X98000092; Keitt TH, 2000, LANDSCAPE ECOL, V15, P479, DOI 10.1023/A:1008193015770; KOCH GW, 1995, 36 INT GEOSPH BIOSPH; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Malamud BD, 1998, SCIENCE, V281, P1840, DOI 10.1126/science.281.5384.1840; Manrubia SC, 1997, J THEOR BIOL, V187, P159, DOI 10.1006/jtbi.1997.0409; Molofsky J, 2001, P ROY SOC B-BIOL SCI, V268, P273, DOI 10.1098/rspb.2000.1355; Nathan R, 2002, NATURE, V418, P409, DOI 10.1038/nature00844; Pascual M, 2005, TRENDS ECOL EVOL, V20, P88, DOI 10.1016/j.tree.2004.11.012; Pascual M, 2002, PHILOS T ROY SOC B, V357, P657, DOI 10.1098/rstb.2001.0983; Plotkin JB, 2002, AM NAT, V160, P629, DOI 10.1086/342823; Scanlon TM, 2002, REMOTE SENS ENVIRON, V82, P376, DOI 10.1016/S0034-4257(02)00054-8; Schlesinger WH, 1996, ECOLOGY, V77, P364, DOI 10.2307/2265615; Scholes RJ, 2002, J VEG SCI, V13, P419, DOI 10.1111/j.1654-1103.2002.tb02066.x; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; SOLE RV, 1995, J THEOR BIOL, V173, P31, DOI 10.1006/jtbi.1995.0040; Stauffer D., 1985, INTRO PERCOLATION TH; Wang GL, 2000, Q J ROY METEOR SOC, V126, P1261, DOI 10.1256/smsqj.56503; Wootton JT, 2001, NATURE, V413, P841, DOI 10.1038/35101595; Yeomans J. M., 1992, STAT MECH PHASE TRAN	30	277	286	4	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2007	449	7159					209	U4		10.1038/nature06060	http://dx.doi.org/10.1038/nature06060			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851523				2022-12-01	WOS:000249394500048
J	Emanuele, MJ; Stukenberg, PT				Emanuele, Michael J.; Stukenberg, P. Todd			Xenopus Cep57 is a novel kinetochore component involved in microtubule attachment	CELL			English	Article							BUDDING YEAST KINETOCHORE; TUBULIN RING COMPLEX; MITOTIC SPINDLE; EGG EXTRACTS; MOTOR ACTIVITIES; NDC80 COMPLEX; DASH COMPLEX; CENTROSOMES; ARCHITECTURE; NUCLEATION	For chromosomes to congress and segregate during cell division, kinetochores must form stable attachments with spindle microtubules. We find that the centrosome protein, xCep57, localizes to kinetochores and interacts with the kinetochore proteins Zwint, Mis12, and CLIP-170. Immunodepletion of xCep57 from egg extracts yields weakened and elongated bipolar spindles which fail to align chromosomes. In the absence of xCep57, tension is lost between sister kinetochores, and spindle microtubules are no longer resistant to low doses of nocodazole. xCep57 inhibition on isolated mitotic chromosomes inhibits kinetochore-microtubule binding in vitro. xCep57 also interacts with g-tubulin. In xCep57 immunodepleted extracts, sperm centrosomes nucleate with normal kinetics, but are unable maintain microtubule anchorage. This characterization places xCep57 in a novel class of proteins required for stable microtubule attachments at the kinetochore and at the centrosome and suggests that the mechanism of microtubule binding at these two places is mechanistically similar.	Univ Virginia, Dept Mol Genet & Biochem, Charlottesville, VA 22908 USA	University of Virginia	Stukenberg, PT (corresponding author), Univ Virginia, Dept Mol Genet & Biochem, Charlottesville, VA 22908 USA.	pts7h@virginia.edu		Stukenberg, Todd/0000-0002-6788-2111	NICHD NIH HHS [HD07528] Funding Source: Medline; NIGMS NIH HHS [R01GM063045-06] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063045] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Bossard C, 2003, NAT CELL BIOL, V5, P433, DOI 10.1038/ncb979; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cheeseman IM, 2001, J CELL BIOL, V152, P197, DOI 10.1083/jcb.152.1.197; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; Desai A, 1999, METHOD CELL BIOL, V61, P385; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Emanuele MJ, 2005, MOL BIOL CELL, V16, P4882, DOI 10.1091/mbc.E05-03-0239; Gaglio T, 1996, J CELL BIOL, V135, P399, DOI 10.1083/jcb.135.2.399; Gordon MB, 2001, J CELL BIOL, V152, P425, DOI 10.1083/jcb.152.3.425; HARLOW E, 1988, ANTIBIODIES LAB MANU; He XW, 2001, CELL, V106, P195, DOI 10.1016/S0092-8674(01)00438-X; Heald R, 1997, J CELL BIOL, V138, P615, DOI 10.1083/jcb.138.3.615; Hoffman DB, 2001, MOL BIOL CELL, V12, P1995, DOI 10.1091/mbc.12.7.1995; HYMAN AA, 1991, NATURE, V351, P206, DOI 10.1038/351206a0; Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Maresca TJ, 2005, CURR BIOL, V15, P1755, DOI 10.1016/j.cub.2005.08.049; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Miranda JJL, 2005, NAT STRUCT MOL BIOL, V12, P138, DOI 10.1038/nsmb896; MITCHISON TJ, 1985, J CELL BIOL, V101, P755, DOI 10.1083/jcb.101.3.755; MITCHISON TJ, 1985, J CELL BIOL, V101, P766, DOI 10.1083/jcb.101.3.766; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Salmon ED, 2005, CURR BIOL, V15, pR299, DOI 10.1016/j.cub.2005.04.005; SHAMU CE, 1992, J CELL BIOL, V117, P921, DOI 10.1083/jcb.117.5.921; Shang C, 2003, MOL BIOL CELL, V14, P3342, DOI 10.1091/mbc.E02-11-0765; Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771; Varmark H, 2004, J CELL BIOCHEM, V91, P904, DOI 10.1002/jcb.20013; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Wiese C, 2000, NAT CELL BIOL, V2, P358, DOI 10.1038/35014051; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; Wignall SM, 2001, METHOD CELL BIOL, V67, P241; Wittmann T, 1999, METHOD CELL BIOL, V61, P137; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; WORDEMAN L, 1991, J CELL BIOL, V114, P285, DOI 10.1083/jcb.114.2.285; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zimmerman W, 2000, TRAFFIC, V1, P927, DOI 10.1034/j.1600-0854.2000.011202.x	46	42	46	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2007	130	5					893	905		10.1016/j.cell.2007.07.023	http://dx.doi.org/10.1016/j.cell.2007.07.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	212GI	17803911	Bronze			2022-12-01	WOS:000249581500020
J	Hessell, AJ; Hangartner, L; Hunter, M; Havenith, CEG; Beurskens, FJ; Bakker, JM; Lanigan, CMS; Landucci, G; Forthal, DN; Parren, PWHI; Marx, PA; Burton, DR				Hessell, Ann J.; Hangartner, Lars; Hunter, Meredith; Havenith, Carin E. G.; Beurskens, Frank J.; Bakker, Joost M.; Lanigan, Caroline M. S.; Landucci, Gary; Forthal, Donald N.; Parren, Paul W. H. I.; Marx, Preston A.; Burton, Dennis R.			Fc receptor but not complement binding is important in antibody protection against HIV	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RHESUS MACAQUES; MONOCLONAL-ANTIBODY; NEUTRALIZING ANTIBODY; MEDIATED PROTECTION; DENDRITIC CELLS; IN-VITRO; TRANSMISSION; REPLICATION; CHALLENGE	Most successful vaccines elicit neutralizing antibodies and this property is a high priority when developing an HIV vaccine(1,2). Indeed, passively administered neutralizing antibodies have been shown to protect against HIV challenge in some of the best available animal models. For example, antibodies given intravenously can protect macaques against intravenous or mucosal SHIV (an HIV/SIV chimaera) challenge and topically applied antibodies can protect macaques against vaginal SHIV challenge(3,4). However, the mechanism(s) by which neutralizing antibodies afford protection against HIV is not understood and, in particular, the role of antibody Fc-mediated effector functions is unclear. Here we report that there is a dramatic decrease in the ability of a broadly neutralizing antibody to protect macaques against SHIV challenge when Fc receptor and complement-binding activities are engineered out of the antibody. No loss of antibody protective activity is associated with the elimination of complement binding alone. Our in vivo results are consistent with in vitro assays indicating that interaction of Fc-receptor-bearing effector cells with antibody-complexed infected cells is important in reducing virus yield from infected cells. Overall, the data suggest the potential importance of activity against both infected cells and free virus for effective protection against HIV.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA 70433 USA; Genmab, NL-3584 CM Utrecht, Netherlands; Univ Calif Irvine, Sch Med, Dept Med, Div Infect Dis, Irvine, CA 92697 USA	Scripps Research Institute; Scripps Research Institute; Tulane University; Genmab; University of California System; University of California Irvine	Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	burton@scripps.edu	Hangartner, Lars/AAS-1320-2021; Lima, Thaísa/AAG-6483-2021; Hangartner, Lars/H-3503-2011	Hangartner, Lars/0000-0002-3165-2058; Hessell, Ann/0000-0001-7471-9366; Parren, Paul/0000-0002-4365-3859				BALDRIDGE JR, 1992, J VIROL, V66, P4252, DOI 10.1128/JVI.66.7.4252-4257.1992; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2000, VIROLOGY, V270, P237, DOI 10.1006/viro.2000.0254; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; DEMBERG T, 2006, RETROVIROLOGY S1, V3, pS26; Florese RH, 2006, J IMMUNOL, V177, P4028, DOI 10.4049/jimmunol.177.6.4028; Forthal DN, 2006, J VIROL, V80, P9217, DOI 10.1128/JVI.02746-05; Gauduin MC, 1998, AIDS RES HUM RETROV, V14, P205, DOI 10.1089/aid.1998.14.205; Gomez-Roman VR, 2005, J IMMUNOL, V174, P2185, DOI 10.4049/jimmunol.174.4.2185; Harouse JM, 1999, SCIENCE, V284, P816, DOI 10.1126/science.284.5415.816; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Holl V, 2006, BLOOD, V107, P4466, DOI 10.1182/blood-2005-08-3490; Holl V, 2006, J VIROL, V80, P6177, DOI 10.1128/JVI.02625-05; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Klasse PJ, 2002, J GEN VIROL, V83, P2091, DOI 10.1099/0022-1317-83-9-2091; Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084; Mascola JR, 2002, VACCINE, V20, P1922, DOI 10.1016/S0264-410X(02)00068-3; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Parren PWHI, 2001, ADV IMMUNOL, V77, P195, DOI 10.1016/S0065-2776(01)77018-6; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; Tan RCH, 1999, J MED PRIMATOL, V28, P164, DOI 10.1111/j.1600-0684.1999.tb00265.x; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zwick MB, 2001, J VIROL, V75, P6692, DOI 10.1128/JVI.75.14.6692-6699.2001	30	710	768	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2007	449	7158					101	U75		10.1038/nature06106	http://dx.doi.org/10.1038/nature06106			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207ED	17805298				2022-12-01	WOS:000249233500044
J	Frank, RG				Frank, Richard G.			Regulation of follow-on biologics	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Frank, RG (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							CAREY S, 2002, WALL STREET J   0430; *IMS HLTH, IMS REP US PRESCR SA; *OFF TECHN ASS, 1993, PHARM R D COSTS RISK; *PHARM RES MAN AM, 2007, PHARM IND PROF 2007; Reiffen D, 2005, REV ECON STAT, V87, P37, DOI 10.1162/0034653053327694	5	30	30	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 30	2007	357	9					841	843		10.1056/NEJMp078095	http://dx.doi.org/10.1056/NEJMp078095			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	204TA	17761588				2022-12-01	WOS:000249065700001
J	Koh, LP; Wilcove, DS				Koh, Lian Pin; Wilcove, David S.			Cashing in palm oil for conservation	NATURE			English	Editorial Material									Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	Princeton University; Princeton University	Koh, LP (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.		Koh, Lian Pin/A-5794-2010	Koh, Lian Pin/0000-0001-8152-3871; Wilcove, David S./0000-0002-1354-0503				BILLINGTON C, 1996, ESTIMATED ORIGINAL F; Corley R. H. V., 2006, Planter, V82, P121; Corley R.H.V, 2003, OIL PALM; *FAO, 2006, FAOSTAT ONL STAT SER; FAO, 2005, 147 FAO; IREMONGER S, 1997, GLOBAL OVERVIEW FORE; *IUCN WORLD CONS U, 2006, IUCN RED LIST THREAT; Langholz J, 1996, CONSERV BIOL, V10, P271, DOI 10.1046/j.1523-1739.1996.10010271.x; *WORLD BANK, 2006, WORLD DEV IND ONL	9	167	172	0	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2007	448	7157					993	994		10.1038/448993a	http://dx.doi.org/10.1038/448993a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205EU	17728739				2022-12-01	WOS:000249097600016
J	Kinseth, MA; Anjard, C; Fuller, D; Guizzunti, G; Loomis, WF; Malhotra, V				Kinseth, Matthew A.; Anjard, Christophe; Fuller, Danny; Guizzunti, Gianni; Loomis, William F.; Malhotra, Vivek			The golgi-associated protein GRASP is required for unconventional protein secretion during development	CELL			English	Article							DICTYOSTELIUM-DISCOIDEUM; MAMMALIAN-CELLS; TERMINAL DIFFERENTIATION; PLASMA-MEMBRANE; SPORE DIFFERENTIATION; COMPLEX; STACKING; FRAGMENTATION; CISTERNAE; PATHWAYS	During Dictyostelium development, prespore cells secrete acyl-CoA binding protein (AcbA). Upon release, AcbA is processed to generate a peptide called spore differentiation factor-2 (SDF-2), which triggers terminal differentiation of spore cells. We have found that cells lacking Golgi reassembly stacking protein (GRASP), a protein attached peripherally to the cytoplasmic surface of Golgi membranes, fail to secrete AcbA and, thus, produce inviable spores. Surprisingly, AcbA lacks a signal sequence and is not secreted via the conventional secretory pathway (endoplasmic reticulum-Golgi-cell surface). GRASP is not required for conventional protein secretion, growth, and the viability of vegetative cells. Our findings reveal a physiological role of GRASP and provide a means to understand unconventional secretion and its role in development.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Malhotra, V (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	vivek@biomail.ucsd.edu	Malhotra, Vivek/O-9811-2014; Anjard, Christophe/H-5012-2017	Malhotra, Vivek/0000-0001-6198-7943; Anjard, Christophe/0000-0002-6905-1493	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078175] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53747, GM46224, GM78175] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anjard C, 2005, P NATL ACAD SCI USA, V102, P7607, DOI 10.1073/pnas.0501820102; Anjard C, 2002, EUKARYOT CELL, V1, P643, DOI 10.1128/EC.1.4.643-652.2002; Anjard C, 1998, DEV BIOL, V193, P146, DOI 10.1006/dbio.1997.8804; Anjard C, 1997, DIFFERENTIATION, V62, P43, DOI 10.1046/j.1432-0436.1997.6210043.x; Anjard C, 2006, DEVELOPMENT, V133, P2253, DOI 10.1242/dev.02399; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Behnia R, 2007, J CELL BIOL, V176, P255, DOI 10.1083/jcb.200607151; Brock DA, 2005, DEVELOPMENT, V132, P4553, DOI 10.1242/dev.02032; Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X; Colanzi A, 2007, EMBO J, V26, P2465, DOI 10.1038/sj.emboj.7601686; DEVINE KM, 1983, DEV BIOL, V99, P437, DOI 10.1016/0012-1606(83)90293-2; FARQUHAR MG, 1981, J CELL BIOL, V91, P77; Feinstein TN, 2007, MOL BIOL CELL, V18, P594, DOI 10.1091/mbc.E06-06-0530; FIEGER O, 2003, FEBS LETT, V551, P78; Good JR, 2003, DEVELOPMENT, V130, P2953, DOI 10.1242/dev.00523; GUIDOTTI A, 1983, P NATL ACAD SCI-BIOL, V80, P3531, DOI 10.1073/pnas.80.11.3531; HUYER G, 2006, CELL, V5, P1560; Kondylis V, 2005, MOL BIOL CELL, V16, P4061, DOI 10.1091/mbc.E04-10-0938; Metcalf T, 2003, MICROBIOL-SGM, V149, P305, DOI 10.1099/mic.0.25984-0; MIERENDORF RC, 1985, J CELL BIOL, V100, P1777, DOI 10.1083/jcb.100.5.1777; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Norman TC, 1999, SCIENCE, V285, P591, DOI 10.1126/science.285.5427.591; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Schafer T, 2004, J BIOL CHEM, V279, P6244, DOI 10.1074/jbc.M310500200; Schneider N, 2000, BIOL CELL, V92, P495, DOI 10.1016/S0248-4900(00)01102-3; Seelenmeyer C, 2005, J CELL BIOL, V171, P373, DOI 10.1083/jcb.200506026; Shaulsky G, 1996, DEV BIOL, V174, P214, DOI 10.1006/dbio.1996.0067; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Sim KL, 2002, MOL CELL PROTEOMICS, V1, P983, DOI 10.1074/mcp.M200032-MCP200; SPRAGUE GF, 1991, METHOD ENZYMOL, V194, P77; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; Stegmayer C, 2005, J CELL SCI, V118, P517, DOI 10.1242/jcs.01645; Struck NS, 2005, J CELL SCI, V118, P5603, DOI 10.1242/jcs.02673; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Sutterlin C, 2005, MOL BIOL CELL, V16, P3211, DOI 10.1091/mbc.E04-12-1065; VOLLRATH D, 1988, P NATL ACAD SCI USA, V85, P6027, DOI 10.1073/pnas.85.16.6027; Wang N, 1999, MOL CELL BIOL, V19, P4750; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; West CM, 2003, INT REV CYTOL, V222, P237; WOOD L, 1985, J CELL BIOL, V101, P2063, DOI 10.1083/jcb.101.6.2063; Yoshimura S, 2005, J BIOL CHEM, V280, P23048, DOI 10.1074/jbc.M502442200; Zhou Y, 2007, CELL, V129, P163, DOI 10.1016/j.cell.2007.02.037	45	176	180	1	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2007	130	3					524	534		10.1016/j.cell.2007.06.029	http://dx.doi.org/10.1016/j.cell.2007.06.029			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17655921	Bronze			2022-12-01	WOS:000249038100019
J	Boutet, SC; Disatnik, MH; Chan, LS; Iori, K; Rando, TA				Boutet, Stephane C.; Disatnik, Marie-Helene; Chan, Lauren S.; Iori, Kevin; Rando, Thomas A.			Regulation of Pax3 by proteasomal degradation of monoubiquitinated protein in skeletal muscle progenitors	CELL			English	Article							MULTIUBIQUITIN-CHAIN; MET RECEPTOR; UBA DOMAINS; UBIQUITIN; BINDING; SUBUNIT; CELLS; EXPRESSION; MIGRATION; KINASE	Pax3 and Pax7 play distinct but overlapping roles in developmental and postnatal myogenesis. The mechanisms involved in the differential regulation of these highly homologous proteins are unknown. We present evidence that Pax3, but not Pax7, is regulated by ubiquitination and proteasomal degradation during adult muscle stem cell activation. Intriguingly, only monoubiquitinated forms of Pax3 could be detected. Mutation of two specific lysine residues in the C-terminal region of Pax3 reduced the extent of its monoubiquitination and susceptibility to proteasomal degradation, whereas introduction of a key lysine into the C-terminal region of Pax7 rendered that protein susceptible to monoubiquitination and proteasomal degradation. Monoubiquitinated Pax3 was shuttled to the intrinsic proteasomal protein S5a by interacting specifically with the ubiquitin-binding protein Rad23B. Functionally, sustained expression of Pax3 proteins inhibited myogenic differentiation, demonstrating that Pax3 degradation is an essential step for the progression of the myogenic program. These results reveal an important mechanism of Pax3 regulation in muscle progenitors and an unrecognized role of protein monoubiquitination in mediating proteasomal degradation.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, GRECC, Palo Alto, CA 34304 USA; Vet Affairs Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA 94304 USA	Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	rando@stanford.edu		Rando, Thomas/0000-0001-5843-8564	NATIONAL INSTITUTE ON AGING [R37AG023806, R01AG023806] Funding Source: NIH RePORTER; NIA NIH HHS [AG23806] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Barr FG, 2001, ONCOGENE, V20, P5736, DOI 10.1038/sj.onc.1204599; Bennicelli JL, 1999, ONCOGENE, V18, P4348, DOI 10.1038/sj.onc.1202812; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; BOBER E, 1994, DEVELOPMENT, V120, P603; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Coffino P, 2001, BIOCHIMIE, V83, P319, DOI 10.1016/S0300-9084(01)01252-4; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; HERSHKO A, 1991, J BIOL CHEM, V266, P16376; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; Janse DM, 2004, J BIOL CHEM, V279, P21415, DOI 10.1074/jbc.M402954200; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Quach NL, 2006, DEV BIOL, V293, P38, DOI 10.1016/j.ydbio.2005.12.040; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Yang XM, 1996, DEVELOPMENT, V122, P2163; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461	43	145	148	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					349	362		10.1016/j.cell.2007.05.044	http://dx.doi.org/10.1016/j.cell.2007.05.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662948	Bronze			2022-12-01	WOS:000248588000023
J	Chen, MH; Wilson, CW; Chuang, PT				Chen, Miao-Hsueh; Wilson, Christopher W.; Chuang, Pao-Tien			SnapShot: Hedgehog signaling pathway	CELL			English	Editorial Material							MECHANISM; TRANSDUCTION; DIVERGENCE; DROSOPHILA		Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Chen, MH (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.			Chen, Miao-Hsueh/0000-0002-9715-3067				Davey MG, 2006, GENE DEV, V20, P1365, DOI 10.1101/gad.369106; Eaton S, 2006, CURR OPIN GENET DEV, V16, P17, DOI 10.1016/j.gde.2005.12.006; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gonzalez-Quevedo R, 2005, J CELL BIOL, V168, P453, DOI 10.1083/jcb.200409078; Guerrero I, 2007, TRENDS CELL BIOL, V17, P1, DOI 10.1016/j.tcb.2006.11.002; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Incardona JP, 2002, CURR BIOL, V12, P983, DOI 10.1016/S0960-9822(02)00895-3; Jia J, 2006, CELL MOL LIFE SCI, V63, P1249, DOI 10.1007/s00018-005-5519-z; Kalderon D, 2005, BIOCHEM SOC T, V33, P1509, DOI 10.1042/BST0331509; Lu XW, 2006, GENE DEV, V20, P2539, DOI 10.1101/gad.1461306; Nieuwenhuis E, 2005, CLIN GENET, V67, P193, DOI 10.1111/j.1399-0004.2004.00360.x; Ogden SK, 2004, BIOCHEM PHARMACOL, V67, P805, DOI 10.1016/j.bcp.2004.01.002; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wilson CW, 2006, CELL, V125, P435, DOI 10.1016/j.cell.2006.04.016	17	24	28	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2007	130	2					386	U26	e1	10.1016/j.cell.2007.07.017	http://dx.doi.org/10.1016/j.cell.2007.07.017			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662951	Bronze			2022-12-01	WOS:000248588000028
J	Guenther, MG; Levine, SS; Boyer, LA; Jaenisch, R; Young, RA				Guenther, Matthew G.; Levine, Stuart S.; Boyer, Laurie A.; Jaenisch, Rudolf; Young, Richard A.			A chromatin landmark and transcription initiation at most promoters in human cells	CELL			English	Article							RNA-POLYMERASE-II; EMBRYONIC STEM-CELLS; HISTONE H3; SACCHAROMYCES-CEREVISIAE; ACTIVE GENES; HIV-1 TAT; IN-VIVO; METHYLATION; ELONGATION; METHYLTRANSFERASE	We describe the results of a genome- wide analysis of human cells that suggests that most protein- coding genes, including most genes thought to be transcriptionally inactive, experience transcription initiation. We found that nucleosomes with H3K4me3 and H3K9,14Ac modifications, together with RNA polymerase II, occupy the promoters of most protein- coding genes in human embryonic stem cells. Only a subset of these genes produce detectable full- length transcripts and are occupied by nucleosomes with H3K36me3 modifications, a hallmark of elongation. The other genes experience transcription initiation but show no evidence of elongation, suggesting that they are predominantly regulated at post-initiation steps. Genes encoding most developmental regulators fall into this group. Our results also identify a class of genes that are excluded from experiencing transcription initiation, at which mechanisms that prevent initiation must predominate. These observations extend to differentiated cells, suggesting that transcription initiation at most genes is a general phenomenon in human cells.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Levine, Stuart/0000-0001-7363-562X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG002668, R01 HG002668-04A1, R01 HG002668] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Brandenberger Ralph, 2004, BMC Developmental Biology, V4, P1; Brinkman AB, 2006, EMBO REP, V7, P628, DOI 10.1038/sj.embor.7400686; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; Dvir A, 2002, BBA-GENE STRUCT EXPR, V1577, P208, DOI 10.1016/S0167-4781(02)00453-0; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; KRUMM A, 1993, BIOESSAYS, V15, P659, DOI 10.1002/bies.950151005; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; LASPIA MF, 1993, J MOL BIOL, V232, P732, DOI 10.1006/jmbi.1993.1427; Law A, 1998, NUCLEIC ACIDS RES, V26, P919, DOI 10.1093/nar/26.4.919; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Mayhall EA, 2004, CURR OPIN CELL BIOL, V16, P713, DOI 10.1016/j.ceb.2004.09.007; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Parada CA, 1999, EMBO J, V18, P3688, DOI 10.1093/emboj/18.13.3688; Pera MF, 2004, DEVELOPMENT, V131, P5515, DOI 10.1242/dev.01451; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ptashne M, 1986, GENETIC SWITCH; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tenney K, 2005, J CELL BIOCHEM, V95, P429, DOI 10.1002/jcb.20421; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Wei CL, 2005, STEM CELLS, V23, P166, DOI 10.1634/stemcells.2004-0162; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503	61	1456	1497	1	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2007	130	1					77	88		10.1016/j.cell.2007.05.042	http://dx.doi.org/10.1016/j.cell.2007.05.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632057	Bronze, Green Accepted			2022-12-01	WOS:000248587000012
J	De Wals, P; Tairou, F; Van Allen, MI; Uh, S; Lowry, R B; Sibbald, B; Evans, JA; Van den Hof, MC; Zimmer, P; Crowley, M; Fernandez, B; Lee, NS; Niyonsenga, T				De Wals, Philippe; Tairou, Fassiatou; Van Allen, Margot I.; Uh, Soo-Hong; Lowry, R. Brian; Sibbald, Barbara; Evans, Jane A.; Van den Hof, Michiel C.; Zimmer, Pamela; Crowley, Marian; Fernandez, Bridget; Lee, Nora S.; Niyonsenga, Theophile			Reduction in neural-tube defects after folic acid fortification in Canada	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOOD FORTIFICATION; AFFECTED PREGNANCIES; FOLATE; WOMEN; PREVALENCE; DIAGNOSIS; RISK; AGE	BACKGROUND: In 1998, folic acid fortification of a large variety of cereal products became mandatory in Canada, a country where the prevalence of neural-tube defects was historically higher in the eastern provinces than in the western provinces. We assessed changes in the prevalence of neural-tube defects in Canada before and after food fortification with folic acid was implemented. METHODS: The study population included live births, stillbirths, and terminations of pregnancies because of fetal anomalies among women residing in seven Canadian provinces from 1993 to 2002. On the basis of published results of testing of red-cell folate levels, the study period was divided into prefortification, partial-fortification, and full-fortification periods. We evaluated the relationship between baseline rates of neural-tube defects in each province and the magnitude of the decrease after fortification was implemented. RESULTS: A total of 2446 subjects with neural-tube defects were recorded among 1.9 million births. The prevalence of neural-tube defects decreased from 1.58 per 1000 births before fortification to 0.86 per 1000 births during the full-fortification period, a 46% reduction (95% confidence interval, 40 to 51). The magnitude of the decrease was proportional to the prefortification baseline rate in each province, and geographical differences almost disappeared after fortification began. The observed reduction in rate was greater for spina bifida (a decrease of 53%) than for anencephaly and encephalocele (decreases of 38% and 31%, respectively). CONCLUSIONS: Food fortification with folic acid was associated with a significant reduction in the rate of neural-tube defects in Canada. The decrease was greatest in areas in which the baseline rate was high.	Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ G1K 7P4, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; British Columbia Minist Hlth, Victoria, BC, Canada; Alberta Hlth & Wellness, Calgary, AB, Canada; Univ Manitoba, Winnipeg, MB, Canada; Dalhousie Univ, Halifax, NS, Canada; IWK Hlth Ctr, Halifax, NS, Canada; Hlth Sci Ctr, St John, NF, Canada; Hlth Canada, Food Directorate, Ottawa, ON K1A 0L2, Canada; Florida Int Univ, Robert Stempel Sch Publ Hlth, Miami, FL 33199 USA	Laval University; University of British Columbia; Alberta Health Services (AHS); University of Manitoba; Dalhousie University; Dalhousie University; Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba; Health Canada; State University System of Florida; Florida International University	De Wals, P (corresponding author), Univ Laval, Dept Med Sociale & Prevent, Pavillon Est,Local 1110,2180 Chemin St Foy, Quebec City, PQ G1K 7P4, Canada.	dewals@msp.ulaval.ca	Niyonsenga, Theo/C-3759-2014	Niyonsenga, Theo/0000-0002-6723-0316; , Fassiatou O./0000-0002-9410-4278				Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; Caudill MA, 1997, J NUTR, V127, P2363, DOI 10.1093/jn/127.12.2363; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P362; CRANE JMG, 2001, J SOC OBSTET GYNAECO, V23, P510; De Wals P, 1999, CAN J PUBLIC HEALTH, V90, P237, DOI 10.1007/BF03404123; De Wals P, 2003, BIRTH DEFECTS RES A, V67, P919, DOI 10.1002/bdra.10124; Food and Nutrition Board, 1998, DIET REF INT THIAM R, P196; French MR, 2003, J AM DIET ASSOC, V103, P181, DOI 10.1053/jada.2003.50062; House JD, 2006, CAN J PUBLIC HEALTH, V97, P132, DOI 10.1007/BF03405331; LEMIRE RJ, 1988, JAMA-J AM MED ASSOC, V259, P558, DOI 10.1001/jama.259.4.558; LITTLE J, 1992, EPIDEMIOLOGY CONTROL, P92; Liu Shiliang, 2004, BMC Pregnancy Childbirth, V4, P20, DOI 10.1186/1471-2393-4-20; Morin P, 2002, PREV MED, V35, P143, DOI 10.1006/pmed.2002.1041; Morin P, 2002, CAN J PUBLIC HEALTH, V93, P259, DOI 10.1007/BF03405012; NEVIN NC, 1983, ILLUSTRATED GUIDE MA; Pacheco-Jacome E, 2003, NEUROIMAG CLIN N AM, V13, P327, DOI 10.1016/S1052-5149(03)00028-5; Persad VL, 2002, CAN MED ASSOC J, V167, P241; Quinlivan EP, 2003, AM J CLIN NUTR, V77, P221, DOI 10.1093/ajcn/77.1.221; Ray JG, 2002, LANCET, V360, P2047, DOI 10.1016/S0140-6736(02)11994-5; Ray JG, 2002, EPIDEMIOLOGY, V13, P238, DOI 10.1097/00001648-200203000-00026; Ray JG, 2002, CAN J PUBLIC HEALTH, V93, P249, DOI 10.1007/BF03405010; Morris MS, 2007, AM J CLIN NUTR, V85, P193, DOI 10.1093/ajcn/85.1.193; Shaw GM, 1996, JAMA-J AM MED ASSOC, V275, P1093, DOI 10.1001/jama.275.14.1093; Tairou Fassiatou, 2006, Chronic Dis Can, V27, P120; Van Allen MI, 2006, J APPL GENET, V47, P151, DOI 10.1007/BF03194615; Velie EM, 2006, PAEDIATR PERINAT EP, V20, P219, DOI 10.1111/j.1365-3016.2006.00722.x	27	557	569	1	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 12	2007	357	2					135	142		10.1056/NEJMoa067103	http://dx.doi.org/10.1056/NEJMoa067103			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	188NX	17625125				2022-12-01	WOS:000247927700007
J	Rowland, HM; Ihalainen, E; Lindstrom, L; Mappes, J; Speed, MP				Rowland, Hannah M.; Ihalainen, Eira; Lindstrom, Leena; Mappes, Johanna; Speed, Michael P.			Co-mimics have a mutualistic relationship despite unequal defences	NATURE			English	Article							MULLERIAN MIMICRY; NATURAL-SELECTION; PHYLOGENETIC EVIDENCE; ALTERNATIVE PREY; WARNING-COLOR; EVOLUTION; PREDATION; DYNAMICS; MODEL	In the first clear mathematical treatment of natural selection, Muller(1) proposed that a shared warning signal ( mimicry) would benefit defended prey species by sharing out the per capita mortality incurred during predator education. Although mimicry is a mainstay of adaptationist thinking, there has been repeated debate on whether there is a mutualistic or a parasitic relationship between unequally defended co-mimic species(2-5). Here we show that the relationship between unequally defended species is mutualistic. We examined this in a 'novel world'(6) of artificial prey with wild predators ( great tit, Parus major). We kept the abundance of a highly defended prey ('model') constant and increased the density of a moderately defended prey ('defended mimic') of either perfect or imperfect mimetic resemblance to the model. Both model and defended mimic showed a net benefit from a density-dependent decrease in their per capita mortality. Even when the effect of dilution through density was controlled for, defended mimics did not induce additional attacks on the model, but we found selection for accurate signal mimicry. In comparison, the addition of fully edible (batesian) mimics did increase additional attacks on the model, but as a result of dilution this resulted in no overall increase in per capita mortality. By ignoring the effects of density, current theories may have overestimated the parasitic costs imposed by less defended mimics on highly defended models.	Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland	University of Liverpool; University of Jyvaskyla	Rowland, HM (corresponding author), Univ Liverpool, Sch Biol Sci, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	h.m.rowland@liv.ac.uk	Lindstrom, Leena/B-2326-2012; Mappes, Johanna/AAZ-3627-2021; Rowland, Hannah/D-8114-2012	Lindstrom, Leena/0000-0002-6452-4538; Rowland, Hannah/0000-0002-1040-555X; Mappes, Johanna/0000-0002-1117-5629				Alatalo RV, 1996, NATURE, V382, P708, DOI 10.1038/382708a0; Bates HW, 1862, T LINN SOC LONDON, V23, P495, DOI [10.1111/j.1096-3642.1860.tb00146.x, DOI 10.1111/J.1096-3642.1860.TB00146.X]; BENSON WW, 1972, SCIENCE, V176, P936, DOI 10.1126/science.176.4037.936; DIXEY FA, 1919, REP BR ASS ADVMT SCI, P199; Dumbacher JP, 2001, P ROY SOC B-BIOL SCI, V268, P1971, DOI 10.1098/rspb.2001.1717; Fisher R., 2005, TEACHING CHILDREN TH; HUHEEY J E, 1988, American Naturalist, V131, pS22, DOI 10.1086/284765; HUHEEY JE, 1980, J HERPETOL, V14, P223, DOI 10.2307/1563543; Ihalainen E, 2007, J EVOLUTION BIOL, V20, P780, DOI 10.1111/j.1420-9101.2006.01234.x; Kapan DD, 2001, NATURE, V409, P338, DOI 10.1038/35053066; Kokko H, 2003, ECOL LETT, V6, P1068, DOI 10.1046/j.1461-0248.2003.00532.x; Lindstrom L, 2001, P NATL ACAD SCI USA, V98, P9181, DOI 10.1073/pnas.161071598; Lindstrom L, 2006, ANIM BEHAV, V72, P323, DOI 10.1016/j.anbehav.2005.10.015; Lindstrom L, 2004, EVOLUTION, V58, P1294, DOI 10.1554/03-271; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Mallet J, 1999, EVOL ECOL, V13, P777, DOI 10.1023/A:1011060330515; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; Marshall G. A. K., 1908, T ENTOMOLOGICAL SOC, V1908, P93; Mualler F., 1878, ZOOL ANZ, V1, P54; NONACS P, 1985, AM NAT, V126, P165, DOI 10.1086/284407; OWEN RE, 1984, J THEOR BIOL, V109, P217, DOI 10.1016/S0022-5193(84)80004-1; Rowe C, 2004, P ROY SOC B-BIOL SCI, V271, P407, DOI 10.1098/rspb.2003.2615; SHEPPARD PM, 1959, COLD SPRING HARB SYM, V24, P131, DOI 10.1101/SQB.1959.024.01.013; SHEPPARD PM, 1975, NATURAL SELECTION HE; Sherratt TN, 2004, J THEOR BIOL, V228, P217, DOI 10.1016/j.jtbi.2003.12.009; Sherratt TN, 2003, OIKOS, V103, P93, DOI 10.1034/j.1600-0706.2003.12576.x; SPEED MP, 1993, ANIM BEHAV, V45, P571, DOI 10.1006/anbe.1993.1067; Speed MP, 2000, P ROY SOC B-BIOL SCI, V267, P725, DOI 10.1098/rspb.2000.1063; Speed MP, 1999, EVOL ECOL, V13, P755, DOI 10.1023/A:1010871106763; Symula R, 2001, P ROY SOC B-BIOL SCI, V268, P2415, DOI 10.1098/rspb.2001.1812	30	114	114	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					64	67		10.1038/nature05899	http://dx.doi.org/10.1038/nature05899			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17611539				2022-12-01	WOS:000247720900038
J	John, M; Constien, R; Akinc, A; Goldberg, M; Moon, YA; Spranger, M; Hadwiger, P; Soutschek, J; Vornlocher, HP; Manoharan, M; Stoffel, M; Langer, R; Anderson, DG; Horton, JD; Koteliansky, V; Bumcrot, D				John, Matthias; Constien, Rainer; Akinc, Akin; Goldberg, Michael; Moon, Young-Ah; Spranger, Martina; Hadwiger, Philipp; Soutschek, Juergen; Vornlocher, Hans-Peter; Manoharan, Muthiah; Stoffel, Markus; Langer, Robert; Anderson, Daniel G.; Horton, Jay D.; Koteliansky, Victor; Bumcrot, David			Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway	NATURE			English	Article							IN-VIVO; MICE; INTERFERENCE	Systemic administration of synthetic small interfering RNAs (siRNAs) effectively silences hepatocyte gene expression in rodents and primates(1-3). Whether or not in vivo gene silencing by synthetic siRNA can disrupt the endogenous microRNA (miRNA) pathway remains to be addressed. Here we show that effective target-gene silencing in the mouse and hamster liver can be achieved by systemic administration of synthetic siRNA without any demonstrable effect on miRNA levels or activity. Indeed, siRNA targeting two hepatocyte-specific genes (apolipoprotein B and factor VII) that achieved efficient (80%) silencing of messenger RNA transcripts and a third irrelevant siRNA control were administered to mice without significant changes in the levels of three hepatocyte-expressed miRNAs (miR-122, miR-16 and let-7a) or an effect on miRNA activity. Moreover, multiple administrations of an siRNA targeting the hepatocyte-expressed gene Scap in hamsters achieved long-term mRNA silencing without significant changes in miR-122 levels. This study advances the use of siRNAs as safe and effective tools to silence gene transcripts in animal studies, and supports the continued advancement of RNA interference therapeutics using synthetic siRNA.	Alnylam Pharmaceut Inc, Cambridge, MA 02142 USA; Alnylam Europe AG, D-95326 Kulmbach, Germany; MIT, Dept Chem, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; ETH, Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bumcrot, D (corresponding author), Alnylam Pharmaceut Inc, 300 3rd St, Cambridge, MA 02142 USA.	dbumcrot@alnylam.com		Stoffel, Markus/0000-0003-1304-5817	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000244, R01EB000244] Funding Source: NIH RePORTER; NIBIB NIH HHS [R01 EB000244, R01 EB000244-27, R37 EB000244] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		AKINC A, UNPUB NATURE BIOTECH; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Narvaiza I, 2006, J VIROL, V80, P12236, DOI 10.1128/JVI.01205-06; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	12	116	145	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2007	449	7163					745	U12		10.1038/nature06179	http://dx.doi.org/10.1038/nature06179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218VV	17898712	Green Accepted			2022-12-01	WOS:000250045000049
J	Yan, CT; Boboila, C; Souza, EK; Franco, S; Hickernell, TR; Murphy, M; Gumaste, S; Geyer, M; Zarrin, AA; Manis, JP; Rajewsky, K; Alt, FW				Yan, Catherine T.; Boboila, Cristian; Souza, Ellen Kris; Franco, Sonia; Hickernell, Thomas R.; Murphy, Michael; Gumaste, Sunil; Geyer, Mark; Zarrin, Ali A.; Manis, John P.; Rajewsky, Klaus; Alt, Frederick W.			IgH class switching and translocations use a robust non-classical end-joining pathway	NATURE			English	Article							DOUBLE-STRAND BREAK; DNA-LIGASE-IV; MAMMALIAN-CELLS; V(D)J RECOMBINATION; REPAIR; XRCC4; MICE; LYMPHOCYTES; PROTEINS; REGIONS	Immunoglobulin variable region exons are assembled in developing B cells by V(D)J recombination. Once mature, these cells undergo class-switch recombination (CSR) when activated by antigen. CSR changes the heavy chain constant region exons (CH) expressed with a given variable region exon from Cm to a downstream CH (for example, C gamma, C epsilon or C alpha), thereby switching expression from IgM to IgG, IgE or IgA. Both V(D)J recombination and CSR involve the introduction of DNA double-strand breaks and their repair by means of end joining(1,2). For CSR, double-strand breaks are introduced into switch regions that flank Cm and a downstream CH, followed by fusion of the broken switch regions(1). In mammalian cells, the 'classical' non-homologous end joining (C-NHEJ) pathway repairs both general DNA double-strand breaks and programmed double-strand breaks generated by V(D)J recombination(2,3). C-NHEJ, as observed during V(D)J recombination, joins ends that lack homology to form 'direct' joins, and also joins ends with several base-pair homologies to form microhomology joins(3,4). CSR joins also display direct and microhomology joins, and CSR has been suggested to use C-NHEJ(5-8). Xrcc4 and DNA ligase IV (Lig4), which cooperatively catalyse the ligation step of C-NHEJ, are the most specific C-NHEJ factors; they are absolutely required for V(D)J recombination and have no known functions other than C-NHEJ(2). Here we assess whether C-NHEJ is also critical for CSR by assaying CSR in Xrcc4- or Lig4-deficient mouse B cells. C-NHEJ indeed catalyses CSR joins, because C-NHEJ-deficient B cells had decreased CSR and substantial levels of IgH locus (immunoglobulin heavy chain, encoded by Igh) chromosomal breaks. However, an alternative end-joining pathway, which is markedly biased towards microhomology joins, supports CSR at unexpectedly robust levels in C-NHEJ-deficient B cells. In the absence of C-NHEJ, this alternative end-joining pathway also frequently joins Igh locus breaks to other chromosomes to generate translocations.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Alt, FW (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu	Geyer, Mark/AAK-7720-2020; Hickernell, Thomas/ABG-2642-2021	Hickernell, Thomas/0000-0003-0897-8487; Rajewsky, Klaus/0000-0002-6633-6370; Geyer, Mark/0000-0001-5248-9117	NCI NIH HHS [P01 CA092625] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA092625] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Bryans M, 1999, MUTAT RES-DNA REPAIR, V433, P53, DOI 10.1016/S0921-8777(98)00063-9; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Chen S, 2001, J BIOL CHEM, V276, P24323, DOI 10.1074/jbc.M010544200; Daley JM, 2005, MOL CELL BIOL, V25, P896, DOI 10.1128/MCB.25.3.896-906.2005; Ehrenstein MR, 2001, P NATL ACAD SCI USA, V98, P14553, DOI 10.1073/pnas.241525998; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Gu JF, 2007, EMBO J, V26, P1010, DOI 10.1038/sj.emboj.7601559; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Jones KR, 2005, MOL CANCER THER, V4, P1541, DOI 10.1158/1535-7163.MCT-05-0193; Kabotyanski EB, 1998, NUCLEIC ACIDS RES, V26, P5333, DOI 10.1093/nar/26.23.5333; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; Manis JP, 2002, IMMUNITY, V16, P607, DOI 10.1016/S1074-7613(02)00306-0; Pan-Hammarstrom Q, 2005, J EXP MED, V201, P189, DOI 10.1084/jem.20040772; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Roth DB, 2003, NAT REV IMMUNOL, V3, P656, DOI 10.1038/nri1152; Roth DB, 2002, MOL CELL, V10, P1, DOI 10.1016/S1097-2765(02)00573-7; Schrader CE, 2002, J EXP MED, V195, P367, DOI 10.1084/jem.20011877; Verkaik NS, 2002, EUR J IMMUNOL, V32, P701, DOI 10.1002/1521-4141(200203)32:3<701::AID-IMMU701>3.0.CO;2-T; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Weinstock DM, 2006, DNA REPAIR, V5, P1065, DOI 10.1016/j.dnarep.2006.05.028; Yan CT, 2006, P NATL ACAD SCI USA, V103, P7378, DOI 10.1073/pnas.0601938103; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	31	445	452	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2007	449	7161					478	U9		10.1038/nature06020	http://dx.doi.org/10.1038/nature06020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17713479				2022-12-01	WOS:000249724800044
J	Dong, JX; Feldmann, G; Huang, JB; Wu, S; Zhang, NL; Comerford, SA; Gayyed, MF; Anders, RA; Maitra, A; Pan, DJ				Dong, Jixin; Feldmann, Georg; Huang, Jianbin; Wu, Shian; Zhang, Nailing; Comerford, Sarah A.; Gayyed, Mariana F.; Anders, Robert A.; Maitra, Anirban; Pan, Duojia			Elucidation of a universal size-control mechanism in Drosophila and mammals	CELL			English	Article							YES-ASSOCIATED PROTEIN; TUMOR-SUPPRESSOR; CELL; YAP; APOPTOSIS; CANCER; DOMAIN; MICE; TRANSCRIPTION; WW	Coordination of cell proliferation and cell death is essential to attain proper organ size during development and for maintaining tissue homeostasis throughout postnatal life. In Drosophila, these two processes are orchestrated by the Hippo kinase cascade, a growth- suppressive pathway that ultimately antagonizes the transcriptional coactivator Yorkie ( Yki). Here we demonstrate that a single phosphorylation site in Yki mediates the growth suppressive output of the Hippo pathway. Hippo- mediated phosphorylation inactivates Yki by excluding it from the nucleus, whereas loss of Hippo signaling leads to nuclear accumulation and therefore increased Yki activity. We further delineate a mammalian Hippo signaling pathway that culminates in the phosphorylation of YAP, the mammalian homolog of Yki. Using a conditional YAP transgenic mouse model, we demonstrate that the mammalian Hippo pathway is a potent regulator of organ size, and that its dysregulation leads to tumorigenesis. These results uncover a universal size- control mechanism in metazoan.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	Johns Hopkins University; Johns Hopkins University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Pan, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	djpan@jhmi.edu		Wu, Shian/0000-0003-4990-6594; Comerford, Sarah Ann/0000-0002-7452-7759; Gayyed, Mariana/0000-0002-9455-2257	NCI NIH HHS [R01 CA113669-05, R01CA113669, R01 CA113669-04, R01 CA113669-01, R01 CA113669-03, R01 CA113669, R01 CA113669-02] Funding Source: Medline; NEI NIH HHS [EY015708, R01 EY015708] Funding Source: Medline; NIDDK NIH HHS [R21DK072532, R21 DK072532, R01 DK081417, K08 DK067187, DK067187] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA113669] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK067187, R01DK081417, R21DK072532] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Espanel X, 2001, J BIOL CHEM, V276, P14514, DOI 10.1074/jbc.M008568200; FAN JL, 1994, P NATL ACAD SCI USA, V91, P8724, DOI 10.1073/pnas.91.18.8724; Ferrigno O, 2002, ONCOGENE, V21, P4879, DOI 10.1038/sj.onc.1205623; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Howell M, 2004, J BIOL CHEM, V279, P26300, DOI 10.1074/jbc.M401070200; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Lamartina S, 2002, HUM GENE THER, V13, P199, DOI 10.1089/10430340252769734; Lee KM, 2005, LAB INVEST, V85, P1003, DOI 10.1038/labinvest.3700298; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mohler PJ, 1999, J CELL BIOL, V147, P879, DOI 10.1083/jcb.147.4.879; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; SUDOL M, 1994, ONCOGENE, V9, P2145; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	40	1690	1734	7	187	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6					1120	1133		10.1016/j.cell.2007.07.019	http://dx.doi.org/10.1016/j.cell.2007.07.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889654	Bronze, Green Accepted			2022-12-01	WOS:000250507500020
J	Mochida, S; Hunt, T				Mochida, Satoru; Hunt, Tim			Calcineurin is required to release Xenopus egg extracts from meiotic M phase	NATURE			English	Article							CYTOSTATIC FACTOR; PROTEIN PHOSPHATASE; CELL-CYCLE; METAPHASE ARREST; MAP KINASE; LAEVIS EGGS; PHOSPHORYLATION; FERTILIZATION; DEGRADATION; INHIBITOR	Fertilization induces a transient increase in cytoplasmic Ca2+ concentration in animal eggs that releases them from cell cycle arrest in the second meiotic metaphase(1). In frog eggs, Ca2+ activates Ca2+/calmodulin-activated kinase, which inactivates cytostatic factor(2-5), allowing the anaphase-promoting factor to turn on and ubiquitinate cyclins and securin, which returns the cell cycle to interphase(6). Here we show that the calcium-activated protein phosphatase calcineurin(7) is also important in this process. Calcineurin is transiently activated after adding Ca2+ to egg extracts, and inhibitors of calcineurin such as cyclosporin A (ref. 8) delay the destruction of cyclins, the global dephosphorylation of M-phase-specific phosphoproteins and the re-formation of a fully functional nuclear envelope. We found that a second wave of phosphatase activity directed at mitotic phosphoproteins appears after the spike of calcineurin activity. This activity disappeared the next time the extract entered M phase and reappeared at the end of mitosis. We surmise that inhibition of this second phosphatase activity is important in allowing cells to enter mitosis, and, conversely, that its activation is required for a timely return to interphase. Calcineurin is required to break the deep cell cycle arrest imposed by the Mos-MAP (mitogen-activated protein) kinase pathway(4,5,9), and we show that Fizzy/Cdc20, a key regulator of the anaphase-promoting factor(6), is an excellent substrate for this phosphatase.	Imperial Canc Res Fund, Clare Hall Labs, London Res Ctr, Canc Res UK, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Hunt, T (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, London Res Ctr, Canc Res UK, S Mimms EN6 3LD, Herts, England.	tim.hunt@cancer.org.uk	Hunt, Tim/O-8544-2019	Hunt, Tim/0000-0001-5174-6038				BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; BUSA WB, 1985, J CELL BIOL, V100, P1325, DOI 10.1083/jcb.100.4.1325; Chatterjee S, 1997, EXP CELL RES, V236, P346, DOI 10.1006/excr.1997.3746; Chung EN, 2003, NAT CELL BIOL, V5, P748, DOI 10.1038/ncb1022; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; HACCARD O, 1993, SCIENCE, V262, P1262, DOI 10.1126/science.8235656; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Liu J, 2007, ONCOGENE, V26, P1286, DOI 10.1038/sj.onc.1210203; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu JJ, 2005, CURR BIOL, V15, P1458, DOI 10.1016/j.cub.2005.07.030; LORCA T, 1991, MOL CELL BIOL, V11, P1171, DOI 10.1128/MCB.11.2.1171; LORCA T, 1993, NATURE, V366, P270, DOI 10.1038/366270a0; MACKINTOSH C, 1999, PROTEIN PHOSPHORYLAT, P153; Maller JL, 2001, BIOL CELL, V93, P27, DOI 10.1016/S0248-4900(01)01127-3; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mertz P, 1997, J BIOL CHEM, V272, P21296, DOI 10.1074/jbc.272.34.21296; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; NEBREDA AR, 1993, EMBO J, V12, P1979, DOI 10.1002/j.1460-2075.1993.tb05847.x; Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 1996, SCIENCE, V274, P1199, DOI 10.1126/science.274.5290.1199; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; Schmidt A, 2006, J CELL SCI, V119, P1213, DOI 10.1242/jcs.02919; Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705; STEWART AA, 1982, FEBS LETT, V137, P80, DOI 10.1016/0014-5793(82)80319-0; STEWART AA, 1983, EUR J BIOCHEM, V132, P289, DOI 10.1111/j.1432-1033.1983.tb07361.x; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Yamano H, 2004, MOL CELL, V13, P137, DOI 10.1016/S1097-2765(03)00480-5; Yudkovsky Y, 2000, BIOCHEM BIOPH RES CO, V271, P299, DOI 10.1006/bbrc.2000.2622	32	115	117	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2007	449	7160					336	+		10.1038/nature06121	http://dx.doi.org/10.1038/nature06121			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17882219				2022-12-01	WOS:000249557300044
J	Kiick, KL				Kiick, Kristi L.			Polymer therapeutics	SCIENCE			English	Editorial Material									Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA	University of Delaware	Kiick, KL (corresponding author), Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.	kiick@udel.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017716] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR017716, P20 RR017716-010004] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Alexander C, 2006, ADV MATER, V18, P3321, DOI 10.1002/adma.200502640; Baessler KA, 2006, CHEM BIOL, V13, P251, DOI 10.1016/j.chembiol.2005.12.010; Dhal PK, 2006, ADV POLYM SCI, V192, P9, DOI 10.1007/12_020; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; Fischbach C, 2007, BIOMATERIALS, V28, P2069, DOI 10.1016/j.biomaterials.2006.12.029; Gestwicki JE, 2002, NATURE, V415, P81, DOI 10.1038/415081a; Grubbs RH, 2006, ANGEW CHEM INT EDIT, V45, P3760, DOI 10.1002/anie.200600680; Gujraty KV, 2006, BIOMACROMOLECULES, V7, P2082, DOI 10.1021/bm060210p; Illies Z, 2004, P NATL ACAD SCI USA, V101, P11749, DOI 10.1073/pnas.0403833101; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Mowery P, 2004, CHEM BIOL, V11, P725, DOI 10.1016/j.chembiol.2004.03.027; Puffer EB, 2007, ACS CHEM BIOL, V2, P252, DOI 10.1021/cb600489g; Schmeltzer RC, 2005, BIOMACROMOLECULES, V6, P359, DOI 10.1021/bm049544+; Wang Y, 2005, J AM CHEM SOC, V127, P16392, DOI 10.1021/ja055102+	15	71	72	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2007	317	5842					1182	1183		10.1126/science.1145951	http://dx.doi.org/10.1126/science.1145951			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205PJ	17761873	Green Accepted			2022-12-01	WOS:000249126800029
J	Leung, AKL; Sharp, PA				Leung, Anthony K. L.; Sharp, Phillip A.			microRNAs: A safeguard against turmoil?	CELL			English	Editorial Material							TRANSLATIONAL REPRESSION; GENE-EXPRESSION; CELLULAR STRESS; TARGET; APOPTOSIS; LET-7; LOCALIZATION; MIR-34A; TRISTETRAPROLIN; METABOLISM	Emerging data suggest that microRNAs ( miRNAs) are instrumental in a variety of stress responses in addition to their more recognized role in development. Surprisingly, miRNAs, which normally suppress expression of target transcripts, may become activators of expression during stress. This might be partially explained by new interactions of miRNA/Argonaute complexes with RNA-binding proteins that relocate from different subcellular compartments during stress.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sharp, PA (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02139 USA.	sharppa@mit.edu		Leung, Anthony/0000-0001-5569-4036				Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; BROMMER GT, 2007, CURR BIOL; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Jackson R.J., 2007, SCI STKE, pre1, DOI DOI 10.1126/STKE.3672007RE1; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; LEUNG AK, 2006, S QUANT BIOL, V71, P29; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Nolde MJ, 2007, DEV BIOL, V305, P551, DOI 10.1016/j.ydbio.2007.02.040; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stohr N, 2006, J CELL BIOL, V175, P527, DOI 10.1083/jcb.200608071; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Tahbaz N, 2001, J BIOL CHEM, V276, P43294, DOI 10.1074/jbc.M107808200; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Vastag B, 2006, NAT BIOTECHNOL, V24, P1307, DOI 10.1038/nbt1106-1307; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wang W, 2002, MOL CELL BIOL, V22, P3425, DOI 10.1128/MCB.22.10.3425-3436.2002; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1	37	161	178	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 24	2007	130	4					581	585		10.1016/j.cell.2007.08.010	http://dx.doi.org/10.1016/j.cell.2007.08.010			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	208KY	17719533	Bronze			2022-12-01	WOS:000249319400006
J	Sjostrom, L; Narbro, K; Sjostrom, D; Karason, K; Larsson, B; Wedel, H; Lystig, T; Sullivan, M; Bouchard, C; Carlsson, B; Bengtsson, C; Dahlgren, S; Gummesson, A; Jacobson, P; Karlsson, J; Lindroos, AK; Lonroth, H; Naslund, I; Olbers, T; Stenlof, K; Torgerson, J; Agren, G; Carlsson, LMS				Sjostrom, Lars; Narbro, Kristina; Sjostrom, David; Karason, Kristjan; Larsson, Bo; Wedel, Hans; Lystig, Ted; Sullivan, Marianne; Bouchard, Claude; Carlsson, Bjorn; Bengtsson, Calle; Dahlgren, Sven; Gummesson, Anders; Jacobson, Peter; Karlsson, Jan; Lindroos, Anna-Karin; Lonroth, Hans; Naslund, Ingmar; Olbers, Torsten; Stenlof, Kaj; Torgerson, Jarl; Agren, Goran; Carlsson, Lena M. S.		Swedish Obese Subjects Study	Effects of bariatric surgery on mortality in Swedish obese subjects	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; INTENTIONAL WEIGHT-LOSS; AGED 40-64 YEARS; UNITED-STATES; SUBJECTS SOS; OLDER PERSONS; FOLLOW-UP; OVERWEIGHT; COHORT; INTERVENTION	Background: Obesity is associated with increased mortality. Weight loss improves cardiovascular risk factors, but no prospective interventional studies have reported whether weight loss decreases overall mortality. In fact, many observational studies suggest that weight reduction is associated with increased mortality. Methods: The prospective, controlled Swedish Obese Subjects study involved 4047 obese subjects. Of these subjects, 2010 underwent bariatric surgery (surgery group) and 2037 received conventional treatment (matched control group). We report on overall mortality during an average of 10.9 years of follow-up. At the time of the analysis (November 1, 2005), vital status was known for all but three subjects (follow-up rate, 99.9%). Results: The average weight change in control subjects was less than +/-2% during the period of up to 15 years during which weights were recorded. Maximum weight losses in the surgical subgroups were observed after 1 to 2 years: gastric bypass, 32%; vertical-banded gastroplasty, 25%; and banding, 20%. After 10 years, the weight losses from baseline were stabilized at 25%, 16%, and 14%, respectively. There were 129 deaths in the control group and 101 deaths in the surgery group. The unadjusted overall hazard ratio was 0.76 in the surgery group (P=0.04), as compared with the control group, and the hazard ratio adjusted for sex, age, and risk factors was 0.71 (P=0.01). The most common causes of death were myocardial infarction (control group, 25 subjects; surgery group, 13 subjects) and cancer (control group, 47; surgery group, 29). Conclusions: Bariatric surgery for severe obesity is associated with long-term weight loss and decreased overall mortality.	Gothenburg Univ, Sahlgrenska Acad, Inst Med, S-41345 Gothenburg, Sweden; Gothenburg Univ, Sahlgrenska Acad, Inst Anesthesiol, S-41345 Gothenburg, Sweden; Gothenburg Univ, Sahlgrenska Acad, Inst Surg, S-41345 Gothenburg, Sweden; Gothenburg Univ, Sahlgrenska Acad, Inst Primary Healthcare, S-41345 Gothenburg, Sweden; Nord Sch Publ Hlth, Gothenburg, Sweden; Univ Hosp, Orebro, Sweden; No Alvsborg Hosp, Trollhattan, Sweden; Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; Univ Cambridge, Med Res Council Human Nutr Res, Elsie Widdowson Lab, Cambridge, England	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; Orebro University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge	Sjostrom, L (corresponding author), Gothenburg Univ, Sahlgrens Hosp, Swedish Obese Subjects Secretariat, Vita Straket 15, S-41345 Gothenburg, Sweden.	lars.sjostrom@medfak.gu.se	Bouchard, Claude/AAE-2035-2019; Carlsson, Lena/F-7570-2018; Kohn, Geoffrey P/A-9056-2009; Bouchard, Claude/A-7637-2009; Lystig, Theodore/E-4149-2015	Carlsson, Lena/0000-0003-4145-6242; Bouchard, Claude/0000-0002-0048-491X; Lystig, Theodore/0000-0002-4523-0761; Karason, Kristjan/0000-0002-2802-1191; Olbers, Torsten/0000-0002-7218-3390; Gummesson, Anders/0000-0003-0024-960X; Jacobson, Peter/0000-0002-1769-1827	Medical Research Council [MC_U105960389] Funding Source: Medline; MRC [MC_U105960389] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; [Anonymous], 1992, AM J CLIN NUTR S, V55, p615S; [Anonymous], 2005, R LANG ENV STAT COMP; BROLIN RE, 1987, GASTROENTEROL CLIN N, V16, P317; Christou NV, 2004, ANN SURG, V240, P416, DOI 10.1097/01.sla.0000137343.63376.19; CORNONIHUNTLEY JC, 1991, J CLIN EPIDEMIOL, V44, P743, DOI 10.1016/0895-4356(91)90126-T; COX DR, 1972, J R STAT SOC B, V34, P187; Fagerberg B, 2000, EUR J HEART FAIL, V2, P315, DOI 10.1016/S1388-9842(00)00101-X; Flegal KM, 2005, PHYSIOL BEHAV, V86, P599, DOI 10.1016/j.physbeh.2005.08.050; Flum DR, 2005, JAMA-J AM MED ASSOC, V294, P1903, DOI 10.1001/jama.294.15.1903; Flum DR, 2004, J AM COLL SURGEONS, V199, P543, DOI 10.1016/j.jamcollsurg.2004.06.014; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Freedman DM, 2006, INT J OBESITY, V30, P822, DOI 10.1038/sj.ijo.0803193; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; GRUNSTEIN RR, 1995, SLEEP, V18, P635, DOI 10.1093/sleep/18.8.635; HIGGINS M, 1993, ANN INTERN MED, V119, P758, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00025; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; KARLSSON J, 1995, J CLIN EPIDEMIOL, V48, P817, DOI 10.1016/0895-4356(94)00196-W; MacDonald K G Jr, 1997, J Gastrointest Surg, V1, P213, DOI 10.1016/S1091-255X(97)80112-6; Nilsson PM, 2002, J INTERN MED, V252, P70, DOI 10.1046/j.1365-2796.2002.01010.x; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; PAMUK ER, 1993, ANN INTERN MED, V119, P744, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00023; PAMUK ER, 1992, AM J EPIDEMIOL, V136, P686, DOI 10.1093/oxfordjournals.aje.a116548; Price GM, 2006, AM J CLIN NUTR, V84, P449; RABKIN SW, 1977, AM J CARDIOL, V39, P452, DOI 10.1016/S0002-9149(77)80104-5; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; SJOSTROM L, 1992, INT J OBESITY, V16, P465; Sjostrom L, 2000, ENDOCRINE, V13, P213, DOI 10.1385/ENDO:13:2:213; Sjostrom L, 1996, PROGR OBESITY RES, V7, P309; SJOSTROM L, 2004, HDB OBESITY CLIN APP, P359; SJOSTROM L V, 1992, American Journal of Clinical Nutrition, V55, p516S, DOI 10.1093/ajcn/55.2.516s; Steinbrook R, 2004, NEW ENGL J MED, V350, P1075, DOI 10.1056/NEJMp048029; Sullivan M., 2001, International textbook of obesity, P485, DOI 10.1002/0470846739.ch33; van Dam RM, 2006, ANN INTERN MED, V145, P91, DOI 10.7326/0003-4819-145-2-200607180-00006; WAALER HT, 1984, ACTA MED SCAND, P1; Williamson DF, 2000, DIABETES CARE, V23, P1499, DOI 10.2337/diacare.23.10.1499; Williamson DF, 1999, AM J EPIDEMIOL, V149, P491, DOI 10.1093/oxfordjournals.aje.a009843; WILLIAMSON DF, 1995, AM J EPIDEMIOL, V141, P1128, DOI 10.1093/oxfordjournals.aje.a117386; Yan LJL, 2006, JAMA-J AM MED ASSOC, V295, P190, DOI 10.1001/jama.295.2.190	41	3122	3209	1	146	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2007	357	8					741	752		10.1056/NEJMoa066254	http://dx.doi.org/10.1056/NEJMoa066254			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202MU	17715408				2022-12-01	WOS:000248906700003
J	Morrison, AJ; Kim, JA; Person, MD; Highland, J; Xiao, J; Wehr, TS; Hensley, S; Bao, Y; Shen, J; Collins, SR; Weissman, JS; Delrow, J; Krogan, NJ; Haber, JE; Shen, X				Morrison, Ashby J.; Kim, Jung-Ae; Person, Maria D.; Highland, Jessica; Xiao, Jing; Wehr, Tammy S.; Hensley, Sean; Bao, Yunhe; Shen, Jianjun; Collins, Sean R.; Weissman, Jonathan S.; Delrow, Jeff; Krogan, Nevan J.; Haber, James E.; Shen, Xuetong			Mec1/Tel1 phosphorylation of the INO80 Chromatin Remodeling Complex Influences DNA damage checkpoint responses	CELL			English	Article							DOUBLE-STRAND BREAK; SACCHAROMYCES-CEREVISIAE; S-PHASE; HISTONE H2AX; REPAIR; PROTEINS; KINASE; MRC1; RECOMBINATION; RECRUITMENT	The yeast Mec1/Tel1 kinases, ATM/ATR in mammals, coordinate the DNA damage response by phosphorylating proteins involved in DNA repair and checkpoint pathways. Recently, ATP-dependent chromatin remodeling complexes, such as the INO80 complex, have also been implicated in DNA damage responses, although regulatory mechanisms that direct their function remain unknown. Here, we show that the Ies4 subunit of the INO80 complex is phosphorylated by the Mec1/Tel1 kinases during exposure to DNA-damaging agents. Mutation of Ies4's phosphorylation sites does not significantly affect DNA repair processes, but does influence DNA damage checkpoint responses. Additionally, ies4 phosphorylation mutants are linked to the function of checkpoint regulators, such as the replication checkpoint factors Tof1 and Rad53. These findings establish a chromatin remodeling complex as a functional component in the Mec1/Tel1 DNA damage signaling pathway that modulates checkpoint responses and suggest that posttranslational modification of chromatin remodeling complexes regulates their involvement in distinct processes.	Univ Texas, MD Anderson Canc Ctr, Div Sci Pk Res, Dept Carcinogenesis, Smithville, TX 78957 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Rosentiel Ctr, Waltham, MA 02454 USA; Univ Texas, Div Pharmacol & Toxicol, Coll Pharm, Austin, TX 78712 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of Texas System; UTMD Anderson Cancer Center; Brandeis University; Brandeis University; University of Texas System; University of Texas Austin; Fred Hutchinson Cancer Center; University of California System; University of California San Francisco	Shen, X (corresponding author), Univ Texas, MD Anderson Canc Ctr, Div Sci Pk Res, Dept Carcinogenesis, Smithville, TX 78957 USA.	snowshen@mac.com	Morrison, Ashby/AHE-2820-2022	Haber, James/0000-0002-1878-0610; Weissman, Jonathan/0000-0003-2445-670X; Morrison, Ashby/0000-0003-1228-5093; Shen, Xuetong/0000-0002-4267-5298; Collins, Sean/0000-0002-4276-5840	NCI NIH HHS [1K22CA100017] Funding Source: Medline; NIEHS NIH HHS [ES07784] Funding Source: Medline; NIGMS NIH HHS [R01 GM061766, R01 GM061766-07, GM20056, R01 GM061766-08] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K22CA100017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061766, R01GM020056, R37GM020056] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bouazoune K, 2005, J BIOL CHEM, V280, P41912, DOI 10.1074/jbc.M507084200; Brondello JM, 1999, MOL CELL BIOL, V19, P4262; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Foss EJ, 2001, GENETICS, V157, P567; Fritsch O, 2004, MOL CELL, V16, P479, DOI 10.1016/j.molcel.2004.09.034; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kawashima S, 2007, BIOCHEM BIOPH RES CO, V355, P835, DOI 10.1016/j.bbrc.2007.02.036; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Lee SE, 2000, COLD SPRING HARB SYM, V65, P303, DOI 10.1101/sqb.2000.65.303; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Mallory JC, 2000, P NATL ACAD SCI USA, V97, P13749, DOI 10.1073/pnas.250475697; Meister P, 2007, EMBO J, V26, P1315, DOI 10.1038/sj.emboj.7601538; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Morrison AJ, 2005, CELL CYCLE, V4, P568; Morrison AJ, 2006, RES PRO CEL, V41, P109, DOI 10.1007/008; MORROW DM, 1995, CELL, V82, P831, DOI 10.1016/0092-8674(95)90480-8; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Redon C, 2006, GENETICS, V172, P67, DOI 10.1534/genetics.105.046128; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2004, METHOD ENZYMOL, V377, P401; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Vidanes GM, 2005, CELL, V121, P973, DOI 10.1016/j.cell.2005.06.013; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Wong LY, 2006, J MOL HISTOL, V37, P261, DOI 10.1007/s10735-006-9047-4; Xu H, 2004, MOL CELL BIOL, V24, P7082, DOI 10.1128/MCB.24.16.7082-7090.2004	54	97	106	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 10	2007	130	3					499	511		10.1016/j.cell.2007.06.010	http://dx.doi.org/10.1016/j.cell.2007.06.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	204IV	17693258	Bronze			2022-12-01	WOS:000249038100017
J	Yuzawa, S; Opatowsky, Y; Zhang, ZT; Mandiyan, V; Lax, I; Schlessinger, J				Yuzawa, Satoru; Opatowsky, Yarden; Zhang, Zhongtao; Mandiyan, Valsan; Lax, Irit; Schlessinger, Joseph			Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor	CELL			English	Article							C-KIT; CRYSTAL-STRUCTURE; SIGNAL-TRANSDUCTION; BIVALENT BINDING; LIGAND-BINDING; DIMERIZATION; ADHESION; DOMAIN; PIEBALDISM; PROTEIN	Stem Cell Factor (SCF) initiates its multiple cellular responses by binding to the ectodomain of KIT, resulting in tyrosine kinase activation. We describe the crystal structure of the entire ectodomain of KIT before and after SCF stimulation. The structures show that KIT dimerization is driven by SCF binding whose sole role is to bring two KIT molecules together. Receptor dimerization is followed by conformational changes that enable lateral interactions between membrane proximal Ig-like domains D4 and D5 of two KIT molecules. Experiments with cultured cells show that KIT activation is compromised by point mutations in amino acids critical for D4-D4 interaction. Moreover, a variety of oncogenic mutations are mapped to the D5-D5 interface. Since key hallmarks of KIT structures, ligand-induced receptor dimerization, and the critical residues in the D4-D4 interface, are conserved in other receptors, the mechanism of KIT stimulation unveiled in this report may apply for other receptor activation.	New York Med Coll, Dept Biochem, Valhalla, NY 10595 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	New York Medical College; Yale University	Schlessinger, J (corresponding author), New York Med Coll, Dept Biochem, Valhalla, NY 10595 USA.	joseph.schlessinger@yale.edu		zhang, zhongtao/0000-0002-1910-4753; Yuzawa, Satoru/0000-0002-1031-5781	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051886, R01AR051448, P50AR054086] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 051448, AR 051886, P50 AR 054086] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; BERNSTEIN A, 1990, CIBA F SYMP, V148, P158; BESMER P, 1986, J VIROL, V60, P194, DOI 10.1128/JVI.60.1.194-203.1986; BLECHMAN JM, 1995, CELL, V80, P103, DOI 10.1016/0092-8674(95)90455-7; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Fleischman RA, 1996, J INVEST DERMATOL, V107, P703, DOI 10.1111/1523-1747.ep12365596; FLEISCHMAN RA, 1991, P NATL ACAD SCI USA, V88, P10885, DOI 10.1073/pnas.88.23.10885; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Greenwald J, 2004, MOL CELL, V15, P485, DOI 10.1016/j.molcel.2004.07.011; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; HOLDEN HM, 1992, J MOL BIOL, V227, P840, DOI 10.1016/0022-2836(92)90226-A; Hsu YR, 1998, BIOCHEMISTRY-US, V37, P2251, DOI 10.1021/bi972372z; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; Jiang XL, 2000, EMBO J, V19, P3192, DOI 10.1093/emboj/19.13.3192; LANGLEY KE, 1994, ARCH BIOCHEM BIOPHYS, V311, P55, DOI 10.1006/abbi.1994.1208; Lemmon MA, 1997, J BIOL CHEM, V272, P6311, DOI 10.1074/jbc.272.10.6311; LEV S, 1992, J BIOL CHEM, V267, P15970; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Mueller TD, 2002, BBA-MOL CELL RES, V1592, P237, DOI 10.1016/S0167-4889(02)00318-X; Murakami T, 2005, J INVEST DERMATOL, V124, P670, DOI 10.1111/j.0022-202X.2005.23637.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PHILO JS, 1996, KIT J BIOL CHEM, V271, P6895; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Ruch C, 2007, NAT STRUCT MOL BIOL, V14, P249, DOI 10.1038/nsmb1202; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; TAN JC, 1990, SCIENCE, V247, P209, DOI 10.1126/science.1688471; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Vigers GPA, 1997, NATURE, V386, P190, DOI 10.1038/386190a0; Zhang ZT, 2000, P NATL ACAD SCI USA, V97, P7732, DOI 10.1073/pnas.97.14.7732	35	238	262	1	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 27	2007	130	2					323	334		10.1016/j.cell.2007.05.055	http://dx.doi.org/10.1016/j.cell.2007.05.055			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662946	Bronze			2022-12-01	WOS:000248588000021
J	Christakis, NA; Fowler, JH				Christakis, Nicholas A.; Fowler, James H.			The spread of obesity in a large social network over 32 years	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS-INDEX; SMOKING-CESSATION; FRIENDS; IMPACT	ackground: The prevalence of obesity has increased substantially over the past 30 years. We performed a quantitative analysis of the nature and extent of the person-to-person spread of obesity as a possible factor contributing to the obesity epidemic. Methods: We evaluated a densely interconnected social network of 12,067 people assessed repeatedly from 1971 to 2003 as part of the Framingham Heart Study. The body-mass index was available for all subjects. We used longitudinal statistical models to examine whether weight gain in one person was associated with weight gain in his or her friends, siblings, spouse, and neighbors. Results: Discernible clusters of obese persons (body-mass index [the weight in kilograms divided by the square of the height in meters], greater/equal 30) were present in the network at all time points, and the clusters extended to three degrees of separation. These clusters did not appear to be solely attributable to the selective formation of social ties among obese persons. A person's chances of becoming obese increased by 57% (95% confidence interval [CI], 6 to 123) if he or she had a friend who became obese in a given interval. Among pairs of adult siblings, if one sibling became obese, the chance that the other would become obese increased by 40% (95% CI, 21 to 60). If one spouse became obese, the likelihood that the other spouse would become obese increased by 37% (95% CI, 7 to 73). These effects were not seen among neighbors in the immediate geographic location. Persons of the same sex had relatively greater influence on each other than those of the opposite sex. The spread of smoking cessation did not account for the spread of obesity in the network. Conclusions: Network phenomena appear to be relevant to the biologic and behavioral trait of obesity, and obesity appears to spread through social ties. These findings have implications for clinical and public health interventions.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Mt Auburn Hosp, Dept Med, Cambridge, MA USA; Harvard Univ, Dept Sociol, Cambridge, MA 02138 USA; Univ Calif San Diego, Dept Polit Sci, San Diego, CA 92103 USA	Harvard University; Harvard Medical School; Harvard University; Mount Auburn Hospital; Harvard University; University of California System; University of California San Diego	Christakis, NA (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	christakis@hcp.med.harvard.edu	Christakis, Nicholas A/C-3205-2009; 白, 纯歌/V-1853-2017; Fowler, James H/C-2750-2008; Christakis, Nicholas A/B-6690-2008	Fowler, James H/0000-0001-7795-1638; 	NATIONAL INSTITUTE ON AGING [R01AG024448] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andrews JA, 2002, HEALTH PSYCHOL, V21, P349, DOI 10.1037//0278-6133.21.4.349; Atwood LD, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batagelj V, 2004, MATH VIS, P77; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; Beck N, 2001, ANNU REV POLIT SCI, V4, P271, DOI 10.1146/annurev.polisci.4.1.271; Bruckner H, 2005, J ADOLESCENT HEALTH, V36, P271, DOI 10.1016/j.jadohealth.2005.01.005; Carrington P.J., 2005, MODELS METHODS SOCIA; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Chang VW, 2002, SOCIOL HEALTH ILL, V24, P151, DOI 10.1111/1467-9566.00289; Christakis NA, 2006, NEW ENGL J MED, V354, P719, DOI 10.1056/NEJMsa050196; Christakis NA, 2004, BRIT MED J, V329, P184, DOI 10.1136/bmj.329.7459.184; Dawber TR., 1980, FRAMINGHAM STUDY EPI, DOI DOI 10.4159/HARVARD.9780674492097; Eisenberg D, 2006, HEALTH SERV RES, V41, P2255, DOI 10.1111/j.1475-6773.2006.00594.x; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; KING G, 2000, AM J POLIT SCI, V0044; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Liljeros F, 2003, MICROBES INFECT, V5, P189, DOI 10.1016/S1286-4579(02)00058-8; Malchodi CS, 2003, OBSTET GYNECOL, V101, P504, DOI 10.1016/S0029-7844(02)03070-3; MCKNIGHT AJ, 1986, ACCIDENT ANAL PREV, V18, P339, DOI 10.1016/0001-4575(86)90047-3; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Montgomery GH, 2003, PREV MED, V37, P242, DOI 10.1016/S0091-7435(03)00120-8; Moody J, 2005, AM J SOCIOL, V110, P1206, DOI 10.1086/421509; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Philipson TJ, 2003, PERSPECT BIOL MED, V46, pS87; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; SACKETT DL, 1975, CIRCULATION, V52, P589, DOI 10.1161/01.CIR.52.4.589; Schildcrout JS, 2005, BIOSTATISTICS, V6, P633, DOI 10.1093/biostatistics/kxi033; Sobal J, 1999, SOCIAL PROB SO ISS, P231; STUNKARD AJ, 1986, NEW ENGL J MED, V314, P193, DOI 10.1056/NEJM198601233140401; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WECHSLER H, 1995, J STUD ALCOHOL, V56, P628, DOI 10.15288/jsa.1995.56.628; Whigham LD, 2006, AM J PHYSIOL-REG I, V290, pR190, DOI 10.1152/ajpregu.00479.2005; Wing RR, 1999, J CONSULT CLIN PSYCH, V67, P132, DOI 10.1037/0022-006X.67.1.132	42	2942	2990	18	603	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 26	2007	357	4					370	379		10.1056/NEJMsa066082	http://dx.doi.org/10.1056/NEJMsa066082			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193OL	17652652	Green Published			2022-12-01	WOS:000248283500008
J	Baurle, I; Smith, L; Baulcombe, DC; Dean, C				Baeurle, Isabel; Smith, Lisa; Baulcombe, David C.; Dean, Caroline			Widespread role for the flowering-time regulators FCA and FPA in RNA-mediated chromatin silencing	SCIENCE			English	Article							DIRECTED DNA METHYLATION; PROCESSING CENTER; ARABIDOPSIS; PROTEIN; HETEROCHROMATIN; SIRNA; IV; ARGONAUTE4; ENCODES; DOMAINS	The RRM-domain proteins FCA and FPA have previously been characterized as flowering-time regulators in Arabidopsis. We show that they are required for RNA-mediated chromatin silencing of a range of loci in the genome. At some target loci, FCA and FPA promote asymmetric DNA methylation, whereas at others they function in parallel to DNA methylation. Female gametophytic development and early embryonic development are particularly susceptible to malfunctions in FCA and FPA. We propose that FCA and FPA regulate chromatin silencing of single and low-copy genes and interact in a locus-dependent manner with the canonical small interfering RNA-directed DNA methylation pathway to regulate common targets.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Baurle, I (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	isabel.baurle@bbsrc.ac.uk; caroline.dean@bbsrc.ac.uk	Bäurle, Isabel/ABD-6356-2021; Smith, Lisa/E-6506-2011	Bäurle, Isabel/0000-0001-5633-8068; Smith, Lisa/0000-0003-2364-8187; Baulcombe, David/0000-0003-0780-6878; Dean, Caroline/0000-0002-6555-3525	Natural Environment Research Council [NE/C507629/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Habu Y, 2006, EMBO REP, V7, P1279, DOI 10.1038/sj.embor.7400835; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; LIU F, IN PRESS MOL CELL; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Martienssen RA, 2005, TRENDS GENET, V21, P450, DOI 10.1016/j.tig.2005.06.005; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Sarnowski TJ, 2002, NUCLEIC ACIDS RES, V30, P3412, DOI 10.1093/nar/gkf458; Scheid OM, 2002, P NATL ACAD SCI USA, V99, P13659, DOI 10.1073/pnas.202380499; Schlichter A, 2005, EMBO J, V24, P1222, DOI 10.1038/sj.emboj.7600607; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Smith LM, 2007, PLANT CELL, V19, P1507, DOI 10.1105/tpc.107.051540; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	29	143	152	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847					109	112		10.1126/science.1146565	http://dx.doi.org/10.1126/science.1146565			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916737				2022-12-01	WOS:000249915400053
J	Hawkins, PT; Stephens, LR				Hawkins, Phillip T.; Stephens, Len R.			PI3K gamma is a key regulator of inflammatory responses and cardiovascular homeostasis	SCIENCE			English	Editorial Material							PHOSPHOINOSITIDE 3-KINASE P110-GAMMA; INHIBITION; SUBUNIT; KINASE	Class I phosphoinositide 3-kinase (PI3K) signaling pathways regulate several important cellular functions, including cellular growth, division, survival, and movement. Class IB PI3K (also known as PI3K gamma) links heterotrimeric GTP-binding protein-coupled receptors to these pathways. Activation of class IB PI3K results in the rapid synthesis of phosphatidylinositol-3,4,5-trisphosphate [PtdIns(3,4,5)P-3] and its dephosphorylation product PtdIns(3,4)P-2 in the plasma membrane. These two lipid messengers bind to pleckstrin homology domain-containing effectors that regulate a complex signaling web downstream of receptor activation. Characteristic features of this pathway are the regulation of protein kinases and the regulation of small guanosine triphosphatases that control cellular movement, adhesion, contraction, and secretion. Most of the ligands that activate class IB PI3K are involved in coordinating the body's response to injury and infection, and recent studies suggest that small molecule inhibitors of this enzyme may represent a novel class of anti-inflammatory therapeutic agents.	Babraham Inst, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Hawkins, PT (corresponding author), Babraham Inst, Cambridge CB22 3AT, England.	phillip.hawkins@bbsrc.ac.uk; len.stephens@bbsrc.ac.uk		Hawkins, Phillip/0000-0002-6979-0464; stephens, len/0000-0002-2771-3487				Andrews S., 2007, SCI STKE, V2007; Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Chang JD, 2007, P NATL ACAD SCI USA, V104, P8077, DOI 10.1073/pnas.0702663104; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hirsch E, 2006, THROMB HAEMOSTASIS, V95, P29, DOI 10.1160/TH05-07-0476; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Suire S, 2005, CURR BIOL, V15, P566, DOI 10.1016/j.cub.2005.02.020; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Vecchione C, 2005, J EXP MED, V201, P1217, DOI 10.1084/jem.20040995; Voigt P, 2006, J BIOL CHEM, V281, P9977, DOI 10.1074/jbc.M512502200	14	52	55	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847					64	66		10.1126/science.1145420	http://dx.doi.org/10.1126/science.1145420			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916723				2022-12-01	WOS:000249915400037
J	Kavanagh, KD; Evans, AR; Jernvall, J				Kavanagh, Kathryn D.; Evans, Alistair R.; Jernvall, Jukka			Predicting evolutionary patterns of mammalian teeth from development	NATURE			English	Article							EXPRESSION PATTERNS; TOOTH DEVELOPMENT; GENETIC-BASIS; 3RD MOLAR; REDUCTION; DENTITIONS; GROWTH; SIZE; DIFFERENTIATION; MORPHOGENESIS	One motivation in the study of development is the discovery of mechanisms that may guide evolutionary change. Here we report how development governs relative size and number of cheek teeth, or molars, in the mouse. We constructed an inhibitory cascade model by experimentally uncovering the activator-inhibitor logic of sequential tooth development. The inhibitory cascade acts as a ratchet that determines molar size differences along the jaw, one effect being that the second molar always makes up one-third of total molar area. By using a macroevolutionary test, we demonstrate the success of the model in predicting dentition patterns found among murine rodent species with various diets, thereby providing an example of ecologically driven evolution along a developmentally favoured trajectory. In general, our work demonstrates how to construct and test developmental rules with evolutionary predictability in natural systems.	SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; Univ Helsinki, Inst Biotechnol, Evolut & Dev Unit, FIN-00014 Helsinki, Finland	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Helsinki	Kavanagh, KD (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	kathryn_kavanagh@yahoo.com; jernvall@fastmail.fm	Evans, Alistair R/D-4239-2011	Evans, Alistair R/0000-0002-4078-4693				Aberg T, 1997, DEV DYNAM, V210, P383, DOI 10.1002/(SICI)1097-0177(199712)210:4<383::AID-AJA3>3.0.CO;2-C; Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; ALBERCH P, 1985, EVOLUTION, V39, P8, DOI 10.1111/j.1558-5646.1985.tb04076.x; Bateson W., 1894, MAT STUDY VARIATION; Boughner JC, 2004, J HUM EVOL, V46, P255, DOI 10.1016/j.jhevol.2003.11.007; Brakefield PM, 2006, AM NAT, V168, pS4, DOI 10.1086/509049; Butler PM, 1939, P ZOOL SOC LOND B-SY, V109, P1; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Emlen DJ, 2005, AM NAT, V166, pS42, DOI 10.1086/444599; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Ferguson CA, 1998, GENE DEV, V12, P2636, DOI 10.1101/gad.12.16.2636; GARN SM, 1963, NATURE, V200, P488, DOI 10.1038/200488a0; GAUNT WA, 1963, ACTA ANAT, V54, P220; Godfrey Laurie R., 2003, P177; GOULD SJ, 1969, EVOLUTION, V23, P276, DOI 10.1111/j.1558-5646.1969.tb03512.x; Gritli-Linde A, 2002, DEVELOPMENT, V129, P5323, DOI 10.1242/dev.00100; GUTHRIE RD, 1965, EVOLUTION, V19, P214, DOI 10.1111/j.1558-5646.1965.tb01708.x; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Jansa SA, 2006, SYST BIOL, V55, P73, DOI 10.1080/10635150500431254; Jernvall J, 1998, DEVELOPMENT, V125, P161; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Kawasaki K, 2005, P NATL ACAD SCI USA, V102, P18063, DOI 10.1073/pnas.0509263102; Kist R, 2005, HUM MOL GENET, V14, P3605, DOI 10.1093/hmg/ddi388; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; KURTEN BJORN, 1953, ACTA ZOOL FENNICA, V76, P1; Macchiarelli R, 2006, NATURE, V444, P748, DOI 10.1038/nature05314; Nijhout HF, 1998, P NATL ACAD SCI USA, V95, P3685, DOI 10.1073/pnas.95.7.3685; OSBORN JW, 1978, DEV FUNCTION EVOLUTI; Plikus MV, 2005, EVOL DEV, V7, P440, DOI 10.1111/j.1525-142X.2005.05048.x; Polly PD, 2005, EVOL DEV, V7, P29, DOI 10.1111/j.1525-142X.2005.05004.x; Polly PD, 1998, BIOL J LINN SOC, V64, P83; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Sahlberg Carin, 2002, Methods Mol Biol, V188, P373; Salazar-Ciudad I, 2004, EVOL DEV, V6, P6, DOI 10.1111/j.1525-142X.2004.04002.x; Salazar-Ciudad I, 2002, P NATL ACAD SCI USA, V99, P8116, DOI 10.1073/pnas.132069499; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Silvestri AR, 2003, J AM DENT ASSOC, V134, P450, DOI 10.14219/jada.archive.2003.0194; SMITH BH, 1991, AM J PHYS ANTHROPOL, V86, P157, DOI 10.1002/ajpa.1330860206; SOFAER JA, 1971, EVOLUTION, V25, P509, DOI 10.1111/j.1558-5646.1971.tb01910.x; Sokal R., 2000, BIOMETRY, V3rd ed., P451; Tanaka M, 2005, DEV BIOL, V281, P227, DOI 10.1016/j.ydbio.2005.02.016; True JR, 2001, EVOL DEV, V3, P109, DOI 10.1046/j.1525-142x.2001.003002109.x; VANVALEN L, 1962, EVOLUTION, V16, P272; Wagner GP, 2000, AM ZOOL, V40, P819, DOI 10.1668/0003-1569(2000)040[0819:DEAAMS]2.0.CO;2; Wang XP, 2004, DEV DYNAM, V231, P98, DOI 10.1002/dvdy.20118; [No title captured]	50	279	286	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2007	449	7161					427	U1		10.1038/nature06153	http://dx.doi.org/10.1038/nature06153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17898761				2022-12-01	WOS:000249724800033
J	Keller, A; Zhuang, HY; Chi, QY; Vosshall, LB; Matsunami, H				Keller, Andreas; Zhuang, Hanyi; Chi, Qiuyi; Vosshall, Leslie B.; Matsunami, Hiroaki			Genetic variation in a human odorant receptor alters odour perception	NATURE			English	Article							FUNCTIONAL EXPRESSION; ENHANCED SENSITIVITY; ANDROSTENONE; PLASTICITY; ABILITY; PEOPLE	Human olfactory perception differs enormously between individuals, with large reported perceptual variations in the intensity and pleasantness of a given odour. For instance, androstenone (5 alpha-androst-16-en-3-one), an odorous steroid derived from testosterone, is variously perceived by different individuals as offensive ("sweaty, urinous''), pleasant ("sweet, floral'') or odourless(1-3). Similar variation in odour perception has been observed for several other odours(4-6). The mechanistic basis of variation in odour perception between individuals is unknown. We investigated whether genetic variation in human odorant receptor genes accounts in part for variation in odour perception between individuals(7,8). Here we show that a human odorant receptor, OR7D4, is selectively activated in vitro by androstenone and the related odorous steroid androstadienone (androsta-4,16-dien-3-one) and does not respond to a panel of 64 other odours and two solvents. A common variant of this receptor (OR7D4 WM) contains two non-synonymous single nucleotide polymorphisms (SNPs), resulting in two amino acid substitutions (R88W, T133M; hence 'RT') that severely impair function in vitro. Human subjects with RT/WM or WM/WM genotypes as a group were less sensitive to androstenone and androstadienone and found both odours less unpleasant than the RT/RT group. Genotypic variation in OR7D4 accounts for a significant proportion of the valence (pleasantness or unpleasantness) and intensity variance in perception of these steroidal odours. Our results demonstrate the first link between the function of a human odorant receptor in vitro and odour perception.	Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Rockefeller University; Duke University	Vosshall, LB (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	leslie@mail.rockefeller.edu; hiroaki.matsunami@duke.edu		Keller, Andreas/0000-0001-5491-2214; Vosshall, Leslie/0000-0002-6060-8099				Bremner EA, 2003, CHEM SENSES, V28, P423, DOI 10.1093/chemse/28.5.423; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dalton P, 2002, NAT NEUROSCI, V5, P199, DOI 10.1038/nn803; DORRIES KM, 1989, DEV PSYCHOBIOL, V22, P423, DOI 10.1002/dev.420220502; Doty R. L., 2003, HDB OLFACTION GUSTAT, P203, DOI DOI 10.1201/9780203911457; Doty RL, 1995, CHEM SENSES, V20, P645, DOI 10.1093/chemse/20.6.645; DRAVNIEKS A, 1982, SCIENCE, V218, P799, DOI 10.1126/science.7134974; Gilad Y, 2003, MOL BIOL EVOL, V20, P307, DOI 10.1093/molbev/msg013; Gilbert AN, 1996, CHEM SENSES, V21, P411, DOI 10.1093/chemse/21.4.411; GOWER DB, 1998, PERFUMERY, P47; GUILLOT M, 1948, CR HEBD ACAD SCI, V226, P1307; Jacob S, 2001, NEUROREPORT, V12, P2391, DOI 10.1097/00001756-200108080-00021; Keller A, 2004, CURR BIOL, V14, pR875, DOI 10.1016/j.cub.2004.09.066; Keller A, 2004, NAT NEUROSCI, V7, P337, DOI 10.1038/nn1215; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; LAIRD DW, 1988, INVEST OPHTH VIS SCI, V29, P419; Mainland JD, 2002, NATURE, V419, P802, DOI 10.1038/419802a; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Menashe I, 2003, NAT GENET, V34, P143, DOI 10.1038/ng1160; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; STEVENS DA, 1995, CHEM SENSES, V20, P413, DOI 10.1093/chemse/20.4.413; Wang LW, 2004, J PHYSIOL-LONDON, V554, P236, DOI 10.1113/jphysiol.2003.054726; WHISSELLBUECHY D, 1973, NATURE, V242, P271, DOI 10.1038/242271a0; Wyart C, 2007, J NEUROSCI, V27, P1261, DOI 10.1523/JNEUROSCI.4430-06.2007; WYSOCKI CJ, 1989, P NATL ACAD SCI USA, V86, P7976, DOI 10.1073/pnas.86.20.7976; WYSOCKI CJ, 1984, P NATL ACAD SCI-BIOL, V81, P4899, DOI 10.1073/pnas.81.15.4899; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200	28	439	457	1	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2007	449	7161					468	U6		10.1038/nature06162	http://dx.doi.org/10.1038/nature06162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17873857	Green Submitted			2022-12-01	WOS:000249724800042
J	Sugarman, SD				Sugarman, Stephen D.			Cases in vaccine court - Legal battles over vaccines and austism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif Berkeley, Sch Law, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Sugarman, SD (corresponding author), Univ Calif Berkeley, Sch Law, Boalt Hall, Berkeley, CA 94720 USA.							*DEP HLTH HUM SERV, NAT VACC INJ COMP PR; Horton R, 2004, LANCET, V363, P820, DOI 10.1016/S0140-6736(04)15699-7; Murch SH, 2004, LANCET, V363, P750, DOI 10.1016/S0140-6736(04)15715-2; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0	4	28	32	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2007	357	13					1275	1277		10.1056/NEJMp078168	http://dx.doi.org/10.1056/NEJMp078168			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214BR	17898095				2022-12-01	WOS:000249711500002
J	Huang, J; Sengupta, R; Espejo, AB; Lee, MG; Dorsey, JA; Richter, M; Opravil, S; Shiekhattar, R; Bedford, MT; Jenuwein, T; Berger, SL				Huang, Jing; Sengupta, Roopsha; Espejo, Alexsandra B.; Lee, Min Gyu; Dorsey, Jean A.; Richter, Mario; Opravil, Susanne; Shiekhattar, Ramin; Bedford, Mark T.; Jenuwein, Thomas; Berger, Shelley L.			p53 is regulated by the lysine demethylase LSD1	NATURE			English	Article							HISTONE DEMETHYLATION; ANDROGEN-RECEPTOR; DNA-BINDING; PHD FINGER; METHYLATION; 53BP1; DOMAIN; TRANSCRIPTION; ACTIVATION; PROTEINS	p53, the tumour suppressor and transcriptional activator, is regulated by numerous post-translational modifications, including lysine methylation(1,2). Histone lysine methylation has recently been shown to be reversible; however, it is not known whether nonhistone proteins are substrates for demethylation. Here we show that, in human cells, the histone lysine-specific demethylase LSD1 (refs 3, 4) interacts with p53 to repress p53-mediated transcriptional activation and to inhibit the role of p53 in promoting apoptosis. We find that, in vitro, LSD1 removes both monomethylation (K370me1) and dimethylation (K370me2) at K370, a previously identified Smyd2-dependent monomethylation site(2). However, in vivo, LSD1 shows a strong preference to reverse K370me2, which is performed by a distinct, but unknown, methyltransferase. Our results indicate that K370me2 has a different role in regulating p53 from that of K370me1: K370me1 represses p53 function, whereas K370me2 promotes association with the coactivator 53BP1 (p53-binding protein 1) through tandem Tudor domains in 53BP1. Further, LSD1 represses p53 function through the inhibition of interaction of p53 with 53BP1. These observations show that p53 is dynamically regulated by lysine methylation and demethylation and that the methylation status at a single lysine residue confers distinct regulatory output. Lysine methylation therefore provides similar regulatory complexity for non-histone proteins and for histones.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Texas, MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX 78957 USA	The Wistar Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Texas System; UTMD Anderson Cancer Center	Berger, SL (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	berger@wistar.org	Huang, Jing/A-2566-2009; Bedford, Mark T/E-7856-2011	Huang, Jing/0000-0002-7163-5156; Berger, Shelley/0000-0001-5398-4400; Espejo, Alexsandra/0000-0002-8841-7219				Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Iwabuchi K, 1998, J BIOL CHEM, V273, P26061, DOI 10.1074/jbc.273.40.26061; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Morales JC, 2006, P NATL ACAD SCI USA, V103, P3310, DOI 10.1073/pnas.0511259103; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Sengupta S, 2004, J CELL BIOL, V166, P801, DOI 10.1083/jcb.200405128; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Ward I, 2006, J BIOL CHEM, V281, P38472, DOI 10.1074/jbc.M607577200; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	28	578	646	3	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2007	449	7158					105	U80		10.1038/nature06092	http://dx.doi.org/10.1038/nature06092			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207ED	17805299				2022-12-01	WOS:000249233500045
J	Gorrini, C; Squatrito, M; Luise, C; Syed, N; Perna, D; Wark, L; Martinato, F; Sardella, D; Verrecchia, A; Bennett, S; Confalonieri, S; Cesaroni, M; Marchesi, F; Gasco, M; Scanziani, E; Capra, M; Mai, S; Nuciforo, P; Crook, T; Lough, J; Amati, B				Gorrini, Chiara; Squatrito, Massimo; Luise, Chiara; Syed, Nelofer; Perna, Daniele; Wark, Landon; Martinato, Francesca; Sardella, Domenico; Verrecchia, Alessandro; Bennett, Samantha; Confalonieri, Stefano; Cesaroni, Matteo; Marchesi, Francesco; Gasco, Milena; Scanziani, Eugenio; Capra, Maria; Mai, Sabine; Nuciforo, Paolo; Crook, Tim; Lough, John; Amati, Bruno			Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response	NATURE			English	Article							MYC-INDUCED LYMPHOMAGENESIS; C-MYC; GENOMIC INSTABILITY; HISTONE ACETYLTRANSFERASE; INDUCED APOPTOSIS; P53 PATHWAY; ATM; TUMORIGENESIS; ACETYLATION; ACTIVATION	The acetyl-transferase Tip60 might influence tumorigenesis in multiple ways(1). First, Tip60 is a co-regulator of transcription factors that either promote or suppress tumorigenesis, such as Myc and p53(2-4). Second, Tip60 modulates DNA-damage response (DDR) signalling(1), and a DDR triggered by oncogenes can counteract tumour progression(5,6). Using E-mu-myc transgenic mice that are heterozygous for a Tip60 gene (Htatip) knockout allele (hereafter denoted as Tip60(+/-) mice), we show that Tip60 counteracts Myc-induced lymphomagenesis in a haplo-insufficient manner and in a time window that is restricted to a pre- or early-tumoral stage. Tip60 heterozygosity severely impaired the Myc-induced DDR7-9 but caused no general DDR defect in B cells. Myc- and p53-dependent transcription were not affected, and neither were Myc- induced proliferation, activation of the ARF-p53 tumour suppressor pathway or the resulting apoptotic response(10-13). We found that the human TIP60 gene (HTATIP) is a frequent target for mono-allelic loss in human lymphomas and head-and-neck and mammary carcinomas, with concomitant reduction in mRNA levels. Immunohistochemical analysis also demonstrated loss of nuclear TIP60 staining in mammary carcinomas. These events correlated with disease grade and frequently concurred with mutation of p53. Thus, in both mouse and human, Tip60 has a haplo-insufficient tumour suppressor activity that is independent from-but not contradictory with-its role within the ARF-p53 pathway(1-3,14-16). We suggest that this is because critical levels of Tip60 are required for mounting an oncogene-induced DDR in incipient tumour cells(5,6), the failure of which might synergize with p53 mutation towards tumour progression(17-20).	European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; FIRC Inst Mol Oncol, IFOM, I-20139 Milan, Italy; Inst Canc Res, Chester Beatty Labs, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada; Univ Manitoba, Genom Ctr Canc Res & Diag, Winnipeg, MB R3E 0V9, Canada; Univ Milan, Dept Vet Pathol Hyg & Publ Hlth, Sect Vet & Avian Pathol, I-20133 Milan, Italy; San Croce & Carle Hosp, Dept Med Oncol, I-12100 Cuneo, Italy; Med Coll Wisconsin, Milwaukee, WI 53226 USA	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Manitoba; University of Manitoba; University of Milan; Medical College of Wisconsin	Amati, B (corresponding author), European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy.	bruno.amati@ifom-ieo-campus.it	Amati, Bruno/AAM-3418-2020; Capra, Maria/AAM-8054-2020; Mai, Sabine/E-5667-2017; Confalonieri, Stefano/AAQ-6786-2020; Nuciforo, Paolo/Q-2885-2019; Squatrito, Massimo/F-4149-2016; Verrecchia, Alessandro/AAQ-6454-2020; Scanziani, Eugenio/G-8046-2017	Mai, Sabine/0000-0002-5797-2201; Confalonieri, Stefano/0000-0001-6886-9851; Squatrito, Massimo/0000-0002-4593-3790; Verrecchia, Alessandro/0000-0002-8596-6650; Scanziani, Eugenio/0000-0003-3996-5048; Amati, Bruno/0000-0002-2958-1799; Nuciforo, Paolo/0000-0003-1380-0990; Gorrini, Chiara/0000-0002-5239-6671	Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline	Breast Cancer Now		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergamaschi D, 2003, CANCER CELL, V3, P387, DOI 10.1016/S1535-6108(03)00079-5; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; CORCORAN LM, 1985, CELL, V40, P71, DOI 10.1016/0092-8674(85)90310-1; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Eischen CM, 2001, MOL CELL BIOL, V21, P7653, DOI 10.1128/MCB.21.22.7653-7662.2001; Eymin B, 2006, MOL CELL BIOL, V26, P4339, DOI 10.1128/MCB.02240-05; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jiang XF, 2006, J BIOL CHEM, V281, P15741, DOI 10.1074/jbc.M513172200; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Kamijo T, 1999, CANCER RES, V59, P2464; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Morales JC, 2006, P NATL ACAD SCI USA, V103, P3310, DOI 10.1073/pnas.0511259103; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Prochownik EV, 2007, CELL CYCLE, V6, P1024, DOI 10.4161/cc.6.9.4161; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; REIMANN M, 2007, BLOOD           0611; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Shreeram S, 2006, J EXP MED, V203, P2793, DOI 10.1084/jem.20061563; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Syed N, 2006, BLOOD, V107, P250, DOI 10.1182/blood-2005-03-1194; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tyteca S, 2006, EMBO J, V25, P1680, DOI 10.1038/sj.emboj.7601066; Westphal CH, 1997, NAT GENET, V16, P397, DOI 10.1038/ng0897-397	43	257	266	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2007	448	7157					1063	U12		10.1038/nature06055	http://dx.doi.org/10.1038/nature06055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205EU	17728759				2022-12-01	WOS:000249097600041
J	Tang, CL; Toomajian, C; Sherman-Broyles, S; Plagnol, V; Guo, YL; Hu, TT; Clark, RM; Nasrallah, JB; Weigel, D; Nordborg, M				Tang, Chunlao; Toomajian, Christopher; Sherman-Broyles, Susan; Plagnol, Vincent; Guo, Ya-Long; Hu, Tina T.; Clark, Richard M.; Nasrallah, June B.; Weigel, Detlef; Nordborg, Magnus			The evolution of selfing in Arabidopsis thaliana	SCIENCE			English	Article							S-LOCUS; INCOMPATIBILITY	Unlike most of its close relatives, Arabidopsis thaliana is capable of self-pollination. In other members of the mustard family, outcrossing is ensured by the complex self-incompatibility (S) locus, which harbors multiple diverged specificity haplotypes that effectively prevent selfing. We investigated the role of the S locus in the evolution of and transition to selfing in A. thaliana. We found that the S locus of A. thaliana harbored considerable diversity, which is an apparent remnant of polymorphism in the outcrossing ancestor. Thus, the fixation of a single inactivated S-locus allele cannot have been a key step in the transition to selfing. An analysis of the genome-wide pattern of linkage disequilibrium suggests that selfing most likely evolved roughly a million years ago or more.	Univ So Calif, Los Angeles, CA 90089 USA; Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA; Univ Cambridge, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn, Cambridge CB2 2XY, England; Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	University of Southern California; Cornell University; University of Cambridge; Max Planck Society; Salk Institute	Nordborg, M (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	magnus@usc.edu	Toomajian, Christopher/ABA-2615-2021; Tang, Chunlao/F-9203-2010; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/C-1418-2008; Plagnol, Vincent/A-5667-2011; Guo, Yalong/G-4742-2011	Toomajian, Christopher/0000-0002-6763-0678; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Nordborg, Magnus/0000-0001-7178-9748; Plagnol, Vincent/0000-0002-5597-9215; Guo, Yalong/0000-0002-4643-4889	NHGRI NIH HHS [P50 HG002790] Funding Source: Medline; NIGMS NIH HHS [GM62932, R01 GM062932] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062932] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Bechsgaard JS, 2006, MOL BIOL EVOL, V23, P1741, DOI 10.1093/molbev/msl042; Charlesworth D, 2005, BIOESSAYS, V27, P472, DOI 10.1002/bies.20231; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; IOERGER TR, 1990, P NATL ACAD SCI USA, V87, P9732, DOI 10.1073/pnas.87.24.9732; KAPLAN NL, 1989, GENETICS, V123, P887; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Kusaba M, 2001, PLANT CELL, V13, P627, DOI 10.1105/tpc.13.3.627; Liu P, 2007, CURR BIOL, V17, P734, DOI 10.1016/j.cub.2007.03.022; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Nasrallah JB, 2000, CURR OPIN PLANT BIOL, V3, P368, DOI 10.1016/S1369-5266(00)00098-4; Nasrallah ME, 2004, P NATL ACAD SCI USA, V101, P16070, DOI 10.1073/pnas.0406970101; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 2000, GENETICS, V154, P923; Sherman-Broyles S, 2007, PLANT CELL, V19, P94, DOI 10.1105/tpc.106.048199; Shimizu KK, 2004, SCIENCE, V306, P2081, DOI 10.1126/science.1103776; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]	18	122	138	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2007	317	5841					1070	1072		10.1126/science.1143153	http://dx.doi.org/10.1126/science.1143153			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203AE	17656687				2022-12-01	WOS:000248946700041
J	Katzman, S; Kern, AD; Bejerano, G; Fewell, G; Fulton, L; Wilson, RK; Salama, SR; Haussler, D				Katzman, Sol; Kern, Andrew D.; Bejerano, Gill; Fewell, Ginger; Fulton, Lucinda; Wilson, Richard K.; Salama, Sofie R.; Haussler, David			Human genome ultraconserved elements are ultraselected	SCIENCE			English	Article							REGIONS		Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Washington University (WUSTL); Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Haussler, D (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA.	haussler@soe.ucsc.edu	Salama, Sofie/K-6412-2019; Wilson, Richard K./AAF-4139-2019	Wilson, Richard K./0000-0002-1992-1358; Salama, Sofie/0000-0001-6999-7193				Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Keightley PD, 2005, PLOS BIOL, V3, P282, DOI 10.1371/journal.pbio.0030042; Kryukov GV, 2005, HUM MOL GENET, V14, P2221, DOI 10.1093/hmg/ddi226; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295	6	187	194	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					915	915		10.1126/science.1142430	http://dx.doi.org/10.1126/science.1142430			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702936				2022-12-01	WOS:000248780200030
J	Fortin, PD; Walsh, CT; Magarvey, NA				Fortin, Pascal D.; Walsh, Christopher T.; Magarvey, Nathan A.			A transglutaminase homologue as a condensation catalyst in antibiotic assembly lines	NATURE			English	Article							HETEROLOGOUS EXPRESSION; BIOSYNTHESIS; GENE; IDENTIFICATION; INACTIVATION; AMINOMUTASE; POLYKETIDE; BACTERIUM	The unrelenting emergence of antibiotic- resistant bacterial pathogens demands the investigation of antibiotics with new modes of action. The pseudopeptide antibiotic andrimid is a nanomolar inhibitor of the bacterial acetyl- CoA carboxylase that catalyses the first committed step in prokaryotic fatty acid biosynthesis(1). Recently, the andrimid ( adm) biosynthetic gene cluster was isolated and heterologously expressed in Escherichia coli(2). This establishes a heterologous biological host in which to rapidly probe features of andrimid formation and to use biosynthetic engineering to make unnatural variants of this important and promising new class of antibiotics. Bioinformatic analysis of the adm cluster revealed a dissociated biosynthetic assembly system lacking canonical amide synthases between the first three carrier protein domains. Here we report that AdmF, a transglutaminase ( TGase) homologue, catalyses the formation of the first amide bond, an N-acyl-beta-peptide link, in andrimid biosynthesis. Hence, AdmF is a newly discovered biosynthetic enzyme that acts as a stand- alone amide synthase between protein- bound, thiotemplated substrates in an antibiotic enzymatic assembly line. TGases ( enzyme class ( EC) 2.3.2.13) normally catalyse the cross- linking of ( poly) peptides by creating isopeptidic bonds between the gamma-carboxamide group of a glutamine side chain of one protein and various amine donors, including lysine side chains(3). To the best of our knowledge, the present study constitutes the first report of a TGase- like enzyme recruited for the assembly of an antibiotic. Moreover, genome mining using the AdmF sequence yielded additional TGases in unassigned natural product biosynthetic pathways. With many more microbial genomes being sequenced, such a strategy could potentially unearth biosynthetic pathways producing new classes of antibiotics.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Walsh, CT (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	christopher_walsh@hms.harvard.edu		Fortin, Pascal/0000-0001-9796-791X				Christenson SD, 2003, BIOCHEMISTRY-US, V42, P12708, DOI 10.1021/bi035223r; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; FREDENHAGEN A, 1987, J AM CHEM SOC, V109, P4409, DOI 10.1021/ja00248a055; Freiberg C, 2004, J BIOL CHEM, V279, P26066, DOI 10.1074/jbc.M402989200; Jin M, 2006, J AM CHEM SOC, V128, P10660, DOI 10.1021/ja063194c; Keating TA, 1999, CURR OPIN CHEM BIOL, V3, P598, DOI 10.1016/S1367-5931(99)00015-0; Liolios K, 2006, NUCLEIC ACIDS RES, V34, pD332, DOI 10.1093/nar/gkj145; Molnar-Perl I, 2001, J CHROMATOGR A, V913, P283, DOI 10.1016/S0021-9673(00)01200-0; NEEDHAM J, 1994, J ORG CHEM, V59, P2058, DOI 10.1021/jo00087a020; OCLARIT JM, 1994, MICROBIOS, V78, P7; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; SAMPSON BA, 1989, GENETICS, V122, P491; STAAB HA, 1962, CHEM BER-RECL, V95, P1275, DOI 10.1002/cber.19620950526; Tonge PJ, 1995, BIOSPECTROSCOPY, V1, P387, DOI 10.1002/bspy.350010604; Walker KD, 2004, J BIOL CHEM, V279, P53947, DOI 10.1074/jbc.M411215200; Walsh C., 2006, POSTTRANSLATIONAL MO; Xiang LK, 2002, J BIOL CHEM, V277, P32505, DOI 10.1074/jbc.M204171200; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296	19	49	51	3	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 16	2007	448	7155					824	U11		10.1038/nature06068	http://dx.doi.org/10.1038/nature06068			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17653193				2022-12-01	WOS:000248754200044
J	Webster, M				Webster, Mark			A Cambrian peak in morphological variation within trilobite species	SCIENCE			English	Article							EVOLUTION; PATTERNS; LINES	Morphological variation within species is a raw material subject to natural selection. However, temporal change in morphological diversity has usually been studied in terms of variation among rather than within species. The distribution of polymorphic traits in cladistic character-taxon matrices reveals that the frequency and extent of morphological variation in 982 trilobite species are greatest early in the evolution of the group: Stratigraphically old and/or phylogenetically basal taxa are significantly more variable than younger and/or more derived taxa. Through its influence on evolutionary tempo, high intraspecific variation may have played a major role in the pronounced Cambrian diversification of trilobites.	Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Chicago	Webster, M (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	mwebster@geosci.uchicago.edu						Adrain J.M, 2006, GEOL SOC AM ABSTR, V38, P207; Adrain JM, 1998, SCIENCE, V280, P1922, DOI 10.1126/science.280.5371.1922; [Anonymous], 1994, ACTA PALAEONTOL POL; Budd GE, 2006, BIOL REV, V81, P609, DOI 10.1017/S1464793106007135; Cotton TJ, 2005, CRUSTACEAN ISS, V16, P95, DOI 10.1201/9781420037548.ch5; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Erwin DH, 2007, PALAEONTOLOGY, V50, P57, DOI 10.1111/j.1475-4983.2006.00614.x; FOOTE M, 1991, PALAEONTOLOGY, V34, P461; FOOTE M, 1988, PALEOBIOLOGY, V14, P258, DOI 10.1017/S0094837300011994; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; FOOTE M, 1993, PALEOBIOLOGY, V19, P185, DOI 10.1017/S0094837300015864; Fortey R.A., 1990, P121; Fortey RA, 2001, J PALEONTOL, V75, P1141, DOI 10.1666/0022-3360(2001)075<1141:TSTLY>2.0.CO;2; Gould S.J., 1989, WONDERFUL LIFE BURGE; GOULD SJ, 1987, SCIENCE, V236, P1437, DOI 10.1126/science.236.4807.1437; Hughes NC, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P139; Hughes NC, 1999, EVOL DEV, V1, P24, DOI 10.1046/j.1525-142x.1999.99005.x; HUGHES NC, 1991, GEOLOGY, V19, P913, DOI 10.1130/0091-7613(1991)019<0913:MPAGFI>2.3.CO;2; JAANUSSON V, 1975, Fossils and Strata, V4, P209; Jablonski D, 2007, PALAEONTOLOGY, V50, P87, DOI 10.1111/j.1475-4983.2006.00615.x; MCNAMARA KJ, 1986, BIOL REV, V61, P121, DOI 10.1111/j.1469-185X.1986.tb00464.x; Naimark EB, 2006, PALEONTOL J+, V40, P541, DOI 10.1134/S003103010605008X; RAMSKOLD L, 1991, T ROY SOC EDIN-EARTH, V82, P143, DOI 10.1017/S0263593300007616; Renaud S, 2006, EVOLUTION, V60, P1701; Riedl R., 1978, ORDER LIVING ORGANIS; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Sniegowski PD, 2006, CURR BIOL, V16, pR831, DOI 10.1016/j.cub.2006.08.080; VALENTINE JW, 1995, PALAIOS, V10, P190, DOI 10.2307/3515182; Wagner GP, 2004, J EXP ZOOL PART B, V302B, P92, DOI 10.1002/jez.b.20005; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; West-Eberhard Mary Jane, 2003, pi	31	77	79	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 27	2007	317	5837					499	502		10.1126/science.1142964	http://dx.doi.org/10.1126/science.1142964			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656721				2022-12-01	WOS:000248339800041
J	Teh, OK; Moore, I				Teh, Ooi-kock; Moore, Ian			An ARF-GEF acting at the Golgi and in selective endocytosis in polarized plant cells	NATURE			English	Article							REGULATES VESICLE TRAFFICKING; NUCLEOTIDE-EXCHANGE FACTORS; ENDOPLASMIC-RETICULUM; BREFELDIN-A; PLASMA-MEMBRANE; AUXIN TRANSPORT; H+-ATPASE; ARABIDOPSIS; PROTEIN; GTPASE	Circumstantial evidence suggests that intracellular membrane trafficking pathways diversified independently in the plant kingdom(1-10), but documented examples are rare(6,11,12). ARF-GEFs (guanine-nucleotide exchange factors for ADP-ribosylation factor GTPases) are essential for vesicular trafficking in all eukaryotic kingdoms, but of the eight ARF-GEF families, only the ancestral BIG and GBF types are found in plants(1,2). Whereas fungal and animal GBF proteins perform conserved functions at the Golgi, the Arabidopsis thaliana GBF protein GNOM is thought to act in only the process of recycling from endosomes(3-5). We now show that the related Arabidopsis GBF protein GNOM-LIKE1 (GNL1) has an ancestral function at the Golgi but is also required for selective internalization from the plasma membrane in the presence of brefeldin A (BFA). We identified gnl1 mutants that accumulated biosynthetic and recycling endoplasmic reticulum markers in enlarged internal compartments. Notably, in the absence of functional GNL1, Golgi stacks were rendered sensitive to the selective ARF-GEF inhibitor BFA, which caused them to fuse with the endoplasmic reticulum. Furthermore, in BFA-treated gnl1 roots, the internalization of a polar plasma-membrane marker, the auxin efflux carrier PIN2, was selectively inhibited. Thus, GNL1 is a BFA-resistant GBF protein that functions with a BFA-sensitive ARF-GEF both at the Golgi and in selective endocytosis, but not in recycling from endosomes. We propose that the evolution of endocytic trafficking in plants was accompanied by neo-functionalization within the GBF family, whereas in other kingdoms it occurred independently by elaboration of additional ARF-GEF families.	Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	University of Oxford	Moore, I (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	ian.moore@plants.ox.ac.uk		Teh, Ooi-kock/0000-0001-6800-2748	Biotechnology and Biological Sciences Research Council [REI20537, BBS/B/09562] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Batoko H, 2000, PLANT CELL, V12, P2201, DOI 10.1105/tpc.12.11.2201; Cheung AY, 2002, PLANT CELL, V14, P945, DOI 10.1105/tpc.000836; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.e02-11-0730; Geldner N, 2004, PLANTA, V219, P547, DOI 10.1007/s00425-004-1302-x; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Grebe M, 2003, CURR BIOL, V13, P1378, DOI 10.1016/S0960-9822(03)00538-4; Hawes C, 2005, NEW PHYTOL, V165, P29, DOI 10.1111/j.1469-8137.2004.01218.x; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Jaillais Y, 2006, NATURE, V443, P106, DOI 10.1038/nature05046; Jurgens G, 2004, ANNU REV CELL DEV BI, V20, P481, DOI 10.1146/annurev.cellbio.20.082503.103057; Kotzer AM, 2004, J CELL SCI, V117, P6377, DOI 10.1242/jcs.01564; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Lefebvre B, 2004, PLANT CELL, V16, P1772, DOI 10.1105/tpc.022277; Li G, 2007, PLANT CELL, V19, P281, DOI 10.1105/tpc.106.041426; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Macia E, 2004, J CELL SCI, V117, P2389, DOI 10.1242/jcs.01090; Mouratou B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-20; Murphy AS, 2005, ANNU REV PLANT BIOL, V56, P221, DOI 10.1146/annurev.arplant.56.032604.144150; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Renna L, 2005, PLANT MOL BIOL, V58, P109, DOI 10.1007/s11103-005-4618-4; Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Saint-Jore CM, 2002, PLANT J, V29, P661, DOI 10.1046/j.0960-7412.2002.01252.x; Samalova M, 2006, TRAFFIC, V7, P1701, DOI 10.1111/j.1600-0854.2006.00502.x; Sanderfoot AA, 2000, PLANT PHYSIOL, V124, P1558, DOI 10.1104/pp.124.4.1558; SatiatJeunemaitre B, 1996, J MICROSC-OXFORD, V181, P162, DOI 10.1046/j.1365-2818.1996.112393.x; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Zheng HQ, 2005, PLANT CELL, V17, P2020, DOI 10.1105/tpc.105.031112; Zheng HQ, 2004, PLANT J, V37, P398, DOI 10.1046/j.1365-313X.2003.01969.x	35	197	203	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 26	2007	448	7152					493	496		10.1038/nature06023	http://dx.doi.org/10.1038/nature06023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	193VG	17653191				2022-12-01	WOS:000248302700051
J	Lunyak, VV; Prefontaine, GG; Nunez, E; Cramer, T; Ju, BG; Ohgi, KA; Hutt, K; Roy, R; Garcia-Diaz, A; Zhu, XY; Yung, Y; Montoliu, L; Glass, CK; Rosenfeld, MG				Lunyak, Victoria V.; Prefontaine, Gratien G.; Nunez, Esperanza; Cramer, Thorsten; Ju, Bong-Gun; Ohgi, Kenneth A.; Hutt, Kasey; Roy, Rosa; Garcia-Diaz, Angel; Zhu, Xiaoyan; Yung, Yun; Montoliu, Lluis; Glass, Christopher K.; Rosenfeld, Michael G.			Developmentally regulated activation of a SINE B2 repeat as a domain boundary in organogenesis	SCIENCE			English	Article							LOCUS-CONTROL REGION; BETA-GLOBIN INSULATOR; GROWTH-HORMONE GENE; RNA-POLYMERASE-II; NUCLEAR ARCHITECTURE; METHYLTRANSFERASES; HETEROCHROMATIN; ELEMENTS; CELLS; TRANSCRIPTION	The temporal and spatial regulation of gene expression in mammalian development is linked to the establishment of functional chromatin domains. Here, we report that tissue-specific transcription of a retrotransposon repeat in the murine growth hormone locus is required for gene activation. This repeat serves as a boundary to block the influence of repressive chromatin modifications. The repeat element is able to generate short, overlapping Pol II- and Pol III-driven transcripts, both of which are necessary and sufficient to enable a restructuring of the regulated locus into nuclear compartments. These data suggest that transcription of interspersed repetitive sequences may represent a developmental strategy for the establishment of functionally distinct domains within the mammalian genome to control gene activation.	Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, Div Endocrinol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, Dept Med, Sch Med, La Jolla, CA 92093 USA; CSIC, CNB, Dept Mol & Cellular Biol, Madrid 28049, Spain; Charite Univ Med Berlin, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lunyak, VV (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, 9500 Gilman Dr,Room 345, La Jolla, CA 92093 USA.	vlunyak@uscd.edu; mrosenfeld@ucsd.edu	ROY, ROSA/AAA-9584-2019; Cramer, Thorsten/S-2479-2016; Garcia-Diaz, Angel/AAT-9213-2020; Glass, Christopher/AAI-3933-2021; Montoliu, Lluis/I-2039-2015; lunyak, victoria/R-3765-2017	Cramer, Thorsten/0000-0002-6462-239X; Garcia-Diaz, Angel/0000-0001-6139-6764; Glass, Christopher/0000-0003-4344-3592; Montoliu, Lluis/0000-0003-3941-1176; lunyak, victoria/0000-0001-9093-2714; Roy Barcelona, Rosa/0000-0003-0729-3849				Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; Antes TJ, 2001, BIOCHEMISTRY-US, V40, P6731, DOI 10.1021/bi0100743; BACHVAROVA R, 1988, DEV BIOL, V130, P513, DOI 10.1016/0012-1606(88)90346-6; Bennani-Baiti IM, 1998, GENOMICS, V48, P258, DOI 10.1006/geno.1997.5171; Bennani-Baiti IM, 1998, P NATL ACAD SCI USA, V95, P10655, DOI 10.1073/pnas.95.18.10655; Biron VL, 2004, DEV BIOL, V276, P337, DOI 10.1016/j.ydbio.2004.08.038; Capelson M, 2004, BIOL CELL, V96, P617, DOI 10.1016/j.biolcel.2004.06.004; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; CILIBERTO G, 1983, CELL, V32, P725, DOI 10.1016/0092-8674(83)90058-2; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Espinoza CA, 2004, NAT STRUCT MOL BIOL, V11, P822, DOI 10.1038/nsmb812; Ferrigno O, 2001, NAT GENET, V28, P77, DOI 10.1038/ng0501-77; Gasser SM, 2002, SCIENCE, V296, P1412, DOI 10.1126/science.1067703; Giraldo P, 2003, NUCLEIC ACIDS RES, V31, P6290, DOI 10.1093/nar/gkg793; JONES BK, 1995, MOL CELL BIOL, V15, P7010; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Noma KI, 2006, CELL, V125, P859, DOI 10.1016/j.cell.2006.04.028; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Recillas-Targa F, 1999, P NATL ACAD SCI USA, V96, P14354, DOI 10.1073/pnas.96.25.14354; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Rice JC, 2001, NATURE, V414, P258, DOI 10.1038/35104721; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Shewchuk BM, 2001, NUCLEIC ACIDS RES, V29, P3356, DOI 10.1093/nar/29.16.3356; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Valadez-Graham V, 2004, NUCLEIC ACIDS RES, V32, P1354, DOI 10.1093/nar/gkh301	27	197	209	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2007	317	5835					248	251		10.1126/science.1140871	http://dx.doi.org/10.1126/science.1140871			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17626886				2022-12-01	WOS:000247968600044
J	Ma, JF; Yamaji, N; Mitani, N; Tamai, K; Konishi, S; Fujiwara, T; Katsuhara, M; Yano, M				Ma, Jian Feng; Yamaji, Naoki; Mitani, Namiki; Tamai, Kazunori; Konishi, Saeko; Fujiwara, Toru; Katsuhara, Maki; Yano, Masahiro			An efflux transporter of silicon in rice	NATURE			English	Article							PLANTS; ROOTS; RESISTANCE	Silicon is an important nutrient for the optimal growth and sustainable production of rice(1-4). Rice accumulates up to 10% silicon in the shoot, and this high accumulation is required to protect the plant from multiple abiotic and biotic stresses(1-5). A gene, Lsi1, that encodes a silicon influx transporter has been identified in rice(6). Here we describe a previously uncharacterized gene, low silicon rice 2 (Lsi2), which has no similarity to Lsi1. This gene is constitutively expressed in the roots. The protein encoded by this gene is localized, like Lsi1, on the plasma membrane of cells in both the exodermis and the endodermis, but in contrast to Lsi1, which is localized on the distal side, Lsi2 is localized on the proximal side of the same cells. Expression of Lsi2 in Xenopus oocytes did not result in influx transport activity for silicon, but preloading of the oocytes with silicon resulted in a release of silicon, indicating that Lsi2 is a silicon efflux transporter. The identification of this silicon transporter revealed a unique mechanism of nutrient transport in plants: having an influx transporter on one side and an efflux transporter on the other side of the cell to permit the effective transcellular transport of the nutrients.	Okayama Univ, Bioresources Res Inst, Kurashiki, Okayama 7100046, Japan; Inst Soc Technoinnovat Agr Forestry & Fisheries, Tsukuba, Ibaraki 3050854, Japan; Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan; Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Tokyo 1030027, Japan; Natl Inst Agrobiol Sci, QTL Genom Res Ctr, Tsukuba, Ibaraki 3058602, Japan	Okayama University; University of Tokyo; Japan Science & Technology Agency (JST); National Institute of Agrobiological Sciences - Japan	Ma, JF (corresponding author), Okayama Univ, Bioresources Res Inst, Chuo 2-20-1, Kurashiki, Okayama 7100046, Japan.	maj@rib.okayama-u.ac.jp	Ma, Jianfeng/GZB-0110-2022; YAMAJI, Naoki/B-2524-2011; Yano, Masahiro/AAC-5441-2019; FUJIWARA, Toru/A-4119-2011; Feng, Jian/C-7213-2009	YAMAJI, Naoki/0000-0002-7499-3004; Feng, Jian/0000-0003-3411-827X; Yano, Masahiro/0000-0003-1510-4622; Katsuhara, Maki/0000-0002-8264-3063				[Anonymous], 2005, MINERAL NUTR PLANTS; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Fauteux F, 2005, FEMS MICROBIOL LETT, V249, P1, DOI 10.1016/j.femsle.2005.06.034; Fuse T., 2001, PLANT BIOTECHNOL, V18, P219, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.18.219; Gong HJ, 2006, PLANT CELL ENVIRON, V29, P1970, DOI 10.1111/j.1365-3040.2006.01572.x; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HILDEBRAND M, 1993, GENE, V132, P213, DOI 10.1016/0378-1119(93)90198-C; Hildebrand M, 1997, NATURE, V385, P688, DOI 10.1038/385688b0; Hodson MJ, 2005, ANN BOT-LONDON, V96, P1027, DOI 10.1093/aob/mci255; Kawai M, 1998, PLANTA, V204, P277, DOI 10.1007/s004250050257; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; Ma JF, 2004, SOIL SCI PLANT NUTR, V50, P11, DOI 10.1080/00380768.2004.10408447; Ma JF, 2003, PLANT SOIL, V249, P383, DOI 10.1023/A:1022842421926; Ma JF, 2002, PLANT PHYSIOL, V130, P2111, DOI 10.1104/pp.010348; Ma JF, 2001, PLANT PHYSIOL, V127, P1773, DOI 10.1104/pp.010271; Ma JF, 2006, TRENDS PLANT SCI, V11, P392, DOI 10.1016/j.tplants.2006.06.007; Ma JianFeng, 2002, Soil, fertilizer and plant silicon research in Japan, DOI 10.1016/B978-044451166-9/50007-5; Meng YL, 2004, J BIOL CHEM, V279, P18334, DOI 10.1074/jbc.M400037200; Rains DW, 2006, PLANT SOIL, V280, P223, DOI 10.1007/s11104-005-3082-x; Raven JA., 2001, SILICON AGR, P41, DOI [10.1016/S0928-3420(01)80007-0, DOI 10.1016/S0928-3420(01)80007-0]; Savant NK, 1997, ADV AGRON, V58, P151; Taiz L, 1998, PLANT PHYSIOL, P103; Takahashi E., 1976, Journal of the Science of Soil and Manure, Japan, V47, P191; Takahashi E., 1976, Journal of the Science of Soil and Manure, Japan, V47, P183; Takahashi E., 1990, Comments on Agricultural and Food Chemistry, V2, P99; Tallberg P, 2002, WATER RES, V36, P956, DOI 10.1016/S0043-1354(01)00312-8; Tamai K, 2003, NEW PHYTOL, V158, P431, DOI 10.1046/j.1469-8137.2003.00773.x; YOSHIDA SHOICHI, 1965, BULL NAT INST AGR SCI SER B [JAP], V15, P1	28	564	619	12	263	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 12	2007	448	7150					209	U12		10.1038/nature05964	http://dx.doi.org/10.1038/nature05964			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17625566				2022-12-01	WOS:000247934500046
J	Rutz, C; Bluff, LA; Weir, AAS; Kacelnik, A				Rutz, Christian; Bluff, Lucas A.; Weir, Alex A. S.; Kacelnik, Alex			Video cameras on wild birds	SCIENCE			English	Article									Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Rutz, C (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	christian.rutz@zoo.ox.ac.uk	Weir, Alex/B-4664-2008	Rutz, Christian/0000-0001-5187-7417	Biotechnology and Biological Sciences Research Council [BB/C517392/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bluff LA, 2007, COMP COGN BEHAV REV, V2, P1; Hunt G.R., 2006, ACTA ZOOL SINICA, V52, P622	2	74	76	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2007	318	5851					765	765		10.1126/science.1146788	http://dx.doi.org/10.1126/science.1146788			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	226IY	17916693				2022-12-01	WOS:000250583900032
J	Lim, RYH; Fahrenkrog, B; Koser, J; Schwarz-Herion, K; Deng, J; Aebi, U				Lim, Roderick Y. H.; Fahrenkrog, Birthe; Koeser, Joachim; Schwarz-Herion, Kyrill; Deng, Jie; Aebi, Ueli			Nanomechanical basis of selective gating by the nuclear pore complex	SCIENCE			English	Article							PHENYLALANINE-GLYCINE NUCLEOPORINS; NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN IMPORT; BINDING-DYNAMICS; REPEAT REGIONS; MECHANISM; PERMEABILITY; SPECTROSCOPY; TOPOLOGY; CYCLE	The nuclear pore complex regulates cargo transport between the cytoplasm and the nucleus. We set out to correlate the governing biochemical interactions to the nanoscopic responses of the phenylalanine-glycine (FG)-rich nucleoporin domains, which are involved in attenuating or promoting cargo translocation. We found that binding interactions with the transport receptor karyopherin-beta 1 caused the FG domains of the human nucleoporin Nup153 to collapse into compact molecular conformations. This effect was reversed by the action of Ran guanosine triphosphate, which returned the FG domains into a polymer brush-like, entropic barrier conformation. Similar effects were observed in Xenopus oocyte nuclei in situ. Thus, the reversible collapse of the FG domains may play an important role in regulating nucleocytoplasmic transport.	Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland; Inst Mat Res & Engn, Singapore 117602, Singapore	University of Basel; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Materials Research & Engineering (IMRE)	Lim, RYH (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.	roderick.lim@unibas.ch; birthe.fahrenkrog@unibas.ch	Fahrenkrog, Birthe/D-5840-2011	Fahrenkrog, Birthe/0000-0003-4080-9413; Lim, Roderick/0000-0001-5015-6087				Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Chattopadhyay K, 2005, P NATL ACAD SCI USA, V102, P2385, DOI 10.1073/pnas.0500127102; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Eijkel JCT, 2005, MICROFLUID NANOFLUID, V1, P249, DOI 10.1007/s10404-004-0012-9; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; Lim RYH, 2007, J STRUCT BIOL, V159, P277, DOI 10.1016/j.jsb.2007.01.018; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Paradise A, 2007, J MOL BIOL, V365, P50, DOI 10.1016/j.jmb.2006.09.089; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; Timney BL, 2006, J CELL BIOL, V175, P579, DOI 10.1083/jcb.200608141; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053	29	235	235	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 26	2007	318	5850					640	643		10.1126/science.1145980	http://dx.doi.org/10.1126/science.1145980			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223XL	17916694				2022-12-01	WOS:000250409200045
J	Jacob, L; Lum, L				Jacob, Leni; Lum, Lawrence			Deconstructing the hedgehog pathway in development and disease	SCIENCE			English	Editorial Material							SIGNAL-TRANSDUCTION; CELL; DIVERGENCE; DROSOPHILA; NETWORK; COMPLEX; IHOG; SMO	The Hedgehog (Hh) family of secreted signaling proteins is a master regulator of cell fate determination in metazoans, contributing to both pattern formation during embryonic development and postembryonic tissue homeostasis. In a universally used mode of action, graded distribution of Hh protein induces differential cell fate in a dose-dependent manner in cells that receive Hh. Though much of this pathway has been elucidated from genetically based studies in model organisms, such as Drosophila and mice, the importance of Hh-mediated signaling in humans is clearly evident from malformations and a broad range of cancers that arise when the pathway is corrupted.	Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Lum, L (corresponding author), Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA.	lawrence.lum@utsouthwestern.edu			NIGMS NIH HHS [R01 GM076398] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076398] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Claret S, 2007, CURR BIOL, V17, P1326, DOI 10.1016/j.cub.2007.06.059; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Jacob L., 2007, SCI STKE, V2007, pcm7; Liu YJ, 2007, GENE DEV, V21, P1949, DOI 10.1101/gad.1557407; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; McLellan JS, 2006, P NATL ACAD SCI USA, V103, P17208, DOI 10.1073/pnas.0606738103; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040	16	52	65	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847					66	68		10.1126/science.1147314	http://dx.doi.org/10.1126/science.1147314			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916724	Green Accepted			2022-12-01	WOS:000249915400038
J	Muller, B; Sheen, J				Mueller, Bruno; Sheen, Jen			Advances in cytokinin signaling	SCIENCE			English	Editorial Material							RESPONSE REGULATORS; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; TRANSDUCTION; DIFFERENTIATION; RECEPTOR; PATHWAY; AHK3; ARR2		Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sheen, J (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	sheen@molbio.mgh.harvard.edu	Mueller, Bruno/E-9888-2017	Mueller, Bruno/0000-0003-2664-7219				Amasino R, 2005, PLANT PHYSIOL, V138, P1177, DOI 10.1104/pp.104.900160; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Dortay H, 2006, FEBS J, V273, P4631, DOI 10.1111/j.1742-4658.2006.05467.x; Ferreira FJ, 2005, CURR OPIN PLANT BIOL, V8, P518, DOI 10.1016/j.pbi.2005.07.013; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Kakimoto T, 1996, SCIENCE, V274, P982, DOI 10.1126/science.274.5289.982; Kim HJ, 2006, P NATL ACAD SCI USA, V103, P814, DOI 10.1073/pnas.0505150103; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Mahonen AP, 2006, CURR BIOL, V16, P1116, DOI 10.1016/j.cub.2006.04.030; Mizuno T, 2004, CURR OPIN PLANT BIOL, V7, P499, DOI 10.1016/j.pbi.2004.07.015; MULLER B, 2007, SCI STKE; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Romanov GA, 2006, J EXP BOT, V57, P4051, DOI 10.1093/jxb/erl179; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Yokoyama A, 2007, PLANT CELL PHYSIOL, V48, P84, DOI 10.1093/pcp/pcl040	19	132	139	4	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847					68	69		10.1126/science.1145461	http://dx.doi.org/10.1126/science.1145461			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916725				2022-12-01	WOS:000249915400039
J	Curtis, LH; Al-Khatib, SM; Shea, AM; Hammill, BG; Hernandez, AF; Schulman, KA				Curtis, Lesley H.; Al-Khatib, Sana M.; Shea, Alisa M.; Hammill, Bradley G.; Hernandez, Adrian F.; Schulman, Kevin A.			Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VENTRICULAR ARRHYTHMIAS; UNITED-STATES; HIGH-RISK; SURVIVAL; MANAGEMENT; ICD-9-CM	Context Previous studies of sex differences in the use of implantable cardioverter-defibrillators (ICDs) predate recent expansions in Medicare coverage and did not provide patient follow-up over multiple years. Objective To examine sex differences in ICD use for primary and secondary prevention of sudden cardiac death. Design, Setting, and Participants Analysis of a 5% national sample of research-identifiable files obtained from the US Centers for Medicare & Medicaid Services for the period 1991 through 2005. Patients were those aged 65 years or older with Medicare fee-for-service coverage and diagnosed with acute myocardial infarction and either heart failure or cardiomyopathy but no prior cardiac arrest or ventricular tachycardia (ie, the primary prevention cohort [n = 65 917 men and 70 504 women]), or with cardiac arrest or ventricular tachycardia (ie, the secondary prevention cohort [n = 52 252 men and 47 411 women]), from 1999 through 2005. Main Outcome Measures Receipt of ICD therapy and all-cause mortality at 1 year. Results In the 2005 primary prevention cohort, 32.3 per 1000 men and 8.6 per 1000 women received ICD therapy within 1 year of cohort entry. In multivariate analyses, men were more likely than women to receive ICD therapy (hazard ratio [HR], 3.15; 95% confidence interval [CI], 2.86-3.47). Among men and women alive at 180 days after cohort entry, the hazard of mortality in the subsequent year was not significantly lower among those who received ICD therapy (HR, 1.01; 95% CI, 0.82-1.23). In the 2005 secondary prevention cohort, 102.2 per 1000 men and 38.4 per 1000 women received ICD therapy. Controlling for demographic variables and comorbid conditions, men were more likely than women to receive ICD therapy (HR, 2.44; 95% CI, 2.30-2.59). Among men and women alive at 30 days after cohort entry, the hazard of mortality in the subsequent year was significantly lower among those who received ICD therapy (HR, 0.65; 95% CI, 0.60-0.71). Conclusion In the Medicare population, women are significantly less likely than men to receive ICD therapy for primary or secondary prevention of sudden cardiac death.	Duke Univ, Sch Med, Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC 27715 USA; Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA	Duke University; Duke University	Curtis, LH (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, Ctr Clin & Genet Econ, POB 17969, Durham, NC 27715 USA.	lesley.curtis@duke.edu	Hernandez, Adrian F/A-7818-2016	Hernandez, Adrian F/0000-0003-3387-9616	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026038] Funding Source: NIH RePORTER; NHLBI NIH HHS [5U01HL66461-05] Funding Source: Medline; NIA NIH HHS [1R01AG026038-01A1] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alexander M, 2002, AM HEART J, V144, P431, DOI 10.1067/mhj.2002.125500; ANDERSON JR, 1983, J CLIN ONCOL, V1, P710, DOI 10.1200/JCO.1983.1.11.710; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Bursi F, 2006, JAMA-J AM MED ASSOC, V296, P2209, DOI 10.1001/jama.296.18.2209; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; European Heart Rhythm Association, 2006, J Am Coll Cardiol, V48, pe247, DOI 10.1016/j.jacc.2006.07.010; Ezekowitz JA, 2003, ANN INTERN MED, V138, P445, DOI 10.7326/0003-4819-138-6-200303180-00007; Gauri AJ., 2006, AM J MED, V119, DOI [DOI 10.1016/J.AMJMED.2005.08.021, 10.1016/j.amjmed.2005.08.021]; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Groeneveld PW, 2005, J AM COLL CARDIOL, V45, P72, DOI 10.1016/j.jacc.2004.07.061; Hlatky MA, 2002, AM HEART J, V144, P397, DOI 10.1067/mhj.2002.125496; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Myerburg RJ, 2001, J CARDIOVASC ELECTR, V12, P369, DOI 10.1046/j.1540-8167.2001.00369.x; Phurrough S., 2003, DECISION MEMORANDUM; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Russo AM, 2004, J CARDIOVASC ELECTR, V15, P993, DOI 10.1046/j.1540-8167.2004.04050.x; Sheifer SE, 2000, AM HEART J, V139, P848, DOI 10.1016/S0002-8703(00)90017-6; Voigt A, 2004, J AM COLL CARDIOL, V44, P855, DOI 10.1016/j.jacc.2004.05.053; Wyse DG, 2001, J AM COLL CARDIOL, V38, P1718, DOI 10.1016/S0735-1097(01)01597-2; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	24	192	192	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2007	298	13					1517	1524		10.1001/jama.298.13.1517	http://dx.doi.org/10.1001/jama.298.13.1517			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216EE	17911496				2022-12-01	WOS:000249860500023
J	Mathonnet, G; Fabian, MR; Svitkin, YV; Parsyan, A; Huck, L; Murata, T; Biffo, S; Merrick, WC; Darzynkiewicz, E; Pillai, RS; Filipowicz, W; Duchaine, TF; Sonenberg, N				Mathonnet, Geraldine; Fabian, Marc R.; Svitkin, Yuri V.; Parsyan, Armen; Huck, Laurent; Murata, Takayuki; Biffo, Stefano; Merrick, William C.; Darzynkiewicz, Edward; Pillai, Ramesh S.; Filipowicz, Witold; Duchaine, Thomas F.; Sonenberg, Nahum			MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex elF4F	SCIENCE			English	Article							MECHANISMS; CELLS; RNA	MicroRNAs (miRNAs) play an important role in gene regulatory networks in animals. Yet, the mechanistic details of their function in translation inhibition or messenger RNA (mRNA) destabilization remain controversial. To directly examine the earliest events in this process, we have developed an in vitro translation system using mouse Krebs-2 ascites cell-free extract that exhibits an authentic miRNA response. We show here that translation initiation, specifically the 5' cap recognition process, is repressed by endogenous let-7 miRNAs within the first 15 minutes of mRNA exposure to the extract when no destabilization of the transcript is observed. Our results indicate that inhibition of translation initiation is the earliest molecular event effected by miRNAs. Other mechanisms, such as mRNA degradation, may subsequently consolidate mRNA silencing.	McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada; Univ Piemonte Orientale, Dept Environm & Life Sci, I-15100 Alessandria, Italy; Ist Sci San Raffaele, Lab Mol Histol, I-20132 Milan, Italy; Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; Univ Warsaw, Inst Phys Expt, Dept Biophys, PL-02089 Warsaw, Poland; Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland	McGill University; McGill University; University of Eastern Piedmont Amedeo Avogadro; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Case Western Reserve University; University of Warsaw; Friedrich Miescher Institute for Biomedical Research	Sonenberg, N (corresponding author), McGill Univ, Dept Biochem, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	thomas.duchaine@mcgill.ca; nahum.sonenberg@mcgill.ca	Duchaine, Thomas/U-2399-2019; Murata, Takayuki/I-2621-2013	Murata, Takayuki/0000-0001-7228-0839; Duchaine, Thomas/0000-0002-3454-1839; Mathonnet, Geraldine/0000-0002-9898-6490; Svitkin, Yuri/0000-0003-3819-2143; biffo, stefano/0000-0002-3780-1050				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Jackson R.J., 2007, SCI STKE, pre1, DOI DOI 10.1126/STKE.3672007RE1; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034	15	376	393	5	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1764	1767		10.1126/science.1146067	http://dx.doi.org/10.1126/science.1146067			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17656684	Green Submitted			2022-12-01	WOS:000249585900052
J	Hadders, MA; Beringer, DX; Gros, P				Hadders, Michael A.; Beringer, Dennis X.; Gros, Piet			Structure of C8 alpha-MACPF reveals mechanism of membrane attack in complement immune defense	SCIENCE			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSINS; PORE-FORMING TOXINS; MACPF DOMAIN; KILLER CELLS; 2 PARTS; BINDING; PERFORIN; POLYMERIZATION; INTERMEDILYSIN; IMMUNOLOGY	Membrane attack is important for mammalian immune defense against invading microorganisms and infected host cells. Proteins of the complement membrane attack complex (MAC) and the protein perforin share a common MACPF domain that is responsible for membrane insertion and pore formation. We determined the crystal structure of the MACPF domain of complement component C8 alpha at 2.5 angstrom resolution and show that it is structurally homologous to the bacterial, pore-forming, cholesterol-dependent cytolysins. The structure displays two regions that (in the bacterial cytolysins) refold into transmembrane beta hairpins, forming the lining of a barrel pore. Local hydrophobicity explains why C8 alpha is the first complement protein to insert into the membrane. The size of the MACPF domain is consistent with known C9 pore sizes. These data imply that these mammalian and bacterial cytolytic proteins share a common mechanism of membrane insertion.	Univ Utrecht, Fac Sci, Dept Chem, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands	Utrecht University	Gros, P (corresponding author), Univ Utrecht, Fac Sci, Dept Chem, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands.	p.gros@chem.uu.nl	Gros, Piet/AAD-6452-2019; Gros, Piet/I-5569-2016	Gros, Piet/0000-0002-7782-2585; Gros, Piet/0000-0002-7782-2585; Beringer, Dennis/0000-0002-5986-1134				Brannen CL, 2007, MOL IMMUNOL, V44, P960, DOI 10.1016/j.molimm.2006.03.012; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; DENNERT G, 1983, J EXP MED, V157, P1483, DOI 10.1084/jem.157.5.1483; DISCIPIO RG, 1985, J BIOL CHEM, V260, P4802; ESSER AF, 1994, TOXICOLOGY, V87, P229, DOI 10.1016/0300-483X(94)90253-4; GEE AP, 1980, J IMMUNOL, V124, P1905; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Huang Y, 2006, J BIOL CHEM, V281, P27398, DOI 10.1074/jbc.M603690200; LOCKERT DH, 1995, J BIOL CHEM, V270, P19723, DOI 10.1074/jbc.270.34.19723; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; PEITSCH MC, 1990, MOL IMMUNOL, V27, P589, DOI 10.1016/0161-5890(90)90001-G; PODACK ER, 1991, ANNU REV IMMUNOL, V9, P129, DOI 10.1146/annurev.iy.09.040191.001021; PODACK ER, 1983, NATURE, V302, P442, DOI 10.1038/302442a0; Polekhina G, 2005, P NATL ACAD SCI USA, V102, P600, DOI 10.1073/pnas.0403229101; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Slade DJ, 2006, BIOCHEMISTRY-US, V45, P5290, DOI 10.1021/bi0601860; SODETZ JM, 1989, CURR TOP MICROBIOL, V140, P19; STECKEL EW, 1983, J BIOL CHEM, V258, P4318; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; TSCHOPP J, 1984, J BIOL CHEM, V259, P7857; TSCHOPP J, 1982, NATURE, V298, P534, DOI 10.1038/298534a0; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wurzner R, 1992, Immunodefic Rev, V3, P123	30	186	193	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2007	317	5844					1552	1554		10.1126/science.1147103	http://dx.doi.org/10.1126/science.1147103			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872444	Green Submitted			2022-12-01	WOS:000249467900042
J	Mehta, RS; Wainwright, PC				Mehta, Rita S.; Wainwright, Peter C.			Raptorial jaws in the throat help moray eels swallow large prey	NATURE			English	Article							BLUEGILL SUNFISH; FISHES; KINEMATICS; MECHANISMS; STRATEGIES; EVOLUTION; PREDATION; PATTERNS; CAPTURE	Most bony fishes rely on suction mechanisms to capture and transport prey(1). Once captured, prey are carried by water movement inside the oral cavity to a second set of jaws in the throat, the pharyngeal jaws, which manipulate the prey and assist in swallowing(1,2). Moray eels display much less effective suction-feeding abilities(3). Given this reduction in a feeding mechanism that is widespread and highly conserved in aquatic vertebrates, it is not known how moray eels swallow large fish and cephalopods(4-7). Here we show that the moray eel (Muraena retifera) overcomes reduced suction capacity by launching raptorial pharyngeal jaws out of its throat and into its oral cavity, where the jaws grasp the struggling prey animal and transport it back to the throat and into the oesophagus. This is the first described case of a vertebrate using a second set of jaws to both restrain and transport prey, and is the only alternative to the hydraulic prey transport reported in teleost fishes. The extreme mobility of the moray pharyngeal jaws is made possible by elongation of the muscles that control the jaws(8), coupled with reduction of adjacent gill-arch structures(9). The discovery that pharyngeal jaws can reach up from behind the skull to grasp prey in the oral jaws reveals a major innovation that may have contributed to the success of moray eels as apex predators hunting within the complex matrix of coral reefs(10,11). This alternative prey transport mode is mechanically similar to the ratcheting mechanisms used in snakes(12,13)-a group of terrestrial vertebrates that share striking morphological, behavioural(14) and ecological convergence with moray eels.	Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA	University of California System; University of California Davis	Mehta, RS (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, 1 Shields Ave, Davis, CA 95616 USA.	rsmehta@ucdavis.edu	Wainwright, Peter/A-7882-2013					Abrams R.W., 1983, Coral Reefs, V1, P185, DOI 10.1007/BF00571196; Alfaro ME, 2001, AM ZOOL, V41, P1266, DOI 10.1668/0003-1569(2001)041[1266:MCATSM]2.0.CO;2; Bohlke Eugenia B., 1989, P104; CARR MH, 1995, MAR ECOL PROG SER, V124, P31, DOI 10.3354/meps124031; Carroll AM, 2004, J EXP BIOL, V207, P3873, DOI 10.1242/jeb.01227; Cundall David, 2000, P293, DOI 10.1016/B978-012632590-4/50010-1; Day SW, 2005, J EXP BIOL, V208, P2661, DOI 10.1242/jeb.01708; DINGERKUS G, 1977, STAIN TECHNOL, V52, P229, DOI 10.3109/10520297709116780; Gilbert M, 2005, ENVIRON BIOL FISH, V73, P415, DOI 10.1007/s10641-005-2228-2; GILLIS GB, 1995, J EXP BIOL, V198, P709; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Hulsey CD, 2005, ZEBRAFISH, V2, P243, DOI 10.1089/zeb.2005.2.243; Kley NJ, 2002, ZOOLOGY, V105, P153, DOI 10.1078/0944-2006-00056; Lauder G.V., 1983, P280; LAUDER GV, 1983, ZOOL J LINN SOC-LOND, V77, P1, DOI 10.1111/j.1096-3642.1983.tb01719.x; LIEM KF, 1973, SYST ZOOL, V22, P425, DOI 10.2307/2412950; Mehta RS, 2007, J EXP BIOL, V210, P495, DOI 10.1242/jeb.02663; MILLER TJ, 1987, COPEIA, P1055; NELSON GJ, 1967, PAC SCI, V21, P348; NELSON GJ, 1966, PAC SCI, V20, P391; PARRISH JD, 1986, ENVIRON BIOL FISH, V14, P285; POPTA CML, 1909, ANN SCI NAT, V19, P367; Randall J. E., 1967, STUD TROP OCEANOGR U, V5, P655; RICHARD BA, 1995, J EXP BIOL, V198, P419; Robins C. Richard, 1989, P9; Schwenk Kurt, 2000, P21, DOI 10.1016/B978-012632590-4/50003-4; Wainwright PC, 2006, FISH PHYSIOL, V23, P77, DOI 10.1016/S1546-5098(05)23003-0; Westneat MW, 2004, INTEGR COMP BIOL, V44, P378, DOI 10.1093/icb/44.5.378; Young RF, 2003, COPEIA, P44; Yukihira H., 1994, APPL BIOL SCI, V33, P159	30	60	61	2	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2007	449	7158					79	U53		10.1038/nature06062	http://dx.doi.org/10.1038/nature06062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207ED	17805293				2022-12-01	WOS:000249233500039
J	Minegishi, Y; Saito, M; Tsuchiya, S; Tsuge, I; Takada, H; Hara, T; Kawamura, N; Ariga, T; Pasic, S; Stojkovic, O; Metin, A; Karasuyama, H				Minegishi, Yoshiyuki; Saito, Masako; Tsuchiya, Shigeru; Tsuge, Ikuya; Takada, Hidetoshi; Hara, Toshiro; Kawamura, Nobuaki; Ariga, Tadashi; Pasic, Srdjan; Stojkovic, Oliver; Metin, Ayse; Karasuyama, Hajime			Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome	NATURE			English	Article							B-CELL DEVELOPMENT; ALLERGIC DISEASE; PATHWAY; INTERLEUKIN-6; ACTIVATION; IMMUNITY; INNATE; ROLES	Hyper-immunoglobulin E syndrome (HIES) is a compound primary immunodeficiency characterized by a highly elevated serum IgE, recurrent staphylococcal skin abscesses and cyst-forming pneumonia, with disproportionately milder inflammatory responses, referred to as cold abscesses, and skeletal abnormalities(1). Although some cases of familial HIES with autosomal dominant or recessive inheritance have been reported, most cases of HIES are sporadic, and their pathogenesis has remained mysterious for a long time. Here we show that dominant-negative mutations in the human signal transducer and activator of transcription 3 (STAT3) gene result in the classical multisystem HIES. We found that eight out of fifteen unrelated non-familial HIES patients had heterozygous STAT3 mutations, but their parents and siblings did not have the mutant STAT3 alleles, suggesting that these were de novo mutations. Five different mutations were found, all of which were located in the STAT3 DNA-binding domain. The patients' peripheral blood cells showed defective responses to cytokines, including interleukin (IL)-6 and IL-10, and the DNA-binding ability of STAT3 in these cells was greatly diminished. All five mutants were non-functional by themselves and showed dominant-negative effects when co-expressed with wild-type STAT3. These results highlight the multiple roles played by STAT3 in humans, and underline the critical involvement of multiple cytokine pathways in the pathogenesis of HIES.	Tokyo Med & Dent Univ, Dept Immune Regulat, Tokyo 1138519, Japan; Tohoku Univ, Grad Sch Med, Dept Pediat, Sendai, Miyagi 9808575, Japan; Fujita Hlth Univ, Dept Pediat, Aichi 4701192, Japan; Kyushu Univ, Dept Pediat, Fukuoka 8128582, Japan; Hokkaido Univ, Grad Sch Med, Dept Pediat, Sapporo, Hokkaido 0608638, Japan; Mother & Child Hlth Inst Serbia, Belgrade 11070, Serbia; Univ Belgrade, Inst Forens Med, Lab Forens Genet, Belgrade 11070, Serbia; SB Ankara Diskapi Childrens Hosp, Dept Pediat Immunol, TR-06110 Ankara, Turkey	Tokyo Medical & Dental University (TMDU); Tohoku University; Fujita Health University; Kyushu University; Hokkaido University; University of Belgrade; Ankara Children's Hematology Oncology Training & Research Hospital	Minegishi, Y (corresponding author), Tokyo Med & Dent Univ, Dept Immune Regulat, Tokyo 1138519, Japan.	yminegishi.mbch@tmd.ac.jp	Karasuyama, Hajime/A-7966-2011; Ariga, Tadashi/A-4252-2012	Karasuyama, Hajime/0000-0003-0689-0836; Stojkovic, Oliver/0000-0002-4794-1882				AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; BUCKLEY RH, 1972, PEDIATRICS, V49, P59; Chapman BLW, 2006, CURR MED IMAGING REV, V2, P131, DOI 10.2174/157340506775541695; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DAVIS SD, 1966, LANCET, V1, P1013; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; Grimbacher B, 1999, AM J HUM GENET, V65, P735, DOI 10.1086/302547; Grimbacher B, 2005, IMMUNOL REV, V203, P244, DOI 10.1111/j.0105-2896.2005.00228.x; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Grimbacher B, 2002, ALLERGY, V57, P995, DOI 10.1034/j.1398-9995.2002.02168.x; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; HORVATH CM, 1995, GENE DEV, V9, P984, DOI 10.1101/gad.9.8.984; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Itoh S, 2006, BONE, V39, P505, DOI 10.1016/j.bone.2006.02.074; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li W, 2002, J BIOL CHEM, V277, P28411, DOI 10.1074/jbc.M202807200; Minegishi Y, 1999, J CLIN INVEST, V104, P1115, DOI 10.1172/JCI7696; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Minegishi Y, 2001, IMMUNITY, V14, P631, DOI 10.1016/S1074-7613(01)00131-5; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; O'Brien CA, 1999, J BIOL CHEM, V274, P19301, DOI 10.1074/jbc.274.27.19301; Renner ED, 2004, J PEDIATR-US, V144, P93, DOI 10.1016/S0022-3476(03)00449-9; Robinson DS, 2004, J CLIN INVEST, V114, P1389, DOI 10.1172/JCI200423595; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	30	717	743	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2007	448	7157					1058	U10		10.1038/nature06096	http://dx.doi.org/10.1038/nature06096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205EU	17676033				2022-12-01	WOS:000249097600040
J	Hamzelou, J				Hamzelou, Jessica			Where have all the bees gone?	LANCET			English	Editorial Material									UCL, London WC1E 6BT, England	University of London; University College London	Hamzelou, J (corresponding author), UCL, Mortimer St, London WC1E 6BT, England.	j.hamzelou@ucl.ac.uk						CUMMINS J, 2007, REQUIEM HONEYBEE; FRAZIER M, 2007, COLONY COLLAPSE DISO; MAHESHWARI JK, 2003, ENVIRONEWS       JAN; Maus Christian, 2003, Bulletin of Insectology, V56, P51; PETTIS J, 2007, COLONY COLLAPSE DISO; Sylvers E., 2007, INT HERALD TRIB 0422; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; Underwood RM, 2007, COLONY COLLAPSE DISO	8	7	7	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 25	2007	370	9588					639	639		10.1016/S0140-6736(07)61319-1	http://dx.doi.org/10.1016/S0140-6736(07)61319-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205RD	17720000				2022-12-01	WOS:000249131400009
J	Grenier, MB; McDonald, DB; Buskirk, SW				Grenier, M. B.; McDonald, D. B.; Buskirk, S. W.			Rapid population growth of a critically endangered carnivore	SCIENCE			English	Article									Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; Wyoming Game & Fish Dept, Lander, WY 82520 USA	University of Wyoming	Grenier, MB (corresponding author), Univ Wyoming, Dept Zool & Physiol, 1000 E Univ Ave, Laramie, WY 82071 USA.	martin.grenier@wgf.state.wy.us	Buskirk, Steven W/K-2871-2016; McDonald, David Bartelle/C-3195-2008	Buskirk, Steven W/0000-0003-0611-6648; McDonald, David Bartelle/0000-0001-8582-3775				Caswell H., 2001, MATRIX POPULATION MO, V2nd; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Lockhart J.M., 2006, RECOVERY BLACK FOOTE, P6; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Wisely SM, 2005, ANIM CONSERV, V8, P321, DOI 10.1017/S1367943005002283; Wisely SM, 2002, J HERED, V93, P231, DOI 10.1093/jhered/93.4.231	6	28	31	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2007	317	5839					779	779		10.1126/science.1144648	http://dx.doi.org/10.1126/science.1144648			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690288	Green Submitted			2022-12-01	WOS:000248624500032
J	Lee, GM; Santoli, JM; Hannan, C; Messonnier, ML; Sabin, JE; Rusinak, D; Gay, C; Lett, SM; Lieu, TA				Lee, Grace M.; Santoli, Jeanne M.; Hannan, Claire; Messonnier, Mark L.; Sabin, James E.; Rusinak, Donna; Gay, Charlene; Lett, Susan M.; Lieu, Tracy A.			Gaps in vaccine financing for underinsured children in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE; IMPACT; PROGRAM	Context The number of new vaccines recommended for children and adolescents has nearly doubled during the past 5 years, and the cost of fully vaccinating a child has increased dramatically in the past decade. Anecdotal reports from state policy makers and clinicians suggest that new gaps have arisen in financial coverage of vaccines for children who are underinsured (ie, have private insurance that does not cover all recommended vaccines). In 2000, approximately 14% of children were underinsured for vaccines in the United States. Objectives To describe variation among states in the provision of new vaccines to underinsured children and to identify barriers to state purchase and distribution of new vaccines. Design, Setting, and Participants A 2-phase mixed-methods study of state immunization program managers in the United States. The first phase included 1-hour qualitative telephone interviews conducted from November to December 2005 with 9 program managers chosen to represent different state vaccine financing policies. The second phase incorporated findings from phase 1 to develop a national telephone and paper-based survey of state immunization program managers that was conducted from January to June 2006. Main Outcome Measures Percentage of states in which underinsured children are unable to receive publicly purchased vaccines in the private or public sectors. Results Immunization program managers from 48 states ( 96%) participated in the study. Underinsured children were not eligible to receive publicly purchased meningococcal conjugate or pneumococcal conjugate vaccines in the private sector in 70% and 50% of states, respectively, or in the public sector in 40% and 17% of states, respectively. Due to limited financing for new vaccines, 10 states changed their policies for provision of publicly purchased vaccines between 2004 and early 2006 to restrict access to selected new vaccines for underinsured children. The most commonly cited barriers to implementation in underinsured children were lack of sufficient federal and state funding to purchase vaccines. Conclusions The current vaccine financing system has resulted in gaps for underinsured children in the United States, many of whom are now unable to receive publicly purchased vaccines in either the private or public sectors. Additional strategies are needed to ensure financial coverage for all vaccines, particularly new vaccines, among this vulnerable population.	Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Pilgrim Hlth Care, Boston, MA USA; Childrens Hosp Boston, Div Infect Dis, Boston, MA USA; Childrens Hosp Boston, Div Gen Pediat, Boston, MA USA; Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; Assoc Immunizat Managers, Rockville, MD USA; Massachusetts Dept Publ Hlth, Jamaica Plain, MA USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Centers for Disease Control & Prevention - USA; Massachusetts Department of Public Health	Lee, GM (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, 133 Brookline Ave,6th Floor, Boston, MA 02215 USA.	grace_lee@hphc.org			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS013908] Funding Source: NIH RePORTER; AHRQ HHS [K-08 HS013908-01 A1] Funding Source: Medline; NCIRD CDC HHS [1U01IP000029-01] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCIRD CDC HHS		Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P717; ARNOLD PJ, 1992, AM J DIS CHILD, V146, P728, DOI 10.1001/archpedi.1992.02160180088023; Banthin JS, 2006, JAMA-J AM MED ASSOC, V296, P2712, DOI 10.1001/jama.296.22.2712; *CDCP, ENR PUBL PRIV HEALTH; *CDCP, VFC ACIP VFC VACC RE; *CDCP, VACC IMM PROGR TOOLS; Davis MM, 2003, PEDIATRICS, V112, P521, DOI 10.1542/peds.112.3.521; Davis MM, 2002, AM J PUBLIC HEALTH, V92, P1982, DOI 10.2105/AJPH.92.12.1982; Fairbrother G, 2000, AM J PREV MED, V19, P54, DOI 10.1016/S0749-3797(00)00207-5; Freed GL, 1999, ARCH PEDIAT ADOL MED, V153, P748, DOI 10.1001/archpedi.153.7.748; HIMMELSTEIN DU, 1995, AM J PUBLIC HEALTH, V85, P341, DOI 10.2105/AJPH.85.3.341; *KAIS FAM FDN, EMPL HLTH BEN 2006 S; Maciosek MV, 2006, AM J PREV MED, V31, P90, DOI 10.1016/j.amepre.2006.03.011; McInerny TK, 2007, PEDIATRICS, V119, P622, DOI 10.1542/peds.2006-3687; Miles M., 2019, QUALITATIVE DATA ANA, V4th; *QSR INT PTY LTD, 2002, NVIVO VERS 2 0 COMP; Santoli JM, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.2.e15; Stokley S, 2006, AM J PUBLIC HEALTH, V96, P1308, DOI 10.2105/AJPH.2004.057810; 2004, FINANCING VACCINES 2	19	63	65	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2007	298	6					638	643		10.1001/jama.298.6.638	http://dx.doi.org/10.1001/jama.298.6.638			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	197RS	17684186	Bronze			2022-12-01	WOS:000248574800024
J	Larson, RG				Larson, Ronald G.			Going with the flow	SCIENCE			English	Editorial Material							DNA; DYNAMICS; ELASTICITY		Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Larson, RG (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	rlarson@umich.edu						Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Chen YL, 2005, MACROMOLECULES, V38, P6680, DOI 10.1021/ma050238d; DEGENNES PG, 1971, J CHEM PHYS, V55, P572, DOI 10.1063/1.1675789; DOI M, 1978, J CHEM SOC FARAD T 2, V74, P1789, DOI 10.1039/f29787401789; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fang L, 2005, J RHEOL, V49, P127, DOI 10.1122/1.1822930; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; Perkins TT, 1997, SCIENCE, V276, P2016, DOI 10.1126/science.276.5321.2016; Robertson RM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.126001; Schroeder CM, 2003, SCIENCE, V301, P1515, DOI 10.1126/science.1086070; Shaqfeh ESG, 2005, J NON-NEWTON FLUID, V130, P1, DOI 10.1016/j.jnnfm.2005.05.011; Weihs D, 2006, BIOPHYS J, V91, P4296, DOI 10.1529/biophysj.106.081109; Zhou Q, 2006, MACROMOLECULES, V39, P6737, DOI 10.1021/ma060670a	16	12	13	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					57	58		10.1126/science.1142441	http://dx.doi.org/10.1126/science.1142441			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916719				2022-12-01	WOS:000249915400033
J	Saether, SA; Saetre, GP; Borge, T; Wiley, C; Svedin, N; Andersson, G; Veen, T; Haavie, J; Servedio, MR; Bures, S; Kral, M; Hjernquist, MB; Gustafsson, L; Traff, J; Qvarnstrom, A				Saether, Stein A.; Saetre, Glenn-Peter; Borge, Thomas; Wiley, Chris; Svedin, Nina; Andersson, Gunilla; Veen, Thor; Haavie, Jon; Servedio, Maria R.; Bures, Stanislav; Kral, Miroslav; Hjernquist, Marten B.; Gustafsson, Lars; Traeff, Johan; Qvarnstroem, Anna			Sex chromosome-linked species recognition and evolution of reproductive isolation in flycatchers	SCIENCE			English	Article							SPECIATION; REINFORCEMENT; SELECTION; RECOMBINATION; INHERITANCE; DIVERGENCE; EXPRESSION; GENETICS; LINKAGE; MALES	Interbreeding between species (hybridization) typically produces unfit offspring. Reduced hybridization should therefore be favored by natural selection. However, this is difficult to accomplish because hybridization also sets the stage for genetic recombination to dissociate species-specific traits from the preferences for them. Here we show that this association is maintained by physical linkage (on the same chromosome) in two hybridizing Ficedula flycatchers. By analyzing the mating patterns of female hybrids and cross-fostered offspring, we demonstrate that species recognition is inherited on the Z chromosome, which is also the known location of species-specific male plumage traits and genes causing low hybrid fitness. Limited recombination on the Z chromosome maintains associations of Z-linked genes despite hybridization, suggesting that the sex chromosomes may be a hotspot for adaptive speciation.	Netherlands Inst Ecol, Dept Anim Populat Biol, NL-6666 ZG Heteren, Netherlands; Uppsala Univ, EBC, Dept Evolutionary Biol, SE-75236 Uppsala, Sweden; Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, N-0316 Oslo, Norway; Uppsala Univ, EBC, Dept Anim Ecol, SE-75236 Uppsala, Sweden; Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; Univ Groningen, Ctr Ecol & Evolutionary Studies, Theoret Biol Grp, NL-9751 NN Haren, Netherlands; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Palacky Univ, Ornithol Lab, Olomouc 77146, Czech Republic; Forestry Commiss, Dlouha Loucka 78386, Czech Republic	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Uppsala University; University of Oslo; Uppsala University; Cornell University; University of Groningen; University of North Carolina; University of North Carolina Chapel Hill; Palacky University Olomouc	Saether, SA (corresponding author), Netherlands Inst Ecol, Dept Anim Populat Biol, POB 40, NL-6666 ZG Heteren, Netherlands.	s.a.sather@bio.uio.no	Gustafsson, Lars/A-7634-2012; Servedio, Maria R/A-9743-2008; Svedin, Nina/D-9369-2016; Gustafsson, Lars/O-8056-2019	Gustafsson, Lars/0000-0001-6566-2863; Servedio, Maria R/0000-0002-3965-4445; Svedin, Nina/0000-0002-6224-4655; Gustafsson, Lars/0000-0001-6566-2863; Qvarnstrom, Anna/0000-0002-1178-4053				Coyne J.A., 2004, SPECIATION; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Grant PR, 1997, BIOL J LINN SOC, V60, P317; GRULA JW, 1980, EVOLUTION, V34, P688, DOI 10.1111/j.1558-5646.1980.tb04007.x; Hall DW, 2006, EVOLUTION, V60, P908; Irwin DE, 1999, HEREDITY, V82, P347, DOI 10.1038/sj.hdy.6885270; Iyengar VK, 2002, NATURE, V419, P830, DOI 10.1038/nature01027; Kaiser VB, 2006, EVOLUTION, V60, P1945, DOI 10.1111/j.0014-3820.2006.tb00537.x; Kirkpatrick M, 2004, EVOLUTION, V58, P683; KIRKPATRICK M, 2000, AM NAT, V159, P865; Lemmon AR, 2006, GENETICS, V173, P1145, DOI 10.1534/genetics.105.048199; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; O'Neill MJ, 2000, DEV GENES EVOL, V210, P18, DOI 10.1007/PL00008182; Ortiz-Barrientos D, 2005, SCIENCE, V310, P1467, DOI 10.1126/science.1121260; Ortiz-Barrientos D, 2002, GENETICA, V116, P167, DOI 10.1023/A:1021296829109; Reeve HK, 2003, P NATL ACAD SCI USA, V100, P1089, DOI 10.1073/pnas.0337427100; Ritchie MG, 1998, ENDLESS FORMS, P291; Saetre GP, 1997, J AVIAN BIOL, V28, P259, DOI 10.2307/3676978; Saetre GP, 2003, P ROY SOC B-BIOL SCI, V270, P53, DOI 10.1098/rspb.2002.2204; Saetre GP, 1997, NATURE, V387, P589; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Servedio MR, 2000, EVOLUTION, V54, P21, DOI 10.1111/j.0014-3820.2000.tb00003.x; Servedio MR, 2003, P ROY SOC B-BIOL SCI, V270, P1473, DOI 10.1098/rspb.2003.2391; SERVEDIO MR, IN PRESS EVOL ECOL; ten Cate C, 1999, ADV STUD BEHAV, V28, P1; TRICKETT AJ, 1994, HEREDITY, V73, P339, DOI 10.1038/hdy.1994.180; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000	28	186	187	1	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					95	97		10.1126/science.1141506	http://dx.doi.org/10.1126/science.1141506			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916732				2022-12-01	WOS:000249915400048
J	Kaufman, AJ; Johnston, DT; Farquhar, J; Masterson, AL; Lyons, TW; Bates, S; Anbar, AD; Arnold, GL; Garvin, J; Buick, R				Kaufman, Alan J.; Johnston, David T.; Farquhar, James; Masterson, Andrew L.; Lyons, Timothy W.; Bates, Steve; Anbar, Ariel D.; Arnold, Gail L.; Garvin, Jessica; Buick, Roger			Late Archean biospheric oxygenation and atmospheric evolution	SCIENCE			English	Article							IRON-FORMATION DEPOSITION; TRANSVAAL SUPERGROUP; SULFUR ISOTOPES; MOLECULAR FOSSILS; FRACTIONATION; TRANSITION; SEDIMENTS; LIMESTONE; SEQUENCE; BASIN	High-resolution geochemical analyses of organic-rich shale and carbonate through the 2500 million-year-old Mount McRae Shale in the Hamersley Basin of northwestern Australia record changes in both the oxidation state of the surface ocean and the atmospheric composition. The Mount McRae record of sulfur isotopes captures the widespread and possibly permanent activation of the oxidative sulfur cycle for perhaps the first time in Earth's history. The correlation of the time-series sulfur isotope signals in northwestern Australia with equivalent strata from South Africa suggests that changes in the exogenic sulfur cycle recorded in marine sediments were global in scope and were linked to atmospheric evolution. The data suggest that oxygenation of the surface ocean preceded pervasive and persistent atmospheric oxygenation by 50 million years or more.	Univ Maryland, Dept Geol, College Pk, MD 20742 USA; Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; Univ Washington, Astrobiol Program, Seattle, WA 98195 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of California System; University of California Riverside; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kaufman, AJ (corresponding author), Univ Maryland, Dept Geol, College Pk, MD 20742 USA.	kaufman@geol.umd.edu	Johnston, David/A-9796-2010; Arnold, Gail L/A-5572-2010	Arnold, Gail L/0000-0001-9631-9830; Buick, Roger/0000-0003-0139-1659; Johnston, David/0000-0002-2487-1084				Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; Baublys KA, 2004, RAPID COMMUN MASS SP, V18, P2765, DOI 10.1002/rcm.1681; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; BEUKES NJ, 1987, SEDIMENT GEOL, V54, P1, DOI 10.1016/0037-0738(87)90002-9; BEUKES NJ, 1990, ECON GEOL BULL SOC, V85, P663, DOI 10.2113/gsecongeo.85.4.663; Brocks JJ, 2003, GEOCHIM COSMOCHIM AC, V67, P4289, DOI 10.1016/S0016-7037(03)00208-4; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Cheney ES, 1996, PRECAMBRIAN RES, V79, P3, DOI 10.1016/0301-9268(95)00085-2; Farquhar J, 2005, GEOL SOC SPEC PUBL, V248, P167, DOI 10.1144/GSL.SP.2005.248.01.09; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2000, NATURE, V404, P50, DOI 10.1038/35003517; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Farquhar J, 2001, J GEOPHYS RES-PLANET, V106, P32829, DOI 10.1029/2000JE001437; Farquhar J, 2007, GEOCHIM COSMOCHIM AC, V71, pA269; FRY B, 1986, J BACTERIOL, V165, P328, DOI 10.1128/jb.165.1.328-330.1986; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; HARRISON AG, 1958, T FARADAY SOC, V54, P84, DOI 10.1039/tf9585400084; Johnston DT, 2006, GEOCHIM COSMOCHIM AC, V70, P5723, DOI 10.1016/j.gca.2006.08.001; Johnston DT, 2005, SCIENCE, V310, P1477, DOI 10.1126/science.1117824; Kamber BS, 2007, GEOBIOLOGY, V5, P5, DOI 10.1111/j.1472-4669.2006.00091.x; Kaufman AJ, 1996, PRECAMBRIAN RES, V79, P171, DOI 10.1016/0301-9268(95)00093-3; KLEIN C, 1989, ECON GEOL, V84, P1733, DOI 10.2113/gsecongeo.84.7.1733; Krapez B, 2003, SEDIMENTOLOGY, V50, P979, DOI 10.1046/j.1365-3091.2003.00594.x; LOVLEY DR, 1994, APPL ENVIRON MICROB, V60, P2394, DOI 10.1128/AEM.60.7.2394-2399.1994; Ohmoto H, 2006, NATURE, V442, P908, DOI 10.1038/nature05044; Ono S, 2006, GEOCHIM COSMOCHIM AC, V70, P2238, DOI 10.1016/j.gca.2006.01.022; Ono S, 2003, EARTH PLANET SC LETT, V213, P15, DOI 10.1016/S0012-821X(03)00295-4; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; Summons RE, 2006, PHILOS T R SOC B, V361, P951, DOI 10.1098/rstb.2006.1837	30	275	284	5	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846					1900	1903		10.1126/science.1138700	http://dx.doi.org/10.1126/science.1138700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901329				2022-12-01	WOS:000249764300034
J	Unanue, ER				Unanue, Emil R.			Viral infections and nonspecific protection - Good or bad?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Unanue, ER (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.							Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; BLANDEN RV, 1973, AUST J EXP BIOL MED, V51, P393, DOI 10.1038/icb.1973.35; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; MACKANESS GB, 1969, J EXP MED, V129, P973, DOI 10.1084/jem.129.5.973; Vercelli D, 2006, CURR OPIN IMMUNOL, V18, P733, DOI 10.1016/j.coi.2006.09.002	5	5	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2007	357	13					1345	1346		10.1056/NEJMcibr074519	http://dx.doi.org/10.1056/NEJMcibr074519			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214BR	17898106				2022-12-01	WOS:000249711500014
J	Kim, WY; Fujiwara, S; Suh, SS; Kim, J; Kim, Y; Han, LQ; David, K; Putterill, J; Nam, HG; Somers, DE				Kim, Woe-Yeon; Fujiwara, Sumire; Suh, Sung-Suk; Kim, Jeongsik; Kim, Yumi; Han, Linqu; David, Karine; Putterill, Joanna; Nam, Hong Gil; Somers, David E.			ZEITLUPE is a circadian photoreceptor stabilized by GIGANTEA in blue light	NATURE			English	Article							CLOCK-CONTROLLED GENE; ARABIDOPSIS-THALIANA; FLOWERING TIME; WHITE COLLAR-1; PROTEIN; BINDING; DEGRADATION; ENCODES; PHOTOTROPIN; EXPRESSION	The circadian clock is essential for coordinating the proper phasing of many important cellular processes. Robust cycling of key clock elements is required to maintain strong circadian oscillations of these clock-controlled outputs. Rhythmic expression of the Arabidopsis thaliana F-box protein ZEITLUPE (ZTL) is necessary to sustain a normal circadian period by controlling the proteasome-dependent degradation of a central clock protein, TIMING OF CAB EXPRESSION 1 (TOC1)(1,2). ZTL messenger RNA is constitutively expressed, but ZTL protein levels oscillate with a threefold change in amplitude through an unknown mechanism(3). Here we show that GIGANTEA (GI) is essential to establish and sustain oscillations of ZTL by a direct protein-protein interaction. GI, a large plant-specific protein with a previously undefined molecular role, stabilizes ZTL in vivo. Furthermore, the ZTL-GI interaction is strongly and specifically enhanced by blue light, through the amino-terminal flavin-binding LIGHT, OXYGEN OR VOLTAGE (LOV) domain of ZTL. Mutations within this domain greatly diminish ZTL-GI interactions, leading to strongly reduced ZTL levels. Notably, a C82A mutation in the LOV domain, implicated in the flavin-dependent photochemistry, eliminates blue-light-enhanced binding of GI to ZTL. These data establish ZTL as a blue-light photoreceptor, which facilitates its own stability through a blue-light-enhanced GI interaction. Because the regulation of GI transcription is clock-controlled, consequent GI protein cycling confers a post-translational rhythm on ZTL protein. This mechanism of establishing and sustaining robust oscillations of ZTL results in the high-amplitude TOC1 rhythms necessary for proper clock function.	Ohio State Univ, Dept Plant Cellular & Mol Biol, Ctr Plant Biotechnol, Columbus, OH 43210 USA; Gyeongsang Natl Univ, BK21 Program, Environm Biotechnol Natl Core Res Ctr, Jinju 660701, South Korea; Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, Kyungbuk, South Korea; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University System of Ohio; Ohio State University; Gyeongsang National University; Pohang University of Science & Technology (POSTECH); University of Auckland	Somers, DE (corresponding author), Ohio State Univ, Dept Plant Cellular & Mol Biol, Ctr Plant Biotechnol, 054 Rightmire Hall,1060 Carmack Rd, Columbus, OH 43210 USA.	somers.24@osu.edu	Kim, Yumi/AAA-9398-2021; Kim, Jeongsik/I-6184-2019; Somers, David E/A-9209-2010	Kim, Yumi/0000-0001-6369-5055; Kim, Jeongsik/0000-0002-2729-6003; David, Karine/0000-0002-3924-5078				Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cheng XF, 2005, PLANT J, V43, P758, DOI 10.1111/j.1365-313X.2005.02491.x; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; David KM, 2006, FEBS LETT, V580, P1193, DOI 10.1016/j.febslet.2006.01.016; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Gould PD, 2006, PLANT CELL, V18, P1177, DOI 10.1105/tpc.105.039990; Han LQ, 2004, PLANT J, V40, P291, DOI 10.1111/j.1365-313X.2004.02207.x; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Kevei E, 2006, PLANT PHYSIOL, V140, P933, DOI 10.1104/pp.105.074864; Kim WY, 2003, P NATL ACAD SCI USA, V100, P4933, DOI 10.1073/pnas.0736949100; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Martin-Tryon EL, 2007, PLANT PHYSIOL, V143, P473, DOI 10.1104/pp.106.088757; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Rubio V, 2005, PLANT J, V41, P767, DOI 10.1111/j.1365-313X.2004.02328.x; Ryu JS, 2005, CELL, V120, P395, DOI 10.1016/j.cell.2004.12.019; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Schultz TF, 2001, PLANT CELL, V13, P2659, DOI 10.1105/tpc.13.12.2659; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 2004, PLANT CELL, V16, P769, DOI 10.1105/tpc.016808; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171	33	411	441	2	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2007	449	7160					356	+		10.1038/nature06132	http://dx.doi.org/10.1038/nature06132			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17704763				2022-12-01	WOS:000249557300048
J	Hvorup, RN; Goetz, BA; Niederer, M; Hollenstein, K; Perozo, E; Locher, KP				Hvorup, Rikki N.; Goetz, Birke A.; Niederer, Martina; Hollenstein, Kaspar; Perozo, Eduardo; Locher, Kaspar P.			Asymmetry in the structure of the ABC transporter-binding protein complex BtuCD-BtuF	SCIENCE			English	Article							ESCHERICHIA-COLI; ATP-BINDING; SALMONELLA-TYPHIMURIUM; STAPHYLOCOCCUS-AUREUS; CASSETTE TRANSPORTER; IDENTIFICATION; VITAMIN-B12; MECHANISM; DYNAMICS; SYSTEM	BtuCD is an adenosine triphosphate-binding cassette (ABC) transporter that translocates vitamin B-12 from the periplasmic binding protein BtuF into the cytoplasm of Escherichia coli. The 2.6 angstrom crystal structure of a complex BtuCD-F reveals substantial conformational changes as compared with the previously reported structures of BtuCD and BtuF. The lobes of BtuF are spread apart, and B-12 is displaced from the binding pocket. The transmembrane BtuC subunits reveal two distinct conformations, and the translocation pathway is closed to both sides of the membrane. Electron paramagnetic resonance spectra of spin-labeled cysteine mutants reconstituted in proteoliposomes are consistent with the conformation of BtuCD-F that was observed in the crystal structure. A comparison with BtuCD and the homologous HI1470/71 protein suggests that the structure of BtuCD-F may reflect a posttranslocation intermediate.	ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; Univ Chicago, Dept Biochem & Mol Biol, Gordon Ctr Integrat Sci W206, Chicago, IL 60637 USA; Univ Chicago, Inst Mol Pediat Sci, Gordon Ctr Integrat Sci W206, Chicago, IL 60637 USA; Univ Chicago, Inst Biophys Dynam, Gordon Ctr Integrat Sci W206, Chicago, IL 60637 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Chicago; University of Chicago; University of Chicago	Locher, KP (corresponding author), ETH, Inst Mol Biol & Biophys, HPK D14-3, CH-8093 Zurich, Switzerland.	kaspar.locher@mol.biol.ethz.ch	Winnen, Brit/B-9223-2008	Hollenstein, Kaspar/0000-0001-7606-4105				Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; Cadieux N, 2002, J BACTERIOL, V184, P706, DOI 10.1128/JB.184.3.706-717.2002; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DEVEAUX LC, 1986, J BACTERIOL, V167, P920, DOI 10.1128/jb.167.3.920-927.1986; Holland I. B., 2003, ABC PROTEINS BACTERI; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hustedt EJ, 1999, ANNU REV BIOPH BIOM, V28, P129, DOI 10.1146/annurev.biophys.28.1.129; Janakiraman A, 2000, MOL MICROBIOL, V35, P1146, DOI 10.1046/j.1365-2958.2000.01783.x; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Pattery T, 1999, MOL MICROBIOL, V33, P791, DOI 10.1046/j.1365-2958.1999.01526.x; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; PROSSNITZ E, 1991, J BIOL CHEM, V266, P9673; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; REYNOLDS PR, 1980, J BIOL CHEM, V255, P4313; Sebulsky MT, 2003, J BIOL CHEM, V278, P49890, DOI 10.1074/jbc.M305073200; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657	25	226	240	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 7	2007	317	5843					1387	1390		10.1126/science.1145950	http://dx.doi.org/10.1126/science.1145950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209GR	17673622				2022-12-01	WOS:000249377500045
J	Lindholm, LH; Mendis, S				Lindholm, Lars H.; Mendis, Shanthi			Prevention of cardiovascular disease in developing countries	LANCET			English	Editorial Material							RISK		Umea Univ, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden; WHO, CH-1211 Geneva, Switzerland	Umea University; World Health Organization	Lindholm, LH (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden.	larsh.lindholm@fammed.umu.se	Mendis, Shanthi/GLT-0465-2022	mendis, shanthi/0000-0002-8959-5738				Abegunde DO, 2007, B WORLD HEALTH ORGAN, V85, P432, DOI 10.2471/BLT.06.032177; [Anonymous], 2002, WORLD HLTH REP 2002; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Mendis S, 2007, J HYPERTENS, V25, P1578, DOI 10.1097/HJH.0b013e3282861fd3; *WHO, 2001, INT MAN CARD RISK; WHO, 2003, PREV REC HEART ATT S; [WHO] World Health Organization, 2005, CARD DIS PREV CONTR; World Health Organization, 2007, PREVENTION CARDIOVAS; World Health Organization, 2005, PREVENTING CHRONIC D	9	39	39	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2007	370	9589					720	722		10.1016/S0140-6736(07)61356-7	http://dx.doi.org/10.1016/S0140-6736(07)61356-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206UV	17765507				2022-12-01	WOS:000249209300008
J	Reijmers, LG; Perkins, BL; Matsuo, N; Mayford, M				Reijmers, Leon G.; Perkins, Brian L.; Matsuo, Naoki; Mayford, Mark			Localization of a stable neural correlate of associative memory	SCIENCE			English	Article							FEAR; AMYGDALA; HIPPOCAMPAL; ACTIVATION; EXPRESSION; RETRIEVAL; NEURONS; RAT	Do learning and retrieval of a memory activate the same neurons? Does the number of reactivated neurons correlate with memory strength? We developed a transgenic mouse that enables the long-lasting genetic tagging of c-fos-active neurons. We found neurons in the basolateral amygdala that are activated during Pavlovian fear conditioning and are reactivated during memory retrieval. The number of reactivated neurons correlated positively with the behavioral expression of the fear memory, indicating a stable neural correlate of associative memory. The ability to manipulate these neurons genetically should allow a more precise dissection of the molecular mechanisms of memory encoding within a distributed neuronal network.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Mayford, M (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	mmayford@scripps.edu	Perkins, Brian/N-3780-2013; Matsuo, Naoki/B-9929-2008; Perkins, Brian Lee/Q-5823-2019	Perkins, Brian/0000-0001-9281-5909; Matsuo, Naoki/0000-0003-0988-4706; Mayford, Mark/0000-0002-9001-5024	PHS HHS [5-74653, 57368] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Calandreau L, 2005, LEARN MEMORY, V12, P383, DOI 10.1101/lm.92305; Calandreau L, 2006, J NEUROSCI, V26, P13556, DOI 10.1523/JNEUROSCI.3713-06.2006; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; MAREN S, 1995, J NEUROSCI, V15, P7548; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Radulovic J, 1998, J NEUROSCI, V18, P7452; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022; SMEYNE RJ, 1992, NEURON, V8, P13, DOI 10.1016/0896-6273(92)90105-M; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Thompson RE, 2005, ANNU REV PSYCHOL, V56, P1, DOI 10.1146/annurev.psych.56.091103.070239; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang WP, 2005, LEARN MEMORY, V12, P239, DOI 10.1101/lm.90005	21	462	472	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2007	317	5842					1230	1233		10.1126/science.1143839	http://dx.doi.org/10.1126/science.1143839			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205PJ	17761885				2022-12-01	WOS:000249126800043
J	Richards, T				Richards, Tessa			The hitch hiker's guide to population growth - Educating and empowering young girls in poor countries is part of the solution	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 25	2007	335	7616					374	374		10.1136/bmj.39311.494676.59	http://dx.doi.org/10.1136/bmj.39311.494676.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	206VC	17717365	Green Published			2022-12-01	WOS:000249210000023
J	Simpson, SJ; Travis, J				Simpson, Stephen J.; Travis, John			Testing our defenses - Introduction	SCIENCE			English	Editorial Material																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					611	611		10.1126/science.317.5838.611	http://dx.doi.org/10.1126/science.317.5838.611			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	196PL	17673647				2022-12-01	WOS:000248494400028
J	Iwasawa, T; Hooley, RJ; Rebek, J				Iwasawa, Tetsuo; Hooley, Richard J.; Rebek, Julius, Jr.			Stabilization of labile carbonyl addition intermediates by a synthetic receptor	SCIENCE			English	Article							MOLECULAR RECOGNITION; TRIOSEPHOSPHATE ISOMERASE; ENZYME; CATALYSIS; CAVITANDS; MECHANISM; CAGE	Products of unfavorable chemical equilibria are not readily observed because their high energy and increased reactivity result in low concentrations. Biological macromolecules use binding forces to access unfavorable equilibria and stabilize reactive intermediates by isolating them from the medium. In a similar vein, we describe here a synthetic receptor that allows direct observation of labile tetrahedral intermediates: hemiaminals formed in the reaction of an aldehyde carbonyl group with amines. The receptor encapsulates alkyl-substituted primary amines, then orients them toward a covalently tethered aldehyde function. The hemiaminal intermediates appear at high concentration, confined from the bulk solution and observable at ambient temperature by conventional nuclear magnetic resonance spectroscopy.	Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Rebek, J (corresponding author), Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jrebek@scripps.edu	Iwasawa, Tetsuo/E-4047-2016	Iwasawa, Tetsuo/0000-0002-5913-5167	NIGMS NIH HHS [GM 50174] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050174] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5627, DOI 10.1021/bi00670a031; Anslyn E. V., 2006, MODERN PHYS ORGANIC; CHUDEK JA, 1985, J CHEM SOC PERK T 2, P1285, DOI 10.1039/p29850001285; Dong VM, 2006, J AM CHEM SOC, V128, P14464, DOI 10.1021/ja0657915; Evans DA, 2002, ANGEW CHEM INT EDIT, V41, P3188, DOI 10.1002/1521-3773(20020902)41:17<3188::AID-ANIE3188>3.0.CO;2-H; Fersht AA, 1984, ENZYME STRUCTURE MEC, P47; Fiedler D, 2004, ANGEW CHEM INT EDIT, V43, P6748, DOI 10.1002/anie.200461776; FLORIANI L, 1984, J CHEM RES, P126; Gottschalk T, 2007, ANGEW CHEM INT EDIT, V46, P260, DOI 10.1002/anie.200603366; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Hooley RJ, 2005, J AM CHEM SOC, V127, P11904, DOI 10.1021/ja052910s; Iwasawa T, 2006, J AM CHEM SOC, V128, P9308, DOI 10.1021/ja062768a; Kawano M, 2006, J AM CHEM SOC, V128, P6558, DOI 10.1021/ja0609250; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; Lin SN, 2005, TETRAHEDRON LETT, V46, P4315, DOI 10.1016/j.tetlet.2005.04.101; Lorentzen E, 2005, BIOCHEMISTRY-US, V44, P4222, DOI 10.1021/bi048192o; Masel R.I., 2001, CHEM KINETICS CATALY; Purse BW, 2005, J AM CHEM SOC, V127, P11222, DOI 10.1021/ja052877+; Purse BW, 2003, J AM CHEM SOC, V125, P14682, DOI 10.1021/ja036595q; REBEK J, 1979, TETRAHEDRON, V35, P723, DOI 10.1016/0040-4020(79)80087-3; Renslo AR, 2000, ANGEW CHEM INT EDIT, V39, P3281, DOI 10.1002/1521-3773(20000915)39:18<3281::AID-ANIE3281>3.0.CO;2-P; Rozovsky S, 2007, P NATL ACAD SCI USA, V104, P2080, DOI 10.1073/PNAS.0608876104; Rudkevich DM, 1999, EUR J ORG CHEM, V1999, P1991; Yoshizawa M, 2000, J AM CHEM SOC, V122, P6311, DOI 10.1021/ja000779c; Zhang XY, 2005, ACCOUNTS CHEM RES, V38, P379, DOI 10.1021/ar040257s; Ziegler M, 2000, ANGEW CHEM INT EDIT, V39, P4119, DOI 10.1002/1521-3773(20001117)39:22<4119::AID-ANIE4119>3.0.CO;2-1	26	220	220	3	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					493	496		10.1126/science.1143272	http://dx.doi.org/10.1126/science.1143272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	194JD	17656719				2022-12-01	WOS:000248339800039
J	Oh, SD; Lao, JP; Hwang, PYH; Taylor, AF; Smith, GR; Hunter, N				Oh, Steve D.; Lao, Jessica P.; Hwang, Patty Yi-Hwa; Taylor, Andrew F.; Smith, Gerald R.; Hunter, Neil			BLM ortholog, Sgs1, prevents aberrant crossing-over by suppressing formation of multichromatid joint molecules	CELL			English	Article							DOUBLE-STRAND-BREAK; SYNDROME GENE-PRODUCT; MEIOTIC RECOMBINATION; SACCHAROMYCES-CEREVISIAE; SISTER CHROMATIDS; HOMOLOGOUS RECOMBINATION; HOLLIDAY JUNCTIONS; GENOME STABILITY; RECQ HELICASES; MEIOSIS	Bloom's helicase (BLM) is thought to prevent crossing-over during DNA double-strand-break repair (DSBR) by disassembling double-Holliday junctions (dHJs) or by preventing their formation. We show that the Saccharomyces cerevisiae BLM ortholog, Sgs1, prevents aberrant crossing-over during meiosis by suppressing formation of joint molecules (JMs) comprising three and four interconnected duplexes. Sgs1 and procrossover factors, Msh5 and Mlh3, are antagonistic since Sgs1 prevents dHJ formation in msh5 cells and sgs1 mutation alleviates crossover defects of both msh5 and mlh3 mutants. We propose that differential activity of Sgs1 and procrossover factors at the two DSB ends effects productive formation of dHJs and crossovers and prevents multichromatid JMs and counterproductive crossing-over. Strand invasion of different templates by both DSB ends may be a common feature of DSBR that increases repair efficiency but also the likelihood of associated crossing-over. Thus, by disrupting aberrant JMs, BLM-related helicases maximize repair efficiency while minimizing the risk of deleterious crossing-over.	Univ Calif Davis, Sect Microbiol & Mol & Cellular Biol, Davis, CA 95616 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	University of California System; University of California Davis; Fred Hutchinson Cancer Center	Hunter, N (corresponding author), Univ Calif Davis, Sect Microbiol & Mol & Cellular Biol, 1 Shields Ave, Davis, CA 95616 USA.	nhunter@ucdavis.edu		Smith, Gerald/0000-0002-8747-1352	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074223, R01GM031693, R56GM031693] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM031693, GM074223, R01 GM031693, R56 GM031693, R01 GM031693-25, R01 GM074223, R01 GM074223-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Allers T, 2001, MOL CELL, V8, P225, DOI 10.1016/S1097-2765(01)00280-5; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Bachrati CZ, 2006, METHOD ENZYMOL, V409, P86, DOI 10.1016/S0076-6879(05)09005-1; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; BELL L, 1983, ANAL BIOCHEM, V130, P527, DOI 10.1016/0003-2697(83)90628-0; BELL LR, 1982, COLD SPRING HARB SYM, V47, P829, DOI 10.1101/SQB.1983.047.01.095; Bennett RJ, 1999, J MOL BIOL, V289, P235, DOI 10.1006/jmbi.1999.2739; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; DAVIS RW, 1971, METHOD ENZYMOL, V21, P413; de los Santos T, 2003, GENETICS, V164, P81; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K; GOYON C, 1993, MOL CELL BIOL, V13, P373, DOI 10.1128/MCB.13.1.373; Grushcow JM, 1999, GENETICS, V153, P607; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hoffmann ER, 2004, CYTOGENET GENOME RES, V107, P232, DOI 10.1159/000080601; Hoffmann ER, 2003, GENETICS, V163, P515; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N, 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; KADYK LC, 1992, GENETICS, V132, P387; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kolas NK, 2004, CYTOGENET GENOME RES, V107, P216, DOI 10.1159/000080600; Langland G, 2001, J BIOL CHEM, V276, P30031, DOI 10.1074/jbc.M009664200; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; MAGUIRE MP, 1980, HEREDITY, V45, P127, DOI 10.1038/hdy.1980.56; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Moens PB, 2002, J CELL SCI, V115, P1611; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; MULLER K, 2000, GENE FUNCT DIS, V1, P154; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; NILSSON NO, 1995, J THEOR BIOL, V173, P93, DOI 10.1006/jtbi.1995.0046; Opresko PL, 2004, J BIOL CHEM, V279, P18099, DOI 10.1074/jbc.R300034200; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pedrazzi G, 2001, NUCLEIC ACIDS RES, V29, P4378, DOI 10.1093/nar/29.21.4378; PERKINS DD, 1949, GENETICS, V34, P607; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Pochart P, 1997, J BIOL CHEM, V272, P30345, DOI 10.1074/jbc.272.48.30345; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Rockmill B, 2003, CURR BIOL, V13, P1954, DOI 10.1016/j.cub.2003.10.059; Rockmill B, 2006, GENETICS, V174, P1745, DOI 10.1534/genetics.106.058933; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Shinohara A, 2004, CYTOGENET GENOME RES, V107, P201, DOI 10.1159/000080598; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; van Veen JE, 2003, CURR BIOL, V13, pR831, DOI 10.1016/j.cub.2003.10.014; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang TF, 2002, BIOCHEM BIOPH RES CO, V296, P949, DOI 10.1016/S0006-291X(02)02034-X; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Watt PM, 1996, GENETICS, V144, P935; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	65	213	216	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					259	272		10.1016/j.cell.2007.05.035	http://dx.doi.org/10.1016/j.cell.2007.05.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662941	Green Accepted, Bronze			2022-12-01	WOS:000248588000016
J	Richards, T				Richards, Tessa			Who is at the helm on patient journeys?	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com						2007, BRIT MED J, V334, P1130	1	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 14	2007	335	7610					76	76		10.1136/bmj.39272.484248.59	http://dx.doi.org/10.1136/bmj.39272.484248.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	192JM	17626961	Green Published			2022-12-01	WOS:000248197500031
J	Depue, BE; Curran, T; Banich, MT				Depue, Brendan E.; Curran, Tim; Banich, Marie T.			Prefrontal regions orchestrate suppression of emotional memories via a two-phase process	SCIENCE			English	Article							CORTEX; FMRI; AMYGDALA; MECHANISMS	Whether memories can be suppressed has been a controversial issue in psychology and cognitive neuroscience for decades. We found evidence that emotional memories are suppressed via two time-differentiated neural mechanisms: (i) an initial suppression by the right inferior frontal gyrus over regions supporting sensory components of the memory representation ( visual cortex, thalamus), followed by (ii) right medial frontal gyrus control over regions supporting multimodal and emotional components of the memory representation ( hippocampus, amygdala), both of which are influenced by fronto-polar regions. These results indicate that memory suppression does occur and, at least in nonpsychiatric populations, is under the control of prefrontal regions.	Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA; Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA; Univ Denver Hlth Sci, Dept Psychiat, Denver, CO 80208 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus	Depue, BE (corresponding author), Univ Colorado, Dept Psychol, Campus Box 345, Boulder, CO 80309 USA.	depue@colorado.edu		BANICH, MARIE/0000-0001-9373-9194				Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Depue BE, 2006, PSYCHOL SCI, V17, P441, DOI 10.1111/j.1467-9280.2006.01725.x; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Hamann S, 2001, TRENDS COGN SCI, V5, P394, DOI 10.1016/S1364-6613(00)01707-1; Hertel PT, 2005, PSYCHON B REV, V12, P484, DOI 10.3758/BF03193792; Jacoby LL, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P383; Kastner S, 2004, J NEUROPHYSIOL, V91, P438, DOI 10.1152/jn.00553.2003; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kihlstrom JF, 2002, TRENDS COGN SCI, V6, P502, DOI 10.1016/S1364-6613(02)02006-5; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Lang PJ, 1998, PSYCHOPHYSIOLOGY, V35, P199, DOI 10.1017/S0048577298001991; Loftus E, 2003, NAT REV NEUROSCI, V4, P231, DOI 10.1038/nrn1054; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; O'Reilly RC, 2006, SCIENCE, V314, P91, DOI 10.1126/science.1127242; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Purdon C, 1999, BEHAV RES THER, V37, P1029, DOI 10.1016/S0005-7967(98)00200-9; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Raye CL, 2007, CORTEX, V43, P135, DOI 10.1016/S0010-9452(08)70451-9; ROLLS ET, 1984, HUM NEUROBIOL, V3, P209; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; vanderKolk BA, 1996, AM J PSYCHIAT, V153, P83; vanderKolk BA, 1997, ANN NY ACAD SCI, V821, P99; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Wraga M, 2000, J COGNITIVE NEUROSCI, P75	31	300	318	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2007	317	5835					215	219		10.1126/science.1139560	http://dx.doi.org/10.1126/science.1139560			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17626877	Green Submitted			2022-12-01	WOS:000247968600033
J	Giorgi, C; Yeo, GW; Stone, ME; Katz, DB; Burge, C; Turrigiano, G; Moore, MJ				Giorgi, Corinna; Yeo, Gene W.; Stone, Martha E.; Katz, Donald B.; Burge, Christopher; Turrigiano, Gina; Moore, Melissa J.			The EJC factor eIF4AIII modulates synaptic strength and neuronal protein expression	CELL			English	Article							MESSENGER-RNA LOCALIZATION; MAMMALIAN-CELLS; ABERRANT TERMINATION; STAUFEN; TRANSLATION; ARC/ARG3.1; NUCLEAR; AMPA; PLASTICITY; COMPLEX	tProper neuronal function and several forms of synaptic plasticity are highly dependent on precise control of mRNA translation, particularly in dendrites. We find that eIF4AIII, a core exon junction complex ( EJC) component loaded onto mRNAs by pre- mRNA splicing, is associated with neuronal mRNA granules and dendritic mRNAs. eIF4AIII knockdown markedly increases both synaptic strength and GLUR1 AMPA receptor abundance at synapses. eIF4AIII depletion also increases ARC, a protein required for maintenance of long- term potentiation; arc mRNA, one of the most abundant in dendrites, is a natural target for nonsense-mediated decay ( NMD). Numerous new NMD candidates, some with potential to affect synaptic activity, were also identified computationally. Two models are presented for how translation- dependent decay pathways such as NMD might advantageously function as critical brakes for protein synthesis in cells such as neurons that are highly dependent on spatially and temporally restricted protein expression.	Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA; Brandeis Univ, Dept Psychol, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Salk Inst Biol Studies, Crick Jacobs Ctr Computat & Theoret Biol, La Jolla, CA 92037 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Brandeis University; Howard Hughes Medical Institute; Brandeis University; Brandeis University; Brandeis University; Salk Institute; Massachusetts Institute of Technology (MIT)	Moore, MJ (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA.	mmoore@brandeis.edu	Burge, Christopher B./AAH-2177-2020; giorgi, corinna/G-7794-2011; Yeo, Gene/AAE-7676-2019	Yeo, Gene/0000-0002-0799-6037; giorgi, corinna/0000-0003-1065-369X; Stone, Martha/0000-0001-6771-994X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036853] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amrani N, 2006, BIOCHEM SOC T, V34, P39, DOI 10.1042/BST0340039; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Buhler M, 2006, NAT STRUCT MOL BIOL, V13, P462, DOI 10.1038/nsmb1081; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Du TG, 2007, SEMIN CELL DEV BIOL, V18, P171, DOI 10.1016/j.semcdb.2007.01.010; Farina KL, 2002, TRENDS CELL BIOL, V12, P466, DOI 10.1016/S0962-8924(02)02357-7; Giorgi C, 2007, SEMIN CELL DEV BIOL, V18, P186, DOI 10.1016/j.semcdb.2007.01.002; Glanzer J, 2005, P NATL ACAD SCI USA, V102, P16859, DOI 10.1073/pnas.0503783102; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Ichikawa H, 2003, J PHARMACOL SCI, V91, P247; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kiebler MA, 2005, TRENDS BIOCHEM SCI, V30, P228, DOI 10.1016/j.tibs.2005.03.005; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Lai DM, 2006, RNA, V12, P1446, DOI 10.1261/rna.94306; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; Macchi P, 2003, J NEUROSCI, V23, P5778; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Monshausen M, 2004, NEUROMOL MED, V6, P127, DOI 10.1385/NMM:6:2-3:127; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Steward O, 2002, NEUROBIOL LEARN MEM, V78, P508, DOI 10.1006/nlme.2002.4102; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sutton MA, 2005, J NEUROBIOL, V64, P116, DOI 10.1002/neu.20152; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Tzingounis AV, 2006, NEURON, V52, P403, DOI 10.1016/j.neuron.2006.10.016; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Vanderklish PW, 2005, GENES BRAIN BEHAV, V4, P360, DOI 10.1111/j.1601-183X.2005.00134.x; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Wallace CS, 1998, J NEUROSCI, V18, P26; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Weil JE, 2006, RNA, V12, P102, DOI 10.1261/rna.2129806; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006; [No title captured]	67	216	220	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2007	130	1					179	191		10.1016/j.cell.2007.05.028	http://dx.doi.org/10.1016/j.cell.2007.05.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632064	Bronze			2022-12-01	WOS:000248587000020
J	Miled, N; Yan, Y; Hon, WC; Perisic, O; Zvelebil, M; Inbar, Y; Schneidman-Duhovny, D; Wolfson, HJ; Backer, JM; Williams, RL				Miled, Nabil; Yan, Ying; Hon, Wai-Ching; Perisic, Olga; Zvelebil, Marketa; Inbar, Yuval; Schneidman-Duhovny, Dina; Wolfson, Haim J.; Backer, Jonathan M.; Williams, Roger L.			Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit	SCIENCE			English	Article							PHOSPHATIDYLINOSITOL 3'-KINASE; FUNCTIONAL-ANALYSIS; REGULATORY SUBUNIT; PIK3CA MUTATIONS; INTER-SH2 DOMAIN; PI 3-KINASE; ACTIVATION; PATHWAY; TARGETS; GENE	Many human cancers involve up-regulation of the phosphoinositide 3-kinase PI3K alpha, with oncogenic mutations identified in both the p110 alpha catalytic and the p85 alpha regulatory subunits. We used crystallographic and biochemical approaches to gain insight into activating mutations in two noncatalytic p110 alpha domains-the adaptor-binding and the helical domains. A structure of the adaptor-binding domain of p110 alpha in a complex with the p85 alpha inter-Src homology 2 (inter-SH2) domain shows that oncogenic mutations in the adaptor-binding domain are not at the inter-SH2 interface but in a polar surface patch that is a plausible docking site for other domains in the holo p110/p85 complex. We also examined helical domain mutations and found that the Glu(545) to Lys(545) (E545K) oncogenic mutant disrupts an inhibitory charge-charge interaction with the p85 N-terminal SH2 domain. These studies extend our understanding of the architecture of PI3Ks and provide insight into how two classes of mutations that cause a gain in function can lead to cancer.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; UCL, Ludwig Inst Canc Res, London, England; Tel Aviv Univ, Sch Comp Sci, Raymond & Beverly Sackler Fac Exact Sci, IL-69978 Tel Aviv, Israel	MRC Laboratory Molecular Biology; Yeshiva University; Albert Einstein College of Medicine; Ludwig Institute for Cancer Research; University of London; University College London; Tel Aviv University	Backer, JM (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	backer@aecom.yu.edu; rlw@mrc-lmb.cam.ac.uk	Miled, Nabil/ABC-6773-2020; Wolfson, Haim/A-1837-2011; Schneidman, Dina/ABH-6654-2020	Miled, Nabil/0000-0001-7445-6324; Wolfson, Haim/0000-0002-7600-2702; Schneidman, Dina/0000-0003-0480-0438; Perisic, Olga/0000-0002-3842-2896; Zvelebil, Marketa/0000-0001-8018-5591; Williams, Roger/0000-0001-7754-4207	MRC [MC_U105184308] Funding Source: UKRI; Medical Research Council [MC_U105184308] Funding Source: Medline; NIGMS NIH HHS [GM55692] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; CARPENTER CL, 1993, J BIOL CHEM, V268, P9478; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Elis W, 2006, BIOL CHEM, V387, P1567, DOI 10.1515/BC.2006.195; Fu Z, 2003, P NATL ACAD SCI USA, V100, P3275, DOI 10.1073/pnas.0535975100; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Ikenoue T, 2005, CANCER RES, V65, P4562, DOI 10.1158/0008-5472.CAN-04-4114; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Jimenez C, 2002, J BIOL CHEM, V277, P41556, DOI 10.1074/jbc.M205893200; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Nolte RT, 1996, NAT STRUCT BIOL, V3, P364, DOI 10.1038/nsb0496-364; Okkenhaug K, 2001, Sci STKE, V2001, ppe1; Pirola L, 2001, J BIOL CHEM, V276, P21544, DOI 10.1074/jbc.M011330200; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shekar SC, 2005, J BIOL CHEM, V280, P27850, DOI 10.1074/jbc.M506005200; Stephens L, 2005, CURR OPIN PHARMACOL, V5, P357, DOI 10.1016/j.coph.2005.03.002; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Wetzker R, 2004, CURR PHARM DESIGN, V10, P1915, DOI 10.2174/1381612043384402; Workman P, 2004, BIOCHEM SOC T, V32, P393, DOI 10.1042/BST0320393; Wymann MP, 2005, CURR OPIN CELL BIOL, V17, P141, DOI 10.1016/j.ceb.2005.02.011; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; Yu JH, 1998, J BIOL CHEM, V273, P30199, DOI 10.1074/jbc.273.46.30199	29	306	324	3	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2007	317	5835					239	242		10.1126/science.1135394	http://dx.doi.org/10.1126/science.1135394			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17626883				2022-12-01	WOS:000247968600041
J	Lai, CL; Yuen, MF				Lai, Ching-Lung; Yuen, Man-Fung			The natural history and evaluation of standard treatment of chronic hepatitis B: A critical treatment criteria and end points	ANNALS OF INTERNAL MEDICINE			English	Article							HBV-DNA LEVELS; LAMIVUDINE THERAPY; CONSENSUS STATEMENT; UNITED-STATES; INFECTION; MANAGEMENT; CHINESE; CIRRHOSIS; UPDATE; LIVER	The definite indications for the treatment of chronic hepatitis B are serum hepatitis B virus (HBV) DNA levels greater than 10(5) copies/mL and alanine aminotransferase (ALT) levels more than 2 times the upper limit of normal. if cirrhosis is present, an HBV DNA level greater than 105 copies/mL is the sole criterion for treatment. Treatment end points include hepatitis B e antigen (HEeAg) seroconversion for HBeAg-positive patients, reduction of HEV DNA levels to less than 105 copies/mL, and normalization of ALT values. These guidelines may apply to patients who acquire the hepatitis B infection during adolescence or adulthood but are less suitable for most hepatitis B carriers, who are infected in early life. Cirrhosis complications, including hepatocellular carcinoma, often occur in this latter group despite HBeAg seroconversion, HBV DNA levels less than 10(4) copies/mL, or ALT levels between 0.5 and 2 times the upper limit of normal. Therefore, HBeAg seroconversion may not be an adequate end point for these patients; the ideal treatment end points are permanent suppression of HBV DNA to levels undetectable by polymerase chain reaction and reduction of ALT levels to less than 0.5 times the upper limit of normal.	Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Lai, CL (corresponding author), Queen Mary Hosp, Dept Med, 102 Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	hrmelcl@hkucc.hku.hk	Yuen, Man-Fung/C-4466-2009; Lai, Ching Lung/C-4298-2009	Yuen, Man-Fung/0000-0001-7985-7725; Lai, Ching-Lung/0000-0002-5927-2436				Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chu CJ, 2002, HEPATOLOGY, V36, P1408, DOI 10.1053/jhep.2002.36949; de Franchis R, 2003, J HEPATOL, V39, pS3, DOI 10.1016/S0168-8278(03)00378-7; DIBISCEGLIE AM, 1987, GASTROENTEROLOGY, V93, P1236, DOI 10.1016/0016-5085(87)90250-2; Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013; Hadziyannis SJ, 2005, NEW ENGL J MED, V352, P2673, DOI 10.1056/NEJMoa042957; Keeffe EB, 2006, CLIN GASTROENTEROL H, V4, P936, DOI 10.1016/j.cgh.2006.05.016; Kim HC, 2004, BMJ-BRIT MED J, V328, P983, DOI 10.1136/bmj.38050.593634.63; Lee TA, 2004, J CLIN GASTROENTEROL, V38, pS144, DOI 10.1097/00004836-200411003-00005; LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310; Liaw YF, 2005, LIVER INT, V25, P472, DOI 10.1111/j.1478-3231.2005.01134.x; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; Manno M, 2004, GASTROENTEROLOGY, V127, P756, DOI 10.1053/j.gastro.2004.06.021; Newman TB, 1996, JAMA-J AM MED ASSOC, V275, P55, DOI 10.1001/jama.275.1.55; Nguyen MH, 2005, HEPATOLOGY, V42, p593A; Niederau C, 1996, NEW ENGL J MED, V334, P1422, DOI 10.1056/NEJM199605303342202; Sherman M, 2005, GUT, V54, P1521, DOI 10.1136/gut.2005.071332; *TAIW COMM BAS CAN, 2002, NEW ENGL J MED, V347, P168; Wong DKH, 2006, ANTIVIR THER, V11, P909; Yuan HJ, 2005, J VIRAL HEPATITIS, V12, P373, DOI 10.1111/j.1365-2893.2005.00603.x; Yuen MF, 2005, AM J GASTROENTEROL, V100, P1099, DOI 10.1111/j.1572-0241.2005.41530.x; Yuen MF, 2004, HEPATOLOGY, V39, P1694, DOI 10.1002/hep.20240; Yuen MF, 2005, HEPATOLOGY, V42, p583A; Yuen MF, 2005, GUT, V54, P1610, DOI 10.1136/gut.2005.065136	26	143	148	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 3	2007	147	1					58	61		10.7326/0003-4819-147-1-200707030-00010	http://dx.doi.org/10.7326/0003-4819-147-1-200707030-00010			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	186MN	17606962				2022-12-01	WOS:000247782900008
J	Park, SW; Kaimoyo, E; Kumar, D; Mosher, S; Klessig, DF				Park, Sang-Wook; Kaimoyo, Evans; Kumar, Dhirendra; Mosher, Stephen; Klessig, Daniel F.			Methyl salicylate is a critical mobile signal for plant systemic acquired resistance	SCIENCE			English	Article							ACID-BINDING PROTEIN-2; INNATE IMMUNITY; TOBACCO PLANTS; ARABIDOPSIS; EXPRESSION; VIRUS	In plants, the mobile signal for systemic acquired resistance (SAR), an organism-wide state of enhanced defense to subsequent infections, has been elusive. By stimulating immune responses in mosaic tobacco plants created by grafting different genetic backgrounds, we showed that the methyl salicylate (MeSA) esterase activity of salicylic acid-binding protein 2 (SABP2), which converts MeSA into salicylic acid (SA), is required for SAR signal perception in systemic tissue, the tissue that does not receive the primary (initial) infection. Moreover, in plants expressing mutant SABP2 with unregulated MeSA esterase activity in SAR signal-generating, primary infected leaves, SAR was compromised and the associated increase in MeSA levels was suppressed in primary infected leaves, their phloem exudates, and systemic leaves. SAR was also blocked when SA methyl transferase (which converts SA to MeSA) was silenced in primary infected leaves, and MeSA treatment of lower leaves induced SAR in upper untreated leaves. Therefore, we conclude that MeSA is a SAR signal in tobacco.	Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	Cornell University; Boyce Thompson Institute for Plant Research	Kumar, D (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	dfk8@cornell.edu	Kalra, D/H-6661-2019	Kalra, D/0000-0001-5254-4067; Mosher, Stephen/0000-0002-3752-1606				CHEN ZX, 1993, SCIENCE, V262, P1883, DOI 10.1126/science.8266079; Dempsey DA, 1999, CRIT REV PLANT SCI, V18, P547, DOI 10.1080/07352689991309397; Du H, 1997, PLANT PHYSIOL, V113, P1319, DOI 10.1104/pp.113.4.1319; Dudareva N, 1998, PLANT PHYSIOL, V116, P599, DOI 10.1104/pp.116.2.599; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Forouhar F, 2005, P NATL ACAD SCI USA, V102, P1773, DOI 10.1073/pnas.0409227102; JENNS AE, 1979, PHYTOPATHOLOGY, V69, P753, DOI 10.1094/Phyto-69-753; Kumar D, 2006, PLANT J, V45, P863, DOI 10.1111/j.1365-313X.2005.02645.x; Kumar D, 2003, P NATL ACAD SCI USA, V100, P16101, DOI 10.1073/pnas.0307162100; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Nandi A, 2004, PLANT CELL, V16, P465, DOI 10.1105/tpc.016907; Pallas JA, 1996, PLANT J, V10, P281, DOI 10.1046/j.1365-313X.1996.10020281.x; Seskar M, 1998, PLANT PHYSIOL, V116, P387, DOI 10.1104/pp.116.1.387; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; VERNOOIJ B, 1994, PLANT CELL, V6, P959, DOI 10.1105/tpc.6.7.959; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	18	623	681	8	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2007	318	5847					113	116		10.1126/science.1147113	http://dx.doi.org/10.1126/science.1147113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916738				2022-12-01	WOS:000249915400054
J	Tang, XL; Gao, JS; Guan, YJ; McLane, KE; Yuan, ZL; Ramratnam, B; Chin, YE				Tang, Xiaoli; Gao, Jin-Song; Guan, Ying-Jie; McLane, Katya E.; Yuan, Zheng-Long; Ramratnam, Bharat; Chin, Y. Eugene			Acetylation-dependent signal transduction for type I interferon receptor	CELL			English	Article							ALPHA-STIMULATED TRANSCRIPTION; CRYSTAL-STRUCTURE; STAT2; DOMAIN; BINDING; PREASSOCIATION; AUTOINHIBITION; EXPRESSION; PROTEINS; FACTOR-3	Cytokine-activated receptors initiate intracellular signaling by recruiting protein kinases that phosphorylate the receptors on tyrosine residues, thus enabling docking of SH2 domainbearing activating factors. Here we report that in response to type 1 interferon (IFNa), IFNa receptors recruit cytoplasmic CREB-binding protein (CBP). By binding to IFN alpha R2 within the region where two adjacent proline boxes bear phospho-Ser364 and phospho-Ser384, CBP acetylates IFN alpha R2 on Lys399, which in turn serves as the docking site for interferon regulatory factor 9 (IRF9). IRF9 interacts with the acetyl-Lys399 motif by means of its IRF homology2 (IH2) domain, leading to formation of the ISGF3 complex that includes IRF9, STAT1, and STAT2. All three components are acetylated by CBP. Remarkably, acetylation within the DNA-binding domain (DBD) of both IRF9 and STAT2 is critical for the ISGF3 complex activation and its associated antiviral gene regulation. These results have significant implications concerning the central role of acetylation in cytokine receptor signal transduction.	Brown Univ, Rhode Isl Hosp, Sch Med, Dept Surg, Providence, RI 02903 USA; Brown Univ, Rhode Isl Hosp, Sch Med, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02903 USA; Brown Univ, Rhode Isl Hosp, Sch Med, Dept Med, Providence, RI 02903 USA; Upstate Chemicon Int Inc, Temecula, CA 92590 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Chin, YE (corresponding author), Brown Univ, Rhode Isl Hosp, Sch Med, Dept Surg, 593 Eddy st, Providence, RI 02903 USA.	y_eugene_chin@brown.edu						Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Caillaud A, 2002, J BIOL CHEM, V277, P49417, DOI 10.1074/jbc.M207484200; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Horvath CM, 1996, MOL CELL BIOL, V16, P6957; Inoue Y, 2007, ONCOGENE, V26, P500, DOI 10.1038/sj.onc.1209826; KALVAKOLANU DVR, 1991, P NATL ACAD SCI USA, V88, P7459, DOI 10.1073/pnas.88.17.7459; Kramer OH, 2006, GENE DEV, V20, P473, DOI 10.1101/gad.364306; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; LEVY DE, 1989, GENE DEV, V3, P1362, DOI 10.1101/gad.3.9.1362; Li XX, 1997, MOL CELL BIOL, V17, P2048, DOI 10.1128/MCB.17.4.2048; Lin RT, 1999, MOL CELL BIOL, V19, P2465; MartinezMoczygemba M, 1997, J BIOL CHEM, V272, P20070, DOI 10.1074/jbc.272.32.20070; Masumi A, 2003, J BIOL CHEM, V278, P25401, DOI 10.1074/jbc.M213037200; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Nguyen VP, 2002, J BIOL CHEM, V277, P9713, DOI 10.1074/jbc.m111161200; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Saleh AZM, 2002, BIOCHEMISTRY-US, V41, P11261, DOI 10.1021/bi025913f; Sancho R, 2004, J BIOL CHEM, V279, P37349, DOI 10.1074/jbc.M401993200; Stancato LF, 1996, J BIOL CHEM, V271, P4134; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Wagner TC, 2002, J BIOL CHEM, V277, P1493, DOI 10.1074/jbc.M108928200; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166	30	149	154	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2007	131	1					93	105		10.1016/j.cell.2007.07.034	http://dx.doi.org/10.1016/j.cell.2007.07.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923090	Bronze			2022-12-01	WOS:000249934700014
J	Wolf, D; Goff, SP				Wolf, Daniel; Goff, Stephen P.			TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells	CELL			English	Article							LONG TERMINAL REPEAT; CARCINOMA-CELLS; RETROVIRUS EXPRESSION; NEGATIVE REGULATION; GENE-EXPRESSION; TRANSFER-RNA; REPRESSOR; COREPRESSOR; PROTEINS; TRANSCRIPTION	Moloney murine leukemia virus (M-MLV) replication is restricted in embryonic carcinoma (EC) and embryonic stem (ES) cells, likely to protect the germ line from insertional mutagenesis. Proviral DNAs are potently silenced at the level of transcription in these cells. This silencing is largely due to an unidentified trans-acting factor that is thought to bind to the primer binding site (PBS) of M-MLV and repress transcription from the viral promoter. We have partially purified a large PBS-mediated silencing complex and identified TRIM28 (Kap-1), a known transcriptional silencer, as an integral component of the complex. We show that RNAi-mediated knockdown of TRIM28 in EC and ES cells relieves the restriction and that TRIM28 is bound to the PBS in vivo when restriction takes place. The identification of TRIM28 as a retroviral silencer adds to the growing body of evidence that many TRIM family proteins are involved in retroviral restriction.	Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Goff, SP (corresponding author), Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	goff@cancercenter.columbia.edu	Goff, Stephen P/K-6337-2014	Goff, Stephen P/0000-0003-0693-5547	NATIONAL CANCER INSTITUTE [R37CA030488] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA30488] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKGUN E, 1991, J VIROL, V65, P382; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; BARKLIS E, 1986, CELL, V47, P391, DOI 10.1016/0092-8674(86)90596-9; BERWIN B, 1993, NUCLEIC ACIDS RES, V21, P2399, DOI 10.1093/nar/21.10.2399; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; Eberhardy SR, 2006, J VIROL, V80, P2873, DOI 10.1128/JVI.80.6.2873-2883.2006; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; FEUER G, 1989, J VIROL, V63, P2317, DOI 10.1128/JVI.63.5.2317-2324.1989; FLANAGAN JR, 1989, MOL CELL BIOL, V9, P739, DOI 10.1128/MCB.9.2.739; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; GREZ M, 1990, P NATL ACAD SCI USA, V87, P9202, DOI 10.1073/pnas.87.23.9202; Haas DL, 2003, J VIROL, V77, P9439, DOI 10.1128/JVI.77.17.9439-9450.2003; HARADA F, 1979, J BIOL CHEM, V254, P979; HILBERG F, 1987, P NATL ACAD SCI USA, V84, P5232, DOI 10.1073/pnas.84.15.5232; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; LENARDO MJ, 1989, SCIENCE, V243, P544, DOI 10.1126/science.2536195; Leung J, 2006, EMBO J, V25, P2155, DOI 10.1038/sj.emboj.7601097; LINNEY E, 1984, NATURE, V308, P470, DOI 10.1038/308470a0; LOH TP, 1988, J VIROL, V62, P4086, DOI 10.1128/JVI.62.11.4086-4095.1988; LOH TP, 1990, MOL CELL BIOL, V10, P4045, DOI 10.1128/MCB.10.8.4045; LOH TP, 1987, MOL CELL BIOL, V7, P3775, DOI 10.1128/MCB.7.10.3775; Modin C, 2000, J VIROL, V74, P11697, DOI 10.1128/JVI.74.24.11697-11707.2000; Modin C, 2000, VIROLOGY, V278, P368, DOI 10.1006/viro.2000.0683; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Ng P, 2000, BIOTECHNIQUES, V29, P524, DOI 10.2144/00293st04; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; NIWA O, 1983, CELL, V32, P1105, DOI 10.1016/0092-8674(83)90294-5; OSHIMA RG, 1982, J BIOL CHEM, V257, P3414; Peng HZ, 2000, J MOL BIOL, V295, P1139, DOI 10.1006/jmbi.1999.3402; PENGUE G, 1995, J VIROL, V69, P6577, DOI 10.1128/JVI.69.10.6577-6580.1995; PETERSEN R, 1991, MOL CELL BIOL, V11, P1214, DOI 10.1128/MCB.11.3.1214; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; TEICH NM, 1977, CELL, V12, P973, DOI 10.1016/0092-8674(77)90162-3; TSUKIYAMA T, 1989, MOL CELL BIOL, V9, P4670, DOI 10.1128/MCB.9.11.4670; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Vernet M, 1996, J VIROL, V70, P5630, DOI 10.1128/JVI.70.8.5630-5633.1996; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; YAMAUCHI M, 1995, J VIROL, V69, P1142, DOI 10.1128/JVI.69.2.1142-1149.1995	43	251	269	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2007	131	1					46	57		10.1016/j.cell.2007.07.026	http://dx.doi.org/10.1016/j.cell.2007.07.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923087	Bronze			2022-12-01	WOS:000249934700010
J	Dunn, FA; Lankheet, MJ; Rieke, F				Dunn, Felice A.; Lankheet, Martin J.; Rieke, Fred			Light adaptation in cone vision involves switching between receptor and post-receptor sites	NATURE			English	Article							RETINAL GANGLION-CELLS; SLOW CONTRAST ADAPTATION; PRIMATE RETINA; SENSITIVITY REGULATION; BIPOLAR CELLS; OUTER RETINA; PHOTORECEPTORS; DYNAMICS; PHOTOVOLTAGE; SALAMANDER	We see over an enormous range of mean light levels, greater than the range of output signals retinal neurons can produce. Even highlights and shadows within a single visual scene can differ similar to 10,000-fold in intensity-exceeding the range of distinct neural signals by a factor of similar to 100. The effectiveness of daylight vision under these conditions relies on at least two retinal mechanisms that adjust sensitivity in the similar to 200 ms intervals between saccades(1). One mechanism is in the cone photoreceptors (receptor adaptation)(2-5) and the other is at a previously unknown location within the retinal circuitry that benefits from convergence of signals from multiple cones (post-receptor adaptation)(6,7). Here we find that post-receptor adaptation occurs as signals are relayed from cone bipolar cells to ganglion cells. Furthermore, we find that the two adaptive mechanisms are essentially mutually exclusive: as light levels increase the main site of adaptation switches from the circuitry to the cones. These findings help explain how human cone vision encodes everyday scenes, and, more generally, how sensory systems handle the challenges posed by a diverse physical environment.	Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Utrecht, Funct Neurobiol & Helmholtz Inst, NL-3584 CH Utrecht, Netherlands	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utrecht University	Rieke, F (corresponding author), Univ Washington, Program Neurobiol & Behav, Seattle, WA 98195 USA.	rieke@u.washington.edu						Armstrong-Gold CE, 2003, J NEUROSCI, V23, P3796; Baccus SA, 2002, NEURON, V36, P909, DOI 10.1016/S0896-6273(02)01050-4; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P729, DOI 10.1113/jphysiol.1974.sp010732; BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; BOYNTON RM, 1970, SCIENCE, V170, P1423, DOI 10.1126/science.170.3965.1423; Dunn FA, 2006, J NEUROSCI, V26, P3959, DOI 10.1523/JNEUROSCI.5148-05.2006; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Hood DC, 1998, ANNU REV PSYCHOL, V49, P503, DOI 10.1146/annurev.psych.49.1.503; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Lee BB, 2003, J VISION, V3, P513, DOI 10.1167/3.7.5; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; Lee BB, 1999, P NATL ACAD SCI USA, V96, P14611, DOI 10.1073/pnas.96.25.14611; Manookin MB, 2006, NEURON, V50, P453, DOI 10.1016/j.neuron.2006.03.039; MATTHEWS HR, 1990, J PHYSIOL-LONDON, V420, P447, DOI 10.1113/jphysiol.1990.sp017922; PURPURA K, 1990, VISUAL NEUROSCI, V4, P75, DOI 10.1017/S0952523800002789; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; SCHNEEWEIS DM, 1995, SCIENCE, V268, P1053, DOI 10.1126/science.7754386; Schneeweis DM, 1999, J NEUROSCI, V19, P1203; Smith VC, 2001, J NEUROPHYSIOL, V85, P545, DOI 10.1152/jn.2001.85.2.545; TRANCHINA D, 1984, NATURE, V310, P314, DOI 10.1038/310314a0; VALETON JM, 1983, VISION RES, V23, P1539, DOI 10.1016/0042-6989(83)90167-0; Yarbus A. L., 1967, EYE MOVEMENTS VISION; Yeh TY, 1996, VISION RES, V36, P913, DOI 10.1016/0042-6989(95)00332-0	25	123	123	5	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					603	U12		10.1038/nature06150	http://dx.doi.org/10.1038/nature06150			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17851533				2022-12-01	WOS:000249893500046
J	Hadden, JM; Declais, AC; Carr, SB; Lilley, DMJ; Phillips, SEV				Hadden, Jonathan M.; Declais, Anne-Cecile; Carr, Stephen B.; Lilley, David M. J.; Phillips, Simon E. V.			The structural basis of Holliday junction resolution by T7 endonuclease	NATURE			English	Article							4-WAY DNA JUNCTION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; COMPLEX; RUVA; SITE; BACTERIOPHAGE-T7; RECOGNITION; BINDING	The four-way (Holliday) DNA junction is the central intermediate in homologous recombination, a ubiquitous process that is important in DNA repair and generation of genetic diversity(1). The penultimate stage of recombination requires resolution of the DNA junction into nicked-duplex species by the action of a junction-resolving enzyme, examples of which have been identified in a wide variety of organisms(2). These enzymes are nucleases that are highly selective for the structure of branched DNA. The mechanism of this selectivity has, however, been unclear in the absence of structural data. Here we present the crystal structure of the junction-resolving enzyme phage T7 endonuclease I in complex with a synthetic four-way DNA junction. Although the enzyme is structure-selective, significant induced fit occurs in the interaction, with changes in the structure of both the protein and the junction. The dimeric enzyme presents two binding channels that contact the backbones of the junction's helical arms over seven nucleotides. These interactions effectively measure the relative orientations and positions of the arms of the junction, thereby ensuring that binding is selective for branched DNA that can achieve this geometry.	Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Dundee, Canc Res UK, Nucl Acid Struct Res Grp, Dundee DD1 4HN, Scotland	University of Leeds; Cancer Research UK; University of Dundee	Phillips, SEV (corresponding author), Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	s.e.v.phillips@leeds.ac.uk		Declais, Anne-Cecile/0000-0002-1904-6469	BBSRC [BB/E001777/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E001777/1] Funding Source: Medline; Cancer Research UK [11722] Funding Source: Medline; Wellcome Trust Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Ariyoshi M, 2000, P NATL ACAD SCI USA, V97, P8257, DOI 10.1073/pnas.140212997; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENNETT RJ, 1995, J MOL BIOL, V252, P213, DOI 10.1006/jmbi.1995.0489; BHATTACHARYYA A, 1991, J MOL BIOL, V221, P1191, DOI 10.1016/0022-2836(91)90928-Y; CENTER MS, 1970, J BIOL CHEM, V245, P6285; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Declais AC, 2003, EMBO J, V22, P1398, DOI 10.1093/emboj/cdg132; Declais AC, 2006, J MOL BIOL, V359, P1261, DOI 10.1016/j.jmb.2006.04.037; DEMASSY B, 1984, COLD SPRING HARB SYM, V49, P715, DOI 10.1101/SQB.1984.049.01.081; DUCKETT DR, 1995, J MOL BIOL, V246, P95, DOI 10.1006/jmbi.1994.0069; Eichman BF, 2000, P NATL ACAD SCI USA, V97, P3971, DOI 10.1073/pnas.97.8.3971; Evans W, 1997, CHEM BRIT, V33, P22; Gopaul DN, 1998, EMBO J, V17, P4175, DOI 10.1093/emboj/17.14.4175; Hadden JM, 2002, EMBO J, V21, P3505, DOI 10.1093/emboj/cdf337; Hadden JM, 2001, NAT STRUCT BIOL, V8, P62; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Joo C, 2004, J MOL BIOL, V341, P739, DOI 10.1016/j.jmb.2004.06.024; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, ESF EAMCB NEWSL PROT, V26; Lilley DMJ, 2000, P NATL ACAD SCI USA, V97, P9351, DOI 10.1073/pnas.97.17.9351; Lilley DMJ, 2001, NAT REV MOL CELL BIO, V2, P433, DOI 10.1038/35073057; Liu J, 2006, BIOCHEMISTRY-US, V45, P3934, DOI 10.1021/bi0523254; McKinney SA, 2003, NAT STRUCT BIOL, V10, P93, DOI 10.1038/nsb883; Newman M, 1998, EMBO J, V17, P5466, DOI 10.1093/emboj/17.18.5466; Ortiz-Lombardia M, 1999, NAT STRUCT BIOL, V6, P913; Parkinson MJ, 1997, J MOL BIOL, V270, P169, DOI 10.1006/jmbi.1997.1128; Pohler JRG, 1996, J MOL BIOL, V260, P678; Roe SM, 1998, MOL CELL, V2, P361, DOI 10.1016/S1097-2765(00)80280-4; SADOWSKI PD, 1971, J BIOL CHEM, V246, P200; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; White MF, 1997, J MOL BIOL, V266, P122, DOI 10.1006/jmbi.1996.0795	32	66	68	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2007	449	7162					621	U15		10.1038/nature06158	http://dx.doi.org/10.1038/nature06158			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17873858				2022-12-01	WOS:000249893500050
J	Florez, JC				Florez, Jose C.			Knowledge is power	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DOWN-SYNDROME; PRENATAL-DIAGNOSIS; MOTHERS					jcflorez@partners.org						American College of Obstetricians and Gynecologists, 2007, OBSTET GYNECOL, V110, P217; Britt DW, 2000, AM J MED GENET, V93, P410, DOI 10.1002/1096-8628(20000828)93:5<410::AID-AJMG12>3.3.CO;2-6; Caruso TM, 1998, GENET MED, V1, P22; Mansfield C, 1999, PRENATAL DIAG, V19, P808, DOI 10.1002/(SICI)1097-0223(199909)19:9<808::AID-PD637>3.0.CO;2-B; Skotko B, 2005, PEDIATRICS, V115, P64, DOI 10.1542/peds.2004-0928; Skotko BG, 2005, AM J OBSTET GYNECOL, V192, P670, DOI 10.1016/j.ajog.2004.11.001	6	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2007	298	13					1489	1490		10.1001/jama.298.13.1489	http://dx.doi.org/10.1001/jama.298.13.1489			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216EE	17911487				2022-12-01	WOS:000249860500001
J	Gu, J; Xie, ZG; Gao, ZC; Liu, JH; Korteweg, C; Ye, JX; Lau, LT; Lu, J; Gao, ZF; Zhang, B; McNutt, MA; Lu, M; Anderson, VM; Gong, EC; Yu, ACH; Lipkin, WI				Gu, Jiang; Xie, Zhigang; Gao, Zhancheng; Liu, Jinhua; Korteweg, Christine; Ye, Juxiang; Lau, Lok Ting; Lu, Jie; Gao, Zifen; Zhang, Bo; McNutt, Michael A.; Lu, Min; Anderson, Virginia M.; Gong, Encong; Yu, Albert Cheung Hoi; Lipkin, W. Ian			H5N1 infection of the respiratory tract and beyond: a molecular pathology study	LANCET			English	Article							INFLUENZA-A H5N1; HUMAN AIRWAY EPITHELIUM; AVIAN INFLUENZA; HUMAN-DISEASE; VIRUS INFECTION; IN-VITRO; TRANSMISSION; EXPRESSION; SARS; PATHOGENESIS	Background Human infection with avian influenza H5N1 is an emerging infectious disease characterised by respiratory symptoms and a high fatality rate. Previous studies have shown that the human infection with avian influenza H5N1 could also target organs apart from the lungs. Methods We studied post-mortem tissues of two adults (one man and one pregnant woman) infected with H5N1 influenza virus, and a fetus carried by the woman. In-situ hybridisation (with sense and antisense probes to haemagglutinin and nucleoprotein) and immunohistochemistry (with monoclonal antibodies to haemagglutinin and nucleoprotein) were done on selected tissues. Reverse-transcriptase (RT) PCR, real-time RT PCR, strand-specific RT PCR, and nucleic acid sequence-based amplification (NASBA) detection assays were also undertaken to detect viral RNA in organ tissue samples. Findings We detected viral genomic sequences and antigens in type II epithelial cells of the lungs, ciliated and non-ciliated epithelial cells of the trachea, T cells of the lymph node, neurons of the brain, and Hofbauer cells and cytotrophoblasts of the placenta. Viral genomic sequences (but no viral antigens) were detected in the intestinal mucosa. In the fetus, we found viral sequences and antigens in the lungs, circulating mononuclear cells, and macrophages of the liver. The presence of viral sequences in the organs and the fetus was also confirmed by RT PCR, strand-specific RT PCR, real-time RT PCR, and NASBA. Interpretation In addition to the lungs, H5N1 influenza virus infects the trachea and disseminates to other organs including the brain. The virus could also be transmitted from mother to fetus across the placenta.	Peking Univ, Ctr Infect Dis, Beijing 100083, Peoples R China; Peking Univ, Sch Basic Med Sci, Dept Pathol, Beijing 100083, Peoples R China; Peking Univ, Peoples Hosp, Beijing 100083, Peoples R China; Peking Univ, Neurosci Res Inst, Beijing 100083, Peoples R China; China Agr Univ, Coll Vet Med, Beijing, Peoples R China; SUNY, Hlth Sci Ctr, Dept Pathol, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	Peking University; Peking University; Peking University; Peking University; China Agricultural University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; SUNY Community College; SUNY Maritime College; SUNY Optometry; Columbia University	Gu, J (corresponding author), Peking Univ, Ctr Infect Dis, Beijing 100083, Peoples R China.	jianggu@bjmu.edu.cn	Lau, Lok Ting/C-3866-2013; Lipkin, W. Ian/ABE-6216-2020	Lipkin, W. Ian/0000-0002-8768-9386; Gu, Jiang/0000-0002-0706-8329; Lau, Lok Ting/0000-0001-7517-1486				Brown LM, 2005, HISTOCHEM CELL BIOL, V124, P499, DOI 10.1007/s00418-005-0051-7; Cerna A, 2002, ACTA HISTOCHEM, V104, P339, DOI 10.1078/0065-1281-00669; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Chutinimitkul S, 2006, EMERG INFECT DIS, V12, P1041, DOI 10.3201/eid1206.060227; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Farcas GA, 2005, J INFECT DIS, V191, P193, DOI 10.1086/426870; Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000; Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828; GU J, 1994, CELL VISION, V1, P76; Horimoto T, 2001, CLIN MICROBIOL REV, V14, P129, DOI 10.1128/CMR.14.1.129-149.2001; Irving WL, 2000, BRIT J OBSTET GYNAEC, V107, P1282, DOI 10.1111/j.1471-0528.2000.tb11621.x; KANEKO Y, 1995, J HISTOCHEM CYTOCHEM, V43, P945, DOI 10.1177/43.9.7642967; Lau LT, 2004, BIOCHEM BIOPH RES CO, V313, P336, DOI 10.1016/j.bbrc.2003.11.131; Li L, 2005, CLIN INFECT DIS, V41, P815, DOI 10.1086/432720; Lin Y, 2003, CELL RES, V13, P141, DOI 10.1038/sj.cr.7290158; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Mori I, 1997, CLIN INFECT DIS, V24, P736; Nicholls JM, 2006, PLOS MED, V3, P222, DOI 10.1371/journal.pmed.0030027; Normile D, 2006, SCIENCE, V312, P1855; Park CH, 2002, ARCH VIROL, V147, P1425, DOI 10.1007/s00705-001-0750-x; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; *PEK U SCH BAS MED, SOURC DIL INC TIM PR; *PEK U SCH BAS MED, HA SEQ VIR IS CAS 2; RAMPHAL R, 1980, AM J OBSTET GYNECOL, V138, P347, DOI 10.1016/0002-9378(80)90265-3; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Shu YL, 2006, NEW ENGL J MED, V354, P1421, DOI 10.1056/NEJMc053524; Takahashi T, 2001, J BIOCHEM-TOKYO, V130, P279, DOI 10.1093/oxfordjournals.jbchem.a002983; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Uiprasertkul M, 2005, EMERG INFECT DIS, V11, P1036, DOI 10.3201/eid1107.041313; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; World Health Organization, CUM NUMB CONF HUM CA; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005; Zhang Qing-ling, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P1125; Zhou JF, 2006, J INFECT DIS, V194, P61, DOI 10.1086/504690	42	291	319	1	60	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2007	370	9593					1137	1145		10.1016/S0140-6736(07)61515-3	http://dx.doi.org/10.1016/S0140-6736(07)61515-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221YQ	17905166	Green Published, Bronze			2022-12-01	WOS:000250263700028
J	Morrison, HG; McArthur, AG; Gillin, FD; Aley, SB; Adam, RD; Olsen, GJ; Best, AA; Cande, WZ; Chen, F; Cipriano, MJ; Davids, BJ; Dawson, SC; Elmendorf, HG; Hehl, AB; Holder, ME; Huse, SM; Kim, UU; Lasek-Nesselquist, E; Manning, G; Nigam, A; Nixon, JEJ; Palm, D; Passamaneck, NE; Prabhu, A; Reich, CI; Reiner, DS; Samuelson, J; Svard, SG; Sogin, ML				Morrison, Hilary G.; McArthur, Andrew G.; Gillin, Frances D.; Aley, Stephen B.; Adam, Rodney D.; Olsen, Gary J.; Best, Aaron A.; Cande, W. Zacheus; Chen, Feng; Cipriano, Michael J.; Davids, Barbara J.; Dawson, Scott C.; Elmendorf, Heidi G.; Hehl, Adrian B.; Holder, Michael E.; Huse, Susan M.; Kim, Ulandt U.; Lasek-Nesselquist, Erica; Manning, Gerard; Nigam, Anuranjini; Nixon, Julie E. J.; Palm, Daniel; Passamaneck, Nora E.; Prabhu, Anjali; Reich, Claudia I.; Reiner, David S.; Samuelson, John; Svard, Staffan G.; Sogin, Mitchell L.			Genomic minimalism in the early diverging intestinal parasite Giardia lamblia	SCIENCE			English	Article							TRICHOMONAS-VAGINALIS; ENTAMOEBA-HISTOLYTICA; SPLICEOSOMAL INTRON; GENES; EUKARYOTE; ORIGIN; EVOLUTION; DICTYOSTELIUM; MITOCHONDRIA; PROTEINS	The genome of the eukaryotic protist Giardia lamblia, an important human intestinal parasite, is compact in structure and content, contains few introns or mitochondrial relics, and has simplified machinery for DNA replication, transcription, RNA processing, and most metabolic pathways. Protein kinases comprise the single largest protein class and reflect Giardia's requirement for a complex signal transduction network for coordinating differentiation. Lateral gene transfer from bacterial and archaeal donors has shaped Giardia's genome, and previously unknown gene families, for example, cysteine-rich structural proteins, have been discovered. Unexpectedly, the genome shows little evidence of heterozygosity, supporting recent speculations that this organism is sexual. This genome sequence will not only be valuable for investigating the evolution of eukaryotes, but will also be applied to the search for new therapeutics for this parasite.	Marine Biol Lab, Woods Hole, MA 02543 USA; Univ Calif San Diego, Dept Pathol, Div Infect Dis, San Diego, CA 92103 USA; Univ Texas, Dept Biol Sci, El Paso, TX 79968 USA; Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85724 USA; Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85724 USA; Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; Hope Coll, Dept Biol, Holland, MI 49423 USA; Univ Calif Berkeley, Berkeley, CA 94720 USA; Univ Penn, Philadelphia, PA 19194 USA; Georgetown Univ, Dept Biol, Washington, DC 20057 USA; Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland; Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA; Swedish Inst Infect Dis Control, Ctr Microbiol Preparedness, S-17182 Solna, Sweden; Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; Uppsala Univ, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden	Marine Biological Laboratory - Woods Hole; University of California System; University of California San Diego; University of Texas System; University of Texas El Paso; University of Arizona; University of Arizona; University of Illinois System; University of Illinois Urbana-Champaign; Hope College; University of California System; University of California Berkeley; University of Pennsylvania; Georgetown University; University of Zurich; Salk Institute; Swedish Institute for Infectious Disease Control; Boston University; Uppsala University	Morrison, HG (corresponding author), Marine Biol Lab, Woods Hole, MA 02543 USA.	morrison@mbl.edu	Sogin, Mitchell/AAE-7186-2019; Chen, Feng/A-4497-2011; Reiner, David S./F-6106-2012; Manning, Gerard/C-8308-2009	Reiner, David S./0000-0002-8289-7311; Samuelson, John/0000-0001-9533-3040; Cipriano, Michael/0000-0001-8163-8812; Hehl, Adrian/0000-0002-2110-4445; Svard, Staffan/0000-0002-7392-1746; Manning, Gerard/0000-0002-5087-9151; Morrison, Hilary/0000-0003-0281-326X; McArthur, Andrew/0000-0002-1142-3063; Dawson, Scott/0000-0002-0843-1759	NHGRI NIH HHS [R01 HG004164-01, R01 HG004164] Funding Source: Medline; NIAID NIH HHS [AI51687, AI42488, R01 AI054693, R01 AI048082, AI43273] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048082, R01AI042488, R01AI054693, R01AI051687, R01AI043273] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAM RD, 1991, MICROBIOL REV, V55, P706, DOI 10.1128/MMBR.55.4.706-732.1991; Andersson JO, 2003, CURR BIOL, V13, P94, DOI 10.1016/S0960-9822(03)00003-4; Andersson SGE, 2003, PHILOS T R SOC B, V358, P165, DOI 10.1098/rstb.2002.1193; Banerjee S, 2007, P NATL ACAD SCI USA, V104, P11676, DOI 10.1073/pnas.0704862104; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Barry JD, 2003, INT J PARASITOL, V33, P29, DOI 10.1016/S0020-7519(02)00247-3; Beck DL, 2005, EUKARYOT CELL, V4, P722, DOI 10.1128/EC.4.4.722-732.2005; Bernander R, 2001, CELL MICROBIOL, V3, P55, DOI 10.1046/j.1462-5822.2001.00094.x; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; BROWN DM, 1995, MOL BIOCHEM PARASIT, V72, P47, DOI 10.1016/0166-6851(95)00065-9; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Davids BJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000044; Eckmann L, 2000, J IMMUNOL, V164, P1478, DOI 10.4049/jimmunol.164.3.1478; Elmendorf HG, 2005, INT J PARASITOL, V35, P1001, DOI 10.1016/j.ijpara.2005.03.009; FEELY DE, 1982, EXP PARASITOL, V53, P145, DOI 10.1016/0014-4894(82)90100-X; Hilario E, 1998, J MOL EVOL, V46, P703, DOI 10.1007/PL00006351; Hlavsa Michele C., 2005, Morbidity and Mortality Weekly Report, V54, P1; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; LEIPE DD, 1993, MOL BIOCHEM PARASIT, V59, P41, DOI 10.1016/0166-6851(93)90005-I; Li EQ, 2006, J IMMUNOL, V176, P516, DOI 10.4049/jimmunol.176.1.516; LUJAN HD, 1995, J BIOL CHEM, V270, P4612, DOI 10.1074/jbc.270.9.4612; Marti M, 2003, MOL BIOL CELL, V14, P1433, DOI 10.1091/mbc.E02-08-0467; McArthur AG, 2001, MOL BIOL EVOL, V18, P1455, DOI 10.1093/oxfordjournals.molbev.a003931; Nagasaki A, 2002, J CELL SCI, V115, P2241; NARCISI EM, 1994, J PARASITOL, V80, P468, DOI 10.2307/3283419; Nash TE, 2001, INFECT IMMUN, V69, P1922, DOI 10.1128/IAI.69.3.1922-1923.2001; Nixon JEJ, 2002, EUKARYOT CELL, V1, P181, DOI 10.1128/EC.1.2.181-190.2002; Nixon JEJ, 2002, P NATL ACAD SCI USA, V99, P3701, DOI 10.1073/pnas.042700299; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; Regoes A, 2005, J BIOL CHEM, V280, P30557, DOI 10.1074/jbc.M500787200; Roger AJ, 1998, P NATL ACAD SCI USA, V95, P229, DOI 10.1073/pnas.95.1.229; Russell AG, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-45; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Simpson AGB, 2002, NATURE, V419, P270, DOI 10.1038/419270a; Simpson AGB, 2002, MOL BIOL EVOL, V19, P1782, DOI 10.1093/oxfordjournals.molbev.a004000; Suguri S, 2001, J EUKARYOT MICROBIOL, V48, P493, DOI 10.1111/j.1550-7408.2001.tb00184.x; Tachezy J, 2001, MOL BIOL EVOL, V18, P1919, DOI 10.1093/oxfordjournals.molbev.a003732; Thomarat F, 2004, J MOL EVOL, V59, P780, DOI 10.1007/s00239-004-2673-0; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Vanacova S, 2005, P NATL ACAD SCI USA, V102, P4430, DOI 10.1073/pnas.0407500102	41	581	622	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846					1921	1926		10.1126/science.1143837	http://dx.doi.org/10.1126/science.1143837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901334				2022-12-01	WOS:000249764300040
J	Jaeger, WL; Keszthelyi, LP; McEwen, AS; Dundas, CM; Russell, PS				Jaeger, W. L.; Keszthelyi, L. P.; McEwen, A. S.; Dundas, C. M.; Russell, P. S.			Athabasca Valles, Mars: A lava-draped channel system	SCIENCE			English	Article							SURFACE	Athabasca Valles is a young outflow channel system on Mars that may have been carved by catastrophic water floods. However, images acquired by the High-Resolution Imaging Science Experiment camera onboard the Mars Reconnaissance Orbiter spacecraft reveal that Athabasca Valles is now entirely draped by a thin layer of solidified lava-the remnant of a once-swollen river of molten rock. The lava erupted from a fissure, inundated the channels, and drained downstream in geologically recent times. Purported ice features in Athabasca Valles and its distal basin, Cerberus Palus, are actually composed of this lava. Similar volcanic processes may have operated in other ostensibly fluvial channels, which could explain in part why the landers sent to investigate sites of ancient flooding on Mars have predominantly found lava at the surface instead.	US Geol Survey, Astrogeol Team, Flagstaff, AZ 86001 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland	United States Department of the Interior; United States Geological Survey; University of Arizona; University of Bern	Jaeger, WL (corresponding author), US Geol Survey, Astrogeol Team, Flagstaff, AZ 86001 USA.	wjaeger@usgs.gov		Dundas, Colin/0000-0003-2343-7224; Kestay, Laszlo/0000-0003-1879-4331				Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Burr DA, 2005, ICARUS, V178, P56, DOI 10.1016/j.icarus.2005.04.012; Burr DM, 2002, ICARUS, V159, P53, DOI 10.1006/icar.2002.6921; Carr M.H, 1996, WATER MARS; CARR MH, 1990, ICARUS, V87, P210, DOI 10.1016/0019-1035(90)90031-4; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Edgett KS, 1997, J GEOPHYS RES-PLANET, V102, P21545, DOI 10.1029/97JE01685; Feldman WC, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002207; Gaidos E, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002000; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002035; Harmon JK, 1999, J GEOPHYS RES-PLANET, V104, P14065, DOI 10.1029/1998JE900042; HOFFMAN N, 2002, LUNAR PLANET SCI, V33; LANAGAN PD, 2004, THESIS U ARIZONA TUC; McEwen AS, 2005, ICARUS, V176, P351, DOI 10.1016/j.icarus.2005.02.009; MILAZZO MP, 2005, THESIS U ARIZONA TUC; MUHLEMAN DO, 1991, SCIENCE, V253, P1508, DOI 10.1126/science.253.5027.1508; Murray JB, 2005, NATURE, V434, P352, DOI 10.1038/nature03379; Page DP, 2006, ICARUS, V183, P46, DOI 10.1016/j.icarus.2006.01.017; PLESCIA JB, 1990, ICARUS, V88, P465, DOI 10.1016/0019-1035(90)90095-Q; Putzig NE, 2005, ICARUS, V173, P325, DOI 10.1016/j.icarus.2004.08.017; RICE JW, 2002, LUNAR PLANET SCI, V33; TANAKA KL, 1986, LUNAR PLANET SCI, V17, P865	22	122	124	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2007	317	5845					1709	1711		10.1126/science.1143315	http://dx.doi.org/10.1126/science.1143315			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885126				2022-12-01	WOS:000249585900035
J	Nishiyama, T; Yoshizaki, N; Kishimoto, T; Ohsumi, K				Nishiyama, Tomoko; Yoshizaki, Norio; Kishimoto, Takeo; Ohsumi, Keita			Transient activation of calcineurin is essential to initiate embryonic development in Xenopus laevis	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; M-M TRANSITION; CYTOSTATIC FACTOR; EXTRACELLULAR-MATRIX; OOCYTE EXTRACTS; EGG ACTIVATION; FERTILIZATION; CALCIUM; DEGRADATION; ARREST	At fertilization, an increase of cytosolic calciumions (Ca2+) triggers various activation responses in animal eggs(1,2). In vertebrates, these responses include exit from metaphase arrest in meiosis II (MII exit) and cortical remodelling initiated by cortical granule exocytosis. Although the essential requirement of Ca2+/calmodulin-dependent protein kinase II for inducing MII exit has been documented(3), a role of the Ca2+/calmodulin-dependent protein phosphatase calcineurin in egg activation has not been investigated. Here we show, using cell-free extracts from unfertilized eggs of Xenopus laevis, that calcineurin is transiently activated immediately after Ca2+ addition to a concentration that induces MII exit. When calcineurin activation is inhibited, cyclin-dependent kinase 1 (Cdk1) inactivation by means of cyclin B degradation is prevented and sperm chromatin incubated in the extracts remains condensed. Similarly, if calcineurin is inhibited in intact eggs, MII exit on egg activation is prevented. In addition, the activation contraction(4) in the cortex is suppressed whereas cortical granule exocytosis occurs. We further demonstrate that, when a high level of calcineurin activity is maintained after activation, growth of sperm asters is prevented in egg extracts and, consistently, migration of male and female pronuclei towards each other is hindered in fertilized eggs. Thus, both activation and the subsequent inactivation of calcineurin in fertilized eggs are crucial for the commencement of vertebrate embryonic development.	Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Lab Cell & Dev Biol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Gifu Univ, Dept Anim Resource Product, United Grad Sch Agr Sci, Gifu 5011193, Japan	Tokyo Institute of Technology; Gifu University	Ohsumi, K (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Lab Cell & Dev Biol, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	kohsumi@bio.titech.ac.jp						BEMENT WM, 1990, CELL REGUL, V1, P315, DOI 10.1091/mbc.1.3.315; BLUMENTHAL DK, 1986, J BIOL CHEM, V261, P8140; CAPCO DG, 1992, J EXP ZOOL, V264, P395, DOI 10.1002/jez.1402640405; CHRISTENSEN K, 1984, NATURE, V310, P150, DOI 10.1038/310150a0; COLBRAN RJ, 1988, J BIOL CHEM, V263, P18145; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; HAMAGUCHI MS, 1986, DEV GROWTH DIFFER, V28, P143, DOI 10.1111/j.1440-169x.1986.00143.x; Hansen DV, 2006, P NATL ACAD SCI USA, V103, P608, DOI 10.1073/pnas.0509549102; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; HEDRICK JL, 1991, J ELECTRON MICR TECH, V17, P319, DOI 10.1002/jemt.1060170306; Iwabuchi M, 2000, EMBO J, V19, P4513, DOI 10.1093/emboj/19.17.4513; JAFFE LF, 1983, DEV BIOL, V99, P265, DOI 10.1016/0012-1606(83)90276-2; LARABELL C, 1991, J ELECTRON MICR TECH, V17, P294, DOI 10.1002/jemt.1060170305; Liu JJ, 2005, CURR BIOL, V15, P1458, DOI 10.1016/j.cub.2005.07.030; LOHKA MJ, 1985, J CELL BIOL, V101, P518, DOI 10.1083/jcb.101.2.518; LORCA T, 1993, NATURE, V366, P270, DOI 10.1038/366270a0; MACKINTOSH C, 1999, PROTEIN PHOSPHORYLAT, P153; Masui Y, 2000, NAT REV MOL CELL BIO, V1, P228, DOI 10.1038/35043096; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; NAVARA CS, 1994, DEV BIOL, V162, P29, DOI 10.1006/dbio.1994.1064; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696; Ohsumi Keita, 2006, V322, P445; PALECEK J, 1978, J EMBRYOL EXP MORPH, V45, P203; Rauh NR, 2005, NATURE, V437, P1048, DOI 10.1038/nature04093; Reinsch S, 1997, CURR BIOL, V7, P211, DOI 10.1016/S0960-9822(97)70092-7; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sardet C, 2006, SEMIN CELL DEV BIOL, V17, P223, DOI 10.1016/j.semcdb.2006.03.001; Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Sultana F, 2003, J ANAT, V203, P115, DOI 10.1046/j.1469-7580.2003.00197.x; Uto K, 1999, DEV BIOL, V208, P456, DOI 10.1006/dbio.1999.9231; WANGH LJ, 1989, J CELL SCI, V93, P1; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; Yamamoto TM, 2005, DEV BIOL, V279, P345, DOI 10.1016/j.ydbio.2004.12.025	35	70	70	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2007	449	7160					341	+		10.1038/nature06136	http://dx.doi.org/10.1038/nature06136			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17882220				2022-12-01	WOS:000249557300045
J	Herrmann, E; Call, J; Hernandez-Lloreda, MV; Hare, B; Tomasello, M				Herrmann, Esther; Call, Josep; Hernandez-Lloreda, Maria Victoria; Hare, Brian; Tomasello, Michael			Humans have evolved specialized skills of social cognition: The cultural intelligence hypothesis	SCIENCE			English	Article							NEOCORTEX SIZE; BRAIN; LANGUAGE	Humans have many cognitive skills not possessed by their nearest primate relatives. The cultural intelligence hypothesis argues that this is mainly due to a species-specific set of social-cognitive skills, emerging early in ontogeny, for participating and exchanging knowledge in cultural groups. We tested this hypothesis by giving a comprehensive battery of cognitive tests to large numbers of two of humans' closest primate relatives, chimpanzees and orangutans, as well as to 2.5-year-old human children before literacy and schooling. Supporting the cultural intelligence hypothesis and contradicting the hypothesis that humans simply have more "general intelligence," we found that the children and chimpanzees had very similar cognitive skills for dealing with the physical world but that the children had more sophisticated cognitive skills than either of the ape species for dealing with the social world.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Duke Univ, Dept Biol Anthropol & Anat, Durham, NC 27705 USA; Univ Complutense Madrid, Dept Metodol Ciencias Comportamiento, E-28040 Madrid, Spain	Max Planck Society; Duke University; Complutense University of Madrid	Herrmann, E (corresponding author), Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany.	eherrman@eva.mpg.de		Hernandez-Lloreda, Maria Victoria/0000-0003-0966-7453; Call Balaguer, Josep/0000-0002-8597-8336				AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Boyd Robert, 1996, Proceedings of the British Academy, V88, P77; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Byrne R., 1988, MACHIAVELLIAN INTELL; BYRNE RW, 1996, MODELLING EARLY HUMA, P49; Cheney D. L., 2007, BABOON METAPHYSICS E; CHENEY DL, 1990, MONKEYS SEE WORLD MI; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Coqueugniot H, 2004, NATURE, V431, P299, DOI 10.1038/nature02852; de Waal F., 1982, P1; Deaner R. O., 2006, EVOL PSYCHOL, V4, DOI [10.1177/147470490600400114, DOI 10.1177/147470490600400114]; DUNBAR RIM, 1993, BEHAV BRAIN SCI, V16, P681, DOI 10.1017/S0140525X00032325; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.3.CO;2-P; Dunbar RIM, 2003, ANNU REV ANTHROPOL, V32, P163, DOI 10.1146/annurev.anthro.32.061002.093158; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Fischer A, 2006, CURR BIOL, V16, P1133, DOI 10.1016/j.cub.2006.04.033; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Harvey P.H., 1987, P181; Haun DBM, 2006, P NATL ACAD SCI USA, V103, P17568, DOI 10.1073/pnas.0607999103; Hauser M, 2005, NATURE, V437, P60, DOI 10.1038/nature03917; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P1441, DOI 10.1098/rspb.2003.2414; Humphrey N.K., 1976, GROWING POINTS ETHOL, P303, DOI DOI 10.2307/375925; Jerison HJ., 1973, EVOLUTION BRAIN INTE, DOI 10.4324/9781315787107-3; KLEIN RG, 1999, HUMAN CAREER HUMAN B; Kudo H, 2001, ANIM BEHAV, V62, P711, DOI 10.1006/anbe.2001.1808; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Milton K., 1988, MACHIAVELLIAN INTELL, P285; Shettleworth, 2010, COGNITION EVOLUTION; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Tomasello M., 1997, PRIMATE COGNITION; Tomasello M., 1999, CULTURAL ORIGINS HUM; Tooby J., 1992, ADAPTED MIND, P19, DOI DOI 10.4324/9781410608994; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Vygotsky L.S., 1978, MIND SOC DEV HIGHER, P79; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; WHITEN A, 1996, THEORIES THEORIES MI, P277, DOI DOI 10.1017/CBO9780511597985.018	38	762	773	9	332	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2007	317	5843					1360	1366		10.1126/science.1146282	http://dx.doi.org/10.1126/science.1146282			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209GR	17823346				2022-12-01	WOS:000249377500038
J	Nakamura, T; Imai, Y; Matsumoto, T; Sato, S; Takeuchi, K; Igarashi, K; Harada, Y; Azuma, Y; Krust, A; Yamamoto, Y; Nishina, H; Takeda, S; Takayanagi, H; Metzger, D; Kanno, J; Takaoka, K; Martin, TJ; Chambon, P; Kato, S				Nakamura, Takashi; Imai, Yuuki; Matsumoto, Takahiro; Sato, Shingo; Takeuchi, Kazusane; Igarashi, Katsuhide; Harada, Yoshifumi; Azuma, Yoshiaki; Krust, Andree; Yamamoto, Yoko; Nishina, Hiroshi; Takeda, Shu; Takayanagi, Hiroshi; Metzger, Daniel; Kanno, Jun; Takaoka, Kunio; Martin, T. John; Chambon, Pierre; Kato, Shigeaki			Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts	CELL			English	Article							ANDROGEN RECEPTOR; MICE LACKING; MECHANISMS; OSTEOPETROSIS; RESORPTION; APOPTOSIS	Estrogen prevents osteoporotic bone loss by attenuating bone resorption; however, the molecular basis for this is unknown. Here, we report a critical role for the osteoclastic estrogen receptor alpha (ER alpha) in mediating estrogendependent bone maintenance in female mice. We selectively ablated ER alpha in differentiated osteoclasts (ER alpha(Delta Oc/Delta Oc)) and found that ER alpha(Delta Oc/Delta Oc) females, but not males, exhibited trabecular bone loss, similar to the osteoporotic bone phenotype in postmenopausal women. Further, we show that estrogen induced apoptosis and upregulation of Fas ligand (FasL) expression in osteoclasts of the trabecular bones of WT but not ER alpha(Delta Oc/Delta Oc) mice. The expression of ER alpha was also required for the induction of apoptosis by tamoxifen and estrogen in cultured osteoclasts. Our results support a model in which estrogen regulates the life span of mature osteoclasts via the induction of the Fas/FasL system, thereby providing an explanation for the osteoprotective function of estrogen as well as SERMs.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Kawaguchi, Saitama 3320012, Japan; Osaka City Univ, Dept Orthopaed Surg, Grad Sch Med, Abeno Ku, Osaka 5458585, Japan; Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo 1138510, Japan; Natl Inst Hlth Sci, Div Cellular & Mol Toxicol, Setagaya Ku, Tokyo 1588501, Japan; Teijin Inst Biomed Res, Tokyo 1918512, Japan; Univ Strasbourg, CNRS,Inst Genet & Biol Mol & Cellulaire, UMR7104,Dept Physiol Genet, INSERM,U596, F-67400 Strasbourg, France; St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia	University of Tokyo; Japan Science & Technology Agency (JST); Osaka Metropolitan University; Tokyo Medical & Dental University (TMDU); National Institute of Health Sciences - Japan; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; St. Vincent's Institute of Medical Research	Kato, S (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	uskato@mail.ecc.u-tokyo.ac.jp	Imai, Yuuki/ABC-4687-2020; takeda, shu/B-5195-2012	Nakamura, Takashi/0000-0002-6124-061X; Metzger, Daniel/0000-0002-5555-046X; Sato, Shingo/0000-0002-6227-5910				Belandia B, 2003, CELL, V114, P277, DOI 10.1016/S0092-8674(03)00599-3; Bland R, 2000, CLIN SCI, V98, P217, DOI 10.1042/CS19990252; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chien KR, 2005, CELL, V120, P533, DOI 10.1016/j.cell.2005.02.006; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Delmas PD, 2002, LANCET, V359, P2018, DOI 10.1016/S0140-6736(02)08827-X; Dupont S, 2000, DEVELOPMENT, V127, P4277; Gowen M, 1999, J BONE MINER RES, V14, P1654, DOI 10.1359/jbmr.1999.14.10.1654; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Kameda T, 1997, J EXP MED, V186, P489, DOI 10.1084/jem.186.4.489; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; KATO S, 1989, BIOCHIM BIOPHYS ACTA, V991, P36, DOI 10.1016/0304-4165(89)90025-1; Kawano H, 2003, P NATL ACAD SCI USA, V100, P9416, DOI 10.1073/pnas.1533500100; KIMBLE RB, 1995, ENDOCRINOLOGY, V136, P3054, DOI 10.1210/en.136.7.3054; Kobayashi Y, 2000, J BONE MINER RES, V15, P1924, DOI 10.1359/jbmr.2000.15.10.1924; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Li CY, 2006, J BONE MINER RES, V21, P865, DOI 10.1359/JBMR.060313; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Mueller Stefan O., 2001, Current Opinion in Pharmacology, V1, P613, DOI 10.1016/S1471-4892(01)00105-9; Mundy GR, 2006, CELL, V126, P441, DOI 10.1016/j.cell.2006.07.015; Nakamichi Y, 2003, MOL CELL BIOL, V23, P636, DOI 10.1128/MCB.23.2.636-644.2003; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sato T, 2004, P NATL ACAD SCI USA, V101, P1673, DOI 10.1073/pnas.0305303101; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shiina H, 2006, P NATL ACAD SCI USA, V103, P224, DOI 10.1073/pnas.0506736102; Simpson ER, 2001, ENDOCRINOLOGY, V142, P4589, DOI 10.1210/en.142.11.4589; Sims NA, 2003, J CLIN INVEST, V111, P1319, DOI 10.1172/JCI200317246; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Sun L, 2006, CELL, V125, P247, DOI 10.1016/j.cell.2006.01.051; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Syed F, 2005, BIOCHEM BIOPH RES CO, V328, P688, DOI 10.1016/j.bbrc.2004.11.097; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Takezawa S, 2007, EMBO J, V26, P764, DOI 10.1038/sj.emboj.7601548; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1857; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Tolar J, 2004, NEW ENGL J MED, V351, P2839, DOI 10.1056/NEJMra040952; Windahl SH, 2002, TRENDS ENDOCRIN MET, V13, P195, DOI 10.1016/S1043-2760(02)00594-5; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Zaman G, 2006, J BONE MINER RES, V21, P1297, DOI 10.1359/JBMR.060504	48	696	742	2	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2007	130	5					811	823		10.1016/j.cell.2007.07.025	http://dx.doi.org/10.1016/j.cell.2007.07.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	212GI	17803905	Bronze			2022-12-01	WOS:000249581500014
J	Dueber, ELC; Corn, JE; Bell, SD; Berger, JM				Dueber, Erin L. Cunningham; Corn, Jacob E.; Bell, Stephen D.; Berger, James M.			Replication origin recognition and deformation by a heterodimeric archaeal Orc1 complex	SCIENCE			English	Article							DNA-REPLICATION; ESCHERICHIA-COLI; AEROPYRUM-PERNIX; STRUCTURAL BASIS; INITIATION; CHROMOSOME; PROTEINS; BINDING; DOMAINS	The faithful duplication of genetic material depends on essential DNA replication initiation factors. Cellular initiators form higher-order assemblies on replication origins, using adenosine triphosphate ( ATP) to locally remodel duplex DNA and facilitate proper loading of synthetic replisomal components. To better understand initiator function, we determined the 3.4 angstrom-resolution structure of an archaeal Cdc6/Orc1 heterodimer bound to origin DNA. The structure demonstrates that, in addition to conventional DNA binding elements, initiators use their AAA+ ATPase domains to recognize origin DNA. Together these interactions establish the polarity of initiator assembly on the origin and induce substantial distortions into origin DNA strands. Biochemical and comparative analyses indicate that AAA+/DNA contacts observed in the structure are dynamic and evolutionarily conserved, suggesting that the complex forms a core component of the basal initiation machinery.	Univ Calif Berkeley, Dept Mol & Cell Biol, Inst QB3, Berkeley, CA 94720 USA; Univ Calif Berkeley, Miller Inst Basic Res Sci, Berkeley, CA 94720 USA; MRC, Hutchinson MRC Res Ctr, Canc Cell Unit, Cambridge CB2 2XZ, England	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Berger, JM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Inst QB3, Stanley Hall 3220, Berkeley, CA 94720 USA.	jmberger@berkeley.edu		Bell, Stephen/0000-0002-8474-6592	NIGMS NIH HHS [GM071747] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071747] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Capaldi SA, 2004, NUCLEIC ACIDS RES, V32, P4821, DOI 10.1093/nar/gkh819; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2002, EMBO J, V21, P4763, DOI 10.1093/emboj/cdf496; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Gaudier M, 2007, SCIENCE, V317, P1213, DOI 10.1126/science.1143664; Grainge I, 2006, J MOL BIOL, V363, P355, DOI 10.1016/j.jmb.2006.07.076; HARLAND RM, 1980, CELL, V21, P761, DOI 10.1016/0092-8674(80)90439-0; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kelman LM, 2003, MOL MICROBIOL, V48, P605, DOI 10.1046/j.1365-2958.2003.03369.x; Kornberg A., 1992, DNA REPLICATION; Lee DG, 2000, CURR OPIN CELL BIOL, V12, P280, DOI 10.1016/S0955-0674(00)00089-2; Liu JY, 2000, MOL CELL, V6, P637, DOI 10.1016/S1097-2765(00)00062-9; Lundgren M, 2004, P NATL ACAD SCI USA, V101, P7046, DOI 10.1073/pnas.0400656101; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Rappas M, 2005, SCIENCE, V307, P1972, DOI 10.1126/science.1105932; Robinson NP, 2004, CELL, V116, P25, DOI 10.1016/S0092-8674(03)01034-1; Seki T, 2000, P NATL ACAD SCI USA, V97, P14115, DOI 10.1073/pnas.97.26.14115; Singleton MR, 2004, J MOL BIOL, V343, P547, DOI 10.1016/j.jmb.2004.08.044; Sutton MD, 1997, J MOL BIOL, V274, P546, DOI 10.1006/jmbi.1997.1425; YUNG BYM, 1989, J BIOL CHEM, V264, P6146	25	118	121	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2007	317	5842					1210	1213		10.1126/science.1143690	http://dx.doi.org/10.1126/science.1143690			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205PJ	17761879				2022-12-01	WOS:000249126800037
J	Ramirez, SR; Gravendeel, B; Singer, RB; Marshall, CR; Pierce, NE				Ramirez, Santiago R.; Gravendeel, Barbara; Singer, Rodrigo B.; Marshall, Charles R.; Pierce, Naomi E.			Dating the origin of the Orchidaceae from a fossil orchid with its pollinator	NATURE			English	Article							FLOWERING PLANTS; ANGIOSPERMS; SEQUENCES; EVOLUTION; MORPHOLOGY; AMBER; AGE	Since the time of Darwin(1), evolutionary biologists have been fascinated by the spectacular adaptations to insect pollination exhibited by orchids. However, despite being the most diverse plant family on Earth(2), the Orchidaceae lack a definitive fossil record and thus many aspects of their evolutionary history remain obscure. Here we report an exquisitely preserved orchid pollinarium (of Meliorchis caribea gen. et sp. nov.) attached to the mesoscutellum of an extinct stingless bee, Proplebeia dominicana, recovered from Miocene amber in the Dominican Republic, that is 15-20 million years (Myr) old(3). This discovery constitutes both the first unambiguous fossil of Orchidaceae(4) and an unprecedented direct fossil observation of a plant-pollinator interaction(5,6). By applying cladistic methods to a morphological character matrix, we resolve the phylogenetic position of M. caribea within the extant subtribe Goodyerinae (subfamily Orchidoideae). We use the ages of other fossil monocots and M. caribea to calibrate a molecular phylogenetic tree of the Orchidaceae. Our results indicate that the most recent common ancestor of extant orchids lived in the Late Cretaceous (76-84 Myr ago), and also suggest that the dramatic radiation of orchids began shortly after the mass extinctions at the K/T boundary. These results further support the hypothesis of an ancient origin for Orchidaceae.	Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; Leiden Univ, Natl Herbarium Nederland, Leiden, Netherlands; Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Bot, BR-91501970 Porto Alegre, RS, Brazil; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University; Leiden University; Leiden University - Excl LUMC; Universidade Federal do Rio Grande do Sul; Harvard University	Ramirez, SR (corresponding author), Harvard Univ, Museum Comparat Zool, 26 Oxford St, Cambridge, MA 02138 USA.	sramirez@oeb.harvard.edu	Singer, Rodrigo B/E-1945-2013; Ramirez, Santiago/B-4948-2012	Singer, Rodrigo B/0000-0001-8980-7713; 				Bremer K, 2000, P NATL ACAD SCI USA, V97, P4707, DOI 10.1073/pnas.080421597; Camargo Joao M.F., 2000, American Museum Novitates, V3293, P1, DOI 10.1206/0003-0082(2000)293<0001:TEFOSB>2.0.CO;2; Cameron KM, 1999, AM J BOT, V86, P208, DOI 10.2307/2656938; Chase MW, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-4-reviews1012; CREPET WL, 1991, PHILOS T ROY SOC B, V333, P187, DOI 10.1098/rstb.1991.0067; CREPET WL, 1979, BIOSCIENCE, V29, P102, DOI 10.2307/1307746; CREPET WL, 1979, REV PALAEOBOT PALYNO, V27, P213, DOI 10.1016/0034-6667(79)90013-7; Darwin C., 1862, VARIOUS CONTRIVANCES; Dressler R.L., 1981, ORCHIDS NATURAL HIST; Freudenstein JV, 2004, AM J BOT, V91, P149, DOI 10.3732/ajb.91.1.149; Freudenstein JV, 1999, AM J BOT, V86, P225, DOI 10.2307/2656939; Freudenstein JV, 1997, PLANT SYST EVOL, V205, P125, DOI 10.1007/BF01464400; Friis EM, 2004, P NATL ACAD SCI USA, V101, P16565, DOI 10.1073/pnas.0407174101; Gandolfo MA, 2004, P NATL ACAD SCI USA, V101, P8056, DOI 10.1073/pnas.0402473101; Grimaldi D, 1999, ANN MO BOT GARD, V86, P373, DOI 10.2307/2666181; Grimaldi David, 2005, pi; Heard TA, 1999, ANNU REV ENTOMOL, V44, P183, DOI 10.1146/annurev.ento.44.1.183; HERENDEEN PS, 1995, MONOCOTYLEDONS SYSTE, P1; IturraldeVinent MA, 1996, SCIENCE, V273, P1850, DOI 10.1126/science.273.5283.1850; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; Labandeira CC, 1998, SCIENCE, V280, P57, DOI 10.1126/science.280.5360.57; Penalver E, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3541[1:FWIDAH]2.0.CO;2; Poinar GO, 2006, SCIENCE, V314, P614, DOI 10.1126/science.1134103; Ren D, 1998, SCIENCE, V280, P85, DOI 10.1126/science.280.5360.85; Roubik DW, 2000, PLANT SYST EVOL, V222, P271, DOI 10.1007/BF00984106; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Schmid R., 1977, ORCHID BIOL REV PERS, V1, P17; Singer RB, 2001, ANN BOT-LONDON, V88, P989, DOI 10.1006/anbo.2001.1534; van den Berg C, 2005, AM J BOT, V92, P613, DOI 10.3732/ajb.92.4.613; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782	30	194	210	2	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2007	448	7157					1042	1045		10.1038/nature06039	http://dx.doi.org/10.1038/nature06039			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205EU	17728756				2022-12-01	WOS:000249097600036
J	Schmid, EM; McMahon, HT				Schmid, Eva M.; McMahon, Harvey T.			Integrating molecular and network biology to decode endocytosis	NATURE			English	Article							MEDIATED ENDOCYTOSIS; CLATHRIN; DYNAMIN; PROTEINS; ACTIN; COAT; TOPOLOGY; HUB	The strength of network biology lies in its ability to derive cell biological information without a priori mechanistic or molecular knowledge. It is shown here how a careful understanding of a given biological pathway can refine an interactome approach. This permits the elucidation of additional design principles and of spatio-temporal dynamics behind pathways, and aids in experimental design and interpretation.	MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	McMahon, HT (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	hmm@mrc-lmb.cam.ac.uk			MRC [MC_U105178795] Funding Source: UKRI; Medical Research Council [MC_U105178795] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Brett TJ, 2006, CURR OPIN CELL BIOL, V18, P395, DOI 10.1016/j.ceb.2006.06.014; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Mishra SK, 2004, J BIOL CHEM, V279, P46191, DOI 10.1074/jbc.M408095200; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Niethammer P, 2007, PLOS BIOL, V5, P190, DOI 10.1371/journal.pbio.0050029; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; PERRY MM, 1979, J CELL SCI, V39, P257; Prachumwat A, 2006, MOL BIOL EVOL, V23, P30, DOI 10.1093/molbev/msi249; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Smith CJ, 1998, EMBO J, V17, P4943, DOI 10.1093/emboj/17.17.4943; Wienke DC, 1999, MOL BIOL CELL, V10, P225, DOI 10.1091/mbc.10.1.225; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.E04-09-0774	42	241	248	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 23	2007	448	7156					883	888		10.1038/nature06031	http://dx.doi.org/10.1038/nature06031			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202OM	17713526				2022-12-01	WOS:000248912900038
J	Auffray, C; Fogg, D; Garfa, M; Elain, G; Join-Lambert, O; Kayal, S; Sarnacki, S; Cumano, A; Lauvau, G; Geissmann, F				Auffray, Cedric; Fogg, Darin; Garfa, Meriem; Elain, Gaelle; Join-Lambert, Olivier; Kayal, Samer; Sarnacki, Sabine; Cumano, Ana; Lauvau, Gregoire; Geissmann, Frederic			Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior	SCIENCE			English	Article							DENDRITIC CELLS; IN-VIVO; FRACTALKINE; ADHESION; IDENTIFICATION; CHEMOKINE; DISTINCT; RECRUITMENT; MACROPHAGES; EMIGRATION	The cellular immune response to tissue damage and infection requires the recruitment of blood leukocytes. This process is mediated through a classical multistep mechanism, which involves transient rolling on the endothelium and recognition of inflammation followed by extravasation. We have shown, by direct examination of blood monocyte functions in vivo, that a subset of monocytes patrols healthy tissues through long-range crawling on the resting endothelium. This patrolling behavior depended on the integrin LFA-1 and the chemokine receptor CX(3)CR1 and was required for rapid tissue invasion at the site of an infection by this "resident" monocyte population, which initiated an early immune response and differentiated into macrophages.	Inst Federat Rech Necker Enfants Malades, INSERM, Lab Biol Mononucl Phagocyte Syst, U838, Paris, France; Inst Federat Rech Necker Enfants Malades, INSERM, Cellular & Mol Imaging Core Facil, U838, Paris, France; Univ Paris 05, Paris, France; Hop Necker Enfants Malad, AP HP, Paris, France; Inst Pasteur, INSERM, Unite Dev Lymphocytes, U668, Paris, France; Inst Pharmacol Mol & Cellulaire, INSERM, E03 44, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Geissmann, F (corresponding author), Inst Federat Rech Necker Enfants Malades, INSERM, Lab Biol Mononucl Phagocyte Syst, U838, Paris, France.	geissmann@necker.fr	Sarnacki, Sabine/I-2692-2017; VOUGNY, Marie-Christine/K-8938-2017; Join-Lambert, Olivier/AAE-5205-2019; Auffray, Cedric/M-3225-2017	Sarnacki, Sabine/0000-0003-4304-5578; GARFA TRAORE, Meriem/0000-0001-8597-6472; Cumano, Ana/0000-0002-4578-959X; geissmann, frederic/0000-0001-5029-2468	Medical Research Council [G0900867] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; Fischer A, 1988, Immunodefic Rev, V1, P39; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ghassabeh GH, 2006, BLOOD, V108, P575, DOI 10.1182/blood-2005-04-1485; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Goda S, 2000, J IMMUNOL, V164, P4313, DOI 10.4049/jimmunol.164.8.4313; Haskell CA, 2000, J BIOL CHEM, V275, P34183, DOI 10.1074/jbc.M005731200; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Iwahashi M, 2004, ARTHRITIS RHEUM-US, V50, P1457, DOI 10.1002/art.20219; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Smith ML, 2003, BIOPHYS J, V85, P637, DOI 10.1016/S0006-3495(03)74507-X; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Steppich B, 2000, AM J PHYSIOL-CELL PH, V279, pC578, DOI 10.1152/ajpcell.2000.279.3.C578; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Umehara H, 2004, ARTERIOSCL THROM VAS, V24, P34, DOI 10.1161/01.ATV.0000095360.62479.1F; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011	27	1311	1345	4	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2007	317	5838					666	670		10.1126/science.1142883	http://dx.doi.org/10.1126/science.1142883			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	196PL	17673663				2022-12-01	WOS:000248494400047
J	Hakonarson, H; Grant, SFA; Bradfield, JP; Marchand, L; Kim, CE; Glessner, JT; Grabs, R; Casalunovo, T; Taback, SP; Frackelton, EC; Lawson, ML; Robinson, LJ; Skraban, R; Lu, Y; Chiavacci, RM; Stanley, CA; Kirsch, SE; Rappaport, EF; Orange, JS; Monos, DS; Devoto, M; Qu, HQ; Polychronakos, C				Hakonarson, Hakon; Grant, Struan F. A.; Bradfield, Jonathan P.; Marchand, Luc; Kim, Cecilia E.; Glessner, Joseph T.; Grabs, Rosemarie; Casalunovo, Tracy; Taback, Shayne P.; Frackelton, Edward C.; Lawson, Margaret L.; Robinson, Luke J.; Skraban, Robert; Lu, Yang; Chiavacci, Rosetta M.; Stanley, Charles A.; Kirsch, Susan E.; Rappaport, Eric F.; Orange, Jordan S.; Monos, Dimitri S.; Devoto, Marcella; Qu, Hui-Qi; Polychronakos, Constantin			A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene	NATURE			English	Article							LYMPHOID TYROSINE PHOSPHATASE; NATURAL-KILLER-CELLS; SUSCEPTIBILITY GENES; FUNCTIONAL VARIANT; INSULIN GENE; LOCUS; MELLITUS; AUTOIMMUNITY; MHC; POLYMORPHISMS	Type 1 diabetes (T1D) in children results from autoimmune destruction of pancreatic beta cells, leading to insufficient production of insulin(1). A number of genetic determinants of T1D have already been established through candidate gene studies, primarily within the major histocompatibility complex(2-4) but also within other loci(5-12). To identify new genetic factors that increase the risk of T1D, we performed a genome-wide association study in a large paediatric cohort of European descent. In addition to confirming previously identified loci(2-9), we found that T1D was significantly associated with variation within a 233-kb linkage disequilibrium block on chromosome 16p13. This region contains KIAA0350, the gene product of which is predicted to be a sugar-binding, C-type lectin. Three common non-coding variants of the gene (rs2903692, rs725613 and rs17673553) in strong linkage disequilibrium reached genome-wide significance for association with T1D. A subsequent transmission disequilibrium test replication study in an independent cohort confirmed the association. These results indicate that KIAA0350 might be involved in the pathogenesis of T1D and demonstrate the utility of the genome-wide association approach in the identification of previously unsuspected genetic determinants of complex traits.	Childrens Hosp Philadelphia, Ctr Appl Genom, Abramson Res Ctr, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Abramson Res Ctr, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Endocrinol, Philadelphia, PA 19104 USA; McGill Univ, Dept Pediat, Montreal, PQ H3H 1P3, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3H 1P3, Canada; Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3E 0Z2, Canada; Univ Ottawa, Div Endocrinol, Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; Markham Stouffville Hosp, Markham, ON L3P 7P3, Canada; Childrens Hosp Philadelphia Nucleic Acid & Prot C, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; McGill University; McGill University; University of Manitoba; University of Ottawa; Children's Hospital of Eastern Ontario; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Abramson Res Ctr, Philadelphia, PA 19104 USA.	hakonarson@chop.edu; constantin.polychronakos@mcgill.ca	Rappaport, Eric/GRO-4051-2022; Polychronakos, Constantin/B-8151-2008; Qu, Hui-Qi/B-4719-2009; Devoto, Marcella/AAP-7595-2021; Orange, Jordan S/D-5239-2009; Lawson, Margaret/M-6969-2015	Qu, Hui-Qi/0000-0001-9317-4488; Lawson, Margaret/0000-0002-2370-9552; Polychronakos, Constantin/0000-0002-7624-6635; orange, jordan/0000-0001-7117-7725; STANLEY, CHARLES/0000-0003-4881-9392; Glessner, Joseph/0000-0001-5131-2811; DEVOTO, MARCELLA/0000-0002-4431-5114; Grant, Struan/0000-0003-2025-5302				Anjos SM, 2004, J CLIN ENDOCR METAB, V89, P6257, DOI 10.1210/jc.2004-0881; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Biason-Lauber A, 2005, DIABETOLOGIA, V48, P900, DOI 10.1007/s00125-005-1723-5; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cambi A, 2005, CURR OPIN IMMUNOL, V17, P345, DOI 10.1016/j.coi.2005.05.011; Concannon P, 1998, NAT GENET, V19, P292, DOI 10.1038/985; Cucca F, 1998, NAT GENET, V19, P301, DOI 10.1038/995; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Devendra D, 2004, BMJ-BRIT MED J, V328, P750, DOI 10.1136/bmj.328.7442.750; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fisher RA, 1958, STAT METHODS RES WOR, P80; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Kristiansen OP, 2000, GENES IMMUN, V1, P170, DOI 10.1038/sj.gene.6363655; Mein CA, 1998, NAT GENET, V19, P297, DOI 10.1038/991; Mirel DB, 2002, DIABETES, V51, P3336, DOI 10.2337/diabetes.51.11.3336; NERUP J, 1974, LANCET, V2, P864; Noble JA, 1996, AM J HUM GENET, V59, P1134; Poirot L, 2004, P NATL ACAD SCI USA, V101, P8102, DOI 10.1073/pnas.0402065101; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; PURCELL S, IN PRESS AM J HUM GE; Rodacki M, 2007, DIABETES, V56, P177, DOI 10.2337/db06-0493; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; TODD JA, 2007, NATURE GENET, DOI DOI 10.1038/NG2068; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843	35	412	431	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2007	448	7153					591	U7		10.1038/nature06010	http://dx.doi.org/10.1038/nature06010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17632545				2022-12-01	WOS:000248446700043
J	Kerszberg, M; Wolpert, L				Kerszberg, Michel; Wolpert, Lewis			Specifying positional information in the embryo: Looking beyond morphogens	CELL			English	Article							GRADIENT FORMATION; SONIC HEDGEHOG; CELL POLARITY; TRANSPORT; PATTERN; ESTABLISHMENT; XENOPUS	Concentration gradients of small diffusible molecules called morphogens are key regulators of development, specifying position during pattern formation in the embryo. It is now becoming clear that additional or alternative mechanisms involving interactions among cells are also crucial for positional specification.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Univ Paris 06, UMR 7138, CNRS, Paris, France	University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Kerszberg, M (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	mkersz@ccr.jussieu.fr; profwolpert@yahoo.com						Baena-Lopez LA, 2006, P NATL ACAD SCI USA, V103, P13734, DOI 10.1073/pnas.0606092103; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Freeman M, 2002, ANNU REV CELL DEV BI, V18, P515, DOI 10.1146/annurev.cellbio.18.012502.083458; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Kerszberg M, 2004, CURR OPIN GENET DEV, V14, P440, DOI 10.1016/j.gde.2004.06.001; Kerszberg M, 1998, J THEOR BIOL, V191, P103, DOI 10.1006/jtbi.1997.0575; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lawrence PA, 2004, DEVELOPMENT, V131, P4651, DOI 10.1242/dev.01351; Le Garrec JF, 2006, DEV DYNAM, V235, P235, DOI 10.1002/dvdy.20617; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; MEINHARDT H, 1978, J THEOR BIOL, V74, P307, DOI 10.1016/0022-5193(78)90078-4; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Piepenburg O, 2004, DEVELOPMENT, V131, P4977, DOI 10.1242/dev.01323; Reilly KM, 1996, CELL, V86, P743, DOI 10.1016/S0092-8674(00)80149-X; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Tickle C, 2003, DEV CELL, V4, P449, DOI 10.1016/S1534-5807(03)00095-9; Williams PH, 2004, CURR BIOL, V14, P1916, DOI 10.1016/j.cub.2004.10.020; Wilson CW, 2006, CELL, V125, P435, DOI 10.1016/j.cell.2006.04.016; WILSON PA, 1994, CURR BIOL, V4, P676, DOI 10.1016/S0960-9822(00)00152-4; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; WOLPERT L, 2006, PRINCIPLES DEV, P24; Zhu AJ, 2004, GENE DEV, V18, P2985, DOI 10.1101/gad.1233104	37	109	110	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 27	2007	130	2					205	209		10.1016/j.cell.2007.06.038	http://dx.doi.org/10.1016/j.cell.2007.06.038			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WT	17662932	Bronze			2022-12-01	WOS:000248588000007
J	Mehl, MR; Vazire, S; Ramirez-Esparza, N; Slatcher, RB; Pennebaker, JW				Mehl, Matthias R.; Vazire, Simine; Ramirez-Esparza, Nairan; Slatcher, Richard B.; Pennebaker, James W.			Are women really more talkative than men?	SCIENCE			English	Article									Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA; Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Univ Texas, Dept Psychol, Austin, TX 78712 USA	University of Arizona; Washington University (WUSTL); University of Texas System; University of Texas Austin	Mehl, MR (corresponding author), Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA.	mehl@email.arizona.edu	Ramirez-Esparza, Nairan/Q-2854-2018; Pennebaker, James/GLR-6058-2022; Pennebaker, James W/E-5997-2013	Pennebaker, James W/0000-0001-9091-214X; Vazire, Simine/0000-0002-3933-9752	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052391] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 52391] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brizendine Louann, 2006, FEMALE BRAIN; James D., 1993, GENDER CONVERSATIONA, P281; LAKOFF R, 1975, LANGUAGE WORNANS PLA; LIBERMAN M, SEX LINKED LEXICAL B; Litosseliti L., 2006, GENDER LANGUAGE THEO; Mehl MR, 2001, BEHAV RES METH INS C, V33, P517, DOI 10.3758/BF03195410; Rayson Paul., 1997, INT J CORPUS LINGUIS, V2, P133, DOI DOI 10.1075/IJCL.2.1.07RAY	7	217	222	4	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2007	317	5834					82	82		10.1126/science.1139940	http://dx.doi.org/10.1126/science.1139940			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17615349				2022-12-01	WOS:000247776700054
J	Vega, FM; Ridley, AJ				Vega, Francisco M.; Ridley, Anne J.			SnapShot: Rho family GTPases	CELL			English	Editorial Material							PROTEINS; CANCER		Kings Coll London, Randall Div Cell & Mol Biophys, London, England	University of London; King's College London	Vega, FM (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London, England.		Vega, Francisco M./C-4678-2008	Vega, Francisco M./0000-0002-9015-864X				Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sorokina EM, 2005, J CELL BIOCHEM, V94, P225, DOI 10.1002/jcb.20327; Villalonga P, 2006, GROWTH FACTORS, V24, P159, DOI 10.1080/08977190600560651; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012	9	50	56	2	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 29	2007	129	7					1430	U2		10.1016/j.cell.2007.06.021	http://dx.doi.org/10.1016/j.cell.2007.06.021			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	188HQ	17604728	Bronze			2022-12-01	WOS:000247911400027
J	Cohen, S; Janicki-Deverts, D; Miller, GE				Cohen, Sheldon; Janicki-Deverts, Denise; Miller, Gregory E.			Psychological stress and disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEART-DISEASE; RISK-FACTORS; PATHOGENESIS; MORTALITY; PATHWAYS		Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	Carnegie Mellon University; University of British Columbia	Cohen, S (corresponding author), Carnegie Mellon Univ, Dept Psychol, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.	scohen@cmu.edu		Cohen, Sheldon/0000-0003-2248-4600				Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; BAUM A, 1993, PSYCHOSOM MED, V55, P274, DOI 10.1097/00006842-199305000-00005; Capitanio JP, 1998, P NATL ACAD SCI USA, V95, P4714, DOI 10.1073/pnas.95.8.4714; Cohen S., 1995, MEASURING STRESS GUI, P3; Cole SW, 2003, BIOL PSYCHIAT, V54, P1444, DOI 10.1016/S0006-3223(02)01888-7; Dong MX, 2004, CIRCULATION, V110, P1761, DOI 10.1161/01.CIR.0000143074.54995.7F; Duijts SFA, 2003, INT J CANCER, V107, P1023, DOI 10.1002/ijc.11504; Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938; Heffner KL, 2003, BRAIN BEHAV IMMUN, V17, pS109; Kiecolt-Glaser JK, 2002, ANNU REV PSYCHOL, V53, P83, DOI 10.1146/annurev.psych.53.100901.135217; Kivimaki M, 2006, SCAND J WORK ENV HEA, V32, P431, DOI 10.5271/sjweh.1049; Krantz DS, 2002, ANNU REV PSYCHOL, V53, P341, DOI 10.1146/annurev.psych.53.100901.135208; Leserman J, 2002, PSYCHOL MED, V32, P1059, DOI 10.1017/S0033291702005949; Li J, 2002, CIRCULATION, V106, P1634, DOI 10.1161/01.CIR.0000031569.45667.58; Mazure CM, 1998, CLIN PSYCHOL-SCI PR, V5, P291, DOI 10.1111/j.1468-2850.1998.tb00151.x; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; Pereira DB, 2003, J PSYCHOSOM RES, V54, P237, DOI 10.1016/S0022-3999(02)00494-4; PORGES SW, 1995, NEUROSCI BIOBEHAV R, V19, P225, DOI 10.1016/0149-7634(94)00066-A; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Turner-Cobb J.M., 2001, PSYCHONEUROIMMUNOLOG, V3rd, P565; Van Praag HM., 2004, STRESS BRAIN DEPRESS, DOI [10.1017/CBO9780511544422, DOI 10.1017/CBO9780511544422]; Vedhara K., 2005, HUMAN PSYCHONEUROIMM	24	1607	1665	6	250	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2007	298	14					1685	1687		10.1001/jama.298.14.1685	http://dx.doi.org/10.1001/jama.298.14.1685			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218IO	17925521				2022-12-01	WOS:000250009400025
J	Karres, JS; Hilgers, V; Carrera, I; Treisman, J; Cohen, SM				Karres, Janina S.; Hilgers, Valerie; Carrera, Ines; Treisman, Jessica; Cohen, Stephen M.			The conserved microRNA MiR-8 tunes atrophin levels to prevent neurodegeneration in drosophila	CELL			English	Article							HISTONE DEACETYLASE; GENE-EXPRESSION; TRANSCRIPTION FACTOR; PROTEINS; IMPACT; RNAS	microRNAs ( miRNAs) bind to specific messenger RNA targets to posttranscriptionally modulate their expression. Understanding the regulatory relationships between miRNAs and targets remains a major challenge. Many miRNAs reduce expression of their targets to inconsequential levels. It has also been proposed that miRNAs might adjust target expression to an optimal level. Here we analyze the consequences of mutating the conserved miRNA miR-8 in Drosophila. We identify atrophin as a direct target of miR-8. miR-8 mutant phenotypes are attributable to elevated atrophin activity, resulting in elevated apoptosis in the brain and in behavioral defects. Reduction of atrophin levels in miR-8-expressing cells to below the level generated by miR-8 regulation is detrimental, providing evidence for a "tuning target'' relationship between them. Drosophila atrophin is related to the atrophin family of mammalian transcriptional regulators, implicated in the neurodegenerative disorderDRPLA. The regulatory relationship between miR-8 and atrophin orthologs is conserved in mammals.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 117604, Singapore; NYU, Skirball Inst, New York, NY 10016 USA	European Molecular Biology Laboratory (EMBL); National University of Singapore; National University of Singapore; New York University	Cohen, SM (corresponding author), European Mol Biol Lab, Meyerhof Str 1, D-69117 Heidelberg, Germany.	cohen@tll.org.sg	Cohen, Stephen M/G-9930-2011; Hilgers, Valerie/J-2713-2015	Cohen, Stephen M/0000-0003-2858-9163; Hilgers, Valerie/0000-0002-4551-0931; Treisman, Jessica/0000-0002-7453-107X; Carrera, Ines/0000-0003-0903-4672	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056131] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056131] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asai Y, 2006, P NATL ACAD SCI USA, V103, P9069, DOI 10.1073/pnas.0603453103; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Erkner A, 2002, DEVELOPMENT, V129, P1119; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fortier TA, 2003, DEV BIOL, V257, P153, DOI 10.1016/S0012-1606(03)00036-8; Fristrom D., 1993, DEV DROSOPHILA MELAN, P843; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Kanazawa I, 1999, PHILOS T ROY SOC B, V354, P1069, DOI 10.1098/rstb.1999.0460; Kariya S, 2006, NEUROSCI LETT, V392, P213, DOI 10.1016/j.neulet.2005.09.019; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; ROBERTSON HM, 1988, GENETICS, V118, P461; Ross CA, 1999, PHILOS T ROY SOC B, V354, P1005, DOI 10.1098/rstb.1999.0452; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Waerner T, 2001, CELL GROWTH DIFFER, V12, P201; Wang L, 2006, GENE DEV, V20, P525, DOI 10.1101/gad.1393506; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhang S, 2002, CELL, V108, P45, DOI 10.1016/S0092-8674(01)00630-4; Zoltewicz JS, 2004, DEVELOPMENT, V131, P3, DOI 10.1242/dev.00908	43	207	234	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2007	131	1					136	145		10.1016/j.cell.2007.09.020	http://dx.doi.org/10.1016/j.cell.2007.09.020			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923093	Bronze			2022-12-01	WOS:000249934700017
J	Xiao, B; Heath, R; Saiu, P; Leiper, FC; Leone, P; Jing, C; Walker, PA; Haire, L; Eccleston, JF; Davis, CT; Martin, SR; Carling, D; Gamblin, SJ				Xiao, Bing; Heath, Richard; Saiu, Peter; Leiper, Fiona C.; Leone, Philippe; Jing, Chun; Walker, Philip A.; Haire, Lesley; Eccleston, John F.; Davis, Colin T.; Martin, Stephen R.; Carling, David; Gamblin, Steven J.			Structural basis for AMP binding to mammalian AMP-activated protein kinase	NATURE			English	Article							FATTY-ACID OXIDATION; SKELETAL-MUSCLE; GAMMA-SUBUNITS; MUTATIONS; SYSTEM; DOMAIN; LIVER; GAUGE; BETA	AMP-activated protein kinase (AMPK) regulates cellular metabolism in response to the availability of energy and is therefore a target for type II diabetes treatment(1). It senses changes in the ratio of AMP/ATP by binding both species in a competitive manner(2). Thus, increases in the concentration of AMP activate AMPK resulting in the phosphorylation and differential regulation of a series of downstream targets that control anabolic and catabolic pathways(1,2). We report here the crystal structure of the regulatory fragment of mammalian AMPK in complexes with AMP and ATP. The phosphate groups of AMP/ATP lie in a groove on the surface of the gamma domain, which is lined with basic residues, many of which are associated with disease-causing mutations. Structural and solution studies reveal that two sites on the gamma domain bind either AMP or Mg center dot ATP, whereas a third site contains a tightly bound AMP that does not exchange. Our binding studies indicate that under physiological conditions AMPK mainly exists in its inactive form in complex with Mg center dot ATP, which is much more abundant than AMP. Our modelling studies suggest how changes in the concentration of AMP ([AMP]) enhance AMPK activity levels. The structure also suggests a mechanism for propagating AMP/ATP signalling whereby a phosphorylated residue from the alpha and/or beta subunits binds to the gamma subunit in the presence of AMP but not when ATP is bound.	Natl Inst Med Res, MRC, London NW7 1AA, England; Imperial Coll, MRC, Ctr Clin Sci, London W12 0NN, England	MRC National Institute for Medical Research; Imperial College London	Martin, SR (corresponding author), Natl Inst Med Res, MRC, Ridgeway,Mill Hill, London NW7 1AA, England.	smartin@nimr.mrc.ac.uk; david.carling@csc.mrc.ac.uk; sgambli@nimr.mrc.ac.uk	Carling, David/F-1943-2014	Carling, David/0000-0002-2316-1830; Gamblin, Steve/0000-0001-5331-639X; Leiper, Fiona/0000-0001-6681-681X	Medical Research Council [MC_U117584222, MC_U120027537] Funding Source: Medline; MRC [MC_U117584222] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI14571; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chen ZP, 2000, AM J PHYSIOL-ENDOC M, V279, pE1202, DOI 10.1152/ajpendo.2000.279.5.E1202; CORKEY BE, 1986, J BIOL CHEM, V261, P2567; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Fujii N, 2000, BIOCHEM BIOPH RES CO, V273, P1150, DOI 10.1006/bbrc.2000.3073; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HARDIE DG, 1989, TRENDS BIOCHEM SCI, V14, P20; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Jameson DM, 1997, METHOD ENZYMOL, V278, P363; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; McConell GK, 2005, J PHYSIOL-LONDON, V568, P665, DOI 10.1113/jphysiol.2005.089839; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; YEH LA, 1980, J BIOL CHEM, V255, P2308; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	37	421	439	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2007	449	7161					496	U14		10.1038/nature06161	http://dx.doi.org/10.1038/nature06161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17851531				2022-12-01	WOS:000249724800048
J	McGuire, AL; Cho, MK; McGuire, SE; Caulfield, T				McGuire, Amy L.; Cho, Mildred K.; McGuire, Sean E.; Caulfield, Timothy			Medicine - The future of personal Genomics	SCIENCE			English	Editorial Material							HEALTH; GENETICS		Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; Stanford Univ, Stanford Ctr Biomed Ethics, Palo Alto, CA 94304 USA; Univ Texas, MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA; Univ Alberta, Hlth Law Inst, Edmonton, AB, Canada	Baylor College of Medicine; Stanford University; University of Texas System; UTMD Anderson Cancer Center; University of Alberta	McGuire, AL (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA.	amcguire@bcm.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004333, P50HG003389] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG003389-04, R01HG004333, P50 HG003389, P50HG003389] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Carlsten C, 2006, JAMA-J AM MED ASSOC, V296, P2480, DOI 10.1001/jama.296.20.2480; Couzin J, 2007, SCIENCE, V316, P820, DOI 10.1126/science.316.5826.820; Grosse SD, 2006, GENET MED, V8, P448, DOI 10.1097/01.gim.0000227935.26763.c6; Guttmacher AE, 2007, NAT REV GENET, V8, P151, DOI 10.1038/nrg2007; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; LEI HH, 2007, PERSONAL GENOME CO 2; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Scheuner MT, 2006, GENET MED, V8, P141, DOI 10.1097/01.gim.0000206657.19102.a0; Silversides A, 2007, CAN MED ASSOC J, V176, P315, DOI 10.1503/cmaj.061726; WADE N, 2007, NY TIMES        0601, pA19	11	46	53	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2007	317	5845					1687	1687		10.1126/science.1147475	http://dx.doi.org/10.1126/science.1147475			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885116	Green Accepted			2022-12-01	WOS:000249585900025
J	Danzon, PM				Danzon, Patricia M.			At what price?	NATURE			English	Editorial Material							DISCRIMINATION		Univ Penn, Wharton Sch, Hlth Care Management Dept, Philadelphia, PA 19104 USA	University of Pennsylvania	Danzon, PM (corresponding author), Univ Penn, Wharton Sch, Hlth Care Management Dept, Philadelphia, PA 19104 USA.							BRITTIN RV, 1992, B COUNCIL RES MUSIC, V113, P1; Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; Danzon P., 2003, HLTH AFFAIRS; Danzon Patricia M, 2003, Int J Health Care Finance Econ, V3, P183, DOI 10.1023/A:1025384819575; Danzon PM, 2005, HEALTH ECON, V14, P269, DOI 10.1002/hec.931; DANZON PM, 1997, INT J EC BUSINESS, V4, P301; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Dumoulin J, 2001, INT J BIOTECHNOLOGY, V3, P338; HAUSMAN JA, 1988, RAND J ECON, V19, P253, DOI 10.2307/2555703; Maskus Keith E., 2001, PARALLEL IMPORTS PHA; Ramsey FP, 1927, ECON J, V37, P47, DOI 10.2307/2222721; VARIAN HR, 1985, AM ECON REV, V75, P870; *WORLD TRAD ORG, 2003, WTGCM82 WORLD TRAD O; *WORLD TRAD ORG, 2003, WTL540 WORLD TRAD RO	14	22	22	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2007	449	7159					176	179		10.1038/449176a	http://dx.doi.org/10.1038/449176a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209NF	17851515				2022-12-01	WOS:000249394500039
J	Burgoyne, JR; Madhani, M; Cuello, F; Charles, RL; Brennan, JP; Schroder, E; Browning, DD; Eaton, P				Burgoyne, Joseph R.; Madhani, Melanie; Cuello, Friederike; Charles, Rebecca L.; Brennan, Jonathan P.; Schroeder, Ewald; Browning, Darren D.; Eaton, Philip			Cysteine redox sensor in PKGI alpha enables oxidant-induced activation	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; RELAXING FACTOR; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; ACID FORMATION; SULFINIC ACID; NITRIC-OXIDE; NITROSYLATION; SUBUNIT; COMPLEX	Changes in the concentration of oxidants in cells can regulate biochemical signaling mechanisms that control cell function. We have found that guanosine 3', 5'-monophosphate (cGMP)-dependent protein kinase (PKG) functions directly as a redox sensor. The I alpha isoform, PKGI alpha, formed an interprotein disulfide linking its two subunits in cells exposed to exogenous hydrogen peroxide. This oxidation directly activated the kinase in vitro, and in rat cells and tissues. The affinity of the kinase for substrates it phosphorylates was enhanced by disulfide formation. This oxidation-induced activation represents an alternate mechanism for regulation along with the classical activation involving nitric oxide and cGMP. This mechanism underlies cGMP-independent vasorelaxation in response to oxidants in the cardiovascular system and provides a molecular explanation for how hydrogen peroxide can operate as an endothelium-derived hyperpolarizing factor.	Kings Coll London, Rayne Inst, St Thomas Hosp, Dept Cardiol,Cardiovasc Div, London SE1 7EH, England; Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University System of Georgia; Augusta University	Eaton, P (corresponding author), Kings Coll London, Rayne Inst, St Thomas Hosp, Dept Cardiol,Cardiovasc Div, London SE1 7EH, England.	philip.eaton@kcl.ac.uk	Madhani, Melanie/I-4342-2014; Cuello, Friederike/A-9642-2016; Eaton, Philip/I-5444-2015	Madhani, Melanie/0000-0001-8596-763X; Eaton, Philip/0000-0003-0748-2367; Browning, Darren/0000-0003-0497-7620; Burgoyne, Joseph/0000-0001-7325-7382; Charles, Rebecca/0000-0003-4115-6135	Medical Research Council [G0700320] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Brennan JP, 2004, J BIOL CHEM, V279, P41352, DOI 10.1074/jbc.M403827200; Eaton P, 2006, FREE RADICAL BIO MED, V40, P1889, DOI 10.1016/j.freeradbiomed.2005.12.037; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Hasdai D, 1998, HYPERTENSION, V32, P228, DOI 10.1161/01.HYP.32.2.228; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; IGNARRO LJ, 1986, J PHARMACOL EXP THER, V237, P893; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; LANDGRAF W, 1991, J BIOL CHEM, V266, P16305; Miura H, 2003, CIRC RES, V92, pE31, DOI 10.1161/01.RES.0000054200.44505.AB; MONKEN CE, 1980, J BIOL CHEM, V255, P7067; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Rhee S G, 2000, Sci STKE, V2000, ppe1; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Saurin AT, 2004, P NATL ACAD SCI USA, V101, P17982, DOI 10.1073/pnas.0404762101; Schnell JR, 2005, PROTEIN SCI, V14, P2421, DOI 10.1110/ps.051528905; Soberman RJ, 2003, J CLIN INVEST, V111, P571, DOI 10.1172/JCI200318099; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273	24	374	379	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2007	317	5843					1393	1397		10.1126/science.1144318	http://dx.doi.org/10.1126/science.1144318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209GR	17717153				2022-12-01	WOS:000249377500047
J	Kohanski, MA; Dwyer, DJ; Hayete, B; Lawrence, CA; Collins, JJ				Kohanski, Michael A.; Dwyer, Daniel J.; Hayete, Boris; Lawrence, Carolyn A.; Collins, James J.			A common mechanism of cellular death induced by bactericidal antibiotics	CELL			English	Article							ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATION; HYDROGEN-PEROXIDE; OXIDATIVE DAMAGE; GENE ONTOLOGY; DNA-DAMAGE; IRON; SUPEROXIDE; OXYGEN; MUTANTS	Antibioticmode-of-action classification is based upon drug-target interaction and whether the resultant inhibition of cellular function is lethal to bacteria. Here we show that the three major classes of bactericidal antibiotics, regardless of drug-target interaction, stimulate the production of highly deleterious hydroxyl radicals in Gram-negative and Gram-positive bacteria, which ultimately contribute to cell death. We also show, in contrast, that bacteriostatic drugs do not produce hydroxyl radicals. We demonstrate that the mechanism of hydroxyl radical formation induced by bactericidal antibiotics is the end product of an oxidative damage cellular death pathway involving the tricarboxylic acid cycle, a transient depletion of NADH, destabilization of iron-sulfur clusters, and stimulation of the Fenton reaction. Our results suggest that all three major classes of bactericidal drugs can be potentiated by targeting bacterial systems that remediate hydroxyl radical damage, including proteins involved in triggering the DNA damage response, e. g., RecA.	Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; Boston Univ, Ctr Adv Biotechnol, Boston, MA 02215 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Boston Univ, Program Mol Biol Cell Biol & Biochem, Boston, MA 02215 USA; Boston Univ, Bioinformat Program, Boston, MA 02215 USA	Boston University; Boston University; Boston University; Boston University; Boston University	Collins, JJ (corresponding author), Boston Univ, Ctr BioDynam, Boston, MA 02215 USA.	jcollins@bu.edu	Hayete, Boris/ABD-4515-2020; Matin, AC/A-1315-2007	Hayete, Boris/0000-0002-2521-1889; Matin, AC/0000-0003-4468-980X				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; CRONAN JE, 2006, ESCHERICHIA COLI SAL; Cunningham L, 1997, MICROBIOL-UK, V143, P3795, DOI 10.1099/00221287-143-12-3795; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; Djaman O, 2004, J BIOL CHEM, V279, P44590, DOI 10.1074/jbc.M406487200; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; ENG RHK, 1991, ANTIMICROB AGENTS CH, V35, P1824, DOI 10.1128/AAC.35.9.1824; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Friedberg EC, 2005, DNA REPAIR MUTAGENES; GREENBERG JT, 1990, P NATL ACAD SCI USA, V87, P6181, DOI 10.1073/pnas.87.16.6181; Gruer MJ, 1997, MICROBIOL-UK, V143, P1837, DOI 10.1099/00221287-143-6-1837; Gutteridge JMC, 1998, FREE RADICAL RES, V28, P1, DOI 10.3109/10715769809097871; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; HELLING RB, 1971, J BACTERIOL, V105, P1224, DOI 10.1128/JB.105.3.1224-1226.1971; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; IMLAY JA, 1986, J BACTERIOL, V166, P519, DOI 10.1128/jb.166.2.519-527.1986; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Leonardo MR, 1996, J BACTERIOL, V178, P6013, DOI 10.1128/jb.178.20.6013-6018.1996; LEWIN CS, 1989, J MED MICROBIOL, V29, P139, DOI 10.1099/00222615-29-2-139; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Liochev SI, 1999, IUBMB LIFE, V48, P157, DOI 10.1080/152165499307161; Macomber L, 2007, J BACTERIOL, V189, P1616, DOI 10.1128/JB.01357-06; MARTIN JP, 1987, J BACTERIOL, V169, P2516, DOI 10.1128/jb.169.6.2516-2522.1987; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Moeck GS, 1998, MOL MICROBIOL, V28, P675, DOI 10.1046/j.1365-2958.1998.00817.x; MORRISSEY I, 1994, MICROBIOS, V79, P43; NOVOGRODSKY A, 1982, P NATL ACAD SCI-BIOL, V79, P1171, DOI 10.1073/pnas.79.4.1171; Pankey GA, 2004, CLIN INFECT DIS, V38, P864, DOI 10.1086/381972; Poehlsgaard J, 2005, NAT REV MICROBIOL, V3, P870, DOI 10.1038/nrmicro1265; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; REPINE JE, 1981, J BIOL CHEM, V256, P7094; REYNOLDS PE, 1989, EUR J CLIN MICROBIOL, V8, P943, DOI 10.1007/BF01967563; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; TABER HW, 1987, MICROBIOL REV, V51, P439, DOI 10.1128/MMBR.51.4.439-457.1987; Tenson T, 2003, J MOL BIOL, V330, P1005, DOI 10.1016/S0022-2836(03)00662-4; TOMASZ A, 1979, ANNU REV MICROBIOL, V33, P113, DOI 10.1146/annurev.mi.33.100179.000553; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Umezawa N, 1997, ARCH BIOCHEM BIOPHYS, V342, P275, DOI 10.1006/abbi.1997.0124; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; WEHRLI W, 1971, BACTERIOL REV, V35, P290, DOI 10.1128/MMBR.35.3.290-309.1971; WEISBLUM B, 1968, BACTERIOL REV, V32, P493, DOI 10.1128/MMBR.32.4_Pt_2.493-528.1968	58	1808	1892	48	629	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2007	130	5					797	810		10.1016/j.cell.2007.06.049	http://dx.doi.org/10.1016/j.cell.2007.06.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	212GI	17803904	Bronze			2022-12-01	WOS:000249581500013
J	Thorvaldsen, JL; Bartolomei, MS				Thorvaldsen, Joanne L.; Bartolomei, Marisa S.			Snapshot: Imprinted gene clusters	CELL			English	Editorial Material							NONCODING RNAS; GROWTH		Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Thorvaldsen, JL (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.							Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Lalande M, 2007, CELL MOL LIFE SCI, V64, P947, DOI 10.1007/s00018-007-6460-0; O'Neill MJ, 2005, HUM MOL GENET, V14, pR113, DOI 10.1093/hmg/ddi108; Pauler FM, 2007, TRENDS GENET, V23, P284, DOI 10.1016/j.tig.2007.03.018; Peery EG, 2007, MAMM GENOME, V18, P255, DOI 10.1007/s00335-007-9019-3; Plagge A, 2006, CYTOGENET GENOME RES, V113, P178, DOI 10.1159/000090830; Smith AC, 2007, PEDIATR RES, V61, p43R, DOI 10.1203/pdr.0b013e3180457660; Smith FM, 2006, CYTOGENET GENOME RES, V113, P279, DOI 10.1159/000090843; Valleley EM, 2007, HUM MOL GENET, V16, P972, DOI 10.1093/hmg/ddm041; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717; Zhang ZM, 2006, GENE, V366, P77, DOI 10.1016/j.gene.2005.08.020	12	28	46	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2007	130	5							958.e1	10.1016/j.cell.2007.08.033	http://dx.doi.org/10.1016/j.cell.2007.08.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	212GI	17803916	Bronze			2022-12-01	WOS:000249581500025
J	Yao, I; Takagi, H; Ageta, H; Kahyo, T; Sato, S; Hatanaka, K; Fukuda, Y; Chiba, T; Morone, N; Yuasa, S; Inokuchi, K; Ohtsuka, T; MacGregor, GR; Tanaka, K; Setou, M				Yao, Ikuko; Takagi, Hiroshi; Ageta, Hiroshi; Kahyo, Tomoaki; Sato, Showbu; Hatanaka, Ken; Fukuda, Yoshiyuki; Chiba, Tomoki; Morone, Nobuhiro; Yuasa, Shigeki; Inokuchi, Kaoru; Ohtsuka, Toshihisa; MacGregor, Grant R.; Tanaka, Keiji; Setou, Mitsutoshi			SCRAPPER-dependent ubiquitination of active zone protein RIM1 regulates synaptic vesicle release	CELL			English	Article							ACID TRANSPORTER ATA2; MECHANISMS; RECEPTOR; LIGASE; MICE; DEGRADATION; SYNAPSES; MUNC13-1; STIMULUS; KINESIN	Little is known about how synaptic activity is modulated in the central nervous system. We have identified SCRAPPER, a synapse-localized E3 ubiquitin ligase, which regulates neural transmission. SCRAPPER directly binds and ubiquitinates RIM1, a modulator of presynaptic plasticity. In neurons from Scrapper-knockout (SCR-KO) mice, RIM1 had a longer half-life with significant reduction in ubiquitination, indicating that SCRAPPER is the predominant ubiquitin ligase that mediates RIM1 degradation. As anticipated in a RIM1 degradation defect mutant, SCR-KO mice displayed altered electrophysiological synaptic activity, i.e., increased frequency of miniature excitatory postsynaptic currents. This phenotype of SCR-KO mice was phenocopied by RIM1 overexpression and could be rescued by re-expression of SCRAPPER or knockdown of RIM1. The acute effects of proteasome inhibitors, such as upregulation of RIM1 and the release probability, were blocked by the impairment of SCRAPPER. Thus, SCRAPPER has an essential function in regulating proteasome-mediated degradation of RIM1 required for synaptic tuning.	MITILS, Machida, Tokyo 1948511, Japan; Natl Inst Physiol Sci, Okazaki, Aichi 4448787, Japan; Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Kodaira, Tokyo 1878502, Japan; Toyama Univ, Grad Sch Med, Fac Med, Dept Clin & Mol Pathol, Toyama 9300194, Japan; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA	Mitsubishi Kagaku Institute of Life Sciences (MITILS); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Tokyo Metropolitan Institute of Medical Science; National Center for Neurology & Psychiatry - Japan; University of Toyama; University of California System; University of California Irvine; University of California System; University of California Irvine	Setou, M (corresponding author), MITILS, 11 Minamiooya, Machida, Tokyo 1948511, Japan.	setou@nips.ac.jp	Inokuchi, Kaoru/AAI-9693-2020	Inokuchi, Kaoru/0000-0002-5393-3133; Morone, Nobuhiro/0000-0002-7672-158X	NICHD NIH HHS [U01 HD045913-04, U01 HD045913-03] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD045913] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abraham WC, 1997, PROG NEUROBIOL, V52, P303, DOI 10.1016/S0301-0082(97)00018-X; Ageta H, 2001, J BIOL CHEM, V276, P15893, DOI 10.1074/jbc.M011097200; Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BROWN TH, 1990, ANNU REV NEUROSCI, V13, P475, DOI 10.1146/annurev.ne.13.030190.002355; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Ching A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-19; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Hata Y, 1999, CELL MOL LIFE SCI, V56, P461, DOI 10.1007/s000180050445; Hatanaka K, 2006, BIOCHEM BIOPH RES CO, V350, P610, DOI 10.1016/j.bbrc.2006.09.093; Hatanaka T, 2006, J BIOL CHEM, V281, P35922, DOI 10.1074/jbc.M606577200; Hatanaka T, 2006, J BIOL CHEM, V281, P39273, DOI 10.1074/jbc.M604534200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hsiung YG, 2001, MOL CELL BIOL, V21, P2506, DOI 10.1128/MCB.21.7.2506-2520.2001; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kaeser PS, 2005, BIOCHEM SOC T, V33, P1345, DOI 10.1042/BST0331345; Kato A, 2001, EUR J NEUROSCI, V13, P1292, DOI 10.1046/j.0953-816x.2001.01498.x; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Kreft M, 2003, AM J PHYSIOL-CELL PH, V284, pC547, DOI 10.1152/ajpcell.00333.2002; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Omori A, 2002, ELECTROPHORESIS, V23, P4167, DOI 10.1002/elps.200290034; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wheeler TC, 2002, J BIOL CHEM, V277, P10273, DOI 10.1074/jbc.M107857200; Willeumier K, 2006, J NEUROSCI, V26, P11333, DOI 10.1523/JNEUROSCI.1684-06.2006; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Yao I, 1999, J BIOL CHEM, V274, P27463, DOI 10.1074/jbc.274.39.27463; Yao I, 2002, J NEUROSCI, V22, P5354; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	49	162	172	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2007	130	5					943	957		10.1016/j.cell.2007.06.052	http://dx.doi.org/10.1016/j.cell.2007.06.052			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	212GI	17803915	Bronze, Green Accepted			2022-12-01	WOS:000249581500024
J	Fabbri, LM; Rabe, KF				Fabbri, Leonardo M.; Rabe, Klaus F.			From COPD to chronic systemic inflammatory syndrome?	LANCET			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC HEART-FAILURE; METABOLIC SYNDROME; GUIDELINES; ASSOCIATION; COMBINATION; PREVALENCE; MANAGEMENT; MORBIDITY; MORTALITY		Univ Modena & Reggio Emilia, Dept Oncol Haematol & Resp Dis, Modena, Italy; Leiden Univ, Med Ctr, Dept Pulm Med, Leiden, Netherlands	Universita di Modena e Reggio Emilia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rabe, KF (corresponding author), Univ Med Ctr, Dept Pulm Med, POB 9600, NL-2300 Leiden, Netherlands.	k.f.rabe@lumc.nl	Rabe, Klaus F./AAW-6296-2021; Fabbri, Leonardo M/I-4055-2012	Rabe, Klaus F./0000-0002-7020-1401; Fabbri, Leonardo M/0000-0001-8894-1689				Agusti Alvar, 2006, Proc Am Thorac Soc, V3, P478, DOI 10.1513/pats.200603-058MS; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Broekhuizen R, 2006, THORAX, V61, P17, DOI 10.1136/thx.2005.041996; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Charlson M, 2007, J GEN INTERN MED, V22, P464, DOI 10.1007/s11606-007-0130-7; Dahlstrom U, 2005, EUR J HEART FAIL, V7, P309, DOI 10.1016/j.ejheart.2005.01.008; FABBRI LM, 2007, P EUR RESP SOC RES S; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Jorgensen NR, 2007, RESP MED, V101, P177, DOI 10.1016/j.rmed.2006.03.029; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; MacNee William, 2005, Proc Am Thorac Soc, V2, P50, DOI 10.1513/pats.200411-056SF; Mancini GBJ, 2006, J AM COLL CARDIOL, V47, P2554, DOI 10.1016/j.jacc.2006.04.039; Mannino DM, 2006, EUR RESPIR J, V27, P627, DOI 10.1183/09031936.06.00024605; Marquis Karine, 2005, J Cardiopulm Rehabil, V25, P226, DOI 10.1097/00008483-200507000-00010; McGarvey LP, 2007, THORAX, V62, P411, DOI 10.1136/thx.2006.072348; Omori H, 2006, RESPIROLOGY, V11, P205, DOI 10.1111/j.1440-1843.2006.00827.x; Poulain M, 2006, CAN MED ASSOC J, V174, P1293, DOI 10.1503/cmaj.051299; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rutten FH, 2006, EUR J HEART FAIL, V8, P706, DOI 10.1016/j.ejheart.2006.01.010; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Sevenoaks MJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-70; Sin DD, 2007, CURR OPIN PULM MED, V13, P90; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; VANDERHARST P, 2006, CARDIOVASC RES, V3, pE333; Walker CG, 2007, CLIN SCI, V112, P93, DOI 10.1042/CS20060150; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179	29	459	481	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2007	370	9589					797	799		10.1016/S0140-6736(07)61383-X	http://dx.doi.org/10.1016/S0140-6736(07)61383-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	206UV	17765529				2022-12-01	WOS:000249209300034
J	Silver, JR				Silver, John Russell			Silver syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material							FAMILIAL SPASTIC PARAPLEGIA; AMYOTROPHY; HANDS		Stoke Mandeville Hosp, Wendover HP22 6EA, Bucks, England		Silver, JR (corresponding author), Stoke Mandeville Hosp, Wendover HP22 6EA, Bucks, England.	jrussellsilver@aol.com						BELL J, 1948, TREASURY HUMAN INHER, V4; Delatycki MB, 2005, MED J AUSTRALIA, V182, P439, DOI 10.5694/j.1326-5377.2005.tb06779.x; HARDING AE, 1984, HEREDITARY ATAXIAS R, P191; Patel H, 2001, AM J HUM GENET, V69, P209, DOI 10.1086/321267; Patel H, 2001, AM J MED GENET, V102, P68, DOI 10.1002/1096-8628(20010722)102:1<68::AID-AJMG1411>3.0.CO;2-R; SILVER JR, 1966, J NEUROL NEUROSUR PS, V29, P135, DOI 10.1136/jnnp.29.2.135; SILVER JR, 1966, ANN HUM GENET, V30, P69, DOI 10.1111/j.1469-1809.1966.tb00007.x; WALTON J, 1993, BRAINS DIS NERVOUS S, P442; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313	9	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 1	2007	335	7617					422	423		10.1136/bmj.39210.408414.AD	http://dx.doi.org/10.1136/bmj.39210.408414.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	208VF	17762032	Green Published			2022-12-01	WOS:000249346600028
J	Donahoe, SM; Stewart, GC; McCabe, CH; Mohanavelu, S; Murphy, SA; Cannon, CP; Antman, EM				Donahoe, Sean M.; Stewart, Garrick C.; McCabe, Carolyn H.; Mohanavelu, Satishkumar; Murphy, Sabina A.; Cannon, Christopher P.; Antman, Elliott M.			Diabetes and mortality following acute coronary syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ELEVATION MYOCARDIAL-INFARCTION; AMERICAN-HEART-ASSOCIATION; TIMI RISK SCORE; CARDIOVASCULAR-DISEASES; FASTING GLUCOSE; BLOOD-GLUCOSE; MELLITUS; PREVALENCE; THERAPY; INTERVENTION	Context The worldwide epidemic of diabetes mellitus is increasing the burden of cardiovascular disease, the leading cause of death among persons with diabetes. The independent effect of diabetes on mortality following acute coronary syndromes (ACS) is uncertain. Objective To evaluate the influence of diabetes on mortality following ACS using a large database spanning the full spectrum of ACS. Design, Setting, and Patients A subgroup analysis of patients with diabetes enrolled in randomized clinical trials that evaluated ACS therapies. Patients with ACS in 11 independent Thrombolysis in Myocardial Infarction (TIMI) Study Group clinical trials from 1997 to 2006 were pooled, including 62 036 patients (46 577 with ST-segment elevation myocardial infarction [STEMI] and 15 459 with unstable angina/non-STEMI [UA/NSTEMI]), of whom 10 613 (17.1%) had diabetes. A multivariable model was constructed to adjust for baseline characteristics, aspects of ACS presentation, and treatments for the ACS event. Main Outcome Measures Mortality at 30 days and 1 year following ACS among patients with diabetes vs patients without diabetes. Results Mortality at 30 days was significantly higher among patients with diabetes than without diabetes presenting with UA/NSTEMI (2.1% vs 1.1%, P < .001) and STEMI (8.5% vs 5.4%, P < .001). After adjusting for baseline characteristics and features and management of the ACS event, diabetes was independently associated with higher 30-day mortality after UA/NSTEMI (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.24-2.56) or STEMI (OR, 1.40; 95% CI, 1.24-1.57). Diabetes at presentation with ACS was associated with significantly higher mortality 1 year after UA/NSTEMI (hazard ratio [HR], 1.65; 95% CI, 1.30-2.10) or STEMI (HR, 1.22; 95% CI, 1.08-1.38). By 1 year following ACS, patients with diabetes presenting with UA/NSTEMI had a risk of death that approached patients without diabetes presenting with STEMI (7.2% vs 8.1%). Conclusion Despite modern therapies for ACS, diabetes confers a significant adverse prognosis, which highlights the importance of aggressive strategies to manage this high-risk population with unstable ischemic heart disease.	Harvard Univ, Sch Med, Brigham & Womens Hosp, TIMI Study Grp,Cardiovasc Div,Dept Med, Boston, MA 02115 USA; Cornell Univ, Med Ctr, Dept Med, Div Cardiol, New York, NY 10021 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cornell University	Antman, EM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, TIMI Study Grp,Cardiovasc Div,Dept Med, 75 Francis St, Boston, MA 02115 USA.	eantman@rics.bwh.harvard.edu	Cannon, Christopher P/AAY-7644-2020	Cannon, Christopher P/0000-0003-4596-2791				[Anonymous], 2005, DIABETES CARE, V28, pS4; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Antman EM, 2006, NEW ENGL J MED, V354, P1477, DOI 10.1056/NEJMoa060898; Antman EM, 2002, CIRCULATION, V105, P1642, DOI 10.1161/01.CIR.0000013402.34759.46; Braunwald E, 2000, EUR HEART J, V21, P2005; Brooks MM, 2006, AM J CARDIOL, V97, p9G, DOI 10.1016/j.amjcard.2006.02.023; Buse JB, 2007, CIRCULATION, V115, P114, DOI 10.1161/CIRCULATIONAHA.106.179294; *CAN DIAB ASS CLIN, 2003, CAN J DIABETES S2, V27, pS1; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Cannon CP, 2000, CIRCULATION, V102, P149, DOI 10.1161/01.CIR.102.2.149; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; Franco OH, 2007, ARCH INTERN MED, V167, P1145, DOI 10.1001/archinte.167.11.1145; Franklin K, 2004, ARCH INTERN MED, V164, P1457, DOI 10.1001/archinte.164.13.1457; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; GARCIA MJ, 1974, DIABETES, V23, P105, DOI 10.2337/diab.23.2.105; Gavin JR, 1997, DIABETES CARE, V20, P1183; Giugliano RP, 2003, J AM COLL CARDIOL, V41, P1251, DOI 10.1016/S0735-1097(03)00123-2; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Kim SH, 2006, J AM COLL CARDIOL, V48, P293, DOI 10.1016/j.jacc.2006.03.043; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Mak KH, 1997, J AM COLL CARDIOL, V30, P171, DOI 10.1016/S0735-1097(97)00118-6; Malmberg K, 2000, CIRCULATION, V102, P1014, DOI 10.1161/01.CIR.102.9.1014; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Morrow DA, 2001, LANCET, V358, P1571, DOI 10.1016/S0140-6736(01)06649-1; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; Nikolaidis LA, 2004, CIRCULATION, V109, P962, DOI 10.1161/01.CIR.0000120505.91348.58; Norhammar A, 2002, LANCET, V359, P2140, DOI 10.1016/S0140-6736(02)09089-X; Ohman EM, 2005, AM HEART J, V150, P79, DOI 10.1016/j.ahj.2005.01.007; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pinto DS, 2005, J AM COLL CARDIOL, V46, P178, DOI 10.1016/j.jacc.2005.03.052; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Suleiman M, 2005, CIRCULATION, V111, P754, DOI 10.1161/01.CIR.0000155235.48601.2A; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wiviott SD, 2006, J AM COLL CARDIOL, V47, P1553, DOI 10.1016/j.jacc.2005.11.075; Wiviott SD, 2005, CIRCULATION, V111, P3366, DOI 10.1161/CIRCULATIONAHA.104.502815; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; COMP 2 TREATMENTS MU	49	489	512	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2007	298	7					765	775		10.1001/jama.298.7.765	http://dx.doi.org/10.1001/jama.298.7.765			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	199XP	17699010	Bronze			2022-12-01	WOS:000248728800021
J	Rousseau, P				Rousseau, Paul			Chemotherapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												palliativedoctor@aol.com						Ferrell BR, 2006, ONCOL NURS FORUM, V33, P922, DOI 10.1188/06.ONF.922-930	1	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2007	298	6					604	604		10.1001/jama.298.6.604	http://dx.doi.org/10.1001/jama.298.6.604			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197RS	17684174				2022-12-01	WOS:000248574800001
J	Gregor, T; Tank, DW; Wieschaus, EF; Bialek, W				Gregor, Thomas; Tank, David W.; Wieschaus, Eric F.; Bialek, William			Probing the limits to positional information	CELL			English	Article							EARLY DROSOPHILA EMBRYO; GENE-EXPRESSION; BICOID PROTEIN; DNA-BINDING; FLUORESCENCE MICROSCOPY; MORPHOGEN GRADIENTS; PHYSICAL LIMITS; SINGLE-CELL; PATTERN; DOMAIN	The reproducibility and precision of biological patterning is limited by the accuracy with which concentration profiles of morphogen molecules can be established and read out by their targets. We consider four measures of precision for the Bicoid morphogen in the Drosophila embryo: the concentration differences that distinguish neighboring cells, the limits set by the random arrival of Bicoid molecules at their targets ( which depends on absolute concentration), the noise in readout of Bicoid by the activation of Hunchback, and the reproducibility of Bicoid concentration at corresponding positions in multiple embryos. We show, through a combination of different experiments, that all of these quantities are similar to 10%. This agreement among different measures of accuracy indicates that the embryo is not faced with noisy input signals and readout mechanisms; rather, the system exerts precise control over absolute concentrations and responds reliably to small concentration differences, approaching the limits set by basic physical principles.	Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University	Gregor, T (corresponding author), Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA.	tg2@princeton.edu		Gregor, Thomas/0000-0001-9460-139X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077599, P50GM071508] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM077599-01, P50 GM071508, R01 GM077599-02, P50 GM071508-01, R01 GM077599] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; BARLOW HB, 1981, PROC R SOC SER B-BIO, V212, P1, DOI 10.1098/rspb.1981.0022; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; BIALEK W, 2006, COOPERATIVITY SENSIT; BIALEK W, 2002, PHYS BIOMOLECULES CE, P485; Burz DS, 1998, EMBO J, V17, P5998, DOI 10.1093/emboj/17.20.5998; Crauk O, 2005, CURR BIOL, V15, P1888, DOI 10.1016/j.cub.2005.09.046; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DEVRIES H, 1956, PROG BIOPHYS MOL BIO, V6, P208, DOI 10.1016/S0096-4174(18)30108-2; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Eldar A, 2004, CURR OPIN GENET DEV, V14, P435, DOI 10.1016/j.gde.2004.06.009; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Gao Q, 1998, DEVELOPMENT, V125, P4185; Gergen J. P., 1986, S SOC DEV BIOL, V43, P195; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Holloway DM, 2006, DEV DYNAM, V235, P2949, DOI 10.1002/dvdy.20940; Houchmandzadeh B, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061920; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Howard M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.208103; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; Lawrence P. A., 1992, MAKING FLY GENETICS; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Ma XG, 1996, DEVELOPMENT, V122, P1195; MARGOLIS JS, 1995, DEVELOPMENT, V121, P3067; McHale P, 2006, PHYS BIOL, V3, P107, DOI 10.1088/1478-3975/3/2/003; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Pedone PV, 1996, P NATL ACAD SCI USA, V93, P2822, DOI 10.1073/pnas.93.7.2822; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Ptashne M., 1992, A GENETIC SWITCH; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rieke F, 1998, REV MOD PHYS, V70, P1027, DOI 10.1103/RevModPhys.70.1027; RIVERAPOMAR R, 1995, NATURE, V376, P253, DOI 10.1038/376253a0; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; SCHRODINGER E, 1944, WHAT LIFE; Slonim N, 2005, ESTIMATING MUTUAL IN; Spirov Alexander V., 2003, In Silico Biology, V3, P89; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Winston RL, 1999, BIOCHEMISTRY-US, V38, P5138, DOI 10.1021/bi982856a; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Zhao C, 2002, DEVELOPMENT, V129, P1669	50	481	486	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2007	130	1					153	164		10.1016/j.cell.2007.05.025	http://dx.doi.org/10.1016/j.cell.2007.05.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632062	Bronze, Green Submitted, Green Accepted			2022-12-01	WOS:000248587000018
J	Hector, A; Bagchi, R				Hector, Andy; Bagchi, Robert			Biodiversity and ecosystem multifunctionality	NATURE			English	Article							STATISTICAL INEVITABILITY; EUROPEAN GRASSLANDS; CURRENT KNOWLEDGE; DIVERSITY; STABILITY; PRODUCTIVITY; ECOLOGY; COMMUNITIES; SERVICES	Biodiversity loss can affect ecosystem functions and services(1-4). Individual ecosystem functions generally show a positive asymptotic relationship with increasing biodiversity, suggesting that some species are redundant(5-8). However, ecosystems are managed and conserved for multiple functions, which may require greater biodiversity. Here we present an analysis of published data from grassland biodiversity experiments(9-11), and show that ecosystem multifunctionality does require greater numbers of species. We analysed each ecosystem function alone to identify species with desirable effects. We then calculated the number of species with positive effects for all possible combinations of functions. Our results show appreciable differences in the sets of species influencing different ecosystem functions, with average proportional overlap of about 0.2 to 0.5. Consequently, as more ecosystem processes were included in our analysis, more species were found to affect overall functioning. Specifically, for all of the analysed experiments, there was a positive saturating relationship between the number of ecosystem processes considered and the number of species influencing overall functioning. We conclude that because different species often influence different functions, studies focusing on individual processes in isolation will underestimate levels of biodiversity required to maintain multifunctional ecosystems.	Univ Zurich, Inst Environm Sci, CH-8057 Zurich, Switzerland	University of Zurich	Hector, A (corresponding author), Univ Zurich, Inst Environm Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	ahector@uwinst.uzh.ch	Bagchi, Robert/F-1732-2011; Hector, Andrew/H-4199-2011	Bagchi, Robert/0000-0003-4035-4105; Hector, Andrew/0000-0002-1309-7716				Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Burnham KP., 2002, MODEL SELECTION MULT, V2; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; CARLANDER KD, 1955, J FISH RES BOARD CAN, V12, P543, DOI 10.1139/f55-029; COMTET L, 1974, ADV COMBINATORICS AR, P176; Cottingham KL, 2001, ECOL LETT, V4, P72, DOI 10.1046/j.1461-0248.2001.00189.x; Darwin C., 1858, J LINNEAN SOC ZOOLOG, V3, P45, DOI DOI 10.1111/J.1096-3642.1858.TB02500.X; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2002, SCIENCE, V295, P639, DOI 10.1126/science.1064815; HECTOR A, 2005, ECOL ARCH, pS1; HECTOR A, IN PRESS FUNCT ECOL; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kinzig A. P., 2002, FUNCTIONAL CONSEQUEN; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Loreau M, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P79; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McCullagh P, 2019, GEN LINEAR MODELS; *R DEV COR TEAM, 2007, LANG ENV STAT COMP; RIPLEY BD, 2004, METHODS MODELS STAT, P155; Sanderson MA, 2004, CROP SCI, V44, P1132, DOI 10.2135/cropsci2004.1132; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Steiner CF, 2006, ECOLOGY, V87, P996, DOI 10.1890/0012-9658(2006)87[996:PACRIM]2.0.CO;2; TAPER ML, 2005, NATURE SCI EVIDENCE, P488; Tilman D, 1998, AM NAT, V151, P277, DOI 10.1086/286118; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Venables WN., 2002, MODERN APPL STAT S 4, V4th Ed., DOI [10.1007/978-0-387-21706-2, 10.1007/978-1-4757-2719-7_7]; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	32	714	809	85	933	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 12	2007	448	7150					188	U6		10.1038/nature05947	http://dx.doi.org/10.1038/nature05947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188QN	17625564				2022-12-01	WOS:000247934500041
J	Wood, E; Kerr, T; Montaner, JSG				Wood, Evan; Kerr, Thomas; Montaner, Julio S. G.			HIV treatment, injection drug use, and illicit drug policies	LANCET			English	Editorial Material									St Pauls Hosp, Providence Hlth Care, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; Univ British Columbia, Fac Med, Dept Med, Vancouver, BC V5Z 1M9, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia	Montaner, JSG (corresponding author), St Pauls Hosp, Providence Hlth Care, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	jmontaner@cfenet.ubc.ca	Montaner, Julio/K-7621-2012					Aceijas C, 2006, ADDICTION, V101, P1246, DOI 10.1111/j.1360-0443.2006.01509.x; Davis CS, 2005, AM J PUBLIC HEALTH, V95, P233, DOI 10.2105/AJPH.2003.031310; Des Jarlais DC, 1999, PUBLIC HEALTH, V113, P182; GRUND JPC, 1992, J PSYCHOACTIVE DRUGS, V24, P41, DOI 10.1080/02791072.1992.10471617; Kerr T, 2004, LANCET, V364, P1918, DOI 10.1016/S0140-6736(04)17490-4; Mattick RP, 2003, COCHRANE DB SYST REV, V2; Small Dan, 2007, Harm Reduct J, V4, P13, DOI 10.1186/1477-7517-4-13; Swan N, 1999, JAMA-J AM MED ASSOC, V281, P1782, DOI 10.1001/jama.281.19.1782; UNAIDS, 2006, REP GLOB AIDS EP; Wainberg MA, 2006, CAN MED ASSOC J, V175, P1395, DOI 10.1503/cmaj.061404; Wood E, 2005, LANCET, V366, P1834, DOI 10.1016/S0140-6736(05)67737-9; 2005, LANCET, V365, P629	12	16	16	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 7	2007	370	9581					8	10		10.1016/S0140-6736(07)61025-3	http://dx.doi.org/10.1016/S0140-6736(07)61025-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	187QE	17617253				2022-12-01	WOS:000247862300007
J	Flierl, MA; Rittirsch, D; Nadeau, BA; Chen, AJ; Sarma, JV; Zetoune, FS; McGuire, SR; List, RP; Day, DE; Hoesel, LM; Gao, H; Van Rooijen, N; Huber-Lang, MS; Neubig, RR; Ward, PA				Flierl, Michael A.; Rittirsch, Daniel; Nadeau, Brian A.; Chen, Anthony J.; Sarma, J. Vidya; Zetoune, Firas S.; McGuire, Stephanie R.; List, Rachel P.; Day, Danielle E.; Hoesel, L. Marco; Gao, Hongwei; Van Rooijen, Nico; Huber-Lang, Markus S.; Neubig, Richard R.; Ward, Peter A.			Phagocyte-derived catecholamines enhance acute inflammatory injury	NATURE			English	Article							BETA(2)-ADRENERGIC RECEPTOR; LUNG INJURY; NOREPINEPHRINE; PATHOGENESIS; STIMULATION; LYMPHOCYTES; NEUTROPHILS; COMPLEMENT; METABOLISM; ACTIVATION	It is becoming increasingly clear that the autonomic nervous system and the immune system demonstrate cross-talk during inflammation by means of sympathetic and parasympathetic pathways(1,2). We investigated whether phagocytes are capable of de novo production of catecholamines, suggesting an autocrine/paracrine self-regulatory mechanism by catecholamines during inflammation, as has been described for lymphocytes(3). Here we show that exposure of phagocytes to lipopolysaccharide led to a release of catecholamines and an induction of catecholamine-generating and degrading enzymes, indicating the presence of the complete intracellular machinery for the generation, release and inactivation of catecholamines. To assess the importance of these findings in vivo, we chose two models of acute lung injury. Blockade of alpha(2)-adrenoreceptors or catecholamine-generating enzymes greatly suppressed lung inflammation, whereas the opposite was the case either for an alpha(2)-adrenoreceptor agonist or for inhibition of catecholamine-degrading enzymes. We were able to exclude T cells or sympathetic nerve endings as sources of the injury-modulating catecholamines. Our studies identify phagocytes as a new source of catecholamines, which enhance the inflammatory response.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; Vrije Univ Amsterdam, Dept Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands; Univ Ulm, Sch Med, Dept Trauma Hand & Reconstruct Surg, D-89075 Ulm, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vrije Universiteit Amsterdam; Ulm University	Ward, PA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	pward@umich.edu	Van Rooijen, Nico/Z-1578-2019; Huber-Lang, Markus/AAJ-2209-2020	Rittirsch, Daniel/0000-0002-1185-2431; Neubig, Richard/0000-0003-0501-0008				BERGQUIST J, 1994, P NATL ACAD SCI USA, V91, P12912, DOI 10.1073/pnas.91.26.12912; Bergquist J, 2000, ANN NY ACAD SCI, V917, P281; BONE RC, 1976, AM J MED, V61, P585, DOI 10.1016/0002-9343(76)90135-2; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Brown SW, 2003, J NEUROIMMUNOL, V135, P47, DOI 10.1016/S0165-5728(02)00435-6; BYLUND DB, 1994, PHARMACOL REV, V46, P121; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Cosentino M, 1999, LIFE SCI, V64, P975, DOI 10.1016/S0024-3205(99)00023-5; Czermak BJ, 1999, AM J PATHOL, V154, P1513, DOI 10.1016/S0002-9440(10)65405-3; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Gao HW, 2004, J IMMUNOL, V172, P7703, DOI 10.4049/jimmunol.172.12.7703; Hoesel LM, 2005, SHOCK, V24, P40, DOI 10.1097/01.shk.0000170353.80318.d5; HOFFMAN BB, 2006, GOODMAN GILMANS PHAR, P845; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Kohm AP, 2002, J IMMUNOL, V168, P6314, DOI 10.4049/jimmunol.168.12.6314; Musso NR, 1996, J CLIN ENDOCR METAB, V81, P3553, DOI 10.1210/jc.81.10.3553; Sanders VM, 1997, J IMMUNOL, V158, P4200; SPENGLER RN, 1990, J IMMUNOL, V145, P1430; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Swanson MA, 2001, J IMMUNOL, V166, P232, DOI 10.4049/jimmunol.166.1.232; Torres KCL, 2005, J NEUROIMMUNOL, V166, P144, DOI 10.1016/j.jneuroim.2005.06.006; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; UELAND PM, 1982, PHARMACOL REV, V34, P223; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Ward PA, 1996, AM J PATHOL, V149, P1079; Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586	26	324	332	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2007	449	7163					721	U8		10.1038/nature06185	http://dx.doi.org/10.1038/nature06185			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218VV	17914358	Green Published			2022-12-01	WOS:000250045000044
J	Montori, VM; Gandhi, GY; Guyatt, GH				Montori, Victor M.; Gandhi, Gunjan Y.; Guyatt, Gordon H.			Patient-important outcomes in diabetes - time for consensus	LANCET			English	Editorial Material							ROSIGLITAZONE; COMPLICATIONS; PROGRESSION; METFORMIN; MELLITUS; DEATH		Mayo Clin & Mayo Fdn, Coll Med, Div Endocrinol Diabet Metab Nutr & Internal Med, Knowledge & Encounter Res Unit, Rochester, MN 55905 USA; McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, CLARITY Res Grp, Hamilton, ON, Canada	Mayo Clinic; McMaster University	Montori, VM (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Div Endocrinol Diabet Metab Nutr & Internal Med, Knowledge & Encounter Res Unit, 200 1st St SW, Rochester, MN 55905 USA.	Montori.victor@mayo.edu		Montori, Victor/0000-0003-0595-2898				Guyatt Gordon, 2004, ACP J Club, V140, pA11; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Montori VM, 2006, DIABETES CARE, V29, P1833, DOI 10.2337/dc06-0077; Montori VM, 2006, HEALTH EXPECT, V9, P25, DOI 10.1111/j.1369-7625.2006.00359.x; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; *U DIAB GROUP PROG, 1970, DIABETES S2, V10, pS785	11	38	41	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 29	2007	370	9593					1104	1106		10.1016/S0140-6736(07)61489-5	http://dx.doi.org/10.1016/S0140-6736(07)61489-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221YQ	17905147				2022-12-01	WOS:000250263700005
J	Convey, P; Stevens, MI				Convey, Peter; Stevens, Mark I.			Antarctic biodiversity	SCIENCE			English	Editorial Material							ICE; DIVERSITY; ECOLOGY; HISTORY		British Antarctic Survey, NERC, Cambridge CB3 0ET, England; Massey Univ, Inst Mol Biosci, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Massey University	Convey, P (corresponding author), British Antarctic Survey, NERC, High Cross,Madingley Rd, Cambridge CB3 0ET, England.	p.convey@bas.ac.uk; m.i.stevens@massey.ac.nz	Convey, Peter/AAV-5728-2020	Convey, Peter/0000-0001-8497-9903	Natural Environment Research Council [bas010015] Funding Source: researchfish; NERC [bas010015] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Adams BJ, 2007, POLAR BIOL, V30, P809, DOI 10.1007/s00300-006-0241-3; Allegrucci G, 2006, POLAR BIOL, V29, P320, DOI 10.1007/s00300-005-0056-7; Ashworth AC, 2004, PALAEOGEOGR PALAEOCL, V213, P65, DOI 10.1016/j.palaeo.2004.07.002; Ashworth AC, 2003, NATURE, V423, P135, DOI 10.1038/423135a; Bayly IAE, 2003, ANTARCT SCI, V15, P439, DOI 10.1017/S0954102003001548; Brundin L., 1970, P41; Chown SL, 2007, PHILOS T R SOC LON B, P362; Cromer L, 2006, J BIOGEOGR, V33, P1314, DOI 10.1111/j.1365-2699.2006.01490.x; Gressitt JL, 1967, ANTARCTIC RES SERIES, V10; Huybrechts P, 2002, QUATERNARY SCI REV, V21, P203, DOI 10.1016/S0277-3791(01)00082-8; Livermore R, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2005GC001224; Marshall DJ, 2000, ZOOL J LINN SOC-LOND, V129, P111, DOI 10.1006/zjls.1999.0209; Maslen NR, 2006, SOIL BIOL BIOCHEM, V38, P3141, DOI 10.1016/j.soilbio.2005.12.007; Pugh P. J. A., 2003, Polar Record, V39, P239; Smellie JL, 2006, PALAEOGEOGR PALAEOCL, V231, P233, DOI 10.1016/j.palaeo.2005.07.035; Stevens MI, 2006, MOL BIOL EVOL, V23, P874, DOI 10.1093/molbev/msj073; Sugden DE, 2006, PHILOS T R SOC A, V364, P1607, DOI 10.1098/rsta.2006.1791; WISE KAJ, 1965, NATURE, V207, P101, DOI 10.1038/207101a0	18	134	139	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2007	317	5846					1877	1878		10.1126/science.1147261	http://dx.doi.org/10.1126/science.1147261			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17901323				2022-12-01	WOS:000249764300027
J	Corneo, B; Wendland, RL; Deriano, L; Cui, XP; Klein, IA; Wong, SY; Arnal, S; Holub, AJ; Weller, GR; Pancake, BA; Shah, S; Brandt, VL; Meek, K; Roth, DB				Corneo, Barbara; Wendland, Rebecca L.; Deriano, Ludovic; Cui, Xiaoping; Klein, Isaac A.; Wong, Serre-Yu; Arnal, Suzzette; Holub, Abigail J.; Weller, Geoffrey R.; Pancake, Bette A.; Shah, Sundeep; Brandt, Vicky L.; Meek, Katheryn; Roth, David B.			Rag mutations reveal robust alternative end joining	NATURE			English	Article							STRAND BREAK REPAIR; COMBINED IMMUNE-DEFICIENCY; V(D)J RECOMBINATION; MAMMALIAN-CELLS; ERROR-PRONE; PROTEINS; MICE; CLEAVAGE; REGIONS; SIGNAL	Mammalian cells repair DNA double-strand breaks (DSBs) through either homologous recombination or non-homologous end joining (NHEJ). V(D)J recombination, a cut-and-paste mechanism for generating diversity in antigen receptors, relies on NHEJ for repairing DSBs introduced by the Rag1-Rag2 protein complex. Animals lacking any of the seven known NHEJ factors are therefore immunodeficient(1). Nevertheless, DSB repair is not eliminated entirely in these animals: evidence of a third mechanism, 'alternative NHEJ', appears in the form of extremely rare V(D)J junctions(2-4) and a higher rate of chromosomal translocations(5,6). The paucity of these V(D)J events has suggested that alternative NHEJ contributes little to a cell's overall repair capacity, being operative only (and inefficiently) when classical NHEJ fails. Here we find that removing certain portions of murine Rag proteins reveals robust alternative NHEJ activity in NHEJ-deficient cells and some alternative joining activity even in wildtype cells. We propose a two-tier model in which the Rag proteins collaborate with NHEJ factors to preserve genomic integrity during V(D)J recombination.	NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; CUNY Mt Sinai Sch Med, Dept Gene & Cell Biol, Black Family Stem Cell Inst, New York, NY 10029 USA; Michigan State Univ, Coll Vet Med Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA; Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA	New York University; New York University; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Michigan State University; Baylor College of Medicine	Roth, DB (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA.	roth@saturn.med.nyu.edu	Deriano, Ludovic/D-2048-2019; Brandt, Vicky L/J-5202-2014	Deriano, Ludovic/0000-0002-9673-9525; Corneo, Barbara/0000-0001-5189-6749; Brandt, Vicky/0000-0002-5512-3724				Bentley J, 2004, NUCLEIC ACIDS RES, V32, P5249, DOI 10.1093/nar/gkh842; Bogue MA, 1997, IMMUNITY, V7, P37, DOI 10.1016/S1074-7613(00)80508-7; CUOMO CA, 1994, NUCLEIC ACIDS RES, V22, P1810, DOI 10.1093/nar/22.10.1810; Deriano L, 2006, BRIT J HAEMATOL, V133, P520, DOI 10.1111/j.1365-2141.2006.06071.x; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Ferguson DO, 2001, ONCOGENE, V20, P5572, DOI 10.1038/sj.onc.1204767; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Kabotyanski EB, 1998, NUCLEIC ACIDS RES, V26, P5333, DOI 10.1093/nar/26.23.5333; Kirch SA, 1996, EUR J IMMUNOL, V26, P886, DOI 10.1002/eji.1830260425; Landree MA, 1999, GENE DEV, V13, P3059, DOI 10.1101/gad.13.23.3059; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; Posey JE, 2004, NAT IMMUNOL, V5, P476, DOI 10.1038/ni0504-476; Qiu JX, 2001, MOL CELL, V7, P77, DOI 10.1016/S1097-2765(01)00156-3; Roth DB, 2003, NAT REV IMMUNOL, V3, P656, DOI 10.1038/nri1152; ROTH DB, 1986, MOL CELL BIOL, V6, P4295, DOI 10.1128/MCB.6.12.4295; SADOFSKY MJ, 1994, NUCLEIC ACIDS RES, V22, P1805, DOI 10.1093/nar/22.10.1805; SADOFSKY MJ, 1993, NUCLEIC ACIDS RES, V21, P5644, DOI 10.1093/nar/21.24.5644; SCHULER W, 1986, CELL, V46, P963, DOI 10.1016/0092-8674(86)90695-1; Schultz HY, 2001, MOL CELL, V7, P65, DOI 10.1016/S1097-2765(01)00155-1; Talukder SR, 2004, NUCLEIC ACIDS RES, V32, P4539, DOI 10.1093/nar/gkh778; Verkaik NS, 2002, EUR J IMMUNOL, V32, P701, DOI 10.1002/1521-4141(200203)32:3<701::AID-IMMU701>3.0.CO;2-T; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	24	244	248	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2007	449	7161					483	U10		10.1038/nature06168	http://dx.doi.org/10.1038/nature06168			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214GQ	17898768				2022-12-01	WOS:000249724800045
J	Duan, X; Chang, JH; Ge, S; Faulkner, RL; Kim, JY; Kitabatake, Y; Liu, XB; Yang, CH; Jordan, JD; Ma, DK; Liu, CY; Ganesan, S; Cheng, HJ; Ming, GL; Lu, B; Song, H				Duan, Xin; Chang, Jay H.; Ge, Shaoyu; Faulkner, Regina L.; Kim, Ju Young; Kitabatake, Yasuji; Liu, Xiao-bo; Yang, Chih-Hao; Jordan, J. Dedrick; Ma, Dengke K.; Liu, Cindy Y.; Ganesan, Sundar; Cheng, Hwai-Jong; Ming, Guo-li; Lu, Bai; Song, Hongjun			Disrupted-in-schizophrenia 1 regulates integration of newly generated neurons in the adult brain	CELL			English	Article							GRANULE CELLS; DENTATE GYRUS; NEURITE OUTGROWTH; MOUSE HIPPOCAMPUS; BASAL DENDRITES; CEREBRAL-CORTEX; SCHIZOPHRENIA; DISC1; NEUROGENESIS; GENES	Adult neurogenesis occurs throughout life in discrete regions of the adultmammalian brain. Little is known about the mechanism governing the sequential developmental process that leads to integration of new neurons from adult neural stem cells into the existing circuitry. Here, we investigated roles of Disrupted- In- Schizophrenia 1 ( DISC1), a schizophrenia susceptibility gene, in adult hippocampal neurogenesis. Unexpectedly, downregulation of DISC1 leads to accelerated neuronal integration, resulting in aberrant morphological development and mispositioning of new dentate granule cells in a cell- autonomous fashion. Functionally, newborn neurons with DISC1 knockdown exhibit enhanced excitability and accelerated dendritic development and synapse formation. Furthermore, DISC1 cooperates with its binding partner NDEL1 in regulating adult neurogenesis. Taken together, our study identifies DISC1 as a key regulator that orchestrates the tempo of functional neuronal integration in the adult brain and demonstrates essential roles of a susceptibility gene for major mental illness in neuronal development, including adult neurogenesis.	Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; NIMH, Genes Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; NICHHD, Sect Neural Dev, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Johns Hopkins University; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, 733 N Broadway, Baltimore, MD 21205 USA.	gming1@jhmi.edu; bailu@mail.nih.gov; shongju1@jhmi.edu	Ming, Guo-li/J-7880-2013; Cheng, Hwai-Jong/AAY-5067-2021	Cheng, Hwai-Jong/0000-0003-0647-0567; Kitabatake, Yasuji/0000-0002-2907-9512; Ming, Guo-li/0000-0002-2517-6075; Faulkner, Regina/0000-0003-0231-1745; Jordan, Dedrick/0000-0002-0706-9583; Lu, Bai/0000-0001-5418-9759	NIA NIH HHS [R01 AG024984, R01 AG024984-04, AG024984] Funding Source: Medline; NICHD NIH HHS [R01 HD069184, R01 HD045757, HD045757] Funding Source: Medline; NINDS NIH HHS [R01 NS048271, R01 NS047344-05, R01 NS047344, NS047344, R01 NS048271-04, R37 NS047344, R56 NS047344, NS048271] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714, R01HD045757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047344, R01NS047344, R56NS047344, R01NS048271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; ANGEVINE JAY B., 1965, EXP NEUROL SUPPL, V2, P1; Arnold SE, 2005, PROG BRAIN RES, V147, P319, DOI 10.1016/S0079-6123(04)47023-X; Austin CP, 2004, NEUROSCIENCE, V124, P3, DOI 10.1016/j.neuroscience.2003.11.010; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Brandon NJ, 2004, MOL CELL NEUROSCI, V25, P42, DOI 10.1016/j.mcn.2003.09.009; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Carter CJ, 2006, SCHIZOPHR RES, V86, P1, DOI 10.1016/j.schres.2006.05.023; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fleck MW, 2000, J NEUROSCI, V20, P2439; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Hamshere ML, 2005, ARCH GEN PSYCHIAT, V62, P1081, DOI 10.1001/archpsyc.62.10.1081; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Ishizuka K, 2006, BIOL PSYCHIAT, V59, P1189, DOI 10.1016/j.biopsych.2006.03.065; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2006, HUM MOL GENET, V15, P3313, DOI 10.1093/hmg/ddl407; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1999, SCI AM, V280, P48, DOI 10.1038/scientificamerican0599-48; Kirkpatrick B, 2006, J COMP NEUROL, V497, P436, DOI 10.1002/cne.21007; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Lauer M, 2003, PSYCHIAT RES-NEUROIM, V122, P89, DOI 10.1016/S0925-4927(02)00122-1; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Liu XB, 2003, J COMP NEUROL, V466, P457, DOI 10.1002/cne.10901; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Mackie S, 2007, CURR OPIN NEUROBIOL, V17, P95, DOI 10.1016/j.conb.2007.01.007; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Millar JK, 2003, BIOCHEM BIOPH RES CO, V311, P1019, DOI 10.1016/j.bbrc.2003.10.101; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Porteous DJ, 2006, TRENDS MOL MED, V12, P255, DOI 10.1016/j.molmed.2006.04.009; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Sasaki S, 2005, MOL CELL BIOL, V25, P7812, DOI 10.1128/MCB.25.17.7812-7827.2005; Scharfman HE, 2007, SCIENCE, V315, P336, DOI 10.1126/science.1138711; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Senitz D, 2003, J NEURAL TRANSM, V110, P317, DOI 10.1007/s00702-002-0776-6; SERESS L, 1981, J ANAT, V133, P181; Shapiro LA, 2006, EPILEPSY RES, V69, P53, DOI 10.1016/j.eplepsyres.2005.12.003; Shinoda T, 2007, J NEUROSCI, V27, P4, DOI 10.1523/JNEUROSCI.3825-06.2007; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	58	479	506	1	58	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6					1146	1158		10.1016/j.cell.2007.07.010	http://dx.doi.org/10.1016/j.cell.2007.07.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17825401	Green Accepted, Bronze			2022-12-01	WOS:000250507500022
J	Kim, C; Cheng, CY; Saldanha, SA; Taylor, SS				Kim, Choel; Cheng, Cecilia Y.; Saldanha, S. Adrian; Taylor, Susan S.			PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation	CELL			English	Article							PROTEIN-KINASE-A; REGULATORY SUBUNIT; CATALYTIC SUBUNIT; CYCLIC-AMP; BINDING-SITES; CRYSTAL-STRUCTURE; ALPHA SUBUNIT; ISOFORMS; PHOSPHORYLATION; MUTATIONS	Protein kinase A ( PKA) holoenzyme is one of the major receptors for cyclic adenosine monophosphate ( cAMP), where an extracellular stimulus is translated into a signaling response. We report here the structure of a complex between the PKA catalytic subunit and a mutant RI regulatory subunit, RIa( 91 - 379: R333K), containing both cAMP- binding domains. Upon binding to the catalytic subunit, RI undergoes a dramatic conformational change in which the two cAMP- binding domains uncouple and wrap around the large lobe of the catalytic subunit. This large conformational reorganization reveals the concerted mechanism required to bind and inhibit the catalytic subunit. The structure also reveals a holoenzyme- specific salt bridge between two conserved residues, Glu261 and Arg366, that tethers the two adenine capping residues far from their cAMPbinding sites. Mutagenesis of these residues demonstrates their importance for PKA activation. Our structural insights, combined with the mutagenesis results, provide a molecular mechanism for the ordered and cooperative activation of PKA by cAMP.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	staylor@ucsd.edu			NIDDK NIH HHS [DK 54441] Funding Source: Medline; NIGMS NIH HHS [GM08326] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; Anand GS, 2003, P NATL ACAD SCI USA, V100, P13264, DOI 10.1073/pnas.2232255100; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; BUBIS J, 1988, J BIOL CHEM, V263, P9668; BUBIS J, 1988, BIOCHEMISTRY-US, V27, P1570, DOI 10.1021/bi00405a026; Canaves JM, 2000, BIOCHEMISTRY-US, V39, P15022, DOI 10.1021/bi001563q; Cheng XD, 2001, J BIOL CHEM, V276, P4102, DOI 10.1074/jbc.M006447200; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Gangal M, 1998, BIOCHEMISTRY-US, V37, P13728, DOI 10.1021/bi980560z; Gullingsrud J, 2006, STRUCTURE, V14, P141, DOI 10.1016/j.str.2005.09.019; Herberg FW, 1996, BIOCHEMISTRY-US, V35, P2934, DOI 10.1021/bi951647c; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Kapphahn MA, 1997, ARCH BIOCHEM BIOPHYS, V348, P347, DOI 10.1006/abbi.1997.0431; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; KNIGHTON DR, 1991, J MOL BIOL, V220, P217, DOI 10.1016/0022-2836(91)90005-Q; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; OGREID D, 1981, FEBS LETT, V129, P282, DOI 10.1016/0014-5793(81)80184-6; OGREID D, 1981, FEBS LETT, V129, P287, DOI 10.1016/0014-5793(81)80185-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Saldanha SA, 2006, ANAL CHEM, V78, P8265, DOI 10.1021/ac061104g; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; SYMCOX MM, 1994, J BIOL CHEM, V269, P23025; Vigil D, 2006, PROTEIN SCI, V15, P113, DOI 10.1110/ps.051723606; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu J, 2004, BIOCHEMISTRY-US, V43, P6620, DOI 10.1021/bi0302503	37	255	264	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2007	130	6					1032	1043		10.1016/j.cell.2007.07.018	http://dx.doi.org/10.1016/j.cell.2007.07.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889648	Bronze			2022-12-01	WOS:000250507500013
J	Seu, R; Phillips, RJ; Alberti, G; Biccari, D; Bonaventura, F; Bortone, M; Calabrese, D; Campbell, BA; Cartacci, M; Carter, LM; Catallo, C; Croce, A; Croci, R; Cutigni, M; Di Placido, A; Dinardo, S; Federico, C; Flamini, E; Fois, F; Frigeri, A; Fuga, O; Giacomoni, E; Gim, YY; Guelfi, M; Holt, JW; Kofman, W; Leuschen, CJ; Marinangeli, L; Marras, P; Masdea, A; Mattei, S; Mecozzi, R; Milkovich, SM; Morlupi, A; Mouginot, J; Orosei, R; Papa, C; Paterno, T; del Marmo, PP; Pettinelli, E; Pica, G; Picardi, G; Plaut, JJ; Provenziani, M; Putzig, NE; Russo, F; Safaeinili, A; Salzillo, G; Santovito, MR; Smrekar, SE; Tattarletti, B; Vicari, D				Seu, Roberto; Phillips, Roger J.; Alberti, Giovanni; Biccari, Daniela; Bonaventura, Francesco; Bortone, Marco; Calabrese, Diego; Campbell, Bruce A.; Cartacci, Marco; Carter, Lynn M.; Catallo, Claudio; Croce, Anna; Croci, Renato; Cutigni, Marco; Di Placido, Antonio; Dinardo, Salvatore; Federico, Costanzo; Flamini, Enrico; Fois, Franco; Frigeri, Alessandro; Fuga, Oreste; Giacomoni, Emanuele; Gim, Yonggyu; Guelfi, Mauro; Holt, John W.; Kofman, Wlodek; Leuschen, Carlton J.; Marinangeli, Lucia; Marras, Paolo; Masdea, Arturo; Mattei, Stefania; Mecozzi, Riccardo; Milkovich, Sarah M.; Morlupi, Antonio; Mouginot, Jeremie; Orosei, Roberto; Papa, Claudio; Paterno, Tobia; del Marmo, Paolo Persi; Pettinelli, Elena; Pica, Giulia; Picardi, Giovanni; Plaut, Jeffrey J.; Provenziani, Marco; Putzig, Nathaniel E.; Russo, Federica; Safaeinili, Ali; Salzillo, Giuseppe; Santovito, Maria Rosaria; Smrekar, Suzanne E.; Tattarletti, Barbara; Vicari, Danilo			Accumulation and erosion of Mars' south polar layered deposits	SCIENCE			English	Article							RADAR; SUBSURFACE; TOPOGRAPHY; FEATURES; MISSION; HISTORY; CAP	Mars' polar regions are covered with ice-rich layered deposits that potentially contain a record of climate variations. The sounding radar SHARAD on the Mars Reconnaissance Orbiter mapped detailed subsurface stratigraphy in the Promethei Lingula region of the south polar plateau, Planum Australe. Radar reflections interpreted as layers are correlated across adjacent orbits and are continuous for up to 150 kilometers along spacecraft orbital tracks. The reflectors are often separated into discrete reflector sequences, and strong echoes are seen as deep as 1 kilometer. In some cases, the sequences are dipping with respect to each other, suggesting an interdepositional period of erosion. In Australe Sulci, layers are exhumed, indicating recent erosion.	Univ Roma La Sapienza, Dept Info Com, I-00184 Rome, Italy; Washington Univ, St Louis, MO 63130 USA; Consorzio Ric Sistemi Telesensori, I-80125 Naples, Italy; Thales Alenia Space Italia, I-00131 Rome, Italy; Smithsonian Inst, Washington, DC 20013 USA; Univ Perugia, I-06123 Perugia, Italy; Agenzia Spaziale Italiana, I-00198 Rome, Italy; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Texas, Austin, TX 78758 USA; CNRS, F-38041 Grenoble, France; Univ Grenoble 1, F-38041 Grenoble, France; Univ Kansas, Lawrence, KS 66045 USA; Int Res Sch Planetary Sci, I-65127 Pescara, Italy; Ist Nazl Astrofis, I-00133 Rome, Italy; Univ Roma Tre, I-00146 Rome, Italy	Sapienza University Rome; Washington University (WUSTL); Thales Group; Smithsonian Institution; University of Perugia; Agenzia Spaziale Italiana (ASI); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Texas System; University of Texas Austin; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Kansas; Istituto Nazionale Astrofisica (INAF); Roma Tre University	Seu, R (corresponding author), Univ Roma La Sapienza, Dept Info Com, I-00184 Rome, Italy.	roberto.seu@uniroma1.it	Smrekar, Suzanne/AAH-8074-2020; Kofman, Wlodek/C-4556-2008; Mouginot, Jeremie/G-7045-2015; Frigeri, Alessandro/K-9679-2019; Frigeri, Alessandro/F-2151-2010; Holt, John/C-4896-2009; Carter, Lynn/D-2937-2012	Smrekar, Suzanne/0000-0001-8775-075X; Kofman, Wlodek/0000-0002-6744-8796; Mouginot, Jeremie/0000-0001-9155-5455; Frigeri, Alessandro/0000-0002-9140-3977; Frigeri, Alessandro/0000-0002-9140-3977; Carter, Lynn/0000-0002-6245-4142; Calabrese, Diego/0000-0002-2598-1111; MARINANGELI, Lucia/0000-0001-5417-6122; Putzig, Nathaniel/0000-0003-4485-6321; PETTINELLI, Elena/0000-0002-7066-6516; Cartacci, Marco/0000-0001-9825-1817				Bibring JP, 2004, NATURE, V428, P627, DOI 10.1038/nature02461; Byrne S, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002267; Byrne S, 2003, SCIENCE, V299, P1051, DOI 10.1126/science.1080148; CLIFFORD SM, 1987, J GEOPHYS RES-SOLID, V92, P9135, DOI 10.1029/JB092iB09p09135; Doute S, 2007, PLANET SPACE SCI, V55, P113, DOI 10.1016/j.pss.2006.05.035; FISHER DA, 1993, ICARUS, V105, P501, DOI 10.1006/icar.1993.1144; Graf JE, 2005, ACTA ASTRONAUT, V57, P566, DOI 10.1016/j.actaastro.2005.03.043; Herkenhoff KE, 2000, ICARUS, V144, P243, DOI 10.1006/icar.1999.6287; HOWARD AD, 1978, ICARUS, V34, P581, DOI 10.1016/0019-1035(78)90047-7; Howard AD, 2000, ICARUS, V144, P267, DOI 10.1006/icar.1999.6305; Kolb E.J., 2006, INT J MARS SCI EXPLO, V2, P1, DOI [10.1038/s41598-021-83329-3, 10.1555/mars.2006.0001, DOI 10.1555/MARS.2006.0001]; Koutnik MR, 2005, ICARUS, V174, P490, DOI 10.1016/j.icarus.2004.09.015; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Mellon MT, 1996, ICARUS, V124, P268, DOI 10.1006/icar.1996.0203; Nouvel JF, 2004, RADIO SCI, V39, DOI 10.1029/2003RS002903; Nunes DC, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002609; Nye JF, 2000, ICARUS, V144, P449, DOI 10.1006/icar.1999.6306; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Picardi G, 2005, SCIENCE, V310, P1925, DOI 10.1126/science.1122165; Plaut JJ, 2007, SCIENCE, V316, P92, DOI 10.1126/science.1139672; Seu R, 2004, PLANET SPACE SCI, V52, P157, DOI 10.1016/j.pss.2003.08.024; Seu R, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002745; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Tanaka KL, 2001, ICARUS, V154, P3, DOI 10.1006/icar.2001.6675; Thomas P., 1992, MARS, P767; TOON OB, 1980, ICARUS, V44, P552, DOI 10.1016/0019-1035(80)90130-X	26	63	65	2	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1715	1718		10.1126/science.1144120	http://dx.doi.org/10.1126/science.1144120			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885128				2022-12-01	WOS:000249585900037
J	Dentin, R; Liu, Y; Koo, SH; Hedrick, S; Vargas, T; Heredia, J; Yates, J; Montminy, M				Dentin, Renaud; Liu, Yi; Koo, Seung-Hoi; Hedrick, Susan; Vargas, Thomas; Heredia, Jose; Yates, John, III; Montminy, Marc			Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2	NATURE			English	Article							UBIQUITIN LIGASE COP1; HEPATIC GLUCONEOGENESIS; PHOSPHORYLATION; IDENTIFICATION; DEGRADATION; RESISTANCE; REGULATOR; GLUCOSE; FKHR; GENE	During feeding, increases in circulating pancreatic insulin inhibit hepatic glucose output through the activation of the Ser/Thr kinase AKT and subsequent phosphorylation of the forkhead transcription factor FOXO1 (refs 1-3). Under fasting conditions, FOXO1 increases gluconeogenic gene expression in concert with the cAMP responsive coactivator TORC2 (refs 4-8). In response to pancreatic glucagon, TORC2 is de-phosphorylated at Ser 171 and transported to the nucleus, in which it stimulates the gluconeogenic programme by binding to CREB. Here we show in mice that insulin inhibits gluconeogenic gene expression during re-feeding by promoting the phosphorylation and ubiquitin-dependent degradation of TORC2. Insulin disrupts TORC2 activity by induction of the Ser/Thr kinase SIK2, which we show here undergoes AKT2-mediated phosphorylation at Ser 358. Activated SIK2 in turn stimulated the Ser 171 phosphorylation and cytoplasmic translocation of TORC2. Phosphorylated TORC2 was degraded by the 26S proteasome during re-feeding through an association with COP1, a substrate receptor for an E3 ligase complex that promoted TORC2 ubiquitination at Lys 628. Because TORC2 protein levels and activity were increased in diabetes owing to a block in TORC2 phosphorylation, our results point to an important role for this pathway in the maintenance of glucose homeostasis.	Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; Sungkyunkwan Univ, Sch Med, Dept Mol & Cell Biol, Suwon 440746, South Korea; Scripps Res Inst, La Jolla, CA 92037 USA	Salk Institute; Sungkyunkwan University (SKKU); Scripps Research Institute	Montminy, M (corresponding author), Salk Inst Biol Studies, Peptide Biol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu	Dentin, Renaud/AAV-5818-2020; Koo, Seung-Hoi/E-2763-2015; dentin, Renaud/P-4939-2017	Dentin, Renaud/0000-0003-0988-4458; Koo, Seung-Hoi/0000-0001-8769-2879; dentin, Renaud/0000-0003-0988-4458				Bianchi E, 2003, J BIOL CHEM, V278, P19682, DOI 10.1074/jbc.M212681200; Cheng A, 2006, BIOESSAYS, V28, P231, DOI 10.1002/bies.20375; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Dornan D, 2006, SCIENCE, V313, P1122, DOI 10.1126/science.1127335; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Holm M, 2001, EMBO J, V20, P118, DOI 10.1093/emboj/20.1.118; Itahana Y, 2006, MOL CELL BIOL, V26, P4675, DOI 10.1128/MCB.01830-05; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; O'Keefe K, 2003, MOL CELL BIOL, V23, P6396, DOI 10.1128/MCB.23.18.6396-6405.2003; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Suzuki M, 1996, HUM GENE THER, V7, P1883, DOI 10.1089/hum.1996.7.15-1883; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549	23	313	334	0	50	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 20	2007	449	7160					366	+		10.1038/nature06128	http://dx.doi.org/10.1038/nature06128			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17805301				2022-12-01	WOS:000249557300050
J	Kazmierczak, P; Sakaguchi, H; Tokita, J; Wilson-Kubalek, EM; Milligan, RA; Muller, U; Kachar, B				Kazmierczak, Piotr; Sakaguchi, Hirofumi; Tokita, Joshua; Wilson-Kubalek, Elizabeth M.; Milligan, Ronald A.; Mueller, Ulrich; Kachar, Bechara			Cadherin 23 and protocadherin 15 interact to form tip-link filaments in sensory hair cells	NATURE			English	Article							SYNDROME TYPE 1D; C-CADHERIN; TRANSDUCTION; MUTATIONS; STEREOCILIA; CDH23; EAR; COMPONENT; ADHESION; WALTZER	Hair cells of the inner ear are mechanosensors that transduce mechanical forces arising from sound waves and head movement into electrochemical signals to provide our sense of hearing and balance. Each hair cell contains at the apical surface a bundle of stereocilia. Mechanoelectrical transduction takes place close to the tips of stereocilia in proximity to extracellular tip-link filaments that connect the stereocilia and are thought to gate the mechanoelectrical transduction channel(1-3). Recent reports on the composition(4-8), properties and function(9-11) of tip links are conflicting(29). Here we demonstrate that two cadherins that are linked to inherited forms of deafness in humans(12-15) interact to form tip links. Immunohistochemical studies using rodent hair cells show that cadherin 23 (CDH23) and protocadherin 15 (PCDH15) localize to the upper and lower part of tip links, respectively. The amino termini of the two cadherins co-localize on tip-link filaments. Biochemical experiments show that CDH23 homodimers interact in trans with PCDH15 homodimers to form a filament with structural similarity to tip links. Ions that affect tip-link integrity and a mutation in PCDH15 that causes a recessive form of deafness(16) disrupt interactions between CDH23 and PCDH15. Our studies define the molecular composition of tip links and provide a conceptual base for exploring the mechanisms of sensory impairment associated with mutations in CDH23 and PCDH15.	Scripps Res Inst, Inst Dept Cell Biol, La Jolla, CA 92037 USA; Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA; NIDCD, Lab Cellular Biol, NIH, Bethesda, MD 20892 USA	Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Muller, U (corresponding author), Scripps Res Inst, Inst Dept Cell Biol, La Jolla, CA 92037 USA.	umueller@scripps.edu; kacharb@nidcd.nih.gov	Kaźmierczak, Piotr/AAD-7059-2021	Kaźmierczak, Piotr/0000-0002-4060-3055	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000002, ZIADC000002] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; ANNIKO M, 1986, HEARING RES, V22, P279, DOI 10.1016/0378-5955(86)90104-8; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Buchel C, 2001, J MOL BIOL, V312, P371, DOI 10.1006/jmbi.2001.4951; Corey D, 2003, J CELL SCI, V116, P1, DOI 10.1242/jcs.00101; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Gillespie PG, 2005, CURR OPIN NEUROBIOL, V15, P389, DOI 10.1016/j.conb.2005.06.007; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Hudspeth AJ, 1997, NEURON, V19, P947, DOI 10.1016/S0896-6273(00)80385-2; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Lagziel A, 2005, DEV BIOL, V280, P295, DOI 10.1016/j.ydbio.2005.01.015; Michel V, 2005, DEV BIOL, V280, P281, DOI 10.1016/j.ydbio.2005.01.014; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Phillips KR, 2006, J NEUROSCI, V26, P10777, DOI 10.1523/JNEUROSCI.1847-06.2006; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; Schneider ME, 2006, J NEUROSCI, V26, P10243, DOI 10.1523/JNEUROSCI.2812-06.2006; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Tsuprun V, 2004, BIOPHYS J, V87, P4106, DOI 10.1529/biophysj.104.049031	29	484	503	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2007	449	7158					87	U59		10.1038/nature06091	http://dx.doi.org/10.1038/nature06091			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207ED	17805295				2022-12-01	WOS:000249233500041
J	Bibring, JP; Arvidson, RE; Gendrin, A; Gondet, B; Langevin, Y; Le Mouelic, S; Mangold, N; Morris, RV; Mustard, JF; Poulet, F; Quantin, C; Sotin, C				Bibring, J.-P.; Arvidson, R. E.; Gendrin, A.; Gondet, B.; Langevin, Y.; Le Mouelic, S.; Mangold, N.; Morris, R. V.; Mustard, J. F.; Poulet, F.; Quantin, C.; Sotin, C.			Coupled ferric oxides and sulfates on the Martian surface	SCIENCE			English	Article							MERIDIANI-PLANUM; BURNS FORMATION; REFLECTIVITY SPECTRA; TERRESTRIAL ANALOG; HEMATITE; MARS; GOETHITE; SYSTEM; REGION	The Mars Exploration Rover ( MER), Opportunity, showed that layered sulfate deposits in Meridiani Planum formed during a period of rising acidic ground water. Crystalline hematite spherules formed in the deposits as a consequence of aqueous alteration and were concentrated on the surface as a lag deposit as wind eroded the softer sulfate rocks. On the basis of Mars Express Observatoire pour la Mineralogie, l'Eau, les Glaces et l'Activite ( OMEGA) orbital data, we demonstrate that crystalline hematite deposits are associated with layered sulfates in other areas on Mars, implying that Meridiani-like ground water systems were indeed widespread and representative of an extensive acid sulfate aqueous system.	Inst Astrophys Spatiale, F-91405 Orsay, France; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Univ Nantes, F-44322 Nantes 03, France; Interact & Dynam Environm Surface, F-91405 Orsay, France; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Brown Univ, Providence, RI 02912 USA	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Washington University (WUSTL); Nantes Universite; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Brown University	Bibring, JP (corresponding author), Inst Astrophys Spatiale, Batiment 121, F-91405 Orsay, France.	bibring@ias.fr	Quantin, Cathy/H-1516-2014	Le Mouelic, Stephane/0000-0001-5260-1367				ADAMS JB, 1986, J GEOPHYS RES-SOLID, V91, P8098, DOI 10.1029/JB091iB08p08098; Arvidson RE, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002728; Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001982; Bibring J.-P., 2004, EUR SPACE AGENCY SPE, P37; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Chan MA, 2004, NATURE, V429, P731, DOI 10.1038/nature02600; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Christensen PR, 2004, SPACE SCI REV, V110, P85, DOI 10.1023/B:SPAC.0000021008.16305.94; Crowley J.K., 2003, GEOCHEM-EXPLOR ENV A, V3, P219, DOI DOI 10.1144/1467-7873/03-001; GEISSLER PE, 1993, ICARUS, V106, P380, DOI 10.1006/icar.1993.1179; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Grotzinger JP, 2005, EARTH PLANET SC LETT, V240, P11, DOI 10.1016/j.epsl.2005.09.039; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Lane MD, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001832; McLennan SM, 2005, EARTH PLANET SC LETT, V240, P95, DOI 10.1016/j.epsl.2005.09.041; MORRIS RV, 1990, J GEOPHYS RES-SOLID, V95, P5101, DOI 10.1029/JB095iB04p05101; Morris RV, 2005, EARTH PLANET SC LETT, V240, P168, DOI 10.1016/j.epsl.2005.09.044; Morris RV, 1997, J GEOPHYS RES-PLANET, V102, P9125, DOI 10.1029/96JE03993; Morris RV, 1998, ICARUS, V134, P1, DOI 10.1006/icar.1998.5939; Morris RV, 2000, J GEOPHYS RES-PLANET, V105, P1757, DOI 10.1029/1999JE001059; MORRIS RV, 1985, J GEOPHYS RES-SOLID, V90, P3126, DOI 10.1029/JB090iB04p03126; MUSTARD JF, 1995, SCIENCE, V267, P1623, DOI 10.1126/science.7886449; Nordstrom DK, 1999, GEOCHEMISTRY OF THE EARTH'S SURFACE, P139; SHERMAN DM, 1982, J GEOPHYS RES, V87, P169, DOI 10.1029/JB087iB12p10169; Smith AB, 2003, ORG LETT, V5, P1, DOI 10.1021/ol0202520; Squyres SW, 2004, SCIENCE, V306, P1698, DOI 10.1126/science.1106171; SUNSHINE JM, 1990, J GEOPHYS RES-SOLID, V95, P6955, DOI 10.1029/JB095iB05p06955; Tosca NJ, 2005, EARTH PLANET SC LETT, V240, P122, DOI 10.1016/j.epsl.2005.09.042	29	135	136	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2007	317	5842					1206	1210		10.1126/science.1144174	http://dx.doi.org/10.1126/science.1144174			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205PJ	17673623				2022-12-01	WOS:000249126800036
J	Krimpenfort, P; IJpenberg, A; Song, JY; van der Valk, M; Nawijn, M; Zevenhoven, J; Berns, A				Krimpenfort, Paul; IJpenberg, Annemieke; Song, Ji-Ying; van der Valk, Martin; Nawijn, Martijn; Zevenhoven, John; Berns, Anton			p15(Ink4b) is a critical tumour suppressor in the absence of p16(Ink4a)	NATURE			English	Article							INK4A LOCUS; MICE; TUMORIGENESIS; P19(ARF); INHIBITORS; GENES; PRODUCT; CANCER; CELLS; P53	The CDKN2b-CDKN2a locus on chromosome 9p21 in human (chromosome 4 in mouse) is frequently lost in cancer. The locus encodes three cell cycle inhibitory proteins: p15(INK4b) encoded by CDKN2b, p16(INK4a) encoded by CDKN2a and p14(ARF) (p19(Arf) in mice) encoded by an alternative reading frame of CDKN2a (ref. 1). Whereas the tumour suppressor functions for p16(INK4a) and p14(ARF) have been firmly established, the role of p15(INK4b) remains ambiguous. However, many 9p21 deletions also remove CDKN2b, so we hypothesized a synergistic effect of the combined deficiency for p15(INK4b), p14(ARF) and p16(INK4a). Here we report that mice deficient for all three open reading frames (Cdkn2ab(-/-)) are more tumour-prone and develop a wider spectrum of tumours than Cdkn2a mutant mice, with a preponderance of skin tumours and soft tissue sarcomas (for example, mesothelioma) frequently composed of mixed cell types and often showing biphasic differentiation. Cdkn2ab(-/-) mouse embryonic fibroblasts (MEFs) are substantially more sensitive to oncogenic transformation than Cdkn2a mutant MEFs. Under conditions of stress, p15(Ink4b) protein levels are significantly elevated in MEFs deficient for p16(Ink4a). Our data indicate that p15(Ink4b) can fulfil a critical backup function for p16(Ink4a) and provide an explanation for the frequent loss of the complete CDKN2b-CDKN2a locus in human tumours.	Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Dept Expt Anim Pathol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Berns, A (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	a.berns@nki.nl		Nawijn, Martijn/0000-0003-3372-6521				Bagui TK, 2003, MOL CELL BIOL, V23, P7285, DOI 10.1128/MCB.23.20.7285-7290.2003; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Drexler HG, 1998, LEUKEMIA, V12, P845, DOI 10.1038/sj.leu.2401043; Fahraeus R, 1999, EMBO J, V18, P2106, DOI 10.1093/emboj/18.8.2106; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; HARRISON PTC, 1984, LAB ANIM, V18, P325, DOI 10.1258/002367784780865324; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Krug U, 2002, ONCOGENE, V21, P3475, DOI 10.1038/sj.onc.1205322; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; Lyons SK, 2003, CANCER RES, V63, P7042; Murao K, 2006, BRIT J DERMATOL, V155, P999, DOI 10.1111/j.1365-2133.2006.07487.x; Orlow I, 1999, J NATL CANCER I, V91, P73, DOI 10.1093/jnci/91.1.73; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Pantoja C, 2001, EXP GERONTOL, V36, P1289, DOI 10.1016/S0531-5565(01)00104-8; Parry D, 1999, MOL CELL BIOL, V19, P1775; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074; Zou XH, 2002, GENE DEV, V16, P2923, DOI 10.1101/gad.1033002	24	195	200	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2007	448	7156					943	U11		10.1038/nature06084	http://dx.doi.org/10.1038/nature06084			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202OM	17713536				2022-12-01	WOS:000248912900050
J	Chapman, HN; Hau-Riege, SP; Bogan, MJ; Bajt, S; Barty, A; Boutet, S; Marchesini, S; Frank, M; Woods, BW; Benner, WH; London, RA; Rohner, U; Szoke, A; Spiller, E; Moller, T; Bostedt, C; Shapiro, DA; Kuhlmann, M; Treusch, R; Plonjes, E; Burmeister, F; Bergh, M; Caleman, C; Huldt, G; Seibert, MM; Hajdu, J				Chapman, Henry N.; Hau-Riege, Stefan P.; Bogan, Michael J.; Bajt, Sasa; Barty, Anton; Boutet, Sebastien; Marchesini, Stefano; Frank, Matthias; Woods, Bruce W.; Benner, W. Henry; London, Richard A.; Rohner, Urs; Szoeke, Abraham; Spiller, Eberhard; Moeller, Thomas; Bostedt, Christoph; Shapiro, David A.; Kuhlmann, Marion; Treusch, Rolf; Ploenjes, Elke; Burmeister, Florian; Bergh, Magnus; Caleman, Carl; Huldt, Goesta; Seibert, M. Marvin; Hajdu, Janos			Femtosecond time-delay X-ray holography	NATURE			English	Article							FREE-ELECTRON LASER; PULSES; GENERATION; LIGHT; SCATTERING; RADIATION; DYNAMICS	Extremely intense and ultrafast X-ray pulses from free-electron lasers offer unique opportunities to study fundamental aspects of complex transient phenomena in materials. Ultrafast time-resolved methods usually require highly synchronized pulses to initiate a transition and then probe it after a precisely defined time delay. In the X-ray regime, these methods are challenging because they require complex optical systems and diagnostics. Here we propose and apply a simple holographic measurement scheme, inspired by Newton's 'dusty mirror' experiment(1), to monitor the X-ray-induced explosion of microscopic objects. The sample is placed near an X-ray mirror; after the pulse traverses the sample, triggering the reaction, it is reflected back onto the sample by the mirror to probe this reaction. The delay is encoded in the resulting diffraction pattern to an accuracy of one femtosecond, and the structural change is holographically recorded with high resolution. We apply the technique to monitor the dynamics of polystyrene spheres in intense free-electron-laser pulses, and observe an explosion occurring well after the initial pulse. Our results support the notion that X-ray flash imaging(2,3) can be used to achieve high resolution, beyond radiation damage limits for biological samples(4). With upcoming ultrafast X-ray sources we will be able to explore the three-dimensional dynamics of materials at the time-scale of atomic motion.	Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; Univ Calif Davis, Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA; Stanford Univ, Stanford Linear Accelerator Ctr, Stanford Synchrotron Radiat Lab, Stanford, CA 94305 USA; Uppsala Univ, Dept Cell & Mol Biol, Lab Mol Biophys, SE-75124 Uppsala, Sweden; Tech Univ Berlin, Inst Opt & Atomare Phys, D-10623 Berlin, Germany; DESY, D-22607 Hamburg, Germany	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Davis; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Uppsala University; Technical University of Berlin; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Chapman, HN (corresponding author), Lawrence Livermore Natl Lab, 7000 East Ave, Livermore, CA 94550 USA.	henry.chapman@llnl.gov	Frank, Matthias/O-9055-2014; Treusch, Rolf/C-3935-2015; FRS, Henry N Chapman/G-2153-2010; Bogan, Mike/I-6962-2012; Marchesini, Stefano/A-6795-2009; Barty, Anton/K-5137-2014; Treusch, Rolf/P-4876-2019; Bajt, Sasa/O-4695-2019; Marchesini, Stefano/GYR-1409-2022; Bajt, Sasa/G-2228-2010	FRS, Henry N Chapman/0000-0002-4655-1743; Bogan, Mike/0000-0001-9318-3333; Marchesini, Stefano/0000-0002-6798-2913; Barty, Anton/0000-0003-4751-2727; Treusch, Rolf/0000-0001-8479-8862; Bajt, Sasa/0000-0002-7163-7602; Frank, Matthias/0000-0002-5244-0791; Seibert, Mark Marvin/0000-0003-0251-0744				Ayvazyan V, 2006, EUR PHYS J D, V37, P297, DOI 10.1140/epjd/e2005-00308-1; Bartels RA, 2002, SCIENCE, V297, P376, DOI 10.1126/science.1071718; Bergh M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051904; BOGAN MJ, UNPUB J AEROSOL SCI; Bohren C F, 2008, ABSORPTION SCATTERIN; Cavalieri AL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.114801; Cavalleri A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.237401; Chapman HN, 2006, NAT PHYS, V2, P839, DOI 10.1038/nphys461; DEWITTE AJ, 1967, AM J PHYS, V35, P301, DOI 10.1119/1.1974069; FIENUP JR, 1987, J OPT SOC AM A, V4, P118, DOI 10.1364/JOSAA.4.000118; GAUR U, 1982, J PHYS CHEM REF DATA, V11, P313, DOI 10.1063/1.555663; Goodman J.W., 1996, INTRO FOURIER OPTICS, V2nd ed.; Hau-Riege SP, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051906; Hau-Riege SP, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.145502; HENKE BL, 1993, ATOM DATA NUCL DATA, V54, P181, DOI 10.1006/adnd.1993.1013; HOWELLS MR, 2005, IN PRESS J ELECT SPE; Jurek Z, 2004, EUR PHYS J D, V29, P217, DOI 10.1140/epjd/e2004-00033-3; Larabell CA, 2004, MOL BIOL CELL, V15, P957, DOI 10.1091/mbc.E03-07-0522; Lee RW, 2003, J OPT SOC AM B, V20, P770, DOI 10.1364/JOSAB.20.000770; Marchesini S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.140101; Marinak MM, 2001, PHYS PLASMAS, V8, P2275, DOI 10.1063/1.1356740; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; NEWTON I, 1952, OPTICKS BOOK 4, V2; Schoenlein RW, 1996, SCIENCE, V274, P236, DOI 10.1126/science.274.5285.236; Schoenlein RW, 2000, SCIENCE, V287, P2237, DOI 10.1126/science.287.5461.2237; Shapiro D, 2005, P NATL ACAD SCI USA, V102, P15343, DOI 10.1073/pnas.0503305102; SOLEM JC, 1982, SCIENCE, V218, P229, DOI 10.1126/science.218.4569.229; Sorokin AA, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2397561; Temnov VV, 2006, J OPT SOC AM B, V23, P1954, DOI 10.1364/JOSAB.23.001954; Young T., 1802, PHILOS T R SOC LOND, V92, P12, DOI DOI 10.1098/RSTL.1802.0004; ZIMMERMAN GB, 1980, J QUANT SPECTROSC RA, V23, P517, DOI 10.1016/0022-4073(80)90055-2	32	199	200	3	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2007	448	7154					676	679		10.1038/nature06049	http://dx.doi.org/10.1038/nature06049			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17687320	Green Published, Green Submitted			2022-12-01	WOS:000248598000040
J	Kioussis, D; Georgopoulos, K				Kioussis, Dimitris; Georgopoulos, Katia			Perspective - Epigenetic flexibility underlying lineage choices in the adaptive immune system	SCIENCE			English	Editorial Material							EMBRYONIC STEM-CELLS; B-CELLS; CHROMATIN; LYMPHOCYTE; EXPRESSION; COMPLEXES; DIVISION; IKAROS; GENES; CD4	Although fundamental models have emerged in recent years describing how chromatin and transcription regulation interface with one another in the developing immune system, the order of events and their biological impact are still being resolved. Recent advances have provided a flexible, rather than static, view of chromatin regulation to reveal how both positive and negative forces work concomitantly to establish specific chromatin structures and regulate gene expression. The challenge will now be to explore new epigenetic models and validate them during lymphocyte development, with the ultimate goal of unraveling the long-sought mechanisms that support the emerging complexity of the adaptive immune response.	Natl Inst Med Res, MRC, London NW7 1AA, England; Harvard Univ, Sch Med, Cutaneous Biol Res Ctr, Massachusetts Gen Hosp, Charlestown, MA 02129 USA	MRC National Institute for Medical Research; Harvard University; Massachusetts General Hospital	Kioussis, D (corresponding author), Natl Inst Med Res, MRC, Ridgeway, London NW7 1AA, England.	dkiouss@nimr.mrc.ac.uk			MRC [MC_U117512796] Funding Source: UKRI; Medical Research Council [MC_U117512796] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akashi K, 2005, ANN NY ACAD SCI, V1044, P125, DOI 10.1196/annals.1349.016; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Festenstein R, 2000, CURR OPIN GENET DEV, V10, P199, DOI 10.1016/S0959-437X(00)00060-5; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Medina KL, 2005, CURR OPIN HEMATOL, V12, P203, DOI 10.1097/01.moh.0000160735.67596.a0; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Ng SYM, 2007, CURR OPIN IMMUNOL, V19, P116, DOI 10.1016/j.coi.2007.02.014; Reiner SL, 2007, SCIENCE, V317, P622, DOI 10.1126/science.1143775; Rothenberg EV, 2007, NAT IMMUNOL, V8, P441, DOI 10.1038/ni1461; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563	31	20	20	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2007	317	5838					620	622		10.1126/science.1143777	http://dx.doi.org/10.1126/science.1143777			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	196PL	17673651				2022-12-01	WOS:000248494400032
J	McGregor, AP; Orgogozo, V; Delon, I; Zanet, J; Srinivasan, DG; Payre, F; Stern, DL				McGregor, Alistair P.; Orgogozo, Virginie; Delon, Isabelle; Zanet, Jennifer; Srinivasan, Dayalan G.; Payre, Francois; Stern, David L.			Morphological evolution through multiple cis-regulatory mutations at a single	NATURE			English	Article							DROSOPHILA-MELANOGASTER; EPIDERMIS DIFFERENTIATION; EXPRESSION; GENE; WINGLESS; MAIZE; OVO/SHAVENBABY; PARALLELISM; GERMLINE; PROTEINS	One central, and yet unsolved, question in evolutionary biology is the relationship between the genetic variants segregating within species and the causes of morphological differences between species. The classic neo-darwinian view postulates that species differences result from the accumulation of small-effect changes at multiple loci. However, many examples support the possible role of larger abrupt changes in the expression of developmental genes in morphological evolution(1-3). Although this evidence might be considered a challenge to a neo-darwinian micromutationist view of evolution, there are currently few examples of the actual genes causing morphological differences between species(4-10). Here we examine the genetic basis of a trichome pattern difference between Drosophila species, previously shown to result from the evolution of a single gene, shavenbaby (svb), probably through cis-regulatory changes(6). We first identified three distinct svb enhancers from D. melanogaster driving reporter gene expression in partly overlapping patterns that together recapitulate endogenous svb expression. All three homologous enhancers from D. sechellia drive expression in modified patterns, in a direction consistent with the evolved svb expression pattern. To test the influence of these enhancers on the actual phenotypic difference, we conducted interspecific genetic mapping at a resolution sufficient to recover multiple intragenic recombinants. This functional analysis revealed that independent genetic regions upstream of svb that overlap the three identified enhancers are collectively required to generate the D. sechellia trichome pattern. Our results demonstrate that the accumulation of multiple small-effect changes at a single locus underlies the evolution of a morphological difference between species. These data support the view that alleles of large effect that distinguish species may sometimes reflect the accumulation of multiple mutations of small effect at select genes.	Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; Ctr Dev Biol, F-31062 Toulouse 4, France	Princeton University	Stern, DL (corresponding author), Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA.	dstern@princeton.edu		Stern, David/0000-0002-1847-6483; PAYRE, Francois/0000-0002-8144-6711; Courtier-Orgogozo, Virginie/0000-0002-9297-9230; McGregor, Alistair/0000-0002-2908-2420	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063622] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM063622, R01 GM063622-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; Bokor P, 1996, DEVELOPMENT, V122, P1083; Chanut-Delalande H, 2006, PLOS BIOL, V4, P1549, DOI 10.1371/journal.pbio.0040290; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Delon I, 2003, MECH DEVELOP, V120, P747, DOI 10.1016/S0925-4773(03)00081-9; DOEBLEY J, 1995, GENETICS, V141, P333; GLEASON JM, 2004, DROSOPHILA INFO SERV, V87, P107; Harr B, 1998, CURR BIOL, V8, P1183, DOI 10.1016/S0960-9822(07)00490-3; Hatini V, 2005, GENE DEV, V19, P709, DOI 10.1101/gad.1268005; Hay A, 2006, NAT GENET, V38, P942, DOI 10.1038/ng1835; Khila A, 2003, INSECT BIOCHEM MOLEC, V33, P691, DOI 10.1016/S0965-1748(03)00063-8; Marcellini S, 2006, PLOS BIOL, V4, P2252, DOI 10.1371/journal.pbio.0040386; MEVELNINIO M, 1995, MECH DEVELOP, V49, P83, DOI 10.1016/0925-4773(94)00305-7; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Powell J.R., 1997, PROGR PROSPECTS EVOL; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; ROBERTSON HM, 1988, GENETICS, V118, P461; Roch F, 2003, J CELL SCI, V116, P1199, DOI 10.1242/jcs.00298; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Stam LF, 1996, GENETICS, V144, P1559; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; STERN DL, 2000, DROSOPHILA PROTOCOLS, P601; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; Tao H, 2006, PLOS GENET, V2, P848, DOI 10.1371/journal.pgen.0020093; Thummel CS, 1992, DROS INF SERV, V71, P150; True JR, 1996, GENETICS, V142, P507; Walters JW, 2005, DEV BIOL, V286, P415, DOI 10.1016/j.ydbio.2005.06.031; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang XD, 2002, GENE DEV, V16, P2345, DOI 10.1101/gad.996302; Weatherbee, 2001, DNA DIVERSITY MOL GE; Wiellette EL, 1999, DEVELOPMENT, V126, P1985; Yoon HS, 2004, P NATL ACAD SCI USA, V101, P6524, DOI 10.1073/pnas.0401824101	37	233	236	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 2	2007	448	7153					587	U6		10.1038/nature05988	http://dx.doi.org/10.1038/nature05988			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	195XV	17632547				2022-12-01	WOS:000248446700042
J	Pilling, S; Strang, J; Gerada, C				Pilling, Stephen; Strang, John; Gerada, Clare		Guideline Dev Grp	Psychosocial interventions and opioid detoxification for drug misuse: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Article									UCL, Ctr Outcomes Res & Effectiveness, Dept Psychol, London WC1E 8XA, England; Kings Coll London, Natl Addict Ctr, Inst Psychiat, London SE5 8AF, England; Hurley Clin, London SE11 4HJ, England	University of London; University College London; University of London; King's College London	Pilling, S (corresponding author), UCL, Ctr Outcomes Res & Effectiveness, Dept Psychol, London WC1E 8XA, England.	s.pilting@uct.ac.uk	Gerada, Clare/O-8264-2019; Strang, John/H-5460-2011	Strang, John/0000-0002-5413-2725				*NAT I HLTH CLIN E, 2007, DRUG MIS OP DET; National Institute for Health and Clinical Excellence, 2007, DRUG MIS PSYCH INT; Strang J, 2005, BRIT J GEN PRACT, V55, P444	3	38	39	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2007	335	7612					203	205		10.1136/bmj.39265.639641.AD	http://dx.doi.org/10.1136/bmj.39265.639641.AD			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	198YA	17656545	Green Submitted, Green Published			2022-12-01	WOS:000248662200033
J	Ortega-Martinez, O; Pernas, M; Carol, RJ; Dolan, L				Ortega-Martinez, Olga; Pernas, Monica; Carol, Rachel J.; Dolan, Liam			Ethylene modulates stem cell division in the Arabidopsis thaliana root	SCIENCE			English	Article							AUXIN; PROTEIN; DIFFERENTIATION; BIOSYNTHESIS; MUTANTS; GROWTH; NICHE; FATE; ETO1	The construction of multicellular organisms depends on stem cells-cells that can both regenerate and produce daughter cells that undergo differentiation. Here, we show that the gaseous messenger ethylene modulates cell division in the cells of the quiescent center, which act as a source of stem cells in the seedling root. The cells formed through these ethylene-induced divisions express quiescent center-specific genes and can repress differentiation of surrounding initial cells, showing that quiescence is not required for these cells to signal to adjacent stem cells. We propose that ethylene is part of a signaling pathway that modulates cell division in the quiescent center in the stem cell niche during the postembryonic development of the root system.	John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dolan, L (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.	liam.dolan@bbsrc.ac.uk	Pernas, Monica/G-3485-2015	Pernas, Monica/0000-0002-6521-9164; Dolan, Liam/0000-0003-1206-7096; Carol, Rachel/0000-0002-6193-5163	Biotechnology and Biological Sciences Research Council [BBS/E/J/00000168] Funding Source: Medline; Natural Environment Research Council [NE/C510732/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Chae HS, 2003, PLANT CELL, V15, P545, DOI 10.1105/tpc.006882; Chilley PM, 2006, PLANT CELL, V18, P3058, DOI 10.1105/tpc.106.040790; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Kidner C, 2000, PLANTA, V211, P191, DOI 10.1007/s004250000284; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Rahman A, 2002, PLANT PHYSIOL, V130, P1908, DOI 10.1104/pp.010546; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; van den Berg C, 1998, PLANTA, V205, P483, DOI 10.1007/s004250050347; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Wang KLC, 2004, NATURE, V428, P945, DOI 10.1038/nature02516; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449	18	170	177	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					507	510		10.1126/science.1143409	http://dx.doi.org/10.1126/science.1143409			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656722				2022-12-01	WOS:000248339800043
J	Jimenez-Guri, E; Philippe, H; Okamura, B; Holland, PWH				Jimenez-Guri, Eva; Philippe, Herve; Okamura, Beth; Holland, Peter W. H.			Buddenbrockia is a Cnidarian worm	SCIENCE			English	Article							BILATERAL SYMMETRY; ANIMAL PHYLOGENY; SEA-ANEMONE; MYXOZOA; ORIGIN; VERTEBRATES; EVOLUTION; PROTISTS	A major evolutionary divide occurs in the animal kingdom between the so-called radially symmetric animals, which includes the cnidarians, and the bilaterally symmetric animals, which includes all worm phyla. Buddenbrockia plumatellae is an active, muscular, parasitic worm that belongs to the phylum Myxozoa, a group of morphologically simplified microscopic endoparasites that has proved difficult to place phylogenetically. Phylogenetic analyses of multiple protein-coding genes demonstrate that Buddenbrockia is a cnidarian. This active muscular worm increases the known diversity in cnidarian body plans and demonstrates that a muscular, wormlike form can evolve in the absence of overt bilateral symmetry.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Montreal, Canadian Inst Adv Res, Ctr Robert Cedergren, Dept Biochim, Montreal, PQ H3C 3J7, Canada; Univ Reading, Sch Biol Sci, Reading RG6 6BX, Berks, England; Nat Hist Museum, Dept Zool, London SW7 5BD, England	University of Oxford; Canadian Institute for Advanced Research (CIFAR); Universite de Montreal; University of Reading; Natural History Museum London	Holland, PWH (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	peter.holland@zoo.ox.ac.uk		Holland, Peter/0000-0003-1533-9376; jimenez-guri, eva/0000-0002-9592-1077	Biotechnology and Biological Sciences Research Council [G19271] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Anderson CL, 1998, NATURE, V392, P346, DOI 10.1038/32801; Baurain D, 2007, MOL BIOL EVOL, V24, P6, DOI 10.1093/molbev/msl137; Canning EU, 2002, J EUKARYOT MICROBIOL, V49, P280, DOI 10.1111/j.1550-7408.2002.tb00371.x; Canning EU, 2004, ADV PARASIT, V56, P43, DOI 10.1016/S0065-308X(03)56002-X; Collins AG, 2006, BIOL LETT-UK, V2, P120, DOI 10.1098/rsbl.2005.0372; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Finnerty JR, 2005, BIOESSAYS, V27, P1174, DOI 10.1002/bies.20299; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Hyman L. H., 1940, INVERTEBRATES PROTOZ; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lom J, 2006, FOLIA PARASIT, V53, P1, DOI 10.14411/fp.2006.001; Monteiro AS, 2002, MOL BIOL EVOL, V19, P968, DOI 10.1093/oxfordjournals.molbev.a004155; Okamura B, 2002, PARASITOLOGY, V124, P215, DOI 10.1017/S0031182001001184; Philippe H, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-50; Philippe H, 2005, ANNU REV ECOL EVOL S, V36, P541, DOI 10.1146/annurev.ecolsys.35.112202.130205; PICKENS PE, 1988, J EXP BIOL, V135, P133; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; Schroder O, 1910, Z WISS ZOOL ABT A, V96, P525; Seipel K, 2006, INT J DEV BIOL, V50, P589, DOI 10.1387/ijdb.062150ks; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Siddall ME, 1995, J PARASITOL, V81, P961, DOI 10.2307/3284049; SMOTHERS JF, 1994, SCIENCE, V265, P1719, DOI 10.1126/science.8085160; Stolc A, 1899, B INT ACAD SCI BOHEM, V22, P1; WADA H, 1994, P NATL ACAD SCI USA, V91, P1801, DOI 10.1073/pnas.91.5.1801; Weill R, 1938, TRAVAUX STATION ZOOL, V13, P727; Westfall JA, 2004, HYDROBIOLOGIA, V530, P117, DOI 10.1007/s10750-004-2678-0; Zrzavy J, 2003, CLADISTICS, V19, P164, DOI 10.1016/S0748-3007(03)00007-0	29	117	122	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2007	317	5834					116	118		10.1126/science.1142024	http://dx.doi.org/10.1126/science.1142024			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17615357				2022-12-01	WOS:000247776700064
J	Hutton, DW; Tan, D; So, SK; Brandeau, ML				Hutton, David W.; Tan, Daniel; So, Samuel K.; Brandeau, Margaret L.			Cost-effectiveness of screening and vaccinating Asian and pacific islander adults for hepatitis B	ANNALS OF INTERNAL MEDICINE			English	Article							FRANCISCO BAY AREA; UNITED-STATES; HEPATOCELLULAR-CARCINOMA; ADEFOVIR DIPIVOXIL; LIVER-TRANSPLANTATION; IMMUNE GLOBULIN; VIRUS-INFECTION; ECONOMIC-EVALUATION; INTERFERON-ALPHA; VIRAL-HEPATITIS	Background: As many as 10% of Asian and Pacific Islander adults in the United States are chronically infected with hepatitis B virus (HBV), and up to two thirds are unaware that they are infected. Without proper medical management and antiviral therapy, up to 25% of Asian and Pacific Islander persons with chronic HBV infection will die of liver disease. Objective: To assess the cost-effectiveness of 4 HBV screening and vaccination programs for Asian and Pacific Islander adults in the United States. Design: Markov model with costs and benefits discounted at 3%. Data Sources: Published literature and expert opinion. Target Population: Asian and Pacific Islander adults (base-case age, 40 years; sensitivity analysis conducted on ages 20 to 60 years). Time Horizon: Lifetime. Perspective: U.S. societal. Interventions: A universal vaccination strategy in which all individuals are given a 3-dose vaccination series; a screen-and-treat strategy, in which individuals are given blood tests to determine whether they are chronically infected, and infected persons are monitored and treated; a screen, treat, and ring vaccinate strategy, in which all individuals are tested for chronic HBV infection and close contacts of infected persons are screened and vaccinated if needed; and a screen, treat, and vaccinate strategy, in which all individuals are tested and then vaccinated with a 3-dose series if needed. in all cases, persons found to be chronically infected are monitored and treated if indicated. Outcome Measures: Costs (2006 U.S. dollars), quality-adjusted life-years (QALYs), and incremental cost-effectiveness. Results of Base-Case Analysis: Compared with the status quo, the screen-and-treat strategy has an incremental cost-effectiveness ratio of $36088 per QALY gained. The screen, treat, and ring vaccinate strategy gains more QALYs than the screen and treat strategy and incurs modest incremental costs, leading to incremental cost-effectiveness of $39 903 per QALY gained compared with the screen and treat strategy. The universal vaccination and screen, treat, and vaccinate strategies were weakly dominated by the other 2 strategies. Results of Sensitivity Analysis: Over a wide range of variables, the incremental cost-effectiveness ratios of the screen and treat and screen, treat, and ring vaccinate strategies were less than $50 000 per QALY gained. Limitations: Results depend on the accuracy of the underlying data and assumptions. The long-term effectiveness of new and future HBV treatments is uncertain. Conclusions: Screening programs for HBV among Asian and Pacific Islander adults are likely to be cost effective. Clinically significant benefits accrue from identifying chronically infected persons for medical management and vaccinating their close contacts. Such efforts can greatly reduce the burden of HBV-associated liver cancer and chronic liver disease in the Asian and Pacific Islander population.	Stanford Univ, Dept Management Sci & Engn, Asian Liver Ctr, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Brandeau, ML (corresponding author), Stanford Univ, Dept Management Sci & Engn, Asian Liver Ctr, Terman Bldg, Stanford, CA 94305 USA.	brandeau@stanford.edu						*ACIP, 2005, MMWR-MORBID MORTAL W, V54, P1; Alderman EM, 1998, CLIN INFECT DIS, V26, P1459, DOI 10.1086/516346; Alimonos K, 1998, CLIN INFECT DIS, V26, P566, DOI 10.1086/514575; ALTER MJ, 1987, AM J EPIDEMIOL, V125, P133, DOI 10.1093/oxfordjournals.aje.a114496; *AM CANC SOC, 2007, CAL CANC FACTS FIG; ANDRE FE, 1987, POSTGRAD MED J, V63, P169; ANDRE FE, 1994, J MED VIROL, V44, P144, DOI 10.1002/jmv.1890440206; ANDRE FE, 1989, AM J MED, V87, pS14, DOI 10.1016/0002-9343(89)90525-1; [Anonymous], 1991, MMWR Recomm Rep, V40, P1; Arias Elizabeth, 2006, Natl Vital Stat Rep, V54, P1; *AS LIV CTR STANF, JAD RIBB CAM; *AS LIV CTR STANF, ADV; ATKINSON W, 2007, CDCP EPIDEMIOLOGY PR; BEASLEY RP, 1983, HEPATOLOGY, V3, P135; Bennett WG, 1997, ANN INTERN MED, V127, P855, DOI 10.7326/0003-4819-127-10-199711150-00001; BLOOM BS, 1993, ANN INTERN MED, V118, P298, DOI 10.7326/0003-4819-118-4-199302150-00009; Blostein J, 2001, PUBLIC HEALTH REP, V116, P165, DOI 10.1016/S0033-3549(04)50008-0; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brooks EA, 2001, AM J MANAG CARE, V7, P677; *CDC, 2000, MMWR-MORBID MORTAL W, V49, P616; *CDC, 1995, MMWR-MORBID MORTAL W, V44, P574; *CDC, 2005, 60 US DEP HHS; *CDC, 1999, MMWR-MORBID MORTAL W, V48, P33; *CDCP, 1982, MMWR-MORBID MORTAL W, V31, P317; *CDCP, DIS BURD HEP A B C U; *CDCP, 2004, EST VACC COV HEP B V; *CDCP, HEP B FACT SHEET; Centers for Disease Control and Prevention, CDC VACC PRIC LIST; Chan HLY, 2005, ANN INTERN MED, V142, P240, DOI 10.7326/0003-4819-142-4-200502150-00006; Chang ET, 2007, CANCER-AM CANCER SOC, V109, P2100, DOI 10.1002/cncr.22642; Chao S, 2004, HEPATOLOGY, V40, p717A; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Choe JH, 2005, CANCER-AM CANCER SOC, V104, P2955, DOI 10.1002/cncr.21518; Cooksley WG, 2004, SEMIN LIVER DIS, V24, P45, DOI 10.1055/s-2004-828678; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; Fiore Anthony E., 2006, Morbidity and Mortality Weekly Report, V55, P1; Gold MR., 1996, COST EFFECTIVENESS H; Guane R, 2004, HEPATOLOGY, V40, p716A; Gust ID, 1996, GUT, V38, pS18, DOI 10.1136/gut.38.Suppl_2.S18; Han SHB, 2000, LIVER TRANSPLANT, V6, P741, DOI 10.1053/jlts.2000.18702; HERNANDEZ S, 2003, ANTIVIR THER, V8, P1; Hu RH, 2005, CLIN TRANSPLANT, V19, P175, DOI 10.1111/j.1399-0012.2005.00277.x; Hwang SJ, 1996, J GASTROEN HEPATOL, V11, P949, DOI 10.1111/j.1440-1746.1996.tb00279.x; Jacobs RJ, 2003, J AM COLL HEALTH, V51, P227, DOI 10.1080/07448480309596355; Jacobs RJ, 2003, PUBLIC HEALTH REP, V118, P550, DOI 10.1016/S0033-3549(04)50291-1; Kanwal F, 2005, ANN INTERN MED, V142, P821, DOI 10.7326/0003-4819-142-10-200505170-00007; Kaur S, 1996, HEPATOLOGY, V24, P979; Kim SY, 2006, AM J PREV MED, V30, P498, DOI 10.1016/j.amepre.2006.01.017; Kim WR, 1997, ANN INTERN MED, V127, P866, DOI 10.7326/0003-4819-127-10-199711150-00002; KRAHN M, 1993, MED DECIS MAKING, V13, P4, DOI 10.1177/0272989X9301300103; Krahn M, 1998, AM J PUBLIC HEALTH, V88, P1638, DOI 10.2105/AJPH.88.11.1638; Krogsgaard K, 1998, J VIRAL HEPATITIS, V5, P389, DOI 10.1046/j.1365-2893.1998.00118.x; Lee H, 2005, APPL NURS RES, V18, P2, DOI 10.1016/j.apnr.2004.04.002; LIN SY, 2007, HEPATOLOGY; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; LOK ASF, 1987, AM J EPIDEMIOL, V126, P492, DOI 10.1093/oxfordjournals.aje.a114681; Maluf DG, 2007, TRANSPLANT P, V39, P153, DOI 10.1016/j.transproceed.2006.10.029; MARGOLIS HS, 1995, JAMA-J AM MED ASSOC, V274, P1201, DOI 10.1001/jama.274.15.1201; McQuillan GM, 1999, AM J PUBLIC HEALTH, V89, P14, DOI 10.2105/AJPH.89.1.14; Meara E, 2004, HEALTH AFFAIR, V23, P176, DOI 10.1377/hlthaff.23.4.176; Nath DS, 2006, CLIN TRANSPLANT, V20, P206, DOI 10.1111/j.1399-0012.2005.00467.x; Nguyen MH, 2002, J CLIN GASTROENTEROL, V35, pS86, DOI 10.1097/00004836-200211002-00004; *ORG PROC TRANSP N, DAT VIEW DAT RP; Owens DK, 1998, J GEN INTERN MED, V13, P716, DOI 10.1046/j.1525-1497.1998.00211.x; Owens DK, 2005, ANN INTERN MED, V142, P863, DOI 10.7326/0003-4819-142-10-200505170-00013; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Perrillo R, 2004, GASTROENTEROLOGY, V126, P81, DOI 10.1053/j.gastro.2003.10.050; Peters MG, 2004, GASTROENTEROLOGY, V126, P91, DOI 10.1053/j.gastro.2003.10.051; Pierie JPEN, 2005, ANN SURG ONCOL, V12, P552, DOI 10.1245/ASO.2004.03.029; Pisu M, 2002, VACCINE, V21, P312, DOI 10.1016/S0264-410X(02)00457-7; Pollack H., 2006, Morbidity and Mortality Weekly Report, V55, P505; Salomon JA, 2003, JAMA-J AM MED ASSOC, V290, P228, DOI 10.1001/jama.290.2.228; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Shepard C., 2004, Morbidity and Mortality Weekly Report, V53, P1015; Shepherd J, 2006, HEALTH TECHNOL ASSES, V10, P1; Shivanada, 2006, CLIN VACCINE IMMUNOL, V13, P661, DOI 10.1128/CVI.00087-06; Takeda A, 2007, J VIRAL HEPATITIS, V14, P75, DOI 10.1111/j.1365-2893.2006.00808.x; Taylor VM, 2005, J COMMUN HEALTH, V30, P477, DOI 10.1007/s10900-005-7282-3; Terrault NA, 2006, LIVER TRANSPLANT, V12, P801, DOI 10.1002/lt.20776; U.S. Bureau of the Census, 1997, STAT ABSTR US; *US CEN BUR, 2005, AM COMM SURV; *US CEN BUR, STAT COUNT QUICKF RA; *US CENS BUR, 2000, US CENS FACTF; van Steenbergen JE, 2004, J HEPATOL, V40, P979, DOI 10.1016/j.jhep.2004.02.025; Wallace LA, 2005, VACCINE, V23, P5624, DOI 10.1016/j.vaccine.2005.06.034; Wasley Annemarie, 2007, MMWR Surveill Summ, V56, P1; *WHO, 2000, HEP B FACT SHEET; Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562; Wu CA, 2007, ASIAN PAC J CANCER P, V8, P127; Yao FY, 1999, LIVER TRANSPLANT SUR, V5, P491, DOI 10.1002/lt.500050605; Yuen MF, 2000, HEPATOLOGY, V31, P330, DOI 10.1002/hep.510310211; Zhou FJ, 2003, PEDIATRICS, V111, P1289, DOI 10.1542/peds.111.6.1289	93	130	132	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2007	147	7					460	469		10.7326/0003-4819-147-7-200710020-00004	http://dx.doi.org/10.7326/0003-4819-147-7-200710020-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	221GF	17909207				2022-12-01	WOS:000250214700003
J	Thompson, WW; Price, C; Goodson, B; Shay, DK; Benson, P; Hinrichsen, VL; Lewis, E; Eriksen, E; Ray, P; Marcy, SM; Dunn, J; Jackson, LA; Lieu, TA; Black, S; Stewart, G; Weintraub, ES; Davis, RL; DeStefano, F				Thompson, William W.; Price, Cristofer; Goodson, Barbara; Shay, David K.; Benson, Patti; Hinrichsen, Virginia L.; Lewis, Edwin; Eriksen, Eileen; Ray, Paula; Marcy, S. Michael; Dunn, John; Jackson, Lisa A.; Lieu, Tracy A.; Black, Steve; Stewart, Gerrie; Weintraub, Eric S.; Davis, Robert L.; DeStefano, Frank		Vaccine Safety Datalink Team	Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VACCINE SAFETY DATALINK; DEVELOPMENTAL DISORDERS; METHYLMERCURY EXPOSURE; CONFOUNDER-SELECTION; UNITED-KINGDOM; CELL-DEATH; INFANTS; NEURODEVELOPMENT; NEUROTOXICITY; ACTIVATION	Background It has been hypothesized that early exposure to thimerosal, a mercury-containing preservative used in vaccines and immune globulin preparations, is associated with neuropsychological deficits in children. Methods We enrolled 1047 children between the ages of 7 and 10 years and administered standardized tests assessing 42 neuropsychological outcomes. (We did not assess autism-spectrum disorders.) Exposure to mercury from thimerosal was determined from computerized immunization records, medical records, personal immunization records, and parent interviews. Information on potential confounding factors was obtained from the interviews and medical charts. We assessed the association between current neuropsychological performance and exposure to mercury during the prenatal period, the neonatal period (birth to 28 days), and the first 7 months of life. Results Among the 42 neuropsychological outcomes, we detected only a few significant associations with exposure to mercury from thimerosal. The detected associations were small and almost equally divided between positive and negative effects. Higher prenatal mercury exposure was associated with better performance on one measure of language and poorer performance on one measure of attention and executive functioning. Increasing levels of mercury exposure from birth to 7 months were associated with better performance on one measure of fine motor coordination and on one measure of attention and executive functioning. Increasing mercury exposure from birth to 28 days was associated with poorer performance on one measure of speech articulation and better performance on one measure of fine motor coordination. Conclusions Our study does not support a causal association between early exposure to mercury from thimerosal-containing vaccines and immune globulins and deficits in neuropsychological functioning at the age of 7 to 10 years.	Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Immunizat Safety Off, Atlanta, GA 30333 USA; ABT Associates Inc, Cambridge, MA 02138 USA; Grp Hlth Ctr Hlth Studies, Seattle, WA USA; Harvard Pilgrim Hlth Care, Dept Ambulatory Care & Prevent, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Kaiser Permanente, Div Res, Oakland, CA USA; Vaccine Study Ctr, Oakland, CA USA; Univ Calif Los Angeles, Ctr Vaccine Res, Torrance, CA USA; So Calif Kaiser Permanente, Los Angeles, CA USA; RTI Int, Atlanta, GA USA; Stanford Univ, Palo Alto, CA 94304 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; ABT Associates; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Kaiser Permanente; University of California System; University of California Los Angeles; Kaiser Permanente; Research Triangle Institute; Stanford University	Thompson, WW (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, MS A32,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	wct2@cdc.gov		Shay, David/0000-0001-9619-4820				Abramson JS, 1999, PEDIATRICS, V104, P570, DOI 10.1542/peds.104.3.570; Andrews N, 2004, PEDIATRICS, V114, P584, DOI 10.1542/peds.2003-1177-L; [Anonymous], 1999, PEDIATRICS, V104, P568; Ball LK, 2001, PEDIATRICS, V107, P1147, DOI 10.1542/peds.107.5.1147; Baskin DS, 2003, TOXICOL SCI, V74, P361, DOI 10.1093/toxsci/kfg126; BRADLEY RH, 1984, DEV PSYCHOL, V20, P315, DOI 10.1037/0012-1649.20.2.315; Budtz-Jorgensen E, 2007, ANN EPIDEMIOL, V17, P27, DOI 10.1016/j.annepidem.2006.05.007; Burbacher TM, 2005, ENVIRON HEALTH PERSP, V113, P1015, DOI 10.1289/ehp.7712; Chen RT, 2000, B WORLD HEALTH ORGAN, V78, P186; Chen RT, 1997, PEDIATRICS, V99, P765, DOI 10.1542/peds.99.6.765; Crump KS, 1998, RISK ANAL, V18, P701, DOI 10.1023/B:RIAN.0000005917.52151.e6; Davidson PU, 2001, JAMA-J AM MED ASSOC, V285, P1291, DOI 10.1001/jama.285.10.1291-a; Davidson PW, 1998, JAMA-J AM MED ASSOC, V280, P701, DOI 10.1001/jama.280.8.701; Goldfrank L. R., 2002, GOLDFRANKS TOXICOLOG; Goth SR, 2006, ENVIRON HEALTH PERSP, V114, P1083, DOI 10.1289/ehp.8881; Grandjean P, 1999, AM J EPIDEMIOL, V150, P301, DOI 10.1093/oxfordjournals.aje.a010002; Havarinasab S, 2006, TOXICOL APPL PHARM, V214, P43, DOI 10.1016/j.taap.2005.12.004; Havarinasab S, 2005, TOXICOL APPL PHARM, V204, P109, DOI 10.1016/j.taap.2004.08.019; Heron J, 2004, PEDIATRICS, V114, P577, DOI 10.1542/peds.2003-1176-L; Hornig M, 2004, MOL PSYCHIATR, V9, P833, DOI 10.1038/sj.mp.4001529; Hunter JE, 2002, HUM COMMUN RES, V28, P552, DOI 10.1093/hcr/28.4.552; Jacobson JL, 2001, NEUROTOXICOLOGY, V22, P667, DOI 10.1016/S0161-813X(01)00040-7; James SJ, 2005, NEUROTOXICOLOGY, V26, P1, DOI 10.1016/j.neuro.2004.07.012; KIM JO, 1981, SOCIOL METHOD RES, V10, P187, DOI 10.1177/004912418101000203; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; *MED EC, 1995, PHYS DESK REF; Medical Economics, 1999, PHYS DESK REF, V53rd; Mutkus L, 2005, BIOL TRACE ELEM RES, V105, P71, DOI 10.1385/BTER:105:1-3:071; Parran DK, 2005, TOXICOL SCI, V86, P132, DOI 10.1093/toxsci/kfi175; Pichichero ME, 2002, LANCET, V360, P1737, DOI 10.1016/S0140-6736(02)11682-5; PRICE C, 2007, INFANT ENV EXPOSURE, V1; Stern Alan H, 2004, Environ Health, V3, P2, DOI 10.1186/1476-069X-3-2; Stewart G, 2007, INFANT ENV EXPOSURE, VII; Totsika Vasiliki, 2004, Child Adolesc Ment Health, V9, P25, DOI 10.1046/j.1475-357X.2003.00073.x; Verstraeten T, 2003, PEDIATRICS, V112, P1039, DOI 10.1542/peds.112.2.e98; Waly M, 2004, MOL PSYCHIATR, V9, P358, DOI 10.1038/sj.mp.4001476	36	174	182	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2007	357	13					1281	1292		10.1056/NEJMoa071434	http://dx.doi.org/10.1056/NEJMoa071434			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214BR	17898097				2022-12-01	WOS:000249711500004
J	Tirosh, A; Rudich, A; Shochat, T; Tekes-Manova, D; Israeli, E; Henkin, Y; Kochba, I; Shai, I				Tirosh, Amir; Rudich, Assaf; Shochat, Tzippora; Tekes-Manova, Dorit; Israeli, Eran; Henkin, Yaakov; Kochba, Ilan; Shai, Iris			Changes in triglyceride levels and risk for coronary heart disease in young men	ANNALS OF INTERNAL MEDICINE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN-B; PLASMA TRIGLYCERIDE; FOLLOW-UP; ATHEROSCLEROSIS; ADULTS; PREDICTION; MORTALITY; TRENDS; LIPIDS	Background: Current triglyceride levels might be only a weak predictor of risk for coronary heart disease (CHID). Objective: To assess the association between changes over time in fasting triglyceride levels and CHID risk in young adults. Design: Follow-up study over 5.5 years after 2 measurements of fasting triglycerides 5 years apart. Setting: The Staff Periodic Examination Center of the Israel Defense Forces, Zrifin, Israel. Patierts: 13 953 apparently healthy, untreated, young men (age 26 to 45 years) with triglycericle levels less than 3.39 mmol/L (< 300 mg/dL). Measurements: Two triglycericle measurements (at enrollment [time 1] and 5 years later [time 2]), lifestyle variables, and incident cases of angiography-proven CHID. Results: Within 5.5 years, 158 new cases of CHID were identified. The multivariate model was adjusted for age; family history; fasting glucose; high-density lipoprotein cholesterol; blood pressure; body mass index; and changes between time 1 and time 2 in body mass index, physical activity, smoking status, and habit of eating breakfast. Investigators categorized triglyceride levels according to low, intermediate, and high tertiles (as measured at time 1 and time 2 [expressed as tertile at time 1/tertile at time 2]). The risk for CHID in men with high-tertile triglyceride levels at time 1 changed depending on the tertile at time 2 (hazard ratios, 8.23 [95% Cl, 2.50 to 27.13] for high/high, 6.84 [Cl, 1.95 to 23.98] for high/intermediate, and 4.90 [Cl, 1.01 to 24.55] for high/low, compared with the stable low/low group). The risk for CHD in men with low-tertile levels at time 1 also changed depending on the tertile at time 2 (hazard ratios, 3.81 [Cl, 0.96 to 15.31] for low/intermediate and 6.76 [Cl, 1.34 to 33.92] for low/high, compared with the stable low/low group). Limitations: Participants were healthy and had a low incidence rate of CHD. The study was observational. Conclusions: Two triglyceride measurements obtained 5 years apart may assist in assessing CHD risk in young men. A decrease in initially elevated triglyceride levels is associated with a decrease in CHD risk compared with stable high triglyceride levels. However, this risk remains higher than in those with persistently low triglyceride levels.	Ben Gurion Univ Negev, S Daniel Abraham Int Ctr Hlth Nutr, Soroka Med Ctr, Dept Epidemiol & Hlth Syst Evaluat, IL-84105 Beer Sheva, Israel; Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; Israel Def Forces Med Corps, Zerifin, Israel	Ben Gurion University; Soroka Medical Center; Chaim Sheba Medical Center	Shai, I (corresponding author), Ben Gurion Univ Negev, S Daniel Abraham Int Ctr Hlth Nutr, Soroka Med Ctr, Dept Epidemiol & Hlth Syst Evaluat, PO Box 653, IL-84105 Beer Sheva, Israel.	irish@bgu.ac.il		Tirosh, Amir/0000-0003-2210-5906; Rudich, Assaf/0000-0002-1366-1444				AUSTIN MA, 1991, ARTERIOSCLER THROMB, V11, P2, DOI 10.1161/01.ATV.11.1.2; BRENNER H, 1990, EUR HEART J, V11, P1054, DOI 10.1093/oxfordjournals.eurheartj.a059642; Breuer HWM, 2001, CURR MED RES OPIN, V17, P60, DOI 10.1185/03007990152005379; BRUCE RA, 1983, J AM COLL CARDIOL, V2, P565, DOI 10.1016/S0735-1097(83)80286-1; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; CASTELLI WP, 1992, AM J CARDIOL, V70, pH3, DOI 10.1016/0002-9149(92)91083-G; CRIQUI MH, 1993, NEW ENGL J MED, V328, P1220, DOI 10.1056/NEJM199304293281702; DATTILO AM, 1992, AM J CLIN NUTR, V56, P320, DOI 10.1093/ajcn/56.2.320; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; GEURIAN K, 1992, ANN PHARMACOTHER, V26, P1109, DOI 10.1177/106002809202600913; Ginsberg HN, 2000, AM J CARDIOL, V86, p41L; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; JACOBS DR, 1982, AM J EPIDEMIOL, V116, P878, DOI 10.1093/oxfordjournals.aje.a113490; Jeppesen J, 1998, CIRCULATION, V97, P1029, DOI 10.1161/01.CIR.97.11.1029; Juonala M, 2004, J INTERN MED, V255, P457, DOI 10.1111/j.1365-2796.2004.01308.x; McGill HC, 2000, ARTERIOSCL THROM VAS, V20, P1998, DOI 10.1161/01.ATV.20.8.1998; Navas-Nacher EL, 2001, ANN INTERN MED, V134, P433, DOI 10.7326/0003-4819-134-6-200103200-00007; Patel A, 2004, CIRCULATION, V110, P2678, DOI 10.1161/01.CIR.0000145615.33955.83; Pischon T, 2005, CIRCULATION, V112, P3375, DOI 10.1161/CIRCULATIONAHA.104.532499; Roux AVD, 2002, DIABETES CARE, V25, P1976, DOI 10.2337/diacare.25.11.1976; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Shai I, 2004, CIRCULATION, V110, P2824, DOI 10.1161/01.CIR.0000146339.57154.9B; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Stampfer MJ, 1996, JAMA-J AM MED ASSOC, V276, P882, DOI 10.1001/jama.276.11.882; Szapary Philippe O, 2003, Curr Cardiol Rep, V5, P488, DOI 10.1007/s11886-003-0112-2; Talmud PJ, 2002, ARTERIOSCL THROM VAS, V22, P1918, DOI 10.1161/01.ATV.0000035521.22199.C7; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Urbina EM, 2004, ATHEROSCLEROSIS, V176, P157, DOI 10.1016/j.atherosclerosis.2004.04.023	30	122	174	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2007	147	6					377	385		10.7326/0003-4819-147-6-200709180-00007	http://dx.doi.org/10.7326/0003-4819-147-6-200709180-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	214GY	17876021				2022-12-01	WOS:000249726200003
J	Enquist, BJ; Kerkhoff, AJ; Stark, SC; Swenson, NG; McCarthy, MC; Price, CA				Enquist, Brian J.; Kerkhoff, Andrew J.; Stark, Scott C.; Swenson, Nathan G.; McCarthy, Megan C.; Price, Charles A.			A general integrative model for scaling plant growth, carbon flux, and functional trait spectra	NATURE			English	Article							ECOSYSTEM; RESPIRATION; ALLOMETRY; RANGE; FORM	Linking functional traits to plant growth is critical for scaling attributes of organisms to the dynamics of ecosystems(1,2) and for understanding how selection shapes integrated botanical phenotypes(3). However, a general mechanistic theory showing how traits specifically influence carbon and biomass flux within and across plants is needed. Building on foundational work on relative growth rate(4-6), recent work on functional trait spectra(7-9), and metabolic scaling theory(10,11), here we derive a generalized trait-based model of plant growth. In agreement with a wide variety of empirical data, our model uniquely predicts how key functional traits interact to regulate variation in relative growth rate, the allometric growth normalizations for both angiosperms and gymnosperms, and the quantitative form of several functional trait spectra relationships. The model also provides a general quantitative framework to incorporate additional leaf-level trait scaling relationships(7,8) and hence to unite functional trait spectra with theories of relative growth rate, and metabolic scaling. We apply the model to calculate carbon use efficiency. This often ignored trait, which may influence variation in relative growth rate, appears to vary directionally across geographic gradients. Together, our results show how both quantitative plant traits and the geometry of vascular transport networks can be merged into a common scaling theory. Our model provides a framework for predicting not only how traits covary within an integrated allometric phenotype but also how trait variation mechanistically influences plant growth and carbon flux within and across diverse ecosystems.	Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85719 USA; Santa Fe Inst, Santa Fe, NM 87501 USA; Sci Conservat Int, Ctr Appl Biodivers, Arlington, VA 22202 USA; Kenyon Coll, Dept Biol, Gambier, OH 43022 USA; Kenyon Coll, Dept Math, Gambier, OH 43022 USA	University of Arizona; The Santa Fe Institute; Kenyon College; Kenyon College	Enquist, BJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85719 USA.	benquist@email.arizona.edu	Price, Charles A/B-1171-2011; Enquist, Brian J/B-6436-2008; Swenson, Nathan/A-3514-2012	Enquist, Brian J/0000-0002-6124-7096; Swenson, Nathan/0000-0003-3819-9767; Stark, Scott C/0000-0002-1579-1648; Kerkhoff, Andrew/0000-0001-9617-8687				Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Bonser SP, 2006, OIKOS, V114, P187, DOI 10.1111/j.2006.0030-1299.14425.x; Chambers JQ, 2004, ECOL APPL, V14, pS72; Diaz S, 1997, J VEG SCI, V8, P463, DOI 10.2307/3237198; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; ENQUIST BJ, 2007, NATURE, V13, P591; Enquist BJ, 2007, GLOBAL CHANGE BIOL, V13, P591, DOI 10.1111/j.1365-2486.2006.01222.x; Enquist BJ, 2007, NATURE, V445, pE9, DOI 10.1038/nature05548; Field C., 1986, EC PLANT FORM FUNCTI, P25; Gifford RM, 2003, FUNCT PLANT BIOL, V30, P171, DOI 10.1071/FP02083; GRIME JP, 1975, J ECOL, V63, P393, DOI 10.2307/2258728; Hunt R., 1978, PLANT GROWTH ANAL, Vfirst; Kerkhoff AJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P585, DOI 10.1111/j.1466-822x.2005.00187.x; KONINGS H, 1989, VARIATION GROWTH RAT, P101; Lambers H., 1989, CAUSES CONSEQUENCES, P1; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; Pickup M, 2005, FUNCT ECOL, V19, P88, DOI 10.1111/j.0269-8463.2005.00927.x; POORTER H, 1989, VARIATION GROWTH RAT, P45; Price CA, 2007, P NATL ACAD SCI USA, V104, P13204, DOI 10.1073/pnas.0702242104; Reich P. B., 2003, International Journal of Plant Sciences, V164, pS143, DOI 10.1086/374368; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Santiago LS, 2004, OECOLOGIA, V140, P543, DOI 10.1007/s00442-004-1624-1; Shipley B, 2006, ECOLOGY, V87, P535, DOI 10.1890/05-1051; TILMAN D, 1988; Waring RH, 1998, TREE PHYSIOL, V18, P129; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; WRIGHT IJ, ANN BOT-LONDON, DOI DOI 10.1093/AOB.MCL066	31	160	178	8	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2007	449	7159					218	222		10.1038/nature06061	http://dx.doi.org/10.1038/nature06061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17851525				2022-12-01	WOS:000249394500050
J	Singh, S				Singh, Seema			From exotic spice to modern drug?	CELL			English	Editorial Material								The global demand for more affordable therapeutics and concerns about side effects of commonly used drugs are refocusing interest on Eastern traditional medicines, particularly those of India and China.											0	158	165	2	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 7	2007	130	5					765	768		10.1016/j.cell.2007.08.024	http://dx.doi.org/10.1016/j.cell.2007.08.024			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	212GI	17803897	Bronze			2022-12-01	WOS:000249581500006
J	Gaudier, M; Schuwirth, BS; Westcott, SL; Wigley, DB				Gaudier, Martin; Schuwirth, Barbara S.; Westcott, Sarah L.; Wigley, Dale B.			Structural basis of DNA replication origin recognition by an ORC protein	SCIENCE			English	Article							ARCHAEON SULFOLOBUS-SOLFATARICUS; HYPERTHERMOPHILIC ARCHAEON; AEROPYRUM-PERNIX; IDENTIFICATION; BINDING; CHROMOSOME; CDC6/ORC1; ATPASES	DNA replication in archaea and in eukaryotes share many similarities. We report the structure of an archaeal origin recognition complex protein, ORC1, bound to an origin recognition box, a DNA sequence that is found in multiple copies at replication origins. DNA binding is mediated principally by a C-terminal winged helix domain that inserts deeply into the major and minor grooves, widening them both. However, additional DNA contacts are made with the N-terminal AAA+ domain, which inserts into the minor groove at a characteristic G-rich sequence, inducing a 35 degrees bend in the duplex and providing directionality to the binding site. Both contact regions also induce substantial unwinding of the DNA. The structure provides insight into the initial step in assembly of a replication origin and recruitment of minichromosome maintenance ( MCM) helicase to that origin.	Canc Res UK, Clare Hall Labs, London Res Inst, Potters Bar EN6 3LD, Herts, England	Cancer Research UK	Wigley, DB (corresponding author), Canc Res UK, Clare Hall Labs, London Res Inst, Blanche Lane, Potters Bar EN6 3LD, Herts, England.	Dale.Wigley@cancer.org.uk						Berquist BR, 2003, J BACTERIOL, V185, P5959, DOI 10.1128/JB.185.20.5959-5966.2003; Capaldi SA, 2004, NUCLEIC ACIDS RES, V32, P4821, DOI 10.1093/nar/gkh819; DEFELICE M, 2004, BIOCHEM J, V278, P46424; Edgell DR, 1997, CELL, V89, P995, DOI 10.1016/S0092-8674(00)80285-8; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Grabowski B, 2001, J BACTERIOL, V183, P5459, DOI 10.1128/JB.183.18.5459-5464.2001; Grainge I, 2006, J MOL BIOL, V363, P355, DOI 10.1016/j.jmb.2006.07.076; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kasiviswanathan R, 2006, J BACTERIOL, V188, P4577, DOI 10.1128/JB.00168-06; Liu JY, 2000, MOL CELL, V6, P637, DOI 10.1016/S1097-2765(00)00062-9; Lopez P, 1999, MOL MICROBIOL, V32, P883, DOI 10.1046/j.1365-2958.1999.01370.x; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Lundgren M, 2004, P NATL ACAD SCI USA, V101, P7046, DOI 10.1073/pnas.0400656101; Matsunaga F, 2003, EMBO REP, V4, P154, DOI 10.1038/sj.embor.embor732; Matsunaga F, 2001, P NATL ACAD SCI USA, V98, P11152, DOI 10.1073/pnas.191387498; Myllykallio H, 2000, SCIENCE, V288, P2212, DOI 10.1126/science.288.5474.2212; Neuwald AF, 1999, GENOME RES, V9, P27; NORAIS C, IN PRESS PLOS GENET; Robinson NP, 2007, EMBO J, V26, P816, DOI 10.1038/sj.emboj.7601529; Robinson NP, 2004, CELL, V116, P25, DOI 10.1016/S0092-8674(03)01034-1; Singleton MR, 2004, J MOL BIOL, V343, P547, DOI 10.1016/j.jmb.2004.08.044	21	115	118	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2007	317	5842					1213	1216		10.1126/science.1143664	http://dx.doi.org/10.1126/science.1143664			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205PJ	17761880				2022-12-01	WOS:000249126800038
J	Mozaffarian, D; Marfisi, R; Levantesi, G; Silletta, MG; Tavazzi, L; Tognoni, G; Valagussa, F; Marchioli, R				Mozaffarian, Dariush; Marfisi, RosaMaria; Levantesi, Giacomo; Silletta, Maria G.; Tavazzi, Luigi; Tognoni, Gianni; Valagussa, Franco; Marchioli, Roberto			Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors	LANCET			English	Article							CORONARY-HEART-DISEASE; POLYUNSATURATED FATTY-ACIDS; MEDITERRANEAN DIET; HIGH-CARBOHYDRATE; RICH DIET; OLIVE OIL; MORTALITY; MELLITUS; IMPACT; PREVENTION	Background Individuals with diabetes are at higher risk of myocardial infarction than non-diabetics. However, much less is known about the incidence of, and risk factors for, development of diabetes and impaired fasting glucose in patients who have had a myocardial infarction. We set out to estimate this incidence and investigate whether lifestyle factors such as dietary habits might alter this risk. Methods We used prospectively obtained data for 8291 Italian patients with a myocardial infarction within the previous 3 months, who were free of diabetes (determined by medication use, a physician-reported diagnosis, or fasting glucose >= 7 mmol/L) at baseline. Incidence of new-onset diabetes (new diabetes medication or fasting glucose 0 mmol/L) and impaired fasting glucose (fasting glucose >= 6 center dot 1 mmol/L and < 7 mmol/L) were assessed at follow-up at 0 center dot 5, 1 center dot 0, 1 center dot 5, 2 center dot 5, and 3 center dot 5 years. Baseline data for body-mass index (BMI), other risk factors, dietary habits, and medications were updated during follow-up. A Mediterranean diet score was assigned according to consumption of cooked and raw vegetables, fruit, fish, and olive oil. Associations of demographic, clinical, and lifestyle risk-factors with incidence of diabetes and impaired fasting glucose were assessed with multivariable Cox proportional hazards. Findings During 26 795 person-years (mean follow-up 3 center dot 2 years [SD 0 center dot 9]), 998 individuals (12%) developed new-onset diabetes (incidence 37 cases per 1000 person-years). Of the 7533 without impaired fasting glucose at baseline, 2514 (33%) developed new-onset impaired fasting glucose or diabetes (incidence 123 cases per 1000 person-years), rising to 3859 (62%) of 6229 with the lower cutoff for impaired fasting glucose of 5 center dot 6 mmol/L (incidence 321 cases per 1000 person-years). Independent risk factors for new-onset diabetes or impaired fasting glucose included older age, hypertension, use of beta-blockers, lipid-lowering medications (protective), and diuretic use. Independent lifestyle risk-factors included higher BMI, greater BMI gain during follow-up, current smoking, a lower Mediterranean dietary score, and wine consumption of more than 1 L/day. Data for physical activity were unavailable, but inability to perform exercise testing was associated with higher incidence of diabetes and impaired fasting glucose. Interpretation Compared with population-based cohorts, patients with a recent myocardial infarction had a higher annual incidence rate of impaired fasting glucose (1 center dot 8 vs 27 center dot 5% in our study) and diabetes (0 center dot 8-1 center dot 6% compared with 3 center dot 7%) in this study. Thus, our results indicate that myocardial infarction could be a prediabetes risk equivalent. Smoking cessation, prevention of weight gain, and consumption of typical Mediterranean foods might lower this risk, which emphasises the need for guidance on diet and other lifestyle factors for patients who have had a myocardial infarction.	Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Consorzio Mario Negri Sud, Chieti, Italy; IRCCS, Policlin San Matteo, Pavia, Italy; Osped San Gerardo, Monza, Italy	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Consorzio Mario Negri Sud; IRCCS Fondazione San Matteo; University of Pavia; San Gerardo Hospital	Mozaffarian, D (corresponding author), Harvard Univ, Sch Med, Dept Med, 665 Huntington Ave, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu	Mozaffarian, Dariush/B-2276-2008; Tavazzi, Luigi/ABD-5119-2020	Tavazzi, Luigi/0000-0003-0336-8356	NHLBI NIH HHS [K08-HL-075628] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL075628] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AM DIAB ASS, LINK DIAB CARD DIS; Ambring A, 2004, CLIN SCI, V106, P519, DOI 10.1042/CS20030315; Arcavi L, 2004, AM HEART J, V147, P239, DOI 10.1016/j.ahj.2003.09.013; Barzi F, 2003, EUR J CLIN NUTR, V57, P1034, DOI 10.1038/sj.ejcn.1601575; BERNELMANS WJ, 2002, AM J CLIN NUTR, V75, P221; Bonora E, 2004, DIABETES, V53, P1782, DOI 10.2337/diabetes.53.7.1782; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Cho E, 2002, J AM COLL CARDIOL, V40, P954, DOI 10.1016/S0735-1097(02)02044-2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cugati S, 2007, MED J AUSTRALIA, V186, P131, DOI 10.5694/j.1326-5377.2007.tb00836.x; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Fito M, 2005, ATHEROSCLEROSIS, V181, P149, DOI 10.1016/j.atherosclerosis.2004.12.036; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Fuentes F, 2001, ANN INTERN MED, V134, P1115, DOI 10.7326/0003-4819-134-12-200106190-00011; Genuth S, 2003, DIABETES CARE, V26, P3160; GISSI Prevenzione Investigators, 2000, ITAL HEART J, V1, P810; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hashimoto K, 2005, DIABETES CARE, V28, P1182, DOI 10.2337/diacare.28.5.1182; Hu FB, 2001, ARCH INTERN MED, V161, P1717, DOI 10.1001/archinte.161.14.1717; Jula A, 2002, JAMA-J AM MED ASSOC, V287, P598, DOI 10.1001/jama.287.5.598; Lapointe A, 2006, J NUTR BIOCHEM, V17, P645, DOI 10.1016/j.jnutbio.2006.01.001; Lotufo PA, 2001, ARCH INTERN MED, V161, P242, DOI 10.1001/archinte.161.2.242; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; Michalsen A, 2006, EUR J CLIN NUTR, V60, P478, DOI 10.1038/sj.ejcn.1602340; Mozaffarian D, 2005, CIRCULATION, V111, P157, DOI 10.1161/01.CIR.0000152099.87287.83; Mukamal KJ, 2001, DIABETES CARE, V24, P1422, DOI 10.2337/diacare.24.8.1422; Norhammar A, 2002, LANCET, V359, P2140, DOI 10.1016/S0140-6736(02)09089-X; Padwal R, 2005, DIABETES CARE, V28, P736, DOI 10.2337/diacare.28.3.736; Perez-Jimenez F, 2001, DIABETOLOGIA, V44, P2038, DOI 10.1007/s001250100009; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Rodriguez-Villar C, 2004, DIABETIC MED, V21, P142, DOI 10.1046/j.1464-5491.2003.01086.x; Ryan M, 2000, QJM-MON J ASSOC PHYS, V93, P85, DOI 10.1093/qjmed/93.2.85; Sarafidis Pantelis A, 2007, Curr Diab Rep, V7, P191, DOI 10.1007/s11892-007-0031-5; Sofi F, 2005, EUR J CLIN NUTR, V59, P584, DOI 10.1038/sj.ejcn.1602112; Sondergaard E, 2003, AM HEART J, V145, DOI 10.1016/S0002-8703(03)00078-4; Stas S, 2006, CURR HYPERTENS REP, V8, P403, DOI 10.1007/s11906-006-0086-8; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Vincent-Baudry S, 2005, AM J CLIN NUTR, V82, P964, DOI 10.1093/ajcn/82.5.964	40	121	126	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 25	2007	370	9588					667	675		10.1016/S0140-6736(07)61343-9	http://dx.doi.org/10.1016/S0140-6736(07)61343-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	205RD	17720018				2022-12-01	WOS:000249131400031
J	Lavizzo-Mourey, R				Lavizzo-Mourey, Risa			Childhood obesity - What it means for physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIOVASCULAR RISK-FACTORS; OVERWEIGHT; PREVALENCE; ADULTHOOD; CHILDREN; ADOLESCENTS		Robert Wood Johnson Fdn, Princeton, NJ 08043 USA	Robert Wood Johnson Foundation (RWJF)	Lavizzo-Mourey, R (corresponding author), Robert Wood Johnson Fdn, Route 1 & Coll Rd E, Princeton, NJ 08043 USA.	oped@rwjf.org						*ACHI, 2006, TRACK PROGR 3 ANN AR; *AMA WORK GROUP MA, 2007, EXP COMM REC ASS PRE; [Anonymous], 2000, Pediatrics, V105, P671; *CDCP, 2004, CIG SMOK AM AD US; COTTON A, UB OBESITY REPORT CA; ERIKSEN M, 2005, PREVENTING CHILDHOOD, P343; Finkelstein EA, 2003, HLTH AFF MILLWOOD S, pW3; Haas JS, 2003, AM J PUBLIC HEALTH, V93, P2105, DOI 10.2105/AJPH.93.12.2105; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; *I HEALTHC IMPR, COMM; *I MED, 2006, PROGR PREV CHILDH OB; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; *RW JOHNS FDN, CHRON CAR MOD IMPR C; SATCHER D, OVERWEIGHT OBESITY T; Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813; *US DEP HHS, OV OB; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; [No title captured]; 2006, USA TODAY       1212	22	28	28	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2007	298	8					920	922		10.1001/jama.298.8.920	http://dx.doi.org/10.1001/jama.298.8.920			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202CS	17712075				2022-12-01	WOS:000248880200026
J	Abraham, C; Cho, JH				Abraham, Clara; Cho, Judy H.			Bugging of the intestinal mucosa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE; COLI		Univ Chicago, Dept Med, Chicago, IL 60637 USA; Yale Univ, Sch Med, Dept Med & Genet, New Haven, CT USA	University of Chicago; Yale University	Abraham, C (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.							Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Xavier R, 2005, GASTROENTEROLOGY, V128, P1122, DOI 10.1053/j.gastro.2005.02.053	5	19	20	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2007	357	7					708	710		10.1056/NEJMcibr073420	http://dx.doi.org/10.1056/NEJMcibr073420			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200EF	17699823				2022-12-01	WOS:000248746000014
J	Tung, A				Tung, Avery			The other side	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2007	298	7					722	723		10.1001/jama.298.7.722	http://dx.doi.org/10.1001/jama.298.7.722			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	199XP	17699001				2022-12-01	WOS:000248728800001
J	Arkin, IT; Xu, HF; Jensen, MO; Arbely, E; Bennett, ER; Bowers, KJ; Chow, E; Dror, RO; Eastwood, MP; Flitman-Tene, R; Gregersen, BA; Klepeis, JL; Kolossvary, I; Shan, YB; Shaw, DE				Arkin, Isaiah T.; Xu, Huafeng; Jensen, Morten O.; Arbely, Eyal; Bennett, Estelle R.; Bowers, Kevin J.; Chow, Edmond; Dror, Ron O.; Eastwood, Michael P.; Flitman-Tene, Ravenna; Gregersen, Brent A.; Klepeis, John L.; Kolossvary, Istvan; Shan, Yibing; Shaw, David E.			Mechanism of Na+/H+ antiporting	SCIENCE			English	Article							ESCHERICHIA-COLI; NHAA; PH; HISTIDINE-226; DYNAMICS; DOMAIN; MODEL; PART; ANT	Na+/H+ antiporters are central to cellular salt and pH homeostasis. The structure of Escherichia coli NhaA was recently determined, but its mechanisms of transport and pH regulation remain elusive. We performed molecular dynamics simulations of NhaA that, with existing experimental data, enabled us to propose an atomically detailed model of antiporter function. Three conserved aspartates are key to our proposed mechanism: Asp(164) (D164) is the Na+-binding site, D163 controls the alternating accessibility of this binding site to the cytoplasm or periplasm, and D133 is crucial for pH regulation. Consistent with experimental stoichiometry, two protons are required to transport a single Na+ ion: D163 protonates to reveal the Na+-binding site to the periplasm, and subsequent protonation of D164 releases Na+. Additional mutagenesis experiments further validated the model.	DE Shaw Res, New York, NY 10036 USA; Hebrew Univ Jerusalem, Dept Biol Chem, IL-91904 Jerusalem, Israel; Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	D. E. Shaw Research; Hebrew University of Jerusalem; Columbia University	Shaw, DE (corresponding author), DE Shaw Res, New York, NY 10036 USA.	david@deshaw.com	Kolossvary, Istvan/AHD-3572-2022; Arbely, Eyal/G-1530-2013; Bennett, Estelle R/A-5067-2017; Kolossvary, Istvan/CAA-8254-2022; Xu, Huafeng/GZK-8527-2022; Arkin, Isaiah/GQA-4328-2022; Xu, Huafeng/V-2206-2019	Xu, Huafeng/0000-0001-5447-0452; Dror, Ron/0000-0002-6418-2793; Arkin, Isaiah/0000-0002-7659-1746				Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Bowers KJ, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2191489; Bowers KJ, 2007, J COMPUT PHYS, V221, P303, DOI 10.1016/j.jcp.2006.06.014; BOWERS KJ, 2006, P 2006 ASS COMP MACH; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Galili L, 2002, BIOCHEMISTRY-US, V41, P609, DOI 10.1021/bi011655v; GERCHMAN Y, 1993, P NATL ACAD SCI USA, V90, P1212, DOI 10.1073/pnas.90.4.1212; Gutman N, 2003, J BIOL CHEM, V278, P16082, DOI 10.1074/jbc.M213120200; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; NEEDLEMAN R, 1991, J BIOL CHEM, V266, P11478; Nozaki K, 1996, BIOCHEM BIOPH RES CO, V222, P774, DOI 10.1006/bbrc.1996.0820; Olkhova E, 2006, P NATL ACAD SCI USA, V103, P2629, DOI 10.1073/pnas.0510914103; Olkhova E, 2007, BIOPHYS J, V92, P3784, DOI 10.1529/biophysj.106.098269; Padan E, 2004, BBA-BIOENERGETICS, V1658, P2, DOI 10.1016/j.bbabio.2004.04.018; PADAN E, 1989, J BIOL CHEM, V264, P20297; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; Rimon A, 1998, J BIOL CHEM, V273, P26470, DOI 10.1074/jbc.273.41.26470; RIMON A, 1995, J BIOL CHEM, V270, P26813, DOI 10.1074/jbc.270.45.26813; Rothman A, 1996, J BIOL CHEM, V271, P32288, DOI 10.1074/jbc.271.50.32288; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; Shaw DE, 2005, J COMPUT CHEM, V26, P1318, DOI 10.1002/jcc.20267; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	28	125	126	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 10	2007	317	5839					799	803		10.1126/science.1142824	http://dx.doi.org/10.1126/science.1142824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690293				2022-12-01	WOS:000248624500039
J	Schousboe, JT; Taylor, BC; Fink, HA; Kane, RL; Cummings, SR; Orwoll, ES; Melton, LJ; Bauer, DC; Ensrud, KE				Schousboe, John T.; Taylor, Brent C.; Fink, Howard A.; Kane, Robert L.; Cummings, Steven R.; Orwoll, Eric S.; Melton, L. Joseph, III; Bauer, Douglas C.; Ensrud, Kristine E.			Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; EUROPEAN VERTEBRAL OSTEOPOROSIS; FRACTURE INTERVENTION TRIAL; HIP FRACTURE; ELDERLY-WOMEN; POPULATION HEALTH; EXCESS MORTALITY; RISK-FACTORS; BACK-PAIN; ALENDRONATE	Context Osteoporotic fractures are common among elderly men. Objective To evaluate among older men the cost-effectiveness of bone densitometry followed by 5 years of oral bisphosphonate therapy to prevent fractures for those found to have osteoporosis ( femoral neck T score <=-2.5), compared with no intervention. Design, Setting, and Population Computer Markov microsimulation model using a societal perspective and a lifetime horizon. Simulations were performed for hypothetical cohorts of white men aged 65, 70, 75, 80, or 85 years, with or without prior clinical fracture. Data sources for model parameters included the Rochester Epidemiology Project for fracture costs and population-based age-specific fracture rates; the Osteoporotic Fractures in Men (MrOS) study and published meta-analyses for the associations among prior fractures, bone density, and incident fractures; and published studies of fracture disutility. Main Outcome Measures Costs per quality-adjusted life-year ( QALY) gained for the densitometry and follow-up treatment strategy compared with no intervention, calculated from lifetime costs and accumulated QALYs for each strategy. Results Lifetime costs per QALY gained for the densitometry and follow-up treatment strategy were less than $ 50 000 for men aged 65 years or older with a prior clinical fracture and for men aged 80 years or older without a prior fracture. These results were most sensitive to oral bisphosphonate cost and fracture reduction efficacy, the strength of association between bone mineral density and fractures, fracture rates and disutility, and medication adherence. Conclusions Bone densitometry followed by bisphosphonate therapy for those with osteoporosis may be cost-effective for men aged 65 years or older with a self-reported prior clinical fracture and for men aged 80 to 85 years with no prior fracture. This strategy may also be cost-effective for men as young as 70 years without a prior clinical fracture if oral bisphosphonate costs are less than $ 500 per year or if the societal willingness to pay per QALY gained is $ 100 000.	Univ Minnesota, Pk Nicollet Hlth Serv, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55416 USA; Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55416 USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55416 USA; Univ Minnesota, Clin Outcomes Res Ctr, Ctr Chron Dis Outcomes Res, Minneapolis, MN 55416 USA; Vet Adm Med Ctr, Dept Med, Vet Affairs Med Ctr, Minneapolis, MN 55417 USA; Univ Calif San Francisco, San Francisco Coordinating Ctr, Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med & Epidemiol, San Francisco, CA 94143 USA; Mayo Clin, Coll Med, Div Epidemiol, Rochester, MN USA; Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; California Pacific Medical Center; California Pacific Medical Center Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Mayo Clinic; Oregon Health & Science University	Schousboe, JT (corresponding author), Univ Minnesota, Pk Nicollet Hlth Serv, Ctr Chron Dis Outcomes Res, 3800 Pk Nicollet Blvd, Minneapolis, MN 55416 USA.	john.schousboe@parknicollet.com	Fink, Howard/F-3933-2012; Taylor, Brent C/A-8069-2009	Taylor, Brent C/0000-0002-2140-8377; Orwoll, Eric/0000-0002-8520-7355; Ensrud, Kristine/0000-0002-9069-3036	NCRR NIH HHS [UL1 RR024140] Funding Source: Medline; NIAMS NIH HHS [U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45580, U01 AR45654, U01 AR45583] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR045647, U01AR045632, U01AR045614, U01AR045583, U01AR045654, U01AR045580] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Arias Elizabeth, 2006, Natl Vital Stat Rep, V54, P1; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Blank JB, 2005, CONTEMP CLIN TRIALS, V26, P557, DOI 10.1016/j.cct.2005.05.005; BLINKLEY N, 2006, J CLIN DENSITOM, V9, P4; Borgstrom F, 2006, OSTEOPOROSIS INT, V17, P637, DOI 10.1007/s00198-005-0015-8; Borgstrom F, 2004, BONE, V34, P1064, DOI 10.1016/j.bone.2003.12.028; Brown JP, 2002, CAN MED ASSOC J, V167, pS1; *BUR LAB STAT US C, CPS ANN DEM SURV; Burstrom K, 2001, QUAL LIFE RES, V10, P621, DOI 10.1023/A:1013171831202; Centers for Medicare and Medicaid Services, 2007, PHYS FEE SCHED SEARC; *CTR MED MED SERV, 5 YEAR REV WORK REL; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Cummings SR, 2006, J BONE MINER RES, V21, P1550, DOI 10.1359/JBMR.060708; Feldstein AC, 2005, OSTEOPOROSIS INT, V16, P953, DOI 10.1007/s00198-005-1950-0; Gabriel SE, 2002, OSTEOPOROSIS INT, V13, P323, DOI 10.1007/s001980200033; Haentjens P, 2003, J BONE JOINT SURG AM, V85A, P1936, DOI 10.2106/00004623-200310000-00011; Hasserius R, 2003, BONE, V32, P180, DOI 10.1016/S8756-3282(02)00951-1; Hasserius R, 2003, OSTEOPOROSIS INT, V14, P61, DOI 10.1007/s00198-002-1316-9; Huybrechts KF, 2006, BONE, V38, P922, DOI 10.1016/j.bone.2005.10.022; Jackson SA, 2000, OSTEOPOROSIS INT, V11, P680, DOI 10.1007/s001980070066; JACOBSEN SJ, 1992, AM J PUBLIC HEALTH, V82, P1147, DOI 10.2105/AJPH.82.8.1147; Joakimsen RM, 2001, OSTEOPOROSIS INT, V12, P1001, DOI 10.1007/s001980170008; Johnell O, 1997, OSTEOPOROSIS INT, V7, P138, DOI 10.1007/BF01623689; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Johnell O, 2004, OSTEOPOROSIS INT, V15, P38, DOI 10.1007/s00198-003-1490-4; JONES G, 1994, OSTEOPOROSIS INT, V4, P277, DOI 10.1007/BF01623352; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P20, DOI 10.1007/s00198-003-1463-7; Kanis JA, 2002, J BONE MINER RES, V17, pS146; Kanis JA, 2003, BONE, V32, P468, DOI 10.1016/S8756-3282(03)00061-9; KELLIE SE, 1990, AM J PUBLIC HEALTH, V80, P326, DOI 10.2105/AJPH.80.3.326; Leibson CL, 2002, J AM GERIATR SOC, V50, P1644, DOI 10.1046/j.1532-5415.2002.50455.x; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Macran S, 2003, MED CARE, V41, P218; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; *MED EC CO, 2001, DRUG TOP 2001 RED BO; Meerding WJ, 2004, J TRAUMA, V56, P150, DOI 10.1097/01.TA.0000062969.65847.8B; MELTON LJ, 1993, OSTEOPOROSIS INT, V3, P113, DOI 10.1007/BF01623271; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Melton LJ, 2000, J AM GERIATR SOC, V48, P338, DOI 10.1111/j.1532-5415.2000.tb02658.x; Melton LJ, 1999, OSTEOPOROSIS INT, V9, P29, DOI 10.1007/s001980050113; Mussolino ME, 1998, J BONE MINER RES, V13, P918, DOI 10.1359/jbmr.1998.13.6.918; Nevitt MC, 1998, ANN INTERN MED, V128, P793, DOI 10.7326/0003-4819-128-10-199805150-00001; NEVITT MC, 1992, AM J EPIDEMIOL, V135, P490, DOI 10.1093/oxfordjournals.aje.a116315; O'Neill TW, 2004, OSTEOPOROSIS INT, V15, P760, DOI 10.1007/s00198-004-1615-4; Oleksik A, 2000, J BONE MINER RES, V15, P1384, DOI 10.1359/jbmr.2000.15.7.1384; Olszynski WP, 2004, CLIN THER, V26, P15, DOI 10.1016/S0149-2918(04)90002-1; ONeill TW, 1996, J BONE MINER RES, V11, P1010; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; Orwoll E, 2000, NEW ENGL J MED, V343, P604, DOI 10.1056/NEJM200008313430902; Papadimitropoulos EA, 1997, CAN MED ASSOC J, V157, P1357; Ringe JD, 2004, RHEUMATOL INT, V24, P110, DOI 10.1007/s00296-003-0388-y; Sawka AM, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-39; Schousboe John T, 2007, Curr Rheumatol Rep, V9, P50, DOI 10.1007/s11926-007-0022-1; Schousboe JT, 2005, J AM GERIATR SOC, V53, P1697, DOI 10.1111/j.1532-5415.2005.53504.x; Tosteson ANA, 2001, OSTEOPOROSIS INT, V12, P1042, DOI 10.1007/s001980170015; Trombetti A, 2002, OSTEOPOROSIS INT, V13, P731, DOI 10.1007/s001980200100; van der Klift M, 2004, J BONE MINER RES, V19, P1172, DOI 10.1359/JBMR.040215; Wright VJ, 2006, J AM ACAD ORTHOP SUR, V14, P347, DOI 10.5435/00124635-200606000-00004	60	117	120	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2007	298	6					629	637		10.1001/jama.298.6.629	http://dx.doi.org/10.1001/jama.298.6.629			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	197RS	17684185	Bronze			2022-12-01	WOS:000248574800023
J	Albert, MS				Albert, Marilyn S.			Changing the trajectory of cognitive decline?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ENVIRONMENTAL ENRICHMENT; AMYLOID DEPOSITION; TRANSGENIC MICE		Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Johns Hopkins University	Albert, MS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.							Arendash GW, 2004, NEUROREPORT, V15, P1751, DOI 10.1097/01.wnr.0000137183.68847.4e; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558	5	9	13	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 2	2007	357	5					502	503		10.1056/NEJMcibr073273	http://dx.doi.org/10.1056/NEJMcibr073273			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195UB	17671260				2022-12-01	WOS:000248436300016
J	Charlat, S; Hornett, EA; Fullard, JH; Davies, N; Roderick, GK; Wedell, N; Hurst, GDD				Charlat, Sylvain; Hornett, Emily A.; Fullard, James H.; Davies, Neil; Roderick, George K.; Wedell, Nina; Hurst, Gregory D. D.			Extraordinary flux in sex ratio	SCIENCE			English	Article									UCL, Dept Biol, 4 Stephenson Way, London NW1 2HE, England; Univ Calif Berkeley, Gump S Pacific Res Stn, F-98728 Moorea, France; Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; Univ Calif Berkeley, ESPM, Berkeley, CA 94720 USA; Univ Exeter, Sch Biosci, Tremough TR10 9EZ, Penryn, England	University of London; University College London; University of California System; University of California Berkeley; University of Toronto; University Toronto Mississauga; University of California System; University of California Berkeley; University of Exeter	Charlat, S (corresponding author), UCL, Dept Biol, 4 Stephenson Way, London NW1 2HE, England.	s.charlat@ucl.ac.uk	Davies, Neil/E-5863-2012; Hurst, Gregory D D/C-2723-2008	Davies, Neil/0000-0001-8085-5014; Hurst, Gregory D D/0000-0002-7163-7784; Roderick, George/0000-0001-7557-2415; Charlat, Sylvain/0000-0003-0760-0087	Natural Environment Research Council [NE/B503292/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Charlat S, 2007, CURR BIOL, V17, P273, DOI 10.1016/j.cub.2006.11.068; Dyson EA, 2004, P NATL ACAD SCI USA, V101, P6520, DOI 10.1073/pnas.0304068101; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hornett EA, 2006, PLOS BIOL, V4, P1643, DOI 10.1371/journal.pbio.0040283	4	90	96	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2007	317	5835					214	214		10.1126/science.1143369	http://dx.doi.org/10.1126/science.1143369			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	189DC	17626876				2022-12-01	WOS:000247968600032
J	Junttila, MR; Puustinen, P; Niemela, M; Ahola, R; Arnold, H; Bottzauw, T; Ala-Aho, R; Nielsen, C; Ivaska, J; Taya, Y; Lu, SL; Lin, SJ; Chan, EKL; Wang, XJ; Grenman, R; Kast, J; Kallunki, T; Sears, R; Kahari, VM; Westermarck, J				Junttila, Melissa R.; Puustinen, Pietri; Niemela, Minna; Ahola, Raija; Arnold, Hugh; Bottzauw, Trine; Ala-aho, Risto; Nielsen, Christina; Ivaska, Johanna; Taya, Yoichi; Lu, Shi-Long; Lin, Shujun; Chan, Edward K. L.; Wang, Xiao-Jing; Grenman, Reidar; Kast, Juergen; Kallunki, Tuula; Sears, Rosalie; Kahari, Veli-Matti; Westermarck, Jukka			CIP2A inhibits PP2A in human malignancies	CELL			English	Article							PROTEIN PHOSPHATASE 2A; HUMAN CELL-TRANSFORMATION; C-MYC; COLON-CANCER; SUBUNIT; ALPHA; SERINE/THREONINE; DEGRADATION; HOLOENZYME; ELEMENTS	Inhibition of protein phosphatase 2A ( PP2A) activity has been identified as a prerequisite for the transformation of human cells. However, the molecular mechanisms by which PP2A activity is inhibited in human cancers are currently unclear. In this study, we describe a cellular inhibitor of PP2A with oncogenic activity. The protein, designated Cancerous Inhibitor of PP2A ( CIP2A), interacts directly with the oncogenic transcription factor c- Myc, inhibits PP2A activity toward c- Myc serine 62 ( S62), and thereby prevents c- Myc proteolytic degradation. In addition to its function in cMyc stabilization, CIP2A promotes anchorage-independent cell growth and in vivo tumor formation. The oncogenic activity of CIP2A is demonstrated by transformation of human cells by overexpression of CIP2A. Importantly, CIP2A is overexpressed in two common human malignancies, head and neck squamous cell carcinoma ( HNSCC) and colon cancer. Thus, our data show that CIP2A is a human oncoprotein that inhibits PP2A and stabilizes c- Myc in human malignancies.	Univ Turku, Ctr Biotechnol, FIN-20520 Turku, Finland; Abo Akad Univ, FIN-20520 Turku, Finland; Univ Turku, Turku Grad Sch Biomed Sci, FIN-20520 Turku, Finland; Univ Turku, Dept Med Biochem & Mol Biol, FIN-20520 Turku, Finland; Univ Turku, Medic Res Lab, FIN-20520 Turku, Finland; Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Danish Canc Soc, Inst Canc Biol, Apoptosis Lab, DK-2100 Copenhagen, Denmark; VTT Tech Res Ctr Finland, Med Biotechnol, FIN-20520 Turku, Finland; Natl Canc Ctr, Res Inst, Tokyo 1040045, Japan; OHSU, Dept Otolaryngol, Portland, OR 97239 USA; OHSU, Dept Dermatol, Portland, OR 97239 USA; OHSU, Dept Cell & Dev Biol, Portland, OR 97239 USA; Univ British Columbia, Biomed Res Ctr, Vancouver, BC V5Z 1M9, Canada; Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, FIN-20520 Turku, Finland; Turku Univ Hosp, Dept Dermatol, FIN-20520 Turku, Finland; Univ Tampere, Inst Med Technol, FIN-33520 Tampere, Finland; Tampere Univ Hosp, FIN-33520 Tampere, Finland	University of Turku; Abo Akademi University; University of Turku; University of Turku; University of Turku; Oregon Health & Science University; Danish Cancer Society; VTT Technical Research Center Finland; National Cancer Center - Japan; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of British Columbia; State University System of Florida; University of Florida; University of Turku; University of Turku; Tampere University; Tampere University; Tampere University Hospital	Westermarck, J (corresponding author), Univ Turku, Ctr Biotechnol, FIN-20520 Turku, Finland.	ltjuwe@uta.fi	Kahari, Veli-Matti/T-4925-2019; Chan, Edward K. L./B-5671-2009; Pope, Janet/G-3342-2011; Kähäri, Veli-Matti/E-5144-2011; Westermarck, Jukka/AAL-6464-2020	Kahari, Veli-Matti/0000-0003-2421-9368; Chan, Edward K. L./0000-0003-3938-9503; Pope, Janet/0000-0003-1479-5302; Kähäri, Veli-Matti/0000-0003-2421-9368; Westermarck, Jukka/0000-0001-7478-3018; Kallunki, Tuula/0000-0002-8571-383X; Ivaska, Johanna/0000-0002-6295-6556	NCI NIH HHS [R01-CA100855] Funding Source: Medline; NIDCR NIH HHS [DE15953] Funding Source: Medline; NIGMS NIH HHS [T32-GM08617] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008617] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Dietrich N, 2004, CELL DEATH DIFFER, V11, P301, DOI 10.1038/sj.cdd.4401353; Escamilia-Powers JR, 2007, J BIOL CHEM, V282, P5432, DOI 10.1074/jbc.M611437200; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Grady WM, 2002, ANNU REV GENOM HUM G, V3, P101, DOI 10.1146/annurev.genom.3.022502.103043; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Honeycutt KA, 2004, J DERMATOL, V31, P368, DOI 10.1111/j.1346-8138.2004.tb00687.x; Hoo LS, 2002, ONCOGENE, V21, P5006, DOI 10.1038/sj.onc.1205625; Janssens IA, 2005, BIOGEOSCIENCES, V2, P15, DOI 10.5194/bg-2-15-2005; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; LANSFORD CD, 1999, HUMAN CELL CULTURE, V2, P185; Lu SL, 2006, GENE DEV, V20, P1331, DOI 10.1101/gad.1413306; Moreno CS, 2004, CANCER RES, V64, P6978, DOI 10.1158/0008-5472.CAN-04-1150; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Moule MG, 2004, P NATL ACAD SCI USA, V101, P14063, DOI 10.1073/pnas.0405533101; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; Pastula C, 2003, COMB CHEM HIGH T SCR, V6, P341; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhao JJ, 2004, TRENDS MOL MED, V10, P344, DOI 10.1016/j.molmed.2004.05.005	33	474	516	1	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2007	130	1					51	62		10.1016/j.cell.2007.04.044	http://dx.doi.org/10.1016/j.cell.2007.04.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632056	Bronze			2022-12-01	WOS:000248587000010
J	Watts, G				Watts, Geoff			Commentary: Liquid automation refreshes Dr Papanicolaou	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						DAVEY E, 2007, BMJ; DAWSON AE, 2004, CANC CYTOPATHOLOGY; Henstock E., 2002, EVALUATION HPV LBC C; LINDER J, 2004, EUR INT EXP M NIC OC; RONCO G, 2007, BMJ	5	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 7	2007	335	7609					35	36		10.1136/bmj.39260.482616.DE	http://dx.doi.org/10.1136/bmj.39260.482616.DE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	191LY	17615223	Green Published			2022-12-01	WOS:000248133900033
J	Dai, SD; Friemann, R; Glauser, DA; Bourquin, F; Manieri, W; Schurmann, P; Eklund, H				Dai, Shaodong; Friemann, Rosmarie; Glauser, Dominique A.; Bourquin, Florence; Manieri, Wanda; Schuermann, Peter; Eklund, Hans			Structural snapshots along the reaction pathway of ferredoxin-thioredoxin reductase	NATURE			English	Article							CRYSTAL-STRUCTURE; S-ADENOSYLMETHIONINE; 4FE-4S CLUSTER; FERREDOXINTHIOREDOXIN REDUCTASE; DISULFIDE REDUCTION; SPINACH FERREDOXIN; ACTIVE-SITE; CHLOROPLAST; PROTEIN; CHEMISTRY	Oxygen-evolving photosynthetic organisms regulate carbon metabolism through a light-dependent redox signalling pathway(1). Electrons are shuttled from photosystem I by means of ferredoxin (Fdx) to ferredoxin - thioredoxin reductase (FTR), which catalyses the two-electron-reduction of chloroplast thioredoxins (Trxs). These modify target enzyme activities by reduction, regulating carbon flow(2). FTR is unique in its use of a [4Fe - 4S] cluster and a proximal disulphide bridge in the conversion of a light signal into a thiol signal(2). We determined the structures of FTR in both its one- and its two-electron-reduced intermediate states and of four complexes in the pathway, including the ternary Fdx - FTR - Trx complex. Here we show that, in the first complex ( Fdx - FTR) of the pathway, the Fdx [2Fe - 2S] cluster is positioned suitably for electron transfer to the FTR [ 4Fe - 4S] centre. After the transfer of one electron, an intermediate is formed in which one sulphur atom of the FTR active site is free to attack a disulphide bridge in Trx and the other sulphur atom forms a fifth ligand for an iron atomin the FTR [ 4Fe - 4S] centre - a unique structure in biology. Fdx then delivers a second electron that cleaves the FTR - Trx heterodisulphide bond, which occurs in the Fdx - FTR - Trx complex. In this structure, the redox centres of the three proteins are aligned to maximize the efficiency of electron transfer from the Fdx [2Fe - 2S] cluster to the active-site disulphide of Trxs. These results provide a structural framework for understanding the mechanism of disulphide reduction by an iron - sulphur enzyme(3) and describe previously unknown interaction networks for both Fdx and Trx ( refs 4 - 6).	Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Integrated Dept Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO 80206 USA; Swedish Univ Agr Sci, Ctr Biomed, Dept Mol Biol, S-75124 Uppsala, Sweden; Univ Neuchatel, Mol & Cellular Biol Lab, CH-2009 Neuchatel, Switzerland	Howard Hughes Medical Institute; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Swedish University of Agricultural Sciences; University of Neuchatel	Dai, SD (corresponding author), Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Integrated Dept Immunol, 1400 Jackson St, Denver, CO 80206 USA.	dais@njc.org	Glauser, Dominique/B-3918-2012; Friemann, Rosmarie/C-1018-2008	Glauser, Dominique/0000-0002-3228-7304; Friemann, Rosmarie/0000-0002-5633-2894				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balmer Y, 2003, P NATL ACAD SCI USA, V100, P370, DOI 10.1073/pnas.232703799; Balmer Y, 2001, FEBS LETT, V492, P58, DOI 10.1016/S0014-5793(01)02229-3; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; BUCHANAN BB, 1994, ARCH BIOCHEM BIOPHYS, V314, P257, DOI 10.1006/abbi.1994.1439; Chen DW, 2003, J AM CHEM SOC, V125, P11788, DOI 10.1021/ja036120z; Chen KS, 2002, NAT STRUCT BIOL, V9, P188, DOI 10.1038/nsb751; Dai SD, 2000, Q REV BIOPHYS, V33, P67, DOI 10.1017/S0033583500003607; Dai SD, 2000, SCIENCE, V287, P655, DOI 10.1126/science.287.5453.655; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Duin EC, 2002, FEBS LETT, V512, P263, DOI 10.1016/S0014-5793(02)02281-0; Giastas P, 2006, J BIOL INORG CHEM, V11, P445, DOI 10.1007/s00775-006-0094-9; Glauser DA, 2004, J BIOL CHEM, V279, P16662, DOI 10.1074/jbc.M313851200; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Hirasawa M, 1999, BIOCHEMISTRY-US, V38, P5200, DOI 10.1021/bi982783v; Jameson GNL, 2003, J AM CHEM SOC, V125, P1146, DOI 10.1021/ja029338e; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 2003, STRUCTURE, V11, P1051, DOI 10.1016/S0969-2126(03)00186-2; Knaff D. B., 1996, ADV PHOTOSYNTHESIS O, P333; Kurisu G, 2001, NAT STRUCT BIOL, V8, P117, DOI 10.1038/84097; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAUBLE H, 1994, J MOL BIOL, V237, P437, DOI 10.1006/jmbi.1994.1246; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; LELONG C, 1995, BIOCHEMISTRY-US, V34, P14462, DOI 10.1021/bi00044a024; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; Lepore BW, 2005, P NATL ACAD SCI USA, V102, P13819, DOI 10.1073/pnas.0505726102; Manieri W, 2003, FEBS LETT, V549, P167, DOI 10.1016/S0014-5793(03)00811-1; Morales R, 2000, EMBO REP, V1, P271, DOI 10.1093/embo-reports/kvd057; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ONUCHIC JN, 1992, ANNU REV BIOPH BIOM, V21, P349, DOI 10.1146/annurev.biophys.21.1.349; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; SCHURMANN P, 1993, CHIMIA, V47, P245; Schurmann P, 2003, ANTIOXID REDOX SIGN, V5, P69, DOI 10.1089/152308603321223559; Schurmann P, 1995, PHOTOSYNTH RES, V46, P309, DOI 10.1007/BF00020445; SCHURMANN P, 1995, METHOD ENZYMOL, V252, P274; Staples CR, 1996, BIOCHEMISTRY-US, V35, P11425, DOI 10.1021/bi961007p; Staples CR, 1998, BIOCHEMISTRY-US, V37, P4612, DOI 10.1021/bi9729763; STURA EA, 1999, CRYSTALLIZATION NUCL, P99; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van den Heuvel RHH, 2003, J MOL BIOL, V330, P113, DOI 10.1016/S0022-2836(03)00522-9; Walters EM, 2005, J AM CHEM SOC, V127, P9612, DOI 10.1021/ja051909q; Walters EM, 2004, PHOTOSYNTH RES, V79, P249, DOI 10.1023/B:PRES.0000017195.05870.61; WEDEL N, 1992, PLANT MOL BIOL, V18, P527, DOI 10.1007/BF00040668; Xu XF, 2006, FEBS LETT, V580, P6714, DOI 10.1016/j.febslet.2006.11.027	51	103	111	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					92	102		10.1038/nature05937	http://dx.doi.org/10.1038/nature05937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17611542				2022-12-01	WOS:000247720900044
J	Cox-Foster, DL; Conlan, S; Holmes, EC; Palacios, G; Evans, JD; Moran, NA; Quan, PL; Briese, T; Hornig, M; Geiser, DM; Martinson, V; vanEngelsdorp, D; Kalkstein, AL; Drysdale, A; Hui, J; Zhai, JH; Cui, LW; Hutchison, SK; Simons, JF; Egholm, M; Pettis, JS; Lipkin, WI				Cox-Foster, Diana L.; Conlan, Sean; Holmes, Edward C.; Palacios, Gustavo; Evans, Jay D.; Moran, Nancy A.; Quan, Phenix-Lan; Briese, Thomas; Hornig, Mady; Geiser, David M.; Martinson, Vince; vanEngelsdorp, Dennis; Kalkstein, Abby L.; Drysdale, Andrew; Hui, Jeffrey; Zhai, Junhui; Cui, Liwang; Hutchison, Stephen K.; Simons, Jan Fredrik; Egholm, Michael; Pettis, Jeffery S.; Lipkin, W. Ian			A metagenomic survey of microbes in honey bee colony collapse disorder	SCIENCE			English	Article							RIBOSOMAL-RNA; INSECT TRYPANOSOMATIDS; APIS-MELLIFERA; DIVERSITY	In colony collapse disorder (CCD), honey bee colonies inexplicably lose their workers. CCD has resulted in a loss of 50 to 90% of colonies in beekeeping operations across the United States. The observation that irradiated combs from affected colonies can be repopulated with naive bees suggests that infection may contribute to CCD. We used an unbiased metagenomic approach to survey microflora in CCD hives, normal hives, and imported royal jelly. Candidate pathogens were screened for significance of association with CCD by the examination of samples collected from several sites over a period of 3 years. One organism, Israeli acute paralysis virus of bees, was strongly correlated with CCD.	Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10032 USA; Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, Mueller Lab, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; USDA ARS, Bee Res Lab, Beltsville, MD 20705 USA; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; Penn State Univ, Dept Plant Pathol, University Pk, PA 16802 USA; Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA; Penn Dept Hlth, Bur Plant Ind Apiculture, Harrisburg, PA 17110 USA	Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); United States Department of Agriculture (USDA); University of Arizona; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Arizona	Lipkin, WI (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10032 USA.	wil2001@columbia.edu	Cox-Foster, Diana/L-1538-2013; Palacios, Gustavo/I-7773-2015; vanEngelsdorp, Dennis/E-7934-2010; Conlan, Sean/B-4401-2008; Evans, Jay D/C-8408-2012; Hornig, Mady/AAE-8431-2020; Moran, Nancy A/G-1591-2010; Geiser, David/J-9950-2013; Lipkin, W. Ian/ABE-6216-2020; Holmes, Edward/Y-2789-2019; Holmes, Edward/GVR-9499-2022	Palacios, Gustavo/0000-0001-5062-1938; Conlan, Sean/0000-0001-6848-3465; Evans, Jay D/0000-0002-0036-4651; Hornig, Mady/0000-0001-7572-3092; Lipkin, W. Ian/0000-0002-8768-9386; Holmes, Edward/0000-0001-9596-3552; Martinson, Vincent/0000-0001-5824-3548	NIAID NIH HHS [U54AI57158, U01AI070411] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, U01AI070411] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; BARRIONUEVO A, 2007, NY TIMES        0424, P1; BURNSIDE C. E., 1935, AMER BEE JOUR, V25, P75; Gregory PG, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.7; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Hughes AL, 2003, MOL BIOL EVOL, V20, P644, DOI 10.1093/molbev/msg062; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Maori E, 2007, VIROLOGY, V362, P342, DOI 10.1016/j.virol.2006.11.038; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Pettis J, 2007, AM BEE J, V147, P595; Pettis JS, 2004, APIDOLOGIE, V35, P605, DOI 10.1051/apido:2004056; Podlipaev S, 2001, INT J PARASITOL, V31, P648, DOI 10.1016/S0020-7519(01)00139-4; Podlipaev SA, 2004, J EUKARYOT MICROBIOL, V51, P283, DOI 10.1111/j.1550-7408.2004.tb00568.x; RAWEN W, 2007, UCSF TODAY      0425; Stokstad E, 2007, SCIENCE, V316, P970, DOI 10.1126/science.316.5827.970; VANENGELSDORP D, 2006, FALL DWINDLE DIS PRE; Vanengelsdorp D, 2007, AM BEE J, V147, P599; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102	21	1217	1335	16	759	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2007	318	5848					283	287		10.1126/science.1146498	http://dx.doi.org/10.1126/science.1146498			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219LG	17823314				2022-12-01	WOS:000250086100050
J	Ma, L; Teruya-Feldstein, J; Weinberg, RA				Ma, Li; Teruya-Feldstein, Julie; Weinberg, Robert A.			Tumour invasion and metastasis initiated by microRNA 10b in breast cancer	NATURE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; E-CADHERIN EXPRESSION; GENE-EXPRESSION; CELLS; RHOC; DROSOPHILA; TWIST; TRANSFORMATION; MORPHOGENESIS	MicroRNAs have been implicated in regulating diverse cellular pathways. Although there is emerging evidence that some microRNAs can function as oncogenes or tumour suppressors, the role of microRNAs in mediating cancer metastasis remains unexplored. Here we show, using a combination of mouse and human cells, that microRNA-10b (miR-10b) is highly expressed in metastatic breast cancer cells and positively regulates cell migration and invasion. Overexpression of miR-10b in otherwise non-metastatic breast tumours initiates robust invasion and metastasis. Expression of miR-10b is induced by the transcription factor Twist, which binds directly to the putative promoter of mir-10b (MIRN10B). The miR-10b induced by Twist proceeds to inhibit translation of the messenger RNA encoding homeobox D10, resulting in increased expression of a well-characterized pro-metastatic gene, RHOC. Significantly, the level of miR-10b expression in primary breast carcinomas correlates with clinical progression. These findings suggest the workings of an undescribed regulatory pathway, in which a pleiotropic transcription factor induces expression of a specific microRNA, which suppresses its direct target and in turn activates another pro-metastatic gene, leading to tumour cell invasion and metastasis.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Memorial Sloan Kettering Cancer Center	Weinberg, RA (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu	Vickers, Michael M/E-4095-2010	Ma, Li/0000-0001-9965-989X				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carrio M, 2005, CANCER RES, V65, P7177, DOI 10.1158/0008-5472.CAN-04-1717; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Cripps RM, 1998, GENE DEV, V12, P422, DOI 10.1101/gad.12.3.422; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Enright AJ, 2004, GENOME BIOL, V5; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; ETHIER SP, 1993, CANCER RES, V53, P627; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kleer CG, 2006, CLIN CANCER RES, V12, P4485, DOI 10.1158/1078-0432.CCR-06-0376; Kondo T, 2004, PATHOBIOLOGY, V71, P19, DOI 10.1159/000072958; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuperwasser C, 2005, CANCER RES, V65, P6130, DOI 10.1158/0008-5472.CAN-04-1408; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Makiyama K, 2005, ONCOL REP, V13, P673; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Myers C, 2002, AM J PATHOL, V161, P2099, DOI 10.1016/S0002-9440(10)64488-4; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; REICHMANN E, 1992, CELL, V71, P1103, DOI 10.1016/S0092-8674(05)80060-1; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wang Wei, 2004, Zhonghua Zhongliu Zazhi, V26, P279; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zhang X, 2003, J BIOL CHEM, V278, P7580, DOI 10.1074/jbc.M212050200; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	48	2057	2267	3	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2007	449	7163					682	U2		10.1038/nature06174	http://dx.doi.org/10.1038/nature06174			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218VV	17898713				2022-12-01	WOS:000250045000035
J	Hu, HL; Real, E; Takamiya, K; Kang, MG; Ledoux, J; Huganir, RL; Malinow, R				Hu, Hailan; Real, Eleonore; Takamiya, Kogo; Kang, Myoung-Goo; Ledoux, Joseph; Huganir, Richard L.; Malinow, Roberto			Emotion enhances learning via norepinephrine regulation of AMPA-Receptor trafficking	CELL			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; HIPPOCAMPAL CA1 REGION; BETA-ADRENERGIC-RECEPTORS; SYNAPTIC PLASTICITY; GLUTAMATE RECEPTORS; GLUR1 SUBUNIT; VISUAL-CORTEX; FREQUENCY STIMULATION; PHOSPHORYLATION SITES	Emotion enhances our ability to form vivid memories of even trivial events. Norepinephrine ( NE), a neuromodulator released during emotional arousal, plays a central role in the emotional regulation of memory. However, the underlying molecular mechanism remains elusive. Toward this aim, we have examined the role of NE in contextual memory formation and in the synaptic delivery of GluR1-containing alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid ( AMPA)-type glutamate receptors during longterm potentiation (LTP), a candidate synaptic mechanism for learning. We found that NE, as well as emotional stress, induces phosphorylation of GluR1 at sites critical for its synaptic delivery. Phosphorylation at these sites is necessary and sufficient to lower the threshold for GluR1 synaptic incorporation during LTP. In behavioral experiments, NE can lower the threshold for memory formation in wild-type mice but not in mice carrying mutations in the GluR1 phosphorylation sites. Our results indicate that NE-driven phosphorylation of GluR1 facilitates the synaptic delivery of GluR1-containing AMPARs, lowering the threshold for LTP, thereby providing a molecular mechanism for how emotion enhances learning and memory.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA; NYU, New York, NY 10003 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Johns Hopkins University; New York University	Malinow, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.org	Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051; Hu, Hailan/0000-0002-0425-5057; Takamiya, Kogo/0000-0001-7240-6307; Real, Dr Eleonore/0000-0002-5523-4408; Kang, Myoung-Goo/0000-0003-2649-219X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049159] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH049159] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Chao SZ, 2002, J NEUROCHEM, V81, P984, DOI 10.1046/j.1471-4159.2002.00877.x; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Christianson Sven -Ake, 1992, HDB EMOTION MEMORY; CLERN RL, 2006, NEURON, V49, P663; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Frankland PW, 2004, HIPPOCAMPUS, V14, P557, DOI 10.1002/hipo.10208; Gelinas JN, 2005, J NEUROSCI, V25, P3294, DOI 10.1523/JNEUROSCI.4175-04.2005; GRAY R, 1987, NATURE, V327, P620, DOI 10.1038/327620a0; HAAS HL, 1983, NATURE, V302, P432, DOI 10.1038/302432a0; Hall RA, 2004, SEMIN CELL DEV BIOL, V15, P281, DOI 10.1016/j.semcdb.2003.12.017; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hayley S, 2001, BRAIN RES, V892, P293, DOI 10.1016/S0006-8993(00)03262-5; HESTRIN S, 1992, NEURON, V9, P991, DOI 10.1016/0896-6273(92)90250-H; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HUANG CC, 1993, NEUROSCI LETT, V161, P207, DOI 10.1016/0304-3940(93)90295-V; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kandel ER., 2000, PRINCIPLES NEURAL SC, P67; Katsuki H, 1997, J NEUROPHYSIOL, V77, P3013, DOI 10.1152/jn.1997.77.6.3013; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kolleker A, 2003, NEURON, V40, P1199, DOI 10.1016/S0896-6273(03)00722-0; Kopec CD, 2007, NEUROPHARMACOLOGY, V52, P228, DOI 10.1016/j.neuropharm.2006.07.028; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; LIANG KC, 1986, BRAIN RES, V368, P125, DOI 10.1016/0006-8993(86)91049-8; MADISON DV, 1982, NATURE, V299, P636, DOI 10.1038/299636a0; MADISON DV, 1988, BRAIN RES, V442, P131, DOI 10.1016/0006-8993(88)91440-0; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McGaugh JL, 1996, P NATL ACAD SCI USA, V93, P13508, DOI 10.1073/pnas.93.24.13508; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Price CJ, 1999, J NEUROCHEM, V73, P2441, DOI 10.1046/j.1471-4159.1999.0732441.x; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Raman IM, 1996, NEURON, V16, P415, DOI 10.1016/S0896-6273(00)80059-8; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Richter-Levin G, 2003, BRAIN RES REV, V43, P247, DOI 10.1016/j.brainresrev.2003.08.005; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; SARVEY JM, 1989, J NEUROSCI METH, V28, P109, DOI 10.1016/0165-0270(89)90016-2; Sheng M, 2003, NEUROSCI RES, V46, P127, DOI 10.1016/S0168-0102(03)00040-3; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Silva AJ, 1998, NEUROBIOL LEARN MEM, V70, P44, DOI 10.1006/nlme.1998.3837; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Svenningsson P, 2002, P NATL ACAD SCI USA, V99, P3182, DOI 10.1073/pnas.052712799; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; Vanhoose AM, 2003, J NEUROSCI, V23, P5827; Wang W, 2004, CIRC RES, V95, P798, DOI 10.1161/01.RES.0000145361.50017.aa; Watabe AM, 2000, J NEUROSCI, V20, P5924, DOI 10.1523/JNEUROSCI.20-16-05924.2000; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	75	355	381	7	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2007	131	1					160	173		10.1016/j.cell.2007.09.017	http://dx.doi.org/10.1016/j.cell.2007.09.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923095	Bronze			2022-12-01	WOS:000249934700019
J	Kenyon, S; Ullman, R; Mori, R; Whittle, M				Kenyon, S.; Ullman, R.; Mori, R.; Whittle, M.		Guideline Dev Grp	Care of healthy women and their babies during childbirth: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Leicester, Dept Canc Studies & Mol Med, Reprod Sci Sect, Leicester LE2 7LX, Leics, England; Royal Coll Obstet & Gynaecologists, Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England	University of Leicester	Kenyon, S (corresponding author), Univ Leicester, Dept Canc Studies & Mol Med, Reprod Sci Sect, Leicester LE2 7LX, Leics, England.	oracle@le.ac.uk		Kenyon, Sara/0000-0002-0756-9617; Mori, Rintaro/0000-0001-7656-6156				National Institute for Health and Clinical Excellence, 2007, INTR CAR CAR HLTH WO	1	10	11	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 29	2007	335	7621					667	668		10.1136/bmj.39322.703380.AD	http://dx.doi.org/10.1136/bmj.39322.703380.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	218AY	17901518	Green Published			2022-12-01	WOS:000249989600044
J	Riedel-Kruse, IH; Muller, C; Oates, AC				Riedel-Kruse, Ingmar H.; Mueller, Claudia; Oates, Andrew C.			Synchrony dynamics during initiation, failure, and rescue of the segmentation clock	SCIENCE			English	Article							ZEBRAFISH SOMITOGENESIS; SOMITE SEGMENTATION; EXPRESSION; OSCILLATOR; GENES; HER1; BOUNDARIES; MECHANISM; PATHWAY; EMBRYO	The "segmentation clock" is thought to coordinate sequential segmentation of the body axis in vertebrate embryos. This clock comprises a multicellular genetic network of synchronized oscillators, coupled by intercellular Delta-Notch signaling. How this synchrony is established and how its loss determines the position of segmentation defects in Delta and Notch mutants are unknown. We analyzed the clock's synchrony dynamics by varying strength and timing of Notch coupling in zebrafish embryos with techniques for quantitative perturbation of gene function. We developed a physical theory based on coupled phase oscillators explaining the observed onset and rescue of segmentation defects, the clock's robustness against developmental noise, and a critical point beyond which synchrony decays. We conclude that synchrony among these genetic oscillators can be established by simultaneous initiation and self-organization and that the segmentation defect position is determined by the difference between coupling strength and noise.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Riedel-Kruse, IH (corresponding author), CALTECH, Div Biol, MC 139-74, Pasadena, CA 91125 USA.	ingmar@caltech.edu; oates@mpi-cbg.de	Riedel-Kruse, Ingmar/B-8818-2008	Riedel-Kruse, Ingmar/0000-0002-6068-5561				Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Deniziak M, 2007, EXP CELL RES, V313, P156, DOI 10.1016/j.yexcr.2006.10.005; Forgacs G, 2005, BIOLOGICAL PHYSICS OF THE DEVELOPING EMBRYO, P1, DOI 10.1017/CBO9780511755576; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Henry CA, 2002, DEVELOPMENT, V129, P3693; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; Holley SA, 2006, GENE DEV, V20, P1831, DOI 10.1101/gad.1453706; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Jouve C, 2002, DEVELOPMENT, V129, P1107; Julich D, 2005, DEV BIOL, V286, P391, DOI 10.1016/j.ydbio.2005.06.040; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Muller M, 1996, DEVELOPMENT, V122, P2071; Oates AC, 2005, DEV BIOL, V280, P133, DOI 10.1016/j.ydbio.2005.01.010; Oates AC, 2002, DEVELOPMENT, V129, P2929; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; Pikovsky A., 2003, SYNCHRONIZATION; Pourquie O, 2001, CLIN GENET, V60, P409, DOI 10.1034/j.1399-0004.2001.600602.x; Sawada A, 2001, DEVELOPMENT, V128, P4873; Shankaran SS, 2007, DEV BIOL, V304, P615, DOI 10.1016/j.ydbio.2007.01.004; Smithers L, 2000, MECH DEVELOP, V90, P119, DOI 10.1016/S0925-4773(99)00231-2; Van Eeden FJM, 1998, DEV GENET, V23, P65; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Weinmaster G, 2003, ANNU REV CELL DEV BI, V19, P367, DOI 10.1146/annurev.cellbio.19.111301.115434; Westin J, 1997, DEV GENES EVOL, V207, P51, DOI 10.1007/s004270050091; Winfree AT, 2002, SCIENCE, V298, P2336, DOI 10.1126/science.1072560	32	182	185	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2007	317	5846					1911	1915		10.1126/science.1142538	http://dx.doi.org/10.1126/science.1142538			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	214US	17702912	Green Submitted			2022-12-01	WOS:000249764300037
J	Michniewicz, M; Zago, MK; Abas, L; Weijers, D; Schweighofer, A; Meskiene, I; Heisler, MG; Ohno, C; Zhang, J; Huang, F; Schwab, R; Weigel, D; Meyerowitz, EM; Luschnig, C; Offringa, R; Friml, J				Michniewicz, Marta; Zago, Marcelo K.; Abas, Lindy; Weijers, Dolf; Schweighofer, Alois; Meskiene, Irute; Heisler, Marcus G.; Ohno, Carolyn; Zhang, Jing; Huang, Fang; Schwab, Rebecca; Weigel, Detlef; Meyerowitz, Elliot M.; Luschnig, Christian; Offringa, Remko; Friml, Jiri			Antagonistic regulation of PIN phosphorylation by PP2A and PINOID directs auxin flux	CELL			English	Article							PROTEIN-KINASE; ARABIDOPSIS; EFFLUX; TRANSPORT; GRADIENTS; GROWTH; PHOSPHOPROTEOMICS; PHOSPHATASE-2A; GRAVITROPISM; ENDOCYTOSIS	In plants, cell polarity and tissue patterning are connected by intercellular flow of the phytohormone auxin, whose directional signaling depends on polar subcellular localization of PIN auxin transport proteins. The mechanism of polar targeting of PINs or other cargos in plants is largely unidentified, with the PINOID kinase being the only known molecular component. Here, we identify PP2A phosphatase as an important regulator of PIN apical- basal targeting and auxin distribution. Genetic analysis, localization, and phosphorylation studies demonstrate that PP2A and PINOID both partially colocalize with PINs and act antagonistically on the phosphorylation state of their central hydrophilic loop, hence mediating PIN apicalbasal polar targeting. Thus, in plants, polar sorting by the reversible phosphorylation of cargos allows for their conditional delivery to specific intracellular destinations. In the case of PIN proteins, this mechanism enables switches in the direction of intercellular auxin fluxes, which mediate differential growth, tissue patterning, and organogenesis.	Univ Tubingen, Zentrum Mole Biol Pfflanzen, Tubingen, Germany; Leiden Univ, Inst Biol Leiden, Leiden, Netherlands; Univ Nat Resources & Appl Life Sci BOKU, Inst Appl Genet & Cell Biol, Vienna, Austria; Wageningen Univ, Biochem Lab, Wageningen, Netherlands; Univ Vienna, Max F Perutz Labs, Vienna, Austria; CALTECH, Div Biol, Pasadena, CA 91125 USA; Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; Univ Gottingen, Albrecht von Haller Inst Pflanzenwissensch, Gottingen, Germany	Eberhard Karls University of Tubingen; Leiden University; Leiden University - Excl LUMC; University of Natural Resources & Life Sciences, Vienna; Wageningen University & Research; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); California Institute of Technology; Max Planck Society; University of Gottingen	Friml, J (corresponding author), Univ Tubingen, Zentrum Mole Biol Pfflanzen, Tubingen, Germany.	jifri@psb.ugent.be	Weigel, Detlef/C-1418-2008; Meyerowitz, Elliot M/A-7118-2009; Weijers, Dolf/ABI-1332-2020; Weigel, Detlef/GSJ-0799-2022; Schwab, Rebecca/I-9352-2012; heisler, marcus G/B-9738-2015; Weigel, Detlef/AAR-3312-2021; Friml, Jiri/D-9511-2012; Weijers, Dolf/A-2076-2010	Weigel, Detlef/0000-0002-2114-7963; Weijers, Dolf/0000-0003-4378-141X; Weigel, Detlef/0000-0002-2114-7963; Schwab, Rebecca/0000-0001-9933-9669; heisler, marcus G/0000-0001-5644-8398; Friml, Jiri/0000-0002-8302-7596; Weijers, Dolf/0000-0003-4378-141X; Schweighofer, Alois/0000-0002-8466-0924; Luschnig, Christian/0000-0003-2099-9280	Austrian Science Fund FWF [P 18840] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Benjamins R, 2001, DEVELOPMENT, V128, P4057; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; CASANOVA JE, 1990, SCIENCE, V248, P742, DOI 10.1126/science.2110383; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; Christensen SK, 2000, CELL, V100, P469, DOI 10.1016/S0092-8674(00)80682-0; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Garbers C, 1996, EMBO J, V15, P2115, DOI 10.1002/j.1460-2075.1996.tb00565.x; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Lee SH, 2006, PLANT CELL, V18, P1604, DOI 10.1105/tpc.105.035972; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Meskiene I, 2003, J BIOL CHEM, V278, P18945, DOI 10.1074/jbc.M300878200; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Rashotte AM, 2001, PLANT CELL, V13, P1683, DOI 10.1105/tpc.13.7.1683; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Sauer M, 2006, NAT PROTOC, V1, P98, DOI 10.1038/nprot.2006.15; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; Scarpella E, 2006, GENE DEV, V20, P1015, DOI 10.1101/gad.1402406; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Shin H, 2005, PLANT J, V42, P188, DOI 10.1111/j.1365-313X.2005.02369.x; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Zegzouti H, 2006, P NATL ACAD SCI USA, V103, P6404, DOI 10.1073/pnas.0510283103; Zhou HW, 2004, PLANT CELL, V16, P709, DOI 10.1105/tpc.018994	37	490	525	6	110	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 21	2007	130	6					1044	1056		10.1016/j.cell.2007.07.033	http://dx.doi.org/10.1016/j.cell.2007.07.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889649	Bronze			2022-12-01	WOS:000250507500014
J	Fonseca, C; Lindahl, GE; Ponticos, M; Sestini, P; Renzoni, EA; Holmes, AM; Spagnolo, P; Pantelidis, P; Leoni, P; McHugh, N; Stock, CJ; Xu, SW; Denton, CP; Black, CM; Welsh, KI; du Bois, RM; Abraham, DJ				Fonseca, Carmen; Lindahl, Gisela E.; Ponticos, Markella; Sestini, Piersante; Renzoni, Elisabetta A.; Holmes, Alan M.; Spagnolo, Paolo; Pantelidis, Panagiotis; Leoni, Patricia; McHugh, Neil; Stock, Carmel J.; Xu, Shi-Wen; Denton, Christopher P.; Black, Carol M.; Welsh, Kenneth I.; du Bois, Roland M.; Abraham, David J.			A polymorphism in the CTGF promoter region associated with systemic sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TISSUE GROWTH-FACTOR; SCLERODERMA FIBROBLASTS; EXPRESSION; ANTICENTROMERE; AUTOANTIBODIES; DISEASE; ACTIVATION; GENETICS; BINDING; SCL-70	Background Systemic sclerosis (scleroderma) is a life-threatening autoimmune disease that is characterized by the presence of specific autoantibodies and fibrosis of the skin and major internal organs. Methods We genotyped a polymorphism (G-945C) in the promoter of the connective-tissue growth factor (CTGF) gene in 1000 subjects in two groups: group 1, consisting of 200 patients with systemic sclerosis and 188 control subjects; and group 2, consisting of 300 patients with systemic sclerosis and 312 control subjects. The combined groups represented an estimated 10% of patients with systemic sclerosis in the United Kingdom. We tested the effect of the polymorphism on the transcription of CTGF. Results The GG genotype was significantly more common in patients with systemic sclerosis than in control subjects in both groups, with an odds ratio for the combined group of 2.2 (95% confidence interval [CI], 1.5 to 3.2; P<0.001 for trend). Analysis of the combined group of patients with systemic sclerosis showed a significant association between homozygosity for the G allele and the presence of anti-topoisomerase I antibodies (odds ratio, 3.3; 95% CI, 2.0 to 5.6; P<0.001) and fibrosing alveolitis (odds ratio, 3.1; 95% CI, 1.9 to 5.0; P<0.001). We observed that the substitution of cytosine for guanine created a binding site of the transcriptional regulators Sp1 and Sp3. The C allele has high affinity for Sp3 and is associated with severely reduced transcriptional activity. A chromatin immunoprecipitation assay showed a marked shift in the ratio of Sp1 to Sp3 binding at this region, demonstrating functional relevance in vivo. Conclusions The G-945C substitution represses CTGF transcription, and the -945G allele is significantly associated with susceptibility to systemic sclerosis.	Royal Free & Univ Coll Med, Ctr Rheumatol, London, England; Univ Siena, Inst Resp Dis, I-53100 Siena, Italy; Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Clin Genom Grp, London, England; Royal Natl Hosp Rheumat Dis, Ctr Rheumatol, Bath BA1 1RL, Avon, England	University of London; University College London; University of Siena; Imperial College London; Royal National Hospital for Rheumatic Diseases (RNHRD)	Abraham, DJ (corresponding author), UCL, Dept Rheumatol, Hampstead Campus,Rowland Hill St, London NW3 2PF, England.	d.abraham@medsch.ucl.ac.uk	Sestini, Piersante/AAF-8570-2019	Ponticos, Markella/0000-0001-5957-5851; Stock, Carmel/0000-0003-4090-8761; Renzoni, Elisabetta/0000-0002-1118-797X; Sestini, Piersante/0000-0002-8195-0811				[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Assassi S, 2005, CURR OPIN RHEUMATOL, V17, P761, DOI 10.1097/01.bor.0000179943.27777.b1; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; BUNCE M, 1995, TISSUE ANTIGENS, V45, P81, DOI 10.1111/j.1399-0039.1995.tb02422.x; Bunn CC, 1998, BRIT J RHEUMATOL, V37, P15; Chen M, 2005, ARTHRITIS RHEUM-US, V52, P877, DOI 10.1002/art.20962; Chen YL, 2005, AM J PATHOL, V167, P1699, DOI 10.1016/S0002-9440(10)61252-7; Denton CP, 2006, NAT CLIN PRACT RHEUM, V2, P134, DOI 10.1038/ncprheum0115; Fonseca C, 2005, ARTHRITIS RHEUM-US, V52, pS176; Fonseca C, 2006, ARTHRITIS RHEUM-US, V54, P3034, DOI 10.1002/art.22036; Gardner H, 2006, ARTHRITIS RHEUM-US, V54, P1961, DOI 10.1002/art.21894; Gourh P, 2006, ARTHRITIS RHEUM-US, V54, P3945, DOI 10.1002/art.22196; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; HAGEN G, 1994, EMBO J, V13, P3843, DOI 10.1002/j.1460-2075.1994.tb06695.x; Henault J, 2006, ARTHRITIS RHEUM-US, V54, P963, DOI 10.1002/art.21646; Hitraya EG, 1998, ARTHRITIS RHEUM-US, V41, P2048, DOI 10.1002/1529-0131(199811)41:11<2048::AID-ART21>3.0.CO;2-X; Holmes A, 2003, J BIOL CHEM, V278, P41728, DOI 10.1074/jbc.M305019200; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Hudson LL, 2005, GENES IMMUN, V6, P274, DOI 10.1038/sj.gene.6364180; Ihn H, 2000, ARTHRITIS RHEUM, V43, P2240, DOI 10.1002/1529-0131(200010)43:10<2240::AID-ANR11>3.0.CO;2-2; Ihn H, 2000, J INVEST DERMATOL, V114, P1011, DOI 10.1046/j.1523-1747.2000.00956.x; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Leask Andrew, 2002, Curr Rheumatol Rep, V4, P136, DOI 10.1007/s11926-002-0009-x; LEROY EC, 1988, J RHEUMATOL, V15, P202; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Pan LH, 2001, EUR RESPIR J, V17, P1220, DOI 10.1183/09031936.01.00074101; Pearce SHS, 2006, TRENDS MOL MED, V12, P90, DOI 10.1016/j.molmed.2005.12.005; Reveille JD, 2005, J RHEUMATOL, V32, P10; Reveille JD, 2003, ARTHRIT RHEUM-ARTHR, V49, P399, DOI 10.1002/art.11113; Sato H, 2004, ARTHRITIS RHEUM-US, V50, P558, DOI 10.1002/art.20065; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Steen VD, 2005, SEMIN ARTHRITIS RHEU, V35, P35, DOI 10.1016/j.semarthrit.2005.03.005; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Tan FK, 2003, RHEUM DIS CLIN N AM, V29, P211, DOI 10.1016/S0889-857X(03)00015-2; Tsunoda T, 1999, BIOINFORMATICS, V15, P622, DOI 10.1093/bioinformatics/15.7.622; Whitfield ML, 2003, P NATL ACAD SCI USA, V100, P12319, DOI 10.1073/pnas.1635114100; Xu SW, 1997, ARTHRITIS RHEUM-US, V40, P1237; Zhou XD, 2005, ARTHRITIS RHEUM-US, V52, P3305, DOI 10.1002/art.21355; Zhou XD, 2003, ARTHRITIS RHEUM-US, V48, P2585, DOI 10.1002/art.11220	39	139	142	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2007	357	12					1210	1220		10.1056/NEJMoa067655	http://dx.doi.org/10.1056/NEJMoa067655			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	211RM	17881752				2022-12-01	WOS:000249541000006
J	Brown, CD; Johnson, DS; Sidow, A				Brown, Christopher D.; Johnson, David S.; Sidow, Arend			Functional architecture and evolution of transcriptional elements that drive gene coexpression	SCIENCE			English	Article							CIS-REGULATORY MODULES; DE-NOVO DISCOVERY; CIONA-INTESTINALIS; ASCIDIAN EMBRYOS; EXPRESSION; NETWORKS; CONSERVATION; SELECTION; GENOME; TISSUE	Transcriptional coexpression of interacting gene products is required for complex molecular processes; however, the function and evolution of cis-regulatory elements that orchestrate coexpression remain largely unexplored. We mutagenized 19 regulatory elements that drive coexpression of Ciona muscle genes and obtained quantitative estimates of the cis-regulatory activity of the 77 motifs that comprise these elements. We found that individual motif activity ranges broadly within and among elements, and among different instantiations of the same motif type. The activity of orthologous motifs is strongly constrained, although motif arrangement, type, and activity vary greatly among the elements of different co-regulated genes. Thus, the syntactical rules governing this regulatory function are flexible but become highly constrained evolutionarily once they are established in a particular element.	Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Sidow, A (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	arend@stanford.edu		Brown, Christopher/0000-0002-3785-5008				Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Bertrand V, 2003, CELL, V115, P615, DOI 10.1016/S0092-8674(03)00928-0; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Davidson EH, 2001, GENOMIC REGULATORY S; Dermitzakis ET, 2003, MOL BIOL EVOL, V20, P703, DOI 10.1093/molbev/msg077; Johnson DS, 2005, GENOME RES, V15, P1315, DOI 10.1101/gr.4062605; Johnson DS, 2004, GENOME RES, V14, P2448, DOI 10.1101/gr.2964504; Kusakabe T, 2004, DEV BIOL, V276, P563, DOI 10.1016/j.ydbio.2004.09.037; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Meedel TH, 2007, DEV BIOL, V302, P333, DOI 10.1016/j.ydbio.2006.09.043; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; Oda-Ishii I, 2005, DEVELOPMENT, V132, P1663, DOI 10.1242/dev.01707; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Small KS, 2007, P NATL ACAD SCI USA, V104, P5698, DOI 10.1073/pnas.0700890104; Sokal R., 2000, BIOMETRY, V3rd ed., P451; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Yagi K, 2005, DEV BIOL, V282, P535, DOI 10.1016/j.ydbio.2005.03.029; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zeller RW, 2006, DEV DYNAM, V235, P1921, DOI 10.1002/dvdy.20815; Zeller RW, 2004, METHOD CELL BIOL, V74, P713; Zhou Q, 2004, P NATL ACAD SCI USA, V101, P12114, DOI 10.1073/pnas.0402858101	24	95	96	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2007	317	5844					1557	1560		10.1126/science.1145893	http://dx.doi.org/10.1126/science.1145893			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872446				2022-12-01	WOS:000249467900044
J	Kolfschoten, MV; Schuurman, J; Losen, M; Bleeker, WK; Martinez-Martinez, P; Vermeulen, E; den Bleker, TH; Wiegman, L; Vink, T; Aarden, LA; De Baets, MH; van De Winkel, JGJ; Aalberse, RC; Parren, PWHI				Kolfschoten, Marijn van der Neut; Schuurman, Janine; Losen, Mario; Bleeker, Wim K.; Martinez-Martinez, Pilar; Vermeulen, Ellen; den Bleker, Tamara H.; Wiegman, Luus; Vink, Tom; Aarden, Lucien A.; De Baets, Marc H.; van De Winkel, Jan G. J.; Aalberse, Rob C.; Parren, Paul W. H. I.			Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange	SCIENCE			English	Article							MYASTHENIA-GRAVIS; RECEPTOR; MONOVALENCY	Antibodies play a central role in immunity by forming an interface with the innate immune system and, typically, mediate proinflammatory activity. We describe a novel posttranslational modification that leads to anti-inflammatory activity of antibodies of immunoglobulin G, isotype 4 (IgG4). IgG4 antibodies are dynamic molecules that exchange Fab arms by swapping a heavy chain and attached light chain (half-molecule) with a heavy-light chain pair from another molecule, which results in bispecific antibodies. Mutagenesis studies revealed that the third constant domain is critical for this activity. The impact of IgG4 Fab arm exchange was confirmed in vivo in a rhesus monkey model with experimental autoimmune myasthenia gravis. IgG4 Fab arm exchange is suggested to be an important biological mechanism that provides the basis for the anti-inflammatory activity attributed to IgG4 antibodies.	Genmab, NL-3584 CM Utrecht, Netherlands; Sanquin Res, AMC Landsteiner Lab, Dept Immunopathol, NL-1066 CX Amsterdam, Netherlands; Univ Maastricht, Dept Neurosci, Inst Mental Hlth & Neurosci, Maastricht, Netherlands; Hasselt Univ, Neuroimmunol Grp, Biomed Res Inst, Diepenbeek, Belgium; Univ Med Ctr, Dept Immunol, Immunotherapy Lab, Utrecht, Netherlands	Genmab; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Hasselt University; Utrecht University; Utrecht University Medical Center	Aalberse, RC (corresponding author), Genmab, NL-3584 CM Utrecht, Netherlands.	r.aalberse@sanquin.nl; p.parren@genmab.com	Losen, Mario/C-2676-2008	Losen, Mario/0000-0002-9761-0002; Martinez Martinez, Pilar/0000-0002-5990-3373; Parren, Paul/0000-0002-4365-3859				Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Aalberse RC, 1999, INT ARCH ALLERGY IMM, V118, P187, DOI 10.1159/000024062; Bleeker WK, 2004, J IMMUNOL, V173, P4699, DOI 10.4049/jimmunol.173.7.4699; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Graus YF, 1997, J IMMUNOL, V158, P1919; JEFFERIS R, 1990, HUMAN IGG SUBCLASSES, P15; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Losen M, 2005, BRAIN, V128, P2327, DOI 10.1093/brain/awh612; MARGNI RA, 1988, ANNU REV IMMUNOL, V6, P535, DOI 10.1146/annurev.iy.06.040188.002535; Nanda A, 2004, J ALLERGY CLIN IMMUN, V114, P1339, DOI 10.1016/j.jaci.2004.08.049; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Scallon BJ, 2006, J IMMUNOTHER, V29, P351, DOI 10.1097/01.cji.0000199196.97845.c3; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Teeling JL, 2004, BLOOD, V104, P1793, DOI 10.1182/blood-2004-01-0039; VANDERZEE JS, 1986, J IMMUNOL, V137, P3566; VANDERZEE JS, 1986, CLIN EXP IMMUNOL, V64, P415	20	653	751	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2007	317	5844					1554	1557		10.1126/science.1144603	http://dx.doi.org/10.1126/science.1144603			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210PK	17872445				2022-12-01	WOS:000249467900043
J	Kim, J; Inoue, K; Ishii, J; Vanti, WB; Voronov, SV; Murchison, E; Hannon, G; Abeliovich, A				Kim, Jongpil; Inoue, Keiichi; Ishii, Jennifer; Vanti, William B.; Voronov, Sergey V.; Murchison, Elizabeth; Hannon, Gregory; Abeliovich, Asa			A microRNA feedback circuit in midbrain dopamine neurons	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; SUBSTANTIA-NIGRA; PITX3	MicroRNAs ( miRNAs) are evolutionarily conserved, 18- to 25- nucleotide, non-protein coding transcripts that posttranscriptionally regulate gene expression during development. miRNAs also occur in postmitotic cells, such as neurons in the mammalian central nervous system, but their function is less well characterized. We investigated the role of miRNAs in mammalian midbrain dopaminergic neurons ( DNs). We identified a miRNA, miR-133b, that is specifically expressed in midbrain DNs and is deficient in midbrain tissue from patients with Parkinson's disease. miR-133b regulates the maturation and function of midbrain DNs within a negative feedback circuit that includes the paired-like homeodomain transcription factor Pitx3. We propose a role for this feedback circuit in the fine-tuning of dopaminergic behaviors such as locomotion.	Columbia Univ, Coll Phys & Surg 15 403, Dept Pathol, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg 15 403, Dept Neurol, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg 15 403, Taub Inst, New York, NY 10032 USA; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Columbia University; Columbia University; Columbia University; Cold Spring Harbor Laboratory	Abeliovich, A (corresponding author), Columbia Univ, Coll Phys & Surg 15 403, Dept Pathol, Ctr Neurobiol & Behav, 630 W 168th St, New York, NY 10032 USA.	aa900@columbia.edu	Vanti, William/E-6518-2016; Hannon, Gregory/AAB-3568-2019	Vanti, William/0000-0002-5591-5350; Inoue, Keiichi/0000-0002-7101-486X; Murchison, Elizabeth Proby/0000-0001-7462-8907	NINDS NIH HHS [R01 NS064433, R01 NS064433-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064433] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Chuhma N, 2004, J NEUROSCI, V24, P972, DOI 10.1523/JNEUROSCI.4317-03.2004; Davidson TJ, 2004, J NEUROSCI, V24, P10040, DOI 10.1523/JNEUROSCI.3643-04.2004; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hwang DY, 2003, MOL BRAIN RES, V114, P123, DOI 10.1016/S0169-328X(03)00162-1; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Smidt MP, 2004, CELL TISSUE RES, V318, P35, DOI 10.1007/s00441-004-0943-1; van den Munckhof P, 2003, DEVELOPMENT, V130, P2535, DOI 10.1242/dev.00464; Wallen A, 2003, ANN NY ACAD SCI, V991, P48	16	917	977	1	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 31	2007	317	5842					1220	1224		10.1126/science.1140481	http://dx.doi.org/10.1126/science.1140481			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205PJ	17761882	Green Accepted			2022-12-01	WOS:000249126800040
J	Spektor, A; Tsang, WY; Khoo, D; Dynlacht, BD				Spektor, Alexander; Tsang, William Y.; Khoo, David; Dynlacht, Brian David			Cep97 and CP110 suppress a cilia assembly program	CELL			English	Article							CELL-CYCLE; CENTRIOLE DUPLICATION; CENTROSOMAL PROTEIN; JOUBERT-SYNDROME; MAMMALIAN-CELLS; CYTOKINESIS; GLUTAMYLATION; SUBSTRATE; TUBULIN; DISEASE	Mammalian centrioles play a dynamic role in centrosome function, but they also have the capacity to nucleate the assembly of cilia. Although controls must exist to specify these different fates, the key regulators remain largely undefined. We have purified complexes associated with CP110, a protein that plays an essential role in centrosome duplication and cytokinesis, and have identified a previously uncharacterized protein, Cep97, that recruits CP110 to centrosomes. Depletion of Cep97 or expression of dominant-negative mutants results in CP110 disappearance from centrosomes, spindle defects, and polyploidy. Remarkably, loss of Cep97 or CP110 promotes primary cilia formation in growing cells, and enforced expression of CP110 in quiescent cells suppresses their ability to assemble cilia, suggesting that Cep97 and CP110 collaborate to inhibit a ciliogenesis program. Identification of Cep97 and other genes involved in regulation of cilia assembly may accelerate our understanding of human ciliary diseases, including renal disease and retinal degeneration.	NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; NYU, Sch Med, NYU Canc Inst, New York, NY 10016 USA	New York University; New York University	Dynlacht, BD (corresponding author), NYU, Sch Med, Dept Pathol, 522 First Ave, New York, NY 10016 USA.	brian.dynlacht@med.nyu.edu		Tsang, William/0000-0002-1584-616X				Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Beisson J, 2003, CURR OPIN CELL BIOL, V15, P96, DOI 10.1016/S0955-0674(02)00017-0; Bobinnec Y, 1998, CELL MOTIL CYTOSKEL, V39, P223, DOI 10.1002/(SICI)1097-0169(1998)39:3<223::AID-CM5>3.0.CO;2-5; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Gromley A, 2003, J CELL BIOL, V161, P535, DOI 10.1083/jcb.200301105; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Michaud EJ, 2006, CANCER RES, V66, P6463, DOI 10.1158/0008-5472.CAN-06-0462; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Quarmby LM, 2005, J CELL BIOL, V169, P707, DOI 10.1083/jcb.200503053; RIEDER CL, 1979, J ULTRA MOL STRUCT R, V68, P173, DOI 10.1016/S0022-5320(79)90152-7; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; SOROKIN SP, 1968, J CELL SCI, V3, P207; Tsang WY, 2006, MOL BIOL CELL, V17, P3423, DOI 10.1091/mbc.E06-04-0371; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015; Zou CZ, 2005, J CELL BIOL, V171, P437, DOI 10.1083/jcb.200506185	23	298	306	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 24	2007	130	4					678	690		10.1016/j.cell.2007.06.027	http://dx.doi.org/10.1016/j.cell.2007.06.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	208KY	17719545	Bronze			2022-12-01	WOS:000249319400018
J	Torres, EM; Sokolsky, T; Tucker, CM; Chan, LY; Boselli, M; Dunham, MJ; Amon, A				Torres, Eduardo M.; Sokolsky, Tanya; Tucker, Cheryl M.; Chan, Leon Y.; Boselli, Monica; Dunham, Maitreya J.; Amon, Angelika			Effects of aneuploidy on cellular physiology and cell division in haploid yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION; EXPRESSION; CANCER; RESISTANCE; GENOME; KINASE; GENES; CYCLE; WHI5	Aneuploidy is a condition frequently found in tumor cells, but its effect on cellular physiology is not known. We have characterized one aspect of aneuploidy: the gain of extra chromosomes. We created a collection of haploid yeast strains that each bear an extra copy of one or more of almost all of the yeast chromosomes. Their characterization revealed that aneuploid strains share a number of phenotypes, including defects in cell cycle progression, increased glucose uptake, and increased sensitivity to conditions interfering with protein synthesis and protein folding. These phenotypes were observed only in strains carrying additional yeast genes, which indicates that they reflect the consequences of additional protein production as well as the resulting imbalances in cellular protein composition. We conclude that aneuploidy causes not only a proliferative disadvantage but also a set of phenotypes that is independent of the identity of the individual extra chromosomes.	MIT, Canc Res Ctr, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Princeton University	Amon, A (corresponding author), MIT, Canc Res Ctr, Howard Hughes Med Inst, E17-233,40 Ames St, Cambridge, MA 02139 USA.	angelika@mit.edu		Amon, Angelika/0000-0001-9837-0314; Dunham, Maitreya/0000-0001-9944-2666	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM056800, R01GM056800, P50GM071508] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM56800, GM071508] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALZI E, 1994, J BIOL CHEM, V269, P2206; BISSINGER PH, 1994, J BIOL CHEM, V269, P4180; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hartwell L.H., 1982, REC ADV YEAST MOL BI, V1, P28; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; KATZ W, 1990, MOL CELL BIOL, V10, P5286, DOI 10.1128/MCB.10.10.5286; Lehninger A. L., 1993, PRINCIPLES BIOCH; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LINDSLEY DL, 1972, GENETICS, V71, P157; NILSSONTILLGREN T, 1980, CARLSBERG RES COMMUN, V45, P113, DOI 10.1007/BF02906512; Niwa O, 2006, YEAST, V23, P937, DOI 10.1002/yea.1411; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; ROSENSTRAUS MJ, 1978, GENETICS, V90, P735; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SEGAL DJ, 1974, J CELL PHYSIOL, V83, P85, DOI 10.1002/jcp.1040830112; STUART D, 1995, GENE DEV, V9, P2780, DOI 10.1101/gad.9.22.2780; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; WITTENBERG C, 1990, CELL, V62, P225, DOI 10.1016/0092-8674(90)90361-H	29	621	629	5	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					916	924		10.1126/science.1142210	http://dx.doi.org/10.1126/science.1142210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702937				2022-12-01	WOS:000248780200031
J	Avorn, J				Avorn, Jerry			Keeping science on top in drug evaluation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Avorn J., 2005, POWERFUL MED BENEFIT; *CTR DRUG EV RES, 2007, 21888 NDA CTR DRUG E; *FDA ARTHR ADV COM, 2007, ARC ET; HARRIS G, 2005, NY TIMES        0827, pA1	4	15	16	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 16	2007	357	7					633	635		10.1056/NEJMp078134	http://dx.doi.org/10.1056/NEJMp078134			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	200EF	17699813				2022-12-01	WOS:000248746000001
J	Borneman, AR; Gianoulis, TA; Zhang, ZDD; Yu, HY; Rozowsky, J; Seringhaus, MR; Wang, LY; Gerstein, M; Snyder, M				Borneman, Anthony R.; Gianoulis, Tara A.; Zhang, Zhengdong D.; Yu, Haiyuan; Rozowsky, Joel; Seringhaus, Michael R.; Wang, Lu Yong; Gerstein, Mark; Snyder, Michael			Divergence of transcription factor binding sites across related yeast species	SCIENCE			English	Article							CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; GENES; GENOME; SEQUENCE; GROWTH; FILAMENTATION; PROTEINS; ELEMENTS	Characterization of interspecies differences in gene regulation is crucial for understanding the molecular basis of both phenotypic diversity and evolution. By means of chromatin immunoprecipitation and DNA microarray analysis, the divergence in the binding sites of the pseudohyphal regulators Ste12 and Tec1 was determined in the yeasts Saccharomyces cerevisiae, S. mikatae, and S. bayanus under pseudohyphal conditions. We have shown that most of these sites have diverged across these species, far exceeding the interspecies variation in orthologous genes. A group of Ste12 targets was shown to be bound only in S. mikatae and S. bayanus under pseudohyphal conditions. Many of these genes are targets of Ste12 during mating in S. cerevisiae, indicating that specialization between the two pathways has occurred in this species. Transcription factor binding sites have therefore diverged substantially faster than ortholog content. Thus, gene regulation resulting from transcription factor binding is likely to be a major cause of divergence between related species.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA; Yale Univ, Program Computat Biol, New Haven, CT 06511 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; Siemens Corp Res, Integrated Data Syst Dept, Princeton, NJ 08540 USA; Yale Univ, Dept Comp Sci, New Haven, CT 06511 USA	Yale University; Yale University; Yale University; Siemens AG; Yale University	Snyder, M (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA.	michael.snyder@yale.edu		Borneman, Anthony/0000-0001-8491-7235; Snyder, Michael/0000-0003-0784-7987; Rozowsky, Joel/0000-0002-3565-0762				Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BIRSE CE, 1993, INFECT IMMUN, V61, P3648, DOI 10.1128/IAI.61.9.3648-3655.1993; Borneman AR, 2006, GENE DEV, V20, P435, DOI 10.1101/gad.1389306; BORNEMAN AR, IN PRESS FUNCT INTEG; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Braun BR, 2000, GENETICS, V156, P31; Braun BR, 2000, GENETICS, V155, P57; Chou S, 2006, MOL CELL BIOL, V26, P4794, DOI 10.1128/MCB.02053-05; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; DOLAN JW, 1989, P NATL ACAD SCI USA, V86, P5703, DOI 10.1073/pnas.86.15.5703; FIELDS S, 1985, CELL, V42, P923, DOI 10.1016/0092-8674(85)90288-0; Gavrias V, 1996, MOL MICROBIOL, V19, P1255, DOI 10.1111/j.1365-2958.1996.tb02470.x; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Piskur J, 2004, MOL MICROBIOL, V53, P381, DOI 10.1111/j.1365-2958.2004.04182.x; Prinz S, 2004, GENOME RES, V14, P380, DOI 10.1101/gr.2020604; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Sanchez-Martinez C, 2001, CURR OPIN MICROBIOL, V4, P214, DOI 10.1016/S1369-5274(00)00191-0; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; WHITE TC, 1993, J BACTERIOL, V175, P6126, DOI 10.1128/JB.175.19.6126-6133.1993; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5	27	279	285	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2007	317	5839					815	819		10.1126/science.1140748	http://dx.doi.org/10.1126/science.1140748			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690298				2022-12-01	WOS:000248624500044
J	Crosby, SS; Apovian, CM; Grodin, MA				Crosby, Sondra S.; Apovian, Caroline M.; Grodin, Michael A.			Hunger strikes, force-feeding, and physicians' responsibilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA USA	Boston University; Boston University; Boston University	Crosby, SS (corresponding author), Boston Med Ctr, Sect Gen Internal Med ACC5, 850 Harrison Ave, Boston, MA 02118 USA.	scrosby@bu.edu		Apovian, Caroline/0000-0002-8029-1922; Grodin, Michael/0000-0002-0929-8929; Crosby, Sondra/0000-0002-1672-5407				Altun G, 2004, FORENSIC SCI INT, V146, P35, DOI 10.1016/j.forsciint.2004.03.022; Annas GJ, 2006, NEW ENGL J MED, V355, P1377, DOI 10.1056/NEJMhle062316; APOVIAN CM, 1990, CRIT CARE MED, V18, P1030, DOI 10.1097/00003246-199009000-00021; Cahill GF, 1998, AM J CLIN NUTR, V68, P1; Crook MA, 2001, NUTRITION, V17, P632, DOI 10.1016/S0899-9007(01)00542-1; FELIG P, 1970, NEW ENGL J MED, V282, P166; Fessler DMT, 2003, J MED ETHICS, V29, P243, DOI 10.1136/jme.29.4.243; GOLDEN T, 2007, NY TIMES        0409, pA12; Golden Tim, 2006, N Y Times Web, pA20; *J WEIR FDN HLTH H, 1995, ASS HUNG STRIK MAN P; KALK WJ, 1991, LANCET, V337, P660, DOI 10.1016/0140-6736(91)92465-E; KERNDT PR, 1982, WESTERN J MED, V137, P379; Nicholson FB, 2000, J GASTROEN HEPATOL, V15, P21, DOI 10.1046/j.1440-1746.2000.02004.x; OCONNOR A, 1988, MED SCI LAW, V28, P62, DOI 10.1177/002580248802800115; Peel M, 1997, BRIT MED J, V315, P829, DOI 10.1136/bmj.315.7112.829	15	35	35	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2007	298	5					563	566		10.1001/jama.298.5.563	http://dx.doi.org/10.1001/jama.298.5.563			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	195US	17666678				2022-12-01	WOS:000248438100025
J	Galan, JE				Galan, Jorge E.			SnapShot: Effector proteins of type III secretion systems	CELL			English	Editorial Material							HOST-CELLS; IMMUNE-RESPONSES; SHIGELLA; MIMICRY		Yale Univ, Sch Med, Clin Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Clin Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.							Abrahams GL, 2006, CELL MICROBIOL, V8, P728, DOI 10.1111/j.1462-5822.2006.00706.x; Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Caron E, 2006, CURR OPIN MICROBIOL, V9, P40, DOI 10.1016/j.mib.2005.12.008; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Mukherjee S, 2007, TRENDS BIOCHEM SCI, V32, P210, DOI 10.1016/j.tibs.2007.03.007; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Rytkonen A, 2007, P NATL ACAD SCI USA, V104, P3502, DOI 10.1073/pnas.0610095104; Tam VC, 2007, CELL HOST MICROBE, V1, P95, DOI 10.1016/j.chom.2007.03.005; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Worley MJ, 2006, P NATL ACAD SCI USA, V103, P17915, DOI 10.1073/pnas.0604054103; Yoshida S, 2006, SCIENCE, V314, P985, DOI 10.1126/science.1133174; Zhang L, 2006, MOL PHARMACEUT, V3, P62, DOI 10.1021/mp050095h	16	17	19	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2007	130	1					192	U5	e1	10.1016/j.cell.2007.06.042	http://dx.doi.org/10.1016/j.cell.2007.06.042			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632065	Bronze			2022-12-01	WOS:000248587000021
J	Nakatogawa, H; Ichimura, Y; Ohsumi, Y				Nakatogawa, Hitoshi; Ichimura, Yoshinobu; Ohsumi, Yoshinori			Atg8, a ubiquitin-like protein required for autophagosome formation, mediates membrane tethering and hemifusion	CELL			English	Article							MAMMALIAN HOMOLOG; FUSION; YEAST; RECONSTITUTION; BINDING; STATE	Autophagy involves de novo formation of double membrane- bound structures called autophagosomes, which engulf material to be degraded in lytic compartments. Atg8 is a ubiquitinlike protein required for this process in Saccharomyces cerevisiae that can be conjugated to the lipid phosphatidylethanolamine by a ubiquitin- like system. Here, we show using an in vitro system that Atg8 mediates the tethering and hemifusion of membranes, which are evoked by the lipidation of the protein and reversibly modulated by the deconjugation enzyme Atg4. Mutational analyses suggest that membrane tethering and hemifusion observed in vitro represent an authentic function of Atg8 in autophagosome formation in vivo. In addition, electron microscopic analyses indicate that these functions of Atg8 are involved in the expansion of autophagosomal membranes. Our results provide further insights into the mechanisms underlying the unique membrane dynamics of autophagy and also indicate the functional versatility of ubiquitin- like proteins.	Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Ohsumi, Y (corresponding author), Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan.	yohsumi@nibb.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Nakatogawa, Hitoshi/D-5155-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Nakatogawa, Hitoshi/0000-0002-5828-0741				Akiyama Y, 2003, J BIOL CHEM, V278, P18146, DOI 10.1074/jbc.M302152200; Amar N, 2006, EMBO REP, V7, P635, DOI 10.1038/sj.embor.7400698; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Chen XC, 2006, BIOPHYS J, V90, P2062, DOI 10.1529/biophysj.105.071415; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; Coyle JE, 2002, NEURON, V33, P63, DOI 10.1016/S0896-6273(01)00558-X; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Hanada T, 2005, AUTOPHAGY, V1, P110, DOI 10.4161/auto.1.2.1858; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KEMBLE GW, 1994, CELL, V76, P383, DOI 10.1016/0092-8674(94)90344-1; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Meers P, 2000, BBA-BIOMEMBRANES, V1467, P227, DOI 10.1016/S0005-2736(00)00224-8; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Paz Y, 2000, J BIOL CHEM, V275, P25445, DOI 10.1074/jbc.C000307200; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395	28	842	879	2	100	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2007	130	1					165	178		10.1016/j.cell.2007.05.021	http://dx.doi.org/10.1016/j.cell.2007.05.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632063	Bronze			2022-12-01	WOS:000248587000019
J	Tomita, K; Cooper, JP				Tomita, Kazunori; Cooper, Julia Promisel			The telomere bouquet controls the meiotic spindle	CELL			English	Article							OSCILLATORY NUCLEAR-MOVEMENT; YEAST SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; POLE BODY; CHROMOSOME SYNAPSIS; TAZ1 PROTEIN; MEIOSIS; RECOMBINATION; PROPHASE; MICROTUBULES	Bouquet formation, in which telomeres gather to a small region of the nuclear membrane in early meiosis, has been observed in diverse eukaryotes, but the function of the bouquet has remained a mystery. Here, we demonstrate that the telomere bouquet plays a crucial role in controlling the behavior of the fission yeast microtubule- organizing center ( known as the spindle pole body or SPB) and the meiotic spindle. Using mutations that specifically disrupt the bouquet, we analyze chromosome, SPB, and spindle dynamics throughout meiosis. If the bouquet fails to form, the SPB becomes fragmented at meiosis I, leading to monopolar, multiple, and mislocalized spindles. Correct SPB and spindle behavior require not only the SPB recruitment of telomere proteins but also that the proteins are properly bound to telomeric DNA. This discovery illuminates an unanticipated level of communication between chromosomes and the spindle apparatus that may be widely conserved among eukaryotes.	Canc Res UK, Telomere Biol Lab, London WC2A 3PX, England	Cancer Research UK	Cooper, JP (corresponding author), Canc Res UK, Telomere Biol Lab, London WC2A 3PX, England.	julie.cooper@cancer.org.uk	Tomita, Kazunori/P-6363-2019	Tomita, Kazunori/0000-0003-1096-6725; cooper, julia promisel/0000-0003-2171-2587				Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Bridge AJ, 1998, GENE DEV, V12, P927, DOI 10.1101/gad.12.7.927; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chang L, 2000, P NATL ACAD SCI USA, V97, P5249, DOI 10.1073/pnas.97.10.5249; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Chikashige Y, 1997, EMBO J, V16, P193, DOI 10.1093/emboj/16.1.193; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Chua PR, 1997, GENE DEV, V11, P1786, DOI 10.1101/gad.11.14.1786; Conrad MN, 1997, SCIENCE, V276, P1252, DOI 10.1126/science.276.5316.1252; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; DEVEAUX LC, 1992, GENETICS, V130, P251; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; Ding DQ, 1998, J CELL SCI, V111, P701; Ding R, 1997, MOL BIOL CELL, V8, P1461, DOI 10.1091/mbc.8.8.1461; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Flory MR, 2002, CELL GROWTH DIFFER, V13, P47; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Golubovskaya IN, 2002, GENETICS, V162, P1979; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; Harper L, 2004, J CELL SCI, V117, P4025, DOI 10.1242/jcs.01363; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jin Y, 2005, DEV CELL, V9, P63, DOI 10.1016/j.devcel.2005.04.016; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Liebe B, 2004, MOL BIOL CELL, V15, P827, DOI 10.1091/mbc.E03-07-0524; Mahoney NM, 2006, CURR BIOL, V16, P564, DOI 10.1016/j.cub.2006.01.053; MARO B, 1985, J CELL BIOL, V101, P1665, DOI 10.1083/jcb.101.5.1665; Martin-Castellanos C, 2005, CURR BIOL, V15, P2056, DOI 10.1016/j.cub.2005.10.038; MESSINGER SM, 1991, J CELL SCI, V100, P289; Miki F, 2002, MOL BIOL CELL, V13, P930, DOI 10.1091/mbc.01-11-0543; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Niccoli T, 2004, J CELL SCI, V117, P5543, DOI 10.1242/jcs.01475; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; Saito TT, 2006, J CELL BIOL, V173, P27, DOI 10.1083/jcb.200512129; Saito TT, 2005, J CELL SCI, V118, P447, DOI 10.1242/jcs.01629; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Scherthan H, 2000, MOL BIOL CELL, V11, P4189, DOI 10.1091/mbc.11.12.4189; Shimanuki M, 1997, MOL GEN GENET, V254, P238, DOI 10.1007/s004380050412; Tanaka K, 2005, CURR BIOL, V15, P1479, DOI 10.1016/j.cub.2005.07.058; Tang X, 2006, J CELL BIOL, V173, P845, DOI 10.1083/jcb.200602152; Trelles-Sticken E, 2000, J CELL BIOL, V151, P95, DOI 10.1083/jcb.151.1.95; Tuzon CT, 2004, J CELL BIOL, V165, P759, DOI 10.1083/jcb.200312061; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; West RR, 1998, MOL BIOL CELL, V9, P2839, DOI 10.1091/mbc.9.10.2839; Wu HY, 2006, MOL CELL BIOL, V26, P3683, DOI 10.1128/MCB.26.10.3683-3694.2006; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233; Yamashita A, 2006, GENETICS, V173, P1187, DOI 10.1534/genetics.105.050062; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013	55	83	83	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 13	2007	130	1					113	126		10.1016/j.cell.2007.05.024	http://dx.doi.org/10.1016/j.cell.2007.05.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	197WK	17632059	Bronze			2022-12-01	WOS:000248587000015
J	Naugler, WE; Sakurai, T; Kim, S; Maeda, S; Kim, K; Elsharkawy, AM; Karin, M				Naugler, Willscott E.; Sakurai, Toshiharu; Kim, Sunhwa; Maeda, Shin; Kim, KyoungHyun; Elsharkawy, Ahmed M.; Karin, Michael			Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production	SCIENCE			English	Article							NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; CHEMICAL HEPATOCARCINOGENESIS; ESTROGEN-RECEPTOR; INNATE IMMUNITY; RISK-FACTORS; INFLAMMATION; MICE; REGENERATION; CIRRHOSIS	Hepatocellular carcinoma (HCC), the most common liver cancer, occurs mainly in men. Similar gender disparity is seen in mice given a chemical carcinogen, diethylnitrosamine ( DEN). DEN administration caused greater increases in serum interleukin-6 (IL-6) concentration in males than it did in females. Furthermore, ablation of IL-6 abolished the gender differences in hepatocarcinogenesis in mice. DEN exposure promoted production of IL-6 in Kupffer cells (KCs) in a manner dependent on the Toll-like receptor adaptor protein MyD88, ablation of which also protected male mice from DEN-induced hepatocarcinogenesis. Estrogen inhibited secretion of IL-6 from KCs exposed to necrotic hepatocytes and reduced circulating concentrations of IL-6 in DEN-treated male mice. We propose that estrogen-mediated inhibition of IL-6 production by KCs reduces liver cancer risk in females, and these findings may be used to prevent HCC in males.	Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, Div Gastroenterol, San Diego, CA 93093 USA; Asahi Life Fdn, Inst Adult Dis, Div Gastroenterol, Chiyoda Ku, Tokyo 1000005, Japan; Univ Newcastle Upon Tyne, Liver Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Asahi Life Foundation; Newcastle University - UK	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Rd,Mail Code 0723, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu		Kim, Kyounghyun/0000-0002-7240-2768; Elsharkawy, Ahmed Mohamed/0000-0001-5369-3734	NATIONAL CANCER INSTITUTE [R01CA118165, T32CA121938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004151, R37ES004151, R01ES006376] Funding Source: NIH RePORTER; NCI NIH HHS [CA118165, T32 CA121938, R01 CA118165] Funding Source: Medline; NIDDK NIH HHS [DK007202, T32 DK007202] Funding Source: Medline; NIEHS NIH HHS [ES006376, R01 ES006376, ES004151] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abiru S, 2006, LIVER INT, V26, P39, DOI 10.1111/j.1478-3231.2005.01191.x; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Erikoglu M, 2005, SURG TODAY, V35, P467, DOI 10.1007/s00595-004-2958-3; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Ghebranious N, 1998, HEPATOLOGY, V27, P383, DOI 10.1002/hep.510270211; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; KOVALSZKY I, 1992, CARCINOGENESIS, V13, P773, DOI 10.1093/carcin/13.5.773; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Nakatani T, 2001, JPN J CANCER RES, V92, P249, DOI 10.1111/j.1349-7006.2001.tb01089.x; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Sherman M, 2005, SEMIN LIVER DIS, V25, P143, DOI 10.1055/s-2005-871194; Soresi M, 2006, WORLD J GASTROENTERO, V12, P2563, DOI 10.3748/wjg.v12.i16.2563; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Suzuki T, 2007, J APPL PHYSIOL, V102, P163, DOI 10.1152/japplphysiol.00964.2006; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Velayudham A, 2006, J HEPATOL, V45, P813, DOI 10.1016/j.jhep.2006.06.017; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Zheng R, 2006, MOL MED, V12, P65, DOI 10.2119/2006-00030.Zheng	27	1388	1470	11	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2007	317	5834					121	124		10.1126/science.1140485	http://dx.doi.org/10.1126/science.1140485			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17615358				2022-12-01	WOS:000247776700066
J	Rakoff-Nahoum, S; Medzhitov, R				Rakoff-Nahoum, Seth; Medzhitov, Ruslan			Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88	SCIENCE			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; SYSTEMIC INFLAMMATION; COLORECTAL-CANCER; KNOCKOUT MICE; MUTATION; INJURY; MOUSE; SUPPRESSION; INHIBITION	Inflammation is increasingly recognized as an important component of tumorigenesis, although the mechanisms and pathways involved are not well understood. Tumor development is regulated by products of several modifier genes, but instructions for their tumor-specific expression are currently unknown. We show that the signaling through the adaptor protein MyD88 has a critical role in spontaneous tumor development in mice with heterozygous mutation in the adenomatous polyposis coli (APC) gene. We found that MyD88-dependent signaling controls the expression of several key modifier genes of intestinal tumorigenesis and has a critical role in both spontaneous and carcinogen-induced tumor development. This study thus reveals the important role of an innate immune signaling pathway in intestinal tumorigenesis.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu						Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; CHO CH, 2002, FRONTIERS GASTROINTE, V25; Chulada PC, 2000, CANCER RES, V60, P4705; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; GUKATA M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hong KH, 2001, P NATL ACAD SCI USA, V98, P3935, DOI 10.1073/pnas.051635898; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kettunen HL, 2003, CANCER RES, V63, P5136; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Takaku K, 2000, J BIOL CHEM, V275, P34013, DOI 10.1074/jbc.C000586200; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402	28	456	475	4	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2007	317	5834					124	127		10.1126/science.1140488	http://dx.doi.org/10.1126/science.1140488			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	186KD	17615359				2022-12-01	WOS:000247776700067
J	Yazawa, M; Ferrante, C; Feng, J; Mio, K; Ogura, T; Zhang, M; Lin, PH; Pan, Z; Komazaki, S; Kato, K; Nishi, M; Zhao, XL; Weisleder, N; Sato, C; Ma, JJ; Takeshima, H				Yazawa, Masayuki; Ferrante, Christopher; Feng, Jue; Mio, Kazuhiro; Ogura, Toshihiko; Zhang, Miao; Lin, Pei-Hui; Pan, Zui; Komazaki, Shinji; Kato, Kazuhiro; Nishi, Miyuki; Zhao, Xiaoli; Weisleder, Noah; Sato, Chikara; Ma, Jianjie; Takeshima, Hiroshi			TRIC channels are essential for Ca2+ handling in intracellular stores	NATURE			English	Article							SARCOPLASMIC-RETICULUM VESICLES; AUTOMATIC PARTICLE PICKUP; CALCIUM-RELEASE; RECEPTOR; ION; EXPRESSION; TOPOLOGY; NETWORK; FAMILY; BLOCK	Cell signalling requires efficient Ca2+ mobilization from intracellular stores through Ca2+ release channels, as well as predicted counter-movement of ions across the sarcoplasmic/endoplasmic reticulum membrane to balance the transient negative potential generated by Ca2+ release(1-7). Ca2+ release channels were cloned more than 15 years ago(8,9), whereas the molecular identity of putative counter- ion channels remains unknown. Here we report two TRIC ( trimeric intracellular cation) channel subtypes that are differentially expressed on intracellular stores in animal cell types. TRIC subtypes contain three proposed transmembrane segments, and form homo-trimers with a bullet-like structure. Electrophysiological measurements with purified TRIC preparations identify a monovalent cation-selective channel. In TRIC-knockout mice suffering embryonic cardiac failure, mutant cardiac myocytes show severe dysfunction in intracellular Ca2+ handling. The TRIC-deficient skeletal muscle sarcoplasmic reticulum shows reduced K+ permeability, as well as altered Ca2+ 'spark' signalling and voltage-induced Ca2+ release. Therefore, TRIC channels are likely to act as counter- ion channels that function in synchronization with Ca2+ release from intracellular stores.	Kyoto Univ, Dept Biol Chem, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; Tohoku Univ, Dept Med Chem, Grad Sch Med, Miyagi 9808575, Japan; Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Ogura, Toshihiko; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Ibaraki 3058568, Japan; Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan; Saitama Med Univ, Dept Anat, Saitama 3500495, Japan	Kyoto University; Tohoku University; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); Saitama Medical University	Takeshima, H (corresponding author), Kyoto Univ, Dept Biol Chem, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan.	takeshim@pharm.kyoto-u.ac.jp	Mio, Kazuhiro/L-7488-2018; Lin, Pei-Hui/I-3011-2015; Weisleder, Noah L/A-7098-2013; Sato, Chikara/M-7183-2016	Mio, Kazuhiro/0000-0002-1655-8231; Lin, Pei-Hui/0000-0002-3894-5099; Weisleder, Noah L/0000-0002-2619-8022; Sato, Chikara/0000-0001-5543-4496; Pan, Zui/0000-0003-4105-901X; Weisleder, Noah/0000-0003-2710-3088; Takeshima, Hiroshi/0000-0003-4525-3725				ANTOON FM, 2000, DEV BIOL, V223, P279; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Collet C, 1999, J PHYSIOL-LONDON, V520, P417, DOI 10.1111/j.1469-7793.1999.00417.x; CORONADO R, 1980, NATURE, V288, P495, DOI 10.1038/288495a0; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DANI JA, 1995, CURR OPIN NEUROBIOL, V5, P310, DOI 10.1016/0959-4388(95)80043-3; EBASHI S, 1976, ANNU REV PHYSIOL, V38, P293, DOI 10.1146/annurev.ph.38.030176.001453; ENDO M, 1977, PHYSIOL REV, V57, P71, DOI 10.1152/physrev.1977.57.1.71; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; FAULK WP, 1971, IMMUNOCHEMISTRY, V8, P1081; Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200; FERNANDEZ JL, 1980, BIOCHIM BIOPHYS ACTA, V599, P552, DOI 10.1016/0005-2736(80)90199-6; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Fink RHA, 1996, ACTA PHYSIOL SCAND, V156, P387, DOI 10.1046/j.1365-201X.1996.212000.x; Frank J, 2006, 3 DIMENSIONAL ELECT; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; HARAUZ G, 1986, OPTIK, V73, P146; Kourie JI, 1996, BIOPHYS J, V70, P202, DOI 10.1016/S0006-3495(96)79564-4; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LIU QY, 1991, FEBS LETT, V291, P13, DOI 10.1016/0014-5793(91)81092-M; MA JJ, 1993, J GEN PHYSIOL, V102, P1031, DOI 10.1085/jgp.102.6.1031; MEISSNER G, 1983, MOL CELL BIOCHEM, V55, P65; MEISSNER G, 1980, J BIOL CHEM, V255, P6814; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Mio K, 2005, BIOCHEM BIOPH RES CO, V337, P998, DOI 10.1016/j.bbrc.2005.09.141; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Ogura T, 2004, J STRUCT BIOL, V145, P63, DOI 10.1016/S1047-8477(03)00139-4; Ogura T, 2004, J STRUCT BIOL, V146, P344, DOI 10.1016/j.jsb.2004.01.007; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; SOMLYO AV, 1977, NATURE, V268, P556, DOI 10.1038/268556a0; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; Takeshima H, 1998, EMBO J, V17, P3309, DOI 10.1093/emboj/17.12.3309; Takeshima H, 1998, BIOCHEM J, V331, P317, DOI 10.1042/bj3310317; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Weisleder N, 2006, J CELL BIOL, V174, P639, DOI 10.1083/jcb.200604166; ZHANG M, IN PRESS CELL CALCIU	40	115	125	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 5	2007	448	7149					78	82		10.1038/nature05928	http://dx.doi.org/10.1038/nature05928			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	185OS	17611541				2022-12-01	WOS:000247720900041
J	Hierro, A; Rojas, AL; Rojas, R; Murthy, N; Effantin, G; Kajava, AV; Steven, AC; Bonifacino, JS; Hurley, JH				Hierro, Aitor; Rojas, Adriana L.; Rojas, Raul; Murthy, Namita; Effantin, Gregory; Kajava, Andrey V.; Steven, Alasdair C.; Bonifacino, Juan S.; Hurley, James H.			Functional architecture of the retromer cargo-recognition complex	NATURE			English	Article							POLYCISTRONIC EXPRESSION; RETROGRADE TRANSPORT; MAMMALIAN RETROMER; REQUIRES RETROMER; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MODEL; PROTEINS; DOMAINS; VPS29	The retromer complex(1,2) is required for the sorting of acid hydrolases to lysosomes(3-7), transcytosis of the polymeric immunoglobulin receptor(8), Wnt gradient formation(9,10), iron transporter recycling(11) and processing of the amyloid precursor protein(12). Human retromer consists of two smaller complexes: the cargo recognition VPS26-VPS29-VPS35 heterotrimer and a membrane-targeting heterodimer or homodimer of SNX1 and/or SNX2 (ref. 13). Here we report the crystal structure of a VPS29-VPS35 subcomplex showing how the metallophosphoesterase-fold subunit VPS29 (refs 14, 15) acts as a scaffold for the carboxyterminal half of VPS35. VPS35 forms a horseshoe-shaped, right-handed, alpha-helical solenoid, the concave face of which completely covers the metal-binding site of VPS29, whereas the convex face exposes a series of hydrophobic interhelical grooves. Electron microscopy shows that the intact VPS26-VPS29-VPS35 complex is a stick-shaped, flexible structure, approximately 21 nm long. A hybrid structural model derived from crystal structures, electron microscopy, interaction studies and bioinformatics shows that the alpha-solenoid fold extends the full length of VPS35, and that VPS26 is bound at the opposite end from VPS29. This extended structure presents multiple binding sites for the SNX complex and receptor cargo, and appears capable of flexing to conform to curved vesicular membranes.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; NIAMSD, Struct Biol Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA; Univ Montpellier, CNRS, Ctr Rech Biochim Macromol, F-34293 Montpellier, France	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Hierro, Aitor/F-9998-2011; Rojas, Adriana/G-2403-2011; Kajava, Andrey V/E-1107-2014	Hierro, Aitor/0000-0002-7721-1581; Rojas, Adriana/0000-0002-7358-3505; Kajava, Andrey V/0000-0002-2342-6886; Bonifacino, Juan S./0000-0002-5673-6370	Intramural NIH HHS [Z01 DK036118-14] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR027015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036118, Z01DK036128] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Collins BM, 2005, NAT STRUCT MOL BIOL, V12, P594, DOI 10.1038/nsmb954; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Damen E, 2006, BIOCHEM J, V398, P399, DOI 10.1042/BJ20060033; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hierro A, 2005, METHOD ENZYMOL, V403, P322, DOI 10.1016/S0076-6879(05)03027-2; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Martina JA, 2003, J BIOL CHEM, V278, P29376, DOI 10.1074/jbc.M301294200; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Nothwehr SF, 2000, J CELL BIOL, V151, P297, DOI 10.1083/jcb.151.2.297; Nothwehr SF, 1999, MOL BIOL CELL, V10, P875, DOI 10.1091/mbc.10.4.875; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Shiba T, 2002, NATURE, V415, P937, DOI 10.1038/415937a; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Strochlic TI, 2007, J CELL BIOL, V177, P115, DOI 10.1083/jcb.200609161; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Verges M, 2004, NAT CELL BIOL, V6, P763, DOI 10.1038/ncb1153; Wang DQ, 2005, J BIOL CHEM, V280, P22962, DOI 10.1074/jbc.M500464200; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Ybe JA, 1999, NATURE, V399, P371, DOI 10.1038/20708	43	210	216	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2007	449	7165					1063	U8		10.1038/nature06216	http://dx.doi.org/10.1038/nature06216			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223TK	17891154	Green Accepted			2022-12-01	WOS:000250395000055
J	Xiao, CC; Calado, DP; Galler, G; Thai, TH; Patterson, HC; Wang, J; Rajewsky, N; Bender, TP; Rajewsky, K				Xiao, Changchun; Calado, Dinis Pedro; Galler, Gunther; Thai, To-Ha; Patterson, Heide Christine; Wang, Jing; Rajewsky, Nikolaus; Bender, Timothy P.; Rajewsky, Klaus			MiR-150 controls B cell differentiation by targeting the transcription factor c-myb	CELL			English	Article							PERITONEAL-CELLS; GENE-EXPRESSION; MARGINAL ZONE; PROLIFERATION; MICRORNAS; APOPTOSIS; MOTIFS; RNAS; GUT	MiR-150 is a microRNA ( miRNA) specifically expressed in mature lymphocytes, but not their progenitors. A top predicted target of miR-150 is c-Myb, a transcription factor controlling multiple steps of lymphocyte development. Combining loss- and gain-of-function gene targeting approaches for miR-150 with conditional and partial ablation of c-Myb, we show that miR150 indeed controls c-Myb expression in vivo in a dose-dependent manner over a narrow range of miRNA and c-Myb concentrations and that this dramatically affects lymphocyte development and response. Our results identify a key transcription factor as a critical target of a stage-specifically expressed miRNA in lymphocytes and suggest that this and perhaps other miRNAs have evolved to control the expression of just a few critical target proteins in particular cellular contexts.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; NYU, Dept Biol, Ctr Comparat Funct Genom, New York, NY 10003 USA; Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; New York University; University of Virginia	Rajewsky, K (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	rajewsky@cbr.med.harvard.edu	Calado, Dinis/U-8379-2019	Calado, Dinis/0000-0001-8239-7184; Rajewsky, Klaus/0000-0002-6633-6370; Rajewsky, Nikolaus/0000-0002-4785-4332; Galler, Gunther/0000-0003-4507-5957	NCI NIH HHS [R01 CA085842, CA85842] Funding Source: Medline; NIAID NIH HHS [AI054636, AI064345, R01 AI059294, AI059294] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064345, R37AI054636, R01AI059294] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; FORSTER I, 1987, EUR J IMMUNOL, V17, P521, DOI 10.1002/eji.1830170414; GOLAY J, 1992, J IMMUNOL, V149, P300; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Kaminski DA, 2006, J IMMUNOL, V177, P6025, DOI 10.4049/jimmunol.177.9.6025; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; PAUZA CD, 1987, MOL CELL BIOL, V7, P342, DOI 10.1128/MCB.7.1.342; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; Salomoni P, 1997, P NATL ACAD SCI USA, V94, P3296, DOI 10.1073/pnas.94.7.3296; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Taylor D, 1996, GENE DEV, V10, P2732, DOI 10.1101/gad.10.21.2732; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Unoki M, 2003, INT J ONCOL, V22, P1217; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	39	804	870	2	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2007	131	1					146	159		10.1016/j.cell.2007.07.021	http://dx.doi.org/10.1016/j.cell.2007.07.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	217FV	17923094	Bronze			2022-12-01	WOS:000249934700018
J	Baker, J				Baker, Joanne			Water, water, not everywhere? Introduction	SCIENCE			English	Editorial Material																			0	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2007	317	5845					1705	1705		10.1126/science.317.5845.1705	http://dx.doi.org/10.1126/science.317.5845.1705			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	212HD	17885124				2022-12-01	WOS:000249585900033
J	Dai, C; Whitesell, L; Rogers, AB; Lindquist, S				Dai, Chengkai; Whitesell, Luke; Rogers, Arlin B.; Lindquist, Susan			Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis	CELL			English	Article							PROTEIN-KINASE-A; TRANSCRIPTION FACTOR-1; TARGETED DISRUPTION; IN-VITRO; EXPRESSION; PROTECTION; APOPTOSIS; CELLS; HSF1; THERMOTOLERANCE	Heat shock factor 1 ( HSF1) is the master regulator of the heat shock response in eukaryotes, a very highly conserved protective mechanism. HSF1 function increases survival under a great many pathophysiological conditions. How it might be involved in malignancy remains largely unexplored. We report that eliminating HSF1 protects mice from tumors induced by mutations of the RAS oncogene or a hot spot mutation in the tumor suppressor p53. In cell culture, HSF1 supports malignant transformation by orchestrating a network of core cellular functions including proliferation, survival, protein synthesis, and glucose metabolism. The striking effects of HSF1 on oncogenic transformation are not limited to mouse systems or tumor initiation; human cancer lines of diverse origins show much greater dependence on HSF1 function to maintain proliferation and survival than their nontransformed counterparts. While it enhances organismal survival and longevity under most circumstances, HSF1 has the opposite effect in supporting the lethal phenomenon of cancer.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; MIT, Div Comparat Med, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; Beausejour CM, 2006, NATURE, V443, P404, DOI 10.1038/nature05221; Birch-Machin I, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r63; BISSELL MJ, 1976, SCIENCE, V191, P856, DOI 10.1126/science.175441; Bossis I, 2004, ENDOCR-RELAT CANCER, V11, P265, DOI 10.1677/erc.0.0110265; Christians ES, 2002, CRIT CARE MED, V30, pS43, DOI 10.1097/00003246-200201001-00006; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Ferguson SB, 2005, GENETICS, V169, P1203, DOI 10.1534/genetics.104.034256; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gutsmann-Conrad A, 1998, EXP CELL RES, V241, P404, DOI 10.1006/excr.1998.4069; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Khaleque MA, 2005, ONCOGENE, V24, P6564, DOI 10.1038/sj.onc.1208798; Lu AG, 2002, J NEUROCHEM, V81, P355, DOI 10.1046/j.1471-4159.2002.00835.x; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; McNaught KSP, 2004, ANN NEUROL, V56, P149, DOI 10.1002/ana.20186; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; MIVECHI NF, 1995, CANCER RES, V55, P5512; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; SAWAJI Y, 1999, NY ACAD SCI, V878, P707; Sebti SM, 2004, SEMIN ONCOL, V31, P28, DOI 10.1053/j.seminoncol.2003.12.012; Stanhill A, 2006, ONCOGENE, V25, P1485, DOI 10.1038/sj.onc.1209193; Tang D, 2005, CELL STRESS CHAPERON, V10, P46, DOI 10.1379/CSC-44R.1; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Wang J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-1; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; WESTWOOD JT, 1991, NATURE, V353, P822, DOI 10.1038/353822a0; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0; YUSPA SH, 1994, CANCER RES, V54, P1178; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232	43	619	641	3	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2007	130	6					1005	1018		10.1016/j.cell.2007.07.020	http://dx.doi.org/10.1016/j.cell.2007.07.020			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889646	Green Accepted, Bronze			2022-12-01	WOS:000250507500011
J	Denchi, EL; de Lange, T				Denchi, Eros Lazzerini; de lange, Titia			Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1	NATURE			English	Article							CELL-CYCLE ARREST; DNA-DAMAGE; DYSFUNCTIONAL TELOMERES; HOMOLOGOUS RECOMBINATION; ATAXIA-TELANGIECTASIA; CHECKPOINT; COMPLEX; END; MAINTENANCE; SENESCENCE	When telomeres are rendered dysfunctional through replicative attrition of the telomeric DNA or by inhibition of shelterin(1), cells show the hallmarks of ataxia telangiectasia mutated (ATM) kinase signalling(2-4). In addition, dysfunctional telomeres might induce an ATM-independent pathway, such as ataxia telangiectasia and Rad3-related (ATR) kinase signalling, as indicated by the phosphorylation of the ATR target CHK1 in senescent cells(2,5) and the response of ATM-deficient cells to telomere dysfunction(6,7). However, because telomere attrition is accompanied by secondary DNA damage, it has remained unclear whether there is an ATM-independent pathway for the detection of damaged telomeres. Here we show that damaged mammalian telomeres can activate both ATM and ATR and address the mechanism by which the shelterin complex represses these two important DNA damage signalling pathways. We analysed the telomere damage response on depletion of either or both of the shelterin proteins telomeric repeat binding factor 2 (TRF2) and protection of telomeres 1 (POT1) from cells lacking ATM and/or ATR kinase signalling. The data indicate that TRF2 and POT1 act independently to repress these two DNA damage response pathways. TRF2 represses ATM, whereas POT1 prevents activation of ATR. Unexpectedly, we found that either ATM or ATR signalling is required for efficient non-homologous end-joining of dysfunctional telomeres. The results reveal how mammalian telomeres use multiple mechanisms to avoid DNA damage surveillance and provide an explanation for the induction of replicative senescence and genome instability by shortened telomeres.	Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10021 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10021 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011; lazzerini denchi, eros/F-7913-2010; Denchi, Eros Lazzerini/AAD-8208-2020	de Lange, Titia/0000-0002-9267-367X; lazzerini denchi, eros/0000-0001-5378-4644; 				Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bertuch AA, 2006, CURR OPIN CELL BIOL, V18, P247, DOI 10.1016/j.ceb.2006.04.005; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [DOI 10.1038/NATURE02118, 10.1038/nature02118]; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Denchi EL, 2006, GENE DEV, V20, P2648, DOI 10.1101/gad.1453606; Dimitrova N, 2006, GENE DEV, V20, P3238, DOI 10.1101/gad.1496606; Enomoto S, 2002, MOL BIOL CELL, V13, P2626, DOI 10.1091/mbc.02-02-0012; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; HOCKEMEYER D, 2007, NATURE STRUCT MOL BI; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Karlseder J, 2004, PLOS BIOL, V2, P1150, DOI 10.1371/journal.pbio.0020240; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Lobrich M, 2005, DNA REPAIR, V4, P749, DOI 10.1016/j.dnarep.2004.12.008; Qi L, 2003, CANCER RES, V63, P8188; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	29	610	639	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 30	2007	448	7157					1068	1071		10.1038/nature06065	http://dx.doi.org/10.1038/nature06065			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205EU	17687332				2022-12-01	WOS:000249097600042
J	Retchless, AC; Lawrence, JG				Retchless, Adam C.; Lawrence, Jeffrey G.			Temporal fragmentation of speciation in bacteria	SCIENCE			English	Article							HOMOLOGOUS RECOMBINATION; ESCHERICHIA-COLI; DIVERSITY	Because bacterial recombination involves the occasional transfer of small DNA fragments between strains, different sets of niche-specific genes may be maintained in populations that freely recombine at other loci. Therefore, genetic isolation may be established at different times for different chromosomal regions during speciation as recombination at niche-specific genes is curtailed. To test this model, we separated sequence divergence into rate and time components, revealing that different regions of the Escherichia coli and Salmonella enterica chromosomes diverged over a similar to 70-million-year period. Genetic isolation first occurred at regions carrying species-specific genes, indicating that physiological distinctiveness between the nascent Escherichia and Salmonella lineages was maintained for tens of millions of years before the complete genetic isolation of their chromosomes.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lawrence, JG (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	jlawrenc@pitt.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078092] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM078092] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cohan FM, 2001, SYST BIOL, V50, P513, DOI 10.1080/10635150118398; DYKHUIZEN DE, 1991, J BACTERIOL, V173, P7257, DOI 10.1128/jb.173.22.7257-7268.1991; Falush D, 2006, PHILOS T R SOC B, V361, P2045, DOI 10.1098/rstb.2006.1925; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Hanage WP, 2006, J THEOR BIOL, V239, P210, DOI 10.1016/j.jtbi.2005.08.035; Lawrence JG, 2002, THEOR POPUL BIOL, V61, P449, DOI 10.1006/tpbi.2002.1587; Mayr E., 1942, SYSTEMATICS ORIGIN S, DOI 10.2307/1790142; SHEN P, 1986, GENETICS, V112, P441; Vulic M, 1997, P NATL ACAD SCI USA, V94, P9763, DOI 10.1073/pnas.94.18.9763; Wildschutte H, 2004, P NATL ACAD SCI USA, V101, P10644, DOI 10.1073/pnas.0404028101	11	82	84	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 24	2007	317	5841					1093	1096		10.1126/science.1144876	http://dx.doi.org/10.1126/science.1144876			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	203AE	17717188				2022-12-01	WOS:000248946700048
J	Dunckley, T; Huentelman, MJ; Craig, DW; Pearson, JV; Szelinger, S; Joshipura, K; Halperin, RF; Stamper, C; Jensen, KR; Letizia, D; Hesterlee, SE; Pestronk, A; Levine, T; Bertorini, T; Graves, MC; Mozaffar, T; Jackson, CE; Bosch, P; McVey, A; Dick, A; Barohn, R; Lomen-Hoerth, C; Rosenfeld, J; O'Connor, DT; Zhang, KX; Crook, R; Ryberg, H; Hutton, M; Katz, J; Simpson, EP; Mitsumoto, H; Bowser, R; Miller, RG; Appel, SH; Stephan, DA				Dunckley, Travis; Huentelman, Matthew J.; Craig, David W.; Pearson, John V.; Szelinger, Szabolcs; Joshipura, Keta; Halperin, Rebecca F.; Stamper, Chelsea; Jensen, Kendall R.; Letizia, David; Hesterlee, Sharon E.; Pestronk, Alan; Levine, Todd; Bertorini, Tulio; Graves, Michael C.; Mozaffar, Tahseen; Jackson, Carlayne E.; Bosch, Peter; McVey, April; Dick, Arthur; Barohn, Richard; Lomen-Hoerth, Catherine; Rosenfeld, Jeffrey; O'Connor, Daniel T.; Zhang, Kuixing; Crook, Richard; Ryberg, Henrik; Hutton, Michael; Katz, Jonathan; Simpson, Ericka P.; Mitsumoto, Hiroshi; Bowser, Robert; Miller, Robert G.; Appel, Stanley H.; Stephan, Dietrich A.			Whole-genome analysis of sporadic amyotrophic lateral sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOTOR-NEURON DEGENERATION	Background: Approximately 90% of persons with amyotrophic lateral sclerosis (ALS) have the sporadic form, which may be caused by the interaction of multiple environmental factors and previously unknown genes. Methods: We performed a genomewide association analysis using 766,955 single-nucleotide polymorphisms (SNPs) found in 386 white patients with sporadic ALS and 542 neurologically normal white controls (the discovery series). Associations of SNPs with sporadic ALS were confirmed in two independent replication populations: replication series 1, with 766 case patients with the disease and 750 neurologically normal controls, and replication series 2, with 135 case patients and 275 controls. Results: We identified 10 genetic loci that are significantly associated (P<0.05) with sporadic ALS in three independent series of case patients and controls and an additional 41 loci that had significant associations in two of the three series. The most significant association with disease in white case patients as compared with controls was found for a SNP near an uncharacterized gene known as FLJ10986 (P=3.0 x 10(sup -4); odds ratio for having the genotype in patients vs. controls, 1.35; 95% confidence interval, 1.13 to 1.62). The FLJ10986 protein was found to be expressed in the spinal cord and cerebrospinal fluid of patients and of controls. Specific SNPs seem to be associated with sex, age at onset, and site of onset of sporadic ALS. Conclusions: Variants of FLJ10986 may confer susceptibility to sporadic ALS. FLJ10986 and 50 other candidate loci warrant further investigation for their potential role in conferring susceptibility to the disease.	Translat Genom Res Inst, Phoenix, AZ 85004 USA; Muscular Dystrophy Assoc, Tucson, AZ USA; Washington Univ, Sch Med, St Louis, MO USA; Phoenix Neurol Assoc, Phoenix, AZ USA; Univ Tennessee, Memphis, TN USA; Univ Calif Los Angeles, Los Angeles, CA USA; Univ Calif Irvine, Irvine, CA USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; Mayo Clin, Scottsdale, AZ USA; Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Carolinas Med Ctr, Charlotte, NC 28203 USA; Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; Mayo Clin, Coll Med, Jacksonville, FL 32224 USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; Calif Pacific Med Ctr, San Francisco, CA USA; Methodist Neurol Inst, Houston, TX USA; Columbia Univ, Med Ctr, New York, NY USA	Translational Genomics Research Institute; Washington University (WUSTL); University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California Los Angeles; University of California System; University of California Irvine; University of Texas System; University of Texas Health San Antonio; Mayo Clinic; Mayo Clinic Phoenix; University of Kansas; University of Kansas Medical Center; University of California System; University of California San Francisco; Carolinas Medical Center; University of California System; University of California San Diego; Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; California Pacific Medical Center; The Methodist Hospital System; The Methodist Hospital - Houston; Columbia University	Stephan, DA (corresponding author), Translat Genom Res Inst, 445 N 5th St, Phoenix, AZ 85004 USA.	dstephan@tgen.org	Ryberg, Henrik/AFT-8978-2022; Craig, David Wesley/K-6961-2019; Pearson, John/AAT-4211-2020; Mozaffar, Tahseen/AAE-6971-2020; Pearson, John V/F-2249-2011	Craig, David Wesley/0000-0003-2040-1955; Pearson, John V/0000-0003-0904-4598; Ryberg, Henrik/0000-0002-2652-6612				Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; Frey D, 2000, J NEUROSCI, V20, P2534; Ince P, 2000, AMYOTROPHIC LATERAL, P83; Mi RF, 2007, P NATL ACAD SCI USA, V104, P4664, DOI 10.1073/pnas.0603243104; Motegi A, 2004, J CELL SCI, V117, P3319, DOI 10.1242/jcs.01183; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pearson JV, 2007, AM J HUM GENET, V80, P126, DOI 10.1086/510686; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Wang W, 2004, J BIOL CHEM, V279, P53491, DOI 10.1074/jbc.M410370200; Wu DC, 2006, P NATL ACAD SCI USA, V103, P12132, DOI 10.1073/pnas.0603670103	16	190	199	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 23	2007	357	8					775	788		10.1056/NEJMoa070174	http://dx.doi.org/10.1056/NEJMoa070174			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202MU	17671248				2022-12-01	WOS:000248906700006
J	Tezuka, H; Abe, Y; Iwata, M; Takeuchi, H; Ishikawa, H; Matsushita, M; Shiohara, T; Akira, S; Ohteki, T				Tezuka, Hiroyuki; Abe, Yukiko; Iwata, Makoto; Takeuchi, Hajime; Ishikawa, Hiromichi; Matsushita, Masayuki; Shiohara, Tetsuo; Akira, Shizuo; Ohteki, Toshiaki			Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells	NATURE			English	Article							TARGETED DISRUPTION; BACTERIAL-INFECTION; COMMENSAL BACTERIA; DEFICIENT MOUSE; IMMUNE-SYSTEM; B-LYMPHOCYTES; RECEPTOR; GUT; RESPONSES; APRIL	Immunoglobulin-A has an irreplaceable role in the mucosal defence against infectious microbes(1-6). In human and mouse, IgA-producing plasma cells comprise similar to 20% of total plasma cells of peripheral lymphoid tissues, whereas more than 80% of plasma cells produce IgA in mucosa-associated lymphoid tissues (MALT)(1-6). One of the most biologically important and long-standing questions in immunology is why this 'biased' IgA synthesis takes place in the MALT but not other lymphoid organs. Here we show that IgA class-switch recombination (CSR) is impaired in inducible-nitric-oxide-synthase-deficient (iNOS(-/-); gene also called Nos2) mice. iNOS regulates the T-cell-dependent IgA CSR through expression of transforming growth factor-beta receptor, and the T-cell-independent IgA CSR through production of a proliferation-inducing ligand (APRIL, also called Tnfsf13) and a B-cell-activating factor of the tumour necrosis factor (TNF) family (BAFF, also called Tnfsf13b). Notably, iNOS is preferentially expressed in MALT dendritic cells in response to the recognition of commensal bacteria by toll-like receptor. Furthermore, adoptive transfer of iNOS(+) dendritic cells rescues IgA production in iNOS(-/-) mice. Further analysis revealed that the MALT dendritic cells are a TNF-alpha/iNOS-producing dendritic-cell subset, originally identified in mice infected with Listeria monocytogenes(7,8). The presence of a naturally occurring TNF-alpha/iNOS-producing dendritic-cell subset may explain the predominance of IgA production in the MALT, critical for gut homeostasis.	Akita Univ, Grad Sch Med, Dept Immunol, Akita 0108543, Japan; Tokushima Bunri Univ, Fac Pharmaceut Sci, Kagawa 7692193, Japan; Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan; Kyorin Univ, Sch Med, Dept Dermatol, Tokyo 1818611, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka 5650871, Japan	Akita University; Tokushima Bunri University; Keio University; Mitsubishi Kagaku Institute of Life Sciences (MITILS); Kyorin University; Osaka University	Ohteki, T (corresponding author), Akita Univ, Grad Sch Med, Dept Immunol, Akita 0108543, Japan.	tohteki@med.akita-u.ac.jp	Akira, Shizuo/C-3134-2009					Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Borsutzky S, 2004, J IMMUNOL, V173, P3305, DOI 10.4049/jimmunol.173.5.3305; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P141, DOI 10.1016/S0167-5699(98)01413-3; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Fujihashi K, 1996, J EXP MED, V183, P1929, DOI 10.1084/jem.183.4.1929; He B, 2003, J IMMUNOL, V171, P5215, DOI 10.4049/jimmunol.171.10.5215; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Matsunaga T, 1998, IMMUNOL REV, V166, P177, DOI 10.1111/j.1600-065X.1998.tb01262.x; MESTECKY J, 1987, ADV IMMUNOL, V40, P153, DOI 10.1016/S0065-2776(08)60240-0; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nishiyama Y, 2002, J IMMUNOL, V168, P2626, DOI 10.4049/jimmunol.168.6.2626; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Park SR, 2001, EUR J IMMUNOL, V31, P1706, DOI 10.1002/1521-4141(200106)31:6<1706::AID-IMMU1706>3.0.CO;2-Z; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shimada S, 1999, J IMMUNOL, V163, P5367; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; van Egmond M, 2001, TRENDS IMMUNOL, V22, P205, DOI 10.1016/S1471-4906(01)01873-7; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3	34	315	328	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 23	2007	448	7156					929	U7		10.1038/nature06033	http://dx.doi.org/10.1038/nature06033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	202OM	17713535				2022-12-01	WOS:000248912900047
J	Patsopoulos, NA; Tatsioni, A; Ioannidis, JPA				Patsopoulos, Nikolaos A.; Tatsioni, Athina; Ioannidis, John P. A.			Claims of sex differences - An empirical assessment in genetic associations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							GENDER-SPECIFIC ASSOCIATION; DENSITY-LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN-E GENE; SINGLE-NUCLEOTIDE POLYMORPHISM; DEPENDENT ASSOCIATION; SUBGROUP ANALYSIS; RANDOMIZED-TRIALS; CLINICAL-TRIALS; PROMOTER POLYMORPHISMS; ESSENTIAL-HYPERTENSION	Context Many studies try to probe for differences in risks between men and women, and this is a major challenge in the expanding literature of associations between genetic variants and common diseases or traits. Objective To evaluate whether prominently claimed sex differences for genetic effects have sufficient internal and external validity. Data Sources We searched PubMed through July 6, 2007, for genetic association studies claiming sex-related differences in the articles' titles. Titles and abstracts and, if necessary, the full text of the article were assessed for eligibility. Study Selection Two hundred fifteen articles were retrieved by the search. We considered eligible all retrieved association studies that claimed different genetic effects across sexes of 1 or more gene variants for any human disease or phenotype. We considered both biallelic and multiallelic markers (including haplotypes) and both binary and continuous phenotypes and traits. We excluded non-English-language studies; studies evaluating only 1 sex; studies in which sex was treated only as an independent predictor of disease; studies that did not address any association of the investigated genetic variant with a disease or trait; studies not involving humans; and studies in which the authors did not claim any sex difference. Data Extraction Two evaluators independently extracted data with a third evaluator arbitrating their discrepancies. Data evaluation included whether analyses were stated to have been specified a priori; whether sex effects were evaluated in the whole study or subgroups thereof; and whether the claims were appropriately documented, insufficiently documented, or spurious. For appropriately and insufficiently documented claims we performed the calculations for gene-sex interaction whenever raw data were available. Finally, we compared the sex-difference claims with the best internal validity against the results of other studies addressing the same interaction. Results We appraised 432 sex-difference claims in 77 eligible articles. Authors stated that sex comparisons were decided a priori for 286 claims (66.2%), while the entire sample size was used in 210 (48.6%) claims. Appropriate documentation of gene-sex interaction was recorded in 55 claims (12.7%); documentation was insufficient for 303 claims and spurious for the other 74. Data for reanalysis of claims were available for 188 comparisons. Of these, 83 (44.1%) were nominally statistically significant at a P=.05 threshold, and more than half of them (n=44) had modest P values between .01 and .05. Of 60 claims with seemingly the best internal validity, only 1 was consistently replicated in at least 2 other studies. Conclusion In this sample of highly prominent claims of sex-related differences in genetic associations, most claims were insufficiently documented or spurious, and claims with documented good internal and external validity were uncommon.	Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece; Fdn Res & Technol Hellas, Ioannina, Greece; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA	University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); Tufts University	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, Univ Campus, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Tatsioni, Athina/AAQ-5413-2020; Ioannidis, John P. A./G-9836-2011	Patsopoulos, Nikolaos/0000-0003-3757-8941				Ahmed ARH, 1999, NEUROSCI LETT, V263, P217, DOI 10.1016/S0304-3940(99)00126-3; Asselbergs FW, 2006, THROMB HAEMOSTASIS, V96, P471, DOI 10.1160/TH06-06-0335; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Austin PC, 2006, J CLIN EPIDEMIOL, V59, P964, DOI 10.1016/j.jclinepi.2006.01.012; Barnett JH, 2007, AM J PSYCHIAT, V164, P142, DOI 10.1176/appi.ajp.164.1.142; Baud P, 2007, AM J MED GENET B, V144B, P1042, DOI 10.1002/ajmg.b.30541; Ben Assayag E, 2006, THROMB HAEMOSTASIS, V95, P428, DOI 10.1160/THOS-08-0578; Beyens G, 2007, J BONE MINER RES, V22, P1062, DOI 10.1359/JBMR.070333; Bolufer P, 2007, HAEMATOLOGICA, V92, P308, DOI 10.3324/haematol.10752; Brookes S T, 2001, Health Technol Assess, V5, P1; Brookes ST, 2004, J CLIN EPIDEMIOL, V57, P229, DOI 10.1016/j.jclinepi.2003.08.009; Bullido MJ, 2000, NEUROSCI LETT, V289, P213, DOI 10.1016/S0304-3940(00)01304-5; *CAN COOP STUD GRO, 1978, NEW ENGL J MED, V299, P53; Carter AM, 1997, ARTERIOSCL THROM VAS, V17, P589, DOI 10.1161/01.ATV.17.3.589; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Chang JC, 2004, PEDIAT ALLERG IMM-UK, V15, P506, DOI 10.1111/j.1399-3038.2004.00161.x; Chen WY, 2004, BIOCHEM BIOPH RES CO, V319, P866, DOI 10.1016/j.bbrc.2004.05.060; Chen Y, 2004, TISSUE ANTIGENS, V63, P41, DOI 10.1111/j.1399-0039.2004.00150.x; Collins R, 1996, OXFORD TXB MED, V1, P21; Corder EH, 2004, ANN NY ACAD SCI, V1019, P24, DOI 10.1196/annals.1297.005; Cui JX, 2004, ARTERIOSCL THROM VAS, V24, pE183, DOI 10.1161/01.ATV.0000147304.67100.ee; Dedoussis GVZ, 2007, AM J MED SCI, V333, P10, DOI 10.1097/00000441-200701000-00002; Derzbach L, 2005, J PERINAT MED, V33, P461, DOI 10.1515/JPM.2005.082; Du LS, 2000, PSYCHIATR GENET, V10, P159, DOI 10.1097/00041444-200010040-00002; Durlach A, 1999, J CLIN ENDOCR METAB, V84, P3656, DOI 10.1210/jc.84.10.3656; Ellsworth DL, 2001, J MOL MED-JMM, V79, P390, DOI 10.1007/s001090100235; Espino-Montoro A, 2003, NUTR METAB CARDIOVAS, V13, P194, DOI 10.1016/S0939-4753(03)80011-X; FERRIERES J, 1994, ARTERIOSCLER THROMB, V14, P1553, DOI 10.1161/01.ATV.14.10.1553; Foltynie T, 2005, J NEUROL, V252, P833, DOI 10.1007/s00415-005-0756-5; Freemantle N, 2001, BRIT MED J, V322, P989, DOI 10.1136/bmj.322.7292.989; Freire MBS, 1998, HYPERTENSION, V31, P896, DOI 10.1161/01.HYP.31.4.896; Froehlich TE, 2007, BIOL PSYCHIAT, V62, P243, DOI 10.1016/j.biopsych.2006.09.039; Gallagher CJ, 2007, CANCER EPIDEM BIOMAR, V16, P823, DOI 10.1158/1055-9965.EPI-06-0823; Gloria-Bottini F, 2005, PLACENTA, V26, P846, DOI 10.1016/j.placenta.2004.12.002; Glorioso N, 2007, CIRC RES, V100, P1522, DOI 10.1161/01.RES.0000267716.96196.60; Gong MN, 2004, CHEST, V125, P203, DOI 10.1378/chest.125.1.203; Greenland S, 1983, Stat Med, V2, P243, DOI 10.1002/sim.4780020219; Gyorffy B, 2002, EUR J ENDOCRINOL, V147, P803, DOI 10.1530/eje.0.1470803; Hahn S, 2000, STAT MED, V19, P3325, DOI 10.1002/1097-0258(20001230)19:24<3325::AID-SIM827>3.0.CO;2-D; HANSEN PS, 1994, CLIN GENET, V45, P78; HARRISON TR, 2004, HARRISONS PRINCIPLES; Hayashi K, 2007, AM J HYPERTENS, V20, P650, DOI 10.1016/j.amjhyper.2007.01.007; Hernandez AV, 2005, NEUROSURGERY, V57, P1244, DOI 10.1227/01.NEU.0000186039.57548.96; Higaki J, 2000, CIRCULATION, V101, P2060, DOI 10.1161/01.CIR.101.17.2060; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Ioannidis JPA, 2006, AM J EPIDEMIOL, V164, P609, DOI 10.1093/aje/kwj259; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Ioannidis JPA, 2003, TRENDS MOL MED, V9, P135, DOI 10.1016/S1471-4914(03)00030-3; Kajinami K, 2005, ATHEROSCLEROSIS, V178, P331, DOI 10.1016/j.atherosclerosis.2004.08.034; Kajinami K, 2004, AM J CARDIOL, V93, P1046, DOI 10.1016/j.amjcard.2004.01.014; Kantarci OH, 2005, GENES IMMUN, V6, P153, DOI 10.1038/sj.gene.6364164; Kark JD, 2000, ATHEROSCLEROSIS, V151, P509, DOI 10.1016/S0021-9150(99)00408-6; Kates WR, 2006, AM J MED GENET B, V141B, P274, DOI 10.1002/ajmg.b.30284; Ko YL, 2004, ATHEROSCLEROSIS, V172, P135, DOI 10.1016/j.atherosclerosis.2003.09.013; Korner A, 2007, INT J OBESITY, V31, P353, DOI 10.1038/sj.ijo.0803428; KOTZE MJ, 1993, ARTERIOSCLER THROMB, V13, P1460, DOI 10.1161/01.ATV.13.10.1460; Laule M, 2003, J MOL MED, V81, P305, DOI 10.1007/s00109-003-0433-z; Lehtimaki T, 1997, AM J CLIN NUTR, V66, P599, DOI 10.1093/ajcn/66.3.599; Leung KH, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-19; Lin BK, 2006, AM J EPIDEMIOL, V164, P1, DOI 10.1093/aje/kwj175; Lio D, 2002, GENES IMMUN, V3, P30, DOI 10.1038/sj.gene.6363827; Liu G, 2004, CANCER LETT, V214, P69, DOI 10.1016/j.canlet.2004.06.027; Liu ZH, 2002, NEPHRON, V90, P174, DOI 10.1159/000049039; Mata P, 1998, ATHEROSCLEROSIS, V137, P367, DOI 10.1016/S0021-9150(97)00265-7; Meng QH, 1997, J INTERN MED, V241, P373, DOI 10.1046/j.1365-2796.1997.122139000.x; Meplan C, 2007, FASEB J, V21, P3063, DOI 10.1096/fj.07-8166com; Minihane AM, 2002, BBA-MOL CELL BIOL L, V1583, P311, DOI 10.1016/S1388-1981(02)00264-0; Mizuno T, 2006, J PSYCHOSOM RES, V60, P91, DOI 10.1016/j.jpsychores.2005.06.068; Mlynarski WM, 2005, DIABETES, V54, P3331, DOI 10.2337/diabetes.54.11.3331; MORGAN TM, 2000, JAMA-J AM MED ASSOC, V297, P1551; Nakanishi S, 2004, DIABETES OBES METAB, V6, P45, DOI 10.1111/j.1463-1326.2004.00313.x; Niemi M, 2006, CLIN PHARMACOL THER, V80, P356, DOI 10.1016/j.clpt.2006.06.010; O'Donnell CJ, 1998, CIRCULATION, V97, P1766, DOI 10.1161/01.CIR.97.18.1766; Oh JY, 2001, CLIN GENET, V60, P132, DOI 10.1034/j.1399-0004.2001.600207.x; Ordovas JM, 2002, AM J CLIN NUTR, V75, P38, DOI 10.1093/ajcn/75.1.38; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; Ozawa T, 2006, CIRC J, V70, P645, DOI 10.1253/circj.70.645; Paladino N, 2006, J VIROL, V80, P9144, DOI 10.1128/JVI.00339-06; Parra-Bonilla G, 2003, NEUROSCI LETT, V349, P159, DOI 10.1016/S0304-3940(03)00816-4; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Reich H, 2003, KIDNEY INT, V63, P1443, DOI 10.1046/j.1523-1755.2003.00867.x; Reynolds WF, 1999, EXP NEUROL, V155, P31, DOI 10.1006/exnr.1998.6977; Rochon PA, 1998, CAN MED ASSOC J, V159, P321; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; Russo P, 2007, J HUM HYPERTENS, V21, P333, DOI 10.1038/sj.jhh.1002136; Sagnella GA, 1999, J HYPERTENS, V17, P657, DOI 10.1097/00004872-199917050-00009; Schott E, 2007, J HEPATOL, V46, P372, DOI 10.1016/j.jhep.2006.09.011; Schrijver HM, 2004, J INTERF CYTOK RES, V24, P536, DOI 10.1089/jir.2004.24.536; Sciacca FL, 2002, J NEUROIMMUNOL, V122, P94, DOI 10.1016/S0165-5728(01)00449-0; Seripa D, 2006, J GERONTOL A-BIOL, V61, P918, DOI 10.1093/gerona/61.9.918; Shi QL, 2005, CANCER EPIDEM BIOMAR, V14, P1477, DOI 10.1158/1055-9965.EPI-04-0905; Sjoberg RL, 2006, INT J NEUROPSYCHOPH, V9, P443, DOI 10.1017/S1461145705005936; Song J, 2003, J MED GENET, V40, P372, DOI 10.1136/jmg.40.5.372; Stankovic A, 2002, SCAND J CLIN LAB INV, V62, P469, DOI 10.1080/00365510260390028; Suarez F, 1997, J CLIN ENDOCR METAB, V82, P2966, DOI 10.1210/jc.82.9.2966; Sundar PD, 2007, NEUROBIOL AGING, V28, P856, DOI 10.1016/j.neurobiolaging.2006.04.005; Szczeklik W, 2004, J ALLERGY CLIN IMMUN, V114, P248, DOI 10.1016/j.jaci.2004.05.030; Tan EC, 2005, MOL BRAIN RES, V139, P212, DOI 10.1016/j.molbrainres.2005.05.010; Vandenbroeck K, 2003, ARTHRITIS RHEUM-US, V48, P2773, DOI 10.1002/art.11236; VONECKARDSTEIN A, 1994, ARTERIOSCLER THROMB, V14, P1114, DOI 10.1161/01.ATV.14.7.1114; Watson MA, 2003, CLIN SCI, V104, P537, DOI 10.1042/CS20020329; Wu Yuan, 2001, Kobe Journal of Medical Sciences, V47, P255; XU CF, 1993, GENET EPIDEMIOL, V10, P113, DOI 10.1002/gepi.1370100204; Yamaguchi S, 2007, INT J MOL MED, V19, P631; Yang KD, 2007, CLIN EXP ALLERGY, V37, P680, DOI 10.1111/j.1365-2222.2007.02698.x; Yang KD, 2004, CLIN EXP ALLERGY, V34, P32, DOI 10.1111/j.1365-2222.2004.01776.x; Yang QH, 2005, INT J EPIDEMIOL, V34, P1129, DOI 10.1093/ije/dyi130; Yiannakouris Nikos, 2003, Hormones (Athens), V2, P229; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	111	115	116	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 22	2007	298	8					880	893		10.1001/jama.298.8.880	http://dx.doi.org/10.1001/jama.298.8.880			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	202CS	17712072				2022-12-01	WOS:000248880200022
J	Yang, ZY; Wei, CJ; Kong, WP; Wu, L; Xu, L; Smith, DF; Nabel, GJ				Yang, Zhi-Yong; Wei, Chih-Jen; Kong, Wing-Pui; Wu, Lan; Xu, Ling; Smith, David F.; Nabel, Gary J.			Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity	SCIENCE			English	Article							VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; PANDEMIC INFLUENZA; ESCAPE MUTANTS; A VIRUSES; GLYCOPROTEIN; CORONAVIRUS; SITES; ENTRY	Influenza virus entry is mediated by the receptor binding domain (RBD) of its spike, the hemagglutinin (HA). Adaptation of avian viruses to humans is associated with HA specificity for alpha 2,6- rather than alpha 2,3-linked sialic acid (SA) receptors. Here, we define mutations in influenza A subtype H5N1 (avian) HA that alter its specificity for SA either by decreasing alpha 2,3- or increasing alpha 2,6- SA recognition. RBD mutants were used to develop vaccines and monoclonal antibodies that neutralized new variants. Structure-based modification of HA specificity can guide the development of preemptive vaccines and therapeutic monoclonal antibodies that can be evaluated before the emergence of human-adapted H5N1 strains.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; Emory Univ, Sch Med, Atlanta, GA 30322 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bldg 40,Room 4502,Mailstop Code MSC-3005,40 Conve, Bethesda, MD 20892 USA.	gnabel@nih.gov	Yang, Ziheng/C-1358-2008; Wei, Chih/GVT-5734-2022		Intramural NIH HHS [Z99 AI999999] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005003] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEAN WJ, 1992, J VIROL, V66, P1129, DOI 10.1128/JVI.66.2.1129-1138.1992; BIZEBARD T, 1995, NATURE, V376, P92, DOI 10.1038/376092a0; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Ilyushina N, 2004, VIROLOGY, V329, P33, DOI 10.1016/j.virol.2004.08.002; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Laeeq S, 1997, J VIROL, V71, P2600, DOI 10.1128/JVI.71.4.2600-2605.1997; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; MURPHY BR, 1996, FIELDS VIROLOGY, P1403; Parrish CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/annurev.micro.59.030804.121059; PAULSON JC, 1987, METHOD ENZYMOL, V138, P162; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Stevens J, 2006, NAT REV MICROBIOL, V4, P857, DOI 10.1038/nrmicro1530; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004; Yang ZY, 1998, SCIENCE, V279, P1034, DOI 10.1126/science.279.5353.1034	24	179	215	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 10	2007	317	5839					825	828		10.1126/science.1135165	http://dx.doi.org/10.1126/science.1135165			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	198JN	17690300	Green Accepted			2022-12-01	WOS:000248624500047
J	Sun, YG; Chen, ZF				Sun, Yan-Gang; Chen, Zhou-Feng			A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord	NATURE			English	Article							PROTEINASE-ACTIVATED RECEPTOR; BOMBESIN-LIKE PEPTIDES; SCRATCHING BEHAVIOR; HUMAN SKIN; MICE; PRURITUS; AGONISTS; PATHWAY; BRAIN	Itching, or pruritus, is defined as an unpleasant cutaneous sensation that serves as a physiological self-protective mechanism to prevent the body from being hurt by harmful external agents. Chronic itch represents a significant clinical problem resulting from renal diseases and liver diseases, as well as several serious skin diseases such as atopic dermatitis(1-3). The identity of the itch-specific mediator in the central nervous system, however, remains elusive. Here we describe that the gastrin-releasing peptide receptor (GRPR) plays an important part in mediating itch sensation in the dorsal spinal cord. We found that gastrin-releasing peptide is specifically expressed in a small subset of peptidergic dorsal root ganglion neurons, whereas expression of its receptor GRPR is restricted to lamina I of the dorsal spinal cord. GRPR mutant mice showed comparable thermal, mechanical, inflammatory and neuropathic pain responses relative to wild-type mice. In contrast, induction of scratching behaviour was significantly reduced in GRPR mutant mice in response to pruritogenic stimuli, whereas normal responses were evoked by painful stimuli. Moreover, direct spinal cerebrospinal fluid injection of a GRPR antagonist significantly inhibited scratching behaviour in three independent itch models. These data demonstrate that GRPR is required for mediating the itch sensation rather than pain, at the spinal level. Our results thus indicate that GRPR may represent the first molecule that is dedicated to mediating the itch sensation in the dorsal horn of the spinal cord, and thus may provide a central therapeutic target for antipruritic drug development.	Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Pain Ctr, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Pain Ctr, Dept Psychiat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Chen, ZF (corresponding author), Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA.	chenz@wustl.edu						Andrew D, 2001, NAT NEUROSCI, V4, P72, DOI 10.1038/82924; BATTEY J, 1991, TRENDS NEUROSCI, V14, P524, DOI 10.1016/0166-2236(91)90005-F; Chen ZF, 2001, NEURON, V31, P59, DOI 10.1016/S0896-6273(01)00341-5; COWAN A, 1985, LIFE SCI, V37, P135, DOI 10.1016/0024-3205(85)90416-3; GMEREK DE, 1983, BRIT J DERMATOL, V109, P239, DOI 10.1111/j.1365-2133.1983.tb07091.x; GMEREK DE, 1983, PEPTIDES, V4, P907, DOI 10.1016/0196-9781(83)90089-X; GREAVES MW, 2005, DERMATOL THER, V1, P323; Green AD, 2006, PAIN, V124, P50, DOI 10.1016/j.pain.2006.03.023; Hampton LL, 1998, P NATL ACAD SCI USA, V95, P3188, DOI 10.1073/pnas.95.6.3188; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Inan S, 2004, EUR J PHARMACOL, V502, P233, DOI 10.1016/j.ejphar.2004.09.010; KROOG GS, 1995, MED RES REV, V15, P389, DOI 10.1002/med.2610150502; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Ladenheim EE, 1996, AM J PHYSIOL-REG I, V271, pR180, DOI 10.1152/ajpregu.1996.271.1.R180; MCMAHON SB, 1992, TRENDS NEUROSCI, V15, P497, DOI 10.1016/0166-2236(92)90102-E; Moody TW, 2004, PEPTIDES, V25, P511, DOI 10.1016/j.peptides.2004.02.012; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; ODONOHUE TL, 1984, J NEUROSCI, V4, P2956; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; Roesler R., 2006, CNS & Neurological Disorders-Drug Targets, V5, P197, DOI 10.2174/187152706776359673; Schmelz M, 1997, J NEUROSCI, V17, P8003; Shimada SG, 2006, EUR J PHARMACOL, V530, P281, DOI 10.1016/j.ejphar.2005.11.012; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; SOWUNMI A, 1989, LANCET, V2, P213; Stander S, 2006, EUR J PAIN, V10, P473, DOI 10.1016/j.ejpain.2006.03.005; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; WANG LH, 1990, J BIOL CHEM, V265, P15695; Wozniak DF, 2004, NEUROBIOL DIS, V17, P403, DOI 10.1016/j.nbd.2004.08.006	30	528	550	8	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 9	2007	448	7154					700	U10		10.1038/nature06029	http://dx.doi.org/10.1038/nature06029			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	197ZY	17653196				2022-12-01	WOS:000248598000046
J	Reiner, SL; Sallusto, F; Lanzavecchia, A				Reiner, Steven L.; Sallusto, Federica; Lanzavecchia, Antonio			Perspective - Division of labor with a workforce of one: Challenges in specifying effector and memory T cell fate	SCIENCE			English	Editorial Material							DIFFERENTIATION; T(H)1	In the course of the immune response against microbes, naive T cells proliferate and generate varied classes of effector cells, as well as memory cells with distinct properties and functions. Owing to recent technological advances, some of the most imposing questions regarding effector and memory T cell differentiation are now becoming experimentally soluble: How many classes of antigen-specific T cells exist, and how malleable are they in their fate and in their functional state? How might a spectrum of cell fates be imparted to the clonal descendants of a single lymphocyte? Where, when, and how does pathogen-associated information refine the instruction, selection, and direction of newly activated T cells as they perform their tasks in different locations and times? Some surprising new glimpses ahead on these subjects and other yet-unanswered questions are discussed.	Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Inst Res Biomed, CH-6500 Bellinzona, Switzerland	University of Pennsylvania; Pennsylvania Medicine; Universita della Svizzera Italiana	Lanzavecchia, A (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	sreiner@mail.med.upenn.edu; federica.sallusto@irb.unisi.ch; lanzavecchia@irb.unisi.ch						Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Catron DM, 2006, J EXP MED, V203, P1045, DOI 10.1084/jem.20051954; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Garcia Z, 2007, P NATL ACAD SCI USA, V104, P4553, DOI 10.1073/pnas.0610019104; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Henrickson SE, 2007, CURR OPIN IMMUNOL, V19, P249, DOI 10.1016/j.coi.2007.04.013; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Peixoto A, 2007, J EXP MED, V204, P1193, DOI 10.1084/jem.20062349; Reinhardt RL, 2006, J IMMUNOL, V177, P1618, DOI 10.4049/jimmunol.177.3.1618; Sakaguchi S, 2007, SCIENCE, V317, P627, DOI 10.1126/science.1142331; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714	23	83	84	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 3	2007	317	5838					622	625		10.1126/science.1143775	http://dx.doi.org/10.1126/science.1143775			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	196PL	17673652				2022-12-01	WOS:000248494400033
J	Williams, DA				Williams, David A.			Clinical implications of basic research - A new mechanism of leukemia drug resistance?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELLS		Univ Cincinnati, Coll Med, Childrens Hosp Med Ctr, Div Expt Hematol, Cincinnati, OH 45221 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Williams, DA (corresponding author), Univ Cincinnati, Coll Med, Childrens Hosp Med Ctr, Div Expt Hematol, Cincinnati, OH 45221 USA.							DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Iwamoto S, 2007, J CLIN INVEST, V117, P1049, DOI 10.1172/JCI30235; SCHOFIELD R, 1983, BIOMED PHARMACOTHER, V37, P375; Silverman LB, 2001, BLOOD, V97, P1211, DOI 10.1182/blood.V97.5.1211; Williams DA, 2006, NATURE, V444, P827, DOI 10.1038/444827a	5	12	15	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 5	2007	357	1					77	78		10.1056/NEJMcibr072412	http://dx.doi.org/10.1056/NEJMcibr072412			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	185OR	17611211				2022-12-01	WOS:000247720800016
J	Araki, H; Cooper, B; Blouin, MS				Araki, Hitoshi; Cooper, Becky; Blouin, Michael S.			Genetic effects of captive breeding cause a rapid, cumulative fitness decline in the wild	SCIENCE			English	Article							SALMON ONCORHYNCHUS-TSHAWYTSCHA; REPRODUCTIVE SUCCESS; STEELHEAD TROUT; HATCHERY; DOMESTICATION; POPULATION; PROGRAMS; SIZE	Captive breeding is used to supplement populations of many species that are declining in the wild. The suitability of and long-term species survival from such programs remain largely untested, however. We measured lifetime reproductive success of the first two generations of steelhead trout that were reared in captivity and bred in the wild after they were released. By reconstructing a three-generation pedigree with microsatellite markers, we show that genetic effects of domestication reduce subsequent reproductive capabilities by similar to 40% per captive-reared generation when fish are moved to natural environments. These results suggest that even a few generations of domestication may have negative effects on natural reproduction in the wild and that the repeated use of captive-reared parents to supplement wild populations should be carefully reconsidered.	Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	Oregon State University	Araki, H (corresponding author), Oregon State Univ, Dept Zool, 3029 Cordley Hall, Corvallis, OR 97331 USA.	arakih@science.oregonstate.edu						Araki H, 2005, MOL ECOL, V14, P4097, DOI 10.1111/j.1365-294X.2005.02689.x; Araki H, 2007, CONSERV BIOL, V21, P181, DOI 10.1111/j.1523-1739.2006.00564.x; Augerot X, 2005, ATLAS PACIFIC SALMON; BEREJIKIAN B, 2004, NNMFSNWFSC61; Berejikian BA, 1997, ICES J MAR SCI, V54, P1040, DOI 10.1016/S1054-3139(97)80008-2; CUENCO ML, 1993, NATO ADV SCI INST SE, V248, P269; Fleming IA, 2000, P ROY SOC B-BIOL SCI, V267, P1517, DOI 10.1098/rspb.2000.1173; Fleming Ian A., 2001, Nordic Journal of Freshwater Research, V75, P71; Ford MJ, 2002, CONSERV BIOL, V16, P815, DOI 10.1046/j.1523-1739.2002.00257.x; Frankham R., 2010, INTRO CONSERVATION G; Fritts AL, 2007, CAN J FISH AQUAT SCI, V64, P813, DOI 10.1139/F07-057; Goodman D, 2005, CAN J FISH AQUAT SCI, V62, P374, DOI 10.1139/F04-187; HEARD WR, 1995, 154 NMFS NOAA N PAC; Heath DD, 2003, SCIENCE, V299, P1738, DOI 10.1126/science.1079707; Hercus MJ, 2000, P ROY SOC B-BIOL SCI, V267, P2105, DOI 10.1098/rspb.2000.1256; Kyneb A, 2006, ECOL ENTOMOL, V31, P322, DOI 10.1111/j.1365-2311.2006.00775.x; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lynch M, 2001, CONSERV GENET, V2, P363, DOI 10.1023/A:1012550620717; *NW FISH SCI CTR, 2004, M HELD AUG 20 SEPT 2; Olney PJS., 1994, CREATIVE CONSERVATIO; Pearsons TN, 2007, CAN J FISH AQUAT SCI, V64, P803, DOI 10.1139/F07-058; REISENBICHLER RR, 1977, J FISH RES BOARD CAN, V34, P123, DOI 10.1139/f77-015; REZNICK D, 1981, EVOLUTION, V35, P941, DOI [10.2307/2407865, 10.1111/j.1558-5646.1981.tb04960.x]; Williams R.N., 2006, RETURN RIVER RESTORI	24	613	643	4	388	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2007	318	5847					100	103		10.1126/science.1145621	http://dx.doi.org/10.1126/science.1145621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216YR	17916734				2022-12-01	WOS:000249915400050
J	Karnoub, AE; Dash, AB; Vo, AP; Sullivan, A; Brooks, MW; Bell, GW; Richardson, AL; Polyak, K; Tubo, R; Weinberg, RA				Karnoub, Antoine E.; Dash, Ajeeta B.; Vo, Annie P.; Sullivan, Andrew; Brooks, Mary W.; Bell, George W.; Richardson, Andrea L.; Polyak, Kornelia; Tubo, Ross; Weinberg, Robert A.			Mesenchymal stem cells within tumour stroma promote breast cancer metastasis	NATURE			English	Article							EXPRESSION; PROGRESSION; CARCINOMA; DELIVERY; GROWTH; RANTES; MICROENVIRONMENT; CHEMOKINES; VEHICLES; REVEALS	Mesenchymal stem cells have been recently described to localize to breast carcinomas, where they integrate into the tumour-associated stroma. However, the involvement of mesenchymal stem cells (or their derivatives) in tumour pathophysiology has not been addressed. Here, we demonstrate that bone-marrow-derived human mesenchymal stem cells, when mixed with otherwise weakly metastatic human breast carcinoma cells, cause the cancer cells to increase their metastatic potency greatly when this cell mixture is introduced into a subcutaneous site and allowed to form a tumour xenograft. The breast cancer cells stimulate de novo secretion of the chemokine CCL5 (also called RANTES) from mesenchymal stem cells, which then acts in a paracrine fashion on the cancer cells to enhance their motility, invasion and metastasis. This enhanced metastatic ability is reversible and is dependent on CCL5 signalling through the chemokine receptor CCR5. Collectively, these data demonstrate that the tumour microenvironment facilitates metastatic spread by eliciting reversible changes in the phenotype of cancer cells.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Genzyme Corp, Framingham, MA 01701 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Sanofi-Aventis; Genzyme Corporation; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu	Thomson, Axel/A-7893-2013		NCI NIH HHS [R01 CA116235-01A1, P50 CA089393-080014, P50 CA089393-060014, R01 CA116235-02, R01 CA116235-03, P50 CA089393, R01 CA116235, P50 CA089393-070014] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA089393, R01CA116235] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Azenshtein E, 2002, CANCER RES, V62, P1093; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Fox JM, 2007, BRIT J HAEMATOL, V137, P491, DOI 10.1111/j.1365-2141.2007.06610.x; Gregory CA, 2005, EXP CELL RES, V306, P330, DOI 10.1016/j.yexcr.2005.03.018; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hall B., 2007, V180, P263; Hillyer P, 2005, IMMUNOL CELL BIOL, V83, P375, DOI 10.1111/j.1440-1711.2005.01345.x; Hung SC, 2005, CLIN CANCER RES, V11, P7749, DOI 10.1158/1078-0432.CCR-05-0876; Karnoub Antoine E, 2006, Breast Dis, V26, P75; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Komarova S, 2006, MOL CANCER THER, V5, P755, DOI 10.1158/1535-7163.MCT-05-0334; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lodie TA, 2002, TISSUE ENG, V8, P739, DOI 10.1089/10763270260424105; Luboshits G, 1999, CANCER RES, V59, P4681; Menon LG, 2007, STEM CELLS, V25, P520, DOI 10.1634/stemcells.2006-0257; Mira E, 2001, EMBO REP, V2, P151, DOI 10.1093/embo-reports/kve027; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Niwa Y, 2001, CLIN CANCER RES, V7, P285; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Palani A, 2006, J MED CHEM, V49, P2851, DOI 10.1021/jm060009x; Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Robinson SC, 2003, CANCER RES, V63, P8360; Studeny M, 2002, CANCER RES, V62, P3603; Tanaka T, 2005, CANCER SCI, V96, P317, DOI 10.1111/j.1349-7006.2005.00059.x; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; West RB, 2005, PLOS BIOL, V3, P1101, DOI 10.1371/journal.pbio.0030187; Young HE, 2001, ANAT RECORD, V263, P350, DOI 10.1002/ar.1112; Young HE, 2001, ANAT RECORD, V264, P51, DOI 10.1002/ar.1128	36	2381	2524	9	362	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2007	449	7162					557	U4		10.1038/nature06188	http://dx.doi.org/10.1038/nature06188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	216QG	17914389				2022-12-01	WOS:000249893500036
J	Hernandez, AF; Fonarow, GC; Liang, L; Al-Khatib, SM; Curtis, LH; LaBresh, KA; Yancy, CW; Albert, NM; Peterson, ED				Hernandez, Adrian F.; Fonarow, Gregg C.; Liang, Li; Al-Khatib, Sana M.; Curtis, Lesley H.; LaBresh, Kenneth A.; Yancy, Clyde W.; Albert, Nancy M.; Peterson, Eric D.			Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUDDEN CARDIAC DEATH; ACUTE MYOCARDIAL-INFARCTION; PREVENTION; SURVIVAL; DISEASE; AMIODARONE; GUIDELINES; ARRHYTHMIA; MORTALITY; COMMUNITY	Context Practice guidelines recommend implantable cardioverter-defibrillator (ICD) therapy for patients with heart failure and left ventricular ejection fraction of 30% or less. The influence of sex and race on ICD use among eligible patients is unknown. Objective To examine sex and racial differences in the use of ICD therapy. Design, Setting, and Patients Observational analysis of 13 034 patients admitted with heart failure and left ventricular ejection fraction of 30% or less and discharged alive from hospitals in the American Heart Association's Get With the Guidelines Heart Failure quality-improvement program. Patients were treated between January 2005 and June 2007 at 217 participating hospitals. Main Outcome Measures Use of ICD therapy or planned ICD therapy at discharge. Results Among patients eligible for ICD therapy, 4615 (35.4%) had ICD therapy at discharge (1614 with new ICDs, 527 with planned ICDs, and 2474 with prior ICDs). ICDs were used in 375 of 1329 eligible black women (28.2%), 754 of 2531 white women (29.8%), 660 of 1977 black men (33.4%), and 2356 of 5403 white men (43.6%) (P < .001). After adjustment for patient characteristics and hospital factors, the adjusted odds of ICD use were 0.73 (95% confidence interval, 0.60-0.88) for black men, 0.62 (95% confidence interval, 0.56-0.68) for white women, and 0.56 (95% confidence interval, 0.44-0.71) for black women, compared with white men. The differences were not attributable to the proportions of women and black patients at participating hospitals or to differences in the reporting of left ventricular ejection fraction. Conclusions Less than 40% of potentially eligible patients hospitalized for heart failure received ICD therapy, and rates of use were lower among eligible women and black patients than among white men.	Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27715 USA; Duke Univ, Sch Med, Dept Med, Durham, NC 27715 USA; Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90024 USA; Masspro, Waltham, MA USA; Baylor Heart & Vasc Inst, Dallas, TX USA; Cleveland Clin, Cleveland, OH 44106 USA	Duke University; Duke University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Cleveland Clinic Foundation	Hernandez, AF (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	adrian.hernandez@duke.edu	Hernandez, Adrian F/A-7818-2016; LaBresh, Kenneth A/A-6995-2017; Peterson, Eric David/ABF-5033-2021; Fonarow, Gregg C/D-5988-2014	Hernandez, Adrian F/0000-0003-3387-9616; LaBresh, Kenneth A/0000-0001-9040-1956; Fonarow, Gregg C/0000-0002-3192-8093				*AM HEART ASS, 2006, 2006 HEART STROK STA; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bonow RO, 2005, CIRCULATION, V112, P1853, DOI 10.1161/CIRCULATIONAHA.105.170072; Bursi F, 2006, JAMA-J AM MED ASSOC, V296, P2209, DOI 10.1001/jama.296.18.2209; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Fonarow GC, 2004, AM HEART J, V148, P43, DOI 10.1016/j.ahj.2004.03.004; Groeneveld PW, 2006, J GEN INTERN MED, V21, P559, DOI 10.1111/j.1525-1497.2006.00453.x; GUARI AJ, 2006, AM J MED, V119, DOI UNSP 167.E17-167.E21; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jha AK, 2005, NEW ENGL J MED, V353, P683, DOI 10.1056/NEJMsa050672; LaBresh KA, 2004, ARCH INTERN MED, V164, P203, DOI 10.1001/archinte.164.2.203; LaBresh Kenneth A, 2003, Jt Comm J Qual Saf, V29, P539; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Mark DB, 2006, CIRCULATION, V114, P135, DOI 10.1161/CIRCULATIONAHA.105.581884; McClellan MB, 2005, NEW ENGL J MED, V352, P222, DOI 10.1056/NEJMp048354; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; PETERSON ED, 1994, JAMA-J AM MED ASSOC, V271, P1175, DOI 10.1001/jama.271.15.1175; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Russo AM, 2004, J CARDIOVASC ELECTR, V15, P993, DOI 10.1046/j.1540-8167.2004.04050.x; Skinner J, 2005, CIRCULATION, V112, P2634, DOI 10.1161/CIRCULATIONAHA.105.543231; Smaha LA, 2004, AM HEART J, V148, pS46, DOI 10.1016/j.ahj.2004.09.015; Smedley BD, 2003, INTERVENTIONS CROSS, DOI DOI 10.17226/12875; Stevenson LW, 2006, CIRCULATION, V114, P101, DOI 10.1161/CIRCULATIONAHA.106.637405; *US DEP HHS, HOSP QUAL IN; Yancy CW, 2005, CIRCULATION, V111, P1339, DOI 10.1161/01.CIR.0000157740.93598.51; Zareba W, 2005, J CARDIOVASC ELECTR, V16, P1265, DOI 10.1111/j.1540-8167.2005.00224.x; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334; Zipes DP, 2001, CIRCULATION, V103, P1372, DOI 10.1161/01.CIR.103.10.1372	31	295	295	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2007	298	13					1525	1532		10.1001/jama.298.13.1525	http://dx.doi.org/10.1001/jama.298.13.1525			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	216EE	17911497				2022-12-01	WOS:000249860500024
J	Chan, AOO; Jim, MH; Lam, KF; Morris, JS; Siu, DCW; Tong, T; Ng, FH; Wong, SY; Hui, WM; Chan, CK; Lai, KC; Cheung, TK; Chan, P; Wong, G; Yuen, MF; Lau, YK; Lee, S; Szeto, ML; Wong, BCY; Lam, SK				Chan, Annie On On; Jim, Man Hong; Lam, Kwok Fai; Morris, Jeffrey S.; Siu, David Chun Wah; Tong, Teresa; Ng, Fook Hong; Wong, Siu Yin; Hui, Wai Mo; Chan, Chi Kuen; Lai, Kam Chuen; Cheung, Ting Kin; Chan, Pierre; Wong, Grace; Yuen, Man Fung; Lau, Yuk Kong; Lee, Stephen; Szeto, Ming Leung; Wong, Benjamin C. Y.; Lam, Shiu Kum			Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; HEART-DISEASE; CANCER; RISK; ASSOCIATION; INFLAMMATION; REGRESSION; CHINESE; POLYPS	Context Colorectal neoplasm and coronary artery disease (CAD) share similar risk factors, and their co-occurrence may be associated. Objectives To investigate the prevalence of colorectal neoplasm in patients with CAD in a cross-sectional study and to identify the predisposing factors for the association of the 2 diseases. Design, Setting, and Participants Patients in Hong Kong, China, were recruited for screening colonoscopy after undergoing coronary angiography for suspected CAD during November 2004 to June 2006. Presence of CAD (n = 206) was defined as at least 50% diameter stenosis in any 1 of the major coronary arteries; otherwise, patients were considered CAD-negative (n = 208). An age- and sex-matched control group was recruited from the general population (n = 207). Patients were excluded for use of aspirin or statins, personal history of colonic disease, or colonoscopy in the past 10 years. Main Outcome Measures The prevalence of colorectal neoplasm in CAD-positive, CAD-negative, and general population participants was determined. Bivariate logistic regression was performed to study the association between colorectal neoplasm and CAD and to identify risk factors for the association of the 2 diseases after adjusting for age and sex. Results The prevalence of colorectal neoplasm in the CAD-positive, CAD-negative, and general population groups was 34.0%, 18.8%, and 20.8% (P < .001 by chi(2) test), prevalence of advanced lesions was 18.4%, 8.7%, and 5.8% (P < .001), and prevalence of cancer was 4.4%, 0.5%, and 1.4% (P = .02), respectively. Fifty percent of the cancers in CAD-positive participants were early stage. After adjusting for age and sex, an association still existed between colorectal neoplasm and presence of CAD (odds ratio [OR], 1.88; 95% confidence interval [CI], 1.25-2.70; P = .002) and between advanced lesions and presence of CAD (OR, 2.51; 95% CI, 1.43-4.35; P = .001). The metabolic syndrome (OR, 5.99; 95% CI, 1.43-27.94; P = .02) and history of smoking (OR, 4.74; 95% CI, 1.38-18.92; P = .02) were independent factors for the association of advanced colonic lesions and CAD. Conclusions In this study population undergoing coronary angiography, the prevalence of colorectal neoplasm was greater in patients with CAD. The association between the presence of advanced colonic lesions and CAD was stronger in persons with the metabolic syndrome and a history of smoking.	Univ Texas, MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; Tuen Mun Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; Ruttonjee Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Stat & Actuarial Sci, Hong Kong, Hong Kong, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Tuen Mun Hospital; University of Hong Kong; University of Hong Kong	Chan, AOO (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China.	aoochan@hku.hk	Siu, David/C-4394-2009; Yuen, Man-Fung/C-4466-2009; Wong, Benjamin Chun Yu/C-4436-2009; Wong, Benjamin Chun Yu/ABB-1962-2020; Siu, Chung Wah/C-6947-2011	Yuen, Man-Fung/0000-0001-7985-7725; Lam, Kwok/0000-0001-5453-994X				Ahmed RL, 2006, CANCER-AM CANCER SOC, V107, P28, DOI 10.1002/cncr.21950; American Cancer Society, 2000, CANC FACTS FIG 2000; Ananth CV, 1999, STAT MED, V18, P2011; Bowers K, 2006, AM J EPIDEMIOL, V164, P652, DOI 10.1093/aje/kwj253; Chan AOO, 2006, ALIMENT PHARM THER, V24, P535, DOI 10.1111/j.1365-2036.2006.02958.x; Chan JSK, 1997, BIOMETRICAL J, V39, P409, DOI 10.1002/bimj.4710390403; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; CORREA P, 1982, J CHRON DIS, V35, P313, DOI 10.1016/0021-9681(82)90002-9; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Giovannucci E, 2001, CANCER EPIDEM BIOMAR, V10, P725; HOLM S, 1979, SCAND J STAT, V6, P65; Hospital Authority Hong Kong SAR Government, HONG KONG CANC REG; Kwon Hyuk Sang, 2005, Korean Journal of Internal Medicine, V20, P310; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; LAKLER JB, 1992, AM J MED, V93, pS8; Lieberman DA, 2003, JAMA-J AM MED ASSOC, V290, P2959, DOI 10.1001/jama.290.22.2959; Lin RT, 2004, J FORMOS MED ASSOC, V103, P317; McEwen JE, 2005, CURR OPIN CARDIOL, V20, P399, DOI 10.1097/01.hco.0000175517.50181.89; Minino Arialdi M, 2007, Natl Vital Stat Rep, V55, P1; Morita Takako, 2005, Asian Pac J Cancer Prev, V6, P485; *MULT RISK FACT IN, 1975, DHEW PUBL NIH; NEUGUT AI, 1995, DIS COLON RECTUM, V38, P873, DOI 10.1007/BF02049845; Neugut AI, 1998, CANCER EPIDEM BIOMAR, V7, P869; Parker S, 2005, HIST TODAY, V55, P2; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Reicher-Reiss H, 2001, AM J CARDIOL, V87, P459, DOI 10.1016/S0002-9149(00)01405-3; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Sepulveda JL, 2005, CURR OPIN CARDIOL, V20, P407; Simmons DT, 2006, ALIMENT PHARM THERAP, V24, P965, DOI 10.1111/j.1365-2036.2006.03080.x; Sung JJY, 2003, GASTROENTEROLOGY, V124, P608, DOI 10.1053/gast.2003.50090; Tiong AY, 2005, AM HEART J, V150, P11, DOI 10.1016/j.ahj.2004.12.019; Wang YY, 2005, J GASTROEN HEPATOL, V20, P1410, DOI 10.1111/j.1440-1746.2005.03971.x; Wilson PWF, 1999, ARCH INTERN MED, V159, P1104, DOI 10.1001/archinte.159.10.1104; Winawer Sidney J., 1999, American Journal of Medicine, V106, p3S, DOI 10.1016/S0002-9343(98)00338-6	36	115	128	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2007	298	12					1412	1419		10.1001/jama.298.12.1412	http://dx.doi.org/10.1001/jama.298.12.1412			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	213WV	17895457	Bronze			2022-12-01	WOS:000249698900020
J	Luke, CJ; Pak, SC; Askew, YS; Naviglia, TL; Askew, DJ; Nobar, SM; Vetica, AC; Long, OS; Watkins, SC; Stolz, DB; Barstead, RJ; Moulder, GL; Bromme, D; Silverman, GA				Luke, Cliff J.; Pak, Stephen C.; Askew, Yuko S.; Naviglia, Terra L.; Askew, David J.; Nobar, Shila M.; Vetica, Anne C.; Long, Olivia S.; Watkins, Simon C.; Stolz, Donna B.; Barstead, Robert J.; Moulder, Gary L.; Bromme, Dieter; Silverman, Gary A.			An intracellular serpin regulates necrosis by inhibiting the induction and sequelae of lysosomal injury	CELL			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; CELL-DEATH; LIFE-SPAN; SIGNALING PATHWAY; CALPAIN; STRESS; NEURODEGENERATION; DISRUPTION; MECHANISMS	Extracellular serpins such as antithrombin and a1- antitrypsin are the quintessential regulators of proteolytic pathways. In contrast, the biological functions of the intracellular serpins remain obscure. We now report that the C. elegans intracellular serpin, SRP- 6, exhibits a prosurvival function by blocking necrosis. Minutes after hypotonic shock, srp- 6 null animals underwent a catastrophic series of events culminating in lysosomal disruption, cytoplasmic proteolysis, and death. This newly defined hypo- osmotic stress lethal ( Osl) phenotype was dependent upon calpains and lysosomal cysteine peptidases, two in vitro targets of SRP- 6. By protecting against both the induction of and the lethal effects from lysosomal injury, SRP- 6 also blocked death induced by heat shock, oxidative stress, hypoxia, and cation channel hyperactivity. These findings suggest that multiple noxious stimuli converge upon a peptidase- driven, core stress response pathway that, in the absence of serpin regulation, triggers a lysosomal- dependent necrotic cell death routine.	Childrens Hosp Pittsburgh, Dept Pediat, UPMC Newborn Med Program, Pittsburgh, PA 15213 USA; Magee Womens Res Inst, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15261 USA; Oklahoma Med Res Fdn, Dept Mol & Cell Biol, Oklahoma City, OK 73104 USA; Univ British Columbia, Fac Dent, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Oklahoma Medical Research Foundation; University of British Columbia	Silverman, GA (corresponding author), Childrens Hosp Pittsburgh, Dept Pediat, UPMC Newborn Med Program, Pittsburgh, PA 15213 USA.	gsilverman@mail.magee.edu	Silverman, Gary/AAJ-1269-2020; Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552; Pak, Stephen/0000-0002-8089-3237	NCI NIH HHS [R01 CA086002-03, R01 CA087006-05, R01 CA087006-03, R01 CA087007, R01 CA086002-05, R01 CA086002-04, R01 CA086002, CA87007, R01 CA087006-04, R01 CA087006-01, R01 CA087006, R01 CA087006-06, R01 CA086002-02, CA86007, R01 CA087006-02] Funding Source: Medline; NCRR NIH HHS [RR02241] Funding Source: Medline; NHGRI NIH HHS [R01 HG001843] Funding Source: Medline; CGH CDC HHS [GH001843] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA087007, R01CA087006, R01CA086002, R01CA086007] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001843] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); CGH CDC HHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Barger AJ, 1998, J NEUROSCI, V18, P2871; Bolger BS, 1997, GYNECOL ONCOL, V65, P309, DOI 10.1006/gyno.1997.4619; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; Church F. C., 2007, MOL CELLULAR ASPECTS, P509; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; DEDUVE C, 1983, EUR J BIOCHEM, V137, P391, DOI 10.1111/j.1432-1033.1983.tb07841.x; Dougherty KM, 1999, P NATL ACAD SCI USA, V96, P686, DOI 10.1073/pnas.96.2.686; Driscoll M, 2003, NAT REV GENET, V4, P181, DOI 10.1038/nrg1018; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Harbinder S, 1997, P NATL ACAD SCI USA, V94, P13128, DOI 10.1073/pnas.94.24.13128; Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060; Hirsch C, 2006, TRENDS CELL BIOL, V16, P657, DOI 10.1016/j.tcb.2006.10.006; Hiruma H, 2007, J PHOTOCH PHOTOBIO B, V86, P1, DOI 10.1016/j.jphotobiol.2006.08.003; Jakab M, 2002, CELL PHYSIOL BIOCHEM, V12, P235, DOI 10.1159/000067895; Kokel M, 1998, GENE DEV, V12, P1425, DOI 10.1101/gad.12.10.1425; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; LLOYD JB, 1986, TRENDS BIOCHEM SCI, V11, P365, DOI 10.1016/0968-0004(86)90205-7; Luke CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P581, DOI 10.2741/1820; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Melloni E, 2006, J BIOL CHEM, V281, P24945, DOI 10.1074/jbc.M601449200; Nehrke K, 2003, J BIOL CHEM, V278, P44657, DOI 10.1074/jbc.M307351200; NELSON FK, 1984, J EXP ZOOL, V231, P45, DOI 10.1002/jez.1402310107; Scarff KL, 2004, MOL CELL BIOL, V24, P4075, DOI 10.1128/MCB.24.9.4075-4082.2004; Schick C, 1998, P NATL ACAD SCI USA, V95, P13465, DOI 10.1073/pnas.95.23.13465; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Tawe WN, 1998, NUCLEIC ACIDS RES, V26, P1621, DOI 10.1093/nar/26.7.1621; Tcherepanova I, 2000, J BIOL CHEM, V275, P26359, DOI 10.1074/jbc.M000956200; Wendt A, 2004, BIOL CHEM, V385, P465, DOI 10.1515/BC.2004.054; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Yamashima T, 2003, HIPPOCAMPUS, V13, P791, DOI 10.1002/hipo.10127; Yamashima T, 1996, EUR J NEUROSCI, V8, P1932, DOI 10.1111/j.1460-9568.1996.tb01337.x; Yassin L, 2001, MOL CELL NEUROSCI, V17, P589, DOI 10.1006/mcne.2000.0944; Zatz M, 2005, NEW ENGL J MED, V352, P2413, DOI 10.1056/NEJMra043361; Zhang ML, 2006, IMMUNITY, V24, P451, DOI 10.1016/j.immuni.2006.02.002; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	44	118	145	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2007	130	6					1108	1119		10.1016/j.cell.2007.07.013	http://dx.doi.org/10.1016/j.cell.2007.07.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	225HK	17889653	Green Accepted, Bronze			2022-12-01	WOS:000250507500019
J	Travis, MA; Reizis, B; Melton, AC; Masteller, E; Tang, QZ; Proctor, JM; Wang, YL; Bernstein, X; Huang, XZ; Reichardt, LF; Bluestone, JA; Sheppard, D				Travis, Mark A.; Reizis, Boris; Melton, Andrew C.; Masteller, Emma; Tang, Qizhi; Proctor, John M.; Wang, Yanli; Bernstein, Xin; Huang, Xiaozhu; Reichardt, Louis F.; Bluestone, Jeffrey A.; Sheppard, Dean			Loss of integrin alpha(v)beta(8) on dendritic cells causes autoimmunity and colitis in mice	NATURE			English	Article							REGULATORY T-CELLS; TRANSCRIPTION FACTOR FOXP3; TGF-BETA-1; DISEASE; HOMEOSTASIS; ACTIVATION; EXPRESSION; INFLAMMATION; MECHANISMS; TOLERANCE	The cytokine transforming growth factor-beta (TGF-beta) is an important negative regulator of adaptive immunity(1-3). TGF-beta is secreted by cells as an inactive precursor that must be activated to exert biological effects(4), but the mechanisms that regulate TGF-beta activation and function in the immune system are poorly understood. Here we show that conditional loss of the TGF-beta-activating integrin alpha(v)beta(8) on leukocytes causes severe inflammatory bowel disease and age-related autoimmunity in mice. This autoimmune phenotype is largely due to lack of alpha(v)beta(8) on dendritic cells, as mice lacking alpha(v)beta(8) principally on dendritic cells develop identical immunological abnormalities as mice lacking alpha(v)beta(8) on all leukocytes, whereas mice lacking alpha(v)beta(8) on T cells alone are phenotypically normal. We further show that dendritic cells lacking alpha(v)beta(8) fail to induce regulatory T cells (T-R cells) in vitro, an effect that depends on TGF-beta activity. Furthermore, mice lacking alpha(v)beta(8) on dendritic cells have reduced proportions of T-R cells in colonic tissue. These results suggest that alpha(v)beta(8)-mediated TGF-beta activation by dendritic cells is essential for preventing immune dysfunction that results in inflammatory bowel disease and autoimmunity, effects that are due, at least in part, to the ability of alpha(v)beta(8) on dendritic cells to induce and/or maintain tissue T-R cells.	Univ Calif San Francisco, Dept Med, Lung Biol Ctr, San Francisco, CA 94158 USA; Columbia Univ, Dept Microbiol, New York, NY 10032 USA; Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Columbia University; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Sheppard, D (corresponding author), Univ Calif San Francisco, Dept Med, Lung Biol Ctr, 1550 4th St,Room 545, San Francisco, CA 94158 USA.	dean.sheppard@ucsf.edu	Travis, Mark/E-9643-2015	Travis, Mark/0000-0002-8485-2272; Tang, Qizhi/0000-0001-7313-3574; Reizis, Boris/0000-0003-1140-7853	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019090] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS019090, R01 NS019090-25] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bohr URM, 2006, J CLIN MICROBIOL, V44, P738, DOI 10.1128/JCM.44.3.738-742.2006; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Huang XZ, 1996, J CELL BIOL, V133, P921, DOI 10.1083/jcb.133.4.921; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; LEFRANCOIS L, 2001, CURR PROTOCOLS IMMUN; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Marie JC, 2006, IMMUNITY, V25, P441, DOI 10.1016/j.immuni.2006.07.012; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Proctor JM, 2005, J NEUROSCI, V25, P9940, DOI 10.1523/JNEUROSCI.3467-05.2005; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Taylor NS, 2007, J CLIN MICROBIOL, V45, P2166, DOI 10.1128/JCM.00137-07; Whary MT, 2006, LAB ANIMAL, V35, P25, DOI 10.1038/laban0706-25; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Zhu JW, 2002, DEVELOPMENT, V129, P2891	30	398	408	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2007	449	7160					361	+		10.1038/nature06110	http://dx.doi.org/10.1038/nature06110			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211XP	17694047	Green Accepted			2022-12-01	WOS:000249557300049
J	Heath, I				Heath, Iona			The blind leading the blind	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath@dst.pipex.com							0	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2007	335	7619					540	540		10.1136/bmj.39331.651250.59	http://dx.doi.org/10.1136/bmj.39331.651250.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215ED	17855320	Green Published			2022-12-01	WOS:000249790200030
J	Jia, D; Jurkowska, RZ; Zhang, X; Jeltsch, A; Cheng, XD				Jia, Da; Jurkowska, Renata Z.; Zhang, Xing; Jeltsch, Albert; Cheng, Xiaodong			Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation	NATURE			English	Article							HISTONE MODIFICATIONS; MOUSE; REGIONS; METHYLTRANSFERASES; SPERMATOGENESIS; STIMULATION; MECHANISM; IGF2R; MARKS	Genetic imprinting, found in flowering plants and placental mammals, uses DNA methylation to yield gene expression that is dependent on the parent of origin(1). DNA methyltransferase 3a (Dnmt3a) and its regulatory factor, DNA methyltransferase 3-like protein (Dnmt3L), are both required for the de novo DNA methylation of imprinted genes in mammalian germ cells. Dnmt3L interacts specifically with unmethylated lysine 4 of histone H3 through its amino-terminal PHD (plant homeodomain)-like domain(2). Here we show, with the use of crystallography, that the carboxy-terminal domain of human Dnmt3L interacts with the catalytic domain of Dnmt3a, demonstrating that Dnmt3L has dual functions of binding the unmethylated histone tail and activating DNA methyltransferase. The complexed C-terminal domains of Dnmt3a and Dnmt3L showed further dimerization through Dnmt3a-Dnmt3a interaction, forming a tetrameric complex with two active sites. Substitution of key non-catalytic residues at the Dnmt3a-Dnmt3L interface or the Dnmt3a-Dnmt3a interface eliminated enzymatic activity. Molecular modelling of a DNA Dnmt3a dimer indicated that the two active sites are separated by about one DNA helical turn. The C-terminal domain of Dnmt3a oligomerizes on DNA to form a nucleoprotein filament. A periodicity in the activity of Dnmt3a on long DNA revealed a correlation of methylated CpG sites at distances of eight to ten base pairs, indicating that oligomerization leads Dnmt3a to methylate DNA in a periodic pattern. A similar periodicity is observed for the frequency of CpG sites in the differentially methylated regions of 12 maternally imprinted mouse genes. These results suggest a basis for the recognition and methylation of differentially methylated regions in imprinted genes, involving the detection of both nucleosome modification and CpG spacing.	Jacobs Univ Bremen, Sch Sci & Engn, Biochem Lab, D-28759 Bremen, Germany; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Jacobs University; Emory University	Jeltsch, A (corresponding author), Jacobs Univ Bremen, Sch Sci & Engn, Biochem Lab, D-28759 Bremen, Germany.	a.jeltsch@jacobs-university.de; xcheng@emory.edu	Jurkowska, Renata/AAE-2504-2020; Hu, Ruogu/B-2203-2008; Jeltsch, Albert/O-7404-2014	Jurkowska, Renata/0000-0002-4507-2222; Jeltsch, Albert/0000-0001-6113-9290; Jia, Da/0000-0002-2205-1998	NIGMS NIH HHS [R01 GM049245-14, R01 GM049245] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049245] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Delaval K, 2007, EMBO J, V26, P720, DOI 10.1038/sj.emboj.7601513; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Flaus A, 1998, J MOL BIOL, V275, P427, DOI 10.1006/jmbi.1997.1464; Fournier C, 2002, EMBO J, V21, P6560, DOI 10.1093/emboj/cdf655; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gowher H, 2006, J MOL BIOL, V357, P928, DOI 10.1016/j.jmb.2006.01.035; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Gowher H, 2002, J BIOL CHEM, V277, P20409, DOI 10.1074/jbc.M202148200; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Kobayashi H, 2006, CYTOGENET GENOME RES, V113, P130, DOI 10.1159/000090824; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Vu TH, 2004, HUM MOL GENET, V13, P2233, DOI 10.1093/hmg/ddh244; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Yamasaki Y, 2005, HUM MOL GENET, V14, P2511, DOI 10.1093/hmg/ddi255	30	567	594	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2007	449	7159					248	U13		10.1038/nature06146	http://dx.doi.org/10.1038/nature06146			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209NF	17713477	Green Accepted			2022-12-01	WOS:000249394500056
J	Mortier-Barriere, I; Velten, M; Dupaigne, P; Mirouze, N; Pietrement, O; McGovern, S; Fichant, G; Martin, B; Noirot, P; Le Cam, E; Polard, P; Claverys, JP				Mortier-Barriere, Isabelle; Velten, Marion; Dupaigne, Pauline; Mirouze, Nicolas; Pietrement, Olivier; McGovern, Stephen; Fichant, Gwennaele; Martin, Bernard; Noirot, Philippe; Le Cam, Eric; Polard, Patrice; Claverys, Jean-Pierre			A key presynaptic role in transformation for a widespread bacterial protein: DprA conveys incoming ssDNA to RecA	CELL			English	Article							SINGLE-STRANDED-DNA; GRAM-POSITIVE BACTERIA; STREPTOCOCCUS-PNEUMONIAE; BACILLUS-SUBTILIS; ECLIPSE COMPLEX; DEOXYRIBONUCLEIC-ACID; GENETIC-RECOMBINATION; SSB PROTEIN; COMPETENCE; PNEUMOCOCCUS	Natural transformation is a mechanism for genetic exchange in many bacterial genera. It proceeds through the uptake of exogenous DNA and subsequent homology-dependent integration into the genome. In Streptococcus pneumoniae, this integration requires the ubiquitous recombinase, RecA, and DprA, a protein of unknown function widely conserved in bacteria. To unravel the role of DprA, we have studied the properties of the purified S. pneumoniae protein and its Bacillus subtilis ortholog (Smf). We report that DprA and Smf bind cooperatively to single-stranded DNA (ssDNA) and that these proteins both self-interact and interact with RecA. We demonstrate that DprA-RecA-ssDNA filaments are produced and that these filaments catalyze the homology-dependent formation of joint molecules. Finally, we show that while the Escherichia coli ssDNA-binding protein SSB limits access of RecA to ssDNA, DprA lowers this barrier. We propose that DprA is a new member of the recombination-mediator protein family, dedicated to natural bacterial transformation.	INRA, Lab Genet Microbienne, F-31062 Jouy En Josas, France; Univ Toulouse 3, CNRS, UMR 5100, Lab Microbiol & Genet Mol, F-31062 Toulouse 09, France; Inst Cancer Gustave Roussy, CNRS, UMR8126, Lab Microscopie Mol & Cellulaire, F-94805 Villejuif, France; Univ Paris Sud, F-94805 Villejuif, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Polard, P (corresponding author), INRA, Lab Genet Microbienne, F-31062 Jouy En Josas, France.	patrice.polard@ibcg.biotoul.fr; claverys@ibcg.biotoul.fr	Mirouze, Nicolas/F-3086-2017; Dupaigne, Pauline/C-6873-2019; PIETREMENT, Olivier/T-2555-2017	Mirouze, Nicolas/0000-0002-1038-0495; Dupaigne, Pauline/0000-0001-7033-4055; PIETREMENT, Olivier/0000-0002-0018-7202; Fichant, Gwennaele/0000-0001-5480-0239; Le cam, Eric/0000-0002-6832-6117				ALONSO JC, 1993, MOL GEN GENET, V239, P129, DOI 10.1007/BF00281611; Ando T, 1999, J BACTERIOL, V181, P5572, DOI 10.1128/JB.181.18.5572-5580.1999; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; Beloin C, 2003, J BIOL CHEM, V278, P5333, DOI 10.1074/jbc.M207489200; Berge M, 2003, MOL MICROBIOL, V50, P527, DOI 10.1046/j.1365-2958.2003.03702.x; Berge M, 2002, MOL MICROBIOL, V45, P411, DOI 10.1046/j.1365-2958.2002.03013.x; Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Claverys JP, 2003, TRENDS MICROBIOL, V11, P161, DOI 10.1016/S0966-842X(03)00064-7; Dagkessamanskaia A, 2004, MOL MICROBIOL, V51, P1071, DOI 10.1111/j.1365-2958.2003.03892.x; Desai BV, 2007, MOL MICROBIOL, V63, P1107, DOI 10.1111/j.1365-2958.2006.05558.x; Desai BV, 2006, J BACTERIOL, V188, P5177, DOI 10.1128/JB.00103-06; EPHRUSSITAYLOR H, 1960, SOC BIOL FILL, V154, P1951; FOX MS, 1960, NATURE, V187, P1002, DOI 10.1038/1871002a0; GHEI OK, 1967, J BACTERIOL, V93, P816, DOI 10.1128/JB.93.3.816-829.1967; GROVE DE, 2005, J BIOL CEHM, V280, P11607; Guiral S, 2006, MICROBIOL-SGM, V152, P323, DOI 10.1099/mic.0.28425-0; Hahn J, 2005, CELL, V122, P59, DOI 10.1016/j.cell.2005.04.035; Hamon L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm147; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; KARUDAPURAM S, 1995, J BACTERIOL, V177, P3235, DOI 10.1128/jb.177.11.3235-3240.1995; Kidane D, 2005, CELL, V122, P73, DOI 10.1016/j.cell.2005.04.036; Koonin EV, 1997, MOL MICROBIOL, V25, P619, DOI 10.1046/j.1365-2958.1997.4821861.x; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; LUISIDELUCA C, 1994, J MOL BIOL, V236, P124, DOI 10.1006/jmbi.1994.1123; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MARTIN B, 1995, MOL MICROBIOL, V15, P367, DOI 10.1111/j.1365-2958.1995.tb02250.x; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; MEJEAN V, 1988, MOL GEN GENET, V213, P444, DOI 10.1007/BF00339614; MIAO R, 1970, J BACTERIOL, V101, P361, DOI 10.1128/JB.101.2.361-364.1970; MORRISON DA, 1979, J BACTERIOL, V140, P655, DOI 10.1128/JB.140.2.655-665.1979; MORRISON DA, 1977, J BACTERIOL, V132, P576, DOI 10.1128/JB.132.2.576-583.1977; MORRISON DA, 1978, J BACTERIOL, V136, P548, DOI 10.1128/JB.136.2.548-557.1978; Morrison DA, 2007, J BACTERIOL, V189, P6497, DOI 10.1128/JB.00687-07; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogura M, 2002, J BACTERIOL, V184, P2344, DOI 10.1128/JB.184.9.2344-2351.2002; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; Simonson AB, 2005, P NATL ACAD SCI USA, V102, P6608, DOI 10.1073/pnas.0501996102; SMITH JM, 1991, NATURE, V349, P29, DOI 10.1038/349029a0; Steffen SE, 2000, ARCH BIOCHEM BIOPHYS, V382, P303, DOI 10.1006/abbi.2000.2029; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; WEINRAUCH Y, 1983, J BACTERIOL, V154, P1077, DOI 10.1128/JB.154.3.1077-1087.1983	50	163	169	2	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2007	130	5					824	836		10.1016/j.cell.2007.07.038	http://dx.doi.org/10.1016/j.cell.2007.07.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	212GI	17803906	Bronze			2022-12-01	WOS:000249581500015
J	Wapinski, I; Pfeffer, A; Friedman, N; Regev, A				Wapinski, Ilan; Pfeffer, Avi; Friedman, Nir; Regev, Aviv			Natural history and evolutionary principles of gene duplication in fungi	NATURE			English	Article							PHYLOGENETIC TREES; GENOME SEQUENCE; EXPRESSION; DATABASE; MECHANISMS; ORTHOLOGS; ACCURACY; HOMOLOGY; PARALOGS; REVEALS	Gene duplication and loss is a powerful source of functional innovation. However, the general principles that govern this process are still largely unknown. With the growing number of sequenced genomes, it is now possible to examine these events in a comprehensive and unbiased manner. Here, we develop a procedure that resolves the evolutionary history of all genes in a large group of species. We apply our procedure to seventeen fungal genomes to create a genome-wide catalogue of gene trees that determine precise orthology and paralogy relations across these species. We show that gene duplication and loss is highly constrained by the functional properties and interacting partners of genes. In particular, stress-related genes exhibit many duplications and losses, whereas growth-related genes show selection against such changes. Whole- genome duplication circumvents this constraint and relaxes the dichotomy, resulting in an expanded functional scope of gene duplication. By characterizing the functional fate of duplicate genes we show that duplicated genes rarely diverge with respect to biochemical function, but typically diverge with respect to regulatory control. Surprisingly, paralogous modules of genes rarely arise, even after whole-genome duplication. Rather, gene duplication may drive the modularization of functional networks through specialization, thereby disentangling cellular systems.	MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; Harvard Univ, FAS, Ctr Syst Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; Hebrew Univ Jerusalem, Dept Comp Sci & Engn, IL-91904 Jerusalem, Israel; MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard University; Hebrew University of Jerusalem; Massachusetts Institute of Technology (MIT)	Regev, A (corresponding author), MIT, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	aregev@broad.mit.edu	Friedman, Nir/H-9692-2012	Friedman, Nir/0000-0002-9678-3550				ARNAUD MBC, 2006, CANDIDA GENOME DATAB; Arvestad L, 2003, BIOINFORMATICS, V19, pi7, DOI 10.1093/bioinformatics/btg1000; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Davis JC, 2005, TRENDS GENET, V21, P548, DOI 10.1016/j.tig.2005.07.008; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Dufayard JF, 2005, BIOINFORMATICS, V21, P2596, DOI 10.1093/bioinformatics/bti325; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; EDDY S, 2003, HMMER HIDDEN MARKOV; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feisenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Force A, 2005, GENETICS, V170, P433, DOI 10.1534/genetics.104.027607; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gu ZL, 2004, NAT GENET, V36, P577, DOI 10.1038/ng1355; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; HONG EL, 2005, SACCHAROMYCES GENOME; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jothi R, 2006, BIOINFORMATICS, V22, P779, DOI 10.1093/bioinformatics/btl009; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Kellis M, 2004, J COMPUT BIOL, V11, P319, DOI 10.1089/1066527041410319; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kuramae EE, 2006, GENOMICS, V88, P387, DOI 10.1016/j.ygeno.2006.07.001; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Makova KD, 2003, GENOME RES, V13, P1638, DOI 10.1101/gr.1133803; Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148; *MIT BROAD I HARV, 2003, FUS GRAM SEQ PROJ; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ninio M, 2007, BIOINFORMATICS, V23, pE136, DOI 10.1093/bioinformatics/btl304; Ohno S., 1970, EVOLUTION GENE DUPLI, DOI [DOI 10.1007/978-3-642-86659-3, 10.1007/978-3-642-86659-3_11]; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Tzung KW, 2001, P NATL ACAD SCI USA, V98, P3249, DOI 10.1073/pnas.061628798; WAPINSKI I, 2007, BIOINFORMATICS, DOI DOI 10.1093/BIOINFORMATICS/BMT103; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	62	484	494	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2007	449	7158					54	U36		10.1038/nature06107	http://dx.doi.org/10.1038/nature06107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207ED	17805289				2022-12-01	WOS:000249233500034
J	Iwai, H; Kim, M; Yoshikawa, Y; Ashida, H; Ogawa, M; Fujita, Y; Muller, D; Kirikae, T; Jackson, PK; Kotani, S; Sasakawa, C				Iwai, Hiroki; Kim, Minsoo; Yoshikawa, Yuko; Ashida, Hiroshi; Ogawa, Michinaga; Fujita, Yukihiro; Muller, Daniel; Kirikae, Teruo; Jackson, Peter K.; Kotani, Shuji; Sasakawa, Chihiro			A bacterial effector targets Mad2L2, an APC inhibitor, to modulate host cell cycling	CELL			English	Article							ANAPHASE-PROMOTING COMPLEX; CYTOLETHAL DISTENDING TOXIN; SPINDLE CHECKPOINT; MITOTIC REGULATOR; SHIGELLA; PROTEIN; DEGRADATION; MITOSIS; PROGRESSION; MECHANISM	The gut epithelium self-renews every several days, providing an important innate defense system that limits bacterial colonization. Nevertheless, many bacterial pathogens, including Shigella, efficiently colonize the intestinal epithelium. Here, we show that the Shigella effector IpaB, when delivered into epithelial cells, causes cell-cycle arrest by targeting Mad2L2, an anaphase-promoting complex/cyclosome ( APC) inhibitor. Cyclin B1 ubiquitination assays revealed that APC undergoes unscheduled activation due to IpaB interaction with the APC inhibitor Mad2L2. Synchronized HeLa cells infected with Shigella failed to accumulate Cyclin B1, Cdc20, and Plk1, causing cell-cycle arrest at the G2/M phase in an IpaB/Mad2L2-dependent manner. IpaB/Mad2L2-dependent cell-cycle arrest by Shigella infection was also demonstrated in rabbit intestinal crypt progenitors, and the IpaB-mediated arrest contributed to efficient colonization of the host cells. These results strongly indicate that Shigella employ special tactics to influence epithelial renewal in order to promote bacterial colonization of intestinal epithelium.	Univ Tokyo, Inst Med Sci, Minato Ku, Dept Microbiol & Immunol, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Dept Infect Dis Control, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Minato Ku, Tokyo 1088639, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Bunkyo Ku, Tokyo 1130034, Japan; Int Med Ctr Japan, Inst Res, Dept Infect Dis, Shinjuku Ku, Tokyo 1628655, Japan; Genentech Inc, San Francisco, CA 94080 USA; Japan Sci & Technol Agcy, CREST, Kawaguchi 3320012, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Tokyo Medical & Dental University (TMDU); National Center for Global Health & Medicine - Japan; Roche Holding; Genentech; Japan Science & Technology Agency (JST)	Sasakawa, C (corresponding author), Univ Tokyo, Inst Med Sci, Minato Ku, Dept Microbiol & Immunol, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sasakawa@ims.u-tokyo.ac.jp	Muller, Daniel/C-6827-2008	Muller, Daniel/0000-0002-6619-4691; Ashida, Hiroshi/0000-0003-1408-6864; Kim, Minsoo/0000-0001-8536-8653; Jackson, Peter/0000-0002-1742-2539				Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683; Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Chen J, 2001, GENE DEV, V15, P1765, DOI 10.1101/gad.898701; Chen YJ, 1996, EMBO J, V15, P3853, DOI 10.1002/j.1460-2075.1996.tb00759.x; Cheung HW, 2006, CANCER RES, V66, P4357, DOI 10.1158/0008-5472.CAN-05-3602; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Habu T, 2002, EMBO J, V21, P6419, DOI 10.1093/emboj/cdf659; Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lara-Tejero M, 2002, TRENDS MICROBIOL, V10, P147, DOI 10.1016/S0966-842X(02)02316-8; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Murakumo Y, 2006, GENES CELLS, V11, P193, DOI 10.1111/j.1365-2443.2006.00938.x; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Ogawa M, 2006, CELL MICROBIOL, V8, P177, DOI 10.1111/j.1462-5822.2005.00652.x; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Page AL, 2001, MOL MICROBIOL, V42, P1133, DOI 10.1046/j.1365-2958.2001.02715.x; Parsot C, 2005, FEMS MICROBIOL LETT, V252, P11, DOI 10.1016/j.femsle.2005.08.046; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2001, GENE DEV, V15, P1759, DOI 10.1101/gad.897901; Philpott DJ, 2000, J IMMUNOL, V165, P903, DOI 10.4049/jimmunol.165.2.903; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Shim DH, 2007, J IMMUNOL, V178, P2476, DOI 10.4049/jimmunol.178.4.2476; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Whitehouse CA, 1998, INFECT IMMUN, V66, P1934, DOI 10.1128/IAI.66.5.1934-1940.1998; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; ZYCHLINSKY A, 1992, NATURE, V358, P167, DOI 10.1038/358167a0	47	115	119	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 24	2007	130	4					611	623		10.1016/j.cell.2007.06.043	http://dx.doi.org/10.1016/j.cell.2007.06.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	208KY	17719540	Bronze			2022-12-01	WOS:000249319400013
J	Klassen, MP; Shen, K				Klassen, Matthew P.; Shen, Kang			Wnt signaling positions neuromuscular connectivity by inhibiting synapse formation in C-elegans	CELL			English	Article							ASYMMETRIC CELL DIVISIONS; VENTRAL NERVE CORD; CAENORHABDITIS-ELEGANS; POSTSYNAPTIC DIFFERENTIATION; AXON GUIDANCE; II RECEPTOR; DROSOPHILA; PROTEIN; POLARITY; MOLECULES	Nervous system function is mediated by a precisely patterned network of synaptic connections. While several cell-adhesion and secreted molecules promote the assembly of synapses, the contribution of signals that negatively regulate synaptogenesis is not well understood. We examined synapse formation in the Caenorhabditis elegans motor neuron DA9, whose presynapses are restricted to a specific segment of its axon. We report that the Wnt lin-44 localizes the Wnt receptor lin-17/Frizzled ( Fz) to a subdomain of the DA9 axon that is devoid of presynaptic specializations. When this signaling pathway, composed of the Wnts lin-44 and egl-20, lin-17/Frizzled and dsh-1/Dishevelled, is compromised, synapses develop ectopically in this subdomain. Conversely, overexpression of LIN-44 in cells adjacent to DA9 is sufficient to expand LIN-17 localization within the DA9 axon, thereby inhibiting presynaptic assembly. These results suggest that morphogenetic signals can spatially regulate the patterning of synaptic connections by subdividing an axon into discrete domains.	Stanford Univ, Dept Biol Sci & Neurosci Program, Stanford, CA 94305 USA	Stanford University	Shen, K (corresponding author), Stanford Univ, Dept Biol Sci & Neurosci Program, Stanford, CA 94305 USA.	kangshen@stanford.edu						Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Akins MR, 2006, CURR OPIN NEUROBIOL, V16, P83, DOI 10.1016/j.conb.2006.01.009; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HALL DH, 1991, J NEUROSCI, V11, P1; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Inoue T, 2004, CELL, V118, P795, DOI 10.1016/j.cell.2004.09.001; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Liu XB, 2005, J NEUROSCI, V25, P9124, DOI 10.1523/JNEUROSCI.2648-05.2005; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170; Maloof JN, 1999, DEVELOPMENT, V126, P37; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Montcouquiol M, 2006, ANNU REV NEUROSCI, V29, P363, DOI 10.1146/annurev.neuro.29.051605.112933; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pan CL, 2006, DEV CELL, V10, P367, DOI 10.1016/j.devcel.2006.02.010; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Sawa H, 1996, GENE DEV, V10, P2189, DOI 10.1101/gad.10.17.2189; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yeh E, 2005, J NEUROSCI, V25, P3833, DOI 10.1523/JNEUROSCI.4978-04.2005; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	53	161	181	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 24	2007	130	4					704	716		10.1016/j.cell.2007.06.046	http://dx.doi.org/10.1016/j.cell.2007.06.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	208KY	17719547	Bronze			2022-12-01	WOS:000249319400020
J	Russell, AF; Langmore, NE; Cockburn, A; Astheimer, LB; Kilner, RM				Russell, A. F.; Langmore, N. E.; Cockburn, A.; Astheimer, L. B.; Kilner, R. M.			Reduced egg investment can conceal helper effects in cooperatively breeding birds	SCIENCE			English	Article							EVOLUTION; VERTEBRATES; SELECTION; INCREASE; BEHAVIOR; SIZE; CARE; NEST	Cooperative breeding systems are characterized by nonbreeding helpers that assist breeders in offspring care. However, the benefits to offspring of being fed by parents and helpers in cooperatively breeding birds can be difficult to detect. We offer experimental evidence that helper effects can be obscured by an undocumented maternal tactic. In superb fairy-wrens (Malurus cyaneus), mothers breeding in the presence of helpers lay smaller eggs of lower nutritional content that produce lighter chicks, as compared with those laying eggs in the absence of helpers. Helpers compensate fully for such reductions in investment and allow mothers to benefit through increased survival to the next breeding season. We suggest that failure to consider maternal egg-investment strategies can lead to underestimation of the force of selection acting on helping in avian cooperative breeders.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Macquarie Univ, Ctr Integrat Study Anim Behav, N Ryde, NSW 2109, Australia; Australian Natl Univ, Sch Bot & Zool, Canberra, ACT 0200, Australia; Univ Cape Town, Percy Fitzpatrick Inst African Ornithol, Dept Sci & Technol, Natl Res Fdn Ctr Excellence, ZA-7701 Rondebosch, South Africa; Univ Wollongong, Sch Hlth Sci, Wollongong, NSW 2522, Australia; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Sheffield; Macquarie University; Australian National University; National Research Foundation - South Africa; University of Cape Town; University of Wollongong; University of Cambridge	Russell, AF (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	a.f.russell@sheffield.ac.uk	Kilner, Rebecca/B-2867-2012; Langmore, Naomi E/C-9302-2009	Kilner, Rebecca/0000-0003-1159-0758; 				BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock TH, 2006, NATURE, V444, P1065, DOI 10.1038/nature05386; Cockburn A, 1998, ANNU REV ECOL SYST, V29, P141, DOI 10.1146/annurev.ecolsys.29.1.141; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; Dunn PO, 1996, EVOLUTION, V50, P2542, DOI 10.1111/j.1558-5646.1996.tb03643.x; DUNN PO, 1995, P ROY SOC B-BIOL SCI, V259, P339, DOI 10.1098/rspb.1995.0050; GASTON AJ, 1978, AM NAT, V112, P1091, DOI 10.1086/283348; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hatchwell BJ, 1999, AM NAT, V154, P205, DOI 10.1086/303227; Hatchwell BJ, 2004, BEHAV ECOL, V15, P1, DOI 10.1093/beheco/arg091; JAMIESON IG, 1989, AM NAT, V133, P394, DOI 10.1086/284925; Kokko H, 2002, BEHAV ECOL, V13, P291, DOI 10.1093/beheco/13.3.291; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; LIGON JD, 1978, NATURE, V276, P496, DOI 10.1038/276496a0; MacGregor NA, 2002, ANIM BEHAV, V63, P923, DOI 10.1006/anbe.2001.1991; Russell AF, 2007, P R SOC B, V274, P513, DOI 10.1098/rspb.2006.3698; Russell AF, 2001, P ROY SOC B-BIOL SCI, V268, P2169, DOI 10.1098/rspb.2001.1790; Russell AF, 2003, P NATL ACAD SCI USA, V100, P3333, DOI 10.1073/pnas.0636503100; Stacey P.B., 1990, COOPERATIVE BREEDING; WILLIAMS TD, 1994, BIOL REV, V69, P35, DOI 10.1111/j.1469-185X.1994.tb01485.x; Wright J, 1998, J AVIAN BIOL, V29, P105, DOI 10.2307/3677187	23	158	160	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 17	2007	317	5840					941	944		10.1126/science.1146037	http://dx.doi.org/10.1126/science.1146037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200RJ	17702942				2022-12-01	WOS:000248780200038
J	Honer, OP; Wachter, B; East, ML; Streich, WJ; Wilhelm, K; Burke, T; Hofer, H				Hoener, O. P.; Wachter, B.; East, M. L.; Streich, W. J.; Wilhelm, K.; Burke, T.; Hofer, H.			Female mate-choice drives the evolution of male-biased dispersal in a social mammal	NATURE			English	Article							INBREEDING AVOIDANCE; SPOTTED HYENAS; TACTICS; SOCIETY; BIRDS	Dispersal has a significant impact on lifetime reproductive success(1), and is often more prevalent in one sex than the other(2). In group- living mammals, dispersal is normally male- biased and in theory this sexual bias could be a response by males to female mate preferences, competition for access to females or resources, or the result of males avoiding inbreeding(2-7). There is a lack of studies on social mammals that simultaneously assess these factors and measure the fitness consequences of male dispersal decisions. Here we show that male- biased dispersal in the spotted hyaena ( Crocuta crocuta) most probably results from an adaptive response by males to simple female mate- choice rules that have evolved to avoid inbreeding. Microsatellite profiling revealed that females preferred sires that were born into or immigrated into the female's group after the female was born. Furthermore, young females preferred short- tenured sires and older females preferred longer- tenured sires. Males responded to these female mate preferences by initiating their reproductive careers in groups containing the highest number of young females. As a consequence, 11% of males started their reproductive career in their natal group and 89% of males dispersed. Males that started reproduction in groups containing the highest number of young females had a higher long- term reproductive success than males that did not. The female mate- choice rules ensured that females effectively avoided inbreeding without the need to discriminate directly against close kin or males born in their own group, or to favour immigrant males. The extent of male dispersal as a response to such female mate preferences depends on the demographic structure of breeding groups, rather than the genetic relatedness between females and males.	Leibniz Inst Zoo & Wildlife Res, D-10315 Berlin, Germany; Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Leibniz Institut fur Zoo und Wildtierforschung; University of Sheffield	Honer, OP (corresponding author), Leibniz Inst Zoo & Wildlife Res, Alfred Kowalke Str 17, D-10315 Berlin, Germany.	hoener@izw-berlin.de	Burke, Terry/B-3196-2011; Hofer, Heribert/AAF-7854-2021; Höner, Oliver P./N-3224-2014; Wachter, Bettina/AAJ-9663-2020	Burke, Terry/0000-0003-3848-1244; Hofer, Heribert/0000-0002-2813-7442; Höner, Oliver P./0000-0002-0658-3417; Wachter, Bettina/0000-0002-0414-2298				ALBERT R, 2002, THESIS FREIE U BERLI; ALBERTS SC, 1995, AM NAT, V145, P279, DOI 10.1086/285740; Blum M.S., 1979, SEXUAL SELECTION REP, P123, DOI DOI 10.1016/B978-0-12-108750-0.50010-0; COCKBURN A, 1985, ANIM BEHAV, V33, P908, DOI 10.1016/S0003-3472(85)80025-7; DOBSON FS, 1982, ANIM BEHAV, V30, P1183; EAST ML, 1991, ANIM BEHAV, V42, P651, DOI 10.1016/S0003-3472(05)80247-7; EAST ML, 1993, BEHAV ECOL SOCIOBIOL, V33, P355; East ML, 2003, P ROY SOC B-BIOL SCI, V270, P1247, DOI 10.1098/rspb.2003.2363; East ML, 2001, BEHAV ECOL, V12, P558, DOI 10.1093/beheco/12.5.558; Engh AL, 2002, BEHAV ECOL, V13, P193, DOI 10.1093/beheco/13.2.193; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Hofer H., 1995, SERENGETI, P332, DOI DOI 10.1186/1471-2148-9-253; Honer OP, 2005, OIKOS, V108, P544, DOI 10.1111/j.0030-1299.2005.13533.x; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.es.21.110190.002313; KEANE B, 1990, ANIM BEHAV, V40, P143, DOI 10.1016/S0003-3472(05)80674-8; Kokko H, 1998, AM NAT, V152, P354, DOI 10.1086/286174; Kruuk H., 1972, SPOTTED HYENA STUDY; Lehmann L, 2003, AM NAT, V162, P638, DOI 10.1086/378823; Manly B.F.J., 1993, RESOURCE SELECTION A, V20, P577, DOI 10.2307/2845733; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MATTHEWS L. HARRISON, 1939, PHIL TRANS ROY SOC LONDON SER B BIOL SCI, V230, P1; McFadden D., 1973, CONDITIONAL LOGIT AN, DOI DOI 10.1108/EB028592; MOORE J, 1984, ANIM BEHAV, V32, P94, DOI 10.1016/S0003-3472(84)80328-0; Parker G.A., 1983, P141; Pusey A., 1986, PRIMATE SOC, P250; Sherman Paul W., 1997, P69; Smale L, 1997, ADV STUD BEHAV, V26, P181, DOI 10.1016/S0065-3454(08)60380-0; SMITH RH, 1979, HEREDITY, V43, P205, DOI 10.1038/hdy.1979.75; Trivers R.L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Wilhelm K, 2003, MOL ECOL NOTES, V3, P360, DOI 10.1046/j.1471-8286.2003.00450.x	30	79	79	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					798	U5		10.1038/nature06040	http://dx.doi.org/10.1038/nature06040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17700698				2022-12-01	WOS:000248754200038
J	Santamaria, D; Barriere, C; Cerqueira, A; Hunt, S; Tardy, C; Newton, K; Caceres, JF; Dubus, P; Malumbres, M; Barbacid, M				Santamaria, David; Barriere, Cedric; Cerqueira, Antonio; Hunt, Sarah; Tardy, Claudine; Newton, Kathryn; Caceres, Javier F.; Dubus, Pierre; Malumbres, Marcos; Barbacid, Mariano			Cdk1 is sufficient to drive the mammalian cell cycle	NATURE			English	Article							EMBRYONIC LETHALITY; DEPENDENT KINASES; GENE; MICE; DISRUPTION; P27(KIP1); MOUSE	Unicellular organisms such as yeasts require a single cyclin-dependent kinase, Cdk1, to drive cell division(1). In contrast, mammalian cells are thought to require the sequential activation of at least four different cyclin- dependent kinases, Cdk2, Cdk3, Cdk4 and Cdk6, to drive cells through interphase, as well as Cdk1 to proceed through mitosis(2). This model has been challenged by recent genetic evidence that mice survive in the absence of individual interphase Cdks(3-8). Moreover, most mouse cell types proliferate in the absence of two or even three interphase Cdks(8-10). Similar results have been obtained on ablation of some of the activating subunits of Cdks, such as the D- type and E- type cyclins(11-14). Here we show that mouse embryos lacking all interphase Cdks ( Cdk2, Cdk3, Cdk4 and Cdk6) undergo organogenesis and develop to midgestation. In these embryos, Cdk1 binds to all cyclins, resulting in the phosphorylation of the retinoblastoma protein pRb and the expression of genes that are regulated by E2F transcription factors. Mouse embryonic fibroblasts derived from these embryos proliferate in vitro, albeit with an extended cell cycle due to inefficient inactivation of Rb proteins. However, they become immortal on continuous passage. We also report that embryos fail to develop to the morula and blastocyst stages in the absence of Cdk1. These results indicate that Cdk1 is the only essential cell cycle Cdk. Moreover, they show that in the absence of interphase Cdks, Cdk1 can execute all the events that are required to drive cell division.	Ctr Nacl Invest Oncol CNIO, Mol Oncol Programme, E-28029 Madrid, Spain; Univ Bordeaux 2, EA2406, F-33076 Bordeaux, France; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	UDICE-French Research Universities; Universite de Bordeaux; University of Edinburgh	Barbacid, M (corresponding author), Ctr Nacl Invest Oncol CNIO, Mol Oncol Programme, E-28029 Madrid, Spain.	mbarbacid@cnio.es	Malumbres, Marcos/E-8834-2011; Tardy, Claudine/AAE-5026-2019; Tardy, Claudine/G-2737-2017; Caceres, Javier F/D-5260-2013; Santamaria, David/D-3930-2011	Malumbres, Marcos/0000-0002-0829-6315; Tardy, Claudine/0000-0002-5292-0672; Caceres, Javier F/0000-0001-8025-6169; Santamaria, David/0000-0002-4711-3569; Dubus, Pierre/0000-0003-1803-4711	MRC [MC_U127584479] Funding Source: UKRI; Medical Research Council [MC_U127584479] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Barriere C, 2007, MOL ONCOL, V1, P72, DOI 10.1016/j.molonc.2007.03.001; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Berthet C, 2006, DEV CELL, V10, P563, DOI 10.1016/j.devcel.2006.03.004; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Brandeis M, 1998, P NATL ACAD SCI USA, V95, P4344, DOI 10.1073/pnas.95.8.4344; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Geng Y, 2007, MOL CELL, V25, P127, DOI 10.1016/j.molcel.2006.11.029; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Martin A, 2005, CANCER CELL, V7, P591, DOI 10.1016/j.ccr.2005.05.006; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Parisi T, 2003, EMBO J, V22, P4794, DOI 10.1093/emboj/cdg482; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; ROBLES MTS, 1994, MOL CELL BIOL, V14, P2686, DOI 10.1128/MCB.14.4.2686; Schnutgen F, 2005, P NATL ACAD SCI USA, V102, P7221, DOI 10.1073/pnas.0502273102; Sutherland HGE, 2001, HUM MOL GENET, V10, P1995, DOI 10.1093/hmg/10.18.1995; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; Ye X, 2001, P NATL ACAD SCI USA, V98, P1682, DOI 10.1073/pnas.041596198; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738	24	704	725	3	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 16	2007	448	7155					811	U8		10.1038/nature06046	http://dx.doi.org/10.1038/nature06046			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200HJ	17700700				2022-12-01	WOS:000248754200041
J	Donsante, A; Miller, DG; Li, Y; Vogler, C; Brunt, EM; Russell, DW; Sands, MS				Donsante, Anthony; Miller, Daniel G.; Li, Yi; Vogler, Carole; Brunt, Elizabeth M.; Russell, David W.; Sands, Mark S.			AAV vector integration sites in mouse hepatocellular carcinoma	SCIENCE			English	Article							LIVER; CELLS; TUMOR		Univ Washington, Dept Med, Seattle, WA 98112 USA; Univ Washington, Dept Biochem, Seattle, WA 98112 USA; St Louis Univ, Sch Med, Dept Pediat, St Louis, MO 63104 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Univ Washington, Dept Pediat, Seattle, WA 98112 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Saint Louis University; Washington University (WUSTL); Washington University (WUSTL); University of Washington; University of Washington Seattle	Russell, DW (corresponding author), Univ Washington, Dept Med, Mail Stop 357720, Seattle, WA 98112 USA.	drussell@u.washington.edu; msands@im.wustl.edu		Sands, Mark/0000-0002-5559-0832; Miller, Daniel/0000-0002-5700-3048; Donsante, Anthony/0000-0002-7591-7417	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071657] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Astuti D, 2005, BRIT J CANCER, V92, P1574, DOI 10.1038/sj.bjc.6602478; Bell P, 2006, MOL THER, V14, P34, DOI 10.1016/j.ymthe.2006.03.008; Donsante A, 2001, GENE THER, V8, P1343, DOI 10.1038/sj.gt.3301541; Embury JE, 2006, MOL THER, V13, pS83, DOI 10.1016/j.ymthe.2006.08.241; EPSTEIN CJ, 1967, NATURE, V214, P1050, DOI 10.1038/2141050a0; Kawakami T, 2006, HUM MOL GENET, V15, P821, DOI 10.1093/hmg/ddl001; Miller DG, 2005, J VIROL, V79, P11434, DOI 10.1128/JVI.79.17.11434-11442.2005; Nakai H, 2005, J VIROL, V79, P3606, DOI 10.1128/JVI.79.6.3606-3614.2005	8	441	467	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 27	2007	317	5837					477	477		10.1126/science.1142658	http://dx.doi.org/10.1126/science.1142658			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	194JD	17656716				2022-12-01	WOS:000248339800034
J	Woywodt, A; Matteson, E; Whitworth, JA				Woywodt, Alexander; Matteson, Eric; Whitworth, Judith A.			Should eponyms be abandoned?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Lancashire Teaching Hosp NHS Trust, Renal Unit, Preston PR2 9HT, Lancs, England; Mayo Clin, Coll Med, Rochester, MN USA; Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 0200, Australia	Mayo Clinic; Australian National University; John Curtin School of Medical Research	Woywodt, A (corresponding author), Lancashire Teaching Hosp NHS Trust, Renal Unit, Preston PR2 9HT, Lancs, England.	Mail@Alexander-Woywodt.com; director@jcsmr.anu.edu.au	Woywodt, Alexander/ABD-2711-2020	Woywodt, Alexander/0000-0002-3825-6955					0	118	126	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2007	335	7617					424	425		10.1136/bmj.39308.342639.AD	http://dx.doi.org/10.1136/bmj.39308.342639.AD			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	208VF	17762034	Green Published			2022-12-01	WOS:000249346600029
